PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Pachalska, M; Moskala, M; MacQueen, BD; Polak, J; Wilk-Franczuk, M				Pachalska, Maria; Moskala, Marek; MacQueen, Bruce Duncan; Polak, Jaroslaw; Wilk-Franczuk, Magdalena			Early neurorehabilitation in a patient with severe traumatic brain injury to the frontal lobes	MEDICAL SCIENCE MONITOR			English	Article						neurostimulation; frontal syndrome; executive dysfunction; Community-Based Rehabilitation	BEHAVIORAL INVENTORY; REHABILITATION; DEMENTIA; MEMORY; CORTEX	Background: It seems to be generally believed that early neurostimulation after severe TBI is useless or even harmful, and neuropsychological intervention should not be initiated until the patient is medically stable. On the other hand, the unstimulated brain can incur irreversible damage. The purpose of the present study is to assess the impact of early neuropsychological rehabilitation on a patient with an extremely severe TBI. Case Report: The patient, a 32-year old male, suffered a massive cranio-facial injury with significant loss of tissue in the right frontal lobes after being struck by a tram. Beginning two weeks after injury, after pharmacological coma, he was attended on a daily basis by a neuropsychologist and a neurolinguist, with the active assistance of his family, when he was still in critical condition and essentially without logical contact. By the time he returned to Scotland 4 weeks later, he was sitting up, writing complete, sensible and grammatical sentences, and making rapid progress every day despite the development of hydrocephalus. Over the course of neurorehabilitation, most of MY's cognitive dysfunctions resolved. Six months later, however, hydrocephalus was increasing and the patient was showing severe frontal syndrome. A personalized version of Community Based Rehabilitation was applied. After two weeks of intensive treatment considerable improvement was achieved and frontal syndrome was reduced. Conclusions: The present case suggests that the prevailing views regarding the inadvisability of early neurorehabilitation in the acute phase after TBI should be reconsidered.	[Pachalska, Maria] Univ Gdansk, Inst Psychol, PL-80952 Gdansk, Poland; [Pachalska, Maria; Wilk-Franczuk, Magdalena] Andrzej Frycz Modrzewski Cracow Univ, Krakow, Poland; [Moskala, Marek; Polak, Jaroslaw] Jagiellonian Univ, Colegium Med, Neurosurg & Neurotraumatol Clin, Krakow, Poland; [MacQueen, Bruce Duncan] Univ Gdansk, Inst English, PL-80952 Gdansk, Poland		Pachalska, M (corresponding author), Univ Gdansk, Inst Psychol, Bazynskiego 4 Str, PL-80952 Gdansk, Poland.						Blair M, 2007, DEMENT GERIATR COGN, V23, P406, DOI 10.1159/000101908; Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown J., 2005, PROCESS AUTHENTIC LI; Brown J.W., 2000, MIND NATURE ESSAYS T; Brown J.W, 2002, SELF EMBODYING MIND SELF EMBODYING MIND; BROWN WJ, 2010, NEUROPSYCHOLOGICAL F; CHESTERTON GK, 1910, WHATS WRONG WORLD; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Freud S, 2009, GEN INTRO PSYCHOANAL; Fuster, 2015, PREFRONTAL CORTEX; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCS67; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KACZMAREK BLJ, 1984, BRAIN LANG, V21, P52, DOI 10.1016/0093-934X(84)90035-X; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; LeDoux J.E., 1998, EMOTIONAL BRAIN MYST; MacQueen B.D., 2008, NEUROPSYCHOLOGY PHIL, P194; Malec JF, 2008, ACTA NEUROPSYCHOL, V6, P27; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Modirrousta M, 2008, NEUROPSYCHOLOGIA, V46, P2958, DOI 10.1016/j.neuropsychologia.2008.06.011; MOSKALA M, 2000, NEUROTRAUMATOLOGIA, V1, P28; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Pachalska M., 2004, PSYCHOGERIATRIA POLS, V1, P119; PACHALSKA M, 1980, KOMPLEKSOWY MODEL RE; PACHALSKA M, 1986, RIV CARE S, V1, P1; PACHALSKA M, 2002, PRAGMATICS NEW SERIE, V98, P481; Pachalska M., 1993, APHASIA TREATMENT WO, P145; Pachalska M., 2002, J NEUROPSYCHOANALYSI, V4, P109; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; PACHALSKA M, 2011, ENCY HIST PSYCHOL TH; PACHALSKA M, 1978, COMUNITY BASED REHAB; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Rigaux P., 2003, Annales de Readaptation et de Medecine Physique, V46, P219, DOI 10.1016/S0168-6054(03)00082-5; SANDISON R, 1998, GROUP ANAL, V31, P53; TULVING E, 1970, ANNU REV PSYCHOL, V21, P437, DOI 10.1146/annurev.ps.21.020170.002253; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; WADE N, 2006, NYTIMES         1218; White M., 2007, MAPS NARRATIVE PRACT, V1st	41	9	9	0	11	INT SCIENTIFIC LITERATURE, INC	ALBERTSON	1125 WILLIS AVE, ALBERTSON, NY 11507 USA	1234-1010			MED SCI MONITOR	Med. Sci. Monitor	DEC	2010	16	12					CS157	CS167					11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	708KW	WOS:000286361700019	21119585				2022-02-06	
J	Potvin, O; Hudon, C; Grenier, S; Preville, M				Potvin, Olivier; Hudon, Carol; Grenier, Sebastien; Preville, Michel			Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia	INTERNATIONAL PSYCHOGERIATRICS			English	Article						cognitive impairment; elders; fatigue; sleep disturbance; cognitive complaints; depression	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; SLEEP DISORDERS; FATIGUE; PREVALENCE; POPULATION; COMPLAINTS; PROGRESSION; DEFINITION; HEALTH	Background: Several neuropsychiatric symptoms observed in elders with cognitive impairment no dementia (CIND) can be part of a major depressive episode (MDE) or a "subthreshold" depressive episode. Certain neuropsychiatric symptoms of CIND are essential symptoms of MDE (e.g. dysphoria, anhedonia), while other are non-essential symptoms (NESD; e. g. fatigue, insomnia, cognitive complaint). Contrary to essential symptoms, NESD are not specific to MDE and are present in other disorders. It is unknown whether NESD are linked to CIND in absence of MDE or subthreshold MDE. The present study examined the association between NESD and probable CIND in elders without essential MDE symptoms. Methods: Participants were 2028 community-dwelling individuals aged 65-96 years who had not experienced dysphoria/anhedonia during the year preceding the interview. Semi-structured in-home interviews evaluated the following NESD: alteration of appetite, sleep disturbance, psychomotor alteration, fatigue/loss of energy, worthlessness/guilt, and cognitive complaints. Probable CIND cases were defined based on the Mini-mental State Examination cut-offs (15th percentile) stratified for age, education and sex. Results: Symptoms of fatigue/loss of energy (OR: 2.41, 95% CI: 1.42-4.09), sleep disturbance (OR: 3.04 CI: 1.69-5.46) and cognitive complaints (OR: 2.86 CI: 1.71-4.77) were significantly associated with CIND. These associations were not modified after adjustments for potential confounders (age, education level, sex, benzodiazepine use, chronic diseases, and brain disorders). Conclusion: A psychiatric symptomatology occurs in older adults with CIND in the absence of MDE or subthreshold MDE. NESD encountered in the absence of dysphoria/anhedonia should receive particular attention by clinicians since they can be linked to cognitive difficulties.	[Potvin, Olivier; Grenier, Sebastien; Preville, Michel] Hop Charles LeMoyne, Longueuil, PQ, Canada; [Potvin, Olivier; Hudon, Carol] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ, Canada; [Potvin, Olivier; Grenier, Sebastien; Preville, Michel] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Hudon, Carol] Univ Laval, Quebec City, PQ, Canada		Potvin, O (corresponding author), Univ Laval Robert Giffard F4500, Ctr Rech, 2601 Canardiere, Quebec City, PQ G1J 2G3, Canada.	Olivier.Potvin@crulrg.ulaval.ca	Grenier, Sebastien/AAA-4573-2021	Hudon, Carol/0000-0002-7554-3187	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200403MOP]; Fonds de recherche en sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec [9854]; Alzheimer Society of Canada	This study was supported by research grants from the Canadian Institutes of Health Research (200403MOP) and the Fonds de recherche en sante du Quebec (FRSQ; ref: 9854). Olivier Potvin was supported by a postdoctoral trainee award from the FRSQ and Alzheimer Society of Canada Partnership Program. Sebastien Grenier was supported by a postdoctoral trainee award from the FRSQ. Michel Preville was supported by a Senior Research Scientist Award from the FRSQ.	Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Apostolova LG, 2008, DEMENT GERIATR COGN, V25, P115, DOI 10.1159/000112509; Artero S, 2008, J NEUROL NEUROSUR PS, V79, P979, DOI 10.1136/jnnp.2007.136903; Beaulieu-Bonneau S, 2009, INT PSYCHOGERIATR, V21, P654, DOI 10.1017/S1041610209009120; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Busse A, 2003, BRIT J PSYCHIAT, V182, P449, DOI 10.1192/bjp.182.5.449; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Fisk JD, 2003, NEUROLOGY, V61, P1179, DOI 10.1212/01.WNL.0000089238.07771.C7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Herrmann LL, 2007, PSYCHOL MED, V37, P1693, DOI 10.1017/S0033291707001134; Kumar R, 2006, INT PSYCHOGERIATR, V18, P471, DOI 10.1017/S1041610205003005; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mitchell AJ, 2008, AGE AGEING, V37, P497, DOI 10.1093/ageing/afn147; MOSKO S, 1989, J CLIN PSYCHOL, V45, P51, DOI 10.1002/1097-4679(198901)45:1<51::AID-JCLP2270450107>3.0.CO;2-H; Nebes RD, 2001, AM J PSYCHIAT, V158, P878, DOI 10.1176/appi.ajp.158.987.878; Palmer K, 2002, AM J PSYCHIAT, V159, P436, DOI 10.1176/appi.ajp.159.3.436; Palmer K, 2008, AM J GERIAT PSYCHIAT, V16, P603, DOI 10.1097/JGP.0b013e3181753a64; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Preville M, 2008, CAN J PSYCHIAT, V53, P822, DOI 10.1177/070674370805301208; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Statistics Canada (StatCan), 2006, 2006 CENS POP; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	30	9	9	1	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	DEC	2010	22	8					1344	1352		10.1017/S1041610210001419			9	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Geriatrics & Gerontology; Psychiatry	678AO	WOS:000284039700017	20836912				2022-02-06	
J	Sharma, S; Rakoczy, S; Dahlheimer, K; Brown-Borg, H				Sharma, Sunita; Rakoczy, Sharlene; Dahlheimer, Kristine; Brown-Borg, Holly			The hippocampus of Ames dwarf mice exhibits enhanced antioxidative defenses following kainic acid-induced oxidative stress	EXPERIMENTAL GERONTOLOGY			English	Article						Ames dwarf; Hippocampus; Oxidative stress; Glutathione; Glutathione peroxidase; Kainic acid	TRAUMATIC BRAIN-INJURY; KAINATE-INDUCED SEIZURES; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; GROWTH-HORMONE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; PROTEIN OXIDATION; RAT HIPPOCAMPUS; FLUORO-JADE	Introduction: The vulnerability of the hippocampus to the effects of aging has been found to be associated with a decline in growth hormone/insulin like growth factor-1 (GH/IGF-1), and an increase in oxidative stress. We have evidence that long-living GH-deficient Ames dwarf mice have enhanced antioxidant protection in the periphery but the protection in the central nervous system is less clear. Material and methods: In the present study, we evaluated the antioxidative defense enzyme status in the hippocampus of Ames dwarf and wild type mice at 3, 12 and 24 months of age and examined the ability of each genotype to resist kainic acid-induced (KA) oxidative stress. An equiseizure concentration of KA was administered such that both genotypes responded with similar seizure scores and lipid peroxidation. Results: We found that GH-sufficient wild type mice showed an increase in oxidative stress as indicated by the reduced ratio of glutathione: glutathione disulfide following MA injection while this ratio was maintained in GH-deficient Ames dwarf mice. In addition, glutathione peroxidase activity (GPx) as well as GPx1 mRNA expression was enhanced in KA-injected Ames dwarf mice but decreased in wild type mice. There was no induction of Nrf-2 (an oxidative stress-induced transcription factor) gene expression in Ames dwarf mice following MA further suggesting maintenance of antioxidant defense in GH-deficiency under oxidative stress conditions. Discussion: Therefore, based on equiseizure administration of KA, Ames dwarf mice have an enhanced antioxidant defense capacity in the hippocampus similar to that observed in the periphery. This improved defense capability in the brain is likely due to increased GPx availability in Ames mice and may contribute to their enhanced longevity. (C) 2010 Elsevier Inc. All rights reserved.	[Sharma, Sunita; Rakoczy, Sharlene; Dahlheimer, Kristine; Brown-Borg, Holly] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA		Brown-Borg, H (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA.	brownbrg@medicine.nodak.edu			Glenn Foundation for Biomedical Research; Department of Pharmacology, Physiology and Therapeutic at the University of North Dakota School of Medicine and Health Sciences; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034206] Funding Source: NIH RePORTER	We wish to thank Drs. Thad Rosenberger, John Watt and Patrick Carr for providing assistance with the immunohistochemistry experiments. This work was supported by the Glenn Foundation for Biomedical Research, and by the Department of Pharmacology, Physiology and Therapeutic at the University of North Dakota School of Medicine and Health Sciences.	Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; Bokov AF, 2009, J GERONTOL A-BIOL, V64, P819, DOI 10.1093/gerona/glp052; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown-Borg H, 2001, J AM AGING ASSOC, V24, P85, DOI 10.1007/s11357-001-0012-6; Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6; Brown-Borg HM, 2003, MECH AGEING DEV, V124, P1013, DOI 10.1016/j.mad.2003.07.001; Brown-Borg HM, 2002, EXP BIOL MED, V227, P94, DOI 10.1177/153537020222700203; Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41; Brown-Borg HM, 2005, EXP GERONTOL, V40, P115, DOI 10.1016/j.exger.2004.11.004; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Brown-Borg HM, 2009, EXP GERONTOL, V44, P10, DOI 10.1016/j.exger.2008.07.002; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; Cardozo-Pelaez F, 2000, FREE RADICAL BIO MED, V28, P779, DOI 10.1016/S0891-5849(00)00172-6; CARLBERG I, 1985, GLUTATHIONE REDUCTAS, P484; Ceccon M, 2000, BRAIN RES, V862, P83, DOI 10.1016/S0006-8993(00)02074-6; Chung SY, 2003, J PINEAL RES, V34, P95, DOI 10.1034/j.1600-079X.2003.00010.x; Cooper AJL, 1997, BIOL CHEM, V378, P793; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Donahue AN, 2006, MECH AGEING DEV, V127, P57, DOI 10.1016/j.mad.2005.09.003; Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380; Duffy KB, 2008, NEUROBIOL AGING, V29, P1680, DOI 10.1016/j.neurobiolaging.2007.04.002; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farooqui AA, 2001, BRAIN RES REV, V38, P61, DOI 10.1016/S0169-328X(01)00214-5; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Gine E, 2010, ENDOCRINOLOGY, V151, P3267, DOI 10.1210/en.2010-0070; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guo ZH, 2000, EXP NEUROL, V166, P173, DOI 10.1006/exnr.2000.7497; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HALLIWELL B, 1992, ANN NEUROL, V32, pS10, DOI 10.1002/ana.410320704; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hayakawa N, 2008, EXP MOL PATHOL, V85, P135, DOI 10.1016/j.yexmp.2008.05.001; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Heiman ML, 2003, ENDOCRINE, V20, P149, DOI 10.1385/ENDO:20:1-2:149; HIKIJI M, 1993, LIFE SCI, V53, P857, DOI 10.1016/0024-3205(93)90508-Z; Hirata H, 1997, MOL BRAIN RES, V48, P145, DOI 10.1016/S0169-328X(97)00121-6; Joseph JA, 1996, FREE RADICAL BIO MED, V20, P821, DOI 10.1016/0891-5849(95)02225-2; Joshi G, 2007, J NEUROSCI RES, V85, P497, DOI 10.1002/jnr.21158; KAMPHUIS W, 1995, NEUROSCIENCE, V67, P551, DOI 10.1016/0306-4522(95)00070-Y; Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim HC, 2000, NEUROSCI LETT, V281, P65, DOI 10.1016/S0304-3940(99)00969-6; Kim HC, 2002, BEHAV BRAIN RES, V131, P211, DOI 10.1016/S0166-4328(01)00382-5; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Leutner S, 2001, J NEURAL TRANSM, V108, P955, DOI 10.1007/s007020170015; LEVY DI, 1991, NEUROREPORT, V2, P345, DOI 10.1097/00001756-199106000-00011; Liang LP, 2007, NEUROSCIENCE, V147, P1114, DOI 10.1016/j.neuroscience.2007.03.026; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Lovell MA, 1998, NEUROLOGY, V51, P1562, DOI 10.1212/WNL.51.6.1562; Lupberger J, 2002, MOL CELL PROBE, V16, P25, DOI 10.1006/mcpr.2001.0392; MacGregor DG, 1996, BRAIN RES, V727, P133, DOI 10.1016/0006-8993(96)00362-9; MANNERVIK B, 1987, CARCINOGENESIS, V8, P1929, DOI 10.1093/carcin/8.12.1929; MARKLUND SL, 1982, CANCER RES, V42, P1955; Mitruskova B, 2005, CELL MOL NEUROBIOL, V25, P1255, DOI 10.1007/s10571-005-8502-1; Miyamoto R, 2008, BRAIN RES, V1209, P85, DOI 10.1016/j.brainres.2008.02.064; Ogita K, 2004, NEUROPHARMACOLOGY, V46, P580, DOI 10.1016/j.neuropharm.2003.11.002; Ong WY, 2000, EXP BRAIN RES, V132, P510, DOI 10.1007/s002210000347; Ong WY, 2000, FREE RADICAL BIO MED, V28, P1214, DOI 10.1016/S0891-5849(00)00238-0; Oyama Y, 1997, BRAIN RES, V760, P277, DOI 10.1016/S0006-8993(97)00398-3; Pias EK, 2002, FASEB J, V16, DOI 10.1096/fj.01-0784com; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reynolds DS, 1998, J NEUROSCI METH, V79, P115, DOI 10.1016/S0165-0270(97)00168-4; Rojo AI, 2008, MOL CELL NEUROSCI, V39, P125, DOI 10.1016/j.mcn.2008.06.007; SAIJA A, 1994, GEN PHARMACOL-VASC S, V25, P97, DOI 10.1016/0306-3623(94)90016-7; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schrag M, 2008, HIPPOCAMPUS, V18, P239, DOI 10.1002/hipo.20387; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Sharma S, 2010, MECH AGEING DEV, V131, P422, DOI 10.1016/j.mad.2010.06.004; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shin EJ, 2008, NEUROCHEM INT, V52, P1134, DOI 10.1016/j.neuint.2007.12.003; Shin EJ, 2008, CELL SIGNAL, V20, P645, DOI 10.1016/j.cellsig.2007.11.014; Shin EJ, 2009, J NEUROSCI RES, V87, P710, DOI 10.1002/jnr.21880; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; SUN AY, 1992, MOL CHEM NEUROPATHOL, V17, P51, DOI 10.1007/BF03159981; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Waeg G, 1996, FREE RADICAL RES, V25, P149, DOI 10.3109/10715769609149920; Wang Q, 2004, NEUROCHEM RES, V29, P2105, DOI 10.1007/s11064-004-6883-z; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Wells W W, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P149; Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; ZUCKER DK, 1983, EXP NEUROL, V79, P422, DOI 10.1016/0014-4886(83)90223-6	96	9	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	DEC	2010	45	12					936	949		10.1016/j.exger.2010.08.013			14	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	695KE	WOS:000285368200003	20804841	Green Accepted			2022-02-06	
J	Widmayer, MA; Browning, JL; Gopinath, SP; Robertson, CS; Baskin, DS				Widmayer, Marsha A.; Browning, Jeffrey L.; Gopinath, Shankar P.; Robertson, Claudia S.; Baskin, David S.			Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury	NEUROLOGICAL RESEARCH			English	Article						Head injury; Trauma; Antidiuretic hormone; Vasopressin; Intracranial pressure	TRAUMATIC BRAIN-INJURY; VASOPRESSIN RECEPTOR ANTAGONIST; ATRIAL-NATRIURETIC-PEPTIDE; FOCAL CEREBRAL-ISCHEMIA; ARGININE-VASOPRESSIN; DECOMPRESSIVE CRANIECTOMY; EDEMA FORMATION; STROKE PATIENTS; V-2 RECEPTORS; RATS	Objectives: Head injury frequently results in increased intracranial pressure and brain edema. Investigators have demonstrated that ischemic injury causes an increase in cerebrospinal fluid (CSF) levels of antidiuretic hormone (ADH); increased CSF ADH levels exacerbate cerebral edema, and inhibition of the ADH system with specific ADH antagonists reduces cerebral edema. The current study was designed to test the hypothesis that elevated levels of ADH are present in the CSF of subjects with head injury. Methods: Ventricular CSF and blood samples were taken from 11 subjects with head injury and 12 subjects with no known head trauma or injury. ADH levels were analyzed using radioimmunoassay. Severity of increased intracranial pressure (ICP) was rated in head-injured subjects using a four-point ordinal scale, based on which treatments were necessary to reduce ICP. Results: Subjects with head injury had higher CSF (3.2 versus 1.2 pg/ml; P < 0.02) and plasma (4.1 versus 1.4 pg/ml; P < 0.02) levels of ADH than did control subjects. In head-injured subjects, CSF ADH levels positively correlated with severity of ICP. Discussion: The results of this study suggest that ADH plays a role in brain edema associated with closed head injury.	[Widmayer, Marsha A.; Gopinath, Shankar P.; Robertson, Claudia S.; Baskin, David S.] Methodist Hosp, Dept Neurosurg, Houston, TX 77030 USA; [Widmayer, Marsha A.; Browning, Jeffrey L.; Baskin, David S.] Methodist Hosp Res Inst, Houston, TX 77030 USA; [Widmayer, Marsha A.; Browning, Jeffrey L.; Gopinath, Shankar P.; Robertson, Claudia S.; Baskin, David S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Browning, Jeffrey L.; Baskin, David S.] Cent Texas Vet Hlth Care Syst, Ctr Excellence Res ReturningWar Vet, Temple, TX 76504 USA; [Browning, Jeffrey L.; Baskin, David S.] Texas A&M Hlth Sci Ctr, Dept Psychiat & Behav Sci, Temple, TX 76504 USA; [Widmayer, Marsha A.; Browning, Jeffrey L.; Baskin, David S.] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Baskin, David S.] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA		Baskin, DS (corresponding author), Methodist Hosp, Dept Neurosurg, 6560 Fannin,Suite 944, Houston, TX 77030 USA.	dbaskin@tmhs.org	Baskin, David/AAK-2694-2020		National Cancer Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA78912]; Texas Higher Education Coordinating Board [004949-054]; VAUS Department of Veterans Affairs; American Heart Association, Texas AffiliateAmerican Heart Association; Taub Foundation; Henry J. N. Taub Fund for Neurosurgical Research; Pauline Sterne Wolff Memorial Foundation; George A. Robinson, IV Foundation; Neurological Research Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA078912] Funding Source: NIH RePORTER	This research was supported in part, by R01 CA78912 from the National Cancer Institute, National Institutes of Health, by 004949-054 from the Texas Higher Education Coordinating Board, and by grants from the VA Merit Review Board, The American Heart Association, Texas Affiliate, The Taub Foundation, The Henry J. N. Taub Fund for Neurosurgical Research, The Blanche Greene Estate Fund of the Pauline Sterne Wolff Memorial Foundation, The George A. Robinson, IV Foundation, and The Koppelman Fund of the Neurological Research Foundation.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; BABINI R, 1993, RES COMMUN CHEM PATH, V80, P131; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; BASKIN DS, 1994, STROKE, V25, P2047, DOI 10.1161/01.STR.25.10.2047; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brown CH, 2007, BIOCHEM SOC T, V35, P1236, DOI 10.1042/BST0351236; Cook AM, 2007, ADV EMERG NURS J, V29, P309, DOI 10.1097/01.TME.0000300112.24819.5c; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; Gruen P, 1998, EMERG MED CLIN N AM, V16, P63, DOI 10.1016/S0733-8627(05)70349-7; HAMMER M, 1982, ACTA ENDOCRINOL-COP, V100, P211, DOI 10.1530/acta.0.1000211; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; HOFFMAN KK, 1995, SOC NEUR ABST, V21, P1067; Ikeda Y, 1997, ACTA NEUROCHIR, V139, P1166, DOI 10.1007/BF01410978; JENKINS JS, 1980, J CLIN ENDOCR METAB, V50, P364; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; JOYNT RJ, 1981, ANN NEUROL, V9, P182, DOI 10.1002/ana.410090212; Kao TK, 2008, NEUROCHEM INT, V52, P1256, DOI 10.1016/j.neuint.2008.01.007; KATZMAN R, 1997, STROKE, V8, P512; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Lessard A, 2002, BRIT J PHARMACOL, V136, P753, DOI 10.1038/sj.bjp.0704780; LIU XF, 1991, CHINESE MED J-PEKING, V104, P480; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Miller M, 2006, J AM GERIATR SOC, V54, P345, DOI 10.1111/j.1532-5415.2005.00609.x; Molnar AH, 2008, ACTA NEUROCHIR, V150, P265, DOI 10.1007/s00701-007-1400-1; Molnar AH, 2008, PROG BRAIN RES, V170, P519, DOI 10.1016/S0079-6123(08)00439-1; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; NAGAO S, 1994, ACTA NEUROCHIR, P502; OISO Y, 1988, NEUROENDOCRINOLOGY, V48, P658, DOI 10.1159/000125078; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; POST RM, 1988, ANN NY ACAD SCI, V531, P15, DOI 10.1111/j.1749-6632.1988.tb31808.x; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; REEDER RF, 1986, J NEUROSURG, V64, P941, DOI 10.3171/jns.1986.64.6.0941; REID AC, 1982, J NEUROL SCI, V54, P295, DOI 10.1016/0022-510X(82)90190-3; ROBERTSON C, 1993, ACTA NEUROCHIR, P25; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; SILVIA RC, 1987, BRAIN RES, V403, P52, DOI 10.1016/0006-8993(87)90121-1; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; SORENSEN PS, 1983, J NEUROL NEUROSUR PS, V46, P911, DOI 10.1136/jnnp.46.10.911; SUNDQUIST J, 1983, J NEUROL NEUROSUR PS, V46, P14, DOI 10.1136/jnnp.46.1.14; TANG AH, 1988, LIFE SCI, V43, P399, DOI 10.1016/0024-3205(88)90518-8; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vajda Z, 2001, NEUROSURGERY, V49, P697, DOI 10.1097/00006123-200109000-00031; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; VERBALIS JG, 1993, J AM SOC NEPHROL, V3, P1600; WELLS T, 1991, J ENDOCRINOL, V129, P411, DOI 10.1677/joe.0.1290411; Yeung PKK, 2009, J CEREBR BLOOD F MET, V29, P1891, DOI 10.1038/jcbfm.2009.175	54	9	9	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2010	32	10					1021	1026		10.1179/016164110X12714125204155			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	670LD	WOS:000283422300002	20810023				2022-02-06	
J	Bauman Johnson, WL; Maricle, DE; Miller, DC; Allen, DN; Mayfield, J				Bauman Johnson, Wendi L.; Maricle, Denise E.; Miller, Daniel C.; Allen, Dan N.; Mayfield, Joan			Utilization of the Comprehensive Trail Making Test as a Measure of Executive Functioning in Children and Adolescents with Traumatic Brain Injuries	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Executive function; Children; Adolescents; Comprehensive Trail Making Test; Confirmatory factor analysis	EARLY-CHILDHOOD	Traumatic brain injury (TBI) often results in long-term negative effects in attention, memory, perception, language, and executive functioning. Children and adolescents are the most vulnerable as TBIs are the leading cause of death and disability for this age group. Despite these high proportions and detrimental effects, few studies have utilized a developmentally appropriate, standardized measure to assess executive functioning within a pediatric TBI population. The current study compared children and adolescents who had sustained a TBI with a non-injured, matched control group on executive functioning using the Comprehensive Trail Making Test (CTMT). Data analyses revealed significant differences between groups on the CTMT Composite Index, each individual trail, and a combination of trails but with no within-group differences. Confirmatory factor analysis revealed that a single-factor model was a better fit for the present sample of TBI participants than the two-factor model evident within the CTMT standardization sample.	[Bauman Johnson, Wendi L.] Denton Independent Sch Dist, Denton, TX 76201 USA; [Maricle, Denise E.; Miller, Daniel C.] Texas Womans Univ, Dept Psychol & Philosophy, Denton, TX 76204 USA; [Allen, Dan N.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX 75204 USA		Bauman Johnson, WL (corresponding author), 1205 Univ Dr, Denton, TX 76201 USA.	wendileighjohnson@gmail.com		Allen, Daniel/0000-0003-4868-2242			Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V., 2010, PEDIAT TRAUMATIC BRA; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Blair C, 2005, DEV NEUROPSYCHOL, V28, P561, DOI 10.1207/s15326942dn2802_1; BOLL TJ, 1977, PERCEPT MOTOR SKILL, V44, P535, DOI 10.2466/pms.1977.44.2.535; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Diamond A, 2005, DEV NEUROPSYCHOL, V28, P689, DOI 10.1207/s15326942dn2802_7; Epsy K., 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; FARMER JE, 1997, CHILDHOOD TRAUMATIC, P33; Gioia G. A., 2001, PSYCHOL DEV ASSESSME PSYCHOL DEV ASSESSME; Gray R, 2006, J PSYCHOEDUC ASSESS, V24, P88; Hamdan Amer C., 2009, Psychol. Neurosci., V2, P199, DOI 10.3922/j.psns.2009.2.012; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P87; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MARICLE DE, 2010, BEST PRACTICES SCH N; MOSES JA, 2004, CLIN NEUROPSYCHOLOGY, V19, P703; NEYENS LGJ, 1996, CHILD NEUROPSYCHOL, V2, P161; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; SERVESKO AM, 2006, NAT AC NEUR SAN ANT; TAYLOR HG, 1997, J INT NEUROPSYCH SOC, V3, P1; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Zalonis I., 2010, ANN GEN PSYCHIAT S, V9, pS145; ZELAZO PD, 2003, Child Dev */* SERIAL, V68, P274	31	9	10	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2010	25	7					601	609		10.1093/arclin/acq049			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	673KK	WOS:000283658500002	20615903	Bronze, Green Published			2022-02-06	
J	Cohn, SM; Blackbourne, LH; Landry, DW; Proctor, KG; Walley, KR; Wenzel, V				Cohn, Stephen M.; Blackbourne, Lorne H.; Landry, Donald W.; Proctor, Kenneth G.; Walley, Keith R.; Wenzel, Volker			San Antonio Vasopressin in Shock Symposium Report	RESUSCITATION			English	Article						Conference report; Vasopressin; Shock; Cardiac arrest; Traumatic brain injury; Septic shock; Haemorrhagic shock	HEMORRHAGIC-SHOCK; EPINEPHRINE; RESUSCITATION; MANAGEMENT; SURVIVAL; INFUSION	The San Antonio Vasopressin Symposium reviewed substantial accumulated data concerning vasopressin in haemorrhagic, septic, and cardiac arrest shock conditions and found that there is considerable evidence to support the use of vasopressin in overcoming vasopressin deficiency or insufficiency. The value of vasopressin in the setting of trauma requires further investigation. It was concluded that a large, multicenter controlled trial of vasopressin is needed to assess the therapeutic benefit of vasopressin replacement in the setting of trauma with haemorrhagic shock that is prolonged and profound. (c) 2010 Elsevier Ireland Ltd. All rights reserved.	[Wenzel, Volker] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; [Cohn, Stephen M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Blackbourne, Lorne H.] USA, Inst Surg Res, San Antonio, TX USA; [Landry, Donald W.] Columbia Univ, New York, NY USA; [Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Walley, Keith R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada		Wenzel, V (corresponding author), Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	volker.wenzel@uki.at	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628	University of Texas Health Sciences Center, Department of Surgery; U.S. Army Institute of Surgical Research, San Antonio, Texas	The meeting was sponsored by the University of Texas Health Sciences Center, Department of Surgery, and the U.S. Army Institute of Surgical Research, San Antonio, Texas.	Blackbourne LH, 2009, J TRAUMA, V66, pS27, DOI 10.1097/TA.0b013e31819cdf83; Cohn SM, 2007, J TRAUMA, V62, pS56, DOI 10.1097/TA.0b013e318065ab06; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Dunser MW, 2003, DRUGS, V63, P237, DOI 10.2165/00003495-200363030-00001; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feinstein AJ, 2005, J TRAUMA, V59, P882; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Kreutziger J, 2009, RESUSCITATION, V80, P723, DOI 10.1016/j.resuscitation.2009.04.028; KWAN I, 2001, COCHRANE DB SYST REV; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2009, CRIT CARE MED, V37, P811, DOI 10.1097/CCM.0b013e3181961ace; Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431	19	9	9	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	NOV	2010	81	11					1473	1475		10.1016/j.resuscitation.2010.06.005			3	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	692BQ	WOS:000285126900006	20655650				2022-02-06	
J	Bales, JW; Ma, XC; Yan, HQ; Jenkins, LW; Dixon, CE				Bales, James W.; Ma, Xiecheng; Yan, Hong Q.; Jenkins, Larry W.; Dixon, C. Edward			Regional calcineurin subunit B isoform expression in rat hippocampus following a traumatic brain injury	BRAIN RESEARCH			English	Article						Calcineurin; TBI; Hippocampus; CCI	FLUID PERCUSSION INJURY; CONTROLLED CORTICAL IMPACT; CYCLOSPORINE-A; CELL-DEATH; PROTEIN; MEMORY; MAINTENANCE; PLASTICITY; RECEPTORS; MECHANISM	Calcineurin subunit isoforms are implicated in long term potentiation, long term depression, and structural plasticity. Calcineurin inhibitors benefit axonal damage, cellular dysfunction, and cognitive outcomes in animal models of traumatic brain injury (TBI). Distribution of the catalytic calcineurin A subunit is altered and calcineurin activity increased following fluid percussion injury. Alterations in calcineurin subunit A isoform distribution within the hippocampus also occur post controlled cortical impact (CCI) demonstrating a reduction in catalytic subunit distribution in CA1-2 dendritic fields. Furthermore the effect of TBI on the regulatory subunit, calcineurin B, is unknown. Understanding the role of both subunits is necessary to effectively target alterations in calcineurin signaling as current calcineurin inhibitors, such as cyclosporin A and FK-506, rely upon binding sites on both subunits for complete inhibition. The effect of moderate CCI on the expression and distribution of calcineurin B isoforms within the hippocampus was examined at 2 h and 2 weeks post injury. Calcineurin B isoforms showed increased expression throughout the CA1 and CA2 while there was a decrease in expression within the ipsilateral dentate gyms. Alterations in CnB isoform expression within the CA1, CA1-2, and dentate gyrus have significant implications for persistent hippocampal dysfunction following TBI. Regional changes in regulatory subunit expression may alter the effect of calcineurin inhibitors regionally following a traumatic brain injury. Published by Elsevier B.V.	[Bales, James W.; Ma, Xiecheng; Yan, Hong Q.; Jenkins, Larry W.; Dixon, C. Edward] Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Bales, James W.; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bales, James W.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), 201 Hill Bldg,3434 5th Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P50-NS030318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, R01NS060672, P50NS030318] Funding Source: NIH RePORTER	We would like to thank Melanie Grubisha for her invaluable advice regarding this research. This work supported by NIH grant 2P50-NS030318.	Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Butcher SP, 1997, J NEUROSCI, V17, P6939; CHANG HY, 1995, NATURE, V376, P686, DOI 10.1038/376686a0; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; GUERINI D, 1989, P NATL ACAD SCI USA, V86, P9183, DOI 10.1073/pnas.86.23.9183; Halpain S, 1998, J NEUROSCI, V18, P9835; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1990, ACT NEUR S, V51, P331; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; KAY JE, 1989, CELL IMMUNOL, V124, P175, DOI 10.1016/0008-8749(89)90121-4; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; SHAPIRA Y, 1989, Neurological Research, V11, P169; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Wiederrecht Greg, 1993, V696, P9; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	36	9	9	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 28	2010	1358						211	220		10.1016/j.brainres.2010.08.029			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	675GL	WOS:000283814800022	20713027	Green Accepted			2022-02-06	
J	Nagy, D; Knapp, L; Marosi, M; Farkas, T; Kis, Z; Vecsei, L; Teichberg, VI; Toldi, J				Nagy, David; Knapp, Levente; Marosi, Mate; Farkas, Tamas; Kis, Zsolt; Vecsei, Laszlo; Teichberg, Vivian I.; Toldi, Jozsef			Effects of Blood Glutamate Scavenging on Cortical Evoked Potentials	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Neurotoxicity; Neuroprotection; Brain glutamate levels; Glutamate; Oxaloacetate; Glutamate-oxaloacetate transaminase; Glutamate; scavenging; Evoked potential; Somatosensory cortex	NEURODEGENERATIVE DISORDERS; MOTOR CORTEX; AMINO-ACIDS; RELEASE; INJURY; BRAIN; RAT; MODULATION; NEUROPROTECTION; MECHANISMS	It is well known that traumatic or ischemic brain injury is followed by acute excitotoxicity caused by the presence of abnormally high glutamate (Glu) in brain fluids. It has recently been demonstrated that excess Glu can be eliminated from brain into blood following the intravenous administration of oxaloacetate (OxAc), which, by scavenging blood Glu, induces an enhanced and neuroprotective brain-to-blood Glu efflux. In this study, we subjected rats to intravenous OxAc administration (i.v., 12.5, 25, and 50 mg/kg, respectively), and studied its effects on somatosensory evoked cortical potentials (EPs). Against our expectation, the amplitudes of EPs did not decrease but increased in a dose- and time-dependent manner after OxAc administration. Similar effects were observed when blood Glu scavenging was enhanced by combining OxAc (12.5 mg/kgbw) with recombinant glutamate-oxaloacetate transaminase (GOT, 0.14 nmol/100 g rat). On the basis of these results, we suggest that the changes of amplitudes of the EPs involve not only a glutamatergic but also the weakening of a GABAergic component. We cannot rule out the possibility that OxAc penetrates into the brain and improves mitochondrial functions.	[Nagy, David; Knapp, Levente; Marosi, Mate; Farkas, Tamas; Kis, Zsolt; Toldi, Jozsef] Univ Szeged, Dept Physiol Anat & Neurosci, H-6726 Szeged, Hungary; [Vecsei, Laszlo] Univ Szeged, Dept Neurol, Albert Szent Gyorgyi Med & Pharmaceut Ctr, H-6726 Szeged, Hungary; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Toldi, J (corresponding author), Univ Szeged, Dept Physiol Anat & Neurosci, Kozep Fasor 52, H-6726 Szeged, Hungary.	toldi@bio.u-szeged.hu	Farkas, Tamas/B-7193-2008; Toldi, Jozsef/M-4858-2018; Vecsei, Laszlo/ABA-6137-2021; Nagy, David/C-7775-2011; Vecsei, Laszlo/B-2066-2010; Kis, Zsolt/A-4583-2009	Toldi, Jozsef/0000-0001-7355-0503; Vecsei, Laszlo/0000-0001-8037-3672; Kis, Zsolt/0000-0002-6896-5883	OTKAOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K75628]; Nella and Leon Benoziyo Center for Neurological Diseases at the Weizmann Institute	This study was supported by the OTKA K75628. FT is a Bolyai Fellow of the Hungarian Academy of Sciences. V.I.T. has received support from Nella and Leon Benoziyo Center for Neurological Diseases at the Weizmann Institute.	Belan PV, 2002, PFLUG ARCH EUR J PHY, V444, P26, DOI 10.1007/s00424-002-0783-3; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Farazifard R, 2010, BRAIN RES, V1325, P28, DOI 10.1016/j.brainres.2010.02.021; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Farkas T, 2000, EUR J NEUROSCI, V12, P2190, DOI 10.1046/j.1460-9568.2000.00096.x; Foster AC, 2006, CURR OPIN PHARMACOL, V6, P7, DOI 10.1016/j.coph.2005.11.005; Franceschini MA, 2008, NEUROIMAGE, V41, P189, DOI 10.1016/j.neuroimage.2008.02.061; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; HOLMES O, 1970, J PHYSIOL-LONDON, V209, P433, DOI 10.1113/jphysiol.1970.sp009173; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kamsler A, 2003, J NEUROSCI, V23, P269; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Kullmann DM, 2002, EPILEPSIA, V43, P174, DOI 10.1046/j.1528-1157.43.s.5.12.x; Liu SQJ, 2007, J NEUROPHYSIOL, V98, P550, DOI 10.1152/jn.00352.2007; Lur G, 2006, CELL MOL NEUROBIOL, V26, P1505, DOI 10.1007/s10571-006-9073-5; Mate M, 2009, EUR J PHARMACOL, V604, P51, DOI 10.1016/j.ejphar.2008.12.022; Nagy D, 2009, CELL MOL NEUROBIOL, V29, P827, DOI 10.1007/s10571-009-9364-8; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Stone TW, 2007, METAB BRAIN DIS, V22, P337, DOI 10.1007/s11011-007-9064-3; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; TOLDI J, 1994, NEUROSCI LETT, V167, P1, DOI 10.1016/0304-3940(94)91014-6; Toldi J, 1999, NEUROREPORT, V10, P2143, DOI 10.1097/00001756-199907130-00027; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	30	9	10	1	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2010	30	7					1101	1106		10.1007/s10571-010-9542-8			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	657RA	WOS:000282428800013	20607387				2022-02-06	
J	Wong, MN; Murdoch, BE; Whelan, BM				Wong, Min Ney; Murdoch, Bruce E.; Whelan, Brooke-Mai			Kinematic analysis of lingual function in dysarthric speakers with Parkinson's disease: An electromagnetic articulograph study	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Dysarthria; Parkinson's disease; articulation; tongue; kinematic; electromagnetic articulography	TRAUMATIC BRAIN-INJURY; TONGUE-PALATE CONTACT; SPEECH RATE; ARTICULATORY FUNCTION; OROFACIAL MOVEMENTS; ACOUSTIC ANALYSIS; VOCAL-TRACT; L-DOPA; LEVODOPA; THERAPY	Dysarthria in people with Parkinson's disease (PD) has been widely studied. However, a limited number of studies have investigated lingual function during speech production in this population. This study aimed to investigate lingual kinematics during speech production using electromagnetic articulography (AG-200 EMA). The PD group consisted of eight dysarthric speakers with PD and was matched with a group of eight controls. The tongue tip and tongue back movements of all participants during sentence production were recorded by EMA. Results showed that, perceptually, the participants with PD were mildly dysarthric. Kinematic results documented comparable (for alveolar sentence production) and increased (for velar sentence production) range of lingual movement in the PD group when compared to the control group. Lingual movement velocity, acceleration, and deceleration were also increased in the PD group, predominantly for the release phase of consonant production during sentence utterances. The PD group had longer duration in the production of alveolar consonant and comparable duration in the production of velar consonant. The results of the present study suggest the presence of impaired lingual control in individuals with PD. Increased range of articulatory movement, primarily in the release phase of consonant production, may account for articulatory imprecision in this population.	[Wong, Min Ney] Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia		Wong, MN (corresponding author), Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	min.wong@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Wong, Min Ney/0000-0003-0585-3566; Whelan, Brooke-Mai/0000-0002-7909-3160			ACKERMANN H, 1993, FOLIA PHONIATR, V45, P84, DOI 10.1159/000266222; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Adams S. G., 2009, CLIN MANAGEMENT SENS; BABA Y, 2005, PARKINSONS DIS, P745; BARLOW SM, 2009, CLIN MANAGEMENT SENS; Bartle-Meyer CJ, 2009, CLIN LINGUIST PHONET, V23, P93, DOI 10.1080/02699200802564284; Blanchet PG, 2009, J MED SPEECH-LANG PA, V17, P1; Brown J.R., 1975, MOTOR SPEECH DISORDE; Chen Y.-T., 2008, J MED SPEECH-LANG PA, V16, P21; Chenery H. J., 1988, AUSTR J HUMAN COMMUN, V16, P17, DOI [10.3109/asl2.1988.16.issue-2.02., DOI 10.3109/ASL2.1988.16.ISSUE-2.02]; Cheng HY, 2005, J MED SPEECH-LANG PA, V13, P15; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; De Letter M, 2006, ACTA NEUROL BELG, V106, P19; De Letter M, 2007, CLIN NEUROL NEUROSUR, V109, P495, DOI 10.1016/j.clineuro.2007.04.003; Duffy J. R., 2005, MOTOR SPEECH DISORDE, P187; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; Field A., 2017, DISCOVERING STAT USI, V5th; FORREST K, 1989, J ACOUST SOC AM, V85, P2608, DOI 10.1121/1.397755; Goberman AM, 2002, NEUROREHABILITATION, V17, P237; Goozee JV, 2005, CLIN LINGUIST PHONET, V19, P319, DOI 10.1080/02699200420002268862; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HIROSE H, 1982, FOLIA PHONIATR, V34, P210, DOI 10.1159/000265651; HOODIN RB, 1989, J COMMUN DISORD, V22, P169, DOI 10.1016/0021-9924(89)90014-2; HUNKER CJ, 1982, NEUROLOGY, V32, P749, DOI 10.1212/WNL.32.7.749; JOHNSON JA, 1990, BRIT J DISORD COMMUN, V25, P183; KATZ W, 1990, BRAIN LANG, V38, P555, DOI 10.1016/0093-934X(90)90137-6; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; Kompoliti K, 2000, NEUROLOGY, V54, P458, DOI 10.1212/WNL.54.2.458; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; Kuruvilla M, 2007, BRAIN INJURY, V21, P601, DOI 10.1080/02699050701427525; Le Dorze G, 1998, FOLIA PHONIATR LOGO, V50, P1, DOI 10.1159/000021444; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; Louis ED, 2001, MOVEMENT DISORD, V16, P562, DOI 10.1002/mds.1081; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P1, DOI 10.1080/02699200400001044; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P19, DOI 10.1080/0269-9200400001069; McAuliffe MJ, 2005, J GERONTOL A-BIOL, V60, P667, DOI 10.1093/gerona/60.5.667; McAuliffe MJ, 2005, J MED SPEECH-LANG PA, V13, P149; MCAULIFFE MJ, 2007, ADV SPEECH LANGUAGE, V9, P13; Montgomery EB, 2007, J MED SPEECH-LANG PA, V15, pIX; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; Nutt JG, 2001, PARKINSONISM RELAT D, V8, P101, DOI 10.1016/S1353-8020(01)00024-4; Plowman-Prine EK, 2009, NEUROREHABILITATION, V24, P131, DOI 10.3233/NRE-2009-0462; Rice JE, 2002, MOVEMENT DISORD, V17, P524, DOI 10.1002/mds.10072; Sanabria J, 2001, CLIN NEUROPHARMACOL, V24, P99, DOI 10.1097/00002826-200103000-00006; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; Schulz GM, 2002, CURR MED CHEM, V9, P1359, DOI 10.2174/0929867023369808; Schulz GM, 2001, CLIN LINGUIST PHONET, V15, P157, DOI 10.3109/02699200109167649; Scott S., 1985, COMMUNICATION PARKIN; SHAWKER TH, 1984, J CLIN ULTRASOUND, V12, P125, DOI 10.1002/jcu.1870120303; Skodda S, 2008, MOVEMENT DISORD, V23, P985, DOI 10.1002/mds.21996; Skodda S, 2009, MOVEMENT DISORD, V24, P716, DOI 10.1002/mds.22430; SMITH A, 1992, CRIT REV ORAL BIOL M, V3, P233, DOI 10.1177/10454411920030030401; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; Solomon NP, 1995, J MED SPEECH-LANG PA, V3, P13; Steele CM, 2004, J SPEECH LANG HEAR R, V47, P342, DOI 10.1044/1092-4388(2004/027); VONLIESHOUT PHH, 2000, PHONETICAN, V81, P9; WOLFE VI, 1975, J COMMUN DISORD, V8, P271, DOI 10.1016/0021-9924(75)90019-2; WONG MN, J MED SPEEC IN PRESS; [No title captured]	61	9	9	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	OCT	2010	12	5					414	425		10.3109/17549507.2010.495784			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	657HM	WOS:000282403800005	20586528				2022-02-06	
J	Colantonio, A; Gerber, G; Bayley, M; Deber, R; Kim, H; Yin, JL				Colantonio, Angela; Gerber, Gary; Bayley, Mark; Deber, Raisa; Kim, Hwan; Yin, Junlang			WHO WAITS FOR INPATIENT REHABILITATION SERVICES IN CANADA AFTER NEUROTRAUMA? A POPULATION-BASED STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; spinal cord injuries; rehabilitation; outcomes	FUNCTIONAL INDEPENDENCE MEASURE; RELIABILITY; OUTCOMES; IMPROVE	Objective: This study examined characteristics of patients with acquired brain injury associated with wait times for inpatient rehabilitation compared with a control population of patients with acquired spinal cord injury. Methods: This cross-sectional study was based on 9458 patients captured in the National Rehabilitation Reporting System in Canada. Results: Waiting for inpatient rehabilitation was found to be associated with language, geographical location, informal support, pre-admission living arrangement and payer source. The median differences in wait time, however, were at most a few days. Persons already receiving care had the longest median wait times. Conclusion: The data reflect only the perspective of providers, and further research needs to examine days to inpatient admission using data from acute care.	[Colantonio, Angela; Bayley, Mark; Kim, Hwan; Yin, Junlang] Univ Toronto, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; [Gerber, Gary] Univ Toronto, W Pk Healthcare Ctr, Toronto, ON M5G 1V7, Canada; [Deber, Raisa] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, 500 Univ Ave,Room 160, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Bayley, Mark/0000-0001-7860-9463; Deber, Raisa/0000-0003-0598-3926; Colantonio, Angela/0000-0003-2094-4765	Ontario Ministry of HealthMinistry of Health and Long-Term Care, Ontario; Long Term Care to the Toronto Rehabilitation Institute; Toronto Rehabilitation Institute Foundation	We acknowledge support from a grant from the Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute and the Toronto Rehabilitation Institute Foundation. We thank the Canadian Institute for Health Information (CIHI) for providing access to National Rehabilitation Reporting System (NRS) data and for use of the FIM (TM) instrument. The FIM (TM) instrument, data set and impairment codes referenced herein are the property of Uniform Data System for Medical Rehabilitation, a division of UB Foundation Activities, Inc. We would also like to thank Sandra Sokoloff for her assistance.	Blendon RJ, 2004, HEALTH AFFAIR, V23, P119, DOI 10.1377/hlthaff.23.3.119; *CAN I HLTH INF, 2005, INP REH CAN 2003 200; *CAN INT C SECR, 2006, P 1 MIN M 2004 SEPT; Canadian Institute for Health Information, 2006, WAIT HLTH CAR CAN WH; COLANTONIO A, 2008, PHYS MED REHABIL, V89, pE12; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Hurley Jeremiah, 2008, Healthc Policy, V3, P100; MECHANDA K, 2009, GEOGRAPHY WORKING PA; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; PLATA C, 2007, J HEAD TRAUMA REHAB, V22, P113; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	15	9	9	0	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	SEP	2010	42	8					773	779		10.2340/16501977-0582			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	651KQ	WOS:000281927000011	20809060	gold, Green Submitted, Green Published			2022-02-06	
J	Martin, JE; Teff, RJ; Spinella, PC				Martin, Jonathan E.; Teff, Richard J.; Spinella, Philip C.			Care of pediatric neurosurgical patients in Iraq in 2007: clinical and ethical experience of a field hospital Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						deployment neurosurgery; pediatric trauma; penetrating head injury; penetrating spine injury; bioethics	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; LEBANESE CONFLICT; PRACTICAL SCALE; CHILDREN; AFGHANISTAN; MISSION; COMA; WAR	Object. Care for host-nation pediatric casualties and disease or nonbattle injuries is an essential mission of deployed military medical assets. Clinical experience with pediatric patients at field hospitals has been increasingly reported since 2001, with neurotrauma identified as a major cause of morbidity and death in this population. A concentrated pediatric neurosurgical experience at a deployed medical facility has not been reported. The authors reviewed their experience with pediatric neurosurgical patients at a field hospital in Iraq in 2007 to provide insight into the management of this patient population. Methods. A retrospective review was conducted using a prospective database constructed by the authors for quality improvement during a single combat rotation in 2007. Results. Forty-two patients among 287 consultations were 17 years of age or younger. Twenty-six of these children were 8 years old or younger. Penetrating head injuries were the most common indication for consultation (22 of 42 patients). Twenty-eight of 130 surgical procedures were performed in the children. One patient died in the perioperative period, for a trauma-related operative mortality rate of 4%. Seven patients received palliative care based on the extent of presenting injuries. Twenty-five patients were discharged with minimal or no neurological deficits. Conclusions. Pediatric patients represent a significant proportion of the neurosurgical patient volume at field medical hospitals in the Iraqi theater. The mature medical theater environment present in 2007 allowed for remarkable diagnostic evaluation and treatment of these patients. Penetrating and closed craniospinal injuries were the most common indication for consultation. Disease and nonbattle injuries were also encountered, with care provided when deemed appropriate. The deployed environment presents unique medical and ethical challenges to neurosurgeons serving in forward medical facilities. (DOI: 10.3171/2010.6.PEDS1031)	[Martin, Jonathan E.] Univ Connecticut, Sch Med, Dept Surg, Div Neurosurg,Connecticut Childrens Med Ctr, Hartford, CT 06106 USA; [Teff, Richard J.] Univ Connecticut, Sch Med, Dept Pediat, Hartford, CT 06106 USA; [Spinella, Philip C.] Brooke Army Med Ctr, Dept Surg, Div Neurosurg, San Antonio, TX USA		Martin, JE (corresponding author), Univ Connecticut, Sch Med, Dept Surg, Div Neurosurg,Connecticut Childrens Med Ctr, 282 Washington St, Hartford, CT 06106 USA.	jmartin03@ccmckids.org		Martin, Jonathan/0000-0003-3180-2084			Aboutanos MB, 1997, J TRAUMA, V43, P719, DOI 10.1097/00005373-199710000-00031; American College of Surgeons, 2008, ADV TRAUM LIF SUPP M; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Burnett MW, 2008, PEDIATRICS, V121, P261, DOI 10.1542/peds.2006-3666; Cannon JW, 2009, CRIT CARE MED, V37, P2322, DOI 10.1097/CCM.0b013e3181a9f7db; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; Fuenfer MM, 2009, MIL MED, V174, P887, DOI 10.7205/MILMED-D-02-2308; Gross ML, 2004, HASTINGS CENT REP, V34, P22, DOI 10.2307/3528174; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kempe LG, 1968, OPERATIVE NEUROSURGE, V1, P180; Mainthia R, 2009, J NEUROSURG-PEDIATR, V4, P4, DOI 10.3171/2009.1.PEDS08193; Matos RI, 2008, PEDIATRICS, V122, pE959, DOI 10.1542/peds.2008-1244; Place RJ, 2006, SURG CLIN N AM, V86, P765, DOI 10.1016/j.suc.2006.02.004; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TEASDALE G, 1974, LANCET, V2, P81; United States Army Institute of Surgical Research, JOINT THEAT TRAUM SY, V1; VANDIVER J, 2008, STARS STRIPES M 0520	24	9	9	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	SEP	2010	6	3					250	256		10.3171/2010.6.PEDS1031			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	641FT	WOS:000281110900011	20809709				2022-02-06	
J	Charriere, K; Risold, PY; Fellmann, D				Charriere, Karine; Risold, Pierre-Yves; Fellmann, Dominique			In vitro interactions between bone marrow stromal cells and hippocampal slice cultures	COMPTES RENDUS BIOLOGIES			English	Article						Hippocampal slice cultures; Bone marrow stromal cells; In vitro; Neuroprotection	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; PROGENITOR CELLS; ORGANOTYPIC CULTURES; RAT; STROKE; DIFFERENTIATE; SURVIVAL; THERAPY; NEURONS	Bone marrow stromal cells (BMSCs) are capable of differentiating into various cell types including brain cells. Several groups have also demonstrated trophic effects of MSC grafts in experimental ischemia models. However, the underlying molecular mechanisms of these effects are not fully understood. We developed an "in vitro graft model" which consisted in a coculture of GFP-expressing BMSCs and hippocampal organotypic slice cultures. Total marrow cells (MCs) or BMSCs after one (BMSC1P) or five passages (BMSC5P) were transplanted on hippocampal slices. During the 10 days of our experiments, MCs and BMSC1P migrated toward the tissue, but their total number remained constant. Conversely, the number of BMSC5P decreased over the 10 days of the experiment, and no migration could be detected. Using immunohistochemistry, we observed that the hippocampal slices induced the expression of neural antigens in very few grafted cells, but MCs and BMSC1P improved the conservation of the hippocampal slice culture. Similar experiments using BMSC5P did not produce any significant change. We conclude that the number of passages greatly influence BMSCs survival rate, migration and neuroprotective capacities. (C) 2010 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Charriere, Karine; Risold, Pierre-Yves; Fellmann, Dominique] Univ Franche Comte, E43922, IFR133 IBCT, F-25000 Besancon, France		Charriere, K (corresponding author), Univ Franche Comte, E43922, IFR133 IBCT, 19 Rue Ambroise Pare, F-25000 Besancon, France.	kcharrie@univ-fcomte.fr	Risold, Pierre-Yves/AAJ-9535-2021; Risold, Pierre-Yves/M-7730-2018	Risold, Pierre-Yves/0000-0001-6801-591X	Franche-Comte Alzheimer Association	This work was supported in part with a grant from the "Franche-Comte Alzheimer Association".	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Anwar MR, 2008, J NEUROCHEM, V105, P460, DOI 10.1111/j.1471-4159.2007.05164.x; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bayer L, 1999, CELL TISSUE RES, V297, P23, DOI 10.1007/s004410051330; Bouchez G, 2008, NEUROCHEM INT, V52, P1332, DOI 10.1016/j.neuint.2008.02.003; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Delcroix GJR, 2009, BRAIN RES, V1255, P18, DOI 10.1016/j.brainres.2008.12.013; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Hachisuka H, 2007, J ORTHOP SCI, V12, P161, DOI 10.1007/s00776-006-1098-6; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Horn AP, 2009, NEUROSCI RES, V63, P35, DOI 10.1016/j.neures.2008.10.001; Kan I., 2007, V180, P219; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Price J, 2001, CURR OPIN NEUROBIOL, V11, P564, DOI 10.1016/S0959-4388(00)00250-6; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Sadan O, 2009, EXPERT OPIN BIOL TH, V9, P1487, DOI 10.1517/14712590903321439; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2008, NEUROREHAB NEURAL RE, V22, P447, DOI 10.1177/1545968308315596; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Vallieres L, 2003, J NEUROSCI, V23, P5197; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219; Wehner T, 2003, J NEUROSCI, V23, P5004; Wilson KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002609; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6	59	9	9	0	10	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1631-0691	1768-3238		CR BIOL	C. R. Biol.	AUG	2010	333	8					582	590		10.1016/j.crvi.2010.05.004			9	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	648VL	WOS:000281722400002	20688278				2022-02-06	
J	Corella, F; Horna, L; Villa, A; Gonzalez, JL; Soleto, J				Corella, Fernando; Horna, Lissete; Villa, Angel; Luis Gonzalez, Jose; Soleto, Javier			Irreducible 'pulled elbow': report of two cases and review of the literature	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						annular ligament displacement; nursemaid's elbow; pulled elbow; radial head subluxation	RADIAL-HEAD SUBLUXATION; NURSEMAIDS ELBOW; CHILDREN	Subluxation of the radial head is a common injury in young children. It occurs after longitudinal traction on the extended arm with the forearm in pronation. Diagnosis is made from history and clinical presentation. Closed reduction achieved by supination and flexion or by hyperpronating the affected arm can usually restore normal anatomy satisfactorily. Rarely, it requires open reduction. There are very few cases in the literature that have required open reduction and no article shows intraoperative photographs. We present two cases of delayed diagnosis owing to an atypical clinical history that required open reduction. J Pediatr Orthop B 19:304-306 (c) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Corella, Fernando; Horna, Lissete] Hosp Infanta Leonor, Dept Orthopaed Surg, Madrid 28031, Spain; [Villa, Angel; Luis Gonzalez, Jose; Soleto, Javier] Hosp Univ Gregorio Maranon, Dept Pediat Orthopaed Surg, Madrid, Spain		Corella, F (corresponding author), Hosp Infanta Leonor, Dept Orthopaed Surg, C Gran Via Este, Madrid 28031, Spain.	fernando.corella@gmail.com		Corella, Fernando/0000-0002-8044-8416			AMIR D, 1990, CLIN ORTHOP RELAT R, P94; BRETLAND PM, 1994, BRIT J RADIOL, V67, P1176, DOI 10.1259/0007-1285-67-804-1176; CHOUNG W, 1995, J PEDIATR ORTHOPED, V15, P454, DOI 10.1097/01241398-199507000-00008; Kaplan RE, 2002, PEDIATRICS, V110, P171, DOI 10.1542/peds.110.1.171; KOSUWON W, 1993, J BONE JOINT SURG BR, V75, P421, DOI 10.1302/0301-620X.75B3.8496211; Macias CG, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e10; MCRAE R, 1965, J BONE JOINT SURG BR, V47, P808; MEHARA AK, 1995, INT ORTHOP, V19, P174; Meiner EM, 2004, AM J EMERG MED, V22, P502, DOI 10.1016/j.ajem.2004.07.010; RYAN JR, 1969, J BONE JOINT SURG AM, VA 51, P781, DOI 10.2106/00004623-196951040-00020; SALTER RB, 1971, CLIN ORTHOP RELAT R, P134; Scapinelli R, 2005, RADIOL MED, V10, P655; SCHUNK JE, 1990, ANN EMERG MED, V19, P1019, DOI 10.1016/S0196-0644(05)82567-3; SNYDER H S, 1990, Journal of Emergency Medicine, V8, P265, DOI 10.1016/0736-4679(90)90003-E; Taha AM, 2000, ARCH ORTHOP TRAUM SU, V120, P336, DOI 10.1007/s004020050477; Teach SJ, 1996, ARCH PEDIAT ADOL MED, V150, P164, DOI 10.1001/archpedi.1996.02170270046006; Toupin P, 2007, CAN J EMERG MED, V9, P333; TRIANTAFYLLOU SJ, 1992, CLIN ORTHOP RELAT R, P153	18	9	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X			J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2010	19	4					304	306		10.1097/BPB.0b013e3283339a1b			3	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	615QR	WOS:000279151000004	20549851				2022-02-06	
J	Oster, I; Shamdeen, GM; Gottschling, S; Gortner, L; Meyer, S				Oster, Isabel; Shamdeen, Ghiath M.; Gottschling, Sven; Gortner, Ludwig; Meyer, Sascha			Electroencephalogram in children with minor traumatic brain injury	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						children; electroencephalogram (EEG); mild traumatic brain injury	BLUNT HEAD TRAUMA; DECISION RULE; EEG FINDINGS	Background: Mild traumatic brain injury (MTBI) is one of the most frequent causes for hospitalisation in childhood. Because of different guidelines in the management the diagnostic approach varies substantially. Apart from neuroimaging studies (CT, MRI, sonography) an electroencephalogram (EEG) is often performed without any evidence-based data supporting its use. Methods: Retrospective analysis of 150 children with MTBI (age 0-16 years), who were admitted to the Children's Hospital of the University of Saarland from January 2006 to December 2007. Results: Mean age was 4.3 (SD 3.6) years: 55.3% were boys. The most common mechanisms of injury were: Minor fall <1 m of height (60%) and fall >1.5 m of height (10%). The most common symptoms were: one or more episodes of vomiting (60%), somnolence (26.7%) and headache (12.7%). On 118 patients an EEG was performed; 106 (89.8%) were normal, 11 (9.3%) pathological and 1 (0.9%) invalid because of artefacts. The pathological EEGs showed focal findings with localised slowing in nine cases, spike-wave complexes in one case and general slowing in one case. Of the 11 patients with pathological EEG, two had a CT scan, two a MRI and two had cranial sonography; all the neuro-imaging was normal. None of the children required neurosurgical intervention, had a negative outcome or showed persistent symptoms. Conclusion: The routine performance of an EEG after MTBI in children is not indicated because in most of the cases it is unrevealing, and may lead to unnecessary diagnostic procedures. Instead, children with MTBI should be closely monitored for possible clinical complications and neurological deterioration.	[Oster, Isabel; Shamdeen, Ghiath M.; Meyer, Sascha] Univ Childrens Hosp Saarland, Sect Neuropediat, Homburg, Germany; [Gottschling, Sven] Univ Childrens Hosp Saarland, Sect Pediat Oncol & Hematol, Homburg, Germany; [Gortner, Ludwig; Meyer, Sascha] Univ Childrens Hosp Saarland, Dept Pediat Intens Care Med & Neonatol, Homburg, Germany		Meyer, S (corresponding author), Univ Hosp Saarland, Dept Pediat Intens Care Med & Neonatol & Neuroped, Bldg 9, D-66421 Homburg, Germany.	meyers1@gosh.uk.nhs					DENKER PG, 1954, NEUROLOGY, V4, P912, DOI 10.1212/WNL.4.12.912; ENOMOTO T, 1986, CHILD NERV SYST, V2, P72; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gerberding J.L., 2003, C MILD TRAUM BRAIN I; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Jacobson M, 1993, MINOR HEAD TRAUMA AS; JACOME DE, 1984, CLIN ELECTROENCEPHAL, V15, P214, DOI 10.1177/155005948401500406; Kooi K. A., 1978, FUNDAMENTALS ELECTRO; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Leblanc Kim Edward, 1999, Comprehensive Therapy, V25, P39, DOI 10.1007/BF02889833; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LIGUORI G, 1989, CHILD NERV SYST, V5, P160, DOI 10.1007/BF00272119; Meyer S, 2006, KLIN PADIATR, V218, P49, DOI 10.1055/s-2005-836607; Niedermeyer E., 1993, ELECTROENCEPHALOGRAP, P167; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; QUAYLE KS, 1997, PEDIATRICS, V99, P11; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214	24	9	9	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1034-4810			J PAEDIATR CHILD H	J. Paediatr. Child Health	JUL-AUG	2010	46	7-8					373	377		10.1111/j.1440-1754.2010.01754.x			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	626SK	WOS:000279987000003	20546098				2022-02-06	
J	Apostol, A; Apostol, R; Ali, E; Choi, A; Ehsuni, N; Hu, B; Li, L; Altura, BT; Altura, BM				Apostol, Alexander; Apostol, Radu; Ali, Erum; Choi, Anne; Ehsuni, Nazanin; Hu, Bin; Li, Lei; Altura, Bella T.; Altura, Burton M.			Cerebral spinal fluid and serum ionized magnesium and calcium levels in preeclamptic women during administration of magnesium sulfate	FERTILITY AND STERILITY			English	Article						Cerebral spinal fluid; preeclampsia; MgSO4 treatment; ionized magnesium; ionized calcium; ionized calcium:magnesium ratio; infants born to preeclamptic mothers	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; SUBARACHNOID HEMORRHAGE; PLASMA MAGNESIUM; PREGNANT-WOMEN; ACUTE STROKE; THERAPY; BLOOD; PHOSPHORUS; RECEPTORS	Objective: To study the distribution of ionized and total magnesium (Mg) in serum and cerebral spinal fluid (CSF) in preeclamptic women receiving MgSO4 and how this treatment affects the ionized calcium (Ca2+) and ionized Ca:Mg ratios compared with healthy nonpregnant women and pregnant control women (HP). Design: Controlled clinical study. Setting: An academic medical center. Patient(s): African-American women older than 20 and less than 35 years. The pregnant preeclamptic study and pregnant control groups each consisted of 16 women; the nonpregnant group consisted of 10 subjects. Intervention(s): The preeclamptic women received a 6-g bolus of MgSO4 IV started at least 4.5 hours before delivery during 15-20 minutes, then 2 g/h baseline. Main Outcome Measure(s): The CSF and serum levels of Ca2+ and Mg2+ and total Mg were measured in all three groups of women. The Ca2+:Mg2+ ratios were determined. Physiologic monitoring was done and recorded every 4 hours where appropriate. Bloods were drawn every 6 hours for complete blood count, metabolic panel, lactate dehydrogenase, uric acid, and electrolytes. Serum pH, total Mg, Apgar scores, and general health of the infants born to preeclamptic mothers given MgSO4 were followed. Result(s): The HP showed a reduction in mean serum ionized and total Mg, increase in ionized Ca, and a large increase in Ca2+:Mg2+ ratios compared with healthy nonpregnant women. Although the CSF ionized and total Mg and Ca2+:Mg2+ ratios were not altered with MgSO4 treatment in the preeclamptic women receiving MgSO4, the mean serum Mg values increased 3-fold. All infants were full-term, regardless of MgSO4 treatment, and normal with respect to birth weight, Apgar scores, blood pH, total Mg, and neurologic scores. Conclusion(s): The data indicate that there is a direct relationship between the serum and CSF Ca2+:Mg2+ ratios in HP and this ratio may be crucial in preventing vascular and neurologic complications in preeclampsia-eclampsia. (Fertil Steril (R) 2010; 94: 276-82. (C) 2010 by American Society for Reproductive Medicine.)	[Altura, Bella T.; Altura, Burton M.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Apostol, Alexander; Ali, Erum; Hu, Bin; Li, Lei] Suny Downstate Med Ctr, Dept Anesthesiol, Brooklyn, NY 11203 USA; [Apostol, Radu] Suny Downstate Med Ctr, Dept Obstet & Gynecol, Long Isl Coll Hosp, Brooklyn, NY 11203 USA; [Choi, Anne; Ehsuni, Nazanin] Suny Downstate Med Ctr, Dept Obstet & Gynecol, Brooklyn, NY 11203 USA		Altura, BM (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 31,450 Clarkson Ave, Brooklyn, NY 11203 USA.	baltura@downstate.edu					Altura B T, 1991, Magnes Trace Elem, V10, P90; ALTURA BM, 1983, SCIENCE, V221, P376, DOI 10.1126/science.6867714; Altura BM, 1995, CELL MOL BIOL RES, V41, P347; ALTURA BM, 1994, SCAND J CLIN LA S217, V54, P1; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P21, DOI 10.3109/00365519409095208; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P53, DOI 10.3109/00365519409095211; Altura BM, 2007, NEW PERSPECTIVES IN MAGNESIUM RESEARCH: NUTRITION AND HEALTH, P239, DOI 10.1007/978-1-84628-483-0_19; AULT B, 1980, J PHYSIOL-LONDON, V307, P413, DOI 10.1113/jphysiol.1980.sp013443; BARDICEF M, 1995, AM J OBSTET GYNECOL, V172, P1009, DOI 10.1016/0002-9378(95)90035-7; Belfort MA, 2003, NEW ENGL J MED, V348, P304, DOI 10.1056/NEJMoa021180; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; CHAISTITWANICH R, 1987, PHARMACOL BIOCHEM BE, V27, P443, DOI 10.1016/0091-3057(87)90347-9; CHARBON GA, 1962, ACTA PHYSIOL PHARM N, V11, P141; CHESLEY LC, 1957, SURG CLIN N AM, V37, P353; CHI OZ, 1990, ARCH INT PHARMACOD T, V304, P196; DeLorenzo R J, 1986, Adv Neurol, V44, P435; DeLorenzo RJ, 1996, ADV NEUROL, V71, P37; Demougeot C, 2004, NEUROSCI LETT, V362, P17, DOI 10.1016/j.neulet.2004.01.034; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Emoto M, 2007, NEW PERSPECTIVES IN MAGNESIUM RESEARCH: NUTRITION AND HEALTH, P197, DOI 10.1007/978-1-84628-483-0_16; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; FLOWERS CE, 1965, AM J OBSTET GYNECOL, V91, P763, DOI 10.1016/0002-9378(65)90451-5; FuchsBuder T, 1997, J NEUROSURG ANESTH, V9, P324, DOI 10.1097/00008506-199710000-00006; HALL DG, 1957, OBSTET GYNECOL, V9, P158; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; Hallak M, 1998, MAGNESIUM RES, V11, P117; HANDWERKER SM, 1993, AM J PERINAT, V10, P392, DOI 10.1055/s-2007-994770; Handwerker SM, 1996, J AM COLL NUTR, V15, P36; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; HEINEMANN U, 1986, EXP BRAIN RES, V65, P1; Heitner JC, 2006, J CHROMATOGR B, V840, P10, DOI 10.1016/j.jchromb.2006.06.002; Hirschfelder AD, 1934, J AMER MED ASSOC, V102, P1138, DOI 10.1001/jama.1934.02750140024010; Holland E., 1909, J OBSTET GYN BR COMM, V16, P255; HORNE CHW, 1970, J CLIN PATHOL, V23, P514, DOI 10.1136/jcp.23.6.514; HUANG J, 1990, FOOD STRUCT, V9, P113; Jin YH, 2008, SYNTHETIC MET, V158, P64, DOI 10.1016/j.synthmet.2007.12.005; KROLL MH, 1985, CLIN CHEM, V31, P244; Lampl Y, 2001, CLIN NEUROPHARMACOL, V24, P11, DOI 10.1097/00002826-200101000-00003; Laurant P, 2000, J HYPERTENS, V18, P1177, DOI 10.1097/00004872-200018090-00003; Lazard EM, 1925, AM J OBSTET GYNECOL, V9, P178, DOI 10.1016/S0002-9378(25)90068-3; LINDHEIMER MD, 1981, ANNU REV MED, V32, P273, DOI 10.1146/annurev.me.32.020181.001421; LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401; Lyall F, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P20; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MACGILLIVRAY I, 1957, J OBSTET GYNAECOL, V64, P361; MACK HC, 1955, PLASMA PROTEINS PREG; Marier JR, 1982, MAGNESIUM, V1, P3; MARIER JR, 1982, MAGNESIUM, V1, P266; Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Mikuni N, 1999, EPILEPSIA, V40, P1683, DOI 10.1111/j.1528-1157.1999.tb01584.x; Mittendorf R, 2002, J PEDIATR-US, V140, P540, DOI 10.1067/mpd.2002.123283; Miyamoto Y, 2004, PEDIATR INT, V46, P394, DOI 10.1111/j.1442-200x.2004.01922.x; Muir KW, 1998, MAGNESIUM RES, V11, P43; PARBY P, 1960, J OBSTET GYN BRIT EM, V67, P43; REBOUD P, 1963, AM J OBSTET GYNECOL, V86, P820; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Schendel DE, 1996, JAMA-J AM MED ASSOC, V276, P1805, DOI 10.1001/jama.276.22.1805; SEELIG MS, 1981, MAGNESIUM-B, V3, P26; SEELIG MS, 1980, MAGNESIUM DEFICIENCY; SEGAL M, 1992, J PHYSIOL-LONDON, V448, P655, DOI 10.1113/jphysiol.1992.sp019063; Sinert R, 2007, SCAND J CLIN LAB INV, V67, P317, DOI 10.1080/00365510601051441; SPEICH M, 1981, CLIN CHEM, V27, P246; Studd J W, 1970, J Obstet Gynaecol Br Commonw, V77, P796; STUDD J W W, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P511; STUDD J W W, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P42, DOI 10.1111/j.1471-0528.1970.tb03406.x; STUDD WW, 1970, BRIT MED J, V1, P568, DOI 10.1136/bmj.1.5695.568-a; THURNAU GR, 1987, AM J OBSTET GYNECOL, V157, P1435, DOI 10.1016/S0002-9378(87)80239-9; van den Bergh WM, 2003, ACTA NEUROCHIR, V145, P195, DOI 10.1007/s00701-002-1064-9; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Watchorn E, 1932, BIOCHEM J, V26, P54, DOI 10.1042/bj0260054; Zhang AM, 1996, BRAIN RES, V728, P204, DOI 10.1016/S0006-8993(96)00401-5; ZUSPAN FP, 1969, J REPROD MED, V2, P116	75	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	JUN	2010	94	1					276	282		10.1016/j.fertnstert.2009.02.024			7	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	611XM	WOS:000278858200046	19324346				2022-02-06	
J	Fletcher, JJ; Bergman, K; Carlson, G; Feucht, EC; Blostein, PA				Fletcher, Jeffrey J.; Bergman, Karen; Carlson, Glenn; Feucht, Eric C.; Blostein, Paul A.			Continuous Renal Replacement Therapy for Refractory Intracranial Hypertension?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Continuous renal replacement therapy; Intracranial pressure; Refractory intracranial hypertension; Traumatic brain injury	CONTINUOUS VENOVENOUS HEMOFILTRATION; TRAUMATIC BRAIN-INJURY; HEPATIC-ENCEPHALOPATHY; PRESSURE; FAILURE; HEMODIALYSIS; DIALYSIS; UREMIA; WATER	Background: Continuous renal replacement therapy (CRRT) is the preferred mode of renal replacement therapy in patients with acute brain injury (ABI). There are limited data available describing the effects of CRRT on intracranial pressure (ICP). This study aims to evaluate changes in ICP during CRRT in patients after ABI. Methods: This is a retrospective observational cohort study of patients with ABI, who had ICP monitoring as part of routine management and also underwent CRRT. Hourly ICP and fluid balance, type and indication for CRRT, ICP management, and patient demographics were extracted from the medical record. Wilcoxon signed-rank test was used to evaluate changes in ICP and volume during the 12 hours before and after the initiation of CRRT. Results: Two patients with severe traumatic brain injury, one patient with moderate traumatic brain injury and one patient with subarachnoid hemorrhage were identified. Three patients were diagnosed with refractory intracranial hypertension (RIH) before the initiation of therapy and had a nonsignificant trend toward reduction of ICP during CRRT (p = 0.1810). One patient with chronic renal failure, who developed elevated ICP during conventional intermittent hemodialysis, demonstrated stability of ICP when switched to CRRT. Conclusions: CRRT may have beneficial effects in patients with RIH. Given the high mortality rate and poor neurological outcome associated with RIH, further research may be warranted.	[Fletcher, Jeffrey J.] Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Fletcher, Jeffrey J.] Univ Michigan Hosp & Hlth Ctr, Dept Neurol, Ann Arbor, MI 48109 USA; [Bergman, Karen; Carlson, Glenn; Blostein, Paul A.] Bronson Methodist Hosp, Dept Trauma Surg & Crit Care, Kalamazoo, MI USA; [Feucht, Eric C.] Bronson Methodist Hosp, Dept Crit Care Med, Kalamazoo, MI USA		Fletcher, JJ (corresponding author), Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, 3552 Taubman Hlth Care Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jeffletc@med.umich.edu					ARIEFF AI, 1973, KIDNEY INT, V4, P177, DOI 10.1038/ki.1973.100; ARIEFF AI, 1976, J CLIN INVEST, V58, P306, DOI 10.1172/JCI108473; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BELLOMO R, 1993, CRIT CARE MED, V21, P522, DOI 10.1097/00003246-199304000-00011; BERTRAND YM, 1983, INTENS CARE MED, V9, P321, DOI 10.1007/BF01692550; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; DAVENPORT A, 1987, BRIT MED J, V295, P1028, DOI 10.1136/bmj.295.6605.1028; Davenport A, 1999, KIDNEY INT, V56, pS62, DOI 10.1046/j.1523-1755.56.s.72.3.x; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; DAVENPORT A, 1991, CONTRIB NEPHROL, V93, P225; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846; Fletcher JJ, 2009, NEUROCRIT CARE, V11, P101, DOI 10.1007/s12028-009-9197-9; Galons JP, 1996, J CLIN INVEST, V98, P750, DOI 10.1172/JCI118847; Goldsmith DJA, 1997, CLIN SCI, V93, P593, DOI 10.1042/cs0930593; Lin CM, 2008, ACTA NEUROCHIR SUPPL, V101, P141; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Silver SM, 1995, J AM SOC NEPHROL, V6, P1600; TRACHTMAN H, 1993, J AM SOC NEPHROL, V3, P1913; MANAGEMENT SEVERE TR	22	9	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1506	1509		10.1097/TA.0b013e3181dbbf1b			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	610ES	WOS:000278714600043	20539193				2022-02-06	
J	Helmy, A; Timofeev, I; Palmer, CR; Gore, A; Menon, DK; Hutchinson, PJ				Helmy, Adel; Timofeev, Ivan; Palmer, Christopher R.; Gore, Alison; Menon, David K.; Hutchinson, Peter J.			Hierarchical log linear analysis of admission blood parameters and clinical outcome following traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Statistical models; Hematologic tests; Hierarchical log linear model	PROGNOSTIC VALUE; HEAD-INJURY; IMPACT; REGRESSION; VARIABLES; SCALE; TREE	Numerous statistical methods have been utilised to generate predictive models that identify clinical and biochemical parameters of prognostic value following traumatic brain injury. While these methods provide an accurate statistical description between these variables and outcome, they are difficult to interpret intuitively. Hierarchical log linear analysis can be utilised to present the complex interactions between these variables and outcome visually. We compiled a database of 327 traumatic brain injury patients, their admission blood parameters, clinical admission parameters, and 6-month Glasgow Outcome Score. Seven variables (age, injury severity, Glasgow Coma Score, glucose, albumin, haemoglobin, white cell count) that correlated with outcome in a univariate analysis and two further variables, included on the basis of biological plausibility, (abnormal clotting and magnesium) were used to derive and present a hierarchical log linear model. Seventeen (out of an original forty-five possible) inter-relationships between the chosen variables were identified as remaining in the hierarchical log linear model. This data is presented pictorially in a hierarchy demonstrating the directness of the statistical association between each of the variables and dichotomised outcome. Four variables within the hierarchical log linear model (age, raised serum glucose, low haemoglobin, Glasgow Coma Score) had a direct independent statistical relationship with outcome. The remaining five variables only had a statistical relationship with outcome via at least one other variable. Hierarchical log linear analysis allows the presentation of multivariate, categorical data sets in a pictorial and more easily interpretable fashion.	[Helmy, Adel] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Helmy, Adel; Timofeev, Ivan; Hutchinson, Peter J.] Univ Cambridge, Dept Neurosurg, Cambridge CB2 0QQ, England; [Palmer, Christopher R.; Gore, Alison] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge CB2 0QQ, England; [Menon, David K.] Univ Cambridge, Dept Anaesthesia, Cambridge CB2 0QQ, England		Helmy, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Addenbrookes Hosp, Box 167,Hills Rd, Cambridge CB2 0QQ, England.	adelhelmy@cantab.net	Timofeev, Ivan/AAE-7019-2019; Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Timofeev, Ivan/0000-0002-1168-0393	Medical Research Council/Royal College of Surgeons of EnglandUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Raymond and Beverly Sackler Fellowship; Academy of Medical Sciences/Health Foundation; UK National Institute for Health ResearchNational Institute for Health Research (NIHR); NIHRNational Institute for Health Research (NIHR); East of England RDS; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0802251, G0601025, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G0802251, G9439390, G0600986, G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2006-14-004, NF-SI-0508-10327] Funding Source: researchfish	AH is supported by a joint Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship and a Raymond and Beverly Sackler Fellowship.; PJH is supported by the Academy of Medical Sciences/Health Foundation Fellowship; DKM is supported by a Senior Investigator Award from the UK National Institute for Health Research.; The Centre for Applied Medical Statistics is supported by NIHR and East of England RDS.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Meloni BP, 2006, MAGNESIUM RES, V19, P123; *NHS HOSP, NHS HOSP EP STAT; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034	15	9	9	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUN	2010	152	6					953	957		10.1007/s00701-009-0584-y			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	597TA	WOS:000277783300004	20069321				2022-02-06	
J	Hesselmann, V; Lippert-Gruner, M; Rommel, T; Wedekind, C				Hesselmann, Volker; Lippert-Gruener, Marcela; Rommel, Thomas; Wedekind, Christoph			Abnormal functional MRI BOLD contrast in the vegetative state after severe traumatic brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						cerebral autoregulation; functional imaging; minimally conscious state; persistent vegetative state; rehabilitation; traumatic brain injury	CEREBRAL-BLOOD-FLOW; FMRI; DISORDERS; RECOVERY; INFANTS	For the rehabilitation process, the treatment of patients surviving brain injury in a vegetative state is still a serious challenge. The aim of this study was to investigate patients exhibiting severely disturbed consciousness using functional magnetic resonance imaging. Five cases of posttraumatic vegetative state and one with minimal consciousness close to the vegetative state were studied clinically, electrophysiologically, and by means of functional magnetic resonance imaging. Visual, sensory, and acoustic paradigms were used for stimulation. In three patients examined less than 2 months after trauma, a consistent decrease in blood oxygen level dependent (BOLD) signal ('negative activation') was observed for visual stimulation; one case even showed a decrease in BOLD activation for all three activation paradigms. In the remaining three cases examined more than 6 months after trauma, visual stimulation yielded positive BOLD contrast or no activation. In all cases, sensory stimulation was followed by a decrease in BOLD signal or no activation, whereas auditory stimulation failed to elicit any activation with the exception of one case. Functional magnetic resonance imaging in the vegetative state indicates retained yet abnormal brain function; this abnormality can be attributed to the impairment of cerebral vascular autoregulation or an increase in the energy consumption of activated neocortex in severe traumatic brain injury. International Journal of Rehabilitation Research 33:134-141 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Hesselmann, Volker] Univ Cologne, Dept Neurosurg, Cologne, Germany; [Hesselmann, Volker] Univ Cologne, Dept Radiol, Cologne, Germany; [Lippert-Gruener, Marcela] Charles Univ Prague, Dept Rehabil Med, Prague, Czech Republic; [Rommel, Thomas] RehaNova Rehabil Ctr, Cologne, Germany; [Wedekind, Christoph] City Hosp, Dept Neurosurg, Bamberg, Germany		Wedekind, C (corresponding author), Klinikum Bamberg, Dept Neurosurg, D-96049 Bamberg, Germany.	christoph.wedekind@sozialstiftung-bamberg.de					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; Chiappa K.H., 1997, EVOKED POTENTIALS CL; CHILDS NL, 1993, NEUROLOGY, V280, P77; Eickhoff SB, 2008, EXP NEUROL, V214, P240, DOI 10.1016/j.expneurol.2008.08.007; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hesselmann V, 2001, HEARING RES, V158, P160, DOI 10.1016/S0378-5955(01)00307-0; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Moritz CH, 2001, MAGN RESON IMAGING, V19, P1129, DOI 10.1016/S0730-725X(01)00432-5; OWEN AM, 2008, NEUROSCIENCE, V3, P235; Rother J, 2002, NEUROIMAGE, V15, P98, DOI 10.1006/nimg.2001.0965; Rousseau MC, 2008, BRAIN INJURY, V22, P123, DOI 10.1080/02699050801895415; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Rudolf J, 1999, J NEUROSURG ANESTH, V11, P17, DOI 10.1097/00008506-199901000-00004; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Yamada H, 1997, NEUROREPORT, V8, P3775, DOI 10.1097/00001756-199712010-00024	24	9	9	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2010	33	2					151	157		10.1097/MRR.0b013e328331c5b3			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	602CS	WOS:000278116700008	19966571				2022-02-06	
J	Kleinert, K; Schleich, F; Biasca, N; Simmen, HP				Kleinert, K.; Schleich, F.; Biasca, N.; Simmen, H. P.			Is there a Correlation between S100 beta and Post-Concussion Symptoms after Mild Traumatic Brain Injury?	ZENTRALBLATT FUR CHIRURGIE			German	Article						biochemical marker; mTBI; headache; PCS; S100 beta		In the past a lot of patients suffered from post-concussive symptoms (PCS) after mild traumatic brain injury (mTBI). The present prospective study (n=73) was intended to help predict the outcome after mTBI with blood asservation for analysis of S100 beta 3hours after trauma. There was no statistically significant correlation between PCS or even of single symptoms and elevated marker levels. Serum S100 beta appears to be a poor predictor of the outcome following mild TBI. Establishing a diagnosis of "PCS" will still be hard in future, since no objective diagnostic method exists. The most important facts are a precise examination and a history of the patient with a negative CT scan of the head.	[Kleinert, K.; Schleich, F.; Biasca, N.; Simmen, H. P.] Spital Oberengadin, Unfallchirurg Klin, CH-7503 Samedan, Switzerland		Kleinert, K (corresponding author), Univ Zurich, Orthopad Univ Klin Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	kathi-KK@web.de					ABDESSELAM OB, 2003, CLIN CHEM, V49, P836; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; ZIMMER DB, 1987, AM J PHYSIOL, V252, P285	5	9	9	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-409X			ZBL CHIR	Zent.bl. Chir.	JUN	2010	135	3					277	278		10.1055/s-0028-1098766			2	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	628QG	WOS:000280134900015	19842078				2022-02-06	
J	Soo, C; Tate, RL; Aird, V; Allaous, J; Browne, S; Carr, B; Coulston, C; Diffley, L; Gurka, J; Hummell, J				Soo, Cheryl; Tate, Robyn L.; Aird, Vanessa; Allaous, Jeanine; Browne, Stuart; Carr, Belinda; Coulston, Carissa; Diffley, Louise; Gurka, Joseph; Hummell, Jill			Validity and Responsiveness of the Care and Needs Scale for Assessing Support Needs After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Mid-Year Meeting of the International-Neuropsychological-Society	JUL 02-05, 2008	Buenos Aires, ARGENTINA	Int Neuropsychol Soc		Brain injuries; Needs assessment; Rehabilitation; Responsiveness; Validity	FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY RATING-SCALE; PSYCHOMETRIC PROPERTIES; ENVIRONMENTAL-FACTORS; SERVICE NEEDS; HEAD-INJURY; TBI; PRODUCTIVITY; RELIABILITY; COMMUNITY	Objective: To investigate the validity and responsiveness of the Care and Needs Scale (CANS), which was designed to assess support needs of people with traumatic brain injury (TBI). Design: Two samples of community clients (n=38, n=30) were recruited to examine concurrent, convergent/divergent, and discriminant validity. The ability of the CANS to detect change over a 6-month period from the time of inpatient rehabilitation discharge (predictive validity and responsiveness) was investigated in a third sample of 40 rehabilitation inpatients. Setting: Two Brain Injury Rehabilitation Units in Sydney, Australia. Participants: People (N=108) aged between 16 and 70 years admitted for rehabilitation after TBI. Interventions: Not applicable. Main Outcome Measures: The CANS, Supervision Rating Scale, FIM, Sydney Psychosocial Reintegration Scale, and Disability Rating Scale. Results: Evidence for concurrent validity was shown with fair to moderate correlation coefficients between the CANS and measures of supervision, functional independence, and psychosocial functioning (absolute value, r(s)=.43.68; P<.01). Support for convergent and divergent validity was provided by correlation coefficients that were higher for measures tapping similar constructs (absolute value, r(s)=46; P<.01) but lower for measures of dissimilar constructs (absolute value, r(s)=.07.26; not significant). In addition, the CANS discriminated between levels of injury severity, functional independence, and overall functioning (P<.01). In terms of predictive validity and responsiveness, CANS scores at inpatient rehabilitation discharge predicted the participant's functioning 6 months later. Conclusions: These results show the CANS is a valid and responsive tool and, together with its previously shown reliability, is suitable for routine application in clinical and research practice.	[Soo, Cheryl; Tate, Robyn L.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, No Clin Sch, Sydney, NSW 2006, Australia; [Soo, Cheryl] Murdoch Childrens Res Inst Melbourne, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia; [Aird, Vanessa; Allaous, Jeanine; Browne, Stuart; Carr, Belinda; Coulston, Carissa] Royal Rehabil Ctr Sydney, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Coulston, Carissa] Univ Sydney, Discipline Psychol Med, Sydney, NSW 2006, Australia; [Coulston, Carissa] Royal N Shore Hosp, CADE Clin, Dept Acad Psychiat, Sydney, NSW, Australia; [Diffley, Louise; Gurka, Joseph; Hummell, Jill] Westmead Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Tate, RL (corresponding author), Univ Sydney, Rehabil Studies Unit, Royal Rehabil Ctr Sydney, POB 6, Ryde, NSW 1680, Australia.	rtate@med.usyd.edu.au	Coulston, Carissa/ABB-8090-2020				Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Costa P. T., 1992, REVISED NEO PERSONAL; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOUGEYROLLAS P, 1995, DISABIL REHABIL, V17, P145, DOI 10.3109/09638289509166709; Glang A, 2004, NEUROREHABILITATION, V19, P219; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; HOLDEN RR, 1994, PERS INDIV DIFFER, V17, P441, DOI 10.1016/0191-8869(94)90291-7; HOLZER CE, 1984, RES COMMUNITY MENTAL, V0004; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Keith MS, 1998, BRAIN INJURY, V12, P1037, DOI 10.1080/026990598121945; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2008, DEV NEUROREHABIL, V11, P204, DOI 10.1080/17518420802259498; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	9	9	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2010	91	6					905	912		10.1016/j.apmr.2009.11.033			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	610SM	WOS:000278755800012	20510982				2022-02-06	
J	Wait, JW; Schoeman, JF				Wait, J. W.; Schoeman, J. F.			Behaviour Profiles After Tuberculous Meningitis	JOURNAL OF TROPICAL PEDIATRICS			English	Article						TBM; CBCL; behaviour; social problems; attention; child	TRAUMATIC BRAIN-INJURY; MILIARY TUBERCULOSIS; CHILDREN; CHILDHOOD; SEIZURES; EPILEPSY	The purpose of the study was to investigate child behaviour in children who recovered from tuberculous meningitis (TBM) and to compare behaviour profiles of stage II and stage III patients. The mean age of the cohort of 74 children at the time of evaluation was 10 years and 7 months. At follow-up all patients underwent a thorough neurological examination and a psychometric test battery, which included intellectual assessment and evaluation of behaviour by means of the CBCL/6-18. Results indicated elevated mean scores (T > 60) on CBCL/6-18 scales which measure problems with anxiety, depression, attention, social relationships, disruptive and rule-breaking behaviour. Mean CBCL scores of stage III patients were significantly higher than the mean scores of stage II patients on scales which measure social problems, disruptive and rule-breaking behaviour. In addition, problems with conduct, attention, attention-deficit/hyperactivity problems, affective problems as well as the total problem scores were more pronounced in the patients with stage III TBM. We conclude that general behavioural disinhibitions as well as internalized emotional disorder probably are long-term complications in more than 10% of the survivors of TBM.	[Schoeman, J. F.] Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, Cape Town, South Africa; [Schoeman, J. F.] Univ Stellenbosch, Fac Hlth Sci, ZA-7600 Stellenbosch, South Africa; [Wait, J. W.; Schoeman, J. F.] Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa		Schoeman, JF (corresponding author), Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, POB 19063, ZA-7505 Tygerberg, Cape Town, South Africa.	jfs@sun.ac.za					Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Austin JK, 2002, EPILEPSIA, V43, P1564, DOI 10.1046/j.1528-1157.2002.26002.x; Bearden CE, 2004, NEUROCASE, V10, P198, DOI 10.1080/13554790490495519; Caplan R, 2005, EPILEPSY BEHAV, V6, P218, DOI 10.1016/j.yebeh.2004.11.020; Caplan R, 2004, EPILEPSIA, V45, P1273, DOI 10.1111/j.0013-9580.2004.58703.x; DEENY JE, 1985, S AFR MED J, V68, P75; DONALD PR, 1987, J TROP PEDIATRICS, V33, P213, DOI 10.1093/tropej/33.4.213; Donald PR, 2005, J INFECTION, V50, P193, DOI 10.1016/j.jinf.2004.02.010; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Duval J, 2002, Appl Neuropsychol, V9, P74, DOI 10.1207/S15324826AN0902_2; Fossen A, 1998, PEDIATR HEMAT ONCOL, V15, P479, DOI 10.3109/08880019809018309; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; Hausler M, 2004, KLIN PADIATR, V216, P244, DOI 10.1055/s-2004-44900; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Kalita J, 2002, Electromyogr Clin Neurophysiol, V42, P39; KARANDE S, 2005, NEUROL INDIA, V53, P375; MARSHALL G, 1948, LANCET, V254, P582; MULHERN RK, 1993, J PEDIATR PSYCHOL, V18, P339, DOI 10.1093/jpepsy/18.3.339; Padayatchi NI, 2006, PEDIATR INFECT DIS J, V25, P147, DOI 10.1097/01.inf.0000199314.88063.4c; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Schoeman J, 2002, DEV MED CHILD NEUROL, V44, P522, DOI 10.1017/S0012162201002493; Schoeman JF, 1997, CLIN NEUROPATHOL, V16, P303; Schoeman JF, 2000, CHILD NERV SYST, V16, P203, DOI 10.1007/s003810050497; Sengoz G, 2005, TUBERK TORAK, V53, P50; Seth Rachna, 2002, Indian Journal of Pediatrics, V69, P299; van den Bos F, 2004, TROP MED INT HEALTH, V9, P309, DOI 10.1046/j.1365-3156.2003.01185.x; Wait JWV, 2002, J TROP PEDIATRICS, V48, P294, DOI 10.1093/tropej/48.5.294; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325	29	9	9	2	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	JUN	2010	56	3					166	171		10.1093/tropej/fmp080			6	Pediatrics; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Tropical Medicine	616XG	WOS:000279244200005	19710247	Bronze			2022-02-06	
J	Lundberg, J; Jonsson, S; Holmin, S				Lundberg, Johan; Jonsson, Stefan; Holmin, Staffan			New Endovascular Method for Transvascular Exit of Arteries and Veins: Developed in Simulator, in Rat and in Rabbit with Full Clinical Integration	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; STROMAL CELL TREATMENT; STEM-CELLS; ISLET TRANSPLANTATION; MIGRATION; STROKE	Background: Endovascular technique has benefits vis-a-vis surgical access to organs with less accessible anatomical locations. To minimize surgical risk we propose a novel endovascular technique, to create parenchymal access through endovascular methods. Methodology/Principal Findings: We have developed, manufactured and tested an endovascular catheter with a depth limiting collar and a penetrating tip that is used to perforate vessels, thereby creating a working channel to the extravascular space. Computer simulations and subsequent interventions have been performed ex vivo and in vivo in both small and large animals by testing different prototypes. All tests were designed for testing extravascular hemostasis and absence of thrombo-embolic complications when exiting the vessels from the inside to the extra vascular space. We have deposited prototypes after intervention in vascular walls over a period of 14 days in rat with no impairment on blood flow and no signs of thrombo-embolic complications upon re-exploration (n = 7). We have also incorporated the catheter system with clinically available systems both in an ex vivo simulator setting and in a full scale clinical angiographical setting in rabbit were no bleeding (0%) in any of the interventions performed (n = 40). To prevent hemorrhage during termination of the procedure, a hollow electrolysis detachment-zone leaves the distal tip in the vessel-wall after the intervention. This has also been tested with absolute hemostasis in large animals (n = 6). Conclusions/Significance: We have developed and tested a new system for transvascular tissue access in simulations, ex vivo and in vivo in small and large animals, integrating it with standard clinical catheters and angiographical environment, with absolute hemostasis and without thromboembolic complications. In a clinical setting for stem cell transplantation, local substance administration or tissue sampling, the benefit should be greatest in organs that are difficult or high-risk to access with other techniques, such as the pancreas, the central nervous system (CNS) and the heart.	[Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Jonsson, Stefan] Royal Inst Technol, Dept Mat Sci & Engn, Stockholm, Sweden		Lundberg, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	staffan.holmin@karolinska.se		Holmin, Staffan/0000-0002-1628-1615	Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2006-73X-20139-01-3]; Karolinska InstitutetKarolinska Institutet; Karolinska Institutet Innovations; Swedish Society of Medicine; Strokefonden	This study was supported by grants from the Swedish Research Council (K2006-73X-20139-01-3), Karolinska Institutet funds, Karolinska Institutet Innovations, the Swedish Society of Medicine and Strokefonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale R, 2007, MINIM INVASIV THER, V16, P196, DOI 10.1080/13645700701520578; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; FAY JA, 1994, INTRO FLUID MECH; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P165, DOI 10.1001/jama.298.2.165; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; John D. B., 1996, THEORY PRACTICE HIST; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; LUNDBERG J, 2009, NEURORADIOLOGY; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Siminiak T, 2005, EUR HEART J, V26, P1188, DOI 10.1093/eurheartj/ehi159; Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8; Villiger P, 2005, AM J TRANSPLANT, V5, P2992, DOI 10.1111/j.1600-6143.2005.01108.x; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342	19	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2010	5	5							e10449	10.1371/journal.pone.0010449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	590PW	WOS:000277240300022	20454668	gold, Green Published, Green Submitted			2022-02-06	
J	Endele, SM; Wirth, T; Eberhardt, O; Fernandez, FF				Endele, Sandra Maria; Wirth, Thomas; Eberhardt, Oliver; Fernandez, Francisco F.			The treatment of radial neck fractures in children according to Metaizeau	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						children; closed intramedullary pin reduction; Metaizeau; radial neck fractures	DISPLACED FRACTURES; OSTEOSYNTHESIS; MANAGEMENT; REDUCTION; HEAD	Treatment of displaced radial neck fractures is challenging. Between 1993 and 2006, we treated 63 children using the closed intramedullary pin reduction technique according to Metaizeau in our department. In a retrospective study, associated injuries and complications were evaluated. Eighty-six percent of the patients could be contacted for follow-up questioning. Thirty-nine percent had associated injuries. All Judet II, III and most of type IV fractures could be treated with the closed method. Ninety-eight percent showed an excellent or good result according to Morrey, 90% to Metaizeau score. The closed intramedullary pin reduction technique proved to be an innovative minimal invasive technique for displaced radial neck fractures by allowing anatomical reconstruction and stable treatment. J Pediatr Orthop B 19:246-255 (V) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Endele, Sandra Maria; Wirth, Thomas; Eberhardt, Oliver; Fernandez, Francisco F.] Olgahosp Stuttgart, Dept Orthoped & Trauma, D-70176 Baden Wurttemberg, Germany		Endele, SM (corresponding author), Olgahosp Stuttgart, Dept Orthoped & Trauma, Bismarkstr 8, D-70176 Baden Wurttemberg, Germany.	sandramariah@web.de					CHAMBERS HG, 2001, FRACTURES CHILDREN, V5, P483; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Evans MC, 1999, J PEDIATR ORTHOP B, V8, P93; GonzalezHerranz P, 1997, J PEDIATR ORTHOPED, V17, P325, DOI 10.1097/00004694-199705000-00011; JUDET J, 1962, Ann Chir, V16, P1377; Metaizeau JP, 2005, INJURY, V36, pA75, DOI 10.1016/j.injury.2004.12.016; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; Metaizeau JP, 1993, J PEDIATR ORTHOPED, V63, P245; Morrey BF, 1985, ELBOW ITS DISORDERS, V3rd, P73; Prathapkumar KR, 2006, J BONE JOINT SURG BR, V88B, P358, DOI 10.1302/0301-620X.88B3.17099; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Sessa S, 1996, J PEDIATR ORTHOP B, V5, P200, DOI 10.1097/01202412-199605030-00012; Stiefel D, 2001, J BONE JOINT SURG BR, V83B, P536, DOI 10.1302/0301-620X.83B4.11060; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; Ursei Monica, 2006, Acta Orthop Belg, V72, P131; Vocke AK, 1998, J PEDIATR ORTHOP B, V7, P217, DOI 10.1097/01202412-199807000-00007	16	9	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	MAY	2010	19	3					246	255		10.1097/BPB.0b013e32833918c0			10	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	586AV	WOS:000276874000008	20603904				2022-02-06	
J	Lange, RT; Brubacher, JR; Iverson, GL; Procyshyn, RM; Mitrovic, S				Lange, Rael T.; Brubacher, Jeffrey R.; Iverson, Grant L.; Procyshyn, Ric M.; Mitrovic, Suzana			Differential Effects of Alcohol Intoxication on S100B Levels Following Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Alcohol; Traumatic brain injury; S100B; Biochemical marker	NEURON-SPECIFIC ENOLASE; GLASGOW COMA SCALE; SERUM-LEVELS; HEAD-INJURY; BIOCHEMICAL MARKERS; SUBSTANCE-ABUSE; SYSTEMATIC BIAS; ELITE PLAYERS; S-100B; PROTEIN	Background: In an acute care setting, evaluation of traumatic brain injury (TBI) is often complicated by alcohol intoxication. The purpose of this study is to evaluate the clinical utility of the protein S100B as a biochemical marker for identifying brain injury in patients who are intoxicated at the time of injury. Methods: The study participants were 160 patients who presented to a large urban Level I Trauma Centre in Vancouver, Canada. Patients were classified into four clinical groups (medical controls, trauma controls, mild TBI, and definite TBI) and two day-of-injury alcohol intoxication groups (i.e., sober and intoxicated). Blood samples were collected via venipuncture in heparinized tubes within 8 hours of injury. Measures of S100B concentration were obtained using a commercially available assay kit (Sangtec 100 Elisa). Results: For those patients who were sober at the time of injury, higher S100B levels were associated with TBI when compared with other physical injuries and general medical complaints. However, for patients who were intoxicated at the time of injury, there were uniformly low S100B levels across all clinical groups. Conclusions: Although there seems to be a strong association between S100B levels and TBI, further research is required to establish the clinical role of S100B in patients with suspected TBI, particularly in patients whose clinical presentation is complicated by alcohol intoxication.	[Lange, Rael T.] British Columbia Mental Hlth & Addict Serv, PHSA Res & Networks, Dept Res, Vancouver, BC V5Z 4C2, Canada; [Lange, Rael T.; Brubacher, Jeffrey R.; Iverson, Grant L.; Procyshyn, Ric M.; Mitrovic, Suzana] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada; [Brubacher, Jeffrey R.] Vancouver Gen Hosp, Emergency Dept, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Lange, RT (corresponding author), British Columbia Mental Hlth & Addict Serv, PHSA Res & Networks, Dept Res, Suite 201,601 W Broadway St, Vancouver, BC V5Z 4C2, Canada.	rlange@bcmhs.bc.ca	Procyshyn, Ric/AAE-5499-2019	Iverson, Grant/0000-0001-7348-9570; Procyshyn, Ric/0000-0002-4348-0855; Brubacher, Jeffrey/0000-0002-4866-4231	British Columbia Mental Health and Addictions Research Network, Vancouver, Canada	Supported in part by a Development Grant from the British Columbia Mental Health and Addictions Research Network, Vancouver, Canada.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Biberthaler P, 2000, ACT NEUR S, V76, P177; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; *CAN I HLTH INF, 2000, ONT TRAUM REG B ALC; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; COWIE SE, 2005, CANADIAN TRAUMA SCI; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; Miller Norman S., 1994, P471; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	40	9	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2010	68	5					1065	1071		10.1097/TA.0b013e3181bb9890			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	595MQ	WOS:000277615200008	20016383				2022-02-06	
J	Bigler, ED				Bigler, Erin D.			Neuroimaging in Mild Traumatic Brain Injury	PSYCHOLOGICAL INJURY & LAW			English	Article						Mild traumatic brain injury (mTBI); Neuroimaging; Neuropsychological outcome; White matter; Magnetic resonance imaging (MRI); Computed tomography (CT); Functional neuroimaging		Neuroimaging in mild traumatic brain injury (mTBI) is reviewed. While computed tomography remains the acute standard for neuroimaging of mTBI, it is only sensitive to gross abnormalities and is typically performed as a measure to rule out more serious and life-threatening injury. Magnetic resonance imaging (MRI), especially at field strength of 3.0 T, is the follow-up neuroimaging standard for assessing potential underlying structural injury to the brain. Several MRI sequences are particularly sensitive to subtle hemorrhagic lesions and signal abnormalities in white matter, sensitive enough to detect pathology when present in mTBI. Clinical correlation of neuropsychological outcome with neuroimaging findings is discussed along with the future potential for functional neuroimaging in evaluating the mTBI patient.	[Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu					Adams J, 2007, CLIN J SPORT MED, V17, P304, DOI 10.1097/JSM.0b013e31803202c8; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Altrocchi PH, 1996, NEUROLOGY, V46, P278; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Barrett LF, 2009, PERSPECT PSYCHOL SCI, V4, P326, DOI 10.1111/j.1745-6924.2009.01134.x; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.1155/2009/616581, 10.3233/BEN-2009-0226]; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Chastain C. A., 2009, J NEUROTRAUM, DOI [10.1089/neu.2008-0650, DOI 10.1089/NEU.2008-0650]; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chu Z., 2009, AM J NEURORADIOLOGY; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dong Q, 2004, J MAGN RESON IMAGING, V19, P6, DOI 10.1002/jmri.10424; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Filippi M, 2009, PROG BRAIN RES, V175, P465, DOI 10.1016/S0079-6123(09)17531-3; Fischbach F, 2008, ACTA RADIOL, V49, P358, DOI 10.1080/02841850701824127; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gean AD, 1994, IMAGING HEAD TRAUMA; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V1; Granacher RP, 2008, J AM ACAD PSYCHIATRY, V36, P323; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Guzel A, 2009, PEDIATR NEUROSURG, V45, P262, DOI 10.1159/000228984; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Heidemann RM, 2006, NEUROIMAG CLIN N AM, V16, P311, DOI 10.1016/j.nic.2006.02.001; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hesselink J R, 1986, Acta Radiol Suppl, V369, P46; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hillary FG, 2007, FUNCTIONAL NEUROIMAG; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holdsworth SJ, 2008, SEMIN NEUROL, V28, P395, DOI 10.1055/s-0028-1083697; Huang M., 2009, J NEUROTRAUM, DOI [10.1089/neu.2008-0672, DOI 10.1089/NEU.2008-0672]; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Kidwell CS, 2006, CURR NEUROL NEUROSCI, V6, P9, DOI 10.1007/s11910-996-0003-1; Korfias S, 2009, MINI-REV MED CHEM, V9, P227, DOI 10.2174/138955709787315994; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Mehr SH, 2001, NEUROREHABILITATION, V16, P87; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Osborn AG, 1994, DIAGNOSTIC NEURORADI; Pagani E, 2008, NEUROL SCI, V29, pS290, DOI 10.1007/s10072-008-1001-7; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Parkin PC, 2009, LANCET, V374, P1127, DOI 10.1016/S0140-6736(09)61634-2; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scarabino Tommaso, 2003, Radiol Med, V105, P150; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sicotte NL, 2003, INVEST RADIOL, V38, P423, DOI 10.1097/01.RLI.0000065426.07178.fl; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Singh M., 2009, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.1005.1049; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; Veevers AE, 2009, J FORENSIC SCI, V54, P1466, DOI 10.1111/j.1556-4029.2009.01201.x; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	155	9	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2010	3	1			SI		36	49		10.1007/s12207-010-9064-1			14	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3XZ	WOS:000415448300004					2022-02-06	
J	Friedman, IB; Hancock, AB; Schulz, G; Bamdad, MJ				Friedman, Ilana B.; Hancock, Adrienne B.; Schulz, Geralyn; Bamdad, Michael J.			Using Principles of Motor Learning to Treat Apraxia of Speech after Traumatic Brain Injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							LIMB APRAXIA; ORDER; REHABILITATION; PROGRAM	Background: This study examined the effectiveness of a modified version of the Motor Learning Guided (MLG) approach, a treatment protocol to establish functional speech that incorporates principles of motor learning: blocked and random practice schedules, delayed and summary knowledge of response (KR) feedback, and specificity of training. Methods: A 29-year-old male survivor of traumatic brain injury diagnosed with moderate-severe apraxia of speech (AOS) participated in this protocol. A time-series ABA design measured the participant's production of two sets of five target items, and his ability to maintain accurate productions several months after treatment. Results: Improvements were seen in the participant's ability to produce both sets of trained items; however, the second set of target items were practiced with more frequency, which may have lead to a greater accuracy of production in less time compared to the first set of five target items. Conclusions: Application of motor learning principles through the modified MLG approach can lead to increased accuracy and automaticity of trained target items, and the ability to maintain accurate phrase production following cessation of treatment. Adherence to a frequent practice schedule and other motor learning principles is influential to success of this treatment for AOS.	[Friedman, Ilana B.] Natl Rehabil Hosp, Washington, DC USA; [Hancock, Adrienne B.; Schulz, Geralyn; Bamdad, Michael J.] George Washington Univ, Washington, DC USA		Hancock, AB (corresponding author), 2115 G St NW,Suite 201, Washington, DC 20052 USA.	hancock@gwu.edu		Schulz, Geralyn/0000-0003-3831-8105			Adams SG, 2002, J MED SPEECH-LANG PA, V10, P215; Adams SG, 2000, J MED SPEECH-LANG PA, V8, P215; Ballard KJ, 2000, APHASIOLOGY, V14, P969, DOI 10.1080/02687030050156575; Ballard KJ, 2001, J COMMUN DISORD, V34, P3, DOI 10.1016/S0021-9924(00)00038-1; Buxbaum LJ, 2008, AM J PHYS MED REHAB, V87, P149, DOI 10.1097/PHM.0b013e31815e6727; Clark HM, 2003, AM J SPEECH-LANG PAT, V12, P400, DOI 10.1044/1058-0360(2003/086); Duffy, 2005, MOTOR SPEECH DISORDE; Hageman C. F, 2002, ANN M AM SPEECH LANG; Hesse S, 2001, NEUROREHABILITATION, V16, P133; HULA SNA, 2007, PERSPECTIVES NEUROPS, V17, P3; KAYS S, 2007, PERSPECTIVES NEUROPH, V17, P11; Kilduski NC, 2003, AM J OCCUP THER, V57, P329, DOI 10.5014/ajot.57.3.329; Knock TR, 2000, APHASIOLOGY, V14, P653, DOI 10.1080/026870300401379; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Langhammer B, 2000, CLIN REHABIL, V14, P361, DOI 10.1191/0269215500cr338oa; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; LEITENBERG H, 1973, J ABNORM PSYCHOL, V82, P87, DOI 10.1037/h0034966; Lin CH, 2007, PHYS THER, V87, P1120, DOI 10.2522/ptj.20060228; Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); McReynolds L., 1983, SINGLE SUBJECT EXPT; Oliveira FTP, 2004, PERCEPT MOTOR SKILL, V99, P315, DOI 10.2466/pms.99.1.315-324; PLATZ T, 1994, NEUROPSYCHOLOGIA, V32, P1209, DOI 10.1016/0028-3932(94)90103-1; Rosenbek, 1984, APRAXIA SPEECH ADULT; ROSENBEK JC, 1973, J SPEECH HEAR DISORD, V38, P462, DOI 10.1044/jshd.3804.462; RUTHERFORD OM, 1986, EUR J APPL PHYSIOL O, V55, P100, DOI 10.1007/BF00422902; Schmidt RA., 1991, MOTOR LEARNING PERFO; Schulz GM, 1999, J SPEECH LANG HEAR R, V42, P1157, DOI 10.1044/jslhr.4205.1157; Smania N, 2006, NEUROLOGY, V67, P2050, DOI 10.1212/01.wnl.0000247279.63483.1f; Spaulding S.J., 2001, PHYS OCCUPATIONAL TH, V20, P1, DOI DOI 10.1080/J148V20N01_; STIERWALT J, 2004, M WORLD C INT ASS LO; STIERWALT JAG, 2002, STAFF APPR S FLOR ST; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; TAYLOR O, 1988, NATURE COMMUNICATION; Wambaugh Julie L., 2002, Seminars in Speech and Language, V23, P293, DOI 10.1055/s-2002-35802; WULF G, 1993, J EXP PSYCHOL LEARN, V19, P1134, DOI 10.1037/0278-7393.19.5.1134	35	9	9	0	16	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2010	18	1					13	34					22	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	559WG	WOS:000274858300003					2022-02-06	
J	Ochalski, PG; Fellows-Mayle, W; Hsieh, LB; Srinivas, R; Okonkwo, DO; Dixon, CE; Adelson, PD				Ochalski, Pawel G.; Fellows-Mayle, Wendy; Hsieh, Lily B.; Srinivas, Ravi; Okonkwo, David O.; Dixon, C. Edward; Adelson, P. David			Flumazenil Administration Attenuates Cognitive Impairment in Immature Rats after Controlled Cortical Impact	JOURNAL OF NEUROTRAUMA			English	Article						benzodiazepine; controlled cortical impact; flumazenil; GABA	TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; HIPPOCAMPAL ACETYLCHOLINE-RELEASE; EXCITATORY AMINO-ACIDS; FREELY MOVING RATS; GABA(A) RECEPTOR; HEAD-INJURY; DAMAGE; RECOVERY; BENZODIAZEPINES	Evidence suggests that the gamma-aminobutyric acid (GABA) ergic system may be involved in cognitive dysfunction following traumatic brain injury (TBI). We investigated the effect of flumazenil treatment, a benzodiazepine antagonist approved by the U.S. Food and Drug Administration, on learning and memory in the immature rat following experimental brain injury. Post-natal day 17 rats were injured using controlled cortical impact. Systemic treatment with flumazenil at 1, 5, and 10 mg/kg was initiated on post-injury day 1 and administered for 13 days via daily intraperitoneal injections. Morris water maze (MWM) testing was used to measure latency to find a submerged platform and the results from experimental and control animals were compared. We demonstrated a significant dose-dependent improvement in MWM performance in drug-treated animals. This is the first study demonstrating the efficacy of flumazenil in reducing post-TBI cognitive deficits and we propose that these effects may be related to modulation of the GABA(A) receptor.	[Ochalski, Pawel G.; Fellows-Mayle, Wendy; Hsieh, Lily B.; Srinivas, Ravi; Okonkwo, David O.; Dixon, C. Edward] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Adelson, P. David] Phoenix Childrens Neurosci Inst, Dept Neurol Surg, Phoenix, AZ USA		Ochalski, PG (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurosurg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	ochalskipg@upmc.edu	Adelson, David/W-2083-2019		Pittsburgh Foundation; American Association of Neurological Surgeons	Funding for this research was provided by the Walter L. Copeland Fund of The Pittsburgh Foundation and a grant from the Neurosurgery Research and Education Foundation of the American Association of Neurological Surgeons.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Diez-Ariza M, 2002, BRAIN RES, V956, P81, DOI 10.1016/S0006-8993(02)03483-2; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FILE SE, 1986, PSYCHOPHARMACOLOGY, V88, P1, DOI 10.1007/BF00310505; Giorgetti M, 2000, EUR J NEUROSCI, V12, P1941, DOI 10.1046/j.1460-9568.2000.00079.x; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; IMPERATO A, 1994, BRAIN RES, V647, P167, DOI 10.1016/0006-8993(94)91413-3; IMPERATO A, 1993, EUR J PHARMACOL, V238, P135, DOI 10.1016/0014-2999(93)90518-M; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; LEONARD CT, 1994, PHYS THER, V74, P753, DOI 10.1093/ptj/74.8.753; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LISTER RG, 1985, NEUROSCI BIOBEHAV R, V9, P87, DOI 10.1016/0149-7634(85)90034-X; MCNAMARA RK, 1992, PHARMACOL BIOCHEM BE, V41, P529, DOI 10.1016/0091-3057(92)90368-P; MCNAMARA RK, 1993, BRAIN RES, V626, P63, DOI 10.1016/0006-8993(93)90563-3; Moor E, 1998, EUR J PHARMACOL, V359, P119, DOI 10.1016/S0014-2999(98)00642-6; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; NUTT DJ, 1982, NATURE, V295, P436, DOI 10.1038/295436a0; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Ochalski PG, 2009, J NEUROSURG-PEDIATR, V3, P240, DOI 10.3171/2008.12.PEDS08185; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Savic MM, 2004, PHARMACOL BIOCHEM BE, V79, P279, DOI 10.1016/j.pbb.2004.07.013; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Weiss M, 2002, NEUROCHEM RES, V27, P1605, DOI 10.1023/A:1021674708556	33	9	9	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2010	27	3					647	651		10.1089/neu.2009.1142			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	575PJ	WOS:000276079100016	19929186				2022-02-06	
J	Roza, BD; Pestana, JOM; Barbosa, SDF; Schirmer, J				Roza, Bartira de Aguiar; Medina Pestana, Jose Osmar; Faria Barbosa, Sayonara de Fatima; Schirmer, Janine			Organ donation procedures: an epidemiological study	PROGRESS IN TRANSPLANTATION			English	Article							FAMILIES	Objective-To evaluate the impact of organ and tissue donation processes oil family members of deceased donors and the probability that they would be an organ or tissue donor in the future. Methods-Cross-sectional survey of 69 families of deceased donors of the organ procurement organizations of the Federal University of Sao Paulo. Results-Donors were predominantly men (57% vs 43%) with a median age of 35.9 years. The primary causes of death were classified as natural (65%), traumatic injury (33%), and other (1%). Of the family members surveyed, 40% had an elementary school education and 59% were unemployed. Family members expressed an understanding of the brain death diagnosis (67%). Among them, 74% had no doubt about brain death and had time to ask questions. The diagnosis was provided by the doctor responsible for the patient (89%). Family members also used funeral aid benefit (63%), perceived organ donation positively (97%), and indicated that they would donate again (79%). A significant relationship was found between families that took advantag-e of the funeral aid benefit and families that would donate again (79% vs 22%, P=.002). Conclusion-The intent to donate organs for transplantation may be based more on moral and cultural factors that go beyond the family members' knowledge about the donation process per se. (Progress in Transplantation. 2010;20:88-95)	[Medina Pestana, Jose Osmar; Schirmer, Janine] Univ Fed Sao Paulo, BR-04024002 Sao Paulo, Brazil; [Faria Barbosa, Sayonara de Fatima] Univ Fed Santa Catarina, Florianopolis, SC, Brazil		Schirmer, J (corresponding author), Univ Fed Sao Paulo, Rua Napoleao de Barros 754, BR-04024002 Sao Paulo, Brazil.	schirmer.janine@unifesp.br	De Aguiar Roza, Bartira/H-4416-2011; Barbosa, Sayonara FF/H-4695-2011; Schirmer, Janine/P-3867-2019; Roza, Bartira Aguiar/T-6341-2019; de Fatima Faria Barbosa, Sayonara/M-8738-2014	De Aguiar Roza, Bartira/0000-0002-6445-6846; Barbosa, Sayonara FF/0000-0002-2342-3300; Schirmer, Janine/0000-0003-0783-2961; Roza, Bartira Aguiar/0000-0002-6445-6846; de Fatima Faria Barbosa, Sayonara/0000-0002-2342-3300			BERLINGUER G, 1994, HUMANIDADES, V9, P358; CASTRO L, 2003, BIOETICA PODER INJUS, P427; CLARK PA, 2003, CURRENT OPINION ORGA, V8, P334; DOUGLASS GE, 1995, ANAESTH INTENS CARE, V23, P96, DOI 10.1177/0310057X9502300126; FABBRO L, 1999, BIOETICA, V7, P7; GARCIA V.D, 1997, TRANSPLANTE ORGAOS T, P91; Garcia VD, 2003, TRANSPL P, V35, P1673, DOI 10.1016/S0041-1345(03)00568-2; GARRAFA V, 1997, ENC COM 10 AN INT TR; GARRAFA V, 1999, AN SEM INT BIOD TRAN, P9; *I BRAS GEOGR EST, 2008, SER EST PESQ INF DEM, V23; Jasper JD, 2004, MED CARE, V42, P378, DOI 10.1097/01.mlr.0000118863.47574.0f; LAMB D., 2000, TRANSPLANTE ORGAOS E; MANFRO RC, 2004, MANUAL TRANSPLANTE R; May T, 2000, MILBANK Q, V78, P323, DOI 10.1111/1468-0009.00172; *MIN SAUD SAS, 2002, REL GEST SECR ASS SA, P220; *MIN SAUD SECR VIG, 2006, AN SIT SAUD BRAS, P620; Ojo AO, 2004, AM J TRANSPLANT, V4, P27, DOI 10.1111/j.1600-6135.2004.00396.x; PEREIRA WA, 2003, 1 REUN DIR CAPT RET; Sadala MLA, 2001, J BRAS NEFROL, V23, P143; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Siminoff LA, 2001, CLIN TRANSPLANT, V15, P39, DOI 10.1034/j.1399-0012.2001.150107.x; Siminoff Laura A, 2003, Prog Transplant, V13, P218; WHO, 2003, CONS ETH ACC SAF TIS; Zoboli ELCZ, 2003, THESIS U SAO PAULO S	24	9	10	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-9248	2164-6708		PROG TRANSPLANT	Prog. Transplant.	MAR	2010	20	1					88	95					8	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	569RK	WOS:000275616700013	20397352				2022-02-06	
J	Schultke, E; Griebel, RW; Juurlink, BHJ				Schueltke, E.; Griebel, R. W.; Juurlink, B. H. J.			Quercetin Administration After Spinal Cord Trauma Changes S-100 beta Levels	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SERUM S-100B PROTEIN; CEREBROSPINAL-FLUID; BRAIN-DAMAGE; S100-BETA PROTEIN; INJURY; S100; ELEVATION; PROMOTES; ENOLASE; MARKERS	Background: It has been shown previously that S-100 beta levels in serum correspond with the severity of central nervous system (CNS) trauma. It also has been suggested that S-100 beta in CNS tissue is involved in neuroprotection and neuroregeneration. We have previously shown that administration of quercetin results in improved motor function in an animal model of spinal cord trauma. Methods: Mid-thoracic spinal cord compression injury was produced in adult male Wistar rats. Serum and tissue samples were acquired from quercetin-treated animals (25 mu mol/kg) and saline controls at 6, 12 and 24 hours after the trauma. S-100 beta levels were measured using a luminometric assay in the damaged tissue and in the serum of the animals. Results: The increase in serum S-100 beta levels seen in saline controls after spinal cord trauma was ameliorated in the quercetin-treated animals at all time points, although the difference to saline controls became statistically significant only at 24 hrs after the trauma. Compared to tissue S-100 beta levels in healthy animals, values were significantly decreased in saline controls at all three time points, while they were decreased at 6 hrs and increased at both 12 and 24 hrs in quercetin-treated animals. At all three time points tissue S-100 beta levels were significantly higher in quercetin-treated animals than in saline controls. Conclusions: Administration of quercetin results in modification of S-100 beta levels in the setting of experimental spinal cord trauma. The kinetic patterns of the S-100 beta fluctuations in serum and tissue suggest that post-traumatic administration of quercetin decreases the extent a CNS injury.	[Schueltke, E.] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; [Schueltke, E.; Juurlink, B. H. J.] Univ Saskatchewan, Dept Surg, Saskatoon, SK S7N 5E5, Canada; [Schueltke, E.; Griebel, R. W.] Univ Saskatchewan, Div Neurosurg, Saskatoon, SK S7N 5E5, Canada; [Schueltke, E.] Univ Freiburg, Dept Stereotact & Funct Neurosurg, D-7800 Freiburg, Germany; [Juurlink, B. H. J.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia		Schultke, E (corresponding author), Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, A302 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.		Schultke, Elisabeth/M-3959-2013				Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Iwasaki Y, 1997, J NEUROL SCI, V151, P7, DOI 10.1016/S0022-510X(97)00073-7; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Khaladj N, 2008, EUR J VASC ENDOVASC, V36, P11, DOI 10.1016/j.ejvs.2008.01.011; Kunihara T, 2001, J THORAC CARDIOV SUR, V122, P1019, DOI 10.1067/mtc.2001.115151; Liu Jin-bo, 2006, Chin J Traumatol, V9, P303; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Nishi M, 1997, NEUROSCI LETT, V229, P212, DOI 10.1016/S0304-3940(97)00443-6; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Schultke E, 2003, J NEUROTRAUM, V20, P583, DOI 10.1089/089771503767168500; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Thorngren-Jerneck K, 2001, PEDIATR RES, V49, P495, DOI 10.1203/00006450-200104000-00010; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; van Dongen EP, 1998, J VASC SURG, V27, P344, DOI 10.1016/S0741-5214(98)70365-9; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026	30	9	10	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAR	2010	37	2					223	228		10.1017/S0317167100009963			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577KS	WOS:000276222500011	20437933	Bronze			2022-02-06	
J	Sut, N; Memis, D				Sut, Necdet; Memis, Dilek			Intensive care cost and survival analyses of traumatic brain injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Cost analysis; intensive care; survival; trauma; traumatic brain injury	CHARGES; OUTCOMES; TRENDS; STAY	BACKGROUND Intensive care of Traumatic Brain Injury (TB!) is associated with substantial morbidity, mortality and cost; however, there is very little published work on this topic. The purpose of this study was to examine direct costs and survival outcomes of patients with TBI admitted to an intensive care unit (ICU). METHODS A retrospective review of the records of Trakya University Hospital's ICU from 2002-2006 was undertaken. Patients with TBI were determined and assessed regarding costs and survival. RESULTS The study group consisted of 126 patients, and 27.8% of them had been operated. Male gender (80.2%) was dominant, mean length of stay was 9.8 +/- 8.7 days, and motor vehicle injury (59.5%) was the major reason for ICU admission. Mortality rate was 50% and the Glasgow Coma Score (GCS) of the patients was 6.1 +/- 1.9. The average cost per ICU stay was US$ 4846 +/- 5084. Cost per life saved and per life-year saved were USS 9533 and US$ 313.60, respectively. Survival rates were significantly different among injury types (p=0.010). GCS appeared to be a prognostic parameter in patient survival (Hazard Ratio: 0.643; 95%CI: 0.529-0.781; p<0.001). CONCLUSION Intensive care of TBI cases is characterized by high mortality and high cost.	[Sut, Necdet; Memis, Dilek] Trakya Univ, Tip Fak, Biyoistat Anabilim Dali, TR-22030 Edirne, Turkey		Sut, N (corresponding author), Trakya Univ, Tip Fak, Biyoistat Anabilim Dali, TR-22030 Edirne, Turkey.	necdetsut@yahoo.com					BENNETT BR, 1989, J TRAUMA, V29, P556, DOI 10.1097/00005373-198905000-00003; Brooks CA, 1995, J HEAD TRAUMA REHAB, V104, P1; *CDC, 1997, MMWR-MORBID MORTAL W, V46, P8; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Finkelstein E., 2006, INCIDENCE EC BURDEN; Havill JH, 1998, NEW ZEAL MED J, V111, P161; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Kleinbaum D.G., 1995, SURVIVAL ANAL SELF L, Vthird; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; SAIP S, POSTTRAVMATIK BAS AG; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sut N, 2007, RHEUMATOLOGY, V46, P678, DOI 10.1093/rheumatology/kel382; Sut N, 2007, TRAK UNIV TIP FAK DE, V24, P109; Sut N, 2008, CLIN TOXICOL, V46, P457, DOI 10.1080/15563650701644295; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; *WORLD BANK, WORLD DEV IND DAT GN; SURVIVAL ANAL; WORLD HLTH REPORT 20	23	9	9	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2010	16	2					149	154					6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	572IM	WOS:000275822500010	20517770				2022-02-06	
J	Tsirka, V; Simos, P; Vakis, A; Vourkas, M; Arzoglou, V; Syrmos, N; Stavropoulos, S; Micheloyannis, S				Tsirka, Vassiliki; Simos, Panagiotis; Vakis, Antonios; Vourkas, Michael; Arzoglou, Vasileios; Syrmos, Nikolaos; Stavropoulos, Stavros; Micheloyannis, Sifis			Material-Specific Difficulties in Episodic Memory Tasks in Mild Traumatic Brain Injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						episodic memory; pictures; response bias; sensitivity	MINOR HEAD-INJURY; RECOGNITION MEMORY; POSTCONCUSSIVE SYMPTOMS; PREFRONTAL CORTEX; WORDS; POPULATION; PICTURES; TBI	The study examines acute, material-specific secondary memory performance in 26 patients with mild traumatic brain injury (MTBI) and 26 healthy controls, matched on demographic variables and indexes of crystallized intelligence. Neuropsychological tests were used to evaluate primary and secondary memory, executive functions, and verbal fluency. Participants were also tested on episodic memory tasks involving words, pseudowords, pictures of common objects, and abstract kaleidoscopic images. Patients showed reduced performance on episodic memory measures, and on tasks associated with visuospatial processing and executive function (Trail Making Test part B, semantic fluency). Significant differences between groups were also noted for correct rejections and response bias on the kaleidoscope task. MTBI patients' reduced performance on memory tasks for complex, abstract stimuli can be attributed to a dysfunction in the strategic component of memory process.	[Tsirka, Vassiliki; Vakis, Antonios; Micheloyannis, Sifis] Univ Crete, Div Med, GR-71409 Iraklion, Greece; [Simos, Panagiotis] Univ Crete, Dept Psychol, Rethimnon, Greece; [Vourkas, Michael] Tech High Sch Crete, Iraklion, Greece; [Arzoglou, Vasileios; Syrmos, Nikolaos; Stavropoulos, Stavros] Venizelio Gen Hosp, Dept Neurosurg, Iraklion, Greece		Tsirka, V (corresponding author), Univ Crete, Div Med, GR-71409 Iraklion, Greece.	tsirkav@yahoo.com	SIMOS, PANAGIOTIS/L-2107-2019	SIMOS, PANAGIOTIS/0000-0002-0116-8564; Syrmos, Nikolaos/0000-0001-6703-8095			Abdi H., 2007, ENCY MEASUREMENT STA, P886; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bellhouse-King MW, 2007, PERCEPT MOTOR SKILL, V104, P758, DOI 10.2466/PMS.104.3.758-762; Benton A., 1976, MULTILINGUAL APHASIA; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Dawson KS, 2007, BRAIN INJURY, V21, P943, DOI 10.1080/02699050701553171; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; GENTILINI M, 1989, MILD HEAD INJURY, P163; Ghetti S, 2003, J MEM LANG, V48, P722, DOI 10.1016/S0749-596X(03)00005-6; Golby AJ, 2001, BRAIN, V124, P1841, DOI 10.1093/brain/124.9.1841; Grady CL, 1998, P NATL ACAD SCI USA, V95, P2703, DOI 10.1073/pnas.95.5.2703; GRANT DA, 2003, MILD HEAD INJURY, P153; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P414; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; McBride DM, 2002, CONSCIOUS COGN, V11, P423, DOI 10.1016/S1053-8100(02)00007-7; Miller MB, 1999, PSYCHOL REV, V106, P398, DOI 10.1037/0033-295X.106.2.398; Moscovitch Morris, 1994, P269; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Paivio Allan, 1995, P977; Perea M, 2002, MEM COGNITION, V30, P34, DOI 10.3758/BF03195263; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Rotello CM, 2000, J MEM LANG, V43, P67, DOI 10.1006/jmla.1999.2701; Ruff R. M., 1989, MILD HEAD INJURY, P176; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Swick D, 1999, NEUROPSYCHOLOGY, V13, P155, DOI 10.1037/0894-4105.13.2.155; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Windmann S, 1998, CONSCIOUS COGN, V7, P603, DOI 10.1006/ccog.1998.0337; WRIGHT AA, 1990, J EXP PSYCHOL LEARN, V16, P1043, DOI 10.1037/0278-7393.16.6.1043	48	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	MAR	2010	120	3					184	191		10.3109/00207450903585308			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	579ZD	WOS:000276415100004	20374085				2022-02-06	
J	Donat, CK; Walter, B; Kayser, T; Deuther-Conrad, W; Schliebs, R; Nieber, K; Bauer, R; Hartig, W; Brust, P				Donat, Cornelius K.; Walter, Bernd; Kayser, Tanja; Deuther-Conrad, Winnie; Schliebs, Reinhard; Nieber, Karen; Bauer, Reinhard; Haertig, Wolfgang; Brust, Peter			Effects of lateral fluid percussion injury on cholinergic markers in the newborn piglet brain	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Immature brain; Cholinergic system; Acetylcholine esterase	CLOSED-HEAD INJURY; VESICULAR ACETYLCHOLINE TRANSPORTER; COLORED MICROSPHERE TECHNIQUE; RAT-BRAIN; RECEPTOR-BINDING; BLOOD-FLOW; OXIDATIVE STRESS; IMMATURE BRAIN; NEURONS; EXPERIENCE	Traumatic brain injury is a leading Cause of death and disability in children. Studies using adult animal models showed alterations of the central cholinergic neurotransmission as a result of trauma. However, there is a lack of knowledge about consequences of brain trauma on cholinergic function in the immature brain. it is hypothesized that trauma affects the relative acetylcholine esterase activity and causes a loss of cholinergic neurons in the immature brain. Severe fluid percussion trauma (FP-TBI, 3.8 +/- 0.3 atm) was induced in 15 female newborn piglets, monitored for 6 h and compared with 12 control animals. The hemispheres ipsilateral to FP-TBI obtained from seven piglets were used for acetylcholine esterase histochemistry on frozen sagittal slices, while regional cerebral blood flow and oxygen availability was determined in the remaining eight FP-TBI animals. Post-fixed slices were immunohistochemically labelled for choline acetyltransferase as well as for low-affinity neurotrophin receptor in order to characterize cholinergic neurons in the basal forebrain. Regional cerebral blood flow and brain oxygen availability were reduced during the first 2 h after FP-TBI (P < 0.05). In addition, acetylcholine esterase activity was significantly increased in the neocortex, basal forebrain, hypothalamus and medulla after trauma (P < 0.05), whereas the number of choline acetyltransferase and low-affinity neurotrophin receptor positive cells in the basal forebrain were unaffected by the injury. \ Thus, traumatic brain injury evoked an increased relative activity of the acetylcholine esterase in the immature brain early after injury, without loss of cholinergic neurons in the basal forebrain. These changes may contribute to developmental impairments after immature traumatic brain injury. (C) 2009 ISDN. Published by Elsevier Ltd. All rights reserved.	[Donat, Cornelius K.; Kayser, Tanja; Deuther-Conrad, Winnie; Brust, Peter] Inst Interdisciplinary Isotope Res, D-04318 Leipzig, Germany; [Walter, Bernd; Bauer, Reinhard] Univ Jena, Inst Mol Cell Biol, Jena, Germany; [Walter, Bernd] Zentralklin Bad Berka, Dept Neurosurg, Bad Berka, Germany; [Schliebs, Reinhard; Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Nieber, Karen] Univ Leipzig, Inst Pharm, Leipzig, Germany		Donat, CK (corresponding author), Inst Interdisciplinary Isotope Res, Permoserstr 15, D-04318 Leipzig, Germany.	donat@iif-leipzig.de	Deuther-Conrad, Winnie/B-7558-2015	, Peter/0000-0001-5555-7058; Deuther-Conrad, Winnie/0000-0003-3168-3062			ANDRA J, 1986, HISTOCHEMISTRY, V84, P575, DOI 10.1007/BF00482994; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; ARMSTEAD WM, 2009, 24 INT S CER BLOOD F, P185; Bauer R, 1996, EXP TOXICOL PATHOL, V48, P415; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Berger-Sweeney J, 2003, NEUROSCI BIOBEHAV R, V27, P401, DOI 10.1016/S0149-7634(03)00070-8; Bond CE, 2006, EUR J NEUROSCI, V24, P381, DOI 10.1111/j.1460-9568.2006.04898.x; CARDONE C, 1994, ANESTHESIOLOGY, V80, P1155, DOI 10.1097/00000542-199405000-00025; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; EISENHAUER CL, 1994, LAB ANIM SCI, V44, P245; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; GEULA C, 1995, EXP NEUROL, V134, P157, DOI 10.1006/exnr.1995.1046; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Hartig W, 2002, REV NEUROSCIENCE, V13, P95; HARTIG W, 1995, HISTOCHEM CELL BIOL, V104, P467, DOI 10.1007/BF01464337; Jonsson M, 2006, ANESTHESIOLOGY, V105, P521, DOI 10.1097/00000542-200609000-00016; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; PASTUSZKO A, 1993, J NEUROCHEM, V60, P161, DOI 10.1111/j.1471-4159.1993.tb05834.x; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Shohami E, 2000, J MOL MED-JMM, V78, P228, DOI 10.1007/s001090000104; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; WERBA A, 1992, BRIT J ANAESTH, V69, P382, DOI 10.1093/bja/69.4.382	48	9	10	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	FEB	2010	28	1					31	38		10.1016/j.ijdevneu.2009.10.001			8	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	565OQ	WOS:000275304000005	19822201				2022-02-06	
J	Kanji, S; Jones, E; Goddard, R; Meggison, HE; Neilipovitz, D				Kanji, Salmaan; Jones, Erika; Goddard, Rob; Meggison, Hilary E.; Neilipovitz, David			Efficiency and Safety of a Standardized Protocol for Intravenous Insulin Therapy in ICU Patients with Neurovascular or Head Injury	NEUROCRITICAL CARE			English	Article						Insulin; Intensive care units; Hypoglycemia; Nervous system diseases; Blood glucose; Neurotrauma; Neurovascular injury	GLUCOSE CONTROL; BLOOD-GLUCOSE; HYPERGLYCEMIA; MORTALITY; STROKE; IMPACT	Background To evaluate the safety and efficiency of a protocol for glycemic control in intensive care unit (ICU) patients with neurovascular or head injury. Methods Two cohorts of 50 consecutive patients admitted to the ICU with an admission diagnosis of neurovascular or head injury before and after protocol implementation were evaluated. All patients in the interventional cohort received insulin using a standardized intravenous insulin infusion protocol targeting blood glucose levels of 7-9 mmol/l. Efficiency (time to reach and time within target range), safety (hypoglycemia), and nursing compliance (protocol violations) were evaluated. Results The median time to reach the target blood glucose range was shorter in the interventional cohort than the conventional cohort (5.0 h [0.5-20.5 h] vs. 12.9 h [1.3-90.3h]; P < 0.001). More time was spent within target range in the interventional cohort than in the conventional cohort (36.4 +/- 16.3% vs. 27.1 +/- 19.0%; P < 0.001). The median prevalence of mild (< 4.9 mmol/l) hypoglycemia (0 [0-1.11]% vs. 0.58 [0-2.79]%; P < 0.001) and moderate (< 3.9) hypoglycemia (0[0-0.55]% vs. 0 [1-1.25]%; p < 0.001) was significantly lower in the interventional cohort. Conclusions The intravenous insulin infusion protocol improved the safety and efficiency of glycemic control for ICU patients with neurovascular or head injury.	[Kanji, Salmaan; Jones, Erika; Goddard, Rob] Ottawa Gen Hosp, Dept Pharm, Ottawa, ON K1H 8L6, Canada; [Kanji, Salmaan] Ottawa Gen Hosp, Dept Crit Care, Ottawa, ON K1H 8L6, Canada; [Kanji, Salmaan] Ottawa Hlth Res Inst, Dept Clin Epidemiol, Ottawa, ON, Canada; [Meggison, Hilary E.] Ottawa Hosp, Dept Endocrinol & Metab, Ottawa, ON, Canada; [Meggison, Hilary E.; Neilipovitz, David] Ottawa Hosp, Dept Crit Care, Ottawa, ON, Canada; [Neilipovitz, David] Ottawa Hosp, Dept Anesthesiol, Ottawa, ON, Canada		Kanji, S (corresponding author), Ottawa Gen Hosp, Dept Pharm, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	skanji@ottawahospital.on.ca		Neilipovitz, David/0000-0001-7667-1773			Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; Diringer MN, 2006, CRIT CARE MED, V34, P930, DOI 10.1097/01.CCM.0000202433.99341.D6; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Gentile NT, 2006, ACAD EMERG MED, V13, P174, DOI 10.1197/j.aem.2005.08.009; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kanji S, 2004, INTENS CARE MED, V30, P804, DOI 10.1007/s00134-004-2252-2; Krinsley JS, 2008, CRIT CARE, V12, DOI 10.1186/cc6889; Preiser JC, 2007, INTENS CARE MED, V33, P570, DOI 10.1007/s00134-006-0485-y; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Strong AJ, 2005, CRIT CARE MED, V33, P2147, DOI 10.1097/01.CCM.0000179029.95415.51; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80	22	9	9	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2010	12	1					43	49		10.1007/s12028-009-9275-z			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	571HL	WOS:000275742800008	19777385				2022-02-06	
J	Dodson, MB				Dodson, Matthew B.			A model to guide the rehabilitation of high-functioning employees after mild brain injury	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Executive Function; Return to Work; Employee Performance Enablers; Workplace Ecology	DEPRESSION FOLLOWING MILD; DISORDERS	Impairment in executive functioning can occur after mild stroke, mild Traumatic Brain Injury, and neurodegenerative disease, and this can have deleterious effects on employment outcomes, occupational functioning, and general quality of life. What is not as well identified is the symbiotic relationship between executive functioning and other important psychosocial constructs inherent in successful employees ("Employee Performance Enablers"), and how various aspects of the employment environment can enable or inhibit the success of the employee with executive functioning deficits in meeting their essential job functions ("Workplace Ecology"). From an extensive review of the literature and the author's practice experience, a clinical model was developed to elucidate these two critical variables, as well as to provide guidance for organizing, planning, and implementing interventions that will address both employee enablers and workplace ecology to affect positive return to work outcomes for individuals with mild brain injury.	Washington Univ, Sch Med, Program Occupat Therapy, Occupat Performance Ctr, St Louis, MO 63130 USA		Dodson, MB (corresponding author), Washington Univ, Sch Med, Program Occupat Therapy, Occupat Performance Ctr, 4444 Forest Pk Ave,Box 8505, St Louis, MO 63130 USA.	m.b.dodson@gmail.com					Bowen A, 1999, BRAIN INJURY, V13, P547; Brandt EN, 1997, ENABLING AM ASSESSIN; Bricout John C, 2003, Work, V21, P45; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; DODSON M, 2007, OT PRACTICE, V7, pCE1; Fleishman EA., 1995, FLEISHMAN JOB ANAL S; *JOB ACC NETW, SOAR SEARCH ONL ACC; Kaskutas V., 2008, 2008 AM OCC THER ASS; Katz N, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P323; KELLER M, 2000, J NEUROLOGY NEUROSUR, V68; Lee J, 2001, IEEE T CIRCUITS-I, V48, P35, DOI 10.1109/81.903186; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; MATHESON L, 1997, OCCUPATIONAL THERAPY, P430; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; *N CAR EMPL SEC CO, O NET ONL PUBL; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; WOLF T, WORK OCCUPA IN PRESS, pCH9; Wolf TJ, 2008, WORK, V31, P221; World Health Organization, 2007, INT CLASS FUNCT DIS; Zoltan B, 1996, VISION PERCEPTION CO; [No title captured]	28	9	9	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815			WORK	Work		2010	36	4					449	457		10.3233/WOR-2010-1044			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	639IY	WOS:000280969700011	20714101				2022-02-06	
B	Eskes, GA; Barrett, AM		Festa, JR; Lazar, RM		Eskes, Gail A.; Barrett, Anna M.			Neuropsychological Rehabilitation	NEUROVASCULAR NEUROPSYCHOLOGY			English	Article; Book Chapter							UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE STROKE; CLOSED-HEAD-INJURY; DOPAMINE AGONIST THERAPY; MEMORY-IMPAIRED PATIENTS; ACQUIRED BRAIN-INJURY; COGNITIVE IMPAIRMENT; DIRECTIONAL HYPOKINESIA; ATTENTION DEFICITS; PRISMATIC ADAPTATION		[Eskes, Gail A.] Dalhousie Univ, Brain Repair Ctr, Dept Psychiat, Halifax, NS, Canada; [Eskes, Gail A.] Dalhousie Univ, Brain Repair Ctr, Dept Psychol, Halifax, NS, Canada; [Eskes, Gail A.] Dalhousie Univ, Brain Repair Ctr, Dept Med Neurol, Halifax, NS, Canada; [Barrett, Anna M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Kessler Med Rehabil Res & Educ Ctr, W Orange, NJ 07052 USA; [Barrett, Anna M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol, Kessler Med Rehabil Res & Educ Ctr, W Orange, NJ 07052 USA; [Barrett, Anna M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Kessler Med Rehabil Res & Educ Ctr, W Orange, NJ 07052 USA		Eskes, GA (corresponding author), Dalhousie Univ, Brain Repair Ctr, Dept Psychiat, Halifax, NS, Canada.	Gail.Eskes@Dal.Ca					Appelros P, 2003, J REHABIL MED, V35, P254, DOI 10.1080/16501970310012455; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Barker-Collo S, 2006, NEUROPSYCHOL REV, V16, P53, DOI 10.1007/s11065-006-9007-5; Barrett AM, 2001, ARCH PHYS MED REHAB, V82, P516, DOI 10.1053/apmr.2001.21973; Barrett AM, 1999, ARCH PHYS MED REHAB, V80, P600, DOI 10.1016/S0003-9993(99)90205-8; Barrett AM, 2000, NEUROPSYCHOLOGIA, V38, P778, DOI 10.1016/S0028-3932(99)00144-X; Barrett AM, 2006, J REHABIL RES DEV, V43, P337, DOI 10.1682/JRRD.2005.01.0015; Bayley MT, 2007, ARCH PHYS MED REHAB, V88, P526, DOI 10.1016/j.apmr.2007.01.005; Berberovic N, 2003, NEUROPSYCHOLOGIA, V41, P493, DOI 10.1016/S0028-3932(02)00090-8; Berberovic N, 2004, NEUROREPORT, V15, P1199, DOI 10.1097/00001756-200405190-00024; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P66; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; BISIACH E, 1993, Q J EXP PSYCHOL-A, V46, P435, DOI 10.1080/14640749308401056; BISIACH E, 1990, NEUROLOGY, V40, P1278, DOI 10.1212/WNL.40.8.1278; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Bookheimer S, 2007, NEUROPSYCHOL REV, V17, P145, DOI 10.1007/s11065-007-9026-x; Bowen A, 1999, STROKE, V30, P1196, DOI 10.1161/01.STR.30.6.1196; Bowen A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub2; BOWEN A, 2002, COCHRANE LIB; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; BURKE JM, 1994, BRAIN INJURY, V8, P71, DOI 10.3109/02699059409150960; Butler BC, 2004, NEUROPSYCHOLOGIA, V42, P346, DOI 10.1016/j.neuropsychologia.2003.08.008; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cherney LR, 2001, ARCH PHYS MED REHAB, V82, P322, DOI 10.1053/apmr.2001.21511; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cirstea CM, 2006, STROKE, V37, P1237, DOI 10.1161/01.STR.0000217417.89347.63; Claesson L, 2005, CEREBROVASC DIS, V19, P102, DOI 10.1159/000082787; Coslett HB, 1997, BRAIN, V120, P1163, DOI 10.1093/brain/120.7.1163; COSLETT HB, 1990, BRAIN, V113, P475, DOI 10.1093/brain/113.2.475; Cowey A, 1999, NEUROPSYCHOLOGIA, V37, P1; Crosson B, 2007, J INT NEUROPSYCH SOC, V13, P582, DOI 10.1017/S1355617707070737; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; Desmond DW, 1996, STROKE, V27, P1798, DOI 10.1161/01.STR.27.10.1798; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Elman RJ, 1999, J SPEECH LANG HEAR R, V42, P411, DOI 10.1044/jslhr.4202.411; Eskes GA, 2006, RESTOR NEUROL NEUROS, V24, P385; Eslamboli A, 2003, EXP NEUROL, V183, P418, DOI 10.1016/S0014-4886(03)00139-0; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; FERRO JM, 1988, STROKE, V19, P982, DOI 10.1161/01.STR.19.8.982; FLEET WS, 1987, NEUROLOGY, V37, P1765, DOI 10.1212/WNL.37.11.1765; FULLERTON KJ, 1988, Q J MED, V66, P147; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; GASPARRINI B, 1979, Journal of Clinical Neuropsychology, V1, P137, DOI 10.1080/01688637908414447; Geminiani G, 1998, J NEUROL NEUROSUR PS, V65, P344, DOI 10.1136/jnnp.65.3.344; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; Gillen R, 2005, ARCH PHYS MED REHAB, V86, P763, DOI 10.1016/j.apmr.2004.10.029; Gillespie DC, 2006, CLIN NEUROPSYCHOL, V20, P59, DOI 10.1080/13854040500203308; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GODFREY HPD, 1985, J CONSULT CLIN PSYCH, V53, P555, DOI 10.1037/0022-006X.53.4.555; GORDON WA, 1985, ARCH PHYS MED REHAB, V66, P353; GOUVIER WD, 1987, INT J CLIN NEUROPSYC, V9, P74; Grujic Z, 1998, NEUROLOGY, V51, P1395, DOI 10.1212/WNL.51.5.1395; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; Heilman KM, 2004, FRONT BIOSCI-LANDMRK, V9, P694, DOI 10.2741/1261; HENLEY S, 1985, J NEUROL NEUROSUR PS, V48, P1, DOI 10.1136/jnnp.48.1.1; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Hillis AE, 2007, NEUROLOGY, V69, P200, DOI 10.1212/01.wnl.0000265600.69385.6f; Hochstenbach J, 2005, ARCH PHYS MED REHAB, V86, P1587, DOI 10.1016/j.apmr.2004.11.050; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; Hochstenbach JB, 2003, ARCH PHYS MED REHAB, V84, P1499, DOI 10.1016/S0003-9993(03)00370-8; Hoffmann M, 2001, NEUROREHAB NEURAL RE, V15, P113, DOI 10.1177/154596830101500205; Honda Tetsumi, 1999, Top Stroke Rehabil, V6, P15, DOI 10.1310/CN46-B2WU-NGVN-37YJ; Hyndman D, 2003, DISABIL REHABIL, V25, P817, DOI 10.1080/0963828031000122221; Jutai Jeffrey W, 2003, Top Stroke Rehabil, V10, P77; KALRA L, 1994, STROKE, V25, P821, DOI 10.1161/01.STR.25.4.821; KASCHEL R, 2000, NEUROPSYCHOL REHABIL, V12, P127; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; KELLY MP, 1985, REHABIL PSYCHOL, V30, P35, DOI 10.1037//0090-5550.30.1.35; LADAVAS E, 1994, NEUROPSYCHOL REHABIL, V4, P155, DOI 10.1080/09602019408402275; Ladavas E, 1997, EXP BRAIN RES, V116, P493, DOI 10.1007/PL00005777; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lillie R, 2006, J HEAD TRAUMA REHAB, V21, P119, DOI 10.1097/00001199-200603000-00005; Lincoln NB, 2006, RESTOR NEUROL NEUROS, V24, P401; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136/jnnp.72.1.93; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malouin F, 2004, ARCH PHYS MED REHAB, V85, P177, DOI 10.1016/S0003-9993(03)00771-8; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; MARK VW, 1993, NEUROLOGY, V43, P1859, DOI 10.1212/WNL.43.9.1859; Marshall J, 2005, EFFECTIVENESS REHABI, P195; MARSHALL JF, 1979, BRAIN RES, V177, P311, DOI 10.1016/0006-8993(79)90782-0; Mazer BL, 2003, ARCH PHYS MED REHAB, V84, P541, DOI 10.1053/apmr.2003.50085; McDowd JM, 2003, J GERONTOL B-PSYCHOL, V58, pP45, DOI 10.1093/geronb/58.1.P45; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Michel J A, 2006, Eura Medicophys, V42, P59; Milton AL, 2004, BEHAV BRAIN RES, V150, P55, DOI 10.1016/S0166-4328(03)00231-6; Mok VCT, 2004, J NEUROL NEUROSUR PS, V75, P560, DOI 10.1136/jnnp.2003.015107; Na DL, 1999, NEUROLOGY, V52, P1569, DOI 10.1212/WNL.52.8.1569; Na DL, 1998, J NEUROL NEUROSUR PS, V64, P331, DOI 10.1136/jnnp.64.3.331; Nico D, 1996, NEUROPSYCHOLOGIA, V34, P471, DOI 10.1016/0028-3932(95)00123-9; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; Nys GMS, 2005, J INT NEUROPSYCH SOC, V11, P795, DOI 10.1017/S1355617705050952; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; OTT BR, 1993, STROKE, V24, P1033, DOI 10.1161/01.STR.24.7.1033; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Paolucci S, 2001, ARCH PHYS MED REHAB, V82, P743, DOI 10.1053/apmr.2001.23191; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; PARK NW, 1999, ROTM RES I ANN M; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Payne BR, 2004, EXP BRAIN RES, V154, P127, DOI 10.1007/s00221-003-1660-9; Plohmann AM, 1998, J NEUROL NEUROSUR PS, V64, P455, DOI 10.1136/jnnp.64.4.455; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Riepe MW, 2004, DEMENT GERIATR COGN, V17, P49, DOI 10.1159/000074082; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; ROBERTSON IH, 1993, NEUROPSYCHOLOGIA, V31, P293, DOI 10.1016/0028-3932(93)90093-F; ROBERTSON IH, 1992, J NEUROL NEUROSUR PS, V55, P799, DOI 10.1136/jnnp.55.9.799; ROBERTSON IH, 1992, NEUROPSYCHOLOGIA, V30, P553, DOI 10.1016/0028-3932(92)90058-T; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; ROBERTSON IH, 1993, UNILATERAL NEGLECT C, P279; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P172, DOI 10.1044/jslhr.4101.172; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Rothi LJG, 2006, J INT NEUROPSYCH SOC, V12, P812, DOI 10.1017/S1355617706060991; Rothi LJG, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.08.0086; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SCHNEIDER JS, 1992, NEUROLOGY, V42, P1565, DOI 10.1212/WNL.42.8.1565; SCHNEIDER MB, 1984, CLIN NEUROPHARMACOL, V7, P247, DOI 10.1097/00002826-198409000-00006; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Schwartz RL, 1999, NEUROLOGY, V53, P2017, DOI 10.1212/WNL.53.9.2017; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Sohlberg MM, 2001, ANN NY ACAD SCI, V931, P359; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stapleton T, 2001, CLIN REHABIL, V15, P437, DOI 10.1191/026921501678310243; Stephens S, 2005, J AM GERIATR SOC, V53, P103, DOI 10.1111/j.1532-5415.2005.53019.x; Stewart FM, 1996, BRIT J CLIN PSYCHOL, V35, P369, DOI 10.1111/j.2044-8260.1996.tb01191.x; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Stone SP, 1998, NEUROLOGY, V50, P1902, DOI 10.1212/WNL.50.6.1902; Sturm W, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P365; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; STURM W, 1993, DEV ASSESSMENT REHAB, P49; Sturm W, 1991, NEUROPSYCHOL REHABIL, V1, P259, DOI DOI 10.1080/09602019108402258; Stuss D. T., 2007, HUMAN FRONTAL LOBES; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Taub E, 2006, Eura Medicophys, V42, P241; Taub E, 1999, J REHABIL RES DEV, V36, pVII; TEASELL R, 2007, STROKENGINE SYSTEMAT; TEASELL R, 2006, EVIDENCE BASED REV S; TEASELL R, 2007, EVIDENCE BASED REV S; TEGNER R, 1991, BRAIN, V114, P1943, DOI 10.1093/brain/114.4.1943; Tham W, 2002, J NEUROL SCI, V203, P49, DOI 10.1016/S0022-510X(02)00260-5; Towle D, 2016, CLIN REHABIL, V2, P303, DOI [10.1177/026921558800200406, DOI 10.1177/026921558800200406], DOI 10.1177/026921558800200406]; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; UNGERSTEDT U, 1976, PHARMACOL THER PT B, V2, P37, DOI 10.1016/0306-039X(76)90016-7; Vuilleumier P, 1998, ANN NEUROL, V43, P406, DOI 10.1002/ana.410430324; Wade D T, 1986, Int Rehabil Med, V8, P60; Wagenaar R C, 1992, Disabil Rehabil, V14, P51; Walker R, 1996, NEUROPSYCHOL REHABIL, V6, P219, DOI 10.1080/713755508; Webster JS, 2001, ARCH PHYS MED REHAB, V82, P769, DOI 10.1053/apmr.2001.23201; WEBSTER JS, 1984, BEHAV THER, V15, P129, DOI 10.1016/S0005-7894(84)80015-5; WEINBERG J, 1979, ARCH PHYS MED REHAB, V60, P491; WEINBERG J, 1977, ARCH PHYS MED REHAB, V58, P479; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022; [No title captured]	181	9	9	0	6	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-6541-7				2010							281	305		10.1007/978-0-387-70715-0_19			25	Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BSV22	WOS:000285894000019					2022-02-06	
J	Gezici, AR; Karakas, A; Ergun, R; Gunduz, B				Gezici, A. R.; Karakas, A.; Ergun, R.; Gunduz, B.			Rhythms of serum melatonin in rats with acute spinal cord injury at the cervical and thoracic regions	SPINAL CORD			English	Article						melatonin; neuroprotection; spinal cord injury	CORTISOL; LESIONS; DAMAGE; MODEL	Objective: To evaluate the serum melatonin levels in acute period of the spinal cord injury (SCI) caused by trauma in the rats. Background: Traumatic SCI induces many types of physiological and pathological damage, including hormonal level variations. Methods: Forty male Sprague-Dawley rats were divided randomly into four groups. In the control group, neither laminectomy nor SCI were performed; only a large laminectomy was performed without SCI in the sham group. In the cervical and thoracic spinal trauma groups, laminectomies at C5-6 and a T6-7 were performed, respectively, followed by clip compression of the spinal cord. Blood samples were drawn 2, 6, 12 and 24 h after the procedures and assayed immediately. Results: The levels of melatonin in the neurotrauma groups were high in the first 2 h, but at the end of sixth hour, melatonin levels increased in sham-operated group, decreased in neurotrauma groups and did not change in control group. At the 12th hour, melatonin levels continued to decrease in thoracic group significantly. At the 24th hour, the melatonin levels decreased in the cervical, control and sham groups, whereas melatonin levels increased in the thoracic group. Conclusions: The present study revealed that (1) activation of endogen melatonin secretion of the organism starts immediately after the SCI, but it shows a great lowering trend between 2 and 6h post-SCI, (2) the tetraplegic rats, which had complete injuries at the lower cervical spinal cord, could not produce enough melatonin secretion; on the contrary, the paraplegic rats, which had complete injury at the upper thoracic spinal cord, showed normal melatonin secretion. Spinal Cord (2010) 48, 10-14; doi:10.1038/sc.2009.73; published online 23 June 2009	[Gezici, A. R.; Ergun, R.] Abant Izzet Baysal Univ, Fac Med, Dept Neurosurg, TR-14300 Bolu, Turkey; [Karakas, A.] Abant Izzet Baysal Univ, Fac Arts & Sci, Dept Biol, TR-14300 Bolu, Turkey; [Gunduz, B.] Canakkale Onsekiz Mart Univ, Fac Arts & Sci, Dept Biol, Canakkale, Turkey		Gezici, AR (corresponding author), Abant Izzet Baysal Univ, Fac Med, Dept Neurosurg, Oznur Apartment 16-8, TR-14300 Bolu, Turkey.	geziciar@gmail.com	Gunduz, Bulent/AAA-5763-2019				Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Fujimoto T, 2000, SPINE, V25, P769, DOI 10.1097/00007632-200004010-00003; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Gunduz B, 2002, COMP BIOCHEM PHYS A, V132, P393, DOI 10.1016/S1095-6433(02)00041-7; Kennaway DJ, 1998, J CLIN ENDOCR METAB, V83, P1013, DOI 10.1210/jc.83.3.1013; KLEIN DC, 1993, LIGHT BIOL RHYTHMS M, P55; KNEISLEY LW, 1978, J NEURAL TRANSM, P311; LI Y, 1989, CLIN ENDOCRINOL, V30, P47, DOI 10.1111/j.1365-2265.1989.tb03726.x; Liu JB, 2004, CHINESE MED J-PEKING, V117, P571; Melchiorri Daniela, 1995, Life Sciences, V56, P83, DOI 10.1016/0024-3205(94)00417-Q; Persengiev SP, 2001, J STEROID BIOCHEM, V77, P151, DOI 10.1016/S0960-0760(01)00037-1; Pierre C., 1994, LIFE SCI, V55, P271; REITER RJ, 1994, ANN NY ACAD SCI, V719, P1, DOI 10.1111/j.1749-6632.1994.tb56817.x; REPPERT SM, 1981, J NEUROSCI, V1, P1414; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Sparks DL, 1998, NEUROSCI LETT, V248, P179, DOI 10.1016/S0304-3940(98)00365-6; Topsakal C, 2003, SPINE, V28, P1643, DOI 10.1097/00007632-200308010-00004; Zeitzer JM, 2000, J CLIN ENDOCR METAB, V85, P2189, DOI 10.1210/jc.85.6.2189	19	9	12	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	JAN	2010	48	1					10	14		10.1038/sc.2009.73			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	540QB	WOS:000273349400003	19546875	Bronze			2022-02-06	
B	Goldstein, G; Saklofske, DH		Weiss, LG; Saklofske, DH; Coalson, DL; Raiford, SE		Goldstein, Gerald; Saklofske, Donald H.			The Wechsler Intelligence Scales in the Assessment of Psychopathology	WAIS-IV CLINICAL USE AND INTERPRETATION: SCIENTIST-PRACTITIONER PERSPECTIVES	Practical Resources for the Mental Health Professional		English	Article; Book Chapter							CONFIRMATORY FACTOR-ANALYSIS; TRAUMATIC BRAIN-INJURY; HIGH-FUNCTIONING AUTISM; WAIS-III; GENDER-DIFFERENCES; PERFORMANCE; RECOVERY; SCHIZOPHRENIA; IQ; HETEROGENEITY		[Goldstein, Gerald] VA Pittsburgh Healthcare Ctr, MIRECC, Pittsburgh, PA USA; [Goldstein, Gerald] VA Pittsburgh Healthcare Ctr, Res Serv, Pittsburgh, PA USA; [Saklofske, Donald H.] Univ Calgary, Div Appl Psychol, Calgary, AB, Canada		Goldstein, G (corresponding author), VA Pittsburgh Healthcare Ctr, MIRECC, Pittsburgh, PA USA.						Aguirre F, 2008, SCHIZOPHR RES, V104, P255, DOI 10.1016/j.schres.2008.05.007; Allen DN, 2007, SCHIZOPHR RES, V93, P325, DOI 10.1016/j.schres.2007.02.008; Allen DN, 2003, J INT NEUROPSYCH SOC, V9, P56, DOI 10.1017/S135561770391006X; Allen DN, 1998, SCHIZOPHR RES, V34, P87, DOI 10.1016/S0920-9964(98)00090-5; ALLEN DN, 2006, QUANTIFIED PROCESS A; ANDIA AM, 1995, J NERV MENT DIS, V183, P522, DOI 10.1097/00005053-199508000-00005; ASARNOW RF, 1983, J NERV MENT DIS, V171, P662, DOI 10.1097/00005053-198311000-00004; Balinsky B., 1941, PSYCHOL MONOGR, V23, P191; Bowden S.C., 2010, INVARIANCE MEA UNPUB; Bowden SC, 2008, EDUC PSYCHOL MEAS, V68, P1024, DOI 10.1177/0013164408318769; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Burton DB, 2002, ARCH CLIN NEUROPSYCH, V17, P371, DOI 10.1016/S0887-6177(01)00121-4; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; COHEN J, 1952, J CONSULT PSYCHOL, V16, P272; CROCKETT DJ, 1993, J CLIN EXP NEUROPSYC, V15, P903, DOI 10.1080/01688639308402607; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Dickinson D, 2002, ASSESSMENT, V9, P171, DOI 10.1177/10791102009002008; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; Eisenberg L., 1958, PSYCHOPATHOLOGY SOUR, P209; Esterberg ML, 2009, CURR PSYCHIAT REP, V11, P179, DOI 10.1007/s11920-009-0028-7; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; Goldstein G, 2002, ARCH CLIN NEUROPSYCH, V17, P461, DOI 10.1016/S0887-6177(01)00129-9; Goldstein G, 1990, Arch Clin Neuropsychol, V5, P251, DOI 10.1016/0887-6177(90)90024-J; Goldstein G, 2005, ARCH CLIN NEUROPSYCH, V20, P153, DOI 10.1016/j.acn.2004.03.008; Goldstein G, 2001, Appl Neuropsychol, V8, P148, DOI 10.1207/S15324826AN0803_3; Goldstein G., 2004, COMPREHENSIVE HDB PS; Goldstein G., 2010, BRAIN INJUR IN PRESS; Goldstein G, 2008, NEUROPSYCHOLOGY, V22, P301, DOI 10.1037/0894-4105.22.3.301; Gooding DC, 2006, SCHIZOPHR RES, V82, P27, DOI 10.1016/j.schres.2005.11.015; Greve KW, 2008, APPL NEUROPSYCHOL, V15, P161, DOI 10.1080/09084280802324085; Harkness A. R., 1994, DIFFERENTIATING NORM; HARKNESS AR, 1995, PSYCHOL ASSESSMENT, V7, P104, DOI 10.1037/1040-3590.7.1.104; Heinrichs RW, 2008, NEUROPSYCHOLOGY, V22, P321, DOI 10.1037/0894-4105.22.3.321; HEINRICHS RW, 1993, SCHIZOPHR RES, V9, P49, DOI 10.1016/0920-9964(93)90009-8; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 2001, PSYCHOL REP, V89, P457, DOI 10.2466/pr0.2001.89.2.457; Joreskog K. G., 1993, LISREL 8 USERS REFER; Katz L. J., 2001, CRIT ISS NE; Kraemer DJM, 2009, J NEUROSCI, V29, P3792, DOI 10.1523/JNEUROSCI.4635-08.2009; LANSDELL H, 1975, J CONSULT CLIN PSYCH, V43, P923; LINCOLN AJ, 1988, J AUTISM DEV DISORD, V18, P505, DOI 10.1007/BF02211870; Lineweaver T. T., 2003, CLIN INTERPRETATION; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCDERMOTT PA, 1989, PSYCHOL ASSESSMENT J, V1, P118; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; MEEHL PE, 1989, ARCH GEN PSYCHIAT, V46, P935; Palmer BW, 1997, NEUROPSYCHOLOGY, V11, P437, DOI 10.1037/0894-4105.11.3.437; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; RAPAPORT D, 1945, DIAGNOSTIC PSYCHOL T; Rourke BP., 1998, WISC 3 CLIN USE INTE, P139; RUTTER M, 1987, J AUTISM DEV DISORD, V17, P159, DOI 10.1007/BF01495054; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; SCHWEAN VL, 1993, J PSYCHOEDUC ASSESS, P56; Seaton BE, 2001, NEUROPSYCHOL REV, V11, P45, DOI 10.1023/A:1009013718684; Seckinger RA, 2004, SCHIZOPHR RES, V69, P55, DOI 10.1016/S0920-9964(03)00124-5; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Siegel DJ, 1996, J AUTISM DEV DISORD, V26, P389, DOI 10.1007/BF02172825; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Snowling, 1983, BRIT J DEV PSYCHOL, V1, P329, DOI [10.1111/j.2044-835X.1983.tb00906.x, DOI 10.1111/J.2044-835X.1983.TB00906.X]; SOLOVAY MR, 1986, SCHIZOPHRENIA BULL, V12, P483; Taub GE, 2004, PSYCHOL ASSESSMENT, V16, P85, DOI 10.1037/1040-3590.16.1.85; Tulsky D., 2003, CLIN INTERPRETATION, P147; Tulsky D. S., 2000, HDB PSYCHOL ASSESSME, P97; TULSKY DS, 2003, CLIN INTERPRETATION; van der Heijden P, 2003, J CLIN EXP NEUROPSYC, V25, P59, DOI 10.1076/jcen.25.1.59.13627; Voglmaier MM, 2005, SCHIZOPHR RES, V74, P43, DOI 10.1016/j.schres.2004.09.013; Ward LC, 2000, PSYCHOL ASSESSMENT, V12, P341, DOI [10.1037/1040-3590.12.3.341, 10.1037//1040-3590.12.3.341]; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 2001, WECHSLER INDIVIDUAL; Wechsler D., 2008, WECHSLER FUNDAMENTAL; Wechsler D, 1941, MEASUREMENT ADULT IN; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Weiser M, 2000, SCHIZOPHR RES, V45, P185, DOI 10.1016/S0920-9964(99)00190-5; Wilk CM, 2005, NEUROPSYCHOLOGY, V19, P778, DOI 10.1037/0894-4105.19.6.778; Williams DL, 2008, RES AUTISM SPECT DIS, V2, P353, DOI 10.1016/j.rasd.2007.08.005; Wolfson, 1993, HALSTEAD REITAN NEUR; Wolitzky R, 2006, J CLIN EXP NEUROPSYC, V28, P167, DOI 10.1080/13803390500360315; [No title captured]	83	9	9	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-08-096321-1; 978-0-12-375035-8	PRACT RESOUR MENT			2010							189	216		10.1016/B978-0-12-375035-8.10007-2			28	Psychology, Clinical	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BES29	WOS:000317925500009					2022-02-06	
J	Kvinnsland, SR; Bardsen, A; Fristad, I				Kvinnsland, S. R.; Bardsen, A.; Fristad, I.			Apexogenesis after initial root canal treatment of an immature maxillary incisor - a case report	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						apexogenesis; diagnosis; endodontic treatment; immature tooth; pulp necrosis; root development	PULP; TEETH; DIFFERENTIATION; DIAGNOSIS; PROGNOSIS; FRACTURE	P>Aim To present a case where a traumatized, immature tooth still showed capacity for continued root development and apexogenesis after root canal treatment was initiated based on an inaccurate pulpal diagnosis. Summary Traumatic dental injuries may result in endodontic complications. Treatment strategies for traumatized, immature teeth should aim at preserving pulp vitality to ensure further root development and tooth maturation. A 9-year-old boy, who had suffered a concussion injury to the maxillary anterior teeth, was referred after endodontic treatment was initiated in tooth 21 one week earlier. The tooth had incomplete root length, thin dentinal walls and a wide open apex. The pulp chamber had been accessed, and the pulp canal instrumented to size 100. According to the referral, bleeding from the root made it difficult to fill the root canal with calcium hydroxide. No radiographic signs of apical breakdown were recorded. Based on radiographic and clinical findings, a conservative treatment approach was followed to allow continued root development. Follow-up with radiographic examination every 3rd month was performed for 15 months. Continued root formation with apical closure was recorded. In the cervical area, a hard tissue barrier developed, which was sealed with white mineral trioxide aggregate (MTA). Bonded composite was used to seal the access cavity. At the final 2 years follow-up, the tooth showed further root development and was free from symptoms. Key learning points Endodontic treatment of immature teeth may result in a poor long-term prognosis. The pulp of immature teeth has a significant repair potential as long as infection is prevented. Treatment strategies of traumatized, immature permanent teeth should aim at preserving pulp vitality to secure further root development and tooth maturation. Radiographic interpretation of the periapical area of immature teeth may be confused by the un-mineralized radiolucent zone surrounding the dental papilla.	[Bardsen, A.; Fristad, I.] Univ Bergen, Dept Clin Dent Endodont, N-5009 Bergen, Norway		Fristad, I (corresponding author), Univ Bergen, Dept Clin Dent Endodont, Arstadveien 17, N-5009 Bergen, Norway.	inge.fristad@iko.uib.no		Bardsen, Asgeir/0000-0001-6471-9362			ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P90; ANDREASEN F M, 1987, Endodontics and Dental Traumatology, V3, P103; Andreasen F.M., 2007, TEXTBOK COLOUR ATLAS, V4, P372; ANDREASEN FM, 1989, ENDOD DENT TRAUMATOL, V5, P111; Andreasen J O, 1970, Scand J Dent Res, V78, P273; ANDREASEN JO, 1988, ENDOD DENT TRAUMATOL, V4, P145; Asgary S, 2005, J ENDODONT, V31, P101, DOI 10.1097/01.DON.0000133156.85164.B2; BHASKAR SN, 1973, J AM DENT ASSOC, V86, P409, DOI 10.14219/jada.archive.1973.0081; Cox CF, 1996, OPER DENT, V21, P4; CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45; Cvek M., 2007, TXB COLOR ATLAS TRAU, P598; FEIT J, 1970, J DENT RES, V49, P783, DOI 10.1177/00220345700490041301; Fuss Z, 2003, DENT TRAUMATOL, V19, P175, DOI 10.1034/j.1600-9657.2003.00192.x; Glickman GN, 1999, J AM DENT ASSOC, V131, p39S; JACOBSEN I, 1980, SCAND J DENT RES, V88, P306; KVINNSLAND I, 1991, ARCH ORAL BIOL, V36, P815, DOI 10.1016/0003-9969(91)90031-O; LUOSTARINEN V, 1971, SUOMI HAMMASLAAK S2, V67, P3; Magnusson B, 1969, Sven Tandlak Tidskr, V62, P61; RUCH J, 1945, J DENT RES, V64, P489; SVEEN OB, 1968, ARCH ORAL BIOL, V13, P1399, DOI 10.1016/0003-9969(68)90022-8; Watts A, 1981, Int Endod J, V14, P10, DOI 10.1111/j.1365-2591.1981.tb01054.x; YAMAMURA T, 1985, J DENT RES, V64, P530, DOI 10.1177/002203458506400406; ZACH L, 1969, ORAL SURG ORAL MED O, V28, P587, DOI 10.1016/0030-4220(69)90268-0; ZADIK D, 1979, ORAL SURG ORAL MED O, V47, P173, DOI 10.1016/0030-4220(79)90175-0	25	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	JAN	2010	43	1					76	83		10.1111/j.1365-2591.2009.01645.x			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	529RH	WOS:000272534400011	20002804				2022-02-06	
J	Lee, JW; Hsueh, YY; Lee, JS				Lee, Jing-Wei; Hsueh, Yuan-Yu; Lee, Jung-Shun			COMPOSITE SKULL AND DURA DEFECT RECONSTRUCTION USING COMBINED LATISSIMUS DORSI MUSCULOCUTANEOUS AND SERRATUS ANTERIOR MUSCLE-RIB FREE FLAP COUPLED WITH VASCULARIZED GALEA TRANSFER: A CASE REPORT	MICROSURGERY			English	Article							OSSEOUS FLAP; TISSUE; SCALP; BONE	Recalcitrant epidural abscess following cranioplasty is a complicated problem, which becomes even more trying when large span of dura and skull bone are being replaced by alloplastic materials. A 22-year-old male underwent right fronto-temporo-parietal craniectomy and duroplasty with artificial dura graft after traumatic brain injury. Epidural abscesses recurred after cranioplasty with autologous bone graft as well as with a methyl methacrylate bone plate. The massive defects of both the dura and skull bone (15 x 9 cm) caused by radical debridement were reconstructed successfully with a combined free latissimus dorsi and serratus anterior myo-osseous flap transfer plus galea flap transposition. Proper contour and adequate stability of the construct were maintained during 2-year follow up without episodes of relapsing infection. (C) 2010 Wiley-Liss, Inc. Microsurgery 30:632-635, 2010.	[Lee, Jung-Shun] Natl Cheng Kung Univ, Neurosurg Sect, Dept Surg, Coll Med & Hosp, Tainan 70403, Taiwan; [Lee, Jing-Wei; Hsueh, Yuan-Yu] Natl Cheng Kung Univ, Sect Plast Surg, Coll Med & Hosp, Tainan 70403, Taiwan		Lee, JS (corresponding author), Natl Cheng Kung Univ, Neurosurg Sect, Dept Surg, Coll Med & Hosp, 138 Sheng Li Rd, Tainan 70403, Taiwan.	lsj1218hotmail@yahoo.com.tw	Hsueh, Yuan-Yu/AAN-3513-2020	Hsueh, Yuan-Yu/0000-0001-8968-694X			del Campo JAG, 2008, MED ORAL PATOL ORAL, V13, pE666; ARDEN RL, 1987, LARYNGOSCOPE, V97, P1336; BRODY GA, 1990, J HAND SURG-AM, V15A, P322, DOI 10.1016/0363-5023(90)90117-A; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; EDGERTON MT, 1965, AM J SURG, V110, P595, DOI 10.1016/0002-9610(65)90045-0; Georgescu AV, 2003, MICROSURG, V23, P217, DOI 10.1002/micr.10127; Guo L., 2009, PLAST RECONSTR SURG, V124, P340; HARII K, 1982, PLAST RECONSTR SURG, V70, P620, DOI 10.1097/00006534-198211000-00019; Kunstfeld R, 2001, PLAST RECONSTR SURG, V108, P1908, DOI 10.1097/00006534-200112000-00009; Lin CH, 1997, PLAST RECONSTR SURG, V99, P1656, DOI 10.1097/00006534-199705000-00028; RICHARDS MA, 1985, BRIT J PLAST SURG, V38, P466, DOI 10.1016/0007-1226(85)90002-5; Safak T, 2000, PLAST RECONSTR SURG, V105, P1304; Serra MP, 2007, J PLAST RECONSTR AES, V60, P1158, DOI 10.1016/j.bjps.2006.06.020; STUEBER K, 1985, ANN PLAST SURG, V45, P155; Tanaka Y, 1998, BRIT J PLAST SURG, V51, P250, DOI 10.1054/bjps.1997.0030	15	9	9	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0738-1085			MICROSURG	Microsurgery		2010	30	8					632	635		10.1002/micr.20808			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	686CS	WOS:000284675000007	20734432				2022-02-06	
J	Menku, A; Ogden, M; Saraymen, R				Menku, Ahmet; Ogden, Mustafa; Saraymen, Recep			The Protective Effects of Propofol and Citicoline Combination in Experimental Head Injury in Rats	TURKISH NEUROSURGERY			English	Article						Antioxidant; Citicoline; Head injury; Lipid peroxidation; Propofol	SPINAL-CORD-INJURY; TRANSIENT CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; PATHOPHYSIOLOGY; DAMAGE; MECHANISMS; MODEL	AIM: Lipid peroxidation (LP) is an important factor in tissue damage following head injury. Reactive oxygen radicals which damage cellular components play an important role in ischemic or hypoxic tissue. They initiate the lipid peroxidation process after head trauma. However, antioxidant agents may protect brain tissue against oxidative damage MATERIAL and METHODS: 39 male Swiss Albino rats (200-250 g) were used in this experimental study. These animals were divided into 3 groups: 1) control group, 2) propofol group (100 mg/kg) and, 3) citicoline (250 mg/kg) and propofol (100 mg/kg) combination group. Oxidant effect in brain tissue content was assessed by measuring the Malonyldialdehyde (MDA), Superoxide Dismutase (SOD) and Gluthatione Peroxidase (GPx) activities. RESULTS: There was no statistically meaningful difference among the groups regarding GPx levels. MDA levels were significantly lower in the citicoline and combination group than those of the control group. As for the levels of SOD, there was an increase both in the propofol and combination groups. CONCLUSION: A therapeutic benefit of the propofol and citicolin combination in head trauma has not been previously demonstrated. We examined the possible potential protective effect of propofol and citicolin against oxidative damage in experimental head trauma in the present study.	[Menku, Ahmet] Erciyes Univ, Fac Med, Dept Neurosurg, Kayseri, Turkey; [Ogden, Mustafa] Kirikkale State Hosp, Dept Neurosurg, Kirikkale, Turkey; [Saraymen, Recep] Erciyes Univ, Fac Med, Dept Biochem, Kayseri, Turkey		Menku, A (corresponding author), Erciyes Univ, Fac Med, Dept Neurosurg, Kayseri, Turkey.	menkua@erciyes.edu.tr					Adibhatla RM, 2003, J NEUROSCI RES, V73, P308, DOI 10.1002/jnr.10672; Adibhatla RM, 2002, J NEUROCHEM, V80, P12; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; ANDERSON DK, 1985, ANN EMERG MED, V14, P816, DOI 10.1016/S0196-0644(85)80064-0; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; Boland A, 2000, EUR J PHARMACOL, V404, P21, DOI 10.1016/S0014-2999(00)00496-9; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Cakir E, 2005, J CLIN NEUROSCI, V12, P923, DOI 10.1016/j.jocn.2005.03.013; CALATAYUD V, 1991, J NEUROL SCI, V103, P15; CHAN PH, 1978, SCIENCE, V201, P358, DOI 10.1126/science.663662; Chiu WT, 2006, SURG NEUROL, V66, pS37, DOI 10.1016/j.surneu.2006.08.028; Conant Richard, 2004, Altern Med Rev, V9, P17; DEFEUDIS FV, 1991, EFFECTS EGB 761 CNS, P551; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; FERRARI R, 1991, AM J MED, V91, pS95, DOI 10.1016/0002-9343(91)90291-5; Graham D.I., 1996, NEUROTRAUMA, P43; HALL ED, 1993, RES P ARNMD, V71, P81; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Ito H, 1999, ACTA ANAESTH SCAND, V43, P153, DOI 10.1034/j.1399-6576.1999.430206.x; KONAT GW, 1985, J NEUROCHEM, V45, P1113, DOI 10.1111/j.1471-4159.1985.tb05530.x; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller JD, 1996, NEUROTRAUMA, P61; MURPHY PG, 1992, BRIT J ANAESTH, V68, P613, DOI 10.1093/bja/68.6.613; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OZTURK E, 2005, NEUROPSYCHOPHARMACOL, V29, P922; PINAUD M, 1991, ANN FR ANESTH, V10, P2, DOI 10.1016/S0750-7658(05)80264-3; SELIGMAN ML, 1977, LIPIDS, V12, P945, DOI 10.1007/BF02533316; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; Sitar SM, 1999, ANESTHESIOLOGY, V90, P1446, DOI 10.1097/00000542-199905000-00030; Sun J, 2007, CYTOKINE, V40, P151, DOI 10.1016/j.cyto.2007.09.003; Topsakal C, 2002, NEUROSURG REV, V25, P258, DOI 10.1007/s101430100183	33	9	13	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JAN	2010	20	1					57	62					6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	557XD	WOS:000274702500010	20066623				2022-02-06	
J	Richter, HO; Roijezon, U; Bjorklund, M; Djupsjobacka, M				Richter, Hans O.; Roijezon, Ulric; Bjorklund, Martin; Djupsjobacka, Mats			Long-term adaptation to neck/shoulder pain and perceptual performance in a hand laterality motor imagery test	PERCEPTION			English	Article							NECK DISABILITY INDEX; CEREBRAL-BLOOD-FLOW; MENTAL ROTATION; HUMAN BRAIN; WHIPLASH; TRANSFORMATIONS; INFORMATION; MOVEMENT; PROPRIOCEPTION; STIMULATION	The effect of neck/shoulder pain on the performance in a hand laterality motor imagery test was studied. Responses to the Cooper and Shepard (1975, Journal of Experimental Psychology: Human Perception and Performance 104 48-56) hand laterality test were explored in twenty-four individuals with chronic non-specific neck pain and twenty-one subjects with chronic neck pain of traumatic origin (whiplash-associated disorder). Twenty-two controls were also included in the study. Digitalised right- or left-hand stimuli were presented at Five different stimulus angles (0 degrees, 45 degrees laterally, 90 degrees laterally, 135 degrees laterally, and 180 degrees). The experimental task was to decide the laterality as fast and accurately as possible. The performance, both reaction time (RT) and accuracy, of the two experimental groups was contrasted with that of the control group. The main results revealed that the subjects afflicted with whiplash injury on the average exhibited a faster response pattern than symptom-free healthy controls. Despite their musculoskeletal deficits and experience of pain these volunteers also exhibited a preserved speed-accuracy tradeoff. Longer duration of time with symptoms of neck pain was, moreover, associated with progressively faster RTs. These results point to perceptual learning and may reflect different stages of adaptation to neck pain.	[Richter, Hans O.; Djupsjobacka, Mats] Univ Gavle, Mcclure Musculoskeletal Res Ctr, S-80176 Gavle, Sweden; [Roijezon, Ulric; Bjorklund, Martin] Alfta Res Fdn, Alfta, Sweden; [Roijezon, Ulric] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden		Richter, HO (corresponding author), Univ Gavle, Mcclure Musculoskeletal Res Ctr, S-80176 Gavle, Sweden.	hrr@hig.se	Roijezon, Ulrik/Y-8154-2018	Roijezon, Ulrik/0000-0003-3901-0364			Abatzides GJ, 1999, J BACK MUSCULOSKELET, V12, P101, DOI 10.3233/BMR-1999-12203; Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; ALLUM JHJ, 1993, PROG BRAIN RES, V97, P331; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buitenhuis J, 2009, SPINE, V34, P262, DOI 10.1097/BRS.0b013e3181913d07; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Finke R.A., 1989, PRINCIPLES MENTAL IM; Fiorio M, 2006, BRAIN, V129, P47, DOI 10.1093/brain/awh630; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Freitag P, 2001, NEUROREHAB NEURAL RE, V15, P31, DOI 10.1177/154596830101500105; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1995, NEUROPSYCHOLOGIA, V33, P1531, DOI 10.1016/0028-3932(95)00079-I; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; HERTZOG C, 1993, J GERONTOL, V48, pP150, DOI 10.1093/geronj/48.3.P150; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; JACEWICZ MM, 1987, J GERONTOL, V42, P86, DOI 10.1093/geronj/42.1.86; Kelders WPA, 2005, J NEUROTRAUM, V22, P133, DOI 10.1089/neu.2005.22.133; Knox JJ, 2006, CLIN J PAIN, V22, P512, DOI 10.1097/01.ajp.0000210997.53082.c9; Linnman C, 2009, EUR J PAIN, V13, P65, DOI 10.1016/j.ejpain.2008.03.001; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; MARGOLIS RB, 1988, PAIN, V33, P49, DOI 10.1016/0304-3959(88)90202-3; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; Montfoort I, 2006, INVEST OPHTH VIS SCI, V47, P2881, DOI 10.1167/iovs.05-1561; Moseley GL, 2005, COGNITIVE BRAIN RES, V25, P188, DOI 10.1016/j.cogbrainres.2005.05.008; Otte A, 1996, EUR J NUCL MED, V23, P72, DOI 10.1007/BF01736993; Otte A, 1997, J NUCL MED, V38, P1002; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; PELLIZZER G, 1993, EXP BRAIN RES, V93, P165; Richter H, 2002, EXP BRAIN RES, V144, P445, DOI 10.1007/s00221-002-1097-6; Richter W, 2000, J COGNITIVE NEUROSCI, V12, P310, DOI 10.1162/089892900562129; Rijkaart DC, 2004, EXP BRAIN RES, V156, P124, DOI 10.1007/s00221-004-1878-1; ROIJEZON U, 2009, THESIS UMEA U SWEDEN; Sandlund J, 2006, J REHABIL MED, V38, P44, DOI 10.1080/16501970510042847; Sandlund J, 2008, J REHABIL MED, V40, P366, DOI 10.2340/16501977-0175; Schwoebel J, 2001, BRAIN, V124, P2098, DOI 10.1093/brain/124.10.2098; Seurinck R, 2004, NEUROIMAGE, V23, P1440, DOI 10.1016/j.neuroimage.2004.08.010; Shenton JT, 2004, NEUROSCI LETT, V370, P19, DOI 10.1016/j.neulet.2004.07.053; Sjolander P, 2008, MANUAL THER, V13, P122, DOI 10.1016/j.math.2006.10.002; Spitzer W.O., 1995, SPINE S, V20, P8; Steenbergen B, 2007, NEUROPSYCHOLOGIA, V45, P3324, DOI 10.1016/j.neuropsychologia.2007.07.002; Sundstrom T, 2006, EUR SPINE J, V15, P1189, DOI 10.1007/s00586-005-0040-5; TAYLOR J, 1987, PSYCHOPHARMACOLOGY, V91, P369, DOI 10.1007/BF00518193; Thunberg J, 2005, EUR J PAIN, V9, P185, DOI 10.1016/j.ejpain.2004.05.003; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Wexler M, 1998, COGNITION, V68, P77, DOI 10.1016/S0010-0277(98)00032-8; Wilson PH, 2004, DEV MED CHILD NEUROL, V46, P754, DOI 10.1017/S001216220400129X; Zetterlund C, 2009, J OPTOMETRY, V2, P127, DOI DOI 10.3921/joptom.2009.127	63	9	9	1	16	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0301-0066	1468-4233		PERCEPTION	Perception		2010	39	1					119	130		10.1068/p6418			12	Ophthalmology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology; Psychology	569RP	WOS:000275617400012	20301852				2022-02-06	
J	Thaler, NS; Allen, DN; Park, BS; McMurray, JC; Mayfield, J				Thaler, Nicholas S.; Allen, Daniel N.; Park, Brandon S.; McMurray, Janice C.; Mayfield, Joan			Attention processing abnormalities in children with traumatic brain injury and attention-deficit/hyperactivity disorder: Differential impairment of component processes	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Attention-deficit; hyperactivity disorder; Attention; Models; Children	CLOSED-HEAD INJURY; INHIBITORY CONTROL; DEFICITS; SUBTYPES; SYSTEM; MEMORY; ADULTS; SKILLS; MODEL	Individuals with acquired and neurodevelopmental brain disorders often exhibit deficits in attention. Recent models of attention have conceptualized it as a multicomponent system. One influential model proposed by Mirsky et al. (1991) consists of factors that include focus, sustain, shift, and encode components. This model has been used to examine the structure of attention in a variety of clinical populations although few studies have contrasted performance of various clinical groups in order to determine whether these components are differentially affected. To address this issue, the current study investigated the differential sensitivity of these attention components in 90 children: 30 who had sustained traumatic brain injury (TBI), 30 who were diagnosed with attention-deficit/hyperactivity disorder (ADHD), and 30 normal controls. Results demonstrated that the TBI group had significantly lower focus factor scores, the ADHD group had significantly lower sustain scores, and that both clinical groups had lower encode factor scores than controls. Stepwise discriminant function analysis (DFA) retained the focus and encode factors in predicting clinical groups from controls with 75.6% accuracy. A second DFA retained the focus factor in differentiating the two clinical groups with 70.0% accuracy. These findings provide evidence of differential attention deficits resulting from TBI and ADHD.	[Allen, Daniel N.] Univ Nevada, Neuropsychol Res Program, Dept Psychol, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Neuropsychol Res Program, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 1997, SCHIZOPHR RES, V25, P53, DOI 10.1016/S0920-9964(97)00006-6; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; Anderson V, 2010, STUD NEUROPSYCHOL NE, P317; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Army Individual Test Battery, 1944, MAN DIR SCOR; Barkley R. A., 2006, ADHD REPORT, V14, P7, DOI [10.1521/adhd.2006.14.4.7, DOI 10.1521/ADHD.2006.14.4.7]; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Brocki KC, 2008, J CLIN EXP NEUROPSYC, V30, P749, DOI 10.1080/13803390701754720; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chhabildas N, 2001, J ABNORM CHILD PSYCH, V29, P529, DOI 10.1023/A:1012281226028; Combs DR, 2004, SCHIZOPHRENIA BULL, V30, P727, DOI 10.1093/oxfordjournals.schbul.a007126; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303255278; CONNERS CK, 2000, CONNERS CONTINUOUS P, V2; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Egeland J, 2007, ARCH CLIN NEUROPSYCH, V22, P763, DOI 10.1016/j.acn.2007.06.004; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Goldstein G, 2001, J AUTISM DEV DISORD, V31, P433, DOI 10.1023/A:1010620820786; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Kilic BG, 2007, PSYCHIAT CLIN NEUROS, V61, P142, DOI 10.1111/j.1440-1819.2007.01629.x; Konrad KN, 2000, BRAIN INJURY, V14, P859; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levine AJ, 2008, J CLIN EXP NEUROPSYC, V30, P53, DOI 10.1080/13803390601186684; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Marchetta NDJ, 2008, J ATTEN DISORD, V11, P664, DOI 10.1177/1087054707305108; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; Mirsky AF, 1999, MENT RETARD DEV D R, V5, P169, DOI 10.1002/(SICI)1098-2779(1999)5:3<169::AID-MRDD2>3.3.CO;2-B; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; POGGE DL, 1994, J CLIN EXP NEUROPSYC, V16, P344, DOI 10.1080/01688639408402645; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Prifitera A, 1998, WISC 3 CLIN USE INTE; Qiu AQ, 2009, AM J PSYCHIAT, V166, P74, DOI 10.1176/appi.ajp.2008.08030426; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reynolds C. R., 1997, HDB CLIN CHILD NEURO, P296; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; RODRIGUES L, 2009, ROLE REMEDIATION ATT; Rommelse NNJ, 2008, ARCH CLIN NEUROPSYCH, V23, P579, DOI 10.1016/j.acn.2008.06.002; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Sohlberg M., 2001, COGNITIVE REHABILITA; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stanley JA, 2008, ARCH GEN PSYCHIAT, V65, P1419, DOI 10.1001/archgenpsychiatry.2008.503; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TEASDALE G, 1974, LANCET, V2, P81; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; Yeates KO, 1998, HUMAN BRAIN FUNCT, P35; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; ZUBIN J, 1975, EXPT APPROACHES PSYC, P00139; [No title captured]	58	9	9	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	9					929	936	PII 921358315	10.1080/13803391003596488			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	676CU	WOS:000283888500003	20401771				2022-02-06	
J	Turnock, MJE; Layne, CS				Turnock, Matthew J. E.; Layne, Charles S.			Variations in Linear and Nonlinear Postural Measurements under Achilles Tendon Vibration and Unstable Support-Surface Conditions	JOURNAL OF MOTOR BEHAVIOR			English	Article						nonlinear measures; posture; proprioception; surface stability; vibration	CEREBRAL CONCUSSION; PARKINSONS-DISEASE; MUSCLE VIBRATION; SURROGATE DATA; TIME-SERIES; BODY SWAY; STABILITY; PRESSURE; ADAPTATION; COMPLEXITY	Reduced support-surface stability has been shown to attenuate the effect of Achilles tendon vibration on backward body displacement. In the present study, 20 participants performed a quiet, upright standing task oil a stable and sway-referenced support, with and without vibration. The authors calculated equilibrium scones (ES), approximate entropy (ApEn), and mean and peak power spectral density frequencies of center-of-pressure variations. It Was found that ES values decreased with the addition of vibration and in the sway-referenced support condition. ApEn values decreased with the addition of vibration but only with a stable support. Conversely, mean and peak frequencies increased with the addition of vibration, independent of support stability. These results suggest that the role of ankle proprioceptive input changes depending on support-surface characteristics and demonstrate the Value of using both linear and nonlinear measures of postural sway.	[Turnock, Matthew J. E.; Layne, Charles S.] Univ Houston, Int Space Univ, Dept Hlth & Human Performance, Ctr Neuromotor & Biomech Res, Houston, TX 77004 USA		Layne, CS (corresponding author), Univ Houston, Int Space Univ, Dept Hlth & Human Performance, Ctr Neuromotor & Biomech Res, 4800 Calhoun Rd, Houston, TX 77004 USA.	clayne2@uh.edu	Layne, Charles/AAV-5437-2021				Barbieri G, 2008, EXP BRAIN RES, V185, P545, DOI 10.1007/s00221-007-1177-8; Benda B. J., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P3, DOI 10.1109/86.296348; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Caudron S, 2008, EXP BRAIN RES, V184, P53, DOI 10.1007/s00221-007-1079-9; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Ceyte H, 2007, NEUROSCI LETT, V416, P71, DOI 10.1016/j.neulet.2007.01.044; Chaudhry H, 2004, J REHABIL RES DEV, V41, P713, DOI 10.1682/JRRD.2003.09.0140; Chen LC, 2008, EXP BRAIN RES, V186, P293, DOI 10.1007/s00221-007-1236-1; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Fransson PA, 2003, IEEE ENG MED BIOL, V22, P53, DOI 10.1109/MEMB.2003.1195696; Fransson PA, 2002, BIOL CYBERN, V86, P355, DOI [10.1007/s00422-001-0305-y, 10.1007/s00422-001-305-y]; Fransson PA, 2000, GAIT POSTURE, V12, P14, DOI 10.1016/S0966-6362(00)00052-7; Gagey P M, 1998, Ann Otolaryngol Chir Cervicofac, V115, P161; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; HAYASHI R, 1981, EXP BRAIN RES, V43, P217; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; Ivanenko YP, 1997, NEUROSCI LETT, V235, P109, DOI 10.1016/S0304-3940(97)00721-0; Ivanenko YP, 2000, NEUROSCI LETT, V292, P103, DOI 10.1016/S0304-3940(00)01438-5; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kerr HM, 2002, CLIN BIOMECH, V17, P555, DOI 10.1016/S0268-0033(02)00068-2; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V287, P1805; Mezzarane RA, 2008, EXP BRAIN RES, V187, P395, DOI 10.1007/s00221-008-1308-x; MURRAY MP, 1967, J APPL PHYSIOL, V23, P831, DOI 10.1152/jappl.1967.23.6.831; *NEUROCOM INT, 1991, EQ SYST DAT INT MAN; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Pikkujamsa SM, 1999, CIRCULATION, V100, P393, DOI 10.1161/01.CIR.100.4.393; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Polonyova A, 2001, PHYSIOL RES, V50, P405; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Riley MA, 1997, EXP BRAIN RES, V117, P165, DOI 10.1007/s002210050211; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Romero DH, 2003, IEEE ENG MED BIOL, V22, P27, DOI 10.1109/MEMB.2003.1195692; Sabatini AM, 2000, MED BIOL ENG COMPUT, V38, P617, DOI 10.1007/BF02344866; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Speers RA, 1998, J BIOMECH, V31, P883, DOI 10.1016/S0021-9290(98)00065-7; Stergiou N, 2004, INNOVATIVE ANAL HUMA, P63; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thompson C, 2007, CLIN NEUROPHYSIOL, V118, P2456, DOI 10.1016/j.clinph.2007.08.013; Vaillancourt DE, 2003, NEUROBIOL AGING, V24, P25, DOI 10.1016/S0197-4580(02)00014-3; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; VAILLANCOURT DE, 2001, SOC NEUR ABSTR, V27, P1410; van Deursen RWM, 1999, J ORTHOP SPORT PHYS, V29, P718, DOI 10.2519/jospt.1999.29.12.718; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yokoyama K, 2002, IND HEALTH, V40, P14, DOI 10.2486/indhealth.40.14	54	9	9	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-2895	1940-1027		J MOTOR BEHAV	J. Mot. Behav.	JAN-FEB	2010	42	1					61	69					9	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	549RM	WOS:000274071600007	20018587	Green Submitted			2022-02-06	
J	Wiseman-Hakes, C; MacDonald, S; Keightley, M				Wiseman-Hakes, Catherine; MacDonald, Sheila; Keightley, Michelle			Perspectives on evidence based practice in ABI rehabilitation. "Relevant Research": Who decides?	NEUROREHABILITATION			English	Article						Acquired brain injury rehabilitation; traumatic brain injury rehabilitation; evidence based practice; evidence based medicine; rehabilitation research; treatment evidence; outcome; intervention	TRAUMATIC BRAIN-INJURY; EVIDENCE-BASED MEDICINE; QUALITY-OF-LIFE; COGNITIVE REHABILITATION; COMMUNICATION; DISORDERS; PEOPLE; INTERVENTIONS; INDIVIDUALS; CHILDREN	Growing evidence suggests that acquired brain injury (ABI) rehabilitation and research should be guided by a philosophy that focuses on: restoration, compensation, function and participation in all aspects of daily life. Such a broad, more pluralistic approach influences ABI rehabilitation research at a number of levels, including both the generation of evidence, and in searching for, critiquing and applying the evidence to practice. The objective of evidence based medicine/practice (EBM/EBP) is to apply and integrate clinical expertise with evidence gained through systematic research and scientific inquiry to medical/clinical practice. While there is abundant literature debating the practical and sociological implications of EBP, there has been limited examination of EBP within the inherently complex nature of ABI rehabilitation and rehabilitation research. This paper provides a framework for clinical decision making regarding evidence based practice in the context of ABI rehab including: 1. A discussion of the purpose of evidence based practice, 2. Levels of evidence relevant to ABI rehabilitation research, and 3. A rationale for incorporating a broader, more pluralistic concept of evidence or "person-centred EBP". We conclude with a series of key questions for the evaluation and application of systematic reviews of the evidence in the context of ABI rehabilitation.	[Wiseman-Hakes, Catherine; Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Wiseman-Hakes, Catherine] Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5G 1V7, Canada; [MacDonald, Sheila] Sheila MacDonald & Associates, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Psychol, Toronto, ON M5G 1V7, Canada		Wiseman-Hakes, C (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	catherinew.hakes@utoronto.ca		Wiseman-Hakes, Catherine/0000-0001-8441-884X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BLOSSER J, 1994, NEUROGENIC COMMUNICA; *BRAIN INJ NETW, DEF ABI TBI; Broom A, 2009, SOC SCI MED, V68, P192, DOI 10.1016/j.socscimed.2008.10.022; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cooper C. M., 1988, KNOWLEDGE SOC, V1, P104; Creswell JW., 1998, QUAL INQ; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dollaghan C, 2007, HDB EVIDENCE BASED P; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; Furlan AD, 2008, J CLIN EPIDEMIOL, V61, P209, DOI 10.1016/j.jclinepi.2007.04.019; GARVEY WD, 1971, AM PSYCHOL, V26, P349, DOI 10.1037/h0032059; Golper L., 2001, EVIDENCE BASED PRACT; Gupta M, 2003, J EVAL CLIN PRACT, V9, P111, DOI 10.1046/j.1365-2753.2003.00382.x; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hedges LV., 1994, HDB RES SYNTHESIS; Hinckley JJ, 2001, BRAIN LANG, V79, P3; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; KUNTZ R, 2008, J CLIN EPIDEMIOL, V61, P207; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; Law S., 2005, CONCEPTUALIZING COMB; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCormack B, 2006, J RES NURS, V11, P89, DOI 10.1177/1744987106062838; McReynolds Connie J., 2001, Work, V16, P57; Montgomery EB, 2003, J MED SPEECH-LANG PA, V11, pIX; Mykhalovskiy E, 2004, SOC SCI MED, V59, P1059, DOI 10.1016/j.socscimed.2003.12.002; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Odom SL, 2002, J EARLY INTERVENTION, V25, P151, DOI 10.1177/105381510202500212; Perdices M., 2006, BRAIN IMPAIR, V7, P119, DOI DOI 10.1375/BRIM.7.2.119; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SACKETT DL, 2002, EVIDENCE BASED MED L; Schon D.A., 1991, REFLECTIVE PRACTITIO, V2nd; SOHLBERG M, 2007, J MED SPEECH PATHOLO, V15; SOHLBERG MM, 2009, BRAIN INJURY PROFESS, V6, P10; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; UPSHER RE, 2004, BRIEF TREATMENT CRIS; Upshur REG, 2000, J EVAL CLIN PRACT, V6, P93, DOI 10.1046/j.1365-2753.2000.00244.x; Upshur REG, 2002, J EVAL CLIN PRACT, V8, P113, DOI 10.1046/j.1365-2753.2002.00356.x; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHO, 2002, WHO INT CLASS FUNCT; Worrall L, 2002, J COMMUN DISORD, V35, P107, DOI 10.1016/S0021-9924(02)00060-6; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M, 2002, J MED SPEECH-LANG PA, V10, pXXV; YLVISAKER M, 1999, SEMINARS SPEECH LANG, V17, P217; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; YLVISAKER M, 2005, REHABILITATION TRAUM, P205; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	67	9	9	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	4					355	368		10.3233/NRE-2010-0573			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	632NE	WOS:000280430600009	20555159				2022-02-06	
J	Goulden, LG; Silver, CH				Goulden, Laura G.; Silver, Cheryl H.			Concordance of the Children's Executive Functions Scale With Established Tests and Parent Rating Scales	JOURNAL OF PSYCHOEDUCATIONAL ASSESSMENT			English	Article						executive function; neuropsychology; ecological validity; children; parent report	TRAUMATIC BRAIN-INJURY; FUNCTION DEFICITS; PSYCHOPATHOLOGY; AGREEMENT; VALIDITY; DISORDER; DISEASE; TOWER; BASC	An increase can be seen in the number of tests designed to assess executive dysfunction in children, but few address ecological validity by attempting to measure functioning in the natural environment. This study examined the utility of the Children's Executive Functions Scale (CEFS), a 99-item parent-report measure. The CEFS was designed to measure a variety of behaviors related to executive functioning, including social appropriateness, inhibition, problem solving, initiative, and motor planning. A sample of 59 children was evaluated with the CEFS, established tests of executive functioning, Child Behavior Checklist, and Conners' Rating Scale. Correlations between the CEFS and the test variables were modest and produced a pattern slightly different from correlations obtained for the other parent report measures. The CEFS was significantly correlated with the other parent report measures; however, the magnitude of the coefficients suggests that the CEFS is providing unique information.	[Goulden, Laura G.; Silver, Cheryl H.] Univ Texas SW Med Ctr Dallas, Dallas, TX USA		Goulden, LG (corresponding author), 2450A Old Shell Rd, Mobile, AL 36607 USA.	lauraandbrad@yahoo.com					Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Barkley R. A., 2006, ATTENTION DEFICIT HY; BARKLEY RA, 1996, ATTENTION MEMORY EXE, P00307; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Berkelhammer LD, 2007, CHILD NEUROPSYCHOL, V13, P120, DOI 10.1080/09297040600800956; Bodnar LE, 2007, CHILD NEUROPSYCHOL, V13, P345, DOI 10.1080/09297040600899867; Cohen J., 2013, STAT POWER ANAL BEHA; CONNERS CK, 1990, MANUAL CONNERS RATIN; Cripe L., 1996, ECOLOGICAL VALIDITY, P171; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; Duhig AM, 2000, CLIN PSYCHOL-SCI PR, V7, P435, DOI 10.1093/clipsy/7.4.435; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldberg E., 2001, EXECUTIVE BRAIN FRON; GREENAWAY DS, 2004, THESIS U TEXAS SW ME; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Harvey JM, 1999, DEV MED CHILD NEUROL, V41, P292, DOI 10.1017/S0012162299000663; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Jarratt KP, 2005, APPL NEUROPSYCHOL, V12, P83, DOI 10.1207/s15324826an1202_4; Krasnegor N.A., 1996, ATTENTION MEMORY EXE, P263; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Long, 1996, ECOLOGICAL VALIDITY, P15; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; MOLHO CE, 1996, THESIS U TEXAS SW ME; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Reynolds C. R., 1998, BEHAV ASSESSMENT SYS; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; RUFF R, 2001, ANN M NAT AC NEUR SA; Sattler J.M., 2001, ASSESSMENT CHILDREN; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Silver CH, 1993, CHILDRENS EXEC UNPUB; SILVER CH, 1999, M AM PSYCH ASS BOST; Smith SR, 2007, J PSYCHOEDUC ASSESS, V25, P139, DOI 10.1177/0734282906296233; Spreen O., 1969, NEUROSENSORY CTR COM; Sullivan JR, 2006, ARCH CLIN NEUROPSYCH, V21, P495, DOI 10.1016/j.acn.2006.05.008; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Youngstrom E, 2000, J CONSULT CLIN PSYCH, V68, P1038, DOI 10.1037/0022-006X.68.6.1038	49	9	9	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0734-2829	1557-5144		J PSYCHOEDUC ASSESS	J. Psychoeduc. Assess.	DEC	2009	27	6					439	451		10.1177/0734282909335574			13	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	523RA	WOS:000272090900001					2022-02-06	
J	Jakob, H; Brand, J; Marzi, I				Jakob, H.; Brand, J.; Marzi, I.			Multiple trauma in pediatric patients	UNFALLCHIRURG			German	Article						Multiple injured child; Injury pattern; Trauma room management; Age-adapted surgical treatment; Intensive care	CHILDREN; INJURIES; SCORES	Important prerequisites to adequately treat pediatric patients with multiple trauma are a profound knowledge of the underlying mechanisms of injury, common injury patterns and the associated mortality. The younger the child the more injury patterns as well as organ-specific injury severity differ in comparison to adult trauma patients. Traumatic brain and thorax injuries are the key to the prognosis of the injured child. Abdominal injuries rarely require surgery in contrast to adults. Spine and pelvic injuries as well as injuries of the extremities make age-adapted surgical procedures mandatory. The present article describes the established primary diagnostic evaluation after admittance to the emergency room as well as specific treatment options for particular organ systems with respect to age-specific anatomical characteristics and pitfalls in children.	[Jakob, H.; Marzi, I.] Klinikum Johann Wolfgang Goethe Univ, Klin Unfall Hand & Wiederherstellungschirurg, D-60590 Frankfurt, Germany; [Brand, J.] Klinikum Johann Wolfgang Goethe Univ, Zentrum Kinder & Jugendmed, D-60590 Frankfurt, Germany		Jakob, H (corresponding author), Klinikum Johann Wolfgang Goethe Univ, Klin Unfall Hand & Wiederherstellungschirurg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	heike.jakob@kgu.de					Blauth M, 1998, UNFALLCHIRURG, V101, P590, DOI 10.1007/s001130050313; BLAUTH M, 1998, UNFALLCHIRURGIE WIRB, pS383; Bouillon B, 2004, UNFALLCHIRURG, V107, P844, DOI 10.1007/s00113-004-0847-2; Ceran S, 2002, EUR J CARDIO-THORAC, V21, P57, DOI 10.1016/S1010-7940(01)01056-9; Dowd MD, 2007, J TRAUMA, V63, pS136, DOI 10.1097/TA.0b013e31815acd19; Gatzka C, 2005, UNFALLCHIRURG, V108, P470, DOI 10.1007/s00113-005-0921-4; HOLT GE, 2003, J ORTHOP TRAUMA, V31, P82; Jakob H, 2007, UPTO2DATE, V2, P79; JAKOB H, 2008, POLYTRAUMA PRAKLINIS, P321; Kanz KG, 2004, UNFALLCHIRURG, V107, P937, DOI 10.1007/s00113-004-0845-4; Landau A, 2006, INJURY, V37, P66, DOI 10.1016/j.injury.2005.07.013; LAURER H, 2009, UNFALLCHIRU IN PRESS; MAZUREK A, 1994, INT ANESTHESIOL CLIN, V32, P11; NAYDUCH DA, 1991, J TRAUMA, V31, P452, DOI 10.1097/00005373-199104000-00003; Ott R, 2000, J TRAUMA, V49, P729, DOI 10.1097/00005373-200010000-00023; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; ROSE S, 2006, KINDERTRAUMATOLOGIE, P397; Ruchholtz S, 2002, CHIRURG, V73, P194, DOI 10.1007/s00104-002-0424-6; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; *STAT BUND, 2007, ANN REP STAT BUND, P5; Strohm PC, 2008, Z ORTHOP UNFALLCHIR, V146, P38, DOI 10.1055/s-2007-989438; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thannheimer A, 2006, KINDERTRAUMATOLOGIE, P249; TILL H, 2004, KINDLICHE POLYTRAUMA, P75	24	9	11	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	NOV	2009	112	11					951	958		10.1007/s00113-009-1682-2			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	517TW	WOS:000271642100004	19816670				2022-02-06	
J	Wortzel, HS; Frey, KL; Anderson, CA; Arciniegas, DB				Wortzel, Hal S.; Frey, Kimberly L.; Anderson, C. Alan; Arciniegas, David B.			Subtle Neurological Signs Predict the Severity of Subacute Cognitive and Functional Impairments After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							FRONTAL ASSESSMENT BATTERY; PRIMITIVE REFLEXES; HEALTH; FAB	The presence of paratonia and primitive reflexes ("frontal release signs"), such as glabellar, snout, suck, grasp, and palmomental responses, after traumatic brain injury predicts performance on bedside cognitive assessments, level of functional independence, and duration of acute inpatient rehabilitation. (The journal of Neuropsychiatry and Clinical Neurosciences 2009; 21:463-466)	[Wortzel, Hal S.; Frey, Kimberly L.; Arciniegas, David B.] HealthONE Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA; [Wortzel, Hal S.; Anderson, C. Alan; Arciniegas, David B.] Denver Vet Affairs Med Ctr, VISN 19, MIRECC, Denver, CO 80220 USA; [Wortzel, Hal S.; Frey, Kimberly L.; Anderson, C. Alan; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Denver, CO 80262 USA; [Anderson, C. Alan; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Denver, CO USA		Wortzel, HS (corresponding author), Denver Vet Affairs Med Ctr, VISN 19, MIRECC, 1055 Clermont St,Room 4E130, Denver, CO 80220 USA.	Hal.wortzel@ucdenver.edu			Health ONE Spalding Rehabilitation Hospital (KLF, DBA); VISN-19 MIRECC (HSW, CAA, DBA)	This work was supported by Health ONE Spalding Rehabilitation Hospital (KLF, DBA) and the VISN-19 MIRECC (HSW, CAA, DBA). The authors are grateful to Kenneth L. Tyler, M.D., for his assistance during the preparation of this manuscript.	Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; ARCINIEGAS DB, 2001, INTRO APPROACH NEURO; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Damasceno A, 2005, ARQ NEURO-PSIQUIAT, V63, P577, DOI 10.1590/S0004-282X2005000400004; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; HOGAN DB, 1995, AGE AGEING, V24, P375, DOI 10.1093/ageing/24.5.375; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MOLLOY DW, 1991, J AM GERIATR SOC, V39, P1160, DOI 10.1111/j.1532-5415.1991.tb03567.x; *STAT U NEW YORK B, 1997, GUID UN DAT SET MED; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Boxtel MPJ, 2006, J NEUROL, V253, P935, DOI 10.1007/s00415-006-0138-7; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	15	9	10	0	5	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2009	21	4					463	466					4	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	526RR	WOS:000272311300014	19996256	Bronze			2022-02-06	
J	Kreutzer, JS; Livingston, LA; Everley, RS; Gary, KW; Arango-Lasprilla, JC; Powell, VD; Marwitz, JH				Kreutzer, Jeffrey S.; Livingston, Lee A.; Everley, Rachel S.; Gary, Kelli W.; Arango-Lasprilla, Juan Carlos; Powell, Victoria D.; Marwitz, Jennifer H.			Caregivers' Concerns about Judgment and Safety of Patients with Brain Injury: A Preliminary Investigation	PM&R			English	Article								Objective: To identify caregivers' most common concerns about the judgment and safety of patients with brain injury in home and community environments. To quantify caregivers' stress levels and their level of comfort leaving patients at home unsupervised and examine the interrelationships between caregivers' safety and judgment ratings, stress levels, and levels of comfort leaving patients unattended. Design: Retrospective, cross-sectional design. Setting: Outpatient brain injury neuropsychology clinic at a university medical center. Participants: A convenience sample of 121 caregivers of traumatic brain injury survivors at least 1 month postinjury and 18 years of age or older. Main Outcome Measurements: Scores in 9 domains from the Judgment and Safety Screening Inventory; ratings of stress levels and levels of comfort leaving patients at home unattended derived from the General Health and History Questionnaire. Results: Caregivers' most common judgment and safety-related concerns were in the Travel and Financial domains, with many reflecting patients' memory deficits. Heightened caregiver stress levels were prevalent. Higher levels of concern about judgment and safety were associated with higher stress levels and concerns about leaving patients unattended. Conclusions: Consistent with research on patients with other types of neurological disorders, concerns about driving and financial management among caregivers are prevalent. Additional research is needed to identify the most cost-effective methods of evaluating patients and enabling them to function at their highest level in the community.	[Kreutzer, Jeffrey S.; Livingston, Lee A.; Everley, Rachel S.; Gary, Kelli W.; Arango-Lasprilla, Juan Carlos; Powell, Victoria D.; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Kreutzer, JS (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.	jskreutz@vcu.edu			National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Department of Education, Washington, DC [H133P040006]	Supported by Grant #H133P040006 from the National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Department of Education, Washington, DC.	[Anonymous], 2008, ALZHEIMERS DEMENT, V4, P110; [Anonymous], 2008, SILV BOOK CHRON DIS; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Clemson L, 1996, AGE AGEING, V25, P97, DOI 10.1093/ageing/25.2.97; Covinsky KE, 2001, J GERONTOL A-BIOL, V56, pM707, DOI 10.1093/gerona/56.11.M707; DeFrances Carol J, 2007, Adv Data, P1; Dobbs BM, 2002, NEUROLOGIST, V8, P61, DOI 10.1097/00127893-200203000-00001; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gitlin L. N., 2000, ALZHEIMERS CARE Q, V1, P50; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Grant JS, 2006, ARCH PHYS MED REHAB, V87, P343, DOI 10.1016/j.apmr.2005.09.019; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Horvath Kathy J, 2005, Rehabil Nurs, V30, P189; Horvath KJ, 2005, REHABIL NURS, V30, P197; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Ko Jean Y, 2007, J Neurosci Nurs, V39, P217; Kreutzer J., 1987, GEN HLTH HIST QUESTI; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lach HW, 2007, WESTERN J NURS RES, V29, P993, DOI 10.1177/0193945907303098; LACH HW, 1995, GERIATR NURS, V16, P160, DOI 10.1016/S0197-4572(05)80022-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; ONEILL D, 1992, J ROY SOC MED, V85, P199; Opp A, 2008, PROV COST EFF HOM EV; Ott BR, 2008, NEUROLOGY, V70, P1171, DOI 10.1212/01.wnl.0000294469.27156.30; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Pierce LL., 2003, GERONTOL GERIATR EDU, V23, P75, DOI [10.1300/J021v23n04_07, DOI 10.1300/J021V23N04_07]; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAMSDELL JW, 1989, J AM GERIATR SOC, V37, P17, DOI 10.1111/j.1532-5415.1989.tb01563.x; Ramsdell JW, 2004, ALZ DIS ASSOC DIS, V18, P145, DOI 10.1097/01.wad.0000137863.90007.ec; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Thommessen B, 2002, INT J GERIATR PSYCH, V17, P78, DOI 10.1002/gps.524; Travis SS, 2000, J GERONTOL A-BIOL, V55, pM412, DOI 10.1093/gerona/55.7.M412; Travis SS, 2005, J PSYCHOSOC NURS MEN, V43, P13; Wadley VG, 2003, J AM GERIATR SOC, V51, P1621, DOI 10.1046/j.1532-5415.2003.51514.x; Wadley VG, 2008, AM J GERIAT PSYCHIAT, V16, P416, DOI 10.1097/JGP.0b013e31816b7303; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Wild K, 2003, ALZ DIS ASSOC DIS, V17, P27, DOI 10.1097/00002093-200301000-00004; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014	56	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	AUG	2009	1	8					723	728		10.1016/j.pmrj.2009.07.005			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V24LL	WOS:000208411800006	19695524				2022-02-06	
J	McEvoy, C; Cooke, SR; Young, IS				McEvoy, Claire; Cooke, Stephen R.; Young, Ian S.			A Reduced Abbreviated Indirect Calorimetry Protocol Is Clinically Acceptable for Use in Spontaneously Breathing Patients With Traumatic Brain Injury	NUTRITION IN CLINICAL PRACTICE			English	Article						energy metabolism; calorimetry; calorimetry; indirect; brain injuries	RESTING ENERGY-EXPENDITURE; CRITICALLY-ILL PATIENTS; STEADY-STATE; NITROGEN-EXCRETION; METABOLIC-CHANGES; HEAD-INJURY; REQUIREMENTS; VARIABILITY; NUTRITION; ACCURACY	A steady state Should be established when using indirect calorimetry to assess resting energy expenditure, reduce error, and improve the validity of the measurement. Steady-state criteria are often rigorous and difficult to achieve in hospitalized patients, particularly in patients recovering from traumatic brain injury. This study aimed to assess whether reducing the timeframe for steady-state conditions to 2, 3, or 4 minutes When using indirect calorimetry was significantly different from the widely accepted 5-minute steady-state protocol in patients recovering from traumatic brain injury. Indirect calorimetry using an open-circuit calorimeter was used to measure resting energy expenditure in 20 spontaneously breathing patients with traumatic brain injury. Each patient underwent repeated measurements once per day at various stages of his or her recovery. Bland-Altman methods comparison was used for statistical analysis. In total, 124 measurements were recorded, of which 59% met 5-minute, 70% met 4-minute, 76% met 3-minute, and 84% met 2-minute steady-state conditions. Mean within-patient coefficient of variation was 13% (range, 0%-35%). Agreement at the +/- 10% level using Bland-Altman plots was 100% for a 4-minute steady-state protocol, 96% for a 3-minute protocol, and 90% using a 2-minute protocol. A 4-minute or 3-minute abbreviated steady-state indirect calorimetry protocol is clinically acceptable to measure resting energy expenditure in spontaneously breathing patients with a traumatic brain injury. (Nutr Clin Pract. 2009;24:513-519)	[McEvoy, Claire; Young, Ian S.] Queens Univ Belfast, Dept Med, Belfast BT12 6BJ, Antrim, North Ireland; [Cooke, Stephen R.] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland		McEvoy, C (corresponding author), Queens Univ Belfast, Dept Med, Pathol Bldg, Belfast BT12 6BJ, Antrim, North Ireland.	c.mcevoy@qub.ac.uk		McEvoy, Claire/0000-0001-8512-3293; Young, Ian/0000-0003-3890-3152	ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: UKRI; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: researchfish		Bader N, 2005, BRIT J NUTR, V94, P843, DOI 10.1079/BJN20051551; BRANSON R D, 1990, Respiratory Care, V35, P640; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; da Rocha EEM, 2005, CURR OPIN CLIN NUTR, V8, P319, DOI 10.1097/01.mco.0000165012.77567.1e; DEUTSCHMAN CS, 1986, J NEUROSURG, V65, P266; Frankenfield DC, 1996, J AM COLL NUTR, V15, P397; FRANKENFIELD DC, 1998, ENERGY DYNAMICS CONT; FRUIN AH, 1986, SURG NEUROL, V25, P25, DOI 10.1016/0090-3019(86)90109-6; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; GARBY L, 1984, HUM NUTR-CLIN NUTR, V38C, P395; GARROW JS, 1976, P NUTR SOC, V35, P363, DOI 10.1079/PNS19760057; HAIDER W, 1975, EUR J INTEN CARE MED, P19; IRETONJONES CS, 1991, J AM DIET ASSOC, V91, P193; LONG CL, 1979, JPEN-PARENTER ENTER, V3, P69, DOI 10.1177/014860717900300269; McClave S A, 1992, Nutr Clin Pract, V7, P207, DOI 10.1177/0115426592007005207; McClave SA, 2003, JPEN-PARENTER ENTER, V27, P16, DOI 10.1177/014860710302700116; McClave SA, 2003, JPEN-PARENTER ENTER, V27, P21, DOI 10.1177/014860710302700121; McClave SA, 1998, JPEN-PARENTER ENTER, V22, P375, DOI 10.1177/0148607198022006375; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; MURGATROYD PR, 1987, BRIT J NUTR, V58, P347, DOI 10.1079/BJN19870104; OTT L, 1987, JPEN-PARENTER ENTER, V11, P488, DOI 10.1177/0148607187011005488; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Petros S, 2001, INTENS CARE MED, V27, P1164, DOI 10.1007/s001340100941; Plank LD, 2000, WORLD J SURG, V24, P630, DOI 10.1007/s002689910104; Reeves MM, 2004, J APPL PHYSIOL, V97, P130, DOI 10.1152/japplphysiol.01212.2003; SANDSTROM R, 1993, ANN SURG, V217, P185, DOI 10.1097/00000658-199302000-00013; Smyrnios NA, 1997, JPEN-PARENTER ENTER, V21, P168, DOI 10.1177/0148607197021003168; SOARES MJ, 1986, HUM NUTR-CLIN NUTR, V40C, P365; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WEISSMAN C, 1986, CRIT CARE MED, V14, P408, DOI 10.1097/00003246-198604000-00193; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	34	9	9	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	AUG-SEP	2009	24	4					513	519		10.1177/0884533609335308			7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	477ON	WOS:000268528500012	19407141	Green Submitted			2022-02-06	
J	Boto, GR; Gomez, PA; De la Cruz, J; Lobato, RD				Boto, Gregorio R.; Gomez, Pedro A.; De la Cruz, Javier; Lobato, Ramiro D.			A historical analysis of severe head injury	NEUROSURGICAL REVIEW			English	Article						Severe head injury; Death; Outcome; Prognosis	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; COMPUTERIZED-TOMOGRAPHY; PRACTICAL SCALE; STEM LESIONS; DESIGN; IMPACT; TRIALS; BASE; CARE	Severe head injury (SHI) is a significant health, social and economic concern rendering a worldwide health problem. This retrospective study was designed to describe the features and outcomes of patients with SHI treated in a single neurosurgical unit (Hospital "12 de Octubre", Madrid, Spain) over a period approaching 13 years. The subjects enrolled were 895 patients (15 years or older) with non-missile SHI treated over the period January 1987 to August 1999, in whom a computerised tomography scan had been performed within the first 6 h of injury. We considered epidemiological, clinical, analytical, radiological and therapeutic data along with final patient outcomes. The overall mortality rate was 46.8% (419 patients). Of these 419 deaths, 177 (42.2%) occurred within the first 48 h of injury rendering an early death rate of 19.8% (177/895 patients). Despite overall mortality showing a clear decreasing trend by the end of the 1990s, proportions of early deaths (within the first 48 h of injury) dramatically rose in the last 3 years of the study. As a whole, an unfavourable outcome was recorded in 62.6% (560 patients). Despite continued efforts to improve the outcome of patients with SHI, the results of our study are pessimistic in that high mortality and unfavourable outcome rates were recorded in this large series of patients. Although overall mortality has diminished over the years, the number of early deaths has increased.	[Boto, Gregorio R.] Hosp Clin San Carlos, Dept Neurosurg, Madrid, Spain; [Gomez, Pedro A.; De la Cruz, Javier] Hosp 12 Octubre, Dept Neurosurg, E-28041 Madrid, Spain; [De la Cruz, Javier] Hosp 12 Octubre, Epidemiol Unit, E-28041 Madrid, Spain		Boto, GR (corresponding author), Avda Doctor Garcia Tapia 159,Portal D Atico B, Madrid 28030, Spain.	grboto@yahoo.es	Rodriguez-Boto, Gregorio/AAR-9035-2021; Gomez, Pedro/N-5051-2019	Rodriguez-Boto, Gregorio/0000-0001-6361-5713; Gomez, Pedro/0000-0002-4185-5238			Boto GR, 2004, NEUROCIRUGIA, V15, P233; BOWERS SA, 1980, NEUROSURGERY, V6, P237; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gomez PA, 1999, NEUROCIRUGIA, V10, P297; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; MURRAY GD, 1986, STAT MED, V5, P103, DOI 10.1002/sim.4780050202; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Sekulovic N, 1979, Acta Neurochir Suppl (Wien), V28, P203; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P205; TEASDALE G, 1974, LANCET, V2, P81; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	29	9	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607			NEUROSURG REV	Neurosurg. Rev.	JUL	2009	32	3					343	353		10.1007/s10143-008-0178-9			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	453BQ	WOS:000266585400030	18846394				2022-02-06	
J	Sacco, TL; Stapleton, MF; Ingersoll, GL				Sacco, Tara L.; Stapleton, Michael F.; Ingersoll, Gail L.			Support Groups Facilitated by Families of Former Patients: Creating Family-Inclusive Critical Care Units	CRITICAL CARE NURSE			English	Article							TRAUMATIC BRAIN INJURY; OF-LIFE CARE; ILL PATIENTS; ETHICS CONSULTATIONS; CLINICAL-PRACTICE; CONTROLLED-TRIAL; NEEDS; COMMUNICATION; CONFERENCES; RELATIVES		[Sacco, Tara L.; Stapleton, Michael F.] Univ Rochester, Strong Mem Hosp, Ctr Med, Kessler Family Burn Trauma Intens Care Unit, Rochester, NY 14642 USA		Ingersoll, GL (corresponding author), 601 Elmwood Ave,Box 619-7, Rochester, NY 14642 USA.	gail_ingersoll@urmc.rochester.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [D66HP03172] Funding Source: Medline		Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; BENNER P, 1992, ADV NURS SCI, V14, P13, DOI 10.1097/00012272-199203000-00005; Browning G, 2006, CRIT CARE NURS Q, V29, P86, DOI 10.1097/00002727-200601000-00010; Chien WT, 2006, INT J NURS STUD, V43, P39, DOI 10.1016/j.ijnurstu.2005.01.006; Chien WT, 2005, J ADV NURS, V51, P595, DOI 10.1111/j.1365-2648.2005.03545.x; Curtis JR, 2005, AM J RESP CRIT CARE, V171, P844, DOI 10.1164/rccm.200409-1267OC; Daly K, 1994, Clin Nurs Res, V3, P414, DOI 10.1177/105477389400300409; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Halm MA, 2006, CRIT CARE NURSE, V26, P58; Henneman Elizabeth A, 2002, Crit Care Nurse, V22, P12; HICKEY M, 1990, HEART LUNG, V19, P401; Hurst I, 2006, J PERINAT NEONAT NUR, V20, P252, DOI 10.1097/00005237-200607000-00014; Jarrett M H, 1996, Pediatr Nurs, V22, P60; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Lautrette A, 2007, NEW ENGL J MED, V357, P203; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lilly CM, 2003, CRIT CARE MED, V31, pS394, DOI 10.1097/01.CCM.0000065279.77449.B4; Maxwell KE, 2007, HEART LUNG, V36, P367, DOI 10.1016/j.hrtlng.2007.02.005; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; MOLTER NC, 1979, HEART LUNG, V8, P332; Nottage SL, 2005, COMPR CHILD ADOLES N, V28, P257, DOI 10.1080/01460860500396922; Petersen MF, 2004, JOGNN-J OBST GYN NEO, V33, P421, DOI 10.1177/0884217504266772; Potter Patricia, 2007, Nurs Manage, V38, P40; Radwin LE, 1996, J ADV NURS, V23, P1142, DOI 10.1046/j.1365-2648.1996.12910.x; Schneiderman LJ, 2000, CRIT CARE MED, V28, P3920, DOI 10.1097/00003246-200012000-00033; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Whittemore R, 2000, Clin Nurse Spec, V14, P75, DOI 10.1097/00002800-200003000-00010	28	9	9	0	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	JUN	2009	29	3					36	45		10.4037/ccn2009265			10	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	452IN	WOS:000266533800005	19487779				2022-02-06	
J	Sorbo, AK; Blomqvist, M; Emanuelsson, IM; Rydenhag, B				Sorbo, Ann K.; Blomqvist, Maritha; Emanuelsson, Ingrid M.; Rydenhag, Bertil			Psychosocial adjustment and life satisfaction until 5 years after severe brain damage	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						life satisfaction; long-term follow-up; psychosocial adjustment; severe brain injury	QUALITY-OF-LIFE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; PRACTICAL SCALE; FOLLOW-UP; THERAPY; EDEMA; COMA	The objectives of this study were to describe psychosocial adjustment and outcome over time for severely brain-injured patients and to find suitable outcome measures for clinical practice during the rehabilitation process and for individual rehabilitation planning after discharge from hospital. The methods include a descriptive, prospective, population-based study. The participants were assessed at 6 months and annually until 5 years after traumatic brain injury or nontraumatic subarachnoid haemorrhage. Inclusion criteria were age 16-65 years, severe traumatic brain injury or nontraumatic subarachnoid haemorrhage defined as Glasgow Coma Scale 8 or worse and need for neurointensive care for at least 5 days. The main outcome measures were Head Injury Evaluation Chart, Glasgow Outcome Scale Extended (GOSE) and Life Satisfaction Questionnaire (LiSat)-11 checklist. Change over time for the group and the individuals, as measured with the GOSE, was analyzed by a statistical method that is suitable for small datasets and takes into account the nonmetric properties of the data. Eighteen patients were included. Three died and one was excluded for the long-term follow-up (n = 14). The group had a good outcome with no participant remaining in a vegetative state, 93% (12 of 13) went home and 60% (six of 10) returned to work. Eighty percent (eight of 10) of participants rated 'life as a whole' as satisfactory 5 years after the injury. The change at group level was significant (GOSE) until 1 year after the injury. The GOSE and the LiSat-11 were most clinically useful as they were easy to use for the rater/participants.	[Sorbo, Ann K.; Blomqvist, Maritha] Sodra Alvsborgs Sjukhus, Dept Rehabil, S-50182 Boras, Sweden; [Sorbo, Ann K.; Blomqvist, Maritha; Emanuelsson, Ingrid M.; Rydenhag, Bertil] Univ Gothenburg, Sahlgrenska Acad, Sect Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Rydenhag, Bertil] Sahlgrens Univ Hosp, Neurosurg Unit, Gothenburg, Sweden; [Emanuelsson, Ingrid M.] Sahlgrens Univ Hosp, Reg Rehabil Unit, Queen Silvia Childrens Hosp, Gothenburg, Sweden		Sorbo, AK (corresponding author), Sodra Alvsborgs Sjukhus, Dept Rehabil, S-50182 Boras, Sweden.	ann.km.sorbo@vgregion.se		Sorbo, Ann/0000-0002-6744-6942			ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cudmore S, 1996, BRAIN INJURY, V10, P517, DOI 10.1080/026990596124232; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FUGELMEYER AR, 1988, SCAND J REHABIL MED, P51; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; LAPOINTE LL, 1999, SEMIN SPEECH LANG, V20, P16; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rosenthal M, 1999, REHABILITATION ADULT; Sorbo A, 2001, Lakartidningen, V98, P1244; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Svensson E, 1998, STAT MED, V17, P2923, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2923::AID-SIM104>3.0.CO;2-#; Svensson E, 2002, J REHABIL MED, V34, P251, DOI 10.1080/165019702760390338; SVENSSON E, 2007, ROC; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS	38	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2009	32	2					139	147		10.1097/MRR.0b013e328325a5d1			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	452VD	WOS:000266568400007	19169142				2022-02-06	
J	Odriozola, FA; Ibarraran, MI; Gorostidi, AM; Murgialdai, A; Garde, PM				Alberdi Odriozola, Fermin; Iriarte Ibarraran, Marta; Mendia Gorostidi, Angel; Murgialdai, Arantza; Marco Garde, Pilar			PROGNOSIS OF THE SEQUELS AFTER BRAIN INJURY	MEDICINA INTENSIVA			Spanish	Article						Brain injury; Stroke; Brain trauma; Vegetative state; Minimally conscious state; Impairment; Disability; Neurorehabilitation	FUNCTIONAL ASSESSMENT SCALES; SEVERE HEAD-INJURY; VEGETATIVE STATE; RATING-SCALE; COMATOSE SURVIVORS; REHABILITATION; DIAGNOSIS; RECOVERY; GUIDANCE	PROGNOSIS OF THE SEQUELS AFTER BRAIN INJURY Acquired brain injury (ABI) is a major public health problem due to its high incidence and prevalence, long-term effects on patients and their families and enormous socioeconomical costs. In our country, this is treated unequally by the different institutions and specialities. Its etiology, by order of incidence, is due to stroke, traumatic brain injury and anoxic-ischemic encephalopathy and then, at a great distance, a miscellaneous group in which hypoxic encephalopathy stands out. ABI has two extreme poles: deep coma and full reintegration into the community with a similar level as prior to the lesion. Between these poles are the vegetative states, minimally conscious states and, when there is minimal cognitive recovery, a varying range of difficult-to classify impairments, disabilities and handicaps, due to their extreme heterogeneity. The long-term outcome is assessed by descriptive and functional scales, which usually have important feasibility and validity problems. Some scales (GOS, GOSE) classify functional deterioration during the acute and subacute lesional phase. Others analyze neurorehabilitation planning and monitoring (ERLA, Barthel Index). The International Classification of Impairments, Disabilities and Handicaps (ICIDH-2) describes disabilities and impairments. The efficacy of rehabilitation treatment depends on the how early they are done, their adaption to each patient's needs, intensity and performance by qualified rehabilitation centers. It is difficult to quantify their results in order to compare them because of the serious methodological difficulties.	[Alberdi Odriozola, Fermin; Iriarte Ibarraran, Marta; Mendia Gorostidi, Angel; Murgialdai, Arantza; Marco Garde, Pilar] Hosp Donostia, Serv Med Intens, San Sebastian, Guipuzcoa, Spain		Odriozola, FA (corresponding author), Jose Maria Salaberria 51,6 CD, San Sebastian 20010, Guipuzcoa, Spain.	falberdi1952@telefonica.net					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bates D, 2003, CLIN MED, V3, P249; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P123; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hagen C, 1979, LEVELS COGNITIVE FUN; Holzer M, 2002, NEW ENGL J MED, V346, P549; *INE COL TECN FIN, 1999, ENC DISC DEF EST SAL; Instituto Guttmann-Hospital de Neurorrehabilitacion, 2003, CONS RESP MOD AS PLA; JENNETT B, 1975, LANCET, V1, P480; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LOMBARDI F, 2007, BIBLIOTECA COCHRANE; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; NOLLASALAS M, 2004, MED INTENSIVA, V28, P103; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; QUEMADA JI, MODELO ATENCION PERS; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RUSCALLEDA J, 2004, MED INTENSIVA, V28, P116; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Scholten JHG, 1992, FUNCTIONAL STATUS AS; SERRANO LMB, 2005, DANO CEREBRAL SOBREV; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; TURNERSTOKES L, 2007, BILIOTECA COCHRANE P; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; *WHO, 1999, ICIDH 2 INT CLASS FU; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2001, AM J NEURORADIOL, V22, P1561; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; Yagura H, 2003, ARCH PHYS MED REHAB, V84, P1687, DOI 10.1053/S0003-9993(03)00286-7	52	9	16	0	5	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	MAY	2009	33	4					171	181		10.1016/S0210-5691(09)71213-6			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625YM	WOS:000279932800004	19558938				2022-02-06	
J	Jyoti, A; Sethi, P; Sharma, D				Jyoti, Amar; Sethi, Pallavi; Sharma, Deepak			Aging accelerates the progression and manifestation of seizures in post-traumatic model of epilepsy	NEUROSCIENCE LETTERS			English	Article						Post-traumatic epilepsy; Iron-induced epilepsy; Aging; Protein kinase C activity; Electron microscopy	PROTEIN-KINASE-C; AGED RAT; LIPID-PEROXIDATION; OXIDATIVE STRESS; CEREBRAL-CORTEX; IRON INJECTION; BRAIN; FLUIDITY; CONVULSIONS; HIPPOCAMPUS	Traumatic brain injury is a major risk of post-traumatic epilepsy in a large number of individuals of different age groups. Lots of research has been done to elucidate the mechanism of post-traumatic epileptogenesis but age-related vulnerability to develop traumatic seizures is still unknown. Therefore, in the present study investigations were carried out to characterize the electrobehavioral seizure manifestation and associated alterations in young and old epileptic groups. FeCl3 injection model was used to induce post-traumatic seizures as this model closely resembles human post-traumatic epilepsy. Synchronized video-EEG monitoring was performed to diagnose manifestation of seizures in young (4 months) and old (18 months) rats. Biochemical and ultrastructural studies were performed to determine the mechanism behind the altered age-related vulnerability for post-traumatic seizures. Our result shows that old rats were more vulnerable to post-traumatic epilepsy due to faster seizure spread and lower latency for generalization of electro-clinical seizure activity. The observed biochemical and microscopic alterations associated with old age positively correlate with the altered susceptibility to develop seizures in old epileptic groups. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Jyoti, Amar; Sethi, Pallavi; Sharma, Deepak] Jawaharlal Nehru Univ, Sch Life Sci, Neurobiol Lab, New Delhi 110067, India		Sharma, D (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Neurobiol Lab, New Delhi 110067, India.	dpak57@hotmail.com					Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Avshalumov MV, 2000, BRAIN RES, V882, P86, DOI 10.1016/S0006-8993(00)02835-3; Babusikova E, 2007, NEUROCHEM RES, V32, P1351, DOI 10.1007/s11064-007-9314-0; Bala K, 2006, BIOGERONTOLOGY, V7, P81, DOI 10.1007/s10522-006-6495-x; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; CHEN SJ, 1992, J NEUROCHEM, V59, P1761, DOI 10.1111/j.1471-4159.1992.tb11008.x; Covolan L, 2000, EPILEPSY RES, V41, P9, DOI 10.1016/S0920-1211(00)00122-4; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DAIGEN A, 1991, BRAIN RES, V545, P131, DOI 10.1016/0006-8993(91)91278-9; DEBOER T, 1995, BRAIN RES, V670, P153, DOI 10.1016/0006-8993(94)01299-W; Fabene PF, 2006, NEUROBIOL DIS, V21, P80, DOI 10.1016/j.nbd.2005.06.013; Fukaya T, 2007, NEUROBIOL AGING, V28, P1179, DOI 10.1016/j.neurobiolaging.2006.05.023; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GRISAR T, 1992, EPILEPSY RES, V12, P141, DOI 10.1016/0920-1211(92)90034-Q; Head E, 2002, J NEUROCHEM, V82, P375, DOI 10.1046/j.1471-4159.2002.00969.x; Jyoti A, 2007, J ETHNOPHARMACOL, V111, P56, DOI 10.1016/j.jep.2006.10.037; Jyoti A, 2006, NEUROTOXICOLOGY, V27, P451, DOI 10.1016/j.neuro.2005.12.007; KANUNGO MS, 1970, EXP GERONTOL, V5, P261, DOI 10.1016/0531-5565(70)90047-1; Kaur J, 2003, BIOGERONTOLOGY, V4, P105, DOI 10.1023/A:1023351904840; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Leppik IE, 2006, EPILEPSY RES, V68, pS21, DOI 10.1016/j.eplepsyres.2005.07.014; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Malfatti CRM, 2003, EPILEPSIA, V44, P761, DOI 10.1046/j.1528-1157.2003.42902.x; Mizutani T, 1998, MECH AGEING DEV, V105, P151, DOI 10.1016/S0047-6374(98)00094-3; Mori A, 1998, EPILEPSY RES, V30, P153, DOI 10.1016/S0920-1211(97)00097-1; MORI A, 1990, PAVLOVIAN J BIOL SCI, V25, P54; MORIWAKI A, 1992, ELECTROEN CLIN NEURO, V83, P281, DOI 10.1016/0013-4694(92)90087-X; MORIYAMA T, 1989, BIOCHEM PHARMACOL, V38, P1169, DOI 10.1016/0006-2952(89)90264-5; NELSON L, 1986, BRAIN RES, V386, P32, DOI 10.1016/0006-8993(86)90138-1; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; PAXINOS G, 1992, RAT BRAIN STEREOTAXI; Samuelsson C, 2003, EPILEPSY RES, V56, P165, DOI 10.1016/j.eplepsyres.2003.09.004; Sapolsky RM, 2003, NAT REV NEUROSCI, V4, P61, DOI 10.1038/nrn1006; SETHI P, 2008, NEUROTOXICOLOGY; da Silva AV, 2007, EPILEPTIC DISORD, V9, P438; SINGH R, 1990, EPILEPSIA, V31, P15, DOI 10.1111/j.1528-1157.1990.tb05354.x; SINGH R, 2005, MOL CELLULAR NEUROBI, P135; Tang FR, 2004, HIPPOCAMPUS, V14, P87, DOI 10.1002/hipo.10156; VASILETS LA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P201, DOI 10.1016/0304-4157(93)90012-D; VERNET O, 1992, EXP NEUROL, V115, P297, DOI 10.1016/0014-4886(92)90065-X; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; WILLMORE LJ, 1986, BRAIN RES, V382, P422; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Yamamoto Nihei, 2002, Pathophysiology, V8, P205, DOI 10.1016/S0928-4680(02)00009-3	47	9	11	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 3	2009	453	2					86	91		10.1016/j.neulet.2009.01.082			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	426EU	WOS:000264691600003	19356599				2022-02-06	
J	Trojano, L; Moretta, P; Estraneo, A				Trojano, Luigi; Moretta, Pasquale; Estraneo, Anna			COMMUNICATING USING THE EYES WITHOUT REMEMBERING IT: COGNITIVE REHABILITATION IN A SEVERELY BRAIN-INJURED PATIENT WITH AMNESIA, TETRAPLEGIA AND ANARTHRIA	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; amnesia; locked-in syndrome; eye-tracker; cognitive rehabilitation	LOCKED-IN SYNDROME; MEMORY; SCALE; TBI	We describe here a case of cognitive rehabilitation in a young patient with closed head injury, who had dense anterograde amnesia and such disabling neurological defects (tetraplegia and anarthria) that the condition evoked sonic features of an incomplete locked-in syndrome. After a prolonged period of no communicative possibility, the patient underwent a specific training, based oil principles of errorless learning, with the aim of using a computerized eye-tracker system. Although, due to memory disturbances, the patient always denied ever having used the eye-tracker system, learned to use the computerized device and improved interaction with the environment. This favourable outcome may serve as a stimulus for devising new training approaches ill Patients with complex patterns of cognitive impairments. even when associated with severe motor impairments.	[Trojano, Luigi] Univ Naples 2, Dept Psychol, Neuropsychol Lab, IT-81100 Caserta, Italy; [Trojano, Luigi; Moretta, Pasquale; Estraneo, Anna] Sci Inst Telese Terme BN, IRCCS, Salvatore Maugeri Fdn, Telese Terme, Italy		Trojano, L (corresponding author), Univ Naples 2, Dept Psychol, Neuropsychol Lab, Via Vivaldi 43, IT-81100 Caserta, Italy.	luigi.trojano@unina2.it	Trojano, Luigi/F-2396-2016; Moretta, Pasquale/AAE-5162-2021	Trojano, Luigi/0000-0002-0328-9642; Moretta, Pasquale/0000-0003-2244-254X			Anderson ND, 2006, NEUROPSYCHOLOGIA, V44, P2806, DOI 10.1016/j.neuropsychologia.2006.05.026; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BADECKER W, 1990, COGNITION, V35, P205, DOI 10.1016/0010-0277(90)90023-D; Bruno MA, 2008, REV NEUROL-FRANCE, V164, P322, DOI 10.1016/j.neurol.2007.12.010; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Schnakers C, 2008, J NEUROL, V255, P323, DOI 10.1007/s00415-008-0544-0; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; Soderholm S, 2001, J REHABIL MED, V33, P235; Uruma G, 2007, J REHABIL MED, V39, P185, DOI 10.2340/16501977-0030; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	15	9	9	0	10	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	APR	2009	41	5					393	396		10.2340/16501977-0344			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	446CH	WOS:000266097400016	19363575	gold			2022-02-06	
J	Wiseman, DB; Dailey, AT; Lundin, D; Zhou, J; Lipson, A; Falicov, A; Shaffrey, CI				Wiseman, Diana Barrett; Dailey, Andrew T.; Lundin, David; Zhou, Jiegang; Lipson, Adam; Falicov, Alexis; Shaffrey, Christopher I.			Magnesium efficacy in a rat spinal cord injury model Laboratory investigation	JOURNAL OF NEUROSURGERY-SPINE			English	Article						magnesium; methylprednisolone; rat; spinal cord injury	TRAUMATIC BRAIN-INJURY; HIGH-DOSE METHYLPREDNISOLONE; ISCHEMIC-INJURY; SULFATE; PROTECTS; NEURODEGENERATION; NEUROPROTECTION; CONVULSIONS; CHLORIDE; OUTCOMES	Object. Magnesium has been shown to have neuroprotective properties in short-term spinal cord injury (SCI) studies. The authors evaluated the efficacy of magnesium, methylprednisolone, and magnesium plus methylprednisolone in a rat SCI model. Methods. A moderate-to-severe SCI was produced at T9-10 in rats, which then received saline, magnesium, methylprednisolone, or magnesium plus methylprednisolone within 10 minutes of injury. The Basso-Beattie-Bresnahan (BBB) motor score was evaluated weekly, beginning on postinjury Day 1. After 4 weeks, the rats' spinal cords were evaluated histologically to determine myelin index and gross white matter sparing. A second experiment was conducted to evaluate the effect of delayed administration (8, 12, or 24 hours postinjury) of magnesium on recovery. Results. The mean BBB scores at 4 weeks showed that rats in which magnesium was administered (BBB Score 6.9 +/- 3.9) recovered better than controls (4.2 +/- 2.0, p < 0.01). Insufficient numbers of animals receiving, methylprednisolone were available for analysis because of severe weight loss. The rats given magnesium within 8 hours of injury had better motor recovery at 4 weeks than control animals (13.8 +/- 3.7 vs 8.6 +/- 5.1, p < 0.01) or animals in which magnesium was administered at 12 or 24 hours after injury (p < 0.01). Steroids (30.2%), magnesium (32.3%). and a combination of these (42.3%) had a significant effect on white matter sparing (p < 0.05), but the effect was not synergistic (p > 0.8). Neither steroids nor magnesium had a significant effect on the myelin index (p > 0.1). Conclusions. The rats receiving magnesium had significantly better BBB motor scores and white matter sparing 4 weeks after moderate-to-severe SCI than control animals. In addition, the groups given steroids only or magnesium and steroids had improved white matter sparing, although the limited numbers of animals reaching the study end point makes it difficult to draw firm conclusions about the utility of steroids in this model. The optimal timing of magnesium administration appears to be within 8 hours of injury.	[Dailey, Andrew T.] Univ Utah, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Wiseman, Diana Barrett; Dailey, Andrew T.; Lundin, David; Zhou, Jiegang; Lipson, Adam] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Falicov, Alexis] Univ Washington, Dept Orthopaed, Seattle, WA 98195 USA; [Shaffrey, Christopher I.] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA		Dailey, AT (corresponding author), Univ Utah, Dept Neurosurg, 175 N Med Dr, Salt Lake City, UT 84132 USA.	andrew.dailey@hsc.utah.edu					Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Buechner J S, 2000, Med Health R I, V83, P92; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P265, DOI 10.1097/00002826-200109000-00003; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hugenholtz H, 2002, CAN J NEUROL SCI, V29, P227, DOI 10.1017/S0317167100001992; Hurlbert RJ, 2006, SPINE, V31, pS16, DOI 10.1097/01.brs.0000218264.37914.2c; Hurlbert RJ, 2001, SPINE, V26, pS39, DOI 10.1097/00007632-200112151-00009; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Kubeck JP, 2006, SPINE, V31, P257, DOI 10.1097/01.brs.0000197151.95849.7f; Lang-Lazdunski L, 2000, J VASC SURG, V32, P179, DOI 10.1067/mva.2000.105960; Lang-Lazdunski L, 2001, ANN THORAC SURG, V72, P2180, DOI 10.1016/S0003-4975(01)02919-8; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Matsumoto T, 2001, SPINE, V26, P426, DOI 10.1097/00007632-200102150-00020; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Miles AN, 2001, NEUROSURGERY, V49, P1443, DOI 10.1097/00006123-200112000-00025; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; MUIR KW, 1995, STROKE, V26, P1183, DOI 10.1161/01.STR.26.7.1183; Narazaki Douglas Kenji, 2006, Clinics, V61, P453, DOI 10.1590/S1807-59322006000500013; Nava S, 1996, AM J RESP CRIT CARE, V153, P1888, DOI 10.1164/ajrccm.153.6.8665051; Noble LJ, 2002, J NEUROSCI, V22, P7526; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Qian T, 2005, SPINAL CORD, V43, P199, DOI 10.1038/sj.sc.3101681; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; SIMPSON JI, 1994, ANESTHESIOLOGY, V81, P1493, DOI 10.1097/00000542-199412000-00025; Sirin BH, 1998, EUR J CARDIO-THORAC, V14, P82, DOI 10.1016/S1010-7940(98)00140-7; Solaroglu I, 2005, SURG NEUROL, V64, P17, DOI 10.1016/j.surneu.2005.07.058; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Weaver FM, 2000, MED CARE, V38, pS82; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; WOLF G, 1990, NEUROSCI LETT, V117, P207, DOI 10.1016/0304-3940(90)90145-Y; 2000, J SPINAL CORD MED, V23, P153	47	9	10	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	APR	2009	10	4					308	314		10.3171/spi.2009.10.4.308			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	424UQ	WOS:000264594200007	19441987				2022-02-06	
J	Balaratnasingam, C; Ye, L; Morgan, WH; Bass, L; Cringle, SJ; Yu, DY				Balaratnasingam, Chandrakumar; Ye, Linda; Morgan, William H.; Bass, Louise; Cringle, Stephen J.; Yu, Dao-Yi			Protective role of endothelial nitric oxide synthase following pressure-induced insult to the optic nerve	BRAIN RESEARCH			English	Article						Nitric oxide synthase; Optic nerve; Hydrocephalus; Traumatic brain injury; Lamina cribrosa; Pressure	ELEVATED INTRAOCULAR-PRESSURE; CEREBROSPINAL-FLUID PRESSURE; PERCUSSION BRAIN-INJURY; EXPERIMENTAL HYDROCEPHALUS; KAOLIN HYDROCEPHALUS; AXONAL-TRANSPORT; TISSUE PRESSURE; HEAD; ISOFORMS; SYSTEM	Although intracranial pressure (ICP) elevation can induce significant structural and functional changes within the central nervous system (CNS), almost complete neuronal recovery is possible if ICP and associated pathogenic factors are restored in the acute phase of the disease process. Nitric oxide synthase (NOS) isoforms have been implicated in the pathogenesis of many CNS diseases and may play an important role in the development of neuronal tolerance in the early stages of pressure elevation. In this paper we use the pig optic nerve, a typical central white matter tract, to study the time-dependent sequence of NOS isoform change following pressure elevation. The timing of NOS isoform change in relationship to structural and functional changes to axons and glial cells is also discussed. This study demonstrates that endothelial cell nitric oxide synthase (ecNOS), an enzyme that plays a protective role in the CNS, is up-regulated in a time-dependent manner after pressure elevation. ecNOS levels increase after axonal and astrocyte injury, suggesting that it might be a compensatory response that is initiated in an effort to preserve CNS function. Inducible NOS (iNOS) and neuronal NOS (nNOS), which are known to have a deleterious effect on the CNS, were not detected in this study. The increase in ecNOS demonstrated in this study is significantly different to the increase in iNOS and nNOS previously demonstrated following traumatic brain injury. Changes in ecNOS levels may therefore be important in the development of neuronal tolerance in the early stages of CNS diseases such as hydrocephalus. (C) 2009 Elsevier B.V. All rights reserved.	[Balaratnasingam, Chandrakumar; Ye, Linda; Morgan, William H.; Cringle, Stephen J.; Yu, Dao-Yi] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Bass, Louise] Murdoch Univ, Vet Hosp, Dept Anaesthesia, Perth, WA, Australia		Yu, DY (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia.	dyyu@cyllene.uwa.edu.au		Cringle, Stephen/0000-0002-5427-554X; Yu, Dao-Yi/0000-0002-9490-534X	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Australian Research Council Centre of Excellence in Vision ScienceAustralian Research Council	We are grateful for the microscopy help provided by Dr. Paul Rigby from the Centre for Microscopy, Characterisation and Analysis, University of Western Australia. We are also grateful for the technical assistance provided by Mr. Dean Darcey. Grant support was provided by the National Health and Medical Research Council of Australia and the Australian Research Council Centre of Excellence in Vision Science.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aoyama Y, 2006, J NEUROSURG, V104, P332, DOI 10.3171/ped.2006.104.5.332; Balaratnasingam C, 2008, INVEST OPHTH VIS SCI, V49, P986, DOI 10.1167/iovs.07-1090; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Balaratnasingam C, 2008, BRAIN RES, V1244, P142, DOI 10.1016/j.brainres.2008.09.044; Boillat CA, 1997, EXP NEUROL, V147, P377, DOI 10.1006/exnr.1997.6617; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Burns AR, 2007, AM J PHYSIOL-HEART C, V293, pH2904, DOI 10.1152/ajpheart.00871.2007; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Chou SM, 1996, J CHEM NEUROANAT, V10, P249, DOI 10.1016/0891-0618(96)00137-8; CHOVANES GI, 1988, NEUROSURGERY, V22, P86, DOI 10.1227/00006123-198801000-00014; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dawson TM, 1996, ANNU REV MED, V47, P219, DOI 10.1146/annurev.med.47.1.219; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Kim MH, 2005, AM J PHYSIOL-HEART C, V289, pH2551, DOI 10.1152/ajpheart.00602.2005; Klinge P, 2002, ACT NEUR S, V81, P275; Klinge PM, 2003, STROKE, V34, P193, DOI 10.1161/01.STR.0000048820.17198.15; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Liu B, 2000, GLIA, V30, P178, DOI 10.1002/(SICI)1098-1136(200004)30:2<178::AID-GLIA7>3.0.CO;2-C; Meyer P, 1999, CURR EYE RES, V18, P375, DOI 10.1076/ceyr.18.5.375.5355; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; ROOTMAN J, 1971, BRIT J OPHTHALMOL, V55, P808, DOI 10.1136/bjo.55.12.808; SAINTEROSE C, 1996, NEUROLOGICAL SURG, P890; Shareef S, 1999, INVEST OPHTH VIS SCI, V40, P2884; SIMOENS P, 1985, THESIS STATE U GHENT; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; Vidal L, 2006, BRAIN RES BULL, V70, P406, DOI 10.1016/j.brainresbull.2006.07.009; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	35	9	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 31	2009	1263						155	164		10.1016/j.brainres.2009.01.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	431CV	WOS:000265039800017	19368837	Green Published			2022-02-06	
J	Sumann, G; Paal, P; Mair, P; Ellerton, J; Dahlberg, T; Zen-Ruffinen, G; Zafren, K; Brugger, H				Sumann, Guenther; Paal, Peter; Mair, Peter; Ellerton, John; Dahlberg, Tore; Zen-Ruffinen, Gregoire; Zafren, Ken; Brugger, Hermann			Fluid Management in Traumatic Shock: A Practical Approach for Mountain Rescue	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Article						fluid therapy; hemorrhage; mountain rescue; shock; trauma	UNCONTROLLED HEMORRHAGIC-SHOCK; BRAIN-INJURY; RESUSCITATION; THERAPY; HYPOTENSION; SURVIVAL	Sumann, G,nther, Peter Paal, Peter Mair, John Ellerton, Tore Dahlberg, Gregoire Zen-Ruffinen, Ken Zafren, and Hermann Brugger. Fluid management in traumatic shock: a practical approach for mountain rescue. High Alt. Med. Biol. 10:71-75, 2009.-The management of severe injuries leading to traumatic shock in mountains and remote areas is a great challenge for emergency physicians and rescuers. Traumatic brain injury may further aggravate outcome. A mountain rescue mission may face severe limitations from the terrain and required rescue technique. The mission may be characterized by a prolonged prehospital care time, where urban traumatic shock protocols may not apply. Yet optimal treatment is of utmost importance. The aim of this study is to establish scientifically supported recommendations for fluid management that are feasible for the physician or paramedic attending such an emergency. A nonsystematic literature search was performed; the results and recommendations were discussed among the authors and accepted by the International Commission for Mountain Emergency Medicine (ICAR MEDCOM). Diagnostic and therapeutic strategies are discussed, as well as limitations on therapy in mountain rescue. An algorithm for fluid resuscitation, derived from the recommendations, is presented in Fig. 1. Focused on the key criterion of traumatic brain injury, different levels of blood pressure are presented as a goal of therapy, and the practical means for achieving these are given.	[Sumann, Guenther] Gen Hosp Voecklabruck, Dept Anesthesiol & Crit Care Med, Dr Wilhelm Bock Str 1, A-4840 Voecklabruck, Austria; [Sumann, Guenther; Paal, Peter; Mair, Peter] Innsbruck Med Univ, Dept Anesthesiol, Div Anesthesiol & Crit Care Med, Innsbruck, Austria; [Ellerton, John] Mt Rescue Council England & Wales, Penrith, Cumbria, England; [Dahlberg, Tore] Dept Anesthesiol, Gjovik, Norway; [Dahlberg, Tore] Prehosp Div, Gjovik, Norway; [Zen-Ruffinen, Gregoire] Zurich Airport, Swiss Air Ambulance, Zurich, Switzerland; [Zafren, Ken] Alaska Mt Rescue Grp, Anchorage, AK USA; [Brugger, Hermann] Innsbruck Med Univ, Int Commiss Mt Emergency Med ICAR MEDCOM, Innsbruck, Austria		Sumann, G (corresponding author), Gen Hosp Voecklabruck, Dept Anesthesiol & Crit Care Med, Dr Wilhelm Bock Str 1, A-4840 Voecklabruck, Austria.	guenther.sumann@i-med.ac.at	Paal, Peter/E-2110-2011	Paal, Peter/0000-0002-2939-4782; Zafren, Ken/0000-0002-4928-840X			Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Benedetto K P, 1991, Langenbecks Arch Chir Suppl Kongressbd, P460; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brugger H, 2005, HIGH ALT MED BIOL, V6, P226, DOI 10.1089/ham.2005.6.226; Brummel-Ziedins K, 2006, J TRAUMA, V61, P1350, DOI 10.1097/01.ta.0000235525.64176.01; BURTSCHER M, 1987, ERSTVERSORGUNG BERGU, P16; Calkins MD, 2000, J TRAUMA, V48, P1068, DOI 10.1097/00005373-200006000-00012; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DEAKIN CD, 1994, EUR J EMERG MED, V1, P8385; Dubick MA, 2006, SHOCK, V25, P321, DOI 10.1097/01.shk.0000209525.50990.28; Durrer B, 1993, Ther Umsch, V50, P228; Gemma M, 1996, J NEUROSURG ANESTH, V8, P137, DOI 10.1097/00008506-199604000-00007; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hearns S, 2003, EMERG MED J, V20, P281, DOI 10.1136/emj.20.3.281; Hohlrieder M, 2004, HIGH ALT MED BIOL, V5, P349; Innerhofer P, 2002, ANESTH ANALG, V95, P858, DOI 10.1097/00000539-200210000-00012; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Krausz MM, 2001, SHOCK, V16, P383, DOI 10.1097/00024382-200116050-00011; Kreimeier U, 2002, ANAESTHESIST, V51, P787, DOI 10.1007/s00101-002-0398-2; Kreimeier U, 2000, SCHWEIZ MED WSCHR, V130, P1516; Krismer Anette C, 2006, Am J Cardiovasc Drugs, V6, P51, DOI 10.2165/00129784-200606010-00005; Kwan I, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002245; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marshall HP, 1997, J TRAUMA, V43, P673, DOI 10.1097/00005373-199710000-00018; Marsigny B, 1999, WILD ENVIRON MED, V10, P152, DOI 10.1580/1080-6032(1999)010[0152:MMRITM]2.3.CO;2; Mauritz Walter, 2002, Eur J Emerg Med, V9, P315; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Pepe Paul E, 2002, Prehosp Emerg Care, V6, P81, DOI 10.1080/10903120290938887; Raab H, 2007, CRIT CARE MED, V35, P2221, DOI 10.1097/01.CCM.0000281635.77692.9F; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Rainer TH, 2007, RESUSCITATION, V73, P374, DOI 10.1016/j.resuscitation.2006.10.011; Revell M, 2003, J TRAUMA, V54, pS63, DOI 10.1097/01.TA.0000056157.94970.FA; Riddez L, 1998, J TRAUMA, V44, P433, DOI 10.1097/00005373-199803000-00001; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Schimetta W, 2002, WIEN KLIN WOCHENSCHR, V114, P89; Soreide E, 2005, INJURY, V36, P1001, DOI 10.1016/j.injury.2005.01.002; Terkelsen AJ, 2005, AUTON NEUROSCI-BASIC, V121, P101, DOI 10.1016/j.autneu.2005.07.001; Tomazin I, 2003, HIGH ALT MED BIOL, V4, P479, DOI 10.1089/152702903322616236; Vaid SU, 2006, CRIT CARE MED, V34, P1185, DOI 10.1097/01.CCM.0000207341.78696.3A; VOEICKEL WG, 2004, ANAESTHESIST, V53, P1151	40	9	9	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297	1557-8682		HIGH ALT MED BIOL	High Alt. Med. Biol.	MAR	2009	10	1					71	75		10.1089/ham.2008.1067			5	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	417PB	WOS:000264087400008	19278354				2022-02-06	
J	Zhu, L; Jin, W; Pan, H; Hu, ZL; Zhou, J; Hang, CH; Shi, JX				Zhu, Lin; Jin, Wei; Pan, Hao; Hu, Zelan; Zhou, Jing; Hang, Chunhua; Shi, Jixin			Erythropoietin Inhibits the Increase of Intestinal Labile Zinc and the Expression of Inflammatory Mediators After Traumatic Brain Injury in Rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Intestine; Erythropoietin; Zinc; Cytokines	NF-KAPPA-B; MULTIPLE ORGAN FAILURE; SUBARACHNOID HEMORRHAGE; CARDIAC-ARRHYTHMIAS; HYDROXYETHYL STARCH; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; ENDOTOXIC RATS; BOWEL-DISEASE; FREE-RADICALS	Background: The objective of this study was to determine the effect of erythropoietin (Epo) on the intestinal labile zinc and the inflammatory factor in rats after traumatic brain injury (TBI). Methods: Male Sprague-Dawley rats were randomly divided into nine groups: (a) normal group; (b) sham-operation group; (c, d, e, f, and g) TBI group, killed at I hour, 6 hour, 24 hour, and 72 hour and 7 days postinjury, respectively; (h and i) TBI + saline and TBI + Epo, killed at 24 hour or 72 hour postinjury. Parietal brain contusion was produced by a free-falling weight on the exposed dura of the right parietal lobe. Intestinal labile zinc, the tumor necrosis factor-a, interleukin (IL)-8, and wet/dry weight ratio were investigated in different groups. Results: The gut contains a certain amount of labile zinc in normal animals and TBI caused obviously gradual increment of intestinal liabled zinc. The levels of inflammatory mediators and the gut wet/dry weight ratio were also found to increase in the trauma group (p < 0.05). There was a highly positive correlation between the abundance of zinc fluorescence and these proinflammation factors. Epo significantly reduced the intestinal labile zinc, the inflammatory mediators, and the gut wet/dry weight ratio compared with TBI group (p < 0.05). Conclusions: Epo can protect intestine from TBI-induced injury by attenuating intestinal inflammation and labile zinc accumulation in vivo.	[Zhu, Lin; Jin, Wei; Pan, Hao; Hang, Chunhua; Shi, Jixin] Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu Prov, Peoples R China; [Hu, Zelan; Zhou, Jing] Chinese Acad Sci, Inst Neurosci Shanghai, Shanghai, Peoples R China		Shi, JX (corresponding author), Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	shijixin52@163.com					ASPLIN BR, 1994, AM J EMERG MED, V12, P370, DOI 10.1016/0735-6757(94)90163-5; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Chang CJ, 2004, CHEM BIOL, V11, P203, DOI 10.1016/j.chembiol.2004.01.017; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Chong ZZ, 2003, J NEUROSCI RES, V71, P659, DOI 10.1002/jnr.10528; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Cuzzocrea S, 2004, J PHARMACOL EXP THER, V311, P1272, DOI 10.1124/jpet.104.073197; Cuzzocrea S, 2000, MOL MED, V6, P766, DOI 10.1007/BF03402192; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DINSDALE D, 1984, J HISTOCHEM CYTOCHEM, V32, P139, DOI 10.1177/32.2.6693753; DIPASQUALE G, 1987, AM J CARDIOL, V59, P596, DOI 10.1016/0002-9149(87)91176-3; DJEU JY, 1990, J IMMUNOL, V144, P2205; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Dooling Ellen, 2004, J Neurosci Nurs, V36, P130; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; ESTANOLVIDAL B, 1979, NEUROSURGERY, V5, P675; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FORMBY B, 1984, DIABETES, V33, P229, DOI 10.2337/diabetes.33.3.229; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Giblin LJ, 2006, J HISTOCHEM CYTOCHEM, V54, P311, DOI 10.1369/jhc.5A6724.2005; Gol'dberg E D, 1993, Klin Lab Diagn, P25; Grasso G, 2006, J NEUROSURG ANESTH, V18, P91, DOI 10.1097/00008506-200604000-00001; Grasso G, 2001, J Neurosurg Sci, V45, P7; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Juul SE, 1999, PEDIATR RES, V46, P263, DOI 10.1203/00006450-199909000-00003; Juul SE, 2001, GUT, V49, P182, DOI 10.1136/gut.49.2.182; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kim YM, 2006, AM J PHYSIOL-LUNG C, V290, pL1028, DOI 10.1152/ajplung.00479.2005; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MARION DW, 1986, NEUROSURGERY, V18, P101, DOI 10.1227/00006123-198601000-00019; Masuda S, 1999, INT J HEMATOL, V70, P1; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; PARKINSON D, 1984, SURG NEUROL, V21, P132, DOI 10.1016/0090-3019(84)90330-6; RIECKEN EO, 1966, GUT, V7, P86, DOI 10.1136/gut.7.1.86; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; SCHELL AR, 1987, ARCH INTERN MED, V147, P591, DOI 10.1001/archinte.147.3.591; Semrad C E, 1999, Curr Gastroenterol Rep, V1, P398, DOI 10.1007/s11894-999-0021-7; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SPALLONE A, 1987, SURG NEUROL, V27, P253, DOI 10.1016/0090-3019(87)90038-3; Spies M, 2002, AM J PHYSIOL-GASTR L, V283, pG703, DOI 10.1152/ajpgi.00149.2001; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Svigelj V, 1996, ACTA NEUROL SCAND, V94, P120, DOI 10.1111/j.1600-0404.1996.tb07041.x; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Taylor CG, 2005, BIOMETALS, V18, P305, DOI 10.1007/s10534-005-3686-x; Tian J, 2004, ANESTH ANALG, V98, P768; Tian J, 2003, ANN CLIN LAB SCI, V33, P451; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yidirim E, 2005, J TRAUMA, V58, P1252, DOI 10.1097/01.TA.0000169803.09482.F8; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471	66	9	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2009	66	3					730	736		10.1097/TA.0b013e318184b4db			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	419ZU	WOS:000264259000024	19276746				2022-02-06	
J	Gunnes, N; Farewell, DM; Seierstad, TG; Aalen, OO				Gunnes, Nina; Farewell, Daniel M.; Seierstad, Taral G.; Aalen, Odd O.			Analysis of censored discrete longitudinal data: Estimation of mean response	STATISTICS IN MEDICINE			English	Article						discrete longitudinal data; inverse-probability-weighting method; linear-increments method; Markov-process method; mean response; monotone missingness	DROP-OUT; MODELS	The Study of longitudinal data is usually concerned with one or several response variables measured, possibly along with some covariates, at different points in time. In real-life situations this is often complicated by missing observations due to what we usually refer to as 'censoring'. In this paper we consider missingness of a monotone kind; subjects that dropout, i.e. are censored. fail to participate in the study at any of the subsequent Observation times. Our scientific objective is to make inference about the mean response in it hypothetical Population without any dropouts. There are several methods and approaches that address this problem, and we will present two existing methods (the linear-increments method and the inverse-probability-weighting method), as well as propose a new method, based on a discrete Markov process. We examine the performance of the corresponding estimators and compare these with respect to bias and variability. To demonstrate the effectiveness of the approaches in estimating the mean of a response variable. we analyse simulated data of different multistate models with a Markovian structure. Analyses Of Substantive data front (1) a Study of symptoms experienced after a traumatic brain injury, and (2) a Study of cognitive function among the elderly, arc Used as illustrations of the methods presented. Copyright (C) 2008 John Wiley & Sons, Ltd.	[Gunnes, Nina; Seierstad, Taral G.; Aalen, Odd O.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, N-0317 Oslo, Norway; [Farewell, Daniel M.] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales		Gunnes, N (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, POB 1122, N-0317 Oslo, Norway.	nina.gunnes@medisin.uio.no		Farewell, Daniel/0000-0002-8871-1653	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601724] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601724] Funding Source: Medline		Aalen OO, 2008, STAT BIOL HEALTH, P1; Diggle P, 2007, J R STAT SOC C-APPL, V56, P499, DOI 10.1111/j.1467-9876.2007.00590.x; Dufouil C, 2004, STAT MED, V23, P2215, DOI 10.1002/sim.1821; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Kang JDY, 2007, STAT SCI, V22, P523, DOI 10.1214/07-STS227; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Little R. J., 2019, STAT ANAL MISSING DA, V793; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768	12	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	FEB 15	2009	28	4					605	624		10.1002/sim.3492			20	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	402HV	WOS:000263005700005	19035531				2022-02-06	
J	Suh, SW				Suh, Sang Won			Detection of zinc translocation into apical dendrite of CA1 pyramidal neuron after electrical stimulation	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Zinc; Apical dendrite; Translocation; Hippocampus; Electrical stimulation	INTRACELLULAR FREE ZINC; MOSSY FIBER SYNAPSE; HISTOCHEMICALLY REACTIVE ZINC; SYNAPTICALLY-RELEASED ZINC; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMPA KAINATE CHANNELS; FLUORESCENT-PROBE; RAT HIPPOCAMPUS; CEREBRAL-ISCHEMIA	Translocation of the endogenous cation zinc from presynaptic terminals to postsynaptic neurons after brain insult has been implicated as a potential neurotoxic event. Several studies have previously demonstrated that a brief electrical stimulation is sufficient to induce the translocation of zinc from presynaptic vesicles into the cytoplasm (soma) of postsynaptic neurons. In the present work I have extended those findings in three ways: (i) providing evidence that zinc translocation occurs into apical dendrites, (ii) presenting data that there is an apparent translocation into apical dendrites when only a zinc-containing synaptic input is stimulated, and (iii) presenting data that there is no zinc translocation into apical dendrite of ZnT3 KO mice following electrical stimulation. Hippocampal slices were preloaded with the "trappable" zinc fluorescent probe, Newport Green. After washout, a single apical dendrite in the stratum radiatum of hippocampal CA1 area was selected and focused on. Burst stimulation (100 Hz, 500 mu A, 0.2 ms, monopolar) was delivered to either the adjacent Schaffer-collateral inputs (zinc-containing) or to the adjacent temporo-ammonic inputs (zinc-free) to the CA1 dendrites. Stimulation of the Schaffer collaterals increased the dendritic fluorescence, which was blocked by TTX, low-Ca medium, or the extracellular zinc chelator, CaEDTA. Stimulation of the temporo-ammonic pathway caused no significant rise in the fluorescence. Genetic depletion of vesicular zinc by ZnT3 KO showed no stimulation-induced apical dendrite zinc rise. The present study provides evidence that synaptically released zinc translocates into postsynaptic neurons through the apical dendrites of CA1 pyramidal neurons during physiological synaptic activity. (C) 2008 Elsevier B.V. All rights reserved.	[Suh, Sang Won] Vet Adm Med Ctr, San Francisco, CA 94121 USA; [Suh, Sang Won] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Suh, Sang Won] Hallym Univ, Coll Med, Chunchon 200702, South Korea		Suh, SW (corresponding author), Vet Adm Med Ctr, 127 Neurol,4150 Clement St, San Francisco, CA 94121 USA.	sang.suh@ucsf.edu					Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Bastian C, 2007, NEUROSCI LETT, V419, P119, DOI 10.1016/j.neulet.2007.04.047; Budde T, 1997, NEUROSCIENCE, V79, P347, DOI 10.1016/S0306-4522(96)00695-1; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Canzoniero LMT, 1997, NEUROBIOL DIS, V4, P275, DOI 10.1006/nbdi.1997.0160; Cheng CL, 1998, J NEUROCHEM, V71, P2401; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1992, J CHEM NEUROANAT, V5, P521, DOI 10.1016/0891-0618(92)90007-D; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Ketterman JK, 2008, J NEUROSCI RES, V86, P422, DOI 10.1002/jnr.21488; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; LINKOUS DH, 2007, J HISTOCHEM CYTOCHEM; NADLER V, 1990, EUR J PHARM-MOLEC PH, V188, P97, DOI 10.1016/0922-4106(90)90044-X; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; SCHMIDBAUER JM, 1990, HISTOCHEMISTRY, V94, P427; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2000, BRAIN RES, V879, P7, DOI 10.1016/S0006-8993(00)02675-5; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; SUH SW, 2008, J CEREB BLOOD FLOW M; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Yin HZ, 1999, J COMP NEUROL, V409, P250; Yin HZ, 1995, NEUROREPORT, V6, P2553, DOI 10.1097/00001756-199512150-00025; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471	47	9	9	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	FEB 15	2009	177	1					1	13		10.1016/j.jneumeth.2008.09.016			13	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	398BM	WOS:000262706300001	18929598				2022-02-06	
J	Blackman, JA; Gurka, MJ; Bao, Y; Dragulev, BP; Chen, WM; Romness, MJ				Blackman, James A.; Gurka, Matthew J.; Bao, Yongde; Dragulev, Bojan P.; Chen, Wei-Min; Romness, Mark J.			Apolipoprotein E and functional motor severity in cerebral palsy	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; E EPSILON-4 ALLELE; E GENOTYPE; LINKAGE DISEQUILIBRIUM; APOE GENOTYPE; ASSOCIATION; RISK; POLYMORPHISM; RECOVERY; SYSTEM	Cerebral palsy is attributed to non-progressive disturbances in the developing fetal or infant brain. The APOE epsilon 4 allele has been associated with poor outcome after brain injury in adults but may be protective among very young children. We conducted this study to explore the hypothesis that the APOE epsilon 4 is associated with lowered severity of cerebral palsy. 158 individuals with CP and their parents were genotyped for APOE. Mean age was 9.1 years; 54% were males. 61% were preterm at birth; 34% less than 30 weeks gestation. 30% of the CP subjects had at least one epsilon 4 allele. There was a trend towards significance for subjects with at least one epsilon 4 allele assigned to the low severity group (p = 0.11). The greater number of epsilon 4 alleles, the more likely an individual was in the low severity CP group (p = 0.12). Individuals with brain injury in the perinatal period were almost 5 times more likely to be in the low severity group (p < 0.01). Family analysis via the TDT supported a protective effect of APOE epsilon 4. Further study is needed to confirm that, in contrast to adults, the APOE epsilon 4 allele appears to confer protection and/or facilitate recovery after brain injury in the fetus or newborn, particularly when that injury occurs around term.	[Blackman, James A.; Gurka, Matthew J.] Univ Virginia, Dept Pediat, Charlottesville, VA 22903 USA; [Gurka, Matthew J.; Chen, Wei-Min] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22903 USA; [Bao, Yongde; Dragulev, Bojan P.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22903 USA; [Romness, Mark J.] Univ Virginia, Dept Orthopaed, Charlottesville, VA 22903 USA; [Chen, Wei-Min] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA		Blackman, JA (corresponding author), Univ Virginia, Kluge Childrens Rehabil Ctr, 2270 Ivy Rd, Charlottesville, VA 22903 USA.	jab5u@virginia.edu	Romness, Mark/W-5614-2019	Romness, Mark/0000-0001-6917-615X	Cerebral Palsy International Research Foundation; University of Virginia Children's Hospital research grant	This study was supported by the Cerebral Palsy International Research Foundation and a University of Virginia Children's Hospital research grant.	Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Becher JC, 2005, BIOL NEONATE, V88, P164, DOI 10.1159/000086205; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; BLACKMAN JA, 1991, J CHILD NEUROL, V6, P58, DOI 10.1177/088307389100600113; Brewer Jr H. B., 1989, TXB CARDIOVASCULAR M, P121; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; de Barros EMKP, 2000, J PEDIATR ORTHOPED, V20, P786; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Johnston MV, 2006, NEUROMOL MED, V8, P435, DOI 10.1385/NMM:8:4:435; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kuroda MM, 2007, PEDIATRICS, V119, P306, DOI 10.1542/peds.2006-1083; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mahley R. W., 2005, PEDIATR RES, V57, P310; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Schaefer GB, 2008, SEMIN PEDIATR NEUROL, V15, P21, DOI 10.1016/j.spen.2008.01.004; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stokes ME, 2000, CATEGORICAL DATA ANA; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Zetterberg H, 2002, NEUROSCI LETT, V324, P189, DOI 10.1016/S0304-3940(02)00198-2	46	9	9	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2009	2	1					67	74		10.3233/PRM-2009-0063			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7JE	WOS:000448264800008	21791796				2022-02-06	
J	Chou, YC; Wang, TY; Yang, PY; Meng, NH; Chou, LW				Chou, Yi-Chun; Wang, Tzu-Yuan; Yang, Pey-Yu; Meng, Nai-Hsin; Chou, Li-Wei			Permanent central diabetes insipidus after mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; central diabetes insipidus; permanent	PITUITARY DYSFUNCTION; ACUTE-PHASE; ANTERIOR	Aim: The patients in the permanent diabetes insipidus (DI) group are more likely to have more severe TBI, which is defined by a post-resuscitational and pre-sedational Glasgow Coma Scale (GCS) score of 8/15 or less. This study presents a case of permanent, central DI following mild traumatic brain injury with post-resuscitation GCS 13/15. Case report: A 17-year-old boy suffered from mild brain injury and experienced permanent DI without any anatomical changes on image in the early stage of traumatic brain injury. However, 1 year later, magnetic resonance imaging (MRI) of the brain in this patient has revealed some sequel of contusion. Moreover, the patient still has DI after treatment with diamino-8-D-arginine vasopressin (DDAVP). Conclusion: This patient had a rare clinical presentation of permanent, central DI, following a mild traumatic brain injury. Identification of head trauma as the aetiology of hypopituitarism may be overlooked if there is a long delay in onset after trauma. Since anterior hypopituitarism can develop decades after	[Chou, Yi-Chun; Yang, Pey-Yu; Meng, Nai-Hsin; Chou, Li-Wei] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung 404, Taiwan; [Wang, Tzu-Yuan] China Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung 404, Taiwan; [Meng, Nai-Hsin] China Med Univ, Coll Med, Taichung, Taiwan; [Chou, Li-Wei] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan		Chou, LW (corresponding author), China Med Univ Hosp, Dept Phys Med & Rehabil, 2 Yuh Der Rd, Taichung 404, Taiwan.	chouliwe@tcts.seed.net.tw	Chou, Li-Wei/M-6409-2013; Chou, Li-Wei/K-8875-2019	Chou, Li-Wei/0000-0002-3540-6225; Chou, Li-Wei/0000-0002-3540-6225			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Boughey JC, 2004, AM SURGEON, V70, P500; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Su DH, 2005, J FORMOS MED ASSOC, V104, P463; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	8	9	9	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	13-14					1095	1098		10.3109/02699050903379396			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	529YR	WOS:000272556000012	19891534				2022-02-06	
J	Goldblum, G; Alant, E				Goldblum, Glenn; Alant, Erna			Sales assistants serving customers with traumatic brain injury	APHASIOLOGY			English	Article						Traumatic brain injury; Customer with a cognitive-communication disorder; Sales assistants; Communication partner training programme; ICF (WHO; 2001)	COMMUNICATION; PEOPLE; DISCOURSE; APHASIA; PARTICIPATION; PARTNERS; ADULTS	Background: General lack of awareness regarding neurogenic communication disorders generally, and cognitive communication disorders following a traumatic brain injury (TBI) specifically, has resulted in pervasive environmental and attitudinal barriers for these individuals. While collaborative communication partner training programmes have been advocated as a means to remove barriers and provide social supports to enhance participation, a dearth of published programmes is evident within the field of TBI specifically. Similarly within the corporate context, in spite of legislative changes and diversity awareness programmes for employees, few training programmes exist worldwide, and in South Africa particularly, that remove barriers between employees and customers with a communication disability, and with a TBI specifically. In order to address this, the current research targeted the retail supermarket environment as a context in which a significant number of everyday communicative exchanges take place. Aims: The study examined the effects of a specialised once-off training session on the confidence and knowledge of sales assistants in identifying barriers to, and facilitators of, sales interactions with customers with cognitive-communication disorders following a TBI. To do this, a randomised controlled trial design was used. Methods and Procedures: Two questionnaires were developed and administered on two different occasions to the experimental group pre and post training, as well as the control group, to determine the confidence and knowledge with which they identified barriers and facilitators during videotaped sales interactions. The training session was developed based on previously established principles of diversity awareness training. Training and its evaluation used original on-site videotaped scenarios within small group discussion format. Outcomes and Results: Inter- and-intra group comparisons were analysed on the derived confidence and knowledge constructs from item analysis of the questionnaires. All results pointed consistently to the impact of the once-off training session on experimental group participants, who also rated the training session highly. Conclusions: The need for companies to expand their concept of customer service to include the customer with a disability is emphasised. Training programmes empowering their employees to interact with greater knowledge and confidence specifically with customers with a TBI will potentially facilitate deeper participation for both. The current research lays the groundwork for more in-depth research that can be generalised beyond this specific population of individuals with a communication disorder.	[Alant, Erna] Univ Pretoria, Ctr Alternat & Augmentat Commun, ZA-0002 Pretoria, South Africa		Alant, E (corresponding author), Univ Pretoria, Ctr Alternat & Augmentat Commun, ZA-0002 Pretoria, South Africa.	erna.alant@up.ac.za					ACKERMAN R, 2002, HEARING GRASSHOPPERS; ACKERMAN R, 2005, 4 LEGS TABLE RAYMOND; ALANT E, 2005, 13 MULT AAC RES IND; Alant E., 2005, AUGMENTATIVE ALTERNA, P155; Bedrosian JL, 2003, J SPEECH LANG HEAR R, V46, P800, DOI 10.1044/1092-4388(2003/063); Bhengu M. J., 1996, UBUNTU ESSENCE DEMOC; BORNMAN J, 2001, DEV PRIMARY LE UNPUB; BROTHERSON MJ, 1994, TOP EARLY CHILD SPEC, V14, P101, DOI 10.1177/027112149401400110; Brown K, 2006, APHASIOLOGY, V20, P595, DOI 10.1080/02687030600626256; Caffarella R. S., 1994, PLANNING PROGRAMS AD; CHAPEY R, 2000, ASHA LEADER, P4; COATS K, 2003, TOMORROWTODAY BIZ; CODRINGTON G, 2003, TOMORROWTODAY BIZ; Coelho C. A., 1999, BRAIN DAM B; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; COTTRELL S, 2001, THESIS CITY U LONDON; COVEY SR, 1992, 7 HABITS HIGHLY EFFE; COVEY SR, 2004, 8TH HABIT EFFECTIVEN; Cummings SR, 2001, DESIGNING CLIN RES E, P231; *FRANKL, 2001, FRANKL DIS AW RET EN; French S., 1994, EQUAL TERMS WORKING, P3; Garcia LJ, 2002, J COMMUN DISORD, V35, P187, DOI 10.1016/S0021-9924(02)00064-3; GOLDBLUM G, 2005, SALES ASSISTANTS SER; Hammer M., 2001, AGENDA WHAT EVERY BU; HOLLAND AL, 1982, CLIN APHASIOLOGY C P, V14, P345; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Isaki E, 2000, BRAIN INJURY, V14, P441; Jordan L., 1996, APHASIA SOCIAL APPRO; Kagan A, 2002, J COMMUN DISORD, V35, P153, DOI 10.1016/S0021-9924(02)00062-X; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 1993, APHASIA TREATMENT WO, P199; Kagan Aura, 1995, Top Stroke Rehabil, V2, P15; Kotter JP., 2002, HEART CHANGE REAL LI; Krueger R.A., 1988, FOCUS GROUPS PRACTIC; Krueger R. A., 2000, FOCUS GROUPS PRACTIC, V3rd; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Mateer C. A., 2001, COGNITIVE REHABILITA, P3; MAYO GD, 1987, COMPLETE BOOK TRAINI, P145; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MBIGI L., 1995, UBUNTU SPIRIT AFRICA; McMillan J.H., 2001, RES ED CONCEPTUAL IN; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Mertens D. M., 1998, RES METHODS ED PSYCH; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; MINTZBERG H, 2004, MANAGERS NOT MBAS; Oliver M., 1996, UNDERSTANDING DISABI; Parsons G, 2000, MENT RETARD, V38, P244, DOI 10.1352/0047-6765(2000)038<0244:APWIDJ>2.0.CO;2; Penn C, 2000, NEUROGENIC COMMUNICA, P103; POUND C, 2001, APHASIA THERAPIES LI, P1; PRUTTING CA, 1982, J SPEECH HEAR DISORD, V47, P123, DOI 10.1044/jshd.4702.123; Sarno MT, 2004, CHALLENGING APHASIA THERAPIES: BROADENING THE DISCOURSE AND EXTENDING THE BOUNDARIES, P19, DOI 10.4324/9780203462706_chapter_2; SARNO MT, 1986, 5 ANN JC HEMPH LECT; SAXBY H, 1986, BRIT J MENT SUBNORM, V32, P69, DOI 10.1179/bjms.1986.010; Schlosser R. W, 2003, EFFICACY AUGMENTATIV; SILBERMAN M, 1990, ACTIVE TRAINING HDB; SILVER R, 2000, SUCCESSFULLY EMPLOYI; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287; Slavin RE, 1996, CONTEMP EDUC PSYCHOL, V21, P43, DOI 10.1006/ceps.1996.0004; Sohlberg M. M., 2001, COGNITIVE REHABILITA, P306; Sohlberg MM, 1998, BRAIN INJURY, V12, P333; SWART LJ, 2001, ASSESSMENT COS UNPUB; THOMAS RR, 1999, BUILDING HOUSE DIVER, P3; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; Togher L., 2000, BRAIN DAM B, P1; Underhill P., 1999, WHY WE BUY SCI SHOPP; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; *WHO, 2001, ICF INT CLASS FUCT D; Worrall L, 2002, J COMMUN DISORD, V35, P107, DOI 10.1016/S0021-9924(02)00060-6; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN, P1; Ylvisaker M., 1999, CLIN PRACTICE MANAGE, P117; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; YLVISAKER M, 1998, COLLABORATIVE BRAIN, P99; YLVISAKER M, 2001, ED PSYCHOL SCOTLAND, V6, P17; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; YLVISAKER M, 1998, COLLABORATIVE BRAIN, P75; YLVISAKER M, 2002, PERSPECTIVES NEUROPH, V12, P19; Ylvisaker M., 1985, CLIN MANAGEMENT NEUR, V2nd, P243; YLVISAKER M, 1998, COLLABORATIVE BRAIN, P235; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100	84	9	10	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2009	23	1					87	109	PII 794158980	10.1080/02687030802024094			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	378BV	WOS:000261297000005		Green Submitted			2022-02-06	
J	Hwang, K; Nam, YS; Han, SH				Hwang, Kun; Nam, Yong Seok; Han, Seung Ho			Vulnerable Structures During Intraoral Sagittal Split Ramus Osteotomy	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Mandible; osteotomy; facial nerve injuries; carotid artery; veins		The aim of this study was to elucidate the anatomical structures that are vulnerable to injury during sagittal split ramus osteotomy (SSRO). Twenty-nine hemifaces of 19 Korean adult cadavers (I I men and 8 women; age range, 50-91 years) were dissected, and the locations of the facial nerve, retromandibular vein (RMV), and external carotid artery (ECA) were measured on the base of the mandibular posterior border and occlusal plane. Sagittal split ramus osteotomy was performed on the cadaver heads at intervals of 10 mm, and the proximity of the facial nerve was observed. The buccal branch and mandibular branch crossed the posterior border of the mandible (PBM). Most buccal branches (86%) crossed between 7/10 and 10/10 of the distance from gonion to mandibular notch (MN). Most mandibular branches (86%) were between 6/10 and 1/10 of the distance from gonion to MN. Most facial nerve trunks (FNTs) (82%) were within a circle of 9 mm in radius. Its center was located 34 mm posterior and 7 mm inferior to the MN. The FNT was located in the range of I I to 14 mm medial to the PBM. The FNT emerged out of the stylomastoid foramen and ran anteroinferiorly in a direction of 45 degrees. In 10-mm ramus setback osteotomy, FNT was very close to the PBM, running almost vertically. Retromandibular vein was 5.5 to 8.6 nun posterior and 4.2 to 9.1 mm medial to the PBM. The ECA was located at 5.7 to 6.5 mm posterior and 10.5 to 12.9 mm medial to PBM. Facial nerve could be averted from injury by doing less setback. Bleeding after SSRO is likely to be due to the injury of RMV which is closer to the PBM (4-9 mm) than ECA (12-13 mm).	[Hwang, Kun; Nam, Yong Seok] Inha Univ, Coll Med, Dept Plast Surg, Inchon 400711, South Korea; [Hwang, Kun; Nam, Yong Seok] Inha Univ, Coll Med, Ctr Adv Med Educ, Project BK21, Inchon 400711, South Korea; [Han, Seung Ho] Catholic Univ Korea, Dept Anat, Seoul, South Korea; [Han, Seung Ho] Catholic Univ Korea, Inst Appl Anat, Seoul, South Korea		Hwang, K (corresponding author), Inha Univ, Coll Med, Dept Plast Surg, 7-206 Sinheung Dong, Inchon 400711, South Korea.	jokerhg@inha.ac.kr	Nam, Yong-Seok/AAE-9968-2020	Nam, Yong-Seok/0000-0001-8698-639X; Hwang, Kun/0000-0002-1994-2538	Basic Research Program of Korea Science and Engineering FoundationKorea Science and Engineering Foundation [R01-2005-000-10018-0]	This study was supported by grant (R01-2005-000-10018-0) from Basic Research Program of Korea Science and Engineering Foundation.	Fujimura K, 2006, J ORAL MAXIL SURG, V64, P384, DOI 10.1016/j.joms.2005.11.009; Sammartino G, 2005, J CRANIOFAC SURG, V16, P1110, DOI 10.1097/01.SCS.0000157307.62290.41	2	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2009	20	1					229	232		10.1097/SCS.0b013e3181849724			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	399ZS	WOS:000262838400059	19165033				2022-02-06	
J	Kim, DG; Kim, SH; Kim, OL; Cho, YW; Son, SM; Jang, SH				Kim, Dong Gyu; Kim, Seong Ho; Kim, Oh Lyong; Cho, Yun Woo; Son, Su Min; Jang, Sung Ho			Long-term recovery of motor function in a quadriplegic patient with diffuse axonal injury and traumatic hemorrhage: A case report	NEUROREHABILITATION			English	Article						Motor recovery; diffusion tensor imaging; functional MRI; corticospinal tract; diffuse axonal injury; traumatic hemorrhage	CORTICOSPINAL TRACT; BRAIN-INJURY; MRI; TRACTOGRAPHY; CORTEX	There have been no studies on motor recovery in severe quadriplegic patients with traumatic brain injury (TBI) resulting from combined causes of weakness; this type of patient is often seen in rehabilitation clinics. We report on a quadriplegic patient who showed long-term motor recovery from severe weakness caused by a diffuse axonal injury (DAI) on the brainstem and a traumatic intracerebral hemorrhage (ICH) on left cerebral peduncle, as evaluated by diffuse tensor imaging (DTI) and functional MRI (fMRI). A 17-year-old male patient presented with quadriparesis at the onset of TBI. Over the 28-month period following the onset of the injury, the motor function of the four extremities slowly recovered to a range that was nearly normal. Two longitudinal DTIs (at 11 and 28 months from onset) and fMRI (at 28 months) were performed. Fractional anisotropy and an apparent diffusion coefficient were measured using the region of interest method, and diffusion tensor tractography was conducted using a DTI/fMRI combination. Fractional anisotrophy values in the brainstem, which were markedly decreased on the 11-month DTI, were increased on the 28-month DTI. On the fMRI performed at 28 months, the contralateral primary sensori-motor cortex was activated by the movement of either the right or left hand. Diffusion tensor tractography showed that fiber tracts originating from the motor-sensory cortex passed through the known corticospinal tract pathway to the pons. It seems that the weakness of this patient recovered due to the recovery of the damaged corticospinal tracts.	[Kim, Dong Gyu; Son, Su Min; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Seong Ho; Kim, Oh Lyong] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea; [Cho, Yun Woo] Yeungnam Univ, Dept Diagnost Radiol, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Brunnstrom S, 1966, Phys Ther, V46, P357; Cunha IT, 2002, AM J PHYS MED REHAB, V81, P848, DOI 10.1097/00002060-200211000-00008; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Han BS, 2008, NEUROREHABILITATION, V23, P171; Han BS, 2007, NEUROREHABILITATION, V22, P151; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Macdonell RAL, 1999, NEUROLOGY, V53, P1462, DOI 10.1212/WNL.53.7.1462; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Yamada K, 2003, STROKE, V34, DOI 10.1161/01.STR.0000085827.54986.89	18	9	12	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	25	2					117	122		10.3233/NRE-2009-0506			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	515LP	WOS:000271472600005	19822942				2022-02-06	
J	Lewandowski, LJ; Rieger, B				Lewandowski, Lawrence; Rieger, Brian			The Role of a School Psychologist in Concussion	JOURNAL OF APPLIED SCHOOL PSYCHOLOGY			English	Article						concussion; mild traumatic brain injury; school psychologists; assessment		School psychologists historically have received little training on topics such as mild traumatic brain injury or concussion, yet they could play a significant role in assessment, consultation, and intervention with students who have sustained a concussion. The purpose of this article is to educate school psychologists with regard to definition, prevalence, characteristics, and management of concussion in children, especially the various services that a school could provide to assist these students with their recovery. The article includes a case study that highlights the personal challenges faced by a student with concussion.	[Lewandowski, Lawrence] Syracuse Univ, Dept Psychol, Psychol, 472 Huntington Hall, Syracuse, NY 13244 USA; [Rieger, Brian] SUNY Upstate Med Univ, Syracuse, NY 13210 USA		Lewandowski, LJ (corresponding author), Syracuse Univ, Dept Psychol, Psychol, 472 Huntington Hall, Syracuse, NY 13244 USA.	ljlewand@syr.edu					American Psychiatric Association, 1994, DIAGN STAT MAN DIS; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Barth JT, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P81; Batchelor E. S. J., 1996, PEDIAT NEUROPSYCHOLO; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Dykeman B. F., 2001, J INSTRUCTIONAL PSYC, V28, P20; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lezak M.D., 2006, NEUROPSYCHOLOGICAL A; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; National Center for Injury Prevention and Control C. f. d. C. a. i. P., 2003, REP C MILD TRAUM BRA; National Federation of High Schools, 2007, CONC POINT EMPH; RUTHERFORD WH, 1977, LANCET, V1, P1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shinn M. R., 2002, BEST PRACTICES SCH P, VIV, P691; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	39	9	9	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1537-7903	1537-7911		J APPL SCH PSYCHOL	J. Appl. Sch. Psychol.		2009	25	1					95	110		10.1080/15377900802484547			16	Psychology, Educational	Emerging Sources Citation Index (ESCI)	Psychology	V80YS	WOS:000212218500006					2022-02-06	
J	McMillan, TM; McKenzie, P; Swann, IJ; Weir, CJ; McAviney, A				McMillan, T. M.; McKenzie, P.; Swann, I. J.; Weir, C. J.; McAviney, A.			Head injury attenders in the emergency department: The impact of advice and factors associated with early symptom outcome	BRAIN INJURY			English	Article						Head injury; traumatic brain injury; emergency department; post concussional symptoms	POSTCONCUSSION SYMPTOMS; DISCHARGE; ACCIDENT; KNOWLEDGE; PEOPLE	Primary objective: Many who attend hospital after head injury are not admitted to a hospital bed. This study explores the views of hospital attenders about advice received, predictors of memory for and compliance with advice and factors associated with early symptom persistence and outcome that might identify those requiring follow-up. Design: A single group prospective follow-up design. Methods and procedure: Relationships between information obtained by emergency department (ED) staff during admission and about satisfaction with and memory for advice and about symptom persistence was compared in 200 attenders with head injury who were not admitted to hospital. The telephone interview comprised a structured interview and the Post-Concussional Symptoms Checklist. Results: Satisfaction with advice was high. Despite this, a minority remembered advice (alcohol/drugs 44%; medication 38%; rest/sleep 56%; work 36%; sport 36%). At follow-up, symptom complaints were not predicted by information obtained in the ED. Attenders with retrospectively assessed post-traumatic amnesia (PTA) for more than 5 minutes reported more symptoms and poorer memory for advice at follow-up. Conclusions: Although satisfaction with advice was high, memory for advice was relatively poor and was associated with longer durations of PTA. Attenders with PTA 5 minutes should be targeted for follow-up or inpatient admission.	[McMillan, T. M.; McKenzie, P.] Univ Glasgow, Fac Med, Gartnavel Royal Hosp, Glasgow G12 OXH, Lanark, Scotland; [Swann, I. J.; McAviney, A.] Glasgow Royal Infirm, Dept Emergency Med, Glasgow G4 0SF, Lanark, Scotland; [Weir, C. J.] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 OXH, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Fac Med, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 OXH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk		Weir, Christopher/0000-0002-6494-4903	NHS Greater Glasgow and Clyde	Thanks are due to Professor R. Hunter, Dr S. Copstick, Mr D. Gentleman and Mr D. McNaughton for advice and discussion with regard to the project and to Dr A. Carson for comments on a draft of the manuscript. The project was funded by NHS Greater Glasgow and Clyde.	*AM PSYCH ASS, 2002, DIAGN STAT MAN 4 TR; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; Davies R, 2005, BRAIN INJURY, V19, P941, DOI 10.1080/02699050400000565; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Heng K. W. J., 2007, SMJ Singapore Medical Journal, V48, P1107; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kerr J, 2007, EMERG MED J, V24, P330, DOI 10.1136/emj.2006.044230; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moore C, 2004, NZ MED J, V117, P1; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; *SCOTT INT GUID NE, 2000, EARL MAN PAT HEAD IN; Scottish Executive, 2006, SCOTT IND MULT DEPR; SWANN IJ, 1981, INJURY, V12, P274, DOI 10.1016/0020-1383(81)90200-X; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WARD AB, 1992, ARCH EMERG MED, V9, P314	28	9	9	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	6					509	515	PII 911809378	10.1080/02699050902970729			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	451SF	WOS:000266489800004	19484624				2022-02-06	
S	Nolin, P; Martin, C; Bouchard, S		Wiederhold, BK; Riva, G		Nolin, Pierre; Martin, Cyndie; Bouchard, Stephane			Assessment of Inhibition Deficits with the Virtual Classroom in Children with Traumatic Brain Injury: A Pilot-Study	ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE 2009: ADVANCED TECHNOLOGIES IN THE BEHAVIORAL, SOCIAL AND NEUROSCIENCES	Studies in Health Technology and Informatics		English	Article; Book Chapter						Virtual Reality; Virtual Classroom; Children; Traumatic Brain Injury; Inhibition Deficit		This study compared the performance of 8 children who have sustained a traumatic brain injury on the traditional VIGIL Continuous Performance Test and the Continuous Performance Test included in the Virtual Classroom. Results supported the hypothesis, showing that the Continuous Performance Test from the Virtual Classroom showed more sensitivity concerning inhibition deficits. More precisely, children showed more commission errors and longer reaction time. These results can be explained by the ecological character of the Virtual Classroom, meaning that this instrument is close to real-life experiences and requires more attention and inhibition resources.	[Nolin, Pierre] Univ Quebec, Dept Psychol, LARI RV, Trois Rivieres, PQ G9A 5H7, Canada; [Bouchard, Stephane] UQO, Chaire Rech Cyberpsychol, Gatineau, PQ, Canada		Nolin, P (corresponding author), Univ Quebec, Dept Psychol, LARI RV, CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	Pierre.Nolin@uqtr.ca					Anderson V., 2008, EXECUTIVE FUNCTIONS; Digital Mediaworks, VIRT CLASSR; *PSYCH CORP, 1998, VIG CONT PERF TEST U; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940	4	9	9	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0926-9630		978-1-60750-017-9	STUD HEALTH TECHNOL			2009	144						240	242		10.3233/978-1-60750-017-9-240			3	Psychology, Clinical; Computer Science, Cybernetics; Computer Science, Interdisciplinary Applications; Health Policy & Services; Psychology; Psychology, Social	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Computer Science; Health Care Sciences & Services	BKZ13	WOS:000269659900055	19592772				2022-02-06	
J	Penn, C; Watermeyer, J; Schie, K				Penn, Claire; Watermeyer, Jennifer; Schie, Kathryn			Auditory disorders in a South African paediatric TBI population: Some preliminary data	INTERNATIONAL JOURNAL OF AUDIOLOGY			English	Article						Traumatic brain injury; Educational outcome; Hearing loss; South Africa	TRAUMATIC BRAIN-INJURY; BASILAR SKULL FRACTURES; HEAD-INJURY; HEARING-LOSS; CHILDREN; AGE	South Africa has an exceptionally high incidence of traumatic brain injury in its paediatric population but very little systematic research has been conducted on the outcome of such injury. A number of socio demographic variables influence the mechanism of injury as well as its management. This paper reports on a study documenting the educational and audiological outcomes of a group of 100 subjects who sustained their injuries prior to the age of 12 years. The hearing and communication profile of this group is considered in relation to educational outcome. An illustrative case study will demonstrate the multiple influences on outcome in this setting, as well as the need for integrated team management. In the sample, 31% had a reported hearing loss, confirmed audiologically in 14% of subjects. The majority of the sample returned to a mainstream school. However, analysis indicated that about 75% of the sample was in need of specialized education, while only 22% of that sample had received any additional support. The implications of these findings for audiological policy and practice are highlighted.	[Penn, Claire; Watermeyer, Jennifer; Schie, Kathryn] Univ Witwatersrand, Dept Speech Pathol & Audiol, ZA-2050 Johannesburg, South Africa		Penn, C (corresponding author), Univ Witwatersrand, Dept Speech Pathol & Audiol, Private Bag 3,WITS, ZA-2050 Johannesburg, South Africa.	claire.penn@wits.ac.za	Watermeyer, Jennifer/B-1173-2010	Watermeyer, Jennifer/0000-0001-7918-8832			*ACESS, 2002, CHILD POV S AFR; *AIDS LAW PROJ, 2008, KNOW YOUR RIGHTS HLT; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Berry L, 2003, RAPID ASSESSMENT SIT; BRYSIEWICZ P, 2001, S AFRICA ACCIDENT EM, V9, P194; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Christensen L A, 1998, J Am Acad Audiol, V9, P292; *DEP ED, 2001, 6 DEP ED; Dube A. K., 2005, ROLE EFFECTIVENESS D; ENGELBRECHT P, 2001, INT J SPECIAL ED, V16, P80; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; HOWE J, 1975, NEUROLOGY, V91, P50; JACOBS MP, 1993, NEUROPSYCHOL REHABIL, V3, P341, DOI 10.1080/09602019308401446; JERGER S, 1981, AUDITORY DISORDERS M; Khoza K., 2002, S AFR J COMMUN DISOR, V49, P17, DOI DOI 10.4102/SAJCD.V49I1.214; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KITCHENS JL, 1991, J PEDIATR SURG, V26, P992, DOI 10.1016/0022-3468(91)90849-O; Lalloo R, 2004, SAMJ S AFR MED J, V94, P544; Lash M, 2004, NEUROREHABILITATION, V19, P173; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; Lee D, 1998, LARYNGOSCOPE, V108, P816, DOI 10.1097/00005537-199806000-00008; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; LIUSHINDO M, 1989, INT J PEDIATR OTORHI, V17, P109, DOI 10.1016/0165-5876(89)90086-4; MILLER HE, 2004, ARCH DIS CHILD S, V89, pA56; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Morrow N., 2005, S AFRICAN J ED, V25, P164; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; PERAKYLA A, 2004, QUALITATIVE RES THEO, P283; PHURUTSE M.C., 2005, FACTORS AFFECTING TE; POTTAS L, 2004, THESIS U PRETORIA S; SALZER T, 1994, NEUROTOLOGIC MANIFES; SCHIE K, PERSPECT ED UNPUB; Semple PL, 1998, S AFR MED J, V88, P440; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Tokui N, 2005, HEARING RES, V199, P111, DOI 10.1016/j.heares.2004.08.009; Tollman SM, 2007, SCAND J PUBLIC HEALT, V35, P4, DOI 10.1080/14034950701525906; Toroyan T, 2007, YOUTH ROAD SAFETY; *UNAIDS, 2007, CHILDR AIDS PROV PED; VANDIJK C, 2003, THESIS U PRETORIA S; VENTER P, 2000, TRAUMA EMERG MED, V17, P10; WALKER A, 2005, S AFR MED J, V95, P38; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; Wu L, 1997, EVAL HEALTH PROF, V20, P146, DOI 10.1177/016327879702000203; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; YLVISAKER M, 1916, J HEAD TRAUMA REHAB, V76, P93; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	51	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1499-2027	1708-8186		INT J AUDIOL	Int. J. Audiol.		2009	48	3					135	143	PII 909496696	10.1080/14992020802635309			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	418HF	WOS:000264138600006	19283585				2022-02-06	
J	Sandberg, MA; Bush, SS; Martin, T				Sandberg, Mark A.; Bush, Shane S.; Martin, Thomas			BEYOND DIAGNOSIS: UNDERSTANDING THE HEALTHCARE CHALLENGES OF INJURED VETERANS THROUGH THE APPLICATION OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF)	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychology; Rehabilitation; Classification	TRAUMATIC BRAIN-INJURY; DEVELOPING CORE SETS; REHABILITATION-MEDICINE; PSYCHOPATHOLOGY; AFGHANISTAN; PREDICTORS; FRAMEWORK; OUTCOMES; SPEECH; IRAQ	Psychiatric and neurological disorders brought about by exposure to combat can create serious obstacles to community reintegration. Effective therapeutic and rehabilitative methods designed to address disorders that arise from combat are available. Yet there continues to be a need to develop both a deeper understanding of veterans' needs and best-practice methods to alleviate distress and facilitate community participation. Awareness of these needs served as the catalyst for the International Conference on Behavioral Health and Traumatic Brain Injury and is the basis for developing numerous new programs and service refinements across government and non-government organizations. Despite advances, community reintegration remains a complicated endeavor for many veterans returning home who are experiencing traumatic brain- and stress-related disorders. Accurately conceptualizing and codifying symptoms and barriers to community participation, beyond impairment analysis and diagnostic inclusion, is necessary to guide treatment planning and inform programmatic refinements. The International Classification of Function, Disability and Health (ICF) offers a useful taxonomic tool that can assist in refining an understanding of the challenges confronting our returning veterans. In turn, resources can be appropriately allocated, and neuropsychological therapies and other rehabilitation interventions, which assist veterans to resume productive and satisfying lives, will more likely be developed and implemented.	[Martin, Thomas] Univ Missouri, Columbia, MO USA		Sandberg, MA (corresponding author), ABPP, 50 Karl Ave, Smithtown, NY 11787 USA.	MASPSY@Verizon.net					*AM SPEECH HEAR AS, 2001, SCOP PRACT SPEECH LA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barrow FH, 2006, J SOC WORK DISABIL R, V5, P65, DOI 10.1300/J198v05n01_04; BERNABEU M, 2009, NEUROREHABILITATION; Bickenbach JE, 1999, SOC SCI MED, V48, P1173, DOI 10.1016/S0277-9536(98)00441-9; Biering-Sorensen F, 2006, SPINAL CORD, V44, P541, DOI 10.1038/sj.sc.3101918; Bruyere SM, 2005, REHABIL PSYCHOL, V50, P103, DOI 10.1037/0090-5550.50.2.103; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Darzins P., 2006, AUSTR OCCUPATIONAL T, V53, P127, DOI DOI 10.1111/J.1440-1630.2006.00580.X; Eadie TL, 2003, AM J SPEECH-LANG PAT, V12, P189, DOI 10.1044/1058-0360(2003/065); Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; GATCHEL RJ, 1994, ARCH PHYS MED REHAB, V75, P666, DOI 10.1016/0003-9993(94)90191-0; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jelsma J, 2009, J REHABIL MED, V41, P1, DOI 10.2340/16501977-0300; KARNEY BR, 2008, WR546CCF RAND CTR MI; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kearney PM, 2004, J ADV NURS, V46, P162, DOI 10.1111/j.1365-2648.2003.02976.x; Kesselring J, 2008, MULT SCLER J, V14, P252, DOI 10.1177/1352458507082615; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kouzes J.M., 1987, LEADERSHIP CHALLENGE; Larkins B, 2008, BRAIN IMPAIR, V9, P247, DOI 10.1375/brim.9.3.247; Leyshon RT, 2008, WORK, V31, P47; MCCRONE P, 1994, PSYCHOL MED, V24, P1025, DOI 10.1017/S003329170002910X; Oltman R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-139; ORMEL J, 1993, ARCH GEN PSYCHIAT, V50, P759; Peterson DB, 2005, REHABIL PSYCHOL, V50, P105, DOI 10.1037/0090-5550.50.2.105; PETERSON DB, 2005, REHABILITATION ED, V19, P75; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; Rentsch HP, 2003, DISABIL REHABIL, V25, P411, DOI 10.1080/0963828031000069717; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; ROBERTSON E, 1994, CLIN NEUROPSYCHOL, V8, P69; Rundell SD, 2009, PHYS THER, V89, P82, DOI 10.2522/ptj.20080113; Sbordone RJ, 1996, ECOLOGICAL VALIDITY; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Steiner WA, 2002, PHYS THER, V82, P1098, DOI 10.1093/ptj/82.11.1098; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Taber Katherine H, 2009, J Neuropsychiatry Clin Neurosci, V21, P1, DOI 10.1176/appi.neuropsych.21.1.iv; Tempest S, 2006, DISABIL REHABIL, V28, P663, DOI 10.1080/09638280500276992; Thomas-Stonell N, 2009, J COMMUN DISORD, V42, P29, DOI 10.1016/j.jcomdis.2008.08.002; *US GOV ACC OFF, 2008, GAO08615; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Vieta E, 2007, BIPOLAR DISORD, V9, P16, DOI 10.1111/j.1399-5618.2007.00322.x; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	45	9	9	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	8					1416	1432		10.1080/13854040903369425			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	524KF	WOS:000272141500011	19882479				2022-02-06	
J	Shanahan, L; McAllister, L; Curtin, M				Shanahan, Lucie; McAllister, Lindy; Curtin, Michael			Wilderness adventure therapy and cognitive rehabilitation: Joining forces for youth with TBI	BRAIN INJURY			English	Article						Cognitive rehabilitation; traumatic brain injury; adolescent; outdoor experiential education	TRAUMATIC BRAIN-INJURY; BEHAVIORAL SUPPORTS; YOUNG-CHILDREN; HEAD-INJURY; INTERVENTION; OUTCOMES; PROGRAM; INDIVIDUALS; ADOLESCENTS	Primary objective: To highlight the potential application of Wilderness Adventure Therapy (WAT) as a supplementary tool in cognitive rehabilitation with an adolescent TBI population. Literature selection: A review of existing literature pertaining to adolescent TBI, cognitive rehabilitation approaches and Wilderness Adventure Therapy was conducted. Literature was sourced through EBSCOhost (Health and Psychology), Informaworld, Informit Online and Ovid. Key search terms used were: adolescent, adventure therapy, at-risk, brain injury, cognitive rehabilitation, delinquent, head injury, paediatric, outdoor education, wilderness adventure therapy and youth. Main outcomes: Three articles that discuss the use of WAT with adult TBI cohorts were identified; no research reporting the use of WAT with an adolescent TBI cohort was located. The review highlighted theoretical and practice similarities between cognitive rehabilitation and WAT, with both proving to be examples of 'contextualized intervention'. The majority of WAT literature reported programmes aimed at at-risk and delinquent youth and, again, similarities in the difficulties experienced by these adolescents and adolescents with TBI were apparent. Conclusions: A trial study that investigates the application of WAT with adolescents with TBI is warranted. Outcomes for executive functioning skill development, self-esteem development and quality-of-life post-programme should be ascertained to compare with results from adult programmes.	[Shanahan, Lucie] S W Brain Injury Rehabil Serv, Kids Team, Albury, NSW 2640, Australia; [Shanahan, Lucie; Curtin, Michael] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia; [McAllister, Lindy] Univ Queensland, Sch Med, Herston, Qld, Australia		Shanahan, L (corresponding author), S W Brain Injury Rehabil Serv, Kids Team, POB 326, Albury, NSW 2640, Australia.	lucie.shanahan@gsahs.health.nsw.gov.au	McAllister, Lindy/C-8027-2009; Curtin, Michael/G-2650-2014	Curtin, Michael/0000-0002-2152-7501			Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ATTARIAN A, 1992, J PHYSICAL ED RECREA, V63, P56; Autry C. E., 2001, Therapeutic Recreation Journal, V35, P289; Bennett LW, 1998, J SUBST ABUSE TREAT, V15, P469, DOI 10.1016/S0740-5472(97)00222-5; Beringer A, 2004, INT J REHABIL RES, V27, P7, DOI 10.1097/00004356-200403000-00002; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Brand D., 2001, AUSTR J OUTDOOR ED, V6, P40; Brand D., 1999, AUSTR J OUTDOOR ED, V4, P40; Brown SA, 2001, HEAD TRAUMA, P349; Bruyere B., 2002, J EXPERIENTIAL ED, V25, P207, DOI DOI 10.1177/105382590202500104; CHAPMAN L, 2000, HORIZONS, V7, P32; CHAPMAN SB, 1999, ADV SPEECH LANGUAGE, V1, P19; Cho HS, 2005, J ABNORM CHILD PSYCH, V33, P363, DOI 10.1007/s10802-005-3574-4; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Colthart A., 1996, Youth Studies Australia, V15, P31; Davis-Berman J., 1994, J EXPERIENTIAL ED, V17, P49, DOI DOI 10.1177/105382599401700212; Douglas J., 2004, EVIDENCE BASED PRACT, P59; DRUIAN G, 1987, SCH IMPROVEMENT RES, P1; Epstein Iris, 2004, J Pediatr Oncol Nurs, V21, P103, DOI 10.1177/1043454203262684; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Flavell J.H., 1993, COGNITIVE DEV, V3rd ed.; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Fujii DE, 1996, PROF PSYCHOL-RES PR, V27, P266; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; GASS MA, 1993, ADVENTURE THERAPY TH; GILLETTE T, 1990, ADVENTURE ED, P17; GORDON WA, 1992, NEUROPSYCHOLOGY, V6, P361; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; ITIN CM, 1997, EXPLORING BOUNDARIES; Jelalian E, 2006, INT J OBESITY, V30, P31, DOI 10.1038/sj.ijo.0803069; Jordan BD, 2000, JAMA-J AM MED ASSOC, V283, P3123, DOI 10.1001/jama.283.23.3123; Kaptian J., 2003, AM J RECREATION THER, V2, P41; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; KRAFT RJ, 1995, EXPERIENTIAL LEARNIN; Lan P., 2004, AUSTR J OUTDOOR ED, V8, P37; Lemmon J., 1996, J COGNITIVE REHABILI, V14, P18; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Lugg A., 2004, AUSTR J OUTDOOR ED, V8, P4, DOI DOI 10.1007/BF03400790; MALKMUS DD, 1989, TOP LANG DISORD, V9, P50, DOI 10.1097/00011363-198903000-00006; Martin A., 2004, OUTDOOR EXPERIENTIAL; McKenzie M.D., 2003, J EXPERIENT EDUC, V26, P8, DOI [DOI 10.1177/105382590302600104, 10.1177/105382590302600104]; McLuhan M., 1994, UNDERSTANDING MEDIA; Miles J, 1990, ADVENTURE ED; NEILL J, 2006, HIST DEV ASPECTS ACA; NEILL J, 2004, OVERVIEW OUTDOOR ED; NEILL JT, 2003, J EXPERIENT EDUC, V25, P316, DOI DOI 10.1177/105382590302500305; NEWES SL, 2001, THESIS PENNSYLVANIA; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Priest S., 2001, J EXPERIENTIAL ED, V1, P34, DOI DOI 10.1177/105382590102400108; PRIEST S, 1990, ADVENTURE ED, pR13; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROSOL M., 2000, PARKS RECREATION, V35, P42; Russell, 2003, J EXPERIENTIAL ED, V25, P322, DOI DOI 10.1177/105382590302500306; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Thomas M, 2004, BRAIN INJURY, V18, P1271, DOI 10.1080/02699050410001698776; VALLETUTTI PJ, 1992, COGNITIVE DEV FUNCTI; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Walker AJ, 2005, BRAIN INJURY, V19, P1237, DOI 10.1080/02699050500309411; WALSH V, 1976, EXPLORATION OUTWARD; Weston R., 1999, PARKS RECREATION, V34, P30; WHO, REH; WILLIAMS B, 2000, J CHILD ADOLESCENT G, V0010, P00047, DOI DOI 10.1023/A:1009456511437; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	77	9	9	3	33	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	13-14					1054	1064		10.3109/02699050903421115			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	529YR	WOS:000272556000007	19909053				2022-02-06	
J	Wen, L; Wan, S; Zhan, RY; Li, G; Gong, JB; Liu, WG; Yang, XF				Wen, L.; Wan, S.; Zhan, R. Y.; Li, G.; Gong, J. B.; Liu, W. G.; Yang, X. F.			Shunt implantation in a special sub-group of post-traumatic hydrocephaluspatients have normal intracranial pressure without clinical representations of hydrocephalus	BRAIN INJURY			English	Article						Post-traumatic hydrocephalus; prognostic factor; shunt implantation		Background: Post-traumatic hydrocephalus (PTH) is a frequent complication secondary to traumatic brain injury (TBI) and controversy remains over whether to perform a shunt placement for patients with normal pressure hydrocephalus when the patient is too injured to display symptoms or has atypical symptoms. Method: A hospital-based retrospective study was performed in patients who developed normal pressure hydrocephalus, without atypical symptoms, from January 2004 to June 2007. Information regarding patients' demographics, TBI, hydrocephalus and outcome was collected. Results: A total of 31 patients were involved in this study. At the 12-month follow-up, 20 patients (64.5%) showed clear improvement. Among the 10 patients who developed PTH after decompressive craniectomy, cranioplasty was performed after shunt implantation and clinical improvement was observed in nine patients. Additionally, in this series, the patients' age and the severity of hydrocephalus, assessed by CT imaging before shunt placement, significantly correlated with improvement. Conclusion: Although the effect was not definitively established, many patients in the sub-group of PTH patients described here would benefit from shunt placement, especially when they simultaneously have large cranial defects after surgical decompression and underwent cranioplasties after shunt placement. Additionally, younger patients and those with less severe hydrocephalus before shunt placement may expect a better outcome after shunt placement.	[Wen, L.; Wan, S.; Zhan, R. Y.; Li, G.; Gong, J. B.; Yang, X. F.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, W. G.] Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Wen, L.; Wan, S.; Zhan, R. Y.; Li, G.; Gong, J. B.; Liu, W. G.; Yang, X. F.] Zhejiang Univ, Coll Med, Inst Brain Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchn Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com					BELLONI G, 1976, ACTA NEUROCHIR, V33, P1, DOI 10.1007/BF01405737; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Guyot LL, 2000, NEUROL RES, V22, P25; Hong Z, 2006, CHINESE J NEUROMEDIC, V5, P1238; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Li G, 2008, BRAIN INJURY, V22, P333, DOI 10.1080/02699050801958353; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Miki T, 2006, J TRAUMA, V61, P985, DOI 10.1097/01.ta.0000239665.39237.8c; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	12	9	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	1					61	64	PII 908196484	10.1080/02699050802635265			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	399FY	WOS:000262787000011	19172451				2022-02-06	
J	Wilson, FC; Wheatley-Smith, L; Downes, C				Wilson, F. Colin; Wheatley-Smith, Laura; Downes, Ciara			Analysis of intensive outpatient neuro-rehabilitation outcomes using FIM+FAM(UK)	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; FIM; FAM	Objective: To analyse the functional outcomes of adults following acquired brain injury attending an intensive outpatient neuro-rehabilitation programme relative to a comprehensive TBI day programme service in the United States. Method: Design: Retrospective audit of all admissions over a two-year period (2001-2003) to an outpatient neuro-rehabilitation service utilising an interdisciplinary team model. Setting: Outpatient neuro-rehabilitation service. Participants: 89 patients in receipt of 2+ therapies attending for intensive day neuro-rehabilitation programme. Main Outcome Measures: Routine FIM+FAM(UK) scores were compiled on admission and discharge. The FIM+FAMUK is a widely employed outcome measure of activity and participation comprising 30 items across a range of domains including self care, domestic skills, mobility, communication, cognitive and social abilities. The scale is divided into two broad domains of functioning (motor and cognitive). Data Analysis: Descriptive analysis of demographic, patient diagnosis, referral patterns and time since injury to attendance was undertaken. Analysis of FIM+FAM(UK) admission and discharge scores was performed. Results: Complete admission and discharge scores were available for 65 patients. Significant mean improvements in motor (12.0 point change), cognitive (7.3 point change) and composite FIM+FAM(UK) (19.3 point change) scores were observed indicating reduced functional dependence following an intensive period of outpatient neuro-rehabilitation. Conclusion: The FIM+FAM(UK) measure demonstrated sensitivity to change across functional domains relevant to goal directed intensive outpatient interdisciplinary neuro-rehabilitation.	[Wilson, F. Colin; Wheatley-Smith, Laura] Belfast Hlth & Social Care Trust, Musgrave Pk Hosp, Reg Acquired Brain Injury Unit, Belfast BT9 7JB, Antrim, North Ireland; [Downes, Ciara] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland		Wilson, FC (corresponding author), Belfast Hlth & Social Care Trust, Musgrave Pk Hosp, Reg Acquired Brain Injury Unit, Stockmans Lane, Belfast BT9 7JB, Antrim, North Ireland.	colin.wilson@belfasttrust.hscni.net	Viani, Rafael/V-1196-2018				Bajo A, 1999, NEUROPSYCHOL REHABIL, V9, P413, DOI 10.1080/096020199389473; Beckers K, 1999, NEUROPSYCHOL REHABIL, V9, P437, DOI 10.1080/096020199389491; FLEMINGER S, 1999, EVALUATION OUTCOMES; Gill-Thwaites H, 1999, NEUROPSYCHOL REHABIL, V9, P305, DOI 10.1080/096020199389392; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; KONIGZAHN C, 1997, CROSS CULTURAL HLTH, P48; Mahoney F, 1965, MD STATE MED J, V14, P62; Powell J, 1999, NEUROPSYCHOL REHABIL, V9, P457, DOI 10.1080/096020199389518; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Shiel A, 2000, WESSEX HEAD INJURY M; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; TURNERSTOKES L, 2006, REHABILITATION FOLLO; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	20	9	9	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2009	24	4					377	382		10.3233/NRE-2009-0492			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	481VH	WOS:000268839800011	19597276				2022-02-06	
J	Eleuteri, S; Polazzi, E; Contestabile, A				Eleuteri, Simona; Polazzi, Elisabetta; Contestabile, Antonio			Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells	NEUROSCIENCE LETTERS			English	Article						Microglia; Cerebellar granule cells; Neurodegeneration; Neuroprotection; Neuron-microglia interactions	CENTRAL-NERVOUS-SYSTEM; NEURONAL APOPTOSIS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; BRAIN; DIFFERENTIATION; NEUROPATHOLOGY; MACROPHAGES; INHIBITION	Microglia, the immune cells of the mammalian CNS, have often been indicated as dangerous effector cells for their activation in response to traumatic CNS injuries or immunological stimuli and for their involvement in many chronic neurodegenerative diseases. Recently, several in vitro and in vivo studies have emphasized that microglial activity is essential in promoting neuronal survival. We have tested the efficacy of media directly conditioned by microglia or conditioned by microglia after having been exposed to apoptotic neurons, towards neuroprotection of rat cerebellar granule cells (CGCs) challenged with staurosporine or glutamate. Apoptotic death of CGC caused by staurosporine, as well as by a mild excitotoxic stimulus delivered through sub-chronic glutamate treatment, was significantly counteracted by microglia conditioned media. On the other hand, an acute excitotoxic insult delivered through a short pulse of glutamate exposure in the absence of magnesium and resulting in a mix of apoptotic and necrotic death was only marginally counteracted by microglia conditioned media. The present results extend the available information regarding the neuroprotective role of microglia and support the usefulness of employing the culture approach for perspective identification of neuroprotective factors released by these cells. Furthermore, the use of media previously exposed to apoptotic neurons to elicit the neuroprotective response of microglia, indicate the feasibility to re-create also in the isolated culture conditions, at least some of the elements at the basis of neuron/microglia cross-talk. (c) 2008 Elsevier Ireland Ltd. All rights reserved.	[Eleuteri, Simona; Polazzi, Elisabetta; Contestabile, Antonio] Univ Bologna, Dept Biol, I-40126 Bologna, Italy		Contestabile, A (corresponding author), Univ Bologna, Dept Biol, Via Selmi 3, I-40126 Bologna, Italy.	antonio.contestabile@unibo.it			Italian Ministry for Universities and ResearchMinistry of Education, Universities and Research (MIUR); Institute for Advanced Studies of the University of Bologna	The present research was supported by grants from the Italian Ministry for Universities and Research and from the Institute for Advanced Studies of the University of Bologna to A.C.	Aihara N, 2000, GENES CELLS, V5, P397, DOI 10.1046/j.1365-2443.2000.00333.x; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Ciani E, 1996, BRAIN RES, V728, P1; Combrinck MI, 2002, NEUROSCIENCE, V112, P7, DOI 10.1016/S0306-4522(02)00030-1; Franco-Cea A, 2004, NEUROCHEM RES, V29, P227, DOI 10.1023/B:NERE.0000010501.25627.0f; GALLO V, 1987, J NEUROSCI, V7, P2203; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lazarov-Spiegler O, 1998, GLIA, V24, P329, DOI 10.1002/(SICI)1098-1136(199811)24:3<329::AID-GLIA7>3.0.CO;2-X; Lehrmann E, 1998, GLIA, V24, P437, DOI 10.1002/(SICI)1098-1136(199812)24:4<437::AID-GLIA9>3.0.CO;2-X; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; LEVI G, 1993, CLIN NEUROPATHOL, V12, P290; Melchiorri D, 2002, CELL DEATH DIFFER, V9, P609, DOI 10.1038/sj.cdd.4401020; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monti B, 2001, NEUROCHEM INT, V39, P11, DOI 10.1016/S0197-0186(01)00005-5; Navascues J, 2000, AN ACAD BRAS CIENC, V72, P91, DOI 10.1590/S0001-37652000000100013; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Polazzi E, 2001, GLIA, V36, P271, DOI 10.1002/glia.1115; Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7; Rezaie P, 1997, DEV BRAIN RES, V104, P175; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Saab CY, 2008, BRAIN RES REV, V58, P226, DOI 10.1016/j.brainresrev.2008.04.002; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schwab JM, 2004, CELL DEATH DIFFER, V11, P1245, DOI 10.1038/sj.cdd.4401487; Slagsvold HH, 2000, EXP BRAIN RES, V135, P173, DOI 10.1007/s002210000521; Toku K, 1998, J NEUROSCI RES, V53, P415, DOI 10.1002/(SICI)1097-4547(19980815)53:4<415::AID-JNR3>3.0.CO;2-9; Xiang Z, 2006, DIS MARKERS, V22, P95, DOI 10.1155/2006/276239; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	39	9	9	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	DEC 19	2008	448	1					74	78		10.1016/j.neulet.2008.09.033			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	381RO	WOS:000261553800017	18950681				2022-02-06	
J	Chua, K; Kong, KH; Chan, SP				Chua, Karen; Kong, Keng He; Chan, Siew Pang			Prevalence and Risk Factors of Asymptomatic Lower Extremity Deep Venous Thrombosis in Asian Neurorehabilitation Admissions in Singapore	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation; Stroke; Subarachnoid hemorrhage; Venous thromboembolism	VEIN-THROMBOSIS; BRAIN-INJURY; ISCHEMIC-STROKE; REHABILITATION; THROMBOEMBOLISM	Objective: To determine the local prevalence and risk factors of asymptomatic lower limb deep venous thrombosis (DVT) among neurorehabilitation admissions. Design: A prospective observational single-center Study. Setting: Tertiary rehabilitation center affiliated to a public hospital. Participants: A total of 419 Asian neurorehabilitation admissions with a mean of 26 days to rehabilitation. Intervention: Admission screening protocol included quantitative D-dimer assay within 24 to 48 hours of rehabilitation admission and targeted hemiplegic/weaker lower-extremity venous duplex Ultrasonography was performed if D-dimer assay level was elevated at 0.34 mu g/mL or higher. Main Outcome Measures: There were 251 (59.9%) men. and the Subjects were predominantly Chinese (76.6%). Subjects had a mean age of 59 +/- 15 years. Admitting, diagnoses included ischemic stroke (2 12), hemorrhagic stroke and subarachnoid hemorrhage (129), traumatic brain injury (59), and nontraumatic brain injury (19). The screening protocol included it quantitative D-dimer assay within 24 to 48 hours of rehabilitation admission, and hemipleaic/weaker lower-extremity venous duplex ultrasonography was performed if D-dimer assay level was elevated at 0.34 mu g/mL or higher. Results: Altogcther, 247 (58.9%) patients had an elevated D-dimer assay, and all underwent venous duplex ultrasonography. The incidence of lower-limb DVT was 5.01% (21). including 11 proximal and 10 distal DVT. No patients had clinical pulmonary embolism. Using 247 venous duplex ultrasonography results for analyses of correlates with logistic regression analyses, no significant demographic or clinical predictive factors for DVT were found. Conclusions: This Study confirms that asymptomatic lower limb DVT is indeed uncommon in Asian neurorehabilitation admissions. Possible reasons include genetic or ethnic protective factors, early walking initiated at rehabilitation. and timing of the admission protocol (median of 14 days postevent) when the maximal thrombotic risk was on the decline.	[Chua, Karen; Kong, Keng He] Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore; [Chan, Siew Pang] Tan Tock Seng Hosp, Clin Res Unit, Singapore 569766, Singapore		Chua, K (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mo Kio Ave 9, Singapore 569766, Singapore.	Karen_Chua@ttsh.com.sg					Akman MN, 2004, ARCH PHYS MED REHAB, V85, P1091, DOI 10.1016/j.apmr.2003.10.023; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; De Silva DA, 2006, CEREBROVASC DIS, V22, P245, DOI 10.1159/000094011; FRASER D, 2000, VESSEL WMI MECH MORP; Gallus AS, 2002, ANN ACAD MED SINGAP, V31, P685; Harvey RL, 1996, STROKE, V27, P1516, DOI 10.1161/01.STR.27.9.1516; Kelly J, 2004, STROKE, V35, P2320, DOI 10.1161/01.STR.0000140741.13279.4f; Kelly J, 2004, J THROMB HAEMOST, V2, P1321, DOI 10.1111/j.1538-7836.2004.00843.x; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; Kumar K., 2002, SMJ Singapore Medical Journal, V43, P345; Lee LH, 2002, ANN ACAD MED SINGAP, V31, P761; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; OCZKOWSKI WJ, 1992, ARCH PHYS MED REHAB, V73, P712; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Sachdev Ulka, 2006, Vasc Endovascular Surg, V40, P205, DOI 10.1177/153857440604000305; SIOSON ER, 1988, ARCH PHYS MED REHAB, V69, P183; SUN KK, 2004, ZHONGHUA LIU XING BI, V25, P1010; TSO SC, 1980, AUST NZ J MED, V10, P513, DOI 10.1111/j.1445-5994.1980.tb04968.x; WARLOW C, 1972, LANCET, V1, P1305; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006; Wright J, 2000, FIM TM; Yablon SA, 2004, NEUROLOGY, V63, P485, DOI 10.1212/01.WNL.0000133009.24727.9F; 2007, POPULATION HLTH FACT	26	9	9	2	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2008	89	12					2316	2323		10.1016/j.apmr.2008.05.025			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	385GY	WOS:000261803900013	19061744				2022-02-06	
J	Elf, K; Nilsson, P; Ronne-Engstrom, E; Howells, T; Enblad, P				Elf, Kristin; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per			Temperature disturbances in traumatic brain injury: relationship to secondary insults, barbiturate treatment and outcome	NEUROLOGICAL RESEARCH			English	Article						Head injury; neurointensive care; outcome; secondary insults; temperature	ACUTE CEREBRAL-DAMAGE; SEVERE HEAD-INJURY; INTENSIVE-CARE; INTRACRANIAL-PRESSURE; NEUROINTENSIVE CARE; NITRIC-OXIDE; HYPOTHERMIA; THERAPY; HYPERTENSION; HYPERTHERMIA	Objectives: To describe the occurrence of spontaneous hyper- and hypothermia in patients with traumatic brain injury using a computerized data collecting system, to show how temperature correlates with other secondary insults, to describe how temperature affects outcome and to show how barbiturate treatment influences those analyses. Methods: Patients with >= 54 hours of valid monitoring within the first 120 hours after trauma (one value/min) for temperature, intracranial pressure, cerebral perfusion pressure, systolic blood pressure, mean blood pressure and heart rate were included. Correlation analyses were performed between temperature and other secondary insult variables. The non-linear relationship between temperature and outcome (measured by Glasgow outcome scale 6 months post-trauma) was illustrated using a neural network. Results: Of the 53 patients, 44 experienced hyperthermia (>38 degrees C) and 29 experienced hypothermia (<36 degrees C). Hyperthermia correlated with occurrence of high blood pressure and high CPP. In individuals, hyperthermia also correlated with ICP and tachycardia. There was a trend towards better outcome for patients with normal temperature than those with hyper- or hypothermia (favorable outcome 64% versus 29 and 33% respectively). When patients treated with barbiturates were excluded, 60% showed favorable outcome in the hypothermia group as well. Barbiturate treatment also confounded analyses regarding temperature and other secondary insults. Discussion: Patients with hyperthermia, hypertension, high CPP and tachycardia may suffer from a hyperdynamic state. This may worsen outcome and hence clinical awareness is important. Barbiturate treatment confounds several analyses which have not been shown before. We recommend those patients to be analysed separately in future studies. [Neurol Res 2008; 30: 1097-1105]	[Elf, Kristin; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per] Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, S-75185 Uppsala, Sweden		Enblad, P (corresponding author), Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, S-75185 Uppsala, Sweden.	Per.Enblad@neurokir.uu.se			The Anna-Stina and John Mattson foundation; The Laerdal Foundation for Acute Medicine; The Swedish Research CouncilSwedish Research Council [2002/A0799]	The authors are thankful to all our colleagues at the Department of Neurosurgery and all the staff at the NIC unit for their skill and concern for the patients. The Anna-Stina and John Mattson foundation, The Laerdal Foundation for Acute Medicine and The Swedish Research Council are also acknowledged (grant no. 2002/A0799).	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Alm P, 2000, AMINO ACIDS, V19, P383, DOI 10.1007/s007260070069; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; COOPER PR, 2000, HEAD INJURY, P239; Cormio M, 2000, INTENS CARE MED, V26, P552, DOI 10.1007/s001340051203; CORRIE J, 1993, BRIT J INTENSIVE CAR, V6, P225; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elf K, 2003, EUR J TRAUMA, V29, P74; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Majetschak M, 2000, J TRAUMA, V48, P832, DOI 10.1097/00005373-200005000-00006; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Neal R., 1996, LECT NOTES STAT, V118; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Signorini DF, 1997, CRIT CARE MED, V25, P2048, DOI 10.1097/00003246-199712000-00024; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; TRAEGER SM, 1983, CRIT CARE MED, V11, P697, DOI 10.1097/00003246-198309000-00005; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	37	9	10	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2008	30	10					1097	1105		10.1179/174313208X319125			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	402PF	WOS:000263024900015	19079982				2022-02-06	
J	Huang, WD; Pan, J; Xu, M; Su, W; Lu, YQ; Chen, ZJ; Jiang, TY; Yang, YM				Huang, W. D.; Pan, J.; Xu, M.; Su, W.; Lu, Y. Q.; Chen, Z. J.; Jiang, T. Y.; Yang, Y. M.			Changes and effects of plasma arginine vasopressin in traumatic brain injury	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Arginine vasopressin; Glasgow Coma Scale; Glasgow Outcome Scale; neuroendocrinology; traumatic brain injury	SUBARACHNOID HEMORRHAGE; PRACTICAL SCALE; V-1 RECEPTOR; SPINAL-CORD; WATER; EDEMA; VASOCONSTRICTION; ENDOTHELIN; PEPTIDES; VOLUME	Background: Traumatic brain injury (TBI) is a common disease accompanied by chronic morbidity and mortality. The pathological mechanism and effective pharmacological treatments of TBI remain undetermined. It is suggested that AVP is involved in TBI. It is thus interesting to investigate the changes and effects of plasma AVP in clinical trials. Methods: The serum concentrations of AVP, serum electrolytes, and serum osmolarity in a total of 23 TBI patients were dynamically monitored (on admission, Day 1, Day 3, and Day 5). Relationship between AVP and severity of brain injury and functional outcome were evaluated, respectively. Results: The mean AVP serum concentrations in the TBI group were significantly higher than those recorded in the control (CTRL) group on intensive care unit (ICU) admission and Day 1 (p<0.05). On Day 3 and Day 5, the differences between those groups were not significant (p>0.05). The negative correlations were found between sodium and AVP (r=-0.35; p<0.05) and between osmolarity and AVP (r=-0.42; p<0.05). In poor outcome group, the mean AVP serum concentrations were significantly higher than in good outcome group and CTRL group (p<0.05). A statistically significant correlation was also found between AVP on ICU admission and the initial Glasgow Coma Scale (r=0.47; p<0.05). Conclusion: We suggest that AVP is involved in the pathophysiology process of secondary brain damage after TBI. It seems that AVP antagonist is a promising target for the treatment of TBI, while further studies should be carried out. (J. Endocrinol. Invest. 31: 996-1000, 2008) (C) 2008, Editrice Kurtis	[Huang, W. D.; Pan, J.; Lu, Y. Q.; Yang, Y. M.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Emergency, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, M.; Su, W.] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Z. J.; Jiang, T. Y.] Inst Radio Immunol Ctr, Hangzhou, Zhejiang, Peoples R China		Yang, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Geriatr, 79Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	huangweidorg2003@hotmail.com			Department of Science and Technology Zhejiang Province, China [2004C33048]	This study was supported by grants from the Department of Science and Technology Zhejiang Province, China (No. 2004C33048).	Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Armstead WM, 2001, STROKE, V32, P1408, DOI 10.1161/01.STR.32.6.1408; BUIJS RM, 1978, CELL TISSUE RES, V192, P423, DOI 10.1007/bf00224932; DOCZI T, 1982, NEUROSURGERY, V11, P402; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Hertz L, 2000, J NEUROSCI RES, V62, P480, DOI 10.1002/1097-4547(20001115)62:4<480::AID-JNR2>3.0.CO;2-K; HOSLI L, 1991, NEUROSCI LETT, V131, P193, DOI 10.1016/0304-3940(91)90611-V; Huang W, 2001, Chin J Traumatol, V4, P161; Ikeda Y, 1997, ACTA NEUROCHIR, V139, P1166, DOI 10.1007/BF01410978; ISOTANI E, 1994, STROKE, V25, P2198, DOI 10.1161/01.STR.25.11.2198; JENNETT B, 1975, LANCET, V1, P480; Jochberger S, 2006, CRIT CARE MED, V34, P293, DOI 10.1097/01.CCM.0000198528.56397.4F; Johanson CE, 1999, AM J PHYSIOL-CELL PH, V276, pC82; LASZLO FA, 1995, ACTA NEUROCHIR, V133, P122, DOI 10.1007/BF01420062; LLUCH S, 1984, J PHARMACOL EXP THER, V228, P749; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; REEDER RF, 1986, J NEUROSURG, V64, P941, DOI 10.3171/jns.1986.64.6.0941; ROBINSON ICAF, 1983, PROG BRAIN RES, V60, P129; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sarfaraz D, 1999, AM J PHYSIOL-ENDOC M, V276, pE596, DOI 10.1152/ajpendo.1999.276.3.E596; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; TEASDALE G, 1974, LANCET, V2, P81; Thibonnier M, 2002, PROG BRAIN RES, V139, P179; Westermann I, 2007, SHOCK, V28, P644, DOI 10.1097/shk.0b013e3180cab33f	29	9	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	NOV	2008	31	11					996	1000		10.1007/BF03345638			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	401CQ	WOS:000262916300010	19169056				2022-02-06	
J	Stoikes, NF; Magnotti, LJ; Hodges, TM; Weinberg, JA; Schroeppel, TJ; Savage, SA; Fischer, PE; Fabian, TC; Croce, MA				Stoikes, Nathaniel F.; Magnotti, Louis J.; Hodges, Timothy M.; Weinberg, Jordan A.; Schroeppel, Thomas J.; Savage, Stephanie A.; Fischer, Peter E.; Fabian, Timothy C.; Croce, Martin A.			Impact of Intracranial Pressure Monitor Prophylaxis on Central Nervous System Infections and Bacterial Multi-Drug Resistance	SURGICAL INFECTIONS			English	Article								Background: Routine intracranial pressure monitor (ICP) prophylaxis is not practiced at our institution. Nevertheless, some patients receive de facto prophylaxis as a result of the use of antibiotics for injuries such as open or facial fractures. We tested the hypothesis that prophylactic antibiotics do not reduce the incidence of central nervous system (CNS) infections but instead are associated with the acquisition of multi-drug resistant (MDR) bacterial infections. Methods: Patients admitted to the trauma intensive care unit (TICU) from January, 2001 through December, 2004 with blunt, non-operative traumatic brain injury who were managed solely with an ICP monitor were identified from our trauma registry and divided into two groups: (1) Those receiving no antibiotics prior to or during ICP monitoring (NONE; n = 71); and (2) those already receiving antibiotics at the time of ICP monitor insertion (PRO; n = 84). Groups were stratified on the basis of age, Injury Severity Score (ISS), Glasgow Coma Scale (GCS) Score, base excess (BE), ICP days, transfusions in 24 h, ICU days, ventilator days, head Abbreviated Injury Score (NIS), and chest NIS. The study groups did not differ with respect to age, ISS, GCS, BE, ICP days, 24-h transfusions, ICU days, ventilator days, head AIS, or length of stay. In all, 183 patients were identified, of whom 28 died within seven days and were excluded from the analysis. All patients were followed until discharge for both CNS infections and subsequent infectious complications. Results: Only two patients, both in the PRO group, developed CNS infection. Both infectious complications (0.7 vs 1.4 per patient; p < 0.05) and infections secondary to MDR pathogens (0.03 vs. 0.33 per patient; p < 0.01) were significantly more common in the PRO group. Twenty-nine percent of the ventilator-associated pneumonias and 33% of the blood stream infections in the PRO group were MDR, whereas only two blood stream infections in the NONE group (4% of the total infections) were MDR. Conclusions: The routine use of prophylactic antibiotics for ICP monitor insertion is not warranted. This practice does not reduce the CNS infection rate and is associated with more MDR pathogens in any subsequent infectious complications.	[Stoikes, Nathaniel F.; Magnotti, Louis J.; Hodges, Timothy M.; Weinberg, Jordan A.; Schroeppel, Thomas J.; Savage, Stephanie A.; Fischer, Peter E.; Fabian, Timothy C.; Croce, Martin A.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA		Magnotti, LJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, 956 Court Ave,A210, Memphis, TN 38163 USA.	lmagnott@utmem.edu		Schroeppel, Thomas/0000-0001-9164-5004			BLOMSTEDT GC, 1985, J NEUROSURG, V62, P694, DOI 10.3171/jns.1985.62.5.0694; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CHOLE RA, 1987, ARCH OTOLARYNGOL, V113, P1055; Croce MA, 2001, AM SURGEON, V67, P105; DJINDJIAN M, 1990, J NEUROSURG, V73, P383, DOI 10.3171/jns.1990.73.3.0383; FLANAGAN PP, 1997, C NEUR SURG NEW ORL; Flibotte JJ, 2004, NEUROCRIT CARE, V1, P61, DOI 10.1385/NCC:1:1:61; Hartmann B, 2004, CLIN THER, V26, P915, DOI 10.1016/S0149-2918(04)90135-X; Hauser Carl J, 2006, Surg Infect (Larchmt), V7, P379; Hawkey PM, 2000, INTENS CARE MED, V26, pS9, DOI 10.1007/s001340051112; Hoth JJ, 2003, J TRAUMA, V55, P249, DOI 10.1097/01.TA.0000083334.93868.65; Jacobs DG, 1998, J NATL MED ASSOC, V90, P417; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; Martin C, 2005, AM J HEALTH-SYST PH, V62, P732, DOI 10.1093/ajhp/62.7.732; May Addison K, 2006, Surg Infect (Larchmt), V7, P409, DOI 10.1089/sur.2006.7.409; Prabhu VC, 1999, SURG NEUROL, V52, P226, DOI 10.1016/S0090-3019(99)00084-1; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; WILKINS J, 1991, ORTHOP CLIN N AM, V22, P433	19	9	11	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964	1557-8674		SURG INFECT	Surg. Infect.	OCT	2008	9	5					503	508		10.1089/sur.2007.032			6	Infectious Diseases; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Surgery	V12GV	WOS:000207588600003	18687046				2022-02-06	
J	Acerini, CL; Tasker, RC				Acerini, Carlo L.; Tasker, Robert C.			Neuroendocrine consequences of traumatic brain injury	JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM			English	Article						traumatic brain injury (TBI); hypopituitarism; pituitary dysfunction; rehabilitation; endocrine assessment; children; adolescents	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY DYSFUNCTION; SEVERE HEAD-INJURY; LONG-TERM; POSTTRAUMATIC HYPOPITUITARISM; ACUTE-PHASE; CHILDREN; ABNORMALITIES; ADOLESCENTS; PREVALENCE	Severe to moderate traumatic brain injury (TBI) is associated with a high frequency of morbidity in survivors. The pituitary gland is vulnerable to damage following TBI and long-term neuroendocrine dysfunction is a potential complication. Until recently little has been known about the natural history, presentation and characteristics of hypothalamic-pituitary dysfunction following TBI. This article reviews the emerging body of contemporary data from adult survivors of TBI, which suggests that the prevalence! of pituitary hormone problems following head injury may be much more common than previously thought. We also review the epidemiology of childhood TBI and historical case reports that show that pituitary dysfunction has been observed to occur after both mild and severe TBI and may not present clinically until many years after the event. A recent analysis of a large paediatric growth hormone (GH) deficiency patient database highlights fewer than expected registered cases of TBI-related GH deficiency, suggesting that this may be an overlooked phenomenon. This hypothesis is supported by recently published data from the first systematic studies to be carried out in the childhood TBI setting. Given the critical role of anterior pituitary hormones in the regulation of growth and pubertal and neurocognitive development in childhood, early detection of hormone abnormalities is important. We propose that a multidisciplinary approach to follow-up and endocrine assessment is required for the long-term management and rehabilitation of children and adolescents who survive moderate to severe head injury.	[Acerini, Carlo L.; Tasker, Robert C.] Univ Cambridge, Dept Paediat, Cambridge CB2 1TN, England		Acerini, CL (corresponding author), Addenbrookes Hosp, Dept Paediat, Level 8 Box 116, Cambridge CB2 2QQ, England.	cla22@cam.ac.uk	Tasker, Robert C/R-5837-2019	Acerini, Carlo/0000-0003-2121-5871; Tasker, Robert/0000-0003-3647-8113			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BARZILAY Z, 1988, J MED, V19, P47; Benoit R, 2000, J TRAUMA, V49, P477, DOI 10.1097/00005373-200009000-00015; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; DANIEL PM, 1959, LANCET, V2, P927; Della Corte F, 1998, CRIT CARE MED, V26, P1419; EDWARDS OM, 1986, MEDICINE, V65, P281; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mariani R, 1996, ARCH PEDIATRIE, V3, P796, DOI 10.1016/0929-693X(96)82164-6; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; MILLER WL, 1980, NEW ENGL J MED, V302, P724, DOI 10.1056/NEJM198003273021305; Mooney DP, 2004, J TRAUMA, V57, P1241, DOI 10.1097/01.TA.0000106694.75576.69; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; SURTEES R, 1987, HORM RES, V28, P5, DOI 10.1159/000180918; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001	44	9	9	0	9	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-018X	2191-0251		J PEDIATR ENDOCR MET	J. Pediatr. Endocrinol. Metab.	JUL	2008	21	7					611	619					9	Endocrinology & Metabolism; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Pediatrics	344OX	WOS:000258938300002	18780593				2022-02-06	
J	Colombo, CJ; Mount, CA; Popa, CA				Colombo, Christopher J.; Mount, Cristin A.; Popa, Christian A.			Critical care medicine at Walter Reed Army Medical Center in support of the global war on terrorism	CRITICAL CARE MEDICINE			English	Article						military medicine; critical care; intensive care unit; military medical history; Acinetobacter; traumatic brain injury; intensive care; Walter Reed; trauma; posttraumatic stress disorder; history of Walter Reed Army Medical Center	MULTIDRUG-RESISTANT ACINETOBACTER; VENTILATOR-ASSOCIATED PNEUMONIA; VENOUS THROMBOEMBOLISM; PREVENTION; POSITION; INJURY	Background. The military medical experience during wartime is unique and distinct from civilian medical practice. Historically, the military has produced innovations resulting in both civilian and military medical care advances, and our current conflict is no different. In this article, we provide a description of the medical and surgical intensive care units at Walter Reed, their history, and approach to new issues encountered in the care of Operation Iraqi Freedom and Operation Enduring Freedom soldiers. Additionally, descriptive statistics regarding the number of Operation Iraqi Freedom and Operation Enduring Freedom soldiers admitted to the critical care service, basic demographics, general category of injury, and discussion of intensive care unit issues unique to this patient population, such as Acinetobacter and traumatic brain injury, are presented. Discussion: We intend to provide a general description of our Operation Iraqi Freedom/Operation Enduring Freedom trauma population cared for by the critical care service at Walter Reed Army Medical Center, as well as a discussion of our approach to caring for some of their unique issues, to detail experiences that could translate into improvements for civilian trauma centers.	[Colombo, Christopher J.; Mount, Cristin A.; Popa, Christian A.] Walter Reed Army Med Ctr, Washington, DC 20307 USA		Colombo, CJ (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.	colombocj@aol.com	Mount, Cristin A./ABD-8115-2020	Colombo, Christopher/0000-0001-5499-3368			Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Hawley JS, 2007, ANTIMICROB AGENTS CH, V51, P376, DOI 10.1128/AAC.00858-06; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; van Nieuwenhoven CA, 2006, CRIT CARE MED, V34, P396, DOI 10.1097/01.CCM.0000198529.76602.5E; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021; WEED FW, 1923, MED DEP US ARMY WORL, V5	13	9	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2008	36	7		S			S388	S394		10.1097/CCM.0b013e31817e3236			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324AU	WOS:000257490700020	18594268				2022-02-06	
J	Feng, D; Zhang, Y; Chen, G				Feng, D.; Zhang, Y.; Chen, G.			Cortical expression of peroxisome proliferator-activated receptor-alpha after human brain contusion	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						traumatic brain injury (TBI); brain contusion; peroxisome proliferator-activated receptor-alpha (PPAR-alpha); human brain	NF-KAPPA-B; FENOFIBRATE; INDUCTION; AGONIST; INJURY	Recent studies have demonstrated that peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonists can protect the brain against excessive oxidative stress and inflammation in traumatic brain injury (TBI) and stroke through endogenous PPAR-alpha. However, it has not been investigated whether, and to what degree, cerebral expression of PPAR-a changes after TBI, especially in the human brain. In this study, 12 contused brain samples were obtained from 11 patients undergoing surgery for TBI 6 - 98 h after trauma. PPAR-alpha binding activity was measured by electrophoretic mobility shift assay, and temporal and cellular expression of PPAR-alpha by immunohistochemistry. The results showed that a persistent upregulation of PPAR-alpha binding activity and protein expression occurred in injured cortex after TBI, which peaked 24 - 72 h post-injury. Expression of PPAR-alpha was mainly located in glial and vascular endothelial cells with a little expression in the neurons. It is concluded that TBI could greatly upregulate the binding activity and protein expression of PPAR-alpha in injured human brain, which might be important in brain pathophysiology after TBI.	[Feng, D.; Chen, G.] Southeast Univ, Dept Neurosurg, Jiangyin Hosp, Sch Med, Jiangyin 214400, Peoples R China; [Zhang, Y.] Southeast Univ, Dept Radiol, Jiangyin Hosp, Sch Med, Jiangyin 214400, Peoples R China		Feng, D (corresponding author), Southeast Univ, Dept Neurosurg, Jiangyin Hosp, Sch Med, 163 Shoushan Rd, Jiangyin 214400, Peoples R China.	jeanne88@163.com					Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; Everett L, 2000, LIVER, V20, P191, DOI 10.1034/j.1600-0676.2000.020003191.x; Genovese T, 2005, EXP NEUROL, V194, P267, DOI 10.1016/j.expneurol.2005.03.003; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; HUGHES P, 1995, PHARMACOL REV, V47, P133; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Messersmith DJ, 1998, MOL BRAIN RES, V53, P259, DOI 10.1016/S0169-328X(97)00308-2; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N	18	9	9	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	JUL-AUG	2008	36	4					783	791		10.1177/147323000803600421			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	336FG	WOS:000258349100021	18652775	Bronze			2022-02-06	
J	Gautschi, OP; Cadosch, D; Bauer, S; Filgueira, L; Zellweger, R				Gautschi, O. P.; Cadosch, D.; Bauer, S.; Filgueira, L.; Zellweger, R.			Heterotopic ossification - from the aetiology to the current management	UNFALLCHIRURG			German	Article						heterotopic ossification; heterotopic bone formation; osteogenesis; bone metabolism	TOTAL HIP-ARTHROPLASTY; SPINAL-CORD-INJURY; BONE-FORMATION; RANDOMIZED-TRIALS; HEAD-INJURY; PREVENTION; INDOMETHACIN; IRRADIATION; RADIATION; THERAPY	Heterotopic ossifications (HO) are defined as the abnormal formation of bone in soft tissues. It can be classified into acquired and congenital forms. The acquired form, of which the pathogenesis is not fully understood, is often diagnosed in patients with traumatic brain injury, spinal cord injury, musculo-skeletal trauma or injuries associated with burns. HO presents itself mostly asymptomatically, the symptoms of the initial stadium are often unspecific; however, severe forms can lead to severe disability. Imaging techniques, foremost bone szintigraphy, are mostly used for verification of the diagnosis. Local radiotherapy and nonsteroidal anti-inflammatory drugs are the classical therapeutic and prophylactic options. In advanced stages, surgical resection may be required.	[Gautschi, O. P.] Kantonsspital, Neurochirurg Klin, CH-9007 St Gallen, Switzerland; [Gautschi, O. P.; Cadosch, D.; Bauer, S.; Zellweger, R.] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA, Australia; [Gautschi, O. P.; Cadosch, D.; Filgueira, L.; Zellweger, R.] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia		Gautschi, OP (corresponding author), Kantonsspital, Neurochirurg Klin, Rorschacher Str 95, CH-9007 St Gallen, Switzerland.	ogautschi@datacomm.ch	Filgueira, Luis/B-6492-2008; Bauer, Stefan/AAK-5815-2020	Filgueira, Luis/0000-0002-2266-6650			Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Board TN, 2007, J BONE JOINT SURG BR, V89B, P434, DOI 10.1302/0301-620X.89B4.18845; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Burd TA, 2001, J BONE JOINT SURG AM, V83A, P1783, DOI 10.2106/00004623-200112000-00003; CATZ A, 1992, PARAPLEGIA, V30, P361, DOI 10.1038/sc.1992.83; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; DEJERINE MME, 1918, ANN MED, V5, P497; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Jones WE, 2004, J EQUINE VET SCI, V24, P132, DOI 10.1016/j.jevs.2004.03.001; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Maier D, 2005, ORTHOPADE, V34, P120, DOI 10.1007/s00132-004-0754-9; Neal BC, 2000, ACTA ORTHOP SCAND, V71, P122, DOI 10.1080/000164700317413076; ORZEL JA, 1985, J NUCL MED, V26, P125; Padgett DE, 2003, J ARTHROPLASTY, V18, P677, DOI 10.1016/S0883-5403(03)00265-1; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Romano CL, 2004, J ARTHROPLASTY, V19, P14, DOI 10.1016/S0883-5403(03)00279-1; Seegenschmiedt MH, 1997, INT J RADIAT ONCOL, V39, P161, DOI 10.1016/S0360-3016(97)00285-X; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; WARREN SB, 1992, J BONE JOINT SURG AM, V74A, P201, DOI 10.2106/00004623-199274020-00006	23	9	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	JUL	2008	111	7					523	533		10.1007/s00113-008-1475-z			11	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	325LO	WOS:000257590600007	18566787				2022-02-06	
J	Kakefuda, I; Stallones, L; Gibbs, J				Kakefuda, Itsumi; Stallones, Lorann; Gibbs, Julie			Readiness for community-based bicycle helmet use programs - A study using community-and individual-level readiness models	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						bicycle helmet promotion; community-based research; Community Readiness Model; Stages of Change Model; traumatic brain injury (TBI)	HEALTH BEHAVIOR; UNITED-STATES; PREVENTION; INJURIES	Understanding community context is as important to develop effective community-based injury prevention programs as assessing attitudes and behaviors among individuals. Readiness of a community toward community efforts to promote bicycle helmet use and of individuals to use bicycle helmets were examined in a northern Colorado town in the United States, using a semi-qualitative approach. Community readiness and individual readiness to prevent injuries through use of bicycle helmets differed across groups. The findings provide a better understanding of interactions between community perceptions and individual attitudes and behaviors. Further, target groups for improving bicycle helmet use were identified.	[Kakefuda, Itsumi] Colorado State Univ, Colorado Injury Control Res Ctr, Dept Psychol, Ft Collins, CO 80523 USA; [Stallones, Lorann] Ctr Dis Control & Prevent, Acad Res & Training Program, Colorado Injury Control Res Ctr, Ft Collins, CO USA; [Gibbs, Julie] Colorado Injury Control Res Center, Community Programs, Ft Collins, CO USA		Kakefuda, I (corresponding author), Colorado State Univ, Colorado Injury Control Res Ctr, Dept Psychol, 100 Sage Hall, Ft Collins, CO 80523 USA.	kakefuda@lamar.colostate.edu	Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X	NCIPC CDC HHS [1R49CE001168] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001168] Funding Source: NIH RePORTER		*BIC HELM SAF I, 2007, MAND HELM LAWS; Bolen JR, 1998, ARCH FAM MED, V7, P72, DOI 10.1001/archfami.7.1.72; Cohen J., 2013, STAT POWER ANAL BEHA; Edwards RW, 2000, J COMMUNITY PSYCHOL, V28, P291, DOI 10.1002/(SICI)1520-6629(200005)28:3<291::AID-JCOP5>3.3.CO;2-0; Kals E, 2001, J HEALTH PSYCHOL, V6, P131, DOI 10.1177/135910530100600204; KELLY KJ, 2003, MARKETING THEORY, V3, P411, DOI DOI 10.1177/1470593103042006; Nolen Sixten, 2002, Inj Control Saf Promot, V9, P89, DOI 10.1076/icsp.9.2.89.8695; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; Stith Sandra, 2006, J Prim Prev, V27, P599, DOI 10.1007/s10935-006-0062-8; Trifiletti LB, 2005, HEALTH EDUC RES, V20, P298, DOI 10.1093/her/cyg126; U.S. Census Bureau, 2000, US CENS 2000; Von Lengerke T, 2004, J HEALTH PSYCHOL, V9, P157, DOI 10.1177/1359105304036110; Weiss J, 2004, J PEDIATR-US, V145, P360, DOI 10.1016/j.jpeds.2004.05.034; West R, 2005, ADDICTION, V100, P1036, DOI 10.1111/j.1360-0443.2005.01139.x	17	9	9	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053			J HEALTH PSYCHOL	J. Health Psychol.	JUL	2008	13	5					639	643		10.1177/1359105308090935			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	318TD	WOS:000257114800006	18519437				2022-02-06	
J	Kayali, C; Agus, H; Arslantas, M; Turgut, A				Kayali, Cemil; Agus, Haluk; Arslantas, Mustafa; Turgut, Ali			Complications of internally fixed femoral neck fractures	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						avascular femoral head necrosis; femoral neck fracture; internal fixation; nonunion	TOTAL HIP-REPLACEMENT; DISPLACED FRACTURES; SUBCAPITAL FRACTURES; AVASCULAR NECROSIS; COMPRESSION SCREW; FIXATION; FEMUR; ARTHROPLASTY; METAANALYSIS; REDUCTION	BACKGROUND Femoral neck fractures in young patients are the emergent injuries that require precise reduction and stable fixation. Despite all advances, nonunion and avascular necrosis (AVN) of the femoral head are the major complications necessitating salvage procedures. In this retrospective series, we evaluated the complications of internally fixed femoral neck fractures. METHODS This study consisted of 32 cases that had displaced femoral neck fractures. Although some of them admitted to hospital more than 8 hours after initial trauma, all underwent internal fixation as early as possible. All the fractures were reduced and fixed by closed reduction under fluoroscopy control. However, 5 cases needed open reduction. AVN was determined by using Ficat and Arlet criteria. Clinical evaluation was performed based on the scoring system described by Harris. RESULTS Mean follow-up period was 49 +/- 29 months (range 24-126). AVN of the femoral head was observed in 13 cases (40%). However, only 5 of them had unsatisfactory clinical results requiring salvage surgery as total hip replacement. Nonunion of fracture was seen in 5 cases. In the statistical analysis, a negative correlation was observed between the degree of AVN and clinical findings. We found no correlation between the duration of the preoperative period and late complications. CONCLUSION AVN is the most common complication of displaced femoral neck fractures. However, less than half of these cases require salvage procedures. Total hip replacement is the preferred treatment option for these cases.	[Kayali, Cemil; Agus, Haluk; Turgut, Ali] Tepecik Educ & Res Hosp, Dept Orthopaed & Traumatol, Izmir, Turkey; [Arslantas, Mustafa] Hosp Med, Dept Orthopaed & Traumatol, Istanbul, Turkey		Kayali, C (corresponding author), 6445 Sokak 10 D 4, TR-35550 Izmir, Turkey.	cemilkayali@yahoo.com		Agus, Haluk/0000-0003-2831-3642; Kayali, Cemil/0000-0002-6260-0744			ASNIS SE, 1994, J BONE JOINT SURG AM, V76A, P1793, DOI 10.2106/00004623-199412000-00005; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Blomfeldt R, 2005, J BONE JOINT SURG AM, V87A, P1680, DOI 10.2106/JBJS.D.02655; CALANDRUCCIO RA, 1980, CLIN ORTHOP RELAT R, P49; FICAT P, 1973, REV CHIR ORTHOP, V59, P26; FRANZEN H, 1990, J BONE JOINT SURG BR, V72, P784, DOI 10.1302/0301-620X.72B5.2211756; GARDEN RS, 1974, ORTHOP CLIN N AM, V5, P683; GERBER C, 1993, CLIN ORTHOP RELAT R, P77; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; HOLMBERG S, 1987, CLIN ORTHOP RELAT R, P42; Jain R, 2002, J BONE JOINT SURG AM, V84A, P1605, DOI 10.2106/00004623-200209000-00013; Leadbetter GW, 1938, J BONE JOINT SURG, V20, P108; LOWELL JD, 1980, CLIN ORTHOP RELAT R, P162; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; ORT PJ, 1984, CLIN ORTHOP RELAT R, P158; Rogmark C, 2002, J BONE JOINT SURG BR, V84B, P183, DOI 10.1302/0301-620X.84B2.11923; SKINNER PW, 1986, J BONE JOINT SURG BR, V68, P78, DOI 10.1302/0301-620X.68B1.3941145; STROMQVIST B, 1987, CLIN ORTHOP RELAT R, P58; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; Szita J, 2002, INJURY, V33, pS41	22	9	15	1	3	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JUL	2008	14	3					226	230					5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	317CJ	WOS:000256996700011	18781420				2022-02-06	
J	Methodius-Ngwodo, WC; Burkett, AB; Kochupura, PV; Wellons, ED; Fuhrman, G; Rosenthal, D				Methodius-Ngwodo, Walaya C.; Burkett, Allison B.; Kochupura, Paul V.; Wellons, Eric D.; Fuhrman, George; Rosenthal, David			The role of CT angiography in the diagnosis of blunt traumatic thoracic aortic disruption and unsuspected carotid artery injury	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting and Postgraduate Course Program of the Southeastern-Surgical-Congress	FEB 09-12, 2008	Birmingham, AL	SE Surg Congress			ENDOVASCULAR STENT-GRAFTS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; RUPTURE; MANAGEMENT; REPAIR; PLACEMENT; SURGERY	We have replaced aortography and open thoracic surgery to diagnose and treat blunt traumatic thoracic aortic disruption (TTAD) in favor of CT angiography (CTA) and endovascular repair. The purpose of this study is to review our experience with the management and outcomes of TTAD and associated carotid artery injuries. In January 2003, we initiated a protocol that used CTA to evaluate all patients with suspected TTAD from blunt trauma. When TTAD was diagnosed, patients were managed by endovascular repair using abdominal aortic extension cuffs. Twenty-nine patients with TTAD were managed by endovascular repair. In all patients, abdominal endograft extension cuffs successfully excluded the traumatic disruptions. Six (21%) of these patients had concomitant, unsuspected carotid artery injury diagnosed by CTA. One patient had bilateral carotid artery dissections, sustained irreversible brain injury, and died. Four patients with common carotid dissections were successfully treated by anticoagulation and made uneventful recoveries. One patient with a common carotid-innominate artery dissection and pseudoaneurysm underwent endovascular repair. This study indicates that CTA and endovascular repair provide accurate diagnostic and therapeutic results in the management of blunt TTAD. Furthermore, CTA should include arch and cervical views to detect an unsuspected, concomitant carotid artery injury.	Atlanta Med Ctr, Dept Trauma, Atlanta, GA USA; Atlanta Med Ctr, Dept Vasc Surg, Atlanta, GA USA		Rosenthal, D (corresponding author), 315 Blvd NE,Suite 412, Atlanta, GA 30312 USA.	docro@mindspring.com					Agostinelli A, 2006, J THORAC CARDIOV SUR, V131, P1053, DOI 10.1016/j.jtcvs.2005.12.015; Amabile P, 2004, J VASC SURG, V40, P873, DOI 10.1016/j.jvs.2004.08.053; ANSON J, 1991, NEUROSURGERY, V29, P89, DOI 10.1227/00006123-199107000-00015; BAIK SO, 1988, AM J FOREN MED PATH, V9, P38, DOI 10.1097/00000433-198803000-00010; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 2002, J TRAUMA, V53, P850, DOI 10.1097/00005373-200211000-00008; Bortone AS, 2002, CIRCULATION, V106, pI234, DOI 10.1161/01.cir.0000032871.55215.de; Brandt M, 2004, J ENDOVASC THER, V11, P535, DOI 10.1583/04-1219.1; Broux C, 2006, INTENS CARE MED, V32, P770, DOI 10.1007/s00134-006-0115-8; COWLEY RA, 1990, J THORAC CARDIOV SUR, V100, P652; Czermak BV, 2002, AM J ROENTGENOL, V179, P337, DOI 10.2214/ajr.179.2.1790337; Doss M, 2003, ANN THORAC SURG, V76, P1465, DOI 10.1016/S0003-4975(03)00877-4; Dunham MB, 2004, J TRAUMA, V56, P1173, DOI 10.1097/01.TA.0000123039.92225.E5; ERNST A, 1988, ANN EMERG MED, V17, P1091, DOI 10.1016/S0196-0644(88)80452-9; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; FABIAN TC, 1990, J TRAUMA, V30, P953, DOI 10.1097/00005373-199008000-00003; Fattori R, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790603; Ferrari Enrico, 2006, Interact Cardiovasc Thorac Surg, V5, P730, DOI 10.1510/icvts.2006.136325; Fujikawa T, 2001, J TRAUMA, V50, P223, DOI 10.1097/00005373-200102000-00006; Grabenwoger M, 2003, EUR J CARDIO-THORAC, V23, P788, DOI 10.1016/S1010-7940(03)00075-7; Hoffer EK, 2002, J VASC INTERV RADIOL, V13, P1037, DOI 10.1016/S1051-0443(07)61870-3; Hoornweg LL, 2006, J VASC SURG, V43, P1096, DOI 10.1016/j.jvs.2006.01.034; Jamieson WRE, 2002, AM J SURG, V183, P571, DOI 10.1016/S0002-9610(02)00851-6; Karmy-Jones R, 2003, J TRAUMA, V55, P805, DOI 10.1097/01.TA.0000094429.98136.29; Kasirajan K, 2003, ANN VASC SURG, V17, P589, DOI 10.1007/s10016-003-0066-2; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; Kraus RR, 1999, AM J SURG, V178, P190, DOI 10.1016/S0002-9610(99)00157-9; Lachat M, 2002, EUR J CARDIO-THORAC, V21, P959, DOI 10.1016/S1010-7940(02)00062-3; Lawlor DK, 2005, CAN J SURG, V48, P293; Lebl DR, 2006, ARCH SURG-CHICAGO, V141, P177, DOI 10.1001/archsurg.141.2.177; Lew SM, 1999, PEDIATR NEUROSURG, V30, P239, DOI 10.1159/000028804; Lin PH, 2006, ENDOVASC TODAY, V2, P58; McKevitt EC, 2002, J TRAUMA, V53, P472, DOI 10.1097/00005373-200209000-00013; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Orend KH, 2003, J VASC SURG, V37, P91, DOI 10.1067/mva.2003.69; Ott MC, 2004, J TRAUMA, V56, P565, DOI 10.1097/01.TA.0000114061.69699.A3; Parikh AA, 1997, J AM COLL SURGEONS, V185, P80, DOI 10.1016/S1072-7515(97)00002-1; PERRY MO, 1980, ANN SURG, V192, P74, DOI 10.1097/00000658-198007000-00013; REDDY K, 1990, J TRAUMA, V30, P630, DOI 10.1097/00005373-199005000-00020; Rogers FB, 1999, J TRAUMA, V46, P380, DOI 10.1097/00005373-199903000-00005; ROSENBERG JM, 1989, ANN THORAC SURG, V48, P508, DOI 10.1016/S0003-4975(10)66851-8; Ruchat P, 2001, J CARDIOVASC SURG, V42, P77; SANZONE AG, 1995, AM J EMERG MED, V13, P327, DOI 10.1016/0735-6757(95)90212-0; Scharrer-Pamler R, 2003, J ENDOVASC THER, V10, P711, DOI 10.1583/1545-1550(2003)010<0711:CAETOT>2.0.CO;2; Thompson CS, 2002, J TRAUMA, V52, P1173, DOI 10.1097/00005373-200206000-00025; VONCOPPELL UO, 1994, ANN THORAC SURG, V58, P585; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001; ZELENOCK GB, 1982, ARCH SURG-CHICAGO, V117, P425	49	9	9	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUL	2008	74	7					580	585					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	316RP	WOS:000256967700004	18646474				2022-02-06	
J	Tsutsumi, S; Yasumoto, Y; Ito, M				Tsutsumi, Satoshi; Yasumoto, Yukimasa; Ito, Masanori			Pathological laughter caused by frontal glioblastoma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						pathological laughter; functional anatomy; glioblastoma	TRAUMATIC BRAIN-INJURY	A 60-year-old, right-handed female presented with episodes of pathological laughter and left hemiparesis. She had no history of traumatic brain injury, or neurological or psychiatric disease, and showed no signs of drug or alcohol abuse. Neurological examination found moderate left hemiparesis. Her face was symmetrical with intact emotional expression. The episodes of pathological laughter had become more frequent during the 3 months since the onset of hemiparesis, were elicited by non-specific, trivial stimuli, and lasted for a few minutes until she gained some control. Her personal and social behavior was entirely appropriate except for the outbursts of laughter. Cerebral magnetic resonance (MR) imaging revealed a 2.5 x 2.5 x 3 cm ring- enhanced mass in the subcortical area of the right frontal lobe associated with extensive perifocal brain edema. The hypothalamus, thalamus, internal capsule, brainstem, and cerebellum were unaffected. Functional MR imaging showed the tumor located mainly in the prefrontal area with the posterior limit involving the premotor cortex. She underwent total tumor resection. The histological diagnosis was glioblastoma multiforme. The pathological laughter and hemiparesis resolved within 2 weeks after surgery. Invasive tumor in the frontal lobe involving the prefrontal cortex and subcortical structure may cause pathological laughter, and can be cured by surgery.	[Tsutsumi, Satoshi; Yasumoto, Yukimasa; Ito, Masanori] Juntendo Univ, Urayasu Hosp, Dept Neurol Surg, Chiba 2790021, Japan		Tsutsumi, S (corresponding author), Juntendo Univ, Urayasu Hosp, Dept Neurol Surg, 2-1-1 Tomioka, Chiba 2790021, Japan.	shotaro@juntendo-urayasu.jp					Chahine LM, 2006, EPILEPSY BEHAV, V8, P610, DOI 10.1016/j.yebeh.2006.01.017; Feinstein A, 1999, MULT SCLER, V5, P69, DOI 10.1177/135245859900500201; Kosaka H, 2006, J NEUROL NEUROSUR PS, V77, P1376, DOI 10.1136/jnnp.2005.073288; MATSUOKA S, 1993, J NEUROSURG, V79, P428, DOI 10.3171/jns.1993.79.3.0428; McCullagh S, 2000, J NEUROPSYCH CLIN N, V12, P100, DOI 10.1176/jnp.12.1.100; Muzumdar D, 2001, NEUROL MED-CHIR, V41, P505, DOI 10.2176/nmc.41.505; Okuda DT, 2005, MOVEMENT DISORD, V20, P1389, DOI 10.1002/mds.20607; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Schmahmann JD, 2004, BRAIN, V127, P1269, DOI 10.1093/brain/awh138; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Wild B, 2003, BRAIN, V126, P2121, DOI 10.1093/brain/awg226	11	9	9	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2008	48	7					307	310		10.2176/nmc.48.307			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	325FK	WOS:000257573900007	18654050	Bronze			2022-02-06	
J	Reece, RM				Reece, Robert M.			What are we trying to measure? The problems of case ascertainment	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							NONACCIDENTAL HEAD-INJURY; SHAKEN-BABY SYNDROME; YOUNG-CHILDREN	To determine the incidence of a particular phenomenon, one has to know how that phenomenon is defined. The term "shaken baby syndrome" (SBS) came into general usage in the 1980s, followed by shaken impact syndrome (SIS), inflicted childhood neurotrauma, abusive head trauma (AHT), inflicted traumatic brain injury (inflicted TBI), non-accidental head injury (NAHI), and others. Several means of defining this clinical syndrome have been suggested. Keenan has proposed a research definition. Minns has offered a pure clinical definition, and Livingston and Childs suggest a definition that combines the clinical and radiologic features with the history of events leading to the condition. By using these definitions, eight articles describing SBS, published in the last 20 years, were analyzed for these characteristics. A definition of shaken baby syndrome reflecting the common themes in these clinical reports is offered.	[Reece, Robert M.] Tufts Univ, Sch Med, Dept Pediat, Boston, MA 02111 USA		Reece, RM (corresponding author), Tufts Univ, Sch Med, Dept Pediat, 32 Quail Hollow Rd, N Falmouth, MA 02556 USA.	rmreecel@aol.com					ALEXANDER RC, 1991, ABUSIVE HEAD TRAUMA; Barlow KM, 1998, SCOT MED J, V43, P112, DOI 10.1177/003693309804300407; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KEENAN H, 2003, INFLICTED CHILDHOOD; LIVINGSTON JH, 2005, SHAKING OTHER NONACC; Minns RA, 2005, SHAKING OTHER NONACC; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REECE RM, 2002, P C HELD BETH MD OCT; THOMAS SA, 1991, PEDIATRICS, V88, P471; 2000, DORLANDS ILLUSTRATED, P1748	16	9	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797			AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S116	S119		10.1016/j.amepre.2007.11.005			4	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300004	18374260				2022-02-06	
J	Hoane, MR; Gilbert, DR; Barbre, AB; Harrison, SA				Hoane, Michael R.; Gilbert, David R.; Barbre, Adrianne B.; Harrison, Stacy A.			Magnesium dietary manipulation and recovery of function following controlled cortical damage in the rat	MAGNESIUM RESEARCH			English	Article						diet; behavior; magnesium; neuroprotection; sensorimotor; TBI; recovery of function	TRAUMATIC BRAIN-INJURY; FACILITATE RECOVERY; NMDA ANTAGONISTS; THERAPY; LESIONS; CHLORIDE; DECLINE; ATROPHY; CORTEX	Previous research has shown that dietary magnesium (Mg2+) deficiency prior to injury worsens recovery of function and that systemic administration of Mg2+ pre or post-injury significantly improves functional recovery. The purpose of the present study was to determine if manipulations in dietary Mg2+ would alter functional recovery following unilateral cortical injuries. Two weeks prior to injury, rats were placed on a customized diet enriched with Mg2+, deficient in Mg2+, or on a standard Mg2+ diet. Rats were then prepared with unilateral cortical contusion injuries (CCI) of the sensorimotor cortex. Two days following CCI, rats were tested on a battery of sensorimotor (vibrissae-forelimb placing and bilateral tactile adhesive removal tests), as well as the acquisition of reference memory in the Morris water maze. Serum analysis for Mg2+ prior to injury showed a diet-dependent modulation in levels. The Mg2+-enriched diet showed significantly higher levels of serum Mg2+ compared to the normal diet and the Mg2+-deficient diet showed significantly lower levels compared to the Mg2+-normal diet. On the placing and tactile removal tests Mg2+ deficiency significantly worsened recovery compared to the Mg2+-enriched and Mg2+-normal diet conditions. There were no statistically significant differences between the Mg2+-normal and Mg2+-enriched diets on the sensorimotor tests. On the acquisition of reference memory there were no significant difference between diet conditions; however, the Mg2+-deficient diet showed a trend toward impaired performance compared to the other diet conditions. The Mg2+-deficient diet resulted in a larger lesion cavity compared to the other diet conditions. These findings suggest that dietary Mg2+ modulates recovery of function.	[Hoane, Michael R.; Gilbert, David R.; Barbre, Adrianne B.; Harrison, Stacy A.] So Illinois Univ, Dept Psychol Life Sci 2, Restorat Neurosci Lab, Brain & Cognit Sci Program, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol Life Sci 2, Restorat Neurosci Lab, Brain & Cognit Sci Program, Mail Code 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657			Aikawa J.W., 1981, MAGNESIUM ITS BIOL S, P21; Altura BM, 1998, ALCOHOL, V15, P181, DOI 10.1016/S0741-8329(97)00107-9; Bara M., 1984, MAGNESIUM, V3, P212; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Bardgett ME, 2005, BRAIN RES, V1038, P100, DOI 10.1016/j.brainres.2005.01.020; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; BARGETT ME, 2007, MAGNESIUM RES, V20, P58; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; GARFINKEL L, 1985, Magnesium, V4, P60; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2000, BRAIN RES BULL, V53, P175, DOI 10.1016/S0361-9230(00)00327-0; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; Hoane MR, 2001, MAGNESIUM RES, V14, P51; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; RUBIN H, 1976, J CELL PHYSIOL, V89, P613, DOI 10.1002/jcp.1040890418; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757	30	9	10	0	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0953-1424			MAGNESIUM RES	Magnes. Res.	MAR	2008	21	1					29	37					9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	291BE	WOS:000255166500003	18557131				2022-02-06	
J	Kwasnica, C; Brown, AW; Elovic, EP; Kothari, S; Flanagan, SR				Kwasnica, Christina; Brown, Allen W.; Elovic, Elie P.; Kothari, Sunil; Flanagan, Steven R.			Congenital and acquired brain injury. 3. Spectrum of the acquired brain injury population	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain concussion; brain injuries; brain neoplasm; hypoxia; brain; persistent vegetative state; rehabilitation	MINIMALLY CONSCIOUS STATES; POST-CONCUSSION SYNDROME; QUALITY-OF-LIFE; VEGETATIVE STATE; CARDIAC-ARREST; PROFESSIONAL FOOTBALL; FUNCTIONAL OUTCOMES; HIGH-SCHOOL; FOLLOW-UP; RECOVERY	This self-directed learning module highlights the subpopulations of traumatic brain injury (TBI) that are treated by the rehabilitation practitioner. It is part of the chapter on TBI in the self-directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation, Specifically, this article focuses on the management of patients with mild TBI, children, and individuals with acquired brain injury from other etiologies, such as anoxic events or neoplastic lesions. The clinical spectrum of TBI, from the most severe presentation to the mildest, requires similar clinical skills to evaluate and manage. Overall Article Objective: To describe the spectrum of brain injury populations based on age, severity, and etiology.	[Kwasnica, Christina] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Elovic, Elie P.] Kessler Med Rehabil Res & Educ Ctr, W Orange, NJ USA; [Kothari, Sunil] Inst Rehabil & Res, Houston, TX USA; [Flanagan, Steven R.] Mt Sinai Hosp, New York, NY 10029 USA		Kwasnica, C (corresponding author), Barrow Neurol Inst, 222 W Thomas Rd,Ste 212, Phoenix, AZ 85013 USA.	ckwasnica@chw.edu		Flanagan, Steven/0000-0001-9005-5897; Brown, Allen W./0000-0001-7228-3351			Adelson PD, 2003, J NEUROTRAUM, V20, P1116; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; ARMSTRONG K, 2001, J INT NEUROPSYCH SOC, V7, P238; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; *CDCP NAT CTR INJ, 2003, MILD TRAUM BRAIN INJ; Clauss R, 2006, NEUROREHABILITATION, V21, P23; COLEMAN M, 2005, NEUROPSYCHOL REHABIL, P15; Debette S, 2002, J NEUROL, V249, P1678, DOI 10.1007/s00415-002-0903-1; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fins Joseph J, 2006, Palliat Support Care, V4, P169; Frucht SJ, 2002, ADV NEUROL, V89, P85; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2005, REHABILITATION TRAUM, P305; Hau P, 2003, CANCER, V98, P2678, DOI 10.1002/cncr.11845; HERLITZ J, 1994, EUR HEART J, V15, P1628, DOI 10.1093/oxfordjournals.eurheartj.a060445; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Huang ME, 2001, BRAIN INJURY, V15, P843, DOI 10.1080/02699050010013653; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Lundgren-Nilsson A, 2005, RESUSCITATION, V66, P285, DOI 10.1016/j.resuscitation.2005.04.001; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schiff ND, 2002, NEUROL RES, V24, P116, DOI 10.1179/016164102101199576; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Venkatesan A, 2006, NEUROL CLIN, V24, P123, DOI 10.1016/j.ncl.2005.11.001; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	51	9	9	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2008	89	3		1			S15	S20		10.1016/j.apmr.2007.12.006			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	276TX	WOS:000254167100004	18295644				2022-02-06	
J	Tan, KL; Lim, LM; Chiu, LH				Tan, K. L.; Lim, L. M.; Chiu, L. H.			Orthopaedic patients' experience of motor vehicle accident in Singapore	INTERNATIONAL NURSING REVIEW			English	Article						hospitalization; orthopaedic trauma; Singapore; surviving; transformation trauma experience; traumatic event	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; STRESS; ADULTS	Aim: The purpose of this paper is to present a study that explored the experiences of orthopaedic patients injured in motor vehicle accidents (MVAs), from the time of the accident until 6 months after being discharged from hospital. Background: Trauma injuries from MVAs are increasing, with the number of deaths from such injuries continuing to rise. Victims often sustain open fractures to more than one part of their body and need rehabilitation and support to adjust to long-term chronic or permanent disability. In the last decade, research pertaining to trauma nursing has concentrated on neurologically injured patients. Although there is a paucity of research on the nursing perspective of psychological care for non-neurologically injured patients, the majority of studies located were mainly quantitative in nature and did not analyse the personal experiences of orthopaedic patients. Method: A qualitative naturalistic inquiry approach was used, which provided a first-hand account of the traumatic MVA event experienced by six orthopaedic participants in Singapore. Data were collected from face-to-face in-depth interviews. Participants were voluntarily recruited through purposeful sampling and 'snowballing'. Interviews were audiotaped and transcribed verbatim in preparation for analysis. Findings: The analysis of information explicated four main themes: the experience of the event, the effect of hospitalization, surviving the event and self-transformation. Conclusion: The study provided an understanding of orthopaedic patients' experience of MVA in Singapore. The findings of the study have the potential to contribute to the limited qualitative research available concerning victims' experiences of MVAs and nurses caring for MVA victims.	[Tan, K. L.] Victoria Univ, Sch Nursing & Midwifery, Doncaster E, Vic 3109, Australia; [Lim, L. M.; Chiu, L. H.] Victoria Univ, Sch Nursing & Midwifery, Preregistrat Course Overseas Qualified & Reentry, Postgrad Programme Pediat Nursing, Melbourne, Vic, Australia		Tan, KL (corresponding author), Victoria Univ, Sch Nursing & Midwifery, 71 Long Valley Way, Doncaster E, Vic 3109, Australia.	kim_laitan@yahoo.com.sg					Baldacchino D, 2001, J ADV NURS, V34, P833, DOI 10.1046/j.1365-2648.2001.01814.x; Bisson Jonathan I, 2003, J Psychosoc Nurs Ment Health Serv, V41, P42; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Carlson E.B., 2000, TRAUMA VIOLENCE ABUS, V1, P4, DOI [DOI 10.1177/1524838000001001002, https://doi.org/10.1177/1524838000001001002]; Carmack BJ, 1998, NURS CLIN N AM, V33, P701; Carpenter HJ, 1999, QUALITATIVE RES NURS; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Creswell JW., 1998, QUAL INQ; Duggan CH, 2001, REHABIL PSYCHOL, V46, P3, DOI 10.1037/0090-5550.46.1.3; EVERSTINE DS, 1993, TRAUMA RESPONSE TREA; Ferguson Marilyn, 1981, AQUARIAN CONSPIRACY; FRIEDMAN M, 1988, J HUMANIST PSYCHOL, V28, P123, DOI 10.1177/0022167888282012; Guba EG., 1989, 4 GENERATION EVALUAT; Jeavons S, 2001, Aust Health Rev, V24, P128; JEAVONS S, 2000, AUSTR PSYCHIAT, V18, P137; Koutsosimou M, 1996, BRIT J HEALTH PSYCH, V1, P357, DOI 10.1111/j.2044-8287.1996.tb00516.x; Levy RS, 1996, J ORTHOP TRAUMA, V10, P21, DOI 10.1097/00005131-199601000-00004; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; McFarlane Alexander., 2000, INT HDB HUMAN RESPON; MILES MB, 1994, EXPANDED SOURCE QUAL; MUNHALL PL, 1993, NURSING RES QUALITAT; POLKINGHORNE DE, 1989, EXISTENTIAL PHENOMEN, P3; Rask Katja, 2002, Int J Nurs Pract, V8, P137, DOI 10.1046/j.1440-172X.2002.00354.x; Richmond TS, 2000, J ADV NURS, V32, P1341, DOI 10.1046/j.1365-2648.2000.01629.x; ROBERTS K, 2002, NURSING RES PROCESSE, P95; *SING NURS ASS, 1922, SINGAPORE NURSING J; Smith KV, 2002, NURS ETHICS, V9, P301, DOI 10.1191/0969733002ne512oa; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Willis-Helmich J J, 1992, J Burn Care Rehabil, V13, P64, DOI 10.1097/00004630-199201000-00014; WILSON JP, 1996, INT HDB TRAUMATIC ST; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x	34	9	10	0	6	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0020-8132			INT NURS REV	Int. Nurs. Rev.	MAR	2008	55	1					110	116		10.1111/j.1466-7657.2007.00581.x			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	262KR	WOS:000253147900026	18275544				2022-02-06	
J	Sperhake, JP; Herrmann, B				Sperhake, J. P.; Herrmann, B.			Shaken baby syndrome (non-accidental head injury). Current controversies	RECHTSMEDIZIN			German	Article						shaken baby syndrome; subdural hematoma; retinal hemorrhage; non-accidental head injury	INFANT SYNDROME; BRAIN-INJURY; CHILDREN; SHAKING; NEUROPATHOLOGY; HEMORRHAGE; WHIPLASH; DEATHS; TIME	The concept of the shaken baby syndrome is not undisputed. The scientific debate has been carried into the courtrooms and thereby led to considerable uncertainty amongst lay persons and jurists. Part of the problem is due to the principal impossibility to carry out evidence-based research in this particular field. Selected controversies are discussed: can we diagnose shaken baby syndrome (SBS)? Is a non-traumatic etiology of the triad subdural hematoma, encephalopathy, and retinal hemorrhages possible or likely? How much force is required to produce a shaking injury? Do low-level falls lead to fatal head injuries? Is there a lucid interval in infants who sustain significant inflicted head trauma? What is the diagnostic significance of retinal hemorrhages? Even when taking the controversies and restrictions of our knowledge into consideration, there is still substantial evidence for the diagnosis of a non-accidental head injury (NAHI). A multidisciplinary approach significantly improves the quality and certainty of the diagnosis.	[Sperhake, J. P.] Univ Klinikum Hamburg Eppendorf, Inst Rechts Med, D-22529 Hamburg, Germany; [Herrmann, B.] Klinikum Kassel, Kinderklin, Kassel, Germany		Sperhake, JP (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Rechts Med, Butenfeld 34, D-22529 Hamburg, Germany.	sperhake@uke.de					Alexander R. C, 2001, CHILD ABUSE MED DIAG, P47; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Byard RW, 2004, MED J AUSTRALIA, V181, P52, DOI 10.5694/j.1326-5377.2004.tb06162.x; CAFFEY J, 1974, PEDIATRICS, V54, P396; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Herrmann B, 2008, RECHTSMEDIZIN, V18, P9, DOI 10.1007/s00194-007-0482-7; Hymel Kent P, 2002, Child Maltreat, V7, P329, DOI 10.1177/107755902237263; Kairys SW, 2001, PEDIATRICS, V108, P206; Krous Henry F, 2005, Forensic Sci Med Pathol, V1, P9, DOI 10.1385/FSMP:1:1:009; Krous HF, 1999, PEDIATR DEVEL PATHOL, V2, P497, DOI 10.1007/s100249900156; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; LEVIN AV, 2003, INFLICTED CHILDHOOD, P127; Minns RA, 2005, J ROY COLL PHYS EDIN, V35, P5; NASHELSKY MB, 1995, AM J FOREN MED PATH, V16, P154, DOI 10.1097/00000433-199506000-00016; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Reece RM, 2004, BMJ-BRIT MED J, V328, P1316, DOI 10.1136/bmj.328.7451.1316; RIVARA FP, 1993, PEDIATRICS, V92, P61; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9	29	9	10	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	FEB	2008	18	1					48	52		10.1007/s00194-007-0485-4			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	316KH	WOS:000256947800009					2022-02-06	
S	Leung, TS; Tisdall, MM; Tachtsidis, I; Smith, M; Delpy, DT; Elwell, CE		Kang, KA; Harrison, DK; Bruley, DF		Leung, Terence S.; Tisdall, Martin M.; Tachtsidis, Ilias; Smith, Martin; Delpy, David T.; Elwell, Clare E.			Cerebral tissue oxygen saturation calculated using low frequency haemoglobin oscillations measured by near infrared Spectroscopy in adult ventilated patients	OXYGEN TRANSPORT TO TISSUE XXIX	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	34th Annual Conference of the International-Society-on-Oxygen-Transport-to-Tissue	AUG 12-17, 2006	Univ Louisville, Louisville, KY	Int Soc Oxygen Transport Tissue, Off Univ Provost, Univ Louisville, Off Senior Vice President Res, Univ Louisville, Speed Sch Eng, Univ Louisville, Sch Med & Hlth Sci Ctr, Univ Louisville, Chem Eng Dept, Univ Louisville, Ctr Modeling Integrated Metabolic Syst	Univ Louisville		VENOUS SATURATION; NEWBORN-INFANTS; HEMODYNAMICS; ARTERIAL	Oxy- (HbO(2)) and deoxy- (HHb) haemoglobin signals measured by near infrared (NIR) spectroscopy over the human frontal lobes frequently contain respiratory and low frequency oscillations (LFOs). It has been suggested previously that venous oxygen saturation (S(v)O(2)) can be calculated from these respiratory oscillations. In this paper, we investigated the use of a Fourier transform based algorithm to calculate an oxygen saturation measure known as S(osc)O(2) which may be a close estimate of the underlying S(v)O(2). S(osc)02 was calculated using three different frequency ranges, (1) respiratory oscillations only, (2) LFOs only, and (3) both respiratory oscillations and LFOs. At each frequency range S(osc)O(2) was calculated using either (1) the modified Beer-Lambert law (MBL) or (2) spatially resolved spectroscopy (SRS). In total six different measurements of S(osc)O(2) were investigated here. Experiments were performed in six adult ventilated patients with traumatic brain injury. The patients' inspired oxygen fraction (F(i)O(2)) was raised in two hyperoxic phases. The calculated S(osc)O(2) values were compared with other cerebral oxygenation measures including an intraparenchymal catheter based brain tissue oxygen tension (PbrO2) and the NIR based tissue oxygenation index (TOI). It was found that the S(osc)O(2) calculated using the combined respiratory and LFO frequency range and the SRS method resulted in the highest detection rates of hyperoxic changes. This measure Of S(osc)O(2) may provide a viable, continuous, non invasive, bedside measure of cerebral venous oxygen saturation.	[Leung, Terence S.; Tachtsidis, Ilias; Delpy, David T.; Elwell, Clare E.] UCL, Dept Med Phys & Bioengn, London, England; [Tisdall, Martin M.; Smith, Martin] Natl Hosp Neurol & Neurosurg, Dept Neurosnaesthesia & Neurocrit Care, London WC1N 3BG, England		Leung, TS (corresponding author), UCL, Dept Med Phys & Bioengn, London, England.		Tachtsidis, Ilias/N-2747-2018; Smith, Martin/B-2616-2009	Tachtsidis, Ilias/0000-0002-8125-0313; Tisdall, Martin/0000-0001-8880-8386; Elwell, Clare/0000-0002-7281-7234	Wellcome TrustWellcome TrustEuropean Commission [075608] Funding Source: Medline		Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Elwell CE, 1996, J CEREBR BLOOD F MET, V16, P353, DOI 10.1097/00004647-199603000-00022; Elwell CE, 1997, ADV EXP MED BIOL, V411, P453; Franceschini MA, 2002, J APPL PHYSIOL, V92, P372, DOI 10.1152/jappl.2002.92.1.372; Guyton AC, 2000, TXB MED PHYSL; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Levy, 1997, CARDIOVASCULAR PHYSL; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; Nilsson L, 2003, PHYSIOL MEAS, V24, P925, DOI 10.1088/0967-3334/24/4/009; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; SIEBENTHAL K, 1999, BRAIN DEV, V21, P529; SKOV L, 1993, PEDIATR RES, V33, P52, DOI 10.1203/00006450-199301000-00011; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Tachtsidis I, 2004, PHYSIOL MEAS, V25, P437, DOI 10.1088/0967-3334/25/2/003; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012; Wolf M, 1997, CRIT CARE MED, V25, P1579, DOI 10.1097/00003246-199709000-00028; Yoxall CW, 1996, PEDIATR RES, V39, P1103, DOI 10.1203/00006450-199606000-00028	19	9	11	0	2	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0065-2598		978-0-387-74910-5	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2008	614						235	244					10	Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	BHH10	WOS:000253182800027	18290334				2022-02-06	
J	Quinn, M; Mukhida, K; Sadi, D; Hong, M; Mendez, I				Quinn, M.; Mukhida, K.; Sadi, D.; Hong, M.; Mendez, I.			Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						dopamine; mechanical trauma; parkinsonian; rat; transplantation	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; GRAFT-SURVIVAL; NIGRAL GRAFTS; MESENCEPHALIC TISSUE; FUNCTIONAL RECOVERY; INCREASES SURVIVAL; LIPID MONOLAYERS; PARTIAL LESION; TIME-COURSE	Although neural transplantation of fetal dopaminergic cells is a promising therapy for Parkinson's disease, poor transplanted cell survival limits its efficacy. In the present study it was hypothesized that the use of Poloxamer 188 (P188), a non-ionic surfactant, during cell preparation and transplantation may protect cells from associated mechanical injury and thus improve transplanted cell survival in a rat model of Parkinson's disease. Fetal rat dopaminergic tissue was dissociated in media with or without P188 and then cultured for 1 week or transplanted into the striatum of rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal dopaminergic pathway. Fetal dopaminergic cell survival and reinnervation of the host brain were examined using tyrosine hydroxylase immunohistochemistry and stereological quantification. The number of surviving tyrosine hydroxylase-immunoreactive cells in vitro and in vivo was significantly increased by 2.2-fold by incubating fetal dopaminergic cells with P188 during tissue dissociation. Furthermore, the striatal reinnervation in parkinsonian rats that received intrastriatal transplants of P188-exposed dopaminergic cells was significantly enhanced (1.8-fold increase) compared with rats that received non-P188-treated cells. In conclusion, P188 protects fetal dopaminergic cells from mechanical injury by increasing cell survival and enhances dopaminergic fibre outgrowth into the transplanted striatum. Use of P188 may thus be an important adjunct to improve the clinical efficacy of neural transplantation for Parkinson's disease.	Dalhousie Univ, Dept Anat & Neurobiol, Cell Restorat Lab, Halifax, NS, Canada; Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS B3H 4H2, Canada		Mendez, I (corresponding author), Halifax Infirmary, Queen Elizabeth II Hlth Sci Ctr, Div Neurosurg, Room 3806,1796 Summer St, Halifax, NS B3H 4H7, Canada.	mendez@dal.ca					Apostolides C, 1998, NEUROSCIENCE, V83, P363, DOI 10.1016/S0306-4522(97)00369-2; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Barneoud P, 2000, EUR J NEUROSCI, V12, P322, DOI 10.1046/j.1460-9568.2000.00896.x; Bartlett LE, 2004, NEUROSURGERY, V55, P405, DOI 10.1227/01.NEU.0000129550.31643.54; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Cicchetti F, 2002, EXP NEUROL, V177, P376, DOI 10.1006/exnr.2002.8007; Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091; Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198; Emgard M, 2003, J NEUROCHEM, V86, P1223, DOI 10.1046/j.1471-4159.2003.01931.x; Emgard M, 2002, NEUROSCIENCE, V115, P1177, DOI 10.1016/S0306-4522(02)00480-3; Espejo M, 2000, CELL TRANSPLANT, V9, P45, DOI 10.1177/096368970000900107; FORMAN MB, 1992, AM HEART J, V124, P1347, DOI 10.1016/0002-8703(92)90422-R; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Frim DM, 2004, NEUROREPORT, V15, P171, DOI 10.1097/00001756-200401190-00033; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Haque NSK, 1996, BRAIN RES, V712, P45, DOI 10.1016/0006-8993(95)01427-6; HAQUE NSK, 1995, NEUROREPORT, V6, P2177, DOI 10.1097/00001756-199511000-00019; Hebb AO, 2003, J NEUROSURG, V98, P1078, DOI 10.3171/jns.2003.98.5.1078; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mehta V, 1998, J NEUROSURG, V88, P1088, DOI 10.3171/jns.1998.88.6.1088; Mendez I, 2000, J NEUROSURG, V92, P863, DOI 10.3171/jns.2000.92.5.0863; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Mendez I, 1996, J NEUROSCI, V16, P7216; Mendez I, 2002, J NEUROSURG, V96, P589, DOI 10.3171/jns.2002.96.3.0589; Merchant FA, 1998, J SURG RES, V74, P131, DOI 10.1006/jsre.1997.5252; Meyer M, 2001, NEUROSCIENCE, V108, P273, DOI 10.1016/S0306-4522(01)00418-3; Mundt-Petersen U, 1998, EXP NEUROL, V153, P377; NAKAO N, 1994, P NATL ACAD SCI USA, V91, P12408, DOI 10.1073/pnas.91.26.12408; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; PADANILAM JT, 1994, ANN NY ACAD SCI, V720, P111, DOI 10.1111/j.1749-6632.1994.tb30439.x; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RIOUX L, 1991, NEUROSCIENCE, V40, P123, DOI 10.1016/0306-4522(91)90179-R; Rosenblad C, 1999, NEUROREPORT, V10, P1783, DOI 10.1097/00001756-199906030-00029; Rosenblad C, 1996, NEUROSCIENCE, V75, P979; SAUER H, 1991, RESTOR NEUROL NEUROS, V2, P123, DOI 10.3233/RNN-1991-2302; Sautter J, 2000, EXP NEUROL, V164, P121, DOI 10.1006/exnr.2000.7410; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schierle GSK, 1999, NEUROSCIENCE, V94, P17, DOI 10.1016/S0306-4522(99)00324-3; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Sharma V, 1996, BIOPHYS J, V71, P3229, DOI 10.1016/S0006-3495(96)79516-4; Sortwell CE, 2000, EXP NEUROL, V165, P268, DOI 10.1006/exnr.2000.7476; Sortwell CE, 2001, EXP NEUROL, V169, P23, DOI 10.1006/exnr.2001.7644; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Wu GH, 2005, BIOPHYS J, V89, P3159, DOI 10.1529/biophysj.104.052290; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011; Zawada WM, 1998, BRAIN RES, V786, P96, DOI 10.1016/S0006-8993(97)01408-X; Zawada WM, 2001, BRAIN RES, V891, P185	58	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JAN	2008	27	1					43	52		10.1111/j.1460-9568.2007.05991.x			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247ZG	WOS:000252120500005	18093176				2022-02-06	
J	Saval, A; Chiodo, AE				Saval, April; Chiodo, Anthony E.			Effect of intrathecal baclofen concentration on spasticity control: Case series	JOURNAL OF SPINAL CORD MEDICINE			English	Article						spasticity; baclofen; intrathecal; tetraplegia; hemiplegia; cerebral palsy; traumatic brain injury	CATHETER TIP PLACEMENT; CEREBROSPINAL-FLUID; INFUSION; ORIGIN	Background/Objective: Intrathecal baclofen (ITB) has been shown to be an effective treatment for severe spasticity of spinal or cerebral origin. Although most patients respond well to an ITB trial, there are often difficulties in achieving and/or maintaining such effectiveness with ITB pump treatment. There are few published guidelines for dosing efficacy and no studies looking at the effect of concentration of ITB on spasticity management. Methods: Case series of 3 adults with severe spasticity treated with ITB pump: a 44-year-old man with C7 tetraplegia using a 40-mL Medtronic SynchroMed II pump with 500-mu g/mL concentration; a 35-year-old woman with traumatic brain injury with right spastic hemiplegia using a 18-mL Medtronic SynchroMed EL pump with 2,000-mu g/mL concentration; and a 43-year-old woman with spastic diplegic cerebral palsy using a 40-mL Medtronic SynchroMed II pump with 2,000-mu g/mL concentration. Results: After reducing ITB concentrations in the pump, either as part of a standard protocol for dye study to assess the integrity of pump and catheter system or secondary to plateau in therapeutic efficacy, patients experienced temporary, significant reduction in spasticity based on range of motion, Modified Ashworth scores, and verbal feedback. Conclusions: Decreasing the concentration of ITB seems to affect spasticity control. Further research in this area is needed for those patients with refractory spasticity to optimize efficacy of ITB therapy.	[Saval, April; Chiodo, Anthony E.] Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA		Chiodo, AE (corresponding author), Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	tchiodo@med.umich.edu					Albright AL, 2007, DEV MED CHILD NEUROL, V49, P423, DOI 10.1111/j.1469-8749.2007.00423.x; Azouvi P, 1996, ARCH PHYS MED REHAB, V77, P35, DOI 10.1016/S0003-9993(96)90217-8; Bernards CM, 2006, ANESTHESIOLOGY, V105, P169, DOI 10.1097/00000542-200607000-00027; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; Heiss JD, 1999, J NEUROSURG, V91, P553, DOI 10.3171/jns.1999.91.4.0553; Henry-Feugeas MC, 2000, MAGN RESON IMAGING, V18, P387, DOI 10.1016/S0730-725X(99)00142-3; HENRYFEUGEAS MC, 1993, MAGN RESON IMAGING, V11, P1107, DOI 10.1016/0730-725X(93)90238-9; HUGENHOLTZ H, 1993, CAN J NEUROL SCI, V20, P165, DOI 10.1017/S0317167100047776; KROIN JS, 1993, NEUROSURGERY, V33, P226; McCall TD, 2006, NEUROSURGERY, V59, P634, DOI 10.1227/01.NEU.0000227570.40402.77; MEYTHALER JM, 1997, J NEUROSURG, V87, P414; Ordia JI, 2002, NEUROMODULATION, V5, P16, DOI 10.1046/j.1525-1403.2002._2004.x	12	9	10	0	0	AMER PARAPLEGIA SOC	JACKSON HWIGHTS	75-20 ASTORIA BLVD, JACKSON HWIGHTS, NY 11370-1177 USA	1079-0268			J SPINAL CORD MED	J. Spinal Cord. Med.		2008	31	4					394	397		10.1080/10790268.2008.11760742			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356MY	WOS:000259783500007	18959357	Green Published			2022-02-06	
J	Yan, W; Wang, HD; Zhu, L; Feng, XM; Qiao, L; Jin, W; Tang, K				Yan, Wei; Wang, Han-Dong; Zhu, Lin; Feng, Xiao-Mei; Qiao, Liang; Jin, Wei; Tang, Ke			Traumatic brain injury induces the activation of the Nrf2-ARE pathway in the lung in rats	BRAIN INJURY			English	Article						acute lung injury; heme oxygenase-1; NF-E2-related factor 2; Quinone oxidoreductase-1; traumatic brain injury	TRANSCRIPTION FACTOR NRF2; HEME OXYGENASE-1 EXPRESSION; INFLAMMATORY RESPONSE; GENE-EXPRESSION; IN-VIVO; PULMONARY; PROTECTION; POLYMORPHISMS; KEAP1; RISK	Background: Acute lung injury (ALI) is a frequent but poorly understood complication of traumatic brain injury (TBI). The Nrf2-ARE pathway has been proved to be essential for protection against diffuse inflammation and oxidative damage, which are both involved in ALI following TBI. However, whether the Nrf2-ARE pathway is activated after TBI in the lung hasn't been studied. Methods and procedures: In the present study, the nuclear Nrf2 protein level was detected by Western blot and the mRNA levels of heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase-1 (NQO1), two Nrf2-regulated gene products, were determined by RT-PCR at 24 hours after TBI. In addition, the expression of Nrf2 and HO-1 was localized by immunohistochemical study. Main outcomes and results: After TBI, the nuclear Nrf2 protein level in the lung was significantly increased and the mRNA levels of both HO-1 and NQO1 were also up-regulated. Moreover, immunohistochemical study showed that both Nrf2 and HO-1 were mainly localized in tracheobronchial epithelium and alveolar macrophages. Conclusion: These results suggest that the Nrf2-ARE pathway is activated in the lung after TBI.	[Yan, Wei; Wang, Han-Dong; Zhu, Lin; Qiao, Liang; Jin, Wei; Tang, Ke] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Feng, Xiao-Mei] Nanjing Univ, Sch Med, Dept Anesthesiol, Nanjing 210002, Jiangsu Prov, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China.	njwanghd@gmail.com		Yan, Wei/0000-0002-1123-0835	Jinling Hospital Research Funding [nj06004]	We thank Dr Wu Bo for his technical assistance. This work was supported in part by Jinling Hospital Research Funding (nj06004).	BAIGELMAN W, 1981, NEUROSURGERY, V9, P729, DOI 10.1227/00006123-198112000-00021; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Das A, 2006, FREE RADICAL BIO MED, V40, P1843, DOI 10.1016/j.freeradbiomed.2006.01.025; de Haan LHJ, 2006, TOXICOL IN VITRO, V20, P594, DOI 10.1016/j.tiv.2005.10.005; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng XM, 2007, ANN CLIN LAB SCI, V37, P49; Fredenburgh LE, 2005, CELL MOL BIOL, V51, P513, DOI 10.1170/T657; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hopkins RO, 2006, BRAIN INJURY, V20, P263, DOI 10.1080/02699050500488199; Hou LF, 2005, CARCINOGENESIS, V26, P1122, DOI 10.1093/carcin/bgi054; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Laudi S, 2007, INJURY, V38, P1052, DOI 10.1016/j.injury.2007.03.020; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; McHenry MA, 2001, BRAIN INJURY, V15, P741, DOI 10.1080/02699050010013932; Mochizuki M, 2005, AM J RESP CRIT CARE, V171, P1260, DOI 10.1164/rccm.200406-755OC; Nakae H, 2002, BURNS, V28, P305, DOI 10.1016/S0305-4179(01)00097-3; O'Hara KA, 2006, J CELL PHYSIOL, V209, P113, DOI 10.1002/jcp.20710; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Ritz SA, 2007, AM J PHYSIOL-LUNG C, V292, pL33, DOI 10.1152/ajplung.00170.2006; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Tomita M, 2006, INT J MOL MED, V17, P37; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zhu L, 2007, ANN CLIN LAB SCI, V37, P356; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	38	9	9	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	10					802	810		10.1080/02699050802372174			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	347MJ	WOS:000259145400011	18787991				2022-02-06	
J	Timpka, T; Risto, O; Borg, K; Johansson, J				Timpka, T.; Risto, O.; Borg, K.; Johansson, J.			Injury incidence in a men's elite bandy league: an epidemiological study of a full regular season	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						sports injury epidemiology; injury prevention; cohort study design	ICE HOCKEY; SPORT; CONCUSSION	Bandy is a popular European winter team-sport. The best bandy teams participate in semi-professional leagues, where the play-off games attract more than 10 000 spectators. Injury patterns in elite bandy have not been investigated previously. The aim of this study is to examine the incidence and types of injuries sustained during elite bandy games for men. Twelve of the 16 teams in the Swedish elite bandy league during the 2002 season participated in the study. In total, 36 injuries were recorded, corresponding to 7.3 injuries/1000 player game hours and 5.7 injuries/1000 athlete exposures. Collision was the most common injury cause (47%), while contusion was the most common injury type (25%), followed by fracture (22%) and ligament rupture (19%). The study showed that the injury incidence in elite bandy is low, but also that the injuries that are still sustained are relatively severe. This pattern can be explained by the fact that even though bandy rules do not allow body checks, collisions between skaters moving at high speeds still cause the majority of injuries. Further studies of the injury rehabilitation practices, and the implementation and evaluation of safety programs in elite bandy are warranted.	[Timpka, T.; Risto, O.; Borg, K.; Johansson, J.] Linkoping Univ, Fac Hlth Sci, Dept Publ Hlth & Social Med, S-58185 Linkoping, Sweden; [Risto, O.] Linkoping Univ, Fac Hlth Sci, Dept Orthopaed, Linkoping, Sweden		Timpka, T (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Publ Hlth & Social Med, S-58185 Linkoping, Sweden.	tti@ida.liu.se	Timpka, Toomas/E-8065-2018				Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Hagglund M, 2005, SCAND J MED SCI SPOR, V15, P21, DOI 10.1111/j.1600-0838.2004.00395.x; Junge Astrid, 2004, Sports Med, V34, P929, DOI 10.2165/00007256-200434130-00004; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Molsa J, 2000, AM J SPORT MED, V28, P322; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; PELLETIER RL, 1993, AM J SPORT MED, V21, P78, DOI 10.1177/036354659302100114; Tegner Y, 1991, Br J Sports Med, V25, P87; Timpka T, 2002, MED SCI SPORT EXER, V34, P993, DOI 10.1097/00005768-200206000-00014; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; YOUNG K, 1993, SOCIOL SPORT J, V10, P373, DOI 10.1123/ssj.10.4.373	15	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2007	17	6					636	640		10.1111/j.1600-0838.2006.00623.x			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	240LD	WOS:000251588200005	17331084				2022-02-06	
J	Webbe, FM; Ochs, SR				Webbe, Frank M.; Ochs, Shelley R.			Personality Traits Relate to Heading Frequency in Male Soccer Players	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article								Concussions in soccer are often coincident with the act of heading the ball, and some researchers have reported that soccer heading is associated with neurocognitive decrements. This study aimed to understand (a) the personality factors that may predict frequent soccer heading, and (b) how knowledge of players' personality traits might help sport counselors persuade neurologically at-risk players to moderate their heading behavior. Sixty elite male soccer players (ages 16-34) completed structured self-report interviews, the NEO-FFI personality inventory, and the Arnett Inventory of Sensation Seeking. Players who headed most had significantly higher extraversion scores than comparison athletes and soccer players who headed less. Physical height was the best predictor of heading frequency but was not correlated with extraversion, which was also a significant predictor. Players with the typical profile of the high heading group may be more resistant to suggestion that they alter their style of play for safety reasons.	[Webbe, Frank M.; Ochs, Shelley R.] Florida Inst Technol, Sch Psychol, Melbourne, FL 32901 USA		Webbe, FM (corresponding author), Florida Inst Technol, Sch Psychol, Melbourne, FL 32901 USA.	webbe@fit.edu					Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; ARNETT J, 1994, PERS INDIV DIFFER, V16, P289, DOI 10.1016/0191-8869(94)90165-1; Arnett JJ, 1996, PERS INDIV DIFFER, V20, P693, DOI 10.1016/0191-8869(96)00027-X; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Costa Jr P.T., 1992, NEO PI R PROFESSIONA; FRIED T, 1992, SPORTS MED, V14, P269, DOI 10.2165/00007256-199214040-00005; Galambos SA, 2005, BRIT J SPORT MED, V39, P351, DOI 10.1136/bjsm.2005.018440; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kajihara K., 2001, JAPANESE J SPORTS PS, V28; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; LINDENFELD TN, 1994, AM J SPORT MED, V22, P364, DOI 10.1177/036354659402200312; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Rahnama N, 2002, BRIT J SPORT MED, V36, P354, DOI 10.1136/bjsm.36.5.354; Rutherford A, 2005, APPL COGNITIVE PSYCH, V19, P477, DOI 10.1002/acp.1091; Sandelin J, 1985, Br J Sports Med, V19, P30; SCHROTH ML, 1995, PERS INDIV DIFFER, V18, P219, DOI 10.1016/0191-8869(94)00144-H; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zarevski P, 1998, PERS INDIV DIFFER, V25, P763, DOI 10.1016/S0191-8869(98)00119-6; Zuckerman M., 1979, SENSATION SEEKING OP	26	9	9	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	DEC	2007	1	4					379	389		10.1123/jcsp.1.4.379			11	Psychology, Applied	Emerging Sources Citation Index (ESCI)	Psychology	V19PG	WOS:000214830300005					2022-02-06	
J	Dunlop, SA; Tee, LBG; Goossens, MAL; Stirling, RV; Hool, L; Rodger, J; Beazley, LD				Dunlop, Sarah A.; Tee, Lisa B. G.; Goossens, Michel A. L.; Stirling, R. Victoria; Hool, Livia; Rodger, Jenny; Beazley, L. D.			Regenerating optic axons restore topography after incomplete optic nerve injury	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						optic nerve regeneration; incomplete optic nerve transection; visual projections; topography; electrophysiological mapping; axonal tracing; reptiles	RETINAL GANGLION-CELLS; WALLABY MACROPUS-EUGENII; MAMMALIAN RETINOCOLLICULAR PROJECTION; SPINAL-CORD-INJURY; RETINOTECTAL PROJECTION; SUPERIOR COLLICULUS; SECONDARY DEGENERATION; CTENOPHORUS-ORNATUS; VISUAL PATHWAY; EPHRIN-A2 EXPRESSION	Following complete optic nerve injury in a lizard, Ctenophorus ornatus, retinal ganglion cell (RGC) axons regenerate but fail to restore retinotectal topography unless animals are trained on a visual task (Beazley et al. [1997] J Comp Neurol 370:105-120, [20031 J Neurotrauma 20:1263-1270). Here we show that incomplete injury, which leaves some RGC axons intact, restores normal topography. Strict RGC axon topography allowed us to preserve RGC axons on one side of the nerve (projecting to medial tectum) while lesioning those on the other side (projecting to lateral tectum). Topography and response properties for both RGC axon populations were assessed electrophysiologically. The majority of intact RGC axons retained appropriate topography in medial tectum and had normal, consistently brisk, reliable responses. Regenerate RGC axons fell into two classes: those that projected topographically to lateral tectum with responses that tended to habituate and those that lacked topography, responded weakly, and habituated rapidly. Axon tracing by localized retinal application of carbocyanine dyes supported the electrophysiological. data. RGC soma counts were normal in both intact and axotomized RGC populations, contrasting with the 30% RGC loss after complete injury. Unlike incomplete optic nerve injury in mammals, where RGC axon regeneration fails and secondary cell death removes many intact RGC somata, lizards experience a "win-win" situation: intact RGC axons favorably influence the functional outcome for regenerating ones and RGCs do not succumb to either primary or secondary cell death.	Curtin Univ Technol, Sch Pharm, Bentley, WA 6102, Australia; Univ Western Australia, Sch Anim Biol, Crawley, WA 6907, Australia; Univ Western Australia, Inst Med Res, Crawley, WA 6009, Australia; Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia		Dunlop, SA (corresponding author), Curtin Univ Technol, Sch Pharm, Bentley, WA 6102, Australia.	sarah@cyllene.uwa.edu.au	Dunlop, Sarah A/G-9357-2013; Rodger, Jennifer/H-5735-2014; Hool, Livia C/H-5059-2014	Rodger, Jennifer/0000-0003-3413-4229; Hool, Livia C/0000-0001-7758-5252; Dunlop, Sarah/0000-0002-1306-3962			Bach H, 2004, J COMP NEUROL, V477, P43, DOI 10.1002/cne.20238; Bach H, 2003, J COMP NEUROL, V467, P549, DOI 10.1002/cne.10941; Bahr M, 2006, ADV EXP MED BIOL, V557, P148; BASTMEYER M, 1993, GLIA, V8, P1, DOI 10.1002/glia.440080102; Beazley L.D., 2000, AXONAL REGENERATION, P67; Beazley LD, 2003, J NEUROTRAUM, V20, P1263, DOI 10.1089/089771503770802925; Beazley LD, 1997, J COMP NEUROL, V377, P105, DOI 10.1002/(SICI)1096-9861(19970106)377:1<105::AID-CNE10>3.0.CO;2-P; Beazley LD, 2000, DEGENERATION REGENER, P119; BERNHARDT R, 1988, J COMP NEUROL, V277, P403, DOI 10.1002/cne.902770306; BERNHARDT R, 1988, J COMP NEUROL, V277, P420, DOI 10.1002/cne.902770307; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Blair M, 2005, INVEST OPHTH VIS SCI, V46, P884, DOI 10.1167/iovs.04-0731; BLAUGRUND E, 1993, J COMP NEUROL, V330, P105, DOI 10.1002/cne.903300109; BODICK N, 1980, P NATL ACAD SCI-BIOL, V77, P4374, DOI 10.1073/pnas.77.7.4374; BURMEISTER DW, 1987, BRAIN RES, V423, P56, DOI 10.1016/0006-8993(87)90824-9; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chalupa LM, 1996, J COMP NEUROL, V368, P295; Chalupa LM, 1998, J COMP NEUROL, V392, P35, DOI 10.1002/(SICI)1096-9861(19980302)392:1<35::AID-CNE3>3.0.CO;2-Q; Chebat DR, 2006, J COMP NEUROL, V494, P887, DOI 10.1002/cne.20856; Chelvanayagam DK, 1998, J COMP NEUROL, V390, P333, DOI 10.1002/(SICI)1096-9861(19980119)390:3<333::AID-CNE3>3.0.CO;2-2; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COOK JE, 1979, J EMBRYOL EXP MORPH, V52, P89; Dieterich DC, 2002, EUR J NEUROSCI, V15, P1433, DOI 10.1046/j.1460-9568.2002.01977.x; Ding Y, 1997, ANAT EMBRYOL, V196, P141, DOI 10.1007/s004290050087; Dobkin BH, 2000, PROG BRAIN RES, V128, P99; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Dunlop SA, 2004, J COMP NEUROL, V478, P292, DOI 10.1002/cne.20299; Dunlop SA, 2003, EXP NEUROL, V184, P805, DOI 10.1016/j.expneurol.2003.08.013; Dunlop SA, 2000, J COMP NEUROL, V416, P188; DUNLOP SA, 2006, MODEL ORGANISMS SPIN, P323; FINLAY BL, 1979, NATURE, V280, P153, DOI 10.1038/280153a0; FUJISAWA H, 1982, DEV BIOL, V90, P43, DOI 10.1016/0012-1606(82)90210-X; GAZE R M, 1970, Experimental Brain Research, V10, P171; GRANT AC, 1991, BRAIN RES, V560, P106, DOI 10.1016/0006-8993(91)91221-L; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hanke J, 2002, ANN ANAT, V184, P113, DOI 10.1016/S0940-9602(02)80002-4; HARTLIEB E, 1989, J COMP NEUROL, V284, P148, DOI 10.1002/cne.902840111; HERDEGEN T, 1993, J NEUROBIOL, V24, P528, DOI 10.1002/neu.480240410; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Honda H, 2004, DEV GROWTH DIFFER, V46, P425; HUMPHREY MF, 1982, BRAIN RES, V239, P595, DOI 10.1016/0006-8993(82)90534-0; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Key B, 2002, CHEM SENSES, V27, P245, DOI 10.1093/chemse/27.3.245; King Barbara J., 2003, ANTHROPOL THEOR, V3, P5; King C, 2004, EXP NEUROL, V187, P380, DOI 10.1016/j.expneurol.2004.02.006; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Kolls BJ, 2002, J NEUROSCI, V22, P2626, DOI 10.1523/JNEUROSCI.22-07-02626.2002; Kreutz MR, 1999, RESTOR NEUROL NEUROS, V14, P127; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li YM, 2003, J NEUROSCI, V23, P7830; Marcus RC, 1999, J COMP NEUROL, V403, P346; MARK RF, 1993, NEUROREPORT, V5, P117, DOI 10.1097/00001756-199311180-00005; MAROTTE LR, 1993, J COMP NEUROL, V331, P1, DOI 10.1002/cne.903310102; MAROTTE LR, 1990, J COMP NEUROL, V293, P524, DOI 10.1002/cne.902930403; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; MEYER RL, 1980, J COMP NEUROL, V189, P273, DOI 10.1002/cne.901890205; Meyer RL, 1998, NEUROPSYCHOLOGIA, V36, P957, DOI 10.1016/S0028-3932(98)00052-9; MEYER RL, 1985, J COMP NEUROL, V239, P27, DOI 10.1002/cne.902390103; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Nural HF, 2004, J COMP NEUROL, V479, P399, DOI 10.1002/cne.20317; OLSON MD, 1994, J NEUROSCI, V14, P208; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Peker F, 2005, J RECONSTR MICROSURG, V21, P145, DOI 10.1055/s-2005-864849; Petrausch B, 2000, MOL CELL NEUROSCI, V16, P350, DOI 10.1006/mcne.2000.0877; Rodger J, 2000, EXP NEUROL, V166, P196, DOI 10.1006/exnr.2000.7486; Rodger J, 2005, EUR J NEUROSCI, V22, P1840, DOI 10.1111/j.1460-9568.2005.04381.x; Rodger J, 2004, MOL CELL NEUROSCI, V25, P56, DOI 10.1016/j.mcn.2003.09.010; Rodger J, 2001, EUR J NEUROSCI, V14, P1929, DOI 10.1046/j.0953-816x.2001.01822.x; Runko E, 2002, J COMP NEUROL, V451, P289, DOI 10.1002/cne.10356; Sabel B A, 2000, Curr Opin Ophthalmol, V11, P430, DOI 10.1097/00055735-200012000-00008; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P177; SCHMIDT JT, 1988, J COMP NEUROL, V269, P565, DOI 10.1002/cne.902690408; SCHMIDT JT, 1983, J EMBRYOL EXP MORPH, V77, P39; SCHMIDT JT, 1983, BRAIN RES, V269, P29, DOI 10.1016/0006-8993(83)90959-9; Schmidt JT, 2004, J NEUROBIOL, V59, P114, DOI 10.1002/neu.10343; SCHMIDT JT, 1979, PROC R SOC SER B-BIO, V205, P287, DOI 10.1098/rspb.1979.0066; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1991, J COMP NEUROL, V307, P393, DOI 10.1002/cne.903070305; SIMON DK, 1992, J NEUROSCI, V12, P1212; Stirling RV, 1998, J NEUROSCI METH, V81, P85, DOI 10.1016/S0165-0270(98)00020-X; Stirling RV, 1999, VISUAL NEUROSCI, V16, P681, DOI 10.1017/S0952523899164083; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VANEGAS H, 1974, BRAIN RES, V77, P25, DOI 10.1016/0006-8993(74)90802-6; VANEGAS H, 1974, J COMP NEUROL, V154, P43, DOI 10.1002/cne.901540104; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; YOON M, 1971, EXP NEUROL, V33, P395, DOI 10.1016/0014-4886(71)90031-8	94	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	NOV 1	2007	505	1					46	57		10.1002/cne.21477			12	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	219WB	WOS:000250117800004	17729282				2022-02-06	
J	Hanson, SL; Kerkhoff, TR				Hanson, Stephanie L.; Kerkhoff, Thomas R.			Ethical decision making in rehabilitation: Consideration of Latino cultural factors	REHABILITATION PSYCHOLOGY			English	Article						cultural competence; ethics; Latino; rehabilitation	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; MINORITY STATUS; IMPACT; SERVICES; CHILDREN; ACCESS; DISPARITIES; COMPETENCE; SURVIVORS	The current Ethical Principles of Psychologists and Code of Conduct of the American Psychological Association (APA, 2002a) places increased emphasis on respect for different cultures. For example, culture has been added as an important factor in respecting the rights and dignity of those with whom psychologists work (Principle E). APA has also released guidelines meant to influence psychologists' sensitivity and behavior toward multicultural issues in various aspects of professional work (APA, 2002b). The purpose of this article is to discuss cultural issues in the context of rehabilitation practice. The authors focus on Latinos, the fastest growing minority group in the United States. The case example of Cesar Garza is used as a vehicle for discussing how to integrate consideration of cultural factors into rehabilitation practice, consistent with sound ethical decision making. The case illustrates missed opportunities, for which the authors offer concrete solutions that reflect appropriate ethical conduct. The authors also hope to demonstrate that integration of cultural issues is consistent with overall rehabilitation psychology practice.	Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA		Hanson, SL (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, POB 100185, Gainesville, FL 32610 USA.	shanson@phhp.ufl.edu					Alcoff L. M., 2005, PHILOS SOC CRIT, V31, P395, DOI [10.1177/0191453705052972, DOI 10.1177/0191453705052972]; *AM PSYCH ASS, 2002, GUID MULT ED TRAIN R; *AM PSYCH ASS, 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2007, J HEAD TRAUMA REHAB, V22, P73, DOI 10.1097/01.HTR.0000265094.98940.e0; Arcia E., 1998, J CHILD FAM STUD, V7, P79, DOI [10.1023/A:1022964114251, DOI 10.1023/A:1022964114251]; ARREDONDO P, 2004, HDB CHICANA PSYCHOL, P231; Becker G, 2001, WESTERN J MED, V175, P19, DOI 10.1136/ewjm.175.1.19; Berk M L, 2001, J Immigr Health, V3, P151; Berk ML, 2000, HEALTH AFFAIR, V19, P51, DOI 10.1377/hlthaff.19.4.51; Birman D, 1998, AM J COMMUN PSYCHOL, V26, P335, DOI 10.1023/A:1022101219563; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Burnett DM, 2002, NEUROREHABILITATION, V17, P187; Bush SS, 2005, HLTH CARE ETHICS PSY; CASTRO FG, 2004, HDB CHICANA O PSYCHO, P371; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Dana R., 1998, UNDERSTANDING CULTUR; ELLIOTT P, 1994, INT J GYNECOL CANCER, V4, P84, DOI 10.1046/j.1525-1438.1994.04020084.x; Farberman R., 2006, MONITOR PSYCHOL, V37, P40; FELD P, 2000, IMMIGRANTS ACCESS HL, V1608; Fix M., 1999, ALL ONE ROOF MIXED S; Flores G, 1998, ARCH PEDIAT ADOL MED, V152, P1119; Granados G, 2001, AM J PUBLIC HEALTH, V91, P1806, DOI 10.2105/AJPH.91.11.1806; Guendelman S, 2001, HEALTH AFFAIR, V20, P257, DOI 10.1377/hlthaff.20.1.257; HANSON SL, 2004, TRAUMATIC BRAIN INJU, P685; HARRIS M, 2004, HDB CHICANA PSYCHOL, P111; Hartman RG, 2002, AM J LAW MED, V28, P409; HO MK, 2004, FAMILY THERAPY ETHNI; Kaplan SA, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0026; KOHRMAN A, 1995, PEDIATRICS, V95, P314; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kuther TL, 2003, ADOLESCENCE, V38, P343; Lillie-Blanton M, 2001, AM J PUBLIC HEALTH, V91, P1736, DOI 10.2105/AJPH.91.11.1736; Locke D.C., 1998, INCREASING MULTICULT, V2nd ed.; Lomay VT, 2006, REHABIL PSYCHOL, V51, P36, DOI 10.1037/0090-5550.51.1.36; Lopez Rebecca A, 2005, J Immigr Health, V7, P23, DOI 10.1007/s10903-005-1387-8; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; MCNEILL BW, 2004, HDB CHICANA O PSYCHO, P427; McNell, 2004, HDB CHICANA PSYCHOL, P61; MURGUIA E, 1991, LATINO STUDIES J, V2, P8; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; PANIAGUA FA, 2005, ASSESSING TREATING C; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Rehm R S, 2000, J Pediatr Nurs, V15, P89, DOI 10.1053/jn.2000.5448; Rehm RS, 2003, QUAL HEALTH RES, V13, P689, DOI 10.1177/1049732303013005007; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Ruiz-Beltran M, 2001, J COMMUN HEALTH, V26, P123, DOI 10.1023/A:1005229330204; SAMUDA RJ, 1998, PSYCHOL TESTING AM M; SANTIAGORIVERA AL, 2002, COUNSELING LATINOS F; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Smart JF, 1997, J REHABIL, V63, P9; Spector R., 2004, CULTURAL DIVERSITY H; U. S. Department of Health and Human Services, 1996, PERS RESP WORK OPP R; *US BUR CENS, 2000, HISP LAT TYP 2000; *US BUR CENS, 2007, HISP HER MONTH; *US DEP HHS, 2004, GUID FED FIN ASS REC; Velasquez R. J., 2004, HDB CHICANALO PSYCHO, P153; Waldrop J., 2003, DISABILITY STATUS 20; WANG Q, 2005, DISABILITY A FAMILIE; Weinick RM, 2000, AM J PUBLIC HEALTH, V90, P1771, DOI 10.2105/AJPH.90.11.1771; Wilson KB, 2005, J COUNS DEV, V83, P86, DOI 10.1002/j.1556-6678.2005.tb00583.x; ZEQA MC, 1997, PSYCHOL INTERVENTION, P217; ZWEIFLER RM, 1995, STROKE, V26, P245, DOI 10.1161/01.STR.26.2.245	68	9	10	1	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2007	52	4					409	420		10.1037/0090-5550.52.4.409			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	233QG	WOS:000251104800006					2022-02-06	
J	Oncel, D; Demetriades, D; Gruen, P; Salim, A; Inaba, K; Rhee, P; Browder, T; Nomoto, S; Chan, L				Oncel, Didem; Demetriades, Demetrios; Gruen, Peter; Salim, Ali; Inaba, Kenji; Rhee, Peter; Browder, Timothy; Nomoto, Shot; Chan, Linda			Brain lobectomy for severe head injuries is not a hopeless procedure	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						trauma; brain lobectomies; outcomes	DECOMPRESSIVE CRANIOTOMY; TEMPORAL LOBECTOMY; SUBDURAL-HEMATOMA; CEREBRAL EDEMA; HERNIATION	Introduction: Posttraumatic transtentorial herniation or intractable intracranial hypertension are ominous signs, and are associated with very poor outcomes. Aggressive procedures, such as brain lobectomies, may benefit some of these patients. The published experience with brain lobectomies is very limited. Patients: Retrospective study of head injury patients with focal brain lesions and intractable intracranial hypertension or herniation who underwent partial or anatomic brain lobectomies. The following parameters were included in the analysis: age, gender, mechanism of injury, hypotension at admission, initial Glasgow Coma Scale (GCS) score, Abbreviated Injury Scale for head, chest, and abdomen, Injury Severity Score, time from admission to operation, type of brain lobectomy, intensive care unit and hospital stays, survival, and Glasgow Outcome Score. Stepwise logistic regression analysis was used to identify independent risk factors for mortality and functional outcomes. Results: During the 13-year study period, there were 183 patients who underwent brain lobectomy for traumatic injuries. Eighty-eight patients (48.1%) underwent frontal lobectomy, 67 (36.6%) temporal lobectomy, and the remaining 28 (15.3%) other or combination lobectomies. The mean follow-up was 22 days. There were 50 deaths (mortality 27.3%). Excluding patients with major extracranial injuries, there were 47 deaths (26.9%). Patients with blunt trauma had a significantly higher mortality than those with penetrating trauma had (33.1% vs. 12.0%, p = 0.005). Among the risk factors studied, blunt injury mechanism was identified as the only risk factor for mortality. Overall, 48% of the 133 survivors had good functional outcomes, and 51.9% had poor functional outcomes (including 15.0% with persistent vegetative state). Multiple-response logistic regression identified blunt trauma, low initial GCS score, and frontal lobectomy as independent risk factors for poor outcomes. Conclusion: Selected severe head injury patients with focal brain lesions and intractable intracranial hypertension or herniation may benefit from brain lobectomies. The survival and functional outcomes after this procedure are acceptable. Blunt trauma, low initial GCS score, and frontal lobectomies are significant risk factors for poor outcomes.	Univ So Calif, Ctr Med, Dept Neurol Surg, Div Trauma & Surg Critic Care, Los Angeles, CA USA; Univ So Calif, Ctr Med, Dept Biostat, Div Trauma & Surg Critic Care, Los Angeles, CA USA		Demetriades, D (corresponding author), Univ So Calif, Ctr Med, 1200 N State St, Rm 1105, Los Angeles, CA 90033 USA.	demetria@.usc.edu	INABA, KENJI/AAC-8532-2020				Aarabi B, 2006, J NEUROSURG, V104, P460; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; CUSHING HW, 1908, J HOPKINS HOSP B, V19, P48; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; LEE EJ, 1995, J FORMOS MED ASSOC, V94, P341; LITOFSKY NS, 1994, NEUROSURGERY, V34, P628, DOI 10.1227/00006123-199404000-00009; NUSSBAUM ES, 1991, NEUROSURGERY, V29, P62, DOI 10.1227/00006123-199107000-00010; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; VALADKA AB, 2006, TRAUMA, P385	10	9	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2007	63	5					1010	1013		10.1097/TA.0b013e318156ee64			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	232BX	WOS:000250994200009	17993944				2022-02-06	
J	Tang, V; Warden, J; Cullen, N; Rutledge, E				Tang, Vivien; Warden, Julia; Cullen, Nora; Rutledge, Eleanor			Topiramate in traumatic brain injury: Adverse effects on cognitive function	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							EPILEPSY; WITHDRAWAL; ADULTS		Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; McMaster Univ, Sch Med, Hamilton, ON L8S 4L8, Canada; Univ Toronto, Sch Med, Toronto, ON, Canada		Cullen, N (corresponding author), Toronto Rehabil Inst, Room 1023,550 Univ Ave, Toronto, ON M5G 2A2, Canada.	Cullen.Nora@TorontoRehab.on.ca		Cullen, Nora/0000-0001-6359-9418			Antai-Otong D, 2005, PERSPECT PSYCHIATR C, V41, P92, DOI 10.1111/j.1744-6163.2005.00018.x; Fritz N, 2005, EPILEPSY BEHAV, V6, P373, DOI 10.1016/j.yebeh.2005.01.002; Gross-Tsur V, 2004, NEUROLOGY, V62, P299, DOI 10.1212/01.WNL.0000103285.85821.B3; Huber B, 2002, NERVENARZT, V73, P525, DOI 10.1007/s00115-002-1294-3; Jansen JFA, 2006, EPILEPSY BEHAV, V9, P181, DOI 10.1016/j.yebeh.2006.05.004; Kerr MP, 2005, EPILEPSY BEHAV, V7, P472, DOI 10.1016/j.yebeh.2005.07.006; Khan A, 1999, SEIZURE-EUR J EPILEP, V8, P235, DOI 10.1053/seiz.1999.0287; Kober D, 2005, AM J PSYCHIAT, V162, P1542, DOI 10.1176/appi.ajp.162.8.1542; Kockelmann E, 2003, EPILEPSY RES, V54, P171, DOI 10.1016/S0920-1211(03)00078-0; LaRoche SM, 2004, JAMA-J AM MED ASSOC, V291, P605, DOI 10.1001/jama.291.5.605; Lee HW, 2006, EPILEPSY BEHAV, V8, P736, DOI 10.1016/j.yebeh.2006.03.006; Lee S, 2003, EPILEPSIA, V44, P339, DOI 10.1046/j.1528-1157.2003.27402.x; Mula M, 2003, NEUROLOGY, V60, P1104, DOI 10.1212/01.WNL.0000056637.37509.C6; Mula M, 2003, EPILEPSIA, V44, P659, DOI 10.1046/j.1528-1157.2003.05402.x; Rorsman IA, 2001, SEIZURE-EUR J EPILEP, V10, P592, DOI 10.1053/seiz.2001.0554; Schlatter FJ, 2001, J CLIN PSYCHOPHARM, V21, P464, DOI 10.1097/00004714-200108000-00021; Singh BK, 2002, SEIZURE-EUR J EPILEP, V11, P47, DOI 10.1053/seiz.2001.0571; Smith ME, 2006, EPILEPSIA, V47, P695, DOI 10.1111/j.1528-1167.2006.00508.x; Stella F, 2002, ARQ NEURO-PSIQUIAT, V60, P285, DOI 10.1590/S0004-282X2002000200019	19	9	9	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					409	410		10.1097/01.HTR.0000300236.21114.bc			2	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500011	18025973				2022-02-06	
J	Mani, TM; Miller, LS; Yanasak, N; Macciocchi, S				Mani, Tanja M.; Miller, L. Stephen; Yanasak, Nathan; Macciocchi, Stephen			Evaluation of changes in motor and visual functional activation over time following moderate-to-severe brain injury	BRAIN INJURY			English	Article						traumatic brain injury; neuroimaging; functional magnetic resonance imaging (fMRI)	COGNITIVE REHABILITATION; FMRI; CORTEX; MEMORY; MRI; REORGANIZATION; STIMULATION; RECOVERY; OLDER	Primary objective: Relatively little research has documented functional recovery following traumatic brain injury using neuroimaging techniques. This study aimed to examine the effects of moderate- to- severe brain injury on brain functioning over time. Research design: Eight brain-injured participants completed motor and visual tasks during fMRI at two time points within the first year following injury. Changes in functional activation within ROIs and in dispersion of activation were evaluated across time points. Main outcomes and results: Participants demonstrated significantly reduced activation intensity within the ROI over time for the motor task, but not the RPS task. Participants demonstrated a ( non-significant) trend toward reduced functional dispersion over time. Most participants demonstrated greater activation within ( vs outside) the ROI for both tasks. Variability among participants, in terms of activation intensity and dispersion, was evident. Conclusions: The findings provide support for the occurrence of functional recovery over the first year post-injury, with fewer resources utilized during task completion over time. Additionally, results suggest that variability in functional activation and activation in brain regions typically activated among controls could be anticipated in a moderate-severe TBI group. Lastly, simple motor and visual tasks may be useful in efforts to demonstrate functional recovery over time.	Methodist Rehabil Ctr, Neuropsychol Dept, Jackson, MS 39216 USA; Univ Georgia, Dept Psychol, Athens, GA 30602 USA; Med Coll Georgia, Dept Radiol, Augusta, GA 30912 USA; Shepherd Ctr, Neuropsychol Div, Atlanta, GA USA		Mani, TM (corresponding author), Methodist Rehabil Ctr, Neuropsychol Dept, Jackson, MS 39216 USA.	tanja_mani@hotmail.com					Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; CONNELLY A, 1993, RADIOLOGY, V188, P125, DOI 10.1148/radiology.188.1.8511285; Draganski B, 2004, NEUROREPORT, V15, P251, DOI 10.1097/00001756-200402090-00007; GLOVER GH, 1995, MAGNET RESON MED, V33, P624, DOI 10.1002/mrm.1910330507; Grafton S T, 1994, Hum Brain Mapp, V1, P221, DOI 10.1002/hbm.460010307; GRAFTON ST, 1991, J NEUROPHYSIOL, V66, P735, DOI 10.1152/jn.1991.66.3.735; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; KAWASHIMA R, 1994, BRAIN RES, V663, P251, DOI 10.1016/0006-8993(94)91270-X; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Laatsch L, 2004, REHABIL PSYCHOL, V49, P262, DOI 10.1037/0090-5550.49.3.262; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Little DM, 2004, COGNITIVE BRAIN RES, V22, P84, DOI 10.1016/j.cogbrainres.2004.07.011; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; McCarthy G, 1994, HUMAN BRAIN MAPPING, V2, P234, DOI DOI 10.1002/HBM.460020405; Miller LS, 2002, BIOL PSYCHIAT, V51, p196S; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; Prigatano GP, 2004, BRAIN INJURY, V18, P661, DOI 10.1080/02699050310001646170; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; SCHLOSSER MJ, 1997, J CEREBRAL CIRCULATI, V28, P1130; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Williams SE, 2005, BRAIN INJURY, V19, P549, DOI 10.1080/02699050400013576; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yoo SS, 2005, INT J NEUROSCI, V115, P55, DOI 10.1080/00207450490512650	33	9	9	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1155	1163		10.1080/02699050701687367			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900007	17952715				2022-02-06	
J	Zhu, L; Yan, W; Qi, M; Hu, ZL; Lu, TJ; Chen, M; Zhou, J; Hang, CH; Shi, JX				Zhu, Lin; Yan, Wei; Qi, Meng; Hu, Ze Lan; Lu, Ting Jia; Chen, Min; Zhou, Jin; Hang, Chun Hua; Shi, Ji Xin			Alterations of pulmonary zinc homeostasis and cytokine production following traumatic brain injury in rats	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						brain trauma; lung; zinc; cytokines; TNF-alpha; IL-8	AIRWAY EPITHELIAL-CELLS; HYDROXYETHYL STARCH; LABILE ZINC; INFLAMMATION; PERMEABILITY; LUNG; EXPRESSION; APOPTOSIS; RESPONSES; RELEASE	Previous studies have shown that labile zinc and inflammatory mediators participate in many pathophysiological processes. The present study investigated the effects of traumatic brain injury (TBI) on the levels of labile zinc and certain proinflammatory factors in rat lung. Male Wistar rats were randomly assigned to 7 groups as follows: normal group, group with sham operation, and TBI groups that were sacrificed respectively at 1, 6, 24, and 72 hr, and on day 7 post-injury. Pulmonary labile zinc, tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-8, and wet/dry weight ratio were measured at the specified time intervals. TBI caused a gradual increase of pulmonary labile zinc as demonstrated by fluorescence staining with Zinpyr-4 (ZP4). The levels of TNF-alpha and IL-8 and the lung wet/dry weight ratios were higher in the TBI groups compared to the normal and sham-operated groups (p < 0.05). There were highly positive correlations between the intensity of ZP4 fluorescence and the pulmonary levels of TNF-alpha and IL-8. The results suggest that TBI induces rapid increases of labile zinc and inflammatory mediators in lung, which may participate in the pathogenesis of acute lung injury.	Nanjing Univ, Dept Neurosurg, Sch Med, Jinling Hosp, Nanjing 210002, Peoples R China; Chinese Acad Sci, Inst Neurosci Shanghai, Shanghai, Peoples R China		Shi, JX (corresponding author), Nanjing Univ, Dept Neurosurg, Sch Med, Jinling Hosp, 305 E Zhongshan Rd, Nanjing 210002, Peoples R China.	shijixin52@163.com	QI, Meng/F-2802-2012; Chen, Min/A-1134-2014	Yan, Wei/0000-0002-1123-0835			Adamson IYR, 2000, TOXICOL APPL PHARM, V166, P111, DOI 10.1006/taap.2000.8955; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Bao SY, 2006, AM J PHYSIOL-LUNG C, V291, pL1132, DOI 10.1152/ajplung.00207.2006; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Chang CJ, 2004, CHEM BIOL, V11, P203, DOI 10.1016/j.chembiol.2004.01.017; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; D Zalewski P, 2006, CURR OPIN PHARMACOL, V6, P237, DOI 10.1016/j.coph.2006.01.005; DETTBARN CL, 1989, HEART LUNG, V18, P583; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fisher AJ, 1999, LANCET, V353, P1412, DOI 10.1016/S0140-6736(99)00494-8; FORMBY B, 1984, DIABETES, V33, P229, DOI 10.2337/diabetes.33.3.229; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Gol'dberg E D, 1993, Klin Lab Diagn, P25; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Ieshchenko V A, 1994, Lik Sprava, P86; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kim YM, 2006, AM J PHYSIOL-LUNG C, V290, pL1028, DOI 10.1152/ajplung.00479.2005; Lv R, 2005, ANN CLIN LAB SCI, V35, P174; MARON MB, 1989, J APPL PHYSIOL, V67, P305, DOI 10.1152/jappl.1989.67.1.305; Mills PR, 1999, AM J RESP CRIT CARE, V160, pS38, DOI 10.1164/ajrccm.160.supplement_1.11; Ni Shuilleabhain S, 2006, ECOTOX ENVIRON SAFE, V65, P332, DOI 10.1016/j.ecoenv.2005.08.004; Rice TM, 2001, TOXICOL APPL PHARM, V177, P46, DOI 10.1006/taap.2001.9287; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takizawa H, 1998, INT J MOL MED, V1, P367; Tian J, 2003, ANN CLIN LAB SCI, V33, P451; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Truong-Tran AQ, 2000, AM J PHYSIOL-LUNG C, V279, pL1172, DOI 10.1152/ajplung.2000.279.6.L1172; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Woodroofe CC, 2004, CHEM BIOL, V11, P1659, DOI 10.1016/j.chembiol.2004.09.013; Zalewski PD, 2005, PHARMACOL THERAPEUT, V105, P127, DOI 10.1016/j.pharmthera.2004.09.004; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471	34	9	9	0	2	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	FAL	2007	37	4					356	361					6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	230QG	WOS:000250890400008	18000293				2022-02-06	
J	Marciano, D; Shohami, E; Kloog, Y; Alexandrovitch, A; Brandeis, R; Goelman, G				Marciano, Daniele; Shohami, Esther; Kloog, Yoel; Alexandrovitch, Alexander; Brandeis, Rachel; Goelman, Gadi			Neuroprotective effects of the Ras inhibitor S-trans-trans-farnesylthiosalicylic acid, measured by diffusion-weighted imaging after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						MRI; Ras; S-trans-trans-farnesylthiosalicylic acid (FTS); traumatic brain injury	CLOSED-HEAD-INJURY; CEREBRAL-ISCHEMIA; PERFUSION; RECEPTORS; MORTALITY; EDEMA; MODEL; MICE; MRI	Ras proteins play a role in receptor-mediated signaling pathways and are activated after traumatic brain injury. S-trans-trans-farnesylthiosalicylic acid (FTS), a synthetic Ras inhibitor, acts primarily on the active, GTP-bound form of Ras and was shown to improve neurobehavioral outcome after closed head injury (CHI) in mice. To gain a better understanding of the neuroprotective mechanism of FTS, we used diffusion-weighted imaging (DWI) in a rat model of CHI. Apparent diffusion coefficients ( ADC) and transverse relaxation times (T2) were measured in injured rat brains after treatment with vehicle or FTS ( 5 mg/kg). Neuroprotection by FTS was also assessed in terms of the neurological severity score. One week after injury, significantly better recovery was observed in the FTS-treated rats than in the controls ( p = 0.0191). T2 analysis of the magnetic resonance images revealed no differences between the two groups. In contrast, they differed significantly in ADC, particularly at 24 h post-CHI ( p < 0.05): in the vehicle-treated rats ADC had decreased to approximately 26% below baseline, whereas it had increased to about 10% above baseline in the FTStreated rats. As the magnitude of ADC reduction is strongly linked to blood perfusion deficit, these results suggest that the neuroprotective mechanism of FTS might be related to an improvement in cerebral perfusion. We propose that FTS, which is currently being tested in humans for anti-cancer indications, should also be considered as a new strategy for the management of head injury.	Israel Inst Biol Res, Dept Organ Chem, IL-74100 Ness Ziona, Israel; Hebrew Univ Jerusalem, Dept Pharmacol, Sch Pharm, Jerusalem, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, Ramat Aviv, Israel; Hadassah Hebrew Univ Med Ctr, Human Biol Res Ctr, MRI MRS Lab, Jerusalem, Israel		Marciano, D (corresponding author), Israel Inst Biol Res, Dept Organ Chem, POB 19, IL-74100 Ness Ziona, Israel.	daniele@iibr.gov.il					Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; BRANTZAWADZKI M, 1987, AM J ROENTGENOL, V148, P579, DOI 10.2214/ajr.148.3.579; BUSZA AL, 1992, STROKE, V23, P1602, DOI 10.1161/01.STR.23.11.1602; Cernak I, 2004, J CEREBR BLOOD F MET, V24, P564, DOI 10.1097/00004647-200405000-00011; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; DARDZINSKI BJ, 1993, MAGNET RESON MED, V30, P318, DOI 10.1002/mrm.1910300307; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gomori J M, 1988, Radiographics, V8, P427; Graham SH, 2000, J NEUROTRAUM, V17, P831, DOI 10.1089/neu.2000.17.831; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; HENNINGER N, 2007, IN PRESS PARKINSONIS; HOSSMANN KA, 1995, CEREBROVAS BRAIN MET, V7, P187; Ishikawa S, 2002, BRIT J ANAESTH, V89, P605, DOI 10.1093/bja/aef235; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kawata M, 2006, J THORAC CARDIOV SUR, V132, P933, DOI 10.1016/j.jtcvs.2006.03.064; Kloog, 1999, Expert Opin Investig Drugs, V8, P2121, DOI 10.1517/13543784.8.12.2121; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Le Bihan D, 1995, DIFFUSION PERFUSION; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Li FH, 2000, NEUROLOGY, V54, P689, DOI 10.1212/WNL.54.3.689; Lu J, 2005, ACT NEUR S, V95, P281; MARCIANO D, 1995, J MED CHEM, V38, P1267, DOI 10.1021/jm00008a004; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shohami E, 2003, J CEREBR BLOOD F MET, V23, P728, DOI 10.1097/01.WCB.0000067704.86573.83; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1779; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058	39	9	9	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2007	24	8					1378	1386		10.1089/neu.2007.0318			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202QQ	WOS:000248918500009	17711399				2022-02-06	
J	Pissiotis, A; Vanderas, AP; Papagiannoulis, L				Pissiotis, Aristides; Vanderas, Apostole P.; Papagiannoulis, Liza			Longitudinal study on types of injury, complications and treatment in permanent traumatized teeth with single and multiple dental trauma episodes	DENTAL TRAUMATOLOGY			English	Article						multiple trauma episodes; types of injury; complication; treatment; permanent teeth		The purpose of this study was to compare the type of injuries, complications and treatment in permanent traumatized teeth with single and multiple dental trauma episodes (MDTE). One hundred and fifty-five children, aged 6-14 years, sustaining one or more traumatic episodes to permanent teeth were included in this investigation. After the medical and dental history the patients were examined clinically and radiographically and the diagnosis of trauma, the treatment plan and the applied treatment were recorded. Also, information regarding the number of traumatic episodes, the number of injured permanent teeth and the vitality of the pulp was collected. In follow-ups, traumatized teeth were examined clinically and radiographically to evaluate the treatment applied and to detect any complication. The t-statistic was used to test differences in the mean number of teeth per patient with different types of injury, complications and treatment between permanent traumatized teeth with single and multiple trauma episodes. A 95% probability level was used. The results showed that MDTE significantly affected the mean number of teeth per patient with fractured restoration, root fracture, concussion, pulp canal obliteration, root replacement resorption, filling therapy, surgery and prosthetic treatment. It was concluded that MDTE increase the risk of having certain types of injury, complications and treatment.	Private Pract, Volos, Greece; Univ Athens, Sch Dent Med, Dept Pediat Dent, Athens, Greece		Pissiotis, A (corresponding author), Alkistidos 71, Volos 38222, Greece.	arispissiotis@yahoo.com					Al-Jundi SH, 2004, DENT TRAUMATOL, V20, P1, DOI 10.1111/j.1600-4469.2004.00218.x; ANDREASEN JO, 1994, TRAUMATIC INJURIES T, P1; Glendor U, 2000, ENDOD DENT TRAUMATOL, V16, P205; Hedegard B, 1973, Sven Tandlak Tidskr, V66, P431; MCKENNA FP, 1983, ACCIDENT ANAL PREV, V15, P65, DOI 10.1016/0001-4575(83)90008-8; ONETTO JE, 1994, ENDOD DENT TRAUMATOL, V10, P223; RAVN JJ, 1974, COMMUNITY DENT ORAL, V2, P231, DOI 10.1111/j.1600-0528.1974.tb01658.x; Robertson A, 1997, Int J Paediatr Dent, V7, P217, DOI 10.1046/j.1365-263X.1997.00046.x; STOCKWELL AJ, 1988, COMMUNITY DENT ORAL, V16, P294, DOI 10.1111/j.1600-0528.1988.tb01779.x	9	9	10	0	3	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	AUG	2007	23	4					222	225		10.1111/j.1600-9657.2006.00442.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	197CX	WOS:000248532400006	17635355				2022-02-06	
J	Drabek, T; Fisk, JA; Dixon, CE; Garman, RH; Stezosk, J; Wisnewski, SR; Wu, X; Tisherman, SA; Kochanek, PM				Drabek, Tomas; Fisk, Jesse A.; Dixon, C. Edward; Garman, Robert H.; Stezosk, Jason; Wisnewski, Stephen R.; Wu, Xianren; Tisherman, Samuel A.; Kochanek, Patrick M.			Prolonged deep hypothermic circulatory arrest in rats can be achieved without cognitive deficits	LIFE SCIENCES			English	Article						cardiac surgery; cardiopulmonary bypass; deep hypothermic circulatory arrest; neurologic injury; rat	INTESTINAL MUCOSAL PERFUSION; ASPHYXIAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; LOW-FLOW PERFUSION; CARDIOPULMONARY BYPASS; NEUROCOGNITIVE DYSFUNCTION; LETHAL HEMORRHAGE; SWINE MODEL; EMERGENCY PRESERVATION; OPIOID NEUROTOXICITY	Cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) enable surgical repair of cardiovascular defects. However, neurological complications can result after both CPB and DHCA. We sought to investigate if 75 min of CPB or DHCA caused motor, cognitive or histological deficits in rats. Three groups were studied: DHCA, CPB, and sham. Rats in the DHCA group were subjected to 75 min DHCA at 15 degrees C, with a total CPB duration of 75 min. Rats in the CPB group were subjected to 75 min of normothermic CPB. Shams received the same anesthesia, cannulations and infusions. Motor function was assessed using beam testing on days 3-13. Cognitive performance was evaluated using Morris water maze tasks on days 7-13. Overall Performance Category (OPC) and Neurologic Deficit Score (NDS) were assessed daily. Histological Damage Score (HDS) was assessed in survivors on day 14. Sustained deficits on beam testing were seen only in the CPB group. Rats in the CPB and DHCA groups exhibited similar cognitive performance vs. sham. There were no differences in OPC or NDS between groups. Neuronal degeneration was present only in small foci in rats after DHCA (n = 4/7). However, HDS was not different in individual brain regions or viscera between DHCA or CPB vs. sham. Surprisingly, CPB, but not DHCA was associated with motor deficits vs. sham, and no cognitive deficits were seen in either group vs. sham. Future studies with longer DHCA duration will be necessary to provide targets to assess novel preservation strategies. Published by Elsevier Inc.	Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Consultants Vet Pathol Inc, Murrysville, PA 15668 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Epidemiol Data Ctr, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA		Drabek, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, 3434 5th Ae, Pittsburgh, PA 15260 USA.	drabekt@anes.upme.edu	Tisherman, Samuel A./AAK-9377-2020; Drabek, Tomas/AAJ-1595-2021; Kochanek, Patrick M/D-2371-2015	Tisherman, Samuel A./0000-0003-3810-3729; Drabek, Tomas/0000-0002-5702-4498; Kochanek, Patrick M/0000-0002-2627-913X			Alam HB, 2006, J TRAUMA, V60, P134, DOI 10.1097/01.ta.0000198469.95292.ec; Alam HB, 2004, J TRAUMA, V57, P961, DOI 10.1097/01.TA.0000149549.72389.3F; Amory DW, 2002, J CARDIOTHOR VASC AN, V16, P270, DOI 10.1053/jcan.2002.124132; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Brambrink AM, 1999, J NEUROSCI METH, V92, P111, DOI 10.1016/S0165-0270(99)00100-4; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; Charchaflieh J, 1998, ANESTH ANALG, V87, P68, DOI 10.1097/00000539-199807000-00015; Chock VY, 2006, J THORAC CARDIOV SUR, V131, P659, DOI 10.1016/j.jtcvs.2005.09.005; Dieleman JM, 2006, LIFE SCI, V79, P551, DOI 10.1016/j.lfs.2006.01.036; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dong GH, 2005, J SURG RES, V123, P171, DOI 10.1016/j.jss.2004.08.007; Drabek T, 2007, CRIT CARE MED, V35, P532, DOI 10.1097/01.CCM.0000253398.61666.0D; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Forbess JM, 2002, J THORAC CARDIOV SUR, V123, P631, DOI 10.1067/mtc.2002.119342; Gimenez-Llort L, 2002, EUR J NEUROSCI, V16, P547, DOI 10.1046/j.1460-9568.2002.02122.x; Goldberg CS, 2007, J THORAC CARDIOV SUR, V133, P880, DOI 10.1016/j.jtcvs.2006.11.029; GORDAN ML, 2005, J NEUROSURGICAL ANES, V17, P227; Goyagi T, 2006, ANESTH ANALG, V103, P658, DOI 10.1213/01.ane.0000228859.95126.69; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Jungwirth B, 2006, J THORAC CARDIOV SUR, V131, P805, DOI 10.1016/j.jtcvs.2005.11.017; Kawaguchi AT, 1998, CIRCULATION, V98, pII385; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kofke WA, 1996, ANESTH ANALG, V83, P1298, DOI 10.1097/00000539-199612000-00029; Kofke WA, 1999, BRAIN RES, V818, P326, DOI 10.1016/S0006-8993(98)01228-1; Kondratiev TV, 2006, AM J PHYSIOL-HEART C, V291, pH441, DOI 10.1152/ajpheart.01229.2005; Kumral E, 2001, TEX HEART I J, V28, P83; Liachenko S, 2001, J CEREBR BLOOD F MET, V21, P1320, DOI 10.1097/00004647-200111000-00008; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; Mackensen GB, 2001, ANESTHESIOLOGY, V95, P1485, DOI 10.1097/00000542-200112000-00031; Miura Y, 1998, ANESTHESIOLOGY, V89, P391, DOI 10.1097/00000542-199808000-00016; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUJSCE DJ, 1994, STROKE, V25, P1433, DOI 10.1161/01.STR.25.7.1433; Myung RJ, 2004, J THORAC CARDIOV SUR, V127, P1051, DOI 10.1016/j.jtcvs.2003.11.008; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Nygren A, 2006, CRIT CARE MED, V34, P722, DOI 10.1097/01.CCM.0000201879.20281.C6; Nygren A, 2003, INTENS CARE MED, V29, P1322, DOI 10.1007/s00134-003-1829-5; PIRK J, 1995, ANN THORAC SURG, V60, P464, DOI 10.1016/0003-4975(95)98959-X; Rees K, 2001, COCHRANE DB SYST REV, V1, pCD002138, DOI DOI 10.1002/14651858.CD002138; Sailhamer EA, 2007, J AM COLL SURGEONS, V204, P642, DOI 10.1016/j.jamcollsurg.2007.01.017; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Tian GF, 2002, J NEUROPHYSIOL, V88, P236, DOI 10.1152/jn.00572.2001; Vannucci RC, 1996, PEDIATR RES, V40, P177, DOI 10.1203/00006450-199608000-00001; Visconti KJ, 2006, ANN THORAC SURG, V82, P2207, DOI 10.1016/j.athoracsur.2006.06.069; WERNER C, 1990, ANESTHESIOLOGY, V73, P923, DOI 10.1097/00000542-199011000-00021; WU X, J CEREBRAL BLOOD FLO, DOI DOI 10.1035/SJ.JCBFM.9600524; Wu XR, 2006, CIRCULATION, V113, P1974, DOI 10.1161/CIRCULATIONAHA.105.587204; Wypij D, 2003, J THORAC CARDIOV SUR, V126, P1397, DOI 10.1016/S0022-5223(03)00940-1; Zhang TJ, 2006, ANESTH ANALG, V102, P1018, DOI 10.1213/01.ane.0000199221.96250.8c	52	9	11	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	JUL 26	2007	81	7					543	552		10.1016/j.lfs.2007.06.015			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	208PS	WOS:000249332300003	17658556				2022-02-06	
J	Zhang, ZY; Zhang, Z; Fauser, U; Artelt, M; Burnet, M; Schluesener, HJ				Zhang, Z.-Y.; Zhang, Z.; Fauser, U.; Artelt, M.; Burnet, M.; Schluesener, H. J.			Dexamethasone transiently attenuates up-regulation of endostatin/collagen XVIII following traumatic brain injury	NEUROSCIENCE			English	Article						traumatic brain injury; endostatin/collagen XVIII; microglia/macrophages; dexamethasone	NECROSIS-FACTOR-ALPHA; CLOSED-HEAD INJURY; ANGIOGENESIS INHIBITOR; TUMOR-GROWTH; EXPRESSION; VEGF; RAT; DEGENERATION; CONTUSIONS; PROTEINS	Endostatin/collagen XVIII is a specific inhibitor of endothelial proliferation and migration in vitro. It has also been shown to have anti-angiogenic activity and tumor growth inhibitory activity in vivo and in vitro. Here we studied expression of endostatin/collagen XVIII in a rat traumatic brain injury (TBI) model, focusing on the early phase. A significant up-regulation of endostatin/collagen XVIII in TBI began as early as 24 h post-TBI. Double-staining experiment revealed that the major resource of endostatin/collagen XVIII+ cells in our TBI rat model was a subpopulation of reactivated microglia/macrophages. Our data further showed that dexamethasone attenuated up-regulation of endostatin/collagen XVIII expression at days 1 and 2, but not at day 4, post-TBI, indicating that dexamethasone might possess an early and transient influence to the angiogenesis following TBI. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany; Synovo GmbH, D-72076 Tubingen, Germany		Zhang, Z (corresponding author), Univ Tubingen, Inst Brain Res, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	zhang, zhiren/I-1046-2014; Burnet, Michael/AAB-2958-2019; Zhang, Zhiren/O-1012-2019	zhang, zhiren/0000-0002-5238-2835; Zhang, Zhiren/0000-0002-5238-2835; Zhang, Zhi-Yuan/0000-0001-9067-0670			Berger AC, 2000, J SURG RES, V91, P26, DOI 10.1006/jsre.2000.5890; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bloch W, 2000, FASEB J, V14, P2373; Deininger MH, 2006, J NEUROTRAUM, V23, P1103, DOI 10.1089/neu.2006.23.1103; Deininger MH, 2003, FASEB J, V17, P1267, DOI 10.1096/fj.02-1118com; Deininger MH, 2002, J NEUROSCI, V22, P10621; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Leifeld L, 2002, J HEPATOL, V37, P613, DOI 10.1016/S0168-8278(02)00271-4; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; MUELLER CA, 2007, IN PRESS LESIONAL EX; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pulliam L, 1998, J NEUROSCI RES, V54, P530, DOI 10.1002/(SICI)1097-4547(19981115)54:4<530::AID-JNR10>3.0.CO;2-1; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; Sbarbati A, 1996, ACTA NEUROPATHOL, V92, P56, DOI 10.1007/s004010050489; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takahashi K, 2003, FASEB J, V17, P896, DOI 10.1096/fj.02-0824fje; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Walski M, 2003, ACTA NEUROBIOL EXP, V63, P77; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhang ZR, 2006, EXP NEUROL, V197, P252, DOI 10.1016/j.expneurol.2005.09.015	43	9	11	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 13	2007	147	3					720	726		10.1016/j.neuroscience.2007.04.052			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191QA	WOS:000248144900017	17560042				2022-02-06	
J	Lexell, J				Lexell, Jan			Rehabilitation of Traumatic Brain Injuries in Sweden	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; rehabilitation; treatment outcome		In Sweden, traumatic brain injury (TBI) is a major cause of disability across all ages, and the need for rehabilitation and long-term follow-up is as important as in many other countries. This article presents the rehabilitation of TBI in Sweden. Strengths and weaknesses of TBI rehabilitation within the Swedish healthcare system are described, together with examples of research and development.	[Lexell, Jan] Univ Lund Hosp, Dept Rehabil, S-22185 Lund, Sweden; [Lexell, Jan] Lund Univ, Dept Clin Sci, Div Rehabil Med, Lund, Sweden; [Lexell, Jan] Lulea Univ Technol, Dept Hlth Sci, S-95187 Lulea, Sweden		Lexell, J (corresponding author), Univ Lund Hosp, Dept Rehabil, S-22185 Lund, Sweden.	jan.lexell@skane.se		Lexell, Jan/0000-0001-5294-3332			DEBOUSSARD CN, 2004, THESIS KAROLINSKA I; EKER C, 2005, THESIS LUND U LUND; ELF K, 2005, THESIS UPPSALA U UPP; Grande PO, 2007, INTENS CARE MED, V33, P559, DOI 10.1007/s00134-006-0522-x; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; JACOBSSON LJ, ACTA NEUROL IN PRESS; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; JUMISKO E, 2005, THESIS LULEA U TECHN; KLEIVEN S, 2000, INJ CONTROL SAF PROM, V10, P173; LEXELL J, LAKARTIDNIN IN PRESS; LUNDIN A, 2007, THESIS KAROLINSKA I; STALNACKE BM, 2004, THESIS UMEA U UPPSAL; *STAT U NEW YORK, 1996, GUID UN DAT SET MED; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	14	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2007	22	4					229	233		10.1097/01.HTR.0000281838.00344.03			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	V87BQ	WOS:000205885400006	17667065				2022-02-06	
J	Marandi, M; Mowla, SJ; Tavallaei, M; Yaghoobi, MM; Jafarnejad, SM				Marandi, Mohammad; Mowla, Seyed Javad; Tavallaei, Mahmoud; Yaghoobi, Mohammad Mehdi; Jafarnejad, Seyed Mehdi			Proprotein convertases 1 and 2 (PC1 and PC2) are expressed in neurally differentiated rat bone marrow stromal stem cells (BMSCs)	NEUROSCIENCE LETTERS			English	Article						BMSCs; PC1; PC2; neural differentiation; gene expression; prohormone convertase	GROWTH-FACTOR PRODUCTION; PROPROTEIN CONVERTASE; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; SECRETORY PATHWAY; BRAIN-INJURY; IN-VITRO; INDUCTION; DEATH; REGENERATION	Neural-like cells derived from bone marrow stromal stem cells (BMSCs) have potential usefulness in cell therapy of degenerative or traumatic diseases of the central nervous system (CNS). The functional recovery mediated by these cells, however, depends on the secretion of neurotrophins (NTs) and their cognate receptors, as the main regulators of neural survival and death. The function of NTs is further modulated by proprotein convertase (PC) enzymes which function in converting proproteins (including proNTs) into their functional end products. Accordingly, failure in converting proprotein forms of NTs into their mature forms may lead to neuronal cell death. In the present study, we have investigated the expression profile of PCs before and during neural differentiation of rat BMSCs by RT-PCR. Our results show that major members of the PC family functioning in the constitutive secretory pathway (furin, PACE4 and PC7/LPQ are highly expressed in both undifferentiated and neurally differentiated BMSCs. In contrast, while PC1/PC3 and PC2 (specific to neural and endocrine cells) are absent in undifferentiated BMSCs, their expression is initiated upon the induction of differentiation. In conclusion, our results suggest that neurally differentiated BMSCs have acquired the functional machinery to process the precursor forms of proteins in both the constitutive and regulated pathways. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	Tarbiat Modares Univ, Sch Basic Sci, Dept Genet, Tehran, Iran; Tarbiat Modares Univ, Fac Basic Sci, Dept Genet, Tehran, Iran; Imam Hossein Univ, Dept Cellular & Mol Biol, Tehran, Iran; High Technol & Environm Sci, Int Ctr Sci, Dept Biotechnol, Kerman, Iran		Mowla, SJ (corresponding author), Tarbiat Modares Univ, Sch Basic Sci, Dept Genet, POB 147115-175, Tehran, Iran.	sjmowla@modares.ac.ir	Tavallaie, Mahmood/V-4447-2019; Mowla, Seyed Javad/B-2242-2009; Yaghoobi, Mohammad Mehdi/AAL-6319-2020	Tavallaie, Mahmood/0000-0003-0080-4298; Yaghoobi, Mohammad Mehdi/0000-0003-1434-6224; Jafarnejad, Seyed Mehdi/0000-0002-5129-7081; Mowla, Seyed Javad/0000-0002-3300-6332			BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Cuevas P, 2002, NEUROL RES, V24, P634, DOI 10.1179/016164102101200564; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Florez-McClure ML, 2004, J NEUROSCI, V24, P4498, DOI 10.1523/JNEUROSCI.5744-03.2004; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hasegawa Yuiko, 2004, Biotechnol Annu Rev, V10, P123, DOI 10.1016/S1387-2656(04)10005-7; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rismanchi N, 2003, BRAIN RES, V991, P46, DOI 10.1016/j.brainres.2003.07.004; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yaghoobi MM, 2006, NEUROSCI LETT, V397, P149, DOI 10.1016/j.neulet.2005.12.009; Yaghoobi MM, 2005, NEUROSCI LETT, V390, P81, DOI 10.1016/j.neulet.2005.08.011; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Ye B, 2006, J NEUROSCI, V26, P10631, DOI 10.1523/JNEUROSCI.3271-06.2006	39	9	11	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUN 15	2007	420	3					198	203		10.1016/j.neulet.2007.04.041			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190JW	WOS:000248056100002	17556096				2022-02-06	
J	Knieriem, M				Knieriem, Melissa			Hyperglycemia in critically ill patients	COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN			English	Article							TOTAL PARENTERAL-NUTRITION; INTENSIVE INSULIN THERAPY; NECROSIS-FACTOR PRODUCTION; CONGESTIVE-HEART-FAILURE; DIABETES-MELLITUS; STRESS-HYPERGLYCEMIA; BRAIN-INJURY; NONENZYMATIC GLYCOSYLATION; GLUCOSE-CONCENTRATIONS; BLOOD-COAGULATION	Hyperglycemia is common in critically ill humans, Recent clinical trials have shown a significant reduction in morbidity and mortality rates with the use of intensive insulin therapy to maintain strict normoglycemia in critically ill patients. Hyperglycemia is associated with many detrimental effects, including reduced immune function, increased inflammation and coagulation, and modulation of the endothelium. Most of the evidence regarding the adverse effects of hyperglycemia is derived from humans with diabetes, cardiac failure, or traumatic brain injury In addition to its anabolic effects on metabolism, insulin has antiinflammatory properties. To define the potential risks and benefits of intensive insulin therapy in critically ill animals, prospective, randomized clinical trials are necessary	Boca Vet Referral Emergency & Crit Care Ctr, Boca Raton, FL USA; Univ Penn, Philadelphia, PA 19104 USA; Auburn Univ, Auburn, AL 36849 USA		Knieriem, M (corresponding author), Boca Vet Referral Emergency & Crit Care Ctr, Boca Raton, FL USA.						AMARAL JF, 1986, SURGERY, V100, P252; Ambrisko TD, 2005, AM J VET RES, V66, P406, DOI 10.2460/ajvr.2005.66.406; BECKNIELSEN H, 1987, DIABETES S1, V36, P30; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BLACK CT, 1990, J TRAUMA, V30, P830, DOI 10.1097/00005373-199007000-00012; Brady CA, 2001, VET CLIN N AM-SMALL, V31, P1147, DOI 10.1016/S0195-5616(01)50097-2; Brady CA, 2004, J VET EMERG CRIT CAR, V14, P177, DOI 10.1111/j.1534-6935.2004.00118.x; Branson K.R., 1995, VET PHARM THERAPEUTI, V7th, P274; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; CARMASSI F, 1992, THROMB RES, V67, P643, DOI 10.1016/0049-3848(92)90068-L; Chan DL, 2002, J VET INTERN MED, V16, P440, DOI 10.1892/0891-6640(2002)016&lt;0440:REOPPN&gt;2.3.CO;2; Chen HC, 2001, KIDNEY INT, V59, pS124, DOI 10.1046/j.1523-1755.2001.59780124.x; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cheung NW, 2005, DIABETES CARE, V28, P2367, DOI 10.2337/diacare.28.10.2367; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; DAHN MS, 1995, SURGERY, V117, P520, DOI 10.1016/S0039-6060(05)80251-X; Das UN, 2001, NUTRITION, V17, P409, DOI 10.1016/S0899-9007(01)00518-4; DIBARTOLA S. P, 2000, FLUID THERAPY SMALL; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Feldman E, 1996, CANINE FELINE ENDOCR, P339; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; FRADE LJG, 1987, THROMB RES, V47, P533; FRAKER DL, 1989, AM J PHYSIOL, V256, pE725, DOI 10.1152/ajpendo.1989.256.6.E725; FRANKENFIELD DC, 1994, JPEN-PARENTER ENTER, V18, P398, DOI 10.1177/0148607194018005398; FREEMAN LM, 1994, J VET INTERN MED, V8, P349, DOI 10.1111/j.1939-1676.1994.tb03249.x; Furnary Anthony P, 2004, Endocr Pract, V10 Suppl 2, P21; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; GUYTO AC, 2000, HDB MED PHYSL, P884; Guyton AC, 2002, TXB MED PHYSL, P772; Guyton AC, 2000, TXB MED PHYSL, P846; GUYTON AC, 2000, TXB MED PHYSL, P697; GUYTON AC, 2000, TXB MED PHYSL, P40; Guyton AC, 2000, TXB MED PHYSL, P869; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P1082, DOI 10.1210/jc.2002-021478; HARDIE EM, 1985, AM J VET RES, V46, P1700; HENNESSEY PJ, 1991, JPEN-PARENTER ENTER, V15, P60, DOI 10.1177/014860719101500160; HOSTETTER MK, 1990, DIABETES, V39, P271, DOI 10.2337/diabetes.39.3.271; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTCHKISS RS, 1992, JAMA-J AM MED ASSOC, V267, P1503, DOI 10.1001/jama.267.11.1503; HSU WH, 1982, AM J VET RES, V43, P2060; HUGHES A, 1983, ACTA HAEMATOL-BASEL, V69, P254, DOI 10.1159/000206901; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kawai N, 1997, STROKE, V28, P149, DOI 10.1161/01.STR.28.1.149; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Li PA, 2000, STROKE, V31, P183, DOI 10.1161/01.STR.31.1.183; Lin LY, 2005, J CELL BIOCHEM, V94, P194, DOI 10.1002/jcb.20195; LIPPERT AC, 1993, J VET INTERN MED, V7, P52, DOI 10.1111/j.1939-1676.1993.tb03170.x; MACINTIRE DK, 1993, J AM VET MED ASSOC, V202, P1266; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; McCowen KC, 2000, CRIT CARE MED, V28, P3606, DOI 10.1097/00003246-200011000-00007; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; MESZAROS K, 1987, J BIOL CHEM, V262, P10965; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Morohoshi M, 1996, DIABETES, V45, P954, DOI 10.2337/diabetes.45.7.954; MOROHOSHI M, 1995, ANN NY ACAD SCI, V748, P562; MOWAT AG, 1971, NEW ENGL J MED, V284, P621, DOI 10.1056/NEJM197103252841201; Nelson R. W., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P1438; OLIVER MF, 1994, LANCET, V343, P155, DOI 10.1016/S0140-6736(94)90939-3; Paolisso G, 1999, AM J CARDIOL, V83, P1338, DOI 10.1016/S0002-9149(99)00097-1; PATRASSI GM, 1982, EUR J CLIN INVEST, V12, P307, DOI 10.1111/j.1365-2362.1982.tb02237.x; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; POZZILLI P, 1994, DIABETIC MED, V11, P935, DOI 10.1111/j.1464-5491.1994.tb00250.x; Pyle SC, 2004, JAVMA-J AM VET MED A, V225, P242, DOI 10.2460/javma.2004.225.242; Rao AK, 1999, DIABETES, V48, P1156, DOI 10.2337/diabetes.48.5.1156; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Saiepour Daniel, 2003, Exp Diabesity Res, V4, P125, DOI 10.1155/EDR.2003.125; Sakaue S, 1999, MOL MED, V5, P361, DOI 10.1007/BF03402125; SATOMI N, 1985, J NATL CANCER I, V74, P1255; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Siroen MPC, 2005, CRIT CARE MED, V33, P504, DOI [10.1097/01.CCM.0000155784.59297.50, 10.1097/01.ccm.0000155784.59297.50]; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; STONER HB, 1986, CIRC SHOCK, V19, P75; Swan JW, 1997, J AM COLL CARDIOL, V30, P527, DOI 10.1016/S0735-1097(97)00185-X; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; Thurmon J. C., 1996, LUMB JONES VET ANEST, P183; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VIRKAMAKI A, 1992, J CLIN ENDOCR METAB, V74, P673, DOI 10.1210/jc.74.3.673; VUKOVICH TC, 1986, DIABETES, V35, P617, DOI 10.2337/diabetes.35.5.617; Weekers F, 2003, ENDOCRINOLOGY, V144, P5329, DOI 10.1210/en.2003-0697; YKIJARVINEN H, 1992, ENDOCR REV, V13, P415, DOI 10.1210/er.13.3.415; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504	92	9	12	0	2	VETERINARY LEARNING SYSTEMS	YARDLEY	780 TOWNSHIP LINE RD, YARDLEY, PA 19067-4200 USA	0193-1903			COMP CONT EDUC PRACT	Compend. Contin. Educ. Pract. Vet.	JUN	2007	29	6					360	+					12	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	184BY	WOS:000247617300008	17724990				2022-02-06	
J	Rutland-Brown, W; Langlois, JA; Nicaj, L; Thomas, RG; Wilt, SA; Bazarian, JJ				Rutland-Brown, Wesley; Langlois, Jean A.; Nicaj, Leze; Thomas, Robert G., Jr.; Wilt, Susan A.; Bazarian, Jeffrey J.			Traumatic Brain Injuries after Mass-Casualty Incidents: Lessons from the 11 September 2001 World Trade Center Attacks	PREHOSPITAL AND DISASTER MEDICINE			English	Article						diagnosis; head protection; masscasualty incidents (MCIs); rescue worker; traumatic brain injuries (TBIs); undetected injury; World Trade Center (WTC)		Introduction: The 11 September 2001 terrorist attacks on the World Trade Center (WTC) resulted in thousands of deaths and injuries. Research on previous bombings and explosions has shown that head injuries, including traumatic brain injuries (TBIs), are among the most common injuries. Objective: The objective of this study was to identify diagnosed and undiagnosed (undetected) TBIs among persons hospitalized in New York City following the 11 September 2001 WTC attacks. Methods: The medical records of persons admitted to 36 hospitals in New York City with injuries or illnesses related to the WTC attacks were abstracted for signs and symptoms of TBIs. Diagnosed TBIs were identified using the International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes. Undiagnosed TBIs were identified by an adjudication team of TBI experts that reviewed the abstracted medical record information. Persons with an undiagnosed TBI were contacted and informed of the diagnosis of potential undetected injury. Results: A total of 282 records were abstracted. Fourteen cases of diagnosed TBIs and 21 cases of undiagnosed TBIs were identified for a total of 35 TBI cases (12% of all of the abstracted records). The leading cause of TBI was being hit by falling debris (22 cases). One-third of the TBIs (13 cases) occurred among rescue workers. More than three years after the event, four out of six persons (66.67%) with an undiagnosed TBI who were contacted reported they currently were experiencing symptoms consistent with a TBI. Conclusions: Not all of the TBIs among hospitalized survivors of the WTC attacks were diagnosed at the time of acute injury care. Some persons with undiagnosed TBIs reported problems that may have resulted from these TBIs three years after the event. For hospitalized survivors of mass-casualty incidents, additional in-hospital, clinical surveys could help improve pre-discharge TBI diagnosis and provide the opportunity to link patients to appropriate outpatient services. The use and adequacy of head protection for rescue workers deserves re-evaluation.	[Rutland-Brown, Wesley; Langlois, Jean A.] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Injury Response, Atlanta, GA USA; [Nicaj, Leze; Wilt, Susan A.] New York City Dept Hlth & Mental Hyg, Bur Injury Epidemiol, New York, NY USA; [Thomas, Robert G., Jr.] CDC, Natl Ctr Injury Prevent & Control, Off Stat & Programming, Atlanta, GA USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA		Langlois, JA (corresponding author), CDC NCIPC DIR, 4770 Buford Highway,NE MS F-41, Atlanta, GA 30341 USA.	jal7@cdc.gov			Centers for Disease Control and Prevention Cooperative AgreementUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; New York City Department of Health and Mental Hygiene [U17/CCU222273-01-1]	The research for this paper was funded through a Centers for Disease Control and Prevention Cooperative Agreement with the New York City Department of Health and Mental Hygiene, number U17/CCU222273-01-1. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP D; Arnold Jeffrey L, 2003, Prehosp Disaster Med, V18, P220; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Biffl WL, 2003, J TRAUMA, V54, P38, DOI 10.1097/00005373-200301000-00005; Brackbill Robert M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks A, 2004, INJURY, V35, P407, DOI 10.1016/S0020-1383(03)00219-5; Buduhan G, 2000, J TRAUMA, V49, P600, DOI 10.1097/00005373-200010000-00005; Richmond Jonathan Y, 2002, MMWR Recomm Rep, V51, P1; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51 Spec No, P16; CHESNUT RM, 1999, 2 AG HLTH CAR POL RE; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; ENDERSON BL, 1990, J TRAUMA, V30, P666, DOI 10.1097/00005373-199006000-00002; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Feeney JM, 2005, ARCH SURG-CHICAGO, V140, P1068, DOI 10.1001/archsurg.140.11.1068; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Groves W. A., 2004, Professional Safety, V49, P31; Halpern Pinchas, 2003, Prehosp Disaster Med, V18, P235; Hirshberg A, 2001, ANN EMERG MED, V37, P647, DOI 10.1067/mem.2001.115650; Hirshberg A, 2005, J TRAUMA, V58, P686, DOI 10.1097/01.TA.0000159243.70507.86; Houshian S, 2002, J TRAUMA, V52, P715, DOI 10.1097/00005373-200204000-00018; Jackson BA., 2002, PROTECTING EMERGENCY; Janjua KJ, 1998, J TRAUMA, V44, P1000, DOI 10.1097/00005373-199806000-00012; Langlois J., 2003, MILD TRAUMATIC UNPUB; MacKenzie E, 1997, ICDMAP 90 USERS GUID; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Marr A., 2004, CENTRAL NERVOUS SYST; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; RIZOLI SB, 1994, ACCIDENT ANAL PREV, V26, P681, DOI 10.1016/0001-4575(94)90030-2; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; SCOTT BA, 1986, NEUROSURGERY, V18, P107, DOI 10.1227/00006123-198601000-00020; SCOTT SG, 2005, FEDERAL PRACT, V22, P66; Soundappan SVS, 2004, J TRAUMA, V57, P114, DOI 10.1097/01.TA.0000108992.51091.F7; *US DEP HHS, 1989, INT CLASS DIS 9 REV	40	9	9	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	JUN	2007	22	3					157	164		10.1017/S1049023X00004593			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	V71VM	WOS:000211601700002	17894207				2022-02-06	
J	Zehtabchi, S; Sinert, R; Soghoian, S; Liu, YJ; Carmody, K; Shah, L; Kumar, M; Lucchesi, M				Zehtabchi, Shahriar; Sinert, Richard; Soghoian, Samara; Liu, Yiju; Carmody, Kristin; Shah, Lekha; Kumar, Mridul; Lucchesi, Michael			Identifying traumatic brain injury in patients with isolated head trauma: are arterial lactate and base deficit as helpful as in polytrauma?	EMERGENCY MEDICINE JOURNAL			English	Article							GLASGOW COMA SCALE; LACTIC-ACIDOSIS; MORTALITY PREDICTION; SUBSTRATE DELIVERY; SEVERITY; RESUSCITATION; SCORE	Background: Increase in lactate (LAC) within the central nervous system after head trauma is an established marker of traumatic brain injury (TBI). Objective: To investigate the utility of arterial base deficit (BD) and LAC in identifying TBI in patients with isolated head injury (IHI). Materials and methods: TBI was defined as Glasgow Coma Scale <= 8, head Abbreviated Injury Severity Score >2 or brain haematoma on CT scan. Patients were divided into two groups: IHI with and without TBI. Data were reported as means (SDs). 131 patients with IHI were studied (mean (SD) age 39 (19) years, 78% male). Results: 17% of the patients sustained TBI. The mean differences for arterial BD (0.65 mmol/l, 95% CI -0.8 to 2.1) and LAC (0.34 mmol/l, 95% CI -0.7 to 1.4) in patients with and without TBI were not significant. Analysis of receiver operating characteristic curves confirmed that arterial BD and LAC were unable to detect TBI in patients with IHI. Conclusion: Arterial BD and LAC are poor predictors of TBI in isolated head trauma.	SUNY Downstate Med Ctr, Dept Emergency Med, Brooklyn, NY 11203 USA		Zehtabchi, S (corresponding author), SUNY Downstate Med Ctr, Dept Emergency Med, Box 1228,450 Clarkson Ave, Brooklyn, NY 11203 USA.	szehtabchi@yahoo.com		zehtabchi, shahriar/0000-0002-6427-986X; Carmody, Kristin/0000-0003-1223-5280; Soghoian, Samara/0000-0002-8767-6681			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Bouma G J, 1995, New Horiz, V3, P384; Chang M C, 1993, J Tenn Med Assoc, V86, P59; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; DAVIS JW, 1994, J TRAUMA, V36, P168, DOI 10.1097/00005373-199402000-00002; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MARMAROU A, 1991, J NEUROSURG, V75, P559; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; MURR R, 1996, ACTA NEUROCHIR WIEN, V138, P936; Ogun CO, 2002, CRIT CARE MED, V30, P2123, DOI 10.1097/01.CCM.0000026326.17262.F3; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; WAGNER KR, 1985, J NEUROSURG, V63, P88, DOI 10.3171/jns.1985.63.1.0088; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; ZAUNER A, 1997, NEUROSURGERY, V41, P1091; Zehtabchi S, 2004, ACAD EMERG MED, V11, P1014, DOI 10.1197/j.aem.2004.06.008	27	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	MAY 1	2007	24	5					333	335		10.1136/emj.2006.044578			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	160CK	WOS:000245914800007	17452699	Green Published			2022-02-06	
J	Schoenberg, MR; Lange, RT; Brickell, TA; Saklofske, DH				Schoenberg, Mike R.; Lange, Rael T.; Brickell, Tracey A.; Saklofske, Donald H.			Estimating premorbid general cognitive functioning for children and adolescents using the American wechsler intelligence scale for children-fourth edition: Demographic and current performance approaches	JOURNAL OF CHILD NEUROLOGY			English	Article						intelligence quotient; IQ; WISC-IV	REGRESSION-BASED METHODS; TRAUMATIC BRAIN INJURY; ABILITY INDEX; VARIABLES; ACCURACY; OUTCOMES; IQ	Neuropsychologic evaluation requires current test performance be contrasted against a comparison standard to determine if change has occurred. An estimate of premorbid intelligence quotient (IQ) is often used as a comparison standard. The Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV) is a commonly used intelligence test. However, there is no method to estimate premorbid IQ for the WISC-IV, limiting the test's utility for neuropsychologic assessment. This study develops algorithms to estimate premorbid Full Scale IQ scores. Participants were the American WISC-IV standardization sample (N = 2172). The sample was randomly divided into 2 groups (development and validation). The development group was used to generate 12 algorithms. These algorithms were accurate predictors of WISC-IV Full Scale IQ scores in healthy children and adolescents. These algorithms hold promise as a method to predict premorbid IQ for patients with known or suspected neurologic dysfunction; however, clinical validation is required.	Univ Hosp Case Med Ctr, Dept Neurol, Amer Board Clin Neuropsychol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA; Riverview Hosp, British Columbia Ment Hlth & Addict Serv, Dept Res, Vancouver, BC, Canada; Back Mot Rehab, Vancouver, BC, Canada; Univ Calgary, Div Appl Psychol, Calgary, AB, Canada		Schoenberg, MR (corresponding author), Univ Hosp Case Med Ctr, Dept Neurol, Amer Board Clin Neuropsychol, HH5,11100 Euclid Ave, Cleveland, OH 44106 USA.	Michael.Schoenberg@UHhospitals.org	Schoenberg, Mike R/J-9018-2012	Schoenberg, Mike/0000-0003-1355-3651			*AM COLL TEST PROG, 1987, ACT ASS PROGR TECHN; Axelrod BN, 1999, ARCH CLIN NEUROPSYCH, V14, P341, DOI 10.1016/S0887-6177(98)00028-6; Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; *COLL BOARD TESTS, 1995, STAT TECH MAN; CRAWFORD JR, 1990, PERS INDIV DIFFER, V11, P1153, DOI 10.1016/0191-8869(90)90028-P; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Lange RT, 2005, ARCH CLIN NEUROPSYCH, V20, P1009, DOI 10.1016/j.acn.2005.06.004; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MCFIE J, 1975, ASSESSMENT ORGANIC I; Nelson H.E., 1982, NATL ADULT READING T; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; *PSYCH CORP, 2001, MAN WECHL TEST AD RE; Putnam SH, 1999, STUD NEUROPSYCHOL DE, P39; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; REYNOLDS CR, 1979, CLIN NEUROPSYCHOLOGY, V1, P36; Sattler J.M., 2001, ASSESSMENT CHILDREN; Sattler J. M., 1988, ASSESSMENT CHILDREN; Schinka J. A., 2000, CLIN GUIDE NEUROPSYC, P39; Schoenberg MR, 2006, CLIN NEUROPSYCHOL, V20, P365, DOI 10.1080/138540491005866; Schoenberg MR, 2004, ARCH CLIN NEUROPSYCH, V19, P1103, DOI 10.1016/j.acn.2003.12.008; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; *US BUR CENS, 2000, CURR POP SURV MARCH; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1998, PSYCHOL ASSESSMENT, V10, P277, DOI 10.1037/1040-3590.10.3.277; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2003, WECHSLER INTELLIGENC; WECHSLER D, 1958, MEASUREMTN APPRAISAL; Wechsler D., 2003, WISC 4 TECHNICAL INT; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; YATES AJ, 1956, J MENT SCI, V102, P409, DOI 10.1192/bjp.102.428.409; YATES KO, 1997, J INT NEUROPSYCH SOC, V3, P617; [No title captured]	52	9	10	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	APR	2007	22	4					379	388		10.1177/0883073807301925			10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	176MH	WOS:000247088900003	17621515				2022-02-06	
J	Schonbrun, SL; Kampfe, CM; Sales, AP				Schonbrun, Staci L.; Kampfe, Charlene M.; Sales, Amos P.			RSA services and employment outcome in consumers with traumatic brain injury	JOURNAL OF REHABILITATION			English	Article							REHABILITATION; INDIVIDUALS; PREDICTION	This research provides an analysis of the relationship between specific services and employment outcome in RSA consumers with traumatic brain injury (TBI). When assessment, job placement, job search, or diagnosis/treatment were provided, consumers were more likely to obtain employment. Job placement, job search, and diagnosis/treatment also predicted consumers' employment. Only three of these services (i.e., job placement, job search, and diagnosis/treatment) were significantly related to consumers' weekly earnings at case closure. Diagnosis/Treatment was positively related, whereas job placement and job search were negatively related to earnings.	Labor Mkt Consulting Serv, Tucson, AZ 85712 USA; Univ Arizona, Tucson, AZ 85721 USA		Schonbrun, SL (corresponding author), Labor Mkt Consulting Serv, 1661 N Swan Rd,Sute 136, Tucson, AZ 85712 USA.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Gamble D, 2003, J REHABIL, V69, P31; Golden T. P., 1993, J REHABIL, P55; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Huck SW, 1996, READING STAT RES; ISAKI E, 2000, BRAIN INJURY, V10, P207; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; KOSCIULEK J, 1994, J APPL REHABILITATIO, V25, P61; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Schonbrun S. L., 2004, J APPL REHABILITATIO, V35, P14; Shadish W. R., 2002, EXPT QUASIEXPT DESIG; UOMOTO JM, 2000, APPL NEUROPSYCHOLOGI; *US DEP ED, 2000, RSDAPD0006 US DEP ED; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Willis SP, 2005, J REHABIL, V71, P42	22	9	9	0	0	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	2007	73	2					26	31					6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	172BF	WOS:000246778400003					2022-02-06	
J	Shields, DC; Leiphart, JW; McArthur, DL; Vespa, PM; Quyen, ML; Martinerie, J; Soss, JR				Shields, Donald C.; Leiphart, James W.; McArthur, David L.; Vespa, Paul M.; Quyen, Michel LeVan; Martinerie, Jacques; Soss, Jason R.			Cortical synchrony changes detected by scalp electrode electroencephalograph as traumatic brain injury patients emerge from coma	SURGICAL NEUROLOGY			English	Article						synchrony; EEG; coma; bead trauma; consciousness	CONSCIOUS STATES; CORTEX; COHERENCE	Background: Recent studies show conscious perception is correlated with firing rate synchronization across multiple neuronal assemblies. This study explores the synchrony between multiple cortical surface sites as brain injury patients emerge from coma. Methods: Scalp electrode EEG recordings were collected and analyzed from 13 traumatic brain injury patients during their stay in a neurosurgical intensive care unit. Neuronal synchrony was calculated between various electrode pairs during comatose and conscious periods defined by the GCS. Frequency bands from I to 30 Hz were evaluated in each patient. Results: As patients emerged from coma at GCS 3 to GCS scores >= 8, synchrony values from all electrode pairs revealed a global decrease in synchrony at higher GCS scores. No significant effects were detected relative to the amount of sedation given, but at higher GCS scores significantly increased neuronal synchrony was observed between occipital lobes and right parietal and temporal lobe sites. Synchrony was decreased between frontal-occipital, frontal-parietal, and parietal-occipital electrodes. Conclusions: In frequencies from I to 30 Hz, synchrony between right parietal and temporal lobes, as well as bilateral occipital lobes, tends to be increased as patients emerge from comatose states. However, synchrony between most intrahemispheric cortical sites is decreased at higher GCS scores in most of the above frequency bands. Thus, brain injury patients demonstrate both increased and decreased cortical surface synchrony between different lobes during emergence from coma. (c) 2007 Elsevier Inc. All rights reserved.	Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Dept Surg,Div Neurosurg, Los Angeles, CA 90095 USA; George Washington Univ, Sch Med, Dept Neurosurg, Washington, DC USA; Hop La Pitie Salpetriere, CNRS, LENA, UPR640,Lab Neurosci Cognit & Imagerie Cerebrale, Paris, France; Univ Paris 06, Paris, France		Soss, JR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Dept Neurol, Los Angeles, CA 90095 USA.	jsoss@mednet.ucla.edu	McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314			Aoki F, 2001, BIOSYSTEMS, V63, P89, DOI 10.1016/S0303-2647(01)00149-6; Cariani P, 2000, CONSCIOUS COGN, V9, P387, DOI 10.1006/ccog.1999.0420; DESMEDT JE, 1994, NEUROSCI LETT, V168, P126, DOI 10.1016/0304-3940(94)90432-4; Goto Y, 2004, CLIN NEUROPHYSIOL, V115, P1409, DOI 10.1016/j.clinph.2004.01.013; JOHN ER, 1972, SCIENCE, V177, P850, DOI 10.1126/science.177.4052.850; John ER, 2002, BRAIN RES REV, V39, P1, DOI 10.1016/S0165-0173(02)00142-X; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Le Van Quyen M, 2005, CLIN NEUROPHYSIOL, V116, P559, DOI 10.1016/j.clinph.2004.10.014; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Meador KJ, 2002, NEUROLOGY, V59, P847, DOI 10.1212/WNL.59.6.847; Niebur E, 2002, BIOSYSTEMS, V67, P157, DOI 10.1016/S0303-2647(02)00102-8; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; Slewa-Younan S, 2002, CLIN NEUROPHYSIOL, V113, P1640, DOI 10.1016/S1388-2457(02)00239-0; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; TONONI G, 2000, UNIVERSE CONSCIOUSNE; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137	21	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.	APR	2007	67	4					354	359		10.1016/j.surneu.2006.09.036			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	156PQ	WOS:000245661900007	17350400				2022-02-06	
J	Zwahlen, RA; Labler, L; Trentz, O; Gratz, KW; Bachmann, LM				Zwahlen, Roger Arthur; Labler, Ludwig; Trentz, Otmar; Graetz, Klaus Wilhelm; Bachmann, Lucas M.			Lateral impact in closed head injury: A substantially increased risk for diffuse axonal injury - A preliminary study	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						closed head injury; intracerebral injury; diffuse axonal injury; facial fractures	TRAUMATIC BRAIN-INJURY; METABOLISM	Assessment, whether location of impact causing different facial fracture patterns was associated with diffuse axonal injury in patients with severe closed head injury. Methods: Retrospectively all patients referred to the Trauma Unit of the University Hospital of Zurich, Switzerland between 1996 and 2002 presenting with severe closed head injuries (Abbreviated Injury Scale (AIS) face of 2-4 and an AIS head and neck of 3-5) were assessed according to the Glasgow Coma Scale (GCS) and the Injury Severity Score (ISS). Facial fracture patterns were classified as resulting from frontal, oblique or lateral impact. All patients had undergone computed tomography. The association between impact location and diffuse axonal injury when correcting for the level of consciousness (using the Glasgow scale) and severity of injury (using the ISS) was calculated with a multivariate regression analysis. Results: Of 200 screened patients, 61 fulfilled the inclusion criteria for severe closed head injury. The medians (interquartile ranges 25;75) for GCS, AIS(face) AIS(head) and neck and ISS were 3 (3;13), 2 (2;4), 4 (4;5) and 30 (24;41), respectively. A total of 51% patients had frontal, 26% had an oblique and 23% had lateral trauma. A total of 21% patients developed diffuse axonal injury (DAI) when compared with frontal impact, the likelihood of diffuse axonal injury increased 11.0 fold (1.7-73.0) in patients with a lateral 'impact. Conclusions: Clinicians should be aware of the substantial increase of diffuse axonal injury related to lateral impact in patients with severe closed head injuries. (c) 2007 European Association for Cranio-Maxillofacial Surgery.	Univ Zurich Hosp, Dept Cranio Maxillofacial Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Traumatol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Horten Ctr Patient Oriented Res, CH-8091 Zurich, Switzerland; Univ Bern, Inst Social & Prevent Med, Div Epidemiol & Biostat, CH-3012 Bern, Switzerland		Zwahlen, RA (corresponding author), Univ Zurich Hosp, Dept Cranio Maxillofacial Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	roger.zwahlen@zzmk.uzh.ch	Bachmann, Lucas M/C-9686-2011	ZWAHLEN, Roger Arthur/0000-0003-4666-7567; , Lucas/0000-0002-9868-154X			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BENNETT M, 1995, IRISH MED J, V88, P59; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Burch JM, 1999, PRINCIPLES SURG, P155; *COMM MED ASP AUT, 1971, JAMA-J AM MED ASSOC, V215, P277; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Heinzelmann M, 1996, Swiss Surg, P35; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; HODGSON VR, 1967, AM J ANAT, V120, P113, DOI 10.1002/aja.1001200109; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; JAMBART S, 1980, ACTA ENDOCRINOL-COP, V93, P264, DOI 10.1530/acta.0.0930264; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rossi NF, 1998, AM J PHYSIOL-ENDOC M, V275, pE687; Sun Xiaochuan, 2002, Chin J Traumatol, V5, P355; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TEASDALE G, 1974, LANCET, V2, P81; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; VANWOERKOM TCAM, 1977, LANCET, V1, P812	29	9	11	1	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	APR	2007	35	3					142	146		10.1016/j.jcms.2007.01.006			5	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	203FG	WOS:000248959900002	17583523				2022-02-06	
J	Adirim, TA				Adirim, Terry A.			Concussions in Sports and Recreation	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						traumatic brain injury; concussion; sports concussion; computed tomography; neuropsychologic assessment	TRAUMATIC BRAIN-INJURY; CEREBRAL CONCUSSION; HEAD-INJURY; HIGH-SCHOOL; MANAGEMENT; SYMPTOMS	In 2004, 475000 children between 0 and 14 years old sustained a traumatic brain injury, and 90% were treated and released from emergency departments (EDs). Concussions are considered one of the most pressing issues in sports medicine and are challenging to diagnose. The clinician has to rely on gross clinical symptoms and/or the athlete's willingness to admit to clinical symptoms. Computed tomography results are often negative and are therefore not helpful for determining the extent of a child's injury or his or her prognosis. Computerized neuropsychologic assessment programs have made the evaluation of athletes easier and more sensitive and are in fact considered the criterion standard for diagnosing and monitoring sports concussions. All athletes presenting to EDs with suspected concussion should be discharged with careful follow-up. Furthermore, return to play should be guided by a gradual increase in activity as recommended by the Prague conference on concussion. A young athlete should never be allowed to return to his or her sport until asymptomatic. (C) 2007 Elsevier Inc. All rights reserved.	[Adirim, Terry A.] Dept Homeland Secur, Washington, DC 20024 USA		Adirim, TA (corresponding author), Dept Homeland Secur, Washington, DC 20024 USA.	ealtaa@comcast.net		Adirim, Terry/0000-0001-6917-5683			Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Bazarian J, 2000, BRAIN INJURY, V14, P285; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Brain Injury Association Inc, 1999, BRAIN INJ TEEN YEARS; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CANTU RC, 2002, AM J SPORTS MED, V4, P152; Colorado Medical Society, 1991, SPORTS MED COMM GUID; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Piland SG, 2003, J ATHL TRAINING, V38, P104; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	35	9	9	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	MAR	2007	8	1					2	6		10.1016/j.cpem.2007.02.002			5	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5E8F	WOS:000219542800002					2022-02-06	
J	Nelson, LA; Rhoades, DA; Noonan, C; Manson, SM				Nelson, Lonnie A.; Rhoades, Dorothy A.; Noonan, Carolyn; Manson, Spero M.		AI-SUPERPFP Team	Traumatic brain injury and mental health among two American Indian populations	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						American Indian; concussion; DSM-IV; bead injury; Native American; prevalence; psychiatric; traumatic brain injury	PSYCHIATRIC-DISORDERS; HEAD-INJURIES; UNITED-STATES; MILD; DEPRESSION; PREVALENCE; ASSOCIATION	Objectives: Describes prevalence of traumatic brain injury (TBI) and associated neuropsychiatric problems among two American Indian (AI) communities. Design: Analysis of cross-sectional epidemiological data. Setting: A Southwest (SW) and 2 Northern Plains (NP) AI reservations. Participants: Al tribal members (N = 2687; 3 94 with history of TBI and 2293 noninjured comparisons) aged 15 to 54. Outcome measures: Mood or anxiety disorders present more than 1 year after injury. Results: Prevalences were high (> 20% in males; > 10% in females) in these populations. Associations between TBI and disorders meeting Diagnostic and Statistical Manual ofMental Disorder Fourth Edition criteria were strong in the SW community (adjusted odds ratio [OR] = 2.4; 95% confidence interval [CI] = 1.5-3.8), less so in the NP community (adjusted OR = 1.4; 95% CI = 0.9-2.2). Conclusions: TBI is prevalent among AIs and is associated with increased OR of neuropsychiatric difficulties. This association may vary between tribes, though no interaction effect was found. Als with TBI may require more thorough psychiatric screening to promote healthier outcomes.	Univ Washington, Sch Med, Dept Psychiat, Seattle, WA 98101 USA; Univ Washington, Dept Gen Internal Med, Seattle, WA 98101 USA; Univ Colorado, Hlth Sci Ctr, Nat Elder Res Ctr, Denver, CO 80202 USA; Univ Colorado, Hlth Sci Ctr, Amer Indian Program, Denver, CO 80202 USA; Univ Colorado, Hlth Sci Ctr, Alaska Native Program, Denver, CO 80202 USA		Nelson, LA (corresponding author), Univ Washington, Sch Med, Dept Psychiat, Seattle, WA 98101 USA.	lanelsonphd@gmail.com	Duran, Bonnie m/A-3029-2009				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beals J, 2003, CULT MED PSYCHIAT, V27, P259, DOI 10.1023/A:1025347130953; Blackmer J, 1999, BRAIN INJURY, V13, P627; Burg JS, 2000, BRAIN INJURY, V14, P513; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kulka R. A., 1988, CONTRACTUAL REPORT F; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; MEL BG, 2001, BRAIN INJURY, V15, P811; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Norton IM, 1996, J CONSULT CLIN PSYCH, V64, P856, DOI 10.1037/0022-006X.64.5.856; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; REEKUM RV, 1996, BRAIN INJURY, V10, P319; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Spicer P, 2003, ALCOHOL CLIN EXP RES, V27, P1785, DOI 10.1097/01.ALC.0000095864.45755.53; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2	28	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2007	22	2					105	112		10.1097/01.HTR.0000265098.52306.a9			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	152NU	WOS:000245369500005	17414312				2022-02-06	
J	Adukauskiene, D; Bivainyte, A; Radaviciute, E				Adukauskiene, Dalia; Bivainyte, Asta; Radaviciute, Edita			Cerebral edema and its treatment	MEDICINA-LITHUANIA			Lithuanian	Article						cerebral edema; pathogenesis; treatment		Cerebral edema is a life-threatening condition that develops as a result of an inflammatory reaction. Most frequently, this is the consequence of cerebral trauma, massive cerebral infarction, hemorrhages, abscess, tumor, allergy, sepsis, hypoxia, and other toxic or metabolic factors. At present, the following types of cerebral edema are differentiated: the vasogenic cerebral edema resulting from an increased permeability of the endothelium of cerebral capillaries to albumin and other plasma proteins; the cytotoxic cerebral edema resulting from the exhaustion of the energy potential of cell membranes without damage to the barrier; the hydrostatic cerebral edema resulting from disturbance of the autoregulation of cerebral blood circulation; the osmotic cerebral edema resulting from dilution of blood; and the interstitial cerebral edema resulting from acute hydrocephaly. Some authors also differentiate ischemic cerebral edema. At present, when various traumas and traumatic cerebral injuries are frequent causes of death in young people, treatment strategy for cerebral edema is of utmost importance. Monitoring of the patient's condition in the intensive care unit is a necessity. It is important to ensure proper positioning of the patient - the head should be tilted at 300 in order to optimize the cerebral perfusion pressure and control of the increase in intracranial pressure. Hyperventilation should be applied. Controlled hypothermia decreases the rate of metabolism in the brain. Slightly positive fluid balance should be maintained using crystalloid or colloid (hypertonic-hyperoncotic) solutions, at the same time maintaining cerebral perfusion pressure exceeding 70 mmHg. The treatment includes administration of antihypertensive medications, nonsteroidal antiinflammatory drugs, and barbiturates. Steroids decrease the permeability of capillaries and the hemato-encephalic barrier, promoting the movement of Na+/K+ ions and water through the main endothelial membrane, and therefore they are used in the treatment of vasogenic cerebral edema as well as edema caused by a cerebral tumor. Glutamate and N-methyl-D-aspartate receptor antagonists improve cerebral microcirculation and metabolism. Trometamol corrects cerebral acidosis. Extended cerebral edema is treated surgically via a bilateral decompressive craniotomy, sometimes including craniotomy of lateral and posterior fossae. The treatment of cerebral edema is complex, and positive results may be expected only if the diagnosis and the provision of assistance are timely.	[Adukauskiene, Dalia] Kaunas Univ Med, Clin Intens Care, LT-44307 Kaunas, Lithuania		Bivainyte, A (corresponding author), Kaunas Univ Med, Clin Intens Care, A Mickeviciaus 9, LT-44307 Kaunas, Lithuania.	astija2@yahoo.com	Adukauskiene, Dalia/R-6854-2019				ADAMS RD, 2001, PRINCIPLES NEUROLOGY, P680; ALBIN MS, 1997, TXB NEUROANESTHESIA, P85; BEKER DP, 1989, TXB HEAD INJURY, P553; BILERRY J, 1997, CURRENT THERAPY NEUR, P191; BUDRYS V, 2003, KLINIKINE NEUROLOGIJ, P724; Duric Amira, 2003, Med Arh, V57, P53; Hemphill J.C., 2001, HARRISONS PRINCIPLES, P2491; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; Juozaityte Elona, 2003, Medicina (Kaunas), V39, P804; KLUMBYS L, 2001, NERVU SISTEMOS CHIRU, P29; Kontautas Egidijus, 2004, Medicina (Kaunas), V40, P345; PITTI R, 1998, CITERA CTR INSTRUCTI, P99; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; SINGER M, 1998, OXFORD HDB CRITICAL, P462; SUAREZ YI, 2001, REV NEUROL, V32, P275; VICTOR M, 2001, PRINCIPLES NEUROLOGY, P821; VINCENT JL, 2004, YB INTENSIVE CARE EM, P812; Ziliene Violeta, 2005, Medicina (Kaunas), V41, P81	18	9	12	3	11	KAUNAS UNIV MEDICINE & VILNIUS UNIV	KAUNAS	KAUNAS UNIV MEDICINE, A MICKEVICIAUS 9, KAUNAS, LT-44307, LITHUANIA	1010-660X			MED LITH	Med. Lith.		2007	43	2					170	176		10.3390/medicina43020021			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280AS	WOS:000254397900012	17329953	Green Submitted, hybrid			2022-02-06	
J	Anderson, GD; Temkin, NR; Awan, AB; Winn, RH				Anderson, Gail D.; Temkin, Nancy R.; Awan, Asaad B.; Winn, Richard H.			Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury	CLINICAL PHARMACOKINETICS			English	Article							PLASMA-PROTEIN BINDING; SEVERE HEAD-INJURY; PARENTERAL-NUTRITION; DRUG BIOTRANSFORMATION; CEREBROSPINAL-FLUID; CLINICAL-RELEVANCE; RAT-LIVER; METABOLISM; PHENYTOIN; CYTOKINES	Background: Traumatic brain injury (TBI) results in an increase in hepatic metabolism. The increased metabolism is in significant contrast to a large body of in vitro and in vivo data demonstrating that activation of the host-defence response downregulates hepatic metabolism. Theoretically, this occurs because of activation of the pro-inflammatory cytokines tumour necrosis factor-alpha, interferon-gamma, interleukin (IL)-1 and IL-6. As part of a large double-blind, placebo-controlled clinical trial evaluating the use of valproic acid for prophylaxis of post-traumatic seizures, we obtained extensive valproic acid concentration-time data. Valproic acid is a hepatically metabolised, low extraction-ratio drug. Therefore, unbound clearance (CLu) is equal to intrinsic or metabolic clearance. Objective: The objective of this study was to evaluate the time-dependent effects of TBI on the pharmacokinetics of total and unbound valproic acid with the goal of identifying patient factors that may predict changes in total clearance (CL) and CLu. In addition, by determining the factors that influence the magnitude and time course of induction of hepatic metabolism and understanding their interaction with the host-defence mediators, we can further our insight into the mechanism(s) responsible for the changes in CL and CLu. Study Design: Valproic acid plasma concentration data were obtained from 158 TBI patients. Unbound valproic acid plasma concentrations were estimated using total valproic acid plasma and albumin concentrations following a Scatchard equation binding model previously developed in a subset of TBI patients. The effect of 13 patient factors on CL and CLu was evaluated initially in a univariate analysis. The significant factors were then included in a multiple linear regression analysis by use of step-wise selection and forward selection procedures. Results: CL and CLu were significantly increased after TBI in a time-dependent manner. The average increase was > 75% by weeks 2 and 3 post-injury. The magnitude of the induction of CL was increased with decreased albumin concentrations, in addition to the presence of ethanol on admission, increased severity of head injury, tube feeding and total parenteral nutrition (TPN). The magnitude of induction of CLu was increased by older age, presence of ethanol on admission, increased severity of head injury, tube feeding, TPN, and if the patient had a post-injury neurosurgical procedure. The time to normalisation of CLu was significantly longer in patients with head injury plus other injuries compared with those with head injury alone. Conclusions: As has been reported with other drugs, TBI results in a significant increase in the metabolism of valproic acid. The patient factors identified in this study that resulted in an increase in the magnitude and time course of the induction of CLu (ethanol, older age, presence of a neurosurgical procedure, severity of TBI and presence of multiple non-TBI injuries) have all been reported to cause a shift to the anti-inflammatory mediators IL-4 and IL-10. This suggests that the increase in hepatic metabolism after TBI may be due to the increased presence of anti-inflammatory mediators in contrast to the inhibition effect of the pro-inflammatory mediators in non-TBI inflammation and infection.	Univ Washington, Dept Pharm, Sch Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Pharm, Sch Med, Seattle, WA 98195 USA; Univ Washington, Dept Pharm, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Sch Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Sch Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Sch Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Sch Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Mt Sinai Sch Med, New York, NY USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Sch Pharm, Box 357630, Seattle, WA 98195 USA.	gaila@u.washington.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19643] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER		AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; ANDERSON GD, 1994, BRIT J CLIN PHARMACO, V37, P559, DOI 10.1111/j.1365-2125.1994.tb04304.x; Anderson GD, 1998, BRIT J CLIN PHARMACO, V45, P101, DOI 10.1046/j.1365-2125.1998.00652.x; ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; Bajpai M, 1996, DRUG METAB DISPOS, V24, P1401; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAUER LA, 1983, J TRAUMA, V23, P1058, DOI 10.1097/00005373-198312000-00007; Benet LZ, 2002, CLIN PHARMACOL THER, V71, P115, DOI 10.1067/mcp.2002.121829; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; BOWDLE TA, 1980, CLIN PHARMACOL THER, V28, P486, DOI 10.1038/clpt.1980.192; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Deaciuc IV, 1997, ALCOHOL, V14, P421, DOI 10.1016/S0741-8329(97)00039-6; DIPIRO JT, 1995, ARCH SURG-CHICAGO, V130, P1159; EARLSALOTTI GL, 1994, JPEN-PARENTER ENTER, V18, P458, DOI 10.1177/0148607194018005458; Engel G, 1996, CLIN PHARMACOL THER, V59, P613, DOI 10.1016/S0009-9236(96)90001-6; FAGAN TC, 1987, CLIN PHARMACOL THER, V41, P402, DOI 10.1038/clpt.1987.48; Franke G, 1995, INT J CLIN PHARM TH, V33, P653; Gosain A, 2005, J BURN CARE REHABIL, V26, P7, DOI 10.1097/01.BCR.0000150214.72984.44; GRIEBEL ML, 1990, CRIT CARE MED, V18, P385, DOI 10.1097/00003246-199004000-00007; Harbrecht BG, 2005, CRIT CARE MED, V33, P541, DOI 10.1097/01.ccm.0000155989.54344.E0; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kao CH, 1998, J NUCL MED, V39, P1798; KAPPAS A, 1976, CLIN PHARMACOL THER, V20, P643; KE J, 1990, J PHARMACOL EXP THER, V255, P351; KODAMA Y, 1992, THER DRUG MONIT, V14, P55, DOI 10.1097/00007691-199202000-00009; KODAMA Y, 1992, THER DRUG MONIT, V14, P349, DOI 10.1097/00007691-199210000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kovacs EJ, 2004, J LEUKOCYTE BIOL, V76, P36, DOI 10.1189/jlb.1103538; Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007; Kovacs SJ, 1998, CLIN PHARMACOL THER, V63, P617, DOI 10.1016/S0009-9236(98)90084-4; Levy RH, 2002, ANTIEPILEPTIC DRUGS, P780; Lum Siew-Kam, 1993, Clinical Chemistry, V39, P1244; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; McKindley DS, 1997, J CLIN PHARMACOL, V37, P129, DOI 10.1002/j.1552-4604.1997.tb04771.x; Morgan EH, 2002, BLOOD CELL MOL DIS, V29, P384, DOI 10.1006/bcmd.2002.0578; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Power BM, 1998, CLIN PHARMACOKINET, V34, P25, DOI 10.2165/00003088-199834010-00002; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; Renton KW, 2001, PHARMACOL THERAPEUT, V92, P147, DOI 10.1016/S0163-7258(01)00165-6; SCHEYER RD, 1990, THER DRUG MONIT, V12, P117; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Seekamp A, 2002, EUR J TRAUMA, V28, P83; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Wagner BKJ, 1997, CLIN PHARMACOKINET, V33, P426, DOI 10.2165/00003088-199733060-00003; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Young CC, 2001, CRIT CARE CLIN, V17, P843, DOI 10.1016/S0749-0704(05)70183-4; Zaman N, 1997, BIOPHARM DRUG DISPOS, V18, P803; Zheng Yi J, 2004, JPEN J Parenter Enteral Nutr, V28, P163, DOI 10.1177/0148607104028003163	58	9	9	0	11	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.		2007	46	4					307	318		10.2165/00003088-200746040-00004			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	156HY	WOS:000245639900004	17375982				2022-02-06	
J	Hillary, FG; Liu, WC; Genova, HM; Maniker, AH; Kepler, K; Greenwald, BD; Cortese, BM; Homnick, A; Deluca, J				Hillary, F. G.; Liu, W. C.; Genova, H. M.; Maniker, A. H.; Kepler, K.; Greenwald, B. D.; Cortese, B. M.; Homnick, A.; Deluca, J.			Examining lactate in severe TBI using proton magnetic resonance spectroscopy	BRAIN INJURY			English	Article						TBI; MRI; MRS; coma; brain injury; lactate	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; SEVERE HEAD-INJURY; IN-VIVO; AXONAL INJURY; MICRODIALYSIS; RECOVERY; GLUCOSE; EDEMA; MRS	Primary objective: Clinical management of acute traumatic brain injury ( TBI) has emphasized identification of secondary mechanisms of pathophysiology. An important objective in this study is to use proton magnetic resonance spectroscopy ( pMRS) to examine early metabolic disturbance due to TBI. Research design: The current design is a case study with repeated measures. Method and procedure: Proton magnetic resonance imaging was used to examine neurometabolism in this case of very severe brain trauma at 9 and 23 days post-injury. MRI was performed on a clinical 1.5 Tesla scanner. Main outcomes and results: These data also reveal that pMRS methods can detect lactate elevations in an adult surviving severe head trauma and are sensitive to changes in basic neurometabolism during the first month of recovery. Conclusions: The current case study demonstrates the sensitivity of pMRS in detecting metabolic alterations during the acute recovery period. The case study reveals that lactate elevations may be apparent for weeks after severe neurotrauma. Further work in this area should endeavour to determine the ideal time periods for pMRS examination in severe TBI as well as the ideal locations of data acquisition ( e. g. adjacent or distal to lesion sites).	Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; Univ Med & Dent New Jersey, New Jersey Dent Sch, Newark, NJ 07103 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Integrat Neurosci Program, Newark, NJ 07103 USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 223 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD042085] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD042085] Funding Source: Medline		Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brooks WM, 1999, MAGNET RESON MED, V41, P193, DOI 10.1002/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.3.CO;2-G; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chan MTV, 2005, ACT NEUR S, V95, P63; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DESALLES AAF, 1987, NEUROSURGERY, V20, P297, DOI 10.1227/00006123-198702000-00017; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; *NAT I HLTH, 1998, NIH CONSENSUS STATE, V26, P1; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Schirmer T, 2000, NMR BIOMED, V13, P28, DOI 10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L; SHIBATA S, 1974, J NEUROSURG, V41, P146, DOI 10.3171/jns.1974.41.2.0146; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; WHYTE J, 1998, REHABILITATION MED P, P1191; Yoon SJ, 2005, CLIN REHABIL, V19, P209, DOI 10.1191/0269215505cr813oa; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137	43	9	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	9					981	991		10.1080/02699050701426964			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	202ZA	WOS:000248942600009	17729050				2022-02-06	
J	Ihrig, C; Schaefer, DP				Ihrig, Carolyn; Schaefer, Daniel P.			Acquired monocular vision rehabilitation program	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						acquired monocular vision; acquired monocular vision rehabilitation; cognitive function; depression; independence; loss of depth perception; monocular motility skills; motor development; nasal or temporal occlusion; neuro-optometric rehabilitation; polycarbonate lenses; prisms; supportive counseling; traumatic brain injury; visual field defects; visual rehabilitation	VISUAL FORM AGNOSIA; DEPTH; PERCEPTION; SIZE; CUES; MANAGEMENT; OCULOMOTOR; THERAPY; MOTION; ANGLE	Existing programs concerning patients with low vision do not readily meet the needs of the patient with acquired monocular vision. This article illustrates the development, need, and benefits of an Acquired Monocular Vision Rehabilitation evaluation and training program. This proposed program will facilitate the organization of vision rehabilitation with eye care professionals and social caseworkers to help patients cope with, as well as accept, and recognize obstacles they will face in transitioning suddenly to monocular vision.	Buffalo Dept Vet Affairs Med Ctr, Buffalo, NY 14215 USA; SUNY Buffalo, Sch Med & Biomed Sci, Dept Otolaryngol, Univ Buffalo, Buffalo, NY USA; SUNY Buffalo, Sch Med & Biomed Sci, Dept Ophthalmol,Univ Buffalo, Ira G Ross Eye Inst,Div Oculoplast Orbital Plast, Buffalo, NY USA		Ihrig, C (corresponding author), Buffalo Dept Vet Affairs Med Ctr, 3495 Bailey Ave, Buffalo, NY 14215 USA.	carolyn.ihrig@va.gov; cihrig@buffalo.edu					BOBIER WR, 1983, AM J OPTOM PHYS OPT, V60, P678; Bradshaw MF, 1996, VISION RES, V36, P3457, DOI 10.1016/0042-6989(96)00072-7; Brady FrankB, 1994, SINGULAR VIEW ART SE; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Coday MP, 2002, OPHTHALMIC PLAST REC, V18, P56, DOI 10.1097/00002341-200201000-00009; Cohen A H, 1992, J Am Optom Assoc, V63, P569; COLLETT TS, 1991, PERCEPTION, V20, P733, DOI 10.1068/p200733; Cutting J. E., 1995, HDB PERCEPTION COGNI, P69, DOI DOI 10.1016/B978-012240530-3/50005-5; Dijkerman HC, 1996, EXP BRAIN RES, V112, P442; Gogel WC, 1997, PERCEPT PSYCHOPHYS, V59, P783, DOI 10.3758/BF03206024; GRUNING CF, 1985, AM J OPTOM PHYS OPT, V62, P386; HOFFMAN L, 1973, AM J OPTOM PHYS OPT, V50, P813; HUNG GK, 1986, DOC OPHTHALMOL, V62, P165, DOI 10.1007/BF00229128; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Kulp MT, 1996, OPTOMETRY VISION SCI, V73, P283, DOI 10.1097/00006324-199604000-00011; Marotta JJ, 1997, EXP BRAIN RES, V116, P113, DOI 10.1007/PL00005731; MCCREADY D, 1985, PERCEPT PSYCHOPHYS, V37, P323, DOI 10.3758/BF03211355; Padula WV, 1996, NEUROREHABILITATION, V6, P165, DOI 10.3233/NRE-1996-6302; PADULA WV, 1997, NEURO OPTOMETR REHAB, V11, P22; PADULA WV, 1996, NEURO OPTOMETR REHAB, P179; ReinhardtRutland AH, 1996, J GEN PSYCHOL, V123, P237, DOI 10.1080/00221309.1996.9921276; Rounds B B, 1991, J Am Optom Assoc, V62, P92; ROUSE MW, 1987, AM J OPTOM PHYS OPT, V64, P415; WOLD RM, 1978, J AM OPTOM ASSOC, V49, P1047	25	9	9	2	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2007	44	4					593	597		10.1682/JRRD.2006.06.0071			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	223DV	WOS:000250350700013	18247256	Bronze			2022-02-06	
J	Bonanni, E; Borghetti, D; Fabbrini, M; Maestri, M; Cignoni, F; Sartucci, F; Murri, L				Bonanni, E.; Borghetti, D.; Fabbrini, M.; Maestri, M.; Cignoni, F.; Sartucci, F.; Murri, L.			Quantitative EEG analysis in post-traumatic anosmia	BRAIN RESEARCH BULLETIN			English	Article						olfaction; alpha; head trauma; frequency maps; anosmia	OLFACTORY STIMULATION; EVOKED-POTENTIALS; HEAD-INJURY; BRAIN; PERSONALITY; APPEARANCE; SMELL	Many objective and quantitative methods have been developed to create a procedure or a device to prove, describe and quantify olfactory deficit and anosmia, especially after a head trauma. Electrophysiological testing throughout olfactoelectroencephalography (olfactoEEG) is based on brain activity desynchronisation, and on the subsequent disappearance of alpha activity on the posterior regions after an olfactory stimulus. Yet traditional evaluation of EEG can be difficult, because of little or hardly detectable alpha activity on the posterior regions ('alpha rare'). The aim of this study was to evaluate the Olfactory Stop Reaction (OSR) by means of frequency band power calculation and subsequent topographical mapping in patients with post-traumatic anosmia, who presented 'alpha rare' EEG. Twenty-five consecutive patients, affected by anosmia caused by head trauma, were submitted to an EEG recording with olfactory stimulation. After signal processing and analysis, an Olfactory Stop Reaction was detected in 17 out of 25 patients; moreover, in these patients we detected a significant decrease in alpha band power in the occipital regions and an increase in theta band power on midline frontal and central regions after olfactory stimulation. In the remaining eight patients, no significant variation in band power was observed. In conclusion, an objective evaluation of the olfactory function with this method of automatic EEG signal analysis allows the limits given by psychophysical methods and traditional EEG to be overcome and attempts to fulfil the requirements for standardization of olfactory function evalution. (c) 2006 Elsevier Inc. All rights reserved.	Univ Pisa, Neurol Sect, Dept Neurosci, I-56124 Pisa, Italy		Bonanni, E (corresponding author), Univ Pisa, Neurol Sect, Dept Neurosci, Via Roma 67, I-56124 Pisa, Italy.	e.bonanni@neuro.med.unipi.it	Bonanni, Enrica/AAC-5826-2022; Sartucci, Ferdinando/M-4143-2016	BONANNI, ENRICA/0000-0001-8500-1149			Aftanas LI, 2002, NEUROSCI LETT, V330, P143, DOI 10.1016/S0304-3940(02)00745-0; AMOORE JE, 1968, PERCEPT MOTOR SKILL, V26, P143, DOI 10.2466/pms.1968.26.1.143; Arellano A. P., 1950, P 1 INT C PSYCH PAR; Breuninger H, 1966, HNO, V14, P370; Burkert S, 2005, MMW-FORTSCH MEDIZIN, V147, P51; Chen D, 2005, CHEM SENSES, V30, P345, DOI 10.1093/chemse/bji029; Davis H, 1936, ARCH NEURO PSYCHIATR, V36, P1214, DOI 10.1001/archneurpsyc.1936.02260120061004; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Geisler MW, 1999, J CLIN NEUROPHYSIOL, V16, P77, DOI 10.1097/00004691-199901000-00008; GERULL G, 1974, HNO, V22, P233; Giovannucci M, 1966, Minerva Med, V57, P40; Gori S, 1995, ITAL J NEUROL SCI, V16, P595, DOI 10.1007/BF02230909; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; HAGAN PJ, 1967, ARCHIV OTOLARYNGOL, V85, P85; Harada H, 1998, CLIN ELECTROENCEPHAL, V29, P96, DOI 10.1177/155005949802900208; Harada H, 2002, CLIN ELECTROENCEPHAL, V33, P189, DOI 10.1177/155005940203300410; HAYASHI H, 1987, ELECTROEN CLIN NEURO, V66, P66, DOI 10.1016/0013-4694(87)90139-8; Herz RS, 2004, CHEM SENSES, V29, P217, DOI 10.1093/chemse/bjh025; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; IHL R, 1989, PSYCHIAT RES, V29, P399, DOI 10.1016/0165-1781(89)90101-7; ISHIHARA T, 1972, ELECTROEN CLIN NEURO, V33, P71, DOI 10.1016/0013-4694(72)90026-0; Jacquot L, 2004, BRAIN RES, V1002, P51, DOI 10.1016/j.brainres.2003.12.011; Kato Toshihiko, 1995, Auris Nasus Larynx, V22, P103; Kay LM, 2005, P NATL ACAD SCI USA, V102, P3863, DOI 10.1073/pnas.0407920102; LANG M, 1987, CURRENT TRENDS EVE S, V40, P322; LAUKKA SJ, 1995, BIOL PSYCHOL, V40, P313, DOI 10.1016/0301-0511(95)05122-Q; LOGAR C, 1991, Brain Topography, V3, P441, DOI 10.1007/BF01129003; LORIG TS, 1994, TOXICOL IND HEALTH, V10, P579; LORIG TS, 1989, PROG NEUROBIOL, V33, P387, DOI 10.1016/0301-0082(89)90007-5; Lorig TS, 2000, INT J PSYCHOPHYSIOL, V36, P91, DOI 10.1016/S0167-8760(99)00104-X; LUBAN-PLOZZA B., 1967, SCHWEIZ ARCH NEUROL NEUROCHIR PSYCHIAT, V99, P270; MAGRI R, 1963, Riv Otoneurooftalmol, V38, P295; Martin GN, 1998, INT J PSYCHOPHYSIOL, V30, P287, DOI 10.1016/S0167-8760(98)00025-7; MATERN G, 1995, LARYNGO RHINO OTOL, V74, P118, DOI 10.1055/s-2007-997702; MIZUKI Y, 1982, FOLIA PSYCHIAT NEU J, V36, P375; MONCRIEFF RW, 1962, PERFUMERY ESSENTIAL, V53, P757; MOTOKIZAWA F, 1973, ELECTROEN CLIN NEURO, V35, P83, DOI 10.1016/0013-4694(73)90134-X; MURRI L, 1991, CURR OPIN NEUROL NEU, V4, P788; Muthuswamy J, 1998, J NEUROSCI METH, V83, P1, DOI 10.1016/S0165-0270(98)00065-X; REBATTU JP, 1966, CHIR MAXILLOFAC, V15, P873; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; SARTESCHI P, 1960, Riv Neurol, V30, P555; Savic-Berglund I, 2004, NUTR REV, V62, pS205, DOI 10.1111/j.1753-4887.2004.tb00100.x; SCHWARTZ GE, 1994, TOXICOL IND HEALTH, V10, P633; Shepherd GM, 2005, NEURON, V46, P166, DOI 10.1016/j.neuron.2005.03.012; Smith TD, 2004, ANAT REC PART A, V281A, P1173, DOI 10.1002/ar.a.20122; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; Sneppe R, 1973, Electrodiagn Ther, V10, P5; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; SOIKKELI R, 1991, ELECTROEN CLIN NEURO, V79, P159, DOI 10.1016/0013-4694(91)90134-P; Takahashi T, 2005, INT J PSYCHOPHYSIOL, V55, P199, DOI 10.1016/j.ijpsycho.2004.07.004; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Walla P, 2002, COGNITIVE BRAIN RES, V14, P309, DOI 10.1016/S0926-6410(02)00121-0; Welge-Lussen A, 1999, HNO, V47, P453, DOI 10.1007/s001060050403	56	9	9	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	DEC 11	2006	71	1-3					69	75		10.1016/j.brainresbull.2006.08.004			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	115LJ	WOS:000242735500011	17113930				2022-02-06	
J	Degos, V; Lescot, T; Zouaoui, A; Hermann, H; Preteux, F; Coriat, P; Puybasset, L				Degos, Vincent; Lescot, Thomas; Zouaoui, Abderrezak; Hermann, Harold; Preteux, Francoise; Coriat, Pierre; Puybasset, Louis			Computed tomography-estimated specific gravity of noncontused brain areas as a marker of severity in human traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HEAD-INJURY; PLASMA-PROTEINS; WATER-CONTENT; BARRIER; EDEMA; CT; DENSITY; RATS; ATTENUATION	In this study, we assessed the relationship between brain estimated specific gravity (eSG) and clinical symptoms, therapeutic intensity level, and outcome in human traumatic brain injury (TBI). Brain weight, volume, and eSG of the nonconfused hemispheric areas were measured from computed tomography (CT) DICOM images on the initial (5 +/- 6 h) CT of 120 patients with severe TBI. Control values were obtained from 40 healthy patients. The eSG of the nonconfused hemispheric areas was significantly higher in TBI patients than in controls. eSG was higher in patients having a Marshall CT classification of 3 or 4 or a low initial Glasgow coma score. Two groups were defined according to the eSG of the nonconfused hemispheric areas: less than (n = 83, 69%) or more than (n = 37,31%) the threshold of normality (defined as 1.96 SD above normal = 1.0355 g/mL). The occurrence of mydriasis, use of osmotherapy at the scene of the accident, and therapeutic intensity level were higher in the increased eSG group. The outcome at intensive care unit discharge was worse in patients with an increased eSG although the difference was no longer significant at 1 yr. eSG determination by CT analysis might be relevant in the early management of TBI.	CHU Pitie Salpetriere, Dept Anesthesiol & Crit Care, Hop Paris, Paris, France; CHU Pitie Salpetriere, Dept Neuroradiol, Hop Paris, Paris, France; Univ Paris 06, F-75252 Paris 05, France; Inst Natl Telecommun, Artemis Project Unit, F-91011 Evry, France		Puybasset, L (corresponding author), CHU Pitie Salpetriere, Dept Anesthesie Reanimat, Unite Neuroreanimat, 47-83 Blvd Hop, F-75651 Paris 13, France.	louis.puybasset@psl.aphp.fr					ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BLACQUEBELAIR A, 1965, DICT CONTANTES BIOL; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Castejon OJ, 2001, HISTOL HISTOPATHOL, V16, P1117, DOI 10.14670/HH-16.1117; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; IKEDA Y, 1994, ACTA NEUROCHIR, P136; LANG DA, 1991, ACTA NEUROCHIR, V109, P5, DOI 10.1007/BF01405689; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; LESCOT T, 2003, J NEUROSURG ANESTHES, V15, pA375; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; LOBERG EM, 1991, ACTA NEUROPATHOL, V81, P479, DOI 10.1007/BF00310126; Malbouisson LM, 2001, AM J RESP CRIT CARE, V163, P1444, DOI 10.1164/ajrccm.163.6.2005001; Malbouisson LM, 2000, AM J RESP CRIT CARE, V161, P2005, DOI 10.1164/ajrccm.161.6.9907067; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; PHELPS ME, 1975, RADIOLOGY, V117, P585, DOI 10.1148/117.3.585; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Stocchetti N, 2005, INTENS CARE MED, V31, P1009, DOI 10.1007/s00134-005-2708-z; TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797; UNGER E, 1988, AM J NEURORADIOL, V9, P687; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456	25	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	NOV	2006	103	5					1229	1236		10.1213/01.ane.0000237401.22688.22			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	099CR	WOS:000241570600028	17056960				2022-02-06	
J	Elliott, MR; Arbogast, KA; Durbin, DR				Elliott, Michael R.; Arbogast, Kristy A.; Durbin, Dennis R.			A latent class analysis of injury patterns among rear-seated, seat-belted children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						passenger vehicle safety; child safety; injury cluster; body region	ANALYZING DEVELOPMENTAL TRAJECTORIES; MODEL	Background. The objective of the study was to determine the constellation of injury patterns in rear-seated, seat-belt-restrained children using data-driven latent class methodology novel to injury prevention research. Methods: A cross-sectional probability sample of rear-seated, belt-restrained children aged 5 to 15 years in crashes was obtained via insurance claims records and a telephone survey. Eight body regions of AIS 2 or greater injury (concussion, nonconcussive head injury, face, chest, abdomen, neck/spine/back, upper extremity, lower extremity) were determined, and a latent class model was fit to determine whether underlying "injury clusters" were present. Results. A three-class model appears to best fit to observed data: an "abdominal/spine" cluster that contained 11% of the population, a "concussion" cluster that contained 56% of the population, and a residual "mixture" cluster that contained the remaining 33% of the population. When compared with the mixture cluster, the abdomen/spine cluster was associated with 4 to 8 year old children, lap-only belt restraint, frontal impacts, and minivans. The concussion cluster was also more common among 4 to 8 and 9 to 12 year olds, with side or rear impact crashes, and with pickup trucks. Conclusions. Latent class analysis allows injury clusters to be estimated from the data, not predetermined by the investigator, and suggests that distinct mechanisms of abdominal injury and concussive head injury exist in a population-based sample of children in motor vehicle crashes.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, TraumaLink, Philadelphia, PA 19104 USA		Elliott, MR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, M4041,SPH 2 1420, Ann Arbor, MI 48109 USA.	mrelliot@umich.edu	Durbin, Dennis/AAD-7829-2022	Arbogast, Kristy/0000-0002-1694-4562			Arbogast KB, 2002, J TRAUMA, V52, P693, DOI 10.1097/00005373-200204000-00014; ARBOGAST KB, 2004, STAPP CAR CRASH J, V48, P1; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BLAZER D, 1991, CURRENT OPINION PSYC, V4, P596; Chen LS, 2000, J AFFECT DISORDERS, V59, P1, DOI 10.1016/S0165-0327(99)00132-9; Clogg C., 1995, HDB STAT MODELS BEHA; Durbin DR, 2001, PEDIATR EMERG CARE, V17, P474, DOI 10.1097/00006565-200112000-00021; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; EATON WW, 1989, BRIT J PSYCHIAT, V155, P48, DOI 10.1192/bjp.155.1.48; GLASSMAN SD, 1992, J TRAUMA, V33, P882, DOI 10.1097/00005373-199212000-00015; HOY GA, 1993, INJURY, V24, P297, DOI 10.1016/0020-1383(93)90048-B; LANE JC, 1994, ACCIDENT ANAL PREV, V26, P813, DOI 10.1016/0001-4575(94)90058-2; LINDSAY B, 1991, J AM STAT ASSOC, V86, P96, DOI 10.2307/2289719; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Rhodes Anne E, 2002, Chronic Dis Can, V23, P139; Rouhana S. W, 2002, ACCIDENTAL INJURY BI, P405; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; TSO EL, 1993, J PEDIATR SURG, V28, P915, DOI 10.1016/0022-3468(93)90696-I; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179	22	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2006	61	5					1244	1248		10.1097/01.ta.0000195983.48529.0d			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	105TB	WOS:000242054100037	17099536				2022-02-06	
J	Fawcett, JW				Fawcett, James W.			Novel strategies for protection and repair of the central nervous system	CLINICAL MEDICINE			English	Article						Alzheimer's disease; axon regeneration; head injury; multiple sclerosis; plasticity; spinal cord injury; stem cells; stroke	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EMBRYONIC STEM-CELLS; MULTIPLE-SCLEROSIS; NEURAL TRANSPLANTATION; PARKINSONS-DISEASE; REGENERATION; THERAPY; DIFFERENTIATION; REMYELINATION	Clinical possibilities in many neurological conditions are limited by our current inability to correct structural damage to the nervous system, and treatments to prevent damage are also limited. Current research has produced promising treatments that promote neuroprotection, plasticity, axon regeneration, remyelination and cell replacement. As these treatments go through clinical trials and enter the clinic, the treatment of several neurological conditions will change greatly.	Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England		Fawcett, JW (corresponding author), Univ Cambridge, Ctr Brain Repair, Robinson Way, Cambridge CB2 2PY, England.	jf108@cam.ac.uk		Fawcett, James/0000-0002-7990-4568			Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Coles A, 2004, CLIN NEUROL NEUROSUR, V106, P270, DOI 10.1016/j.clineuro.2004.02.013; Dergham P, 2002, J NEUROSCI, V22, P6570; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Fricker-Gates RA, 2001, RESTOR NEUROL NEUROS, V19, P119; Goodin D, 2006, LANCET NEUROL, V5, P375, DOI 10.1016/S1474-4422(06)70419-7; Hauser SL, 2006, ANN NEUROL, V59, P731, DOI 10.1002/ana.20877; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Mark VW, 2004, RESTOR NEUROL NEUROS, V22, P317; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Nudo RJ, 1996, J NEUROSCI, V16, P785; Peterson JW, 2005, NEUROL CLIN, V23, P107, DOI 10.1016/j.ncl.2004.09.008; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	31	9	9	0	1	ROY COLL PHYS LONDON EDITORIAL OFFICE	LONDON	11 ST ANDREWS PLACE REGENTS PARK, LONDON NW1 4LE, ENGLAND	1470-2118	1473-4893		CLIN MED	Clin. Med.	NOV-DEC	2006	6	6					598	603		10.7861/clinmedicine.6-6-598			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122IE	WOS:000243218600016	17228561	Green Published			2022-02-06	
J	Warren, J; Schneiders, AG; Sullivan, SJ; Bell, ML				Warren, Jonathan; Schneiders, Anthony G.; Sullivan, S. John; Bell, Melanie L.			Repeated single-limb postural stability testing elicits a practice effect	PHYSICAL THERAPY IN SPORT			English	Article; Proceedings Paper	1st Physical Therapy in Sport International Conference	JUL 07-08, 2006	Birmingham, ENGLAND	Elsevier, ACPSM, IFSP		balance; practice effects; single-leg stance; measurement	ANKLE; CONCUSSION; SWAY	Objective: To document the effects of repeated testing on the single-leg stance balance task. Design: Single cohort repeated measures. Setting: Laboratory in an educational institution. Subjects: Thirty-two healthy males and females. Outcome measure: The number of errors (deviations from the required posture) during each 20-s trial summed over the eight conditions recorded on six occasions. Results: There was a statistically significant (p = .0013) decrease in the number of errors recorded over the six sessions, from 26.8 (95% Cl: 23.1-30.5) to 19.7 (95% Cl: 16.3-23.1). Linear regression confirmed a systematic decrease of 1.5 errors per session on average (95% Cl: 1.0-1.9; p <.0001). Conclusion: The decreased number of errors (increased performance) with repeated testing alerts clinicians to the need for care when using this test protocol to measure rehabilitation interventions. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Otago, Sch Physiotherapy, Dunedin 9015, New Zealand; Kennedy Rd Physiotherapy, Napier, New Zealand; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand		Schneiders, AG (corresponding author), Univ Otago, Sch Physiotherapy, POB 56, Dunedin 9015, New Zealand.	tony.schneiders@otago.ac.nz	Bell, Melanie/N-4166-2019; Bell, Melanie L/D-1839-2011; Schneiders, Anthony/F-4212-2015	Bell, Melanie/0000-0003-4821-4094; Bell, Melanie L/0000-0003-4821-4094; Schneiders, Anthony/0000-0002-1583-3879			[Anonymous], 1999, SAS STAT V8 SOFTW US; Bernier JN, 1998, J ORTHOP SPORT PHYS, V27, P264, DOI 10.2519/jospt.1998.27.4.264; Beynnon BD, 2000, PROPRIOCEPTION AND NEUROMUSCULAR CONTROL IN JOINT STABILITY, P127; CORNWALL MW, 1991, J AM PODIAT MED ASSN, V81, P243, DOI 10.7547/87507315-81-5-243; DIENER HC, 1988, PROG BRAIN RES, V76, P253; Emery CA, 2005, PHYS THER, V85, P502, DOI 10.1093/ptj/85.6.502; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V480, P395, DOI 10.1113/jphysiol.1994.sp020369; Forkin DM, 1996, J ORTHOP SPORT PHYS, V23, P245, DOI 10.2519/jospt.1996.23.4.245; Freeman M A, 1965, J Bone Joint Surg Br, V47, P678; GOLDIE PA, 1994, ARCH PHYS MED REHAB, V75, P969; GOLDIE PA, 1992, ARCH PHYS MED REHAB, V73, P348, DOI 10.1016/0003-9993(92)90008-K; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hals TMV, 2000, J ORTHOP SPORT PHYS, V30, P552, DOI 10.2519/jospt.2000.30.9.552; Isakov E, 1997, BRIT J SPORT MED, V31, P65, DOI 10.1136/bjsm.31.1.65; JEROSCH J, 1996, SPORTS EXERC INJURY, V2, P167; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Nashner L, 1993, PRACTICAL BIOMECHANI; O'Connell M, 1998, GAIT POSTURE, V8, P136, DOI 10.1016/S0966-6362(98)00023-X; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rozzi SL, 1999, J ORTHOP SPORT PHYS, V29, P478, DOI 10.2519/jospt.1999.29.8.478; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; Valovich TC, 2003, J ATHL TRAINING, V38, P51	23	9	9	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2006	7	4					185	190		10.1016/j.ptsp.2006.06.002			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	117YP	WOS:000242909500004	21663830				2022-02-06	
J	Khan, HA				Khan, H. A.			TLC determination of aliphatic polyamines on calcium sulfate layers	CHROMATOGRAPHIA			English	Article						thin layer chromatography; calcium sulfate layers; separation of polar compounds; biogenic polyamines	TRAUMATIC BRAIN INJURY; BIOGENIC-AMINES; ORNITHINE-DECARBOXYLASE; CAPILLARY-ELECTROPHORESIS; CANCER; CHROMATOGRAPHY; RAT; ACCUMULATION; PUTRESCINE; SEPARATION	Biogenic polyamines are sensitive markers for various diseases including cancer. Polyamines are difficult to analyze by chromatography due to their high polarity and water-solubility so that derivatization is an essential step for their chromatographic analysis. Earlier studies have shown the efficacy of calcium sulfate (CaSO4) as a TLC coating material for the separation of polar compounds. The aim of this study was to explore the potential of CaSO4 for the analysis of aliphatic polyamines without derivatization. The TLC of six polyamines (ornithine, citrulline, putrescine, cadaverine, spermidine and spermine) was carried out on CaSO4 and silica gel plates using 11 different mobile phases. The results showed that CaSO4 is superior to silica for the separation of underivatized polyamines. The development time of the CaSO4 plates was also about one-third shorter as compared to silica. Methanol was the only solvent to produce differential R-F values for the polyamines studied. Ornithine (R-F, 0-2) and citrulline (R-F, 1-3) were separated from cadaverine (R-F, 0.93), spermine (R-F, 0.85) and spermidine (R-F, 0.85). For quantitative analysis, the polyamines were eluted from the coating material scratched from the plate and the absorbance of the supernatant was measured at 550 nm. The limits of detection (LOD) and quantification (LOQ) were found to be 0.75 and 1.88 mu g, respectively. The procedure was applied to the quantitative separation of polyamines in spiked human urine samples (12.5-50 mu g). This is probably the first study reporting a TLC method for the separation of underivatized polyamines.	King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia		Khan, HA (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia.	khan_haseeb@yahoo.com	Khan, Haseeb A./E-3872-2014	Khan, Haseeb A./0000-0001-6084-8589			Alberto MR, 2004, METH MOL B, V268, P481; Bachrach U, 2004, AMINO ACIDS, V26, P307, DOI 10.1007/s00726-004-0076-6; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Choi MH, 2000, J CHROMATOGR A, V897, P295, DOI 10.1016/S0021-9673(00)00800-1; ERNESTUS RI, 1993, J NEUROCHEM, V60, P417, DOI 10.1111/j.1471-4159.1993.tb03167.x; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HOSOMI M, 1986, J CHROMATOGR, V375, P267, DOI 10.1016/S0378-4347(00)83719-6; Khalifa A, 1999, CLIN BIOCHEM, V32, P635, DOI 10.1016/S0009-9120(99)00069-7; Khuhawar MY, 1999, J CHROMATOGR B, V723, P17, DOI 10.1016/S0378-4347(98)00478-2; Khuhawar MY, 2001, J CHROMATOGR B, V764, P385, DOI 10.1016/S0378-4347(01)00395-4; Kubo S, 2004, HEPATO-GASTROENTEROL, V51, P208; Lee YK, 2000, J NEUROL SCI, V178, P124, DOI 10.1016/S0022-510X(00)00393-2; LIN JK, 1982, J CHROMATOGR, V227, P369, DOI 10.1016/S0378-4347(00)80390-4; Linares RM, 1998, ANAL LETT, V31, P475, DOI 10.1080/00032719808001853; Liu X, 2003, J CHROMATOGR A, V998, P213, DOI 10.1016/S0021-9673(03)00637-X; LOSER C, 1990, PANCREAS, V5, P119; Malle P, 1996, J AOAC INT, V79, P43; Mehta RA, 2002, NAT BIOTECHNOL, V20, P613, DOI 10.1038/nbt0602-613; Molins-Legua C, 1999, ANALYST, V124, P477, DOI 10.1039/a808736i; Nishioka K, 1995, J CELL BIOCHEM, P87; PASCHEN W, 1987, NEUROCHEM PATHOL, V7, P143, DOI 10.1007/BF02834214; PRICE NPJ, 1993, J CHROMATOGR, V635, P165, DOI 10.1016/0021-9673(93)83129-G; Rathore H.S., 1988, JPC-J PLANAR CHROMAT, V1, P252; RATHORE HS, 1988, J LIQ CHROMATOGR, V11, P3171, DOI 10.1080/01483918808076787; RATHORE HS, 1987, CHROMATOGRAPHIA, V23, P432, DOI 10.1007/BF02311820; RUSSELL DH, 1985, DRUG METAB REV, V16, P1, DOI 10.3109/03602538508991430; RUSTENBECK I, 1995, J CHROMATOGR B, V667, P185, DOI 10.1016/0378-4347(94)00596-W; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; Silva CMG, 2002, FOOD CHEM, V78, P241, DOI 10.1016/S0308-8146(01)00404-6; SIMONSARKADI L, 1995, Z LEBENSM UNTERS FOR, V200, P261, DOI 10.1007/BF01187516; SIMONSARKADI L, 1994, Z LEBENSM UNTERS FOR, V198, P230, DOI 10.1007/BF01192600; SMITH EL, 1985, PRINCIPLES BIOCH GEN, P644; Soulet D, 2003, J CELL BIOL, V162, P257, DOI 10.1083/jcb.200301097; Stabellini G, 2003, INT J CLIN PHARM RES, V23, P17; Sun XH, 2003, J CHROMATOGR A, V1005, P189, DOI 10.1016/S0021-9673(03)00927-0; SZARKA G, 1988, Acta Chirurgica Hungarica, V29, P365; Yatin SM, 2001, J NEUROSCI RES, V63, P395, DOI 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q	37	9	9	1	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	OCT	2006	64	7-8					423	427		10.1365/s10337-006-0048-y			5	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	098FY	WOS:000241507600008					2022-02-06	
J	Berger, RP; Hymel, K; Gao, WM				Berger, Rachel Pardes; Hymel, Kent; Gao, Wei-Min			The Use of Biomarkers After Inflicted Traumatic Brain Injury: Insight into Etiology, Pathophysiology, and Biochemistry	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						biomarkers; child abuse; neuron; specific enolase; S100B; myelin-basic protein; traumatic brain injury		Inflicted traumatic brain injury (iTBI) is the most common cause of severe brain injury in infants. Proper diagnosis is difficult even for experienced emergency department physicians. Misdiagnosis is common and can have catastrophic consequences for patients and society. After iTBI, biochemical markers are released from brain tissue and pass into the cerebrospinal fluid and serum. Measuring the concentrations of these markers may help to identify brain injury that could otherwise be missed. Biomarkers may also be able to help differentiate noninflicted TBI from iTBI, assist in the timing of iTBI, improve our understanding of the pathophysiology of iTBI, and predict outcome after iTBI. (C) 2006 Elsevier Inc. All rights reserved.	[Berger, Rachel Pardes] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Hymel, Kent] Inova Fairfax Hosp Children, Dept Pediat, Falls Church, VA USA; [Gao, Wei-Min] Texas Tech Univ, Inst Environm & Human Hlth, Lubbock, TX USA		Berger, RP (corresponding author), Childrens Hosp Pittsburgh, 3705 Fifth Ave, Pittsburgh, PA 15213 USA.	rberger@pitt.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K23HD43843-01, 1R21HD043351-03]; CDC General Clinical Research Center [R49/CCR323155-01]; Children's Hospital of Pittsburgh Grant [M01 RR00084]	This study was supported in part by NIH 1K23HD43843-01 (RB), NIH 1R21HD043351-03 (KH), CDC R49/CCR323155-01 (RB) General Clinical Research Center, Children's Hospital of Pittsburgh Grant #M01 RR00084 (RB).	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Bandyopadhyay S, 2005, PAS, V57, P1867; BAZARIAN J, 2004, ACAD EMERG MED, V11, P516; Beers SR, 2004, PEDIATR RES, V55, p70A; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger R, 2006, NEUROSCIENC IN PRESS; Berger Rachel, 2003, Pediatr Crit Care Med, V4, P391, DOI 10.1097/01.PCC.0000075324.45784.8A; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Berger RP, 2006, J HEAD TRAU IN PRESS; Campbell K, 2006, PAS, V59; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Davidsson P, 2001, PROTEOMICS, V1, P444; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 1998, PEDIATRICS, P102; Gao WM, 2005, J NEUROTRAUM, V22, P1212; Geddes JF, BRAIN, VI; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Han Yong Y, 2003, Pediatr Crit Care Med, V4, P21, DOI 10.1097/00130478-200301000-00004; HANS P, 1983, J NEUROSURG, V58, P689, DOI 10.3171/jns.1983.58.5.0689; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Hochstrasser DF, 2002, PROTEOMICS, V2, P807, DOI 10.1002/1615-9861(200207)2:7<807::AID-PROT807>3.0.CO;2-4; Hymel KP, 2005, PEDIATR ANN, V34, P358, DOI 10.3928/0090-4481-20050501-10; Hymel KP, 2002, INFANT YOUNG CHILD, V15, P57, DOI 10.1097/00001163-200210000-00008; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Lewandrowski K, 2002, AM J CLIN PATHOL, V118, P93, DOI DOI 10.1309/3EK7-YVV9-228C-E1XT; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; McKeating EG, 1998, ACT NEUR S, V71, P117; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; National Institutes of Health, 1986, APN HOM MON REP CONS; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Overpeck MD, 1998, NEW ENGL J MED, V339; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Pitetti RD, 2002, PEDIATRICS, V110, P557, DOI 10.1542/peds.110.3.557; Rao P, 1999, CLIN RADIOL, V54, P495, DOI 10.1016/S0009-9260(99)90845-0; Raymackers J, 2000, ELECTROPHORESIS, V21, P2266, DOI 10.1002/1522-2683(20000601)21:11<2266::AID-ELPS2266>3.0.CO;2-Z; Reece R., 2000, TREATMENT CHILD ABUS; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Rothoerl RD, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00054; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; THOMAS D G T, 1978, Lancet, V1, P113; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wagner KR, 2005, 4 INT C BIOCH MARK B, P128; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Wiesman D, 2006, PAS, V59, P4335; Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	71	9	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	SEP	2006	7	3					186	193		10.1016/j.cpem.2006.06.001			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5E7B	WOS:000219539800009					2022-02-06	
J	Dressler, J; Mueller, E				Dressler, J.; Mueller, E.			High thyroglobulin (Tg) concentrations in fatal traumatic brain injuries	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						traumatic brain injury; thyroglobulin; TSH; thyroid gland; necrosis of pituitary gland		It is well known that under physiological conditions, the Tg molecule is the substrate for the hon-nones triiodothyronine and thyroxine. Its function outside the thyroid gland is unknown. Under certain pathologic conditions, an increase in Tg concentrations in the blood can occur, a phenomenon that is used in the clinical diagnosis of certain thyroid disorders. However, fatal traumatic brain injuries (TBI) can also produce a raised Tg concentration in blood. In such cases, mean (n = 151) Tg concentrations of 405.8 +/- 353.3 ng/mL have been observed, with the values in 57% of these cases exceeding 200 ng/mL. Since it was possible to rule out specifically any thyroid disorders in these cases, the raised values may be explained by the effect of TSH in the spectrum of the "hypothalamic-pituitary-thyroid axis." This assumption has been substantiated by immunohistochemical tests for TSH and Tg. Compared with the controls (sudden unnatural deaths: Tg 23.3 +/- 27.6 ng/mL), the raised Tg values in the TBI cases were usually accompanied by a reduction in the intensity of immunohistochemical reactions relating to TSH and Tg. The hypophysis showed evidence of significant damage with morphologic changes such as edema, hemorrhages, and focal necrosis in association with reduced TSH levels.	Tech Univ Dresden, Sch Med, Dept Legal Med, D-01307 Dresden, Germany		Dressler, J (corresponding author), Tech Univ Dresden, Sch Med, Dept Legal Med, Fetscherstasse 74, D-01307 Dresden, Germany.	Jan.Dressler@tu-dresden.de					Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; de Vijlder JJM, 1999, EUR J ENDOCRINOL, V140, P7, DOI 10.1530/eje.0.1400007; Dressler J, 2000, FORENSIC SCI INT, V113, P173, DOI 10.1016/S0379-0738(00)00258-9; Marino M, 2000, AM J PHYSIOL-CELL PH, V279, pC1295, DOI 10.1152/ajpcell.2000.279.5.C1295; Muller E, 1997, FORENSIC SCI INT, V90, P165, DOI 10.1016/S0379-0738(97)00158-8; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; SANDTKE S, 2000, PATHOLOGE, V4, P292	9	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2006	27	3					280	282		10.1097/01.paf.0000221049.43363.99			3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	080OT	WOS:000240258100012	16936513				2022-02-06	
J	Dry, A; Colantonio, A; Cameron, JI; Mihailidis, A				Dry, Abigail; Colantonio, Angela; Cameron, Jill I.; Mihailidis, Alex			Technology in the lives of women who live with memory impairment as a result of a traumatic brain injury	ASSISTIVE TECHNOLOGY			English	Article						electronic memory aid; traumatic brain injury; women; focus groups; memory impairment	COGNITIVE REHABILITATION; ASSISTIVE TECHNOLOGY; POCKET-COMPUTER; AID; PEOPLE; GUIDELINES; GENDER	A large number of individuals who have experienced a traumatic brain injury are women; unfortunately, there is a lack of literature focusing on their treatment preferences. Electronic memory aids have the potential to offer tremendous assistance to increase the independence of individuals with memory impairment; however, the use of electronic memory aids with this female population has not been explored. The objective of this study was to investigate the perceptions and use of electronic memory aids in women with memory impairment as a result of a traumatic brain injury to further their use of this technology to enable their independence. Two focus groups were conducted, each with five women who self-reported a moderate to severe head injury. The primary theme that emerged was the willingness and interest of this sample to use this technology when provided with an appropriate introduction and learning environment. The results reaffirm current literature supporting the use of electronic memory aids with a population with a head injury. Individuals not currently using this technology were motivated to employ electronic memory aids in their daily lives. Further research must be conducted to develop strategies to enable this population's use of electronic memory aids.	Univ Toronto, Dept Occupat Therapy, Toronto, ON M5G 1V7, Canada; Queen Elizabeth Ctr, Toronto Rehbail Inst, Toronto, ON, Canada		Mihailidis, A (corresponding author), Univ Toronto, Dept Occupat Therapy, 9th Floor,500 Univ Ave, Toronto, ON M5G 1V7, Canada.			Mihailidis, Alex/0000-0003-2233-0919; Colantonio, Angela/0000-0003-2094-4765; Cameron, Jill/0000-0003-4161-1572			Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Barrett J, 2000, APPL ERGON, V31, P621, DOI 10.1016/S0003-6870(00)00031-4; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Broos A, 2005, CYBERPSYCHOL BEHAV, V8, P21, DOI 10.1089/cpb.2005.8.21; Burke DT, 2001, J HEAD TRAUMA REHAB, V16, P284, DOI 10.1097/00001199-200106000-00007; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Chen SHA, 1997, BRAIN INJURY, V11, P197; CRESWELL JW, 2003, RES ESIGN QUALITATIV; DEPOY E, 1998, INTRO RES UNDERSTAND; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FOLCHLYON E, 1981, STUD FAMILY PLANN, V12, P443, DOI 10.2307/1965656; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Long TE, 1999, PSYCHOL REP, V85, P1139, DOI 10.2466/PR0.85.7.1139-1153; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; Pape TLB, 2002, DISABIL REHABIL, V24, P5, DOI 10.1080/09638280110066235; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Renton L. B. M., 1997, BRIT J OCCUPATIONAL, V60, P199; Scherer MJ, 2002, DISABIL REHABIL, V24, P126, DOI 10.1080/09638280110066253; Stratton M C, 1995, Rehabil Nurs, V20, P323; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Torkelson Lynch R., 1995, J SPEC GROUP WORK, V20, P108, DOI [10.1080/01933929508411333, DOI 10.1080/01933929508411333]; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006	32	9	10	1	3	R E S N A PRESS	ARLINGTON	1700 MOORE ST, STE 1540, ARLINGTON, VA 22209-1903 USA	1040-0435			ASSIST TECHNOL	Assist. Technol.	FAL	2006	18	2					170	180		10.1080/10400435.2006.10131916			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	109CJ	WOS:000242285200005	17236476				2022-02-06	
J	Jones, HN; Donovan, NJ; Sapienza, CM; Shrivastav, R; Fernandez, HH; Rosenbek, JC				Jones, Harrison N.; Donovan, Neila J.; Sapienza, Christine M.; Shrivastav, Rahul; Fernandez, Hubert H.; Rosenbek, John C.			Expiratory muscle strength training in the treatment of mixed dysarthria in a patient with Lance-Adams syndrome	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTION MYOCLONUS; INTELLIGIBILITY; SPEECH	The results of an expiratory muscle strength training (EMST) program is described in the rehabilitation of mixed dysarthria in a patient with Lance-Adams syndrome secondary to a motor vehicle accident (MVA) with associated traumatic brain injury (TBI). A pretest-posttest design was employed. Following EMST, maximum phonation duration, intelligibility scores of 14-word sentences, and Communicative Effectiveness Survey (CES) scores increased. Three months after the discontinuation of EMST, maximum phonation duration had decreased but remained increased in comparison to pretreatment performance, while intelligibility scores dropped below baseline level. CES scores continued to increase following the discontinuation of treatment. These data suggest that EMST was associated with a therapeutic effect for this patient, as evidenced by improved performance measured pre- and posttreatment.	VA RR&D Brain Rehabil Res Ctr, Gainesville, FL USA; Univ Florida, Dept Commun Disorders, Gainesville, FL USA; VA HSR&D, RR&D Rehabil Outcomes Res Ctr, Gainesville, FL USA; Univ Florida, Dept Commun Sci & Disorders, Gainesville, FL USA; Univ Florida, Dept Neurol, Gainesville, FL USA		Jones, HN (corresponding author), 2051 SW 43rd Ave, Gainesville, FL 32608 USA.	hjones@phhp.ufl.edu		Afifa, Sayyidah/0000-0002-1151-9583			ARONSON AE, 1984, CLIN DYS C TUCS AZ; Ball LJ, 2004, J COMMUN DISORD, V37, P197, DOI 10.1016/j.jcomdis.2003.09.002; Beukelman D.R., 1984, ASSESSMENT INTELLIGI; BEUKELMAN DR, 1980, J COMMUN DISORD, V13, P33, DOI 10.1016/0021-9924(80)90019-2; Brandt EN, 1997, ENABLING AM ASSESSIN, P62; CERNY FJ, 1997, J MED SPEECH-LANG PA, V5, P141; Clark HM, 2004, AM J SPEECH-LANG PAT, V12, P400; Donovan N, 2005, MOVEMENT DISORD, V20, pS92; DONOVAN NJ, 2005, DISS ABSTR INT, V66, P3101; DONOVAN NJ, 2003, ASHA LEADER, V8, P203; Duffy, 2005, MOTOR SPEECH DISORDE; Fahn S, 1979, Adv Neurol, V26, P49; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; HUSTAD KC, 1999, MANAGEMENT MOTOR SPE, P438; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; Kim J, 2005, J REHABIL RES DEV, V42, P211, DOI 10.1682/JRRD.2004.07.0077; LANCE JW, 1963, BRAIN, V86, P111, DOI 10.1093/brain/86.1.111; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; LUDLOW CL, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P29; LUSCHEI ES, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P3; McAuliffe MJ, 2005, J GERONTOL A-BIOL, V60, P667, DOI 10.1093/gerona/60.5.667; McHenry M., 1997, AM J SPEECH-LANG PAT, V6, P55; MCHENRY MA, 1994, J SPEECH HEAR RES, V37, P1271, DOI 10.1044/jshr.3706.1271; Nam DH, 2004, YONSEI MED J, V45, P810, DOI 10.3349/ymj.2004.45.5.810; NETSELL R, 1975, J SPEECH HEAR DISORD, V40, P170, DOI 10.1044/jshd.4002.170; POWERS SK, 2003, EXERCISE PHYSL THEOR; SALEEM A, 2005, 5M ANN M AM AC NEUR; SAPIENZA C, 2004, ASHA CONV SEM PHIL P; Sapienza CM, 2002, J VOICE, V16, P495, DOI 10.1016/S0892-1997(02)00125-X; Shadish WR., 2002, EXPT QUASI EXPT DESI; Smeltzer SC, 1996, ARCH PHYS MED REHAB, V77, P909, DOI 10.1016/S0003-9993(96)90281-6; Solomon NP, 1995, J MED SPEECH-LANG PA, V3, P13; Stierwalt J. A. G., 1996, DISORDERS MOTOR SPEE, P243; *SYNTR SOFTW CORP, 2000, COOL ED 2000 1 1 COM; Wang X, 2005, ACTA MECH SOLIDA SIN, V18, P57, DOI 10.1007/s10338-005-0508-1; Werhahn KJ, 1997, MOVEMENT DISORD, V12, P216, DOI 10.1002/mds.870120212; WHEELER K, 2005, ANN ASHA CONV SAN DI; World Health Organization, 2007, INT CLASS FUNCT DIS	38	9	9	0	4	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2006	14	3					207	217					11	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	082XQ	WOS:000240420900011					2022-02-06	
J	Shafi, NI; Mariscalco, MM				Shafi, Nadeem I.; Mariscalco, M. Michele			Considering the use of induced hypothermia in a pediatric patient with traumatic brain injury: A critical appraisal of two meta-analyses	PEDIATRIC CRITICAL CARE MEDICINE			English	Article							THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; HEAD-INJURY; CHILDREN	Objective: To review whether induced hypothermia after traumatic brain injury affects morbidity and mortality based on the results of two meta-analyses. Design: Critical appraisals of McIntyre et al: Prolonged therapeutic hypothermia after traumatic brain injury in adults: A systematic review. JAMA 2003; 289:2992-2999, and Henderson et al: Hypothermia in the management of traumatic brain injury: A systematic review and meta-analysis. Intensive Care Med 2003; 29:1637-1644. Findings: Both meta-analyses included trials of adult patients with severe traumatic brain injury randomized to induced hypothermia or normothermia and evaluated risk of death and poor neurologic outcomes. McIntyre et al. found the overall relative risk of mortality with induced hypothermia to be 0.81 (95% confidence interval 0.69-0.96). By designing a priori analyses, these authors also found that the relative risk of death was reduced in patients cooled for >48 hrs, and the risk of poor neurologic outcome was reduced with all durations of cooling, cooling to 32-33 degrees C, and rewarming in <24 hrs. In contrast, Henderson et al. found that induced hypothermia did not change the odds of death after traumatic brain injury (odds ratio 0.81; 95% confidence interval 0.59-1.13) and that normothermic controls had an odds ratio of 0.42 (95% confidence interval 0.25-0.70) for developing intercurrent pneumonia. Both analyses found trials to be heterogeneous with respect to neurologic outcome. Conclusions. The discrepancies in the results of these contemporaneous meta-analyses may stem, in part, from differences in their trial selection strategies as well as from sources of trial heterogeneity. Nevertheless, McIntyre et al. uncovered the equivalent of a dose-dependent reduction in the risk of death with induced hypothermia, supporting further study of this neuroprotective strategy. Although these meta-analyses included trials containing adult patients, a phase II trial of induced hypothermia in pediatric traumatic brain injury has established its feasibility and safety in infants and children. As in adult patients, induced hypothermia for traumatic brain injury in children can be considered an optional therapy for refractory intracranial hypertension but should not be regarded as standard of care.	Baylor Coll Med, Dept Pediat, Div Crit Care Med, Houston, TX 77030 USA		Shafi, NI (corresponding author), Baylor Coll Med, Dept Pediat, Div Crit Care Med, Houston, TX 77030 USA.						Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ADELSON PD, PEDIAT TRAUMATIC BRA; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Altman DG, 2002, BMC MED RES METHODOL, V2; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Cates C.J., 2002, BMC MED RES METHODOL, V2; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; *CTR HLTH EV, US GUID EV BAS PRACT; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; GADKARY CS, 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001048; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holzer M, 2002, NEW ENGL J MED, V346, P549; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11	25	9	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2006	7	5					468	472		10.1097/01.PCC.0000235258.79253.8C			5	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	096PY	WOS:000241390500010	16885796				2022-02-06	
J	Brvar, M; Finderle, Z; Suput, D; Bunc, M				Brvar, Miran; Finderle, Zarko; Suput, Dusan; Bunc, Matjaz			S100B protein in conscious carbon monoxide-poisoned rats treated with normobaric or hyperbaric oxygen	CRITICAL CARE MEDICINE			English	Article						carbon monoxide; S100b protein; consciousness; hyperbaric oxygenation	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; SERUM S100B; MARKER; S-100B; DAMAGE	Objective: To evaluate S100B, an astroglial structural protein, during normobaric and hyperbaric oxygen therapy of conscious carbon monoxide (CO)-poisoned rats. So far, the usefulness of hyperbaric oxygen therapy in conscious CO-poisoned patients has been shown with neuropsychological testing. The S100B protein has been demonstrated as a possible biochemical marker and prognostic parameter in CO-poisoned rats. Design. Randomized, controlled interventional trial. Setting: University laboratory. Subjects. Male Wistar rats weighing 254 +/- 14 g. Interventions., The rats were exposed to a mixture of 3,000 ppm CO in air for 60 mins. After CO exposure, the first group of eight conscious rats was exposed to ambient air for 30 mins, the second group of six conscious rats was exposed to 100% normobaric oxygen for 30 mins, and the third group of six conscious rats was exposed to 100% hyperbaric oxygen at 3 bars for 30 mins. Blood samples were taken from the jugular vein just before CO exposure and immediately after oxygen therapy. The level of consciousness was evaluated at the end of exposure, and the survival rate was monitored for 14 days. The S100B concentrations were measured with a commercial immunoluminometric assay. Measurements and Main Results. Analyses of differences in S100B levels between different kinds of therapy before and after treatment showed a global significant difference (p =.002). The post hoc test results showed that S100B levels after therapy of the first group treated with ambient air (0.16 +/- 0.07 mu g/L) and the second group treated with normobaric oxygen (0.19 +/- 0.05 mu g/L) were similar (p =.741), and both of them were significantly different, with much higher values of S100B levels after therapy, from the third group treated with hyperbaric oxygen (0.06 +/- 0.03 mu g/L; p =.018 and p =.002, respectively). All the rats survived. Conclusions: S100B is elevated in conscious CO-poisoned rats left on ambient air or treated with normobaric oxygen, but not in conscious CO-poisoned rats treated with hyperbaric oxygen.	Ljubljana Med Ctr, Poison Control Ctr, Ljubljana, Slovenia; Sch Med, Inst Physiol, Ljubljana, Slovenia; Sch Med, Inst Pathophysiol, Ljubljana, Slovenia; Clin Dept Cardiol, Ljubljana, Slovenia		Brvar, M (corresponding author), Ljubljana Med Ctr, Poison Control Ctr, Ljubljana, Slovenia.		Suput, Dusan/AAR-7379-2021	Suput, Dusan/0000-0003-0128-5426; Suput, Dusan/0000-0003-4031-7267			Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Bottiger BW, 2001, CIRCULATION, V103, P2694; Brvar M, 2004, CRIT CARE MED, V32, P2128, DOI 10.1097/01.CCM.0000142702.39718.A0; Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Foerch C, 2005, ARCH NEUROL-CHICAGO, V62, P1130, DOI 10.1001/archneur.62.7.1130; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.x; Schiltz KL, 2000, UNDERSEA HYPERBAR M, V27, P48; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Spinella Philip C, 2004, Pediatr Crit Care Med, V5, P53, DOI 10.1097/01.PCC.0000102221.98378.7D; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3	17	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	AUG	2006	34	8					2228	2230		10.1097/01.CCM.0000228913.61710.9D			3	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067WU	WOS:000239334100030	16763504				2022-02-06	
J	Cuthill, DJ; Fowler, JH; McCulloch, J; Dewar, D				Cuthill, Daniel J.; Fowler, Jill H.; McCulloch, James; Dewar, Deborah			Different patterns of axonal damage after intracerebral injection of malonate or AMPA	EXPERIMENTAL NEUROLOGY			English	Article						APP; axonal damage; excitotoxicity; glucose use; neurofilament; oxidative stress	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; INTRAAXONAL NEUROFILAMENT COMPACTION; FOCAL CEREBRAL-ISCHEMIA; WHITE-MATTER; NITRIC-OXIDE; 3-NITROPROPIONIC ACID; HEAD TRAUMA; RAT; TRANSPORT	White matter damage occurs following stroke and traumatic brain injury. In preclinical studies of potential therapies to reduce acute brain damage, it is important not only to understand the mechanisms by which this damage occurs, but also to employ techniques that fully quantify the extent of damage. In both respects, neurons have previously received greater attention than axons. The aim of the present study was to compare the extent of axonal damage visualised with different immunohistochemical markers following intracerebral injection of either the excitotoxin AMPA or the mitochondrial inhibitor malonate. Adult mice received intrastriatal injection of toxin and 24 h later the amount of white matter damage visualised with either amyloid precursor protein (APP) or neurofilament 200 (NF200) immunohistochemistry. Malonate induced a dose-dependent increase in the extent of axonal damage with either marker. However, AMPA induced a dose-dependent increase in the extent of axonal damage visualised by NF200 immunoreactivity but not by APP immunoreactivity. Malonate and AMPA also differed in their effects on other assessments of white matter integrity and (14)C-2-deoxyglucose autoradiography revealed the two toxins to differ in their initial effects on cerebral metabolism. These data indicate that the ability of commonly-used axonal damage markers to quantify the full extent of white matter damage differs following initial excitotoxicity or mitochondrial inhibition. We also confirmed that the markers reveal different extents of axonal damage in a rat model of focal cerebral ischaemia. Therefore, in preclinical studies designed to assess brain protecting agents, it is advisable to use more than one marker to quantify the true extent of axonal damage. (c) 2006 Elsevier Inc. All rights reserved.	Univ Glasgow, Div Clin Neurosci, Glasgow, Lanark, Scotland; Univ Edinburgh, Div Neurosci, Edinburgh, Midlothian, Scotland		Cuthill, DJ (corresponding author), UCL, Dept Obstet & Gynaecol, Perinatal Brain Injury Grp, 86-96 Chenies Mews, London WC1E 6HX, England.	d.cuthill@ucl.ac.uk		Fowler, Jill/0000-0003-3204-1221			Agrawal SK, 1997, J NEUROSCI, V17, P1055; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; BROUILLET E, 1993, J NEUROCHEM, V60, P356, DOI 10.1111/j.1471-4159.1993.tb05859.x; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; CIANI E, 1994, EXP BRAIN RES, V98, P421; DEWAR D, 1995, BRAIN RES, V684, P70, DOI 10.1016/0006-8993(95)00417-O; Dewar D, 1999, EUR J PHARMACOL, V375, P41, DOI 10.1016/S0014-2999(99)00280-0; Fowler JH, 2003, BRAIN RES, V991, P104, DOI 10.1016/j.brainres.2003.08.004; Garthwaite G, 2002, NEUROSCIENCE, V109, P145, DOI 10.1016/S0306-4522(01)00447-X; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kelly S, 2002, EUR J NEUROSCI, V15, P945, DOI 10.1046/j.1460-9568.2002.01931.x; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; McCracken E, 2002, J CEREBR BLOOD F MET, V22, P1090, DOI 10.1097/00004647-200209000-00006; McCracken E, 2001, BRAIN RES, V892, P329, DOI 10.1016/S0006-8993(00)03266-2; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; NUKINA N, 1992, GERONTOLOGY, V38, P10; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith KJ, 2001, ANN NEUROL, V49, P470; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Stys PK, 2002, NEUROSCI LETT, V328, P150, DOI 10.1016/S0304-3940(02)00469-X; Tekkok SB, 2005, NEUROSCI LETT, V382, P275, DOI 10.1016/j.neulet.2005.03.054; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Tekkok SB, 2003, J CEREBR BLOOD F MET, V23, P1340, DOI 10.1097/01.WCB.0000091763.61714.B7; UNDERHILL SM, 2002, AXONS POTENTIATE OLI; Valeriani V, 2000, J CEREBR BLOOD F MET, V20, P765, DOI 10.1097/00004647-200005000-00002; WOZNIAK DF, 1994, EXP NEUROL, V126, P101, DOI 10.1006/exnr.1994.1046; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4; Yam PS, 2000, J CEREBR BLOOD F MET, V20, P772, DOI 10.1097/00004647-200005000-00003	39	9	9	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	AUG	2006	200	2					509	520		10.1016/j.expneurol.2006.03.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	072BH	WOS:000239647100024	16698016				2022-02-06	
J	Hanten, G; Scheibel, RS; Li, XQ; Oomer, I; Stallings-Robertson, G; Hunter, JV; Levin, HS				Hanten, Gerri; Scheibel, Randall S.; Li, Xiaoqi; Oomer, Imran; Stallings-Robertson, Garland; Hunter, Jill V.; Levin, Harvey S.			Decision-making after traumatic brain injury in children: A preliminary study	NEUROCASE			English	Article							HUMAN PREFRONTAL CORTEX; DAMAGE; LESION; CONSEQUENCES; IMPAIRMENT; MODERATE; AMYGDALA; MODEL; MRI	Decision-making under conditions of uncertainty was studied in 11 children with moderate to severe post-acute traumatic brain injury (TBI) using a modification of the Iowa Gambling Task (Bechara et al., 1994). We hypothesized that decision-making would be compromised in children with TBI. The results revealed that when divided into subgroups by lesion location, children with lesions in the amygdala (AM) were impaired on modified gambling task performance, but children with ventromedial (VM) lesions did not appear to be impaired on the task. These results are in contrast to studies of decision-making in adults with focal lesions of vascular etiology.	Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA		Hanten, G (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	ghanten@bcm.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline		Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson VA, 2000, BRAIN INJURY, V14, P679; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio H, 1995, HUMAN BRAIN ANATOMY; Damasio H., 1989, LESION ANAL NEUROPSY; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; TEASDALE G, 1974, LANCET, V2, P81; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333	21	9	9	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794			NEUROCASE	Neurocase	AUG	2006	12	4					247	251		10.1080/13554790600910490			5	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	087NS	WOS:000240749700009	17000596				2022-02-06	
J	Al-Kashmiri, A; Delaney, JS				Al-Kashmiri, Ammar; Delaney, J. Scott			Head and neck injuries in football (soccer)	TRAUMA-ENGLAND			English	Article						concussion; football; head; injury; neck; soccer		The incidence for concussions in football (soccer) is equivalent to other contact sports such as American football and ice hockey. The risk of concussion is increased in goalkeepers, females and perhaps young players. Head to head contact between athletes is the most common mechanism for concussion, while heading does not appear to be a frequent cause. Research is providing evidence that neck muscle development and protective headgear may play a role in the prevention of concussions. The presence and pathophysiology of a chronic encephalopathy secondary to a cumulative subconcussive blows obtained in football is still controversial. Neck injuries are not as common as head injuries and are not frequently reported in the literature. The biomechanics of neck injuries are different between children and adults which may account for the different types of injuries in these populations. Spinal cord injuries are rarely seen in football and are usually associated with major fractures/dislocations.	Sultan Qaboos Univ Hosp, Accident & Emergency Dept, Muscat, Oman; McGill Univ, Ctr Hlth, Dept Emergency Med, Montreal, PQ, Canada; [Delaney, J. Scott] McGill Sport Med Clin, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada		Delaney, JS (corresponding author), McGill Sport Med Clin, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	j.delaney@mcgill.ca	Al-Kashmiri, Ammar/AAG-4008-2020				[Anonymous], 2000, Pediatrics, V105, P659; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Biros MH., 1998, EMERGENCY MED CONCEP, P416; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Cantu RC., 1997, AM COLL SPORTS MED E, P345; Delaney J, 1997, CLIN J SPORT MED, V2000, P9; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Delaney JS, 1999, CLIN J SPORT MED, V9, P121; Delaney JS, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015735; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; DELANEY JS, 2001, INT S CONC SPORT; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; FESMIRE F M, 1989, Journal of Emergency Medicine, V7, P133, DOI 10.1016/0736-4679(89)90258-8; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; Marx RG, 2002, PEDIATR ANN, V31, P60, DOI 10.3928/0090-4481-20020101-12; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MCGRORY BJ, 1993, J BONE JOINT SURG AM, V75A, P988, DOI 10.2106/00004623-199307000-00004; National Institute of Health Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury, 1998, JAMA-J AM MED ASSOC, V282, P974; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; RACHESKY I, 1987, AM J DIS CHILD, V141, P199, DOI 10.1001/archpedi.1987.04460020089033; SCHMIDTOLSEN S, 1991, AM J SPORT MED, V19, P273, DOI 10.1177/036354659101900311; Schneider RC., 1973, HEAD NECK INJURIES F; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shetter A G, 1979, Adv Neurol, V22, P5; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Smodlaka VN, 1984, PHYSICIAN SPORTSMED, V12, P127, DOI DOI 10.1080/00913847.1984.11701777; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; Tucker AM, 1997, SPORTS MED, V23, P21, DOI 10.2165/00007256-199723010-00003; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196	54	9	9	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JUL	2006	8	3					189	195		10.1177/1460408606071144			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V3B5X	WOS:000218106800007					2022-02-06	
J	Zetaruk, MN; Violan, M; Zurakowski, D; Mitchell, WA; Micheli, LJ				Zetaruk, Merrilee N.; Violan, Mariona; Zurakowski, David; Mitchell, William A., Jr.; Micheli, Lyle J.			Recommendations for training and prevention of injuries in elite rhythmic gymnasts	APUNTS-MEDICINA DE L ESPORT			Spanish	Article						Sports; Injury prevention; Adolescent; Elite; Rhythmic gymnastics		Objective: To identify risk factors for injury in rhythmic sportive gymnastics and to provide recommendations for reducing the risk of injury. Methods: A one-year retrospective survey of injuries in twenty national-level rhythmic gymnasts (ages 14.8 to 18.8 years; mean age 17.1 years). Hours of rhythmic gymnastics (RG) training per week, minutes of stretching per day, and hours of conditioning per week, were analyzed as potential risk factors for injury. Main outcome measures were injuries that required time off, major injuries (at least 7 days off), injuries to muscle-tendon units, and fractures. Results: Thirteen (65%) of 20 gymnasts sustained time-loss injuries, and 4 gymnasts (20%) reported major injuries. Seventeen (85%) gymnasts reported muscle-tendon unit injuries and 5 (25%) suffered fractures. Sixteen (80%) of the gymnasts reported back pain or stress fractures of the back, 8 of whom required time off training. One gymnast (5%) incurred a concussion. Logistic regression indicated that rhythmic gymnastics training and stretching were associated with muscle-tendon unit injury. On multi-variate analysis, stretching was found to be the only independent predictor of muscle-tendon unit injuries with each additional minute lowering the risk by approximately 10% (p <= 0.01). Conditioning and stretching were both independent predictors of fractures. The risk of fracture was estimated to increase by over 60% for each additional hour of weekly conditioning (odds ratio = 1.62, p = 0.03) and decrease by almost 20% for each additional minute of daily stretching (odds ratio = 0.81, p = 0.04). None of the variables studied were predictive of back pain or injury. Conclusions: Injuries in rhythmic gymnastics may be reduced by increasing the amount of time spent stretching per day (at least 40 minutes), and limiting conditioning to a maximum of 6 hours per week.	[Zetaruk, Merrilee N.] Univ Manitoba, Childrens Hosp, Pediat Sport & Dance Med, Winnipeg, MB, Canada; [Violan, Mariona] Fundac Claror, Ctr Talassoterapia Maritim, Cap Med, Barcelona, Spain; [Zurakowski, David] Harvard Med Sch, Childrens Hosp, Dept Orthopaed Surg, Biostat, Boston, MA USA; [Mitchell, William A., Jr.] Harvard Med Sch, Clin Instructor Orthopaed Surg, Boston, MA USA; [Micheli, Lyle J.] Harvard Med Sch, Childrens Hosp, Div Sports Med, Boston, MA USA		Zetaruk, MN (corresponding author), Legacy Sport Med Clin, 14-160 Meadowood Drive, Winnipeg, MB R2M 5L6, Canada.	mzetaruk@mts.net					ALEXANDER MJL, 1991, J HUM MOVEMENT STUD, V20, P49; ALEXANDER MJL, 1987, J HUM MOVEMENT STUD, V13, P473; CIULLO JV, 1985, CLIN SPORT MED, V4, P95; Fetto JF, 1994, SPORTS INJURIES MECH, P455; HARVEY J, 1991, SPORTS MED, V12, P394, DOI 10.2165/00007256-199112060-00005; Herbert RD, 2002, BMJ-BRIT MED J, V325, P425; HOSMER DW, 1989, APPL LOGISTIC REGRES, P38; HUME PA, 1993, J SPORT MED PHYS FIT, V33, P367; Hutchinson MR, 1999, MED SCI SPORT EXER, V31, P1686, DOI 10.1097/00005768-199911000-00027; Hutchinson MR, 1998, MED SCI SPORT EXER, V30, P1543, DOI 10.1097/00005768-199810000-00012; International Federation of Sports Medicine, 1991, CLIN J SPORT MED, V1, P262; Kennedy K, 1994, Orthop Nurs, V13, P17, DOI 10.1097/00006416-199409000-00005; KULUND DN, 1983, ORTHOP CLIN N AM, V14, P427; LINDBOE CF, 1984, EUR J APPL PHYSIOL O, V52, P457, DOI 10.1007/BF00943380; MAFFULLI N, 1990, SPORTS MED, V9, P229, DOI 10.2165/00007256-199009040-00004; Maffulli N, 1990, Br J Sports Med, V24, P237; MICHELI LJ, 1985, CLIN SPORT MED, V4, P85; MICHELI LJ, 1995, CLIN SPORT MED, V14, P727; MICHELI LJ, 1983, CLIN SPORT MED, V2, P473; MICHELI LJ, 1984, PEDIATRIC ADOLESCENT, P167; NATTIV A, 1994, CLIN SPORT MED, V13, P405; ONEILL DB, 1988, CLIN SPORT MED, V7, P591; Shrier I, 1999, CLIN J SPORT MED, V9, P221, DOI 10.1097/00042752-199910000-00007; Thacker SB, 2004, MED SCI SPORT EXER, V36, P371, DOI 10.1249/01.MSS.0000117134.83018.F7; WEIKER GG, 1989, CLIN SPORT MED, V8, P399; WOJTYS EM, 1987, ORTHOP CLIN N AM, V18, P689	26	9	12	0	1	ELSEVIER ESPANA S I	MADRID	INFANTA MERCEDES 90, MADRID, 28020, SPAIN	1886-6581			APUNTS-MED ESPORT	Apunts-Med. Esport	JUL	2006	41	151					100	106		10.1016/S1886-6581(06)70018-4			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V5X2S	WOS:000420022500004					2022-02-06	
J	Cardoso, ED; Pruett, SR; Chan, F; Tansey, TN				Cardoso, ED; Pruett, SR; Chan, F; Tansey, TN			Substance abuse assessment and treatment: The current training and practice of APA division 22 members	REHABILITATION PSYCHOLOGY			English	Article						substance abuse and disability; substance abuse and rehabilitation; substance abuse training; substance abuse services	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; VOCATIONAL-REHABILITATION; PSYCHIATRIC-DISORDERS; ALCOHOL; PROGRAMS	Objective: To determine the preparedness of rehabilitation psychologists to work with people with disabilities with primary or secondary substance-related problems by examining their education, training, and current practice. Design: Mail survey. Participants: 76 (47 men, 29 women) Division 22 members of the American Psychological Association. Results: Although 79% of respondents reported treating individuals with alcohol and other drug issues, over half rated their training in substance abuse treatment as inadequate. Referring to self-help groups and instilling cognitive-behavioral coping skills were common treatments. Participants reported a lack of preparation in substance abuse training in their graduate program coursework, practicum, and internship. Conclusion: Continuing education and changes to curriculum requirements, with linkage to existing certification bodies, should be considered to close the gap between training and practice.	CUNY Hunter Coll, Dept Educ Fdn & Counseling Programs, New York, NY 10021 USA; Univ Florida, Dept Rehabil Counseling, Gainesville, FL 32611 USA; Univ Wisconsin, Dept Rehabil Psychol & Special Educ, Madison, WI 53706 USA; Michigan State Univ, Dept Counseling Educ Psychol & Special Educ, E Lansing, MI 48824 USA		Cardoso, ED (corresponding author), CUNY Hunter Coll, Dept Educ Fdn & Counseling Programs, 695 Pk Ave,W1017, New York, NY 10021 USA.	ecardoso@hunter.cuny.edu					Basford JR, 2002, ARCH PHYS MED REHAB, V83, P517, DOI 10.1053/apmr.2002.30922; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P399, DOI 10.1037/10361-019; Cellucci T, 2001, PROF PSYCHOL-RES PR, V32, P248, DOI 10.1037//0735-7028.32.3.248; CHIERT T, 1994, PROF PSYCHOL-RES PR, V25, P80; CREWE N, 2005, CASE MANAGEMENT REHA, V2, P164; HEINEMANN AW, 2003, SUBSTANCE ABUSE PHYS; Ingraham K., 1992, J APPL REHABILITATIO, V23, P18; Institute of Medicine, 1990, BROAD BAS TREATM ALC; Janikowski T. P., 2005, CASE MANAGEMENT REHA, V2, P247; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; MOORE D, 1994, J REHABIL, V60, P48; National Institute on Disability and Rehabilitation Research, 1994, REHAB BRINGING RES I, V16, P1; Radnitz CL, 1996, J NERV MENT DIS, V184, P431, DOI 10.1097/00005053-199607000-00006; Turner AP, 2003, ARCH PHYS MED REHAB, V84, P358, DOI 10.1053/apmr.2003.50107; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0; [No title captured]	20	9	10	0	6	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2006	51	2					175	178		10.1037/0090-5550.51.2.175			4	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	047PO	WOS:000237891400009					2022-02-06	
J	Yang, HY; Preston, M; Chopp, M; Jiang, F; Zhang, XP; Schallert, T				Yang, Hongyan; Preston, Marnie; Chopp, Michael; Jiang, Feng; Zhang, Xuepeng; Schallert, Timothy			Mass-related traumatic tissue displacement and behavior: A screen for treatments that reduces harm to bystander cells and recovery of function	JOURNAL OF NEUROTRAUMA			English	Article						behavior; brain tumor; hematoma; injury; neuroplasticity; recovery of function	ISCHEMIC BRAIN-DAMAGE; EXTRADURAL COMPRESSION; SENSORIMOTOR CORTEX; CORTICAL DAMAGE; PLASTICITY; RATS; MODEL; PARKINSONISM; ASYMMETRIES; NEURONS	In this study, we focused on a preclinical model of brain compression injury that has relevance to pathological conditions such as tumor, hematoma, blood clot, and intracerebral bony fragment. We investigated behavioral impairment as a result of rapid-onset small mass, and the factors involved in lesion formation and neuroplasticity. An epidural bead implantation method was adopted. Two sizes (1.5 mm and 2.0 mm thick) of hemisphere-shaped beads were used. The heads were implanted into various locations over the sensorimotor cortex (SMC-anterior, middle and posterior). The effects of early versus delayed bead removal were examined to model clinical neurosurgical or other treatment procedures. Forelimb and hind-limb behavioral deficits and recovery were observed, and histological changes were quantified to determine brain reaction to focal compression. Our results showed that the behavioral deficits of compression were influenced by the location, timing of compression release, and magnitude of compression. Even persistent compression by the thicker bead (2.0 mm) caused only minor behavioral deficits, followed by fast recovery within a week in most animals, suggesting a mild lesion pattern for this model. Brain tissue was compressed into a deformed shape under pressure with slight tissue damage, evidenced by pathological evaluation on hematoxylin and eosin (H&E)- and TUNEL-stained sections. Detectable but not severe behavioral dysfunction exhibited by this model makes it particularly suitable for direct assessment of adverse effects of interventions on neuroplasticity after brain compression injury. This model may permit development of treatment strategies to alleviate brain mass effects, without disrupting neuroplasticity.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Inst Neurosci, Austin, TX 78712 USA; Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI USA; Oakland Univ, Dept Phys, Rochester, MI USA		Schallert, T (corresponding author), Univ Texas, Dept Psychol, 1 Univ Stn A8000, Austin, TX 78712 USA.	tschallert@mail.utexas.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS024707, P01NS042345, P01NS024707, R01NS023979, P50NS019608, P01NS019608] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS24707, NS23979, NS042345, NS19608] Funding Source: Medline		ABE T, 1984, SURG NEUROL, V22, P477, DOI 10.1016/0090-3019(84)90306-9; ADAMS FS, 1994, PHYSIOL BEHAV, V55, P947, DOI 10.1016/0031-9384(94)90084-1; Allred RP, 2004, EXP NEUROL, V190, P433, DOI 10.1016/j.expneurol.2004.08.005; BARTH TM, 1990, STROKE, V21, P153; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bergstrom BP, 2001, J NEUROSCI METH, V106, P15, DOI 10.1016/S0165-0270(00)00372-1; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Douzinas EE, 1999, CRIT CARE MED, V27, P978, DOI 10.1097/00003246-199905000-00040; FLEMING SM, 2006, IN PRESS BEHAV BRAIN; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Hua Y, 2005, J THROMB HAEMOST, V3, P1917, DOI 10.1111/j.1538-7836.2005.01446.x; Hua Y, 2005, NEUROL RES, V27, P261, DOI 10.1179/016164105X25270; Im JJ, 2002, NEUROSCI LETT, V317, P139, DOI 10.1016/S0304-3940(01)02455-7; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kundrotiene J, 2004, ACTA NEUROBIOL EXP, V64, P153; Kundrotiene J, 2004, J NEUROTRAUM, V21, P83, DOI 10.1089/089771504772695977; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Lindner MD, 2003, J NEUROSCI, V23, P10913; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schallert T, 2000, CONT NEUROS, P131; Schallert T, 2005, BEHAV LAB RAT, P129; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; YANG H, 2006, IN PRESS BEHAV BRAIN; YANG H, 2006, IN PRESS EXP NEUROL	33	9	9	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2006	23	5					721	732		10.1089/neu.2006.23.721			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	042LJ	WOS:000237529200010	16689673				2022-02-06	
J	Al-Adawi, S; Burke, DT; Dorvlo, ASS				Al-Adawi, Samir; Burke, David T.; Dorvlo, Atsu S. S.			The effect of methylphenidate on the sleep-wake cycle of brain-injured patients undergoing rehabilitation	SLEEP MEDICINE			English	Article						brain injury; sleep pattern; methylphenidate; daytime sleep; nighttime sleep	POSTTRAUMATIC NARCOLEPSY; DISORDERS; DEFICITS; ADULTS	Background and purpose: A number of neurostimulants are routinely used as part of post-acute care of hospitalized brain-injured patients. To our knowledge, the effect of these stimulants on the sleep-wake cycles of brain-injured patients undergoing rehabilitation has not been addressed. We examined the effect of one of the most commonly used neurostimulants, methylphenidate, on the sleep-wake behavior of brain-injured patients undergoing rehabilitation at a dedicated brain injury clinic. Patients and method: For this study, records of patients admitted between January and December 1999 were scrutinized retrospectively for the data on observationally defined sleep-wake distribution. A total of 30 patients diagnosed with traumatic brain injury were identified as having been observed for a full 24 h a day for at least 10 days. Some of these patients (n = 17) were administered methylphenidate on clinical grounds. They served as the experimental group, while the unmedicated patients (n = 13) served as controls. For the present analysis, the sleep-wake cycles were arbitrarily designated as nighttime and daytime, respectively. A cumulative sleep-wake quantity in a 24-h period was also observed. Result: The average number of hours of sleep during a 24-h period was not significantly different for the two cohorts. Similar trends emerged for the nighttime and daytime observations. On the whole, methylphenidate appears not to have unfavorable effects on sleep-wake cycles, presently defined as nighttime, daytime and 24-h, in the traumatic brain injury population. Conclusion: This study sought to gain better understanding of the effect of methylphenidate on daytime sleepiness and nighttime sleep, and the data suggest that administration of methylphenidate, does not appear to have an adverse effect on sleep-wake quantity. (C) 2005 Elsevier B.V. All rights reserved.	Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Muscat 123, Oman; Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, Muscat, Oman		Al-Adawi, S (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, POB 35, Muscat 123, Oman.	adawi@squ.edu.om	Al-Adawi, Samir/A-9663-2016; Sanguansri, Luz/B-6630-2011	Al-Adawi, Samir/0000-0002-9858-5582; Sanguansri, Luz/0000-0003-1908-7604			Al-Adawi S., 2005, Journal of Applied Research, V5, P61; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Bruck D, 2004, BRAIN INJURY, V18, P321, DOI 10.1080/02699050310001617433; Burke DT, 2003, AM J PHYS MED REHAB, V82, P493, DOI 10.1097/00002060-200307000-00001; Burke DT, 2004, J APPL RES, V4, P239; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; CHOKROVERTY S, 1999, SLEEP DISORDERS MED, P7; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Durka PJ, 2003, IEEE T BIO-MED ENG, V50, P526, DOI 10.1109/TBME.2003.809476; Francisco GE, 1996, AM J PHYS MED REHAB, V75, P63, DOI 10.1097/00002060-199601000-00016; Goldstein Larry B, 2003, Phys Med Rehabil Clin N Am, V14, pS125, DOI 10.1016/S1047-9651(02)00060-8; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Guluma K, 2002, SEMIN RESP CRIT CARE, V23, P37, DOI 10.1055/s-2002-20587; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Ilic TV, 2003, NEUROREPORT, V14, P773, DOI 10.1097/01.wnr.0000063251.41814.70; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Means MK, 2003, SLEEP MED, V4, P285, DOI 10.1016/S1389-9457(03)00057-1; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; Ozawa M, 2004, ANN PHYS-NEW YORK, V311, P350, DOI 10.1016/j.aop.2003.12.012; PEACH RK, 1992, J SPEECH HEAR RES, V35, P810, DOI 10.1044/jshr.3504.810; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; ROSENTHAL ML, 1996, SELECTED POEMS 4 PLA; Schootman M, 2000, BRAIN INJURY, V14, P373; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Sprent P., 2001, APPL NONPARAMETRIC S; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tworoger SS, 2005, J PSYCHOSOM RES, V59, P11, DOI 10.1016/j.jpsychores.2005.03.008; WEBB M, 1981, LANCET, V1, P1365; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Zitnay GA, 2005, ACT NEUR S, V93, P131	34	9	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	APR	2006	7	3					287	291		10.1016/j.sleep.2005.11.008			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	043QG	WOS:000237615700013	16564212				2022-02-06	
J	Astrand, R; Unden, J; Bellner, J; Romner, B				Astrand, R; Unden, J; Bellner, J; Romner, B			Survey of the management of children with minor head injuries in Sweden	ACTA NEUROLOGICA SCANDINAVICA			English	Article						children; guidelines; management; paediatric head injury	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN INJURY; GLASGOW-COMA-SCALE; ROUTINE FOLLOW-UP; SKULL FRACTURE; MILD; GUIDELINES; RISK; CLASSIFICATION; HOSPITALS	Background - This study investigates current management practice of children with MHI in Swedish hospitals to define present need for management guidelines for children. Methods - A cross-sectional mail survey including 51 hospitals treating children with MHI outlines management routines concerning clinical and radiological examinations, in-hospital observation, discharge criteria and follow-up. Results - Twenty-seven per cent of the hospitals have established written criteria for referral and management of children with MHI. Eighty-eight per cent use the Swedish Reaction Level Scale for assessing the level of consciousness. Eight per cent use the paediatric Glasgow Coma Scale. Routine computerised tomography is performed in 18% of the hospitals, 12% perform skull radiography and/or radiography of the cervical spine as routine. Eighty-four per cent have established criteria for early discharge without hospitalisation. Conclusion - The management of children with MHI varies in Swedish hospitals. There is a need for standardised protocols for detection of intracranial complications and guidelines for the management of MHI in children.	Univ Lund Hosp, Dept Neurosurg, Neurointens Care Unit, NIVA, S-22185 Lund, Sweden		Romner, B (corresponding author), Univ Lund Hosp, Dept Neurosurg, Neurointens Care Unit, NIVA, S-22185 Lund, Sweden.	bertil.romner@skane.se					Bellner J, 1999, ACTA NEUROL SCAND, V100, P355; Bergman DA, 1999, PEDIATRICS, V104, P1407; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; Hall Per, 2005, Lakartidningen, V102, P214; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Stein SC, 1996, NEUROSURG QUART, V6, P108, DOI 10.1097/00013414-199606000-00004; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	31	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2006	113	4					262	266		10.1111/j.1600-0404.2005.00573.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	019WG	WOS:000235867400008	16542166				2022-02-06	
J	Grosse-Wortmann, L; Bindl, L; Seghaye, MC				Grosse-Wortmann, L; Bindl, L; Seghaye, MC			Multiple types of cardiac arrhythmias in a child with head injury and raised intracranial pressure	PEDIATRIC CARDIOLOGY			English	Article						arrhythmias; intracranial pressure; head injury; QT	SUBARACHNOID HEMORRHAGE; MYOCARDIAL-INFARCTION	Arrhythmias occur as a life-threatening complication in adults with severe head injuries. A wide spectrum of brady- and tachyarrhythmias and different pathogenetic mechanisms have been described. We report an 8-year-old boy with traumatic brain injury who developed a variety of independent types of arrhythmias during the course of his illness, including supraventricular and ventricular extrasystoles, prolonged QT duration and ventricular fibrillation, accelerated junctional rhythm, and reentry tachycardia. Each arrhythmia may have had a distinct pathogenic pathway, and not all were associated with raised intracranial pressure.	Univ Hosp Aachen, Dept Pediat Cardiol, D-52074 Aachen, Germany		Grosse-Wortmann, L (corresponding author), Univ Hosp Aachen, Dept Pediat Cardiol, Pauwelsstr 30, D-52074 Aachen, Germany.	lgrosse-wort-mann@ukaachen.de					ANDREOLI A, 1987, STROKE, V18, P558, DOI 10.1161/01.STR.18.3.558; DIPASQUALE G, 1987, AM J CARDIOL, V59, P596, DOI 10.1016/0002-9149(87)91176-3; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Jung F, 2001, CARDIOLOGY, V95, P48, DOI 10.1159/000047343; Keller C, 1993, J Neurosci Nurs, V25, P349; Randell T, 1999, J NEUROSURG ANESTH, V11, P163, DOI 10.1097/00008506-199907000-00001; WIRTH R, 1988, J TRAUMA, V28, P262, DOI 10.1097/00005373-198802000-00027; Yamanaka O, 1992, Kokyu To Junkan, V40, P715; ZELIKOVIC IN, 1981, HELV PAEDIATR ACTA, V36, P483	9	9	9	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0172-0643			PEDIATR CARDIOL	Pediatr. Cardiol.	APR	2006	27	2					286	288		10.1007/s00246-005-1248-1			3	Cardiac & Cardiovascular Systems; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pediatrics	024MY	WOS:000236200400020	16463127				2022-02-06	
J	Vibert, N; Hoang, T; Gilchrist, DPD; MacDougall, HG; Burgess, AM; Roberts, RD; Vidal, PP; Curthoys, IS				Vibert, N; Hoang, T; Gilchrist, DPD; MacDougall, HG; Burgess, AM; Roberts, RD; Vidal, PP; Curthoys, IS			Psychophysiological correlates of the inter-individual variability of head movement control in seated humans	GAIT & POSTURE			English	Article						posture; visual field-dependence; visual imagery; motion sickness; whiplash injury	VESTIBULO-OCULAR REFLEX; POSTURAL CONTROL; MOTION SICKNESS; RANDOM ROTATIONS; VERTICAL PLANE; VISUAL-FIELD; STABILIZATION; ORIENTATION; MECHANISMS; FRAME	We recently conducted experiments where 24 seated participants were subjected (with eyes closed) to small amplitude. high-jerk impulses of linear acceleration. Responses were distributed as a continuum between two extremes. The "stiff" participants showed little movement of the head relative to the trunk, whereas the "floppy" participants showed a large head rotation in the direction opposite the sled movement. We hypothesized that the stiff behavior resulted from the spontaneous use of an imagined visual frame of reference and undertook this larger-scale study to test that idea. The distribution along the "stiff-floppy" continuum was compared with the scores on psychophysiological tests measuring vividness of imagery, Visual field-dependence and motion sickness susceptibility. Multivariate regression analysis revealed that the "stiffness" of individuals was loosely, but significantly related to the vividness of their imagery. However, "stiffness" was not linked to visual field-dependence or motion sickness susceptibility. Even if it explains only 20% of the variance of the data, the increase of "stiffness" with vividness of imagery fits our hypothesis. With eyes closed, stiff people may use imagined external visual cues to stabilize their head and trunk. Floppy people, who are poorer imagers, may rely more on "egocentric", proprioceptive and vestibular inputs. (c) 2005 Elsevier B.V. All rights reserved.	Univ Paris 05, CNRS, UMR 7060, Lab Neurobiol Reseaux Sensorimoteurs,Ctr Univ St, F-75270 Paris 06, France; Univ Paris 05, CNRS, FRE 2428, Lab Stat Med, F-75270 Paris 06, France; Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia		Vibert, N (corresponding author), Univ Paris 05, CNRS, UMR 7060, Lab Neurobiol Reseaux Sensorimoteurs,Ctr Univ St, 45 Rue St Peres, F-75270 Paris 06, France.	nivi@ccr.jussieu.fr	Curthoys, Ian/ABE-6627-2021	Curthoys, Ian/0000-0002-9416-5038; MacDougall, Hamish/0000-0001-6201-1707			Allum JHJ, 1997, J VESTIBUL RES-EQUIL, V7, P189; BALOH RW, 1984, ACTA OTO-LARYNGOL, V97, P1, DOI 10.3109/00016488409130958; BARNES GR, 1988, J PHYSIOL-LONDON, V395, P383, DOI 10.1113/jphysiol.1988.sp016925; Bles W, 2000, CURR OPIN NEUROL, V13, P19, DOI 10.1097/00019052-200002000-00005; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; CREMIEUX J, 1994, PERCEPT MOTOR SKILL, V78, P67, DOI 10.2466/pms.1994.78.1.67; Ehrenfried T, 2003, COGNITIVE BRAIN RES, V17, P140, DOI 10.1016/S0926-6410(03)00088-0; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; GUITTON D, 1986, EXP BRAIN RES, V64, P59; Harm D L, 1993, J Vestib Res, V3, P297; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Isaac A.R., 1986, J MENTAL IMAGERY, V10, P23, DOI DOI 10.1037/T07980-000; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 1998, HUM MOVEMENT SCI, V17, P367, DOI 10.1016/S0167-9457(98)00005-0; Jeka JJ, 1996, PERCEPT PSYCHOPHYS, V58, P409, DOI 10.3758/BF03206817; Kanaya T, 1995, J PHYSIOL-LONDON, V489, P895, DOI 10.1113/jphysiol.1995.sp021102; Keshner EA, 2004, J VESTIBUL RES-EQUIL, V14, P307; Keshner EA, 2003, J NEUROPHYSIOL, V89, P1891, DOI 10.1152/jn.00836.2001; KESHNER EA, 1995, J NEUROPHYSIOL, V73, P2293, DOI 10.1152/jn.1995.73.6.2293; Keshner EA, 2000, GAIT POSTURE, V11, P1, DOI 10.1016/S0966-6362(99)00046-6; KESHNER EA, 1988, EXP BRAIN RES, V71, P455, DOI 10.1007/BF00248739; Keshner EA, 1996, J MOTOR BEHAV, V28, P324, DOI 10.1080/00222895.1996.10544602; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Mast F, 1999, NEUROREPORT, V10, P3549, DOI 10.1097/00001756-199911260-00016; NYBORG H, 1974, SCAND J PSYCHOL, V15, P119, DOI 10.1111/j.1467-9450.1974.tb00563.x; OLTMAN PK, 1968, PERCEPT MOTOR SKILL, V26, P503, DOI 10.2466/pms.1968.26.2.503; Owen N, 1998, BRAIN RES BULL, V47, P471, DOI 10.1016/S0361-9230(98)00101-4; Peterson BW, 2004, PROG BRAIN RES, V143, P369, DOI 10.1016/S0079-6123(03)43035-5; Peterson BW, 2001, ANN NY ACAD SCI, V942, P381; Raskin E., 1971, MANUAL EMBEDDED FIGU; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x; VIDAL PP, 1982, AVIAT SPACE ENVIR MD, V53, P166; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x; ZOCCOLOTTI P, 1993, PERCEPT PSYCHOPHYS, V54, P14, DOI 10.3758/BF03206933	36	9	9	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	APR	2006	23	3					355	363		10.1016/j.gaitpost.2005.04.006			9	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	026KL	WOS:000236337700014	15935672				2022-02-06	
J	Anselmi, E; Vallisa, D; Berte, R; Vanzo, C; Cavanna, L				Anselmi, Elisa; Vallisa, Daniele; Berte, Raffaella; Vanzo, Carlo; Cavanna, Luigi			Post-traumatic glioma: Report of two cases	TUMORI JOURNAL			English	Article						brain lesion; cranial trauma; glioma	LOS-ANGELES-COUNTY; CENTRAL NERVOUS-SYSTEM; OF-THE-LITERATURE; RISK-FACTORS; MALIGNANT GLIOMA; HEAD TRAUMA; BRAIN-TUMORS; GLIOBLASTOMA; MENINGIOMAS; INJURY	We report two cases of brain glioma that developed in the scar of an old brain trauma. The first is that of a 40-year-old man who presented with severe headaches; CT and MRI showed a large mass in the right parietal region. The tumor was unresectable and surgical biopsy showed a glioblastoma multiforme. The patient had suffered a cranial trauma in a road accident 20 years previously with an intrathecal hematoma in the right parietal region. The second case concerns a 60-year-old man who, 15 years after severe head injury in a road accident, developed a glioblastoma multiforme which was localized in the scar of the brain contusion. These cases fulfill the established criteria for a traumatic origin of brain tumors and add further support to the relationship between cranial trauma and the onset of glioma. As stated by other authors, an association between head trauma and brain tumor risk cannot be ruled out and should be studied further.	Hosp Piacenza, Dept Hematol & Oncol, Piacenza, Italy; Hosp Piacenza, Radiotherapy Unit, Piacenza, Italy		Cavanna, L (corresponding author), Osped Civile, Dipartimento Oncol & Ematol, Via Taverna 49, I-29100 Piacenza, Italy.	l.cavanna@ausl.pc.it	Cavanna, Luigi/AAL-5251-2020	Cavanna, Luigi/0000-0002-0303-3778; Vallisa, Daniele/0000-0002-3130-1979			ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; BOKER DK, 1991, FORTSCHR NEUROL PSYC, V59, P488, DOI 10.1055/s-2007-1000724; CARPENTER AV, 1987, AM J PUBLIC HEALTH, V77, P1180, DOI 10.2105/AJPH.77.9.1180; Chen CS, 1997, VIB SPECTROSC, V14, P9, DOI 10.1016/S0924-2031(96)00067-7; CHOI NW, 1970, AM J EPIDEMIOL, V91, P467, DOI 10.1093/oxfordjournals.aje.a121158; CODD MB, 1985, NEUROLOGY, V35, P1532, DOI 10.1212/WNL.35.10.1532; DiTrapani G, 1996, ITAL J NEUROL SCI, V17, P283, DOI 10.1007/BF01997787; Gruss P, 1993, Zentralbl Neurochir, V54, P186; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HESHMAT MY, 1976, CANCER, V38, P2135, DOI 10.1002/1097-0142(197611)38:5<2135::AID-CNCR2820380543>3.0.CO;2-T; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; JANDA J, 1987, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V133, P55; Magnavita N, 2003, NEUROL SCI, V24, P31, DOI 10.1007/s100720300018; Manuelidis EE., 1972, PATHOLOGY NERVOUS SY, V2, P2237; Mirzai Hasan, 2004, Ulus Travma Acil Cerrahi Derg, V10, P257; Moorthy RK, 2004, SURG NEUROL, V61, P180, DOI 10.1016/S0090-3019(03)00423-3; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; Parker HL, 1931, J AMER MED ASSOC, V97, P0535, DOI 10.1001/jama.1931.02730080027008; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; Salvati M, 2004, TUMORI J, V90, P416, DOI 10.1177/030089160409000410; SCHMITT HP, 1983, FORTSCHR NEUROL PSYC, V51, P227, DOI 10.1055/s-2007-1002228; TROOST D, 1984, CLIN NEUROPATHOL, V3, P139; Zulch KJ, 1965, BRAIN TUMORS THEIR B, P51	28	9	9	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-8916	2038-2529		TUMORI J	Tumori J.	MAR-APR	2006	92	2					175	177		10.1177/030089160609200215			3	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	044CF	WOS:000237649100015	16724699				2022-02-06	
J	Kuo, JR; Yeh, TC; Sung, KC; Wang, CC; Chen, CW; Chio, CC				Kuo, JR; Yeh, TC; Sung, KC; Wang, CC; Chen, CW; Chio, CC			Intraoperative applications of intracranial pressure monitoring in patients with severe head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; intracranial pressure; cerebral perfusion pressure	CEREBRAL PERFUSION-PRESSURE; VENOUS OXYGEN-SATURATION; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MANAGEMENT	From December 2002 to January 2004,30 patients (20 men and 10 women; mean age 36.8 years [+/- 14.9 years]) with preoperative Glasgow Coma Scale scores of 8 or less underwent emergency haematoma evacuation surgery and continuous intracranial pressure (ICP), cerebral perfusion pressure (CPP) and mean arterial blood pressure monitoring to determine ICP and CPP thresholds to predict patient outcomes. Receiver-operating characteristic (ROC) curves were plotted. Using the ROC curve, the diagnostic accuracy is given by the area under the curve and at the point on the curve farthest from the diagonal, which indicates the threshold value. The results showed that the initial ICP for unfavourable outcomes was 47.4 +/- 21.4 mmHg, resulting in a CPP of 22.8 +/- 12.83 mmHg. The initial ICP for favourable outcomes was 26.4 +/- 10.1 mmHg, resulting in a CPP of 48.8 +/- 13.4 mmHg. The CPP had the largest area under the ROC curve in all stages of the operation, corresponding to intraoperative CPP thresholds of 37 mmHg (initial), 51.8 mmHg (intraoperative) and 52 mmHg (after scalp closure). The ROC curve analysis showed that CPP was a better predictor of outcome than ICP. (c) 2006 Elsevier Ltd. All rights reserved.	Chi Mei Med Ctr, Dept Neurosurg, Tainan 710, Taiwan		Chio, CC (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan 710, Taiwan.	Chiocc@ms28.hinet.net					*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Haelewyn B, 2003, BRIT J ANAESTH, V91, P390, DOI 10.1093/bja/aeg186; Hoffman WE, 1998, NEUROSURGERY, V43, P1050, DOI 10.1097/00006123-199811000-00026; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kunze E, 1998, ACT NEUR S, V71, P16; KUO JR, 2003, FORMOSAN J SURG, V36, P249; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; NAEGER M, 2003, J NEUROL NEUROSUR PS, V74, P513; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Schneider GH, 2002, ACT NEUR S, V81, P77; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; YOSHIDA A, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P309; ZWEIG MH, 1993, CLIN CHEM, V39, P561	20	9	9	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2006	13	2					218	223		10.1016/j.jocn.2005.01.012			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	023VS	WOS:000236154900011	16459087				2022-02-06	
J	Kurimoto, Y; Morishita, K; Kawaharada, N; Fukada, J; Hachiro, Y; Fujisawa, Y; Saitoh, T; Yama, N; Hase, M; Narimatsu, E; Asai, Y				Kurimoto, Y; Morishita, K; Kawaharada, N; Fukada, J; Hachiro, Y; Fujisawa, Y; Saitoh, T; Yama, N; Hase, M; Narimatsu, E; Asai, Y			Initial experiences in management of blunt aortic injury taking associated brain injury into consideration	CIRCULATION JOURNAL			English	Article						blunt aortic injury; brain injury; open surgery; stent graft	TRAUMATIC RUPTURE; OPEN REPAIR; STENT; SURGERY	Background Although endovascular stent-grafting (SG) has become acceptable for blunt aortic injury (BAI), open surgical repair (OR) does provide reliable, good long-term results. A current surgical strategy for BAI, taking account of associated brain injury, is presented and preferable initial management for BAT is proposed. Methods and Results The surgical strategy for BAT was established in 2001: SG is performed for patients with obvious brain injuries, but OR is performed for patients without brain injury, and conservative treatment should be used initially for patients with critical non-aortic injuries. Between 2001 and 2004 20 patients with BAI were admitted to hospital: 16 blunt aortic ruptures and 4 blunt aortic dissections. Of them 15 patients underwent surgery (SG, 9; OR, 6) and 5 patients were treated conservatively. One patient died from associated lung injury after SG, all patients treated conservatively died because of associated brain injuries or another rupture of BAI, and 2 elderly patients treated by OR died within 1 year from postoperative respiratory failure. Conclusion This brain-injury conscious surgical strategy for BAT provided acceptable early results. OR should be chosen for young patients without brain injury, but endovascular SG seems to be a better initial treatment for elderly patients or patients with other comorbidities.	Sapporo Med Univ, Dept Traumatol & Crit Care Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; Sapporo Med Univ, Dept Thorac & Cardiovasc Surg, Sapporo, Hokkaido 0608543, Japan; Sapporo Med Univ, Dept Radiol, Sapporo, Hokkaido 0608543, Japan		Kurimoto, Y (corresponding author), Sapporo Med Univ, Dept Traumatol & Crit Care Med, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan.	kurimoto@sapmed.ac.jp					BLEGVAD S, 1989, J CARDIOVASC SURG, V30, P559; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Iannelli G, 2004, ANN THORAC SURG, V77, P591, DOI 10.1016/S0003-4975(03)01348-1; Kasirajan K, 2003, ANN VASC SURG, V17, P589, DOI 10.1007/s10016-003-0066-2; Kato M, 2004, CIRC J, V68, P553, DOI 10.1253/circj.68.553; Kurimoto Y, 2003, EUR J VASC ENDOVASC, V26, P445, DOI 10.1016/S1078-5884(03)00077-7; Morishita K, 2004, ANN THORAC SURG, V78, P1630, DOI 10.1016/j.athoracsur.2004.05.014; Ott MC, 2004, J TRAUMA, V56, P565, DOI 10.1097/01.TA.0000114061.69699.A3; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; Rousseau H, 1999, CIRCULATION, V99, P498, DOI 10.1161/01.CIR.99.4.498	11	9	9	0	0	JAPANESE CIRCULATION SOCIETY	KYOTO	KINKI INVENTION CENTER, 14 YOSHIDA KAWAHARACHO, SAKYO-KU, KYOTO, 606-8305, JAPAN	1346-9843			CIRC J	Circ. J.	FEB	2006	70	2					198	201		10.1253/circj.70.198			4	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	007KI	WOS:000234967300009	16434815	Bronze			2022-02-06	
J	Einav, S; Shoshan, Y; Ovadia, H; Matot, I; Hersch, M; Itshayek, E				Einav, Sharon; Shoshan, Yigal; Ovadia, Haim; Matot, Idit; Hersch, Moshe; Itshayek, Eyal			Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study	CRITICAL CARE			English	Article							CARDIOPULMONARY BYPASS; S-100-BETA PROTEIN; CARDIAC-ARREST; MARKER; S100B; S-100B; INJURY; RELEASE; TRAUMA	Introduction Elevated serum levels of S100 beta, an astrocyte-derived protein, correlate with unfavourable neurological outcomes following cardiac surgery, neurotrauma, and resuscitation. This study evaluated whether pre-/postoperative serum S100 beta levels correlate with unfavourable clinical and radiological findings in patients undergoing elective meningioma resection. Methods In 52 consecutive patients admitted for meningioma surgery, serum S100 beta levels were determined upon admission and immediately, 24 hours, and 48 hours after surgery. All patients underwent complete pre- and postoperative neurological examination and mini-mental state examination. Radiological evaluation included preoperative magnetic resonance imaging (MRI) and postoperative computed tomography. Tumour volume, brain edema, and bleeding volume were calculated using BrainSCAN (TM) software. Results Preoperative S100 beta levels did not correlate with the tumour characteristics demonstrated by preoperative MRI ( for example, tumour volume, edema volume, ventricular asymmetry, and/or midline shift). Preoperative serum S100 beta levels (0.065 +/- 0.040 mu g/l) were significantly lower than the levels measured immediately (0.138 +/- 0.081 mu g/l), 24 hours ( 0.142 +/- 0.084 mu g/l), and 48 hours (0.155 +/- 0.119 mu g/l) postoperatively ( p < 0.0001). Significantly greater postcraniotomy S100 beta levels were observed with prolonged surgery ( p = 0.039), deterioration in the mini-mental state examination ( p = 0.005, 0.011, and 0.036 for pre versus immediate, 24 hours, and 48 hours postsurgery, respectively), and with postoperative brain computed tomography evidence of brain injury; bleeding was associated with higher serum S100 beta levels at 24 and 48 hours after surgery ( p = 0.046, 95% confidence interval [CI] - 0.095 to - 0.001 and p = 0.034, 95% CI - 0.142 to - 0.006, respectively) as was the presence of midline shift ( p = 0.005, 95% CI - 0.136 to - 0.025 and p = 0.006, 95% CI - 0.186 to - 0.032, respectively). Edema was associated with higher serum S100 beta levels immediately ( p = 0.022, 95% CI - 0.092 to - 0.007) and at 48 hours after surgery ( p = 0.017, 95% CI - 0.142 to - 0.026). The degree of elevation in S100 beta levels at 24 and 48 hours after surgery also correlated with the severity of midline shift and edema. Conclusion In patients with meningioma, serum S100 beta levels perform poorly as an indicator of tumour characteristics but may suggest ongoing postcraniotomy injury. Serum S100 beta levels may serve as a potentially useful early marker of postcraniotomy brain damage in patients undergoing elective meningioma resection.	Ben Gurion Univ Negev, Fac Hlth Sci, Shaare Zedek Med Ctr, Gen Intens Care Unit, IL-91031 Jerusalem, Israel; Hadassah Hebrew Univ Med Ctr, Dept Neurosurg, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel; Hadassah Hebrew Univ Med Ctr, Dept Anaesthesia & Intens Care Med, IL-91120 Jerusalem, Israel		Einav, S (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shaare Zedek Med Ctr, Gen Intens Care Unit, POB 3235, IL-91031 Jerusalem, Israel.	einav_s@szmc.org.il					Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Arcuri C, 2002, NEUROSCIENCE, V109, P371, DOI 10.1016/S0306-4522(01)00330-X; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Bottiger BW, 2001, CIRCULATION, V103, P2694; de Vries J, 2003, MINIM INVAS NEUROSUR, V46, P33, DOI 10.1055/s-2003-37963; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Gazzolo D, 2002, PEDIATR RES, V51, P215, DOI 10.1203/00006450-200202000-00015; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Marinoni E, 2002, OBSTET GYNECOL, V99, P1093, DOI 10.1016/S0029-7844(02)01996-8; Marquardt G, 2004, ACTA NEUROCHIR, V146, P449, DOI 10.1007/s00701-004-0242-3; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Rasmussen LS, 2000, BRIT J ANAESTH, V84, P242, DOI 10.1093/oxfordjournals.bja.a013410; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Schick U, 2003, ACTA NEUROL SCAND, V108, P161, DOI 10.1034/j.1600-0404.2003.00109.x; Shaaban-Ali M, 2002, ACTA ANAESTH SCAND, V46, P10, DOI 10.1111/j.1399-6576.2002..x; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Snyder-Ramos SA, 2004, ANAESTHESIA, V59, P344, DOI 10.1111/j.1365-2044.2004.03663.x; Stranjalis G, 2005, CLIN CHEM, V51, P202, DOI 10.1373/clinchem.2004.039719; SUZUKI F, 1984, J NEUROCHEM, V43, P1336, DOI 10.1111/j.1471-4159.1984.tb05391.x; Wijnberger LDE, 2002, PEDIATR RES, V51, P492, DOI 10.1203/00006450-200204000-00015; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; ZIMMER DB, 1987, AM J PHYSIOL, V252, P285	27	9	9	0	1	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2006	10	5							R141	10.1186/cc5058			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185NS	WOS:000247718300017	17020600	Green Published, gold			2022-02-06	
J	Hoofien, D; Sharoni, L				Hoofien, Dan; Sharoni, Limor			Measuring unawareness of deficits among patients with traumatic brain injury: Reliability and validity of the Patient Competency Rating Scale - Hebrew version	ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES			English	Article							IMPAIRED AWARENESS; SELF-AWARENESS; BEHAVIORAL LIMITATIONS; COGNITIVE DEFICITS; REHABILITATION; DISTURBANCES; DEPRESSION; INSIGHT; PCRS	Background: Unawareness of deficits is a frequent symptom of traumatic brain injury (TBI), affecting motivation and compliance with treatment. The goal of this study was to validate a Hebrew version of the most commonly used measure of post-TBI unawareness of deficits: the Patient Competency Rating Scale (PCRS). Method: Seven groups of participants were studied: Patients with TBI (two groups), their family members, their therapists (two groups), and matched controls and their family members. The PCRS scores of patients, relatives and therapists were analyzed. Results: The adapted scale shows adequate inter-item consistency coefficients, similar to those reported with the original version, and high inter-rater reliability. As expected, the scale significantly differentiates between patients and controls, shows high positive correlations with depression and is composed of the four expected awareness factors. Normative data are also presented. Limitations: The number of participants in each of the seven study groups and the specificity of the stage at which the patients were examined may limit the generalization power of our findings. Conclusions: The Hebrew version of the PCRS is a reliable and valid scale for measuring post-TBI deficits in self-awareness and may be used for clinical and research purposes.	Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; Natl Inst Rehabil Persons Brain Injuries, Tel Aviv, Israel		Hoofien, D (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, Mt Scopus, IL-91905 Jerusalem, Israel.	mshoofi@mscc.huji.ac.il					ANASTASI A, 1998, PSYCHOL TESTING, P297; Beck A. T., 1993, BECK DEPRESSION INVE; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Goldberg RW, 2001, J NERV MENT DIS, V189, P137, DOI 10.1097/00005053-200103000-00001; Harwood DG, 2000, NEUROPSY NEUROPSY BE, V13, P83; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Langer KG, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P75; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lysaker P.H., 2004, INSIGHT PSYCHOSIS AW, V2nd, P335; NG KC, 1995, ACTA PSYCHIAT SCAND, V92, P75, DOI 10.1111/j.1600-0447.1995.tb09546.x; NIVNADLER N, 1997, DIS ABS INT, V57, P5339; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G. P., 1991, BNI Q, V7, P27; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Pyne JM, 2001, J NERV MENT DIS, V189, P146, DOI 10.1097/00005053-200103000-00002; RAWEH DV, 1999, OCCUPATIONAL THERAPY, V14, P65; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; VAKIL E, 1994, NEUROPSYCHOL REV, V4, P271, DOI 10.1007/BF01876078; Wallace CA, 2000, BRAIN INJURY, V14, P549; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Zalsman G, 2001, J NERV MENT DIS, V189, P338, DOI 10.1097/00005053-200105000-00015	34	9	10	0	5	MEDIAFARM GROUP	TEL-AVIV	23 ZAMENHOFF ST, TEL-AVIV, 64373, ISRAEL	0333-7308			ISR J PSYCHIATR REL	Isr. J. Psychiatr. Relat. Sci.		2006	43	4					296	305					10	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	133DE	WOS:000243991000011	17338451				2022-02-06	
J	Kotulska, K; Larysz-Brysz, M; Marcol, W; Grajkowska, W; Jozwiak, S; Lewin-Kowalik, J				Kotulska, Katarzyna; Larysz-Brysz, Magdalena; Marcol, Wieslaw; Grajkowska, Wieslawa; Jozwiak, Sergiusz; Lewin-Kowalik, Joanna			The role of trkB receptor in the formation of post-traumatic neuroma	FOLIA NEUROPATHOLOGICA			English	Article						peripheral nerve injury; nerve regeneration; nerve fibres; BDNF; mutant mice; nerve grafting	NERVE INJURY; BDNF; REGENERATION; EXPRESSION; PREVENTION; AUTOTOMY; TRANSECTION; INVOLVEMENT; INHIBITION; RECOVERY	The outcome of peripheral nerve injury is often impaired by post-traumatic neuroma developing at the injury site. Neuroma is usually accompanied by neuropathic pain, which is usually resistant to most analgesics and presents a serious clinical problem. The mechanisms underlying post-traumatic neuroma remain unclear, but they are likely associated with regeneration processes. Brain-derived neurotrophic factor (BDNF) and its receptor, trkB, are strongly implicated in axonal regeneration after injury. The aim of this work was to examine the role of trkB in post-traumatic neuroma formation. The sciatic nerve was transected in wild-type and heterozygous trkB-deficient mice. The nerve was either left cut or immediately sewn up or the gap injury model was performed. The gap was provided with an autologous or cross (obtained from another genetic group) graft. Sixteen weeks after surgery, the animals were sacrificed and histologic evaluations were performed. We found very limited or no neuroma formation in wild-type animals, regardless of the surgical procedure. In the majority of trkB-deficient mice, the post-traumatic neuroma was found at the end of the proximal stump of the transected nerve. In the gap injury model, in trkB-deficient animals receiving wild-type graft, there was no neuroma at the join site between the graft and distal stump of the nerve. In contrast, if the graft was autologous, neuroma formed at both joints. We also noticed many more mast cells accumulated at the surgery site in trkB-deficient than in wild-type animals. These results indicate the important role of BDNF receptor in post-traumatic neuroma formation.	Childrens Mem Hlth Inst, Dept Neurol, PL-04730 Warsaw, Poland; Med Univ Silesia, Dept Physiol, Katowice, Poland; Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland		Kotulska, K (corresponding author), Childrens Mem Hlth Inst, Dept Neurol, Al Dzieci Polskich 20, PL-04730 Warsaw, Poland.	k.kotulska@czd.pl		Lewin-Kowalik, Joanna/0000-0002-7971-449X; Jozwiak, Sergiusz/0000-0003-3350-6326; Grajkowska, Wieslawa/0000-0001-8318-5781; Kotulska-Jozwiak, Katarzyna/0000-0002-5015-250X			BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; DVORKIN RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524; Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018; English AW, 2005, EUR J NEUROSCI, V21, P2624, DOI 10.1111/j.1460-9568.2005.04124.x; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Kobayashi NR, 1996, EUR J NEUROSCI, V8, P1018, DOI 10.1111/j.1460-9568.1996.tb01588.x; Koch H, 2003, ANN PLAS SURG, V51, P45, DOI 10.1097/01.SAP.0000054187.72439.57; Kotulska K, 2005, NEUROL RES, V27, P843, DOI 10.1179/016164105X48815; Krishnaswamy G, 2001, FRONT BIOSCI-LANDMRK, V6, pD1109, DOI 10.2741/krishnas; Kryger GS, 2001, J HAND SURG-AM, V26A, P635, DOI 10.1053/jhsu.2001.26035; Lewin-Kowalik J, 2006, NEUROL MED-CHIR, V46, P62, DOI 10.2176/nmc.46.62; Lin Q, 1996, J NEUROSCI, V16, P3026; Marcol W, 2006, J NEUROSURG, V104, P285, DOI 10.3171/jns.2006.104.2.285; NENNESMO I, 1986, NEUROSCI LETT, V69, P296, DOI 10.1016/0304-3940(86)90497-0; Rubinstein RE, 2003, MICROSURG, V23, P363, DOI 10.1002/micr.10149; Sakai Y, 2005, J BIOMED MATER RES B, V73B, P355, DOI 10.1002/jbm.b.30219; Simon M, 2003, EUR J NEUROSCI, V18, P2460, DOI 10.1046/j.1460-9568.2003.02978.x; Stoll G, 1999, BRAIN PATHOL, V9, P313; WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2; Yajima Y, 2005, J NEUROCHEM, V93, P584, DOI 10.1111/j.1471-4159.2005.03045.x; Yajima Y, 2002, BRAIN RES, V958, P338, DOI 10.1016/S0006-8993(02)03666-1; Yong LCJ, 1997, EXP TOXICOL PATHOL, V49, P409, DOI 10.1016/S0940-2993(97)80129-7; Yuen EC, 1999, EXP NEUROL, V159, P297, DOI 10.1006/exnr.1999.7148; Zhang JT, 2000, J NONPARAMETR STAT, V12, P417, DOI 10.1080/10485250008832816	28	9	9	0	11	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2006	44	3					221	227					7	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	118GS	WOS:000242931000010	17039418				2022-02-06	
J	Morris, DM; Shaw, SE; Mark, VW; Uswatte, G; Barman, J; Taub, E				Morris, David M.; Shaw, Sharon E.; Mark, Victor W.; Uswatte, Gitendra; Barman, Joydip; Taub, Edward			The influence of neuropsychological characteristics on the use of CI therapy with persons with traumatic brain injury	NEUROREHABILITATION			English	Article						CI therapy; traumatic brain injury; rehabilitation; neuropsychological assessment; upper extremity	INDUCED MOVEMENT THERAPY; MOTOR FUNCTION-TEST; CHRONIC STROKE; RECOVERY; TBI; REHABILITATION; HEMIPARESIS; RELIABILITY; AGE	The great prevalence of traumatic brain injury ( TBI) and its high economic costs make reducing TBI-related disability a national health care priority. In our research laboratory, CI therapy has been found to significantly improve upper extremity function for persons with chronic TBI. The results have suggested that persons with TBI are less likely to adhere to critical components of the CI therapy protocol than participants with stroke in other studies. Treatment outcomes have also been more variable. Our findings suggest that some cognitive skills appear related to treatment outcome. In addition, cognitive and behavioral deficits, commonly seen with participants with TBI, challenge the delivery of the standard CI therapy protocol with some persons. We discuss the implications of these neuropsychological factors for CI therapy used for chronic TBI and propose further research to more thoroughly investigate these issues.	Univ Alabama, Sch Hlth Profess, Dept Phys Therapy, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Univ Alabama, Sch Social & Behav Sci, Dept Psychol, Birmingham, AL 35294 USA		Morris, DM (corresponding author), Univ Alabama, Sch Hlth Profess, Dept Phys Therapy, RMSB 360,1530 3rd Ave S, Birmingham, AL 35294 USA.	morrisd@uab.edu	Uswatte, Gitendra/C-4913-2009; Mark, Victor/AAT-3772-2020				*ARM IND TEST BATT, 1944, MAN DIR SCOR WAR DEP; BLEECKER ML, 1988, NEUROLOGY, V38, P1565, DOI 10.1212/WNL.38.10.1565; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; *CDC, TRAUM BRAIN INJ US R; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050110034325; Cohen J., 2013, STAT POWER ANAL BEHA; DETTMERS C, IN PRESS ARCH PHYS M; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Hamster K., 1983, MULTILINGUAL APHASIA; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Mark VW, 2004, RESTOR NEUROL NEUROS, V22, P317; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Morris D M, 2001, Top Stroke Rehabil, V8, P16; Morris DM, 1997, NEUROREHABILITATION, V9, P29, DOI 10.3233/NRE-1997-9104; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Novack TA, 2000, BRAIN INJURY, V14, P987; Page SJ, 2002, ARCH PHYS MED REHAB, V83, P286, DOI 10.1053/apmr.2002.28007; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Taub E, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P475, DOI 10.1037/10361-022; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; TAUB E, IN PRESS STROKE; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Wechsler D., 1997, WECHSLER MEMORY SCAL; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	39	9	10	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2006	21	2					131	137					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	076WP	WOS:000239989200004	16917159				2022-02-06	
J	Wong, TM				Wong, Tony M.			Ethical controversies in neuropsychological test selection, administration, and interpretation	APPLIED NEUROPSYCHOLOGY			English	Article						ethical controversies; neuropsychological test selection; administration; interpretation	POST-CONCUSSION SYNDROME; MILD HEAD-INJURY; HOUSTON CONFERENCE; CLINICAL NEUROPSYCHOLOGY; PART I; SYMPTOMS; COMPENSATION; BATTERY; POLICY	Due to the lack of uniform agreement on certain aspects of neuropsychological assessment practice, ethical issues can arise. Ethical controversies related to some of the most basic assessment practices of the clinical neuropsychologist are addressed. Current controversies related to neuropsychological test selection, test administration, and test interpretation are discussed and illustrated by case vignettes. Brief analyses of the ethical ramifications of the controversies are offered, followed by suggestions and recommendations for dealing with these conflicts. By resolving these conflicts as a discipline, more consistent standards of neuropsychological practice could be established, which would be of ultimate benefit to both professional and consumer alike.	Unity Hlth Syst, ABPP CN, Rochester, NY 14611 USA; Univ Rochester, Sch Med & Dent, Dept Orthopaed & Rehabil, Rochester, NY USA		Wong, TM (corresponding author), Unity Hlth Syst, ABPP CN, 89 Genesee St, Rochester, NY 14611 USA.	twong@unityhealth.org					*AM PSYCH ASS, 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; *AM PSYCH ASS, 1989, CLIN NEUROPSYCHOL, V3, P23; *AM PSYCH ASS DIV, 1991, CLIN NEUROPSYCHOL, V5, P20; Ardila A, 2002, NEUROPSYCHOL REV, V12, P147, DOI 10.1023/A:1020329929493; Axelrod B, 2000, ARCH CLIN NEUROPSYCH, V15, P381; Barth J T, 1991, Neuropsychol Rev, V2, P251, DOI 10.1007/BF01109048; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Donders J, 2001, CLIN NEUROPSYCHOL, V15, P137, DOI 10.1076/clin.15.2.137.1893; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FAUST D, 1991, Neuropsychology Review, V2, P205, DOI 10.1007/BF01109045; Hamsher K., 1989, MULTILINGUAL APHASIA; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Heaton RK, 1991, COMPREHENSIVE NORMS; Hom J, 2003, ARCH CLIN NEUROPSYCH, V18, P827, DOI 10.1016/S0887-6177(03)00076-3; IFORTUNY LA, 1998, CLIN NEUROPSYCHOL, V12, P113; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; LEESHALEY, 2004, BRAIN INJURY PROFESS, V1, P6; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; McKinzey RK, 1999, BEHAV SCI LAW, V17, P543, DOI 10.1002/(SICI)1099-0798(199910/12)17:4<543::AID-BSL360>3.0.CO;2-H; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nell V., 2000, CROSS CULTURAL NEURO; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; Reed JE, 1996, BEHAV SCI LAW, V14, P315, DOI 10.1002/(SICI)1099-0798(199622)14:3<315::AID-BSL242>3.0.CO;2-X; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P375, DOI 10.1016/S0887-6177(03)00077-5; Reynolds CR, 2002, NEUROPSYCHOL REV, V12, P143, DOI 10.1023/A:1020395711263; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Wedding D, 1991, Neuropsychol Rev, V2, P233, DOI 10.1007/BF01109046; Wedding D, 1989, Arch Clin Neuropsychol, V4, P233, DOI 10.1016/0887-6177(89)90016-4; Wong TM, 2000, CRIT ISS NE, P43; Wong TM, 2000, CRIT ISS NE, P3; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	41	9	9	1	33	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2006	13	2					68	76		10.1207/s15324826an1302_2			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	097BP	WOS:000241421600002	17009880				2022-02-06	
J	Gordon, WA; Brown, M				Gordon, WA; Brown, M			Building research capacity - The role of partnerships	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						research summit; research capacity; partnerships	TRAUMATIC BRAIN-INJURY; INDIVIDUALS; HEALTH	What "connections"-a broader term than "partnerships"-need to be made to build research capacity? Connections build capacity to the degree that they augment the skills, knowledge and resources of the focal investigator or investigating entity. We suggest that the goal of capacity building through partnerships/ connections is to maximize research utility, i.e., its potential to effect desired changes in targeted systems. Specifically, an investigator or research organization must create connectons that will enable: the selection and framing of research questions to address matters of importance to relevant stakeholders, especially and necessarily responding to the needs of people with disabilities; the development of a research design adhering to the highest standards of science; and the translation of new knowledge into messages about the results useful to those who are potential beneficiaries, tailoring the message so that it will be clearly "heard" by each respective target audience (including clinicians, other researchers administrators and/or people with disabilities and their family members). Utility of research traditionally has not comprised the standard for judging research. However, the current focus in Federal funding appears to be shifting, with a demand to assess outcomes (i.e., utility) of research, thus, bolstering the argument to strengthen research utility through creating appropriate partnerships.	CUNY Mt Sinai Sch Med, New York, NY 10029 USA		Gordon, WA (corresponding author), CUNY Mt Sinai Sch Med, 1 Gustave L Levy,Box 1240, New York, NY 10029 USA.						Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; TROSTLE J, 1992, SOC SCI MED, V35, P1321, DOI 10.1016/0277-9536(92)90035-O	3	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2005	84	12					999	1004		10.1097/01.phm.0000187851.96774.27			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	991QI	WOS:000233828200012	16327418				2022-02-06	
J	Hilsabeck, RC; Gouvier, WD				Hilsabeck, RC; Gouvier, WD			Detecting simulated memory impairment: Further validation of the Word Completion Memory Test (WCMT)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	18th Annual Meeting of the National-Academy-of-Neuropsychology	NOV, 1998	WASHINGTON, D.C.	Natl Acad Neuropsychol		malingering; cognitive; neuropsychological; faking bad; implicit memory	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; REY 15-ITEM TEST; SUSPECT EFFORT; FIGURE TEST; VALIDITY; DEFICITS; MMPI-2; IMPLICIT	The Word Completion Memory Test (WCMT) was developed to detect sophisticated attempts at simulating memory impairment. The primary purpose of the present study was to provide additional validity and reliability information about the WCMT. Seventy-one participants were recruited for this study: 30 normal volunteers and 11 memory-disordered patients instructed to perform their best, and 30 normal volunteers instructed to fake memory impairment. Normal volunteers were administered five tests of neuropsychological functioning and five tests of simulation to explore the convergent and divergent validity of the WCMT. Two weeks later, these participants completed all 10 measures a second time. Memory-disordered patients were administered the WCMT and two additional simulation measures as part of a comprehensive neuropsychological evaluation. The WCMT successfully discriminated simulators from nonsimulators with an overall classification accuracy of 97% and demonstrated good psychometric properties. In conclusion, the WCMT continues to show promise as a measure of simulated memory impairment. (c) 2005 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Louisiana State Univ, Baton Rouge, LA 70803 USA		Hilsabeck, RC (corresponding author), S Texas Vet Hlth Care Syst, Psychol Serv 116B, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	robin.hilsabeck@med.va.gov	Hilsabeck, Robin/ABC-5093-2020				ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 2002, J FORENSIC NEUROPSYC, V2, P27; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Davis HP, 1997, ARCH CLIN NEUROPSYCH, V12, P145, DOI 10.1016/S0887-6177(96)00011-X; Davis HP, 1997, ARCH CLIN NEUROPSYCH, V12, P191; FELDSTEIN S, 2000, AM J FORESNIC PSYCHO, V18, P57; FREDERICK RI, 1995, B AM ACAD PSYCH LAW, V23, P231; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Green P., 2003, GREENS WORD MEMORY T; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1994, PERCEPT MOTOR SKILL, V78, P1179, DOI 10.2466/pms.1994.78.3c.1179; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; HAYES JS, 1999, NEUROBEHAVIORAL DYSF; Hilsabeck RC, 2001, ARCH CLIN NEUROPSYCH, V16, P669, DOI 10.1016/S0887-6177(00)00077-9; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kaplan E, 1983, BOSTON NAMING TEST; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Klove H., 1963, CLIN NEUROPSYCHOLOGY; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Martin RC, 1998, CLIN NEUROPSYCHOL, V12, P84, DOI 10.1076/clin.12.1.84.1722; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; McCaffrey R.J., 2003, J FORENSIC NEUROPSYC, V3, P45, DOI [https://doi.org/10.1300/J151v03n03_03, DOI 10.1300/J151V03N03_03]; MERTEN T, 2004, Z NEUROPSYCHOL, V15, P81; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1996, ASSESSMENT, V3, P157; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Niccolls R., 1991, MULTI DIGIT MEMORY T; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; POULTON RG, 1995, ARCH CLIN NEUROPSYCH, V10, P47, DOI 10.1016/0887-6177(93)E0003-T; Reitan R.M., 1993, HALSTEADREITAN NEURO; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROEDIGER HL, 1990, B PSYCHONOMIC SOC, V28, P373; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROSE FE, 1995, CLIN NEUROPSYCHOL, V10, P163; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wetter MW, 1996, PSYCHOL ASSESSMENT, V8, P39; YOUNG E, 1991, NEW STATESMAN SOC, V4, P29; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]	58	9	9	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2005	20	8					1025	1041		10.1016/j.acn.2005.05.003			17	Psychology, Clinical; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	992LD	WOS:000233884500006	16099137				2022-02-06	
J	Muller-Rath, R; Miltner, O; Mamarvar, M; Mumme, T				Muller-Rath, R; Miltner, O; Mamarvar, M; Mumme, T			Risk of injury in junior competetive karate	SPORTVERLETZUNG-SPORTSCHADEN			German	Article						karate; junior; competition; injury; fist padding		Increasing professionalism in competetive karate has led to a specific injury pattern. The aim of our study was to investigate the injury pattern in junior competetive karate and to evaluate the prophylactic effect of fist padding. During the 4(th) junior World Championships of the World Karate Confederation (WKC) 2004 235 karate fights were observed and injury-related data were recorded. Fist padding was used in 183 fights, 52 fights were carried out without. In 22% of all fights we saw an injury. Most of them were mild injuries of the head and face: 32 bruises of the face (13 with epistaxis), 7 facial lacerations and 3 concussions (mild brain injury). 14 fights were stopped due to an injury. Only in the category male 18-20 years a higher rate of injuries was seen without fist padding (shobu ippon) compared to shobu sanbon (with fist padding). The injury pattern of junior competetive karate is comparable to senior karate. Fist padding does not generally reduce the incidence or severity of injuries.	Rhein Westfal TH Aachen, Univ Klinikum, Med Kommiss WKC, Orthopad Klin, D-52074 Aachen, Germany; Praxis Ganzheitl Orthopadie, Berlin, Germany; Friederikenstift Hannover, Klin Plast & Handchirurg, Hannover, Germany		Muller-Rath, R (corresponding author), Rhein Westfal TH Aachen, Univ Klinikum, Med Kommiss WKC, Orthopad Klin, Pauwelsstr 30, D-52074 Aachen, Germany.						Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; Muller-Rath R, 2000, SPORTVERLETZ SPORTSC, V14, P20, DOI 10.1055/s-2000-3818; NORREGARD FOH, 1988, BRIT J SPORT MED, V22, P114; STRICEVIC MV, 1983, AM J SPORT MED, V11, P320, DOI 10.1177/036354658301100507; Tuominen Risto, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P44; Zetaruk MN, 2000, CLIN J SPORT MED, V10, P117, DOI 10.1097/00042752-200004000-00006; Zetaruk MN, 2000, ACCIDENT ANAL PREV, V32, P421, DOI 10.1016/S0001-4575(99)00120-7	7	9	9	1	6	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0932-0555	1439-1236		SPORTVERLETZ SPORTSC	Sportverletz. Sportschaden	DEC	2005	19	4					191	194		10.1055/s-2005-858818			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	002FW	WOS:000234597900010	16369908				2022-02-06	
J	Moreira, T; Cebers, G; Cebere, A; Wagner, A; Liljequist, S				Moreira, T; Cebers, G; Cebere, A; Wagner, A; Liljequist, S			Extradural compression of the sensorimotor cortex delays the acquisition but not the recalling of a lever-pressing task in Wistar rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						operant behaviour; working memory; cognitive deficits; extradural compression; lever pressing; Fluoro-Jade	TRAUMATIC BRAIN-INJURY; MOTOR CORTEX; FLUORO-JADE; STRIATAL LESIONS; EPISODIC MEMORY; THALAMIC NUCLEI; FRONTAL-CORTEX; REACTION-TIME; HIPPOCAMPUS; PERFORMANCE	The learning and recalling of a lever-press task (LPT) after brief unilateral extradural compression (EC) of the right sensorimotor cortex was studied in Wistar rats. All rats, regardless of the time-point for EC, were trained to lever press for food from D(day) 1 to D6. On D8, the position of the active lever was changed to the right side of the operant box and performance was tested until D14. Total and active lever presses, as well as % errors were used to analyse the performance. Rats submitted to EC 24h before initiating the LPT schedule (naive-compressed group) showed delayed task acquisition and impaired performance until D10. No significant impairments were detected by D3 on a beam-walking test, excluding paresis as the cause to the delay. Rats submitted to EC after they learned the LPT (trained-compressed group) showed only mildly impaired post-compression performance with no effects on the recalling of the task. Using a progressive ratio LPT, the maximum number of presses to obtain a food-pellet (breaking point) was significantly reduced 24 h after EC suggesting reduced motivation for the task early after brain injury. The delayed acquisition of the LPT in naive-compressed rats was accompanied by consistent cortical, striatal and thalamic degeneration detected by Fluoro-Jade and anti-glial fibrillary acidic protein (GFAP) staining, whereas the improvement in the performance of this group was accompanied by a reduction of the cortical damage on D10. Recall of the LPT in trained-compressed rats was not altered by EC, suggesting the contribution of compensatory mechanisms. (c) 2005 Published by Elsevier B.V.	Karolinska Univ Hosp, Div Drug Dependence Res, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Karolinska Inst, Div Neurol, S-17176 Stockholm, Sweden		Liljequist, S (corresponding author), Karolinska Univ Hosp, Div Drug Dependence Res, Dept Clin Neurosci, Bldg L4-00, SE-17176 Stockholm, Sweden.	Sture.Liljequist@cns.ki.se					Aggleton JP, 2001, PHILOS T R SOC B, V356, P1467, DOI 10.1098/rstb.2001.0946; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; Baldwin AE, 2002, J NEUROSCI, V22, P1063, DOI 10.1523/JNEUROSCI.22-03-01063.2002; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Brasted PJ, 1998, BRAIN RES BULL, V46, P487, DOI 10.1016/S0361-9230(98)00044-6; Brooks N, 2003, J NEUROL NEUROSUR PS, V74, P1014, DOI 10.1136/jnnp.74.8.1014; Brown LL, 1998, J COMP NEUROL, V392, P468; Burk JA, 1998, BEHAV NEUROSCI, V112, P54, DOI 10.1037/0735-7044.112.1.54; Burk JA, 2001, BEHAV BRAIN RES, V122, P67, DOI 10.1016/S0166-4328(01)00169-3; Burk JA, 2001, BEHAV BRAIN RES, V123, P49, DOI 10.1016/S0166-4328(01)00202-9; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; Conti AC, 1998, J NEUROSCI, V18, P5663; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Ding YC, 2002, BEHAV BRAIN RES, V132, P29, DOI 10.1016/S0166-4328(01)00405-3; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Floresco SB, 1997, J NEUROSCI, V17, P1880; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Higgins GA, 2002, EUR J NEUROSCI, V15, P1827, DOI 10.1046/j.1460-9568.2002.02018.x; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Jones TA, 1999, J NEUROSCI, V19, P10153; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Krinke GJ, 2001, EXP TOXICOL PATHOL, V53, P365, DOI 10.1078/0940-2993-00202; Kundrotiene J, 2004, J NEUROTRAUM, V21, P83, DOI 10.1089/089771504772695977; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Maeshima S, 2001, J CLIN NEUROSCI, V8, P450, DOI 10.1054/jocn.2000.0801; Mair RG, 1998, BEHAV NEUROSCI, V112, P772, DOI 10.1037/0735-7044.112.4.772; Mair RG, 2002, J NEUROSCI, V22, P6756; McNeill TH, 2003, J COMP NEUROL, V467, P32, DOI 10.1002/cne.10907; Nakano K, 2000, J NEUROL, V247, P1; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rogers RD, 2001, BEHAV NEUROSCI, V115, P799, DOI 10.1037/0735-7044.115.4.799; ROMAN F, 1988, BRAIN RES, V443, P149, DOI 10.1016/0006-8993(88)91607-1; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.0.CO;2-T; SIF J, 1991, BEHAV NEURAL BIOL, V56, P43, DOI 10.1016/0163-1047(91)90279-Y; Stafford D, 1998, PSYCHOPHARMACOLOGY, V139, P169, DOI 10.1007/s002130050702; Torres-Munoz JE, 2004, MOL BRAIN RES, V127, P105, DOI 10.1016/j.molbrainres.2004.05.017; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	54	9	9	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	NOV 7	2005	164	2					250	265		10.1016/j.bbr.2005.06.013			16	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	973IC	WOS:000232515100014	16157396				2022-02-06	
J	Sanchez-Lopez, AM; Cuadros, MA; Calvente, R; Tassi, M; Marin-Teva, JL; Navascues, J				Sanchez-Lopez, AM; Cuadros, MA; Calvente, R; Tassi, M; Marin-Teva, JL; Navascues, J			Activation of immature microglia in response to stab wound in embryonic quail retina	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						activated microglia; ameboid microglia; retinal injury; cell migration; development	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; GANGLION-CELL LAYER; AMEBOID MICROGLIA; OPTIC-NERVE; RAT-BRAIN; NEURONAL DEGENERATION; MACROPHAGES; CNS; EXPRESSION	Activation of mature (ramified) microglia in response to injury in the adult central nervous system (CNS) is well documented. However, the response of immature (ameboid) microglia to injury in the developing CNS has received little attention. In this study, a stab wound was made in embryonic quail retinas at incubation days 7 and 9, and the response of retinal microglial cells was analyzed at different times between days 1 and 37 postinjury. The appearance of microglial cells within the wound occurred at the same time as the arrival of the first migrating ameboid microglial cells at an equivalent area in control retinas. Therefore, no specific attraction of microglia toward the wound was observed. Microglial cells in the wound had phenotypic features similar to those of activated microglia in the adult CNS. Thus, their shape was more compact compared with microglial cells outside the wound, expression of the molecule recognized by the QH1 antibody was up-regulated, and their lysosomal compartment was markedly increased. Transitional forms between normal ameboid and activated-like microglial cells were seen at the wound edge, supporting the view that ameboid microglia become activated when they contact the wound during the normal course of their migration in the retina. The microglial reaction was maintained within the wound at 37 days postinjury. In addition to the stab wound, secondary damage areas were found in experimental retinas. Activated cells could still be observed in these areas at 37 days postinjury.	Univ Granada, Fac Ciencias, Dept Biol Celular, E-18071 Granada, Spain; Hosp Univ San Cecilio, Banco Lineas Celulares Andalucia, Programa Lineas Celulares Tumorales, E-18071 Granada, Spain		Navascues, J (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Celular, E-18071 Granada, Spain.	navascue@ugr.es	Navascues, Julio/P-1336-2014; Cuadros, Miguel A/L-3954-2014	Cuadros, Miguel A/0000-0003-4259-1649; Tassi, Mohamed/0000-0003-2967-4984; Navascues, Julio/0000-0003-2958-2705			Acarin L, 1996, J COMP NEUROL, V367, P361; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; ASHWELL KWS, 1989, VISUAL NEUROSCI, V2, P437, DOI 10.1017/S0952523800012335; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Becher B, 2000, GLIA, V29, P293; Bobryshev YV, 1996, PATHOL RES PRACT, V192, P260, DOI 10.1016/S0344-0338(96)80229-9; Brauer AU, 2004, FEBS LETT, V563, P41, DOI 10.1016/S0014-5793(04)00244-3; Carbonell WS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-5; Cross AK, 2001, MICROSC RES TECHNIQ, V54, P10, DOI 10.1002/jemt.1115; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; CUADROS MA, 1992, NEUROSCI LETT, V148, P11, DOI 10.1016/0304-3940(92)90792-6; Cuadros MA, 2000, J COMP NEUROL, V423, P659, DOI 10.1002/1096-9861(20000807)423:4<659::AID-CNE10>3.0.CO;2-S; Dihne M, 2001, BRAIN RES, V902, P178, DOI 10.1016/S0006-8993(01)02378-2; Egensperger R, 1996, DEV BRAIN RES, V97, P1, DOI 10.1016/S0165-3806(96)00119-8; Engelsberg K, 2004, GRAEF ARCH CLIN EXP, V242, P229, DOI 10.1007/s00417-003-0780-z; Fiske BK, 2000, NEUROSCIENCE, V96, P807, DOI 10.1016/S0306-4522(99)00601-6; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Giulian Dana, 1995, P671; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hanisch Uwe-Karsten, 2002, P79; Hao AJ, 2001, J NEUROSCI RES, V64, P79, DOI 10.1002/jnr.1056; Hughes EH, 2003, INVEST OPHTH VIS SCI, V44, P2229, DOI 10.1167/iovs.02-0824; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Hurley SD, 1999, GLIA, V25, P304, DOI 10.1002/(SICI)1098-1136(19990201)25:3<304::AID-GLIA10>3.0.CO;2-W; Jeon GS, 2004, BRAIN RES, V1023, P15, DOI 10.1016/j.brainres.2004.01.093; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; KOSHINAGA M, 1995, J NEUROTRAUM, V12, P209, DOI 10.1089/neu.1995.12.209; Kunert KS, 1999, CURR EYE RES, V18, P440, DOI 10.1076/ceyr.18.6.440.5265; LAWSON LJ, 1995, EUR J NEUROSCI, V7, P1584, DOI 10.1111/j.1460-9568.1995.tb01154.x; LEONG SK, 1992, GLIA, V6, P39, DOI 10.1002/glia.440060106; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; LING EA, 1981, ADV CELL NEUROBIOL, V2, P33; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; Marin-Teva JL, 1999, ANAT EMBRYOL, V200, P289, DOI 10.1007/s004290050280; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Marin-Teva JL, 1998, GLIA, V22, P31, DOI 10.1002/(SICI)1098-1136(199801)22:1<31::AID-GLIA4>3.0.CO;2-B; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; MORIOKA T, 1991, J NEUROIMMUNOL, V35, P21, DOI 10.1016/0165-5728(91)90158-4; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; NAVASCUES J, 1995, J COMP NEUROL, V354, P209, DOI 10.1002/cne.903540205; Navascues Julio, 2002, P15; Origasa M, 2001, MOL BRAIN RES, V88, P1, DOI 10.1016/S0169-328X(01)00005-5; Pearse DD, 2004, EUR J NEUROSCI, V20, P3387, DOI 10.1111/j.1460-9568.2004.03799.x; PEARSON HE, 1993, DEV BRAIN RES, V76, P249, DOI 10.1016/0165-3806(93)90213-T; Penkowa M, 1999, J NEUROSCI, V19, P2535; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rao NA, 2003, INVEST OPHTH VIS SCI, V44, P22, DOI 10.1167/iovs.02-0199; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Sanchez-Lopez A, 2004, GLIA, V46, P261, DOI 10.1002/glia.20007; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; SCHNITZER J, 1990, J COMP NEUROL, V302, P779, DOI 10.1002/cne.903020410; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2001, NEUROTOXICOLOGY, V22, P619, DOI 10.1016/S0161-813X(01)00033-X; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit Wolfgang J., 1995, P85; Sugama S, 2003, NEUROSCIENCE, V116, P925, DOI 10.1016/S0306-4522(02)00572-9; Thanos S, 1996, PROG RETIN EYE RES, V15, P331, DOI 10.1016/1350-9462(96)00006-7; THANOS S, 1992, BRAIN RES, V588, P21, DOI 10.1016/0006-8993(92)91340-K; Wu CH, 1997, NEUROSCI RES, V27, P133, DOI 10.1016/S0168-0102(96)01140-6	70	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	NOV 7	2005	492	1					20	33		10.1002/cne.20676			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	970DF	WOS:000232284700002	16175556				2022-02-06	
J	Sawaughi, S; Taya, K; Murakami, S; Ishii, T; Ohtsuka, T; Kato, N; Kaku, S; Tanaka, T; Morooka, S; Yuhki, K; Urashima, M; Abe, T				Sawaughi, S; Taya, K; Murakami, S; Ishii, T; Ohtsuka, T; Kato, N; Kaku, S; Tanaka, T; Morooka, S; Yuhki, K; Urashima, M; Abe, T			Serum S-100B protein and neuron-specific enolase after traumatic brain injury	NEUROLOGICAL SURGERY			Japanese	Article						traumatic brain injury; S-100B protein; NSE; CT scan; secondary insult	SEVERE HEAD-INJURY; NEUROBIOCHEMICAL MARKERS; DAMAGE; S100B; RELEASE; TISSUE; STROKE	Objective The aim of this study was to investigate S-100B protein and NSE as a serum marker of brain cell damage after traumatic brain injury. Material and methods Forty-one patients with traumatic brain injury were included in this prospective study. Venous blood samples for S-100B protein and NSE were taken after admission and on the next day. Serum levels of S-100 protein and NSE were compared with Glasgow Coma Scale score, computed tomographic findings and outcome after 3 months. Results Serum S-100B protein and NSE were significantly correlated with Glasgow Coma Scale score and outcome after 3 months. The significant correlation was found between the initial S-100B and NSE (P < 0.001). III patients without parenchymal injuries on computed tomographic scan such as epidural hematoma and concussion, the elevation of S-100B protein and NSE was observed. The initial values of S-100B and NSE in acute subdural hematomas with unfavorable outcome were significantly higher than in those with favorable outcome. Secondary increase of serum markers was associated with the presence of secondary insult such as hypoxia or hypotension, and was found to have an unfavorable outcome. Conclusions Serum concentration and kinetics of S-100B protein mid NSE provide the clinical assessment of the primary brain damage and have a predictive value for outcome after traumatic brain injury.	Jikei Univ, Sch Med, Dept Neurosurg, Kashiwa, Chiba 2778567, Japan; Jikei Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; Jikei Univ, Sch Med, Div Clin Res & Dev, Tokyo, Japan		Sawaughi, S (corresponding author), Jikei Univ, Sch Med, Dept Neurosurg, 163-1 Kashiwashita, Kashiwa, Chiba 2778567, Japan.	sawauchi@jb4.so-net.ne.jp	Kato, Naoki/F-3104-2019	Kato, Naoki/0000-0001-5041-6985			de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Stolz E, 2004, STROKE, V35, P888, DOI 10.1161/01.STR.0000120306.82787.5A; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; 2001, SHINKEI GEKA, V29, P131	17	9	16	0	2	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	NOV	2005	33	11					1073	1080					8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	991MV	WOS:000233819000004	16277220				2022-02-06	
J	Emir, M; Ozisik, K; Cagli, K; Ozisik, P; Tuncer, S; Bakuy, V; Yildirim, E; Kilinc, K; Gol, K				Emir, M; Ozisik, K; Cagli, K; Ozisik, P; Tuncer, S; Bakuy, V; Yildirim, E; Kilinc, K; Gol, K			Beneficial effect of methylprednisolone on cardiac myocytes in a rat model of severe brain injury	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						methylprednisolone; bcl-2; apoptosis; TBARs; myocytes; head injuries	PROGRAMMED CELL-DEATH; HEART; TIME; PCR; PRETREATMENT; PROTECTS	Cardiac injury, occurred after traumatic brain injury (TBI), has been recognized for more than a century. Bcl-2 is a key regulatory component of the mitochondrial cell death pathway, and its overexpression is cytoprotective in many cell types. The therapeutic agents, which induce the expression of bcl-2 protein, might provide a new therapy to prevent cardiac myocyte damage following TBI. In this study, we investigated whether methylprednisolone I sodium succinate (MPSS) influences the expression of bcl-2 in the heart. Wistar-Albino female rats underwent TBI (300 g/cm) generated by the weight-drop method, and were left untreated (n = 6) or treated with either MPSS (30 mg/kg) (n = 6) or vehicle (albumin solution) (n = 6). The heart was isolated from each animal with TBI. For comparison, the hearts were isolated from sham-operated (n = 6) and control rats (n = 6). The relative expression of bcl-2 mRNA in the heart was quantitated by real-time polymerase chain reaction. We also assessed lipid peroxidation in the heart tissue by determining the concentration of thiobarbituric acid-reactive substances (TBARs) as an indicator of tissue damage. The bcl-2 expression level was significantly higher in the hearts of MPSS-treated rats compared to that of other TBI groups (p < 0.0001). Moreover, TBI increased the lipid peroxidation in the heart, which was significantly reduced by the treatment with MPSS (p < 0.0001). These findings provide evidence for the efficacy of MPSS in protection of cardiac myocytes to achieve optimal heart donation after TBI in heart transplantation. (c) 2005 Tohoku University Medical Press.	TYIH, Dept Cardiovasc Surg, Ankara, Turkey; Numune Educ & Res Hosp, Dept Cardiovasc Surg, Ankara, Turkey; Hacettepe Univ, Fac Med, Inst Neurol Sci & Psychiat, Ankara, Turkey; Hacettepe Univ, Fac Med, Dept Biochem, Ankara, Turkey; Metis Biotechnol Ltd, Ankara, Turkey		Ozisik, K (corresponding author), 23 Cad Kirkkonaklar Mah,Simkent Sitesi 2,Blok 6-1, TR-06610 Ankara, Turkey.	sozisik2002@yahoo.com	TUNCER, Serdar/AAG-4780-2021	TUNCER, Serdar/0000-0002-5776-2212; OZISIK, PINAR/0000-0001-5183-8100			Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; DEPASQUA.NP, 1969, AM HEART J, V77, P719, DOI 10.1016/0002-8703(69)90405-0; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; EVANS JP, 1951, AMA ARCH SURG, V63, P107, DOI 10.1001/archsurg.1951.01250040110016; Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hisatomi K, 1995, JPN CIRC J, V59, P815, DOI 10.1253/jcj.59.815; Kalinina O, 1997, NUCLEIC ACIDS RES, V25, P1999, DOI 10.1093/nar/25.10.1999; Kirshenbaum LA, 1997, CIRCULATION, V96, P1580, DOI 10.1161/01.CIR.96.5.1580; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Park CO, 1998, YONSEI MED J, V39, P395, DOI 10.3349/ymj.1998.39.5.395; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; TEOH KHT, 1995, CIRCULATION, V92, P347, DOI 10.1161/01.CIR.92.9.347; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Valen G, 2000, FREE RADICAL RES, V33, P31, DOI 10.1080/10715760000300591; Valen G, 2000, AM J PHYSIOL-HEART C, V279, pH836, DOI 10.1152/ajpheart.2000.279.2.H836; Yamada Y, 2002, NEUROSCIENCE, V114, P165, DOI 10.1016/S0306-4522(02)00210-5; Yamanoi T, 2004, TOHOKU J EXP MED, V203, P133, DOI 10.1620/tjem.203.133; YIN XM, 1994, COLD SPRING HARB SYM, V59, P387, DOI 10.1101/SQB.1994.059.01.043	23	9	9	0	3	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	OCT	2005	207	2					119	124		10.1620/tjem.207.119			6	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	961KH	WOS:000231660600004	16141680	Bronze, Green Published			2022-02-06	
J	Kervick, RB; Kaemingk, KL				Kervick, RB; Kaemingk, KL			Cognitive appraisal accuracy moderates the relationship between injury severity and psychosocial outcomes in traumatic brain injury	BRAIN INJURY			English	Article						brain injury; cognitive; appraisal accuracy; psychosocial outcome	CLOSED-HEAD-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; SELF-AWARENESS; RATING-SCALE; RECOVERY; AMNESIA; ADULTS; REHABILITATION; PERFORMANCE; PREDICTORS	Objective: Traumatic brain injury (TBI) frequently results in significant changes in physical, cognitive and emotional status. Outcomes after TBI may be related to accurate appraisal of these changes. This study examined the relationship between cognitive appraisal accuracy and psychosocial outcomes in TBI survivors. Methods: Participants were male and female TBI survivors (n = 103) who were at least 6 months post-injury and a family member of each survivor. Appraisal accuracy was assessed using self- and observer-report measures of perceived cognitive difficulties. Family members also completed a measure of psychosocial function. Hierarchical regression techniques were used to determine whether cognitive appraisal accuracy accounted for a significant proportion of variance in psychosocial outcomes. Results: Study findings indicated cognitive appraisal accuracy moderated the relationship between injury severity and aspects of psychosocial function. Conclusions: The results suggest that brain injury outcomes may be improved when an individual is able to accurately assess limitations.	Univ Arizona, Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85724 USA		Kervick, RB (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Pediat, 1501 N Campbell Ave,Room 3402, Tucson, AZ 85724 USA.	kervick@email.arizona.edu					Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hair JF, 1995, MULTIVARIATE DATA AN; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Herbert CM, 1989, CLIN REHABIL, V3, P125; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODONNEL WE, 1999, NEUROSPSYCHOLOGICAL; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1987, NEUROBEHAVIORAL RECO; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SCHAPIRO RJ, 1993, MINOR HEAD TRAUMA AS, P86; SEIDENBERG M, 1994, ARCH CLIN NEUROPSYCH, V9, P353, DOI 10.1016/0887-6177(94)90023-X; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SISLER G, 1975, CAN PSYCHIAT ASSOC J, V20, P333, DOI 10.1177/070674377502000502; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Wan C.K., 1990, INTERACTION EFFECTS; West S. G., 1991, MULTIPLE REGRESSION; [No title captured]	47	9	9	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2005	19	11					881	889		10.1080/02699050400025273			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983YY	WOS:000233269500002	16243746				2022-02-06	
J	Crossley, M; Shiel, A; Wilson, B; Coleman, MR; Gelling, L; Fryer, T; Boniface, S; Pickard, J				Crossley, M; Shiel, A; Wilson, B; Coleman, MR; Gelling, L; Fryer, T; Boniface, S; Pickard, J			Monitoring emergence from coma following severe brain injury in an octogenarian using behavioural indicators, electrophysiological measures and metabolic studies: A demonstration of the potential for good recovery in older adults	BRAIN INJURY			English	Article						severe brain injury; coma recovery; interdisciplinary assessment; older adults; case study	GLASGOW OUTCOME SCALE; WESSEX HEAD-INJURY; MATRIX; SF-36; AGE	This case study describes a multi-disciplinary investigation of the emergence from coma of an 80-year old female (KE) following severe traumatic brain injury. The relationship between cognitive/behavioural ability and the integrity of cerebral function was assessed using neuropsychological measures, positron emission tomography, electroencephalography, somatosensory evoked potentials and trans-cranial magnetic stimulation. These investigations were performed as KE was beginning to emerge from coma (4 weeks) and, again, similar to 1 year following brain injury, when she was judged to have achieved her maximum level of recovery. Neuropsychological measures revealed improvement during the first year post-injury in KE's speed of information processing, memory and executive abilities. Electrophysiological and metabolic studies indicated a restoration of functional integrity that was consistent with the gradual recovery in higher brain function documented using behavioural procedures. This case study demonstrates the rehabilitation potential of pre-morbidly healthy older adults following severe traumatic brain injury.	Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 5A5, Canada; Natl Univ Ireland, Galway, Ireland; Addenbrookes Hosp, Cambridge, England; Anglia Polytech Univ, Cambridge, England		Crossley, M (corresponding author), Univ Saskatchewan, Dept Psychol, 9 Campus Dr, Saskatoon, SK S7N 5A5, Canada.	crossley@sask.usask.ca	Shiel, Agnes/AAA-4211-2019		MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390] Funding Source: Medline		Baddeley A., 1992, SPEED CAPACITY LANGU; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; EGELERPEERDEMAN SM, 1996, NEUROSURGERY, V103, P501; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GARRATT AM, 1993, BRIT MED J, V306, P1440, DOI 10.1136/bmj.306.6890.1440; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Goldstein FC., 1998, RECOVERY, V9, P28; Hamsher K., 1989, MULTILINGUAL APHASIA; Hodges J. R., 1994, COGNITIVE ASSESSMENT; HORN S, 1991, J CLIN EXP NEUROPSYC, V13, P19; JENNETT B, 1975, LANCET, V1, P480; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Majerus S, 2000, NEUROPSYCHOL REHABIL, V10, P167, DOI 10.1080/096020100389237; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Raz N, 2000, HDB AGING COGNITION, P1; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Reitan RM, 1992, TRAIL MAKING TEST MA; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SCHEIBEL AB, 1996, HDB PSYCHOL AGING; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Trennery M. R., 1989, STROOP NEUROPSYCHOLO; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson BA, 1999, RIVERMEAD BEHAV MEMO; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; WU HM, 2001, J CEREB BLOOD FLOW S, V21, pS180; [No title captured]	38	9	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2005	19	9					729	737		10.1080/02699050400013733			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	945EH	WOS:000230484600011	16195187				2022-02-06	
J	Pelak, VS; Hoyt, WF				Pelak, VS; Hoyt, WF			Symptoms of akinetopsia associated with traumatic brain injury and Alzheimer's disease	NEURO-OPHTHALMOLOGY			English	Article						akinetopsia; Alzheimer's; motion; traumatic brain injury; visual cortex	POSTERIOR CEREBRAL-LESIONS; VISUAL-MOTION PERCEPTION; BALINTS SYNDROME; DAMAGE; HUMANS; PROSOPAGNOSIA; IMPAIRMENT; BLINDNESS; MOVEMENT; PATIENT	Objective: To describe two patients with symptoms of cerebral akinetopsia (or loss of motion vision) associated with traumatic brain injury (TBI) and Alzheimer's disease. Background: Symptomatic cerebral akinetopsia is defined as the conscious loss of visual motion perception due to extrastriate cortical lesions. There are only two previous clinical reports of symptomatic cerebral akinetopsia. Methods: Clinical evaluations and magnetic resonance imaging (MRI) were conducted on two patients who presented for neuro-ophthalmic consultation with complaints of loss of motion vision in the setting TBI and Alzheimer's disease. Results: Both patients reported an inability to perceive visual motion, with otherwise normal afferent visual function. Each had evidence for bilateral posterior cortical injury, with sparing of the striate cortex. Conclusions: These cases provide additional clinical evidence that damage to bilateral, extrastriate visual cortex can produce symptoms of motion blindness, and they provide the first descriptions of symptoms of cerebral akinetopsia associated with TBI and Alzheimer's disease. Furthermore, they demonstrate that bilateral dysfunction may be necessary for symptoms of motion blindness.	Univ Colorado, Hlth Sci Ctr, Dept Neurol, Rocky Mt Lions Eye Inst, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Ophthalmol, Rocky Mt Lions Eye Inst, Aurora, CO 80045 USA; Vet Affairs Med Ctr, Denver, CO USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA		Pelak, VS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, Rocky Mt Lions Eye Inst, POB 6510,Box F727, Aurora, CO 80045 USA.	Victoria.pelak@uchsc.edu	Pelak, Victoria Susan/J-4275-2019	Pelak, Victoria Susan/0000-0003-3147-8595			BARTON JJS, 1995, ANN NEUROL, V37, P665, DOI 10.1002/ana.410370517; Blanke O, 2003, Cogn Neuropsychiatry, V8, P211; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; Campbell R, 1997, BRAIN, V120, P1793, DOI 10.1093/brain/120.10.1793; Goldstein K, 1918, Z GESAMTE NEUROL PSY, V41, P1, DOI 10.1007/BF02874477; HOF PR, 1989, BRAIN RES, V493, P368, DOI 10.1016/0006-8993(89)91173-6; LANDIS T, 1986, CORTEX, V22, P243, DOI 10.1016/S0010-9452(86)80048-X; MENDEZ MF, 1990, INT J NEUROSCI, V54, P339, DOI 10.3109/00207459008986653; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; MORRISON JH, 1991, ANN NY ACAD SCI, V640, P36; PLANT GT, 1993, BRAIN, V116, P1303, DOI 10.1093/brain/116.6.1303; Potzl O., 1911, WIEN KLIN WOCHENSCHR, V24, P517; RIZZO M, 1995, BRAIN, V118, P1105, DOI 10.1093/brain/118.5.1105; Rizzo M, 1998, BRAIN, V121, P2259, DOI 10.1093/brain/121.12.2259; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1289, DOI 10.1016/S0028-3932(97)00004-3; TOHGI H, 1994, J NEUROL, V241, P470, DOI 10.1007/BF00919707; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Vaina LM, 2001, BRAIN, V124, P310, DOI 10.1093/brain/124.2.310; VAINA LM, 1989, BIOL CYBERN, V61, P347, DOI 10.1007/BF00200800; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721; ZEKI S, 1991, BRAIN, V114, P811, DOI 10.1093/brain/114.2.811; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	25	9	9	0	32	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	0165-8107			NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.	AUG	2005	29	4					137	142		10.1080/01658100500218046			6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	966PM	WOS:000232033100001					2022-02-06	
J	Langeluddecke, PM; Lucas, SK				Langeluddecke, PM; Lucas, SK			WMS-III findings in litigants following moderate to extremely severe brain trauma	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							WECHSLER MEMORY SCALE; CONFIRMATORY FACTOR-ANALYSIS; ADULT INTELLIGENCE SCALE; CLOSED-HEAD-INJURY; WAIS-III; CLINICAL UTILITY; CROSS-VALIDATION; 3RD EDITION; PERFORMANCE; DYSFUNCTION	Published information pertaining to the clinical utility of the WMS-III in assessing memory impairment in traumatic brain injury (TBI) remains inadequate. WMS-III findings are reported for 180 litigants with post-acute moderate to extremely severe TBI, classified into three groups according to injury severity, and a healthy control group. A significant "dose-response" relationship was found between memory impairment and TBI severity for most of the WMS-III indexes and subtests. Effect sizes were large for the Immediate and General Memory Indexes and medium for the Working Memory Index. In general, TBI had a greater effect on the Visual than Auditory Indexes. Effect sizes were greatest for Family Pictures and least for the auditory recognition and working memory tasks. Group findings indicate the immediate memory tasks to be clinically useful in relation to a severe or extremely severe TBI, but not for less severe trauma. Delayed memory tasks do not provide information additional to that obtained from immediate memory measures. The revised Tulsky indexes are no more sensitive to the effects of TBI than the original ones. Differences between WMS-III memory indexes are unlikely to be of diagnostic utility although memory-intelligence discrepancies may be.	Westmead Hosp, Dept Med Psychol, Westmead, NSW 2145, Australia		Langeluddecke, PM (corresponding author), Suite 1003,37 Bligh St, Sydney, NSW 2000, Australia.	Langeluddecke@bigpond.com					Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; Cohen J., 1988, STAT POWER ANAL BEHV, V2nd ed; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; FOX DD, 1994, ARCH CLIN NEUROPSYCH, V9, P211, DOI 10.1016/0887-6177(94)90026-4; Haaland KY, 2003, J INT NEUROPSYCH SOC, V9, P89, DOI 10.1017/S1355617703910101; Hallett JG, 2001, NORTHWEST SCI, V75, P378; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton R.K., 2003, CLIN INTERPRETATION; Iverson G, 1999, J COGNITIVE REHABILI, V17, P16; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langeluddecke PM, 2004, CLIN NEUROPSYCHOL, V18, P423, DOI 10.1080/1385404049052422; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; LANGELUDDECKE PM, 2004, J FORENSIC NEUROPSYC, V4, P49; Larrabee GJ, 1990, NEUROPSYCHOLOGY, V4, P239, DOI 10.1037/0894-4105.4.4.239; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Price LR, 2002, J CLIN EXP NEUROPSYC, V24, P574, DOI 10.1076/jcen.24.5.574.1013; Psychological Corporation, 2001, MAN WECHSL TEST AD R; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; Rey A., 1964, EXAMEN CLIN PSYCHOL; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; *SPSS INC, 2001, STAT PACK SOC SCI; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tremont G, 1997, ARCH CLIN NEUROPSYCH, V12, P757, DOI 10.1016/S0887-6177(97)00049-8; Tulsky DS, 2003, PSYCHOL ASSESSMENT, V15, P149, DOI 10.1037/1040-3590.15.2.149; TULSKY DS, 2003, CLIN INTERPRETATION; Uttl B, 2002, ARCH CLIN NEUROPSYCH, V17, P567, DOI 10.1016/S0887-6177(01)00135-4; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde N, 2002, CLIN NEUROPSYCHOL, V16, P322, DOI 10.1076/clin.16.3.322.13858; Wilde N, 2001, J INT NEUROPSYCH SOC, V7, P881, DOI 10.1017/S1355617701777120; Wilhelm K L, 1995, Appl Neuropsychol, V2, P42, DOI 10.1207/s15324826an0201_8; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; [No title captured]	48	9	9	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2005	27	5					576	590		10.1080/13803390490918372			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	936WB	WOS:000229885000005	16019634				2022-02-06	
J	Nestvold, K; Lundar, T; Mowinckel, R; Stavem, K				Nestvold, K; Lundar, T; Mowinckel, R; Stavem, K			Predictors of headache 22 years after hospitalization for head injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						head injury; long-term headache; prospective cohort study	POPULATION; CONCUSSION; NORWAY; PREVALENCE; SEVERITY; SYMPTOMS; ADULTS; HUNT	Objectives - To assess predictors of headache in patients who had sustained a head injury 22 years earlier. Materials and methods - A questionnaire about headache was sent to 361 subjects hospitalized for head injury in 1974-1975. Results - A total of 249 patients (69%) responded to the questionnaire. The prevalence of headache > 14 days a month last year was 11%. In multivariate logistic regression analysis female sex (OR = 3.4. 95% CI 1.2-9.6), severe headache 3 months after the head injury (OR = 10.6, 95% CI 2.6-43.5) and psychiatric disease (OR = 2.9. 95 % CI 1.1-7.7) predicted chronic headache. There was no significant association between chronic headache and post-traumatic aninesia or other trauma-related variables. Conclusion Female sex and headache 3 months after the head injury were the strongest predictors of long-term headache, while there was little association between long-term headache and trauma variables.	Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway; Norwegian Hlth Serv Res Ctr, Lorenskog, Norway; Univ Hosp, Rikshosp, Dept Neurosurg, Oslo, Norway; Akershus Univ Hosp, Dept Med, Lorenskog, Norway		Nestvold, K (corresponding author), Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway.	knut.nestvold@ahus.no					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Cartlidge NEF, 1981, HEAD INJURY, P95; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Edna T H, 1987, J Oslo City Hosp, V37, P41; Hagen K, 2002, CEPHALALGIA, V22, P672, DOI 10.1046/j.1468-2982.2002.00413.x; Hagen K, 2000, CEPHALALGIA, V20, P244, DOI 10.1046/j.1468-2982.2000.00049.x; Hagen K, 2000, CEPHALALGIA, V20, P900, DOI 10.1046/j.1468-2982.2000.00145.x; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; NIKIFOROW R, 1981, CEPHALALGIA, V1, P99, DOI 10.1111/j.1468-2982.1981.tb00016.x; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Puca F, 1999, CEPHALALGIA, V19, P159, DOI 10.1046/j.1468-2982.1999.1903159.x; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Solomon S, 2001, MED CLIN N AM, V85, P987, DOI 10.1016/S0025-7125(05)70355-2; SYMONDS CP, 1945, BRIT MED BULL, V3, P14, DOI 10.1093/oxfordjournals.bmb.a071858; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2001, HEAD TRAUMA, P327; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WILSON JTL, 1993, J NEUROL NEUROSUR PS, V56, P198; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	27	9	9	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	JUL	2005	112	1					13	18		10.1111/j.1600-0404.2005.00344.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937OD	WOS:000229934500003	15932350				2022-02-06	
J	McAuliffe, MJ; Ward, EC; Murdoch, BE				McAuliffe, MJ; Ward, EC; Murdoch, BE			Articulatory function in hypokinetic dysarthria: An electropalatographic examination of two cases	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; KINEMATIC ANALYSIS; ELECTROMAGNETIC ARTICULOGRAPHY; SPEECH CHARACTERISTICS; TONGUE; MOVEMENTS; DISORDERS; REDUCTION; STRENGTH	The present study employed electropalatography (EPG) and a nonspeech measure of lingual function to examine, in detail, the articulatory production deficits of two individuals with Parkinson disease (PD) and hypokinetic dysarthria. Participants read 10 repetitions of CV words contained within the carrier phrase "I saw a _ today" while wearing an EPG artificial palate. Target consonants included the alveolar stop /t/, lateral approximant /l/, and the alveolar fricative /s/ in the /a/ vowel environment. The results of the two participants were compared to an age-matched control group. Examination of the perceptual features of articulatory production, lingual strength, fine force control and endurance, tongue-palate contact patterns, and segment durations were conducted. Results of the study revealed quite different articulatory deficits in the two participants. Specifically, the articulation of Participant One (P1) was characterized by a fast rate of speech, undershooting of articulatory targets, and reduced duration of consonant closures. In contrast, Participant Two (P2) demonstrated tongue-palate contact patterns indicative of impaired lingual control in the presence of both normal and increased articulatory segment durations. Potential reasons for the differing articulatory deficits were hypothesized. The current study demonstrated that assessment with EPG identified potential causes of consonant imprecision in two individuals with hypokinetic dysarthria. Directions for speech pathology intervention, salient from the results of the study, were also noted.	Univ Queensland, Motor Speech Res Ctr, Brisbane, Qld, Australia		McAuliffe, MJ (corresponding author), Univ Canterbury, Dept Commun Disorders, Private Bag 4800, Christchurch 8020, New Zealand.	megan.mcauliffe@canterbury.ac.nz	Murdoch, Bruce E/C-1397-2012; Ward, Elizabeth/F-9652-2010	Ward, Elizabeth/0000-0002-2680-8978; McAuliffe, Megan/0000-0003-3827-2215			ACKERMANN H, 1993, FOLIA PHONIATR, V45, P84, DOI 10.1159/000266222; Ackermann H, 1997, MOVEMENT DISORD, V12, P1019, DOI 10.1002/mds.870120628; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Adams S. G., 1994, MOTOR SPEECH DISORDE, P213; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217, DOI 10.1044/jshd.3003.217; CANTER GJ, 1963, J SPEECH HEAR DISORD, V28, P221, DOI 10.1044/jshd.2803.221; Chenery H. J., 1988, AUSTR J HUMAN COMMUN, V16, P17, DOI [10.3109/asl2.1988.16.issue-2.02., DOI 10.3109/ASL2.1988.16.ISSUE-2.02]; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Duffy JR., 2020, MOTOR SPEECH DISORDE; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; Gibbon F, 2000, J MED SPEECH-LANG PA, V8, P239; Gibbon Fiona., 1999, COARTICULATION DATA, P229; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Hammen VL, 1996, J COMMUN DISORD, V29, P429, DOI 10.1016/0021-9924(95)00037-2; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; JONES W, 1995, EUR J DISORDER COMM, V30, P183; Kendall D. L., 1999, ADV SPEECH LANGUAGE, V1, P107; Kent RD, 2000, FOLIA PHONIATR LOGO, V52, P48, DOI 10.1159/000021512; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LOGEMANN JA, 1981, J SPEECH HEAR DISORD, V46, P348, DOI 10.1044/jshd.4604.348; LOUCKS TMJ, 2001, J SPEECH LANGUAGE PA, V25, P152; Ludlow C., 1984, DYSARTHRIAS PHYSL AC, P163; McAuliffe M J, 2001, Logoped Phoniatr Vocol, V26, P165, DOI 10.1080/14015430152928357; MCAULIFFE MJ, IN PRESS CLIN LINGUI; MCAULIFFE MJ, 2004, THESIS U QUEENSLAND; MCAULIFFE MJ, IN PRESS J GERONTOLO; MELCON MC, 1989, J SPEECH HEAR DISORD, V54, P282, DOI 10.1044/jshd.5402.282; SCOTT D, 2002, EPGLAB MANUAL; Solomon NP, 2000, AM J SPEECH-LANG PAT, V9, P241, DOI 10.1044/1058-0360.0903.241; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; SOLOMON NP, 1994, MOTOR SPEECH DISORDE; Solomon NP, 1995, J MED SPEECH-LANG PA, V3, P13; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	40	9	10	0	2	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	JUN	2005	13	2					149	168					20	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	934LC	WOS:000229709300009					2022-02-06	
J	Wallesch, CW; Marx, P; Tegenthoff, M; Unterberg, A; Schmidt, R; Fries, W				Wallesch, CW; Marx, P; Tegenthoff, M; Unterberg, A; Schmidt, R; Fries, W			Guideline,,medicolegal evaluation after closed head injury" of the German neurological society (DGN) and the working group on neurological medicolegal evaluation (ANB)	AKTUELLE NEUROLOGIE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; COMPUTED-TOMOGRAPHY; FOCAL LESIONS; COMA; RECOVERY; TESTS	Knowledge of the DGN/ANB guideline,General principles of medicolegal evaluation in neurology" is a prerequisite for the application of this guideline. Clinical findings that traditionally substantiated the diagnosis of structural brain damage remain valid. However, their lack does not exclude causality. The medicolegal expert must ascertain availability of all clinical documentations of the acute phase. The guideline commission considers a brain MRI necessary in all cases, in which the available imaging data do not positively indicate brain damage. The MRI assessment should include T2* weighted images. Months and years after brain injury, deficits of memory, attention and executive functions are the most prominent neuropsychological impairments. These have to be specifically addressed. If such deficits are described or assumed, a professional neuropsychological assessment is mandatory. Brief neurobehavioural tests or scores are not considered valid for neuropsychological assessment in the medicolegal context. Case history data from a third person support the evaluation of every day disability and handicap. Massive brain injury results in damage to midbrain and brainstem structures which correlates with psychomotor slowing, spasticity, ataxia, and hypokinesia. Headache is probably a rare consequence of brain injury. If there are a relevant trauma, other disabling symptoms and plausible complaints we pragmatically recommend to accept them as a tension headache caused by handicap-induced strain and stress intolerance. Following structural brain injury, depression and anxiety disorders are frequent. Post traumatic stress disorder may occur even with amnesia for the accident. We strongly recommend a qualified neurological and behavioural assessment including an EEG within a fortnight after injury in all patients who had suffered from head injury.	Univ Magdeburg, Neurol Klin, D-39106 Magdeburg, Germany; Univ Klinikum Berlin, Berlin, Germany; Univ Bergmannsheil, Neurol Klin, Bochum, Germany; Heidelberg Univ, Neurochirurg Klin, D-6900 Heidelberg, Germany; Kliniken Schmieder, Constance, Germany; Praxis Neuropsychol Rehabil, Munich, Germany		Wallesch, CW (corresponding author), Univ Klinikum Magdeburg, Neurol Klin, Leipziger Str 44, D-39120 Magdeburg, Germany.	wallesch@medizin.uni-magdeburg.de					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P457, DOI 10.1007/s11940-002-0013-5; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1994, HEAD INJURY, P137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Helmchen H, 2001, NERVENARZT, V72, P181, DOI 10.1007/s001150050737; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KAPFHAMMER HP, 2001, FORTSCHE NEUROL PSYC, V69, P1315; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KRASNEY OE, 2000, HDB NEUROLOGISCHEN B; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mellman TA, 2001, DEPRESS ANXIETY, V14, P226, DOI 10.1002/da.1071; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Rauschelbach HH, 1977, MED SACHVERST, V73, P86; RAUSCHELBACH HH, 2000, NEUROLOGISCHE GUTACH; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Teasdale TW, 1997, NEUROPSYCHOL REHABIL, V7, P23, DOI 10.1080/713755521; Toschlog EA, 2003, AM SURGEON, V69, P491; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730	41	9	9	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0302-4350	1438-9428		AKTUEL NEUROL	Aktuelle Neurol.	JUN	2005	32	5					279	287		10.1055/s-2004-834574			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	941NQ	WOS:000230221900008					2022-02-06	
J	Landon, P; Breysse, P; Chen, YJ				Landon, P; Breysse, P; Chen, YJ			Noise exposures of rail workers at a North American chemical facility	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						noise; hearing conservation; personal noise exposure; noise exposure standards; hearing loss; noise-induced hearing loss		Background Both continuous and impact noise exposures of rail yards and railways have been historically understudied. We summarize noise exposures to rail workers at a large chemical facility in North America. Methods Rail workers were surveyed over the course of three 12-hr shifts. Personal noise dosimeters were used to derive a 12-hr time-weighted average (L-AVG), an 8-hr time weighted average (L-TWA), and a percent dose. Peak and maximum sound levels were also recorded during each sampling period. Six workers were sampled on three separate days for a total of 18 full-shift noise samples. Results Full-shift noise exposures were all below the Occupational Safety and Health Administration's (OSHA) permissible exposure limit (PEL) and action level for a 12-hr workday. Peak impact sound levels exceeded 140 dB in 17 of 18 samples (94%) with a mean peak sound level of 143.9 dB. Maximum continuous sound levels were greater than 115 dBA in 4 of 18 samples (22%) with a mean maximum sound level of 113.1 dBA. The source of peak impact sound levels was a daily exposure to a concussion caused by a sudden break in a freight airline. Conclusions Rail workers at this facility are at risk of noise induced hearing loss from high impact noise exposures. Peak impact and maximum continuous sound levels can be attenuated through the use of hearing protection or by increasing distances from railroad noise sources. Am. J. Ind. Med. 47:364-369, 2005. (c) 2005 Wiley-Liss, Inc.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth, Div Environm Hlth Engn, Baltimore, MD 21205 USA; DuPont Co Inc, Wilmington, DE USA		Breysse, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth, Div Environm Hlth Engn, 615 N Wolfe St, Baltimore, MD 21205 USA.	pbreysse@jhsph.edu					AURELIUS JP, 1971, FRARP712A US DEP TRA; CLARK WW, 1989, LARYNGOSCOPE, V99, P1151; JANKOVICH JP, 1972, FRAOPP731 US DEP TRA; KILMER RD, 1980, FRAORD8091 NAT BUR S; KRYTER KD, 1991, J ACOUST SOC AM, V90, P3180, DOI 10.1121/1.401427; National Institute for Occupational Safety and Health (NIOSH), 1998, OCC NOIS EXP REV CRI; PRICE GR, 1989, J ACOUST SOC AM, V86, P2185, DOI 10.1121/1.398479; PROSSER S, 1988, British Journal of Audiology, V22, P85, DOI 10.3109/03005368809077802; Roberto M, 1995, Acta Otorhinolaryngol Ital, V15, P61; SECHAGIRI B, 2003, AIHA J-J SCI OCCUP E, V64, P699; Starck J, 2003, Noise Health, V5, P63; SWING JW, 1973, WCR735 WYL LAB; URMAN S, 1978, PORF SAF, P47	13	9	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	APR	2005	47	4					364	369		10.1002/ajim.20152			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	911WL	WOS:000228037100009	15776466				2022-02-06	
J	Caputo, P; Mattson, DJ				Caputo, P; Mattson, DJ			Recreational ice hockey injuries in adult nonchecking leagues: A United States perspective	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						ice hockey; recreational; adult; old-timer; United States	NECK INJURIES; PLAYERS; HEAD; JUNIOR	The purpose of this study was to analyze injuries among adult recreational ice hockey players. This was an observational prospective cohort study with data collected on injuries sustained during one season in the adult recreational ice hockey leagues of Oneida County, NY. The injury incidence rate was found to be 12.2/1000 player-exposures. The most common anatomic region injured was the head/neck/face (35%). Collisions were most often reported as the mechanism of injury (44%). Fracture was the most common diagnosis. Of players wearing face protection ( full cage or shield, or partial visor/half shield), none suffered facial injuries, while all facial injuries reported were to players not wearing facial protection. The concussion rate was 1.1/1000 player-exposures. A lack of protective equipment was associated with 38% of injuries and 24% of injuries involved penalties. A history of prior injuries was found in 89% of injured players with 28% re-injuring the same body part. This study's findings suggested various strategies to address player injuries such as mandatory full facial protection and shoulder pads, strict enforcement of game rules, and game rule modifications ( no body checking). Further research is needed on the role of preventive rehabilitation in players with previous injury history.	St Elisabeth Med Ctr, Ctr Trauma, Utica, NY USA; Utica Coll, Dept Phys Therapy, Utica, NY USA		Caputo, P (corresponding author), Okeechobee Cty Hlth Dept, POB 1879, Okeechobee, FL 34973 USA.	linocaputo@hotmail.com; dj.mattson@att.net					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; CASTALDI C R, 1991, Dental Clinics of North America, V35, P647; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; Deady B, 1996, J Emerg Med, V14, P645, DOI 10.1016/S0736-4679(96)00134-5; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; LORENTZON R, 1988, AM J SPORT MED, V16, P389, DOI 10.1177/036354658801600414; MARCOTTE G, 1993, SAFETY ICE HOCKEY, V2, P100; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; PASHBY T, 1985, CAN J OPHTHALMOL, V20, P2; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Rampton J, 1997, CLIN J SPORT MED, V7, P162, DOI 10.1097/00042752-199707000-00002; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Smith AM, 1997, AM J SPORT MED, V25, P500, DOI 10.1177/036354659702500413; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Voaklander DC, 1996, CLIN J SPORT MED, V6, P15, DOI 10.1097/00042752-199601000-00005; Voaklander DC, 1996, CAN J PUBLIC HEALTH, V87, P381; VOAKLANDER DC, 1994, CLIN J SPORT MED, V4, P25	19	9	9	1	2	JOURNAL  SPORTS SCIENCE AND MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	MAR	2005	4	1					58	65					8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	915ST	WOS:000228327400008	24431962				2022-02-06	
J	Orendacova, J; Ondrejcak, T; Kucharova, K; Cizkova, D; Jergova, S; Mitruskova, B; Racekova, E; Vanicky, I; Marsala, J				Orendacova, J; Ondrejcak, T; Kucharova, K; Cizkova, D; Jergova, S; Mitruskova, B; Racekova, E; Vanicky, I; Marsala, J			Fluoro-Jade B evidence of induced ischemic tolerance in the rat spinal cord ischemia: Physiological, neurological and histopathological consequences	GENERAL PHYSIOLOGY AND BIOPHYSICS			English	Article						degeneration; improvement; locomotion; Fluoro-Jade B; quantitative analyses	TRAUMATIC BRAIN-INJURY; AORTIC OCCLUSION; PRECONDITIONING PROTECTS; NEURONAL DEGENERATION; BLOOD-FLOW; MODEL; RABBIT; DAMAGE; NEURODEGENERATION; NEUROPATHOLOGY	Fluoro-Jade B, a marker of degenerating neurons, was used to label histopathological changes in the rat spinal cord after transient ischemia and ischemic preconditioning (IPC). To characterize postischemic neurodegenerations and consequent neurological changes, a particular attention was paid to the standardization of ischemic conditions in animals of both groups. 1. The control ischemic rats were submitted to a reversible occlusion of descending aorta by insertion and subsequent inflation of a 2F Fogarty catheter for 12 min. 2. In the IPC rats, an episode of short 3 min occlusion and 30 min reperfusion preceded the 12 min ischemia. Postischemic motor function testing (ambulation and stepping) was provided repeatedly for evaluation of neurological status 2 h and 24 h after surgery and at the end of postischemic survival, i.e. after 48 h. Fluoro-Jade B staining was used to demonstrate degenerated neurons. In the control rats, neurological consequences of histopathological changes in lumbosacral spinal cord, manifested as paraplegia, were present after 12 min ischemia. Thus, numbers of degenerated Fluoro-Jade B positive cells were visible in gray matter of the most injured L-4-S-2 spinal cord segments. Slight motor function impairment, consequential from significant decreasing in Fluoro-Jade B-positivity in the L-4-S-2 spinal cord segments of the IPC rats, was considered the pathomorpfological evidence that IPC induces spinal cord tolerance to ischemia. Our results are consistent with the previously published silver impregnation method for histopathological demonstration of ischemic degeneration.	Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Kosice 04001, Slovakia		Orendacova, J (corresponding author), Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Soltesovej 4, Kosice 04001, Slovakia.	orendac@saske.sk	Vanicky, Ivo/ABB-2298-2021; Racekova, Eniko/AAD-6356-2019; Cizkova, Dasa/AAF-8976-2019	Jergova, Stanislava/0000-0002-9096-7770; cizkova, dasa/0000-0002-2504-3993			Abraham VS, 2000, ANN THORAC SURG, V69, P475, DOI 10.1016/S0003-4975(99)01301-6; Anderson KJ, 2003, J NEUROTRAUM, V20, P1223, DOI 10.1089/089771503770802899; Ballok DA, 2003, BRAIN RES, V964, P200, DOI 10.1016/S0006-8993(02)03980-X; Burdon RD, 2003, SILVAE GENET, V52, P1; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; Cizkova D, 2004, EXP NEUROL, V185, P97, DOI 10.1016/j.expneurol.2003.09.020; Corbett D, 1997, BRAIN RES, V760, P129, DOI 10.1016/S0006-8993(97)00294-1; DANIELISOVA V, 2003, PHYSIOL RES, V52, pP3; DEGIROLAMI U, 1982, J NEUROPATH EXP NEUR, V41, P129, DOI 10.1097/00005072-198203000-00004; Farkas T, 2003, NEUROSCI LETT, V342, P49, DOI 10.1016/S0304-3940(03)00230-1; JOHNSON SH, 1993, STROKE, V24, P1547, DOI 10.1161/01.STR.24.10.1547; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Kucharova K, 2001, BIOLOGIA, V56, P321; Lukacova N, 1999, BIOLOGIA, V54, P29; MARSALA J, 1989, NEUROSCI LETT, V106, P83, DOI 10.1016/0304-3940(89)90206-1; Marsala J, 1997, EXP NEUROL, V145, P165, DOI 10.1006/exnr.1997.6455; MARSALA M, 1994, J CEREBR BLOOD F MET, V14, P526, DOI 10.1038/jcbfm.1994.65; MARTONCIKOVA M, 2003, PHYSIOL RES, V52, pP10; Masada T, 2001, J CEREBR BLOOD F MET, V21, P22, DOI 10.1097/00004647-200101000-00004; MITRUSKOVA B, 2005, IN PRESS CELL MOL NE; NEMETHOVA M, 2003, PHYSIOL RES, V52, pP13; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Ondrejcak T, 2004, BRAIN RES, V995, P267, DOI 10.1016/j.brainres.2003.10.009; ONDREJCAK T, 2001, UPJS KOSICE, P1; Orendacova J, 2004, CELL MOL NEUROBIOL, V24, P477, DOI 10.1023/B:CEMN.0000022775.67975.ed; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; RADONAK J, 2003, PHYSIOL RES, V52, pP16; SAGANOVA K, 1994, EXP NEUROL, V130, P337, DOI 10.1006/exnr.1994.1212; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Simpson MTW, 2001, J NEUROSCI, V21, P7089, DOI 10.1523/JNEUROSCI.21-18-07089.2001; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; VANICKY I, 1992, ANAT EMBRYOL, V186, P167, DOI 10.1007/BF00174954; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; ZIVIN JA, 1980, STROKE, V11, P200, DOI 10.1161/01.STR.11.2.200; Zvara DA, 1999, ANN THORAC SURG, V68, P874, DOI 10.1016/S0003-4975(99)00559-7	40	9	9	0	4	GENERAL PHYSIOL AND BIOPHYSICS	BRATISLAVA	INST OF MOLEC PHYSIOL GENETICS SLOVAK ACAD OF SCI VLARSKA 5, 83334 BRATISLAVA, SLOVAKIA	0231-5882			GEN PHYSIOL BIOPHYS	Gen. Physiol. Biophys.	MAR	2005	24	1					75	87					13	Biochemistry & Molecular Biology; Biophysics; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Physiology	928HF	WOS:000229261400006	15900088				2022-02-06	
J	Doane, BM; Greve, KW; Bianchini, KJ				Doane, BM; Greve, KW; Bianchini, KJ			Agreement between the abbreviated and standard Portland Digit Recognition Test	CLINICAL NEUROPSYCHOLOGIST			English	Article							MALINGERED NEUROCOGNITIVE DYSFUNCTION; SYMPTOM EXAGGERATION	This study sought to determine the classification agreement between the standard and abbreviated forms of the Portland Digit Recognition Test (PDRT), a well-established symptom validity test. PDRTs (N = 200, 100 traumatic brain injury, 100 chronic pain) were randomly selected from case manager and attorney referrals for psychological assessment. Only three cases were misclassified and agreement was as high as 99.5%. This study demonstrated that when using the abbreviated PDRT there is little risk of false negative errors.	Jefferson Neurobehav Grp, Metairie, LA USA; Univ New Orleans, New Orleans, LA 70148 USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; BINDER LM, 1993, PORTLAND DIGIT RECOG; BINDER LM, 2002, J FORENSIC NEUROPSYC, V2, P27; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gunstad J, 2001, CLIN NEUROPSYCHOL, V15, P397, DOI 10.1076/clin.15.3.397.10271; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER	15	9	9	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2005	19	1					99	104		10.1080/13854040490524100			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	912YF	WOS:000228115300007	15814481				2022-02-06	
J	Bullock, LM; Gable, RA; Mohr, JD				Bullock, Lyndal M.; Gable, Robert A.; Mohr, J. Darrell			Traumatic Brain Injury: A Challenge for Educators	PREVENTING SCHOOL FAILURE			English	Article						school personnel; services; traumatic brain injury (TBI)		In this article, the authors provide information designed to enhance the knowledge and understanding of school personnel about traumatic brain injury (TBI). The authors specifically define TBI and enumerate common characteristics associated with traumatic brain injury, discuss briefly the growth and type of services provided, and offer some thoughts on ways to help ensure quality services for these students once they reenter the school environment.	[Bullock, Lyndal M.; Mohr, J. Darrell] Univ North Texas, Dept Special Educ, Dallas, TX 75241 USA; [Gable, Robert A.] Old Dominion Univ, Dept Child Study & Special Educ, Norfolk, VA 23529 USA		Bullock, LM (corresponding author), Univ North Texas, Dept Special Educ, Dallas, TX 75241 USA.						*AG HLTH CAR POL R, 1998, REH TRAUM BRAIN INJ; BERGLAND MM, 1996, ACQUIRED BRAIN INJUR, P171; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Bullock L. M., 2004, UNPUB; BURTON LA, 1993, J REHABIL, V59, P34; COHEN SB, 1991, J HEAD TRAUMA REHAB, V6, P56; D'Amato R. C., 1997, CHILDHOOD TRAUMATIC, P213; Deaton A, 1994, ED DIMENSIONS ACQUIR, P257; Doelling J. E., 1995, INTERV SCH CLIN, V31, P1; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; Gordon W., 2004, BOSTON GLOBE; HIBBARD M, 2001, STUDENTS TRAUMATIC B; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Lash M., 1995, SIGNS STRATEGIES ED; Linder HP, 1999, T ROY SOC S AFR, V54, P1, DOI 10.1080/00359199909520399; Lord-Maes J., 1997, CHILDHOOD TRAUMATIC, P101; PERSINGER MA, 1994, PSYCHOL REP, V75, P1059, DOI 10.2466/pr0.1994.75.3.1059; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RAYMOND MJ, 1999, MILD TRAUMATIC BRAIN; Savage RC, 2005, PREV SCH FAIL, V49, P43, DOI 10.3200/PSFL.49.4.43-52; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; SHURTLEFF HA, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199510000-00008; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Tyler J. S., 1999, TRAUMATIC BRAIN INJU; *US DEP ED, 2002, 24 ANN REP C IMPL IN; WOLCOTT G, 1995, SIGNS STRATEGIES ED; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199512000-00006; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	31	9	9	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1045-988X	1940-4387		PREV SCH FAIL	Prev. Sch. Fail.		2005	49	4					6	10		10.3200/PSFL.49.4.6-10			5	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V2Y9C	WOS:000218037100002					2022-02-06	
J	Kesemenli, CC; Necmioilu, S				Kesemenli, CC; Necmioilu, S			The role of melatonin as a link between head injury and enhanced osteogenesis	MEDICAL HYPOTHESES			English	Article							PINEAL	We hypothesize that in the case of an individual with a head injury, melatonin can enhance osteogenesis. In virtually all species to date whether nocturnal or diurnal, melatonin is synthesized and secreted during the dark phase of the day. In traumatic subarachnoid hemorrhages, in the hypothalamic syndrome, the melatonin content was very high in liquor. This was determined by a fluorimetric method, especially modified for this purpose. Osteoblastic activity rises with the increase of melatonin. Heating of a fracture of Long or large bone can often be accelerated in patients with severe traumatic brain injury. However, a melatonin which could perhaps induce enhanced osteogenesis has not yet been identified. Melatonin might cause early bone heating and hypertrophic callus. (c) 2005 Elsevier Ltd. All rights reserved.	Dicle Univ, Fac Med, Dept Orthoped & Traumatol, Diyarbakir, Turkey		Kesemenli, CC (corresponding author), Dicle Univ, Fac Med, Dept Orthoped & Traumatol, Diyarbakir, Turkey.	ccevdet@dicle.edu.tr	kesemenli, cumhur cevdet/AAR-8183-2020				Gillette MU, 1996, BEHAV BRAIN RES, V73, P135; HAKANSON DO, 1990, PEDIATR RES, V27, P571, DOI 10.1203/00006450-199006000-00006; LUVONE M, 1995, NEUROBIOLOGY CLIN AS, P25; MAKAROV AY, 1977, ZH NEVROPATOL PSIKH, V77, P1814; Nakade O, 1999, J PINEAL RES, V27, P106, DOI 10.1111/j.1600-079X.1999.tb00603.x; Roth JA, 1999, J BIOL CHEM, V274, P22041, DOI 10.1074/jbc.274.31.22041; SANDYK R, 1992, INT J NEUROSCI, V62, P215; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319	9	9	12	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2005	65	3					605	606		10.1016/j.mehy.2005.02.032			2	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	947YK	WOS:000230683000026	15905044				2022-02-06	
J	Roberts, AR; Kim, JH				Roberts, AR; Kim, JH			Exploring the effects of head injuries among battered women: A qualitative study of chronic and severe woman battering	JOURNAL OF SOCIAL SERVICE RESEARCH			English	Article						battered women; head injuries; traumatic brain injury; suicide attempts; depression	POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; VIOLENCE	This qualitative study examined the link between chronic woman battering and head injuries in a sample of 52 battered women. The voices of the women in terms of the qualitative data revealed that severe and repeated women battering seems to be associated with head injuries, flashbacks, insomnia, major depression and nightmares of the batterer killing the victim. The research findings Support the need for neurological workups among battered women with severe head injuries to rule out temporal lobe epilepsy, and other traumatic brain injuries. It is imperative that battered women be assessed and screened for neurological injuries as well as mental disorders so that appropriate medical and mental health set-vices can be provided. Social workers and psychiatric nurses in hospital emergency rooms and other medical settings are in a pivotal role to detect and facilitate intervention for battered women with neurological injuries and mental disorders.	Rutgers State Univ, Adm Justice Dept, Piscataway, NJ 08854 USA		Roberts, AR (corresponding author), Rutgers State Univ, Adm Justice Dept, Livingston Coll Campus,Lucy Stone Hall,B Wing,Roo, Piscataway, NJ 08854 USA.	prof.albertroberts@comcast.net					Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; *AM BAR ASS, 2004, PREV DOM VIOL; *AM COLL EM PHYS, 2003, DOM VIOL FACT SHEETS; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Boes M. E., 1998, BATTERED WOMEN THEIR, P205; CORRIGAN JD, 2001, WOMENS HLTH, V1, P184; CUSHMAN JG, 2001, PRACTICE MANAGEMENT; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; DUTTON MA, 1994, BEHAV SCI LAW, V12, P215, DOI 10.1002/bsl.2370120303; EBY N, 2004, QUALITY MATTERS; GELLER JA, 1998, BATTERED WOMEN THEIR, P76; Goldberg Stuart H., 2000, Orbit, V19, P143, DOI 10.1076/orbi.19.3.143.2659; HAMBERGER LK, 2004, DOMESTIC VIOLENCE SC; Humphreys J, 2001, Health Care Women Int, V22, P401, DOI 10.1080/07399330152398927; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; MILLS LG, 1998, BATTERED WOMEN THEIR, P205; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Pico-Alfonso MA, 2005, NEUROSCI BIOBEHAV R, V29, P181, DOI 10.1016/j.neubiorev.2004.08.010; PONSELL MR, 2003, J AM ACAD PHYS A MAY, P43; Roberson GH, 1998, J DIGIT IMAGING, V11, P2, DOI 10.1007/BF03168169; Roberts A., 2005, ENDING INTIMATE ABUS; Roberts A.R., 1998, BATTERED WOMEN THEIR; Roberts A. R., 2002, HDB DOMESTIC VIOLENC; *US DEP JUST, 2001, INJ VIOL CRIM; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Weaver TL, 2003, ADDICT BEHAV, V28, P1665, DOI 10.1016/j.addbeh.2003.08.041; Woods S J, 2000, Issues Ment Health Nurs, V21, P309, DOI 10.1080/016128400248112; 2001, DAYBREAK        0105; [No title captured]	31	9	9	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0148-8376	1540-7314		J SOC SERV RES	J. Soc. Serv. Res.		2005	32	1					33	47		10.1300/J079v32n01_03			15	Social Work	Social Science Citation Index (SSCI)	Social Work	022TE	WOS:000236078000003					2022-02-06	
J	Stubbe, HD; Greiner, T; Van Aken, H; Rickert, CH; Westphal, M; Wassmann, T; Akcocuk, A; Daudel, F; Erren, M; Hinder, F				Stubbe, HD; Greiner, T; Van Aken, H; Rickert, CH; Westphal, M; Wassmann, T; Akcocuk, A; Daudel, F; Erren, M; Hinder, F			Cerebral vascular and metabolic response to sustained systemic inflammation in ovine traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						head injury; endotoxemia; intracranial pressure; cerebral blood flow; vascular resistance; systemic inflammation	INTERNAL CAROTID-ARTERY; SEVERE HEAD-INJURY; BLOOD-FLOW; NITRIC-OXIDE; ENDOTOXEMIA; SEPSIS; EXPRESSION; RATS; CYTOKINES; KETAMINE	Traumatic brain injury (TBI) is frequently accompanied by a systemic inflammatory response secondary to multiple trauma, shock, or infections. This study investigated the impact of sustained systemic inflammation on cerebral hemodynamics and metabolism in ovine traumatic brain injury. Fifteen sheep were investigated for 14 hours. Head injury was induced with a nonpenetrating stunner in anesthetized, ventilated animals. One group (TBI/Endo, n = 6) subsequently received a continuous endotoxin infusion for 12 hours, whereas a second group (TBI, n = 6) received the carrier. Three instrumented animals served as sham controls. Head impact significantly increased intracranial pressure from 9 +/- 4 mm Hg to 21 +/- 15 mm Hg (TBI/Endo) and from 10 +/- 3 mm Hg to 24 +/- 19 mm Hg (TBI) (means +/- SD). Internal carotid blood flow increased and cerebral vascular resistance decreased (P < 0.05) during the hyperdynamic inflammatory response between 10 and 14 hours in the TBI/Endo group, whereas these parameters were at baseline level in the TBI group. Intracranial pressure remained unchanged during this period, but increased during hypercapnia. The CMRo(2), Paco(2), and arterial hematocrit values were identical among the groups between 10 and 14 hours. It is concluded that chronic endotoxemia in ovine traumatic brain injury was associated with cerebral vasodilation uncoupled from global brain metabolism. Different mechanisms appear to induce cerebral vasodilation in response to inflammation and hypercapnia.	Univ Hosp Munster, Dept Anesthesiol & Intens Care, D-48149 Munster, Germany; Univ Hosp Munster, Dept Neurosurg, D-48149 Munster, Germany; Univ Hosp Munster, Gerhard Domagk Inst Pathol, Inst Neuropathol, D-48149 Munster, Germany; Univ Hosp Munster, Inst Clin Chem & Lab Med, D-48149 Munster, Germany		Stubbe, HD (corresponding author), Univ Hosp Munster, Dept Anesthesiol & Intens Care, Albert Schweitzer Str 33, D-48149 Munster, Germany.	hstubbe@uni-muenster.de					Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Dal Nogare A R, 1991, Am J Med Sci, V302, P50; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Groeneveld PHP, 1997, CYTOKINE, V9, P138, DOI 10.1006/cyto.1996.0147; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hinder F, 2003, CRIT CARE MED, V31, P903, DOI 10.1097/01.CCM.0000050289.15988.67; Hinder F, 1999, AM J RESP CRIT CARE, V159, P252, DOI 10.1164/ajrccm.159.1.9806024; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Meadow W, 1999, PEDIATR RES, V45, P324, DOI 10.1203/00006450-199903000-00006; Moller K, 2002, J CEREBR BLOOD F MET, V22, P1262, DOI 10.1097/01.WCB.0000037999.34930.CA; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Muckart DJJ, 1997, CRIT CARE MED, V25, P1789, DOI 10.1097/00003246-199711000-00014; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; PFENNINGER E, 1985, ACTA NEUROCHIR, V78, P113, DOI 10.1007/BF01808689; Pollard V, 1997, CRIT CARE MED, V25, P1700, DOI 10.1097/00003246-199710000-00020; SCHONING M, 1994, STROKE, V25, P17, DOI 10.1161/01.STR.25.1.17; Sielenkamper AW, 2001, EUR J ANAESTH, V18, P673, DOI 10.1046/j.1365-2346.2001.00905.x; Siren AL, 2001, MOL MED, V7, P219, DOI 10.1007/BF03401841; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; TRABER DL, 1988, AM J PHYSIOL, V254, pH833, DOI 10.1152/ajpheart.1988.254.5.H833; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wong ML, 1996, NAT MED, V2, P581, DOI 10.1038/nm0596-581	35	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2004	24	12					1400	1408		10.1097/01.WCB.0000141516.61418.82			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	881GD	WOS:000225850500009	15625414	Bronze			2022-02-06	
J	Golge, M; Muller, M; Dreesmann, M; Hoppe, B; Wenzelburger, R; Kuhtz-Buschbeck, JP				Golge, M; Muller, M; Dreesmann, M; Hoppe, B; Wenzelburger, R; Kuhtz-Buschbeck, JP			Recovery of the precision grip in children after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting on Neurotraumatology and Neuropsychological Rehabilitation	OCT 30, 2001	MANNHEIM, GERMANY			brain injuries; disabled children; hand; motor skills; rehabilitation	INTELLECTUAL FUNCTION; BASIC COORDINATION; MOTOR; SEVERITY; PERFORMANCE; RELIABILITY; ADOLESCENTS; SCALE	Objective: To identify quantitative parameters that are sensitive enough to detect impairments and improvements of grasping in children after traumatic brain injury (TBI) by analyzing the isometric fingertip forces of a precision grip-lift task. Design: Follow-up and case-control study. Setting: Tertiary pediatric trauma rehabilitation center in Germany. Participants: Thirteen children (age range, 5-14y) with moderate or severe TBI. Trauma severity was assessed with the Glasgow Coma Scale (score range, 3-9) and the Injury Severity Score (range, 16-66 points). Control data were obtained from 13 age- and gender-matched healthy children. Interventions: Not applicable. Main Outcome Measures: Children were examined 3 times (t0, t1, t2). The first date of examination (t0) was defined by the Barthel Index (part B, >20 points). Reexaminations followed after 1 (t1) and 5 (t2) months of inpatient rehabilitation. Quantitative measures included 3 grip-force parameters, 2 load force parameters, 1 parameter of the coordination between grip force and load force, and 3 timing parameters in a precision grip-lift task. Clinical improvements and recovery of activities of daily living were described with the Barthel Index (qualitative measure). Results: Peak grip force, maximum negative load force, grip force in the static phase and its standard deviation, and gripforce/load-force ratio at maximum grip force showed significant improvements during the observation period (5mo). Also, the preparation phase and preload duration, but not the load duration, changed significantly. Conclusions: Impairments and the recovery of grasping in children after TBI can be objectified with quantitative analyses of the precision grip. Several grip-force and timing parameters were sensitive for the description of restitution processes.	Univ Kiel, Inst Physiol, D-24098 Kiel, Germany; Univ Kiel, Dept Neurol, D-24098 Kiel, Germany		Golge, M (corresponding author), Univ Kiel, Inst Physiol, Olshausenstr 40, D-24098 Kiel, Germany.	mn.goelge@physiologie.uni-kiel.de	Kuhtz-Buschbeck, Johann/F-7745-2010	Kuhtz-Buschbeck, Johann P/0000-0002-4603-7103			Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Duval J, 2002, BRAIN COGNITION, V48, P337, DOI 10.1006/brcg.2001.1373; ELIASSON AC, 1991, DEV MED CHILD NEUROL, V33, P661; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; HALEY SM, 1990, J HEAD TRAUMA REHAB, V5, P77; Hepp-Reymond Marie-Claude, 1996, P37, DOI 10.1016/B978-012759440-8/50006-2; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lagerstrom C, 1998, SCAND J REHABIL MED, V30, P113; Laurent-Vannier A, 2000, CHILD NERV SYST, V16, P760, DOI 10.1007/s003810000349; LOEWEN SC, 1988, PHYS THER, V68, P1077, DOI 10.1093/ptj/68.7.1077; MAHONEY F I, 1965, Md State Med J, V14, P61; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Richter M, 2001, UNFALLCHIRURG, V104, P733, DOI 10.1007/s001130170075; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; WESTLING G, 1984, EXP BRAIN RES, V53, P277	33	9	10	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2004	85	9					1435	1444		10.1016/j.apmr.2003.11.029			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	852DW	WOS:000223736400008	15375813				2022-02-06	
J	Chen, YH; Lin, SZ; Chiang, YH; Ju, DT; Liu, MY; Chen, GJ				Chen, YH; Lin, SZ; Chiang, YH; Ju, DT; Liu, MY; Chen, GJ			Supraorbital keyhole surgery for optic nerve decompression and dura repair - Case report	JOURNAL OF NEUROTRAUMA			English	Article						cerebrospinal fluid; optic nerve compression; supraorbital keyhole surgery	FRACTURES; SELECTION; BASE	Supraorbital keyhole surgery is a limited surgical procedure with reduced traumatic manipulation of tissue and entailing little time in the opening and closing of wounds. We utilized the approach to treat head injury patients complicated with optic nerve compression and cerebrospinal fluid leakage (CSF). Eleven cases of basal skull fracture complicated with either optic nerve compression and/or CSF leakage were surgically treated at our department from February 1995 to June 1999. Six cases had primary optic nerve compression, four had CSF leakage and one case involved both injuries. Supraorbital craniotomy was carried out using a keyhole-sized burr hole plus a small craniotomy. The size of craniotomy approximated 2 X 3 cm(2). The optic nerve was decompressed via removal of the optic canal roof and anterior clinoid process with high-speed drills. The defect of dura was repaired with two pieces of tensa fascia lata that were attached on both sides of the torn dural defect with tissue glue. Seven cases with optic nerve injury included five cases of total blindness and two cases of light perception before operation. Vision improved in four cases. The CSF leakage was stopped successfully in all four cases without complication. As optic nerve compression and CSF leakage are skull base lesions, the supraorbital keyhole surgery constitutes a suitable approach. The supraorbital keyhole surgery allows for an anterior approach to the skull base. This approach also allows the treatment of both CSF leakage and optic nerve compression. Our results indicate that supraorbital keyhole operation is a safe and effective method for preserving or improving vision and attenuating CSF leakage following injury.	Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei 00114, Taiwan		Chen, GJ (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, 325 Cheng Kung Rd,Sec 2, Taipei 00114, Taiwan.	tsghns01@ndmctsgh.edu.tw		Ju, Da-Tong/0000-0003-1055-1597			Anand VK, 1991, OP TECH OTOLARYNGOL, V2, P157; Call N B, 1986, Ophthalmic Plast Reconstr Surg, V2, P133, DOI 10.1097/00002341-198601060-00003; CUSTER PL, 1991, EUR J IMPLANT REF SU, V5, P133; ELJAMEL M S M, 1990, British Journal of Neurosurgery, V4, P479, DOI 10.3109/02688699008993796; Fukado Y, 1975, Mod Probl Ophthalmol, V14, P474; Fukushima T, 1991, Acta Neurochir Suppl (Wien), V53, P42; GHOSHHAJRA K, 1980, CT-J COMPUT TOMOGR, V4, P271, DOI 10.1016/0149-936X(80)90019-3; GIRARD BC, 1992, J CLIN NEURO-OPHTHAL, V12, P142; HOLLINSHEAD WH, 1954, ANATOMY SURG, V1, P110; JEFFERSON A, 1972, BRIT J SURG, V59, P585, DOI 10.1002/bjs.1800590802; JOSEPH MP, 1994, CURRENT THERAPY OTOL, P153; Kurze T, 1964, Clin Neurosurg, V11, P128; LANG JK, 1988, ANATOMIE NASE; Mine S, 1999, ACTA NEUROCHIR, V141, P27, DOI 10.1007/s007010050262; RHOTON AL, 1981, NEUROSURGERY, V8, P357, DOI 10.1227/00006123-198103000-00007; Sakas DE, 1998, J NEUROSURG, V88, P471, DOI 10.3171/jns.1998.88.3.0471; SEIFF SR, 1992, OPHTHALMOLOGY CLIN N, V5, P389; Sofferman RA., 1991, OPER TECH OTOLARYNGO, V2, P150; SONG W, 1996, CHUNG HUA YEN KO TSA, V32, P448; TAKAHASHI M, 1989, ARCH OTO-RHINO-LARYN, V246, P113, DOI 10.1007/BF00457466; VOLFGANG L, 1998, LARYNGOSCOPE, V108, P873; WAGA S, 1988, ACTA NEUROCHIR, V91, P42, DOI 10.1007/BF01400526; YASARGIL MG, 1998, CLIN NEUROSURG, V34, P42	23	9	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2004	21	7					976	981		10.1089/0897715041526140			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	842AE	WOS:000222973800014	15307909				2022-02-06	
J	Domahs, F; Lochy, A; Eibl, G; Delazer, M				Domahs, F; Lochy, A; Eibl, G; Delazer, M			Adding colour to multiplication: Rehabilitation of arithmetic fact retrieval in a case of traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							COGNITIVE MECHANISMS; DAMAGED PATIENT; SIMPLE DIVISION; VANISHING CUES; MEMORY; SKILLS; REPRESENTATION; ORGANIZATION; DYSCALCULIA; IMPAIRMENT	This study describes ME, a patient in the chronic stage after a traumatic brain injury. During an extensive training programme ME tried to regain automaticity in the retrieval of simple multiplication facts. He succeeded in substantially decreasing response latencies in multiplication, reducing the handicap at his job. This improvement generalised to a non-trained operand order, to non-trained problems, and to a non-trained output modality. Moreover, these effects were maintained over at least four months. Interestingly, however, ME's training effects were operation specific: No significant improvement occurred in addition, subtraction, or division. As coloured presentation of multiplication problems proved to be a valuable cue in facilitating the patient's performance, this might turn out to be a useful tool in the rehabilitation of fact retrieval in general.	Univ Innsbruck, Neurol Klin, A-6020 Innsbruck, Austria; Univ Potsdam, Potsdam, Germany; Catholic Univ Louvain, B-3000 Louvain, Belgium; Inst Biostat, Innsbruck, Austria		Domahs, F (corresponding author), Univ Innsbruck, Neurol Klin, Anichstr 35, A-6020 Innsbruck, Austria.	frank.domahs@uklibk.ac.at	Domahs, Frank/J-9816-2012	Domahs, Frank/0000-0002-5583-4681; Delazer, Margarete/0000-0001-6482-4445; LOCHY, Aliette/0000-0003-2066-9732			ASHCRAFT MH, 1982, DEV REV, V2, P213, DOI 10.1016/0273-2297(82)90012-0; ASHCRAFT MH, 1992, COGNITION, V44, P75, DOI 10.1016/0010-0277(92)90051-I; BAROODY AJ, 1994, LEARN INDIVID DIFFER, V6, P1, DOI 10.1016/1041-6080(94)90013-2; Campbell J.I.D., 1995, MATH COGNITION, V1, P121; CAMPBELL JID, 1987, MEM COGNITION, V15, P349, DOI 10.3758/BF03197037; CAMPBELL JID, 1988, J EXP PSYCHOL GEN, V117, P204, DOI 10.1037/0096-3445.117.2.204; Campbell JID, 1997, J EXP PSYCHOL LEARN, V23, P1140, DOI 10.1037/0278-7393.23.5.1140; Campbell JID, 1999, MEM COGNITION, V27, P791, DOI 10.3758/BF03198532; CAMPBELL JID, 1987, J EXP PSYCHOL LEARN, V13, P109, DOI 10.1037/0278-7393.13.1.109; CIPOLOTTI L, 1995, CORTEX, V31, P433, DOI 10.1016/S0010-9452(13)80058-5; DAGENBACH D, 1992, BRAIN COGNITION, V20, P345, DOI 10.1016/0278-2626(92)90026-I; Davidoff J., 1991, COGNITION COLOR; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S., 1997, NUMBER SENSE; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; Delazer M, 1999, J INT NEUROPSYCH SOC, V5, P213, DOI 10.1017/S1355617799533043; DELAZER M, IN PRESS CLIN NEUROP; Deloche G, 2000, EUR CHILD ADOLES PSY, V9, P27; DELOCHE G, 1989, COGNITIVE APPROACH N; Diesfeldt H F, 1991, Tijdschr Gerontol Geriatr, V22, P221; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; FENDRICH DW, 1993, APPL COGNITIVE PSYCH, P111; Galton F, 1880, NATURE, V21, P494, DOI DOI 10.1038/021494E0; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Girelli L, 2002, NEUROPSYCHOL REHABIL, V12, P41, DOI 10.1080/09602010143000149; Girelli L, 1996, CORTEX, V32, P49, DOI 10.1016/S0010-9452(96)80016-5; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GRAFMAN G, 1982, CORTEX, V18, P37; HECAEN H., 1961, REV NEUROL [PARIS], V105, P85; HITTMAIRDELAZER M, 1994, BRAIN, V117, P715, DOI 10.1093/brain/117.4.715; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P1255, DOI 10.1016/0028-3932(95)00061-7; KASHIWAGI A, 1987, NEUROPSYCHOLOGIA, V25, P443, DOI 10.1016/0028-3932(87)90032-7; LeFevre JA, 1999, MEM COGNITION, V27, P803, DOI 10.3758/BF03198533; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; LOCHY A, IN PRESS HDB MATH CO; MCCLOSKEY M, 1991, BRAIN COGNITION, V17, P154, DOI 10.1016/0278-2626(91)90074-I; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; McCloskey M., 1992, NATURE ORIGINS MATH; MICELI G, 1991, DISTURBI CALCOLO DIA; Noice H, 2001, MEM COGNITION, V29, P820, DOI 10.3758/BF03196411; Pesenti M, 2000, CORTEX, V36, P445, DOI 10.1016/S0010-9452(08)70853-0; Rickard TC, 1996, J EXP PSYCHOL LEARN, V22, P1281, DOI 10.1037/0278-7393.22.5.1281; RICKARD TC, 1994, J EXP PSYCHOL LEARN, V20, P1139, DOI 10.1037/0278-7393.20.5.1139; SERON X, 1992, COGNITION, V44, P159, DOI 10.1016/0010-0277(92)90053-K; SIEGLER RS, 1988, J EXP PSYCHOL GEN, V117, P258, DOI 10.1037/0096-3445.117.3.258; Smilek D, 2002, BRAIN COGNITION, V48, P570, DOI 10.1006/brcg.2001.1419; THONE AIT, 1995, J INT NEUROPSYCH SOC, V1, P29; van Harskamp NJ, 2001, CORTEX, V37, P363, DOI 10.1016/S0010-9452(08)70579-3; WARRINGTON EK, 1982, Q J EXP PSYCHOL-A, V34, P31, DOI 10.1080/14640748208400856; Whetstone T, 1998, BRAIN COGNITION, V36, P290, DOI 10.1006/brcg.1998.0997; WILSON B, 1987, REHABILITATION MEMOR	54	9	10	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL	2004	14	3					303	328		10.1080/09602010343000246			26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	829WZ	WOS:000222083400003					2022-02-06	
J	Nelson, K; Ward, K; Narang, AS				Nelson, K; Ward, K; Narang, AS			Posttraumatic pseudotumor cerebri in a 4-year-old female	PEDIATRIC EMERGENCY CARE			English	Article						posttraumatic pseudotumor cerebri; dural sinus thrombosis	DURAL SINUS THROMBOSIS; CLOSED-HEAD-INJURY; VENOUS THROMBOSIS; COMPUTED-TOMOGRAPHY; CHILDREN		LSU<Hlth Sci Ctr, Childrens Hosp, Dept Ambulatory Paediat, Pediat Associates, New Orleans, LA 70118 USA; LSU, Childrens Hosp, Dept Pediat Radiol, Hlth Sci Ctr, New Orleans, LA 70118 USA; LSU, Childrens Hosp, Dept Emergency Med, Hlth Sci Ctr, New Orleans, LA 70118 USA		Narang, AS (corresponding author), LSU<Hlth Sci Ctr, Childrens Hosp, Dept Ambulatory Paediat, Pediat Associates, 200 Henry Clay Ave, New Orleans, LA 70118 USA.	snarang41@cox.net					BARRON TF, 1990, PEDIATR NEUROL, V18, P112; BOUUSER MG, 1985, STROKE, V16, P199; Brodsky MC, 1996, PEDIAT NEUROOPHTHALM, P76; Byers RK, 1933, AM J DIS CHILD, V45, P1161; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; GOLDBERG AL, 1986, J COMPUT ASSIST TOMO, V10, P16, DOI 10.1097/00004728-198601000-00003; HAWKINS DB, 1985, LARYNGOSCOPE, V95, P674; Holzmann D, 1999, LARYNGOSCOPE, V109, P645, DOI 10.1097/00005537-199904000-00024; HULCELLE PJ, 1989, NEURORADIOLOGY, V31, P217, DOI 10.1007/BF00344346; KIM KS, 1986, J COMPUT ASSIST TOMO, V10, P386; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; Lancon JA, 1999, PEDIATR NEUROSURG, V30, P23, DOI 10.1159/000028755; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; PANNKE TS, 1991, ANN EMERG MED, V20, P813, DOI 10.1016/S0196-0644(05)80849-2; Preter M, 1996, STROKE, V27, P243, DOI 10.1161/01.STR.27.2.243; RAO KCV, 1981, NEURORADIOLOGY, V21, P391; SNYDER TC, 1986, J COMPUT ASSIST TOMO, V10, P889, DOI 10.1097/00004728-198609000-00041; STRINGER WL, 1983, NEUROSURGERY, V12, P95; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494	20	9	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2004	20	7					460	463		10.1097/01.pec.0000132219.50352.e9			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	838DU	WOS:000222694500010	15232248				2022-02-06	
J	Fujimura, M; Kameyama, M; Motohashi, O; Kon, H; Ishii, K; Onuma, T				Fujimura, M; Kameyama, M; Motohashi, O; Kon, H; Ishii, K; Onuma, T			Cerebral infarction in the caudate nucleus associated with acute epidural hematoma and diffuse brain injury in a child after severe head injury	CHILDS NERVOUS SYSTEM			English	Article						cerebral infarction; caudate nucleus; child; traumatic brain injury; recurrent artery of Heubner	BASAL GANGLIA; ARTERY	Case report: A 6-year-old boy was admitted to our hospital 20 min after receiving a direct impact to his head in an automobile accident. He was semi-comatose on admission and computed tomography showed acute epidural hematoma in the right supratentorial region. Three hours later, his consciousness deteriorated due to the enlargement of the hematoma. Surgical removal of hematoma relieved his consciousness disturbance. Post-operative magnetic resonance imaging revealed spotty high-intensity lesions in the corpus callosum on T2-weighted images, and a solitary high-intensity lesion in the left caudate nucleus extending to the medial globus pallidum on T2-weighted and diffusion-weighted images. Magnetic resonance angiography showed no abnormality in the main arteries. These results suggested cerebral infarction in the vascular territory supplied by the recurrent artery of Heubner in association with diffuse brain injury. Post-operative course was uneventful and he was discharged without neurological deficit. Conclusions: Post-traumatic cerebral infarction in the caudate nucleus is extremely rare, and its association with diffuse brain injury and epidural hematoma is apparently unique.	Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; Sendai City Hosp, Dept Neurosurg, Sendai, Miyagi, Japan; Sendai City Hosp, Dept Radiol, Sendai, Miyagi, Japan		Fujimura, M (corresponding author), Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	fujimur@nsg.med.tohoku.ac.jp					CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; DHARKER SR, 1993, NEUROSURGERY, V33, P863; GENNARELLI TA, 1987, HEAD INJURY, P89; Hirao J, 2001, NEUROL MED-CHIR, V41, P271, DOI 10.2176/nmc.41.271; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; MAKI Y, 1980, CHILD BRAIN, V7, P113; Miller SP, 2000, DEV MED CHILD NEUROL, V42, P344, DOI 10.1017/S0012162200000608; MOTOHASHI O, 1995, NERV SYST CHILD, V20, P141; SATOH S, 1991, STROKE, V22, P586, DOI 10.1161/01.STR.22.5.586	9	9	12	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUN	2004	20	6					430	433		10.1007/s00381-003-0884-0			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	834IE	WOS:000222404000009	14997328				2022-02-06	
J	O'Bryant, SE; Duff, K; Fisher, J; McCaffrey, RJ				O'Bryant, SE; Duff, K; Fisher, J; McCaffrey, RJ			Performance profiles and cut-off scores on the Memory Assessment Scales	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	20th Annual Meeting of the National-Academy-of-Neuropsychology	NOV, 2000	Orlando, FL	Natl Acad Neuropsychol		Memory Assessment Scales; malingering; TBI litigants; test of memory malingering	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; BELIEVABLE DEFICITS; MALINGERING TOMM; INDIVIDUALS; VALIDATION; VALIDITY; TESTS	The increased role of neuropsychologists in the courtroom has led to an increased effort in the detection of possible symptom exaggeration/malingering. Whereas domain specific measures of malingering have traditionally been used in this detection process, the identification of performance profiles and cut-off scores on standard neuropsychological assessment instruments may provide an alternate strategy. The present study evaluated the effectiveness of performance profiles and cut-off scores in discriminating traumatic brain injury (TBI) litigants suspected of malingering from those not suspected of malingering on the Memory Assessment Scales (MAS). Results suggest that TBI litigants suspected of poor effort will perform globally at a lower level than TBI litigants not suspected of poor effort on nearly all MAS indices, however, the performance profiles of each group was similar. Cut-off scores, especially when used in combination, were also effective in correctly classifying individuals in the two groups. The present findings warrant further research examining the utility of the proposed cut-off scores separately and concomitantly. Such research will aid the clinical neuropsychological practitioner in interpreting aberrant performance profiles on the MAS in forensic situations. (C) 2003 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	SUNY Albany, Dept Psychol, Albany, NY 12222 USA; Univ Oklahoma, Hlth Sci Cr, Oklahoma City, OK USA; Albany Psychol Associates, Albany, NY 12203 USA; Brain Injury Consultants, Rochester, NY USA		McCaffrey, RJ (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.	rm188@albany.edu		O'Bryant, Sid/0000-0003-0582-5266			AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; DONDERS J, 1999, J FORENSIC NEUROPSYC, V1, P35; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Slick DJ, 1995, VICTORIA SYMPTOM VAL; SPREEN O, 1998, COMPENDIUIM NEUROPSY; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC	25	9	10	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2004	19	4					489	496		10.1016/j.acn.2003.07.001			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology	830DL	WOS:000222101700003	15163450	Bronze			2022-02-06	
J	Orendacova, J; Racekova, E; Kucharova, K; Pousova, B; Ondrejcak, T; Martoncikova, M; Daxnerova, Z; Marsala, J				Orendacova, J; Racekova, E; Kucharova, K; Pousova, B; Ondrejcak, T; Martoncikova, M; Daxnerova, Z; Marsala, J			Ependyma as a possible morphological basis of ischemic preconditioning tolerance in rat spinal cord ischemia model: Nestin and Fluoro-Jade B observations	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						ischemia; ischemic preconditioning; ependyma; nestin; Fluoro-Jade B; quantitative evaluation	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ADULT MAMMALIAN FOREBRAIN; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NEURONAL DEGENERATION; SUBVENTRICULAR ZONE; SUBEPENDYMAL CELLS; POSITIVE NEURONS; EXPRESSION	1. To test our hypothesis that a transient nonlethal ischemic insult benefits the lumbosacral spinal cord ischemic injury, nestin, the marker of proliferating cells, and Fluoro-Jade B, the marker of degenerating cells, were used in rats. Morphological outcome was evaluated after 12-min ischemia versus 12-min ischemia preconditioned by 3-min ischemic period and 30-min recirculation (IPC), in each group followed by 2, 3, and 4 days of posttreatment survival. 2. Twelve-minute ischemia, inducing nestin-positivity in ependyma and reactive astrocytes at the L1-3 spinal cord segments, shows this region as the viable region of spinal cord in all postischemic survival periods. On the other hand, abundance of Fluoro-Jade B-positive cells, distributed throughout the dorsal horn and intermediate zone of L-4 - S-2 segments, points out the most injured spinal cord region by ischemia. 3. After the same ischemic insult in IPC rats only a few nestin-positive ependymal cell and reactive astrocytes appeared beside the nestin-positive vessels in the lower lumbar and sacral spinal cord segments of all survival periods. The appearance of nestin-positive cells in the spinal cord segments, which "should have been affected" by ischemia indicates protection of this region by the IPC treatment. 4. The number and density evaluation of Fluoro-Jade B fluorescent cells of L4 - S2 segments after ischemia and IPC confirmed that degenerating cells were significantly reduced in the IPC rats in all survival periods. 5. Our results showing the immunohistochemical response of epemdyma, committed to the presence of viable tissue, indicate that the ependymal cells may contribute to the ischemic resistance in the IPC rats.	Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; Safarik Univ, Inst Biol & Ecol, Fac Sci, Kosice, Slovakia		Orendacova, J (corresponding author), Slovak Acad Sci, Inst Neurobiol, Soltesovej 4, Kosice 04001, Slovakia.	orendac@saske.sk	Martoncikova, Marcela/F-3622-2018; Racekova, Eniko/AAD-6356-2019	Daxnerova, Zuzana/0000-0002-5778-8033			Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; BURDA J, 2003, PHYSIOL RES, V52, pP1; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DANIELISOVA V, 2003, PHYSIOL RES, V52, pP3; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; GALLYAS F, 1980, STAIN TECHNOL, V55, P299, DOI 10.3109/10520298009067258; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gritti A, 1996, J NEUROSCI, V16, P1091; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Horner PJ, 2000, J NEUROSCI, V20, P2218; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Kucharova K, 2001, BIOLOGIA, V56, P321; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; LIU K, 2002, CHIN MED J, P339; Lukacova N, 1999, BIOLOGIA, V54, P29; MARSALA J, 1989, NEUROSCI LETT, V106, P83, DOI 10.1016/0304-3940(89)90206-1; Marsala J, 2003, CELL MOL NEUROBIOL, V23, P57, DOI 10.1023/A:1022545117993; Marsala J, 1997, EXP NEUROL, V145, P165, DOI 10.1006/exnr.1997.6455; MARTONCIKOVA M, 2003, PHYSIOL RES, V52, pP10; Maslej P, 2003, BIOLOGIA, V58, P409; MOKRY J, 1999, NEURALNI PREKURZOROV, P44; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; NEMETHOVA M, 2003, PHYSIOL RES, V52, pP13; ONDREJCAK T, 2001, THESIS UPJS KOSICE, P1; ONDREJCAK T, 2003, PHYSIOL RES, V52, pP13; ORENDACOVA J, 2003, PHYSIOL RES, V52, pP14; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; POUSOVA B, 2003, PHYSIOL RES, V52, pP15; RADONAK J, 2003, PHYSIOL RES, V52, pP16; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; SIMPSON SB, 1994, PROG BRAIN RES, V103, P229; Stemple DL, 1997, NEURON, V18, P1, DOI 10.1016/S0896-6273(01)80018-0; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; TOHYAMA T, 1992, LAB INVEST, V66, P303; VAQUERO J, 1981, ACTA NEUROCHIR, V59, P209, DOI 10.1007/BF01406350; WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Yang LC, 2000, CELL MOL NEUROBIOL, V20, P351, DOI 10.1023/A:1007066210294; Zvara DA, 1999, ANN THORAC SURG, V68, P874, DOI 10.1016/S0003-4975(99)00559-7	48	9	10	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JUN	2004	24	3					477	489		10.1023/B:CEMN.0000022775.67975.ed			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	809ZP	WOS:000220674900012	15206826				2022-02-06	
J	Erdogan, B; Caner, H; Volkan Aydin, M; Yildirim, T; Kahveci, S; Sen, O				Erdogan, B; Caner, H; Volkan Aydin, M; Yildirim, T; Kahveci, S; Sen, O			Hemispheric cerebrovascular venous thrombosis due to closed head injury	CHILDS NERVOUS SYSTEM			English	Article						pediatric age group; sinus thrombosis; closed head injury; craniotomy; prognosis	SINUS THROMBOSIS; CHILDREN	Case report. We present the case of an 8-month-old infant who was admitted to our Neurosurgery Department with venous infarction related to sagittal sinus thrombosis. The infarction was radiologically detected 5 days after the baby had undergone surgery for acute subdural hematoma due to a closed head injury. Results and conclusions. Cerebrovascular venous thrombosis is a rare clinical entity that has multiple causes and variable presenting symptoms. There is no consensus on overall strategy concerning surgical, radiosurgical, or medical therapy (anti-coagulation, thrombolytic, and anti-edema treatment), and exactly how, when, or in which cases these should be applied. The treatment planning should be based on clinical findings, and should be modified according to the clinical course. In this case, the clinical and radiological findings regressed with symptomatic treatment alone.	Baskent Univ, Fac Med, Dept Neurosurg, Baskent Hastanesi, TR-01250 Adana, Turkey; Baskent Univ, Fac Med, Dept Radiol, Baskent Hastanesi, TR-01250 Adana, Turkey; Baskent Univ, Fac Med, Dept Pediat, Baskent Hastanesi, TR-01250 Adana, Turkey		Erdogan, B (corresponding author), Baskent Univ, Fac Med, Dept Neurosurg, Baskent Hastanesi, TR-01250 Adana, Turkey.	uberdogan@hotmail.com	Yildirim, Tulin/AAQ-7559-2021	Yildirim, Tulin/0000-0001-7788-9416; Aydin, Mehmet Volkan/0000-0003-1356-7746			BARRON TF, 1992, PEDIATR NEUROL, V8, P112, DOI 10.1016/0887-8994(92)90030-3; Bergui M, 1999, NEURORADIOLOGY, V41, P419, DOI 10.1007/s002340050775; Bousser MG, 2000, J NEUROL, V247, P252, DOI 10.1007/s004150050579; Bousser MG, 1999, STROKE, V30, P481, DOI 10.1161/01.STR.30.3.481; Carvalho KS, 2001, J CHILD NEUROL, V16, P574, DOI 10.2310/7010.2001.16834; Ekseth K, 1998, NEUROSURGERY, V43, P960, DOI 10.1097/00006123-199810000-00144; GREENBERG MS, 2000, HDB NEUROSURGERY, P851; Huisman TAGM, 2001, EUR RADIOL, V11, P1760, DOI 10.1007/s003300100822; KKIRSTEN PN, 2001, AM J NEURORADIOL, V22, P450; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; Peeters E, 2001, AM J NEURORADIOL, V22, P1949; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Witt O, 1999, CHILD NERV SYST, V15, P128, DOI 10.1007/s003810050349	14	9	9	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2004	20	4					239	242		10.1007/s00381-003-0845-7			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	812EF	WOS:000220822100012	14605837				2022-02-06	
J	Sousa, J; O'Brien, D; Bartlett, R; Vaz, J				Sousa, J; O'Brien, D; Bartlett, R; Vaz, J			Sigmoid sinus thrombosis in a child after closed head injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; sigmoid sinus; thrombosis; trauma	OCCLUSION; MR	Sigmoid sinus thrombosis in children following a closed head injury is rare. The authors report such a case with the clinical presentation, radiological findings and current literature.	Hull Royal Infirm, Dept Neurosurg, Kingston Upon Hull, N Humberside, England; Hull Royal Infirm, Dept Radiol, Kingston Upon Hull, N Humberside, England; Hull Royal Infirm, Dept Paediat, Kingston Upon Hull, N Humberside, England		Sousa, J (corresponding author), 397 Fullwood Rd, Sheffield S10 3GE, S Yorkshire, England.	jsousa@doctors.org.uk					AMIRMAJDI NM, 1988, LARYNGOSCOPE, V98, P310; ANDERSON SC, 1987, J COMPUT ASSIST TOMO, V11, P1059, DOI 10.1097/00004728-198711000-00028; BJORNEBRINK J, 1976, ANGIOLOGY, V27, P688, DOI 10.1177/000331977602701203; BUONANNO FS, 1978, J COMPUT ASSIST TOMO, V2, P281, DOI 10.1097/00004728-197807000-00008; CONVERS P, 1986, NEUROCHIRURGIE, V32, P495; GHORAYEB BY, 1987, ARCH OTOLARYNGOL, V113, P749; GOLDBERG AL, 1986, J COMPUT ASSIST TOMO, V10, P16, DOI 10.1097/00004728-198601000-00003; GOLDENBERG RA, 1985, ARCH OTOLARYNGOL, V111, P56; Holzmann D, 1999, LARYNGOSCOPE, V109, P645, DOI 10.1097/00005537-199904000-00024; HULCELLE PJ, 1989, NEURORADIOLOGY, V31, P217, DOI 10.1007/BF00344346; KAPP J, 1985, NEUROSURGERY, P1300; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Luerssen T G, 1991, Neurosurg Clin N Am, V2, P399; MAS JL, 1990, STROKE, V21, P1350, DOI 10.1161/01.STR.21.9.1350; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; SAMUEL J, 1987, J LARYNGOL OTOL, V101, P1227, DOI 10.1017/S0022215100103561; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; TAHA JM, 1993, NEUROSURGERY, V32, P545; TOVI F, 1988, J LARYNGOL OTOL, V102, P623, DOI 10.1017/S0022215100105900; TSURUDA JS, 1991, AM J NEURORADIOL, V12, P481	21	9	12	0	0	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	APR	2004	18	2					187	188		10.1080/02688690410001681082			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	820IJ	WOS:000221381100014	15176564				2022-02-06	
J	Dimopoulou, I; Tsagarakis, S; Korfias, S; Zervakis, D; Douka, E; Thalassinos, N; Sakas, DE; Roussos, C				Dimopoulou, I; Tsagarakis, S; Korfias, S; Zervakis, D; Douka, E; Thalassinos, N; Sakas, DE; Roussos, C			Relationship of thyroid function to post-traumatic S-100b serum levels in survivors of severe head injury: preliminary results	INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; hypothyroidism; protein S-100b; intracranial pressure; Glasgow Coma Scale; Marshall Computerized Tomographic Classification	TRAUMATIC BRAIN-INJURY; COMPUTERIZED-TOMOGRAPHY; MARKERS; PROTEIN	Objective. To assess thyroid function abnormalities in survivors of severe head trauma and to examine their relationship with indices of brain injury severity. Design. Prospective study. Setting. General intensive care unit (ICU) in a university hospital. Patients and participants. Twenty-two (21 men) head-injured patients, with a median age of 25.5 years at the time of injury, were investigated. Severity of brain trauma was assessed by Glasgow Coma Scale (GCS) score, Marshall Computerized Tomographic Classification, intracranial pressure levels and serum S-100b concentrations measured over a 6-day period. Interventions. Thyroid function testing was performed 1 year after ICU discharge and included the measurement of free thyroxine, triiodothyronine and thyrotropin. Measurements and results. On admission to the ICU, GCS ranged from 3 to 8. Peak S-100b was 1.49 mug/l (range: 0.37-5.26 mug/l). Median triiodothyronine and thyrotropin were 123 ng/dl and 1.60 muIU/ml, respectively. Free thyroxine was 1.08+/-0.22 ng/dl (range: 0.7-1.5 ng/dl). Overall, 7 of the 22 patients (32%) had thyroid dysfunction. Four patients had central hypothyroidism and three patients had subclinical hypothyroidism. Peak S-100b correlated negatively with free thyroxine (r=-0.47, p=0.02). There were no correlations between other brain injury severity indices and thyroid hormone levels. Conclusions. A significant subset of brain injury patients presents with changes in thyroid function 1 year after ICU discharge; these depend upon biochemical serum markers of head trauma severity.	Natl & Kapodistrian Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care Med, Athens 10675, Greece; Natl & Kapodistrian Univ Athens, Sch Med, Evangelismos Hosp, Dept Diabet Endocrinol & Metab, Athens 10675, Greece; Natl & Kapodistrian Univ Athens, Sch Med, Evangelismos Hosp, Dept Neurosurg, Athens 10675, Greece		Dimopoulou, I (corresponding author), 2 Pesmazoglou St, Athens 14561, Greece.	idimo@otenet.gr					Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Fatourechi V, 2001, MAYO CLIN PROC, V76, P413; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lamberts SWJ, 1998, LANCET, V352, P127; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	15	9	9	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2004	30	2					298	301		10.1007/s00134-003-2058-7			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770DK	WOS:000188707800019	14593458				2022-02-06	
J	Wodchis, WP; Fries, BE; Pollack, H				Wodchis, WP; Fries, BE; Pollack, H			Payer incentives and physical rehabilitation therapy for nonelderly institutional long-term care residents: Evidence from Michigan and Ontario	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						nursing homes; rehabilitation; reimbursement incentive	MINIMUM DATA SET; FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; NURSING-HOME COSTS; QUALITY-OF-LIFE; CARDIAC-REHABILITATION; CASE-MIX; MEDICAID REIMBURSEMENT; PROSPECTIVE PAYMENT	Objective: To examine the effect of payment incentives on the provision of rehabilitation therapy to nonelderly nursing home residents. Design: Retrospective cross-sectional study. Setting: Nursing homes in Michigan or complex continuing care facilities in Ontario, Canada, in 1998 or 1999. Participants: Nonelderly nursing home residents (N=5189) admitted to nursing homes. Interventions: Not applicable. Main Outcome Measures: The effect of payment on access to physical therapy (PT) and occupational therapy (OT) and total weekly time for each therapy type. Results: A Medicare policy change from cost-based to a patient-specific case-mix payment method was associated with greater likelihood of receiving OT but reduced weekly minutes of PT and OT provided to residents. Medicare cost-based and private insurance were associated with greater likelihood of receiving OT and PT and more therapy time for both types of therapy compared with private-pay residents. Global budget payment was associated with greater access to PT but fewer weekly minutes of OT and PT. Conclusions: Little information exists to describe the characteristics and treatment of nonelderly nursing home residents. This study found that many of these residents received rehabilitation and that residents whose care was paid for by more generous payers, such as Medicare, received more therapy than those paid for by less generous payers. (C) 2004 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Queen Elizabeth Ctr, Toronto Rehabil Inst, Toronto, ON M6K 2R7, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, Dept Hlth Management Policy & Evaluat, Toronto, ON, Canada; Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; VA Med Ctr, Ann Arbor, MI USA		Wodchis, WP (corresponding author), Queen Elizabeth Ctr, Toronto Rehabil Inst, 130 Dunn Ave, Toronto, ON M6K 2R7, Canada.	Wodchis.Walter@torontorehab.on.ca	Pollack, Harold A/A-1166-2007; Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; wodchis, walter/0000-0003-2494-7031			Ades PA, 1999, ARCH INTERN MED, V159, P2357, DOI 10.1001/archinte.159.19.2357; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Babazono A, 1994, Int J Technol Assess Health Care, V10, P376; Berg K, 1997, AGE AGEING, V26, P37, DOI 10.1093/ageing/26.suppl_2.37; BONAR SK, 1990, J AM GERIATR SOC, V38, P1139, DOI 10.1111/j.1532-5415.1990.tb01378.x; COBURN AF, 1993, HEALTH SERV RES, V28, P45; COHEN JW, 1990, INQUIRY-J HEALTH CAR, V27, P183; Cohen JW, 1996, J HEALTH ECON, V15, P23, DOI 10.1016/0167-6296(95)00030-5; Cohen RA, 1999, AM J CARDIOL, V83, P1374, DOI 10.1016/S0002-9149(99)00103-4; DUBACH P, 1995, CHEST, V108, P1434, DOI 10.1378/chest.108.5.1434; Frederiksen K, 1996, J AM GERIATR SOC, V44, P305, DOI 10.1111/j.1532-5415.1996.tb00920.x; FRIES BE, 1994, MED CARE, V32, P668, DOI 10.1097/00005650-199407000-00002; Gibbon B, 1996, Nurs Stand, V11, P51; Goldstein B, 1997, JAMA-J AM MED ASSOC, V277, P1891; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; HARADA N, 1993, MED CARE, V31, P345, DOI 10.1097/00005650-199304000-00006; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; JOSEPH CL, 1993, CLIN GERIATR MED, V9, P859, DOI 10.1016/S0749-0690(18)30382-3; Kosasih JB, 1998, ARCH PHYS MED REHAB, V79, P670, DOI 10.1016/S0003-9993(98)90042-9; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Lavie CJ, 1999, AM J CARDIOL, V83, P1480, DOI 10.1016/S0002-9149(99)00127-7; LIU K, 1984, GERONTOLOGIST, V24, P70, DOI 10.1093/geront/24.1.70; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1402, DOI 10.1016/S0003-9993(99)90251-4; MCSWEENEY MH, 1999, EMPLOYER SPONSORED G; Miller R H, 1993, Health Care Financ Rev, V14, P181; Montgomery P, 1997, Rehabil Nurs, V22, P20; Morris JN, 1997, J AM GERIATR SOC, V45, P1011, DOI 10.1111/j.1532-5415.1997.tb02974.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Murray PK, 1999, ARCH PHYS MED REHAB, V80, P372, DOI 10.1016/S0003-9993(99)90272-1; Murtaugh C M, 1988, Health Serv Res, V23, P467; Pollack H, 1996, MANAGE SCI, V42, P642, DOI 10.1287/mnsc.42.5.642; ROULEAU JL, 1993, NEW ENGL J MED, V328, P779, DOI 10.1056/NEJM199303183281108; SCANLON WJ, 1992, J ECON PERSPECT, V6, P43, DOI 10.1257/jep.6.3.43; Schlenker RE, 1997, HEALTH SERV RES, V32, P651; Segal ME, 1997, AM J PHYS MED REHAB, V76, P154, DOI 10.1097/00002060-199703000-00015; Sgadari A, 1997, AGE AGEING, V26, P27, DOI 10.1093/ageing/26.suppl_2.27; Swan J H, 1993, Health Care Financ Rev, V14, P111; Talo S, 1993, Int J Rehabil Res, V16, P221, DOI 10.1097/00004356-199309000-00005; Taylor VM, 1998, HEALTH SERV RES, V33, P929; Verrilli DK, 1998, HEALTH SERV RES, V33, P467; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Williams BC, 1997, ARCH PHYS MED REHAB, V78, P48, DOI 10.1016/S0003-9993(97)90009-5; YOSHIOKA H, 1994, AM J PHYS MED REHAB, V73, P199, DOI 10.1097/00002060-199406000-00009; 2002, DHHS PUBLICATION	48	9	9	0	6	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2004	85	2					210	217		10.1016/S0003-9993(03)00616-6			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	772FJ	WOS:000188830400005	14966704	Green Submitted			2022-02-06	
J	Kaiser, S; Nisenbaum, LK				Kaiser, S; Nisenbaum, LK			Evaluation of common gene expression patterns in the rat nervous system	PHYSIOLOGICAL GENOMICS			English	Article						phencyclidine; methamphetamine; lysergic acid; brain cortex; spinal cord; hippocampus; traumatic injury; microarray; GeneChip	SLOW-WAVE SLEEP; ACID DIETHYLAMIDE; PREFRONTAL CORTEX; RECEPTOR AGONIST; CIRCADIAN CLOCK; BRAIN-INJURY; IN-VITRO; SCHIZOPHRENIA; SEROTONIN; LSD	In the postgenomic era, integrating data obtained from array technologies ( e. g., oligonucleotide microarrays) with published information on eukaryotic genomes is beginning to yield biomarkers and therapeutic targets that are key for the diagnosis and treatment of disease. Nevertheless, identifying and validating these drug targets has not been a trivial task. Although a plethora of bioinformatics tools and databases are available, major bottlenecks for this approach reside in the interpretation of vast amounts of data, its integration into biologically representative models, and ultimately the identification of pathophysiologically and therapeutically useful information. In the field of neuroscience, accomplishing these goals has been particularly challenging because of the complex nature of nerve tissue, the relatively small adaptive nature of induced- gene expression changes, as well as the polygenic etiology of most neuropsychiatric diseases. This report combines published data sets from multiple transcript profiling studies that used GeneChip microarrays to illustrate a postanalysis approach for the interpretation of data from neuroscience microarray studies. By defining common gene expression patterns triggered by diverse events ( administration of psychoactive drugs and trauma) in different nerve tissues ( telencephalic brain areas and spinal cord), we broaden the conclusions derived from each of the original studies. In addition, the evaluation of the identified overlapping gene lists provides a foundation for generating hypotheses relating alterations in specific sets of genes to common physiological processes. Our approach demonstrates the significance of interpreting transcript profiling data within the context of common pathways and mechanisms rather than specific to a given tissue or stimulus. We also highlight the use of gene expression patterns in predictive biology ( e. g., in toxicogenomics) as well as the utility of combining data derived from multiple microarray studies that examine diverse biological events for a broader interpretation of data from a particular microarray study.	Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA		Nisenbaum, LK (corresponding author), Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA.						Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Biello SM, 2001, BRAIN RES, V920, P202, DOI 10.1016/S0006-8993(01)03070-0; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; BREIER A, 1995, SCHIZOPHR RES, V14, P187, DOI 10.1016/0920-9964(94)00043-8; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; BURRIS KD, 1991, J PHARMACOL EXP THER, V258, P891; Butler TL, 2003, BRAIN RES BULL, V59, P339, DOI 10.1016/S0361-9230(02)00926-7; de Saint Hilaire Z, 2000, NEUROREPORT, V11, P1619, DOI 10.1097/00001756-200006050-00005; FERL GZ, P NATL ACAD SCI US, V100, P10585; FIBIGER HC, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P615; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; Giacomelli S, 1998, LIFE SCI, V63, P215, DOI 10.1016/S0024-3205(98)00262-8; KESHAVAN MS, 1995, ACTA PSYCHIAT SCAND, V91, P289, DOI 10.1111/j.1600-0447.1995.tb09784.x; KOVACEVIC R, 1976, SCIENCE, V193, P1025, DOI 10.1126/science.948760; Krystal J., 1999, NEUROBIOLOGY MENTAL, P214; Lauer CJ, 1998, BIOL PSYCHIAT, V44, P121, DOI 10.1016/S0006-3223(97)00342-9; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Nichols CD, 2002, NEUROPSYCHOPHARMACOL, V26, P634, DOI 10.1016/S0893-133X(01)00405-5; Niculescu AB, 2000, PHYSIOL GENOMICS, V4, P83, DOI 10.1152/physiolgenomics.2000.4.1.83; Nishino S, 1998, Sleep Res Online, V1, P49; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; RAGHAVENDRA RV, 2002, J NEUROCHEM, V83, P1072; Salin-Pascual RJ, 1999, BIOL PSYCHIAT, V46, P141, DOI 10.1016/S0006-3223(98)00372-2; Shoblock JR, 2003, PSYCHOPHARMACOLOGY, V165, P359, DOI 10.1007/s00213-002-1288-7; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; TITELER M, 1988, PSYCHOPHARMACOLOGY, V94, P213; VANREETH O, 1989, NATURE, V339, P49, DOI 10.1038/339049a0; WATTS VJ, 1995, PSYCHOPHARMACOLOGY, V118, P401, DOI 10.1007/BF02245940; Yan LL, 2000, J NEUROSCI RES, V59, P291, DOI 10.1002/(SICI)1097-4547(20000115)59:2<291::AID-JNR16>3.0.CO;2-O; Yokota S, 2000, BRIT J PHARMACOL, V131, P1739, DOI 10.1038/sj.bjp.0703735	33	9	10	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1094-8341			PHYSIOL GENOMICS	Physiol. Genomics	DEC 16	2003	16	1					1	7		10.1152/physiolgenomics.00125.2003			7	Cell Biology; Genetics & Heredity; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity; Physiology	754PW	WOS:000187327300001	14679298				2022-02-06	
J	Emanuelson, I; von Wendt, L; Hagberg, I; Marchioni-Johansson, M; Ekberg, G; Olsson, U; Larsson, J; Egerlund, H; Lindgren, K; Pestat, C				Emanuelson, I; von Wendt, L; Hagberg, I; Marchioni-Johansson, M; Ekberg, G; Olsson, U; Larsson, J; Egerlund, H; Lindgren, K; Pestat, C			Early community outreach intervention in children with acquired brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						intervention; children; brain injury; effectiveness	HEAD-INJURY; OUTCOMES; PROGRAM; TRAUMA	Ten patients with acquired brain injury were recruited over an 18 month period in the south-western health care region of Sweden in order to evaluate the costs and effectiveness of a multidisciplinary community outreach intervention programme. An experienced multidisciplinary project team was involved and patients underwent detailed functional, cognitive and motor assessments following initial contact within two weeks of injury, within six weeks of injury and at a 12-month follow-up. An individualized counselling programme was also offered. Of an expected recruitment number of 50 patients (based on epidemiological and population based figures) 10 children were reached, evaluated and followed; eight patients with traumatic brain injury (five severe, two moderate and one mild), and two patients with non-traumatic brain injury (both severe). At follow-up there was a significant improvement in motor function. No significant changes were seen in other areas of functional assessment or on neuropsychological measures although there were mild improvements in communication and behaviour functions. The financial costs per patient in the programme were deemed relatively modest compared with cost estimates of shorter-term in-patient rehabilitation. Time intensive interventions included supporting caregivers and school staff and the direct and indirect patient interventions were shown to enhance support and promote active involvement of local services.	Queen Silvia Childrens Hosp, Reg Paediat Rehabil Ctr, S-41804 Gothenburg, Sweden; Univ Helsinki, Hosop Children & Adolescent Neurol, Helsinki, Finland; Gothenburg Sch Adm, Gothenburg, Sweden		Emanuelson, I (corresponding author), Queen Silvia Childrens Hosp, Reg Paediat Rehabil Ctr, PB 210 62, S-41804 Gothenburg, Sweden.	ingrid.emanuelson@vgregion.se					ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BECKUNG E, 1997, THESIS GOTEBORG U; BRUININKS KH, 1978, BRUININKSOSERETSKY T; Christensen AL., 1974, LURIAS NEUROPSYCHOLO; CLAESON LE, 1993, CLAESONDAHLS INLARNI; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DIRENZIE A, 1978, TOKEN TEST; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LARSEN A, 1991, GENUPTRAENING BETALA; LEZAK DM, 1995, COMPLEX FIGURE TEST; LEZAK DM, 1995, TRAIL MAKING TEST NE; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Osberg J S, 1997, Pediatr Rehabil, V1, P131; Pace GM, 1999, BRAIN INJURY, V13, P535; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Raven J, 1988, MANUAL RAVENS PROGRE; RAVEN JC, 1977, MANUAL RAVENS COLOUR, P425; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SIMEONSON RJ, 1984, ABILITIES INDEX; SIMEONSON RJ, 1990, SKATTNING FUNKTIONSO; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1992, WECHSLER INTELLIGENC, V3rd	26	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2003	26	4					257	264		10.1097/00004356-200312000-00002			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	814JB	WOS:000220969900002	14634359				2022-02-06	
J	Cusick, CP; Gerhart, KA; Mellick, D; Breese, P; Towle, V; Whiteneck, GG				Cusick, CP; Gerhart, KA; Mellick, D; Breese, P; Towle, V; Whiteneck, GG			Evaluation of the home and community-based services brain injury MEDICAID WAIVER PROGRAMME in Colorado	BRAIN INJURY			English	Article							SICKNESS IMPACT PROFILE; CARE	Primary objectives: To evaluate Colorado's Traumatic Brain Injury (TBI) Waiver programme in terms of functional, community integration and other key psychosocial outcomes. Research design: Results of telephone surveys of 66 TBI survivors who had received services through the Colorado Medicaid programme were compared with those of a matched sample not receiving such services. Methods and procedures: Participants were identified by Colorado's Medicaid programme and a control group was randomly selected from the population-based Colorado Traumatic Brain Injury Registry and Follow-up System. Groups were matched on Glasgow Coma Scale score at injury, age, gender, whether inpatient rehabilitation had been received and the number of years post-injury when the follow-up interview was conducted. All participants completed an extensive follow-up interview, which included CHART, the Sickness Impact Profile, the Satisfaction with Life Scale, the SF-12 and questions on symptoms and service use. Main outcomes and results: For four of the evaluated outcomes - relating to mental health problems (SF-12) and alcohol use - the Medicaid Waiver group had significantly fewer problems than the control group. In eight areas, the Waiver group demonstrated poorer outcomes than the control group. The Waiver group scored significantly lower on most measures of societal participation ( measured by CHART), needed more help with IADLS ( instrumental activities of daily living) and were less likely to be competitively employed. Additionally, Waiver recipients had significantly more case management, physical therapy and group home services and more second rehabilitation admissions than the control group. No significant differences were found for the remaining 62 outcomes that were evaluated. Conclusions: Although there were significant differences between the two groups in a few important areas, it is impossible to conclude that any outcome differences - or lack of differences - are attributable to the Waiver programme alone, since many important potential group differences could not be adequately controlled for by the design. Recommendations are offered for future research to address these limitations.	Craig Hosp Res Dept, Englewood, CO 80110 USA		Gerhart, KA (corresponding author), Craig Hosp Res Dept, 3425 S Clarkson St, Englewood, CO 80110 USA.						BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BOWYLOW JE, 1989, HOME HEALTH CARE SER, V10, P149; Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; BROOKS WB, 1990, MED CARE, V28, P793, DOI 10.1097/00005650-199009000-00009; *CO TRAUM BRAIN IN, 2001, DAT FIL DOC COL TRAU; Damiano AM, 1996, SICKNESS IMPACT PROF; DEINER E, 1985, J PERS ASSESS, V49, P71, DOI DOI 10.1207/S15327752JPA4901_; DELEW N, 1995, JAMA-J AM MED ASSOC, V274, P262; DEYO RA, 1986, SPINE, V11, P951, DOI 10.1097/00007632-198611000-00017; DEYO RA, 1983, SPINE, V8, P636; Dijkers M., 1991, J AM PARAPLEGIA SOC, V14, P85; HARRINGTON C, 2001, 16 DEP ED NAT I DIS; Jenkinson C, 1997, J Health Serv Res Policy, V2, P14; Leutz W, 1999, GERONTOLOGIST, V39, P86, DOI 10.1093/geront/39.1.86; MCHORNEY CA, 1994, MED CARE, V32, P551, DOI 10.1097/00005650-199406000-00002; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Pickard AS, 1999, STROKE, V30, P1213, DOI 10.1161/01.STR.30.6.1213; Shugarman L R, 1999, Home Health Care Serv Q, V18, P25; Smith G, 1996, MENT RETARD, V34, P262; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; *US DEP HHS, 1989, INT CLASS DIS 9 REV; Vertrees J C, 1989, Health Care Financ Rev, V10, P65; WARE JE, 1998, SF12 SCORE SF12 PHYS; Ware JE., 1993, SF36 HLTH SURVEY MAN; Whiteneck G, 2001, COLORADO TRAUMATIC B; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 2007, INT CLASS FUNCT DIS; YEATTS DE, 1987, GERONTOLOGIST, V27, P652, DOI 10.1093/geront/27.5.652; [No title captured]	31	9	10	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2003	17	11					931	945		10.1080/0269905031000110391			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	725GE	WOS:000185534800002	14514446				2022-02-06	
J	Iwata, O; Iwata, S; Tamura, M; Nakamura, T; Sugiura, M; Ogiso, Y; Takashima, S				Iwata, O; Iwata, S; Tamura, M; Nakamura, T; Sugiura, M; Ogiso, Y; Takashima, S			Early head cooling in newborn piglets is neuroprotective even in the absence of profound systemic hypothermia	PEDIATRICS INTERNATIONAL			English	Article						hypothermia; hypoxia-ischemia; newborn infant; pathology; selective head cooling	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; INTRACRANIAL-PRESSURE; CEREBRAL-PALSY; POSTHYPOXIC HYPOTHERMIA; MODERATE HYPOTHERMIA; IMPROVED SURVIVAL; TEMPERATURE; INFANTS	Background: Selective head cooling in the newborn infant has been proposed as a neuroprotective treatment with a lower level of systemic adverse effect than that of systemic hypothermia. However, the efficacy is not confirmed as well as that of systemic hypothermia. In order to analyze the safety and efficacy of selective head cooling, 25 newborn piglets were randomly selected for either normothermic or hypothermic treatment. Methods: Global hypoxic insult was induced by lowering the oxygen concentration to the maximal level to maintain the background electroencephalogram (EEG) voltage under 7 muV for 45 min. The core temperature of normothermic piglets was maintained between 38.5degreesC and 39degreesC, while prophylactic cooling was applied to the hypothermic piglets at the same time of the insult. Very mild systemic hypothermia by 1degreesC was induced in addition to selective head cooling with 10degreesC coolant temperature. Animals were killed for histopathological examination seven hours after the end of the insult. Results: Two normothermic piglets died while all hypothermic piglets survived. Neuropathological findings were significantly severer in the normothermic group than in the hypothermic group. Intracranial pressure was significantly lower, and EEG recovery was significantly better in the hypothermic piglets. There was no significant difference in the lowest oxygen concentration, degrees of acidosis, blood lactate, and blood pressure between the groups, although heart rate was significantly lower in the hypothermic group. Conclusions: We have demonstrated that early head cooling was effective in preventing some of the earliest brain damage due to hypoxic insult even in the absence of profound systemic hypothermia.	Nagano Childrens Hosp, Perinatal Ctr, Div Neonatol, Nagano, Japan; Nagano Childrens Hosp, Div Clin Pathol, Nagano, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Tokyo, Japan		Iwata, O (corresponding author), Rayne Inst, Royal Free & Univ Coll Med Sch, Dept Paediat, 5 Univ St, London WC1E 6JJ, England.						Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Amess PN, 1998, BIOL NEONATE, V73, P40, DOI 10.1159/000013958; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Berger R, 2000, J PERINAT MED, V28, P261, DOI 10.1515/JPM.2000.034; BHUSHAN V, 1993, PEDIATRICS, V91, P1094; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Burger R, 1998, NEUROL RES, V20, pS52; Campistol J, 1999, J CHILD NEUROL, V14, P683, DOI 10.1177/088307389901401011; Foster KA, 2001, BRAIN RES, V919, P122, DOI 10.1016/S0006-8993(01)03011-6; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557, DOI 10.1152/ajpregu.1997.272.2.R557; Hagberg B, 1996, ACTA PAEDIATR, V85, P954, DOI 10.1111/j.1651-2227.1996.tb14193.x; HORBAR JD, 1993, PEDIATRICS, V92, P191; Iwata O, 2003, PEDIATR INT, V45, P163, DOI 10.1046/j.1442-200X.2003.01682.x; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; MMURRAY A, 1986, ANAESTHESIA, V41, P173; Nimkoff L, 1997, J CRIT CARE, V12, P132, DOI 10.1016/S0883-9441(97)90042-3; PATEL IM, 1990, ANESTH ANALG, V70, P635; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; REILLY EL, 1981, CLIN ELECTROENCEPHAL, V12, P69, DOI 10.1177/155005948101200205; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; Roohey T, 1997, EARLY HUM DEV, V47, P115, DOI 10.1016/S0378-3782(96)01773-2; Rung G W, 1991, J Cardiothorac Vasc Anesth, V5, P337, DOI 10.1016/1053-0770(91)90156-N; SCHWEDLER M, 1982, CAN ANAESTH SOC J, V29, P222, DOI 10.1007/BF03007120; THHORESEN M, 1996, ARCH DIS CHILD, V74, pF3; Thoresen M, 2001, PEDIATR RES, V49, P594, DOI 10.1203/00006450-200104000-00024; Thoresen M, 1996, PEDIATR RES, V40, P738, DOI 10.1203/00006450-199611000-00014; Thoresen M, 1997, ACTA PAEDIATR, V86, P1029, DOI 10.1111/j.1651-2227.1997.tb14799.x; Thoresen M, 2000, PEDIATRICS, V106, P92, DOI 10.1542/peds.106.1.92; Tooley JR, 2003, ANN NEUROL, V53, P65, DOI 10.1002/ana.10402; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A	33	9	9	0	1	BLACKWELL PUBLISHING ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1328-8067			PEDIATR INT	Pediatr. Int.	OCT	2003	45	5					522	529		10.1046/j.1442-200X.2003.01784.x			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	727UQ	WOS:000185679600004	14521525				2022-02-06	
J	Dell'Acqua, R; Pashler, H; Stablum, F				Dell'Acqua, R; Pashler, H; Stablum, F			Multitasking costs in close-head injury patients - A fine-grained analysis	EXPERIMENTAL BRAIN RESEARCH			English	Article						closed-head injury; visual encoding; dual-task performance; speed of processing	PSYCHOLOGICAL REFRACTORY-PERIOD; DUAL-TASK PERFORMANCE; WORKING-MEMORY; ATTENTION; DEFICITS; IMPAIRMENTS; BOTTLENECKS; DECISION	The issue of whether severe close-head injury (CHI) patients suffer from disproportionate dual-task deficits compared with matched controls was investigated in two experiments. In the first experiment, either one or three masked letters were presented at the center of a monitor, followed by a pure tone at variable stimulus-onset asynchronies (SOAs). In half of the blocks of trials, the task on the letters required a delayed report of the letters at the end of each trial; in the other half of the blocks, the letters had to be ignored. The tone task always required an immediate manual response based on the tone pitch. In the second experiment, either three masked letters or three masked digits were presented with equal probability in each trial, followed by a tone at variable SOAs. The task required the delayed report of the characters only if they were letters, or ignoring the characters if they were digits. In both experiments, CHI patients and matched controls both exhibited an SOA-locked slowing of the reaction time (RT) to the tone: When characters had to be encoded for delayed report, tone RT increased progressively as SOA was decreased. The SOA effect on tone RT was more pronounced for CHI patients than for controls, suggesting that a substantial component of the slower processing time for CHI patients was related to a selective increase at a central stage of processing shared by the two tasks. Implications for models of the CHI effects on human performance are discussed.	Univ Ferrara, Dept Human Sci, I-44100 Ferrara, Italy; Univ Ferrara, Ctr Neurosci, I-44100 Ferrara, Italy; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy		Dell'Acqua, R (corresponding author), Univ Ferrara, Dept Human Sci, Via Savonarola 38, I-44100 Ferrara, Italy.	dar@unife.it	Dell'Acqua, Roberto/B-1682-2008	Dell'Acqua, Roberto/0000-0002-3393-1907; Stablum, Franca/0000-0003-0123-5090	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH045584] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH45584] Funding Source: Medline		ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BROOKS DN, 1984, CLOSED HEAD INJURY P; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; DEJONG R, 1993, J EXP PSYCHOL HUMAN, V19, P965, DOI 10.1037/0096-1523.19.5.965; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Dell'Acqua R, 2000, MEM COGNITION, V28, P184, DOI 10.3758/BF03213798; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; GENTILINI M, 1989, MILD HEAD INJURY, P163; GOTTSDANKER R, 1980, TUTORIALS MOTOR BEHA, P315; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; JENNETT B, 1975, LANCET, V1, P480; Jolicoeur P, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P309; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Keele S.W., 1973, ATTENTION HUMAN PERF; KOCH R, 1995, ROYAL DUTCH AC SCI A; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levy J, 2001, J EXP PSYCHOL HUMAN, V27, P862, DOI 10.1037//0096-1523.27.4.862; MCCANN RS, 1992, J EXP PSYCHOL HUMAN, V18, P471, DOI 10.1037/0096-1523.18.2.471; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Meyer DE, 1997, PSYCHOL REV, V104, P749, DOI 10.1037/0033-295X.104.4.749; Miller E, 1970, Cortex, V6, P121; MONSELL S, 1996, BRUCE V UNRESOLVED M, P93; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pashler H.E., 1998, PSYCHOL ATTENTION; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; RUTHRUFF E, 2003, IN PRESS PERCEPT PSY; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Schubert T, 1999, J EXP PSYCHOL HUMAN, V25, P408, DOI 10.1037/0096-1523.25.2.408; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; SPINNLER H, 1987, J NEUROL SCI S, V8; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Umilta C, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P37; Van Selst M, 1997, PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P787; Van Selst M, 1999, J EXP PSYCHOL HUMAN, V25, P1268, DOI 10.1037/0096-1523.25.5.1268; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; WELFORD AT, 1959, Q J EXP PSYCHOL, V11, P193, DOI 10.1080/17470215908416312; Wong KFE, 2002, J EXP PSYCHOL HUMAN, V28, P54, DOI 10.1037//0096-1523.28.1.54; [No title captured]	56	9	10	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	SEP	2003	152	1					29	41		10.1007/s00221-003-1512-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	714FR	WOS:000184902100003	12802554				2022-02-06	
J	Stocchetti, N; Longhi, L; Magnoni, S; Zanier, ER; Canavesi, K				Stocchetti, N; Longhi, L; Magnoni, S; Zanier, ER; Canavesi, K			Head injury, subarachnoid hemorrhage and intracranial pressure monitoring in Italy	ACTA NEUROCHIRURGICA			English	Article						intracranial pressure monitoring; traumatic brain injury; subarachnoid hemorrhage	BRAIN-INJURY; MANAGEMENT	Background. Intracranial pressure monitoring is recommended for the management of severe head injury and is increasingly used during intensive care for other pathologies, such as subarachnoid hemorrhage. However. it is still not uniformly applied in different centers. The objectives of this paper are to summarize the frequency and the modalities of intracranial pressure (ICP) monitoring in different centers in Italy; to describe its use in traumatic brain injury (TBI) and in subarachnoid hemorrhage (SAH): and to identify areas for improvement. Method. The medical directors of either the neurosurgical department or the intensive care unit, or both of every Italian neurosurgical center were personally interviewed. They answered specific questions about TBI and SAH patients admitted. and ICP monitoring used, in their units. Data were cleared of any obvious inconsistencies and entered in a database for analysis. All analyses were based simply on the data declared. Findings. The clinical information was obtained from 9137 TBI cases, of whom 4240 severe, and 3151 SAH patients. Among the 106 participating centers. 15 did not use ICP monitoring at all. The remaining 91 had used 3293 ICP devices during the year 2001: 146 were used in tumor cases. 2009 in TBI. and 1138 in SAH. Twenty-two percent of TBI cases admitted to centers with ICP equipment were monitored. Restricting this analysis to severe cases. 47% of TBI with a GCS <8 had ICP. On average, 36% of SAH underwent ICP monitoring. The proportions of head injury and SAH cases who underwent ICP monitoring varied widely in the different centers. Dividing the country into three main areas (north, center and south), there were considerable differences both in the rate of admissions per million inhabitants and in the frequency of ICP monitoring. Interpretation. ICP monitoring in Italy is used in most, but not all, centers. ICP is measured fairly extensively in head injury cases, but a significant proportion of SAH patients is monitored as well. There are substantial differences in the frequency of ICP monitoring in different parts of the country. The use of ICP for both these indications. and the rates of admission to specialized centers, could be improved.	Univ Milan, Osped Maggiore, Policlin IRCCS, Ist Anestesia & Rianimaz, I-20122 Milan, Italy		Stocchetti, N (corresponding author), Univ Milan, Osped Maggiore, Policlin IRCCS, Ist Anestesia & Rianimaz, Via F Sforza 35, I-20122 Milan, Italy.	stocchet@policlinico.mi.it	Magnoni, Sandra/AAC-7479-2022; Zanier, Elisa/AAA-8095-2020; Stocchetti, Nino/O-7444-2017	Magnoni, Sandra/0000-0002-1723-0844; Zanier, Elisa/0000-0002-3011-8718; Stocchetti, Nino/0000-0003-3250-6834			*AANS BRAIN TRAUM, 2000, J NEUTOTRAUMA, V17, P479; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Davella D, 2000, J Neurosurg Sci, V44, P19; Lane PL, 2000, CAN J SURG, V43, P442; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Procaccio F, 2000, J Neurosurg Sci, V44, P11; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825	10	9	10	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2003	145	9					761	765		10.1007/s00701-003-0092-4			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	731RF	WOS:000185899700006	14505102				2022-02-06	
J	Awasthi, D; Kutz, SC; Beuerman, R; Nguyen, D; Carey, ME; Zeiller, S				Awasthi, D; Kutz, SC; Beuerman, R; Nguyen, D; Carey, ME; Zeiller, S			Early gene expression in the rat cortex after experimental traumatic brain injury and hypotension	NEUROSCIENCE LETTERS			English	Article						experimental; gene expression; hypotension; rats; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; OXYGEN DELIVERY; FOS; PATTERNS; JUN	To determine c-fos and egr-1 mRNA levels in the rat cortex after traumatic brain injury (TBI) and TBI plus hemorrhagic hypotension (HH). Sprague-Dawley rats were subjected to TBI. HH was induced by removing 5 ml of blood from the jugular vein for a duration of 20 min. Cortical tissue was harvested at 0 and 120 min, and mRNA levels of the immediate early genes c-fos, egr-1 were obtained. Rats that sustained TBI alone had increased c-fos and egr-1 mRNA expression at 120 min that was significant. Additionally, c-fos mRNA levels after TBI alone were significantly higher than c-fos mRNA levels after TBI + HH at 120 min. Levels of egr-1 mRNA after TBI alone at 120 min were not significantly higher than egr-1 mRNA levels after TBI + HH at 120 min. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.	Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA 70112 USA; Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, Ctr Eye, New Orleans, LA 70112 USA; Jefferson Med Coll, Dept Neurosurg, Philadelphia, PA USA		Kutz, SC (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, 1542 Tulane Ave, New Orleans, LA 70112 USA.						Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; CHALIFOUR LE, 1994, ANAL BIOCHEM, V216, P299, DOI 10.1006/abio.1994.1045; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DOUCET JP, 1990, MOL NEUROBIOL, V4, P27, DOI 10.1007/BF02935584; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; HONKANIEMI J, 1995, MOL BRAIN RES, V28, P157, DOI 10.1016/0169-328X(94)00200-X; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NGUYEN D, 1987, CORNEA, V16, P192; Nose K, 1996, BIOCHEM J, V316, P381, DOI 10.1042/bj3160381; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Soblosky JS, 1997, BEHAV BRAIN RES, V89, P51, DOI 10.1016/S0166-4328(97)00049-1; WALD S, 1991, Journal of Trauma, V31, P1041, DOI 10.1097/00005373-199107000-00102	16	9	11	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUL 10	2003	345	1					29	32		10.1016/S0304-3940(03)00497-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	692ZW	WOS:000183691000008	12809981				2022-02-06	
J	Estevez-Gonzalez, A; Garcia-Sanchez, C; Boltes, A; Garcia-Nonell, C; Rigau-Ratera, E; Otermin, P; Gironell, A; Kulisevsky, J				Estevez-Gonzalez, A; Garcia-Sanchez, C; Boltes, A; Garcia-Nonell, C; Rigau-Ratera, E; Otermin, P; Gironell, A; Kulisevsky, J			Sustained attention in the preclinical phase of Alzheimer's disease	REVISTA DE NEUROLOGIA			Spanish	Article						Alzheimer's disease; CPT; MCI; neuropsychological marker; SMC; sustained attention	CONTINUOUS PERFORMANCE-TEST; DEFICIT HYPERACTIVITY DISORDER; MILD COGNITIVE IMPAIRMENT; CLOSED-HEAD INJURY; TOURETTES-SYNDROME; TONIC ALERTNESS; LEWY BODIES; DEMENTIA; CHILDREN; MEMORY	Introduction. Deterioration of attention in the preclinical phase of dementia of Alzheimer's type (DAT) is not very well-known neither available studies are conclusive. Objective. We outline if would be possible to identify a deficit of sustained attention in preclinical phase of DAT and if this attentional dysfunction could help to identify those patients, referred by subjective memory complaints (SMC), who will progress in a few years to DAT. Patients and methods. We compared basal exploration in a task of sustained attention (CPT) of 70 patients referred by SMC and followed longitudinally for 2 years. Twenty-seven patients developed probable DAT and forty-three remained clinically stable. Results. Patients who will be diagnosed 2 years later with DAT performed significantly more poorly than patients who did not develop DAT Patients who will be diagnosed 2 years later with DAT made a higher number of omission errors and obtained a lower number of correct responses. Conclusion. CPT paradigm is a vigilance task that detects deterioration of sustained attention in the preclinical phase of DAT and could be an objective indicator of the cognitive decline in the preclinical phase of Alzheimer's disease.	Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Unitat Psicobiol, E-08035 Barcelona, Spain; Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Neurol Serv, E-08193 Barcelona, Spain					Gironell, Alexandre/0000-0003-2109-9030			ALEXANDER DA, 1973, PSYCHOL REP, V32, P229, DOI 10.2466/pr0.1973.32.1.229; Ballard C, 2001, ARCH NEUROL-CHICAGO, V58, P977, DOI 10.1001/archneur.58.6.977; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BRAZZELLI M, 1994, J CLIN EXP NEUROPSYC, V16, P851, DOI 10.1080/01688639408402698; Calderon J, 2001, J NEUROL NEUROSUR PS, V70, P157, DOI 10.1136/jnnp.70.2.157; CHAPPELL PB, 1995, J AM ACAD CHILD PSY, V34, P1140, DOI 10.1097/00004583-199509000-00010; Epstein JI, 1996, BIOL PSYCHIAT, V39, P902, DOI 10.1016/0006-3223(95)00588-9; Estevez-Gonzalez A, 1997, REV NEUROLOGIA, V25, P1989; Fleck DE, 2002, ARCH CLIN NEUROPSYCH, V17, P399, DOI 10.1016/S0887-6177(01)00123-8; Foster JK, 1999, NEUROPSYCHOLOGY, V13, P223, DOI 10.1037/0894-4105.13.2.223; Gainotti G, 2001, BRAIN, V124, P731, DOI 10.1093/brain/124.4.731; GARCIASANCHEZ C, 1997, 20 ANN MID YEAR M IN, V3, P220; Johannsen P, 1999, NEUROIMAGE, V10, P269, DOI 10.1006/nimg.1999.0475; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LAWRENCE AD, 1995, ALZ DIS ASSOC DIS, V9, P43; Lin CCH, 1999, J ABNORM CHILD PSYCH, V27, P403, DOI 10.1023/A:1021932119311; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mendez MF, 1997, BRAIN COGNITION, V34, P301, DOI 10.1006/brcg.1997.0923; Milliery M, 2000, PSYCHIAT RES, V96, P199, DOI 10.1016/S0165-1781(00)00210-9; MORROW LA, 1992, NEUROPSYCHOLOGIA, V30, P911, DOI 10.1016/0028-3932(92)90035-K; MOSCOVITCH M, 1986, NEUROPSYCHOLOGIA, V24, P91, DOI 10.1016/0028-3932(86)90044-8; NEBES RD, 1993, CORTEX, V29, P77, DOI 10.1016/S0010-9452(13)80213-4; OToole K, 1997, J AM ACAD CHILD PSY, V36, P531, DOI 10.1097/00004583-199704000-00016; PANDURANGI AK, 1994, SCHIZOPHR RES, V13, P109, DOI 10.1016/0920-9964(94)90091-4; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI [10.1037/0894-4105.7.3.242, DOI 10.1037/0894-4105.7.3.242]; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; REZAI K, 1993, ARCH NEUROL-CHICAGO, V50, P636, DOI 10.1001/archneur.1993.00540060066020; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Riccio CA, 2001, J NEUROPSYCH CLIN N, V13, P326, DOI 10.1176/appi.neuropsych.13.3.326; Rose, 1982, CLIN GERONTOLOGIST, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Shucard DW, 1997, NEUROPSYCHOLOGY, V11, P147, DOI 10.1037/0894-4105.11.1.147; SIEGEL BV, 1995, SCHIZOPHR RES, V17, P85, DOI 10.1016/0920-9964(95)00033-I; STRANDBURG RJ, 1990, BIOL PSYCHIAT, V27, P1103, DOI 10.1016/0006-3223(90)90047-6; TAYLOR EA, 1991, NINO HIPERACTIVO; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	44	9	11	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	MAY 1	2003	36	9					829	832		10.33588/rn.3609.2002613			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	680RP	WOS:000182991400006	12717669				2022-02-06	
J	Kon, T; Hondo, H; Kohno, M; Kasahara, K				Kon, T; Hondo, H; Kohno, M; Kasahara, K			Severe tension pneumocephalus caused by opening of the frontal sinus by head injury 7 years after initial craniotomy - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						tension pneumocephalus; craniotomy; head injury; frontal sinus	VENTRICULOPERITONEAL SHUNT; INTRACEREBRAL PNEUMOCEPHALUS; ANEURYSMS	A 46-year-old man presented with severe tension pneumocephalus triggered by mild head injury 7 years after craniotomy. He had a history of subarachnoid hemorrhage due to ruptured anterior communicating artery aneurysm, coating of the aneurysm performed via a craniotomy, and a ventriculoperitoneal (VP) shunt inserted. He fell from bed in a rehabilitation hospital. Eight hours after the injury, he became comatose and suffered general convulsion. He was then transferred to our hospital. Radiography and computed tomography (CT) revealed a large amount of intracranial air and a widely opened frontal sinus. on the day of admission, the shunt tube was ligated. Surgery was performed to repair the dura mater and close the frontal sinus. Postoperative CT revealed reduction in the amount of air and frontal sinus obstruction. The patient had a good postoperative course without meningitis. Tension pneumocephalus may occur as a complication several years after a craniotomy because of the chronic lowering of intracranial pressure induced by a VP shunt. Complete frontal sinus repair is important during the initial craniotomy.	Toyama Prefectural Cent Hosp, Dept Neurosurg, Toyama, Japan		Kon, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurosurg, 1-757 Asahi Machi, Niigata 9518585, Japan.						ANEGAWA S, 1986, Neurological Surgery, V14, P1017; ASAI A, 1988, NEUROSURGERY, V23, P650, DOI 10.1227/00006123-198811000-00020; DAVIS DH, 1981, NEUROSURGERY, V8, P574, DOI 10.1227/00006123-198105000-00011; Dowd GC, 1998, J NEUROSURG, V89, P1036, DOI 10.3171/jns.1998.89.6.1036; Hasegawa H, 1983, Neurol Med Chir (Tokyo), V23, P891, DOI 10.2176/nmc.23.891; Hotta Takuhiro, 1994, Neurological Surgery, V22, P259; IKEDA K, 1978, J NEUROL NEUROSUR PS, V41, P319, DOI 10.1136/jnnp.41.4.319; Kawajiri Katsuhisa, 1994, Neurologia Medico-Chirurgica, V34, P10, DOI 10.2176/nmc.34.10; Oge K, 1998, ACTA NEUROCHIR, V140, P655, DOI 10.1007/s007010050159; OREBAUGH SL, 1990, J TRAUMA, V30, P1577, DOI 10.1097/00005373-199012000-00025; Patel RS, 2000, AM J NEURORADIOL, V21, P1327; PITTS LH, 1975, J NEUROSURG, V43, P631, DOI 10.3171/jns.1975.43.5.0631; POOL JL, 1972, J NEUROSURG, V36, P212, DOI 10.3171/jns.1972.36.2.0212; SADAMITSU D, 1984, Neurologia Medico-Chirurgica, V24, P278, DOI 10.2176/nmc.24.278; STEUDEL WI, 1986, ACTA NEUROCHIR, V80, P93, DOI 10.1007/BF01812281; TANAKA A, 1986, NEUROSURGERY, V18, P499, DOI 10.1227/00006123-198604000-00024; TERAO T, 2001, NO SHINKEI GEKA J, V10, P173; Wada Tsukasa, 1995, Neurological Surgery, V23, P55; YAMAO N, 1984, Neurological Surgery, V12, P841; YASUI N, 1992, ACTA NEUROCHIR, V118, P91, DOI 10.1007/BF01401292; Young-Su P, 1997, No Shinkei Geka, V25, P1043	21	9	9	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2003	43	5					242	245		10.2176/nmc.43.242			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	679MJ	WOS:000182926000007	12790283	Bronze			2022-02-06	
J	Wang, X; Hauptmann, N; Taylor, E; Foreman, M; Khawli, LA; Maines, MD				Wang, X; Hauptmann, N; Taylor, E; Foreman, M; Khawli, LA; Maines, MD			Neotrofin increases heme oxygenase-1 selectively in neurons	BRAIN RESEARCH			English	Article						heme oxygenase; carbon monoxide; bile pigments; oxidative stress; neuroprotectant; neurodegeneration; neotrofin; hippocampus	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN INJURY; RAT-BRAIN; OXIDATIVE STRESS; CARBON-MONOXIDE; MESSENGER-RNA; IN-VIVO; PROTEIN EXPRESSION; CEREBRAL-ISCHEMIA; RAPID INDUCTION	There is evidence that heme oxygenase plays a role in cellular defense against reactive oxygen species and thereby has neuroprotective effects. We examined the interaction of Neotrofin, a cognitive-enhancing and neuroprotective drug, with the heme oxygenase system. In adult rats, both a single administration or seven daily injections of Neotrofin at 10, 30 or 100 mg/kg intraperitoneally increased HO-1 immunoreactivity in neurons of the hippocampal formation and its connections including CA1-4, fornix, septal nuclei, hippocampal commissure, septohippocampal nucleus, fimbria, anteroventral thalamic nucleus, frontal and parietal cortex. Prominent HO-1 staining of neuronal cells in the proximity of blood vessels and circumventricular organs was also observed. Increasing doses of Neotrofin resulted in an increase in the number of neuronal populations expressing HO-1 with 100 mg/kg evoking a widespread neuronal cell response in brain. Quantification by ELISA confirmed that intraperitoneal administration of 100 mg/kg Neotrofin caused a significant increase in HO-1 protein expression in the hippocampus. The increase was evident by 6 h post-injection, peaked at 24 h with a 4-fold increase, and persisted for at least 48 h. Similarly, oral administration of 100 mg/kg Neotrofin produced a 5-fold increase in HO-1 protein 24 h post-administration. The effect of Neotrofin on HO-1 appears to be at the transcriptional level, as suggested by an increase in HO-1 mRNA levels. Neotrofin treatment was also associated with a significant increase in HO-2 mRNA levels in whole brain homogenate. These data may explain the neuroprotective effects of Neotrofin in models of excitotoxic neuronal injury. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; NeoTherapeut Inc, Irvine, CA 92618 USA; Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA		Maines, MD (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, Box 712,601 Elmwood Ave, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS41043] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041043] Funding Source: NIH RePORTER		Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Bergeron M, 1997, J CEREBR BLOOD F MET, V17, P647; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bintner J. S., 1999, Society for Neuroscience Abstracts, V25, P2131; BINTNER JS, 2000, SOC NEUROSCI, V26, P1364; Caciagli F., 1998, Society for Neuroscience Abstracts, V24, P1941; CICCARELLI R, 1999, SOC NEUROSCI, V25, P407; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Degerman E, 1996, BIOCHEM SOC T, V24, P1010, DOI 10.1042/bst0241010; Di Iorio P, 2001, EXP NEUROL, V169, P392, DOI 10.1006/exnr.2001.7654; Di Iorio P., 1999, Society for Neuroscience Abstracts, V25, P756; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Dwyer BE, 1996, MOL BRAIN RES, V38, P251, DOI 10.1016/0169-328X(95)00341-O; Dwyer BE, 1998, EXP NEUROL, V150, P206, DOI 10.1006/exnr.1997.6763; EWING JF, 1992, J NEUROCHEM, V58, P1140, DOI 10.1111/j.1471-4159.1992.tb09373.x; EWING JF, 1994, J PHARMACOL EXP THER, V271, P408; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Fernandez-Gonzalez A, 2000, EUR J NEUROSCI, V12, P1573, DOI 10.1046/j.1460-9568.2000.00044.x; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Geddes JW, 1996, NEUROSCI LETT, V210, P205, DOI 10.1016/0304-3940(96)12703-8; Glasky A J, 1997, Expert Opin Investig Drugs, V6, P1413, DOI 10.1517/13543784.6.10.1413; GLASKY AJ, 1996, ALZHEIMER DIS MOL BI, P119; GLASKY AJ, 1994, CAN J PHYSL PHARM, V72, P501; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kitamura Y, 1998, LIFE SCI, V62, P1717, DOI 10.1016/S0024-3205(98)00134-9; LANE NJ, 1998, SCI NYAS         SEP, P24; Maines M.D., 1992, HEME OXYGENASE CLIN; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1993, MOL CELL NEUROSCI, V4, P398, DOI 10.1006/mcne.1993.1050; MAINES MD, 1995, J NEUROCHEM, V64, P1769; MAINES MD, 1986, J BIOL CHEM, V261, P411; Maines MD, 1999, J PHARMACOL EXP THER, V291, P911; Matsuoka Y, 1999, NEUROPHARMACOLOGY, V38, P825, DOI 10.1016/S0028-3908(99)00020-9; MATSUSHITA S, 1965, ARCH BIOCHEM BIOPHYS, V112, P476, DOI 10.1016/0003-9861(65)90083-4; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MCDONAGH AF, 1990, CLIN PERINATOL, V17, P359, DOI 10.1016/S0095-5108(18)30572-4; MIDDLEMISS PJ, 1995, NEUROSCI LETT, V199, P131, DOI 10.1016/0304-3940(95)12029-4; Motterlini R, 1998, CIRC RES, V83, P568, DOI 10.1161/01.RES.83.5.568; Nakaso K, 1999, BIOCHEM BIOPH RES CO, V259, P91, DOI 10.1006/bbrc.1999.0724; Nakaso K, 2000, NEUROSCI LETT, V293, P49, DOI 10.1016/S0304-3940(00)01491-9; NATHANSON JA, 1995, NEURON, V14, P781, DOI 10.1016/0896-6273(95)90222-8; Nieuwenhuys R, 1988, HUMAN CENTRAL NERVOU, p[334, 374]; Panahian N, 1999, J NEUROCHEM, V72, P1187; Pappolla MA, 1998, AM J PATHOL, V152, P871; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; Ramirez JJ, 2002, RESTOR NEUROL NEUROS, V20, P51; Rathbone M P, 1999, Expert Opin Investig Drugs, V8, P1255, DOI 10.1517/13543784.8.8.1255; Rathbone MP, 1998, DRUG DEVELOP RES, V45, P356, DOI 10.1002/(SICI)1098-2299(199811/12)45:3/4<356::AID-DDR36>3.0.CO;2-C; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; Sayre LM, 2001, CURR MED CHEM, V8, P721, DOI 10.2174/0929867013372922; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; SUN Y, 1990, J BIOL CHEM, V265, P8212; Takahashi M, 2000, ALZ DIS ASSOC DIS, V14, pS67, DOI 10.1097/00002093-200000001-00011; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Venters HD, 1997, BRAIN RES, V764, P93, DOI 10.1016/S0006-8993(97)00425-3; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; WEBER CM, 1994, J NEUROCHEM, V63, P953; WIELAND S, 2001, RES PRACTICE ALZHEIM, P187; Wilson R. A., 2001, Society for Neuroscience Abstracts, V27, P2368; Zhang F, 2001, AM J HYPERTENS, V14, p62S, DOI 10.1016/S0895-7061(01)02071-4; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	73	9	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 7	2003	962	1-2					1	14	PII S0006-8993(02)03670-3	10.1016/S0006-8993(02)03670-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	641QM	WOS:000180756900003	12543450				2022-02-06	
J	Cairns, CJS; Finfer, SR; Harrington, TJ; Cook, R				Cairns, CJS; Finfer, SR; Harrington, TJ; Cook, R			Papaverine angioplasty to treat cerebral vasospasm following traumatic subarachnoid haemorrhage	ANAESTHESIA AND INTENSIVE CARE			English	Article						head injury : subarachnoid haemorrhage; cerebral vasospasm; papaverine; angioplasty; balloon angioplasty; nimodipine	SEVERE HEAD-INJURY; HEMORRHAGE; HYPEREMIA; BLOOD	The management of vasospasm associated with traumatic subarachnoid haemorrhage presents many challenges. We present a 20-year-old male admitted after sustaining a closed head injury complicated by a Fisher grade III traumatic subarachnoid haemorrhage. Despite treatment with intravenous nimodipine he developed a delayed ischaemic neurological deficit due to cerebral arterial vasospasm. The vasospasm was successfully managed with serial papaverine angioplasty.	Royal N Shore Hosp, Intens Therapy Unit, Sydney, NSW, Australia		Finfer, SR (corresponding author), Royal N Shore Hosp, Intens Therapy Unit, St Leonards, NSW 2065, Australia.						BRAAKMAN R, 1994, J NEUROSURG, V80, P797; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Morgan MK, 2000, J CLIN NEUROSCI, V7, P305, DOI 10.1054/jocn.1999.0224; VARDIMAN AB, 1995, AM J NEURORADIOL, V16, P319; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X	9	9	9	0	0	AUSTRALIAN SOC ANAESTHETISTS	EDGECLIFF	P O BOX 600, EDGECLIFF, NSW 2021, AUSTRALIA	0310-057X			ANAESTH INTENS CARE	Anaesth. Intensive Care	FEB	2003	31	1					87	91		10.1177/0310057X0303100117			5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	649KY	WOS:000181208600016	12635402	Bronze			2022-02-06	
J	Ezra, Y; Oron, L; Moskovich, L; Roses, AD; Beni, SM; Shohami, E; Michaelson, DM				Ezra, Y; Oron, L; Moskovich, L; Roses, AD; Beni, SM; Shohami, E; Michaelson, DM			Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury	NEUROSCIENCE			English	Article						amyloid precursor protein; apolipoprotein E; apolipoprotein E transgenic mice; head trauma	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; EPSILON-4 ALLELE; UP-REGULATION; E-DEFICIENT; E GENOTYPE; APOE; DEPOSITION; RISK	Apolipoprotein E (apoE4) and head trauma are important genetic and environmental risk factors for Alzheimer's disease. Furthermore, apoE4 increases both the acute and chronic consequences of head trauma. The latter are associated with the deposition of amyloid-beta, which is particularly elevated in apoE4 subjects. The short-term effects of head injury are associated with transiently increased metabolism of amyloid precursor protein (APP) and its secreted fragment, APPs. In the present study, we examined the possibility that the acute, short-term pathological effects of apoE4 following head trauma and the corresponding neuroprotective effects of apoE3 are related to isoform-specific effects of apoE on APP metabolism. Accordingly, male transgenic mice expressing human apoE3 or apoE4 on a null mouse apoE background and apoE-deficient and control mice were subjected to closed head injury (CHI). The resulting effects on brain APP, and on its secreted products, APPs and secreted product of the alpha-cleavage of APP (APPsalpha) were then determined 24 h following injury. Immunoblotting revealed no significant differences between the basal APP, APPs and APPsalpha levels of the hippocampus or the cortex of the control and the apoE3 and ApoE4 transgenic mice. The apoE-deficient mice also had similar cortical basal levels of APP and its metabolites, whereas their corresponding basal hippocampal APP and APPs levels were lower than those of the other groups. CHI lowered the hipppocampal APPs and APPsalpha levels of the apoE4 transgenic mice, whereas those of the apoE3 transgenic mice and of the control and apoE-deficient mice were not affected by this insult. In contrast, CHI raised the cortical APP and APPs levels of the apoE3 transgenic mice but had no significant effect on those of the other mice groups. These animal model findings suggest that the acute, short-term pathological effects of apoE4 following CHI and the corresponding neuroprotective effects of apoE3 may be mediated by their opposing effects on the expression and cleavage of cortical and hippocampal APP. Similar isoform-specific interactions between apoE and APP may play a role in the acute, short-term effects of head trauma in humans. (C) 2003 IBRO. Published by Elsevier Ltd. All rights reserved.	Tel Aviv Univ, Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; Duke Univ, Dept Neurol, Durham, NC 27710 USA; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharm, IL-91120 Jerusalem, Israel		Michaelson, DM (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel.	dmichael@post.tau.ac.il					ARAI H, 1992, NEUROLOGY, V42, P1315, DOI 10.1212/WNL.42.7.1315; Barger SW, 1997, J NEUROCHEM, V69, P60; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buttini M, 1999, J NEUROSCI, V19, P4867; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Desdouits-Magnen J, 1998, J NEUROCHEM, V70, P524; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Genis I, 1999, J NEUROCHEM, V72, P206, DOI 10.1046/j.1471-4159.1999.0720206.x; Graham DI, 1996, ACT NEUR S, V66, P96; Graham DI, 1999, CELL MOL NEUROBIOL, V19, P19, DOI 10.1023/A:1006937205905; Greenfield JP, 2000, FRONT BIOSCI, V5, pD72, DOI 10.2741/Greenfield; Grziwa B, 2003, J BIOL CHEM, V278, P6803, DOI 10.1074/jbc.M210047200; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hass S, 1998, J BIOL CHEM, V273, P13892; Herz J, 2001, TRENDS NEUROSCI, V24, P193, DOI 10.1016/S0166-2236(00)01768-9; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; JIN LW, 1994, J NEUROSCI, V14, P5461; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; LEVY O, 2003, IN PRESS NEUROBIOL D; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Macfarlane DP, 1999, NEUROREPORT, V10, P3945, DOI 10.1097/00001756-199912160-00040; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mills J, 1999, J NEUROCHEM, V72, P443, DOI 10.1046/j.1471-4159.1999.0720443.x; Mucke L, 1996, ANN NY ACAD SCI, V777, P82, DOI 10.1111/j.1749-6632.1996.tb34405.x; Muller W, 1998, BRAIN PATHOL, V8, P641; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Ophir G, 2003, NEUROBIOL DIS, V12, P56, DOI 10.1016/S0969-9961(02)00005-0; Oron L, 2000, J NEURAL TRANSM-SUPP, P163; Permanne B, 1997, BIOCHEM BIOPH RES CO, V240, P715, DOI 10.1006/bbrc.1997.7727; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; REBECK GW, 1999, ALZHEIMER DIS, P339; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shohami E, 2000, J MOL MED-JMM, V78, P228, DOI 10.1007/s001090000104; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Sun YL, 1998, J NEUROSCI, V18, P3261; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Veinbergs I, 2002, J NEUROSCI RES, V67, P379, DOI 10.1002/jnr.10138; Vincent B, 2001, EUR J NEUROSCI, V14, P256, DOI 10.1046/j.0953-816x.2001.01643.x; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510	61	9	11	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2003	121	2					315	325		10.1016/S0306-4522(03)00436-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	729YW	WOS:000185803300008	14521991				2022-02-06	
J	Hilsabeck, RC; Thompson, MD; Irby, JW; Adams, RL; Scott, JG; Gouvier, WD				Hilsabeck, RC; Thompson, MD; Irby, JW; Adams, RL; Scott, JG; Gouvier, WD			Partial cross-validation of the Wechsler Memory Scale-Revised (WMS-R) General Memory-Attention/Concentration Malingering Index in a nonlitigating sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; brain injury; WMS-R; neuropsychological	HEAD-INJURY	The Wechsler Memory Scale-Revised (WMS-R) malingering indices proposed by Mittenberg, Azrin, Millsaps, and Heilbronner [Psychol Assess 5 (1993) 34.] were partially cross-validated in a sample of 200 nonlitigants. Nine diagnostic categories were examined, including participants with traumatic brain injury (TBI), brain tumor, stroke/vascular, senile dementia of the Alzheimer's type (SDAT), epilepsy, depression/anxiety, medical problems, and no diagnosis. Results showed that the discriminant function using WMS-R subtests misclassified only 6.5% of the sample as malingering, with significantly higher misclassification rates of SDAT and stroke/vascular groups. The General Memory Index-Attention/Concentration Index (GMI-ACI) difference score misclassified only 8.5% of the sample as malingering when a difference score of greater than 25 points was used as the cutoff criterion. No diagnostic group was significantly more likely to be misclassified. Results support the utility of the GMI-ACI difference score, as well as the WMS-R subtest discriminant function score, in detecting malingering. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; Louisiana State Univ, Baton Rouge, LA 70803 USA; New Orleans Childrens Hosp, New Orleans, LA USA; Univ Virginia, Charlottesville, VA USA		Hilsabeck, RC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Neuropsychiat & Behav Sci, 3601 4th St,STOP 8321, Lubbock, TX 79430 USA.		Hilsabeck, Robin/ABC-5093-2020				Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BUTTERS N, 1988, CLIN NEUROPSYCHOL, V2, P133; CROSSEN JR, 1988, CLIN NEUROPSYCHOL, V2, P393; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HAYES JS, 1999, NEUROBEHAVIORAL DYSF; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; REID DB, 1991, J CLIN EXP NEUROPSYC, V13, P20; Rogers R., 1997, CLIN ASSESSMENT MALI; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; [No title captured]	17	9	9	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2003	18	1					71	79	PII S0887-6177(01)00180-9	10.1016/S0887-6177(01)00180-9			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	645RJ	WOS:000180992000007	14591479				2022-02-06	
J	Zillmer, EA				Zillmer, EA			The neuropsychology of repeated 1-and 3-meter springboard diving among college athletes	APPLIED NEUROPSYCHOLOGY			English	Article						sports-related concussion; springboard diving; neuropsychological assessment		This study examined the neuropsychological effects of repeated springboard diving. It was hypothesized that the impact velocity, which can range from 20 to 30 mph, and accompanying deceleration in the water may lead to concussions and affect the diver's cognitive function. Six varsity National Collegiate Athletic Association Division I springboard divers participated in the study. Each diver performed a total of 50 practice dives from either the 1 or 3-m springboard. After each set of 10 dives, the participants were immediately evaluated at poolside using the Symbol Digit Modalities Test, the Stroop Color Word Test, and the Trail Making Test B. Baseline testing revealed, consistent with their athletic specialty, clear neurocognitive strengths among the divers on tests sensitive to proprioception, motor speed, and visual-spatial organization. Results from the serial assessments indicated no detectable neuropsychological deficits among competitive divers compared to baseline testing. Skilled diving at the collegiate level appears to be a safe sport and water appears to present the perfect medium for gradual deceleration. More Studies, however, are warranted for 5-, 7.5-, and 10-m platform diving since the impact velocity of the diver from these heights is higher.	Drexel Univ, Dept Athlet, Philadelphia, PA 19104 USA		Zillmer, EA (corresponding author), Drexel Univ, Dept Athlet, 3141 Chestnut St, Philadelphia, PA 19104 USA.	zillmer@drexel.edu					Barth JT, 2001, J ATHL TRAINING, V36, P253; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; GOLDEN C, 1976, J PERS ASSESS, V39, P386; Heaton RK, 1991, COMPREHENSIVE NORMS; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MONTVILLE L, 1995, SPORTS ILLUSTRAT AUG, P55; OBRIEN R, 1992, DIVING GOLD BASIC ST; Smith A., 1982, SYMBOL DIGIT MODALIT; Spiers MV., 2001, PRINCIPLES NEUROPSYC; Wechsler D., 1981, WAIS R MANUAL; Wolfson, 1993, HALSTEAD REITAN NEUR; Zillmer E A, 1991, Arch Clin Neuropsychol, V6, P61, DOI 10.1016/0887-6177(91)90022-2	12	9	9	0	5	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	1					23	30		10.1207/S15324826AN1001_4			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	780NF	WOS:000189386900004	12734072				2022-02-06	
J	Mount, DL; Hogg, J; Johnstone, B				Mount, DL; Hogg, J; Johnstone, B			Applicability of the 15-item versions of the Judgement of Line Orientation Test for individuals with traumatic brain injury	BRAIN INJURY			English	Article							BOSTON NAMING TEST; CATEGORY TEST; ALZHEIMERS-DISEASE; SHORT-FORM; JUDGMENT	Primary objective: To determine if short forms (i.e. 15 item) of the Judgment of Line Orientation (JOLO) test are equivalent to the full JOLO (i.e. 30 item). Research design: Retrospective analysis of JOLO test performance. Methods and procedures: Seventy-two persons with TBI evaluated at a Midwestern University neuropsychology laboratory were administered the JOLO test, Form V, as part of a larger battery of neuropsychological tests. Short forms (i.e. odd and even number short forms) were correlated with the 30 item to determine equivalency of forms. The Statistical Package for the Social Sciences (version 10) was used for the data analyses (SPSS). Main outcomes and results: Pearson's correlations indicate that the JOLO odd and even short forms are significantly correlated with the full JOLO score (r = 0 90 and 0.93, respectively), and that 100% of the participants' estimated JOLO full score fell within 2 points of the actual full JOLO score. Conclusions: The results confirm the validity of the short forms of the JOLO for persons with TBI and that gender effects were not significant.	Univ Missouri, Dept Hlth Psychol, Sch Hlth Profess, Columbia, MO 65212 USA		Mount, DL (corresponding author), Univ Missouri, Dept Hlth Psychol, Sch Hlth Profess, DC046-00, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649			AXELROD BN, 1993, CLIN NEUROPSYCHOL, V7, P205, DOI 10.1080/13854049308401523; Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P231, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT231; Benton A., 1994, CONTRIBUTIONS NEUROP; BENTON A L, 1978, Archives of Neurology, V35, P364; Benton A.L., 1983, CONTRIBUTIONS NEUROP; CALSYN DA, 1980, J CONSULT CLIN PSYCH, V48, P788, DOI 10.1037/0022-006X.48.6.788; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANZEN MD, 1995, CLIN NEUROPSYCHOL, V9, P225, DOI 10.1080/13854049508400484; Hogg JR, 2001, CLIN NEUROPSYCHOL, V15, P129, DOI 10.1076/clin.15.1.129.1912; MOEHLE KA, 1988, INT J NEUROSCI, V42, P107, DOI 10.3109/00207458808985764; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; Qualls CE, 2000, ARCH CLIN NEUROPSYCH, V15, P159, DOI 10.1016/S0887-6177(98)00043-2; RUSSELL EW, 1987, J CONSULT CLIN PSYCH, V55, P898, DOI 10.1037/0022-006X.55.6.898; Schopp LH, 1998, ARCH CLIN NEUROPSYCH, V13, P637, DOI 10.1016/S0887-6177(97)00096-6; Vanderploeg RD, 1997, APPL NEUROPSYCHOL, V4, P244, DOI 10.1207/s15324826an0404_6; WILLIAMS BW, 1989, NEUROPSYCHOLOGIA, V27, P1073, DOI 10.1016/0028-3932(89)90186-3; Woodard JL, 1998, J CLIN EXP NEUROPSYC, V20, P457, DOI 10.1076/jcen.20.4.457.1470; Woodard JL, 1996, J CLIN EXP NEUROPSYC, V18, P898, DOI 10.1080/01688639608408311; [No title captured]	19	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2002	16	12					1051	1055		10.1080/02699050210154259			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	617KK	WOS:000179360700003	12487719				2022-02-06	
J	Ros, J; Jones, D; Pecinska, N; Alessandri, B; Boutelle, M; Landolt, H; Fillenz, M				Ros, J; Jones, D; Pecinska, N; Alessandri, B; Boutelle, M; Landolt, H; Fillenz, M			Glutamate infusion coupled with hypoxia has a neuroprotective effect in the rat	JOURNAL OF NEUROSCIENCE METHODS			English	Article; Proceedings Paper	9th International Conference on In Vivo Methods Monitoring Molecules in Neuroscience	JUN 16-19, 2001	UNIV COLL DUBLIN, DUBLIN, IRELAND	Natl Univ Ireland	UNIV COLL DUBLIN	glutamate; hypoxia; glucose; lactate; brain microdialysis	CONCUSSIVE BRAIN INJURY; AMINO-ACIDS; LACTATE; GLUCOSE; CORTEX; MICRODIALYSIS; NEUROTOXICITY; ACCUMULATION; ACTIVATION; TISSUE	Traumatic brain injury leads to a rise in glutamate, interference with oxygen supply and secondary neuronal death in the region surrounding the primary lesion. In the present experiments we have examined the effect of combining glutamate infusion with hypoxia on both brain metabolism and neuronal death. We have used microdialysis in unanaesthetised rats with a novel dual assay for glucose and lactate to monitor the temporal relation of changes in these metabolites resulting from infusion of 100 mM glutamate alone or combined with a reduction of inspired oxygen to 8%. In a parallel series of experiments we have compared the size of heuronal lesions under the same experimental conditions. We have used MAP2 antibody staining to measure the size of the neuronal lesion. Our results demonstrate that a 30 min glutamate infusion causes an immediate increase in neuronal glucose utilisation and a rise in lactate production. When hypoxia is added during the last 15 min of glutamate infusion there is a small rise in glucose and a large additional increase in lactate. The size of the neuronal lesions produced by infusion of 100 mM glutamate is reduced by the addition of hypoxia. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Kantonsspital Basel, Res Dept, Basel, Switzerland; Kings Coll London, Dept Chem, London WC2R 2LS, England; Kantonsspital Aarau, CH-5001 Aarau, Switzerland		Fillenz, M (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	marianne.fillenz@physiol.ox.ac.uk					Alessandri B, 1996, ACT NEUR S, V67, P6; BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; CHOI DW, 1987, J NEUROSCI, V7, P369; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Fujisawa H, 1996, J NEUROTRAUM, V13, P245, DOI 10.1089/neu.1996.13.245; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HILLERED L, 1990, J CEREB BLOOD FLOW M, V10, P19; Jones DA, 2000, J NEUROCHEM, V75, P1703, DOI 10.1046/j.1471-4159.2000.0751703.x; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Pellerin L, 1997, J NEUROCHEM, V69, P2132; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; ROS J, 2000, THESIS U BASEL U BAS; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999	18	9	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2002	119	2					129	133	PII S0165-0270(02)00174-7	10.1016/S0165-0270(02)00174-7			5	Biochemical Research Methods; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	610RZ	WOS:000178975700004	12323416				2022-02-06	
J	Rooker, S; De Visscher, G; Van Deuren, B; Borgers, M; Jorens, PG; Reneman, RS; van Rossem, K; Verlooy, J				Rooker, S; De Visscher, G; Van Deuren, B; Borgers, M; Jorens, PG; Reneman, RS; van Rossem, K; Verlooy, J			Comparison of intracranial pressure measured in the cerebral cortex and the cerebellum of the rat	JOURNAL OF NEUROSCIENCE METHODS			English	Article						rat; cerebellum; cerebrum; cortex; neurotrauma; intracranial pressure	MODIFIED EXPERIMENTAL-MODEL; BLOOD-FLOW	In this study, we evaluated the accuracy of intracranial pressure (ICP) measurement in rats by insertion of a miniature ICP probe in the parenchyma of the cerebellum. A comparison was made between the ICP values measured simultaneously in the parenchyma of the cerebral cortex and the cerebellum. In order to obtain a wide range of ICP, animals were subjected to a severe closed head injury (CHI), a moderate CHI or to a sham operation. ICP values ranged from 0.8 to 43.9 mmHg. After 15 min stabilisation the first measurement was taken and followed by a second measurement 25 min after onset to allow comparison of ICP changes at the two implantation sites. Linear regression analysis showed a highly significant correlation at 15 min: Y = 0.919X + 0.655 (R-2 = 0.977), and at 25 min: Y = 0.931X + 0.698 (R-2 = 0.976). The differences in ICP measurement between cerebellar and cerebral site were not significantly different from zero at both time points. Altman-Bland plots showed that the difference in ICP readings between the two locations could differ maximally by 5.3 mmHg. The largest differences were detected when high ICP values were recorded. We conclude that in rats the ICP measurement in the cerebellum is comparable to the ICP measurement in the cerebral cortex. The cerebellar ICP can be used as a valuable alternative during experimental procedures. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Antwerp Hosp, Dept Neurosurg, B-2650 Antwerp, Belgium; Univ Maastricht, CARIM, Dept Physiol, Maastricht, Netherlands; Catholic Univ Louvain, CEHA, B-3000 Louvain, Belgium; Johnson & Johnson Pharmaceut Res & Dev, Dept Enabling Technol, Beerse, Belgium; Univ Antwerp Hosp, Dept Intens Care Med, Antwerp, Belgium; Johnson & Johnson Pharmaceut Res & Dev, Ctr Excellence Cardiovasc Safety Res, Beerse, Belgium		Rooker, S (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Antwerp, Belgium.	marina.pieters@uza.be	Rooker, Servan/AAD-4316-2020; De Visscher, geofrey/B-9318-2012; De Visscher, Geofrey/ABH-8607-2020	De Visscher, Geofrey/0000-0002-2317-392X			BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brambrink AM, 1999, J NEUROSCI METH, V92, P111, DOI 10.1016/S0165-0270(99)00100-4; De Mulder G, 2000, ACT NEUR S, V76, P409; DEVISSCHER G, 2002, IN PRESS COMP BIOC A; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Engelborghs K, 1997, ACT NEUR S, V70, P123; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; GUILLAUME J, 1951, PRESSE MED, V59, P953; Morgalla MH, 1999, J MED ENG TECHNOL, V23, P144; van Rossem K, 1999, ADV EXP MED BIOL, V471, P209; VANROSSEM K, 1999, J CEREB BLOOD FLOW M, V19, pS391; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; VERLOOY J, 1990, J NEUROSCI METH, V31, P1, DOI 10.1016/0165-0270(90)90002-W	13	9	10	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 15	2002	119	1					83	88	PII S0165-0270(02)00183-8	10.1016/S0165-0270(02)00183-8			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	597DK	WOS:000178206700011	12234639	Green Published			2022-02-06	
J	McCrory, P				McCrory, P			When to retire after concussion?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article							MINOR HEAD-INJURY; APOLIPOPROTEIN-E EPSILON-4; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN INJURY; E-DEFICIENT MICE; SOCCER PLAYERS; FOOTBALL PLAYERS; CEREBRAL CONCUSSION; COLLEGE FOOTBALL; NECK INJURIES	The management of an athlete with recurrent concussions, whether persistently symptomatic or not, remains anecdotal. There are no evidence-based guidelines upon which a team physician can advise the athlete. All doctors involved in athlete care need to be aware of the potential for medicolegal problems if athletes are inappropriately returned to sport prematurely or in the case of professional athletes held out of sport or retired on the basis of non-scientific recommendations.	Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia; Univ Melbourne, Inst Brain Res, Parkville, Vic 3052, Australia		McCrory, P (corresponding author), Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia.		McCrory, Paul/Q-8688-2019				ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; AUBRY M, 2002, IN PRESS BRIT J SPOR, V36; BADCOCK KA, 1988, COMMUNITY HEALTH ST, V12, P428; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; CANTU R, 1996, CATASTROPHIC INJURIE, P14; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 1976, Trans Am Neurol Assoc, V101, P72; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Jordan B. D., 1998, SPORTS NEUROLOGY, P351; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; JORDAN BD, 1988, PHYSICIAN SPORTSMED, V16, P87, DOI 10.1080/00913847.1988.11709407; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; JORDAN BD, 1991, HOSP MED, V27, P93; JORDAN BD, 1993, MED ASPECTS BOXING; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LENINGER B, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, NEUROBEHAVIOURAL REC, P426; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Luria A. R, 1962, HIGHER CORTICAL FUNC; MACFLYN G, 1984, J NEUROL NEUROSUR PS, V47, P1313; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MATEER CA, 1992, REHABILITATION POSTC, P143; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory P, 2000, SPORTS MED, V30, P221, DOI 10.2165/00007256-200030030-00006; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKINSON D, 1992, MED HYPOTHESES, V37, P37, DOI 10.1016/0306-9877(92)90010-A; Povlishock JT, 1996, ACT NEUR S, V66, P81; Shetter A G, 1979, Adv Neurol, V22, P5; SHUTTLEWORTHJOR.AB, 1993, INT NEUR SOC 16 EUR; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; THORNDIKE A, 1952, NEW ENGL J MED, V246, P554; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Van Zomeren A. H., 1981, REACTION TIME ATTENT; WALS KW, 1987, NEUROPSYCHOLOGY CLIN; Walsh KW., 1991, UNDERSTANDING BRAIN; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	81	9	10	0	6	SPORTS MEDICINE AUSTRALIA	DICKSON	PO BOX 237, DICKSON, ACT 2602, AUSTRALIA	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	SEP	2002	5	3					169	182		10.1016/S1440-2440(02)80002-0			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	613TX	WOS:000179148500002	12413034				2022-02-06	
J	Paemeleire, K				Paemeleire, K			Calcium signaling in and between brain astrocytes and endothelial cells	ACTA NEUROLOGICA BELGICA			English	Article						intercellular calcium waves; astrocytes; endothelial cells; blood-brain barrier; neurovascular coupling; traumatic brain injury; flash photolysis	WAVES	Two in vitro co-culture models of the blood-brain barrier (BBB) were developed using primary rat cortical astrocytes and ECV304 endothelial cells or primary rat brain capillary endothelial cells. We showed that intercellular calcium (Ca2+) waves can mediate bidirectional astrocyte-endothelial Call signal communication in both co-culture models. It appears that two signaling pathways are involved. A first mechanism is related to intercellular diffusion of the Ca2+ mobilizing messenger inositoltrisphosphate (IP3) through gap junctions as studied with flash photolysis of caged-IP3. A second pathway involves extracellular diffusion of a purinergic messenger as studied with the purinergic inhibitors apyrase and suramin. Using gap junction-deficient HeLa cells and connexin-GFP transfected HeLa cells, the existence Of the two Ca2+ signaling pathways mentioned was confirmed and their subcellular characteristics and differences were further studied. We also suggest that astrocytic intercellular Call waves may be accompanied by and contribute to some of the ionic shifts observed in the brain upon traumatic brain injury. Further work will be needed to confirm our data in brain slices or even in the brain in vivo, and to establish the role and function of intercellular Ca2+ signals at the BBB.	State Univ Ghent Hosp, Dept Neurol, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Dept Physiol & Patholphysiol, B-9000 Ghent, Belgium; State Univ Ghent, Dept Physiol & Pathophysiol, B-9000 Ghent, Belgium; State Univ Ghent, Dept Neurol, B-9000 Ghent, Belgium		Paemeleire, K (corresponding author), State Univ Ghent Hosp, Dept Neurol, 1K12 IA,Pintelaan 185, B-9000 Ghent, Belgium.			Paemeleire, Koen/0000-0001-8103-3899			BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; Braet K, 2001, EUR J NEUROSCI, V13, P79, DOI 10.1046/j.1460-9568.2001.01372.x; Charles A, 1998, GLIA, V24, P39, DOI 10.1002/(SICI)1098-1136(199809)24:1<39::AID-GLIA5>3.0.CO;2-W; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; KIMELBERG HK, 1989, SCI AM, V260, P76; KIMELBERG HK, 1989, SCI AM, V260, P74; Leybaert L, 1998, GLIA, V24, P398, DOI 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.3.CO;2-I; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; Paemeleire K, 1999, EXP BRAIN RES, V126, P473, DOI 10.1007/s002210050755; Paemeleire K, 2000, J NEUROTRAUM, V17, P345, DOI 10.1089/neu.2000.17.345; Paemeleire K, 2000, BRAIN RES, V857, P235, DOI 10.1016/S0006-8993(99)02436-1; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; SANDERSON MJ, 1995, CIBA F SYMP, V188, P175	16	9	9	0	1	ACTA MEDICA BELGICA	BRUSSELS	AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM	0300-9009			ACTA NEUROL BELG	Acta Neurol. Belg.	SEP	2002	102	3					137	140					4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	607FV	WOS:000178782200006	12400252				2022-02-06	
J	Hillary, FG; Schatz, P; Moelter, ST; Lowry, JB; Ricker, JH; Chute, DL				Hillary, FG; Schatz, P; Moelter, ST; Lowry, JB; Ricker, JH; Chute, DL			Motor vehicle collision factors influence severity and type of TBI	BRAIN INJURY			English	Article							CEREBRAL CONCUSSION; BRAIN-INJURY; CONSCIOUSNESS; COMA	Primary objective: To analyse the relationship between motor vehicle collision factors and TBI. Research design: Retrospective design analysed the difference between the types of brain injuries sustained in distinct collision configurations. Methods and procedures: Medical charts and police accident reports were reviewed for individuals sustaining TBI in 168 motor vehicle collisions between 1985-1998. Main outcomes and results: Lateral collisions and collisions involving contact with a fixed object were associated with the most severe brain injuries. Analysis of safety restraints revealed that seatbelts not only reduce the probability of injury, but they also mediate the severity of brain injury when it is sustained. Conclusions: Future research should focus the prevention of injury by better defining the minimum physical thresholds at which brain injury might be sustained and the mechanisms by which these thresholds are achieved during natural collisions.	Univ Med & Dent New Jersey, Newark, NJ 07103 USA; St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; Drexel Univ, Neuropsychol Programme, Philadelphia, PA 19104 USA		Hillary, FG (corresponding author), Kessler Med Rehabil Res & Educ Corp, 119 Pleasant Valley Way, W Orange, NJ 07052 USA.	fhillary@kmrrec.org	Hillary, Frank/AAN-8622-2021	Ricker, Joseph/0000-0003-3415-991X; Schatz, Philip/0000-0002-6222-6545			Berker E, 1996, INT J NEUROSCI, V85, P195, DOI 10.3109/00207459608986683; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; EVANS L, 1986, J SAFETY RES, V17, P143, DOI 10.1016/0022-4375(86)90065-4; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hillary F, 2001, ARCH CLIN NEUROPSYCH, V16, P171, DOI 10.1016/S0887-6177(00)00050-0; HOLM S, 1979, SCAND J STAT, V6, P65; International Conference on Harmonization (ICH), 1997, FED REG, P62; JONES IS, 1989, J TRAUMA, V29, P646, DOI 10.1097/00005373-198905000-00020; JONES IS, 1982, P 1982 IRCOBI C COL, P1; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Loo GT, 1996, J TRAUMA, V41, P935, DOI 10.1097/00005373-199612000-00001; MASSIMO F, 1999, NEUROLOGY S3, V53; McIntosh TK, 1996, LAB INVEST, V74, P315; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; SIEGEL JH, 1993, J TRAUMA, V35, P920, DOI 10.1097/00005373-199312000-00019; SmithSeemiller L, 1997, BRAIN INJURY, V11, P735; TEASDALE G, 1974, LANCET, V2, P81; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; VIANO D, 1985, IRCOBI C GOT SWED, P24; WHYTE J, 1998, REHABILITATION MED P, P1191	28	9	9	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2002	16	8					729	741		10.1080/02699050110119844			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	583GP	WOS:000177399100008	12167197				2022-02-06	
J	Shiomi, N; Hashimoto, N; Takeuchi, H; Yamanaka, T; Nakagawa, N; Mineura, K				Shiomi, N; Hashimoto, N; Takeuchi, H; Yamanaka, T; Nakagawa, N; Mineura, K			Endoscopic findings in chronic subdural hematoma	NEUROLOGICAL SURGERY			Japanese	Article						chronic subdural hematoma; endoscopic finding; recurrence	CLOSED-SYSTEM DRAINAGE	On the genesis of chronic subdural hematoma (CSH), it is one of the possible explanations that a head injury triggers uncertain cause off for the formation of the hematoma membrane, where the bleeding occurs to form and enlarge the hematoma. Although some reports oil the staging classification based on computed tomography (CT) findings are availabe the natural course or history of the hematoma formation is not yet known. As previously reported, we have been using all endoscopically guided method in which a drainage tube is placed in the most frontal area of the cavity so as to evacuate the residual air efficiently. In this study. we analyzed the endoscopic findings in hematoma cavities and compared them with the clinical data, focusing on the past-trauma interval and recurrence of the hematoma. Between January 1999 and October 2000, we had an opportunity to observe the inner aspect of 60 hematomas in 48 patients. A trabecular structure was found in 39 hematoma cavities (65%). whereas apparent clot formation was observed in 18 cavities (30%). Septum formation leading to a multi-loculated hematoma was observed in 10 cavities (17%). Twenty-six patients with 32 hematomas with the obvious history of head injury were classified into 4 groups according to the peat-traumatic interval to the surgery, which are stage I : less than 30 days. stage II; 31 to 611 days, stage III; 61 to 90 days and stage IV; more than 91 days. Clot formation and a trabecular structure were frequently seen in stages II and III. Clot formation as statistically and significantly seen in the recurrent group. The results suggest that CSHs increase in size in stages II and III, when clot formation and a trabecular structure are frequently observed. Endoscopic observation of hematomas may assist to know hematomas, and clot formation may be a warning of hematoma recurrence.	Kyoto Prefectural Univ Med, Dept Neurosurg, Kyoto 602, Japan								Fukuhara T, 1996, SURG NEUROL, V45, P570, DOI 10.1016/0090-3019(95)00471-8; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Suzuki K, 1998, SURG NEUROL, V50, P231, DOI 10.1016/S0090-3019(97)00339-X; Takahashi Yoshihiko, 1996, Neurologia Medico-Chirurgica, V36, P627, DOI 10.2176/nmc.36.627; Tanikawa M, 2001, ACTA NEUROCHIR, V143, P613, DOI 10.1007/s007010170067; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870	6	9	15	0	1	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	JUL	2002	30	7					717	722					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	584UL	WOS:000177487100004	12134667				2022-02-06	
J	Reider-Groswasser, II; Groswasser, Z; Ommaya, AK; Schwab, K; Pridgen, A; Brown, HR; Cole, R; Salazar, AM				Reider-Groswasser, II; Groswasser, Z; Ommaya, AK; Schwab, K; Pridgen, A; Brown, HR; Cole, R; Salazar, AM			Quantitive imaging in late traumatic brain injury. Part I: late imaging parameters in closed and penetrating head injuries	BRAIN INJURY			English	Article							COMPUTED-TOMOGRAPHY; INTERUNCAL DISTANCE; ALZHEIMER-DISEASE; CT FINDINGS; HIPPOCAMPAL ATROPHY; DIFFUSION; MR; ENLARGEMENT; PERFUSION; DEMENTIA	Objective: To ascertain the value of relatively simple quantitative radiologic measurements after head injury. Despite major advances in neuroradiology, analysis and reporting of imaging studies is based primarily on individual subjective and local experience, rather than on reproducible, standardized parameters; reliance on newer technologies can improve care, but also raises diagnostic costs. Design: Blinded, retrospective, quantitative assessment of computerized tomography studies done some 14 years post-injury. Outcome measures: Frontal horn width (FHW); septum-caudate distance (SCD); temporal horn width (THW); interuncal distance (IUD); third ventricle width (3VW); ventricular score (VS); sulcal width (SW); gray-white matter discriminability (GWMD) and subjective assessment of atrophy (SAOA). Results: Diffuse and frontal damage was noted in both closed (CHI) and penetrating (PHI) head injury groups. Enlargement of frontal lobe parameters (septum-caudate distance and frontal horn width suggest frontal injury in both closed and penetrating traumatic brain injury (TBI). Temporal horn width and inter-uncal distance were related to VS, 3VW and FHW in closed, but not in penetrating head injury. Conclusions: Simple linear CSF space measurements are correlated with volumetric and parenchymal measures, and can represent valuable and reliable low-cost quantitative measures of long term brain damage after TBI.	Loewenstein Hosp & Rehabil Ctr, Dept Brain Injury Rehabil, DVHIP, IL-43100 Raanana, Israel; Loewenstein Hosp & Rehabil Ctr, HM Jackson Fdn Advancement Mil Med, Uniformed Serv Univ Hlth Sci, IL-43100 Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Imaging,Sect Neuroradiol, IL-69978 Tel Aviv, Israel		Groswasser, Z (corresponding author), Loewenstein Hosp & Rehabil Ctr, Dept Brain Injury Rehabil, DVHIP, 278 Achuza St,POB 3, IL-43100 Raanana, Israel.						ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; ARMITSU T, 1977, J COMPUTER ASSISTED, V1, P489; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; AYLWARD EH, 1991, AM J NEURORADIOL, V12, P1217; BOLLER FC, 1972, J NEUROL NEUROSUR PS, V35, P463, DOI 10.1136/jnnp.35.4.463; BROOKS RA, 1980, J COMPUT ASSIST TOMO, V4, P489, DOI 10.1097/00004728-198008000-00016; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; DAHLBECK SW, 1991, AM J NEURORADIOL, V12, P931; DORAISWAMY PM, 1993, AM J NEURORADIOL, V14, P141; EARLY B, 1993, AM J NEURORADIOL, V14, P907; FRONT D, 1972, NEURORADIOLOGY, V4, P6, DOI 10.1007/BF00344802; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GARDEUR D, 1979, J RADIOL ELEC MED N, V60, P79; GEORGE AE, 1981, AM J NEURORADIOL, V2, P205; Granholm L, 1972, Scand J Rehabil Med, V4, P31; GROSWASSER IR, 1995, C REH MED, P137; GROSWASSER IR, 1995, POL ISR NEUR C MAY W; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; GROSWASSER Z, IN PRESS BRAIN INJUR; GYLDENSTED C, 1977, NEURORADIOLOGY, V14, P183, DOI 10.1007/BF00496982; GYLDENSTED C, 1976, NEURORADIOLOGY, V11, P204; HAHN FJY, 1976, AM J ROENTGENOL, V126, P593, DOI 10.2214/ajr.126.3.593; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; HUGHES CP, 1981, RADIOLOGY, V139, P391, DOI 10.1148/radiology.139.2.6971454; INZELBERG R, 1987, NEURORADIOLOGY, V29, P535, DOI 10.1007/BF00350436; INZELBERG R, 1994, DEMENTIA PARKINSONS, P195; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KJOS BO, 1983, AM J ROENTGENOL, V141, P1227, DOI 10.2214/ajr.141.6.1227; KOLLER C, 1981, NEUROLOGY, V31, P404; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1993, HEAD INJURY, P525; MARAVILLA KR, 1978, J COMPUT ASSIST TOMO, V2, P156, DOI 10.1097/00004728-197804000-00005; McDaniel T, 2000, NEUROIMAGING, P699; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1080/028418501127346990; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; ReiderGroswasser I, 1997, BRAIN INJURY, V11, P865, DOI 10.1080/026990597122936; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; TIMMING R, 1982, ARCH PHYS MED REHAB, V63, P154; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; WEINSTEIN MA, 1977, RADIOLOGY, V122, P699, DOI 10.1148/122.3.699	49	9	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2002	16	6					517	525		10.1080/02699050110119141			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	569RK	WOS:000176615800006	12119087				2022-02-06	
J	Basford, JR; Rohe, DE; Barnes, CP; DePompolo, RW				Basford, JR; Rohe, DE; Barnes, CP; DePompolo, RW			Substance abuse attitudes and policies in US rehabilitation training programs: A comparison of 1985 and 2000	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						alcohol; rehabilitation; substance-related disorders; tobacco	SPINAL-CORD INJURY; TRAUMATIC BRAIN INJURY; CIGARETTE-SMOKING; STROKE; ALCOHOL; MISUSE; RISK; PREVALENCE; VETERANS; THERAPY	Objective: To assess and compare the attitudes, beliefs, and policies of physical medicine and rehabilitation (PM&R) training programs toward substance abuse and tobacco use over the last 15 years. Design: A blinded questionnaire was sent to all US rehabilitation medicine training program directors. Results were compared with a survey conducted in 1985. Setting: US PM&R residency training programs with inpatient rehabilitation training. Participants: Training directors or their designated agents. Intervention: A 35-item questionnaire was mailed between November 1999 and April 2000 to the 81 US training programs identified by the American Board of Physical Medicine and Rehabilitation as having rehabilitation training programs with inpatient rehabilitation units. Responses were pooled by our Survey Research Center to preserve anonymity. Training programs that did not respond received additional mailings and telephone calls to improve the response rate. Main Outcome Measures: Chi-square analysis to assess changes in responses with time. Results: Forty-six of the 79 (58%) eligible training programs responded 0 program had merged, I did not provide inpatient rehabilitation. Programs were located in cities ranging from less than 100,000 (n = 2) to greater than a million inhabitants (n = 18). Eighty percent (37/46) of the respondents were "concerned or very concerned" about their patients' alcohol and drug use, and 69% routinely assessed patients for alcohol and drug use compared with only 25% in 1985 (P < .00001). Almost all respondents (43/46) supported written guidelines to prohibit alcohol and drug use by patients in the rehabilitation unit. Eighty-three percent had a prohibition policy, and 72% had written guidelines. Both of those rates represent increases from the 1985 response rates of 65% and 45%, respectively. Ambivalence persisted about appropriate treatment programs for persons with disabilities: in 1985, 51% of the respondents agreed that a person with a disability could be treated appropriately in a substance abuse program designed for persons without a disability; in 2000, the percentage had increased to 64%. All respondents believed that tobacco use is an addiction, but only 25% of their units offered tobacco cessation services to patients on their rehabilitation unit. Conclusion: The survey results are encouraging. Since 1985, not only have substance abuse issues been recognized, but also systemic institutionalized approaches (eg, regular screening, written guidelines) have increased markedly. Tobacco is now uniformly accepted as an addiction, but screening and access to cessation programs are similar to that available for alcohol and drug treatment programs 15 years ago.	Mayo Clin & Mayo Fdn, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; Phoenix Rehabil, Phoenix, AZ USA		Basford, JR (corresponding author), Mayo Clin & Mayo Fdn, Dept Phys Med & Rehabil, 200 1st St SW, Rochester, MN 55905 USA.						ALDERSON MR, 1985, J EPIDEMIOL COMMUN H, V39, P286, DOI 10.1136/jech.39.4.286; ALMENOFF PL, 1995, LUNG, V173, P297; BOYLE MJ, 1991, J ROY SOC MED, V84, P608; COLDITZ GA, 1988, NEW ENGL J MED, V318, P937, DOI 10.1056/NEJM198804143181501; Fiore MC, 2000, TREATING TOBACCO USE; GORELICK PB, 1989, NEUROLOGY, V39, P339, DOI 10.1212/WNL.39.3.339; HEINEMANN AW, 1995, REHABIL PSYCHOL, V40, P125; HEINEMANN AW, 1990, REHABIL PSYCHOL, V35, P217, DOI 10.1037/h0079065; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HEINEMANN AW, 1988, ALCOHOL CLIN EXP RES, V12, P815, DOI 10.1111/j.1530-0277.1988.tb01352.x; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; HIENEMANN AW, 1992, INT J ADDICT, V27, P301; Irby H E, 1990, J Miss State Med Assoc, V31, P189; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KIRUBAKARAN VR, 1986, J STUD ALCOHOL, V47, P223, DOI 10.15288/jsa.1986.47.223; LAMID S, 1983, AM J PHYS MED REHAB, V62, P300; MOORE D, 1991, INT J ADDICT, V26, P65, DOI 10.3109/10826089109056240; Mourer S, 1993, SCI PSYCHOSOC PROCES, V6, P83; PEREZ M, 1989, SOC WORK HEALTH CARE, V14, P15; RADNITZ CL, 1995, INT J ADDICT, V30, P1117, DOI 10.3109/10826089509055831; ROHE DE, 1985, ARCH PHYS MED REHAB, V66, P701; Rothstein J L, 1992, J Am Paraplegia Soc, V15, P217; Skurnik Y, 1998, CLIN DERMATOL, V16, P545, DOI 10.1016/S0738-081X(98)00037-6; SPUNGEN AM, 1995, MIL MED, V160, P308, DOI 10.1093/milmed/160.6.308; Spungen AM, 1997, SPINAL CORD, V35, P652, DOI 10.1038/sj.sc.3100489; Thompson GH, 1998, ANN PHARMACOTHER, V32, P1067, DOI 10.1345/aph.17382; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	28	9	9	2	10	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2002	83	4					517	522		10.1053/apmr.2002.30922			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	538DF	WOS:000174798300012	11932854				2022-02-06	
J	Bowman, ML				Bowman, ML			The perfidy of percentiles	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						percentiles; score interpretation; score bias; neuropsychological test results	TRAUMATIC BRAIN INJURY	Standard texts in neuropsychology, forensic, and educational psychology recommend the use of percentile rank scores (PRs) in reports and in oral "feedback" on the grounds that percentiles are easily understood by nonpsychologists. This study tested that assumption, testing predictions that errors would be made consistent with misunderstanding PR values as units of equal intervals. Four hypotheses about errors in interpretation were tested using a 12-item task to assess third-year psychology undergraduates' estimates comparing PR scores against the familiar metric of IQ. All predictions of significant asymmetrical and systematic errors of interpretation were supported. Even psychometrically educated subjects grossly misinterpret the meaning of PRs. Commonly recommended graphical display formats may unwittingly enhance these errors. Implications are most significant for forensic neuropsychology. Apparently low PRs representing cognitive performance within the Average range will typically be misinterpreted to mean significant impairment and, thus, may distort compensation and personal injury awards. Conversely, apparently high PRs representing offender recidivism risk within the Average range will be misinterpreted as high risk and impede release. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada		Bowman, ML (corresponding author), Simon Fraser Univ, Dept Psychol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.						BERG RA, 1994, SCREENING BRAIN IMPA; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Gay L. R., 1996, ED RES COMPETENCIES, V5; Hare R.D., 1991, HARE PSYCHOPATHY CHE, V1st ed.; Heaton RK, 1991, COMPREHENSIVE NORMS; Jackson C., 1996, UNDERSTANDING PSYCHO; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Linn RL, 1995, MEASUREMENT ASSESSME; Long C. J., 1986, NEUROPSYCHOLOGY HDB, P548; LYMAN HB, 1998, TEST SCORES WHAT THE; McGrew K. S., 1994, CLIN INTERPRETATION; RUSSELL EW, 1994, CLIN GUIDE NEUROPSYC, P211; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Swaby B., 1989, DIAGNOSIS CORRECTION; TANNER BA, 1993, COMPUT HUM BEHAV, V9, P51, DOI 10.1016/0747-5632(93)90020-S; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	18	9	9	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2002	17	3					295	303	PII S0887-6177(01)00116-0	10.1016/S0887-6177(01)00116-0			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	536ZN	WOS:000174731900006	14589729				2022-02-06	
J	Hutchinson, PJ; O'Connell, MT; Coles, JP; Chatfield, DA; Coleman, MR; Al-Rawi, PG; Kett-White, CR; Gupta, AK; Menon, DK; Boniface, SJ; Heazell, M; Kirkpatrick, PJ; Pickard, JD				Hutchinson, PJ; O'Connell, MT; Coles, JP; Chatfield, DA; Coleman, MR; Al-Rawi, PG; Kett-White, CR; Gupta, AK; Menon, DK; Boniface, SJ; Heazell, M; Kirkpatrick, PJ; Pickard, JD			Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						cerebral metabolism; chlormethiazole; head injury; microdialysis; neuroprotection	GAMMA-AMINOBUTYRIC-ACID; TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN INJURY; NEURONAL DAMAGE; INTRACEREBRAL MICRODIALYSIS; GENERAL-ANESTHETICS; GLYCINE RECEPTORS; GABA(A) RECEPTOR; FOCAL ISCHEMIA; RAT	Aims Promising pre-clinical results from laboratory studies of neuro-protective drugs for the treatment of patients with stroke and head injury have not been translated into benefit during clinical trials. The objective of the study was to assess the feasibility of administrating a potential neuro-protective drug (chlormethiazole) in conjunction with multimodality monitoring (including microdialysis) to patients with severe head injury in order to determine the effect of the agent on surrogate endpoints and penetration into the brain. Methods Multimodality monitoring including cerebral and peripheral microdialysis was applied to five head-injured patients on the neuro-intensive care unit. Chlormethiazole (0.8%) was administered as a rapid (10 ml min(-1)) intravenous loading infusion for 5 min followed by a slow (1 ml min(-1)) continuous infusion for 60 min. The following parameters were monitored: heart rate, mean arterial blood pressure, intracranial pressure, cerebral perfusion pressure, peripheral oxygen saturation, continuous arterial oxygen partial pressure, arterial carbon dioxide partial pressure, arterial pH, arterial temperature, cerebral tissue oxygen pressure, cerebral tissue carbon dioxide pressure, cerebral pH, cerebral temperature, electroencephalograph (EEG), bi-spectral index, plasma glucose, plasma chlormethiazole, and cerebral and peripheral microdialysis assay for chlormethiazole, glucose, lactate, pyruvate and amino acids. Results Despite achieving adequate plasma concentrations, chlormethiazole was not detected in the peripheral or cerebral microdialysis samples. The drug was well tolerated and did not induce hypotension, hyperglycaemia or withdrawal seizures. The drug did not change the values of the physiological or chemical parameters including levels of GABA, lactate/pyruvate ratio and glutamate. The drug did, however, induce EEG changes, including burst suppression in two patients. Conclusions Chlormethiazole can be safely given to ventilated patients with severe head injury. There was no evidence of hypotension or withdrawal seizures. Combining a pilot clinical study of a neuro-protective agent with multimodality monitoring is feasible and, despite the lack of effect on physiological and chemical parameters in this study, may be a useful adjunct to the development of neuro-protective drugs in the future. Further investigation of the capability of microdialysis in this setting is required. By investigating the effect of a drug on surrogate end-points, it may be possible to identify promising agents from small pilot clinical studies before embarking on large phase III clinical trials.	Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia & Neurointens Care, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurophysiol, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Pharm, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England		Hutchinson, PJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Box 167, Cambridge CB2 2QQ, England.	p.hutch@which.net		Coles, Jonathan/0000-0003-4013-679X; O'Connell, Mark/0000-0001-6272-8767	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI		Antkowiak B, 1999, ANESTHESIOLOGY, V91, P500, DOI 10.1097/00000542-199908000-00025; Bachli H, 1996, NEUROL RES, V18, P370; BALDWIN HA, 1994, BRIT J PHARMACOL, V112, P188, DOI 10.1111/j.1476-5381.1994.tb13050.x; Belelli D, 1999, NEUROCHEM INT, V34, P447, DOI 10.1016/S0197-0186(99)00037-6; BULLOCK R, 1994, J NEUROSURG, V80, P595; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHOI DW, 1987, J NEUROSCI, V7, P357; CROSS AJ, 1989, BRIT J PHARMACOL, V98, P284, DOI 10.1111/j.1476-5381.1989.tb16893.x; CROSS AJ, 1995, BRIT J PHARMACOL, V114, P1625, DOI 10.1111/j.1476-5381.1995.tb14949.x; CROSS AJ, 1991, BRIT J PHARMACOL, V104, P406, DOI 10.1111/j.1476-5381.1991.tb12443.x; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P305, DOI 10.1111/j.1749-6632.1997.tb48441.x; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; Green AR, 1998, PHARMACOL TOXICOL, V83, P90, DOI 10.1111/j.1600-0773.1998.tb01449.x; Green AR, 2000, BRIT J PHARMACOL, V129, P95, DOI 10.1038/sj.bjp.0703042; HALES TG, 1992, EUR J PHARMACOL, V210, P239, DOI 10.1016/0014-2999(92)90410-6; HILLERED L, 1995, NEUROREPORT, V6, P1816, DOI 10.1097/00001756-199509000-00026; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 1999, NEUROL RES, V21, P352, DOI 10.1080/01616412.1999.11740943; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; JOHANSEN FF, 1991, ACTA NEUROL SCAND, V84, P1; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Marshall JWB, 1999, EXP NEUROL, V156, P121, DOI 10.1006/exnr.1998.6994; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; MELDRUM B, 1985, BRIT J ANAESTH, V57, P44, DOI 10.1093/bja/57.1.44; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; MOODY EJ, 1989, EUR J PHARMACOL, V164, P153, DOI 10.1016/0014-2999(89)90242-2; *MRC, 1998, NEUR AC BRAIN INJ TR; OLNEY JW, 1971, J NEUROPATH EXP NEUR, V30, P75, DOI 10.1097/00005072-197101000-00008; Orser BA, 1998, TOXICOL LETT, V101, P217, DOI 10.1016/S0378-4274(98)00188-X; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; RAVINDRAN J, 1994, NEUROSCI LETT, V176, P209, DOI 10.1016/0304-3940(94)90084-1; Robertson CS, 1998, NEUROL RES, V20, pS91; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SAJI M, 1987, SCIENCE, V235, P66, DOI 10.1126/science.3798095; SCHEYER RD, 1994, EPILEPSY RES, V18, P227, DOI 10.1016/0920-1211(94)90043-4; SHUAIB A, 1994, BRAIN RES, V666, P99, DOI 10.1016/0006-8993(94)90287-9; SHUAIB A, 1992, BRAIN RES, V590, P13, DOI 10.1016/0006-8993(92)91076-Q; SHUAIB A, 1993, EXP NEUROL, V123, P284, DOI 10.1006/exnr.1993.1160; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SNAPE MF, 1993, NEUROSCIENCE, V53, P837, DOI 10.1016/0306-4522(93)90628-S; STERNAU LL, 1989, STROKE, V20, P281, DOI 10.1161/01.STR.20.2.281; SYDSERFF SG, 1995, NEURODEGENERATION, V4, P323, DOI 10.1016/1055-8330(95)90022-5; SYDSERFF SG, 1995, BRIT J PHARMACOL, V114, P1631, DOI 10.1111/j.1476-5381.1995.tb14950.x; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Teasdale GM, 1997, ACTA NEUROCHIR, V139, P797, DOI 10.1007/BF01411397; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Ungerstedt U, 1984, METHODS NEUROSCIENCE, V6, P81; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wahlgren NG, 1999, STROKE, V30, P21, DOI 10.1161/01.STR.30.1.21; Wester P, 1998, CEREBROVASC DIS, V8, P188, DOI 10.1159/000015846; [No title captured]	62	9	9	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	MAR	2002	53	3					275	283		10.1046/j.0306-5251.2001.01552.x			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	530QG	WOS:000174370000009	11874391	Green Published			2022-02-06	
J	Fujita, R; Takayama, N; Ueda, H				Fujita, R; Takayama, N; Ueda, H			The cognition-enhancer nefiracetam is protective in BDNF-independent neuronal cell death under the serum-free condition	NEUROCHEMISTRY INTERNATIONAL			English	Article						nefiracetam; nootropic drugs; apoptosis; calcium channel	TRAUMATIC BRAIN INJURY; EXCITATORY SYNAPTIC TRANSMISSION; CEREBRAL BLOOD-FLOW; INDUCED IMPAIRMENT; MODULATION; APOPTOSIS; DESENSITIZATION; ANIRACETAM; ACTIVATION; RECEPTORS	Cortical cells from embryonic mice (E17) showed a rapid cell-death under the serum-free condition. The addition of nefiracetam. at 0.1-10 muM increased the survival activity, while aniracetam at the same concentrations did not. The cell death was characterized to be apoptotic, since dead cells showed nuclear condensation, fragmentation, and TUNEL-positive staining. The nefiracetam-induced anti-apoptotic activity was completely blocked by 1 muM nifedipine or omega-conotoxin GVIA, and partially by 1 muM verapamil. These results suggest that the reported anti-amnesic action of nefiracetam in ischemic animals may be partly attributed to the neuroprotective action. (C) 2001 Elsevier Science Ltd. All rights reserved.	Nagasaki Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol & Neurosci, Nagasaki 8528521, Japan		Ueda, H (corresponding author), Nagasaki Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol & Neurosci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.			Ueda, Hiroshi/0000-0002-8002-0137			BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOULIAEV AH, 1994, BRAIN RES REV, V19, P180, DOI 10.1016/0165-0173(94)90011-6; Hamabe W, 2000, MOL BRAIN RES, V78, P186, DOI 10.1016/S0169-328X(00)00074-7; Kimura M, 2000, PSYCHIAT CLIN NEUROS, V54, P314, DOI 10.1046/j.1440-1819.2000.00693.x; MUIZELAAR JP, 1994, CAN J NEUROL SCI, V21, pS6, DOI 10.1017/S0084255900003685; NABESHIMA T, 1994, EUR J PHARMACOL, V255, P57, DOI 10.1016/0014-2999(94)90082-5; Nabeshima Toshitaka, 1994, Drugs of Today, V30, P357; Oyaizu M, 1999, BRAIN RES, V822, P72, DOI 10.1016/S0006-8993(99)01077-X; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; RINK A, 1995, AM J PATHOL, V147, P1575; Sasaki Y, 1998, CELL MOL NEUROBIOL, V18, P487, DOI 10.1023/A:1026375225275; Shiotani T, 2000, BRAIN RES, V859, P255, DOI 10.1016/S0006-8993(00)01971-5; UEDA H, 1999, P 16 YOK 21 CENT FOR, P83; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMADA K, 1994, J PHARMACOL EXP THER, V270, P881; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yoshii M, 1997, BEHAV BRAIN RES, V83, P185, DOI 10.1016/S0166-4328(97)86066-4; YOSHII M, 1994, BRAIN RES, V642, P123, DOI 10.1016/0006-8993(94)90913-X; Yoshii M, 2000, ALZ DIS ASSOC DIS, V14, pS95, DOI 10.1097/00002093-200000001-00014; Zhao XL, 2001, MOL PHARMACOL, V59, P674, DOI 10.1124/mol.59.4.674	24	9	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186			NEUROCHEM INT	Neurochem. Int.	FEB	2002	40	2					139	143		10.1016/S0197-0186(01)00080-8			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	510ZG	WOS:000173237000005	11738480				2022-02-06	
J	Caselli, RJ; Hentz, JG; Osborne, D; Graff-Radford, NR; Barbieri, CJ; Alexander, GE; Hall, GR; Reiman, EM; Hardy, J; Saunders, AM				Caselli, RJ; Hentz, JG; Osborne, D; Graff-Radford, NR; Barbieri, CJ; Alexander, GE; Hall, GR; Reiman, EM; Hardy, J; Saunders, AM			Apolipoprotein E and intellectual achievement	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						apolipoprotein E; Alzheimer's disease; aging; intelligence	TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; INTRACEREBRAL HEMORRHAGE; CEREBROVASCULAR-DISEASE; PREMORBID INTELLIGENCE; COGNITIVE RESERVE; EDUCATIONAL-LEVEL; EPSILON-4 ALLELE; MEMORY DECLINE; ANIMAL-MODELS	OBJECTIVES: To determine whether apolipoprotein E (apo E) genotype influences intellectual achievement in cognitively normal individuals. DESIGN: Between 1994 and 1999 we performed apo E testing on 1,000 self-described cognitively normal residents of Maricopa County and detailed neuropsychological testing on a subset of 250. SETTING: Tertiary care academic medical center. PARTICIPANTS: Cognitively normal adults genotyped for apo E. MEASUREMENTS: Measures of intellectual background included years of education and a demographically based estimate of intellectual capacity (demographic intellectual quotient (DIQ)). Measures of intellectual achievement, which included Wechsler Adult Intelligence Scale revised (WAIS-R), information (WAISI), and vocabulary (WAISV) scores, occupational intellectual requirements (OIR), and census-derived estimates of household income, were compared between apo E genetic subgroups while adjusting for intellectual background and demographic variables. RESULTS: WAISI, WAISV, OIR, and income correlated with age, sex, education, and DIQ, but after controlling for these variables there were no clinically significant differences between apo E-e4 homozygotes and noncarriers on any measure. CONCLUSIONS: No clinically significant differences between genotypes were observed for the effects of education and DIQ on WAISI, WAISV, OIR, or income, although a larger sample Size would be required to exclude smaller, clinically insignificant differences.	Mayo Clin Scottsdale, Dept Neurol, Scottsdale, AZ 85259 USA; Mayo Clin Scottsdale, Dept Biostat, Scottsdale, AZ 85259 USA; Mayo Clin Scottsdale, Dept Psychol, Scottsdale, AZ 85259 USA; Mayo Clin Scottsdale, Dept Psychiat, Scottsdale, AZ 85259 USA; Mayo Clin Jacksonville, Dept Neurol, Jacksonville, AZ USA; Mayo Clin Jacksonville, Dept Pharmacol, Jacksonville, AZ USA; Arizona State Univ, Tempe, AZ USA; Univ Arizona, Tucson, AZ USA; Good Samaritan Reg Med Ctr, Phoenix, AZ USA; Duke Univ, Dept Med, Chapel Hill, NC USA		Caselli, RJ (corresponding author), Mayo Clin Scottsdale, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.		Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH057899] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1R01 MH57899-01A1] Funding Source: Medline		ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Caselli RJ, 1999, NEUROLOGY, V53, P201, DOI 10.1212/WNL.53.1.201; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Fleming LM, 1996, EXP NEUROL, V138, P252, DOI 10.1006/exnr.1996.0064; FOGEL ML, 1964, AM J ORTHOPSYCHIAT, V34, P555, DOI 10.1111/j.1939-0025.1964.tb02225.x; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HIXSON JE, 1990, J LIPID RES, V31, P545; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KAUFMAN AS, 1989, INTELLIGENCE, V13, P235, DOI 10.1016/0160-2896(89)90020-2; LADD CE, 1964, J CLIN PSYCHOL, V20, P114, DOI 10.1002/1097-4679(196401)20:1<114::AID-JCLP2270200116>3.0.CO;2-J; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Mayeux R, 2000, NEUROLOGY, V55, P1428, DOI 10.1212/WNL.55.10.1428; McCarron MO, 1998, STROKE, V29, P1882, DOI 10.1161/01.STR.29.9.1882; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Munoz DG, 2000, ARCH NEUROL-CHICAGO, V57, P85, DOI 10.1001/archneur.57.1.85; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; REIMAN EM, 1998, 4 ANN FLINN FDN BIOM, P19; REYNOLDS CR, 1979, CLIN NEUROPSYCHOLOGY, V1, P36; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Smith CD, 1999, NEUROLOGY, V53, P1391, DOI 10.1212/WNL.53.7.1391; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Troncoso JC, 1998, ANN NEUROL, V43, P673, DOI 10.1002/ana.410430519; United States Department of Labor, 1991, DICT OCCUPATIONAL TI, VFourth; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554	49	9	9	0	1	BLACKWELL PUBLISHING INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0002-8614			J AM GERIATR SOC	J. Am. Geriatr. Soc.	JAN	2002	50	1					49	54		10.1046/j.1532-5415.2002.50007.x			6	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	510YY	WOS:000173236200009	12028246				2022-02-06	
J	Joe, WQ; Ferraro, M; Schwartz, MF				Joe, WQ; Ferraro, M; Schwartz, MF			Sequencing and interleaving in routine action production	NEUROCASE			English	Article						sequencing; scripts; naturalistic action; closed head injury	NATURALISTIC ACTION; ACTION DISORGANIZATION; IDEATIONAL APRAXIA; SCRIPTS; MEMORY; INJURY; DAMAGE	We analysed the sequence of steps enacted during the performance of routine action tasks in the context of the 2 x 3 test. This test requires enactment of three routine tasks, each performed twice. Data from 35 healthy controls and 16 closed head injury patients were analysed to derive 'modal routes' through the 'sandwich', 'toast', and 'present' tasks, along with transition probabilities for the steps in the modal routes. Also investigated were the amount of interleaving and a potential structural constraint on interleaving. The results indicate that serial order production is more flexible than some might predict, and that the patients and controls were more similar than dissimilar on the measures taken. The first result argues against script architectures that are overly rigid. The second implies that the vulnerability to sequence and other errors in this patient group is not due to defects in script memories or serial order programming.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Bryn Mawr Coll, Bryn Mawr, PA 19010 USA		Schwartz, MF (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	mschwart@einstein.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 R01 NS31824-07] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031824] Funding Source: NIH RePORTER		ABELSON RP, 1981, AM PSYCHOL, V36, P715, DOI 10.1037/0003-066X.36.7.715; BOTVINICK M, J COGNITIVE NEUROS S; BOWER GH, 1979, COGNITIVE PSYCHOL, V11, P177, DOI 10.1016/0010-0285(79)90009-4; Buxbaum LJ, 1998, COGNITIVE NEUROPSYCH, V15, P617, DOI 10.1080/026432998381032; Buxbaum LJ, 1997, COGNITIVE NEUROPSYCH, V14, P219, DOI 10.1080/026432997381565; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; Cooper R, 2002, NEUROCASE, V8, P61, DOI 10.1093/neucas/8.1.61; GALAMBOS JA, 1982, J VERB LEARN VERB BE, V21, P260, DOI 10.1016/S0022-5371(82)90604-1; GALAMBOS JA, 1986, KNOWLEDGE STRUCTURES, P21; Graesser, 1981, PROSE COMPREHENSION; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; Grafman J., 1989, INTEGRATING THEORY P, P93; Hamilton BB, 1987, REHABILITATION OUTCO; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Houghton G., 1990, Current Research in Natural Language Generation, P287; Humphreys GW, 1998, COGN NEUROPSYCHOL, V15, P771; HUMPHREYS GW, 2000, ATTENTION PERFORMANC, V18; HUMPHREYS GW, 2001, HDB COGNITIVE NEUROP, P565; LEHMKUHL G, 1981, CORTEX, V17, P153, DOI 10.1016/S0010-9452(81)80017-2; Luria A.R., 1966, HIGHER CORTICAL FUNC; MacKay D., 1985, NEUROPSYCHOLOGICAL S, P267; NORMAN DA, 1981, PSYCHOL REV, V88, P1, DOI 10.1037/0033-295X.88.1.1; NOTTENBURG G, 1980, J EXP SOC PSYCHOL, V16, P329, DOI 10.1016/0022-1031(80)90026-8; Reed Edward S., 1992, Ecological Psychology, V4, P129, DOI 10.1207/s15326969eco0403_1; *SAS I, 1989, CATMOD PROC SAS STAT, V1, P405; Schank R, 1977, SCRIPTS PLANS GOALS; Schank RC, 1982, DYNAMIC MEMORY; Schwartz M. F., 1993, J HEAD TRAUMA REHAB, V8, P59, DOI [10.1097/00001199-199303000-00007, DOI 10.1097/00001199-199303000-00007]; SCHWARTZ MF, 1991, COGN NEUROPSYCHOL, V8, P381, DOI 10.1080/02643299108253379; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; Schwartz MF, 1995, ANN NY ACAD SCI, V769, P321, DOI 10.1111/j.1749-6632.1995.tb38148.x; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Trennery M. R., 1989, STROOP NEUROPSYCHOLO	35	9	9	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2002	8	1-2					135	150		10.1093/neucas/8.1.135			16	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	556ZJ	WOS:000175880200012	11997492				2022-02-06	
J	Platz, T; Denzler, P				Platz, T; Denzler, P			Do psychological variables modify motor recovery among patients with mild arm paresis after stroke or traumatic brain injury who receive the Arm Ability Training?	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						stroke; traumatic brain injury; cognition; arm; training; recovery	KINEMATIC MOTION ANALYSIS; INDUCED MOVEMENT THERAPY; SINGLE-BLIND; PERFORMANCE; REHABILITATION; INTERVENTION; HEMIPLEGIA; VALIDITY; DEFICIT; TRIAL	Purpose: The Arm Ability Training improves motor function among stroke and traumatic brain injury patients with mild arm paresis. There is, however, a considerable variability in motor recovery among patients receiving the Arm Ability Training. The study investigated whether psychological variables can explain the variability in motor recovery. Methods: In a sample of 33 patients receiving the Arm Ability Training both motor performance (by use of the standardised arm function test TEMPA) and cognitive functions (attention, perceptual abilities, and learning) as well as depression were assessed before training was commenced. Both univariate correlational analyses and stepwise multiple regression were used to investigate these variables' ability to predict motor improvement (TEMPA difference scores from pre to post test after 3 weeks). Results: The degree of motor dysfunction of the affected arm explained most (70%) of the variance of motor improvement scores of the standardised arm function test (TEMPA). Psychometric scores showed no or at the most weak associations with motor improvement (explaining at the most 10% of the variance). Conclusions: Psychological variables had not been critical modifiers of motor recovery among stroke and traumatic brain injury patients with mild arm paresis receiving the Arm Ability Training.	Free Univ Berlin, Klinikum Benjamin Franklin, Klin Berlin, Abt Neurool Rehabil, D-12200 Berlin, Germany		Platz, T (corresponding author), Klin Berlin, Kladower Damm 223, D-14089 Berlin, Germany.			Platz, Thomas/0000-0003-2629-9744			ASANUMA H, 1991, NEUROREPORT, V2, P217, DOI 10.1097/00001756-199105000-00001; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Cherney LR, 2001, ARCH PHYS MED REHAB, V82, P322, DOI 10.1053/apmr.2001.21511; Dahl G., 1986, HDB REDUZIERTEN WECH; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; DESROSIERS J, 1994, OCCUP THER J RES, V14, P267, DOI 10.1177/153944929401400405; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; Feys HM, 1998, STROKE, V29, P785, DOI 10.1161/01.STR.29.4.785; Fleishman E. A., 1964, STRUCTURE MEASUREMEN; FLEISHMAN EA, 1965, TRAINING RES ED, P137; Fleishman EA, 1967, LEARN INDIVID DIFFER, P165; FLORIAN V, 1996, THESIS HUMBOLDT U BE; Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940; *G SCH GMBH, 1992, FORTL VIS WIED; *G SCHUHFR GMBH, 1993, WIEN REAKT; GOLLIN ES, 1960, PERCEPT MOTOR SKILL, V11, P289; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; HERBERT R, 1988, AGE AGEING, V17, P293; Jonkman EJ, 1998, ACTA NEUROL SCAND, V98, P169, DOI 10.1111/j.1600-0404.1998.tb07289.x; KARNI A, 1995, NATURE, V377, P155; Kessler J., 1993, FRAGMENTIERTE BILDER; KRAFT GH, 1992, ARCH PHYS MED REHAB, V73, P220; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; PINKOWSKI C, 2000, 9 REH K VDR 2000 MAR, P188; PLATZ T, 1994, NEUROPSYCHOLOGIA, V32, P1209, DOI 10.1016/0028-3932(94)90103-1; Platz T, 2001, NEUROPSYCHOLOGIA, V39, P687, DOI 10.1016/S0028-3932(01)00005-7; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Platz T, 1999, ARCH PHYS MED REHAB, V80, P270, DOI 10.1016/S0003-9993(99)90137-5; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; WADE DT, 1992, MEASUREMENT NEUROLOG, P53; Wechsler, 1997, WECHSLER ADULT INTEL; ZIMMERMANN P, 1993, PSYCHOL TESTSYSTEME; 1991, HAMBURGWECHSLER INTE	46	9	9	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2002	20	1-2					37	49					13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	605RX	WOS:000178691800004	12237495				2022-02-06	
J	Mandal, K; West, CGH				Mandal, K; West, CGH			The management of immediate post-traumatic seizures in children following minor head injury - time for a multicentre study?	CHILDS NERVOUS SYSTEM			English	Article						post-traumatic seizure (PTS); immediate PTS; minor head injury	ROUTINE HOSPITALIZATION; POSTTRAUMATIC SEIZURES	Background: Children have a much lower threshold for seizure activity than adults. Consequently, an immediate post-traumatic seizure in a child following a minor head injury does not have the same potentially serious implications as one in an adult. Methods: The records of children admitted with a post-traumatic fit occurring within 24 h of a minor head injury and with a normal CT scan of the brain on admission were critically reviewed. Those with previous neurological disorders, especially fits (excepting febrile convulsions), or systemic injuries requiring admission to an intensive care unit were excluded. Results: There were 13 children who were not intubated and ventilated, forming the control group, and 13 children who were intubated and ventilated and formed the study group. All the children in both these groups made a good recovery, and none of them had any neurological deficit either at discharge or at follow-up. Conclusion: The clinical data suggest that children with immediate post-traumatic seizures following a minor head injury whose CT scan shows no major intracranial abnormalities and who have no prior history of neurological disease are at low risk of developing recurrent seizures or neurological complications and can be safely managed without recourse to intubation and ventilation.	Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England; Hope Hosp, Dept Accident & Emergency, Salford M6 8HD, Lancs, England		West, CGH (corresponding author), Hope Hosp, Dept Neurosurg, Stott Lane, Salford M6 8HD, Lancs, England.						ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Black P, 1972, T AM NEUROL ASSOC, V97, P247; DASILVA AM, 1990, ACT NEUR S, V50, P48; DAVIES RL, 1995, PEDIATRICS, V95, P345; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; ELDRIDGE AR, 1939, T AM NEURAL ASS, V65, P125; FOULON M, 1977, ACTA NEUROL BELG, V77, P276; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HENDRICK EB, 1968, J TRAUM, V8, P547; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; Jennet B, 1976, HDB CLIN NEUROLOGY, V24, P445; JENNETT B, 1973, DEV MED CHILD NEUROL, V15, P56; KADISH HS, 1995, PEDIATRICS, V95, P37; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kollevold T, 1976, J Oslo City Hosp, V26, P99; MISES J, 1970, EPILEPSIA, V11, P37, DOI 10.1111/j.1528-1157.1970.tb03864.x; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; ROSE J, 1977, BRIT MED J, V2, P625; SHAKELFORD SR, 1992, J TRAUMA, V33, P385; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STEIN SC, 1992, J TRAUMA, V97, P769	23	9	9	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	NOV	2001	17	11					670	673		10.1007/s00381-001-0520-9			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	503JW	WOS:000172796200004	11734985				2022-02-06	
J	Lu, J; Ashwell, KWS; Hayek, R; Waite, P				Lu, J; Ashwell, KWS; Hayek, R; Waite, P			Fluororuby as a marker for detection of acute axonal injury in rat spinal cord	BRAIN RESEARCH			English	Article						fluororuby; spinal cord; axonal injury; degeneration; marker; tracer	AMYLOID PRECURSOR PROTEIN; CORTICOSPINAL TRACT; NEURONAL APOPTOSIS; COMPRESSION TRAUMA; DEXTRAN-AMINES; HEAD-INJURY; DEGENERATION; BRAIN; REGENERATION; TRANSPORT	Axonal damage is a common pathological consequence of spinal cord injury. Previous studies have detected axonal injury with silver stains for degeneration or immunohistochemistry for alterations in components such as P-amyloid precursor protein, neurofilament or ubiquitin. Fluororuby has recently been introduced as a neuronal tracer in studies of spinal cord injury and regeneration. Our study was carried out to determine whether Fluororuby can be used to identify injured axons and monitor the time course of axonal damage. Adult rats underwent needle puncture injury to the white matter in the midline and lateral spinal cord at T11. At the same time, 0.05 mul of Fluororuby was injected into the cord at the same sites. After survival times ranging from 6 h to 3 weeks, spinal cords were cut into longitudinal frozen sections and examined with confocal microscopy. Fluororuby was found to label key features of axonal injury including axonal swelling, retraction balls and disrupted axons, Damaged axons close to the injury site were consistently labeled within 6 h. with indications of swollen and disconnected axons spreading further from the site during the first week. Fewer injured axons were labeled after 1 week survival. but the marker revealed longer distances of degenerating axons both distal and rostral to the injury site. Our findings indicate that Fluororuby is a quick, sensitive. reliable and technically simple fluorescent marker for early stages of acute axonal injury and degeneration. (C) 2001 Published by Elsevier Science BY.	Univ New S Wales, Sch Anat, Neural Injury Res Unit, Sydney, NSW 2052, Australia; Macquarie Univ, Dept Chiropract, Sydney, NSW 2109, Australia		Waite, P (corresponding author), Univ New S Wales, Sch Anat, Neural Injury Res Unit, Sydney, NSW 2052, Australia.						Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; BECERRA JL, 1995, AM J NEURORADIOL, V16, P125; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BLIGHT AR, 1993, ADV NEUROL, V59, P91; Borgens RB, 1997, EXP NEUROL, V145, P376, DOI 10.1006/exnr.1997.6499; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; BUNGE RP, 1993, ADV NEUROL, V59, P75; Cajal R., 1928, DEGENERATION REGENER; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; FRITZSCH B, 1991, J NEUROSCI METH, V39, P9, DOI 10.1016/0165-0270(91)90088-H; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Giolli RA, 1978, NEUROANATOMICAL RES, P211; GLOVER JC, 1986, J NEUROSCI METH, V18, P243, DOI 10.1016/0165-0270(86)90011-7; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRIFFIN JW, 1977, J NEUROPATH EXP NEUR, V36, P214, DOI 10.1097/00005072-197703000-00002; Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.0.CO;2-W; Kato H, 1997, EXP NEUROL, V148, P464, DOI 10.1006/exnr.1997.6707; Katoh K, 1996, NEUROSCI LETT, V216, P9; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; LI Y, 1995, EXP NEUROL, V134, P102, DOI 10.1006/exnr.1995.1041; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; PALLINI R, 1988, J NEUROSURG, V68, P124, DOI 10.3171/jns.1988.68.1.0124; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RICHMOND FJR, 1994, J NEUROSCI METH, V53, P35, DOI 10.1016/0165-0270(94)90142-2; SCHMUED L, 1990, BRAIN RES, V526, P127, DOI 10.1016/0006-8993(90)90258-D; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459	38	9	9	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 5	2001	915	1					118	123		10.1016/S0006-8993(01)02940-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481TX	WOS:000171537300016	11578629				2022-02-06	
J	Bakran, Z; Bobinac-Georgievski, A; Dzidic, I; Jelic, M; Eldar, R				Bakran, Z; Bobinac-Georgievski, A; Dzidic, I; Jelic, M; Eldar, R			Medical rehabilitation in Croatia - Impact of the 1991-1995 war: Past problems, present state, future concerns	CROATIAN MEDICAL JOURNAL			English	Article						amputees; community health services; craniocerebral trauma; Croatia; delivery of health care; disabled persons; health care quality, access and evaluation; rehabilitation; rehabilitation centers; spinal cord injuries; war	SPINAL-CORD INJURY; TRAUMATIC BRAIN INJURY; OUTCOMES; QUALITY; AMPUTATION; CARE	Aim. To assess whether the 1991-1995 war has stimulated development of the medical rehabilitation system in Croatia. Methods. Review of documents pertaining to the system, study of clinical reports describing rehabilitation activities as published in the Croatian medical literature, study of data obtained and their consideration in terms of effectiveness and quality of rehabilitation care, and comparison of data from 1991 with those from 1995. Results. There has been no significant change in the number of rehabilitation facilities, beds, and rehabilitation professionals. However, elements of structure and process of rehabilitation care have improved in respect of 1) education and composition of rehabilitation professionals, 2) availability of specialized facilities for rehabilitation of patients with complex impairments (traumatic brain and spinal cord injuries), 3) interdisciplinary team approach, 4) use of functional status measurements, and 5) laying the foundations for community-based rehabilitation in the country. Conclusion. The 1991-1995 war has stimulated the development of medical rehabilitation system in Croatia. Other factors may have played a complementary role, too. This proves that medical rehabilitation is a field that develops in association with war.	Loewenstein Hosp & Rehabil Ctr, Rehabil Ctr, Fleischman Unit Study Disabil, IL-43100 Raanana, Israel; Special Hosp Med Rehabil, Krapinske Toplice, Croatia; Holy Ghost Gen Hosp, Zagreb, Croatia; Special Hosp Med Rehabil, Varazdinske Toplice, Croatia; Natl Referral Ctr Rehabil Amputees, Zagreb, Croatia; Split Univ, Sch Med, Split, Croatia		Eldar, R (corresponding author), Loewenstein Hosp & Rehabil Ctr, Rehabil Ctr, Fleischman Unit Study Disabil, POB 3, IL-43100 Raanana, Israel.						AVERBUCH S, 2001, IN PRESS J PHYSICAL; BAKRAN Z, 2000, PHYSICAL MED REHABIL, P70; BAKRAN Z, 2000, REHABILITATION PATIE; Boake Corwin., 1989, J HEAD TRAUMA REHAB, V4, P1, DOI [10.1097/00001199-198909000-00004, DOI 10.1097/00001199-198909000-00004]; BOBINACGEORGIEV.A, 2000, INT J REHABIL RES, V23, P1; BOBINACGEORGIEV.A, 2000, DISABIL REHABIL S1, V22, P18; BOBINACGEORGIEV.A, 2000, PHYSICAL MED REHABIL, P17; *BUCK HLTH AUTH, 1971, BRIEF HIST STOK MAND; CARONNE PP, 1997, ARCH PHYS MED REHAB, V78, pA1029; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; DEVIVO MJ, 1992, PARAPLEGIA, V30, P108, DOI 10.1038/sc.1992.35; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; DOMLJAN Z, 1993, WHO EURO CONS STAT R; DONABEDIAN A, 1988, INQUIRY-J HEALTH CAR, V25, P173; DUBROJA I, 1998, THESIS U ZAGREB ZAGR; Durance J P, 1989, Int Disabil Stud, V11, P127; Dzidic I, 1997, SPINAL CORD, V35, P620, DOI 10.1038/sj.sc.3100465; DZIDIC I, 2001, SHORT DESCRIPTION DE; Eldar R, 1997, DISABIL REHABIL, V19, P547, DOI 10.3109/09638289709166048; Eldar R, 1999, INT J QUAL HEALTH C, V11, P73, DOI 10.1093/intqhc/11.1.73; Eldar R, 2000, DISABIL REHABIL, V22, P266, DOI 10.1080/096382800296728; Eldar Reuben, 1993, Croatian Medical Journal, V34, P21; Frankel H, 1999, SPINAL CORD, V37, P461, DOI 10.1038/sj.sc.3100869; FULTON JF, 1953, JAMA-J AM MED ASSOC, V153, P482, DOI 10.1001/jama.1953.02940220026008; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; HEINEMANN AW, 1989, ARCH NEUROL-CHICAGO, V46, P1098, DOI 10.1001/archneur.1989.00520460084017; Horton R, 1999, LANCET, V353, P2139, DOI 10.1016/S0140-6736(99)05242-3; Horton R, 1999, LANCET, V353, P2223, DOI 10.1016/S0140-6736(99)06043-2; Inman C, 1999, CLIN REHABIL, V13, P25, DOI 10.1191/026921599674943310; IVEKOVIC V, 1992, KLIN MED MOSCOW, V1, P31; JELIC M, 2000, PHYSICAL MED REHABIL, P380; JELIC M, 2000, REHABILITATION PERSO; JELIC M, 2000, PHYSICAL MED REHABIL, P123; KEITH RA, 1991, ARCH PHYS MED REHAB, V72, P269; Kent R, 1999, CLIN REHABIL, V13, P43, DOI 10.1191/026921599676538002; KOSTENAROVICZIV.D, 2000, PHYSICAL MED REHABIL, P382; Kovacic L, 1998, Croat Med J, V39, P249; KRAPAC L, 2000, PHYSICAL MED REHABIL, P356; LACKOVIC Z, 1992, CROATIAN MED J S2, V33, P110; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MAJSEC M, 2000, PHYSICAL MED REHABIL, P400; MARNO S, 1996, PARAPLEGIA, V34, P382; MARTINOVICVLAHO.R, 2000, PHYSICAL MED REHABIL, P361; McColl I, 1986, REV ARTIFICIAL LIMB; NANKOVIC V, 1992, KLINICKA MED, V1, P52; Palmer RH, 1998, INT J QUAL HEALTH C, V10, P477; PEDERSEN P, 1994, J TRAUMA, V36, P195, DOI 10.1097/00005373-199402000-00008; Pernot HFM, 1997, CLIN REHABIL, V11, P93, DOI 10.1177/026921559701100202; POTREBICA S, 2000, PHYSICAL MED REHABIL, P423; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; SENTE D, 2000, PHYSICAL MED REHABIL, P383; SOPRAMANIEN A, 1993, PARAPLEGIA, V31, P521; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Traballesi M, 1998, DISABIL REHABIL, V20, P380, DOI 10.3109/09638289809166097; TURK M, 1992, KLINICKA MED, V1, P28; Turner-Stokes L, 1999, CLIN REHABIL, V13, P3, DOI 10.1191/026921599673346206; Vuori H, 1993, Qual Assur Health Care, V5, P99; *ZAGR U SCH MED, 1995, INF SYST MIDT REP	60	9	9	0	3	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-9504			CROAT MED J	Croat. Med. J.	OCT	2001	42	5					556	564					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489BF	WOS:000171971600013	11596173				2022-02-06	
J	Hirashima, Y; Endo, S; Nakamura, S; Kurimoto, M; Takaku, A				Hirashima, Y; Endo, S; Nakamura, S; Kurimoto, M; Takaku, A			Cerebrospinal fluid membrane-bound tissue factor and myelin basic protein in the course of vasospasm after subarachnoid hemorrhage	NEUROLOGICAL RESEARCH			English	Article						cerebrospinal fluid; membrane-bound tissue factor; subarachnoid hemorrhage; vasospasm	TRAUMATIC BRAIN INJURY; CEREBRAL VASOSPASM; FACTOR ANTIGEN; LOCALIZATION; PAPAVERINE; CSF	No marker that predicts accurately the time of occurrence of cerebral vasospasm due to subarachnoid hemorrhage (SAH) has been reported. In the present study, membrane-bound tissue factor (mTF) and myelin basic protein (MBP) concentrations in cerebrospinal fluid (CSF) were evaluated as a predictor of the time of occurrence of cerebral vasospasm. The mTF and MBP concentrations were measured in the CSF from 28 patients with SAH due to ruptured aneurysm. Serial assays were performed from day 4 to day 14 after SAH. CSF mTF and MBP concentrations from days 5 to 9 correlated with the volume of cerebral infarction due to vasospasm and outcome three months after SAH. From the serial assays, CSF mTF measurements predicted the time of occurrence and severity and irreversibility of symptoms due to vasospasm. In conclusion, CSF mTF is predictive of the occurrence and the recovery of cerebral vasospasm, while CSF MBP is only an indicator of severity of brain damage due to vasospasm.	Toyama Med & Pharmaceut Univ, Dept Neurosurg, Toyama 9300194, Japan; Kyoto Univ, Primate Res Inst, Dept Cell & Mol Biol, Kyoto, Japan		Hirashima, Y (corresponding author), Toyama Med & Pharmaceut Univ, Dept Neurosurg, 2630 Sugitani, Toyama 9300194, Japan.						DELZOPPO GJ, 1992, THROMB HAEMOSTASIS, V68, P642; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; FINDLAY JM, 1988, J NEUROSURG, V69, P723, DOI 10.3171/jns.1988.69.5.0723; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FLECK RA, 1990, THROMB RES, V57, P765, DOI 10.1016/0049-3848(90)90034-A; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; HIGASHIDA RT, 1989, J NEUROSURG, V71, P648, DOI 10.3171/jns.1989.71.5.0648; Hirashima Y, 1997, STROKE, V28, P1666, DOI 10.1161/01.STR.28.9.1666; JANNETT B, 1975, LANCET, V1, P480; KAKU Y, 1992, J NEUROSURG, V77, P842, DOI 10.3171/jns.1992.77.6.0842; KASSELL NF, 1992, J NEUROSURG, V77, P848, DOI 10.3171/jns.1992.77.6.0848; LAMERS KJB, 1995, ACTA NEUROL SCAND, V92, P247; LONGATTI PL, 1994, CHILD NERV SYST, V10, P96, DOI 10.1007/BF00302771; MCCOMB RD, 1991, AM J PATHOL, V139, P491; Najeme F, 1997, BRAIN RES PROTOC, V1, P133, DOI 10.1016/S1385-299X(96)00021-9; NAKAGAWA H, 1994, NEUROSURGERY, V34, P825, DOI 10.1227/00006123-199405000-00006; NAKAMURA S, 1993, THROMB HAEMOSTASIS, V69, P744; NAKAMURA S, 1994, J MED TECHNOL, V38, P925; OHMAN J, 1988, J NEUROSURG, V69, P683, DOI 10.3171/jns.1988.69.5.0683; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457	20	9	11	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	OCT	2001	23	7					715	720		10.1179/016164101101199225			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504FE	WOS:000172846000005	11680510				2022-02-06	
J	Netsell, R				Netsell, R			Speech aeromechanics and the dysarthrias: Implications for children with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; dysarthria; evaluation; speech disorders; traumatic brain injury; treatment	LANGUAGE PATHOLOGIST; PHYSICAL-EXAMINATION	Background: In addition to cognitive, linguistic, neurobehavioral, and physical challenges, children and adolescents with traumatic brain injury can have a dysarthria that compromises intelligibility and speaking effort. Objective: The focus of this article is on an aeromechanical approach to understanding, evaluating, and treating the moderate-severe dysarthrias in these children.	SW Missouri State Univ, Dept Commun Sci & Disorders, Springfield, MO 65804 USA		Netsell, R (corresponding author), SW Missouri State Univ, Dept Commun Sci & Disorders, 901 S Natl Ave, Springfield, MO 65804 USA.						BERKE G, 1989, LARYNGOSCOPE 2, V102, P770; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; CAMPBELL TF, 1999, CLIN MANAGEMENT MOTO; CERNY FJ, 1997, J MED SPEECH-LANG PA, V5, P141; Duffy JR., 2020, MOTOR SPEECH DISORDE; Hardy J, 1967, CORTEX, V3, P128; Hixon T.J., 1987, RESP FUNCTION SPEECH; Hixon TJ, 1999, AM J SPEECH-LANG PAT, V8, P335, DOI 10.1044/1058-0360.0804.335; Hixon TJ, 1998, AM J SPEECH-LANG PAT, V7, P37, DOI 10.1044/1058-0360.0704.37; Hodge M. M., 1999, CLIN MANAGEMENT MOTO; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Kent R., 1992, INTELLIGIBILITY SPEE; KENT RD, 1999, CLIN MANAGEMENT MOTO; KUEHN DP, 1994, MOTOR SPEECH DISORDE; LEFKOWITZ D, 1994, J MED SPEECH-LANG PA, V2, P1; LOTZ W, 1984, 2 BIENN CLIN DYS C T; Love R. J., 2000, CHILDHOOD MOTOR SPEE; MCHENRY MA, 1994, J MED SPEECH-LANG PA, V2, P59; MCHENRY MA, 1996, DISORDERS MOTOR SPEE; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; NETSELL R, 1985, J SPEECH HEAR DISORD, V50, P103, DOI 10.1044/jshd.5001.103; NETSELL R, 1978, J SPEECH HEAR DISORD, V43, P326, DOI 10.1044/jshd.4303.326; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; NETSELL R, 1992, NEUROPHYSIOLOGY NEUR, V2, P1; Netsell R., 1986, NEUROBIOLOGIC VIEW S; NETSELL R, 1992, ASHA, V34, P152; NETSELL R, 1995, NEWSLETTER SPECIAL I, V5, P7; NETSELL R, 1989, RECENT ADV DYSARTHRI; NETSELL R, 1985, SPEECH LANGUAGE EVAL; NETSELL RW, 1998, J MED SPEECH-LANG PA, V6, P107; RAMIG L, 1995, OTOLARYNGOLOGY HEAD, V3, P174; ROSENBEK JC, 1985, CLIN MANAGEMENT NEUR; RUSSELL ML, 1998, TBI REHABILITATION C; SIMPSON MB, 1988, J SPEECH HEAR DISORD, V53, P433, DOI 10.1044/jshd.5304.433; SMITHERAN JR, 1981, J SPEECH HEAR DISORD, V46, P138, DOI 10.1044/jshd.4602.138; STIERWALT JAG, 1996, DISORDERS MOTOR SPEE; STRAND EA, 1995, SEM SPEECH LANG; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; THEODOROS DG, 1996, DISORDERS MOTOR SPEE; WHITNEY B, 1998, 4 BIENN CLIN DYS C S; WORKINGER MN, 1992, BRAIN INJURY, V6, P182; WORKINGER MS, 1995, NEWSLETTER SPECIAL I, V5, P2; Yorkston KM., 1999, MANAGEMENT MOTOR SPE	44	9	11	0	4	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2001	16	5					415	425		10.1097/00001199-200110000-00002			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483JF	WOS:000171631700002	11574038				2022-02-06	
J	Maejima, S; Katayama, Y				Maejima, S; Katayama, Y			Neurosurgical trauma in Japan	WORLD JOURNAL OF SURGERY			English	Article							THYROTROPIN-RELEASING-HORMONE; CENTRAL-NERVOUS-SYSTEM; CORTICAL IMPACT INJURY; EXPERIMENTAL STROKE; TRH ANALOG; RAT-BRAIN; IN-VIVO; ACETYLCHOLINE; NS-3; ANTAGONIST	According to the statistics compiled by the Institute for Traffic Accident Research and Data Analysis, the total number of head trauma patients has stayed virtually the same for the last 10 years in Japan, although a fraction of people suffering minor head trauma has shown a trend to increase. The Japan Society of Neurotraumatology is in the process of establishing a guideline for head trauma management. No major difference is noted in surgical procedures selected by neurosurgeons in Japan as compared to those in other countries. It appears, however, that the ventriculostomy may be less frequently employed to control elevated intracranial pressure, and the jugular bulb venous oximetry is far more frequently employed to detect cerebral deoxygenation in Japan. There appear to be two obvious differences in selection of pharmacological therapies among neurosurgeons in Japan and those in other countries; neurosurgeons in Japan prefer glycerol to mannitol for osmotic control of intracranial pressure, and barbiturate to morphine as sedatives. Two drugs are currently available in Japan for promoting the recovery from disturbance of consciousness after head trauma: cytidine diphosphate choline (CDP)-choline (Nicholin, Takeda Chemical Industries, Ltd., Osaka) and protirelin tartrate (Hirtonin; thyrotropinreleasing hormone (TRH) analogue, Takeda). Another TRH analogue, NS-3 (montirelin hydrate), is currently submitted to the Ministry of Health and Welfare for approval. A multi-institutional controlled study to examine the efficacy of therapeutic hypothermia for head trauma management is now in progress in Japan. The Japan Neurotrauma Data Bank System was inaugurated 2 years ago, enabling joint statistical processing at 10 major neurotrauma centers. Utilizing such a system, more detailed analysis of head trauma management will be possible, and clinical trials will be conducted systematically and more promptly in future.	Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, Tokyo 1738610, Japan		Maejima, S (corresponding author), Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, Oyaguchi Kami Machi 30-1, Tokyo 1738610, Japan.						ADACHI T, 1990, AUTONOMIC NERVOUS SY, V27, P442; BOLER J, 1969, BIOCHEM BIOPH RES CO, V37, P705, DOI 10.1016/0006-291X(69)90868-7; BREESE GR, 1975, J PHARMACOL EXP THER, V193, P11; BRUNELLO N, 1981, J PHARMACOL EXP THER, V219, P489; Espagno J., 1979, VIE MED, V3, P195; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FLOHE L, 1953, THYROTROPIN RELEASIN, P327; FUKUDA N, 1979, FOLIA PHARMACOL JPN, V75, P321, DOI 10.1254/fpj.75.321; FUKUDA N, 1985, JPN PHARMACOL THER, V13, P5021; GRIFFITHS EC, 1986, NATURE, V322, P212, DOI 10.1038/322212a0; GRIFFITHS EC, 1987, CLIN SCI, V73, P449, DOI 10.1042/cs0730449; HORITA A, 1986, ANNU REV PHARMACOL, V26, P311; HORITA A, 1989, PEPTIDES, V10, P121, DOI 10.1016/0196-9781(89)90087-9; ITOH Y, 1995, J PHARM PHARMACOL, V47, P833, DOI 10.1111/j.2042-7158.1995.tb05750.x; ITOH Y, 1994, J PHARMACOL EXP THER, V271, P884; KAKIHANA M, 1985, JPN PHARMACOL THER, V13, P5043; KOIKE Y, 1970, J NEW REMEND CLIN, V19, P1815; KONO S, 1972, OKAYAMA IGAKUKAI ZAS, V84, P289; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; Kroppenstedt SN, 1998, ACT NEUR S, V71, P114; MANAKA S, 1977, IGAKU NO AYUMI, V102, P867; MINEMATSU K, 1993, NEUROLOGY, V43, P397, DOI 10.1212/WNL.43.2.397; MINEMATSU K, 1993, STROKE, V24, P2074, DOI 10.1161/01.STR.24.12.2074; MIYAKE Y, 1996, J CLIN THER MED, V12, P1013; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; MORLEY JE, 1979, LIFE SCI, V25, P1539, DOI 10.1016/0024-3205(79)90435-1; NAGAI Y, 1985, JPN PHARMACOL THER, V13, P5037; NAKAJIMA M, 1996, J CLIN THER MED, V12, P981; NARUMI S, 1983, LIFE SCI, V32, P1637, DOI 10.1016/0024-3205(83)90871-8; OGASAWARA T, 1993, BIOMED RES-TOKYO, V14, P317, DOI 10.2220/biomedres.14.317; Ohkawa S, 1997, J MED CHEM, V40, P559, DOI 10.1021/jm960411j; OKADA M, 1991, J NEUROCHEM, V56, P1544, DOI 10.1111/j.1471-4159.1991.tb02049.x; PLOTNIKOFF NP, 1972, SCIENCE, V178, P417, DOI 10.1126/science.178.4059.417; SAJI Y, 1975, BASIC CLIN REP, V9, P262; SCHMIDT DE, 1977, COMMUN PSYCHOPHARMAC, V1, P469; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7; TAKAKURA K, 1996, J CLIN THER MED, V12, P1051; TAKAKURA K, 1996, J CLIN THER MED, V12, P1031; TAKAKURA K, 1996, J CLIN THER MED, V12, P1079; TAKAMIYA Y, 1966, KURUME IGAKUKAI ZASS, V29, P985; WATANABE M, 1971, BRAIN NERVE, V23, P721; YAMAMOTO M, 1987, N-S ARCH PHARMACOL, V336, P561; YARBROUGH GG, 1979, PROG NEUROBIOL, V12, P291, DOI 10.1016/0301-0082(79)90012-1; YASUHARA M, 1974, CURR THER RES CLIN E, V16, P346; YOSHIMOTO T, 1976, JPN PHARMACOL THER, V4, P823	45	9	11	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0364-2313			WORLD J SURG	World J.Surg.	SEP	2001	25	9					1205	1209		10.1007/s00268-001-0083-7			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	471NB	WOS:000170934500019	11571959				2022-02-06	
J	Perron, AD; Brady, WJ; Erling, BF				Perron, AD; Brady, WJ; Erling, BF			Commotio cordis: An underappreciated cause of sudden cardiac death in young patients: Assessment and management in the ED	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						commotio cordis; cardiac concussion; sudden cardiac death; sports injuries	ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; CLINICAL IMPLICATIONS; SPORTS ACTIVITIES; CHEST IMPACT; CHILDREN; ADULTS; TRAUMA; ARREST	Commotio cordis is the condition of sudden cardiac death or near sudden cardiac death after blunt, low-impact chest wall trauma in the absence of structural cardiac abnormality. Ventricular fibrillation is the most commonly reported induced arrhythmia in commotio cordis. Blunt impact injury to the chest with a baseball is the most common mechanism. Survival rates for commotio cordis are low, even with prompt CPR and defibrillation. (Am J Emerg Med 2001;19:406-409. Copyright (C) 2001 by W.B. Saunders Company).	Univ Virginia Hlth Syst, Dept Emergency Med, Charlottesville, VA 22908 USA; Univ Virginia, Dept Emergency Med, Charlottesville, VA USA		Perron, AD (corresponding author), Univ Virginia Hlth Syst, Dept Emergency Med, Box 800699, Charlottesville, VA 22908 USA.						Bir CA, 1999, J TRAUMA, V47, P468, DOI 10.1097/00005373-199909000-00006; Brugada J, 1997, J CARDIOVASC ELECTR, V8, P325, DOI 10.1111/j.1540-8167.1997.tb00796.x; Brugada J, 1998, CIRCULATION, V97, P457; Brugada J, 2000, EUR HEART J, V21, P264; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; Crown LA, 1997, AM FAM PHYSICIAN, V55, P2467; Denton JS, 2000, J FORENSIC SCI, V45, P734; ESTES NAM, 1995, NEW ENGL J MED, V333, P380, DOI 10.1056/NEJM199508103330611; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Link MS, 1998, CHEST, V114, P326, DOI 10.1378/chest.114.1.326; Maron BJ, 1997, AM J CARDIOL, V79, P840, DOI 10.1016/S0002-9149(96)00887-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; Meola F, 1879, GIORNALE INT SCI MED, V1, P923; Michalodimitrakis EN, 1997, AM J FOREN MED PATH, V18, P282, DOI 10.1097/00000433-199709000-00010; SCHLOMKA G, 1932, S GES EXP MED, V85, P171; TOWBIN JA, 1995, NEW ENGL J MED, V333, P384, DOI 10.1056/NEJM199508103330613; VIANO DC, 1978, J TRAUMA, V18, P452, DOI 10.1097/00005373-197806000-00010; Vincent GM, 2000, PHYSICIAN SPORTSMED, V28, P31, DOI 10.3810/psm.2000.11.1285; Wang JN, 2000, CARDIOLOGY, V93, P124, DOI 10.1159/000007013	23	9	11	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	SEP	2001	19	5					406	409		10.1053/ajem.2001.24455			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	472EK	WOS:000170970400005	11555799				2022-02-06	
J	Schnirring, L				Schnirring, L			How effective is computerized concussion management?	PHYSICIAN AND SPORTSMEDICINE			English	Article																	ERLANGER D, IN PRESS J ATHLETIC; MAKDISSI M, IN PRESS BR J SPORTS	2	9	9	0	0	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	AUG	2001	29	8					11	+					3	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	461NQ	WOS:000170370700003					2022-02-06	
J	Schopp, LH; Herrman, TD; Johnstone, B; Callahan, CD; Roudebush, IS				Schopp, LH; Herrman, TD; Johnstone, B; Callahan, CD; Roudebush, IS			Two abbreviated versions of the Wechsler Adult Intelligence Scale-III: Validation among persons with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							SHORT FORMS; WAIS-R; VALIDITY; SUBTESTS; UTILITY; SAMPLE	Objective: To examine the clinical value of two 7-subtest versions of the Wechsler Adult Intelligence Scale-III (WAIS-III): one using Block Design (WAIS-III/BD7) and another using Matrix Reasoning (WAIS-III/MR7) among persons with traumatic brain injury (TBI). Study Design: Actual obtained scores from the full WAIS-III were compared with scores that would have been obtained using each of the two abbreviated versions. Participants: One hundred eighteen persons with TBI tested consecutively in an academic medical center outpatient neuropsychology laboratory. Results: For the WAIS-III/BD7, corrected validity coefficients were .97 (Verbal IQ [VIQ]), .94 (Performance IQ [PIQ]), and .97 (Full Scale IQ [FSIQ]); 92%, 70%, and 92% of scores fell within 5 points of full version scores for VIQ, PIQ, and FSIQ, respectively. WAIS-III/MR7 corrected validity coefficients were .97 (VIQ), .95 (PIQ), and .97 (FSIQ); 92%, 76%, and 92% of short-form scores were within 5 points of actual scores for VIQ, PIQ, and FSIQ, respectively. Conclusions: Both abbreviated versions demonstrated acceptable psychometric characteristics, but the matrix reasoning version may be more advantageous in assessing persons with TBI because it can be used with persons who have TBI-related motor skills impairment.	Univ Missouri, Dept Phys Med & Rehabil, Columbia, MO 65212 USA		Schopp, LH (corresponding author), Univ Missouri, Dept Phys Med & Rehabil, DC046-00,1 Hosp Dr, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649			Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P222; Callahan CD, 1997, ARCH CLIN NEUROPSYCH, V12, P133, DOI 10.1016/S0887-6177(96)00029-7; KAUFMAN AS, 1991, J PSYCHOEDUC ASSESS, V9, P4, DOI 10.1177/073428299100900101; KAUFMAN AS, 1977, J CONSULT CLIN PSYCH, V45, P1159, DOI 10.1037/0022-006X.45.6.1159; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Ryan JJ, 1998, J PSYCHOEDUC ASSESS, V16, P315, DOI 10.1177/073428299801600403; SATTLER JM, 1999, ASSESSMENT CHILDREN; Schopp LH, 1998, ARCH CLIN NEUROPSYCH, V13, P637, DOI 10.1016/S0887-6177(97)00096-6; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; SILVERSTEIN AB, 1977, J CONSULT CLIN PSYCH, V45, P1162, DOI 10.1037/h0078060; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1981, WAIS R MANUAL WECHSL	15	9	9	0	2	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2001	46	3					279	287		10.1037/0090-5550.46.3.279			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	472DZ	WOS:000170969400006					2022-02-06	
J	Katano, H; Fujita, K; Kato, T; Asai, K; Kawamura, Y; Masago, A; Yamada, K				Katano, H; Fujita, K; Kato, T; Asai, K; Kawamura, Y; Masago, A; Yamada, K			A metabotropic glutamate receptor antagonist, alpha-methyl-4-carboxyphenylglycine, attenuates immediate early gene mRNA expression following traumatic injury in cultured rat cortical glial cells	NEUROSCIENCE LETTERS			English	Article						immediate early gene; c-fos; c-jun; metabotropic glutamate receptor; (S)-alpha-methyl-4-carboxyphenylglycine; mechanical injury; mRNA; glia	MESSENGER-RNA EXPRESSION; GROUP-I; C-FOS; BRAIN INJURY; ASTROCYTES; NMDA	The effects of three glutamate receptor antagonists, (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine hydrogen maleate (MK-801) for the N-methyl-D-aspartate receptor, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo[f] quinoxaline-7-sulfonamide (NBOX) for the alpha -amino-3-hydroxy-5-methyl-4-isoxazole propionate /kinate receptor and (S)-alpha -methyl-4-carboxyphenylglycine (MCPG) for the metabotropic receptor, on c-fos and c-jun mRNA expression were investigated in cultured cortical glial cells following traumatic scratch injury. Expression of the two genes along the edges of wounds detected by in situ hybridization was not affected by MK-801 and NBQX. However, 100 and 500 muM of MCPG remarkably reduced the hybridization signals for both c-fos and c-jun mRNAs. The present results suggest that group I metabotropic glutamate receptors might have some association with immediate early gene induction after in vitro traumatic injury in glial cells. (C) 2001 Published by Elsevier Science Ireland Ltd.	Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Bioregulat Res, Mizuho Ku, Nagoya, Aichi 467, Japan		Katano, H (corresponding author), Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.		Asai, Kiyofumi/H-2356-2014	Asai, Kiyofumi/0000-0001-7015-2251			Agrawal SK, 1997, J NEUROSCI, V17, P1055; Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; CURRAN T, 1987, ONCOGENE, V2, P79; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Harada S, 1997, NEUROREPORT, V8, P3399, DOI 10.1097/00001756-199710200-00041; Katano H, 1999, NEUROREPORT, V10, P2439, DOI 10.1097/00001756-199908200-00002; KOHMURA E, 1995, MOL BRAIN RES, V28, P117, DOI 10.1016/0169-328X(94)00198-N; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; MILLER S, 1995, J NEUROSCI, V15, P6103; Ohno M, 1998, NEUROSCI LETT, V240, P37, DOI 10.1016/S0304-3940(97)00922-1; Prass K, 1998, RESTOR NEUROL NEUROS, V13, P3; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Schools GP, 1999, J NEUROSCI RES, V58, P533, DOI 10.1002/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G; Silva GA, 1999, NEUROSCI LETT, V263, P117, DOI 10.1016/S0304-3940(99)00145-7; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Wang JQ, 1998, MOL BRAIN RES, V57, P46, DOI 10.1016/S0169-328X(98)00060-6	19	9	12	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUN 22	2001	306	1-2					101	105		10.1016/S0304-3940(01)01832-8			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	445PE	WOS:000169465800026	11403968				2022-02-06	
J	Lee, KS				Lee, KS			Estimation of the incidence of head injury in Korea: An approximation based on national traffic accident statistics	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						incidence; epidemiology; craniocerebral trauma; Korea	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; DISABILITY; MORTALITY; ADULTS	Head injury is a leading cause of death and disability in Korea. It usually results from an avoidable accident. Epidemiologic data on the head injury is important for the effective reduction of this controllable disaster. The aim of this study is to estimate the incidence of head injury in Korea. Data on the incidence of the traffic accidents were collected from Traffic Accident Statistics 1998 by the National Police Agency. Proportion of head injuries due to traffic accidents was obtained from various literatures. The incidence of head injury was approximated simply by a formula H=T/0.625 [the total number of patients after traffic accidents (T) would be 62.5% of the total number of patients with head injury (H)]. In 1998, the estimated number of head injury was 109,462. The annual incidence was 236/100,000 person, 334/100,000 for males and 136/100,000 for females. The causes were road traffic accident in 62.5%, and falls in 15.6%. The operation was performed in 20.2% with a mortality of 4.0% in average. Case fatality rate was 8.2%. Annual death rate was 19/100,000 population. A public campaign is required on the basis of trustworthy epidemiologic data to reduce the incidence of head injury for the public health.	Soonchunhyang Univ, Chonan Hosp, Dept Neurosurg, Cheonan 330721, South Korea		Lee, KS (corresponding author), Soonchunhyang Univ, Chonan Hosp, Dept Neurosurg, 23-20 Bongmyong Dong, Cheonan 330721, South Korea.	kslshl@sparc.schch.co.kr					BROWNE LA, 1977, IRISH MED J, V70, P197; Chen C L, 1995, Gaoxiong Yi Xue Ke Xue Za Zhi, V11, P537; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Cho MK, 1972, J KOREAN NEUROSURG S, V1, P79; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Dunn LT, 2000, BRIT J NEUROSURG, V14, P219; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Hillier SL, 1997, BRAIN INJURY, V11, P649; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; JAMIESON KG, 1974, AUST NZ J SURG, V44, P241, DOI 10.1111/j.1445-2197.1974.tb04411.x; Jun YH, 1986, J KOREAN NEUROSURG S, V15, P395; KIM JS, 1995, KOREAN J EPIDEMIOL, V17, P214; KIM KA, 2000, HANKYOREH       0629; Kim WH, 1989, J KOREAN NEUROSURG S, V18, P290; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; KLONOFF H, 1969, CAN MED ASSOC J, V100, P235; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1993, HEAD INJURY, P1; Lee BW, 1985, J KOREAN NEUROSURG S, V14, P153; LEE SC, 1977, J KOREAN NEUROSURG S, V2, P435; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Moon SB, 1977, J KOREAN NEUROSURG S, V6, P379; *NAT STAT OFF, 1999, ANN REP VIT STAT; Rhee HJ, 1972, J KOREAN NEUROSURG S, V1, P67; Sallee D, 2000, Alaska Med, V42, P37; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; *WHO, 1999, WORLD HLTH REP 1999, P13	34	9	10	0	1	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUN	2001	16	3					342	346		10.3346/jkms.2001.16.3.342			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445JJ	WOS:000169454100015	11410697	Green Published			2022-02-06	
J	Palav, A; Ortega, A; McCaffrey, RJ				Palav, A; Ortega, A; McCaffrey, RJ			Incremental validity of the MMPI-2 content scales: A preliminary study with brain-injured patients	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; psychopathology; rehabilitation; traumatic brain injury	NEUROPSYCHOLOGICAL TEST USAGE; CLOSED-HEAD TRAUMA; PERSONALITY	Objective: To examine the usefulness of the MMPI-2 Content Scales among traumatic brain injury (TBI) patients. Design: Hierarchical stepwise regression analyses with the SCL-90-R scales as the criterion variables were conducted to determine the incremental validity of the Content Scales beyond the information provided by the Clinical Scales. Participants: 27 persons with moderate to severe TBI who had been discharged to the community from inpatient rehabilitation between 6 months and 4 years before the beginning of the study. Results: The Content Scales accounted for an additional 4% to 36% of the variance of SCL-90-R scales beyond that predicted by the Clinical Scales. Conclusions: interpretation of the Content Scales may be particularly valuable with TBI patients, because they provide an additional avenue for the identification of distressing symptoms.	SUNY Albany, Dept Psychol, Albany, NY 12222 USA; Northwoods, Niskayuna, NY USA		McCaffrey, RJ (corresponding author), SUNY Albany, Dept Psychol, SS112, Albany, NY 12222 USA.						ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Archer R. P, 1996, ASSESSMENT, V3, P79, DOI 10.1177/107319119600300109; BENPORATH YS, 1993, J PERS ASSESS, V61, P557, DOI 10.1207/s15327752jpa6103_12; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Butcher J, 1990, DEV USE MMPI 2 CONTE; Butcher J.N., 1989, MMPI 2 MINNESOTA MUL; BUTCHER JN, 1992, ESSENTIALS MMPI 2 MM; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Derogatis L., 1983, ADM SCORING PROCEDUR, V2nd edn; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; Dunn JT, 1995, ASSESSMENT, V2, P47; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GRAHAM JR, 2000, MMPI 2 ASSESSING PER; HATHAWAY SR, 1943, BOOKLET MINNESOTA MI; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; NELSON LD, 1996, FORENSIC APPL MMPI 2, P202; ORTEGA A, 1996, CONTRIBUTIONS NEUROP; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009	22	9	9	0	2	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2001	16	3					275	283		10.1097/00001199-200106000-00006			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	442YY	WOS:000169313600006	11346449				2022-02-06	
J	Bunc, G; Roskar, Z; Vorsic, M				Bunc, G; Roskar, Z; Vorsic, M			Pneumocephalus secondary to a neck stab wound without neurologic injury in a 13-year-old girl	PEDIATRIC NEUROSURGERY			English	Article						neck stab wound; headache; pneumocephalus		Pneumocephalus is usually caused by injury that damages the brain meninges and thus allows air to enter the intracranial cavity, Our intention was to establish the importance of considering a stab wound in the neck as a possible cause of traumatic pneumocephalus, The paper presents the case of a 13-year-old girl who was accidental ly stabbed in the neck with a kitchen knife by her brother. She had no neurological deficit but had developed headaches. An examination showed cerebrospinal fluid leaking from the neck wound and a CT scan revealed the pneumocephalus. Following surgical treatment, the patient's clinical symptoms regressed. To our knowledge, this case is the first report of the manifestation of pneumocephalus as the result of a neck stab wound in a child; overall, there are only three reported cases of pneumocephalus caused by a neck stab wound. Copyright (C) 2001 S. Karger AG, Basel.	Maribor Teaching Hosp, Dept Neurosurg, SI-2000 Maribor, Slovenia; Maribor Teaching Hosp, Clin Dept Pediat, SI-2000 Maribor, Slovenia		Bunc, G (corresponding author), Maribor Teaching Hosp, Dept Neurosurg, Ljubljanska 5, SI-2000 Maribor, Slovenia.						Kabuto M, 1988, Rinsho Hoshasen, V33, P499; KULKARNI MS, 1999, PEDIAT EMERG MED, V1, P70; NASEEM M, 1986, AM J NEURORADIOL, V7, P174; PEACOCK WJ, 1977, S AFR MED J, V51, P961; Uppot RN, 1999, AM J ROENTGENOL, V173, P1504, DOI 10.2214/ajr.173.6.10584791	5	9	9	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	MAY	2001	34	5					239	241		10.1159/000056029			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	449ZW	WOS:000169717900005	11423773				2022-02-06	
J	Perunovic, B; Quilty, RD; Athanasiou, A; Love, S				Perunovic, B; Quilty, RD; Athanasiou, A; Love, S			Damage to intracranial optic pathways in fatal closed head injury in man	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						closed head injury; brain trauma; optic pathways; axonal injury; brain ischaemia; optic tract; optic radiation	TRAUMATIC CHIASMAL SYNDROME; DIFFUSE AXONAL INJURY; NERVE TRAUMA; NEUROPATHY; DIAGNOSIS; CHILDREN	Head injury is a leading cause of visual impairment. This is partly due to direct trauma to the eye and optic nerve hut much of the damage involves the intracranial optic pathways. We have studied the frequency, distribution and nature of the intracranial lesions of the optic pathways at autopsy in 45 cases of severe closed head injury, and examined the correlation between these post-mortem lesions and the ante-mortem clinical findings. Twenty-four of the patients had been involved in road traffic accidents. The ages range fern 9 to 88 years (mean 46.4). the Glasgow Coma Score (GCS) on admission ranged from 3 to 15 (mean 5), and the survival time after injury from 2.5 h to 15 days (mean 3.3 days). Skull fractures were present in 75.6% of the cases. Histological assessment included the use of immunohistochemistry fur beta -amyloid precursor protein (beta -APP) and the microglial marker CD68. Axonal injury of varying severity was demonstrable in all cases, and in 39 (87%) the optic chiasm, tracts or radiations were involved, usually in more than one region. The severity of axonal injury was mild in 11 (24%), moderate in 9 (20%) and severe in 19 (42%) cases. The optic radiation at the level of the trigone of the lateral ventricle was particularly frequently and severely affected. The least affected parts of the intracranial optic pathways were the optic chiasm and the posterior segment of the optic nerve. The severity of injury to the optic pathways did not always reflect severity of axonal injury elsewhere in the brain and correlated poorly with the type of trauma (high- or low-velocity), presence of skull fractures or evidence of raised intracranial pressure (ICP). Of the 39 patients who survived more than 6 h, histological evidence of ischaemic injury to the primary optic cortex was present in 26 (67%) and was severe in 12. We conclude that the visual pathways are affected in a high proportion of patients with fatal closed head injury, nerve fibres in the optic radiations being particularly vulnerable. The findings suggest that damage to the posterior parts of the optic pathways may be under-diagnosed among patients with head injury. (C) 2001 Elsevier Science B.V. All rights reserved.	Frenchay Hosp, Dept Neuropathol, Bristol BS16 1LE, Avon, England; Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England		Love, S (corresponding author), Frenchay Hosp, Dept Neuropathol, Bristol BS16 1LE, Avon, England.		Perunovic, Branko/R-5570-2019; Love, Seth/E-6545-2012				ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDERSON DL, 1964, CAN MED ASSOC J, V90, P110; ANDERSON DP, 1980, CAN J SURG, V23, P163; BELLEZA T, 1979, CORTEX, V15, P19, DOI 10.1016/S0010-9452(79)80003-9; Cook MW, 1996, ARCH OTOLARYNGOL, V122, P389; Cornelius CP, 1996, J CRANIO MAXILL SURG, V24, P1, DOI 10.1016/S1010-5182(96)80070-9; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HUGHES B, 1962, B JOHNS HOPKINS HOSP, V111, P98; HUGHES EBC, 1945, BR J OPTHALMOL, V23, P629; ICHIKAWA T, 1987, JPN J PSYCHIAT NEUR, V41, P19; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1981, MANAGEMENT HEAD INJU; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; KERTESZ A, 1979, CORTEX, V15, P403, DOI 10.1016/S0010-9452(79)80067-2; King J, 1979, Clin Exp Neurol, V16, P205; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; LAURSEN AB, 1971, ACTA OPHTHALMOL, V49, P134; LESSELL S, 1989, ARCH OPHTHALMOL-CHIC, V107, P382, DOI 10.1001/archopht.1989.01070010392031; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Lindenberg R, 1973, NEUROPATHOLOGY VISIO; LOGAN WC, 1967, BRIT J OPHTHALMOL, V51, P258, DOI 10.1136/bjo.51.4.258; Mahapatra A, 1992, J Neurosurg Sci, V36, P79; MAHAPATRA AK, 1993, PEDIATR NEUROSURG, V19, P34, DOI 10.1159/000120698; MENON V, 1992, ACTA OPHTHALMOL, V70, P725; Mine S, 1999, ACTA NEUROCHIR, V141, P27, DOI 10.1007/s007010050262; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; Obenchain T G, 1973, Bull Los Angeles Neurol Soc, V38, P13; OSTERBERG G., 1938, ACTA OPHTHALMOL [COPENHAGEN], V16, P466; PRINGLE JH, 1916, BRIT J SURG, V4, P373; PROSPERI L, 1978, J PEDIAT OPHTH STRAB, V15, P376; RESNECK JD, 1981, AM J OPHTHALMOL, V92, P233, DOI 10.1016/0002-9394(81)90778-9; RUSSELL WR, 1940, INJURIES SKULL BRAIN, P113; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; SEROVA NK, 1994, VESTN OFTALMOL, V110, P10; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; TIBBS PA, 1979, J TRAUMA, V19, P129, DOI 10.1097/00005373-197902000-00013; Tierney D W, 1988, J Am Optom Assoc, V59, P614; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; TROBE JR, 1986, SURV OPHTHALMOL, V30, P328, DOI 10.1016/0039-6257(86)90065-2; Turner JWA, 1943, BRAIN, V66, P140; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017; UZZELL BP, 1987, ACTA NEUROCHIR, V86, P18, DOI 10.1007/BF01419499; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433; WONG VCN, 1991, PEDIATR NEUROL, V7, P178, DOI 10.1016/0887-8994(91)90081-U; WOODWARD G A, 1990, Pediatric Emergency Care, V6, P289, DOI 10.1097/00006565-199012000-00010; [No title captured]	53	9	9	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	MAR 15	2001	185	1					55	62		10.1016/S0022-510X(01)00463-4			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422UQ	WOS:000168138000011	11266692				2022-02-06	
J	Rey, GJ; Feldman, E; Hernandez, D; Levin, BE; Rivas-Vazquez, R; Nedd, KJ; Benton, AL				Rey, GJ; Feldman, E; Hernandez, D; Levin, BE; Rivas-Vazquez, R; Nedd, KJ; Benton, AL			Application of the Multilingual Aphasia Examination-Spanish in the evaluation of Hispanic patients post closed-head trauma	CLINICAL NEUROPSYCHOLOGIST			English	Article							PRACTICAL SCALE; INJURY	Despite the rapid increase of Hispanics in the U.S., there continues to be a lack of adequate psychological assessment tools to examine Spanish-speaking patients with cognitive or neuropsychological disturbances. We investigated the clinical utility of the Multilingual Aphasia Examination-Spanish (MAE-S) in the evaluation of language functions of Hispanic subjects post-traumatic brain injury (TBI). The performance of 40 TBI patients was compared to that of 40 age-, gender-, and education-matched normal controls. Subject groups differed on the Visual Naming (VN), Controlled Oral Word Association (COWA), and Token Test subtests. The VN and COWA subtests were the best discriminators of group membership. Distribution of scores for the patient group on the Rating of Articulation scale additionally indicate subtle articulatory difficulties post-TBI. For all subtests, trauma severity per Glasgow Coma Scale was the best predictor of language performance, over and above the contribution of other clinical and demographic variables. These results are consistent with prior reports of dysphasia post-TBI and suggest that the MAE-S is a sensitive and accurate measure to assess language disturbances in Hispanic populations.	Univ Miami, Sch Med, Dept Neurol, Div Neuropsychol, Miami, FL 33136 USA; Univ Miami, Dept Psychol, Miami, FL 33136 USA; Univ Miami, Dept Informat Resources, Miami, FL 33136 USA; Jackson Mem Hosp, Div Speech Pathol, Miami, FL 33136 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA		Rey, GJ (corresponding author), Univ Miami, Sch Med, Dept Neurol, Div Neuropsychol, 1150 NW 14th St,Suite 715, Miami, FL 33136 USA.						*AM PSYCH ASS BOAR, 1990, GUID PROV PSYCH SERV; Benton A., 1978, MULTILINGUAL APHASIA; BENTON AL, 1969, J NEUROL SCI, V9, P39, DOI 10.1016/0022-510X(69)90057-4; Benton AL, 1994, MULTILINGUAL APHASIA; ECHEMENDIA RJ, 1994, 1994 ANN M AM PSYCH; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Hamsher K., 1989, MULTILINGUAL APHASIA; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1981, ACQUIRED APHASIA; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; REY GJ, 1995, MOVEMENT DISORD, V10, P106, DOI 10.1002/mds.870100117; REY GJ, 1994, ARCH NEUROL-CHICAGO, V51, P95, DOI 10.1001/archneur.1994.00540130129022; REY GJ, 1994, 1994 APA CONV; REY GJ, 1991, MULTILINGUAL APHASIA; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Sattler J. M., 1988, ASSESSMENT CHILDREN; Scarr S., 1978, INTELLIGENCE, V2, P325; Stuss D. T., 1992, J HEAD TRAUMA REHAB, V7, P40; TEASDALE G, 1974, LANCET, V2, P81	21	9	9	0	8	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2001	15	1					13	18		10.1076/clin.15.1.13.1911			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	439AH	WOS:000169086300002	11778575				2022-02-06	
J	Reynolds, WE; Page, SJ; Johnston, MV				Reynolds, WE; Page, SJ; Johnston, MV			Coordinated and adequately funded state streams for rehabilitation of newly injured persons with TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; discharge planning; Medicaid; public policy; rehabilitation; state program models	HEAD-INJURY	Traumatic brain injury (TBI) rates are highest among families with the lowest income levels. A paucity of appropriate funding streams for low-income, recently injured TBI patients is reported to cause delays in provision of early postacute rehabilitation or to cause patients to be discharged without receiving rehabilitation. There are also reports of patients remaining in hospitals with minimal care or being returned home, both because of a lack of a discharge site. The purposes of this exploratory study were to: (1) identify model aspects of existing publicly supported and administered programs for postacute individuals with TBI: (2) present results of a survey measuring to what extent state Medicaid programs fund postacute rehabilitation services for recently injured patients with TBI; (3) present results of interviews with trauma center social workers affiliated with the National Institute on Disability and Rehabilitation Research (NIDRR) TBI Model Systems projects to determine whether and how delays in receiving Medicaid coverage occur; and (4) make recommendations for improved systems of care for postacute individuals with TBI.	New York State Dept Hlth, Off Continuing Care, Bur Program Dev & Coordinat, Delmar, NY 12054 USA; SUNY Albany, Albany, NY 12222 USA; Univ Med & Dent New Jersey, Sch Med, Newark, NJ 07103 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA		Reynolds, WE (corresponding author), New York State Dept Hlth, Off Continuing Care, Bur Program Dev & Coordinat, Delmar, NY 12054 USA.	wer01@health.state.ny.us			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A 98 0030] Funding Source: Medline		ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; Carrasquillo O, 2000, AM J PUBLIC HEALTH, V90, P917, DOI 10.2105/AJPH.90.6.917; CAVALLO M, 1999, TRAUMATIC BRAIN INJU; COLLINS JG, 1987, VITAL HLTH STAT, V10, P175; *COMM FUND, 12 MILL YOUNG AD LAC; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; DIGRE PG, 1994, J HEAD TRAUMA REHAB, V9, P12; Dillman DA, 1978, MAIL TELEPHONE SURVE, V19; FEDER J, 1999, FUNDAMENTALS HL 0129; Finset Arnstein, 1995, Tidsskrift for den Norske Laegeforening, V115, P210; Fleming J, 1999, BRAIN INJURY, V13, P417; Hall KM, 1997, ARCH PHYS MED REHAB, V78, pS5, DOI 10.1016/S0003-9993(97)90149-0; *HLTH CAR FIN ORG, OV MED PROGR; KRAUS JF, REHABILITATION ADULT, P3; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MANEY M, 1996, UNPUB DELAYS TBI PAT; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Miller T.R., 1995, DATABOOK NONFATAL IN; MILLIREN JW, 1994, J HEAD TRAUMA REHAB, V9, P27, DOI DOI 10.1097/00001199-199406000-00005; *MO HEAD INJ ADV C, 1998, 1998 NAT DIR STAT GO; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; PAGE SJ, 1999, TBI MODEL SYSTEMS CA; Paniak C, 1998, J CLIN EXP NEUROPSYC, V20, P852, DOI 10.1076/jcen.20.6.852.1108; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; ROSENBERG RN, 1994, J CHILD NEUROL, V9, P1, DOI 10.1177/088307389400900101; ROVNER J, 2000, REUTERS HLTH    0517; Sakata R, 1991, Brain Inj, V5, P411, DOI 10.3109/02699059109008114; SPEARMAN RC, 2000, J HEAD TRAUMA REHABI, V16; STARR J, 2000, PUBLIC SPENDING TRAU; *URB I, 2000, MED 10 BAS QUEST ANS; VAUGHN S, 2001, J HEAD TRAUMA REHABI, V16; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; 2000, CHICAGO TRIBUNE 0529, P6	36	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2001	16	1					34	46		10.1097/00001199-200102000-00006			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403ZC	WOS:000167072100008	11277849				2022-02-06	
J	Dominguez, TE; Chalom, R; Costarino, AT				Dominguez, TE; Chalom, R; Costarino, AT			The severity and cost of child abuse in the pediatric intensive care unit	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article; Proceedings Paper	28th Educational and Scientific Symposium of the Society-of-Critical-Care-Medicine	JAN 23-27, 1999	SAN FRANCISCO, CALIFORNIA	Soc Crit Care Med			NURSE HOME VISITATION; INJURY; TRIAL	The objective of this study was to describe the severity of illness, costs, and outcomes of child abuse (CA) patients in the pediatric intensive care unit (PICU) and to assess the importance of CA in predicting costs adjusting for severity of illness and diagnosis. A retrospective, cohort study was performed on a consecutive sample of 1,376 patients admitted and discharged to a tertiary care PICU during fiscal pear 1994. Demographic data, diagnoses, pediatric risk of mortality (PRISM) score, length of stay, and deaths were recorded. Hospital charges were converted into costs using cost:charge ratios. Functional outcomes of the CA patients were assessed at the time of discharge. There were 17 cases of CA in 1,376 admissions (1.24%). CA accounted for 6 of 85 deaths (7.06%) and the mortality rate was significantly higher than the rest of the PICU population <35.3% versus 5.8%, p < 0.01). In the traumatic brain injury (TBI) subgroup, total costs and daily costs were significantly higher in the CA patients ($11,926 versus $7,798, P = 0.013 and $3,400 versus $2,479, p = 0.01). Adjusting for severity of illness with multiple regression, there were no differences in costs identified in the CA patients. Nine of 11 (81.8%) CA patients with TBI were severely disabled or died. CA patients have an increased severity of illness, explaining much of the differences in costs seen with these patients. Further resources should be allocated toward prevention given the high costs and high morbidity and mortality in these patients.	Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; St Barnabas Med Ctr, Pediat Intens Care Unit, Livingston, NJ USA		Dominguez, TE (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.						ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; BERGMAN AB, 1986, PEDIATRICS, V77, P113; Chalom R, 1999, CRIT CARE MED, V27, P2079, DOI 10.1097/00003246-199910000-00001; DRUMMOND MF, 1997, METHODS EC EVALUATIO, P56; DUBOWITZ H, 1990, CHILD ABUSE NEGLECT, V14, P177, DOI 10.1016/0145-2134(90)90029-S; DUDLEY RA, 1993, J CLIN EPIDEMIOL, V46, P261; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Evasovich M, 1998, BURNS, V24, P642, DOI 10.1016/S0305-4179(98)00070-9; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Irazuzta JE, 1997, CHILD ABUSE NEGLECT, V21, P751, DOI 10.1016/S0145-2134(97)00036-7; Marshall WN, 1997, ARCH PEDIAT ADOL MED, V151, P273, DOI 10.1001/archpedi.1997.02170400059011; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; OLDS DL, 1986, PEDIATRICS, V78, P65; PECLET MH, 1990, J PEDIATR SURG, V25, P85, DOI 10.1016/S0022-3468(05)80169-1; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Wright MS, 1996, ARCH PEDIAT ADOL MED, V150, P415, DOI 10.1001/archpedi.1996.02170290081013	16	9	9	0	2	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0885-0666			J INTENSIVE CARE MED	J. Intensive Care Med.	JAN-FEB	2001	16	1					35	41		10.1046/j.1525-1489.2001.00035.x			7	Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394MH	WOS:000166527500004					2022-02-06	
J	Guskiewicz, KM				Guskiewicz, KM			Concussion in sport: The grading-system dilemma	ATHLETIC THERAPY TODAY			English	Article						head injury; grading scales; symptomatology	MILD HEAD-INJURY; FOOTBALL PLAYERS; STANDARDIZED ASSESSMENT; POSTURAL STABILITY; COLLEGE FOOTBALL; CONTACT-SPORTS; 2ND IMPACT		Univ N Carolina, Dept Exercise & Sport Sci, Sports Med Res Lab, Chapel Hill, NC 27514 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Sports Med Res Lab, Chapel Hill, NC 27514 USA.						ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Barth JT, 1989, MILD HEAD INJURY, P257; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; *CO MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; FERRARA MS, IN PRESS JNATA; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; JORDAN B, 1994, P MILD BRAIN INJ SPO, P43; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Riemann BL, 2000, J ATHL TRAINING, V35, P19; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1	27	9	9	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, CHAMPAIGN, IL 61820-2200 USA	1078-7895			ATHLET THER TODAY	Athlet. Ther. Today	JAN	2001	6	1					18	27		10.1123/att.6.1.18			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	482AT	WOS:000171553200005					2022-02-06	
J	Jorger, M; Beer, S; Kesselring, J				Jorger, M; Beer, S; Kesselring, J			Impact of neurorehabilitation on disability in patients with acutely and chronically disabling diseases of the nervous system measured by the Extended Barthel Index	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						Extended Barthel Index; disability; neurorehabilitation	INPATIENT REHABILITATION; MULTIPLE-SCLEROSIS; STROKE; COMMUNITY	To study the impact of rehabilitation on disability in an unselected patient group with acutely and chronically disabling neurologic diseases, the Extended Barthel Index (EBI) was determined at the beginning and at the end of the rehabilitation stay in all patients admitted to our Neurorehabilitation Centre in Valens, Switzerland. Patients who reached the highest possible EBI score at entry ("ceiling effect"), with a short stay (< 1 week), or with a deterioration due to other medical complications were excluded. Finally EBI data of 743 patients could be analyzed. The mean EBI at entry was 45 and 51 at discharge. The mean increase of the EBI score per week was 1.1 (SD, 1.7). The change of the EBI score was analyzed independently in patients with acute neurologic diseases admitted in the postacute phase (acute group) and patients with chronically disabling neurologic diseases (chronic group). As expected, the increase of the EBI score was higher in the acute group than in the chronic group; 80.8% of the acute group patients and 42.5% of the chronic group patients showed an increase of the EBI score at discharge. Both groups showed a significant EBI gain with a marked shift to higher EBI scores at discharge. The mean gain per week was 1.6 in the acute group and 0.5 in the chronic group, respectively. Analysis of EBI changes considering the different underlying diseases showed the highest increase in patients with stroke and traumatic brain injury.	Neurorehabil Ctr, CH-7317 Valens, Switzerland		Beer, S (corresponding author), Neurorehabil Ctr, CH-7317 Valens, Switzerland.						Carter GT, 1997, J NEUROL REHABIL, V11, P69; DAM M, 1993, STROKE, V24, P1186, DOI 10.1161/01.STR.24.8.1186; EAMES P, 1995, BRAIN INJURY, V10, P631; Freeman JA, 1997, ANN NEUROL, V42, P236, DOI 10.1002/ana.410420216; Freeman JA, 1999, NEUROLOGY, V52, P50, DOI 10.1212/WNL.52.1.50; HELBIG P, 1997, NEUROL REHABIL, V3, P159; KALRA L, 1993, STROKE, V24, P1462, DOI 10.1161/01.STR.24.10.1462; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Ku┬nig N., 1996, CLIN REHABIL, V10, P309; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; MAHONEY F I, 1965, Md State Med J, V14, P61; Patti F, 1996, J NEUROL REHABIL, V10, P223; Prosiegel M., 1996, NEUROL REHABIL, V1, P7; Rossi PW, 1997, J NEUROL REHABIL, V11, P27; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Solari A, 1999, NEUROLOGY, V52, P57, DOI 10.1212/WNL.52.1.57; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008	19	9	12	0	0	DEMOS MEDICAL PUBLISHING	NEW YORK	386 PARK AVE SOUTH, STE 201, NEW YORK, NY 10016 USA	0888-4390			NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair		2001	15	1					15	22		10.1177/154596830101500103			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	466BH	WOS:000170624100003	11527275				2022-02-06	
J	Park, NW; Conrod, B; Rewilak, D; Kwon, C; Gao, FQ; Black, SE				Park, NW; Conrod, B; Rewilak, D; Kwon, C; Gao, FQ; Black, SE			Automatic activation of positive but not negative attitudes after traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						social judgment; component process model of memory; automatic and controlled processing; emotional processing; automatic attitude activation; amygdala	FACE PROCESSING IMPAIRMENTS; HUMAN AMYGDALA; SPREADING ACTIVATION; FACIAL EXPRESSION; FRONTAL LOBES; RECOGNITION; EMOTION; MEMORY; DAMAGE; PRONUNCIATION	This study investigated social judgment problems of an individual (AM) with bilateral frontal and temporal lobe damage including damage to the amygdala. We hypothesized that AM could automatically process positive, but not negative evaluative information and could process both types of evaluative information using controlled processing. In Phase 1 of Experiment 1 AM and controls were shown a series of words one at a time and were required to make good/bad judgments as quickly as possible. Results showed that AM was more likely than controls to rate words as good, and was significantly slower to make good/bad judgments of negatively, but not positively, evaluated words. In Phase 2 AM was shown a prime (positive or negative) then target (positive or negative) and instructed to evaluate whether the target word was good or bad. Results showed that AM responded more quickly when prime and target were both positive: but not when prime and target were both negative, whereas controls showed both types of priming. Experiment 2 determined whether AM's impaired processing of negative evaluative information could be abolished under controlled processing. AM was explicitly instructed to generate positive and negative connotations of a series of single words and given essentially unlimited time. Under these conditions, AM and controls did not differ significantly in their ability to generate positive versus negative connotations of words. In Experiment 3 AM and controls both showed normal semantic priming effects. The results are interpreted within the component process model of memory. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Toronto, Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; Univ Toronto, Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON M6A 2E1, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON, Canada; York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Div Neurol, Toronto, ON, Canada		Park, NW (corresponding author), Univ Toronto, Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St,Suite 2W-02, Toronto, ON M6A 2E1, Canada.	npark@baycrest.org	Black, Sandra E./C-7294-2011	Black, Sandra/0000-0001-7093-8289			Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Bakeman R., 1986, OBSERVING INTERACTIO; BALOTA DA, 1986, J EXP PSYCHOL LEARN, V12, P336, DOI 10.1037/0278-7393.12.3.336; BARGH JA, 1992, J PERS SOC PSYCHOL, V62, P893, DOI 10.1037/0022-3514.62.6.893; Bargh JA, 1996, J EXP SOC PSYCHOL, V32, P104, DOI 10.1006/jesp.1996.0005; BARGH JA, 1995, SOCIAL PSYCHOL HDB B; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Burgess P.W., 1997, HAYLING BRIXTON TEST; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Callen DJA, 1999, NEUROLOGY, V52, pA570; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; CHAIKEN S, 1993, J PERS SOC PSYCHOL, V64, P759, DOI 10.1037/0022-3514.64.5.759; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Convit A, 1999, PSYCHIAT RES-NEUROIM, V90, P113, DOI 10.1016/S0925-4927(99)00007-4; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Eagly A.H., 1993, PSYCHOL ATTITUDES; Eagly Alice H., 1998, HDB SOCIAL PSYCHOL P, P269; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; FAZIO RH, 1993, J PERS SOC PSYCHOL, V64, P753, DOI 10.1037/0022-3514.64.5.753; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Hamann SB, 1996, NATURE, V379, P497, DOI 10.1038/379497a0; Herman C.P., 1987, SOC INFL ONT S, V5; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; LeDoux J., 1996, EMOTIONAL BRAIN MYST; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Luria A.R., 1973, WORKING BRAIN INTRO; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; MOSCOVITCH M, 1990, PERSPECTIVES COGNITI; Moscovitch M, 1992, ENCY LEARNING MEMORY; Moscovitch M., 1994, NEUROPSYCHOLOGY, V8, P524; Moscovitch Morris, 1994, P269; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Neely J., 1991, BASIC PROCESSES READ; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PARK NW, 2001, INT NEUR SOC 29 ANN; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; Rockel CP, 1999, NEUROLOGY, V52, pA368; ROLLS ET, 1990, COGNITION EMOTION, V4, P161, DOI 10.1080/02699939008410795; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Whalen PJ, 1998, J NEUROSCI, V18, P411; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15; ZAJONC RB, 1984, AM PSYCHOL, V39, P117, DOI 10.1037/0003-066X.39.2.117; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	57	9	9	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia		2001	39	1					7	24		10.1016/S0028-3932(00)00101-9			18	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	379TH	WOS:000165658200002	11115652				2022-02-06	
J	Soldner, F; Holper, BM; Chone, L; Wallenfang, T				Soldner, F; Holper, BM; Chone, L; Wallenfang, T			Evoked potentials in acute head injured patients with MRI-detected intracerebral lesions	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; evoked potentials; magnetic resonance imaging; database	CORPUS-CALLOSUM; COMATOSE PATIENTS; BRAIN-FUNCTION; TRAUMA; FEATURES; DEATH; CT; CONSCIOUSNESS; PREDICTION; PROGNOSIS	Background. Magnetic resonance imaging (MRI) allows precise detection of intracranial lesions in head injured patients. We compared intracranial lesions detected in MRI to somatosensory evoked potentials (SEP) and brainstem auditory evoked potentials (BAEP) concerning their prognostic value. Methods. Thirty patients with traumatic brain injury and prolonged recovery were studied. Size, side and number of 474 intra-and extraparenchymal lesions as well as lesion localisation based on a specific anatomical classification were entered into a database (a total of 7080 data). In addition, we recorded median-nerve SEP (M-SEP), tibial nerve SEP (T-SEP) and BAEP in all of the patients. Findings. M-SEP and Glasgow-Outcome-Score (GOS) one year after injury correlated significantly to patients with lesions in the brainstem (p < 0.0001) and corpus callosum (p < 0.001). Similar results were found for T-SEP (p < 0.0001). All patients with bicortical loss of M-SEP had an unfavourable outcome (GOS 2). Among the analysis of lesion volume, only the volume of brainstem lesions correlated to GOS (p < 0.001), but this was not found for callosal lesions. However, comparing the vegetative (GOS 2) to the nonvegetative group (GOS 3-5), for both callosal (p <less than> 0.02) and brainstem (p < 0.005) lesions a significant correlation was found. Interpretation. MRI does not improve the prognostic reliability of SEP in head injury but offers possibilities for clarifying electrophysiological and clinical pathologies. This explains that the volume of brainstem lesions, essentially influencing the clinical outcome, is strongly correlated to T-SEP and M-SEP. In contrast, callosal lesions did not show a clear relationship to outcome despite large callosal lesions (> 4 ml) which tended to poor outcome. In conclusion, we suggest that MRI and SEP are supplementary to each other concerning prognostic evaluation.	Klinikum Fulda, Neurochirurg Klin, Dept Neurosurg, D-36043 Fulda, Germany; Klinikum Fulda, Inst Radiol, D-36043 Fulda, Germany; Heart & Neuroctr Bodensee, Constance, Germany		Soldner, F (corresponding author), Klinikum Fulda, Neurochirurg Klin, Dept Neurosurg, Pacelliallee 4, D-36043 Fulda, Germany.						Adams HP, 1996, J CLIN NEUROPHYSIOL, V13, P84, DOI 10.1097/00004691-199601000-00009; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; ANDERSSON T, 1991, Electromyography and Clinical Neurophysiology, V31, P109; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRONSTEIN IN, 1995, TASCHENBUCH MATH; BULLOCK R, 1997, HEAD INJURY; CAIRD DM, 1987, ELECTROEN CLIN NEURO, V68, P237, DOI 10.1016/0168-5597(87)90034-7; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Deinsberger W, 1998, NEUROSURGERY, V43, P36, DOI 10.1097/00006123-199807000-00023; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; DEWEERD AW, 1985, ACTA NEUROL SCAND, V72, P489; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KLUG N, 1982, J NEUROL, V227, P219, DOI 10.1007/BF00313389; Kraus R, 1994, Zentralbl Neurochir, V55, P96; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; NAISHIN C, 1986, J NEUROL SCI, V76, P199; Nau H E, 1987, Anasth Intensivther Notfallmed, V22, P273, DOI 10.1055/s-2007-1002550; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PATTERN JP, 1987, NEUROLOGISCHE DIFFER; PERLIK SJ, 1987, MUSCLE NERVE, V10, P481, DOI 10.1002/mus.880100602; RIFFEL B, 1987, EEG-EMG-Z ELEK ELEKT, V18, P192; SALCMAN M, 1992, NEUROCHIRURGIE, V38, P329; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; STOHR M, 1987, J NEUROL, V234, P211, DOI 10.1007/BF00618252; STOHR M, 1987, NERVENARZT, V58, P658; STOHR M, 1986, DEUT MED WOCHENSCHR, V111, P1515, DOI 10.1055/s-2008-1068663; STOHR M, 1989, EVOZIERTE POTENTIALE, V2; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 1997, ACT NEUR S, V70, P80; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; YU YL, 1985, BRAIN, V108, P273, DOI 10.1093/brain/108.2.273; ZENTNER J, 1992, NEUROSURGERY, V31, P429, DOI 10.1227/00006123-199209000-00007	46	9	14	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		2001	143	9					873	883		10.1007/s007010170017			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	480XN	WOS:000171488700006	11685619				2022-02-06	
J	Vakil, E; Gordon, Y; Birnstok, S; Aberbuch, S; Groswasser, Z				Vakil, E; Gordon, Y; Birnstok, S; Aberbuch, S; Groswasser, Z			Declarative and nondeclarative sequence learning tasks: Closed-head injured patients versus control participants	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TEMPORAL-ORDER; MEMORY; INFORMATION; TESTS	Patients who sustained closed-head injury (CHI) have been shown to have impaired memory for temporal order when measured under intentional, but not incidental, retrieval conditions. A group of 26 patients who sustained CHI and a matched control group of 26 individuals were tested on a declarative sequence learning task - "Chain Making'' (CM), and a nondeclarative sequence learning task - Tower of Hanoi puzzle (TOHP). The TOHP is a problem solving task that requires planning and a strategic approach. The latter are cognitive processes known to be impaired following frontal lobe damage, as has been frequently documented in CHI patients. The goal of the present study was to test whether CHI patients' nondeclarative learning as measured by the TOHP task is preserved, as seen in amnesic patients, or impaired, as would be predicted following frontal lobe damage. Half of the participants in each group underwent active training, and the other half went through passive training of the tasks. The results demonstrate that the control group outperformed the CHI group (in most measures) in both declarative and nondeclarative sequence learning tasks. The effect of type of training differed for the two tasks: while performance of the control group on the TOHP was better under passive training (CHI patients did not improve on either one of the training modes), performance on the CM task was better under active training for both groups. The results are discussed in light of the role of the frontal lobes in memory generally, and in sequence learning particularly.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Tel Aviv Univ, Israel Sackler Fac Med, Loewenstein Rehabil Hosp, IL-69978 Tel Aviv, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.						Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; COHEN NJ, 1981, SOC NEUR ABSTR, V7, P235; COHEN NJ, 1985, MEMORY DYSFUNCTIONS, P54; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; MOSCOVITCH M, 1994, ATTENTION PERFORM, V15, P619; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; Squire Larry R., 1994, P203; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; TZENG OJL, 1979, J EXP PSYCHOL-HUM L, V5, P52, DOI 10.1037/0278-7393.5.1.52; Vakil E, 1998, NEUROPSYCHOL REHABIL, V8, P31, DOI 10.1080/713755550; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; Vakil E, 1997, AM J MENT RETARD, V102, P147, DOI 10.1352/0895-8017(1997)102<0147:PADMPI>2.0.CO;2; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vakil E, 1997, J Int Neuropsychol Soc, V3, P327; VAKIL E, 1997, J GERONTOL B-PSYCHOL, V52, P229; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; [No title captured]	23	9	9	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2001	23	2					207	214		10.1076/jcen.23.2.207.1209			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	412QZ	WOS:000167567000007	11309674				2022-02-06	
J	Willinger, R; Baumgartner, D; Chinn, B; Schuller, E				Willinger, R; Baumgartner, D; Chinn, B; Schuller, E			New dummy head prototype: development, validation and injury criteria	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article								Head injuries cause a large proportion of fatalities to road users particularly motorcyclists. Currently, helmets are assessed using rigid headforms and criteria related to acceleration measured at the centre of the headform. This system is not representative of the human head, which comprises a brain that moves relative to the skull in an impact. Finite element techniques were used in the design, development and validation of a new dummy head prototype named Bi-mass 150. It has been constructed using a Hybrid III headform and comprises two masses: a skull and a mass to represent the brain attached to the skull with a damped spring system. The novel feature of this device is that it can simulate the brain - skull relative displacement at a frequency close to 150 Hz. This is the frequency recorded in tests in vivo. The prototype was made by removing mass from a Hybrid III dummy head and fixing to the centre a metallic mass, which simulates the brain. The two components were connected by means of a plastic element such that the natural frequency corresponded to the 150 Hz measured in-vivo. The outputs from thirteen accident reconstructions, using an instrumented helmeted headform, were used as inputs to the FE model. The results are the first part of the process to establish bi-mass related injury criteria, and, in turn, to provide a much more human-like headform for evaluating and optimising head protection systems.	Univ Strasbourg, CNRS, IMR 7505, LSBMC, Strasbourg, France; Transport Res Lab, Crowthorne RG45 6AU, Berks, England; Univ Munich, Inst Rechts Med, D-8000 Munich, Germany		Willinger, R (corresponding author), Univ Strasbourg, CNRS, IMR 7505, LSBMC, 2 Rue Boussingault, Strasbourg, France.						ALBSHARAT AS, 1999, UNPUB J BIOMECH ENG; BRINN J, 1970, P 14 STAPP CAR CRASH; CHINN BP, 1999, P IRCOBI C, P53; Dimasi F, 1991, P INT TECHN C EXP SA, V2, P916; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Ewins DJ, 1988, MODAL TESTING THEORY; GADD CW, 1966, 10 STAPP CAR CRASH C, P164; GURDJIAN ES, 1958, HEAD INJURY; HARRIS CM, 1988, SHOCK VIBRATION HDB; HODGSON VR, 1967, P 11 STAPP CAR CRASH, P79; KENNER VH, 1973, J BIOMECH, V6, P1, DOI 10.1016/0021-9290(73)90032-8; LOWENHIELM P, 1973, IRCOBI LYON, P423; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; RUAN JS, 1993, P 37 STAPP CAR CRASH, P69; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; VIANO DC, 1988, P 32 STAPP CAR CRASH, P1; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Willinger R, 1995, P IRCOBI C BRUNN SWI, P245; WILLINGER R, 1993, P INT RES COUNC BIOK, P229; WILLINGER R, 1992, ACCIDENT ANAL PREV, V26, P767; WILLINGER R, IN PRESS J SOUND VIB; WILLINGER R, 1990, INT C BIOM IMP, P203; ZHOU C, 1996, AGARD C US	24	9	9	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2001	6	3					281	293		10.1533/cras.2001.0178			13	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	467AB	WOS:000170677400001					2022-02-06	
J	Yang, L; Bernardo, LS				Yang, L; Bernardo, LS			Valproate prevents epileptiform activity after trauma in an in vitro model in neocortical slices	EPILEPSIA			English	Article						posttraumatic epilepsy; valproate; neocortex; gamma-aminobutyric acid; inhibition	PROPHYLACTICALLY ADMINISTERED PHENYTOIN; INHIBITORY POSTSYNAPTIC POTENTIALS; POSTTRAUMATIC SEIZURES; EPILEPSY; NEURONS; INVITRO; FAILURE	Purpose: Epileptogenesis is a hallmark of severe cortical trauma, with up to approximately 80% of patients experiencing seizures in the first 24 hours after penetrating head injury. An in vitro model of traumatic brain injury was developed to investigate hyperexcitability and epileptogenesis and their prevention. We determined whether sodium valproate would prevent epileptiform activity in this experimental model. Methods: Rat cortical slices were prepared and maintained in vitro using standard methods. Trauma was effected by removing the superficial 450-500 mum of slices. Traumatized slices were exposed to valproate at Various time points. Intracellular and extracellular recordings were used to assess evoked activities. Results: In untreated traumatized deep segments, hyperexcitability was manifested by depressed inhibition and often (54%) by epileptiform activity. Preparations exposed to valproate at 30 minutes or later after trauma showed abnormal activity similar to control traumatized slices. Epileptogenicity in deep segments was significantly reduced when slices were exposed to valproate (a) continuously immediately after trauma, (b) after a 20-minute delay, or (c) immediately after trauma for I hour and then returned to physiological solution. Finally, slices that were exposed to valproate or pentobarbital beginning 20 minutes after trauma for only I hour and then returned to physiological medium showed a significant reduction in abnormal activity. Valproate was found to enhance fast gamma -aminobutyric acid(A)-ergic inhibitory strength. Conclusions: Valproate significantly reduces epileptiform activity after trauma to the neocortex, likely by restoring the excitation-inhibition balance, perhaps through augmentation of gamma -aminobutyric acid transmission. The timing of this action may have implications for mechanisms of seizure genesis and may suggest a role for rapid treatment.	Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA		Bernardo, LS (corresponding author), Suny Downstate Med Ctr, Dept Neurol, 450 Clarkson Ave,Box 29, Brooklyn, NY 11203 USA.				NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH01431, MH51677] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38132] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH051677, R29MH051677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038132] Funding Source: NIH RePORTER		Albus H, 1998, EPILEPSIA, V39, P124, DOI 10.1111/j.1528-1157.1998.tb01350.x; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; BENARDO LS, 1998, AM AC NEUR ABSTR; CHAPMAN A, 1982, PROG NEUROBIOL, V19, P315, DOI 10.1016/0301-0082(82)90010-7; Dinner Dudley S., 1993, P654; FOHLMEISTER JF, 1984, J PHARMACOL EXP THER, V230, P75; GODIN Y, 1969, J NEUROCHEM, V16, P869, DOI 10.1111/j.1471-4159.1969.tb08975.x; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Ling DSF, 1998, SYNAPSE, V28, P91, DOI 10.1002/(SICI)1098-2396(199801)28:1<91::AID-SYN11>3.0.CO;2-0; LOSCHER W, 1993, NEUROCHEM RES, V18, P485, DOI 10.1007/BF00967253; MCLEAN MJ, 1986, J PHARMACOL EXP THER, V237, P1001; PENRY JK, 1979, NEUROLOGY, V29, P600; PREISENDORFER U, 1987, BRAIN RES, V435, P213, DOI 10.1016/0006-8993(87)91603-9; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SCHAUF CL, 1987, EUR J PHARMACOL, V3, P89; SCHMUTZ M, 1988, J NEURAL TRANSM, V72, P245, DOI 10.1007/BF01243423; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NRHM, 1996, NEUROLOGICAL SURG, P1834; VANDONGEN AMJ, 1986, EPILEPSIA, V27, P177, DOI 10.1111/j.1528-1157.1986.tb03525.x; WADA JA, 1976, ARCH NEUROL-CHICAGO, V33, P426, DOI 10.1001/archneur.1976.00500060032008; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 1998, NEUROSCI LETT, V257, P33, DOI 10.1016/S0304-3940(98)00798-8; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; ZEISE ML, 1991, BRAIN RES, V544, P345, DOI 10.1016/0006-8993(91)90078-A	27	9	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0013-9580			EPILEPSIA	Epilepsia	DEC	2000	41	12					1507	1513					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	382RG	WOS:000165835600002	11114207				2022-02-06	
J	Laurent-Vannier, A; Brugel, DG; De Agostini, M				Laurent-Vannier, A; Brugel, DG; De Agostini, M			Rehabilitation of brain-injured children	CHILDS NERVOUS SYSTEM			English	Article; Proceedings Paper	World Conference on Pediatric Neurosurgery, 2000 A.D: State of the Art and Perspectives for the Third Millennium	NOV 27-DEC 04, 1999	MARTINIQUE			children; brain-injury; network; prognosis; visuo-spatial neglect	PRESCHOOLERS; RECOVERY	A care network has been created in the Paris area according to two criteria - the continuity and the specificity of the care, with a single place to manage pediatric neurosurgical emergencies. This network makes possible research about brain-injured children. Until recently the "Kennard principle", that is, the assumption that recovery after similar lesions is greater in children than in adults has been supposed to be always true. In fact, if the lesions are diffuse, recovery is not greater in children compared with adults, or in younger children compared with older ones: the prognosis depends on the remaining ability to learn new practices. Normal IQ does not mean absence of sequelae. The cognitive deficits are very similar to those found in adults at the acute phase. For instance, visuo-spatial neglect appears as rather frequent when systematically looked for. The final assessment of outcome after childhood traumatic brain-injury should be done only after several years.	Hop Natl St Maurice, Serv Reeduc Pathol Neurol Acquises Enfant, F-94415 St Maurice, France; INSERM U472, Villejuif, France		Laurent-Vannier, A (corresponding author), Hop Natl St Maurice, Serv Reeduc Pathol Neurol Acquises Enfant, 14 Rue Val Osne, F-94415 St Maurice, France.						ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; EWINGCOBBS L, 1995, J HEAD TRAUMA REHAB, V10, P13, DOI 10.1097/00001199-199510000-00004; EWINGCOBBS L, 1997, J INT NEUROPSYCH SOC, V5, P58; FINGER S, 1988, M KENNARD PRINCIPLE, P117; FLETCHER JK, 1990, J CONSULT CLIN PSYCH, V58, P683; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LAURENTVANNIER A, 1997, 2 WORLD C BRAIN INJ; LAURENTVANNIER A, 1996, INT M TRAUM BRAIN IN; LAURENTVANNIER A, 1999, J NEUROLOGIE LANGUE; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; Michaud LJ, 1998, ARCH PHYS MED REHAB, V79, pS26, DOI 10.1016/S0003-9993(98)90117-4; Nybo T, 1999, BRAIN INJURY, V13, P759; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Unsworth C A, 1997, Pediatr Rehabil, V1, P207; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476	19	9	9	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	NOV	2000	16	10-11					760	764		10.1007/s003810000349			5	Clinical Neurology; Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	380BA	WOS:000165677400021	11151729				2022-02-06	
J	Nathoo, N; Nadvi, SS; van Dellen, JR				Nathoo, N; Nadvi, SS; van Dellen, JR			Traumatic cranial empyemas: a review of 55 patients	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Proceedings Paper	World Trauma Congress	JUN 13-19, 1999	DURBAN, SOUTH AFRICA			cranial; depressed fracture; empyema; trauma	SUBDURAL EMPYEMA; COMPUTED-TOMOGRAPHY; ERA; MANAGEMENT; ABSCESS	A 15-year (1983-1997) review of our unit's computed tomographic experience with traumatic cranial empyema (TCE) is reported. Fifty-five patients with documented history and clinical evidence of neurotrauma with secondary cranial empyema at surgery were identified. The clinical records and CT scans were analysed. TCE [four extradural and 51 subdural collections (SDE)] accounted for 7.86% of the total cranial empyemas seen during the study period. Most of the patients were young males (44 patients) and neurological deficits on admission were found only in the SDE group. Forty-one of 53 patients presented with septic compound skull fractures. Fifty-four patients had urgent surgical drainage. Eighty per cent of patients experienced a good outcome (GOS 4 or 5). A morbidity of 16. 4% ( including postoperative seizures) was noted and eight patients died (mortality rate 14.5%). Urgent surgical drainage, removal of osteitic bone, wound debridement and high dose intravenous antibiotic therapy form the mainstay of treatment.	Wentworth Provincial Hosp, Dept Neurosurg, ZA-4026 Durban, South Africa; Univ KwaZulu Natal, Dept Neurosurg, Sch Med, ZA-4001 Durban, South Africa		Nathoo, N (corresponding author), Wentworth Provincial Hosp, Dept Neurosurg, P Bag JACOBS, ZA-4026 Durban, South Africa.	nathoo@wwh.und.ac.za					ALEGRIA C, 1982, S AFR J SURG, V20, P25; BANNISTER G, 1981, J NEUROSURG, V55, P82, DOI 10.3171/jns.1981.55.1.0082; BOK APL, 1993, J NEUROSURG, V78, P574, DOI 10.3171/jns.1993.78.4.0574; BRADLEY PJ, 1984, BRIT J CLIN PRACT, V38, P85; ERASMUS JFP, 1966, SAFR MED J, P416; ERASMUS JFP, 1966, SAFR MED J, P433; GLASAUER FE, 1978, NEUROSURGERY, V3, P385, DOI 10.1227/00006123-197811000-00010; HARRIS LF, 1987, SOUTHERN MED J, V80, P1254, DOI 10.1097/00007611-198710000-00014; JOUBERT MJ, 1977, J NEUROSURG, V47, P73, DOI 10.3171/jns.1977.47.1.0073; LEBEAU J, 1973, J NEUROSURG, V38, P198, DOI 10.3171/jns.1973.38.2.0198; MAUSER HW, 1987, J NEUROL NEUROSUR PS, V50, P1136, DOI 10.1136/jnnp.50.9.1136; MILLER ES, 1987, J NEUROL NEUROSUR PS, V50, P1415, DOI 10.1136/jnnp.50.11.1415; Nathoo N, 1997, NEUROSURGERY, V41, P1263, DOI 10.1097/00006123-199712000-00005; Nathoo N, 1999, NEUROSURGERY, V44, P529, DOI 10.1097/00006123-199903000-00055; Nathoo N, 1999, NEUROSURGERY, V44, P748, DOI 10.1097/00006123-199904000-00033; Nathoo N, 2000, E AFR MED J, V77, P359; PATHAK A, 1990, ACTA NEUROCHIR, V102, P25, DOI 10.1007/BF01402182; VANALPHEN HAM, 1976, J NEUROL NEUROSUR PS, V39, P481, DOI 10.1136/jnnp.39.5.481; WEINGARTEN K, 1989, AM J ROENTGENOL, V152, P615, DOI 10.2214/ajr.152.3.615	19	9	10	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2000	14	4					326	330					5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	352TY	WOS:000089235000006	11045197				2022-02-06	
J	Irazuzta, JE; Mirkin, LD; Zingarelli, B				Irazuzta, JE; Mirkin, LD; Zingarelli, B			Mercaptoethylguanidine attenuates inflamation in bacterial meningitis in rabbits	LIFE SCIENCES			English	Article						peroxynitrite; nitric oxide; meningitis; brain myeloperoxidase; brain injury	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN INJURY; MYELOPEROXIDASE ACTIVITY; PEROXYNITRITE SCAVENGER; MENINGEAL INFLAMMATION; COMBINED INHIBITOR; HEMORRHAGIC-SHOCK; RATS; MERCAPTOALKYLGUANIDINES; CHILDREN	Reactive oxygen and nitrogen species participate in the inflammatory process during meningitis. Among them, superoxide, nitric oxide (NO), and their reaction product peroxynitrite exert cytotoxic effects. Mercaptoethylguanidine (MEG) exerts beneficial effects in in vivo inflammatory conditions by scavenging peroxynitrite and inhibiting the inducible NO synthase. This study was designed to investigate whether MEG may attenuate inflammation and brain injury in experimental meningitis. Meningitis increased nitrite/nitrate, and protein content in the cerebrospinal fluid (CSF), In the brain tissue high levels of malondialdehyde and formation of nitrotyrosine indicated lipid peroxidation and nitrosative stress, respectively. Myeloperoxidase activity was increased indicating accumulation of neutrophils into the brain parenchyma. Treatment with MEG decreased nitrite/nitrate levels whereas it did not affect the bacterial clearance from the CSF. Furthermore, treatment with MEG markedly reduced brain tissue levels of myeloperoxidase and malondialdehyde, These data demonstrate that MEG could have a therapeutic role in meningitis. (C) 2000 Elsevier Science Inc. All rights reserved.	Childrens Hosp Med Ctr, Div Crit Care, Cincinnati, OH USA; Childrens Med Ctr, Dept Pathol, Dayton, OH USA		Irazuzta, JE (corresponding author), Div Crit Care, 1 Childrens Plaza, Dayton, OH 45404 USA.	Irazuzta@aol.com	, Basilia/AAV-7582-2021				AMAEE FR, 1995, ACTA OTO-LARYNGOL, V115, P386, DOI 10.3109/00016489509139334; Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BARONE FC, 1995, MOL CHEM NEUROPATHOL, V24, P13, DOI 10.1007/BF03160109; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; Beckman JS, 1996, ADV NEUROL, V71, P339; BECKMAN JS, 1994, ANN NY ACAD SCI, V738, P69; Boje KMK, 1996, BRAIN RES, V720, P75, DOI 10.1016/0006-8993(96)00142-4; BUSTER BL, 1995, INFECT IMMUN, V63, P3835, DOI 10.1128/IAI.63.10.3835-3839.1995; Crow JP, 1997, J NEUROCHEM, V69, P1936; Cuzzocrea S, 1998, FREE RADICAL BIO MED, V24, P450, DOI 10.1016/S0891-5849(97)00280-3; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Hansbrough JF, 1996, J SURG RES, V61, P17, DOI 10.1006/jsre.1996.0074; Irazuzta J, 1999, CRIT CARE MED, V27, pA74, DOI 10.1097/00003246-199901001-00167; Kim YS, 1996, INFECT IMMUN, V64, P3148, DOI 10.1128/IAI.64.8.3148-3153.1996; KIM YS, 1995, J NEUROPATH EXP NEUR, V54, P531, DOI 10.1097/00005072-199507000-00007; KOEDEL U, 1995, ANN NEUROL, V37, P313, DOI 10.1002/ana.410370307; Koedel U, 1999, BRAIN PATHOL, V9, P57; Kornelisse RF, 1996, J INFECT DIS, V174, P120, DOI 10.1093/infdis/174.1.120; Lahrtz F, 1998, J NEUROIMMUNOL, V85, P33, DOI 10.1016/S0165-5728(97)00267-1; Leib SL, 1996, J INVEST MED, V44, pA111; Matsuoka H, 1999, EUR J ANAESTH, V16, P216, DOI 10.1046/j.1365-2346.1999.00459.x; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; SAEZLLORENS X, 1991, J CLIN INVEST, V88, P2003, DOI 10.1172/JCI115527; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SHAPIRA R, 1957, RADIAT RES, V7, P22, DOI 10.2307/3570551; Southan GJ, 1998, NITRIC OXIDE-BIOL CH, V2, P270, DOI 10.1006/niox.1998.0187; Southan GJ, 1996, BRIT J PHARMACOL, V117, P619, DOI 10.1111/j.1476-5381.1996.tb15236.x; SWARTZ MN, 1984, NEW ENGL J MED, V14, P912; Szabo C, 1997, J BIOL CHEM, V272, P9030; VEDDER NB, 1988, J CLIN INVEST, V81, P939, DOI 10.1172/JCI113407; Zingarelli B, 1997, EUR J PHARMACOL, V338, P55, DOI 10.1016/S0014-2999(97)01325-3; Zingarelli B, 1998, J PHARMACOL EXP THER, V287, P1048; Zingarelli B, 1996, J IMMUNOL, V156, P350; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P357, DOI 10.1038/sj.bjp.0700892	36	9	9	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	JUN 16	2000	67	4					365	372		10.1016/S0024-3205(00)00637-8			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	326QP	WOS:000087746500002	11003046				2022-02-06	
J	Megalooikonomou, V; Davatzikos, C; Herskovits, EH				Megalooikonomou, V; Davatzikos, C; Herskovits, EH			A simulator for evaluating methods for the detection of lesion-deficit associations	HUMAN BRAIN MAPPING			English	Article						brain mapping; computer simulation; databases; Monte Carlo method; sample size; statistical distributions; statistical models; magnetic resonance imaging	BRAIN-IMAGE DATABASE; CLOSED-HEAD INJURY; FISHER EXACT TEST; CONTINGENCY TABLE; STATISTICS; MODELS; POWER; REGISTRATION; INDEPENDENCE; NETWORKS	Although much has been learned about the functional, organization of the human brain through lesion-deficit analysis, the variety of statistical and image-processing methods developed for this purpose precludes a closed-form analysis of the statistical power of these systems. Therefore, we developed a lesion-deficit simulator (LDS), which generates artificial subjects, each of which consists of a set of functional deficits, and a brain image with lesions; the deficits and lesions conform to predefined distributions. We used probability distributions to model the number, sizes, and spatial distribution of lesions, to model the structure-function associations, and to model registration error. We used the LDS to evaluate, as examples, the effects of the complexities and strengths of lesion-deficit associations, and of registration error, on the power of lesion-deficit analysis. We measured the numbers of recovered associations from these simulated data, as a function of the number of subjects analyzed, the strengths and number of associations in the statistical model, the number of structures associated with a particular function, and the prior probabilities of structures being abnormal. The number of subjects required to recover the simulated lesion-deficit associations was found to have an inverse relationship to the strength of associations, and to the smallest probability in the structure-function model. The number of structures associated with a particular function (i.e., the complexity of associations) had a much greater effect on the performance of the analysis method than did the total number of associations. We also found that registration error of 5 mm or less reduces the number of associations discovered by approximately 13% compared to perfect registration. The LDS provides a flexible framework for evaluating many aspects of lesion-deficit analysis. (C) 2000 Wiley-Liss, Inc.	Dartmouth Coll, Dept Comp Sci, Sudikoff Lab 6211, Hanover, NH 03755 USA; Johns Hopkins Univ, Dept Radiol, Div Neuroradiol, Baltimore, MD USA		Megalooikonomou, V (corresponding author), Dartmouth Coll, Dept Comp Sci, Sudikoff Lab 6211, Hanover, NH 03755 USA.		Davatzikos, Christos/ABE-2057-2021	Davatzikos, Christos/0000-0002-1025-8561	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG13743-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG013743] Funding Source: NIH RePORTER		BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1023/A:1022649401552; Davatzikos C, 1998, HUM BRAIN MAPP, V6, P334; Davatzikos C, 1997, COMPUT VIS IMAGE UND, V66, P207, DOI 10.1006/cviu.1997.0605; Fisher LD., 1993, BIOSTATISTICS METHOD; FU YX, 1992, BIOMETRICS, V48, P1103, DOI 10.2307/2532702; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Harwell MR, 1997, COMMUN STAT-SIMUL C, V26, P605, DOI 10.1080/03610919708813400; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; HUERTA MF, 1993, TRENDS NEUROSCI, V16, P436, DOI 10.1016/0166-2236(93)90069-X; LARNTZ K, 1978, J AM STAT ASSOC, V73, P253, DOI 10.2307/2286650; LAURITZEN SL, 1989, ANN STAT, V17, P31, DOI 10.1214/aos/1176347003; LEE CIC, 1994, COMMUN STAT THEORY, V23, P2113, DOI 10.1080/03610929408831374; Letovsky SI, 1998, AM J NEURORADIOL, V19, P1869; MANNAN M, 1995, BIOMETRICAL J, V37, P409, DOI 10.1002/bimj.4710370404; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; OLUYEDE BO, 1994, CAN J STAT, V22, P75, DOI 10.2307/3315824; OSIUS G, 1992, J AM STAT ASSOC, V87, P1145, DOI 10.2307/2290653; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; Pearl J., 1988, PROBABILISTIC REASON; SHACHTER RD, 1989, MANAGE SCI, V35, P527, DOI 10.1287/mnsc.35.5.527; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanizaki H, 1997, J APPL STAT, V24, P603, DOI 10.1080/02664769723576; THOMAS RG, 1992, CONTROL CLIN TRIALS, V13, P134, DOI 10.1016/0197-2456(92)90019-V; Tong Y. L., 1990, MULTIVARIATE NORMAL; [No title captured]; [No title captured]; [No title captured]	29	9	9	2	3	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	1065-9471			HUM BRAIN MAPP	Hum. Brain Mapp.	JUN	2000	10	2					61	73		10.1002/(SICI)1097-0193(200006)10:2<61::AID-HBM20>3.0.CO;2-9			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	321KR	WOS:000087455100002	10864230	Green Published			2022-02-06	
J	Vosswinkel, JA; Brathwaite, CEM; Smith, TR; Ferber, JM; Casella, G; Garlick, PJ				Vosswinkel, JA; Brathwaite, CEM; Smith, TR; Ferber, JM; Casella, G; Garlick, PJ			Hyperventilation increases muscle protein synthesis in critically ill trauma patients	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Academic-Surgery	NOV 18-22, 1999	PHILADELPHIA, PENNSYLVANIA	Assoc Acad Surg		protein synthesis; critical care; trauma; metabolism	EXTRACELLULAR PH; METABOLIC-ACIDOSIS; NITROGEN-BALANCE; DEGRADATION; MYOCYTES; SURGERY; INSULIN; HUMANS	Background. Critically ill trauma patients are often in negative nitrogen balance and demonstrate advanced muscle protein wasting, which is in part due to a decrease in muscle protein synthesis. Previous studies have been performed on the relationship between pH and protein metabolism. Some evidence suggests that alkalosis might enhance protein synthesis. The purpose of the present study is to determine whether protein synthesis is increased in trauma patients who have a respiratory alkalosis from hyperventilation. Methods. Trauma patients in the intensive care unit (n = 8) who were treated with hyperventilation for elevated intracranial pressures were enrolled. Muscle protein synthesis rates were determined in vivo using the flooding method with L-[H-2(5)]phenylalanine. Measurements were performed twice on each patient within a 36-h period, first during hyperventilation and then after hyperventilation was discontinued. Hemoglobin oxygen saturation was maintained above 95% for all measurements. Results. Protein synthesis in muscle was 1.38 +/- 11%/day during hyperventilation (pH 7.50 +/- 0.02, pCO(2) 27.3 +/- 1.0 mm Hg) and 0.93 +/- 0.15%/day after respiratory parameters were normalized (pH 7.39 +/- 0.01, pCO(2) 39.4 +/- 1.5 mm Hg). The synthesis rate was significantly higher (P < 0.01, paired t test), 0.46 +/- 0.13%/day (32.6%), at the time of hyperventilation. Conclusion. Muscle protein synthesis is elevated during hyperventilation in critically ill patients with traumatic brain injury. We believe this preliminary study provides data that warrant confirmation in larger clinical studies. It suggests that this ventilatory therapeutic strategy may have a role in mitigating the negative nitrogen balance and muscle protein wasting that can impair the recovery of these patients. (C) 2000 Academic Press.	SUNY Stony Brook, Univ Hosp & Med Ctr, Dept Surg, Stony Brook, NY 11794 USA		Vosswinkel, JA (corresponding author), SUNY Stony Brook, Univ Hosp & Med Ctr, Dept Surg, Stony Brook, NY 11794 USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR010710] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR10710] Funding Source: Medline		ADIBI SA, 1980, J LAB CLIN MED, V95, P475; ASOH T, 1987, ANN SURG, V206, P770, DOI 10.1097/00000658-198712000-00014; BALLMER PE, 1995, J CLIN INVEST, V95, P39, DOI 10.1172/JCI117668; BIRKHAHN RH, 1980, SURGERY, V88, P294; CERRA FB, 1996, TRAUMA, P1155; ENGLAND BK, 1991, AM J PHYSIOL, V260, pC277, DOI 10.1152/ajpcell.1991.260.2.C277; ESSEN P, 1992, AM J PHYSIOL, V262, pE253, DOI 10.1152/ajpendo.1992.262.3.E253; FULLER SJ, 1989, BIOCHEM J, V259, P173, DOI 10.1042/bj2590173; GAITANAKI CJ, 1990, FEBS LETT, V260, P42, DOI 10.1016/0014-5793(90)80061-M; Imoberdorf R., 1996, European Journal of Clinical Investigation, V26, pA58; INCULET RI, 1986, SURGERY, V99, P752; KLEGER GR, 1996, CLIN NUTR, V15, P13; MCNURLAN MA, 1994, AM J PHYSIOL, V267, pE102, DOI 10.1152/ajpendo.1994.267.1.E102; MICHELSEN CB, 1982, J TRAUMA, V22, P410, DOI 10.1097/00005373-198205000-00011; MJAALAND M, 1990, CLIN NUTR, V9; PAPADOYANNAKIS NJ, 1984, AM J CLIN NUTR, V40, P623, DOI 10.1093/ajcn/40.3.623; REAICH D, 1992, AM J PHYSIOL, V263, pE735, DOI 10.1152/ajpendo.1992.263.4.E735; VINNARS E, 1990, JPEN, V14, P125	18	9	9	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	JUN 1	2000	91	1					61	64		10.1006/jsre.2000.5911			4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	317QW	WOS:000087239300011	10816351				2022-02-06	
J	Jagoda, A; Riggio, S				Jagoda, A; Riggio, S			Mild traumatic brain injury and the postconcussive syndrome	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article							MINOR HEAD-INJURY; BEHAVIORAL SEQUELAE; SYMPTOMS; MANAGEMENT; PREDICTORS; TOMOGRAPHY; DEFICITS	As many as 80% of patients with mild traumatic brain injury initially suffer from symptoms that are attributed to the postconcussion syndrome. Symptoms include headache, dizziness, difficulty with memory or concentration, depression, and peripheral vestibular system dysfunction. Well-motivated, young, male patients are at lowest risk for the postconcussion syndrome. By I year after injury, 85% of patients have a full recovery; patients with symptoms persisting for longer than 1 year are classified as suffering from the persistent postconcussive syndrome. Predictors of the persistent postconcussive syndrome include female gender, low socioeconomic status, other severe illness, alcohol abuse, and prior mild traumatic brain injury. Despite common beliefs, patients with ongoing Litigation do not necessarily have a higher prevalence of postconcussion syndrome or persistent postconcussive syndrome than do other such patients.	CUNY Mt Sinai Sch Med, Dept Emergency Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA		Jagoda, A (corresponding author), CUNY Mt Sinai Sch Med, Dept Emergency Med, 1 Gustave Levy Pl, New York, NY 10029 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BERROL S, 1992, PHYSICAL MED REHABIL, V6, P1; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; CHOI DW, 1987, J NEUROSCI, V7, P369; DIKMAN S, 1992, J NEUROL NEUROSUR PS, V49, P1227; ETTLIN T, 1993, J NEUROL NEUROSUR PS, V55, P943; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Holbourn AHS, 1943, LANCET, V2, P438; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; JENKINS A, 1986, LANCET, V2, P445; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVITT MA, 1995, ACAD EMERG MED, V2, P675, DOI 10.1111/j.1553-2712.1995.tb03617.x; LEVITT MA, 1994, AM J EMERG MED, V12, P172, DOI 10.1016/0735-6757(94)90240-2; LIDVALL H, 1974, ACTA NEUROL SCAND, V50, P42; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; MAZZUCHI A, 1992, J NEUROL, V238, P256; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SLAVI A, 1989, J NEUROPSYCHIAT, V1, pS41; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stewart DP, 1996, ACAD EMERG MED, V3, P21, DOI 10.1111/j.1553-2712.1996.tb03297.x; STRICH SJ, 1961, LANCET, V2, P443; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	46	9	9	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0733-8627			EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	MAY	2000	18	2					355	+		10.1016/S0733-8627(05)70130-9			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	307JV	WOS:000086650900016	10798893				2022-02-06	
J	Donders, J; Strom, D				Donders, J; Strom, D			Neurobehavioral recovery after pediatric head trauma: Injury, pre-injury, and post-injury issues	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; development; traumatic head injury	BRAIN INJURY; ACADEMIC-PERFORMANCE; CHILDREN; ADOLESCENTS; MILD; MANAGEMENT; PREDICTORS; ADJUSTMENT; ATTENTION; CHILDHOOD	This article reviews the most significant demographic, neurological, and psychosocial factors affecting the occurrence of and recovery from traumatic head injury (THI) in children and adolescents. Review of the available literature suggests that, as with adults, there is no compelling evidence for persistent neurobehavioral deficits after mild THI in children. In contrast, neurobehavioral deficits are common in children who have sustained moderate to severe THI. This article emphasizes that a long-term developmental perspective that considers in concert injury, pre-injury and post-injury variables is needed for a proper appreciation of possible sequelae of pediatric THI. Specific pitfalls in forensic assessments of these children are reviewed. Empirical findings are presented to support the position that neuropsychological evaluations of children with THI that do nor consider pre-injury status are likely to lead to misattribution errors. Clinical implications are illustrated with a case example.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Rehabil Ctr, Grand Rapids, MI USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jdonders@mfbrc.com					Achenbach TM, 1991, MANUAL CHILD BEHAV C; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BOLL T, 1993, CHILDRENS CATEGORY T; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Dells D., 1994, CALIFORNIA VERBAL LE; DEPOMPEI R, 1994, ED DIMENSIONS ACQUIR, P489; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; DONDERS J, 1993, DEATH STUD, V17, P517, DOI 10.1080/07481189308252636; Donders J, 1997, Pediatr Rehabil, V1, P179; Donders J, 1996, J HEAD TRAUMA REHAB, V11, P67, DOI 10.1097/00001199-199606000-00010; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; EWINGCOBBS L, 1995, J HEAD TRAUMA REHAB, V10, P13, DOI 10.1097/00001199-199510000-00004; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Hooper SR, 1997, ADV CLIN CHILD PSYCH, V19, P133; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Livingston RB, 1996, CHILD NEUROPSYCHOL, V2, P48, DOI 10.1080/09297049608401350; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; NOAH ZL, 1992, CRIT CARE CLIN, V8, P59, DOI 10.1016/S0749-0704(18)30267-7; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Seidel WT, 1998, ARCH CLIN NEUROPSYCH, V13, P82; Seidman LJ, 1997, J CONSULT CLIN PSYCH, V65, P150, DOI 10.1037/0022-006X.65.1.150; SHURTLEFF HA, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199510000-00008; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Walker B. R., 1997, STUDENTS ACQUIRED BR, P295; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	69	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2000	15	2					792	803		10.1097/00001199-200004000-00004			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	305FY	WOS:000086529800004	10739968				2022-02-06	
J	Isaksson, J; Farooque, M; Olsson, Y				Isaksson, J; Farooque, M; Olsson, Y			Spinal cord injury in ICAM-1-deficient mice: Assessment of functional and histopathological outcome	JOURNAL OF NEUROTRAUMA			English	Article						ICAM-1; inflammation; mouse; spinal cord injury	INTERCELLULAR-ADHESION MOLECULE-1; CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BRAIN INJURY; INFLAMMATORY RESPONSE; MESSENGER-RNA; RATS; INTERLEUKIN-1; PATHOGENESIS	Adhesion molecule-mediated adhesion and estravasation of leukocytes may constitute a mechanism of secondary tissue damage following spinal cord injury (SCI). The objective of the present study was to determine to what extent genetic deficiency in the adhesion molecule ICAM-1 influences functional and histopathological measures of outcome following SCI. ICAM-1-/- (n = 11) and wild-type (n = 9) mice were subjected to a compression-type SCI. Assessment of hind-limb motor function was done on days 1, 2, 4, 7, 10, and 14 after injury, using a motor function scoring system. Injury resulted in a drastically impaired hind limb motor function at day one after injury followed by a partial recovery during the observation period. No significant functional differences were found between the experimental groups at any time-point. Fourteen days after injury the animals were sacrificed and the spinal cords were processed for histopathological and immunohistochemical evaluation. Luxol-stained, MAP2-, GFAP- and iba-1-immunostained cross-sectional areas were quantitated using a computerized image analysis system to investigate white matter damage, neuronal loss, astrocytic response and microglial activation respectively. None of these parameters differed significantly between the groups. Separate experiments revealed that the early (24 h postinjury) infiltration of polymorphonuclear leukocytes was significantly reduced in white matter but not in the grey matter of ICAM-1-/- mice, compared to injured controls. In summary, these results do not support the concept that ICAM-1 alone mediates secondary tissue damage following traumatic SCI in the mouse.	Univ Uppsala Hosp, Dept Genet & Pathol, Res Grp Neuropathol, S-75185 Uppsala, Sweden		Isaksson, J (corresponding author), Univ Uppsala Hosp, Dept Genet & Pathol, Res Grp Neuropathol, S-75185 Uppsala, Sweden.						Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; CLARK WM, 1991, J NEUROSURG, V75, P623, DOI 10.3171/jns.1991.75.4.0623; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Eppihimer MJ, 1997, AM J PHYSIOL-HEART C, V273, pH1903, DOI 10.1152/ajpheart.1997.273.4.H1903; Farooque M, 1999, NEUROREPORT, V10, P131, DOI 10.1097/00001756-199901180-00024; FAROOQUE M, 1995, J NEUROTRAUM, V12, P41, DOI 10.1089/neu.1995.12.41; FAROOQUE M, 1999, IN PRESS ACTA NEUROP; Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.3.CO;2-6; FUJITA H, 1994, ARCH BIOCHEM BIOPHYS, V309, P62, DOI 10.1006/abbi.1994.1085; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Hamada Y, 1996, J NEUROCHEM, V66, P1525; HANCOCK MB, 1984, J HISTOCHEM CYTOCHEM, V32, P311, DOI 10.1177/32.3.6198359; HOLTZ A, 1989, ACTA NEUROL SCAND, V79, P460, DOI 10.1111/j.1600-0404.1989.tb03815.x; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Katoh S, 1997, INJURY, V28, P215, DOI 10.1016/S0020-1383(96)00184-2; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; LI GL, 1995, RESTOR NEUROL NEUROS, V8, P189, DOI 10.3233/RNN-1995-8404; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Ohsawa K, 1997, GLIA, V21, P285; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Ranefall P, 1997, ANAL CELL PATHOL, V15, P145, DOI 10.1155/1997/304073; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; SCHOENBERG MH, 1991, GUT, V32, P905, DOI 10.1136/gut.32.8.905; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Shibayama M, 1996, J NEUROTRAUM, V13, P801, DOI 10.1089/neu.1996.13.801; SHRIKANT P, 1995, J IMMUNOL, V155, P1489; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Watanabe T, 1999, J NEUROTRAUM, V16, P255, DOI 10.1089/neu.1999.16.255; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747	47	9	10	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2000	17	4					333	344		10.1089/neu.2000.17.333			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	302LA	WOS:000086365500006	10776916				2022-02-06	
J	Oliviero, A; Insola, A; Santilli, V; Tartaglione, T; Profice, P; Tonali, P; Di Lazzaro, V				Oliviero, A; Insola, A; Santilli, V; Tartaglione, T; Profice, P; Tonali, P; Di Lazzaro, V			Concomitant post-traumatic craniocervical junction epidural hematoma and pontomedullary junction infarction - Clinical, neurophysiologic, and neuroradiologic features	SPINE			English	Article						brain stem infarction; brain stimulation; epidural hematoma; whiplash injury	CORTICOSPINAL PATHWAYS; PYRAMIDAL DECUSSATION; STIMULATION; LEVEL; HUMANS	Study Design. A case report. Objectives. To report and discuss a case of post-traumatic epidural hematoma of the craniocervical junction with concomitant brain stem infarction. Summary of Background Data. Post-traumatic epidural hematoma of the cervical spine and brain stem post-traumatic infarction are very rare disorders. Posttraumatic epidural hematoma is usually located dorsally in the epidural space. Methods. The clinical, neuroradiologic, and neurophysiologic findings in one patient with post-traumatic epidural hematoma located ventrally at the cervicomedullary junction and associated with medial infarction at the pontomedullary junction are reported. Results. The main clinical finding in this patient was bilateral corticospinal and corticobulbar tract involvement A magnetic resonance image showed displacement and flattening of the medulla oblongata and of the most cranial portion of cervical cord, which were caused by the epidural hematoma associated with an ischemic lesion of the pontomedullary junction. Results of central motor conduction studies indicated that the abnormality of the central motor pathways was localized at brain stem level, and that there was normal conduction from the cervicomedullary junction to spinal cord. Conclusion. This is the first reported case of spinal epidural hematoma located ventrally in the cervical spine at the cervicomedullary junction level and concomitant infarction at the pontomedullary junction resulting from whiplash injury.	Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy; Neurofisiol CTO, Rome, Italy; Unita Spinale CTO, Rome, Italy; Univ Cattolica Sacro Cuore, Ist Radiol, I-00168 Rome, Italy; IRCCS E MEDEA Assoc Nostra Famiglia, Ostuni, Italy; IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy		Di Lazzaro, V (corresponding author), Univ Cattolica Sacro Cuore, Inst Neurol, Lgo A Gemelli 8, I-00168 Rome, Italy.	dilazzar@rm.ats.it	TARTAGLIONE, TOMMASO/K-5390-2017; Di Lazzaro, Vincenzo/L-3731-2018	TARTAGLIONE, TOMMASO/0000-0003-3896-4078; Di Lazzaro, Vincenzo/0000-0002-9113-5925; Profice, Paolo/0000-0001-9923-9246; Santilli, Valter/0000-0002-2547-6801			BOUKOBZA M, 1994, NEURORADIOLOGY, V36, P456, DOI 10.1007/BF00593683; Schroder ML, 1998, ACT NEUR S, V71, P127; UGAWA Y, 1994, ANN NEUROL, V36, P618, DOI 10.1002/ana.410360410; UGAWA Y, 1991, ANN NEUROL, V29, P418, DOI 10.1002/ana.410290413; UGAWA Y, 1992, BRAIN, V115, P1947, DOI 10.1093/brain/115.6.1947	5	9	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	APR 1	2000	25	7					888	890		10.1097/00007632-200004010-00020			3	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	304KQ	WOS:000086483100024	10751303				2022-02-06	
J	Ricard-Hibon, A; Marty, J				Ricard-Hibon, A; Marty, J			Initial management and diagnostic strategy of severely head-injured patients	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	21st Meeting of the Association-de-Neuroanesthesie-Reanimation-de-Langue-Francaise	NOV 18-19, 1999	BORDEAUX, FRANCE	Assoc Neuroanesthesie Reanimat Langue Francaise		head trauma; monitoring; hypotension; hypoxia	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN INJURY; COMA-SCALE SCORE; INTRACRANIAL-PRESSURE; BLUNT-TRAUMA; ENDOTRACHEAL INTUBATION; COMPUTED-TOMOGRAPHY; NATIONAL SURVEY; CERVICAL-SPINE; INTENSIVE-CARE	Limitation of secondary insults after severe head injury is a permanent concern during the early phase of head trauma management. The objectives are to maintain mean arterial pressure between 80 and 100 mmHg, to avoid hypoxaemia, and to maintain arterial PCO2 near to 35 mmHg. Volume loading can be necessary to improve arterial pressure, and is carried out with isotonic critalloid (NaCl 9 parts per thousand) or colloids, with the exclusion of all hypotonic solutions (Ringer lactate or glucose). The use of catecholamines is reserved for patients with unstable haemodynamics despite an adequate volume loading. The rapid sequence induction is recommended for endotracheal intubation and is followed by continuous analgesia-sedation to keep patient-ventilator dysynchrony, but without compromising haemodynamic objectives. Mannitol is used in case of life-threatening intracranial hypertension. Conversely, specific treatment of intracranial hypertension, especially hypocapnia, is not recommended. Initial diagnostic procedures include cerebral tomodensitometry (TDM). However, TDM may be delayed in case of haemorrhage, which requires a rapid treatment. Intrahospital tranport for additional explorations risks secondary insults, and thus requires close monitoring to detect and treat in due time all adverse events. This monitoring includes invasive arterial blood pressure assessment, use of continuous capnography and repeated arterial blood gas measurements. The usefulness of transcranial Doppler for initial management of head-trauma patients needs further evaluation. (C) 2000 Editions scientifiques et medicales Elsevier SAS.	Hop Beaujon, Serv Anesthesie Reanimat Smur, F-92110 Clichy, France		Ricard-Hibon, A (corresponding author), Hop Beaujon, Serv Anesthesie Reanimat Smur, 100 Bd Gen Leclerc, F-92110 Clichy, France.						Abrams K J, 1995, New Horiz, V3, P479; Adnet F, 1998, ACAD EMERG MED, V5, P123, DOI 10.1111/j.1553-2712.1998.tb02596.x; Adnet F, 1998, ANN FR ANESTH, V17, P688, DOI 10.1016/S0750-7658(98)80106-8; *AG NAT ACCR EV SA, 1999, ANN FR ANESTH, V18, P1; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Brimacombe JR, 1997, CAN J ANAESTH, V44, P414, DOI 10.1007/BF03014464; Brown MM, 1996, EUR J ANAESTH, V13, P474, DOI 10.1046/j.1365-2346.1996.00973.x; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; CHOPP M, 1988, STROKE, V19, P1383, DOI 10.1161/01.STR.19.11.1383; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; D'Alise MD, 1999, J NEUROSURG, V91, P54, DOI 10.3171/spi.1999.91.1.0054; David JS, 1999, ANN FR ANESTH, V18, P398, DOI 10.1016/S0750-7658(99)80087-2; FORGET A, 1998, ANN FR ANESTH, V17, P1064; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FULTON RL, 1993, SURG GYNECOL OBSTET, V176, P327; GENTLEMAN D, 1992, INT SURG, V77, P297; Goldstein P, 1998, REAN URG, V7, P465; GOODWIN JR, 1994, J TRAUMA, V37, P119, DOI 10.1097/00005373-199407000-00021; Grenier B, 1999, ANESTH ANALG, V88, P43, DOI 10.1097/00000539-199901000-00009; HUANG MS, 1995, J TRAUMA, V38, P154, DOI 10.1097/00005373-199501000-00035; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Janvier G, 1996, ANN FR ANESTH, V15, P407; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; LAXENAIRE MC, 1994, ANN FR ANESTH, V13, P301, DOI 10.1016/S0750-7658(94)80038-3; LEJAY M, 1998, MED URGENCE, P83; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARTIN C, 1995, ANN FR ANESTH, V14, P444; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; Plaisance P, 1998, MED URGENCE, P95; PLAUD B, 1997, C ACT 39 C NAT AN RE, P319; Prielipp R C, 1995, New Horiz, V3, P456; RAVUSSIN PA, 1994, ANN FR ANESTH, V13, P88, DOI 10.1016/S0750-7658(94)80191-6; RICARDHIBON A, 1998, MED URGENCE, P121; RICARDHIBON A, 1997, ANN FR ANESTH, V16, P723; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUSSELL GB, 1994, J TRAUMA, V36, P317, DOI 10.1097/00005373-199403000-00006; *SOC FRANC AN REAN, 2000, IN PRESS ANN FR ANES; *SOC REAN LANG FRA, 1997, REANIM URG, V6, P335; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; THOMASON M, 1993, J TRAUMA, V34, P40, DOI 10.1097/00005373-199301000-00007; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Warren BB, 1997, ANESTH ANALG, V84, P206, DOI 10.1097/00000539-199701000-00037; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; WINCHELL RJ, 1995, ANN EMERG MED, V25, P737, DOI 10.1016/S0196-0644(95)70200-8; Wysoki MG, 1998, RADIOLOGY, V208, P125, DOI 10.1148/radiology.208.1.9646802; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	57	9	10	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2000	19	4					286	295					10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	313GX	WOS:000086992900012	10836116				2022-02-06	
J	Sahuquillo, J; Robles, A; Poca, A; Ballabriga, A; Mercadal, J; Secades, JJ				Sahuquillo, J; Robles, A; Poca, A; Ballabriga, A; Mercadal, J; Secades, JJ			A controlled, double-blind, randomized pilot clinical trial of nicardipine as compared with a placebo in patients with moderate or severe head injury	REVISTA DE NEUROLOGIA			Spanish	Article						cerebral vasospasm; clinical trial; head injury; nicardipine; posttraumatic subarachnoid hemorrhage transcranial Doppler; treatment; ultrasonography	TRANSCRANIAL DOPPLER ULTRASOUND; CEREBRAL BLOOD-FLOW; TRAUMATIC SUBARACHNOID HEMORRHAGE; ISCHEMIC BRAIN-DAMAGE; INTRAVENOUS NICARDIPINE; COOPERATIVE ANEURYSM; ARTERIAL SPASM; ANGIOGRAPHIC FINDINGS; VASOSPASM; VELOCITY	Introduction. One of the factors involved in the occurrence of ischemic cerebral lesions following head injury is cerebral vasospasm. We analyze the effect of intravenous nicardipine on the prevention and treatment of posttraumatic cerebral vasospasm. Patients and methods. We made a placebo-controlled, randomised, double-blind pilot study of the effect of nicardipine (intravenously 5 mg/hour for one week) on patients with moderate or severe head injury who presented with cerebral vasospasm, defined as an average Doppler flow velocity (DFV) of 100 cm/second or more. The main variable assessed was the evolution of the DFV and the secondary criteria were the evolution of the arterial blood pressure, coma scales, the findings on the Glasgow Coma Scale and the safety of the drug. Results. Eleven patients were included in each homogeneous group. The DFV was found to have become normal on the first day of treatment with nicardipine and on the third day with the placebo (p= 0.023). During the first day of treatment the percentage of cerebral hemispheres diagnosed as having suspected spasm was 11.1% for nicardipine and 64.3% for the placebo (p= 0.02881). The average time for recovery (DFV < 100 cm/second) was 3.33 days with the placebo and 1.22 days with nicardipine (p= 0.0039). The patients treated with nicardipine had 8.89 times more chance of recovery from vasospasm. The incidence of adverse effects was greater with the placebo (p= 0.014). Conclusion. Nicardipine is effective in the reversal and prevention of increased Doppler flow velocity in patients with moderate or severe head injury.	Hosp Traumatol, Serv Neurocirugia, Unidad Invest Neurotraumatol, E-08028 Barcelona, Spain; Hosp Traumatol, Unidad Cuidados Intens Neurotraumatol, E-08028 Barcelona, Spain; Hosp Univ Vall Dhebron, Hosp Traumatol, Unidad Cuidados Intens Neurotraumatol, E-08028 Barcelona, Spain; Grp Ferrer SA, Dept Med, Div Neurofarmacol, E-08028 Barcelona, Spain				Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008	Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abraszko R, 1996, J CLIN NEUROSCI, V3, P21, DOI 10.1016/S0967-5868(96)90078-8; ALBORCH E, 1992, EUR J PHARMACOL, V229, P83, DOI 10.1016/0014-2999(92)90289-G; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHOI DW, 1990, J NEUROSCI, V10, P2493; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; DAVIS SM, 1992, STROKE, V23, P492, DOI 10.1161/01.STR.23.4.492; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ENEVOLDSEN EM, 1977, J NEUROSURG, V47, P699, DOI 10.3171/jns.1977.47.5.0699; FLAMM ES, 1988, J NEUROSURG, V68, P393, DOI 10.3171/jns.1988.68.3.0393; GIANNOTTA SL, 1985, NEUROSURGERY, P1678; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; GROSSET DG, 1992, STROKE, V23, P674, DOI 10.1161/01.STR.23.5.674; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; HALEY EC, 1994, J NEUROSURG, V80, P788, DOI 10.3171/jns.1994.80.5.0788; HALEY EC, 1993, J NEUROSURG, V78, P548, DOI 10.3171/jns.1993.78.4.0548; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HONORATO J, 1988, DRUGS TODAY S4, V24, P1; HUBSCHMANN OR, 1985, J NEUROSURG, V62, P698, DOI 10.3171/jns.1985.62.5.0698; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JENNET B, 1986, DIAGNOSTICO TRATAMIE; JENNETT B, 1975, LANCET, V1, P480; KAECH DL, 1990, NEUROCHIRURGIE, V36, P279; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; KAKARIEKA A, 1995, CEREBROVASC DIS, V5, P403, DOI 10.1159/000107892; KAKARIEKA A, 1994, J NEURAL TRANSM-SUPP, P13; KOSTRON H, 1985, ACTA NEUROCHIR WEIN, V28, P103; KRASZNAI L, 1994, NEUROL RES, V16, P40; KUCHARCZYK J, 1989, STROKE, V20, P268, DOI 10.1161/01.STR.20.2.268; KUROIWA T, 1994, PATHOL INT, V44, P171, DOI 10.1111/j.1440-1827.1994.tb02590.x; Lindegaard K F, 1993, Adv Tech Stand Neurosurg, V20, P39; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MASSIOU H, 1992, SURG NEUROL, V38, P7, DOI 10.1016/0090-3019(92)90205-2; Melon E, 1987, Agressologie, V28, P391; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; MUTTAQIN Z, 1991, NEUROSURG REV, V14, P321, DOI 10.1007/BF00383273; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; NEWELL DW, 1992, CEREBROVAS BRAIN MET, V4, P122; NEWELL DW, 1990, NEUROSURGERY, V27, P574, DOI 10.1227/00006123-199010000-00011; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PETTY GW, 1990, MAYO CLIN PROC, V65, P1350, DOI 10.1016/S0025-6196(12)62146-6; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SAWA H, 1990, NO SHINKEI GEKA SOKU, V1, P19; SCHMIEDER K, 1996, ACTA NEUROL SCAND  S, V166, pS123; SEILER RW, 1987, ACTA NEUROCHIR, V85, P7, DOI 10.1007/BF01402363; SHIGEMORI M, 1990, ACTA NEUROCHIR, V107, P5, DOI 10.1007/BF01402605; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SLOAN MA, 1989, NEUROLOGY, V39, P1514, DOI 10.1212/WNL.39.11.1514; SUWANWELA C, 1986, J NEUROSURG, V65, P80; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TSUKAHARA T, 1989, SURG NEUROL, V32, P188, DOI 10.1016/0090-3019(89)90177-8; VERLOOY J, 1989, ACTA NEUROL BELG, V89, P346; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00172-9	69	9	10	0	2	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	MAR 1	2000	30	5					401	408		10.33588/rn.3005.99063			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	302NU	WOS:000086372300001	10775962				2022-02-06	
J	Clausen, T; Rieger, A; Roth, S; Soukup, J; Furka, I; Lindner, J; Telgmaa, L; Hennig, C; Radke, J; Menzel, M				Clausen, T; Rieger, A; Roth, S; Soukup, J; Furka, I; Lindner, J; Telgmaa, L; Hennig, C; Radke, J; Menzel, M			Cerebrovenous blood temperature-influence of cerebral perfusion pressure changes and hyperventilation - Evaluation in a porcine study and in man	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain; temperature; cerebrovenous; Jugular bulb; monitoring; cerebral perfusion pressure	TRAUMATIC BRAIN INJURY; HEAD-INJURY; HYPOTHERMIA; FLOW; VOLUME	The objective of the first part of this study was to use an animal model to investigate the relationship between temperature in the cerebrovenous compartment and cerebral perfusion pressure. In the second part of the study. the objective was to examine the influence of hyperventilation and hypothermia on jugular bulb temperature and body temperature in patients undergoing elective neurosurgery. Intracranial pressure was increased artificially by inflating an infratentorial supracerebellar placed balloon catheter in nine pigs under general anesthesia. Temperature was monitored by thermocouples inserted in the sagittal sinus, white matter of the left lobe and abdominal aorta during the ensuing decrease in cerebral profusion pressure (CPP). Cerebrovenous blood temperature (jugular bulb) and body temperature (urinary bladder) were simultaneously monitored in 24 patients undergoing craniotomy. Moderate hyperventilation was performed in all patients. Cerebrovenous blood and core body temperature were recorded and differences between these two temperatures calculated at the beginning and the end of hyperventilation. At the beginning of the intracranial pressure (ICP), increase mean temperatures of cerebrovenous blood and cerebral tissue (left lobe) were lower than core body temperature. During CPP reduction the difference between core body temperature and cerebrovenous blood temperature increased significantly from 0.86 +/- 0.44 degrees C prior to ICP rise to 1.19 +/- 0.58 degrees C at maximum ICP. Before hyperventilation, cerebrovenous blood temperature was higher in 19 patients (+/-difference: 0.34 degrees C +/- 0.27) and equal or lower in five patients (difference: -0.08 degrees C +/- 0.11), than core body temperature, Al the end of hyperventilation, the difference between cerebrovenous blood temperature and core body temperature increased (+0.42 degrees C +/- 0.24) in those 19 patients who had started with a higher cerebrovenous blood temperature and decreased (-0.10 degrees C +/- 0.18) in the other five patients. Both studies demonstrated that the temperature of cerebrovenous blood is influenced by maneuvers which are supposed to decrease cerebral blood flow.	Univ Halle Wittenberg, Dept Anesthesiol & Intens Care Med, D-06097 Halle, Germany; Univ Halle Wittenberg, Div Neurosurg, D-06097 Halle, Germany; Univ Debrecen, Dept Expt Surg, Debrecen, Hungary		Menzel, M (corresponding author), Univ Halle Wittenberg, Dept Anesthesiol & Intens Care Med, Magdeburger Str 16, D-06097 Halle, Germany.		Furka, Istvan/AAP-6194-2020				BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHEN H, 1991, NEUROLOGY, V41, P1133, DOI 10.1212/WNL.41.7.1133; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Crowder CM, 1996, J NEUROSURG, V85, P98, DOI 10.3171/jns.1996.85.1.0098; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; JOHNSTON IH, 1973, J NEUROL NEUROSUR PS, V36, P161, DOI 10.1136/jnnp.36.2.161; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; LAPTOOK AR, 1994, PEDIATR RES, V35, P436, DOI 10.1203/00006450-199404000-00010; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MATTA BF, 1994, ANESTH ANALG, V79, P745; MELLERGARD P, 1990, British Journal of Neurosurgery, V4, P31, DOI 10.3109/02688699009000679; METZLER P, 1986, METHODIK MED PSYCHOL, P29; MINAMISAWA H, 1990, STROKE, V21, P758, DOI 10.1161/01.STR.21.5.758; Murr R, 1996, Anasthesiol Intensivmed Notfallmed Schmerzther, V31, P29, DOI 10.1055/s-2007-995864; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; SOUKOP JZA, 1999, IN PRESS J NEUROTRAU; Stone JG, 1997, NEUROSURGERY, V41, P20, DOI 10.1097/00006123-199707000-00007; VERLOOY J, 1995, ACTA NEUROCHIR, V134, P76, DOI 10.1007/BF01428508; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	26	9	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2000	12	1					2	9		10.1097/00008506-200001000-00002			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	270PT	WOS:000084545200002	10636613				2022-02-06	
J	Vath, A; Meixensberger, J; Dings, J; Meinhardt, M; Roosen, K				Vath, A; Meixensberger, J; Dings, J; Meinhardt, M; Roosen, K			Prognostic significance of advanced neuromonitoring after traumatic brain injury using neural networks	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						severe head injury; outcome; cerebral oxygenation; intracranial pressure	SEVERE HEAD-INJURY; EVOKED-POTENTIALS; COMA; MANAGEMENT; PREDICTION; PRESSURE; SCALE	While the therapeutic impact of tissue oxygenation (PtiO2) supplementing ICP-monitoring is proven by several clinical studies, its prognostic value is not well studied. In the following study artificial neural networks (ANN) were used to analyze the accuracy of outcome prediction after traumatic brain injury (TBI) for different combinations of clinical data and parameters derived from neuromonitoring. The total group included 95 patients suffering from TBI. For all patients clinical data (age, GCS, pupillary response etc.) were recorded and outcome was classified using Glasgow outcome scale after 6 months. In a first step a subgroup of 60 patients was chosen to train a neural network to predict outcome based only on clinical data. In a second step the resting 35 patients all having continuous neuromonitoring with automatic data storage of ICP and PtiO2 were chosen. Different network models were composed using the former clinical model plus up to three additional input units for the following parameters: (a) relative number of ICP>40 mmHg, (b) relative number of PtiO2 < 5 mmHg and (c) relative number of ICP > 30 mmHg with simultaneous PtiO2 < 10 mmHg. For each model the following time periods were analyzed: day 1-2, day 1-3 and day 1-4 after trauma and additionally day 1-4 after trauma plus last day of neuromonitoring. Pure clinical data allowed to predict outcome with 74.3% accuracy. A combination of clinical data with ICP (a) significantly increased the confidence levels of outcome prediction in all time periods (p<0.05) with accuracy rates rising up to 82.9% for the longer time periods. The combination of clinical data and [CP&PtiO2 (c) lead to comparable results. In contrast, no significant increases were observed in the early time periods when combining clinical data with PtiO2 (b) while accuracy rates rose up to 80% for extended time periods after trauma. A combination of all parameters lead to results lying between the above results. The results indicate that prediction of outcome can be improved by combining clinical and neuromonitoring data. The prognostic value of ICP might be superior to that of PtiO2.	Univ Wurzburg, Neurochirurg Klin & Poliklin, Dept Neurosurg, D-97080 Wurzburg, Germany			meix@nch.uni-wuerzburg.de					Bardt TF, 1998, ACT NEUR S, V71, P153; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CHOI SC, 1996, NEUROTRAUMA, P779; Dings J, 1998, NEUROL RES, V20, pS71; Facco E, 1998, NEUROL RES, V20, pS40; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; SCHERER A, 1997, GRUNDLAGEN ANWENDUNG; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029	17	9	9	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		2000	61	1					2	6		10.1055/s-2000-8258			5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	314TG	WOS:000087073200002	10859794				2022-02-06	
J	Wagner, RH; Cifu, DX; Keyser-Marcus, L				Wagner, RH; Cifu, DX; Keyser-Marcus, L			Functional outcome of individuals with traumatic brain injury and lower extremity deep venous thrombosis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TERM FOLLOW-UP; VEIN THROMBOSIS; REHABILITATION PROGRAM; INDEPENDENCE MEASURE; CLINICAL COURSE; LENGTH; STAY; CHARGES	Objective: To determine the impact of acute lower extremity (LE) deep venous thrombosis (DVT) on functional outcome after traumatic brain injury (TBI). Setting: Tertiary university medical center rehabilitation unit. Subjects: Ninety-two TBI rehabilitation patients (46 patients with DVT and 46 patients without DVT). Forty-six TBI patients with a diagnosis of LE DVT were 1:1 matched with non-DVT TBI patients. Watching criteria included: primary diagnosis of TBI, admission Functional Independence Measure (FIM), Glasgow Coma Scale (GCS), and age. Outcome Measures: FLU (admission, discharge, change, and efficiency), FLU subscores (activities of daily living [ADL], mobility, cognition), length of stay ([LOS] acute and rehabilitation), and discharge living disposition. Design: Cohort study utilizing prospectively collected data. DVT diagnoses were made upon rehabilitation admission using color flow duplex Doppler ultrasonography. Descriptive statistics were run on demographic variables. Analyses of variance (ANOVAs) were performed on the sample with regard to outcome measures, including FLU scores, FIM subscores, and LOS (acute and rehabilitation). Results: No significant between-group differences were found concerning LOS, rehabilitation costs, FIM total, or FIM subgroup scores. Chi-squared analyses revealed significant differences between groups with regard to discharge living disposition (chi(2) = 4.7, P < .03). Conclusion: Lower extremity DVT does not appear to interfere with functional outcome after TBI. The data suggest that this patient population is appropriate for admission or continued participation in acute inpatient rehabilitation, despite the presence of LE DVT.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Cifu, DX (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, POB 980677, Richmond, VA 23298 USA.			Keyser-Marcus, Lori/0000-0001-6014-2500; Cifu, David/0000-0003-1600-9387			Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BLACK PM, 1986, NEUROSURGERY, V18, P25, DOI 10.1227/00006123-198601000-00005; BRANDSTATER ME, 1992, ARCH PHYS MED REHAB, V73, P8379; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DICKMANN U, 1988, KLIN WOCHENSCHR, V66, P1182, DOI 10.1007/BF01727666; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; JENNETT B, 1976, LANCET, V1, P1031; Johnson BF, 1996, INT ANGIOL, V15, P14; Keith R A, 1987, Adv Clin Rehabil, V1, P6; OShaughnessy AM, 1997, INT ANGIOL, V16, P45; Prandoni P, 1997, HAEMATOLOGICA, V82, P423; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; *STAT U NY BUFF, 1995, GUID UN DAT SYST MED; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	24	9	9	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1999	14	6					558	566		10.1097/00001199-199912000-00004			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	269AV	WOS:000084454300003	10671701				2022-02-06	
J	Burke, JG; Dursun, SM; Reveley, MA				Burke, JG; Dursun, SM; Reveley, MA			Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine	JOURNAL OF PSYCHIATRY & NEUROSCIENCE			English	Article						brain injuries; clozapine; epilepsy, post-traumatic; frontal lobe; head; head injuries; schizophrenia; trauma		A 34-year-old man with a 10-year history of persistent auditory hallucinations and passivity delusions had failed to respond to a variety of conventional antipsychotic medications. He had a history of head trauma 8 years before the onset of psychiatric symptoms. Recent investigations revealed a post-traumatic infarct, situated in the left frontal lobe, on a magnetic resonance imaging scan. Treatment with clozapine for more than 2 years resulted in a marked improvement in his psychotic symptoms. The localization of the brain lesion may be related to the etiology of his symptoms: and to the clinical response to clozapine.	Univ Leicester, Dept Psychiat, Fac Med, Leicester, Leics, England		Dursun, SM (corresponding author), Dalhousie Univ, Psychopharmacol Res Unit, Dept Psychiat, AJLB, 5909 Jubilee Rd,Room 4031, Halifax, NS B3H 2E2, Canada.						ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Brooks WM, 1998, BIOL PSYCHIAT, V43, P263, DOI 10.1016/S0006-3223(97)00462-9; DAVID AS, 1993, NEUROPSYCHOLOGY SCHI, P269; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DENNEY D, 1995, BIOL PSYCHIAT, V37, P427, DOI 10.1016/0006-3223(94)00237-W; Flor-Henry P, 1980, Psychopharmacol Bull, V16, P52; FLORHENRY P, 1976, ANN NY ACAD SCI, V280, P777, DOI 10.1111/j.1749-6632.1976.tb25541.x; HALL DP, 1992, J NEUROL NEUROSUR PS, V55, P1207, DOI 10.1136/jnnp.55.12.1207; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; KENNARD C, 1994, J NEUROL NEUROSUR PS, V57, P881, DOI 10.1136/jnnp.57.8.881; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; McKenna P. J., 1994, SCHIZOPHRENIA RELATE; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; NODA H, 1992, NEUROSCI RES, V13, P163, DOI 10.1016/0168-0102(92)90056-I; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; STARKSTEIN SE, 1991, J NEUROPSYCH CLIN N, V3, P276	16	9	9	0	0	CANADIAN MEDICAL ASSOCIATION	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 3Y6, CANADA	1180-4882			J PSYCHIATR NEUROSCI	J. Psychiatry Neurosci.	NOV	1999	24	5					456	461					6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	258BM	WOS:000083818200006	10586537				2022-02-06	
J	Piguet, O; King, AC; Harrison, DP				Piguet, O; King, AC; Harrison, DP			Assessment of minimally responsive patients: clinical difficulties of single-case design	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; METHYLPHENIDATE; ATTENTION; AROUSAL	Improved management of very severely central nervous system (CNS) injured individuals has given rise to an increasing number of patients in a minimally responsive state. There is a growing literature stressing the importance of accurately determining these patients' level of cognitive functioning and its role in appropriate rehabilitation and long term management. The single case design model appears to be the intervention of choice, with its great flexibility and tailored approach to each individual case. The recent literature has focused on the technical aspects of the assessment, offering clear procedural guidelines. Unfortunately, there is a dearth of information about clinical factors such as clinical setting and family involvement, which may interfere with or prevent a planned intervention. The case of MT is presented, who was the subject of a single case intervention 9 months following an extremely severe traumatic brain injury. The planned intervention was to examine the effects of a psychostimulant on MT's level of arousal, in order to improve his participation in the rehabilitation programme. Beyond the results (which were equivocal), the clinical difficulties in conducting single case study designs in rehabilitation are discussed. Ways to minimize these difficulties are proposed.	Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; Royal Rehabil Ctr, Sydney, NSW, Australia; Oats St Residential Facil, E Victoria Pk, Australia		Piguet, O (corresponding author), Concord Hosp C25, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.		Piguet, Olivier/C-9658-2011	Piguet, Olivier/0000-0002-6696-1440			Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Shiel A, 1998, BRAIN INJURY, V12, P809, DOI 10.1080/026990598122043; SUNDBERG S, 1990, AM J NONINVAS CARD, V4, P181, DOI 10.1159/000470531; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WHYTE J, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI 10.1097/00001199-199409000-00008; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004	9	9	9	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1999	13	10					829	837		10.1080/026990599121223			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	247TV	WOS:000083236800009	10576467				2022-02-06	
J	Turner-Stokes, L				Turner-Stokes, L			Outcome measures for inpatient neurorehabilitation settings	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							ASSESSMENT MEASURE FIM+FAM; TRAUMATIC BRAIN INJURY; REHABILITATION; RELIABILITY	Outcome measures for inpatient neurorehabilitation settings need to take account of cognitive and communicative problems, as well as physical disability, and must be feasible to use as an integral part of clinical practice. Global measures of disability offer the possibility of a common language in outcome measurement between different centres. In the UK, those most commonly used are the Barthel Index, the FIM (Functional Independence Measure) and the FIM+FAM (Functional Assessment Measure). The use and inter-relationship of these measures is discussed, and the recent work of the UK FIM+FAM User Group to develop a common system for data collection and collation is described. Patients with very severe complex disability often fall beneath the floor of standard global disability measures and present a particular problem for resource allocation, since it may be argued that they have little to gain. The demonstration that rehabilitation can be cost-effective in this group becomes important. Two measures, the Northwick Park Dependency Scale and Northwick Park Care Needs Assessment, have been developed specifically for use in severe complex disability, and between them provide a directly costable outcome measure, which can be used to demonstrate the benefits of rehabilitation in reducing the cost of continued care in the community. The application of these various measures is illustrated in a worked example.	Northwick Pk Hosp, Reg Rehabil Unit, London, England				Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462			Alcott D, 1997, DISABIL REHABIL, V19, P355, DOI 10.3109/09638289709166551; Collin C, 1988, Int Disabil Stud, V10, P61; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hamilton BB, 1987, REHABILITATION OUTCO, P137; MAHONEY F I, 1965, Md State Med J, V14, P61; McPherson K, 1997, NEUROPSYCHOL REHABIL, V7, P241, DOI 10.1080/713755530; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; Nyein K, 1999, CLIN REHABIL, V13, P56, DOI 10.1191/026921599701532135; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; Wade D, 1992, MEASUREMENT NEUROLOG	16	9	9	0	4	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-OCT	1999	9	3-4					329	343		10.1080/096020199389419			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	242GV	WOS:000082932900009					2022-02-06	
J	Wood, RL; Worthington, AD				Wood, RL; Worthington, AD			Outcome in community rehabilitation: Measuring the social impact of disability	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; FRONTAL-LOBE DAMAGE; INTEGRATION QUESTIONNAIRE; SUPPORT QUESTIONNAIRE; FAMILY; HANDICAP; LIFE	This payer explores the range of outcome measures that can be employed in a post-acute community-based brain injury rehabilitation programme for people with complex patterns of neurobehavioural disability. In addition to standardised scales and structured interviews, the paper considers the use of behavioural measures of social and functional behaviour that can be used to give structure to observational methods when recording socially adaptive behaviour.	Brain Injury Rehabil Trust, Milton Keynes MK4 2JA, Bucks, England								BARERRA M, 1980, CONNECTIONS, V3, P8; Benson D.F., 1986, FRONTAL LOBES; Billings A G, 1981, J Behav Med, V4, P139, DOI 10.1007/BF00844267; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; CLARE AW, 1978, PSYCHOL MED, V8, P589, DOI 10.1017/S0033291700018808; CONDELUCI A, 1987, COMMUNITY REENTRY HE, P301; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; FORER SK, 1981, REVISED FUNCTIONAL S; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HARVEY RF, 1981, ARCH PHYS MED REHAB, V62, P456; Harwood R H, 1994, Qual Health Care, V3, P11, DOI 10.1136/qshc.3.1.11; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KAZDIN AE, 1989, BEHAV MODIFICATION A; LINN MW, 1982, J AM GERIATR SOC, V30, P378, DOI 10.1111/j.1532-5415.1982.tb02835.x; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; NEWCOMBE F, 1993, NEUROLOGICAL REHABIL; NORRISBAKER C, 1982, ENVIRON BEHAV, V14, P4285; O'Donoghue MF, 1998, BRAIN, V121, P317, DOI 10.1093/brain/121.2.317; OREILLY P, 1988, SOC SCI MED, V26, P863, DOI 10.1016/0277-9536(88)90179-7; PARKERSON GR, 1989, J CLIN EPIDEMIOL, V42, P217, DOI 10.1016/0895-4356(89)90058-9; PETERS DJ, 1995, DISABIL REHABIL, V17, P135, DOI 10.3109/09638289509166708; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; REMINGTON M, 1979, SOC PSYCHIATR, V14, P151, DOI 10.1007/BF00582182; RUTA DA, 1994, MED CARE, V32, P1109, DOI 10.1097/00005650-199411000-00004; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SEEMAN TE, 1988, SOC SCI MED, V26, P737, DOI 10.1016/0277-9536(88)90065-2; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; Wade D, 1992, MEASUREMENT NEUROLOG; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; White S. D., 1992, Waltham International Focus, V2, P2; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Willer B., 1993, BRAIN INJURY REHABIL, P355; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; World Health Organization, 1980, INT CLASS IMP DIS HA	42	9	9	0	3	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-OCT	1999	9	3-4					505	516		10.1080/096020199389554			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	242GV	WOS:000082932900023					2022-02-06	
J	Gilad, GM; Balakrishnan, K; Gilad, VH				Gilad, GM; Balakrishnan, K; Gilad, VH			The course of putrescine immunocytochemical appearance in neurons, astroglia and microglia in rat brain cultures	NEUROSCIENCE LETTERS			English	Article						astrocytes; immunocytochemistry; microglia; neuronal cultures; polyamines; rat; transglutaminase	TRANSGLUTAMINASE ACTIVITY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; IN-VIVO; POLYAMINES; CELLS; IMMUNOREACTIVITY	Putrescine, the diamine precursor for polyamine biosynthesis, is a ubiquitous molecule normally present at low concentration in quiescent cells, During development, or after traumatic stress, putrescine concentrations are greatly increased. Here we describe the localization of putrescine by fluorescence immunocytochemistry in primary cu Itu res of embryonic rat brain using specific antibodies. Antibodies against putrescine conjugated to keyhole limpet hemocyanin (KLH) were produced in rabbits. The antisera were adsorbed on KLH affinity columns and the specificity of the antibodies was assessed by inhibition enzyme-linked immunoassays (ELISA). The cellular localization paralleled the temporal sequence of appearance and disappearance of the different cell types in these mixed cultures. During the first 3 days after plating the antibodies were localized mainly in neurons, As the neurons disappeared the localization was mainly in the growing astroglia, and then, as astroglia reached confluence between 10 and 14 days in vitro, labeled astroglia were diminished in numbers while the number of labeled microglia was greatly increased. The subcellular localization was prominent in the perinuclear region of the cytoplasm, The results indicate that anti bodies to KLH-conjugated putrescine can be used for immunocytochemical studies of changes in putrescine concentrations during development and after traumatic injuries. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Assaf Harofeh Med Ctr, Lab Neurosci Res & Dev, IL-70300 Zerifin, Israel; USA Berkeley Antibody Co Ltd, Richmond, CA 94806 USA		Gilad, GM (corresponding author), Assaf Harofeh Med Ctr, Lab Neurosci Res & Dev, IL-70300 Zerifin, Israel.		Gilad, Gad M/E-7193-2010				Delcros JG, 1997, CYTOMETRY, V27, P255; FUJIWARA K, 1994, HISTOCHEMISTRY, V101, P287, DOI 10.1007/BF00315916; Fujiwara K, 1997, BRAIN RES, V767, P166, DOI 10.1016/S0006-8993(97)00748-8; GEHRMANN J, 1992, J CEREBR BLOOD F MET, V12, P257, DOI 10.1038/jcbfm.1992.36; GILAD GM, 1987, INT J DEV NEUROSCI, V5, P79, DOI 10.1016/0736-5748(87)90053-0; GILAD GM, 1986, INT J DEV NEUROSCI, V4, P401, DOI 10.1016/0736-5748(86)90022-5; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; GILAD GM, 1979, J NEUROCHEM, V33, P1195, DOI 10.1111/j.1471-4159.1979.tb05264.x; GILAD GM, 1995, J NEUROSCI RES, V41, P594, DOI 10.1002/jnr.490410505; GILAD GM, 1989, BRAIN RES, V508, P215; HIETALA OA, 1983, BIOCHEM PHARMACOL, V32, P1581, DOI 10.1016/0006-2952(83)90331-3; HOUGAARD DM, 1992, INT REV CYTOL, V138, P51, DOI 10.1016/S0074-7696(08)61587-9; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Kang H, 1998, BIOCHEM J, V332, P467, DOI 10.1042/bj3320467; Laube G, 1997, GLIA, V19, P171, DOI 10.1002/(SICI)1098-1136(199702)19:2<171::AID-GLIA8>3.0.CO;2-3; McRae A, 1997, GERONTOLOGY, V43, P95; PASCHEN W, 1990, NEUROSCI LETT, V110, P232, DOI 10.1016/0304-3940(90)90817-S; PASCHEN W, 1988, NEUROCHEM PATHOL, V9, P1; Roch AM, 1997, HISTOCHEM CELL BIOL, V107, P303, DOI 10.1007/s004180050115; SCHENKEL E, 1995, J CHROMATOGR B, V668, P189, DOI 10.1016/0378-4347(95)00094-Y; SCHIPPER RG, 1991, J IMMUNOL METHODS, V136, P23, DOI 10.1016/0022-1759(91)90245-B; SEILER N, 1985, NEUROCHEM RES, V10, P529, DOI 10.1007/BF00964656; Seiler N, 1991, Prog Drug Res, V37, P107; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Zhang W, 1998, ACTA NEUROPATHOL, V96, P395, DOI 10.1007/s004010050910	25	9	10	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUN 11	1999	268	1					33	36		10.1016/S0304-3940(99)00375-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	208ZA	WOS:000081021300009	10400071				2022-02-06	
J	Flanagan, S				Flanagan, S			Physiatric management of mild traumatic brain injury	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						traumatic brain injury; rehabilitation	DIFFUSE AXONAL INJURY; MINOR HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; CONCUSSION; MIGRAINE; SYMPTOMS	Mild traumatic brain injury (MTBI) is a common condition, afflicting as many as 1.5 million Americans yearly. Most individuals sustain MTBI as a result of motor vehicle collisions, but it may also occur as a result of falls, physical assault or sporting accidents. Problems related to MTBI include various pain syndromes, cognitive impairments, disorders of affect, cranial nerve dysfunction, and vertigo, arising from injury to the brain, head, or cervical spine. Symptoms are usually transient, although a small percentage of afflicted individuals develop long-lasting problems, often preventing them from leading productive lives. Recognition of these problems as arising from MTBI is difficult due to the frequent lack of abnormal findings on diagnostic tests and failure to identify a history of head trauma. The American Congress of Rehabilitation Medicine has defined MTBI, an important first step in identifying individuals who need treatment. Diagnosis is usually made by directed questions regarding trauma history and careful procurement and interpretation of appropriate tests. Once a diagnosis is made, proper care can be prescribed in order to lead patients toward more productive lives.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Flanagan, S (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240B,1 E 100th St, New York, NY 10029 USA.			Flanagan, Steven/0000-0001-9005-5897			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BRANDT T, 1980, ARCH OTOLARYNGOL, V106, P484; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COSTANZO RM, 1986, CLIN MEASUREMENTS TA; COTANZO RM, 1991, SMELL TASTE HLTH DIS, P711; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; DUCOURS JL, 1989, REV STOMATOL CHIR, V90, P89; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; GACEK RR, 1978, ANN OTO RHINOL LARYN, V87, P300, DOI 10.1177/000348947808700301; GAYRAL L, 1954, NEW YORK STATE J MED, V54, P1920; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hinoki M., 1984, ACTA OTO-LARYNGOL, V419, P9; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JENKINS A, 1986, LANCET, V2, P445; JONES RA, 1974, LANCET, V2, P107; Kelly JP, 1997, NEUROLOGY, V48, P581; KOBAYASHI S, 1971, NEUROLOGY, V21, P297, DOI 10.1212/WNL.21.3.297; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Masdeu J C, 1994, J Neuroimaging, V4, P177; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; McAllister Thomas W., 1994, P357; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; Mesulam M., 1985, PRINCIPLES BEHAV NEU; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; PARKER N, 1977, MED J AUSTRALIA, V2, P318, DOI 10.5694/j.1326-5377.1977.tb99164.x; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; Ruff R. M., 1989, MILD HEAD INJURY, P176; SANDSTROM J, 1962, Acta Otolaryngol, V54, P207, DOI 10.3109/00016486209126940; SIMONS DJ, 1946, PSYCHOSOM MED, V8, P227, DOI 10.1097/00006842-194607000-00001; Sosin DM, 1996, BRAIN INJURY, V10, P47; Swedlow P. E., 1992, Society for Neuroscience Abstracts, V18, P172; TRAVELL J, 1967, HEADACHE, P723; Travell JG., 1983, MYOFASCIAL PAIN DYSF; YAKOTA H, 1992, J TRAUMA, V31, P351; YARNELL PR, 1970, LANCET, V1, P863; ZASLER ND, 1992, PHYS MED REHABIL STA, V6, P33	56	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAY	1999	66	3					152	159					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199UN	WOS:000080502600004	10377546				2022-02-06	
J	Nag, S; Rao, SL				Nag, S; Rao, SL			Remediation of attention deficits in head injury	NEUROLOGY INDIA			English	Article						cognitive retraining; head injury; neuropsychological rehabilitation; attention deficits; cognitive deficits	NEUROPSYCHOLOGICAL DEFICITS	Head injury is associated with psychological sequelae which impair the patient's psychosocial functioning. Information processing, attention and memory deficits are seen in head injuries of all severity, We attempted to improve deficits of focused,sustained and divided attention. The principle of overlapping sources of attention resource pools was utilised in devising the remediation programme. Tasks used simple inexpensive materials. Four head injured young adult males with post concussion syndrome underwent the retraining program for one month. The patients had deficits of focused, sustained and divided attention parallel processing, serial processing, visual scanning, verbal learning and memory and working memory. After the retraining programme the deficits of attention improved in the four patients. Serial processing improved in two patients. Parallel processing and neuropsychological deficits did not improve in any patient. The symptom intensity reduced markedly and behavioural functioning improved in three of the four patients. The results supported an association between improving attention and reduction of symptom intensity. Attention remediation shows promise as a cost effective, time efficient and simple technique to improve the psychological and psychosocial functioning of the head injured patient.	Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore 560029, Karnataka, India								Ben-Yishay Y., 1987, NEUROPSYCHOLOGICAL R, P165; Bond M R, 1975, Ciba Found Symp, P141; GRONWALL D, 1975, LANCET, V2, P995; KINSBOURNE M, 1978, ATTENTION PERFORM, P345; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MARIADAS AC, 1989, NIMHANS J, V7, P37; MAULL KI, 1989, TXB HEAD INJURY, P67; MISHRA S, 1994, NATL I MENTAL HLTH N, V12, P157; MUKUNDAN CR, 1989, 10 ALL IND CONV CLIN, P67; PECK EA, 1989, TXB HEAD INJURY, P378; PONSFORD J, 1986, REMEDIATION ATTENTIO; Rao SL, 1997, NIMHANS J, V15, P157; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; WICKENS DC, 1994, VARIETIES ATTENTION, P63; WOOD LR, 1982, BRAIN IMP WORKSH MEL	16	9	9	0	1	NEUROL SOC INDIA	CHANDIGARH	C/O J S CHOPRA, PGIMER, DEPT NEUROLOGY, CHANDIGARH 160 012, INDIA	0028-3886			NEUROL INDIA	Neurol. India	MAR	1999	47	1					32	39					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	193FP	WOS:000080125500007	10339705				2022-02-06	
J	Bardenhagen, FJ; Bowden, SC; Shields, RB; McKay, V; Smith, PJ; Vogrin, S; Collins, SJ; Cook, MJ				Bardenhagen, FJ; Bowden, SC; Shields, RB; McKay, V; Smith, PJ; Vogrin, S; Collins, SJ; Cook, MJ			Psychosocial and neuropsychological outcomes in two high-functioning males 20 years after traumatic brain injury	NEUROCASE			English	Article						traumatic brain injury; neuropsychology; personality	FRONTAL-LOBE DAMAGE; 10-YEAR FOLLOW-UP; DELAYED-RESPONSE; PREFRONTAL CORTEX; STRATEGY APPLICATION; OBJECT ALTERNATION; EMOTIONAL CHANGES; HEAD-INJURY; WAIS-R; DYSFUNCTION	Researchers have emphasized a need for ongoing rehabilitation and support for individuals with traumatic brain injury (TBI), yet there are few detailed descriptions of long-term outcome, and many people with long-standing TBI do not or cannot access support services, HE and NL, two men who sustained severe TBI, presented for neuropsychological consultation for the first time more than 20 years post-injury. Referral was prompted by significant mood and relationship disturbances, and ongoing mnemonic and cognitive symptoms. Structural imaging showed a very large lesion involving the orbitofrontal and dorsolateral regions of,NL's left frontal robe, while HE had a smaller lesion involving cortical and subcortical matter in the dorsolateral region of the left frontal lobe, Results from a range of neuropsychological tests indicated residual weakness in memory and variable impairments on two experimental tests of prefrontal working memory: Delayed Alternation and Object Alternation. The Minnesota Multiphasic Personality Inventory-2 highlighted a pattern of severe psychological disturbance in HE which improved in response to antidepressant medication. Measures of emotional empathy and adaptive functioning suggested significant changes attributable to disruption of prefrontal aspects of the limbic system,.	Univ Melbourne, Sch Behav Sci, Parkville, Vic 3052, Australia; St Vincents Hosp, Dept Clin Neurosci, Melbourne, Vic 3065, Australia; NW Healthcare Serv, Mental Hlth Program, Cent E Area Mental Hlth Serv, Melbourne, Vic 3001, Australia; St Vincents Hosp, Dept Med Imaging, Melbourne, Vic 3065, Australia			bardenfj@svhm.org.au	Vogrin, Simon John/N-7288-2019; Cook, Mark J/A-7096-2010	Vogrin, Simon John/0000-0003-1004-6849; Cook, Mark J/0000-0002-8875-4135			Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; ATKINSON L, 1991, BRIT J CLIN PSYCHOL, V30, P87, DOI 10.1111/j.2044-8260.1991.tb00923.x; ATKINSON L, 1991, PSYCHOL ASSESSMENT J, V3, P288; BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; BARBAS H, 1995, NEUROSCI BIOBEHAV R, V19, P499, DOI 10.1016/0149-7634(94)00053-4; BARDENHAGEN FJ, 1995, NEUROPSYCHOLOGY, V9, P573, DOI 10.1037/0894-4105.9.4.573; Bardenhagen FJ, 1998, BRAIN COGNITION, V37, P224, DOI 10.1006/brcg.1997.0971; BARDENHAGEN FJ, 1997, THESIS U MELBOURNE V; BAUER RH, 1976, J COMP PHYSIOL PSYCH, V90, P293, DOI 10.1037/h0087996; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck AT, 1987, BECK DEPRESSION INVE; Bellus SB, 1996, BRAIN INJURY, V10, P849, DOI 10.1080/026990596123954; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bowden S., 1992, CLIN NEUROPSYCHOL, V6, P43, DOI [10.1080/13854049208404116, DOI 10.1080/13854049208404116]; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; CRAWFORD JR, 1999, IN PRESS CLIN NEUROP; CROSSEN JR, 1988, CLIN NEUROPSYCHOL, V2, P393; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DUDEK FJ, 1979, PSYCHOL BULL, V86, P335, DOI 10.1037/0033-2909.86.2.335; DYWAN J, 1993, J CLIN EXP NEUROPSYC, V15, P106; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Emilien G, 1996, ACTA NEUROL BELG, V96, P89; Eslinger Paul J., 1996, P415; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; FREEDMAN M, 1994, NEUROPSYCHOLOGIA, V32, P1015, DOI 10.1016/0028-3932(94)90050-7; FREEDMAN M, 1986, BEHAV NEUROSCI, V100, P337, DOI 10.1037/0735-7044.100.3.337; FREEDMAN M, 1990, BRAIN COGNITION, V14, P134, DOI 10.1016/0278-2626(90)90025-J; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; GOLDMANRAKIC PS, 1995, ADV NEUROL, V66, P51; GOLDMANRAKIC PS, 1987, NERVOUS SYSTEM HIGHE, V5, P373; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; ISSEROFF A, 1982, BRAIN RES, V232, P97, DOI 10.1016/0006-8993(82)90613-8; JONIDES J, 1996, THINKING INVITATION, V3, P215; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; Kaemmer, 1989, MINNESOTA MULTIPHASI; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KAPLAN EF, 1993, BOSTON NAMING TEST; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; LEICHTMAN M, 1992, B MENNINGER CLIN, V56, P338; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Lishman WA, 1998, ORGANIC PSYCHIAT; MAHUT H, 1971, NEUROPSYCHOLOGIA, V9, P409, DOI 10.1016/0028-3932(71)90005-4; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; MATARAZZO JD, 1988, J CLIN PSYCHOL, V44, P940, DOI 10.1002/1097-4679(198811)44:6<940::AID-JCLP2270440615>3.0.CO;2-A; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; McLean JE., 1990, PSYCHOL ASSESSMENT J, V2, P289, DOI [10.1037/1040-3590.2.3.289, DOI 10.1037/1040-3590.2.3.289]; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; MISHKIN M, 1987, SCI AM, V256, P62; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nelson H.E., 1982, NATL ADULT READING T; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Oscar-Berman M, 1998, MEMORY NEURODEGENERA, P3; OSCARBERMAN M, 1982, NEUROPSYCHOLOGIA, V20, P187, DOI 10.1016/0028-3932(82)90009-4; OSCARBERMAN M, 1991, INT J NEUROSCI, V58, P135, DOI 10.3109/00207459108985429; OSCARBERMAN M, 1992, BEHAV NEUROSCI, V106, P613, DOI 10.1037/0735-7044.106.4.613; OSCARBERMAN M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P230; Paolo A. M., 1996, ASSESSMENT, V3, P137, DOI [10.1177/107319119600300205, DOI 10.1177/107319119600300205]; Price JL, 1996, PROG BRAIN RES, V107, P523; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Reitan RM, 1985, HALSTEADREITAN NEURO; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SCHMIDT M, 1994, ARCH CLIN NEUROPSYCH, V9, P383, DOI 10.1016/0887-6177(94)90002-7; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SILVERSTEIN AB, 1993, PSYCHOL ASSESSMENT, V5, P72, DOI DOI 10.1037/1040-3590.5.1.72; Speilberger CD., 1983, STATE TRAIT ANXIETY; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); SPREEN O, 1991, CMPENDIUM NEUROPSYCH; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VIRKKUNEN M, 1976, ACTA PSYCHIAT SCAND, V53, P168, DOI 10.1111/j.1600-0447.1976.tb00072.x; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILSON B, 1992, J NEUROL NEUROSUR PS, V55, P177, DOI 10.1136/jnnp.55.3.177; WILSON BA, 1994, J CLIN EXP NEUROPSYC, V16, P354, DOI 10.1080/01688639408402646; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; [No title captured]	93	9	9	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		1999	5	4					325	343					19	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	232XQ	WOS:000082395600007					2022-02-06	
J	Paulig, M; Bottger, S; Sommer, M; Prosiegel, M				Paulig, M; Bottger, S; Sommer, M; Prosiegel, M			Depersonalization after acquired brain damage	NERVENARZT			German	Article						depersonalization; derealization; brain damage; dream	DISORDER; COTARD; EXPERIENCES; ACTIVATION; CONTINUUM; DELUSIONS; CAPGRAS; TRAUMA; SIGNS	Depersonalization after brain damage is still only rarely reported and poorly understood. We describe three patients between the ages of 21 and 25 who experienced depersonalization and derealization for periods of 6 weeks to 4 months, two after traumatic brain injury,the third after surgical and radiation treatment of a pineocytoma. Each one believed to be living in a nightmare and thought about committing suicide in order to wake up. One patient developed symptoms as described in Cotard delusion. Aspects of neuroanatomy, psychodynamics, and anthropology are discussed with reference to the literature. Frontal and temporal lesions seem only to play a facilitating role but not to be a necessary condition. There is evidence for additional influence of psychological and premorbid personality factors. Summarizing the current state of information we consider depersonalization with the experience of being in a dream or being dead as a heuristic reaction to brain damage. Similar models have already been discussed in neuropsychological disorders as for instance reduplicative paramnesias, neglect, and anosognosia.	Neurol Krankenhaus, D-80804 Munich, Germany		Paulig, M (corresponding author), Neurol Krankenhaus, Tristanstr 20, D-80804 Munich, Germany.						BEZZUBOVA YB, 1993, ZH NEVROPATOL PSIKH, V93, P40; BLANKENBURG W, 1986, LEXIKON PSYCHIAT, P239; BRAUTIGAM W, 1985, REAKTIONEN NEUROSEN, P151; CAMUS A, 1991, MYTHOS SISYPHOS EIN, P31; CARDENA E, 1993, AM J PSYCHIAT, V150, P474; Chong S. A., 1995, Singapore Medical Journal, V36, P568; CLASSEN C, 1993, B MENNINGER CLIN, V57, P178; DESCARTES R, 1992, PHILOS BIBLIOTHEK A, V250, P30; DILTHEY W, 1890, SITZUNGSBERICHTE KON, V39, P977; EHRENWALD H, 1931, DEPERSONALISATION WI, P163; Faber J, 1991, Sb Lek, V93, P239; Feinberg T.E., 1997, BEHAV NEUROLOGY NEUR, P369; FILLASTRE M, 1992, Encephale, V18, P65; FORSTL H, 1992, BRIT J PSYCHIAT, V160, P416, DOI 10.1192/bjp.160.3.416; FUCHS T, 1996, FUNDAM PSYCHIAT, V10, P100; GREEN CE, 1996, TRAUME BEWUSST STEUE; GRIGSBY J, 1993, BRAIN INJURY, V7, P507, DOI 10.3109/02699059309008178; HIPPIUS H, 1979, TASCHENBUCHER ALLGEM, P124; HOFFMANN SO, 1986, PSYCHIAT GEGENWART, V1, P56; HOFMANNSTOCKER E, 1990, Z NEUROPSYCHOL, V2, P75; HOLLANDER E, 1992, BIOL PSYCHIAT, V31, P1157, DOI 10.1016/0006-3223(92)90161-R; HOLLANDER E, 1994, AM J PSYCHIAT, V151, P277; HUFFORD DJ, 1992, J NERV MENT DIS, V180, P362, DOI 10.1097/00005053-199206000-00005; JASPERS K, 1973, ALLGEMEINE PSYCHOPAT, P101; LOCATELLI M, 1993, J NEUROPSYCH CLIN N, V5, P409; Lohmann T, 1996, NERVENARZT, V67, P400; MANSER AR, 1967, ENCYCL PHILOS, V1, P414; MATHEW RJ, 1993, BIOL PSYCHIAT, V33, P431, DOI 10.1016/0006-3223(93)90171-9; MAYERGROSS W, 1936, DEPERSONALISATION, P187; MEYER JE, 1968, DEPERSONALISATION, pR7; MEYER JE, 1959, DEPERSONALISATION, P320; NOYES R, 1976, PSYCHIATRY, V39, P19, DOI 10.1080/00332747.1976.11023873; PELISSOLO A, 1994, ENCEPHALE, V20, P147; PERSINGER MA, 1991, PERCEPT MOTOR SKILL, V72, P453, DOI 10.2466/PMS.72.2.453-454; PERSINGER MA, 1993, J CLIN PSYCHOL, V49, P33, DOI 10.1002/1097-4679(199301)49:1<33::AID-JCLP2270490106>3.0.CO;2-H; PETROVICI JN, 1994, FORTSCHR NEUROL PSYC, V62, P256, DOI 10.1055/s-2007-996675; PLATON, 1991, SAMTLICHE WERKE, V6, P207; PROBST P, 1991, Z KLIN PSYCHOL PSYCH, V39, P357; PURCELL SD, 1992, REV GEN PYCHIATRY, P271; RATLIFF NB, 1995, AM J PSYCHIAT, V152, P1689; Risko A, 1996, SUPPORT CARE CANCER, V4, P51, DOI 10.1007/BF01769876; SCHILDER P, 1914, DEPERSONALISATION, P46; Schurg WA, 1979, PSYCHIATRIE, P72; SNO HN, 1994, PSYCHOPATHOLOGY, V27, P144, DOI 10.1159/000284861; STRUNZ F, 1991, FORTSCHR NEUROL PSYC, V59, P117, DOI 10.1055/s-2007-1000685; Weinstein E.A., 1991, AWARENESS DEFICIT BR, P240; WEINSTEIN EA, 1971, PSYCHIAT RES, V8, P439; Weizsacker V., 1996, GESTALTKREIS THEORIE, V6; WILLIAMS D, 1966, BMJ-BRIT MED J, V5501, P1439; WITTCHEN HU, 1991, DIAGNOSTISCHES STAT, P337; WODARZ N, 1993, NERVENARZT, V64, P478; WRIGHT S, 1993, BRIT J CLIN PSYCHOL, V32, P345, DOI 10.1111/j.2044-8260.1993.tb01065.x; WYSS D, 1988, TRAUMBEWUSSTSEIN GRU; YOUNG AW, 1992, PSYCHOL MED, V22, P799, DOI 10.1017/S003329170003823X; YOUNG AW, 1994, PSYCHOPATHOLOGY, V27, P226, DOI 10.1159/000284874	55	9	10	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	DEC	1998	69	12					1100	1106		10.1007/s001150050388			13	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	147DE	WOS:000077472200009	9888147				2022-02-06	
J	Minnes, P; Harrick, L; Carlson, P; Johnston, J				Minnes, P; Harrick, L; Carlson, P; Johnston, J			A transitional living environment for persons with brain injuries: staff and client perceptions	BRAIN INJURY			English	Article							OUTCOMES	Given increasing interest in social ecology and the impact of environmental factors upon rehabilitation outcomes, the purpose of this study was to begin to document the characteristics of a particular environment designed to meet the needs of persons with traumatic brain injuries. Staff and clients at the Transitional Living Centre of Kingston, Ontario (TLC), a community based post-acute rehabilitation programme providing both residential and day programmes for adults who have acquired brain injuries participated in this study by completing the Community-Oriented Programme Environment Scale (COPES). While COPES subscale scores for clients and staff were within the average range, the results of a multivariate analysis of variance indicated that client and staff perceptions of the TLC environment differed significantly on two subscales within the Personal Development Dimension (i.e. Personal Problem Orientation, Anger and Aggression) and on one subscale under the System Maintenance Dimension (i.e. Staff Control). The results of this study suggest that future research should consider the impact of staff and client perceptions on the effectiveness of the: therapeutic environment of brain injury programmes.	Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; Reg Community Brain Injury Serv, Kingston, ON, Canada; Providence Continuing Care Ctr, Transit Living Ctr, Kingston, ON, Canada		Minnes, P (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.						CARLING PJ, 1990, AM PSYCHOL, V45, P969, DOI 10.1037/0003-066X.45.8.969; CARLSON P, 1991, ONTARIO PSYCHOL, V23, P12; DEJONG G, 1979, ARCH PHYS MED REHAB, V60, P435; DUNN PA, 1990, DISABIL HANDICAP SOC, V5, P37, DOI [10.1080/02674649066780031, DOI 10.1080/02674649066780031]; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; MARANS RW, 1977, HOUSING PEOPLE; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Moos R.H., 1988, COMMUNITY ORIENTED P; MOOS RH, 1976, HUMAN CONTEXT ENV DE; Sachs P., 1986, COGNITIVE REHABI NOV, V4, P6; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; World Health Organization, 1997, ICIDH 2 INT CLASS IM	12	9	9	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1998	12	11					987	992		10.1080/026990598122034			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	143NR	WOS:000077262300007	9839031				2022-02-06	
J	Annoni, JM; Vuagnat, H; Frischknecht, R; Uebelhart, D				Annoni, JM; Vuagnat, H; Frischknecht, R; Uebelhart, D			Percutaneous endoscopic gastrostomy in neurological rehabilitation: a report of six cases	DISABILITY AND REHABILITATION			English	Article						brain injury; brain anoxia; multiple sclerosis; percutaneous endoscopic gastrostomy; nutrition; rehabilitation	CENTRAL NERVOUS-SYSTEM; PROTEIN-MALNUTRITION; NUTRITION; RAT; COMPLICATIONS; PATIENT; SCALE	Purpose : This study reports the cases of six patients with severe chronic neurological disability and swallowing difficulties due to traumatic brain injury (TBI), anoxia and multiple sclerosis (MS). Method: The patients required nutritional supplement through percutaneous endoscopic gastrostomy (PEG). Results: Their clinical follow-up showed a decrease of intercurrent medical complications, especially pressure sores. In addition, an improvement of oropharyngeal function was observed in some patients, also accompanied by slightly better basic psychomotor functions such as vigilance, sustained attention and tone or motor control. However, not every patient did improve with this procedure. The two MS patients benefited most, while the improvement was less homogenous in the three TBI patients. Conclusions: The advantages of PEG over nasogastric tube on oropharyngeal function can be related to the absence of pharyngeal irritation and its role in overall recovery could be due to an increase in social activities, a control of infections, a better rehabilitation schedule and a long-term effect on brain function due to better nutritional support.	Univ Hosp Geneva, Neurol Clin, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Spinal Cord Rehabil Unit, CH-1211 Geneva, Switzerland; Univ Lausanne Hosp, Dept Rheumatol & Rehabil, Lausanne, Switzerland; Univ Hosp Geneva, Div Phys Med & Rehabil, CH-1211 Geneva 14, Switzerland		Annoni, JM (corresponding author), Univ Hosp Geneva, Neurol Clin, CH-1211 Geneva 14, Switzerland.						ANDREWS K, 1990, PHYSICAL MED REHABIL, V4, P1; *ASPEN BOARD DIR, 1987, JPEN, V11, P435; BALAZS R, 1985, HUMAN GROWTH COMPREH; Brooke MM, 1989, J NEUROL REHABIL, V3, P27; CABAK V, 1965, ARCH DIS CHILD, V40, P232; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; CRAGG BG, 1972, BRAIN, V95, P143, DOI 10.1093/brain/95.1.143; David Buchholz M.D., 1987, DYSPHAGIA, V1, P152, DOI 10.1007/BF02412331; DOBBING J, 1971, EXP NEUROL, V32, P439, DOI 10.1016/0014-4886(71)90010-0; DONNER MW, 1974, SEMIN ROENTGENOL, V9, P273, DOI 10.1016/0037-198X(74)90045-5; FOUTCH PG, 1986, J CLIN GASTROENTEROL, V8, P10; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; GAUDERER MWL, 1987, J PEDIATR SURG, V15, P8772; Hagen C, 1979, LEVELS COGNITIVE FUN; HAREL G, 1995, OTOLARYNG HEAD NECK, V113, P387, DOI 10.1016/S0194-5998(95)70073-0; HOLMES R, 1987, AM J NURS, V87, P1301, DOI 10.2307/3425690; HOORWEG J, 1976, DEV MED CHILD NEUROL, V18, P330, DOI 10.1111/j.1469-8749.1976.tb03656.x; IBUKI T, 1994, CAN J ANAESTH, V41, P431, DOI 10.1007/BF03009868; JORDAN TC, 1983, BEHAV NEUROSCI, V97, P319, DOI 10.1037/0735-7044.97.2.319; KAMINSKI MV, 1976, SURG GYNECOL OBSTET, V143, P12; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller AJ, 1986, DYSPHAGIA, V1, P91, DOI [10.1007/BF02407121, DOI 10.1007/BF02407121]; MORGANE PJ, 1978, NEUROSCI BIOBEHAV R, V2, P137, DOI 10.1016/0149-7634(78)90059-3; PADILLA GV, 1979, JPEN-PARENTER ENTER, V3, P53, DOI 10.1177/014860717900300253; PARATHYRAS AJ, 1983, NUTR SUPPORT SURVEYS, V4, P556; Popovich MJ, 1996, CRIT CARE MED, V24, P429, DOI 10.1097/00003246-199603000-00011; RESNICK O, 1979, NEUROSCI BIOBEHAV R, V3, P233, DOI 10.1016/0149-7634(79)90011-3; RUSSELL TR, 1984, AM J SURG, V148, P132, DOI 10.1016/0002-9610(84)90300-3; SHELLITO PC, 1985, ANN SURG, V201, P180, DOI 10.1097/00000658-198502000-00008; SIMEON DT, 1989, AM J CLIN NUTR, V49, P646, DOI 10.1093/ajcn/49.4.646; Sturgis TM, 1996, AM J GASTROENTEROL, V91, P2301; TAMURA H, 1994, JPEN-PARENTER ENTER, V18, P185, DOI 10.1177/0148607194018002185; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TSUI JK, 1989, NEUROLOGY, V39, P549, DOI 10.1212/WNL.39.4.549; TURNER WW, 1985, NEUROSURGERY, V16, P707, DOI 10.1227/00006123-198505000-00026; Varella L D, 1989, Crit Care Nurse, V9, P28	37	9	9	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	AUG	1998	20	8					308	314		10.3109/09638289809166086			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	ZV308	WOS:000074291600004	9651689				2022-02-06	
J	Yamanaka, K; Kumura, E; Yoshimine, T; Maruno, M; Taniguchi, M; Kosaka, H; Hayakawa, T				Yamanaka, K; Kumura, E; Yoshimine, T; Maruno, M; Taniguchi, M; Kosaka, H; Hayakawa, T			Cellular expression of inducible nitric oxide synthase following rat cortical incision and its suppression by hydroxyl radical scavenger, 1,2-bis(nicotinamido)propane	NEUROSCIENCE RESEARCH			English	Article						nitric oxide; inducible nitric oxide synthase; hydroxyl radical; cerebral injury; macrophages; 1,2-bis(nicotinamido)propane	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; PEROXYNITRITE; SUPEROXIDE; MICROGLIA	Cellular expression of an inducible isoform of nitric oxide synthase (iNOS) was studied immunohistochemically 1, 3 and 7 days following rat cortical incision. The induction of INOS was demonstrated almost exclusively in the macrophages accumulated within the incision cavity on day 3. They were significantly reduced in number by the treatment with 1,2-bis(nicotinamido)propane (P < 0.01), suggesting the involvement of hydroxyl radicals in the macrophage activation after cortical injury. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Osaka Univ, Sch Med, Dept Neurosurg, Suita, Osaka 565, Japan; Kagawa Med Univ, Dept Physiol 2, Kagawa, Japan		Kumura, E (corresponding author), Osaka Univ, Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 565, Japan.	ekumura@nphys.med.oskaa-u.ac.jp					Asano T, 1984, Neurol Res, V6, P163; Bansal RK, 1997, J CLIN INVEST, V99, P2502, DOI 10.1172/JCI119434; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Calza L, 1997, P NATL ACAD SCI USA, V94, P3368, DOI 10.1073/pnas.94.7.3368; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; ENDOH M, 1994, BRAIN RES, V651, P92, DOI 10.1016/0006-8993(94)90683-1; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; MASANA Y, 1995, NEUROSCI RES, V23, P217, DOI 10.1016/0168-0102(95)00936-N; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Meltzer JC, 1997, J HISTOCHEM CYTOCHEM, V45, P599, DOI 10.1177/002215549704500412; PAAKKARI I, 1995, ANN MED, V27, P369, DOI 10.3109/07853899509002590; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; STUEHR DJ, 1987, J IMMUNOL, V139, P518; Togashi H, 1997, P NATL ACAD SCI USA, V94, P2676, DOI 10.1073/pnas.94.6.2676; YAMANAKA K, 1995, NEUROSCI LETT, V194, P124, DOI 10.1016/0304-3940(95)11715-9	24	9	9	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	AUG	1998	31	4					347	350		10.1016/S0168-0102(98)00052-2			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	130EG	WOS:000076506500011	9809594				2022-02-06	
J	Calhoun, AD; McGwin, G; King, WD; Rousculp, MD				Calhoun, AD; McGwin, G; King, WD; Rousculp, MD			Pediatric pedestrian injuries: A community assessment using a hospital surveillance system	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Society-for-Academic-Emergency-Medicine Annual Meeting	MAY 09-12, 1994	WASHINGTON, D.C.	Soc Acad Emergency Med		wounds and injuries; child; Alabama; prevention and control; accident, traffic; pediatrics; pedestrian injuries; hospital surveillance	TRAUMA SCORE; CHILD; PREDICTOR; SEVERITY	Objective: To provide a descriptive demographic and environmental account of pedestrian injuries among children aged less than or equal to 15 years in Jefferson County, Alabama. Methods: This was a retrospective study with a case definition for inclusion of individuals, aged less than or equal to 15 years, who suffered a pedestrian injury and sought care at The Children's Hospital of Alabama between 1989 and 1991. Demographic and injury-related information was obtained from the medical record and analyses were performed using t-test and a simple correlation. Results: The majority of the cases were nonwhite, and nearly half had Medicaid or were uninsured. The most common injuries were fractures and closed head trauma. The geographic locations of injury events were not uniformly distributed: a comparison of areas wherein an injury occurred with those that were injury-free revealed a number of significant differences with regard to specific demographic, socioeconomic, and ecological factors. Conclusions: Some of the possible manageable environmental risk factors identified in this study were relatively high posted speed limits; sidewalks that were narrow, absent, or in a state of disrepair; vehicular parking on both sides of the street; and the absence of a divided highway. In this community, the most cost-effective educational intervention may best be targeted to elementary-aged schoolchildren living in areas with low-income families and that have a high density of children.	Med Coll Wisconsin, Emergency Med Sect, Dept Pediat, Milwaukee, WI 53226 USA; Univ Alabama Birmingham, Dept Pediat, Sch Med, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA; Childrens Hosp Alabama, SE Child Safety Inst, Birmingham, AL USA; Univ Alabama Birmingham, Injury Control Res Ctr, Birmingham, AL 35294 USA		Rousculp, MD (corresponding author), Univ Alabama Birmingham, Injury Control Res Ctr, 403 CH-19,933 19th St S, Birmingham, AL 35294 USA.	matthew.rousculp@ccc.uab.edu	Alkhalawi, Mohammed j/C-6111-2012		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR403641] Funding Source: Medline		Agran PF, 1996, PEDIATRICS, V98, P1096; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; BARANCIK JI, 1986, AM J EPIDEMIOL, V123, P846, DOI 10.1093/oxfordjournals.aje.a114314; BRADDOCK M, 1991, PEDIATRICS, V88, P1242; BRISON RJ, 1988, AM J PUBLIC HEALTH, V78, P793, DOI 10.2105/AJPH.78.7.793; HOWARTH CI, 1974, ERGONOMICS, V17, P319, DOI 10.1080/00140137408931357; KING WD, 1991, SOUTHERN MED J, V84, P342, DOI 10.1097/00007611-199103000-00010; KING WD, 1992, PEDIATR EMERG CARE, V8, P221, DOI 10.1097/00006565-199208000-00013; KING WD, 1992, PEDIAT INJURY DISCHA; Kraus J F, 1996, Inj Prev, V2, P212, DOI 10.1136/ip.2.3.212; *NAT HIGHW TRAFF S, 1981, HS806148 US DOT NAT; *NAT SAF COUNC, 1996, ACC FACTS; RIVARA FP, 1985, PEDIATRICS, V76, P375; RIVARA FP, 1990, AM J DIS CHILD, V144, P692, DOI 10.1001/archpedi.1990.02150300090023; ROBINSON AH, 1956, ANN ASSOC AM GEOGR, V46, P233, DOI 10.1111/j.1467-8306.1956.tb01507.x; *SAS I INC, 1993, SAS STAT US GUID; Taylor PJ, 1977, QUANTITATIVE METHODS; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4	19	9	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	1998	5	7					685	690		10.1111/j.1553-2712.1998.tb02486.x			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	100KJ	WOS:000074815100007	9678392	Bronze			2022-02-06	
J	Raghupathi, R; Grants, I; Rosenberg, LJ; Mcintosh, TK; Lucas, JH				Raghupathi, R; Grants, I; Rosenberg, LJ; Mcintosh, TK; Lucas, JH			Increased jun immunoreactivity in an in vitro model of mammalian spinal neuron physical injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; axotomy; culture; immediate early genes; programmed cell death; spinal cord injury; trauma	TRAUMATIC BRAIN INJURY; PROGRAMMED CELL-DEATH; C-FOS; GENE-EXPRESSION; ULTRASTRUCTURAL-CHANGES; CALCIUM REGULATION; RAT-BRAIN; INDUCTION; CORD; APOPTOSIS	Dendrites were transected from murine spinal neurons. Unlesioned neurons showed dark nucleolar and patchy cytoplasmic jun immunostaining, By 0.5 and 2 h, most lesioned neurons stained intensely throughout the soma, However, at 24 h only dead neurons displayed intense somal staining, and 100% of the surviving cells stained like unlesioned controls. Correlation of immunostaining patterns with viability, injury, and death suggests jun gene expression may influence the survival of neurons after physical injury.	Ohio State Univ, Dept Physiol, Columbus, OH 43210 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Lucas, JH (corresponding author), Ohio State Univ, Dept Physiol, Hamilton Hall,Room 404,1645 Neil Ave, Columbus, OH 43210 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R01-26818, R01-29683, P01-08803] Funding Source: Medline		BALENTINE JD, 1978, LAB INVEST, V39, P254; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; CROWE MJ, 1995, J NEUROTRAUM, V12, P994; DEFELIPE C, 1993, ADV NEUROL, V59, P263; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; EMERY DG, 1987, EXP BRAIN RES, V67, P41, DOI 10.1007/BF00269451; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; GREENBERG ME, 1992, J PHYSIOLOGY-PARIS, V86, P99, DOI 10.1016/S0928-4257(05)80013-0; GROSS GW, 1983, J NEUROSCI, V3, P1979; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; HERDEGEN T, 1994, PROG BRAIN RES, V103, P153; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LEAH JD, 1991, BRAIN RES, V566, P98; LUCAS J H, 1990, Journal of Neurotrauma, V7, P169, DOI 10.1089/neu.1990.7.169; Lucas JH, 1997, NEUROSCIENTIST, V3, P89; LUCAS JH, 1995, MEMBRANE LINKED DIS, V4, P353; LUCAS JH, 1985, CNS TRAUMA, V4, P231; MAGAL E, 1991, DEV BRAIN RES, V63, P141, DOI 10.1016/0165-3806(91)90074-S; MAY PC, 1992, MOL BRAIN RES, V15, P33, DOI 10.1016/0169-328X(92)90148-5; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MEIRI H, 1981, SCIENCE, V211, P709, DOI 10.1126/science.7455707; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Raghupathi R., 1996, Society for Neuroscience Abstracts, V22, P21; RINK A, 1995, AM J PATHOL, V147, P1575; ROCHE E, 1994, CELL CALCIUM, V16, P331, DOI 10.1016/0143-4160(94)90097-3; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SCHAFFNER AE, 1987, J NEUROSCI, V7, P3088; Shi RY, 1989, J NEUROTRAUM, V6, P261, DOI 10.1089/neu.1989.6.261; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; TRUMP BF, 1974, BEITR PATHOL, V152, P243; WESSEL TC, 1991, BRAIN RES, V567, P231, DOI 10.1016/0006-8993(91)90800-B; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WYLLIE AH, 1993, BRIT J CANCER, V67, P205, DOI 10.1038/bjc.1993.40	43	9	9	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	1998	15	7					555	561		10.1089/neu.1998.15.555			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZY374	WOS:000074614700009	9674558				2022-02-06	
J	McHenry, M				McHenry, M			The ability to effect intended stress following traumatic brain injury	BRAIN INJURY			English	Article							FUNDAMENTAL-FREQUENCY; SPEECH; DYSARTHRIA; INTENSITY; DURATION	This study was designed to explore the production of word stress following traumatic brain injury (TBI). Ten subjects with TBI and ten matched normal controls produced a sentence with stress elicited on different words. The difference between stressed and unstressed productions of the same word was calculated for intensity, fundamental frequency and duration. Subjects' intensity range, fundamental frequency range and vital capacity were also obtained. Naive listeners judged which word was stressed within each sentence. Individuals with TBI were significantly less accurate conveying intended stress compared with normal controls. Individuals with TBI produced significantly less difference in duration between stressed and unstressed words. There was no correlation for either group between percentage change in intensity, fundamental frequency, or duration and the related physiological range. Durational control requires subtle physiological adjustments that individuals with TBI may be unable to accomplish. Further, compensatory strategies may place excessive cognitive demands on the speaker. Thus, the production of stress contrasts may not be amenable to therapeutic intervention. Rather, listeners may be required to rely on context to infer intended stress.	Galveston Inst Human Commun, Transit Learning Community, Galveston, TX 77554 USA		McHenry, M (corresponding author), Galveston Inst Human Commun, Transit Learning Community, 1528 Postoff St, Galveston, TX 77554 USA.						ALAIN C, 1993, J ACOUST SOC AM, V94, P2434, DOI 10.1121/1.407464; BOUGLE F, 1995, FOLIA PHONIATR LOGO, V47, P24, DOI 10.1159/000266339; FEAR BD, 1995, J ACOUST SOC AM, V97, P1893, DOI 10.1121/1.412063; FREEMAN FJ, 1982, SPEECH LANGUAGE HEAR, P652; FRY DB, 1955, J ACOUST SOC AM, V27, P765, DOI 10.1121/1.1908022; HIRD K, 1993, BRAIN LANG, V45, P46, DOI 10.1006/brln.1993.1032; KELLER E, 1991, BRIT J DISORD COMMUN, V26, P75; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LEDORZE G, 1994, J COMMUN DISORD, V27, P1; LIEBERMAN P, 1960, J ACOUST SOC AM, V32, P1337; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; PITT MA, 1990, J EXP PSYCHOL HUMAN, V16, P564, DOI 10.1037/0096-1523.16.3.564; Scukanec GP, 1996, FOLIA PHONIATR LOGO, V48, P231, DOI 10.1159/000266414; Sluijter AMC, 1997, J ACOUST SOC AM, V101, P503, DOI 10.1121/1.417994; Sluijter AMC, 1996, J ACOUST SOC AM, V100, P2471, DOI 10.1121/1.417955; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Turk AE, 1996, J ACOUST SOC AM, V99, P3782, DOI 10.1121/1.414995; Yorkston K., 1984, COMPUTERIZED ASSESSM; YORKSTON KM, 1984, DYSARTHRIA PHYSL ACO, P131; ZIEGLER W, 1993, J SPEECH HEAR RES, V36, P683, DOI 10.1044/jshr.3604.683	21	9	9	2	7	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1998	12	6					495	503		10.1080/026990598122458			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ZU400	WOS:000074193300005	9638326				2022-02-06	
J	Crockett, JA; Chendrasekhar, A; Fagerli, JC; Timberlake, GA				Crockett, JA; Chendrasekhar, A; Fagerli, JC; Timberlake, GA			Assessment of ventilation during the performance of a percutaneous dilatational traceostomy: Hypoventilation is not a common complication	AMERICAN SURGEON			English	Article							TRACHEOSTOMY; GUIDANCE	Percutaneous dilatational tracheostomy (PDT) is becoming an accepted cost-effective alternative to surgical tracheostomy, PDT is performed by progressive dilatation of a tracheal opening placed under bronchoscopic guidance, Case reports of hypoventilation with associated hypercarbia during the performance of PDT have raised concerns about the utility of this procedure in patients in whom hypercarbia is problematic (e.g., patients With closed head injury), In a prospective cohort analysis of 11 critically ill patients, we evaluated the effect of PDT on ventilation during and after the procedure using end tidal capnography, We found that hypercarbia does not occur during or after the performance of PDT as compared to baseline levels.	W Virginia Univ, Dept Surg, Morgantown, WV 26506 USA		Chendrasekhar, A (corresponding author), Iowa Methodist Med Ctr, 1221 Pleasant St,Suite 550, Des Moines, IA 50309 USA.						BARBA CA, 1995, SURGERY, V118, P879, DOI 10.1016/S0039-6060(05)80279-X; BLITT CD, 1990, MONITORING ANESTHESI, P48; CHENDRASEKHAR A, 1995, SOUTHERN MED J, V88, P1062, DOI 10.1097/00007611-199510000-00012; CIAGLIA P, 1992, CHEST, V101, P464, DOI 10.1378/chest.101.2.464; CIAGLIA P, 1985, CHEST, V87, P715, DOI 10.1378/chest.87.6.715; HAZARD P, 1991, CRIT CARE MED, V19, P1018, DOI 10.1097/00003246-199108000-00008; HEFNER JE, 1988, CLIN CHEST MED, V9, P23; HILL BB, 1996, J TRAUMA, V40, P238; PLUMMER AL, 1989, CHEST, V96, P179; REILLY PM, 1995, CHEST, V107, P1760, DOI 10.1378/chest.107.6.1760; WINKLER WB, 1994, INTENS CARE MED, V20, P476, DOI 10.1007/BF01711898	11	9	9	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	MAY	1998	64	5					455	457					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ZL310	WOS:000073419800019	9585784				2022-02-06	
J	Piper, IR; Garrioch, MA; Souter, MJ; Andrews, PJD; Thomson, D				Piper, IR; Garrioch, MA; Souter, MJ; Andrews, PJD; Thomson, D			Effects of diaspirin cross-linked haemoglobin on post-traumatic cerebral perfusion pressure and blood flow in a rodent model of diffuse brain injury	BRITISH JOURNAL OF ANAESTHESIA			English	Article						blood, replacement; brain, blood flow; brain, injury; brain, intracranial pressure; rat; model, rat	NITRIC-OXIDE; HEMOGLOBIN; RATS; HEAD; ISCHEMIA	Diaspirin cross-linked haemoglobin (DCLHb) is a new oxygen carrying blood substitute with vasoactive properties. Vasoactive properties may be mediated via high affinity binding of nitric oxide by the haem moiety. Using a rodent model of head injury combined with ischaemia, we studied the effects of DCLHb on cerebral blood flow (CBF) and intracranial pressure (ICP). Twenty anaesthetized rats were allocated randomly to receive treatment with DCLHb 400 mg kg(-1) i.v. or placebo (oncotically matched plasma protein substitute 4.5% i.v.). To produce diffusely increased ICP, after a severe weight drop injury, all animals underwent a 30-min period of bilateral carotid ligation combined with a period of induced hypotension. After reperfusion, DCLHb or placebo was infused and the animals instrumented for measurement of intraventricular ICP and CBF in the region of the sensorimotor cortex using the hydrogen clearance technique. Mean arterial pressure (MAP), ICP, cerebral perfusion pressure (CPP) (CPP=MAP-ICP) and CBF were measured 4 h after injury in all animals. DCLHb significantly reduced ICP from mean 13 (SEM 2) to 3 (1) mm Hg (P<0.001), increased CPP from 52 (8) to 95 (6) mm Hg (P<0.001) and increased CBF from 21 (2) to 29 (2) ml 100 g(-1) min(-1) (P=0.032). We conclude that DCLHb improved CPP without a reduction in CBF in a rodent model of post-traumatic brain swelling.	So Gen Hosp, Inst Neurol Sci, Dept Clin Phys, Glasgow G51 4TF, Lanark, Scotland; So Gen Hosp, Dept Anaesthesia, Glasgow G51 4TF, Lanark, Scotland; Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland		Piper, IR (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Clin Phys, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.		Souter, Michael/ABE-1890-2020				Alexander RH, 1993, ADV TRAUMA LIFE SUPP, V5th; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; BOWES MP, 1994, STROKE, V25, P2253, DOI 10.1161/01.STR.25.11.2253; CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929; CHOPP M, 1980, J NEUROSURG, V53, P516, DOI 10.3171/jns.1980.53.4.0516; COLE DJ, 1993, CAN J NEUROL SCI, V20, P30, DOI 10.1017/S0317167100047363; CUEVAS P, 1994, NEUROL RES, V16, P113; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KIMURA M, 1994, STROKE, V25, P2227, DOI 10.1161/01.STR.25.11.2227; KITA H, 1993, J NEUROTRAUM, V10, pS62; Mannarou A, 1991, J NEUROSURG S, V75, P21; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PIPER I, 1987, COMPUT BIOL MED, V17, P279, DOI 10.1016/0010-4825(87)90014-X; Piper I. R., 1995, Journal of Neurotrauma, V12, P412; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; SCHULTZ SC, 1993, J LAB CLIN MED, V122, P301; SHARMA AC, 1994, ARTIF CELL BLOOD SUB, V22, P593, DOI 10.3109/10731199409117888; SNYDER SR, 1987, P NATL ACAD SCI USA, V84, P7280, DOI 10.1073/pnas.84.20.7280; WERNER C, 1993, ANESTH ANALG, V76, P971	24	9	9	0	0	PROF SCI PUBL	LONDON	TAVISTOCK HOUSE EAST, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	MAY	1998	80	5					639	643		10.1093/bja/80.5.639			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	ZP062	WOS:000073712700015	9691869	Bronze			2022-02-06	
J	Sarafian, TA; Huang, C; Kim, A; de Vellis, J; Shau, H				Sarafian, TA; Huang, C; Kim, A; de Vellis, J; Shau, H			Expression of the antioxidant gene NKEF in the central nervous system	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article						antioxidant; gene expression; neurons; astrocytes; oligodendrocytes; microglia	KILLER-ENHANCING FACTOR; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; NITRIC-OXIDE; CELL-DEATH; FACTOR-B; INDUCTION; PROTEINS; ENZYME; CULTURES	Free radicals and the oxidative stress they impose can cause serious injury in the nervous system and contribute to pathology associated with a wide variety of degenerative and traumatic disorders. In this study, we examined the expression of an antioxidant defense gene, nkef, in human tissue and isolated populations of rat brain cells using Western and Northern blot analysis. NKEF protein was expressed in human brain, liver, kidney, muscle, and lung. The human endothelial cell line ECV expressed a 25-kDa band in addition to the 22-kDa band normally observed. In the central nervous system, a 22-kDa NKEF band was present in cortical gray and white matter, hippocampus, cerebellum, and spinal cord in roughly similar amounts. Expression of NKEF-A and NKEF-B subtypes was evaluated by Northern analysis of cultured cell types from embryonic rat brain. Astrocyte and microglia expressed both 22- and 25-kDa bands, whereas cortical neurons and oligodendrocytes contained only the 22-kDa protein band. Northern blot analysis of these cell types revealed low levels of NKEF-A message in neurons and oligodendrocytes, and relatively low levels of NKEF-B in microglia. Differential expression of these antioxidant defense genes may contribute to the selective vulnerability of brain cell types to specific kinds of oxidative stress.	Univ Calif Los Angeles, Sch Med, Dept Pathol & Expt Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Div Surg Oncol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA		Sarafian, TA (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Expt Med, Los Angeles, CA 90095 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD006576] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD06576] Funding Source: Medline		BIRNBAUM G, 1995, SPRINGER SEMIN IMMUN, V17, P107; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B; CACHIANES G, 1993, BIOTECHNIQUES, V15, P255; CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189; Cole R., 1989, DISSECTION TISSUE CU, P121; Desagher S, 1996, J NEUROSCI, V16, P2553; GRIGORIAN B, 1997, UNPUB BIOCH BIOPHYS; Ichimiya S, 1997, DNA CELL BIOL, V16, P311, DOI 10.1089/dna.1997.16.311; Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151, DOI 10.1016/S0149-7634(96)00005-X; Kim AT, 1997, TOXICOL APPL PHARM, V147, P135, DOI 10.1006/taap.1997.8270; KUMAR S, 1981, DEV BRAIN RES, V1, P303, DOI 10.1016/0165-3806(81)90118-8; LAZO JS, 1995, J BIOL CHEM, V270, P5506, DOI 10.1074/jbc.270.10.5506; LIM YS, 1994, GENE, V140, P279, DOI 10.1016/0378-1119(94)90558-4; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McDuffee AT, 1997, J CELL PHYSIOL, V171, P143, DOI 10.1002/(SICI)1097-4652(199705)171:2<143::AID-JCP4>3.0.CO;2-O; MITROVIC B, 1995, NEUROSCIENCE, V65, P531, DOI 10.1016/0306-4522(94)00491-M; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; Pinteaux E, 1996, DEV NEUROSCI-BASEL, V18, P397, DOI 10.1159/000111433; RHEE SG, 1994, ANN NY ACAD SCI, V738, P86; Sarafian TA, 1997, FREE RADICAL RES, V26, P281, DOI 10.3109/10715769709097806; SARAFIAN TA, 1994, TOXICOL LETT, V74, P149, DOI 10.1016/0378-4274(94)90093-0; SAURI H, 1995, BIOCHEM BIOPH RES CO, V208, P964, DOI 10.1006/bbrc.1995.1428; SHAU HG, 1994, IMMUNOGENETICS, V40, P129; Shau HY, 1997, FREE RADICAL BIO MED, V22, P497, DOI 10.1016/S0891-5849(96)00372-3; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; SHAU HY, 1994, BIOCHEM BIOPH RES CO, V199, P83, DOI 10.1006/bbrc.1994.1197; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; Wong G H, 1996, EXS, V77, P321; YIM MB, 1994, J BIOL CHEM, V269, P1621	31	9	10	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	MAY	1998	34	1					39	51		10.1007/BF02815135			13	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	119UH	WOS:000075915800003	9778645				2022-02-06	
J	Tiberti, C; Sabe, L; Jason, L; Leiguarda, R; Starkstein, S				Tiberti, C; Sabe, L; Jason, L; Leiguarda, R; Starkstein, S			A randomized, double-blind, placebo-controlled study of methylphenidate in patients with organic amnesia	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						amnesia; dopamine; methylphenidate	APHASIA	We examined the usefulness of methylphenidate (MPH) in the treatment of organic amnesia in a randomized, double-blind, placebo-controlled design. Twenty patients with amnesia due to closed head injuries (n = 10), viral encephalitis (n = 2), stroke lesions (n = 4), or surgical brain resections (n = 4) were assessed with a neuropsychological battery after the intake of MPH (10, 20, 30 or 40 mg), or placebo. We found no significant benefit of MPH for any of the cognitive tests. (C) 1998 Lippincott-Raven Publishers.	Raul Carrea Inst Neurol Res, Dept Neuropsychiat, Buenos Aires, DF, Argentina; Raul Carrea Inst Neurol Res, Dept Clin Neurol, Buenos Aires, DF, Argentina		Tiberti, C (corresponding author), Raul Carrea Inst Neurol Res, Dept Neuropsychiat, Buenos Aires, DF, Argentina.						ALBERT ML, 1988, NEUROLOGY, V38, P877, DOI 10.1212/WNL.38.6.877; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; FLEET WS, 1987, NEUROLOGY, V37, P1765, DOI 10.1212/WNL.37.11.1765; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSS ED, 1981, NEUROLOGY, V31, P1435, DOI 10.1212/WNL.31.11.1435; Sabe L, 1995, NEUROLOGY, V45, P2272, DOI 10.1212/WNL.45.12.2272; Wechsler D., 1995, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wilson B. A., 1992, NEUROPSYCHOLOGY MEMO, P315	11	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1351-5101			EUR J NEUROL	Eur. J. Neurol.	MAY	1998	5	3					297	299		10.1046/j.1468-1331.1998.530297.x			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZL645	WOS:000073455900011	10210846				2022-02-06	
J	Groswasser, Z; Stern, MJ				Groswasser, Z; Stern, MJ			A psychodynamic model of behavior after acute central nervous system damage	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; behavioral issues; cognitive therapy; psychopharmacologic treatment; traumatic brain injury	TRAUMATIC BRAIN INJURY; AGITATION; MANAGEMENT	This article describes a conceptual psychodynamic model for understanding the neurobehavioral manifestations of acute central nervous system damage (ACNSD) displayed by patients during the rehabilitation process. According to the proposed model, patients' behavioral responses are viewed as their only means of emotional expression and therefore may not be considered entirely abnormal when viewed from the perspective of patients' interpersonal contexts. An improved understanding of the dynamic processes through which recovering patients with ACNSD journey may lead to better interaction between the patient and the therapeutic environment, the interdisciplinary team, and family members. Combining this proposed psychodynamic model with an emerging understanding of the neurobehavioral foundations of aggression and depression may also lead to a more rational approach to intervention with various psychopharmacologic agents. During the rehabilitation process, understanding patients' cognitive deficits, motivational drives, and emotional needs and proper implementation of medical and environmental treatment can ultimately lead to a better psychosocial outcome.	Tel Aviv Univ, Psychiat Unit, Loewenstein Rehabil Hosp, Raanana Sackler Fac Med, IL-69978 Tel Aviv, Israel		Stern, MJ (corresponding author), Loewenstein Hosp & Rehabil Ctr, Achuza St,278,POB 3, IL-43100 Raanana, Israel.						BELL KR, 1995, NEUROREHABILITATION, V5, P233, DOI 10.3233/NRE-1995-5306; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BENYISHAY Y, 1981, NYU REHABILITATION M, V62; BENYISHAY Y, 1990, NEUROBEHAVIORAL SEQU; CASSIDY JW, 1994, J HEAD TRAUMA REHAB, V9, P43, DOI 10.1097/00001199-199409000-00005; GROSWASSER Z, 1996, CATASTROPHIC BRAIN I; KOLB LC, 1982, MODERN CLIN PSYCHIAT; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; Lewis L, 1991, J HEAD TRAUMA REHAB, V6, P22; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; PHILLIPS CG, 1984, BRAIN, V107, P328, DOI 10.1093/brain/107.1.328; POLLACK IW, 1994, NEUROPSYCHIATRY TRAU; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; ROWLAND T, 1995, NEUROREHABILITATION, V5, P219, DOI 10.3233/NRE-1995-5305; Silver JM., 1994, NEUROPSYCHIATRY TRAU; STERN JM, 1985, ISRAEL J PSYCHIAT, V22, P83; TADIR M, 1985, SCAND J REHABIL MED, P50	20	9	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1998	13	1					69	79		10.1097/00001199-199802000-00009			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YW212	WOS:000071909700009	9565705				2022-02-06	
J	Bombardier, CH; Kilmer, J; Ehde, D				Bombardier, CH; Kilmer, J; Ehde, D			Screening for alcoholism among persons with recent traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							HEAD-INJURY; ABUSE	This study examined the clinical utility of various brief screening procedures for identifying persons with a prior history of alcoholism among patients with recent traumatic brain injury (TBI). Participants were 50 patients assessed for various aspects of alcohol use and abuse during their acute rehabilitation hospitalization. Predictive indicators were tested against the Michigan Alcoholism Screening Test (MAST) as the criterion measure. Results indicated the 13-item Short Michigan Alcoholism Screening test is a good proxy for the longer MAST in this population. The two screening questions by Cyr and Wartman (1988) also have some limited utility. Practical implications of the results are discussed with a view toward adopting universal screening for alcoholism among persons with recent TBI.	Univ Washington, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA		Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, 325 9Th Ave,Box 359740, Seattle, WA 98104 USA.		Ehde, Dawn/K-1883-2016; Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283; Ehde, Dawn/0000-0002-9555-2347			BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; BRADLEY KA, 1993, ARCH INTERN MED, V153, P2734, DOI 10.1001/archinte.153.24.2734; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CHICK J, 1985, BRIT MED J, V290, P965, DOI 10.1136/bmj.290.6473.965; CONNORS GJ, 1995, TREATMENT HDB SERIES, V4; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CYR MG, 1988, JAMA-J AM MED ASSOC, V259, P51, DOI 10.1001/jama.259.1.51; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; FLEMING MF, 1991, INT J ADDICT, V26, P1173, DOI 10.3109/10826089109062153; GENTILELLO LM, 1995, JAMA-J AM MED ASSOC, V274, P1043, DOI 10.1001/jama.274.13.1043; JACOBSON GR, 1989, HDB ALCOHOLISM TREAT; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Miller WR, 1991, MOTIVATIONAL INTERVI; Moore D, 1992, NEUROREHABILITATION, V2, P7; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Rychtarik, 1992, PROJECT MATCH MONOGR; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; SELZER ML, 1975, J STUD ALCOHOL, V36, P127; Selzer ML, 1971, AM J PSYCHIAT, V127, P89; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; TIMMRECK TC, 1994, INTRO EPIDEMIOLOGY; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	29	9	9	0	3	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	WIN	1997	42	4					259	271					13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	ZC599	WOS:000072597600001					2022-02-06	
J	Arnott, WL; Jordan, FM; Murdoch, BE; Lethlean, JB				Arnott, WL; Jordan, FM; Murdoch, BE; Lethlean, JB			Narrative discourse in multiple sclerosis: An investigation of conceptual structure	APHASIOLOGY			English	Article							CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; CONNECTED SPEECH; LANGUAGE; APHASIA; PERFORMANCE; LISTENER; DEMENTIA; DEFICIT; TASKS	The aim of the present study was to determine whether multiple sclerosis (MS) affects a person's ability to formulate message content in narrative discourse. Discourse samples were elicited from 47 persons with MS and 47 matched controls in response to computer-generated, animated sequences. Within the conceptual level of discourse processing, data were analysed for story schema and informative content. The two groups, MS and control, could not be distinguished by measures of the quantity of information conveyed. However, results revealed a difference in the nature of the information produced by the two groups. The persons with MS produced less essential story information than control subjects, while a tendency for the persons with MS to produce more incorrect and ambiguous information than controls was also noted. A number of factors were considered in an attempt to explain the underlying source of these differences. It was postulated that both pragmatic and cognitive skills impact on performance in the narrative genre; hence, deficits in these areas may have contributed to the observed performance deficits. The nature of the deficits was considered consistent with subcortical plaque damage affecting fibre tracts between and within cerebral hemispheres. The findings of the present study suggest that further research into narrative production in MS is warranted.	UNIV QUEENSLAND,BRISBANE,QLD,AUSTRALIA; PRINCESS ALEXANDRA HOSP,BRISBANE,QLD 4102,AUSTRALIA				Arnott, Wendy/G-3315-2010; Murdoch, Bruce E/C-1397-2012				ACHIRON A, 1992, NEUROLOGY, V42, P2195, DOI 10.1212/WNL.42.11.2195; ADAMS C, 1989, COLOUR ATLAS MULTIPL; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ALEXANDER MP, 1987, BRAIN, V110, P961, DOI 10.1093/brain/110.4.961; ALEXANDER MP, 1988, LANG COMMUN, P215; [Anonymous], 1993, NEUROPSYCHOLOGY, V7, P364, DOI [DOI 10.1037/0894-4105.7.3.364, 10.1037/0894-4105.7.3.364]; BARNARD RO, 1974, J NEUROL NEUROSUR PS, V37, P1259, DOI 10.1136/jnnp.37.11.1259; Beatty W W, 1989, J Geriatr Psychiatry Neurol, V2, P145, DOI 10.1177/089198878900200305; BEATTY WW, 1990, ARCH NEUROL-CHICAGO, V47, P305, DOI 10.1001/archneur.1990.00530030081019; BEATTY WW, 1989, ARCH NEUROL-CHICAGO, V46, P1113, DOI 10.1001/archneur.1989.00520460103020; BEATTY WW, 1988, ARCH NEUROL-CHICAGO, V45, P611, DOI 10.1001/archneur.1988.00520300029013; Bennett T., 1991, COGNITIVE REHABILITA, V9, P18; Benson DF, 1979, APHASIA ALEXIA AGRAP; BERKOGLEASON J, 1980, J SPEECH HEAR RES, V23, P370, DOI DOI 10.1044/JSHR.2302.370; Bisset JD, 1995, CLIN APHASIOL, V23, P217; Blackwood H.D., 1991, CLIN APHASIOLOGY, P121; BOON DL, 1994, APHASIOLOGY, V8, P549, DOI 10.1080/02687039408248681; BRENNEISESARSHAD R, 1991, J SPEECH HEAR RES, V34, P168, DOI 10.1044/jshr.3401.168; Brown Gillian., 1983, DISCOURSE ANAL; Brownell, 1990, DISCOURSE ABILITY BR, P69, DOI 10.1007/978-1-4612-3262-9_4; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; CAINE ED, 1986, ARCH NEUROL-CHICAGO, V43, P249, DOI 10.1001/archneur.1986.00520030039009; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHENERY HJ, 1994, APHASIOLOGY, V8, P159, DOI 10.1080/02687039408248648; CICONE M, 1980, CORTEX, V16, P145, DOI 10.1016/S0010-9452(80)80029-3; COBBLE ND, 1991, ARCH PHYS MED REHAB, V72, pS324; COOPER PV, 1990, J GERONTOL B-PSYCHOL, V45, P210; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; DAMICO JS, 1985, COMMUNICATION SKILLS, P167; DENNIS M, 1990, DISCOURSE ABILITY BR, P199; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; FARMAKIDES MN, 1960, J SPEECH HEAR DISORD, V25, P385, DOI 10.1044/jshd.2504.385; FILIPPI M, 1994, EUR NEUROL, V34, P324, DOI 10.1159/000117071; FILLEY CM, 1989, ARCH NEUROL-CHICAGO, V46, P157, DOI 10.1001/archneur.1989.00520380061013; Foley FW, 1994, J NEUROLOGIC REHABIL, V8, P165, DOI [DOI 10.1177/136140969400800401, 10.1177/136140969400800401]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANKLIN GM, 1989, ARCH NEUROL-CHICAGO, V46, P162, DOI 10.1001/archneur.1989.00520380066014; FRIEDMAN JH, 1983, ANN NEUROL, V13, P222, DOI 10.1002/ana.410130234; GERBER S, 1989, Seminars in Speech and Language, V10, P263, DOI 10.1055/s-2008-1064268; GOODKIN DE, 1989, ARCH NEUROL-CHICAGO, V46, P1107, DOI 10.1001/archneur.1989.00520460093019; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; HUBER W, 1982, BRAIN LANG, V16, P1, DOI 10.1016/0093-934X(82)90069-4; Huber W., 1990, DISCOURSE ABILITY BR, P154; JENNEKENSSCHINKEL A, 1990, J NEUROL SCI, V95, P89, DOI 10.1016/0022-510X(90)90119-8; JENNEKENSSCHINKEL A, 1986, J NEUROL NEUROSUR PS, V49, P1354, DOI 10.1136/jnnp.49.12.1354; JOANETTE Y, 1986, BRAIN LANG, V29, P81, DOI 10.1016/0093-934X(86)90035-0; Joanette Y., 1990, DISCOURSE ABILITY BR, DOI [10.1007/978-1-4612-3262-9_6, DOI 10.1007/978-1-4612-3262-9_6]; JORGENSEN C, 1981, WORD TESTS TEST EXPR; Kaplan E, 1983, BOSTON NAMING TEST; KEMPER S, 1994, J GERONTOL, V49, P223; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kintsch W., 1974, REPRESENTATION MEANI; KNIGHT RG, 1992, NEUROPSYCHOLOGY DEGE; LETHLEAN JB, 1994, J NEUROLINGUIST, V8, P207, DOI 10.1016/0911-6044(94)90027-2; LETHLEAN JB, 1993, J MED SPEECH-LANG PA, V1, P47; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P281, DOI 10.1001/archneur.1988.00520270059021; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MENDEZ MF, 1992, NEUROLOGY, V42, P696, DOI 10.1212/WNL.42.3.696; MENDOZZI L, 1993, J NEUROL SCI, V115, pS42, DOI 10.1016/0022-510X(93)90208-G; Merritt D. D., 1989, J SPEECH HEAR DISORD, V54, P429; MOLFESE V J, 1981, International Journal of Aging and Human Development, V14, P45, DOI 10.2190/M3P2-9WK8-ERR9-QJNR; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; NICHOLAS M, 1985, J SPEECH HEAR RES, V28, P405, DOI 10.1044/jshr.2803.405; NORUSSIS M, 1990, SPSS PC PLUS STAT 4; OLMOSLAU N, 1977, NEUROLOGY, V27, P623, DOI 10.1212/WNL.27.7.623; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; PROSIEGEL M, 1993, J NEUROL SCI, V115, pS51, DOI 10.1016/0022-510X(93)90209-H; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; RAO SM, 1985, ARCH NEUROL-CHICAGO, V42, P678, DOI 10.1001/archneur.1985.04060070068018; RAO SM, 1990, SUBCORTICAL DEMENTIA, P164; Rosche J, 1994, Acta Neurol (Napoli), V16, P249; RUCHKIN DS, 1994, BRAIN, V117, P289, DOI 10.1093/brain/117.2.289; SHADDEN BB, 1991, CLIN APHASIOLOGY, P327; SNOW P, 1995, COGNITIVE LINGUISTIC; Spreen O., 1969, NEUROSENSORY CTR COM; TERRELL B Y, 1989, Seminars in Speech and Language, V10, P282, DOI 10.1055/s-2008-1064269; ULATOWSKA H K, 1989, Seminars in Speech and Language, V10, P298, DOI 10.1055/s-2008-1064270; UOMOTO JM, 1991, COMMUNICATION DISORD, P75; WALLACE GL, 1993, ARCH PHYS MED REHAB, V74, P637, DOI 10.1016/0003-9993(93)90163-5; Wallesch C-W., 1988, APHASIA, P256; Westby C., 1992, BEST PRACTICES SCH S, P53; WEYLMAN ST, 1989, BRAIN LANG, V36, P580, DOI 10.1016/0093-934X(89)90087-4; White R F, 1990, J Neuropsychiatry Clin Neurosci, V2, P422; Wiig EH, 1985, TEST LANGUAGE COMPET; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P175; Williams Sarah E., 1994, Journal of Communication Disorders, V27, P207, DOI 10.1016/0021-9924(94)90001-9; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27; [No title captured]; [No title captured]	95	9	9	1	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0268-7038			APHASIOLOGY	Aphasiology	OCT	1997	11	10					969	991		10.1080/02687039708249422			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	XY420	WOS:A1997XY42000003					2022-02-06	
J	Lebrao, ML; Jorge, MHPD; Laurenti, R				Lebrao, ML; Jorge, MHPD; Laurenti, R			Hospital morbidity by lesions and poisonings .2.	REVISTA DE SAUDE PUBLICA			Portuguese	Article						morbidity surveys; Wounds and injuries, epidemiology; Poisoning, epidemiology		Today in Brazil the ''Hospital Internment Authorizations'' (AIH) represents about 80% of the total internments in the country and constitutes a data base of easy access available in CD-ROM. This high coverage allows one to draw a reasonable picture, close to reality, of the morbidity demanding hospitalization. Among the causes there is the diagnostic category lesions and poisonings noteworthy for severity and frequency. Hospital internments by this diagnostic category occurring in a month in 1994 have been focused on. Some epidemiological and hospital use characteristics, such as demographic aspects, specific diagnostic category, length of stay and mortality are described. It was observed that lesions and poisonings accounted for 5% to 6% of all hospital internments in the country, being predominantly among men under 65 of age. This diagnostic category was the first cause of hospital internments among men of from 15 to 29 years of age. Fractures were the most frequent specific diagnosis (about 37.5%), almost all of them involving members (legs or arms). The injuries were mainly located in hands, arms, head and neck and occurred predominantly among young men, leading to the believe that they were due to work or traffic accidents. Regarding burns, the fregment occurrence among children under 5 years of age is worthy of note. The authors lament the lack of information as to their causes such as would enable appropriate preventive actions to be taken.			Lebrao, ML (corresponding author), UNIV SAO PAULO,FAC SAUDE PUBL,DEPT EPIDEMIOL,BR-01255 SAO PAULO,BRAZIL.						COMRUELLE L, 1995, ETAPES DIAGNOSTIQUES; FERREIRA JMN, 1986, REV FUND SEADES PAUL, V2, P31; FUNDACAO I, 1993, CENSO DEMOGRAFICO 19; FUNDACAO I, 1982, CENSO DEMOGRAFICO 19; FUNDACAO I, 1973, CENSO DEMOGRAFICO 19; JORGE MHP, 1988, THESIS USP; LEBRAO ML, 1994, THESIS USP; Levcovitz E., 1993, SIH SUS SISTEMA AIH; *MIN SAUD DAT, 1995, INT HOSP SUBS AN 199; *MIN SAUD FNS CENE, 1992, INF EPIDEMIOL SUS, V1; *NAT CTR HLTH STAT, 1993, VIT STAT US, V13; *NORD MED STAT COM, 1992, HLTH STAT NORD COUNT; *ORG MUND SAUD, 1980, MAN CLASS EST INT DO; PAIVA TM, 1995, UNPUB ESTUDO MORBIDA; POKRAS R, 1989, VITAL HLTH STAT SER, V13; ROCHA JSY, 1980, REV SAUDE PUBL, V14, P58; SANTO AH, 1988, THESIS USP; VERAS CMT, 1992, THESIS LONDON SCH EC	18	9	22	0	0	REVISTA DE SAUDE PUBLICA	SAO PAULO	FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL	0034-8910			REV SAUDE PUBL	Rev. Saude Publica	AUG	1997	31			S			26	37		10.1590/S0034-89101997000500003			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YG179	WOS:A1997YG17900003	9595756	gold, Green Published			2022-02-06	
J	Phipps, EJ; DiPasquale, M; Blitz, CL; Whyte, J				Phipps, EJ; DiPasquale, M; Blitz, CL; Whyte, J			Interpreting responsiveness in persons with severe traumatic brain injury: Beliefs in families and quantitative evaluations	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article								Objective: To describe beliefs in families of minimally conscious or vegetative patients about the functional abilities of their family member (the patient) and to better understand the relationship between family beliefs and the patient's objectively measured functional status, Design: Qualitative pilot study using audiotaped, semistructured interviews with family members at the beginning of the patient's admission to a brain injury rehabilitation unit (T1) and prior to discharge (T2). Setting: An inpatient brain injury rehabilitation unit at a community-based rehabilitation hospital. Participants: Five families of patients believed to be vegetative or minimally conscious admitted for evaluation between July 1993 and June 1996. Methods: The content of interviews was analyzed with qualitative techniques. Beliefs and evidence cited by the family were recorded and compared with medical injury data and results from single-subject evaluation of sensory and cognitive capacities. Relevant social and demographic data and observations of clinical team discussions about the patients were also used in the analysis of each case. Results: Most observed behaviors, movements, or other cues were given meaning by family members, regardless of the results of objective assessment. Recurrent themes at T1 were: 1) relief that the patient was alive, 2) hope for a full recovery, 3) confusion about the nature and impact of the brain injury, 4) belief that the patient was more functional than he or she appeared to be, and 5) failures to respond were due to functions other than basic limitations of consciousness. Recurrent themes at T2 were: 1) anxiety about the future and impact on the caregiver, 2) continued hope for full recovery, 3) fear about the plateauing of the patient's performance, and 4) coexistence of hope and worry. Conclusions: Beliefs of family members about the functional capacities of persons who are vegetative or minimally conscious are ever present in the evaluation process of these patients. It is important that beliefs be identified and respectfully addressed through education and counseling and that the interpretation of behaviors observed by family members be incorporated into the objective assessment of the patient.	TEMPLE UNIV,SCH MED,DEPT MED,PHILADELPHIA,PA 19122; TEMPLE UNIV,SCH MED,DEPT PHYS MED & REHABIL,PHILADELPHIA,PA 19122; MOSSREHAB,DRUCKER BRAIN INJURY CTR,PHILADELPHIA,PA; UNIV PENN,PHILADELPHIA,PA 19104; MOSS REHABIL RES INST,PHILADELPHIA,PA					Whyte, John/0000-0002-4381-1474			AGAR M, 1976, THEMES REVISITED SOM; ANWELL B, 1989, ARCH PHYS MED REHAB, V70, P104; BERGER P, 1973, SOCIOLOGY KNOWLEDGE; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; DiPasquale MC, 1996, J HEAD TRAUMA REHAB, V11, P9, DOI 10.1097/00001199-199612000-00004; GIACINO J, 1992, ARCH PHYS MED REHAB, V73, P629; Jacobs HE, 1986, J HEAD TRAUMA REHAB, V1, P55, DOI DOI 10.1136/BMJ.M1815; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013; Kleinman Arthur., 1980, PATIENTS HEALERS CON; Opler M., 1945, AM J SOCIOL, V53, P198; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; SACHS PR, 1991, TREATING FAMILIES BR; Spradley J.P., 1979, ETHNOGRAPHIC INTERVI; TRESCH DD, 1991, J AM GERIATR SOC, V39, P17, DOI 10.1111/j.1532-5415.1991.tb05900.x; WHYTE J, 1996, ARCH PHYS MED REHAB, V76, P804	17	9	9	0	8	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1997	12	4					52	69		10.1097/00001199-199708000-00006			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XP104	WOS:A1997XP10400006					2022-02-06	
J	Layton, ME; Wagner, JK; Samson, FE; Pazdernik, TL				Layton, ME; Wagner, JK; Samson, FE; Pazdernik, TL			Redox changes in perfusates following intracerebral penetration of microdialysis probes	NEUROCHEMICAL RESEARCH			English	Article						ascorbic acid; chemiluminescence; hydrogen peroxide; microdialysis; trauma; uric acid	PERFORMANCE LIQUID-CHROMATOGRAPHY; TRAUMATIZED SPINAL-CORD; URIC-ACID; XANTHINE DEHYDROGENASE; ISCHEMIA REPERFUSION; LIPID-PEROXIDATION; FREE-RADICALS; RAT-BRAIN; ASCORBATE; OXIDASE	Microdialysis probe insertion into rat cerebral cortex significantly affects the levels of redox-active substances in brain extracellular fluid. Ascorbic acid levels are high immediately after probe insertion, decline rapidly, and then rise as the rat recovers from anesthesia 5-8 hours after surgery. Uric acid is at a low level for 5 hours and then rapidly increases in parallel with ascorbic acid. High ascorbic acid levels immediately after probe insertion are likely due to a shift from intracellular to extracellular fluids, whereas the delayed increase in uric acid may be due to increased enzymatic formation. After removal from the brain, hydrogen peroxide (H2O2) in microdialysis samples produces catalase-sensitive oxidative chemiluminescence. Microdialysis samples also produce high level catalase-resistant chemiluminescence associated with ascorbic acid levels after penetration injury. Although ascorbic acid is likely an antioxidant at concentrations estimated to be in brain extracellular fluid, it may have prooxidant effects when complexed with transition metals released into the neuronal microenvironment during traumatic brain injury.	UNIV KANSAS,MED CTR,DEPT PHARMACOL TOXICOL & THERAPEUT,KANSAS CITY,KS 66160; UNIV KANSAS,MED CTR,SMITH MENTAL RETARDAT RES CTR,KANSAS CITY,KS 66160; UNIV WASHINGTON,DEPT PSYCHIAT & BEHAV SCI,SEATTLE,WA 98195						NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD02528] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ES07079] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER		AMBERG G, 1989, J PHARMACOL METHOD, V22, P157, DOI 10.1016/0160-5402(89)90012-0; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ASANO T, 1989, MOL CHEM NEUROPATHOL, V10, P101, DOI 10.1007/BF03159717; BATTELLI MG, 1995, DEV BRAIN RES, V86, P340, DOI 10.1016/0165-3806(95)00012-3; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BONDY SC, 1995, P SOC EXP BIOL MED, V208, P337; CHANCE B, 1949, ARCH BIOCHEM, V24, P389; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; DAVISON AJ, 1986, J BIOL CHEM, V261, P1193; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DEMEDIUK P, 1988, J NEUROSCI RES, V20, P115, DOI 10.1002/jnr.490200116; DEMEDIUK P, 1985, PROG BRAIN RES, V63, P211; EMERSON MR, 1996, SOC NEUROSCI, V22, P562; FREI B, 1988, ANAL BIOCHEM, V175, P120, DOI 10.1016/0003-2697(88)90369-7; FREI B, 1992, CURR COMM CELL MOL B, V5, P23; GRUNEWALD RA, 1993, BRAIN RES REV, V18, P123, DOI 10.1016/0165-0173(93)90010-W; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HILLERED L, 1988, NEUROSCI LETT, V95, P286, DOI 10.1016/0304-3940(88)90672-6; HILLERED L, 1990, NEUROSCI LETT, V113, P328, DOI 10.1016/0304-3940(90)90606-A; HUNT J, 1992, J BIOL CHEM, V267, P21479; HWANG H, 1986, ANAL CHEM, V58, P1521, DOI 10.1021/ac00298a055; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; KRAUSE GS, 1987, ANN EMERG MED, V16, P1200, DOI 10.1016/S0196-0644(87)80224-X; LANDOLT H, 1992, J CEREBR BLOOD F MET, V12, P96, DOI 10.1038/jcbfm.1992.12; Layton ME, 1996, J SURG RES, V64, P1, DOI 10.1006/jsre.1996.0297; MARTELL AE, 1982, ADV CHEM SER, V200, P153; MCCORD JM, 1968, J BIOL CHEM, V213, P5753; MILBY K, 1982, NEUROSCI LETT, V28, P15, DOI 10.1016/0304-3940(82)90201-4; NIHEI H, 1989, NEUROSURGERY, V25, P613, DOI 10.1227/00006123-198910000-00016; OMAYE ST, 1987, ANN NY ACAD SCI, V498, P389, DOI 10.1111/j.1749-6632.1987.tb23776.x; ONEILL RD, 1991, J NEUROCHEM, V57, P22, DOI 10.1111/j.1471-4159.1991.tb02094.x; PARKS DA, 1988, AM J PHYSIOL, V254, pG768, DOI 10.1152/ajpgi.1988.254.5.G768; PATT A, 1988, J CLIN INVEST, V81, P1556, DOI 10.1172/JCI113488; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PAZDERNIK TL, 1992, NEUROCHEM RES, V17, P11, DOI 10.1007/BF00966860; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; PRAT AG, 1990, FREE RADICAL BIO MED, V8, P319, DOI 10.1016/0891-5849(90)90096-2; RABOW LE, 1990, J AM CHEM SOC, V112, P3203, DOI 10.1021/ja00164a050; REED GA, 1987, BIOL COPPER COMPLEXE, P287; ROMANAS MM, 1996, OXYGEN, V96; ROMANAS MM, 1995, INT C TOX 7; ROSENBLOOM FM, 1967, J AMER MED ASSOC, V202, P175, DOI 10.1001/jama.202.3.175; SAM JW, 1994, J AM CHEM SOC, V116, P5250, DOI 10.1021/ja00091a032; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; SIMONSON SG, 1993, J CEREBR BLOOD F MET, V13, P125, DOI 10.1038/jcbfm.1993.15; YAMAMOTO Y, 1990, METHOD ENZYMOL, V186, P371	46	9	9	0	0	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0364-3190			NEUROCHEM RES	Neurochem. Res.	JUN	1997	22	6					735	741		10.1023/A:1027362312381			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	XC139	WOS:A1997XC13900011	9178958				2022-02-06	
J	Klimczak, NJ; Donovick, PJ; Burright, R				Klimczak, NJ; Donovick, PJ; Burright, R			The malingering of multiple sclerosis and mild traumatic brain injury	BRAIN INJURY			English	Article							BELIEVABLE DEFICITS	In this investigation, neuropsychological testing was conducted with 69 college students that were instructed to malinger either multiple sclerosis (MS) or traumatic brain injury (TIB) or were non-malingering controls. The two malingering soups were divided into informed and non-informed groups. The informed groups received information concerning their respective condition, and the non-informed groups were asked simply to malinger. Generally, all malingering groups performed considerably below the levels of non-malingering controls on measures of attention, learning and memory, word fluency, abstract reasoning, visuoconstruction and manual dexterity. There appeared to be no difference in the manner in which subjects attempted to malinger MS as opposed to TBI. However, the severity of the portrayed deficit suggested by the test scores was disproportionate to the severity of the injury being requested. The pattern of deficit presented was quite global, with well below average performance demonstrated by all malingering groups across all domains.	SUNY BINGHAMTON,ENVIRONM NEUROPSYCHOL LAB,DEPT PSYCHOL,NEW YORK,NY 13902								*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P683; Denman S.B, 1984, DENMAN NEUROPSYCHOLO; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; KNIGHT J, 1995, 23 ANN M INT NEUR SO; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; ROGERS R, 1993, CLIN ASSESSMENT MALI	9	9	9	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1997	11	5					343	352					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WW455	WOS:A1997WW45500005	9146840				2022-02-06	
J	Harris, JR; DePompei, R				Harris, JR; DePompei, R			Provision of services for students with traumatic brain injury: A survey of Ohio colleges	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						college students with disabilities; traumatic brain injury; university services		Objective: A study was performed to determine (1) the nature of services provided for students with traumatic brain injury (TBI) by offices of disability services (ODSs) in colleges and universities across the state of Ohio and (2) these offices' awareness of such students. Design: A telephone survey was used to obtain data from 74 public, private, and community colleges in Ohio. Subjects and Main Outcome Measures: ODS counselors and other office personnel provided information on ODS service manuals, identification of students with TBI, support services, course requirements, and graduation rates. Conclusions: Findings suggest that (1) provision of services is largely dependent on student self-identification, (2) academic and psychological supports are needed most, and (3) few ODS offices include TBI in pamphlets detailing their services.	UNIV AKRON,SCH COMMUN DISORDERS,AKRON,OH 44325		Harris, JR (corresponding author), OHIO STATE UNIV,DEPT SPEECH & HEARING SCI,110 PRESSEY HALL,1070 CARMACK RD,COLUMBUS,OH 43210, USA.						BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; *BRAIN INJ ASS, 1995, TBI CHALLENGE, V3, P35; Cook J., 1987, ABI HDB SERVING STUD; Cook J, 1991, J HEAD TRAUMA REHAB, V6, P64, DOI [10.1097/00001199-199103000-00011, DOI 10.1097/00001199-199103000-00011]; HALL D, 1986, COGNIT REHABIL, V3, P4; *HEAD INJ ADV COUN, 1994, COMB STRAT PLAN 1995; *OH BOARD REG, 1995, I HIGH ED OH; Savage R. C., 1994, ED DIMENSIONS ACQUIR; Ylvisaker M., 1993, ASSESSMENT TREATMENT	9	9	9	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1997	12	2					67	77		10.1097/00001199-199704000-00007			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WT782	WOS:A1997WT78200008					2022-02-06	
J	Zafonte, RD				Zafonte, RD			Treatment of agitation in the acute care setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; RECEPTORS; SEDATION		REHABIL INST MICHIGAN,TRAUMAT BRAIN INJURY UNIT,DETROIT,MI		Zafonte, RD (corresponding author), WAYNE STATE UNIV,DETROIT,MI 48202, USA.						BERGGREN L, 1987, ACTA ANAESTHIOL SCAN, V31, P228; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; CLINTON JE, 1987, ANN EMERG MED, V16, P319, DOI 10.1016/S0196-0644(87)80179-8; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CRIPPEN DW, 1990, CRIT CARE CLIN, V6, P369; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HORN LJ, 1987, J HEAD TRAUMA REHAB, V2, P18; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; *STUART PHARM, 1994, POP GUID US INT CAR; Zafonte RD, 1996, NEUROREHABILITATION, V7, P189, DOI 10.3233/NRE-1996-7304	12	9	9	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1997	12	2					78	81		10.1097/00001199-199704000-00008			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WT782	WOS:A1997WT78200009					2022-02-06	
J	Hanson, CS; Shechtman, O; Foss, JJ; KraussHooker, A				Hanson, CS; Shechtman, O; Foss, JJ; KraussHooker, A			Occupational therapy: Current practice and training issues in the treatment of cognitive dysfunction	NEUROREHABILITATION			English	Article						cognitive function; cognitive/perceptual skills; occupational roles; intervention approaches	TRAUMATIC BRAIN INJURY; PERCEPTUAL DEFICITS; STROKE PATIENTS; REHABILITATION; ADULTS; REMEDIATION	A significant relationship exists between cognitive abilities and functional performance in activities of daily living. Occupational therapists are involved in providing cognitive rehabilitation to individuals with brain damage by assisting them in fulfilling self-care, work and leisure roles. Since occupational therapists specialize in functioning in the real world, they should have a primary role on the interdisciplinary team in assessing and treating cognition as it relates to function. Particular areas of expertise include assessment and intervention in daily living tasks, safety issues and cognitive/perceptual dysfunction. Treatment strategies in occupational therapy are classified into two approaches: remedial and compensatory. A combination of the two approaches has been found to be the most beneficial method of intervention. Though current training guidelines for occupational therapists in cognitive rehabilitation are vague, the major focus has been on evaluating functional status and intervening when cognitive/perceptual deficits are present. Future training for practitioners in this area will require more specialized experiences and education. Additional research will need to be conducted by therapists to document treatment efficacy. Despite current health care constraints, occupational therapists must not lose sight of delivering quality care in an individualized and holistic manner. Copyright (C) 1997 Elsevier Science Ireland Ltd.	GENESIS REHABIL HOSP,JACKSONVILLE,FL 32216		Hanson, CS (corresponding author), UNIV FLORIDA,DEPT OCCUPAT THERAPY,POB 100164,GAINESVILLE,FL 32610, USA.						ABREU BC, 1987, AM J OCCUP THER, V41, P439, DOI 10.5014/ajot.41.7.439; Allen C., 1992, OCCUPATIONAL THERAPY; ALLEN CK, 1987, J CLIN PSYCHIAT, V48, P185; Allen CK, 1985, OCCUPATIONAL THERAPY; *AM OCC THER ASS, 1991, AM J OCCUP THER, V45, P1067; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BERNSPANG B, 1989, OCCUP THER J RES, V9, P27, DOI 10.1177/153944928900900104; BRACY OL, 1986, COGNITIVE REHABILITA, V4, P10; CARTER LT, 1988, AM J OCCUP THER, V42, P449, DOI 10.5014/ajot.42.7.449; CARTER LT, 1983, AM J OCCUP THER, V37, P320, DOI 10.5014/ajot.37.5.320; COBBLE ND, 1991, ARCH PHYS MED REHAB, V72, P324; DIAMANT JJ, 1989, COGNIT REHABIL, V7, P22; FOSS J, 1993, BODY IMAGE PERCEPTUA, P11; FOTO M, 1995, AM J OCCUP THER, V49, P955, DOI 10.5014/ajot.49.10.955; GIANUTSOS R, 1980, J REHABIL        JUL, P36; GILES GM, 1994, AM J OCCUP THER, V48, P199, DOI 10.5014/ajot.48.3.199; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GORDON WA, 1989, J HEAD TRAUMA REHABI, V43, P76; GREENWOOD R, 1992, J NEUROL NEUROSUR PS, V55, P51, DOI 10.1136/jnnp.55.Suppl.51; HANSON CS, IN PRESS ASSESSMENT; HANSON CS, 1993, BODY IMAGE PERCEPTUA, P39; Katz N., 1994, OCCUPATIONAL THERAPY, V1, P49; KATZ N, 1990, MEASURING CLIN CHANG; Meyer A., 1922, ARCH OCCUP THER, V1, P1, DOI [DOI 10.1192/BJP.68.283.421, 10.1300/J004v02n03_05, DOI 10.1300/J004V02N03_05]; MILLER E, 1980, J NEUROL NEUROSUR PS, V43, P525, DOI 10.1136/jnnp.43.6.525; MORSE PA, 1988, J HEAD TRAUMA REHAB, V3, P33; NEISTADT ME, 1990, AM J OCCUP THER, V44, P299, DOI 10.5014/ajot.44.4.299; NEISTADT ME, 1988, AM J OCCUP THER, V42, P434, DOI 10.5014/ajot.42.7.434; PEPIN M, 1995, J COGNITIVE REHABILI, V13, P8; *PEW HLTH PROF COM, 1992, HLTH AM PRACT 2005 B; PIPITONE P, 1992, HEADLINES        MAY; RADOMSKI MV, 1994, AM J OCCUP THER, V48, P271, DOI 10.5014/ajot.48.3.271; SCHWARTZ SM, 1995, AM J OCCUP THER, V49, P655, DOI 10.5014/ajot.49.7.655; SIEV E, 1986, PERCEPTUAL COGNITIVE; Thomas Karen S., 1994, Physical and Occupational Therapy in Geriatrics, V12, P51; Toglia J. P., 1989, OCCUPATIONAL THERAPY, V1, P36; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; TOGLIA JP, 1996, COMMUNICATION   0429; TOGLIA JP, 1990, COGNITIVE REHABILITA; Van Deusen J., 1993, BODY IMAGE PERCEPTUA; [No title captured]; 1996, OT WEEK         0222	42	9	9	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JAN	1997	8	1					31	41		10.1016/S1053-8135(96)00206-5			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WE987	WOS:A1997WE98700005	24525942				2022-02-06	
J	Heegaard, W; Biros, M; Zink, J				Heegaard, W; Biros, M; Zink, J			Effect of hypothermia, dichloroacetate, and deferoxamine in the treatment for cortical edema and functional recovery after experimental cortical impact in the rat	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	ACEP Scientific Forum	MAR, 1994	SAN DIEGO, CA	ACEP		traumatic brain injury; head trauma; hypothermia; cortical edema; functional recovery; controlled cortical impact; deferoxamine; dichloroacetate	TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; HEAD-INJURY; SUPEROXIDE-DISMUTASE; CEREBRAL EDEMA; ISCHEMIA; MODEL; REPERFUSION; PROTECTION	Objective: To investigate the effects of hypothermia alone or in combination with dichloroacetic acid (DCA) and/or deferoxamine (DFO) in reducing cortical edema (CE) and improving neurologic functional recovery after moderate closed head trauma with controlled cortical impact (CCI). Methods: Anesthetized rats were randomized to receive right parietal moderate CCI (impact depth 2 mm, speed 3.5 m/sec) or sham operations. Immediately after trauma, the animals underwent selective brain cooling to 30 degrees C (temporalis muscle temperatures). Ten minutes after trauma, the randomized animals received intraperitoneal doses of DCA (25 mg/kg), DFO (50 mg/kg), both DCA and DFO, or equivolume normal saline. For evaluation of cortical edema, some animals (n = 42) were sacrificed 4 hours after trauma and cortical specific gravity (SpG) was determined gravimetrically. The other animals (n = 47) were evaluated for functional recovery beginning 6 days posttrauma. Neurobehavioral performance was assessed in the Morris water maze. Results: Cortical edema was significantly less in the animals treated with hypothermia (SpG = 1.041 +/- 0.001, p < 0.05) compared with the untreated traumatized animals (SpG = 1.037 +/- 0.001). Combination treatment with hypothermia and drug treatment did not reduce cortical edema when compared with no treatment. Hypothermia with and without drug treatment did not improve neurobehavioral performance when compared with no treatment. Conclusions: In this pilot study with a relatively small sample size, hypothermia alone significantly reduced post-CCI cortical edema as measured by SpG. Hypothermia combined with drug treatment did not reduce posttraumatic cortical edema. Hypothermia with and without drug therapy did not improve functional neurologic recovery in the rats subjected to CCI.	GUNDERSEN LUTHERAN MED CTR,DEPT EMERGENCY MED,LA CROSSE,WI		Heegaard, W (corresponding author), HENNEPIN CTY MED CTR,DEPT EMERGENCY MED,701 PK AVE,MINNEAPOLIS,MN 55415, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P-20NS30322] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030322] Funding Source: NIH RePORTER		BIROS MH, 1987, AM J EMERG MED, V5, P271, DOI 10.1016/0735-6757(87)90349-4; Biros MH, 1996, AM J EMERG MED, V14, P27, DOI 10.1016/S0735-6757(96)90008-X; CERCHIARI EL, 1987, STROKE, V18, P869, DOI 10.1161/01.STR.18.5.869; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kraus JF, 1993, HEAD INJURY, P1; LYETH B G, 1991, Society for Neuroscience Abstracts, V17, P165; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; MUIZELAAR JP, 1993, ANN EMERG MED, V22, P1014, DOI 10.1016/S0196-0644(05)82744-1; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; NIELSEN MM, 1991, ANN EMERG MED, V20, P479; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; ROSENTHAL RE, 1992, FREE RADICAL BIO MED, V12, P29, DOI 10.1016/0891-5849(92)90055-L; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; STACPOOLE PW, 1983, NEW ENGL J MED, V309, P390, DOI 10.1056/NEJM198308183090702; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; ZINK J, 1991, ANN EMERG MED, V20, P478	30	9	10	0	0	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	JAN	1997	4	1					33	39		10.1111/j.1553-2712.1997.tb03640.x			7	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WB399	WOS:A1997WB39900007	9110009	Bronze			2022-02-06	
J	Roberts, MA; Furuseth, A				Roberts, MA; Furuseth, A			Eliciting parental report following pediatric traumatic brain injury: Preliminary findings on the pediatric inventory of neurobehavioral symptoms	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							DYSFUNCTION; CHILDHOOD; DISORDER; CHILDREN; SEQUELAE; EPILEPSY; ANOSMIA	The current article presents preliminary normative data for the Pediatric Inventory of Neurobehavioral Symptoms (PINS), a parent rating scale consisting of symptoms symptoms associated with post-traumatic cerebral dysfunction, such as disinhibition, perseveration; reduced spontaneity, inappropriate affective responses, episodic phenomena, and disruptions of biologic function. Comparison data from a sample of 50 elementary age children who had sustained traumatic brain injury (TBI) reveals significant differences on the PINS total score and each of five subscale scores. Two of the 5 PINS subscales (Episodic Symptoms, Biologic Signs) significantly differentiated the TBI and Attention Deficit Hyperactivity Disorder (n = 35) groups, suggesting that these may be clinical features that distinguish post-traumatic cerebral dysfunction from developmental psychopathology. Despite the need for additional research, the PINS appears to be a promising new measure iii advancing our understanding of the neurobehavioral sequelae of pediatric traumatic brain injury. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.			Roberts, MA (corresponding author), UNIV IOWA,HOSP SCH 351,DEPT PEDIAT,IOWA CITY,IA 52242, USA.						AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; AUERBACH V, 1992, NEUROLAW LETT, V1, P1; BARKLEY RA, 1992, J ABNORM CHILD PSYCH, V20, P163, DOI 10.1007/BF00916547; Begali V., 1987, HEAD INJURY CHILDREN; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Benton A, 1985, Bull Clin Neurosci, V50, P11; BINNIE CD, 1990, EPILEPSIA, V31, pS2, DOI 10.1111/j.1528-1157.1990.tb05864.x; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; CRIPE LI, 1988, ARM MED DEP PSYCH C; Damasio A., 1994, DESCARTES ERROR EMOT; DENNIS M, 1989, CLIN NEUROPSYCHOL, V3, P203; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; HART T, 1985, NEUROTRAUMA; HELMSTAEDTER C, 1992, EPILEPSIA, V33, P892, DOI 10.1111/j.1528-1157.1992.tb02197.x; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; MATTES JA, 1980, COMPR PSYCHIAT, V21, P358, DOI 10.1016/0010-440X(80)90017-6; McKinlay WW, 1992, HDB NEUROPSYCHOLOGIC, P363; *NAT AC NEUR, 1992, B NATL ACAD NEUROPSY, V8, P3; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; ROBERTS MA, IN PRESS BRAIN INJUR; ROBERTS MA, IN PRESS APPL NEUROP; Roberts RJ, 1990, NEUROPSYCHOLOGY, V4, P65; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; SHEWMON DA, 1988, J CLIN EXPT NEUROPSY, V11, P675; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; SUMNER D, 1976, HDB CLIN NEUROLOGY; TIERNEY JG, 1995, MED PSYCH P, V3, P307; VANDERPLOEG RD, 1994, CLIN GUIDE NEUROPSYC, P1; VARNEY N, 1991, NEUROPSYCHOLOGY, V5, P223; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; ZARNETKIN AJ, 1990, NEW ENGL J MED, V323, P1361; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	46	9	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	5					449	457		10.1016/S0887-6177(96)00039-X			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	XL310	WOS:A1997XL31000002	14590675	Bronze			2022-02-06	
J	Zinner, ES; Ball, JD; Stutts, ML; Philput, C				Zinner, ES; Ball, JD; Stutts, ML; Philput, C			Grief reactions of mothers of adolescents and young adults with traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; FAMILY; PREDICTORS; CHILDREN	One hundred and two mothers of adolescents and young adults with traumatic brain injury completed a modified Grief Experience Inventory (GEI) (Sanders, Mauger, & Strong, 1985) and rated their child's functioning on a modified Neurobehavioral Rating Scale (NRS) (Levin et al., 1987). More severe grief was reported by mothers who rated their children as having poor neurobehavioral functioning and by mothers of young adult rather than adolescent patients. The guilt component of grief varied significantly across the 3-year post-injury period measured in the study. Historical comparisons of these respondents with other bereaved populations showed that mothers of adolescent and young adults with head injury reported more intense grief than parents who had experienced other significant non-death losses. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	EASTERN VIRGINIA MED SCH, DEPT PSYCHIAT & BEHAV MED, NORFOLK, VA 23501 USA; EASTERN VIRGINIA MED SCH, VIRGINIA CONSORTIUM PROFESS PSYCHOL, NORFOLK, VA 23501 USA; NAVAL MED CTR, PORTSMOUTH, VA USA		Zinner, ES (corresponding author), UNIV MARYLAND, DIV APPL PSYCHOL & QUANTITAT METHODS, AC 209B, 1429 N CHARLES ST, BALTIMORE, MD 21201 USA.		Ball, J.D./T-9440-2019				Ball JD, 1988, MED PSYCHOTHERAPY, V1, P15; BERROL S, 1988, J HEAD TRAUMA REHABI, V3, pR6; Bowlby J, 1980, ATTACHMENT LOSS VOLU; BRAY GP, 1987, REHABILITATION PSYCH; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; Bush Gerald W., 1988, J HEAD TRAUMA REHAB, V3, P73; Committee on Trauma Research, 1985, INJ AM; DEATON AV, 1984, PATIENTS FAMILYS TRE; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; EDELSTEIN L, 1984, MATERNAL BEREAVEMENT; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FRANKOWSKI RF, 1986, PSYCHIAT ASPECTS TRA; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; FURMAN E., 1974, CHILDS PARENT DIES; GARDNER RA, 1973, FAMILY BOOK MINIMAL; GRAFFI S, 1989, J APPL SOCIAL SCI, V13, P292; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HAYNES SD, 1994, ARCH CLIN NEUROPSYCH, V9, P323, DOI 10.1016/0887-6177(94)90020-5; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Kbler-Ross E., 1969, DEATH DYING; KLONOFF P, 1987, COMMUNITY REENTRY HE; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MAHONEY WW, 1981, J NEUROL NEUROSUR PS, V44, P527; MUIR CA, 1984, BEHAV ASSESSMENT REH; *NAT HEAD INJ FDN, 1987, TRAUM SIL EP; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; PARKES CM, 1969, BMJ-BRIT MED J, V1, P740, DOI 10.1136/bmj.1.5646.740; Parkes CM, 1983, RECOVERY BEREAVEMENT; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rando Therese., 1993, TREATMENT COMPLICATE; Raphael B., 1983, ANATOMY BEREAVEMENT; Redmond L., 1989, SURVIVING SOMEONE YO; RIDLEY B, 1989, SOC SCI MED, V29, P555, DOI 10.1016/0277-9536(89)90201-3; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; SANDERS CM, 1982, OMEGA-J DEATH DYING, V13, P227, DOI 10.2190/RTPF-M5EA-6N7A-7D0D; SBORDONE RJ, 1984, PROF PSYCHOL-RES PR, V15, P165; SCHNEIDER J, 1983, NATURE LOSS NATURE G; SHNEIDMAN ES, 1974, DEATHS MAN; Strong P E, 1985, MANUAL GRIEF EXPERIE; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; UOMOTO JM, 1992, ARCH PHYS MED REHAB, V73, P674; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Worden J.W., 1991, GRIEF COUNSELING GRI; YOUNG RK, 1977, AM J MATERANL CHILD, V38, P38; ZARSKI JJ, 1987, AM J FAM THER, V15, P62; ZARSKI JJ, 1988, J MENTAL HLTH COUNSE, V10, P145; ZINNER ES, 1990, NEWSLETTER NATL HEAD, V9, P4; ZINNER ES, 1990, YOUTH SUICIDE ISSUES	58	9	10	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	5					435	447		10.1016/S0887-6177(96)00034-0			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	XL310	WOS:A1997XL31000001	14590674	Bronze			2022-02-06	
J	OConnor, M; Walbridge, M; Sandson, T; Alexander, M				OConnor, M; Walbridge, M; Sandson, T; Alexander, M			A neuropsychological analysis of Capgras syndrome	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						amnesia; Capgras syndrome	REDUPLICATIVE PARAMNESIA; DELUSIONS	We report the case of a 74-year-old woman (E.B.) who suffered the delusion that her husband had been psychologically replaced by her father (i.e., Capgras syndrome) after she had sustained a serious traumatic brain injury. Before her head injury, E.B. had severe amnesia of unknown etiology, which had been carefully documented over a 10-year period; there was no evidence of delusional tendencies during this time. Subsequent to her head injury, E.B. displayed persistent misidentification of her husband's identity alongside impaired performance on tests of frontal/executive functions and increased difficulties on measures of remote memory. Longitudinal analyses revealed that E.B.'s delusion resolved in tandem with improved performance on tests of frontal network functions. There was no accompanying change in the status of her amnesia. E.B.'s executive deficits and delusions may have been independent manifestations of her brain injury, which cleared simultaneously. Alternatively, there may have been a causal relationship between these phenomena in that frontal/executive deficits may have been critically involved in the genesis of her delusions.	BOSTON UNIV,SCH MED,MEMORY DISORDERS RES CTR,BOSTON,MA 02118; HARVARD UNIV,SCH MED,DEPT NEUROL,DIV BEHAV NEUROL,BOSTON,MA; BOSTON UNIV,SCH MED,BRAINTREE HOSP,DEPT NEUROL,BRAINTREE,MA								ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BERSON RJ, 1983, AM J PSYCHIAT, V140, P960; Capgras J., 1923, B SOC CLIN MED MENTA, V11, P6; CHRISTODOULOU GN, 1978, J NERV MENT DIS, V166, P68; FLEMINGER S, 1993, BIOL PSYCHIAT, V33, P22, DOI 10.1016/0006-3223(93)90274-H; HATHAWAY SR, 1989, MINNESOTA MULTIPHASI, V2; Hathaway SR, 1967, MINNESOTA MULTIPHASI; Johnson MK., 1991, REALITY MONITORING E, P176; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KORITAR E, 1988, CAN J PSYCHIAT, V33, P62, DOI 10.1177/070674378803300115; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; MALLOY P, 1992, NEUROPSY NEUROPSY BE, V5, P83; MCKANN G, 1984, NEUROLOGY, V34, P939; OCONNOR MG, UNPUB TEST RETEST RE; OREILLY R, 1987, BRIT J PSYCHIAT, V151, P263, DOI 10.1192/bjp.151.2.263; Rey A., 1964, EXAMEN CLIN PSYCHOL; RUFF RL, 1981, J NEUROL NEUROSUR PS, V44, P382, DOI 10.1136/jnnp.44.5.382; STATON RD, 1982, CORTEX, V18, P23, DOI 10.1016/S0010-9452(82)80016-6; Wechsler D, 1987, MEMORY SCALE REVISED; WEINSTEIN EA, 1991, PSYCHIATRY, V54, P78; [No title captured]	24	9	9	0	9	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	OCT	1996	9	4					265	271					7	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	VG776	WOS:A1996VG77600008					2022-02-06	
J	Schwab, S; Schellinger, P; Aschoff, A; Albert, F; Spranger, M; Hacke, W				Schwab, S; Schellinger, P; Aschoff, A; Albert, F; Spranger, M; Hacke, W			Epidural ICP monitoring and antiedema therapy in severe hemispheric stroke	NERVENARZT			German	Article						ICP; monitoring; stroke; neurosurgery; treatment	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; INTRACRANIAL-PRESSURE; CEREBRAL INFARCTION; MASS LESIONS; ISCHEMIC STROKE; INTENSIVE-CARE; BRAIN EDEMA; COMPLICATIONS; DETERIORATION	Background and purpose: A permanent elevation of ICP after severe brain injury for instance in subarachnoid or intracerebral hemorrhage or neurotrauma is associated with a poor clinical outcome. Although increasingly being used in the intensive care of patients with elevated TCP, continous epidural ICP monitoring in ischemic stroke has not been firmly established yet. Patients and methods: We prospectively evaluated the clinical course and outcome of patients with raised ICP due to space occupying ischemic middle cerebral artery (MCA) infarction as seen in CT, who underwent continous ICP monitoring. Epidural ICP probes were inserted ipsilaterally (all patients) and contralaterally (additional in 7 patients) to the side of infarctation. Glasgow Coma and Scandinavian Stroke Scales (GCS and SSS) were obtained initially and in the further clinical course. All patients were subjected to a standardized treatment protocol for raised ICP. ICP values were correlated with clinical presentation at the time point of deterioration, with outcome and CT findings. Effectiveness of different treatment modalities to lower ICP were analyzed and discussed.	UNIV HEIDELBERG, NEUROCHIRURG KLIN, HEIDELBERG, GERMANY		Schwab, S (corresponding author), UNIV HEIDELBERG, NEUROL KLIN, NEUENHEIMER FELD 400, D-69120 HEIDELBERG, GERMANY.		Hacke, Werner/ABE-8661-2020				ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASPLUND K, 1985, STROKE, V16, P885; BARNETT GH, 1988, J NEUROSURG, V68, P585, DOI 10.3171/jns.1988.68.4.0585; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOUNDS JV, 1981, STROKE, V12, P474, DOI 10.1161/01.STR.12.4.474; CLARK WC, 1989, NEUROSURGERY, V25, P20; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; GROTTA J, 1995, NEUROLOGY, V45, P640, DOI 10.1212/WNL.45.4.640; HACKE W, 1994, CEREBROVASC DIS, V4, P385, DOI 10.1159/000108517; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hg LKY, 1970, STROKE, V1, P158, DOI 10.1161/01.STR.1.3.158; KALIA KK, 1993, ARCH NEUROL-CHICAGO, V50, P1293, DOI 10.1001/archneur.1993.00540120010005; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; KRIEGER D, 1995, CRIT CARE MED, V23, P1123, DOI 10.1097/00003246-199506000-00020; MAHONEY F I, 1965, Md State Med J, V14, P61; MARSHALL LF, 1978, CRIT CARE MED, V6, P1, DOI 10.1097/00003246-197801000-00001; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; RANKIN J, 1957, Scott Med J, V2, P200; RENGACHARY SS, 1981, NEUROSURGERY, V8, P321, DOI 10.1227/00006123-198103000-00004; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; ROPPER AH, 1992, ANN NEUROL, V32, P564, DOI 10.1002/ana.410320413; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P725, DOI 10.1001/archneur.1984.04050180047016; SATO M, 1989, RESUSCITATION, V17, P233, DOI 10.1016/0300-9572(89)90039-7; SCHWAB S, 1994, NERVENARZT, V65, P828; SCHWAB S, 1995, NERVENARZT, V66, P430; SHAW CM, 1959, ARCH NEUROL-CHICAGO, V1, P161; TEASDALE G, 1975, LANCET, V1, P480; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WEAVER DD, 1982, J NEUROSURG, V56, P660, DOI 10.3171/jns.1982.56.5.0660; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785	42	9	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	AUG	1996	67	8					659	666		10.1007/s001150050038			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	VC937	WOS:A1996VC93700005	8805111				2022-02-06	
J	Silver, BV; Yablon, SA				Silver, BV; Yablon, SA			Akathisia resulting from traumatic brain injury	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; AGITATION; SCALE; SEQUELAE; LESIONS; RATS	Restlessness and agitation are commonly reported early sequelae of tramatic brain injury (TBI). Severe restlessness (akathisia) is also observed in psychiatric patients as a result of the use of dopamine receptor blocking agents. A recent case study described akathisia in a patient with bilateral orbitofrontal lesions following TBI. We report a case of unusually marked motor restlessness (akathisia) following TBI in a 17-year-old woman. When admitted for rehabilitation she was alert but agitated, severely restless, and mute. She constantly paced her room and the hospital unit, repeatedly retracing the same route. MRI scan revealed large, well-delineated bifrontal contusions. During baseline evaluation prior to anticipated psychopharmacological intervention her restlessness began to resolve rapidly. She became verbal and oriented within expected limits without medication. This case lends support to the observation that akathisia is related to lesions of the prefrontal cortex.	BAYLOR COLL MED, HOUSTON, TX 77030 USA		Silver, BV (corresponding author), INST REHABIL & RES, DEPT NEUROPSYCHOL, 1333 MOURSUND ST, HOUSTON, TX 77030 USA.						Adams JH, 1992, GREENFIELDS NEUROPAT, P106; ADLER LA, 1989, PSYCHOPHARMACOLOGY, V97, P1, DOI 10.1007/BF00443404; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; CARTER CJ, 1978, BRIT J PHARMACOL, V62, pP402; Chandler M C, 1988, Brain Inj, V2, P309; COOLS AR, 1986, PSYCHOPHARMACOLOGY, V88, P451; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; FICHERA S, 1994, ARCH CLIN NEUROPSYCH, V9, P127; FICHERA SM, 1993, J CLIN EXP NEUROPSYC, V15, P105; GIBB WRG, 1986, J NEUROL NEUROSUR PS, V49, P861, DOI 10.1136/jnnp.49.8.861; GRAHAM DI, 1993, HEAD INJURY, P91; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; Herbel K, 1990, Rehabil Nurs, V15, P66; IVERSEN SD, 1971, BRAIN RES, V31, P295, DOI 10.1016/0006-8993(71)90184-3; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; LANG AE, 1993, PARKINSONS DISEASE M, P399; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LOHR JB, 1993, PSYCHIATRY, V3, P1; MALKMUS D, 1980, REHABILITATION HEAD; MARSDEN CD, 1980, PSYCHOL MED, V10, P55, DOI 10.1017/S003329170003960X; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; SACHDEV P, 1991, J NERV MENT DIS, V179, P381, DOI 10.1097/00005053-199107000-00001; SANDEL ME, 1993, BRAIN INJURY, V7, P77, DOI 10.3109/02699059309008159; STEWART J, 1989, J NEUROL NEUROSUR PS, V52, P1200, DOI 10.1136/jnnp.52.10.1200; TASSIN JP, 1978, BRAIN RES, V141, P267, DOI 10.1016/0006-8993(78)90197-X	31	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	1996	10	8					609	614					6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UZ656	WOS:A1996UZ65600007	8836518				2022-02-06	
J	Satz, P; Holston, SG; Uchiyama, CL; Shimahara, G; Mitrushina, M; Forney, DL; Zaucha, K; Light, R; Asarnow, R; Drebing, C; Kline, AE; vanGorp, W; Nelson, LD; Foster, J; Fahy, J; Namerow, N				Satz, P; Holston, SG; Uchiyama, CL; Shimahara, G; Mitrushina, M; Forney, DL; Zaucha, K; Light, R; Asarnow, R; Drebing, C; Kline, AE; vanGorp, W; Nelson, LD; Foster, J; Fahy, J; Namerow, N			Development and evaluation of validity scales for the neuropsychology behavior and affect profile: A dissembling study	PSYCHOLOGICAL ASSESSMENT			English	Article							INJURY	The Neuropsychology Behavior and Affect Profile (NBAP) is a peer-rated inventory of behavioral and affective changes in brain injured individuals and consists of five Clinical Scales that have demonstrated strong external validity. A potential confound is the NBAP's susceptibility to rater bias. In the present investigation, four validity scales were developed and external validity and psychometric properties were examined through a dissembling paradigm. Study 1 describes item selection and construction of the validity scales. Study 2 demonstrates that various combinations of both the clinical and validity scales effectively differentiated dissemblers from informants of two groups of traumatic brain injury patients. Although results differed somewhat when dissemblers were grouped according to their level of neuropsychological training, highly trained dissemblers (licensed clinical neuropsychologists) could be detected.	DANIEL FREEMAN MEM HOSP, DEPT REHABIL, INGLEWOOD, CA USA; CALIF STATE UNIV NORTHRIDGE, DEPT PSYCHOL, NORTHRIDGE, CA 91330 USA; DANIEL FREEMAN MEM HOSP, DEPT PSYCHOL, INGLEWOOD, CA USA		Satz, P (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, NEUROPSYCHIAT INST, ROOM C8-747, 760 WESTWOOD PLAZA, LOS ANGELES, CA 90024 USA.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COOPER WH, 1981, PSYCHOL BULL, V90, P218, DOI 10.1037/0033-2909.90.2.218; DREBING C, IN PRESS ARCH CLIN N; FAUST D, 1991, BRAIN DAMAGE CLAIMS; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Kaemmer, 1989, MINNESOTA MULTIPHASI; KLINE AE, 1992, THESIS CALIFORNIA SC; KOZOL HL, 1946, ARCH NEURO PSYCHIATR, V56, P245, DOI 10.1001/archneurpsyc.1946.02300200002001; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; NELSON LD, IN PRESS J CLIN EXPT; NELSON LD, 1993, PSYCHOL ASSESSMENT, V5, P374; SAAL FE, 1980, PSYCHOL BULL, V88, P413, DOI 10.1037/0033-2909.88.2.413; Satz P, 1993, NEUROPSYCHOLOGY, V7, P553, DOI DOI 10.1037/0894-4105.7.4.553; TELLEGEN A, 1988, J PERS, V56, P621, DOI 10.1111/j.1467-6494.1988.tb00905.x; WETTER MW, 1992, PSYCHOL ASSESSMENT, V4, P369, DOI DOI 10.1037/1040-3590.4.3.369; [No title captured]; [No title captured]	26	9	9	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	1996	8	2					115	124					10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UT983	WOS:A1996UT98300001					2022-02-06	
J	Safar, P				Safar, P			Resuscitation medicine research: Quo vadis	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	2nd Chicago Symposium on Advances in CPR Research and Guidelines for Laboratory Research	OCT, 1994	CHICAGO, IL				PROLONGED CARDIAC-ARREST; HOPELESSLY ILL PATIENTS; CARDIOPULMONARY-RESUSCITATION; PHYSICIANS RESPONSIBILITY; DOGS; HYPOTHERMIA; ISCHEMIA; MODEL; REPERFUSION; STATEMENT	Laboratory research should have clinical relevance. Topics should be selected according to need, gaps in knowledge, and opportunities; the investigator's background, expertise, interests, and ambitions; scientific, clinical, and socioeconomic importance; and feasibility of successful performance and conclusion. The current explosion of knowledge and sophistication of methods will require research by multidisciplinary teams. Systematic goal-oriented studies should be conducted in environments that encourage serendipitous discoveries. Mechanism- and outcome-oriented research, in laboratories and on patients, is needed. In cardiac arrest research, hearts and brains ''too good to die'' offer many challenges. In trauma research, particular challenges include protection-preservation during uncontrolled hemorrhagic shock, suspended animation for delayed resuscitation in exsanguination, and prevention of brain swelling after traumatic brain injury. Emergency physicians have the unique opportunity to initiate clinical resuscitation research in unexplored territory: the prehospital arena.			Safar, P (corresponding author), UNIV PITTSBURGH, SAFAR CTR RESUSCITAT RES, MED CTR, 3434 5TH AVE, PITTSBURGH, PA 15260 USA.						ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; ABRAMSON NS, 1992, ANN EMERG MED, V21, P1480, DOI 10.1016/S0196-0644(05)80066-6; ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; ABRAMSON NS, 1981, JAMA-J AM MED ASSOC, V246, P2828; ABRAMSON NS, 1995, CRIT CARE MED, V23, pA178; American College of Surgeons Committee on Trauma, 1993, ADV TRAUM LIF SUPP C; [Anonymous], 1992, JAMA, V268, P2171; ANSTADT MP, 1991, CHEST, V100, P86, DOI 10.1378/chest.100.1.86; BECK CS, 1960, JAMA-J AM MED ASSOC, V174, P133, DOI 10.1001/jama.1960.03030020021005; Becker LB, 1996, ANN EMERG MED, V27, P539, DOI 10.1016/S0196-0644(96)70155-5; Bellamy R, 1996, CRIT CARE MED, V24, pS24; BERKEBILE P, 1976, CRIT CARE MED, V4, P134; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BIRCHER N, 1985, CRIT CARE MED, V13, P185, DOI 10.1097/00003246-198503000-00009; BIRCHER N, 1984, ANN EMERG MED, V13, P770, DOI 10.1016/S0196-0644(84)80432-1; BIRCHER NG, 1995, COMPREHENSIVE RESP C; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; BOSSAERT L, 1992, RESUSCITATION, V24, P211, DOI 10.1016/0300-9572(92)90181-B; BROWN CG, 1986, ANN EMERG MED, V15, P1138, DOI 10.1016/S0196-0644(86)80853-8; CAPONE A, IN PRESS J TRAUMA; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; CRAIG MT, 1994, RESUSCITATION, V28, pS39; CRIPPEN D, 1991, RESUSCITATION, V21, P271, DOI 10.1016/0300-9572(91)90052-Z; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; DELGUERCIO LR, 1965, CIRCULATION, V31, P171; Ebmeyer U, 1996, CRIT CARE MED, V24, pS95; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; ELAM JO, 1954, NEW ENGL J MED, V250, P749, DOI 10.1056/NEJM195405062501801; Gisvold SE, 1996, CRIT CARE MED, V24, pS69; GORDON AS, 1951, JAMA-J AM MED ASSOC, V147, P1444, DOI 10.1001/jama.1951.73670320008014; GRENVIK A, 1978, CRIT CARE MED, V6, P284, DOI 10.1097/00003246-197807000-00009; IBSEN B, 1954, P ROY SOC MED, V47, P72, DOI 10.1177/003591575404700120; IDRIS AH, 1994, ANN EMERG MED, V23, P9, DOI 10.1016/S0196-0644(94)70001-X; JENNINGS RB, 1988, CRIT CARE MED, V16, P988, DOI 10.1097/00003246-198810000-00010; JUDE JR, 1961, JAMA-J AM MED ASSOC, V178, P1063, DOI 10.1001/jama.1961.03040500005002; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; KIM SH, 1995, ACAD EMERG MED, V2, P364; KOCHANEK PM, 1995, CENTRAL NERVOUS SYST, P247; KOEHLER RC, 1996, CARDIAC ARREST SCI P, P113; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; LENFANT C, 1995, AM J RESP CRIT CARE, V151, P243, DOI 10.1164/ajrccm.151.1.7812561; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LEONOV Y, 1995, ACAD EMERG MED, V2, P401; LUND I, 1968, ACTA ANAESTH SCAND S, V29, P1; Marion DW, 1996, CRIT CARE MED, V24, pS81; MULLIE A, 1988, LANCET, V1, P137; NEGOVSKY VA, 1982, CRIT CARE MED, V10, P130; NEGOVSKY VA, 1983, POSTRESUSCITATION DI; NEMOTO EM, 1977, STROKE, V8, P558, DOI 10.1161/01.STR.8.5.558; NILSSON E, 1951, Acta Med Scand Suppl, V253, P1; NITATORI T, 1995, J NEUROSCI, V15, P1001; OTTO CW, 1985, CRIT CARE MED, V13, P881, DOI 10.1097/00003246-198511000-00001; PARADIS N, 1995, CARDIAC ARREST; PARSLOE C, 1994, J CLIN MONITOR, V10, P147, DOI 10.1007/BF02908854; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; POULSEN H, 1961, ACTA ANAESTH SCAND S, V9, P1; RADOVSKY A, 1995, STROKE, V26, P2127, DOI 10.1161/01.STR.26.11.2127; REDDING JS, 1981, CRIT CARE MED, V9, P357, DOI 10.1097/00003246-198105000-00001; REICH H, 1990, ANN EMERG MED, V19, P887, DOI 10.1016/S0196-0644(05)81562-8; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; S. P, 1989, CARDIOPULMONARY RESU, P1; SAFAR P, 1990, AM J EMERG MED, V8, P55, DOI 10.1016/0735-6757(90)90298-E; SAFAR P, 1961, JAMA-J AM MED ASSOC, V176, P574, DOI 10.1001/jama.1961.03040200010003; SAFAR P, 1959, J APPL PHYSIOL, V14, P760, DOI 10.1152/jappl.1959.14.5.760; SAFAR P, 1993, ANN EMERG MED, V22, P324, DOI 10.1016/S0196-0644(05)80463-9; SAFAR P, 1958, NEW ENGL J MED, V258, P671, DOI 10.1056/NEJM195804032581401; SAFAR P, 1988, CRIT CARE MED, V16, P919; Safar P, 1996, CRIT CARE MED, V24, pS1; SAFAR P, 1959, J APPL PHYSIOL, V14, P84, DOI 10.1152/jappl.1959.14.1.84; Safar P, 1974, Crit Care Med, V2, P1, DOI 10.1097/00003246-197401000-00001; SAFAR P, 1981, CRIT CARE MED, V9, P403; SAFAR P, 1978, CRIT CARE MED, V6, P199, DOI 10.1097/00003246-197807000-00001; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; SAFAR P, 1974, ANAESTHESIST, V23, P507; SAFAR P, 1962, Arch Phys Med Rehabil, V43, P487; Safar P, 1996, CRIT CARE MED, V24, pS3; SAFAR P, 1994, RESUSCITATION, V28, P175, DOI 10.1016/0300-9572(94)90106-6; SAFAR P, 1994, INT RES RES C INTR P; SAFAR P, 1982, PROTECTION TISSUES H, P147; SAFAR P, 1991, ACTA ANAESTHESIO S96, V35, P147; SAFAR P, 1995, CARDIAC ARREST SCI P, P859; SAFAR P, 1995, CARDIAC ARREST SCI P, P702; SAFAR P, 1963, ANESTHESIOLOGY RESUS, V1; SAFAR P, 1960, INTRO PROLONGED ARTI; SAFAR P, 1960, INTRO RESP CARDIAC R; SAFAR P, 1992, PRINCIPLES PRACTICE, V1, P3; SAFAR P, 1995, TXB CRITICAL CARE; Safar P, 1984, MAJOR ISSUES CRITICA, P71; Safar PBN, 1988, CARDIOPULMONARY CERE; Shoemaker W C, 1975, Crit Care Med, V3, P1, DOI 10.1097/00003246-197501000-00001; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; SHOEMAKER WC, 1995, TXB CRITICAL CARE; STEPHENSON HE, 1953, ANN SURG, V137, P731, DOI 10.1097/00000658-195305000-00015; STERZ F, 1990, STROKE, V21, P1178, DOI 10.1161/01.STR.21.8.1178; STERZ F, 1989, ANESTHESIOLOGY, V71, P907, DOI 10.1097/00000542-198912000-00014; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Thompson WL, 1996, CRIT CARE MED, V24, pS90; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; VAAGENES P, 1984, CRIT CARE MED, V12, P846, DOI 10.1097/00003246-198410000-00002; Vaagenes P, 1996, CRIT CARE MED, V24, pS57; VANDENHOEK TL, 1992, ANN EMERG MED, V21, P623; WANZER SH, 1984, NEW ENGL J MED, V310, P955, DOI 10.1056/NEJM198404123101505; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Weil M H, 1973, Crit Care Med, V1, P1, DOI 10.1097/00003246-197301000-00001; WHITE BC, 1991, FREE RADICAL BIO MED, V10, P125, DOI 10.1016/0891-5849(91)90006-O; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7; XIAO F, 1994, RESUSCITATION, V28, pS36; 1968, JAMA-J AM MED ASSOC, V204, P595; 1973, CRIT CARE MED, V1, P39; [No title captured]; 1992, RESUSCITATION, V24, P1; 1972, JAMA-J AM MED ASSOC, V222, P1532	113	9	9	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	MAY	1996	27	5					542	552		10.1016/S0196-0644(96)70156-7			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	UJ065	WOS:A1996UJ06500002	8629774				2022-02-06	
J	Croce, R; Horvat, M; Roswal, G				Croce, R; Horvat, M; Roswal, G			Augmented feedback for enhanced skill acquisition in individuals with traumatic brain injury	PERCEPTUAL AND MOTOR SKILLS			English	Article							KNOWLEDGE	Coincident timing by individuals who exhibit traumatic brain injury was measured under conditions of no knowledge of results (no KR; n=12), KR on every trial (n=14), summary KR (n=13), and average KR (n=12). Following acquisition trials, groups performed immediate and longer retention trials without KR. Absolute constant error and variable error, analyzed in separate repeated-measures analyses of variance, indicated that during acquisition trials subjects receiving KR on every trial were the most accurate and the most consistent in their responses; however, subjects in groups receiving summary and average KR were the most accurate during immediate retention, with the group receiving summary KR being the most accurate during longer retention.	JACKSONVILLE STATE UNIV, JACKSONVILLE, AL 36265 USA; UNIV GEORGIA, ATHENS, GA 30602 USA		Croce, R (corresponding author), UNIV NEW HAMPSHIRE, DEPT KINESIOL, NEW HAMPSHIRE HALL, 124 MAIN ST, DURHAM, NH 03824 USA.						Bruininks, 1978, BRUININKS OSERETSKY; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; GABLE CD, 1991, RES Q EXERCISE SPORT, V62, P285, DOI 10.1080/02701367.1991.10608725; GROCE R, 1995, PERCEPT MOTOR SKILL, V80, P487, DOI 10.2466/pms.1995.80.2.487; JENNETT B, 1975, LANCET, V1, P480; KRIZ G, 1995, ARCH PHYS MED REHAB, V76, P653, DOI 10.1016/S0003-9993(95)80635-0; SALADIN LS, 1994, PHYSICAL THERAPY S, V74, pS122; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; SCHMIDT RA, 1990, HUM MOVEMENT SCI, V9, P325, DOI 10.1016/0167-9457(90)90007-Z; SCHMIDT RA, 1989, J EXP PSYCHOL LEARN, V15, P352, DOI 10.1037/0278-7393.15.2.352; SWINNEN SP, 1990, J EXP PSYCHOL LEARN, V16, P706, DOI 10.1037/0278-7393.16.4.706; WEEKS DL, 1994, RES Q EXERCISE SPORT, V65, P136, DOI 10.1080/02701367.1994.10607608; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WINSTEIN CJ, 1994, RES Q EXERCISE SPORT, V65, P316, DOI 10.1080/02701367.1994.10607635; WRISBERG CA, 1983, AM J MENT DEF, V87, P627; YAO WX, 1994, J MOTOR BEHAV, V26, P273, DOI 10.1080/00222895.1994.9941683; [No title captured]	17	9	9	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	APR	1996	82	2					507	514		10.2466/pms.1996.82.2.507			8	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	UF269	WOS:A1996UF26900027	8724923				2022-02-06	
J	Denys, P; Azouvi, P; Denormandie, P; Samuel, C; Patel, A; Bussel, B				Denys, P; Azouvi, P; Denormandie, P; Samuel, C; Patel, A; Bussel, B			Late cognitive and behavioural improvement following treatment of disabling orthopaedic complications of a severe closed head injury	BRAIN INJURY			English	Article							SCALE	Interactions of physical, emotional, cognitive and behavioural impairments after severe closed head injury (CHI) remain poorly understood. A 47-year-old man was referred to our department 13 months after a severe CHI. He demonstrated severe left hemiplegia and disabling orthopaedic complications (left hip infectious arthritis, after surgical treatment for heterotopic ossification). His hip was blocked and extremely painful. He was totally dependent for daily-life activities (Functional Independence Measure (FIM) score = 18). Moreover he exhibited severe cognitive and behavioural troubles, which had been stable for many months beforehand, e.g. complete disorientation for time and place, major memory disorders, agitation, anxiety, depression, irritability, disinhibition, aggressiveness and lack of initiative. Pain disappeared within a few weeks after treatment. Progressively, functional improvement occurred (sitting position, transfers, walking between parallel bars). The FIM score increased to 63. Aggressiveness, irritability and agitation disappeared. Surprisingly, neuropsychological assessment demonstrated parallel improvement of cognitive functions, especially in regard to orientation, and to a lesser degree attention and memory. Such an observation should encourage use of active treatment of physical disabilities, even in patients presenting with an apparently poor cognitive prognosis at a late stage of severe CHI.	CHU PARIS OUEST,SERV REEDUCAT NEUROL,HOP RAYMOND POINCARE,F-92380 GARCHES,FRANCE; CHU PARIS OUEST,SERV CHIRURG ORTHOPED,HOP RAYMOND POINCARE,F-92380 GARCHES,FRANCE					DENYS, Pierre/0000-0002-4831-6499			GRANGER CV, 1986, GUIDE USE UNIFORM DA; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Signoret JL, 1991, BATTERIE EVALUATION; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398	7	9	9	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					149	153		10.1080/026990596124656			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600010	8696316				2022-02-06	
J	Anderson, SD				Anderson, SD			Postconcussional disorder and loss of consciousness	BULLETIN OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							HEAD-INJURY; POSTTRAUMATIC AMNESIA	Postconcussional disorder (PCD) has been described in the psychiatric, neurological, neuropsychological, and rehabilitation medicine literature for many years. PCD has recently been introduced into DSM-IV, appearing in an appendix that contains a number of proposals for new categories and axes that were suggested for possible inclusion in DSM-IV. There are some major difficulties with the proposed criteria for PCD. This article explores some of these difficulties, particularly focusing on the criteria of loss of consciousness (LOG). A review of the literature demonstrates that LOC is not necessary for PCD to occur. The major difficulty with the DSM-IV criteria is the definition of concussion. The article suggests that, instead, the criteria for mild traumatic brain injury, as defined by the American Congress of Rehabilitation Medicine, may be more appropriate.			Anderson, SD (corresponding author), UNIV BRITISH COLUMBIA,FAC MED,DEPT PSYCHIAT,204-2775 HEATHER ST,VANCOUVER,BC V5Z 1M9,CANADA.						ALEXANDER M.P, 1984, NEUROL NEUROSURG, V5, p[20, 1]; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P704; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P146; ANDERSON SD, 1995, CAN J DIAGN, V12, P77; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; BELL SD, 1992, MED LEGAL ASSESSMENT, P196; BINDER LM, 1989, FRONTIERS CLIN NEURO, V7, P37; CAMPBELL RJ, 1981, PSYCHIAT DICT, P129; Evans RW., 1992, PROGNOSIS NEUROLOGIC, P97; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GORDON B, 1990, CURRENT THERAPY NEUR, V3, P208; Gronwall D, 1989, MILD HEAD INJURY, P153; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HUMANYUN MS, 1989, NUCL MED COMMUN, V10, P355; JENNETT B, 1989, MILD HEAD INJURY, P24; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; LENNINGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P170; McAllister Thomas W., 1994, P357; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	34	9	9	0	1	AMER ACAD PSYCHIATRY LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002	0091-634X			B AM ACAD PSYCH LAW	Bull. Amer. Acad. Psychiat. Law		1996	24	4					493	504					12	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	WB050	WOS:A1996WB05000005	9001747				2022-02-06	
J	Donders, J				Donders, J			Validity of short forms of the intermediate Halstead Category Test in children with traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								The validities of three of Reeder and Boll's (1992) short forms of the intermediate version of the Halstead Category Test (IHCT) were evaluated in a sample of 87 children with traumatic brain injury. All three short forms had acceptable relationships with length of coma. A short form that was based on the first 15 items of every IHCT subtest appeared to be relatively superior to the other forms in terms of discriminating between groups of mild/moderate vs. severe injuries. It was concluded that this short form may be an accurate and valid alternative to the full-length IHCT in children with traumatic brain injury.			Donders, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						BOLL T, 1993, CHILDRENS CATEGORY T; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; JARVIS P, 1994, HALSTEAD REITAN TEST; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; REEDER KP, 1992, ARCH CLIN NEUROPSYCH, V7, P53, DOI 10.1016/0887-6177(92)90018-I; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; [No title captured]; [No title captured]	13	9	9	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1996	11	2					131	137		10.1016/0887-6177(95)00005-4			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TT914	WOS:A1996TT91400004	14588913	Bronze			2022-02-06	
J	Molteni, F				Molteni, F			Botulinum toxin and rehabilitation programs in lower limb spasticity	EUROPEAN JOURNAL OF NEUROLOGY			English	Article; Proceedings Paper	2nd Botulinum Toxin Symposium - Dystonia and Beyond	MAR 18-19, 1995	CANNES, FRANCE	Allergan		spasticity; neuromuscular block; Botulinum toxin A; gait analysis; rehabilitation; stroke		In order to improve the efficacy of neuromuscular block, induced by Botulinum toxin A, in the treatment of lower limb spasticity due to stroke or traumatic brain injury, we used a protocol of combined Botulinum toxin A injections and rehabilitation programs. The evaluation consisted of a speed walk (50 m) during which the following were observed: a video of the walk, dynamic EMG, ground reaction forces analysis and 3-dimensional kinematic analysis. The following treatments were administered: Botulinum toxin A 200 units (Allergan) in two to three target muscles selected by dynamic EMG; taping was put on for 5 days to stretch the injected muscles; orthoses; and training to improve the weight transfer control, stride length and foot contact. We observed a functional improvement in 80% of 40 patients treated; the mean duration of the functional effect was 9 months. We conclude that the association of Botulinum toxin A injection with a rehabilitation program allows the patient to obtain, by small dosages, useful functional results with long-lasting duration.	DEPT PHYS MED & REHABIL,COMO,ITALY								Brin M F, 1991, Arch Neurobiol (Madr), V54 Suppl 3, P7; COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P379; DAS TK, 1989, BRIT J CLIN PRACT, V43, P401; HUGHES R, 1962, J PHYSL, V22, P124; REIMERS J, 1994, CLIN ORTHOP RELAT R, V253, P30; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; THILMANN AF, 1991, BRAIN, V114, P233	7	9	9	0	9	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1351-5101			EUR J NEUROL	Eur. J. Neurol.	NOV	1995	2			3			61	67					7	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU596	WOS:A1995TU59600011					2022-02-06	
J	SANDEL, ME; ZWIL, AS; FUGATE, LP				SANDEL, ME; ZWIL, AS; FUGATE, LP			AN INTERDISCIPLINARY PERSPECTIVE ON THE AGITATED BRAIN-INJURED PATIENT	NEUROREHABILITATION			English	Article						BRAIN INJURY; HEAD INJURY; DELIRIUM; PSYCHOMOTOR AGITATION; PSYCHOPHARMACOLOGY	DISABILITY RATING-SCALE; CLOSED HEAD-INJURY; PRACTICAL SCALE; DELIRIUM; COMA; ORIENTATION; RECOVERY; DRUGS; PREDICTION; ADMISSIONS	The Special Interest Group on Brain Injury of the American Academy of Physical Medicine and Rehabilitation is developing a practice parameter for the agitated patient following traumatic brain injury (TBI). The eventual goal of the project is to create an interdisciplinary practice guideline for classifying and treating these patients using a common nosology, based on contributions from the literatures of neurosurgery, psychology, psychiatry and rehabilitation medicine. It is envisioned that a uniform classification system would ultimately promote interdisciplinary research and serve to advance our understanding and treatment of this patient population. In the acute post-injury period, many TBI patients can be characterized by confusion, agitation, post-traumatic amnesia and delirium. In various acute care settings, psychiatrists, psychologists or rehabilitation medicine physicians (physiatrists) are asked to evaluate and treat this population of patients. Each of these disciplines employ specialty-based diagnostic criteria and rating instruments, with little or no consensus across disciplines concerning the appropriateness of these tools. This article reviews the classification and rating systems utilized within the fields of neurosurgery, rehabilitation medicine, psychology and psychiatry, to describe patients displaying agitated behaviors. The authors review the literature establishing the definitions, measurement and possible neuroanatomic and neurophysiologic substrate for delirium and brain-injury agitation, with its characteristic cognitive and behavioral manifestations. Pharmacologic treatment is briefly reviewed to emphasize the significantly different viewpoints from the fields of rehabilitation medicine and psychiatry. The authors explore support from the literature for an interdisciplinary definition for agitation following TBI which includes criteria for delirium, post-traumatic amnesia, and associated behavioral excesses such as disinhibition, aggression, or emotional lability. Wide acceptance of this definition by medical and research professionals may potentially lead to a greater understanding of this clinical state and its neuropathogenesis through promotion of intra- and inter-disciplinary research.	THOMAS JEFFERSON UNIV HOSP,DEPT PSYCHIAT & HUMAN BEHAV,COMPREHENS NEUROPSYCHIAT PROGRAM,PHILADELPHIA,PA 19107; OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH; OHIO STATE UNIV,DEPT PREVENT MED,COLUMBUS,OH 43210		SANDEL, ME (corresponding author), UNIV PENN,SCH MED,DEPT REHABIL MED,DIV NEUROREHABIL,PHILADELPHIA,PA 19104, USA.						Albert M S, 1992, J Geriatr Psychiatry Neurol, V5, P14; American Psychiatric Association, DIAGN STAT MAN MENT, V4a; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; BOYESON MG, 1994, J HEAD TRAUMA REHAB, V9, P78, DOI 10.1097/00001199-199409000-00007; BRAUDE WM, 1983, BRIT J PSYCHIAT, V143, P139, DOI 10.1192/bjp.143.2.139; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CASSIDY JW, 1994, J HEAD TRAUMA REHAB, V9, P43, DOI 10.1097/00001199-199409000-00005; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; CUMMINGS JL, 1990, SUBCORTICAL DEMENTIA, P251; DAVIS JM, 1977, DRUGS, V14, P260, DOI 10.2165/00003495-197714040-00002; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; FEENY DM, 1982, SCIENCE, V127, P855; FINKEL SI, 1993, J AM GERIATR SOC, V41, P50, DOI 10.1111/j.1532-5415.1993.tb05948.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GERNER RH, 1976, AM J PSYCHIAT, V133, P1177; GLENN MB, 1986, J HEAT TRAUMA REHABI, V4, P74; GOLDSTEIN LB, 1990, J NEURO REHAB, V4, P137; GOODWIN FK, 1971, SEMIN PSYCHIAT, V3, P477; Hagen C, 1979, REHABILITATION HEAD, P87; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Haskovec L., 1902, ARCH BOHEMES MED CLI, V3, P193; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; ITIL T, 1966, J NERV MENT DIS, V143, P492, DOI 10.1097/00005053-196612000-00005; JACKSON RD, 1989, ARCH PHYS MED REHAB, V70, P33; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levkoff S, 1991, Int Psychogeriatr, V3, P253, DOI 10.1017/S1041610291000716; Lipowski ZJ, 1980, DELIRIUM ACUTE BRAIN; Lipowski ZJ., 1990, DELIRIUM ACUTE CONFU; LIPTZIN B, 1993, J NEUROPSYCH CLIN N, V5, P154; MARSDEN CD, 1980, PSYCHOL MED, V10, P55, DOI 10.1017/S003329170003960X; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; MURRAY GB, 1991, MASSACHUSETTS GENERA, P89; MURRY GB, 1991, MASSACHUSETTS GENERA, P121; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PLATT MM, 1994, J NEUROPSYCH CLIN N, V6, P66; PLUM F, 1980, DIAGNOSIS STUPOR COM, P4; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSEN J, 1994, J NEUROPSYCH CLIN N, V6, P30; Sicard JA, 1923, PRESSE MED, V31, P265; SINHA D, 1992, PSYCHIAT RES, V41, P73, DOI 10.1016/0165-1781(92)90020-4; SPITZER RL, 1980, AM PSYCHIATRIC ASS D; STRUB RL, 1988, NEUROBEHAVIORAL DISO, P106; TAYLOR D, 1993, J NEUROL NEUROSUR PS, V56, P742, DOI 10.1136/jnnp.56.7.742; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; TRZEPACZ PT, 1994, PSYCHOSOMATICS, V35, P374, DOI 10.1016/S0033-3182(94)71759-X; TUCKER GJ, 1992, J NEUROPSYCH CLIN N, V4, P360; VANPUTTEN T, 1974, ARCH GEN PSYCHIAT, V31, P67; WOOD RL, 1987, BRAIN INJURY REHABIL, P1; World Health Organisation, 1992, INT CLASS DIS; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	62	9	9	0	7	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	OCT	1995	5	4					299	308		10.1016/1053-8135(95)00129-8			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ211	WOS:A1995TJ21100003	24525574				2022-02-06	
J	HEDRICK, WP; PICKELMAN, HL; WALKER, W				HEDRICK, WP; PICKELMAN, HL; WALKER, W			ANALYSIS OF DEMOGRAPHIC AND FUNCTIONAL SUBACUTE (TRANSITIONAL) REHABILITATION DATA	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; CLINICAL EXAMINATION; BASAL CISTERNS; FOLLOW-UP; PROGNOSIS; BRAIN; SCALE; COMA; CONSCIOUSNESS; PRESSURE	Demographic and functional data were obtained on 102 patients from three subacute rehabilitation units specializing in low-level traumatic brain injury (TBI) patients. Functional assessment evaluation was performed using the Disability Rating Scale (DRS). The average admission and discharge DRS scores were 17.4 and 13.6, respectively. On average this patient population improved from an extremely severe level of disability to a severe level. The TBI patient subset improved on average from 20.4 to 13.1. Significant correlation exists between admission, discharge, and differential DRS scores, as has been demonstrated previously in the evaluation of this scale among only TBI patients. No significant correlation was demonstrated between demographic information and DRS scores. Thus, no demographic predictors of good or bad functional outcome were identified. In addition, analyses of relationships between diagnosis, length of stay, and age will provide information about subactute rehabilitation, an emerging but little-studied branch of rehabilitation medicine.	VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,RICHMOND,VA; IIT,CHICAGO,IL								ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; BAKER CC, 1986, AM J SURG, V148, P483; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; LEURSSEN TG, 1988, J NEUROSURG, V68, P409; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OVERGAARD J, 1973, LANCET, V2, P631; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TIMMING R, 1982, ARCH PHYS MED REHAB, V63, P154; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; WILLIAMS JM, 1984, J NEUROSURG, V66, P875	37	9	9	0	1	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG-SEP	1995	9	6					563	573		10.3109/02699059509008215			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	RU016	WOS:A1995RU01600003	7581352				2022-02-06	
J	OMARA, NB; JONES, PR; ANGLIN, DL; COX, S; NAHATA, MC				OMARA, NB; JONES, PR; ANGLIN, DL; COX, S; NAHATA, MC			PHARMACOKINETICS OF PHENYTOIN IN CHILDREN WITH ACUTE NEUROTRAUMA	CRITICAL CARE MEDICINE			English	Article						PHENYTOIN; PHARMACOKINETICS; DRUG METABOLISM; PROTEIN BINDING; DRUG DOSAGE; NEUROLOGIC INJURY; PEDIATRICS; INTENSIVE CARE UNIT, PEDIATRIC; CRITICAL ILLNESS; NEUROLOGIC EMERGENCIES	BAYESIAN REGRESSION-ANALYSIS; ANALYSIS COMPUTER-PROGRAM; HEPATIC DRUG CLEARANCE; ILL TRAUMA PATIENTS; PEDIATRIC-PATIENTS; UNBOUND PHENYTOIN; PERFORMANCE; INJURY	Objective: To determine the pharmacokinetics of intravenous phenytoin in critically ill infants and children with acute neurologic injury. Design: A prospective, descriptive study. Setting: A pediatric intensive care unit. Patients: Sixteen children, 0.5 to 16 yrs of age (mean 7.6), with various types of acute neurologic injuries, receiving intravenous phenytoin therapy. Interventions: Blood samples were collected to measure total and free phenytoin concentrations in plasma, A 24-hr urine collection was made to determine the concentrations of the major metabolite of phenytoin. Measurements and Main Results: In 12 children who survived the acute illness, a lower-than-predicted Michaelis-Menten constant (K-m) and higher-than-predicted maximum rate of metabolism (V-max) were observed. Initial free phenytoin fractions ranged between 0.08 and 0.15, In the eight patients who had additional free fractions measured, six patients demonstrated an increase (9.1% to 34% increase) in free fraction, while two patients demonstrated a decrease (1.8% and 19.8% decrease) in free fraction. The ratio of amount of phenytoin to phenytoin plus 5-(p-hydroxyphenyl)-5-phenylhydantoin excreted in the urine in a 24-hr urine collection demonstrated a wide interpatient variability. There was no correlation in the difference between the predicted and calculated K-m and V-max values and Glasgow Coma Score, circulating albumin concentration, or concomitant medications. Conclusion: Based on the average R(m) and V-max values of the children enrolled in our study, it appears that children with neurologic injury between the ages of 0.5 and 9 yrs may require dosages of at least 8 to 10 mg/kg/day, and children aged 10 to 16 yrs may require 6 to 8 mg/kg/day to attain therapeutic phenytoin concentrations.	OHIO STATE UNIV,COLL PHARM,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,COLUMBUS,OH 43210; CHILDRENS HOSP,COLUMBUS,OH 43205								ARGYLE JC, 1984, THER DRUG MONIT, V6, P117, DOI 10.1097/00007691-198403000-00019; BAHAL N, 1993, J LIQ CHROMATOGR, V16, P1135, DOI 10.1080/10826079308019576; BAUER LA, 1983, CLIN PHARMACOKINET, V8, P545, DOI 10.2165/00003088-198308060-00006; BAUER LA, 1983, J TRAUMA, V23, P1058, DOI 10.1097/00005373-198312000-00007; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; BURTON ME, 1985, CLIN PHARMACOKINET, V10, P1, DOI 10.2165/00003088-198510010-00001; CHANG T, 1982, ANTIEPILEPTIC DRUGS, P209; DICKINSON RG, 1985, THER DRUG MONIT, V7, P283, DOI 10.1097/00007691-198507030-00008; GODLEY PJ, 1987, CLIN PHARMACY, V6, P634; GREENE MG, 1991, HARRIET LANE HDB MAN; GRIEBEL ML, 1990, CRIT CARE MED, V18, P385, DOI 10.1097/00003246-199004000-00007; KENNEDY CR, 1986, J HEAD TRAUMA REHAB, V1, P66; KILLILEA T, 1989, THER DRUG MONIT, V11, P455; KUTT H, 1971, ANN NY ACAD SCI, V179, P704, DOI 10.1111/j.1749-6632.1971.tb46946.x; LUDDEN TM, 1986, CLIN PHARMACY, V5, P580; NATION RL, 1990, CLIN PHARMACOKINET, V18, P131, DOI 10.2165/00003088-199018020-00004; NATION RL, 1990, CLIN PHARMACOKINET, V18, P37, DOI 10.2165/00003088-199018010-00003; PYRKA RD, 1991, CLIN PHARMACOKINET, V20, P209; REILLY PL, 1988, CHILD NERV SYST, V4, P30; SLAUGHTER RL, 1985, DRUG INTEL CLIN PHAR, V19, P799, DOI 10.1177/106002808501901101; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WANWIMOLRUK S, 1991, THER DRUG MONIT, V13, P443, DOI 10.1097/00007691-199109000-00009; WINTER ME, 1986, APPLIED PHARMACOKINE, P493; YOUNG B, 1979, EPILEPSIA, V20, P671, DOI 10.1111/j.1528-1157.1979.tb04851.x	26	9	9	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0090-3493			CRIT CARE MED	Crit. Care Med.	AUG	1995	23	8					1418	1424		10.1097/00003246-199508000-00017			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN414	WOS:A1995RN41400017	7634814				2022-02-06	
J	BLANCAFORT, JB; MARCO, MO; PUIG, JMP; GARCIA, ER; BARA, PN; BERENGUER, JI				BLANCAFORT, JB; MARCO, MO; PUIG, JMP; GARCIA, ER; BARA, PN; BERENGUER, JI			PREDICTIVE VALUE OF BRAIN-STEM AUDITORY-EVOKED POTENTIALS IN CHILDREN WITH POSTTRAUMATIC COMA PRODUCED BY DIFFUSE BRAIN INJURY	CHILDS NERVOUS SYSTEM			English	Article						CHILDREN; HEAD INJURY; EVOKED POTENTIALS; DIFFUSE BRAIN INJURY; INTRACRANIAL PRESSURE	SEVERE HEAD-INJURY; CLINICAL MEDICINE; RESPONSES; DYSFUNCTION; MIDDLE; PROGNOSIS; RECOVERY; DEATH; SCALE	In the present study, brain-stem auditory evoked potentials (BAEPs) in 31 children in posttraumatic coma with diffuse brain injury were examined. The BAEPs were recorded in the first 72 h after hospital admission and the findings of 29 patients related to the level of neurological recovery at 6 months after head injury. On the basis of the results, children were divided into three groups: the first consisted of children with bilateral and normal BAEPs (n=19); the second of those with asymmetrical BAEPs (n=6); and the third of those in whom BAEPs had disappeared or in whom only responses of the seventh cranial nerve and cochlear nucleus were recorded (n=4). All the patients in the first group presented a good clinical outcome, with excellent recovery in 80%. In the second group three children (42.8%) had a good recovery, two (28.6%) were moderately disabled and one (14.3%) died of extraneurological causes. All the patients in the third group died. Abnormal BAEPs showed a significant correlation with absence of pupillary and/or corneal reflex, but not with the Glasgow Coma Score and anisocoria. Good statistical correlation was observed between normal BAEPs and visualization of basal cisterns on computed tomographic scan. The incidence of increased intracranial pressure was higher in patients with abnormal BAEPs, but the differences were not significant (P=0.06). Our study confirms the predictive value of BAEPs in children's post-traumatic coma due to diffuse brain injury.	HOSP UNIV MATERNOINFANTIL,DEPT NEUROPHYSIOL,E-08035 BARCELONA,SPAIN; HOSP UNIV MATERNOINFANTIL,DEPT NEUROSURG,E-08035 BARCELONA,SPAIN; HOSP UNIV MATERNOINFANTIL,DEPT PEDIAT INTENS CARE UNIT,E-08035 BARCELONA,SPAIN								BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; Bricolo A, 1990, HDB CLIN NEUROLOGY, V13, P181; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1205, DOI 10.1056/NEJM198205203062004; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1140, DOI 10.1056/NEJM198205133061904; FACCO E, 1986, CHILD NERV SYST, V2, P67; GANES T, 1983, J NEUROL NEUROSUR PS, V46, P509, DOI 10.1136/jnnp.46.6.509; Geets W, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P253, DOI 10.1016/S0370-4475(83)80036-7; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HALL JW, 1985, INT J PEDIATR OTORHI, V9, P201, DOI 10.1016/S0165-5876(85)80036-7; HALL JW, 1982, LARYNGOSCOPE, V92, P883; HALL JW, 1985, ARCH OTOLARYNGOL, V111, P613; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; JENNETT B, 1975, LANCET, V1, P480; KAGA K, 1985, LARYNGOSCOPE, V95, P321; KARNAZE DS, 1985, NEUROLOGY, V35, P1122, DOI 10.1212/WNL.35.8.1122; KARNAZE DS, 1982, NEUROLOGY, V32, P299, DOI 10.1212/WNL.32.3.299; KLUG N, 1982, J NEUROL, V227, P219, DOI 10.1007/BF00313389; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; MAHAPATRA AK, 1987, ACTA NEUROCHIR, V87, P19; NAGAO S, 1983, INTRACRANIAL PRESSUR, V5, P474; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; OTTAVIANI F, 1986, ELECTROEN CLIN NEURO, V65, P196, DOI 10.1016/0168-5597(86)90054-7; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PAPANICOLAOU AC, 1986, NEUROSURGERY, V18, P173, DOI 10.1227/00006123-198602000-00009; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUMPL E, 1988, J CLIN NEUROPHYSIOL, V5, P237, DOI 10.1097/00004691-198807000-00002; SAHUQUILLO J, 1985, THESIS U AUTONOMA BA; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SEALES DM, 1979, J TRAUMA, V19, P347, DOI 10.1097/00005373-197905000-00008; STOCKARD JJ, 1978, ANN NEUROL, V3, P368, DOI 10.1002/ana.410030416; STONE JL, 1988, J CLIN NEUROPHYSIOL, V5, P135, DOI 10.1097/00004691-198804000-00002; TEASDALE G, 1974, LANCET, V2, P81; TSUBOKAWA T, 1980, J NEUROL NEUROSUR PS, V43, P1005, DOI 10.1136/jnnp.43.11.1005; UYSAL S, 1993, CHILD NERV SYST, V9, P88, DOI 10.1007/BF00305314; UZIEL A, 1978, ELECTROEN CLIN NEURO, V45, P515, DOI 10.1016/0013-4694(78)90295-X; YAGI T, 1983, ARCH OTO-RHINO-LARYN, V238, P33, DOI 10.1007/BF00453739; 1984, J CLIN NEUROPHYSIOL, V1, P3	40	9	9	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUL	1995	11	7					400	405		10.1007/BF00717405			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RJ664	WOS:A1995RJ66400008	7585668				2022-02-06	
J	PERSINGER, MA; RICHARDS, PM				PERSINGER, MA; RICHARDS, PM			FOOT AGILITY AND TOE GNOSIS GRAPHAESTHESIA AS POTENTIAL INDICATORS OF INTEGRITY OF THE MEDIAL CEREBRAL SURFACE - NORMATIVE DATA AND COMPARISON WITH CLINICAL POPULATIONS	PERCEPTUAL AND MOTOR SKILLS			English	Article							SEIZURES	A protocol was designed to identify quantitative indicators of the function of the medial surfaces of the cerebral hemispheres. Normative data were collected from 40 volunteers for foot agility, toe gnosis, and toe graphaesthesia. A total of 100 patients (most of whom had been referred for possible closed-head injuries) completed thorough neuropsychological and cognitive assessments. Deficits for toe graphaesthesia were most consistently correlated with general brain impairment and with scores for tasks whose normal performance requires the integrity of structures within the dorsal half of the medial cerebral hemispheres.			PERSINGER, MA (corresponding author), LAURENTIAN UNIV,CLIN NEUROPSYCHOL LAB,RAMSEY LAKE RD,SUDBURY,ON P3E 2C6,CANADA.						CARPENTER MB, 1983, HUMAN NEUROANATOMY; FERGUSON GA, 1959, STATISTICAL ANAL PSY; Kolb B., 1990, FUNDAMENTALS HUMAN N; MASDEU JC, 1990, LOCALIZATION CLIN NE, P361; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; MUSIEK FE, 1986, EAR HEARING, V7, P349, DOI 10.1097/00003446-198612000-00001; PAWLIK G, 1990, NEUROPSYCHOLOGICAL F, P65; PERSINGER MA, 1993, PHYSIOL BEHAV, V53, P849, DOI 10.1016/0031-9384(93)90261-D; PERSINGER MA, 1993, PERCEPT MOTOR SKILL, V76, P915, DOI 10.2466/pms.1993.76.3.915; PERSINGER MA, 1994, PHYSIOL BEHAV, V56, P225, DOI 10.1016/0031-9384(94)90188-0; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; PETERS M, 1990, Neuropsychology Review, V1, P165, DOI 10.1007/BF01108716; Reitan RM, 1985, HALSTEADREITAN NEURO; RICHARDS P, 1992, PERCEPT MOTOR SKILL, V74, P1027, DOI 10.2466/PMS.74.4.1027-1030; ROBERTS RJ, 1990, J CLIN EXP NEUROPSYC, V12, P448, DOI 10.1080/01688639008400992; [No title captured]	16	9	9	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	1995	80	3	1				1011	1024		10.2466/pms.1995.80.3.1011			14	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	RG588	WOS:A1995RG58800045	7567379				2022-02-06	
J	RAMSAY, DA; SHKRUM, MJ				RAMSAY, DA; SHKRUM, MJ			HOMICIDAL BLUNT HEAD TRAUMA, DIFFUSE AXONAL INJURY, ALCOHOLIC INTOXICATION, AND CARDIORESPIRATORY ARREST - A CASE-REPORT OF A FORENSIC SYNDROME OF ACUTE BRAIN-STEM DYSFUNCTION	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						ALCOHOLIC INTOXICATION; BRAIN INJURIES; CONCUSSION; DEATH, SUDDEN; DIFFUSE AXONAL INJURY; FORENSIC MEDICINE; HEAD INJURIES; WOUNDS, NONPENETRATING		Sudden death can occur in drunk individuals who are severely beaten about the face. The structural basis for this forensic syndrome is unknown. We herein describe the case of an intoxicated 23-year-old man (blood alcohol 234 mg%, 51 mmol/l) who was involved in an altercation and received blows and kicks to his head. A cardiorespiratory arrest occurred during the assault. He was resuscitated in hospital 23 min later but died 90 h after admission of severe ischemic encephalopathy and bronchopneumonia. Postmortem examination revealed diffuse scalp bruising, no evidence of a skull fracture, multiple small hemispheric contusions, severe cerebral edema secondary to ischemic encephalopathy, and axonal swellings in the corpus callosum, subcortical white matter, midbrain, right rostral inferior cerebellar peduncle, and medulla. This case of near sudden death confirms that blunt head trauma sustained during an assault can cause mild diffuse axonal injury. In addition, it is possible that sudden, alcohol intoxication-associated, craniofacial traumatic death is caused by acute dysfunction of the brainstem cardiorespiratory centers, whose capacity to correct potentially fatal dysrhythmias or apnea, induced by injury to their afferent axons, can be compromised by alcohol ingestion.			RAMSAY, DA (corresponding author), VICTORIA HOSP,DEPT PATHOL,375 SOUTH ST,LONDON,ON N6A 4G5,CANADA.							0	9	9	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	1995	16	2					107	114		10.1097/00000433-199506000-00004			8	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	QZ890	WOS:A1995QZ89000004	7572861				2022-02-06	
J	Semenova, NA; Dubinsky, VZ; Konradov, AA				Semenova, NA; Dubinsky, VZ; Konradov, AA			P-31 NMR in vivo study of rat brain energy metabolism after frontal cortex injury. A method based on convoluted correlation matrices of the spectral data	NMR IN BIOMEDICINE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; GANGLIOSIDE TREATMENTS; GM1 GANGLIOSIDE; PH	Disturbances of energy metabolism in rat brain after frontal lobectomy and post-traumatic effects of monosialic ganglioside GM(1) on brain energy metabolism were studied by P-31 NMR in vivo. Frontal lobectomg caused the statistically significant reversible decrease of ATP and increase of ADP during the compensatory period, In a presence of CM, these post-operational effects were not observed. The mean value of normalized correlation coefficients between NMR-measured phosphomonoesters, P-i, pH, phosphocreatine, gamma-ATP beta-ADP, alpha-ATP+ alpha-ADP + NAD/NADH + diphosphodiesters and beta-ATP for a given group of animals (Z-index) was used to estimate brain energetic status. It has been shown that the variation of the Z-index correlates with the dynamics of locomotor activity during the compensatory period. The Z-index increased by more than 100% for the subgroup with an increased moving activity and only by about 20% for the subgroup with a decreased activity. Moreover, the compositions of these subgroups were almost the same as those from the solution of the reverse task, i.e., the studied group was divided into two subgroups by the Z-index. The Z-index is proposed as a possible criterion of pathology detection in brain energetics.	RUSSIAN ACAD MED SCI,INST BIOL & MED CHEM,MOSCOW 109801,RUSSIA		Semenova, NA (corresponding author), RUSSIAN ACAD SCI,INST CHEM PHYS,KOSYGINA ST 4,MOSCOW 117977,RUSSIA.						BENDALL MR, 1983, J MAGN RESON, V53, P365; Bureg J, 1983, TECHNIQUES BASIC EXP; CHANCE B, 1955, J BIOL CHEM, V217, P383; CROCKARD HA, 1987, J CEREBR BLOOD F MET, V7, P394, DOI 10.1038/jcbfm.1987.82; FASS B, 1984, J NEUROSCI RES, V12, P445, DOI 10.1002/jnr.490120228; GANNUSHKINA IV, 1989, ZH NEVROPATOL PSIKH, V88, P27; GERMANO IM, 1988, J CEREBR BLOOD F MET, V8, P24, DOI 10.1038/jcbfm.1988.4; GREKHOVA TV, 1988, BIOGENIC AMINES, V5, P307; Hucho F., 1986, NEUROCHEMISTRY FUNDA; LI YS, 1986, BRAIN RES, V377, P292, DOI 10.1016/0006-8993(86)90871-1; LIKHODY S, 1987, NEIROKHIMIYA, V6, P439; MORGAN JI, 1979, J SUPRAMOL STR CELL, V10, P111, DOI 10.1002/jss.400100202; Newsholme E., 1973, REGULATION METABOLIS; OWEN DB, 1962, HDB STATISTICAL TABL; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; RAMIREZ JJ, 1987, NEUROSCI LETT, V75, P283, DOI 10.1016/0304-3940(87)90535-0; ROMANOVA GA, 1989, SACHANOV PHYSL J USS, V5, P670; SEMENOVA NA, 1994, NMR BIOMED, V7, P203, DOI 10.1002/nbm.1940070502; Siesj? BK., 1978, BRAIN ENERGY METABOL; TOFFANO G, 1983, BRAIN RES, V261, P163, DOI 10.1016/0006-8993(83)91298-2; [No title captured]	21	9	10	0	1	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD	0952-3480			NMR BIOMED	NMR Biomed.	JUN	1995	8	4					164	170		10.1002/nbm.1940080405			7	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	TP239	WOS:A1995TP23900004	8771091				2022-02-06	
J	ANDERSON, SW; RIZZO, M				ANDERSON, SW; RIZZO, M			RECOVERY AND REHABILITATION OF VISUAL CORTICAL DYSFUNCTION	NEUROREHABILITATION			English	Article						VISUAL PERCEPTION; VISUAL FIELDS; PERCEPTUAL DISCRIMINATION; STROKE	HOMONYMOUS HEMIANOPIA; CENTRAL ACHROMATOPSIA; STROKE; PERCEPTION; PATTERNS; LESIONS; RECOGNITION; NEGLECT; VISION; CORTEX	Damage to the human cerebral cortex can result in a number of distinct visual perceptual impairments, including visual field defects, impaired eye movements, visual agnosia, visuospatial disorders, impaired binocular fusional convergence, achromatopsia, visual hallucinations and defective visuoperceptual discrimination. Such impairments are common following stroke, traumatic brain injury, and other forms of cortical dysfunction, and may have significant implications for the ability to participate in rehabilitation of nonvisual functions and performance of normal daily activities. We review these cortically-based visual impairments, with emphasis on the course of recovery and methods of rehabilitation. In addition, longitudinal data are presented on the recovery of impaired visuoperceptual discrimination in 25 patients with cortical damage caused by stroke. Although the majority of these patients experienced good recovery without specific intervention, approximately one-third were left with significant chronic impairments of visuoperceptual discrimination. Despite promising recent developments in the treatment of cortically-based visual defects, there remains considerable need for information on the natural course of recovery of such impairments, as well as development of empirically validated rehabilitation procedures.	UNIV IOWA,DEPT PSYCHOL,IOWA CITY,IA 52242		ANDERSON, SW (corresponding author), UNIV IOWA,COLL MED,DEPT NEUROL,IOWA CITY,IA 52242, USA.			Anderson, Steven/0000-0002-7364-1680			ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; ANDERSON SW, 1995, IN PRESS HEAD INJURY; ANDERSON SW, 1994, J CLIN EXP NEUROPSYC, V61, P651; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; BALLIET R, 1985, J NEUROL NEUROSUR PS, V48, P1113, DOI 10.1136/jnnp.48.11.1113; Benton A, 1993, CLIN NEUROPSYCHOLOGY, P165; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BISIACH E, 1976, NEUROPSYCHOLOGIA, V14, P335, DOI 10.1016/0028-3932(76)90027-0; BOSLEY TM, 1987, ANN NEUROL, V21, P444, DOI 10.1002/ana.410210505; BRUCE CJ, 1984, TRENDS NEUROSCI, P436; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CHEDRU F, 1973, Cortex, V9, P94; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; CORBETTA M, 1990, BRAIN, V113, P603, DOI 10.1093/brain/113.3.603; COWEY A, 1967, Q J EXP PSYCHOL, V19, P232, DOI 10.1080/14640746708400098; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; Damasio A., 1994, DESCARTES ERROR EMOT; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DAMASIO AR, 1989, HDB NEUROPSYCHOLOGY, V2; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; FEIGENSON JS, 1977, STROKE, V8, P657, DOI 10.1161/01.STR.8.6.657; GAZZANIGA MS, 1994, CURR DIR PSYCHOL SCI, V3, P93, DOI 10.1111/1467-8721.ep10770443; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; Glaser JS, 1990, NEUROOPHTHALMOLOGY; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; HALLETT PE, 1980, VISION RES, V20, P329, DOI 10.1016/0042-6989(80)90019-X; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUXLEY A, 1942, ART SEEING; ICHIKAWA K, 1987, DOC OPHTHALMOL P SER, V46, P133; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; Keller E. L., 1982, FUNCTIONAL BASIS OCU, P497; KEMPEN JH, 1994, J CLIN EXP NEUROPSYC, V16, P223, DOI 10.1080/01688639408402633; KERKHOFF G, 1994, ARCH NEUROL-CHICAGO, V51, P474, DOI 10.1001/archneur.1994.00540170050016; KERKHOFF G, 1994, BRAIN INJURY, V8, P15, DOI 10.3109/02699059409150955; KOLB B, 1990, CAN J PSYCHOL, V44, P130, DOI 10.1037/h0084246; KOLMEL HW, 1984, BRAIN, V107, P155, DOI 10.1093/brain/107.1.155; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MEERWALDT JD, 1983, J NEUROL NEUROSUR PS, V46, P426, DOI 10.1136/jnnp.46.5.426; MEHTA Z, 1987, CORTEX, V23, P447, DOI 10.1016/S0010-9452(87)80006-0; MERIGAN WH, 1993, J NEUROSCI, V13, P3180; MISHRA AV, 1995, IN PRESS HEAD INJURY; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; PALCA J, 1990, SCIENCE, V248, P812, DOI 10.1126/science.2188359; PASIK P, 1982, CONTRIBUTIONS SENSOR, V7; PIZZAMIGLIO L, 1984, CORTEX, V20, P89, DOI 10.1016/S0010-9452(84)80026-X; Pommerenke K, 1989, Restor Neurol Neurosci, V1, P47, DOI 10.3233/RNN-1989-1106; RAVEN JC, 1965, GUIDE STANDARD PROGR; RIZZO M, 1993, BAILLIERE CLIN NEUR, V2, P415; RIZZO M, 1993, NEUROLOGY, V43, P995, DOI 10.1212/WNL.43.5.995; RIZZO M, 1993, INVEST OPHTH VIS SCI, V34, P1231; RIZZO M, 1987, ANN NEUROL, V22, P41, DOI 10.1002/ana.410220111; RIZZO M, UNPUB BILATERAL VISU; RIZZO M, 1994, CEREB CORTEX, V10, P505; ROSSI PW, 1990, NEUROLOGY, V40, P1597, DOI 10.1212/WNL.40.10.1597; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; TAYLOR A M, 1973, Cortex, V9, P82; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Walsh F, 1969, CLIN NEUROOPHTHALMOL; WEINBERG J, 1982, Journal of Clinical Neuropsychology, V4, P59, DOI 10.1080/01688638208401117; WEISKRANTZ L, 1989, HDB NEUROPSYCHOLOGY, V2, P275; WEISKRANTZ L, 1987, BLINDSIGHT CASE STUD; Zeki S., 1993, VISION BRAIN; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; ZIHL J, 1981, EXP BRAIN RES, V44, P159; Zihl J, 1986, NEUROLOGY, P188; 1983, HOOPER VISUAL ORG TE	72	9	9	0	12	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	APR	1995	5	2					129	140		10.1016/1053-8135(94)00111-7			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ880	WOS:A1995RJ88000004	24525494				2022-02-06	
J	HOSACK, KR; ROCCHIO, CA				HOSACK, KR; ROCCHIO, CA			SERVING FAMILIES OF PERSONS WITH SEVERE BRAIN INJURY IN AN ERA OF MANAGED CARE	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						FAMILY SERVICES; MANAGED CARE; TRAUMATIC BRAIN INJURY		This article discusses some of the influences that managed care policies and practices exert on family adjustment to traumatic brain injury. The task of serving families within the real constraints of time and financial resources challenges professionals to reevaluate and revise current thinking, technologies, and family service practices. This article provides theoretical and practical strategies as to how families and professionals can work within managed care practices through the rehabilitation process. Strategies are also proposed as to how families can work with their insurance carriers to maximize benefits and achieve optimal rehabilitation outcomes.	COLORADO HEAD INJURY FDN,LAKEWOOD,CO; NATL HEAD INJURY FDN,FAMILY ADV COUNCIL,DEERFIELD BEACH,FL; FLORIDA HEAD INJURY ASSOC,DEERFIELD BEACH,FL		HOSACK, KR (corresponding author), LEARNING SERV CORP,ROCKY MT REG CAMPUS,LAKEWOOD,CO, USA.						CLINTON WJ, 1993, CLINTON ADM DESCRIPT; DEMBO T, 1984, REHABIL LIT, V45, P90; EVANS RW, 1992, J HEAD TRAUMA REHABI, V24, P186; HART T, 1986, CLIN NEUROPSYCHOLOGY; HOSACK KR, 1992, J VOC REHABIL, V2, P11; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; PATRICK P, 1994, RELEARNING TIMES LEA, V4, P4; ROCCHIO C, 1993, TBI CHALLENGE NHIF N, V1, P12	8	9	9	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					57	65		10.1097/00001199-199504000-00007			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900007					2022-02-06	
J	ROJAS, DC; BENNETT, TL				ROJAS, DC; BENNETT, TL			SINGLE VERSUS COMPOSITE SCORE DISCRIMINATIVE VALIDITY WITH THE HALSTEAD-REITAN BATTERY AND THE STROOP TEST IN MILD BRAIN INJURY	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							MINOR HEAD-INJURY; SYMPTOMS	The predictive validity of single measures from the Halstead-Reitan Neuropsychological Test Battery and Stroop Neuropsychological Screening Test were evaluated in a sample of 25 mild traumatic brain-injured and 25 neurologically normal subjects and compared to the accuracy of composite score measures, specifically the General Neuropsychological Deficit Scale and the Halstead Impairment Index. Whereas several measures from the Halstead impairment Index achieved significantly better than chance prediction, the two summary measures from the Halstead-Reitan Neuropsychological Test Battery predicted the neurological status of the subjects with the most accuracy. The Stroop Neuropsychological Screening Test did not perform well as a single predictor Together these results suggest that single-measure screening tests do not predict mild brain-injury as well as composite neuropsychological measures. The results also give credence to the argument of comprehensive testing for brain-injured patients whose injuries are deemed medically mild.			ROJAS, DC (corresponding author), COLORADO STATE UNIV,DEPT PSYCHOL,FT COLLINS,CO 80523, USA.		Rojas, Don/AAX-6678-2020; Rojas, Don/F-4296-2012	Rojas, Don/0000-0001-6560-9616; 			*AM C REH MED, 1991, DEF MILD TRAUM BRAIN; Berg R., 1987, SCREENING BRAIN IMPA; BETTNER LG, 1971, J GERONTOL, V26, P458, DOI 10.1093/geronj/26.4.458; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; Golden CJ, 1978, STROOP COLOR WORD TE; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241; MORRISON MW, 1979, PERCEPT MOTOR SKILL, V48, P139, DOI 10.2466/pms.1979.48.1.139; NUEGER GJ, 1981, J CONSULT CLIN PSYCH, V49, P722; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; REITAN RM, 1993, OCT M NAT AC NEUR PH; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Trennery M. R., 1989, STROOP NEUROPSYCHOLO; Wolfson, 1993, HALSTEAD REITAN NEUR; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	22	9	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR-APR	1995	10	2					101	110		10.1016/0887-6177(94)E0038-Q			10	Psychology, Clinical; Psychology	Social Science Citation Index (SSCI)	Psychology	QJ432	WOS:A1995QJ43200003	14589732	Bronze			2022-02-06	
J	COUCH, JR				COUCH, JR			POST-CONCUSSION (POSTTRAUMA) SYNDROME	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article							MINOR HEAD-INJURY; MIGRAINE HEADACHE; CLINICAL-FEATURES; PREVALENCE; SEQUELAE		UNIV OKLAHOMA,HLTH SCI CTR,COLL MED,DEPT NEUROL,OKLAHOMA CITY,OK 73190								BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bille BS, 1962, ACTA PAED STOCK S136, V136, P1; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; COUCH J, 1991, CEPHALALGIA, V11, P91, DOI 10.1177/0333102491011S1149; COUCH JR, 1975, HEADACHE, V15, P41, DOI 10.1111/j.1526-4610.1975.hed1501041.x; COUCH JR, HEADACHE DIAGNOSIS T; COUCH JR, 1982, SEMIN NEUROL, V2, P30; Guttmann E, 1943, LANCET, V1, P10; HENRY P, 1992, CEPHALALGIA, V12, P229, DOI 10.1046/j.1468-2982.1992.1204229.x; KELLY R, 1981, J ROY SOC MED, V74, P242; KNOFLACH JG, 1937, ARCH KLIN CHIR, V190, P452; LANCE JW, 1966, ARCH NEUROL-CHICAGO, V15, P356, DOI 10.1001/archneur.1966.00470160022003; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MIKHAIL MG, 1992, AM J EMERG MED, V10, P24, DOI 10.1016/0735-6757(92)90119-I; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MORTIMER MJ, 1992, CEPHALALGIA, V12, P238, DOI 10.1046/j.1468-2982.1992.1204238.x; OPPENHEIMER DR, 1992, J NEUROL NEUROSUR PS, V31, P299; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; RAPOPORT AM, 1988, HEADACHE, V28, P662, DOI 10.1111/j.1526-4610.1988.hed2810662.x; RASMUSSEN BK, 1991, CEPHALAGIA, V12, P221; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1977, LANCET, V1, P1; SELBY G, 1960, J NEUROL NEUROSUR PS, V23, P33; SPEED WG, 1989, HEADACHE, V29, P643, DOI 10.1111/j.1526-4610.1989.hed2910643.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; WATERS W E, 1970, Headache, V9, P178, DOI 10.1111/j.1526-4610.1970.hed0904178.x; WATERS WE, 1975, J NEUROL NEUROSUR PS, V38, P613, DOI 10.1136/jnnp.38.6.613; 1988, CEPHALAGIA, V8, P1	28	9	9	0	1	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1995	9	2					83	89					7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TF488	WOS:A1995TF48800005					2022-02-06	
J	GUILMETTE, TJ; TSOH, JY; MALCOLM, CD				GUILMETTE, TJ; TSOH, JY; MALCOLM, CD			ORIENTATION AND 3-WORD RECALL IN PREDICTING MEMORY - AGE EFFECTS AND FALSE-NEGATIVE ERRORS	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						3-WORD RECALL; LOGICAL MEMORY-II; TRAUMATIC BRAIN INJURY; CEREBROVASCULAR ACCIDENT; SHORT-TERM MEMORY	MINI-MENTAL-STATE	The purpose of this study was to determine how well orientation and three-word recall predict performance on a neuropsychological measure of short-term memory. The relationship between orientation/three-word recall and Logical Memory II (LMII) of the Wechsler Memory Scale-Revised was analyzed using Pearson coefficients and discriminant function analyses. An initial analysis of three patient groups (cerebrovascular accident, mixed neurologic disorders, and traumatic brain injury), which differed also by age, revealed that orientation was insignificantly correlated with LMII across all patient groups. Three-word recall was most highly correlated with LMII with the older, CVA group and least correlated with the younger, traumatic brain injury sample. Discriminant function analyses in predicting impaired or normal LMII scores from orientation and three-word recall revealed the lowest false-negative error rate for memory impairment with the CVA group and the highest false-negative error rate with the traumatic brain injury group. Subsequent analyses with two younger, age-matched groups (a traumatic brain injury group and a mixed neurological group) confirmed that the above findings were related to age and not to diagnosis. Implications for using mental status measures to predict cognitive functioning in different clinical and age groups are discussed.			GUILMETTE, TJ (corresponding author), RHODE ISL HOSP,DEPT PSYCHIAT,APC 608B,593 EDDY ST,PROVIDENCE,RI 02903, USA.		Tsoh, Janice Y./AAF-5628-2020	Tsoh, Janice/0000-0003-0989-7187			BENEDICT RHB, 1992, J GERIATR PSYCH NEUR, V5, P233, DOI 10.1177/002383099200500409; BOWER D, 1989, Neurology, V39, P176; CULLUM CM, 1991, ARCH CLIN NEUROPSYCH, V6, P183; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; KELLER MB, 1981, COMPR PSYCHIAT, V22, P500, DOI 10.1016/0010-440X(81)90039-0; KOKMEN E, 1991, ARCH NEUROL-CHICAGO, V48, P725, DOI 10.1001/archneur.1991.00530190071018; RASILE DA, 1993, CLIN NEUROPSYCHOL, V7, P334; ROCA RP, 1987, PSYCHOSOMATICS, V28, P71, DOI 10.1016/S0033-3182(87)72566-3; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; TILLEY DH, 1981, COMPR PSYCHIAT, V22, P562, DOI 10.1016/0010-440X(81)90004-3; WECHSLER D, 1987, MANUAL WMS R; WELTE PO, 1993, ARCH PHYS MED REHAB, V74, P631, DOI 10.1016/0003-9993(93)90162-4	13	9	9	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JAN	1995	8	1					20	25					6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	PY819	WOS:A1995PY81900004					2022-02-06	
J	JORDAN, FM; MURDOCH, BE; BUTTSWORTH, DL; HUDSONTENNENT, LJ				JORDAN, FM; MURDOCH, BE; BUTTSWORTH, DL; HUDSONTENNENT, LJ			SPEECH AND LANGUAGE PERFORMANCE OF BRAIN-INJURED CHILDREN	APHASIOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; HEAD-INJURY; CHILDHOOD; ADOLESCENTS; DEFICITS; SURGERY; SKILLS; TUMORS	The speech and language performance of three groups of brain-injured children, a closed-head injured (CHI) group, children treated for posterior Fossa tumour (PFT), and children treated for acute lymphoblastic leukaemia (ALL), was compared to a matched control group. The subjects were administered a battery of speech and language assessments including general measures of motor speech abilities, and speaking and listening performance, as well as specific skills tests in the domains of confrontation naming and verbal fluency. Performance of the experimental groups was compared with that of a control group matched for age, sex and educational level. Results indicated that all areas of language competence assessed appeared to be compromised by the various types of brain injury. With the exception of two members of the PFT group, motor speech skills appeared to be spared for all other experimental subjects.	UNIV QUEENSLAND, ST LUCIA, QLD 4067, AUSTRALIA				Murdoch, Bruce E/C-1397-2012				APPLETON RE, 1990, ARCH DIS CHILD, V65, P530, DOI 10.1136/adc.65.5.530; BRUCE DA, 1983, PAEDIATRIC HEAD TRAU; CAPLAN D, DISORDERS SYNTACTIC; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Enderby P, 1983, FRENCHAY DYSARTHRIA; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P59; GERRYTAYLOR H, 1987, J PEDIATR PSYCHOL, V12, P395; HAMMILL DD, 1982, TEST LANGUAGE DEV IN; HUDSON LJ, 1992, APHASIOLOGY, V6, P135, DOI 10.1080/02687039208248585; HUDSON LJ, 1992, APHASIOLOGY, V6, P17, DOI 10.1080/02687039208248574; HUDSON LJ, 1989, APHASIOLOGY, V3, P1, DOI 10.1080/02687038908248972; JACKEL CA, 1990, APHASIOLOGY, V4, P45, DOI 10.1080/02687039008249053; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; JORDAN FM, 1993, UNPUB NAMING PERFORM; Kaplan E, 1983, BOSTON NAMING TEST; Kay J., 1992, PSYCHOLINGUISTIC ASS; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Newcomer P, 1982, TEST LANGUAGE DEV; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; PFEFFERBAUMLEVINE B, 1984, AM J PEDIAT HEMATOL, V6, P123; SEMELMINTZ E, 1982, CLIN EVALUATION LANG; SUC E, 1990, ACTA NEUROCHIR, V106, P93, DOI 10.1007/BF01809448; TEASDALE G, 1974, LANCET, V2, P81; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; 1983, CELF UPDATE 3	32	9	9	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	JAN-FEB	1995	9	1					23	32		10.1080/02687039508248686			10	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	QB072	WOS:A1995QB07200002					2022-02-06	
J	SWAINE, BR; SULLIVAN, SJ; SICOTTE, D				SWAINE, BR; SULLIVAN, SJ; SICOTTE, D			EXPERT OPINION IN THE IDENTIFICATION OF VARIABLES FOR THE MEASUREMENT OF EARLY RECOVERY IN ADULTS WITH TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							DELPHI; PRIORITIES	The expert opinion of 27 experienced physical therapists was systematically sought using a modified Delphi technique in order to identify the important variables to be included in the neurophysical evaluation of the traumatic brain-injured (TBI) adult during the acute stage of rehabilitation (first 3 months). An initial survey of the therapists generated 63 items which were later regrouped into 23 categories. Each category was then rated using a five-point scale (1 = of no importance to 5 = extremely important) by each therapist as to its importance in the early clinical neurophysical evaluation of the TBI patient. Those variables identified as extremely important by at least 50% of experts include: state of consciousness, voluntary movements, spontaneous movement and transfers. The results of this study highlight, for physical therapists and other health professionals, the important variables to be included in the evaluation of neurophysical deficits in persons with TBI in the acute stage of rehabilitation.	UNIV MONTREAL,FAC MED,ECOLE READAPTAT,MONTREAL H3C 3J7,QUEBEC,CANADA; CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL H3G 1M8,QUEBEC,CANADA; HOP SACRE COEUR,DEPT PHYS THERAPY,MONTREAL H4J 1C5,QUEBEC,CANADA		SWAINE, BR (corresponding author), INST READAPTAT MONTREAL,CTR RECH,6300 DARLINGTON AVE,MONTREAL H3S 2J4,PQ,CANADA.						BARAT M, 1986, REEDUCATION READAPTA, P13; Bobath, 1978, ADULT HEMIPLEGIA EVA; BOBERG AL, 1992, CANADIAN J PROGRAM E, V7, P27; Bond M R, 1979, Int Rehabil Med, V1, P155; Bond M R, 1979, Acta Neurochir Suppl (Wien), V28, P126; Chaney H S, 1987, J Nurs Staff Dev, V3, P48; CHARNESS A, 1986, STROKE HEAD INJURY G; COHADON F, 1983, NEUROCHIRURGIE, V29, P303; Crocker L., 1986, INTRO CLASSICAL MODE, P217; DUNCAN PW, 1990, REHABILITATION ADULT, P264; EVANS CD, 1980, INJURY, V8, P80; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; FOX JMS, 1988, COGNITIVE REHABI MAY, P38; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; Green L.W., 1980, HLTH ED PLANNING DIA, V1st ed.; GRIFFITH ER, 1990, REHABILITATION ADULT, P127; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; LINDEMAN CA, 1975, NURS RES, V24, P434, DOI 10.1097/00006199-197511000-00006; LINESTONE HA, 1975, DELPHI METHOD TECHNI, P3; MATHE JF, 1988, READAPTATION, V355, P17; MCMILLAN A, 1991, 11TH P WORLD CONF PH, P1766; MERCER L, 1983, PHYS THER, V63, P1988, DOI 10.1093/ptj/63.12.1988; MILESTAPPING C, 1990, PHYS THER, V70, P448, DOI 10.1093/ptj/70.7.448; MILHOLLAND AV, 1973, NEW ENGL J MED, V288, P1272, DOI 10.1056/NEJM197306142882405; MILLER JD, 1990, REHABILITATION ADULT, P21; NELSON AJ, 1984, REHABILITATION ADULT, P313; SMITH LM, 1985, NEURAL GRAFTING MAMM, P249; Stockmeyer S A, 1967, Am J Phys Med, V46, P900; SULLIVAN S J, 1991, Society for Neuroscience Abstracts, V17, P167; SULLIVAN SJ, BILAN EVOLUTION MOTR; THACKERAY JV, 1970, REHABILITATION, V72, P31; WEINTRAUB AH, 1989, PHYSICAL MED REHABIL, V3, P59; ZOLTAN B, 1990, REHABILITATION ADULT, P284; 1988, CANADIAN HOSPITAL DI, V36; 1991, P 2 STEP C FREDERICK	35	9	9	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1994	8	4					323	334		10.3109/02699059409150983			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	NP445	WOS:A1994NP44500003	8081347				2022-02-06	
J	SHOHAMI, E; NOVIKOV, M; HOROWITZ, M				SHOHAMI, E; NOVIKOV, M; HOROWITZ, M			LONG-TERM EXPOSURE TO HEAT PROTECTS AGAINST BRAIN-DAMAGE INDUCED BY CLOSED-HEAD INJURY IN THE RAT	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						BBB; HEAD TRAUMA; HEAT ACCLIMATION; BRAIN EDEMA	ENVIRONMENTAL HEAT; HYPOTHERMIA; ISCHEMIA; EDEMA	Closed head injury leads to delayed tissue-edema, necrosis and impaired neurological function. In the present study the effect of chronic exposure to heat on the outcome of head injury in rats was investigated. Rats were held at ambient temperature of 24 degrees C (CON) or 34 degrees C (heat acclimated, ACC) for one month, before induction of trauma. Injury was induced by a weight drop device, falling over the left cerebral hemisphere. Twenty-four or 48 h later the rats were sacrificed and their brains removed for evaluation of edema (specific gravity or water content). Blood-brain barrier integrity (Evans blue extravasation) was evaluated 4 h after injury. One, 24 and 48 h after injury the rats were evaluated by a set of criteria which yields their clinical status (Neurological Severity Score - NSS). Forty-eight hours after trauma specific gravity of the contused hemispheres was 1.0389 +/- 0.0019 and 1.0364 +/- 0.0007 (P < 0.01) and water content 81.44 +/- 1.28 and 84.17 +/- 1.03% (P < 0.001), for ACC and CON rats, respectively. Lower degree of edema was also evident at 24 h suggesting slower rate of edema formation in ACC rats. Evans blue uptake by the contused hemisphere was 315 +/- 61 and 50 +/- 23 ng/g tissue in the CON and ACC rats, respectively (P < 0.001). Clinical recovery of the ACC rats was significantly better (P < 0.001) than that of the matched controls as exhibited at 48 h by median NSS values of: 10.8 (range 6-16) and 5 (range 4-6) for CON and ACC, respectively. Based on the present results we suggest that heat acclimation offers protection to rats subjected to head trauma.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT PHYSIOL,IL-91010 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH SCH PHARM,DEPT PHARMACOL,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH SCH PHARM,DEPT PHYSIOL,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH SCH DENT MED,DEPT PHARMACOL,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH SCH DENT MED,DEPT PHYSIOL,JERUSALEM,ISRAEL		SHOHAMI, E (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT PHARMACOL,IL-91010 JERUSALEM,ISRAEL.						BAETHMANN A, 1989, NEUROSURG ANESTHESIO, V2, P567; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; Cossins A., 1987, TEMPERATURE BIOL ANI; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; HADAS H, 1989, THERMAL PHYSL, P395; HOROWITZ M, 1979, J APPL PHYSIOL, V47, P738, DOI 10.1152/jappl.1979.47.4.738; HOROWITZ M, 1986, J MOL CELL CARDIOL, V18, P511, DOI 10.1016/S0022-2828(86)80916-6; HOROWITZ M, 1976, PFLUG ARCH EUR J PHY, V366, P173, DOI 10.1007/BF00585874; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; LEVI E, 1991, P INT UNION PHYSL SC; LEVI E, 1993, J APPL PHYSIOL, V75, P883; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPRIA Y, 1993, J ANASTH ANALG, V77, P141; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1992, EXP NEUROL, V117, P181; SHOHAMI E, 1989, J NEUROCHEM, V53, P541; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; YAROM R, 1990, CARDIOVASC RES, V24, P982, DOI 10.1093/cvr/24.12.982; YOUSEF MK, 1975, AM J PHYSIOL, V229, P427, DOI 10.1152/ajplegacy.1975.229.2.427	24	9	9	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.	MAR	1994	6	2					107	112					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NF005	WOS:A1994NF00500004	21551737				2022-02-06	
J	YOSHII, WY; ROTTMAN, RL; ROSENBLATT, RM; KOTELKO, DM; RASMUS, KT; ROSEN, PJ; WRIGHT, WC; STONE, JJ				YOSHII, WY; ROTTMAN, RL; ROSENBLATT, RM; KOTELKO, DM; RASMUS, KT; ROSEN, PJ; WRIGHT, WC; STONE, JJ			EPIDURAL CATHETER-INDUCED TRAUMATIC RADICULOPATHY IN OBSTETRICS - ONE CENTERS EXPERIENCE	REGIONAL ANESTHESIA			English	Article						OBSTETRIC ANESTHESIA; EPIDURAL CATHETER; COMPLICATION; RADICULOPATHY		Background and Objectives. A report of prolonged neurologic dysfunction following continuous lumbar epidural anesthesia in seven obstetric patients during a 12-month period. Methods. Details were obtained postpartum and after hospital discharge by verbal contact. Results. All of the patients experienced varying degrees of hyperesthesia to touch, limited to one or two adjacent dermatomes, unilaterally distributed to the same side as the paresthesia that occurred during the placement of the epidural catheter. Conclusion. Epidural catheter stiffness and tip construction may be the most critical features in causing neurotrauma.			YOSHII, WY (corresponding author), CEDARS SINAI MED CTR,DEPT ANESTHESIOL,8700 BEVERLY BLVD,LOS ANGELES,CA 90048, USA.							0	9	10	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	NEW YORK	650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011	0146-521X			REGION ANESTH	Reg. Anesth.	MAR-APR	1994	19	2					132	135					4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	NC460	WOS:A1994NC46000009					2022-02-06	
J	WHYTE, J; ROSE, T; GLENN, MB; GUTOWSKI, W; WROBLEWSKI, B; REGER, J				WHYTE, J; ROSE, T; GLENN, MB; GUTOWSKI, W; WROBLEWSKI, B; REGER, J			QUANTIFICATION OF ATTENTION-RELATED BEHAVIORS IN INDIVIDUALS WITH TRAUMATIC BRAIN INJURY - A PILOT-STUDY	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						BRAIN INJURIES; ATTENTION	HYPERACTIVITY	Clinical disorders of attention are common after traumatic brain injury but objective measures of their nature and severity are lacking. We developed a standardized independent work task to be performed by patients in a controlled, distracting environment. Videotaped records of patient behavior were made and coded in 15-s intervals for on-task behavior, presence of distractors and presence of extraneous motor behavior. Interrater reliability was good to excellent across eleven testing sessions involving four patients. This evaluation system revealed clinically important differences in on-task behavior among the four patients, as well as different levels of distraction in response to external stimuli. It also showed effects of different tasks and repeated sessions. These data indicate that this evaluation system and accompanying coding process are reliable and provide preliminary evidence that they produce clinically valid results.	GREENERY REHABIL & SKILLED NURSING CTR,BOSTON,MA; MERRIMACK COLL,DEPT PSYCHOL,N ANDOVER,MA; TUFTS UNIV,SCH MED,DEPT REHABIL MED,BOSTON,MA 02111					Whyte, John/0000-0002-4381-1474	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [2S07-RR05598-20] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS NS27715-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S07RR005598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS027715] Funding Source: NIH RePORTER		BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; CAMPBELL SB, 1977, J CHILD PSYCHOL PSYC, V18, P239, DOI 10.1111/j.1469-7610.1977.tb00436.x; CONNERS CK, 1969, AM J PSYCHIAT, V126, P884, DOI 10.1176/ajp.126.6.884; COPE DN, 1986, J HEAD TRAUMA REHAB, V1, P34; EDELBROCK C, 1985, CLIN PSYCHOL REV, V5, P429, DOI 10.1016/0272-7358(85)90003-0; Evans R. W., 1987, J HEAD TRAUMA REHAB, V2, P29; HENKER B, 1989, AM PSYCHOL, V44, P216, DOI 10.1037/0003-066X.44.2.216; NAATANEN R, 1988, BIOL PSYCHOL, V26, P117, DOI 10.1016/0301-0511(88)90017-8; POSNER MI, 1984, J NEUROSCI, V4, P1863; RAFAL RD, 1988, BRAIN, V111, P267, DOI 10.1093/brain/111.2.267; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WHYTE J, 1988, J HEAD TRAUMA REHAB, V3, P95; WOOD RL, 1986, J HEAD TRAUMA REHAB, V1, P43, DOI DOI 10.1097/00001199-198609000-00008	13	9	9	1	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	1994	73	1					2	9					8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MX590	WOS:A1994MX59000002	8305177				2022-02-06	
J	DUHAIME, AC				DUHAIME, AC			EXCITING YOUR NEURONS TO DEATH - CAN WE PREVENT CELL LOSS AFTER BRAIN INJURY	PEDIATRIC NEUROSURGERY			English	Article						BRAIN INJURY; DEXTROMETHORPHAN; EXCITOTOXICITY; HEAD INJURY, CHILDREN; ISCHEMIA; NEUROPROTECTION; SUBDURAL HEMATOMA	FOCAL CEREBRAL-ISCHEMIA; ACUTE SUBDURAL-HEMATOMA; METHYL-D-ASPARTATE; DEXTROMETHORPHAN PROTECTS; GLUTAMATE ANTAGONIST; NMDA RECEPTORS; DAMAGE; RAT; MK-801; DEXTRORPHAN	During the past 10-15 years, major advances have been made in understanding the pathophysiologic events that occur following central nervous system insults. It has become clear that a variety of insults have in common their ability to initiate a complex cascade of biochemical events at the cellular level which, over time, lead to neuronal death. Because these events take time to occur, interruption of these cascades offers the hope of specific neuron-salvaging therapy, even when given after the insult, and provides a major step forward from conventional supportive care. This paper reviews these principles as they relate to traumatic brain injury, with emphasis on excitatory amino acid neurotransmitter toxicity (excitotoxicity). Preliminary results in animal experiments and in severely head-injured children are discussed.	UNIV PENN,SCH MED,DEPT NEUROSURG,PHILADELPHIA,PA 19104		DUHAIME, AC (corresponding author), CHILDRENS HOSP,DIV NEUROL,34TH & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.						ALBERS GW, 1991, STROKE, V22, P1075, DOI 10.1161/01.STR.22.8.1075; ALBERS GW, 1990, CLIN NEUROPHARMACOL, V13, P177, DOI 10.1097/00002826-199006000-00001; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BUCHAN A, 1990, J NEUROSCI, V10, P311; BULLOCK R, 1990, ACT NEUR S, V51, P274; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1992, J NEUROTRAUMA S2, V9, P443; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; DUHAIME AC, 1992, ANN M ASS NEUROLOGIC; DUHAIME AC, 1990, BRAIN RES, V512, P168; DUHAIME AC, 1992, 10TH ANN M NEUR SOC; DUHAIME AC, 1993, ANN M AM ASS NEUROLO; DUHAIME AC, 1993, 2ND INT NEUR S GLASG; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GEORGE CP, 1988, BRAIN RES, V440, P375, DOI 10.1016/0006-8993(88)91011-6; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; GOLDBERG MP, 1987, NEUROSCI LETT, V80, P11, DOI 10.1016/0304-3940(87)90486-1; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; JORGENSEN MB, 1982, ACTA NEUROL SCAND, V66, P536; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; KURODA Y, 1992, NEUROSURGERY, V30, P687; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MCINTOSH T, 1988, FRONTEIRS EXCITATORY; MCINTOSH TK, 1992, J NEUROTRAUMA S1, V9, P201; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PARK CK, 1988, J CEREBR BLOOD F MET, V8, P757, DOI 10.1038/jcbfm.1988.124; PRINCE DA, 1988, NEUROSCI LETT, V85, P291, DOI 10.1016/0304-3940(88)90581-2; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; ROSS DT, 1993, J CEREBR BLOOD F MET, V13, P558, DOI 10.1038/jcbfm.1993.73; ROSS DT, 1989, BRAIN RES, V501, P129, DOI 10.1016/0006-8993(89)91034-2; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SANCHEZPRIETO J, 1988, J NEUROCHEM, V50, P1322, DOI 10.1111/j.1471-4159.1988.tb10611.x; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; STEINBERG GK, 1988, STROKE, V19, P1112, DOI 10.1161/01.STR.19.9.1112; STEINBERG GK, 1991, J CEREBR BLOOD F MET, V11, P1015, DOI 10.1038/jcbfm.1991.169; STEINBERG GK, 1991, ANN M ASS NEUROLOGIC; VANRIJEN PC, 1991, STROKE, V22, P343, DOI 10.1161/01.STR.22.3.343; WALKER FO, 1989, CLIN NEUROPHARMACOL, V12, P322, DOI 10.1097/00002826-198908000-00010; WIELOCH T, 1987, J CEREB BLOOD FLO S1, V7, P154; WONG BY, 1988, NEUROSCI LETT, V85, P261, DOI 10.1016/0304-3940(88)90362-X; YOON YH, 1989, ARCH OPHTHALMOL-CHIC, V107, P409, DOI 10.1001/archopht.1989.01070010419037	45	9	9	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		1994	21	2					117	122		10.1159/000120825			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	PE507	WOS:A1994PE50700002	7986742				2022-02-06	
J	HAMMELL, KRW				HAMMELL, KRW			PSYCHOSOCIAL OUTCOME FOLLOWING SEVERE CLOSED-HEAD INJURY	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						HEAD INJURIES; PSYCHOLOGICAL OUTCOME; SOCIAL OUTCOME; QUALITY OF LIFE; REHABILITATION	SPINAL-CORD INJURY; SOCIAL RELATIONSHIPS; SELF-ASSESSMENT; ADJUSTMENT; RELATIVES; NEUROSIS; LIFE; POPULATION; DEPRESSION; ADVERSITY	A comprehensive study of outcomes following severe head injury must clearly include an indicator of psychosocial outcome. Several studies have identified the chronic social isolation which is commonly experienced among this group of people. The present study sought to explore the availability and adequacy of social support following traumatic injury and the relationship between this and emotional distress. In an attempt to identify those sequelae which may be specific to brain trauma, the study compared a group of men with severe head injuries, and their partners, with a group of men with spinal cord injuries, and their partners (n = 60). Time since discharge ranged from 4 months to several years. All four groups reported low availability and adequacy of social integration and exhibited high levels of depression, with no relationship between depression and the length of time since discharge. No statistically significant differences were found between the groups, indicating that the social isolation which has previously been identified amongst people with head injuries may not be attributable solely to brain damage. It would also appear that the repercussions of a traumatic injury extend long after discharge from hospital and this may demonstrate a need to re-examine the provision of service to these client groups.	UNIV SOUTHAMPTON,REHABIL RES UNIT,SOUTHAMPTON,HANTS,ENGLAND								BERMOND B, 1987, CLIN REHABIL, V1, P111; BOND MR, 1990, REHABILITATION ADULT; BOWLBY J, 1973, SEPARATION ANXIETY A, V2; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; GLASS CA, 1993, PARAPLEGIA, V31, P93, DOI 10.1038/sc.1993.16; Hammell KR Walley, 1992, DISABILITY HANDICAP, V7, P349; HAMMELL KRW, 1994, IN PRESS PSYCHOSOCIA; HAMMELL KRW, THESIS U SOUTHAMPTON; HENDERSON S, 1978, BRIT J PSYCHIAT, V132, P74, DOI 10.1192/S0007125000283001; HENDERSON S, 1981, BRIT J PSYCHIAT, V138, P391, DOI 10.1192/bjp.138.5.391; HENDERSON S, 1980, PSYCHOL MED, V10, P723, DOI 10.1017/S003329170005501X; HENDERSON S, 1978, BRIT J PSYCHIAT, V132, P463, DOI 10.1192/bjp.132.5.463; HENDERSON S, 1980, BRIT J PSYCHIAT, V136, P574, DOI 10.1192/bjp.136.6.574; HESTER GA, 1971, PSYCHOPHYSIOLOGY, V8, P451, DOI 10.1111/j.1469-8986.1971.tb00477.x; HOHMANN GW, 1966, PSYCHOPHYSIOLOGY, V3, P143, DOI 10.1111/j.1469-8986.1966.tb02690.x; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kinsella G, 1989, Int Disabil Stud, V11, P9; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; LEWINSOHN PM, 1973, J CONSULT CLIN PSYCH, V41, P261, DOI 10.1037/h0035142; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LONDON P S, 1967, Annals of the Royal College of Surgeons of England, V41, P460; LOWE J, 1985, BRIT J CLIN PSYCHOL, V24, P135, DOI 10.1111/j.2044-8260.1985.tb01327.x; MACKELPRANG RW, 1987, SOC WORK HEALTH CARE, V13, P23; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; MILLER PM, 1976, SOC PSYCHIATR, V11, P51, DOI 10.1007/BF00578738; NESTOROS JN, 1982, PSYCHOSOMATICS, V23, P823; NOSEK MA, 1987, ARCH PHYS MED REHAB, V68, P840; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; SNAITH RP, 1978, BRIT J PSYCHIAT, V132, P164, DOI 10.1192/bjp.132.2.164; SNAITH RP, 1976, BRIT J PSYCHIAT, V128, P156, DOI 10.1192/bjp.128.2.156; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1974, SCANDINAVIAN J REHAB, V6, P180; Trieschmann R, 1988, SPINAL CORD INJURIES; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEISSMAN MM, 1981, ARCH GEN PSYCHIAT, V38, P1250	50	9	9	0	5	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.		1994	17	4					319	332					14	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	PW351	WOS:A1994PW35100003	7875925				2022-02-06	
J	NAWASHIRO, H; SHIMA, K; CHIGASAKI, H				NAWASHIRO, H; SHIMA, K; CHIGASAKI, H			BLOOD-BRAIN-BARRIER, CEREBRAL BLOOD-FLOW, AND CEREBRAL PLASMA-VOLUME IMMEDIATELY AFTER HEAD-INJURY IN THE RAT	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; BLOOD-BRAIN BARRIER; CEREBRAL BLOOD FLOW; PLASMA VOLUME	CAPILLARY	The purpose of the present study was to determine blood-brain barrier (BBB) permeability, regional cerebral blood flow (rCBF) and regional cerebral plasma volume (rCPV) in die period immediately after head injury, and thereby to evaluate the effects of vascular factors in the pathophysiology of traumatic brain-injury. Male Sprague-Dawley rats (350-450 g) anesthetized with 1.0-1.5% halothane were subjected to an impact acceleration closed head injury at the moderate level. BBB permeability (n = 5), rCBF (n = 8) and rCPV (n = 9) were measured by quantitative autoradiographic techniques using C-14-alpha-aminoisobutyric acid (AIB), C-14-iodoantipyrine and C-14-sucrose, respectively. Intravenous administration of each radiotracer was simultaneous with the traumatic impact. At 10 min after injury, BBB permeability, the transfer constant for AIB, was less than 0.1 ml/kg/min for all regions except for those with a relatively leaky BBB. At 30 s after injury, a significant and heterogeneous increase in rCBF was observed at 9 subcortical regions (p < 0.05). RCPV increased significantly in the frontal cortex, parietal cortex, thalamus, and hypothalamus (p < 0.05). In our closed head injury model without severe hypertension, BBB disruption did not occur immediately after trauma. Vascular responses in the period immediately after trauma may result from the derangement of cerebral autoregulatuion.			NAWASHIRO, H (corresponding author), NATL DEF MED COLL, DEPT NEUROSURG, 3-2 NAMIKI, TOKOROZAWA, SAITAMA 359, JAPAN.						BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; FODA M, 1993, IN PRESS J NEUROSURG; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; OHNO K, 1978, AM J PHYSIOL, V235, pH299, DOI 10.1152/ajpheart.1978.235.3.H299; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SHIMA K, 1991, ADV EXPT NEUROTRAUMA, V3, P84; SHIMA K, 1990, ADV EXPT NEUROTRAUMA, V2, P53	8	9	9	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			440	442					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600120	7976613				2022-02-06	
J	INGERSOLL, CD				INGERSOLL, CD			LONG-TERM EFFECTS OF CLOSED-HEAD INJURIES IN SPORT	SPORTS MEDICINE			English	Article								Closed head injury has been defined by several authors, but is not agreed upon. The incidence of closed head injury in sports is relatively small, but because the effects may be catastrophic it is an important topic. Forces may be applied to the head from different directions, which results in different types of lesions. The anatomical and physiological changes with head injury have been suggested to explain head injury outcomes. Effects on intelligence and memory have also been reported. Posture had been proposed as a model to examine the subtle effects of head injury. Vision, vestibular input, and somatosensory input are all involved in maintenance of posture. The interaction of these sensory modalities is also pertinent to posture maintenance. Somatosensory input appears to be improperly processed, while vision and vestibular input seem to compensate for lost somatosensation. Attention to regaining the somatosensory component, rather than waiting for compensation to occur, should be addressed in rehabilitation programmes.			INGERSOLL, CD (corresponding author), INDIANA STATE UNIV,DEPT ATHLET TRAINING,SPORTS INJURY RES LAB,TERRE HAUTE,IN 47809, USA.		Ingersoll, Christopher/H-6474-2015	Ingersoll, Christopher/0000-0001-9157-6846				0	9	9	0	3	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0112-1642			SPORTS MED	Sports Med.	NOV	1993	16	5					342	354		10.2165/00007256-199316050-00005			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MG843	WOS:A1993MG84300005	8272689				2022-02-06	
J	LAIZURE, SC; FRANKLIN, LK; KAISER, DG; WILLIAMS, CL; STEVENS, RC; SANDERS, PL; MILLER, M				LAIZURE, SC; FRANKLIN, LK; KAISER, DG; WILLIAMS, CL; STEVENS, RC; SANDERS, PL; MILLER, M			DISPOSITION OF TIRILAZAD (U74006F), A 21-AMINOSTEROID, IN THE PLASMA, HEART, BRAIN, AND LIVER OF THE RAT	DRUG METABOLISM AND DISPOSITION			English	Article							INDOCYANINE GREEN; BLOOD-FLOW; CLEARANCE; MODEL	Tirilazad mesylate (Freedox, Upjohn) is the first agent of a new class of compounds called lazaroids currently under clinical investigation for its potential beneficial effects following neurotrauma. Tirilazad's therapeutic effect is due to its ability to inhibit iron-dependent lipid peroxidation. This study was conducted in Sprague-Dawley rats to determine the basic pharmacokinetics and distribution of tirilazad into the brain, heart, and liver. Rats (N = 50) were killed in groups of five at 0, 10, 20, and 40 min, and at 1.5, 2, 3, 4, 6, and 8 hr after intravenous administration of 10 mg/kg of tirilazad mesylate. Tirilazad was assayed in plasma, heart, liver, and brain tissue by HPLC. Using the mean concentrations at each time point, pharmacokinetic parameters were estimated using standard noncompartmental techniques and statistical moment theory. Tirilazad was rapidly eliminated from the plasma with a half-life of 2.4 hr and clearance of 6.1 ml/min. The volume of distribution at steady-state was large, 4.8 liters/kg. The concentrations of tirilazad were highest in the liver and heart and lowest in the plasma and brain. Elimination from tissues paralleled elimination from plasma with half-lives of 1.9, 1.6, and 1.5 hr in the brain, heart, and liver, respectively. Trilazad appears to be a highly extracted, hepatically eliminated drug, suggesting its clearance is dependent on liver blood flow, and alterations in plasma protein binding are unlikely to affect its clearance but may affect the fraction unbound.	UPJOHN CO,DRUG METAB RES,KALAMAZOO,MI 49001		LAIZURE, SC (corresponding author), UNIV TENNESSEE CTR HLTH SCI,DEPT CLIN PHARM,MEMPHIS,TN 38163, USA.		Laizure, S. Casey/T-8932-2019				Anderson DK, 1991, J NEUROTRAUM, V8, P187, DOI 10.1089/neu.1991.8.187; BRUCK R, 1989, PROSTAGLANDINS, V37, P531, DOI 10.1016/0090-6980(89)90068-3; BURNS E, 1989, CLIN SCI, V76, P503, DOI 10.1042/cs0760503; COX JW, 1989, DRUG METAB DISPOS, V17, P373; COX JW, 1988, J CHROMATOGR-BIOMED, V424, P293, DOI 10.1016/S0378-4347(00)81106-8; DAEMEN MJAP, 1986, J PHARM PHARMACOL, V38, P122, DOI 10.1111/j.2042-7158.1986.tb04524.x; DAEMEN MJAP, 1989, J PHARMACOL METHOD, V21, P287, DOI 10.1016/0160-5402(89)90066-1; FLECKENSTEIN AE, 1991, CIRC SHOCK, V35, P223; FUJITA Y, 1989, ANESTH ANALG, V69, P152; GIBALDI M, 1982, NONCOMPARTMENTAL ANA; GROSZMANN RJ, 1983, HEPATOLOGY, V3, P1039; HALL ED, 1988, STROKE, V19, P340, DOI 10.1161/01.STR.19.3.340; HENDRY PJ, 1992, J HEART LUNG TRANSPL, V11, P636; HOLZ A, 1991, J NEUROTRAUM, V8, P239; KANAMARU K, 1990, NEUROSURGERY, V27, P29, DOI 10.1227/00006123-199007000-00004; KRAUS AL, 1980, LABORATORY RAT, V2, pCH1; POWELL RJ, 1991, AM SURGEON, V57, P86; XUE D, 1992, STROKE, V23, P894, DOI 10.1161/01.STR.23.6.894	18	9	9	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0090-9556			DRUG METAB DISPOS	Drug Metab. Dispos.	SEP-OCT	1993	21	5					951	954					4	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	MA226	WOS:A1993MA22600031	7902261				2022-02-06	
J	MIYAZAKI, S; KATAYAMA, Y; FURUICHI, M; KINOSHITA, K; KAWAMATA, T; TSUBOKAWA, T				MIYAZAKI, S; KATAYAMA, Y; FURUICHI, M; KINOSHITA, K; KAWAMATA, T; TSUBOKAWA, T			IMPAIRMENT OF HIPPOCAMPAL LONG-TERM POTENTIATION FOLLOWING TRANSIENT CEREBRAL-ISCHEMIA IN RAT - EFFECTS OF BIFEMELANE, A POTENT INHIBITOR OF ISCHEMIA-INDUCED ACETYLCHOLINE-RELEASE	NEUROLOGICAL RESEARCH			English	Article						ACETYLCHOLINE; CA1, CEREBRAL ISCHEMIA; HIPPOCAMPUS; LONG-TERM POTENTIATION	DELAYED NEURONAL DEATH; TRAUMATIC BRAIN INJURY; D-ASPARTATE RECEPTORS; INDELOXAZINE HYDROCHLORIDE; SYNAPTIC TRANSMISSION; FOREBRAIN ISCHEMIA; MONGOLIAN GERBILS; CALCIUM-UPTAKE; CA1 SECTOR; STIMULATION	The present study examined the changes in the long-term potentiation (LTP) of the hippocampal Schaffer collateral/CA1 pyramidal cell system in vivo occurring after 12-min forebrain ischaemia in the rat. A population spike (PS) of CA1 pyramidal cells were recorded in 18 rats at 7 h post-ischaemia. While the threshold and amplitude of pretetanic PS were not depressed, the induction of LTP was significantly impaired following ischaemic insult (155+/-28% of baseline PS, mean+/-SD, n=6, p<0.001), as compared to sham-controls (337+/-84%, n=5), without reduction of single pulse responses. Pretreatment with 4(o-benzylphenoxy)-N-methylbutylamine hydrochloride (Bifemelane, 50 mg kg-1 i.p.) slightly but significantly attenuated the impairment in LTP induction (196+/-23%, n=6; p<0.02). The findings in the present study indicate that CA1 pyramidal cells are dysfunctional in; synaptic palsticity long before their death. Bifemelane has been demonstrated to inhibit acetylcholine release strongly during cerebral ischaemia but not interfere with normal cholinergic synaptic transmission. The effect of bifemelane suggests that Ach release during ischaemia is partially involved in the post-ischaemic impairment of LTP induction.			MIYAZAKI, S (corresponding author), NIHON UNIV,SCH MED,DEPT NEUROL SURG,TOKYO 173,JAPAN.						ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; ANDINE P, 1988, J CEREBR BLOOD F MET, V8, P799, DOI 10.1038/jcbfm.1988.135; AUER RN, 1989, J NEUROSCI, V9, P1641; BAIMBRIDGE KG, 1981, BRAIN RES, V221, P299, DOI 10.1016/0006-8993(81)90779-4; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; IZUMI Y, 1987, NEUROSCI LETT, V77, P176, DOI 10.1016/0304-3940(87)90582-9; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1991, BRAIN RES, V562, P352, DOI 10.1016/0006-8993(91)90647-E; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; MELCHERS BPC, 1988, BRAIN RES, V454, P1, DOI 10.1016/0006-8993(88)90798-6; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MIYAZAKI S, 1991, J CEREBR BLOOD FLO S, V11, P342; MIYAZAKI S, 1993, IN PRESS BRAIN RES; NEWLON PG, 1991, BRAIN RES, V544, P320, DOI 10.1016/0006-8993(91)90072-4; OGAWA N, 1988, RES COMMUN CHEM PATH, V61, P285; OGAWA N, 1988, CLIN THER, V10, P704; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; SAITO KI, 1985, JPN J PHARMACOL, V39, P406, DOI 10.1254/jjp.39.406; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SUZUKI R, 1983, ACTA NEUROPATHOL, V60, P217, DOI 10.1007/BF00691869; URBAN L, 1989, J NEUROSCI, V9, P3966; VOLPE BT, 1984, STROKE, V15, P558, DOI 10.1161/01.STR.15.3.558	28	9	10	0	1	FOREFRONT PUBL GROUP	LONDON	MONOMARK HOUSE 27 OLD GLOUCESTER STREET, LONDON, ENGLAND WC1N 3XX	0161-6412			NEUROL RES	Neurol. Res.	AUG	1993	15	4					249	252					4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT091	WOS:A1993LT09100005	8105404				2022-02-06	
J	BLAKELY, TA; HARRINGTON, DE				BLAKELY, TA; HARRINGTON, DE			MILD HEAD-INJURY IS NOT ALWAYS MILD - IMPLICATIONS FOR DAMAGE LITIGATION	MEDICINE SCIENCE AND THE LAW			English	Article							BRAIN; CONCUSSION	The traditional view that mild head injury involves an essentially reversible physiological process is examined and is found to be largely invalid. It is concluded that long-term impairment following mild head injury is fairly common and that the degree of impairment can be assessed clinically. Such an assessment involves a combination of objective electrophysiological and psychometric investigations as well as professional interpretation. With the use of this approach the possibility of malingering can be ruled out in most cases and significant impairment, when it exists, can be demonstrated beyond reasonable doubt.									Benton A.L., 1983, CONTRIBUTIONS NEUROP; BENTON AL, 1983, MILD HEAD INJURY; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLAKELY TA, 1978, UNPUB EXTERNAL REV P; BLONSTEIN JL, 1960, J SPORTS MED PHYSICA, V1, P30; BRUHN AR, 1975, J PERS ASSESS, V39, P244, DOI 10.1207/s15327752jpa3903_5; BURES J, 1963, J COMP PHYSL PSYCH, V56, P368; BURES J, 1960, ELECTROEN CLIN NEURO, V13, P359; CALNE DB, 1991, ARCH NEUROL-CHICAGO, V48, P361, DOI 10.1001/archneur.1991.00530160025009; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; CRONWALL D, 1975, LANCET, V2, P995; DEE HL, 1972, T AM NEUROL ASSOC, V97, P52; DUFFY FH, 1979, ANN NEUROL, V5, P309, DOI 10.1002/ana.410050402; DUFFY FH, 1980, ANN NEUROL, V7, P421, DOI 10.1002/ana.410070506; EDWARDS RM, 1982, ELECTROEN CLIN NEURO, V53, P125, DOI 10.1016/0013-4694(82)90018-9; FAUST D, 1988, SCIENCE, V241, P31, DOI 10.1126/science.3291114; Faust D, 1988, Arch Clin Neuropsychol, V3, P145, DOI 10.1016/0887-6177(88)90060-1; Filskov A. B., 1981, HDB CLIN NEUROPSYCHO; GIBBS FA, 1963, ELECTROEN CLIN NEURO, V15, P553, DOI 10.1016/0013-4694(63)90028-2; GOLDBERG LR, 1959, J CONSULT PSYCHOL, V23, P25, DOI 10.1037/h0048736; Goodglass H, 1983, ASSESSMENT APHASIA R; HARRINGTON DE, 1993, IN PRESS ARCH PHYSIC, V74; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JAKOBSEN J, 1987, ACTA NEUROL SCAND, V75, P341, DOI 10.1111/j.1600-0404.1987.tb05456.x; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Luria AR., 1976, NEUROPSYCHOLOGY MEMO; MANDEL S, 1989, POSTGRAD MED, V85, P213; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Miller E, 1970, Cortex, V6, P121; Milner B, 1975, Adv Neurol, V8, P299; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; REITAN R, 1973, MANUAL ADM NEUROPSYC; ROBINS LN, 1985, ARCH GEN PSYCHIAT, V42, P918; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, V44, P1181, DOI 10.1001/archneur.1987.00520230061015; TEASDALE G, 1974, LANCET, V2, P81; TEMERLIN MK, 1969, PSYCHOTHER-THEOR RES, V6, P24, DOI 10.1037/h0088712; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Walton G. L., 1881, BOSTON MED SURG J, V109, P337, DOI 10.1056/NEJM188310111091501; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; ZISKIN J, 1988, COPING PSYCHIATRIC P, V1; [No title captured]; 1966, CLIN NEUROSURG, V12, P386	43	9	9	0	1	CHILTERN PUBLISHING	BEACONSFIELD	34 AYLESBURY END, BEACONSFIELD, BUCKS, ENGLAND HP9 1LW	0025-8024			MED SCI LAW	Med. Sci. Law	JUL	1993	33	3					231	242		10.1177/002580249303300309			12	Law; Medicine, Legal; Pathology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Government & Law; Legal Medicine; Pathology	LQ093	WOS:A1993LQ09300009	8366786				2022-02-06	
J	MURDOCH, BE; THEODOROS, DG; STOKES, PD; CHENERY, HJ				MURDOCH, BE; THEODOROS, DG; STOKES, PD; CHENERY, HJ			ABNORMAL PATTERNS OF SPEECH BREATHING IN DYSARTHRIC SPEAKERS FOLLOWING SEVERE CLOSED-HEAD INJURY	BRAIN INJURY			English	Article								The respiratory abilities of a group of 20 subjects with a speech disorder resulting from severe closed head injury (CHI) were assessed using both spirometric and kinematic techniques and compared with those of a group of 20 non-neurologically impaired controls matched for age and gender. Results of the spirometric assessment showed that the CHI subjects as a group had lower vital capacities and lower forced expiratory volumes 1 second than the controls. Kinematic assessment also showed that the CHI subjects had problems co-ordinating the action of the rib-cage and abdomen when carrying out speech tasks such as vowel prolongations, syllable repetitions and reading. Results are discussed in terms of the effects of CHI on neuromuscular function.					Theodoros, Deborah/F-1362-2010; Chenery, Helen J/F-5194-2010; Murdoch, Bruce E/C-1397-2012				BOREN HG, 1966, AM J MED, V41, P96, DOI 10.1016/0002-9343(66)90008-8; Brown J.R., 1975, MOTOR SPEECH DISORDE; DE LA TORRE R, 1960, Q Bull Northwest Univ Med Sch, V34, P232; HIXON TJ, 1973, J SPEECH HEAR RES, V16, P78, DOI 10.1044/jshr.1601.78; HODGE MM, 1989, J SPEECH HEAR RES, V32, P466, DOI 10.1044/jshr.3203.466; HOIT JD, 1989, J SPEECH HEAR RES, V32, P353, DOI 10.1044/jshr.3202.353; HOLM S, 1979, SCAND J STAT, V6, P65; HUNKER CAJ, 1983, CLIN DYSARTHRIA, P21; KORY RC, 1961, AM J MED, V30, P243, DOI 10.1016/0002-9343(61)90096-1; MURDOCH BE, 1991, J SPEECH HEAR RES, V34, P768, DOI 10.1044/jshr.3404.768; MURDOCH BE, 1989, J SPEECH HEAR DISORD, V54, P610, DOI 10.1044/jshd.5404.610; PUTNAM AHB, 1984, DYSARTHRIAS PHYSL AC, P37	12	9	9	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL-AUG	1993	7	4					295	308		10.3109/02699059309034956			14	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MA171	WOS:A1993MA17100002	8358403				2022-02-06	
J	RESNICK, C				RESNICK, C			THE EFFECT OF HEAD-INJURY ON FAMILY AND MARITAL STABILITY	SOCIAL WORK IN HEALTH CARE			English	Article							RELATIVES VIEW; SOCIAL SUPPORT; PATIENT; CRISIS	Traumatic brain injury (TBI) is a public health concern with implications for injured persons, families, and society. This study examines how TBI affects family and marital relationships. A retrospective survey was conducted that requested responses from relatives of head injured individuals. The mean interval between the occurrence of head injury and survey response was eight years. Responses revealed the need for support, information, and education. The implementation of a case-management system, incorporating significant roles and functions for social workers can assist families in coping with traumatic brain injury.			RESNICK, C (corresponding author), UNIV TENNESSEE,COLL SOCIAL WORK,KNOXVILLE,TN 37996, USA.						BLAZKY S, 1985, SOCIAL WORK      NOV, P489; BLAZYK S, 1986, SOC WORK HEALTH CARE, V11, P19, DOI 10.1300/J010v11n04_02; BLAZYK S, 1983, SOC WORK HEALTH CARE, V8, P55, DOI 10.1300/J010v08n04_05; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BORNSTEIN RA, 1988, NEUROSURGERY, V23, P622, DOI 10.1227/00006123-198811000-00013; BOURDON SE, 1986, NURSING CLIN N A DEC, P629; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CASSEL J, 1974, INT J HEALTH SERV, V4, P471, DOI 10.2190/WF7X-Y1L0-BFKH-9QU2; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; CONE JB, 1989, SOUTHERN MED J, V82, P23, DOI 10.1097/00007611-198901000-00007; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Graham T W, 1978, J Behav Med, V1, P37, DOI 10.1007/BF00846585; GURDJIAN ES, 1973, J TRAUMA, V13, P931, DOI 10.1097/00005373-197311000-00001; GURDJIAN ES, 1974, J NEUROSURG, V39, P157; Gurdjian ES., 1973, HEAD INJURY ANTIQUIT; HORN LJ, 1989, TRAUMATIC BRAIN INJU; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kaplan B H, 1977, Med Care, V15, P47, DOI 10.1097/00005650-197705001-00006; LEVESQUE JD, 1988, SOC WORK HEALTH CARE, V13, P49, DOI 10.1300/J010v13n04_05; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; MOONILAL JM, 1982, SOC WORK HEALTH CARE, V7, P15, DOI 10.1300/J010v07n04_02; MOORE ST, 1990, SOC WORK, V35, P385; MORBARAK M, 1988, INT SOCIAL WORK, V31, P285; MORROW GR, 1981, J CONSULT CLIN PSYCH, V49, P763, DOI 10.1037/0022-006X.49.5.763; NETTING FE, 1992, SOC WORK, V37, P160; SODERSTROM S, 1988, SCAND J REHABIL ME S, V17, P47; WHITMAN M, 1991, REHABILITATION N JAN, P19; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	35	9	9	0	2	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580	0098-1389			SOC WORK HEALTH CARE	Soc. Work Health Care		1993	18	2					49	62		10.1300/J010v18n02_03			14	Social Work	Social Science Citation Index (SSCI)	Social Work	LH191	WOS:A1993LH19100003	8332939				2022-02-06	
J	HALT, PS; SWANSON, RA; FADEN, AI				HALT, PS; SWANSON, RA; FADEN, AI			ALCOHOL EXACERBATES BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF RAT SPINAL-CORD TRAUMA	ARCHIVES OF NEUROLOGY			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; FOCAL CEREBRAL-ISCHEMIA; ESSENTIAL FATTY-ACIDS; EXTRACELLULAR CALCIUM; ETHANOL POTENTIATION; PROSTACYCLIN LEVELS; METABOLIC CHANGES; IMPACT TRAUMA; BRAIN INJURY; AMINO-ACIDS	Acute alcohol intoxication may exacerbate the consequences of central nervous system trauma, although the mechanism is uncertain. Effects of acute ethanol administration on behavioral and neurochemical changes were examined in rats after traumatic spinal cord injury. Survival rates were reduced and posttraumatic neurologic function worsened in ethanol-treated as compared with saline-treated controls. Ethanol-treated rats had significantly lower tissue levels of excitatory amino acids and higher levels of free fatty acids, thromboxane, and lactic acid than did controls. Tissue magnesium concentration was significantly reduced by trauma and recovered more slowly in ethanol-treated rats. Enhanced phospholipid hydrolysis with free fatty acid and thromboxane accumulation, increased release of excitatory amino acids, and decreased tissue magnesium levels may each serve to worsen secondary tissue damage and diminish neurologic recovery after spinal cord injury associated with acute alcohol intoxication.	GEORGETOWN UNIV,MED CTR,DEPT NEUROL,MED DENT BLDG,NW 101,3900 RESERVOIR RD,WASHINGTON,DC 20007; GEORGETOWN UNIV,MED CTR,DEPT PHARMACOL,WASHINGTON,DC 20007; VET ADM MED CTR,SAN FRANCISCO,CA 94121						PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR903623] Funding Source: Medline		Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Anderson T E, 1986, Cent Nerv Syst Trauma, V3, P183; ANGGARD E, 1983, PHARMACOL BIOCHEM BE, V18, P401; BLACHLEY JD, 1985, AM J MED SCI, V289, P22, DOI 10.1097/00000441-198501000-00004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANCHE CM, 1991, ACCIDENT ANAL PREV, V23, P13, DOI 10.1016/0001-4575(91)90030-9; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; BRODNER RA, 1981, J TRAUMA, V21, P124, DOI 10.1097/00005373-198102000-00005; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DEMPSEY RJ, 1985, J NEUROSURG, V62, P874, DOI 10.3171/jns.1985.62.6.0874; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1987, J NEUROCHEM, V48, P1809, DOI 10.1111/j.1471-4159.1987.tb05740.x; FADEN AI, 1984, NEUROLOGY, V34, P1280, DOI 10.1212/WNL.34.10.1280; FADEN AI, 1990, J PHARMACOL EXP THER, V255, P451; FADEN AI, 1989, UPDATE INTENSIVE CAR, V9, P14; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FLEURETBALTER C, 1983, PHARMACOL BIOCHEM BE, V18, P25, DOI 10.1016/0091-3057(83)90142-9; Frisbie J H, 1984, J Am Paraplegia Soc, V7, P71; GOERTZ B, 1982, EXP BRAIN RES, V48, P438; GONZALES RA, 1991, TRENDS PHARMACOL SCI, V12, P1, DOI 10.1016/0165-6147(91)90478-B; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HEINEMANN AW, 1988, ALCOHOL CLIN EXP RES, V12, P815, DOI 10.1111/j.1530-0277.1988.tb01352.x; HORROBIN DF, 1987, ALCOHOL CLIN EXP RES, V11, P2, DOI 10.1111/j.1530-0277.1987.tb01250.x; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; HUDSPITH M, 1985, ALCOHOL, V2, P133, DOI 10.1016/0741-8329(85)90030-8; JAIN NC, 1971, CLIN CHEM, V17, P82; Kiwerski J, 1989, Chir Narzadow Ruchu Ortop Pol, V54, P14; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; LEDIG M, 1982, Substance and Alcohol Actions-Misuse, V3, P25; LEMKE M, 1990, MOL CHEM NEUROPATHOL, V12, P147, DOI 10.1007/BF03159941; Lemke M, 1990, J NEUROTRAUM, V7, P41, DOI 10.1089/neu.1990.7.41; LEWIN MG, 1974, J NEUROSURG, V40, P65, DOI 10.3171/jns.1974.40.1.0065; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lowry O, 1972, FLEXIBLE SYSTEM ENZY, P194; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARQUES A, 1988, BIOCHEM PHARMACOL, V37, P601, DOI 10.1016/0006-2952(88)90131-1; MCCOY GF, 1989, INJURY, V20, P65, DOI 10.1016/0020-1383(89)90141-1; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MELGAARD B, 1983, ACTA NEUROL SCAND, V67, P131, DOI 10.1111/j.1600-0404.1983.tb04556.x; MICHENFELDER JD, 1973, ANESTHESIOLOGY, V39, P510, DOI 10.1097/00000542-197311000-00010; MOORE JW, 1964, J GEN PHYSIOL, V48, P279, DOI 10.1085/jgp.48.2.279; NEHLS DG, 1987, ANESTHESIOLOGY, V66, P453, DOI 10.1097/00000542-198704000-00002; OLDFIELD EH, 1990, J NEUROSURG, V72, P737, DOI 10.3171/jns.1990.72.5.0737; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PEDICONI M, 1985, PROSTAG OTH LIPID M, V30, P313, DOI 10.1016/0090-6980(85)90194-7; RAO PA, 1985, NEUROCHEM RES, V10, P1577, DOI 10.1007/BF00988600; RAWE SE, 1981, NEUROSURGERY, V9, P40, DOI 10.1227/00006123-198107000-00007; Ridella S A, 1986, Cent Nerv Syst Trauma, V3, P195; RUBIN E, 1983, PHARMACOL BIOCHEM BE, V18, P7, DOI 10.1016/0091-3057(83)90139-9; SALEM N JR, 1988, Advances in Alcohol and Substance Abuse, V7, P183; SALZMAN SK, 1990, BRAIN RES, V521, P33, DOI 10.1016/0006-8993(90)91521-H; SANDLER AN, 1967, J NEUROSURG, V5, P638; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; SEFARNICK DJ, 1985, PHARM BIOCH BEHAV, V23, P71; SELIGMAN ML, 1977, LIPIDS, V12, P945, DOI 10.1007/BF02533316; SMITH AL, 1974, STROKE, V5, P1; STEWART PA, 1988, BRAIN RES, V443, P12, DOI 10.1016/0006-8993(88)91593-4; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; SWANN AC, 1987, REV CLIN BASIC PHARM, V4, P213; TABAKOFF B, 1987, ENZYME, V37, P70, DOI 10.1159/000469242; TARLOV IM, 1954, ANN ARCH NEUROL PSYC, V71, P275; VINK R, 1989, BRAIN RES, V490, P144, DOI 10.1016/0006-8993(89)90440-X; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667	67	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	NOV	1992	49	11					1178	1184		10.1001/archneur.1992.00530350096025			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW864	WOS:A1992JW86400017	1444885				2022-02-06	
J	TRIANTAFYLLOU, SJ; WILSON, SC; RYCHAK, JS				TRIANTAFYLLOU, SJ; WILSON, SC; RYCHAK, JS			IRREDUCIBLE PULLED ELBOW IN A CHILD - A CASE-REPORT	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								"Pulled elbow" is a common pediatric injury that occurs when axial traction is applied to an arm that is extended while the forearm is pronated. These forces can create a transverse tear in the annular ligament, which permits subluxation of the radial head. In most cases, closed reduction can be performed by supinating the forearm and flexing the elbow. In the case of a five-year-old boy, surgical reduction of this injury was necessary to reduce the subluxated radial head.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,BOX 850,ROOM C-5529,HERSHEY,PA 17033								RANG M, 1983, CHILDRENS FRACTURES, P193; Salter R B, 1971, Clin Orthop Relat Res, V77, P134; SOUTHMAYD W, 1976, CLIN ORTHOPAEDICS, V121, P271; WILKINS KE, 1984, FRACTURES CHILDREN, V3, P556	4	9	10	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	NOV	1992		284					153	155					3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	JX204	WOS:A1992JX20400019	1395285				2022-02-06	
J	STEWART, BT; KAYE, AH				STEWART, BT; KAYE, AH			DELAYED CEREBROSPINAL-FLUID RHINORRHEA - A CASE-REPORT	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article						CEREBROSPINAL FLUID; HEAD INJURY; RHINNORRHOEA		Post-traumatic cerebrospinal fluid (CSF) rhinorrhoea is a well recognized complication of closed head injury. Most cases occur soon after injury and a delay in presentation of more than 1 month is unusual. A case is reported of CSF rhinorrhoea presenting 15 years after initial trauma which was complicated by meningitis after 12 months. The management of this condition is reviewed.	ROYAL MELBOURNE HOSP,DEPT NEUROSURG,PARKVILLE,VIC 3050,AUSTRALIA					Kaye, Andrew Henry/0000-0001-5049-8861				0	9	9	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	OCT	1992	62	10					818	820		10.1111/j.1445-2197.1992.tb06927.x			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JT046	WOS:A1992JT04600015	1445065				2022-02-06	
J	LAM, AM				LAM, AM			CHANGE IN CEREBRAL BLOOD-FLOW VELOCITY PATTERN DURING INDUCED HYPOTENSION - A NONINVASIVE INDICATOR OF INCREASED INTRACRANIAL-PRESSURE	BRITISH JOURNAL OF ANAESTHESIA			English	Article						BRAIN, BLOOD FLOW; INTRACRANIAL PRESSURE; EQUIPMENT, TRANSCRANIAL DOPPLER ULTRASONOGRAPHY	TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CIRCULATORY ARREST; ARTERY; NITROGLYCERIN; ADENOSINE; RELEASE; BRAIN	A neurologically intact patient underwent spinal instrumentation under hypotensive anaesthesia 10 days after a mild closed head injury. Transcranial Doppler monitoring of the right middle cerebral artery revealed an abnormal flow pattern, suggesting increased intracranial pressure, impaired autoregulation, or both. Patients with a mild head injury may have altered intracranial haemodynamics and the time course of recovery from these changes is unknown.			LAM, AM (corresponding author), UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT ANESTHESIOL,325 9TH AVE,SEATTLE,WA 98104, USA.						BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; COTTRELL JE, 1978, J NEUROSURG, V48, P329, DOI 10.3171/jns.1978.48.3.0329; COTTRELL JE, 1980, J NEUROSURG, V53, P309, DOI 10.3171/jns.1980.53.3.0309; DAHL A, 1989, STROKE, V20, P1733, DOI 10.1161/01.STR.20.12.1733; FORRESTER T, 1979, J PHYSIOL-LONDON, V296, P343, DOI 10.1113/jphysiol.1979.sp013009; HALSEY JH, 1989, STROKE, V20, P53, DOI 10.1161/01.STR.20.1.53; HASSLER W, 1988, J NEUROSURG, V68, P745; HASSLER W, 1989, J NEUROSURG, V71, P195, DOI 10.3171/jns.1989.71.2.0195; HIRST RP, 1990, ANESTH ANALG, V71, P503; LAM A M, 1989, Anesthesiology (Hagerstown), V71, pA583, DOI 10.1097/00000542-198909001-00583; LINDEGAARD KF, 1986, J NEUROL NEUROSUR PS, V49, P510, DOI 10.1136/jnnp.49.5.510; OBRIST WD, 1980, CEREBRAL CIRCULATION, P119; POWERS AD, 1989, NEUROSURGERY, V24, P884, DOI 10.1227/00006123-198906000-00015; SEILER RW, 1986, J NEUROSURG, V64, P594, DOI 10.3171/jns.1986.64.4.0594; SOLLEVI A, 1987, J CEREBR BLOOD F MET, V7, P673, DOI 10.1038/jcbfm.1987.121; TOWNES BD, 1986, ANESTH ANALG, V65, P955; [No title captured]	18	9	9	0	2	PROF SCI PUBL	LONDON	TAVISTOCK HOUSE EAST, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	APR	1992	68	4					424	428		10.1093/bja/68.4.424			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HL956	WOS:A1992HL95600021	1642924	Bronze			2022-02-06	
J	WISNER, DH; BATTISTELLA, FD; FRESHMAN, SP; WEBER, CJ; KAUTEN, RJ				WISNER, DH; BATTISTELLA, FD; FRESHMAN, SP; WEBER, CJ; KAUTEN, RJ			NUCLEAR-MAGNETIC-RESONANCE AS A MEASURE OF CEREBRAL METABOLISM - EFFECTS OF HYPERTONIC SALINE RESUSCITATION	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	51ST ANNUAL SESSION OF THE AMERICAN ASSOC FOR THE SURGERY OF TRAUMA	SEP 11-14, 1991	PHILADELPHIA, PA	AMER ASSOC SURG TRAUMA			TRAUMATIC BRAIN INJURY; ENERGY PHOSPHATE-METABOLISM; SMALL-VOLUME RESUSCITATION; HEMORRHAGIC-SHOCK; HEAD-INJURY; INTRACELLULAR PH; INTRACRANIAL-PRESSURE; SPECTROSCOPY; P-31; LACTATE	Fears of central nervous system dysfunction from acute hypernatremia and hyperosmolarity with hypertonic saline resuscitation are often cited. We used high-energy phosphate nuclear magnetic resonance to investigate resuscitation effects on cerebral metabolism. Rats were instrumented for hemodynamic monitoring and fluid infusion and a phosphorus surface coil placed on their skulls. After shimming, baseline spectra were obtained. Animals were then bled for one hour to a mean arterial pressure (MAP) of 45 mm Hg, followed by resuscitation for one hour to a MAP of 75 mm Hg with lactated Ringer's (LR, n = 17) or 7.5% hypertonic saline (HS, n = 25). Spectra were obtained again and analyzed for the ratio of high-energy phosphocreatine (PCr) to low-energy inorganic phosphate (P(i)). Intracellular hydrogen ion concentration [H +] was calculated from the PCr/P(i) shift. [GRAPHICS] Conclusions: (1) Hypertonic saline results in a decreased intracellular pH compared with LR without associated changes in high-energy phosphate metabolism. (2) Decreases in pH may be the result of cell dehydration rather than metabolic dysfunction.	UNIV CALIF DAVIS,SACRAMENTO MED CTR,MED CTR,DEPT NEUROSURG,SACRAMENTO,CA 95817		WISNER, DH (corresponding author), UNIV CALIF DAVIS,SACRAMENTO MED CTR,MED CTR,DEPT SURG,4301 X ST,ROOM 2310,SACRAMENTO,CA 95817, USA.						ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; CADOUXHUDSON TAD, 1990, ACTA NEUROCHIR, V104, P1, DOI 10.1007/BF01842884; COMBS DJ, 1990, STROKE, V21, P936, DOI 10.1161/01.STR.21.6.936; DEMLING RH, 1988, AM COLLEGE SURGEONS, V1, pCH1; ELEFF SM, 1991, STROKE, V22, P233, DOI 10.1161/01.STR.22.2.233; FEIG PU, 1981, MED CLIN N AM, V65, P271, DOI 10.1016/S0025-7125(16)31524-3; GUNNAR W, 1988, SURGERY, V103, P398; HANDS R, 1988, SURGERY, V103, P684; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; HOTCHKISS RS, 1989, AM J PHYSIOL, V257, pC1055, DOI 10.1152/ajpcell.1989.257.6.C1055; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; KAUPPINEN RA, 1990, J NEUROSCI RES, V26, P356, DOI 10.1002/jnr.490260313; KOBAYASHI H, 1990, NEUROSURGERY, V27, P240, DOI 10.1227/00006123-199008000-00012; KRAMER GC, 1986, SURGERY, V100, P239; LOWRY SF, 1989, AM COLLEGE SURGEONS, V1, pCH11; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; POOLE GV, 1987, J TRAUMA, V27, P18, DOI 10.1097/00005373-198701000-00004; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; RANGO M, 1990, ANN NEUROL, V28, P661, DOI 10.1002/ana.410280510; SHACKFORD SR, 1988, SURGERY, V104, P553; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; SUTTON LN, 1987, J NEUROSURG, V67, P381, DOI 10.3171/jns.1987.67.3.0381; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011	35	9	9	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1992	32	3					351	358		10.1097/00005373-199203000-00013			8	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HM904	WOS:A1992HM90400013	1548724				2022-02-06	
J	EGNOR, MR; PAGE, LK; DAVID, C				EGNOR, MR; PAGE, LK; DAVID, C			VERTEBRAL ARTERY ANEURYSM - A UNIQUE HAZARD OF HEAD BANGING BY HEAVY-METAL ROCKERS - CASE-REPORT	PEDIATRIC NEUROSURGERY			English	Article						VERTEBRAL ARTERY; VERTEBROBASILAR EMBOLI; CERVICAL VASCULAR INJURY; POSTERIOR CIRCULATION ANEURYSMS		A 15-year-old drummer in a neighborhood rock music band suffered a traumatic true aneurysm of the cervical vertebral artery from violent head and neck motion. He underwent excision of the aneurysm after distal and proximal ligation of the artery. He is neurologically normal 1 year after surgery. The mechanisms of injury caused by extremes of cervical motion, as well as 5 previously reponed cases of extracranial vertebral artery aneurysm from closed trauma, are discussed. Excision of vertebral artery aneurysms in patients with emboli from a mural thrombus is recommended. The consequences of vertebral artery ligation and the indications for distal reconstruction are discussed.	UNIV MIAMI,SCH MED,DEPT NEUROL SURG,MIAMI,FL 33152								BAKAY L, 1953, J NEUROSURG, V10, P353, DOI 10.3171/jns.1953.10.4.0353; BARTON JW, 1975, NEURORADIOLOGY, V9, P117, DOI 10.1007/BF00332957; CASE MFS, 1975, ANGIOLOGY, V30, P138; CHAKERA TMH, 1982, BRIT J RADIOL, V55, P863, DOI 10.1259/0007-1285-55-659-863; DAVIDSON KC, 1975, RADIOLOGY, V115, P651, DOI 10.1148/15.3.651; ELKIN DC, 1946, ANN SURG, V124, P934, DOI 10.1097/00000658-194611000-00009; FAKHRY SM, 1988, J VASC SURG, V8, P501; FALCONER MA, 1951, J NEUROL NEUROSUR PS, V14, P153, DOI 10.1136/jnnp.14.3.153; GEORGE B, 1980, ACTA NEUROCHIR, V51, P259, DOI 10.1007/BF01406753; HUSNI EA, 1967, ANGIOLOGY, P106; KISTER SJ, 1966, PLAST RECONSTR SURG, V37, P546, DOI 10.1097/00006534-196606000-00011; Matas R, 1893, Ann Surg, V18, P477; Miller Jim, 1980, ROLLING STONE ILLUST; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; SORENSEN BF, 1978, NEUROSURGERY, V2, P259, DOI 10.1227/00006123-197805000-00013; TATLOW WFT, 1957, NEUROLOGY, V7, P331, DOI 10.1212/WNL.7.5.331	16	9	9	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		1992	17	3					135	138					4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HX395	WOS:A1992HX39500006					2022-02-06	
J	RAPPAPORT, M; HEMMERLE, AV; RAPPAPORT, ML				RAPPAPORT, M; HEMMERLE, AV; RAPPAPORT, ML			SHORT AND LONG LATENCY AUDITORY EVOKED-POTENTIALS IN TRAUMATIC BRAIN INJURY PATIENTS	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article						AUDITORY EVOKED POTENTIAL; TRAUMATIC BRAIN INJURY	HEAD-INJURY; STEM RESPONSE; DISABILITY				RAPPAPORT, M (corresponding author), UNIV CALIF SAN JOSE,BRAIN FUNCT STUDY UNIT,AGNEWS DEV CTR,RES & EDUC BLDG,SAN JOSE,CA 95134, USA.						CASHMAN MZ, 1983, SCAND AUDIOL, V12, P35, DOI 10.3109/01050398309076222; CHU NS, 1982, ELECTROEN CLIN NEURO, V54, P418, DOI 10.1016/0013-4694(82)90205-X; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; Rappaport M, 1990, J Neuropsychiatry Clin Neurosci, V2, P399; RAPPAPORT M, 1985, CLIN ELECTROENCEPHAL, V16, P183, DOI 10.1177/155005948501600404; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RAPPAPORT M, 1990, CLIN ELECTROENCEPHAL, V21, P188, DOI 10.1177/155005949002100406; RAPPAPORT M, UNPUB FURTHER COMP P; Rappaport M, 1989, J HEAD TRAUMA REHAB, V4, P45; Spehlmann R., 1985, EVOKED POTENTIAL PRI	16	9	9	0	0	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1991	22	4					199	202		10.1177/155005949102200407			4	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	GJ613	WOS:A1991GJ61300003	1934516				2022-02-06	
J	MIRA, MP; TYLER, JS				MIRA, MP; TYLER, JS			STUDENTS WITH TRAUMATIC BRAIN INJURY - MAKING THE TRANSITION FROM HOSPITAL TO SCHOOL	FOCUS ON EXCEPTIONAL CHILDREN			English	Article							HEAD-INJURIES; CHILDREN; SEQUELAE; ADOLESCENTS; RECOVERY; DAMAGE				MIRA, MP (corresponding author), UNIV KANSAS,MED CTR,CHILDRENS REHABIL UNIT,HEAD INJURY PROJECT,LAWRENCE,KS 66045, USA.						ADAMS W, 1990, MAY N COAST REG C SO; BARIN JJ, 1985, HEAD INJURY REHABILI, P361; BAWDEN HN, 1985, J CLIN EXPT NEUROPSY, V7, P30; Begali V., 1987, HEAD INJURY CHILDREN; BLACK P, 1971, P INT S HEAD INJ ED, P131; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DePompei R, 1987, LANG SPEECH HEAR SER, V18, P292, DOI 10.1044/0161-1461.1804.292; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; FAY G, 1986, J HEAD TRAUMA REHABI, V1, P16; Haarbauer-Krupa J, 1985, HEAD INJURY REHABILI, P287; HAUSER WA, 1983, PEDIATRIC HEAD TRAUM, P223; JACOBS MP, 1989, FORUM, V14, P9; JAFFE KM, 1986, J HEAD TRAUMA REHAB, V1, P30; KALSBEEK WD, 1980, J NEUROSURGERY S, V53, P19; KLONOFF H, 1977, NEUROSURGERY PSYCHIA, V40, P122; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1986, CHILD DEV LEARNING B, P317; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; MARQUARDT TP, 1988, J LEARN DISABIL, V21, P340, DOI 10.1177/002221948802100605; MARTIN R, 1988, J LEARN DISABIL, V21, P471, DOI 10.1177/002221948802100804; MIRA M, 1989, 67TH ANN M COUNC EXC; MIRA M, 1988, TRAUMATIC HEAD INJUR; MIRA MP, 1988, DIAGNOSTIQUE, V13, P174; *NAT HEAD INJ F TA, 1988, ED MAN EQ NEED KNOW; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; PRIGATANO GP, 1987, DEC NAT HEAD INJ F S; Rosen CD, 1986, HEAD TRAUMA ED REINT; ROURKE BP, 1986, NEUROPSYCHOLOGICAL A; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SAVAGE R, 1984, COGNITIVE REHABILITA, V2, P28; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; SCOTT MB, 1984, THESIS U PITTSBURGH; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; SLATER EJ, 1987, PSYCHIAT ANN, V17, P786, DOI 10.3928/0048-5713-19871201-08; TYLER J, 1989, UNPUB CHILDREN YOUTH; TYLER J, 1990, TRAUMATIC HEAD INJUR; WALKER N, 1987, DEC NAT HEAD INJ F S; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48	44	9	9	0	0	LOVE PUBL CO	DENVER	1777 SOUTH BELLAIRE ST, DENVER, CO 80222	0015-511X			FOCUS EXCEPT CHILD	Focus Except. Child	JAN	1991	23	5					1	12					12	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	FC942	WOS:A1991FC94200001					2022-02-06	
J	BUTLERHINZ, S; CAPLAN, D; WATERS, G				BUTLERHINZ, S; CAPLAN, D; WATERS, G			CHARACTERISTICS OF SYNTACTIC COMPREHENSION DEFICITS FOLLOWING CLOSED HEAD-INJURY VERSUS LEFT CEREBROVASCULAR ACCIDENT	JOURNAL OF SPEECH AND HEARING RESEARCH			English	Article											BUTLERHINZ, S (corresponding author), MCGILL UNIV,SCH HUMAN COMMUN DISORDERS,BEATTY HALL,1266 PINE AVE W,MONTREAL H3G 1A8,QUEBEC,CANADA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; ANSELL BJ, 1982, BRAIN LANG, V16, P61, DOI 10.1016/0093-934X(82)90072-4; BERNDT R, 1982, ACQUIRED APHASIA, P157; Bradley D. C., 1980, BIOL STUDIES MENTAL, P269; BROOKSHIRE RH, 1978, BRAIN LANG, V6, P149, DOI 10.1016/0093-934X(78)90054-8; CAPLAN D, 1986, BRAIN LANG, V27, P168, DOI 10.1016/0093-934X(86)90011-8; CAPLAN D, 1986, BRAIN LANG, V27, P117, DOI 10.1016/0093-934X(86)90008-8; CAPLAN D, 1985, COGNITION, V21, P117, DOI 10.1016/0010-0277(85)90048-4; Caplan D., 1988, DISORDERS SYNTACTIC; CAPLAN D, 1990, NEUROPSYCHOLOGICAL I; Caplan David, 1987, NEUROLINGUISTICS LIN; CARAMAZZA A, 1976, BRAIN LANG, V3, P572, DOI 10.1016/0093-934X(76)90048-1; CARAMAZZA A, 1981, BRAIN LANG, V14, P235, DOI 10.1016/0093-934X(81)90078-X; CHOMSKY N, 1981, LECTURES GOVT BINDIN; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DERENZI E, 1979, AUDITORY COMPREHENSI, P33; Fodor J.A., 1983, MODULARITY MIND; FRIEDMAN EA, 1987, CLIN OBSTET GYNECOL, V30, P93, DOI 10.1097/00003081-198703000-00014; GRODZINSKY Y, 1986, BRAIN LANG, V27, P135, DOI 10.1016/0093-934X(86)90009-X; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HEILMAN KM, 1976, CORTEX, V12, P258, DOI 10.1016/S0010-9452(76)80007-X; HILDEBRANDT N, 1987, COGNITIVE NEUROPSYCH, V4, P257, DOI 10.1080/02643298708252040; LESSER R, 1976, NEUROPSYCHOLOGIA, V14, P79, DOI 10.1016/0028-3932(76)90009-9; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; MACK JL, 1978, AUDITORY COMPREHENSI, P45; MARTIN RC, 1986, BRAIN LANG, V28, P196, DOI 10.1016/0093-934X(86)90102-1; MCCARTHY RA, 1987, BRAIN, V110, P1545, DOI 10.1093/brain/110.6.1545; McNeil MR, 1978, REVISED TOKEN TEST; MICELI G, 1983, BRAIN LANG, V19, P65, DOI 10.1016/0093-934X(83)90056-1; PEACH RK, 1988, BRAIN LANG, V35, P119, DOI 10.1016/0093-934X(88)90104-6; SAFFRAN EM, 1975, BRAIN LANG, V2, P420, DOI 10.1016/S0093-934X(75)80081-2; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SCHWARTZ MF, 1980, BRAIN LANG, V10, P249, DOI 10.1016/0093-934X(80)90055-3; Spreen O., 1969, NEUROSENSORY CTR COM; WATERS GS, IN PRESS COGNITIVE N; WHITAKER HA, 1972, NEUROPSYCHOLOGIA, V10, P395, DOI 10.1016/0028-3932(72)90002-4	38	9	9	0	1	AMER SPEECH-LANG-HEARING ASSN	ROCKVILLE	10801 ROCKVILLE PIKE RD, ROCKVILLE, MD 20852-3279	0022-4685			J SPEECH HEAR RES	J. Speech Hear. Res.	JUN	1990	33	2					269	280		10.1044/jshr.3302.269			12	Language & Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	DH270	WOS:A1990DH27000007	2359267				2022-02-06	
J	ROBINSON, SE; RYLAND, JE; MARTIN, RM; GYENES, CA; DAVIS, TR				ROBINSON, SE; RYLAND, JE; MARTIN, RM; GYENES, CA; DAVIS, TR			THE EFFECTS OF MORPHINE AND TRAUMATIC BRAIN INJURY ON CENTRAL CHOLINERGIC NEURONS	BRAIN RESEARCH			English	Article											ROBINSON, SE (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,BOX 613,MCV STN,RICHMOND,VA 23298, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS024413] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS24413] Funding Source: Medline		BLOCK CH, 1987, PEPTIDES, V8, P267, DOI 10.1016/0196-9781(87)90102-1; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; DESALLES AAF, 1987, J NEUROSURG, V66, P102, DOI 10.3171/jns.1987.66.1.0102; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; HANIN I, 1970, SCIENCE, V170, P341, DOI 10.1126/science.170.3955.341; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; HAYES RL, 1984, BRAIN RES, V311, P267, DOI 10.1016/0006-8993(84)90089-1; HAYES RL, IN PRESS MILD HEAD I; KASA P, 1986, PROG NEUROBIOL, V26, P211, DOI 10.1016/0301-0082(86)90016-X; KATAYAMA Y, 1985, BRAIN RES, V334, P366, DOI 10.1016/0006-8993(85)90234-3; KATAYAMA Y, 1985, J NEUROSURG, V63, P97, DOI 10.3171/jns.1985.63.1.0097; KATAYAMA Y, 1985, BRAIN RES, V335, P392, DOI 10.1016/0006-8993(85)90502-5; KATAYAMA Y, 1984, BRAIN RES, V296, P241, DOI 10.1016/0006-8993(84)90062-3; KEPPEL G, 1982, DESIGN ANAL RES HDB; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P306; METHERATE R, 1987, NEUROSCIENCE, V22, P75, DOI 10.1016/0306-4522(87)90198-9; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MODY I, 1987, NATURE, V326, P701, DOI 10.1038/326701a0; MORONI F, 1978, BRAIN RES, V150, P333, DOI 10.1016/0006-8993(78)90284-6; MUNOZ FG, 1979, J PHARMACOL EXP THER, V209, P132; OLNEY JW, 1983, NATURE, V301, P520, DOI 10.1038/301520a0; RACAGNI G, 1974, LIFE SCI, V15, P1961, DOI 10.1016/0024-3205(74)90047-2; RASMUSSEN H, 1984, PHYSIOL REV, V64, P938, DOI 10.1152/physrev.1984.64.3.938; ROBINSON SE, 1986, J NEUROCHEM, V46, P1632, DOI 10.1111/j.1471-4159.1986.tb01786.x; ROBINSON SE, 1987, SOC NEUR ABSTR, V17, P1254; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SAIJA A, 1988, J NEUROTRAUMA, V5, P71; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; TEASDALE G, 1976, BRIT J ANAESTH, V49, P761; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WOOD PL, 1980, NEUROPHARMACOLOGY, V19, P975, DOI 10.1016/0028-3908(80)90008-8; YAMANO M, 1987, BRAIN RES, V408, P22, DOI 10.1016/0006-8993(87)90354-4; ZSILLA G, 1976, J PHARMACOL EXP THER, V199, P662	38	9	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	NOV 27	1989	503	1					32	37		10.1016/0006-8993(89)91699-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB548	WOS:A1989CB54800005	2611656				2022-02-06	
J	HAFFEY, WJ; LEWIS, FD				HAFFEY, WJ; LEWIS, FD			PROGRAMMING FOR OCCUPATIONAL OUTCOMES FOLLOWING TRAUMATIC BRAIN INJURY	REHABILITATION PSYCHOLOGY			English	Article									NEW MEDICO HEAD INJURY SYST,LYNN,MA; NEW YORK MED COLL,VALHALLA,NY 10595								Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN MA, 1982, SOCIAL SKILLS TRAINI, P90; BURTON LF, 1987, J REHABIL, V53, P71; CRITES J, 1982, P S APPLIED RES METH, P1; Ellis H.C., 1965, TRANSFER LEARNING; GOLDSTEIN A, 1981, PSYCHOL SKILL TRAINI; HAFFEY W, 1989, MODELS BRAIN INJURY, P205; HAFFEY WJ, IN PRESS NEUROPSYCHO, V1; HAFFEY WJ, 1989, PHYSICAL MED REHABIL, P203; MAPLES MF, 1980, THEOR LEARN, P1; PEPPING M, UNPUB LONG TERM FOLL, V3; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1987, BNI Q, V3, P10; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; WACHTER JF, 1987, COMMUNITY REENTRY HE, P259; WAGNER KA, 1986, NEUROTRAUMA TREATMEN, P213; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012; WILMS WW, 1984, PHI DELTA KAPPAN, V65, P347; Wood RL, 1981, APPL CONDITIONING TH, P81; [No title captured]	22	9	9	0	0	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1989	34	2					147	158		10.1037//0090-5550.34.2.147			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AE974	WOS:A1989AE97400015					2022-02-06	
J	ELWANY, S				ELWANY, S			AUDITORY BRAIN-STEM RESPONSES (ABR) IN PATIENTS WITH ACUTE SEVERE CLOSED HEAD-INJURIES - THE USE OF A GRADING SYSTEM	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article									ALEXANDRIA MED SCH,ALEXANDRIA,EGYPT		ELWANY, S (corresponding author), DR FAKHRY HOSP,POB 251,ALKHOBAR,SOUTH AFRICA.			Elwany, Samy/0000-0002-1951-1842			BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CLIFTON GL, 1980, J NEUROSURGERY, V18, P114; DUCANTI A, 1985, HOSPITAL MED, V5, P32; EGGERMONT JJ, 1980, ANN OTOL RHINOL LA S, V89, P75; ELWANY S, 1985, ORL J OTO-RHINO-LARY, V47, P90, DOI 10.1159/000275750; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; HALL JW, 1982, LARYNGOSCOPE, V92, P883; HALL JW, 1983, OTOLARYNG HEAD NECK, V91, P50, DOI 10.1177/019459988309100110; JENNETT B, 1975, LANCET, V1, P480; JEWETT DL, 1970, ELECTROEN CLIN NEURO, V28, P609, DOI 10.1016/0013-4694(70)90203-8; MOLLER AR, 1980, AM J OTOLARYNGOL, V1, P273; MOLLER MB, 1983, ANN OTO RHINOL LARYN, V92, P645, DOI 10.1177/000348948309200622; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OTTAVIANI F, 1986, ELECTROEN CLIN NEURO, V65, P196, DOI 10.1016/0168-5597(86)90054-7; PLUM F, 1972, DIAGNOSIS STUPOR COM, P35; RANTANEN T, 1967, ACTA OTOLARYNGOLOG S, V224, P256; STOCKARD JJ, 1977, NEUROLOGY, V27, P316, DOI 10.1212/WNL.27.4.316	19	9	11	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD, KENT, ENGLAND TN24 8HH	0022-2151			J LARYNGOL OTOL	J. Laryngol. Otol.	SEP	1988	102	9					755	759		10.1017/S0022215100106383			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	Q2856	WOS:A1988Q285600002	3171365				2022-02-06	
J	FUGELMEYER, AR; FUGLMEYER, KS				FUGELMEYER, AR; FUGLMEYER, KS			THE COPING PROCESS AFTER TRAUMATIC BRAIN INJURY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article											FUGELMEYER, AR (corresponding author), UMEA UNIV, DEPT PHYS MED & REHABIL, S-90187 UMEA, SWEDEN.			Sjogren Fugl-Meyer, Kerstin/0000-0003-4794-0959				0	9	9	0	0	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1988				17			51	53					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	P5160	WOS:A1988P516000009	3165211				2022-02-06	
J	PARKINSON, D; WARKENTIN, TE; JELL, RM				PARKINSON, D; WARKENTIN, TE; JELL, RM			SPINAL-CORD CONCUSSION IN FROGS - A STUDY OF REFLEX CHANGES	SURGICAL NEUROLOGY			English	Article											PARKINSON, D (corresponding author), UNIV MANITOBA,NEUROSURG SECT,WINNIPEG R3E 0W3,MANITOBA,CANADA.						ADAMS RD, 1980, HARRISONS PRINCIPLES, P2014; Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BUNZL A, 1954, BRIT J PHARM CHEMOTH, V9, P229, DOI 10.1111/j.1476-5381.1954.tb00846.x; DARINSKII Y A, 1968, Byulleten' Eksperimental'noi Biologii i Meditsiny, V65, P10; DELBIGIO M, 1980, REVERSIBILITY CONCUS, P23; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; GRINNELL A, 1976, LABORATORY EXPT PHYS, V34, P35; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; Guttmann Sir Ludwig, 1976, SPINAL CORD INJURIES, P74; GUYTON AC, 1976, TXB MED PHYSL, P687; HARTMANN F, 1900, JB PSYCHIAT NEUROL, V19, P380; HUGHES JT, 1966, PATHOLOGY SPINAL COR, P62; JAMAKOSMANOVIC A, 1968, ACTA BIOL IUGOSLAV C, V4, P197; LYUTOV A. I., 1958, UCH ZAP 2 OI MOSK MED INST, V12, P185; MARBURG O, 1936, HDB NEUROLOGIE, V11, P1; MATSUURA S, 1969, EUR J PHARMACOL, V6, P13, DOI 10.1016/0014-2999(69)90058-2; OBERSTEINER H, 1879, WIEN MED JB, P532; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; PARKINSON D, 1977, MAYO CLIN PROC, V52, P492; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; Ruch TC, 1934, AM J PHYSIOL, V110, P362, DOI 10.1152/ajplegacy.1934.110.2.362; SCHIFF JM, 1858, LAHR SCHAUENBURG, V14, P424; Sherrington CS, 1947, INTEGRATIVE ACTION N; Shetter A G, 1979, Adv Neurol, V22, P5	26	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.		1983	20	6					456	460		10.1016/0090-3019(83)90027-7			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RS570	WOS:A1983RS57000005	6606236				2022-02-06	
J	PARKINSON, D				PARKINSON, D			THE BIOMECHANICS OF CONCUSSION	CLINICAL NEUROSURGERY			English	Article											PARKINSON, D (corresponding author), UNIV MANITOBA, NEUROL SURG SECT, WINNIPEG R3T 2N2, MANITOBA, CANADA.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; INCH T, 1913, BOXING BEGINNERS; Jefferson G, 1944, BRIT MED J, V1944, P1; LEAO AAP, 1945, J NEUROPHYSIOL, V8, P33; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; OBERSTEINER H, 1879, MED JB, P532; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; PARE A, 1590, CITED INDIRECTLY; PARKINSON D, 1977, MAYO CLIN PROC, V52, P492; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PARKINSON D, 1982, SURG NEUROL; PARKINSON D, 1981, UNPUB TEMPERATURE CH; PARKINSON D, 1982, UNPUB; PETIT JL, 1944, OEVRES COMPLETES LJ; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SANO K, 1978, NEUROSCI LETT, V8, P255; SANO K, 1972, NEUROTRAUMATOLOGIA; Shetter A G, 1979, Adv Neurol, V22, P5; SYMONDS C, 1962, LANCET, V1, P1; TOWER DB, 1966, HEAD INJURY, P448; VERJAAL A, HDB CLIN NEUROLOGY, V23, P417; WARD AA, 1966, CLIN NEUROSURG, V12, P95; WEST M, 1980, CAN J NEUROL SCI, V7, P320; WEST M, 1980, CAN FED BIOL SCI, V23, P141; 1966, NEUROSURGERY, V12, P386; [No title captured]	32	9	9	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA	0069-4827			CLIN NEUR			1982	29						131	145					15		Science Citation Index Expanded (SCI-EXPANDED)		PK097	WOS:A1982PK09700008	6129089				2022-02-06	
J	Witter, H; Muller, R				Witter, Hermann; Mueller, Rainer			The Activation of the EEG by Evipan in covered traumatic Brain Injuries	NERVENARZT			German	Article																	DUENSING, 1951, NERVENARZT, V22, P281; WELTE, 1948, ARCH PSYCH Z NEUR, V79, P243; WITTER, 1952, FORTSCHR NEUR, V20, P6; WITTER, 1950, NERVENARZT, V21, P260; WITTER, 1952, NERVENARZT, V23, P89; ZILLIG, 1950, DTSCH Z NERVENHEILK, V164, P16	6	9	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	MAR 20	1953	24	3					97	102					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	V03OO	WOS:000207000300003	13072777				2022-02-06	
J	MCCONNELL, AA				MCCONNELL, AA			ON CERTAIN SEQUELAE OF CLOSED HEAD INJURIES THE PATHOLOGICAL BASIS OF THE POST-TRAUMATIC SYNDROME	BRAIN			English	Article																	[Anonymous], 1942, Proc R Soc Med, V35, P601; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; CAIRNS H, 1942, P ROY SOC MED, V35, P299; da Costa DG, 1941, ARCH SURG-CHICAGO, V43, P559, DOI 10.1001/archsurg.1941.01210160020003; Jefferson G., 1942, P ROY SOC MED, V35, P295; Lanigan JP, 1944, LANCET, V2, P686; McCONNELL A A, 1951, Ir J Med Sci, P550; McConnell AA, 1941, J NEUROL PSYCHIATRY, V4, P237, DOI 10.1136/jnnp.4.3-4.237; McConnell AA, 1942, BRAIN, V65, P266, DOI 10.1093/brain/65.3.266; McConnell AA, 1944, LANCET, V1, P273; NAFFZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P1751; ROSS WD, 1944, ARCH NEUROL PSYCHIAT, V36, P75; Trotter W, 1924, LANCET, V1, P935; Trotter W, 1930, LANCET, V1, P169; WYCIS HT, 1945, J NEUROSURG, V2, P340, DOI 10.3171/jns.1945.2.4.0340; [No title captured]	16	9	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950			BRAIN	Brain		1953	76	3					473	484		10.1093/brain/76.3.473			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ828	WOS:A1953UZ82800008	13106180				2022-02-06	
J	McConnell, AA				McConnell, AA			Intracranial conditions after closed head injuries	BRAIN			English	Article																	Denny-Brown D, 1941, LANCET, V1, P371; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; JEFFERSON G, 1932, P ROY SOC MED, V25, P762; McConnell AA, 1941, J NEUROL PSYCHIATRY, V4, P237, DOI 10.1136/jnnp.4.3-4.237; *MED RES COUNC, 1941, 4 MED RES COUNC; NAFTZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P1751; O'Connell JEA, 1941, LANCET, V2, P719; Rowbotham GF, 1942, ACUTE INJURIES HEAD; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Symonds CP, 1935, LANCET, V1, P486; Trotter W, 1924, LANCET, V1, P935; Trotter W, 1930, LANCET, V1, P169; Turner IJA, 1941, BRIT MED J, V1941, P569, DOI 10.1136/bmj.2.4216.569	13	9	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain		1942	65						266	280		10.1093/brain/65.3.266			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V20IX	WOS:000201375100014					2022-02-06	
J	Duret, H				Duret, H			Serious concussion, fatal, without lesions (pure concussion) and enlarged cerebral lesions without concussion in the cranio-cerebral traumatisms	REVUE NEUROLOGIQUE			French	Article																	AUVRAY, 1896, SOC ANAT, P599; BABINSKI, 1912, J PSYCHOL        MAR; BAUDET, 1909, SOC CHIR, P271; BERTHOMMER, 1902, C CHIR, P405; BONNIER P, 1909, REV NEUROL, P1576; BONNIER P, 1909, REV NEUROL, P1662; IMBERT, 1910, REV CHIR, V2, P861; LEPLAT T, SOC ANAT, P19; MAROT, 1876, SOC ANAT, P138; MICHEL L, 1910, REV MED EST, P23; MILLER R, 1909, LANCET, P1339; MILLER T, 1910, LANCET, V1, P31; MOISSY, 1892, SOC ANATOMO CLIN LIL, P149; MOSSE, 1877, SOC ANAT, P619; PICQUE R, 1909, SOC CHIR, P278; SEYDEL, 1894, MUNCH MED WCHNSCHR, P755; SEYDEL, 1895, REV NEUROL, P185; SOURDILLE, 1904, ARCH GEN MED, V2, P1857; 1899, CENTRALBL CHIRURG, P772; 1895, DTSCH Z CHIR, P433; 1894, REV CHIR, P32; 1920, TRAUMATISMES CRANIO, V2	22	9	9	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787			REV NEUROL-FRANCE	Rev. Neurol.		1920	36						888	900					13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V29TB	WOS:000202009900039					2022-02-06	
J	Vanichkachorn, G; Newcomb, R; Cowl, CT; Murad, MH; Breeher, L; Miller, S; Trenary, M; Neveau, D; Higgins, S				Vanichkachorn, Greg; Newcomb, Richard; Cowl, Clayton T.; Murad, M. Hassan; Breeher, Laura; Miller, Sara; Trenary, Michael; Neveau, Daniel; Higgins, Steven			Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort	MAYO CLINIC PROCEEDINGS			English	Article							COVID-19; WORK; ASSOCIATIONS; CONCUSSION	Objective: To describe characteristics of a series of patients reporting prolonged symptoms after an infection with coronavirus disease 2019 (COVID-19). Patients and Methods: This study describes the multidisciplinary COVID-19 Activity Rehabilitation Program, established at Mayo Clinic to evaluate and treat patients with posteCOVID syndrome, and reports the clinical characteristics of the first 100 patients receiving evaluation and management during the timeframe of June 1, 2020, and December 31, 2020. Results: The cohort consisted of 100 patients (mean age, 45.4 +/- 14.2 years; 68% women; mean body mass index, 30.2 kg/m(2); presenting a mean of 93 days after infection). Common preexisting conditions were respiratory (23%) and mental health, including depression and/or anxiety (34%). Most (75%) had not been hospitalized for COVID-19. Common presenting symptoms ware fatigue (80%), respiratory complaints (59%), and neurological complaints (59%) followed by subjective cognitive impairment, sleep disturbance, and mental health symptoms. More than one-third of patients (34%) reported difficulties in performing basic activities of daily living. Only 1 in 3 patients had returned to unrestricted work duty at the time of the analysis. For most patients, laboratory and imaging tests showed no abnormalities or were nondiagnostic despite debilitating symptoms. Most patients required physical therapy, occupational therapy, or brain rehabilitation. Face-to-face and virtual care delivery modalities were feasible. Conclusion: Most of the patients did not have COVID-19erelated symptoms that were severe enough to require hospitalization, were younger than 65 years, and were more likely to be female, and most had no preexisting comorbidities before severe acute respiratory syndrome coronavirus 2 infection. Symptoms including mood disorders, fatigue, and perceived cognitive impairment resulted in severe negative impacts on resumption of functional and occupational activities in patients experiencing prolonged effects. (C) 2021 Mayo Foundation for Medical Education and Research	[Vanichkachorn, Greg; Newcomb, Richard; Cowl, Clayton T.; Murad, M. Hassan; Breeher, Laura; Miller, Sara] Mayo Clin, Div Prevent Occupat & Aerosp Med, 200 First St SW, Rochester, MN 55905 USA; [Trenary, Michael; Neveau, Daniel; Higgins, Steven] Mayo Clin, Div Phys Med & Rehabil, Rochester, MN 55905 USA		Vanichkachorn, G (corresponding author), Mayo Clin, Div Prevent Occupat & Aerosp Med, 200 First St SW, Rochester, MN 55905 USA.	Vanichkachorn.greg@mayo.edu		Murad, Mohammad Hassan/0000-0001-5502-5975	Minority Health AMP; Health Disparities Research Center, National Institute on Minority Health and Health Disparities [U54MD000502]; National Institutes of Health Mentored PatientOriented Research AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K23 HL146887-02]	This work is supported by the Minority Health & Health Disparities Research Center, National Institute on Minority Health and Health Disparities (U54MD000502) , and the National Institutes of Health Mentored PatientOriented Research Award (5K23 HL146887-02) to Dr Pankaj Arora.	Andre A, 2020, CLIN NEUROL NEUROSUR, V196, DOI 10.1016/j.clineuro.2020.106021; [Anonymous], RISK SARS COV 2 INF; [Anonymous], COVID DAT TRACK; Baker HA, 2021, BRIT J ANAESTH, V126, P44, DOI 10.1016/j.bja.2020.09.045; Barker-Davies RM, 2020, BRIT J SPORT MED, V54, P949, DOI 10.1136/bjsports-2020-102596; Bergman E, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035544; Besen E, 2015, J OCCUP REHABIL, V25, P25, DOI 10.1007/s10926-014-9522-9; Cardemil CV, 2021, JMIR PUBLIC HLTH SUR, V7, P222, DOI 10.2196/24502; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Chang MH, 2021, J RACIAL ETHN HEALTH, DOI 10.1007/s40615-020-00960-y; Chopra V, 2021, ANN INTERN MED, V174, P576, DOI 10.7326/M20-5661; Chu L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197811; Chu SY, 2017, BRAIN INJURY, V31, P1674, DOI 10.1080/02699052.2017.1332783; Dai CZL, 2021, CLIN INFECT DIS, V73, P2193, DOI [10.1093/cid/ciab154, 10.1101/2020.10.14.20212803]; Dweck MR, 2020, EUR HEART J-CARD IMG, V21, P949, DOI 10.1093/ehjci/jeaa178; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Geraghty K, 2019, J HEALTH PSYCHOL, V24, P1318, DOI 10.1177/1359105317726152; Goodwin VA, 2021, PHYSIOTHERAPY, V111, P4, DOI 10.1016/j.physio.2021.01.007; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Kanjwal Khalil, 2020, J Innov Card Rhythm Manag, V11, P4302, DOI 10.19102/icrm.2020.111102; Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013; Lau HMC, 2005, AUST J PHYSIOTHER, V51, P213, DOI 10.1016/S0004-9514(05)70002-7; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Lian YL, 2015, J PSYCHOSOM RES, V78, P45, DOI 10.1016/j.jpsychores.2014.09.009; Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830; Macias-Toronjo I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165966; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Merkler AE, 2020, JAMA NEUROL, V77, P1366, DOI 10.1001/jamaneurol.2020.2730; Miglis MG, 2020, CLIN AUTON RES, V30, P449, DOI 10.1007/s10286-020-00727-9; Nemer DM, 2021, J HOSP MED, V16, P7, DOI 10.12788/jhm.3510; Park R, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100519; Sheehy Lisa Mary, 2020, JMIR Public Health Surveill, V6, pe19462, DOI 10.2196/19462; STRAUS SE, 1985, ANN INTERN MED, V102, P7, DOI 10.7326/0003-4819-102-1-7; Telle KE, 2021, SCAND J PUBLIC HEALT, V49, P41, DOI 10.1177/1403494820985172; Tsai ST, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00498; Wang TNJ, 2020, AM J PHYS MED REHAB, V99, P769, DOI 10.1097/PHM.0000000000001505; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang Lu-Lu, 2020, Chronic Dis Transl Med, V6, P79, DOI 10.1016/j.cdtm.2020.05.002; Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065	40	8	8	17	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	JUL	2021	96	7					1782	1791		10.1016/j.mayocp.2021.04.024			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TC9OS	WOS:000668967400015	34218857	Bronze, Green Published			2022-02-06	
J	Roquilly, A; Moyer, JD; Huet, O; Lasocki, S; Cohen, B; Dahyot-Fizelier, C; Chalard, K; Seguin, P; Jeantrelle, C; Vermeersch, V; Gaillard, T; Cinotti, R; Latte, DDD; Mahe, PJ; Vourc'h, M; Martin, FP; Chopin, A; Lerebourg, C; Flet, L; Chiffoleau, A; Feuillet, F; Asehnoune, K				Roquilly, Antoine; Moyer, Jean Denis; Huet, Olivier; Lasocki, Sigismond; Cohen, Benjamin; Dahyot-Fizelier, Claire; Chalard, Kevin; Seguin, Philippe; Jeantrelle, Caroline; Vermeersch, Veronique; Gaillard, Thomas; Cinotti, Raphael; Latte, Dominique Demeure Dit; Mahe, Pierre Joachim; Vourc'h, Mickael; Martin, Florian Pierre; Chopin, Alice; Lerebourg, Celine; Flet, Laurent; Chiffoleau, Anne; Feuillet, Fanny; Asehnoune, Karim		Atlanrea Study Grp; Soc Francaise Anesthesie Reanima	Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury: The COBI Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPY; ASSOCIATION; MODERATE; HYPERNATREMIA; EPIDEMIOLOGY; MULTICENTER; RELIABILITY; GUIDELINES; MANAGEMENT; MORTALITY	Key PointsQuestionWhat is the effect of continuous infusion of hypertonic saline solution in patients with traumatic brain injury? FindingsIn this randomized clinical trial that included 370 adults with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline vs standard care resulted in an odds ratio for better neurological outcomes (based on the Extended Glasgow Outcome Scale) of 1.02 after 6 months; this was not statistically significant. MeaningAmong patients with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline compared with standard care did not result in a significantly better neurological status at 6 months. ImportanceFluid therapy is an important component of care for patients with traumatic brain injury, but whether it modulates clinical outcomes remains unclear. ObjectiveTo determine whether continuous infusion of hypertonic saline solution improves neurological outcome at 6 months in patients with traumatic brain injury. Design, Setting, and ParticipantsMulticenter randomized clinical trial conducted in 9 intensive care units in France, including 370 patients with moderate to severe traumatic brain injury who were recruited from October 2017 to August 2019. Follow-up was completed in February 2020. InterventionsAdult patients with moderate to severe traumatic brain injury were randomly assigned to receive continuous infusion of 20% hypertonic saline solution plus standard care (n=185) or standard care alone (controls; n=185). The 20% hypertonic saline solution was administered for 48 hours or longer if patients remained at risk of intracranial hypertension. Main Outcomes and MeasuresThe primary outcome was Extended Glasgow Outcome Scale (GOS-E) score (range, 1-8, with lower scores indicating worse functional outcome) at 6 months, obtained centrally by blinded assessors and analyzed with ordinal logistic regression adjusted for prespecified prognostic factors (with a common odds ratio [OR] >1.0 favoring intervention). There were 12 secondary outcomes measured at multiple time points, including development of intracranial hypertension and 6-month mortality. ResultsAmong 370 patients who were randomized (median age, 44 [interquartile range, 27-59] years; 77 [20.2%] women), 359 (97%) completed the trial. The adjusted common OR for the GOS-E score at 6 months was 1.02 (95% CI, 0.71-1.47; P=.92). Of the 12 secondary outcomes, 10 were not significantly different. Intracranial hypertension developed in 62 (33.7%) patients in the intervention group and 66 (36.3%) patients in the control group (absolute difference, -2.6% [95% CI, -12.3% to 7.2%]; OR, 0.80 [95% CI, 0.51-1.26]). There was no significant difference in 6-month mortality (29 [15.9%] in the intervention group vs 37 [20.8%] in the control group; absolute difference, -4.9% [95% CI, -12.8% to 3.1%]; hazard ratio, 0.79 [95% CI, 0.48-1.28]). Conclusions and RelevanceAmong patients with moderate to severe traumatic brain injury, treatment with continuous infusion of 20% hypertonic saline compared with standard care did not result in a significantly better neurological status at 6 months. However, confidence intervals for the findings were wide, and the study may have had limited power to detect a clinically important difference. Trial RegistrationClinicalTrials.gov Identifier: NCT03143751 This clinical trial conducted in France explores whether continuous infusion of hypertonic saline solution improves neurological outcome at 6 months in patients with traumatic brain injury.	[Roquilly, Antoine; Cinotti, Raphael; Latte, Dominique Demeure Dit; Mahe, Pierre Joachim; Vourc'h, Mickael; Martin, Florian Pierre; Chopin, Alice; Lerebourg, Celine; Asehnoune, Karim] Univ Nantes, Serv Anesthesie Reanimat Chirurg, CHU Nantes, Pole Anesthesie Reanimat,Hotel Dieu, Nantes, France; [Moyer, Jean Denis; Jeantrelle, Caroline] Beaujon Hosp, AP HP Nord, Dept Anesthesiol & Crit Care, DMU Parabol, Paris, France; [Huet, Olivier; Vermeersch, Veronique] CHU Brest, Anesthesia & Intens Care Unit, Brest, France; [Lasocki, Sigismond; Gaillard, Thomas] CHU Angers, Anesthesia & Intens Care Unit, Angers, France; [Cohen, Benjamin] CHU Tours, Anesthesia & Intens Care Unit, Tours, France; [Dahyot-Fizelier, Claire] CHU Potiers, Anesthesia & Intens Care Unit, Poitiers, France; [Chalard, Kevin] CHU Montpellier, Anesthesia & Intens Care Unit, Montpellier, France; [Seguin, Philippe] CHU Rennes, Anesthesia & Intens Care Unit, Rennes, France; [Flet, Laurent] CHU Nantes, Hotel Dieu, Serv Pharm, Nantes, France; [Chiffoleau, Anne] CHU Nantes, Dept Promot, DRCI, Cellule Vigilances, Nantes, France; [Feuillet, Fanny] CHU Nantes, DRCI, Plateforme Methodol & Biostat, Nantes, France; [Feuillet, Fanny] Univ Nantes, Univ Tours, INSERM, SPHERE U1246, Nantes, France		Roquilly, A (corresponding author), CHU Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, 5 Allee Lile Gloriette, F-4400 Nantes, France.	antoine.roquilly@chu-nantes.fr	Seguin, Philippe/P-9487-2019	Seguin, Philippe/0000-0002-7774-4257; MARTIN, Florian/0000-0002-5968-5484			Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Darmon M, 2010, NEPHROL DIAL TRANSPL, V25, P2510, DOI 10.1093/ndt/gfq067; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Roquilly A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018035; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rowland MJ, 2020, LANCET NEUROL, V19, P208, DOI 10.1016/S1474-4422(20)30003-X; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	40	8	8	6	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2056	2066		10.1001/jama.2021.5561			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	WOS:000655647300020	34032829	Green Published, Bronze			2022-02-06	
J	Shin, MK; Vazquez-Rosa, E; Koh, Y; Dhar, M; Chaubey, K; Cintron-Perez, CJ; Barker, S; Miller, E; Franke, K; Noterman, MF; Seth, D; Allen, RS; Motz, CT; Rao, SR; Skelton, LA; Pardue, MT; Fliesler, SJ; Wang, C; Tracy, TE; Gan, L; Liebl, DJ; Savarraj, JPJ; Torres, GL; Ahnstedt, H; McCullough, LD; Kitagawa, RS; Choi, HA; Zhang, PY; Hou, Y; Chiang, CW; Li, L; Ortiz, F; Kilgore, JA; Williams, NS; Whitehair, VC; Gefen, T; Flanagan, ME; Stamler, JS; Jain, MK; Kraus, A; Cheng, FX; Reynolds, JD; Pieper, AA				Shin, Min-Kyoo; Vazquez-Rosa, Edwin; Koh, Yeojung; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Barker, Sarah; Miller, Emiko; Franke, Kathryn; Noterman, Maria F.; Seth, Divya; Allen, Rachael S.; Motz, Cara T.; Rao, Sriganesh Ramachandra; Skelton, Lara A.; Pardue, Machelle T.; Fliesler, Steven J.; Wang, Chao; Tracy, Tara E.; Gan, Li; Liebl, Daniel J.; Savarraj, Jude P. J.; Torres, Glenda L.; Ahnstedt, Hilda; McCullough, Louise D.; Kitagawa, Ryan S.; Choi, H. Alex; Zhang, Pengyue; Hou, Yuan; Chiang, Chien-Wei; Li, Lang; Ortiz, Francisco; Kilgore, Jessica A.; Williams, Noelle S.; Whitehair, Victoria C.; Gefen, Tamar; Flanagan, Margaret E.; Stamler, Jonathan S.; Jain, Mukesh K.; Kraus, Allison; Cheng, Feixiong; Reynolds, James D.; Pieper, Andrew A.			Reducing acetylated tau is neuroprotective in brain injury	CELL			English	Article							NEURON-SPECIFIC ENOLASE; ALZHEIMERS ASSOCIATION GUIDELINES; AXON INITIAL SEGMENT; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; PHOSPHORYLATION; NITROSYLATION; CYTOSKELETON; BIOMARKERS; DISEASE	Traumatic brain injury (TBI) is the largest non-genetic, non-aging related risk factor for Alzheimer's disease (AD). We report here that TBI induces tau acetylation (ac-tau) at sites acetylated also in human AD brain. This is mediated by S-nitrosylated-GAPDH, which simultaneously inactivates Sirtuin1 deacetylase and activates p300/CBP acetyltransferase, increasing neuronal ac-tau. Subsequent tau mislocalization causes neurodegeneration and neurobehavioral impairment, and ac-tau accumulates in the blood. Blocking GAPDH S-nitrosylation, inhibiting p300/CBP, or stimulating Sirtuin1 all protect mice from neurodegeneration, neurobehavioral impairment, and blood and brain accumulation of ac-tau after TBI. Ac-tau is thus a therapeutic target and potential blood biomarker of TBI that may represent pathologic convergence between TBI and AD. Increased ac-tau in human AD brain is further augmented in AD patients with history of TBI, and patients receiving the p300/CBP inhibitors salsalate or diflunisal exhibit decreased incidence of AD and clinically diagnosed TBI.	[Shin, Min-Kyoo; Vazquez-Rosa, Edwin; Koh, Yeojung; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Barker, Sarah; Miller, Emiko; Franke, Kathryn; Stamler, Jonathan S.; Jain, Mukesh K.; Reynolds, James D.; Pieper, Andrew A.] Univ Hosp Cleveland Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA; [Shin, Min-Kyoo; Vazquez-Rosa, Edwin; Koh, Yeojung; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Barker, Sarah; Miller, Emiko; Franke, Kathryn; Pieper, Andrew A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Shin, Min-Kyoo; Vazquez-Rosa, Edwin; Koh, Yeojung; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Barker, Sarah; Miller, Emiko; Franke, Kathryn; Pieper, Andrew A.] Louis Stokes Cleveland VA Med Ctr Cleveland, GRECC, Geriatr Psychiat, Cleveland, OH 44106 USA; [Shin, Min-Kyoo; Vazquez-Rosa, Edwin; Koh, Yeojung; Dhar, Matasha; Chaubey, Kalyani; Cintron-Perez, Coral J.; Barker, Sarah; Miller, Emiko; Franke, Kathryn; Seth, Divya; Stamler, Jonathan S.; Reynolds, James D.; Pieper, Andrew A.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Noterman, Maria F.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Seth, Divya; Stamler, Jonathan S.; Jain, Mukesh K.] Univ Hosp Cleveland Med Ctr, Dept Med, Cleveland, OH USA; [Allen, Rachael S.; Motz, Cara T.; Pardue, Machelle T.] Atlanta VA Healthcare Syst, Ctr Visual & Neurocognit Rehabil, Atlanta, GA USA; [Allen, Rachael S.; Motz, Cara T.; Pardue, Machelle T.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.] SUNY Univ Buffalo, Dept Ophthalmol, Buffalo, NY USA; [Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.] SUNY Univ Buffalo, Dept Biochem, Buffalo, NY USA; [Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.] SUNY Univ Buffalo, Neurosci Grad Program, Buffalo, NY USA; [Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.] VA Western NY Healthcare Syst, Res Serv, Buffalo, NY USA; [Wang, Chao] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Tracy, Tara E.] Buck Inst, Novato, CA USA; [Gan, Li] Weill Cornell Med, Helen & Robert Appel Alzheimer S Dis Res Inst, New York, NY USA; [Liebl, Daniel J.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Savarraj, Jude P. J.; Torres, Glenda L.; Kitagawa, Ryan S.; Choi, H. Alex] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, McGovern Med Sch, Houston, TX 77030 USA; [Ahnstedt, Hilda; McCullough, Louise D.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA; [Zhang, Pengyue; Chiang, Chien-Wei; Li, Lang] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Hou, Yuan; Cheng, Feixiong] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH USA; [Ortiz, Francisco; Kilgore, Jessica A.; Williams, Noelle S.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA; [Whitehair, Victoria C.] MetroHlth Syst, MetroHlth Rehabil Inst, Cleveland, OH USA; [Whitehair, Victoria C.] Case Western Reserve Univ, Sch Med, Dept Phys Med & Rehabil, Cleveland, OH USA; [Gefen, Tamar] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Gefen, Tamar; Flanagan, Margaret E.] Northwestern Univ, Mesulam Ctr Cognit Neurol & Alzheimers Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [Flanagan, Margaret E.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Kraus, Allison] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Cheng, Feixiong] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Cheng, Feixiong] Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH USA; [Reynolds, James D.] Univ Hosp Cleveland Med Ctr, Dept Anesthesiol, Cleveland, OH USA; [Reynolds, James D.] Univ Hosp Cleveland Med Ctr, Dept Perioperat Med, Cleveland, OH USA; [Pieper, Andrew A.] Cornell Univ, Weill Cornell Med, Weill Cornell Autism Res Program, New York, NY 10021 USA; [Pieper, Andrew A.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA		Pieper, AA (corresponding author), Univ Hosp Cleveland Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Louis Stokes Cleveland VA Med Ctr Cleveland, GRECC, Geriatr Psychiat, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Cornell Univ, Weill Cornell Med, Weill Cornell Autism Res Program, New York, NY 10021 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	andrew.pieper@harringtondiscovey.org	Ramachandra Rao, Sriganesh/AAW-1354-2021	Ramachandra Rao, Sriganesh/0000-0003-1029-1051; Koh, Yeo Jung/0000-0002-4294-7871; Noterman, Maria/0000-0001-8524-2604; Miller, Emiko/0000-0003-3396-591X; Stamler, Jonathan/0000-0002-6866-1572; Barker, Sarah/0000-0002-3927-6966	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG013854 24]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1 P30 AGO62428-01]; Brockman Foundation; Elizabeth Ring Mather and William Gwinn Mather Fund; S. Livingston Samuel Mather Trust; G.R. Lincoln Family Foundation; Wick Foundation; Leonard Krieger Fund of the Cleveland Foundation; Alzheimer's Disease Research, a program of BrightFocus Foundation [A2019551F]; Allen Initiative in Brain Health and Cognitive Impairment [19PABH134580006-AHA]; Free Radical and Radiation Biology, University of Iowa [T32 CA078586]; NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RO1AG066707, KO8AG065463, RO1AG062566]; Miami Project to Cure Paralysis; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS098740]; VA BLRD MERIT Award [2 101 BXOO2439-04A1]; Department of Veterans AffairsUS Department of Veterans Affairs; National Center for Advancing Translational Sciences (NCATS/NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; Department of Veterans AffairsUS Department of Veterans Affairs [CDA-2 RX002928]	We thank those who provided blood and brain samples, Matthew N. Rasband for beta IV-spectrin antibodies, Peter Davies for PHF1 (p-tau S396/S404) antibodies, Mikayla Huntley for tau seeding assay help, and Gloria Lee for providing brain tissue from tau knockout mice. Postmortem brain tissues were provided by the Neuropathology Core of Northwestern University (NIH P30 AG013854 24). We thank the Translational Therapeutics Core of the Cleveland Alzheimer's Disease Research Center (NIH/NIA 1 P30 AGO62428-01) for assisting in the study with human postmortem brain tissues. The SV2 monoclonal antibody developed by K.M. Buckley was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH, and maintained at The University of Iowa, Department of Biology (Iowa City, IA). This work was supported by a grant to A.A.P. from the Brockman Foundation. A.A.P. was also supported by Elizabeth Ring Mather and William Gwinn Mather Fund, S. Livingston Samuel Mather Trust, G.R. Lincoln Family Foundation, Wick Foundation, the Leonard Krieger Fund of the Cleveland Foundation, Gordon and Evie Safran, and Louis Stokes VA Medical Center resources and facilities. Acknowledgment is made to the donors of Alzheimer's Disease Research, a program of BrightFocus Foundation, for support of M.-K.S. in this research (A2019551F). A.A.P., M.K.J., J.D.R., and J.S.S. are supported by Project 19PABH134580006-AHA/Allen Initiative in Brain Health and Cognitive Impairment. E.V.-R. was supported by Free Radical and Radiation Biology, University of Iowa (T32 CA078586). F.C. and A.A.P. are supported together by NIA/NIH (RO1AG066707) and also the Translational Therapeutic Core of the Cleveland Alzheimer's Disease Research Center (NIH/NIA 1 P30 AGO62428-01), which assisted in the study of human postmortem brain tissue and longitudinal analysis of patient data. D.J.L. was supported by The Miami Project to Cure Paralysis and NIH/NINDS (NS098740). S.J.F. and M.T.P. were supported by VA BLR&D MERIT Award (2 101 BXOO2439-04A1) and Research Career Scientist Awards from Department of Veterans Affairs, with resources of VA Western NY Healthcare System (Buffalo, NY), and Atlanta VA Medical Center (Decatur, GA). S.J.F. was supported by Clinical and Translational Science Award (UL1TR001412) to University of Buffalo from National Center for Advancing Translational Sciences (NCATS/NIH). R.S.A. was supported by Career Development Award (CDA-2 RX002928) from Department of Veterans Affairs. T.G. was supported by NIA/NIH (RO1AG062566). M.E.F. was supported by NIA/NIH (KO8AG065463).	Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bolos M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0200-1; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Evans DB, 2000, J BIOL CHEM, V275, P24977, DOI 10.1074/jbc.M000808200; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Geisen U, 2015, EUR J CARDIO-THORAC, V48, P416, DOI 10.1093/ejcts/ezu513; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hughes RO, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108588; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kraus A, 2019, ACTA NEUROPATHOL, V137, P585, DOI 10.1007/s00401-018-1947-3; Kristian Tibor, 2010, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0722s52; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; LoCoco PM, 2017, ELIFE, V6, DOI 10.7554/eLife.29626; LUBKE U, 1994, AM J PATHOL, V145, P175; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nakamura T, 2020, ANTIOXID REDOX SIGN, V32, P817, DOI 10.1089/ars.2019.7916; Neddens J, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0557-6; Newman AJ, 2015, J NEUROSCI METH, V242, P82, DOI 10.1016/j.jneumeth.2015.01.009; Nolan, 2017, J NEUROL NEUROSUR PS, V4; Okamura Y, 2019, J NEUROL SCI, V407, DOI 10.1016/j.jns.2019.116495; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pieper AA, 2018, COLD SH Q B, V83, P207, DOI 10.1101/sqb.2018.83.037622; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Perea JR, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00442; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryan J, 2020, NEUROLOGY, V95, pE320, DOI 10.1212/WNL.0000000000009277; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6765; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shekhar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159099; Shin Min-Kyoo, 2021, Neurotrauma Rep, V2, P1, DOI 10.1089/neur.2020.0020; Shirakawa K, 2016, ELIFE, V5, DOI 10.7554/eLife.11156; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Sparks D.L., 2012, J NEURODEGENER DIS, V1, P99; Tolan NV, 2013, CLIN CHIM ACTA, V424, P216, DOI 10.1016/j.cca.2013.06.009; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; US Food and Drug Administration, MAN DAT SHEET 967620; Vazquez-Rosa E, 2020, P NATL ACAD SCI USA, V117, P27667, DOI 10.1073/pnas.2010430117; Vazquez-Rosa E, 2019, ACS CHEM NEUROSCI, V10, P1595, DOI 10.1021/acschemneuro.8b00543; Vermersch P, 1996, NEUROLOGY, V47, P711, DOI 10.1212/WNL.47.3.711; Waldmeier PC, 2000, N-S ARCH PHARMACOL, V362, P526, DOI 10.1007/s002100000300; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wattiez AS, 2021, PAIN, V162, P1163, DOI 10.1097/j.pain.0000000000002103; Wesseling H, 2020, CELL, V183, P1699, DOI 10.1016/j.cell.2020.10.029; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	66	8	8	16	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2715	+		10.1016/j.cell.2021.03.032			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	WOS:000652830800015	33852912	Green Accepted			2022-02-06	
J	Thapa, K; Khan, H; Singh, TG; Kaur, A				Thapa, Komal; Khan, Heena; Singh, Thakur Gurjeet; Kaur, Amarjot			Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Excitotoxicity; Mitochondrial dysfunction; Oxidative stress; Neuroinflammation; Apoptosis; Nuclear factor-kappa B (NF-&#954; B)	NF-KAPPA-B; PI3K/AKT/MTOR SIGNALING PATHWAY; MESENCHYMAL STEM-CELLS; OXIDATIVE-STRESS; FUNCTIONAL RECOVERY; PROVIDES NEUROPROTECTION; MITOCHONDRIAL-FUNCTION; MICROGLIAL ACTIVATION; COGNITIVE RECOVERY; ALPHA EXPRESSION	Traumatic brain injury (TBI) causes brain damage, which involves primary and secondary injury mechanisms. Primary injury causes local brain damage, while secondary damage begins with inflammatory activity followed by disruption of the blood-brain barrier (BBB), peripheral blood cells infiltration, brain edema, and the discharge of numerous immune mediators including chemotactic factors and interleukins. TBI alters molecular signaling, cell structures, and functions. Besides tissue damage such as axonal damage, contusions, and hemorrhage, TBI in general interrupts brain physiology including cognition, decision-making, memory, attention, and speech capability. Regardless of the deep understanding of the pathophysiology of TBI, the underlying mechanisms still need to be assessed with a desired therapeutic agent to control the consequences of TBI. The current review gives a brief outline of the pathophysiological mechanism of TBI and various biochemical pathways involved in brain injury, pharmacological treatment approaches, and novel targets for therapy.	[Thapa, Komal; Khan, Heena; Singh, Thakur Gurjeet; Kaur, Amarjot] Chitkara Univ, Chitkara Coll Pharm, Chandigarh, Punjab, India; [Thapa, Komal] Sch Pharm, Bilaspur, Himachal Prades, India		Singh, TG (corresponding author), Chitkara Univ, Chitkara Coll Pharm, Chandigarh, Punjab, India.	gurjeet.singh@chitkara.edu.in	Thapa, Komal/AAU-8560-2021; University, Chitkara/AAZ-3040-2021	University, Chitkara/0000-0003-3776-7136; Singh, Thakur Gurjeet/0000-0003-2979-1590; khan, heena/0000-0001-5172-3135			Aarts MM, 2005, PFLUG ARCH EUR J PHY, V451, P243, DOI 10.1007/s00424-005-1439-x; Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arien-Zakay H, 2014, J NEUROTRAUM, V31, P1405, DOI 10.1089/neu.2013.3270; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bhalerao, 2010, BCMEDJ, V53, P26, DOI [10.1089/scd.2015.0160, DOI 10.1089/SCD.2015.0160]; Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Carbonell WS, 2003, J NEUROTRAUM, V20, P327, DOI 10.1089/089771503765172282; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chang CZ, 2015, BRAIN RES, V1608, P215, DOI 10.1016/j.brainres.2015.02.039; Chen X, 2017, J NEUROIMMUNE PHARM, V12, P433, DOI 10.1007/s11481-017-9732-y; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Duberley KE, 2014, INT J BIOCHEM CELL B, V50, P60, DOI 10.1016/j.biocel.2014.02.003; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Farr SA, 2019, J NEUROTRAUM, V36, P1869, DOI 10.1089/neu.2018.5999; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Follett PL, 2000, J NEUROSCI, V20, P9235; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Forgione N, 2014, WORLD NEUROSURG, V82, pE535, DOI 10.1016/j.wneu.2013.01.009; Forraz N, 2013, J TISSUE ENG REGEN M, V7, P523, DOI 10.1002/term.552; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gadoth N, OXIDATIVE STRESS FRE, P99; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Ghosh S, 2020, ACS CHEM NEUROSCI, V11, P2045, DOI 10.1021/acschemneuro.0c00368; Gincberg G, 2018, J MOL NEUROSCI, V64, P185, DOI 10.1007/s12031-017-1008-8; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Grewal AK, 2019, J PHARM PHARMACOL, V71, P956, DOI 10.1111/jphp.13073; Gritti A, 2002, J PHYSIOL-PARIS, V96, P81, DOI 10.1016/S0928-4257(01)00083-3; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Hassan H, 1999, NEUROPHARMACOLOGY, V38, P1841, DOI 10.1016/S0028-3908(99)00067-2; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inoue R, 2005, CURR PHARM DESIGN, V11, P1899, DOI 10.2174/1381612054021079; Islam A, 2018, BBA-MOL BASIS DIS, V1864, P721, DOI 10.1016/j.bbadis.2017.12.022; Ismael S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24350-x; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Just I, 2004, SPECIAL ISSUE EMERGI; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kong L, 2019, IMMUNOPHARM IMMUNOT, V41, P349, DOI 10.1080/08923973.2019.1608560; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Li DW, 2014, MOL MED REP, V9, P2043, DOI 10.3892/mmr.2014.2080; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Ma J, 2014, BIOCHEM J, V462, P489, DOI 10.1042/BJ20140235; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McKeating EG, 1998, BRIT J ANAESTH, V80, P77, DOI 10.1093/bja/80.1.77; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Mulherkar S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010245; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Ni HB, 2018, EXP NEUROL, V304, P102, DOI 10.1016/j.expneurol.2018.03.003; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Patel KS, 2016, POSTTBI HIPPOCAMPAL, DOI [10.25772/8T45-WB49, DOI 10.25772/8T45-WB49]; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pennypacker KR, 2001, EXP NEUROL, V172, P307, DOI 10.1006/exnr.2001.7817; Plata-Salaman CR, 2002, ACTA NEUROPSYCHIATR, V14, P262, DOI 10.1034/j.1601-5215.2002.140602.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rao M, 2007, STEM CELLS DEV, V16, P903, DOI 10.1089/scd.2007.9986; Rossi D, 2003, HAEMATOLOGICA, V88, P212; Sadowski K, 2015, PHARMACOL REP, V67, P636, DOI 10.1016/j.pharep.2014.12.017; Safinia Cyrus, 2016, J Vasc Interv Neurol, V9, P34; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shim HY, 2007, ANTI-CANCER DRUG, V18, P649, DOI 10.1097/CAD.0b013e3280825573; Shohami E, 2000, DRUG DEVELOP RES, V50, P211, DOI 10.1002/1098-2299(200007/08)50:3/4<211::AID-DDR3>3.0.CO;2-G; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Singh S, 2020, CURR NEUROPHARMACOL, V18, P918, DOI 10.2174/1570159X18666200207120949; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Strniskova M, 2002, GEN PHYSIOL BIOPHYS, V21, P231; Su E, 2015, FRONT NEUROSCI, V57, P41; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Suzuki T, 2017, J BIOL CHEM, V292, P16817, DOI 10.1074/jbc.R117.800169; Taguchi A, 2015, STEM CELLS DEV, V24, P2207, DOI 10.1089/scd.2015.0160; Tan L, 2015, BEHAV BRAIN RES, V279, P274, DOI 10.1016/j.bbr.2014.10.037; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; van Gils A, 2020, PRACT NEUROL, V20, P213, DOI 10.1136/practneurol-2018-002087; Vijiaratnam N, 2020, DRUGS, V80, P775, DOI 10.1007/s40265-020-01310-2; Walker CL, 2019, J NEUROTRAUM, V36, P2676, DOI 10.1089/neu.2018.6294; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu XB, 2016, NEURAL REGEN RES, V11, P23, DOI 10.4103/1673-5374.169601; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu HL, 2018, NEUROCHEM INT, V112, P197, DOI 10.1016/j.neuint.2017.07.010; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu NZ, 2018, TRANSL NEUROSCI, V9, P175, DOI 10.1515/tnsci-2018-0026; Yuan DF, 2017, BIOMATERIALS, V142, P1, DOI 10.1016/j.biomaterials.2017.07.011; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang HB, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104375; Zhang L, 2020, BRAIN RES BULL, V157, P26, DOI 10.1016/j.brainresbull.2020.01.019; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhao CL, 2019, DRUG DES DEV THER, V13, P3693, DOI 10.2147/DDDT.S209636; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao JJ, 2020, BRAIN RES BULL, V161, P21, DOI 10.1016/j.brainresbull.2020.04.011; Zheng B, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180892; Zhou ZW, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.827	172	8	8	8	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2021	71	9					1725	1742		10.1007/s12031-021-01841-7		MAY 2021	18	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	UM3MW	WOS:000647966100001	33956297				2022-02-06	
J	Gao, XF; Boryczka, J; Zheng, P; Kasani, S; Yang, F; Engler-Chiurazzi, EB; Simpkins, JW; Wigginton, JG; Wu, NQ				Gao, Xuefei; Boryczka, Jennifer; Zheng, Peng; Kasani, Sujan; Yang, Feng; Engler-Chiurazzi, Elizabeth B.; Simpkins, James W.; Wigginton, Jane G.; Wu, Nianqiang			A "hot Spot"-Enhanced paper lateral flow assay for ultrasensitive detection of traumatic brain injury biomarker S-100 beta in blood plasma	BIOSENSORS & BIOELECTRONICS			English	Article						Traumatic brain injury; Paper lateral flow assay; Blood testing; Biomarker; Surface-enhanced Raman scattering; s-100 beta		Currently colorimetric paper lateral flow strips (PLFS) encounter two major limitations, that is, low sensitivity and severe interference from complex sample matrices such as blood. These shortcomings limit their application in detection of low-concentration analytes in complex samples. To solve these problems, a PLFS has been developed by utilizing surface-enhanced Raman scattering (SERS) for sensing signal transduction. In particular, a hierarchical three-dimensional nanostructure has been designed to create "hot spots", which can significantly amplify the SERS sensing signal, leading to high sensitivity. As a result, this PLFS has demonstrated a limit of detection (LOD) of 5.0 pg mL(-1) toward detection of S-100 beta, a traumatic brain injury (TBI) protein biomarker in blood plasma. The PLFS has been successfully used for rapid measurement of S-100 beta in clinical TBI patient samples taken in the emergency department. Availability of PLFS for blood testing would shift the paradigm of TBI patient management and clinical outcome in emergency departments. It is expected that this type of PLFS can be adapted for rapid detection of various human diseases due to its capability of measuring a low level of protein blood biomarkers in complex human fluids.	[Gao, Xuefei; Zheng, Peng; Kasani, Sujan; Wu, Nianqiang] West Virginia Univ, Dept Mech & Aerosp Engn, Morgantown, WV 26506 USA; [Boryczka, Jennifer; Wu, Nianqiang] Univ Massachusetts Amherst, Dept Chem Engn, Amherst, MA 01003 USA; [Yang, Feng] West Virginia Univ, Ind & Management Syst Engn Dept, Morgantown, WV 26506 USA; [Engler-Chiurazzi, Elizabeth B.; Simpkins, James W.] West Virginia Univ, Ctr Basic & Translat Stroke Res, Rockefeller Neurosci Inst, Dept Neurosci, Morgantown, WV 26505 USA; [Wigginton, Jane G.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Gao, Xuefei; Zheng, Peng; Kasani, Sujan; Wu, Nianqiang] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA		Wu, NQ (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.	nianqiangwa@umass.edu	Wu, Nianqiang/B-9798-2015	Wu, Nianqiang/0000-0002-8888-2444	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS087515]	This work was partially supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R15NS087515). The views and options in this article presented in this article do not necessarily reflect those of NIH.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Association A.S.-L.-H, 2020, TRAUMATIC BRAIN INJU; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; (CDC) C. f.D.C.a.P., 2020, TRAUMATIC BRAIN INJU; David A, 2017, DIAGN INTERV IMAG, V98, P551, DOI 10.1016/j.diii.2017.03.010; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Fabres-Klein MH, 2014, EUR J CLIN MICROBIOL, V33, P2095, DOI 10.1007/s10096-014-2181-0; Gao X., 2014, AM J BIOMED SCI, V6; Gao XF, 2017, ANAL CHEM, V89, P10104, DOI 10.1021/acs.analchem.7b03015; Gao XF, 2016, TALANTA, V146, P648, DOI 10.1016/j.talanta.2015.06.060; Gao XF, 2014, BIOSENS BIOELECTRON, V54, P578, DOI 10.1016/j.bios.2013.10.055; Gordillo-Escobar E, 2016, MED INTENSIVA, V40, P105, DOI 10.1016/j.medin.2015.11.008; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Surgeons A.A.o.N, 2020, TRAUMATIC BRAIN INJU; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089	17	8	8	8	50	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	APR 1	2021	177								112967	10.1016/j.bios.2021.112967			6	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	QI2SJ	WOS:000618825900006	33429202				2022-02-06	
J	Figueroa, JM; Boddu, J; Kader, M; Berry, K; Kumar, V; Ayala, V; Vanni, S; Jagid, J				Figueroa, Javier M.; Boddu, James; Kader, Michael; Berry, Katherine; Kumar, Vignessh; Ayala, Veronica; Vanni, Steven; Jagid, Jonathan			The Effects of Lockdown During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Neurotrauma-Related Hospital Admissions	WORLD NEUROSURGERY			English	Article						Admissions; COVID-19; Lockdown; Neurotrauma; Pandemic		BACKGROUND: The response to the global severe acute respiratory syndrome coronavirus 2 pandemic culminated in mandatory isolation throughout the world, with nationwide confinement orders issued to decrease viral spread. These drastic measures were successful in "flattening the curve" and maintaining the previous rate of coronavirus disease 2019 infections and deaths. To date, the effects of the coronavirus disease 2019 pandemic on neurotrauma has not been reported. METHODS: We retrospectively analyzed hospital admissions from Ryder Trauma Center at Jackson Memorial Hospital, during the months of March and April from 2016 to 2020. Specifically, we identified all patients who had cranial neurotrauma consisting of traumatic brain injury and/or skull fractures, as well as spinal neurotrauma consisting of vertebral fractures and/or spinal cord injury. We then performed chart review to determine mechanism of injury and if emergent surgical intervention was required. RESULTS: Compared with previous years, we saw a significant decline in the number of neurotraumas during the pandemic, with a 62% decline after the lockdown began. The number of emergent neurotrauma surgical cases also significantly decreased by 84% in the month of April. Interestingly, although the number of vehicular traumas decreased by 77%, there was a significant 100% increase in the number of gunshot wounds. CONCLUSIONS: Population seclusion had a direct effect on the frequency of neurotrauma, whereas the change in relative proportion of certain mechanisms may be associated with the psychosocial effects of social distancing and quarantine.	[Figueroa, Javier M.; Boddu, James; Kader, Michael; Berry, Katherine; Kumar, Vignessh; Ayala, Veronica; Vanni, Steven; Jagid, Jonathan] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA		Figueroa, JM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA.	Javier.Figueroa@jhsmiami.org		Berry, Katherine/0000-0001-5422-5115			[Anonymous], CORONAVIRUS LOCATION; Antony J., 2020, WORLD NEUROSURG, V20, P31107; Ashby MPJ, 2020, CRIME SCI, V9, DOI 10.1186/s40163-020-00117-6; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Centers for DiseaseControl and Prevention, NATL VITAL STAT REPO; Chevance A, 2020, ENCEPHALE, V46, P193, DOI 10.1016/j.encep.2020.04.005; Comelli Ivan, 2020, Acta Biomed, V91, P45, DOI 10.23750/abm.v91i2.9565; de Girolamo G, 2020, JAMA PSYCHIAT, V77, P974, DOI 10.1001/jamapsychiatry.2020.1276; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Forrester JD, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000505; Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1; Hassan K, 2020, ANN PLAS SURG, V85, pS161, DOI 10.1097/SAP.0000000000002459; Houshyar R, 2020, EMERG RADIOL, V27, P781, DOI 10.1007/s10140-020-01797-y; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Lee HC, 2020, INT J INFECT DIS, V96, P399, DOI 10.1016/j.ijid.2020.05.031; Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016; Pichard R, 2020, INT ORTHOP, V44, P1497, DOI 10.1007/s00264-020-04654-2; von Dercks N, 2020, ORTHOPADE, V49, P494, DOI 10.1007/s00132-020-03926-4; World Health Organization, 133 WHO; Zagra L, 2020, INT ORTHOP, V44, P1591, DOI 10.1007/s00264-020-04590-1; Zhu WB, 2020, INT J INFECT DIS, V96, P417, DOI 10.1016/j.ijid.2020.04.016	22	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2021	146						e1	e5		10.1016/j.wneu.2020.08.083			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QJ6NI	WOS:000619804900170	32822955	Green Published			2022-02-06	
J	Zhang, XS; Lu, Y; Li, W; Tao, T; Peng, L; Wang, WH; Gao, S; Liu, C; Zhuang, Z; Xia, DY; Hang, CH; Li, W				Zhang, Xiang-Sheng; Lu, Yue; Li, Wen; Tao, Tao; Peng, Lei; Wang, Wei-Han; Gao, Sen; Liu, Cang; Zhuang, Zong; Xia, Da-Yong; Hang, Chun-Hua; Li, Wei			Astaxanthin ameliorates oxidative stress and neuronal apoptosis via SIRT1/NRF2/Prx2/ASK1/p38 after traumatic brain injury in mice	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						astaxanthin; NRF2; oxidative damage; Prx2; sirtuin 1; traumatic brain injury		Background and Purpose Oxidative stress and neuronal apoptosis play key roles in traumatic brain injury. We investigated the protective effects of astaxanthin against traumatic brain injury and its underlying mechanisms of action. Experimental Approach A weight-drop model of traumatic brain injury in vivo and hydrogen peroxide exposure in vitro model were established. Brain oedema, behaviour tests, western blot, biochemical analysis, lesion volume, histopathological study and cell viability were performed. Key Results Astaxanthin significantly reduced oxidative insults on Days 1, 3 and 7 after traumatic brain injury. Neuronal apoptosis was also ameliorated on Day 3. Additionally, astaxanthin improved neurological functions up to 3 weeks after traumatic brain injury. Astaxanthin treatment dramatically enhanced the expression of peroxiredoxin 2 (Prx2), nuclear factor-erythroid 2-related factor 2 (NRF2/Nrf2) and sirtuin 1 (SIRT1), while it down-regulated the phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) and p38. Inhibition of Prx2 by siRNA injection reversed the beneficial effects of astaxanthin against traumatic brain injury. Additionally, Nrf2 knockout prevented the neuroprotective effects of astaxanthin in traumatic brain injury. In contrast, overexpression of Prx2 in Nrf2 knockout mice attenuated the secondary brain injury after traumatic brain injury. Moreover, inhibiting SIRT1 by EX527 dramatically inhibited the neuroprotective effects of astaxanthin and suppressed SIRT1/Nrf2/Prx2/ASK1/p38 pathway both in vivo and in vitro. Conclusion and Implications Astaxanthin improved the neurological functions and protected the brain from injury after traumatic brain injury, primarily by reducing oxidative stress and neuronal death via SIRT1/Nrf2/Prx2/ASK1/p38 signalling pathway and might be a new candidate to ameliorate traumatic brain injury.	[Zhang, Xiang-Sheng; Peng, Lei; Wang, Wei-Han; Liu, Cang] Capital Med Univ, Beijing Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Xiang-Sheng; Lu, Yue; Tao, Tao; Gao, Sen; Zhuang, Zong; Hang, Chun-Hua; Li, Wei] Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp,Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Li, Wen] Capital Med Univ, China Rehabil Res Ctr, Beijing Boai Hosp, Dept Pharm, Beijing, Peoples R China; [Xia, Da-Yong] Wannan Med Coll, Affiliated Hosp 1, Dept Neurosurg, Wuhu, Peoples R China		Li, W (corresponding author), Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp,Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	lwxzlw@126.com	Li, Wei/ABE-4301-2021		First Affiliated Hospital of Wannan Medical College [YR201911]; Natural Science Research Project in Higher Education of Anhui Province [KJ2018A0253]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [0214-14380482]; Nanjing Department of Health [JQX18001]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20201113]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901203, 81971127, 81401029, 81771291, 81870922]	The First Affiliated Hospital of Wannan Medical College, Grant/Award Number: YR201911; Natural Science Research Project in Higher Education of Anhui Province, Grant/Award Number: KJ2018A0253; Fundamental Research Funds for the Central Universities, Grant/Award Number: 0214-14380482; Nanjing Department of Health, Grant/Award Number: JQX18001; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BK20201113; National Natural Science Foundation of China, Grant/Award Numbers: 81901203, 81971127, 81401029, 81771291, 81870922	Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI 10.1111/bph.14752; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS229, DOI 10.1111/bph.14750; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS1, DOI 10.1111/bph.14747; Alexander SPH, 2018, BRIT J PHARMACOL, V175, P407, DOI 10.1111/bph.14112; Angeloni C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112230; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Becchi S, 2017, BRIT J PHARMACOL, V174, P2302, DOI 10.1111/bph.13832; Chen Q, 2018, MAR DRUGS, V16, DOI 10.3390/md16040117; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Connor David E Jr, 2017, Pathophysiology, V24, P169, DOI 10.1016/j.pathophys.2017.04.003; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Huang MZ, 2019, BRIT J PHARMACOL, V176, P906, DOI 10.1111/bph.14592; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kosztelnik M, 2019, FASEB J, V33, P2372, DOI 10.1096/fj.201800565RR; Leak RK, 2013, STROKE, V44, P1124, DOI 10.1161/STROKEAHA.111.680157; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Li ZL, 2020, FASEB J, V34, P4527, DOI 10.1096/fj.201902222R; Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178; Liu L, 2020, FASEB J, V34, P3743, DOI 10.1096/fj.201900393RR; Lu Y, 2019, FASEB J, V33, P3051, DOI 10.1096/fj.201801150R; Ma MW, 2018, FREE RADICAL BIO MED, V117, P66, DOI 10.1016/j.freeradbiomed.2018.01.031; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mete M, 2018, TURK NEUROSURG, V28, P858, DOI 10.5137/1019-5149.JTN.21417-17.2; Omelchenko A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1908-3; Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016; Sharma A, 2018, MOL NEUROBIOL, V55, P276, DOI 10.1007/s12035-017-0740-y; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Tchouague M, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.06.030; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Tsai YR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103252; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wu B, 2018, BRIT J PHARMACOL, V175, P4137, DOI 10.1111/bph.14457; Wu CH, 2019, BRIT J PHARMACOL, V176, P400, DOI 10.1111/bph.14537; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Wu LW, 2020, BRIT J PHARMACOL, V177, P3760, DOI 10.1111/bph.15099; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Ye QY, 2013, MAR DRUGS, V11, P1019, DOI 10.3390/md11041019; Zhan X, 2021, BRIT J BIOMED SCI, V78, P239, DOI 10.1080/09674845.2021.1894706; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang JN, 2019, BRIT J PHARMACOL, V176, P4558, DOI 10.1111/bph.14822; Zhang J, 2017, BBA-GEN SUBJECTS, V1861, P1715, DOI 10.1016/j.bbagen.2017.03.007; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang MK, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0358-z; Zhang XS, 2020, MOL NEUROBIOL, V57, P5286, DOI 10.1007/s12035-020-02095-x; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zhang XS, 2019, FASEB J, V33, P722, DOI 10.1096/fj.201800642RR; Zhang XS, 2018, FREE RADICAL BIO MED, V124, P504, DOI 10.1016/j.freeradbiomed.2018.06.035	57	8	9	12	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	MAR	2021	178	5					1114	1132		10.1111/bph.15346		JAN 2021	19	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QF2HB	WOS:000607785800001	33326114				2022-02-06	
J	Horan, J; Duddy, JC; Gilmartin, B; Amoo, M; Nolan, D; Corr, P; Ben Husien, M; Bolger, C				Horan, Jack; Duddy, John C.; Gilmartin, Brian; Amoo, Michael; Nolan, Deirdre; Corr, Paula; Husien, Mohammed Ben; Bolger, Ciaran			The impact of COVID-19 on trauma referrals to a National Neurosurgical Centre	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						COVID-19; Spinal injury; Subdural; Trauma; Traumatic brain injury		Background To investigate the impact of COVID-19 on trauma referrals to a National Neurosurgical Centre during the first wave of COVID-19 in Ireland. Methods Retrospective analysis of a prospectively maintained database of all trauma referrals to the National Neurosurgical Centre at Beaumont Hospital, Dublin, during the period March 1-May 31, 2019 and 2020. Patient characteristics including age, sex, alcohol use, anticoagulant/antiplatelet use and initial Glasgow Coma Scale (GCS) were recorded. Patients were grouped based on trauma aetiology and diagnosis. Results There were 527 and 437 trauma referrals in 2019 and 2020 respectively. Overall, there was a 17.1% reduction in trauma referrals between 2019 and 2020. Traumatic brain injury, spinal injury and cranial fractures referrals reduced 25% (375 vs 283), 59% (32 vs 13) and 18% (39 vs 32) respectively from 2019 to 2020. Low-energy falls below 2 m was the most common mechanism of injury and accounted for 60 and 61% of referrals in 2019 and 2020. No reduction in road traffic collision (33 vs 34) and assault (40 vs 40) referrals were observed between years. Conclusions COVID-19 has had a significant impact on both the volume and mechanism of trauma referrals to the National Neurosurgical Centre in Ireland, with falls below 2 m the most common mechanism of trauma referral across both years. The workload remains substantial and a fully resourced neurosurgical department is essential in any future COVID-19 waves.	[Horan, Jack; Duddy, John C.; Gilmartin, Brian; Amoo, Michael; Nolan, Deirdre; Corr, Paula; Husien, Mohammed Ben; Bolger, Ciaran] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland		Horan, J (corresponding author), Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland.	jackhoran27@gmail.com; johnduddy@gmail.com; briangilmartin@rcsi.ie; michaelamoo@rcsi.ie; deirdrenolan@beaumont.ie; paulacorr@beaumont.ie; mohammedbhusien@rcsi.ie; cbolger@rcsi.ie	Amoo, Michael/AAZ-8650-2021	Amoo, Michael/0000-0001-6886-6714			Ahuja S, 2021, BRIT J NEUROSURG, V35, P181, DOI 10.1080/02688697.2020.1777263; Amoo M, 2018, BRIT J NEUROSURG, V32, P585, DOI 10.1080/02688697.2018.1522416; An Garda Siochana, 2020, OP FAOIS DOM AB 9 JU; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Census. Central Statistics Office, 2019, STATBANK CENS POP; Christey G, 2020, NEW ZEAL MED J, V133, P81; Department of Health, 2020, LAT UPD COVID 19 COR; Department of the Taoiseach, 2020, LAT GUID PUBL HLTH M; Department of the Taoiseach, 2020, EAS COVID 19 RESTR 1; Evelyn Ring in Irish Examiner, 2020, PAT ADM HOSP DEL SEE; Fahy Stephen, 2020, Bone Jt Open, V1, P261, DOI 10.1302/2046-3758.16.BJO-2020-0040.R1; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Government of Ireland, 2020, IR COVID 19 DAT HUB; Hecht N, 2020, ACTA NEUROCHIR, V162, P1795, DOI 10.1007/s00701-020-04437-z; Henry McDonald in the Guardian, 2020, GUARDIAN; Hernigou J, 2020, INT ORTHOP, V44, P1473, DOI 10.1007/s00264-020-04619-5; Holland K, 2020, IRISH TIMES; Huang ZG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013661; Irish Medical Organisation, 2020, IMO WARNS PAT MAY BE; Mitchell P, 2020, BRIT J NEUROSURG, V34, P117, DOI 10.1080/02688697.2020.1756417; Moroni Francesco, 2020, JACC Case Rep, V2, P1620, DOI 10.1016/j.jaccas.2020.04.010; Motterle G, 2021, WORLD J UROL, V39, P1985, DOI 10.1007/s00345-020-03264-2; National Office of Clincal Audit, 2020, MAJ TRAUM AUD NAT RE; Nunez JH, 2020, INJURY, V51, P1414, DOI 10.1016/j.injury.2020.05.016; Park C, 2020, ACTA ORTHOP, V91, P556, DOI 10.1080/17453674.2020.1783621; Parkinson D, 2019, J INTERPERS VIOLENCE, V34, P2333, DOI 10.1177/0886260517696876; Reinstadler SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072183; Schirmer CM, 2020, J NEUROINTERV SURG, V12, P639, DOI 10.1136/neurintsurg-2020-016299; Sinead Hussey on RTE, 2020, CAR DET TRAV 202KM H; Sugrue CM, 2020, J PLAST RECONSTR AES, V73, P1368, DOI 10.1016/j.bjps.2020.05.031; Tartara F, 2020, ACTA NEUROCHIR, V162, P1501, DOI 10.1007/s00701-020-04385-8; Valand P, 2020, J PLAST RECONSTR AES, V73, P1364, DOI 10.1016/j.bjps.2020.05.037; Zhao J, 2020, STROKE, V51, P1996, DOI 10.1161/STROKEAHA.120.030225	33	8	8	0	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	NOV	2021	190	4					1281	1293		10.1007/s11845-021-02504-7		JAN 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH3UV	WOS:000605938000002	33415689	Bronze, Green Published			2022-02-06	
J	Meng, J; Ding, T; Chen, YH; Long, TL; Xu, QH; Lian, WQ; Liu, W				Meng, Jiao; Ding, Ting; Chen, Yuhua; Long, Tianlin; Xu, Quanhua; Lian, Wenqing; Liu, Wei			LncRNA-Meg3 promotes Nlrp3-mediated microglial inflammation by targeting miR-7a-5p	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						LncRNA-Meg3; miR-7a-5p; Nlrp3 inflammasome; Inflammation; Microglia	LONG NONCODING RNAS; CELL-PROLIFERATION; ACTIVATION; EXPRESSION; MATTER; ROLES	Recent studies have identified neuroinflammation as a significant contributor to the pathological process of traumatic brain injury (TBI) and as a potentially effective target for treatment. LncRNA maternally expressed gene 3 (Meg3) has further been observed to play a critical role in diverse biological processes, including microglial activation and the inflammatory response. However, its target gene and associated signaling pathway require further elucidation. This study found that lipopolysaccharide + ATP upregulated Meg3, promoted microglia activation, Nlrp3/caspase1 activation and inflammation, and markedly reduced miR-7a-5p. Overexpression of miR-7a-5p attenuated Meg3-induced microglial activation, but not Meg3 expression. Bioinformatic analysis and dual-luciferase assays indicated that Meg3 was a direct target of miR-7a-5p that negatively regulates miR-7a-5p expression. Further, we showed that Meg3 acted as a competing endogenous RNA for miR-7a-5p and induced microglial inflammation by regulating nod-like receptor protein 3 (Nlrp3) expression. Our study thus demonstrates Meg3 regulates microglia inflammation by targeting the miR-7a-5p /Nlrp3 pathway.	[Meng, Jiao] Peking Univ, Sch Pharmaceut Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Ding, Ting] Peking Univ, Hosp 1, Dept Anesthesiol & Crit Care Med, Beijing 100034, Peoples R China; [Chen, Yuhua; Long, Tianlin; Xu, Quanhua; Liu, Wei] Bijie First Peoples Hosp, Dept Neurosurg, 112 Guanghui Rd, Bijie 551700, Peoples R China; [Lian, Wenqing] Peking Univ, Hosp 1, Dept Crit Care Med, Beijing 100034, Peoples R China		Liu, W (corresponding author), Bijie First Peoples Hosp, Dept Neurosurg, 112 Guanghui Rd, Bijie 551700, Peoples R China.	vincelau@sina.com		Lian, Wenqing/0000-0003-4836-6805	Natural Science Foundation of Shaanxi ProvinceNatural Science Foundation of Shaanxi Province [2018JM7141]	The authors thank the supports of professor Xuejun Li from Department of Pharmacology Peking University and Ruen Liu form Department of Neurosurgery Peking University People's Hospital on dual-luciferase reporter assay system. This study is supported by the Natural Science Foundation of Shaanxi Province (2018JM7141).	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Cao BQ, 2018, NEUROSCIENCE, V388, P118, DOI 10.1016/j.neuroscience.2018.07.019; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Dai Yuxin, 2018, Cell Physiol Biochem, V51, P2872, DOI 10.1159/000496040; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; He YQ, 2017, ONCOTARGET, V8, P73282, DOI 10.18632/oncotarget.19931; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Jing Y, 2020, NEUROSCI BULL, V36, P625, DOI 10.1007/s12264-020-00471-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luo G, 2015, CELL PHYSIOL BIOCHEM, V37, P2209, DOI 10.1159/000438577; Majidinia M, 2016, MOL BIOL REP, V43, P1193, DOI 10.1007/s11033-016-4054-3; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Quan ZZ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00175; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Saber M, 2020, EUR J NEUROSCI, V52, P2791, DOI 10.1111/ejn.14611; Sen R, 2014, SCI WORLD J, DOI 10.1155/2014/896206; Shin N, 2019, ANTIOXID REDOX SIGN, V30, P1601, DOI 10.1089/ars.2017.7280; Simchovitz A, 2020, AGING CELL, V19, DOI 10.1111/acel.13115; Simchovitz A, 2019, FASEB J, V33, P11223, DOI 10.1096/fj.201900830R; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Su W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/356893; Titze-de-Almeida R, 2018, CURR GENE THER, V18, P143, DOI 10.2174/1566523218666180430121323; Wu JL, 2018, EUR REV MED PHARMACO, V22, P5938, DOI 10.26355/eurrev_201809_15923; Wu M, 2019, J CELL MOL MED, V23, P29, DOI 10.1111/jcmm.13658; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yan HL, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0047-y; Yan HL, 2016, NEUROSCIENCE, V337, P191, DOI 10.1016/j.neuroscience.2016.09.017; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yin DD, 2015, TUMOR BIOL, V36, P4851, DOI 10.1007/s13277-015-3139-2; Zhou Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0094-3; Zhu Y, 2018, EBIOMEDICINE, V30, P148, DOI 10.1016/j.ebiom.2018.03.032	48	8	8	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	JAN	2021	90								107141	10.1016/j.intimp.2020.107141			9	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	PU7KN	WOS:000609480300002	33189612				2022-02-06	
J	Jha, RM; Mondello, S; Bramlett, HM; Dixon, CE; Shear, DA; Dietrich, WD; Wang, KKW; Yang, ZH; Hayes, RL; Poloyac, SM; Empey, PE; Lafrenaye, AD; Yan, HQ; Carlson, SW; Povlishock, JT; Gilsdorf, JS; Kochanek, PM				Jha, Ruchira M.; Mondello, Stefania; Bramlett, Helen M.; Dixon, C. Edward; Shear, Deborah A.; Dietrich, W. Dalton; Wang, Kevin K. W.; Yang, Zhihui; Hayes, Ronald L.; Poloyac, Samuel M.; Empey, Philip E.; Lafrenaye, Audrey D.; Yan, Hong Q.; Carlson, Shaun W.; Povlishock, John T.; Gilsdorf, Janice S.; Kochanek, Patrick M.			Glibenclamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy	JOURNAL OF NEUROTRAUMA			English	Article						cerebral edema; consortium; controlled cortical impact; contusion; fluid percussion injury; glyburide; penetrating ballistic-like brain injury; rat; sulfonylurea receptor-1	SULFONYLUREA RECEPTOR 1; NONSELECTIVE CATION CHANNEL; CEREBRAL EDEMA; HEMORRHAGIC PROGRESSION; INTRAVENOUS GLYBURIDE; REACTIVE ASTROCYTES; CELLULAR EDEMA; DOUBLE-BLIND; RAT MODEL; DAMAGE	Glibenclamide (GLY) is the sixth drug tested by the Operation Brain Trauma Therapy (OBTT) consortium based on substantial pre-clinical evidence of benefit in traumatic brain injury (TBI). Adult Sprague-Dawley rats underwent fluid percussion injury (FPI; n = 45), controlled cortical impact (CCI; n = 30), or penetrating ballistic-like brain injury (PBBI; n = 36). Efficacy of GLY treatment (10-mu g/kg intraperitoneal loading dose at 10 min post-injury, followed by a continuous 7-day subcutaneous infusion [0.2 mu g/h]) on motor, cognitive, neuropathological, and biomarker outcomes was assessed across models. GLY improved motor outcome versus vehicle in FPI (cylinder task, p < 0.05) and CCI (beam balance, p < 0.05; beam walk, p < 0.05). In FPI, GLY did not benefit any other outcome, whereas in CCI, it reduced 21-day lesion volume versus vehicle (p < 0.05). On Morris water maze testing in CCI, GLY worsened performance on hidden platform latency testing versus sham (p < 0.05), but not versus TBI vehicle. In PBBI, GLY did not improve any outcome. Blood levels of glial fibrillary acidic protein and ubiquitin carboxyl terminal hydrolase-1 at 24 h did not show significant treatment-induced changes. In summary, GLY showed the greatest benefit in CCI, with positive effects on motor and neuropathological outcomes. GLY is the second-highest-scoring agent overall tested by OBTT and the only drug to reduce lesion volume after CCI. Our findings suggest that leveraging the use of a TBI model-based phenotype to guide treatment (i.e., GLY in contusion) might represent a strategic choice to accelerate drug development in clinical trials and, ultimately, achieve precision medicine in TBI.	[Jha, Ruchira M.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA USA; [Dixon, C. Edward; Yan, Hong Q.; Carlson, Shaun W.] Univ Pittsburgh, Brain Trauma Res Ctr, Sch Med, Dept Neurol Surg, Pittsburgh, PA USA; [Yan, Hong Q.; Carlson, Shaun W.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol & Clin & Translat Sci, Pittsburgh, PA USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Bramlett, Helen M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL 33136 USA; [Shear, Deborah A.; Dietrich, W. Dalton; Gilsdorf, Janice S.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD USA; [Wang, Kevin K. W.; Yang, Zhihui] Univ Florida, McKnight Brin Inst, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Ctr Prote & Biomarkers Res, Ctr Innovat Res, Alachua, FL USA; [Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Lafrenaye, Audrey D.; Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA		Kochanek, PM (corresponding author), UPMC Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Safar Ctr Resuscitat Res, 6th Floor 4401 Penn Ave, Pittsburgh, PA 15224 USA.	kochanekpm@pitt.edu	Empey, Philip/L-9604-2019; Mondello, Stefania/A-1813-2012	Empey, Philip/0000-0001-7474-2339; Mondello, Stefania/0000-0002-8587-3614	U.S. Department of DefenseUnited States Department of Defense [WH81XWH-10-1-0623, WH81XWH-14-2-0018]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS101036]	We are grateful to the U.S. Department of Defense grants WH81XWH-10-1-0623 and WH81XWH-14-2-0018 for generous support. Dr. Ruchira M. Jha was supported by NIH NINDS K23 NS101036 grant.	Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Dennis EL, 2022, HUM BRAIN MAPP, V43, P149, DOI 10.1002/hbm.25046; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eisenberg HM, 2020, J NEUROTRAUM, V37, P185, DOI 10.1089/neu.2019.6538; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Gerzanich V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195526; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; King ZA, 2018, DRUG DES DEV THER, V12, P2539, DOI 10.2147/DDDT.S150043; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Naraharisetti SB, 2007, J CHROMATOGR B, V860, P34, DOI 10.1016/j.jchromb.2007.10.010; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Puentes F, 2014, J NEUROL NEUROSUR PS, V85, P274, DOI [10.1136/jnnp-2013-305494, 10.1136/jnnp-2013-307454]; SCHALLERT T, 1990, CAN J PSYCHOL, V44, P276, DOI 10.1037/h0084244; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Sheth KN, 2014, NEUROCRIT CARE, V21, P43, DOI 10.1007/s12028-014-9970-2; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2012, ANN NY ACAD SCI, V1268, P95, DOI 10.1111/j.1749-6632.2012.06705.x; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard JM, 2013, J SPINE S4, V4, P2, DOI DOI 10.4172/2165-7939.S4-002; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Stokum JA, 2017, BEHAV BRAIN RES, V333, P43, DOI 10.1016/j.bbr.2017.06.038; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu FL, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1254; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yang ZH, 2019, J NEUROTRAUM, V36, P348, DOI 10.1089/neu.2017.5586; Yang ZH, 2018, MOL NEUROBIOL, V55, P2174, DOI 10.1007/s12035-017-0424-7; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	88	8	8	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					628	645		10.1089/neu.2020.7421		DEC 2020	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000600253300001	33203303				2022-02-06	
J	Czerniak, LL; Liebel, SW; Garcia, GGP; Lavieri, MS; McCrea, MA; McAllister, TW; Broglio, SP				Czerniak, Lauren L.; Liebel, Spencer W.; Garcia, Gian-Gabriel P.; Lavieri, Mariel S.; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.		CARE Consortium Investigators	Sensitivity and Specificity of Computer-Based Neurocognitive Tests in Sport-Related Concussion: Findings from the NCAA-DoD CARE Consortium	SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; TEST-RETEST RELIABILITY; NORMATIVE DATA; HIGH-SCHOOL; COGNITIVE IMPAIRMENT; MANAGEMENT; VALIDITY; IMPACT; PERFORMANCE; SYMPTOMS	Background To optimally care for concussed individuals, a multi-dimensional approach is critical and a key component of this assessment in the athletic environment is computer-based neurocognitive testing. However, there continues to be concerns about the reliability and validity of these testing tools. The purpose of this study was to determine the sensitivity and specificity of three common computer-based neurocognitive tests (Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT], CNS Vital Signs, and CogState Computerized Assessment Tool [CCAT]), to provide guidance on their clinical utility. Methods This study analyzed assessments from a cohort of collegiate athletes and non-varsity cadets from the NCAA-DoD CARE Consortium. The data were collected from 2014-2018. Study participants were divided into two testing groups [concussed, n = 1414 (baseline/24-48 h) and healthy, n = 8305 (baseline/baseline)]. For each test type, change scores were calculated for the components of interest. Then, the Normative Change method, which used normative data published in a similar cohort, and the Reliable Change Index (RCI) method were used to determine if the change scores were significant. Results Using the Normative Change method, ImPACT performed best with an 87.5%-confidence interval and 1 number of components failed (NCF; sensitivity = 0.583, specificity = 0.625, F1 = 0.308). CNS Vital Signs performed best with a 90%-confidence interval and 1 NCF (sensitivity = 0.587, specificity = 0.532, F1 = 0.314). CCAT performed best when using a 75%-confidence interval and 2 NCF (sensitivity = 0.513, specificity = 0.715, F1 = 0.290). When using the RCI method, ImPACT performed best with an 87.5%-confidence interval and 1 NCF (sensitivity = 0.626, specificity = 0.559, F1 = 0.297). Conclusion When considering all three computer-based neurocognitive tests, the overall low sensitivity and specificity results provide additional evidence for the use of a multi-dimensional assessment for concussion diagnosis, including symptom evaluation, postural control assessment, neuropsychological status, and other functional assessments.	[Czerniak, Lauren L.; Lavieri, Mariel S.] Univ Michigan, Dept Ind & Operat Engn, 1205 Beal Ave, Ann Arbor, MI 48109 USA; [Liebel, Spencer W.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Garcia, Gian-Gabriel P.] Harvard Med Sch, Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Czerniak, LL (corresponding author), Univ Michigan, Dept Ind & Operat Engn, 1205 Beal Ave, Ann Arbor, MI 48109 USA.	czernL@umich.edu		Liebel, Spencer/0000-0002-7036-4198; Garcia, Gian-Gabriel/0000-0001-9315-0195; Chrisman, Sara/0000-0001-5373-7223; Czerniak, Lauren/0000-0003-4379-2004	Grand Alliance CARE Consortium - NCAA; Department of DefenseUnited States Department of Defense; US Army Medical Research Acquisition Activity, Fort Detrick, MD, USA; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, by support from the Grand Alliance CARE Consortium, funded by the NCAA and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	[Anonymous], 2016, IMPACT ADM INTERPRET; Aoullay A., 2018, WHATS WRONG METRICS; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; CNS, 2014, CNS VIT SIGNS INT GU; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Garcia GGP, 2020, NEUROSURGERY, V87, P971, DOI 10.1093/neuros/nyaa150; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hinton-Bayre AD, 2012, CLIN J SPORT MED, V22, P105, DOI 10.1097/JSM.0b013e318248a526; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lisacek F, 2019, PACKAGE PROC; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell M, 2000, IMPACT IMMEDIATE POS; Lucini FR, 2017, INT J MED INFORM, V100, P1, DOI 10.1016/j.ijmedinf.2017.01.001; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Thoma RJ, 2018, COGENT PSYCHOL, V5, DOI 10.1080/23311908.2018.1430199; Walpole R. E., 2012, PROBABILITY STAT ENG, Vninth; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152	54	8	8	0	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	FEB	2021	51	2					351	365		10.1007/s40279-020-01393-7		DEC 2020	15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QA5YT	WOS:000598701900001	33315231				2022-02-06	
J	Bohm, JK; Guting, H; Thorn, S; Schafer, N; Rambach, V; Schochl, H; Grottke, O; Rossaint, R; Stanworth, S; Curry, N; Lefering, R; Maegele, M				Boehm, Julia K.; Gueting, Helge; Thorn, Sophie; Schaefer, Nadine; Rambach, Victoria; Schoechl, Herbert; Grottke, Oliver; Rossaint, Rolf; Stanworth, Simon; Curry, Nicola; Lefering, Rolf; Maegele, Marc		CENTER-TBI Participants Investigat	Global Characterisation of Coagulopathy in Isolated Traumatic Brain Injury (iTBI): A CENTER-TBI Analysis	NEUROCRITICAL CARE			English	Article						CENTER-TBI; Traumatic brain injury; Coagulopathy; Risk factors	INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; OLDER-ADULTS; HEAD-INJURY; RISK; MORTALITY; TRANSFUSION; CLOPIDOGREL; HYPOTHERMIA; MORBIDITY	Background Trauma-induced coagulopathy in patients with traumatic brain injury (TBI) is associated with high rates of complications, unfavourable outcomes and mortality. The mechanism of the development of TBI-associated coagulopathy is poorly understood. Methods This analysis, embedded in the prospective, multi-centred, observational Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, aimed to characterise the coagulopathy of TBI. Emphasis was placed on the acute phase following TBI, primary on subgroups of patients with abnormal coagulation profile within 4 h of admission, and the impact of pre-injury anticoagulant and/or antiplatelet therapy. In order to minimise confounding factors, patients with isolated TBI (iTBI) (n = 598) were selected for this analysis. Results Haemostatic disorders were observed in approximately 20% of iTBI patients. In a subgroup analysis, patients with pre-injury anticoagulant and/or antiplatelet therapy had a twice exacerbated coagulation profile as likely as those without premedication. This was in turn associated with increased rates of mortality and unfavourable outcome post-injury. A multivariate analysis of iTBI patients without pre-injury anticoagulant therapy identified several independent risk factors for coagulopathy which were present at hospital admission. Glasgow Coma Scale (GCS) less than or equal to 8, base excess (BE) less than or equal to - 6, hypothermia and hypotension increased risk significantly. Conclusion Consideration of these factors enables early prediction and risk stratification of acute coagulopathy after TBI, thus guiding clinical management.	[Boehm, Julia K.; Gueting, Helge; Schaefer, Nadine; Rambach, Victoria; Lefering, Rolf; Maegele, Marc] Witten Herdecke Univ, Inst Res Operat Med, Fac Hlth, Dept Med, Ostmerheimer Str 200,Bldg 38, D-51109 Cologne, Germany; [Thorn, Sophie] Alfred Hlth, Emergency & Trauma Ctr, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Maegele, Marc] Witten Herdecke Univ, Cologne Merheim Med Ctr CMMC, Dept Traumatol Orthopaed Surg & Sports Traumatol, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Schoechl, Herbert] Paracelsus Med Univ, Acad Teaching Hosp, AUVA Trauma Hosp, Dept Anaesthesiol & Intens Care, Doktor Franz Rehrl Pl 5, A-5010 Salzburg, Austria; [Schoechl, Herbert] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria; [Grottke, Oliver; Rossaint, Rolf] RWTH Aachen Univ Hosp, Dept Anaesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Stanworth, Simon; Curry, Nicola] Oxford Univ Hosp NHS Fdn Trust, NHS Blood & Transplant, Headley Way, Oxford OX3 9DU, England		Maegele, M (corresponding author), Witten Herdecke Univ, Inst Res Operat Med, Fac Hlth, Dept Med, Ostmerheimer Str 200,Bldg 38, D-51109 Cologne, Germany.; Maegele, M (corresponding author), Witten Herdecke Univ, Cologne Merheim Med Ctr CMMC, Dept Traumatol Orthopaed Surg & Sports Traumatol, Ostmerheimer Str 200, D-51109 Cologne, Germany.	Marc.Maegele@t-online.de	Lagares, Alfonso/B-2969-2011; Volovici, Victor/AAZ-8901-2020; Vande Vyvere, Thijs/AAB-5180-2022; Posti, Jussi P./Y-2908-2019; Raj, Rahul/K-7693-2012; Sahuquillo, Juan/B-3577-2008; Gomez, Pedro/E-2411-2014	Lagares, Alfonso/0000-0003-3996-0554; Volovici, Victor/0000-0002-5798-5360; Vande Vyvere, Thijs/0000-0003-4032-5443; Posti, Jussi P./0000-0002-5925-5193; Newcombe, Virginia/0000-0001-6044-9035; Zeiler, Frederick/0000-0003-1737-0510; Parizel, Paul M./0000-0002-0221-2854; Raj, Rahul/0000-0003-4243-9591; Coles, Jonathan/0000-0003-4013-679X; Sanchez-Porras, Renan/0000-0002-9084-8114; Rossi, Sandra/0000-0002-9963-8121; Kondziella, Daniel/0000-0001-5562-9808; van der Naalt, Joukje/0000-0001-9873-2418; Van Essen, Thomas/0000-0003-4657-5283; Grottke, Oliver/0000-0002-0722-3122; Sahuquillo, Juan/0000-0003-0713-5875; Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049; Stewart, William/0000-0003-2199-2582; Radoi, Andreea/0000-0002-0677-3544; Sakowitz, Oliver/0000-0003-3248-6335; Dark, Paul/0000-0003-3309-0164	European UnionEuropean Commission [602150]; Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. The research described above was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 602150 (CENTER-TBI).	Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Chhabra G, 2010, NEUROL INDIA, V58, P756, DOI 10.4103/0028-3886.72175; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kaafarani HMA, 2014, SCAND J SURG, V103, P81, DOI 10.1177/1457496914524388; Lapostolle F, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0349-1; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Nishijima DK, 2013, AM J EMERG MED, V31, P1244, DOI 10.1016/j.ajem.2013.04.035; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Perlman R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1271-z; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Shehata M., 2011, MED J CAIRO U, V79, P131; Shoeb M, 2013, J THROMB THROMBOLYS, V35, P312, DOI 10.1007/s11239-013-0899-7; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Waibel BH, 2009, J AM COLL SURGEONS, V209, P580, DOI 10.1016/j.jamcollsurg.2009.07.021; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	43	8	8	3	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2021	35	1					184	196		10.1007/s12028-020-01151-7		DEC 2020	13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TJ4CL	WOS:000598107300001	33306177	Green Published, hybrid			2022-02-06	
J	Robba, C; Rebora, P; Banzato, E; Wiegers, EJA; Stocchetti, N; Menon, DK; Citerio, G				Robba, Chiara; Rebora, Paola; Banzato, Erika; Wiegers, Eveline J. A.; Stocchetti, Nino; Menon, David K.; Citerio, Giuseppe		Collaborative European NeuroTrauma	Incidence, Risk Factors, and Effects on Outcome of Ventilator-Associated Pneumonia in Patients With Traumatic Brain Injury: Analysis of a Large, Multicenter, Prospective, Observational Longitudinal Study	CHEST			English	Article						mechanical ventilation; outcome; oxygenation; traumatic brain injury; ventilator-associated pneumonia	PROTON-PUMP INHIBITORS; EARLY-ONSET PNEUMONIA; NOSOCOMIAL PNEUMONIA; ATTRIBUTABLE MORTALITY; INTUBATED PATIENTS; CENTER-TBI; PREVENTION; IMPACT; PROPHYLAXIS; SUCRALFATE	BACKGROUND: No large prospective data, to our knowledge, are available on ventilator associated pneumonia (VAP) in patients with traumatic brain injury (TBI). RESEARCH QUESTION: To evaluate the incidence, timing, and risk factors of VAP after TBI and its effect on patient outcome. STUDY DESIGN AND METHODS: This analysis is of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury data set, from a large, multicenter, prospective, observational study including patients with TBI admitted to European ICUs, receiving mechanical ventilation for >= 48 hours and with an ICU length of stay (LOS) >= 72 hours. Characteristics of patients with VAP vs characteristics of patients without VAP were compared, and outcome was assessed at 6 months after injury by using the Glasgow Outcome Scale Extended. RESULTS: The study included 962 patients: 196 (20.4%) developed a VAP at a median interval of 5 days (interquartile range [IQR], 3-7 days) after intubation. Patients who developed VAP were younger (median age, 39.5 [IQR, 25-55] years vs 51 [IQR, 30-66] years; P < .001), with a higher incidence of alcohol abuse (36.6% vs 27.6%; P = .026) and drug abuse (10.1% vs 4.2%; P = .009), more frequent thoracic trauma (53% vs 43%; P = .014), and more episodes of respiratory failure during ICU stay (69.9% vs 28.1%; P < .001). Age (hazard ratio [HR], 0.99; 95% CI, 0.98-0.99; P = .001), chest trauma (HR, 1.4; 95% CI, 1.03-1.90; P = .033), histamine-receptor antagonist intake (HR, 2.16; 95% CI, 1.37-3.39; P = .001), and antibiotic prophylaxis (HR, 0.69; 95% CI, 0.50-0.96; P = .026) were associated with the risk of VAP. Patients with VAP had a longer duration of mechanical ventilation (median, 15 [IQR, 10-22] days vs 8 [IQR, 5-14] days; P < .001) and ICU LOS (median, 20 [IQR, 14-29] days vs 13 [IQR, 8-21] days; P < .001). However, VAP was not associated with increased mortality or worse neurological outcome. Overall mortality at 6 months was 22%. INTERPRETATION: VAP occurs less often than previously described in patients after TBI and has a detrimental effect on ICU LOS but not on mortality and neurological outcome.	[Robba, Chiara] Policlin San Martino IRCCS Oncol & Neurosci, Dept Anesthesia & Intens Care, Genoa, Italy; [Rebora, Paola; Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Rebora, Paola; Banzato, Erika] Univ Milano Bicocca, Ctr Biostat Clin Epidemiol, Monza, Italy; [Banzato, Erika] Univ Padua, Dept Stat Sci, Padua, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci ICU, Milan, Italy; [Wiegers, Eveline J. A.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Menon, David K.] Univ Cambridge, Dept Anesthesia, Cambridge, England; [Citerio, Giuseppe] ASST Monza, NeuroIntens Care, Monza, Italy		Citerio, G (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Milan, Italy.	giuseppe.citerio@unimib.it	Lagares, Alfonso/B-2969-2011; Volovici, Victor/AAZ-8901-2020; Castano-Leon, Ana M/ABF-6322-2020; Sahuquillo, Juan/B-3577-2008; Posti, Jussi P./Y-2908-2019; Stocchetti, Nino/O-7444-2017; Gomez, Pedro/E-2411-2014	Lagares, Alfonso/0000-0003-3996-0554; Volovici, Victor/0000-0002-5798-5360; Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Posti, Jussi P./0000-0002-5925-5193; Radoi, Andreea/0000-0002-0677-3544; Zeiler, Frederick/0000-0003-1737-0510; Kondziella, Daniel/0000-0001-5562-9808; Rossi, Sandra/0000-0002-9963-8121; Coles, Jonathan/0000-0003-4013-679X; Della Corte, Francesco/0000-0003-1736-2318; Stocchetti, Nino/0000-0003-3250-6834; Sanchez-Porras, Renan/0000-0002-9084-8114; Newcombe, Virginia/0000-0001-6044-9035; Van Essen, Thomas/0000-0003-4657-5283; Sakowitz, Oliver/0000-0003-3248-6335; Gomez, Pedro/0000-0002-4185-5238	Seventh Framework Program of the European UnionEuropean Commission [602150]; Hannelore Kohl Foundation (Germany); One Mind (United States); Integra LifeSciences Corporation (United States)	Data used in the preparation of this manuscript were obtained in the context of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTERTBI) study, registered at ClinicalTrials.gov NCT02210221, a large collaborative project, supported by the Seventh Framework Program of the European Union [Grant 602150]. Additional funding was obtained from the Hannelore Kohl Foundation (Germany), from One Mind (United States), and from Integra LifeSciences Corporation (United States).	Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; Ali HS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8231787; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Colombo SM, 2019, INTENS CARE MED, V15, P1; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; Dupont H, 2001, INTENS CARE MED, V27, P355, DOI 10.1007/s001340000640; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Ferrer M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1165-5; Grindlinger GA, 2016, J SURG RES, V206, P398, DOI 10.1016/j.jss.2016.08.028; Gvozdenovic L, 2012, BRAZ J INFECT DIS, V16, P599, DOI 10.1016/j.bjid.2012.07.012; Hammond DA, 2017, PHARMACOTHERAPY, V37, P43, DOI 10.1002/phar.1859; Ibn Saied W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187791; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Kalanuria AA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1206-8; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Kallet RH, 2019, RESP CARE, V64, P994, DOI 10.4187/respcare.06966; Kollef MH, 2012, CRIT CARE MED, V40, P271, DOI 10.1097/CCM.0b013e318232e41d; Koulenti D, 2017, EUR J CLIN MICROBIOL, V36, P1999, DOI 10.1007/s10096-016-2703-z; Leonard KL, 2016, SURG INFECT, V17, P363, DOI 10.1089/sur.2014.076; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Bassi GL, 2017, CURR OPIN INFECT DIS, V30, P214, DOI [10.1097/QCO.0000000000000358, 10.1097/qco.0000000000000358]; Li Y, 2019, NEUROCRIT CARE; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Luyt CE, 2018, CURR OPIN CRIT CARE, V24, P332, DOI 10.1097/MCC.0000000000000526; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Melsen WG, 2011, CRIT CARE MED, V39, P2736, DOI 10.1097/CCM.0b013e3182281f33; Mitchell BG, 2019, INFECT DIS HLTH; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Park Hyun Oh, 2017, Korean J Thorac Cardiovasc Surg, V50, P346, DOI 10.5090/kjtcs.2017.50.5.346; R Core Team, 2018, STATS PACK LANG ENV; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Rello J, 2003, CRIT CARE MED, V31, P2544, DOI 10.1097/01.CCM.0000089928.84326.D2; Rello J, 2015, INTENS CARE MED, V41, P1954, DOI 10.1007/s00134-015-3909-8; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Spalding MC, 2017, CRIT CARE CLIN, V33, P277, DOI 10.1016/j.ccc.2016.12.009; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Torres A, 2001, EUR RESPIR J, V17, P1034, DOI 10.1183/09031936.01.17510340; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	43	8	8	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-3692	1931-3543		CHEST	Chest	DEC	2020	158	6					2292	2303		10.1016/j.chest.2020.06.064			12	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	PG3DB	WOS:000599618400023	32634435	Green Published			2022-02-06	
J	Wang, ZN; Zhang, M; Sun, CZ; Wang, S; Cao, JL; Wang, KKW; Gan, SQ; Huang, WM; Niu, X; Zhu, YN; Sun, YX; Bai, LJ				Wang, Zhuonan; Zhang, Ming; Sun, Chuanzhu; Wang, Shan; Cao, Jieli; Wang, Kevin K. W.; Gan, Shuoqiu; Huang, Wenmin; Niu, Xuan; Zhu, Yanan; Sun, Yingxiang; Bai, Lijun			Single Mild Traumatic Brain Injury Deteriorates Progressive Interhemispheric Functional and Structural Connectivity	JOURNAL OF NEUROTRAUMA			English	Article						corpus callosum; longitudinal study; mild traumatic brain injury; neurodegenerative diseases; voxel-mirrored homotopic connectivity	WHITE-MATTER; CORPUS-CALLOSUM; COGNITIVE IMPAIRMENT; DTI TRACTOGRAPHY; WORKING-MEMORY; AXONAL INJURY; SCALE; NETWORK; STATE; ABNORMALITIES	The present study examined dynamic interhemispheric structural and functional connectivity in mild traumatic brain injury (mTBI) patients with longitudinal observations from early subacute to chronic stages within 1 year of injury. Forty-two mTBI patients and 42 matched healthy controls underwent clinical and neuropsychological evaluations, diffusion tensor imaging, and resting-state functional magnetic resonance imaging. All mTBI patients were initially evaluated within 14 d post-injury (T-1) and at 3 months (T-2) and 6-12 months (T-3) follow-ups. Separate transcallosal fiber tracts in the corpus callosum (CC) with respect to their specific interhemispheric cortical projections were derived with fiber tracking and voxel-mirrored homotopic connectivity analyses. With diffusion tensor imaging-based tractography, five vertical segments of the CC (I-V) were distinguished. Correlation analyses were performed to evaluate relationships between structural and functional imaging measures as well as imaging indices and neuropsychological measures. The loss of integrity in the CC demonstrated saliently persistent and time-dependent regional specificity after mTBI. The impairment spanned multiple segments from CC II at T-1 and CC I, II, VI, and V at T-2 to all subregions at T-3. Moreover, loss of interhemispheric structural connectivity through the CC corresponded well to regions presenting altered interhemispheric functional connectivity. Decreased functional connectivity in the dorsolateral prefrontal cortex thereafter contributed to poor executive function in mTBI patients. The current study provides further evidence that the CC is a sign to interhemispheric highways underpinning the widespread cerebral pathology typifying mTBI syndrome.	[Wang, Zhuonan; Sun, Chuanzhu; Wang, Shan; Cao, Jieli; Gan, Shuoqiu; Huang, Wenmin; Niu, Xuan; Bai, Lijun] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Dept Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Wang, Zhuonan; Zhang, Ming; Gan, Shuoqiu; Niu, Xuan; Zhu, Yanan; Sun, Yingxiang] Xi An Jiao Tong Univ, Dept Med Imaging, Affiliated Hosp 1, Xian, Peoples R China; [Wang, Kevin K. W.] Univ Florida, Program Neurotrauma Neuroprote & Biomarker Res, Dept Emergency Med, Gainesville, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32610 USA		Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Dept Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China.; Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian 710061, Peoples R China.	zhangming01@mail.xjtu.edu.cn; bailijun@xjtu.edu.cn	Wang, Zhuonan/E-3691-2017; Niu, Xuan/AAD-7351-2022; Bai, Lijun/C-5119-2015	Bai, Lijun/0000-0001-8790-5424; Wang, Zhuonan/0000-0002-5745-4340	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914, 81571640]; National Key Research and Development Plan of China [2016YFC0100300]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [Xjj 2018229]	This research was supported by the National Natural Science Foundation of China (Grant nos. 81571752, 81771914, and 81571640), National Key Research and Development Plan of China (No. 2016YFC0100300), and Fundamental Research Funds for the Central Universities (No. Xjj 2018229).	Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman JG, 2017, NEUROLOGY, V88, P1265, DOI 10.1212/WNL.0000000000003764; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Li J, 2017, EUR RADIOL, V27, P325, DOI 10.1007/s00330-016-4302-x; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shen K, 2015, P NATL ACAD SCI USA, V112, P6473, DOI 10.1073/pnas.1503436112; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spielberger CD., 1983, STATE TRAIT ANXIETY; Storey P, 2007, MAGN RESON MED, V57, P614, DOI 10.1002/mrm.21132; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; SWAYZE VW, 1990, ARCH NEUROL-CHICAGO, V47, P805, DOI 10.1001/archneur.1990.00530070103018; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Voineskos AN, 2012, NEUROBIOL AGING, V33, P21, DOI 10.1016/j.neurobiolaging.2010.02.009; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zahr NM, 2009, NEUROIMAGE, V44, P1050, DOI 10.1016/j.neuroimage.2008.09.046; Zhang J., 2017, J NEUROL NEUROSUR PS, V88, P374; Zhang J, 2019, IEEE T INSTRUM MEAS, V68, P4112, DOI [10.1109/TIM.2018.2884583, 10.1111/irfi.12234]; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	75	8	8	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					464	473		10.1089/neu.2018.6196		NOV 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000589714800001	30931824				2022-02-06	
J	Froese, L; Dian, J; Batson, C; Gomez, A; Alarifi, N; Unger, B; Zeiler, FA				Froese, Logan; Dian, Joshua; Batson, Carleen; Gomez, Alwyn; Alarifi, Norah; Unger, Bertram; Zeiler, Frederick A.			The Impact of Vasopressor and Sedative Agents on Cerebrovascular Reactivity and Compensatory Reserve in Traumatic Brain Injury: An Exploratory Analysis	NEUROTRAUMA REPORTS			English	Article						autoregulation; cerebrovascular reactivity; compensatory reserve; sedative drugs; vasopressors	CEREBRAL PERFUSION-PRESSURE; NEUROTRAUMA EFFECTIVENESS RESEARCH; LOWER LIMIT; AUTOREGULATION; THRESHOLDS; VALIDATION; MANAGEMENT; INDEXES	The impact of vasopressor and sedative drugs on cerebrovascular reactivity in traumatic brain injury (TBI) remains unclear. The aim of this study was to evaluate the impact of changes of doses of commonly administered sedation (i.e., propofol, fentanyl, and ketamine) and vasopressor agents (i.e., norepinephrine [NE], phenylephrine [PE], and vasopressin[VSP]) on cerebrovascular reactivity and compensatory reserve in patients with moderate/severe TBI. Using the Winnipeg Acute TBI Database, we identified 38 patients with more than 1000 distinct changes of infusion rates and more than 500 h of paired drug infusion/physiology data. Cerebrovascular reactivity was assessed using pressure reactivity index (PRx) and cerebral compensatory reserve was assessed using RAP (the correlation [R] between pulse amplitude of intracranial pressure [ICP; A] and ICP [P]). We evaluated the data in two phases. First, we assessed the relationship between mean hourly dose of medication and its relation to both mean hourly index values, and time spent above a given index threshold. Second, we evaluated time-series data for each individual dose change per medication, assessing for a statistically significant change in PRx and RAP metrics. The results of the analysis confirmed that, overall, the mean hourly dose of sedative (propofol, fentanyl, and ketamine) and vasopressor (NE, PE, and VSP) agents does not impact hourly cerebrovascular reactivity or compensatory reserve measures. Similarly, incremental dose changes in these medications in general do not lead to significant changes in cerebrovascular reactivity or compensatory reserve. For propofol with incremental dose increases, in situations where PRx is intact (i.e., PRx < 0 prior), a statistically significant increase in PRx was seen. However, this may not indicate deteriorating cerebrovascular reactivity as the final PRx (similar to 0.05) may still be considered to be intact cerebrovascular reactivity. As such, this finding with regards to propofol remains "weak." This study indicates that commonly administered sedative and vasopressor agents with incremental dosing changes have no clinically significant influence on cerebrovascular reactivity or compensatory reserve in TBI. These results should be considered preliminary, requiring further investigation.	[Froese, Logan; Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, SP 422 EITC,75 Chancellors Circle, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Dian, Joshua; Gomez, Alwyn; Alarifi, Norah; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Neurosurg, Dept Surg, Winnipeg, MB, Canada; [Batson, Carleen; Gomez, Alwyn; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada; [Unger, Bertram] Univ Manitoba, Rady Fac Hlth Sci, Dept Med, Sect Crit Care, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England		Froese, L (corresponding author), Univ Manitoba, Biomed Engn, Fac Engn, SP 422 EITC,75 Chancellors Circle, Winnipeg, MB, Canada.	log.froese@gmail.com		Zeiler, Frederick/0000-0003-1737-0510	Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation [38583]; Research Manitoba [3906]; University of Manitoba -Department of Surgery Geographical Full Time (GFT) Research Grant; University of Manitoba Office of Research Services (ORS) -University Research Grant Program (URGP); MPI Neuroscience/TBI Research Endowment; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS Grant) [R03NS114335-01]; Canadian Institutes of Health Research (CIHR Grant)Canadian Institutes of Health Research (CIHR) [432061]; CFICanada Foundation for Innovation [38583]; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Centre on Aging; University of Manitoba Rudy Falk Clinician-Scientist Professorship; University of Manitoba -Department of Surgery GFT Research Grant; ORS -URGP; Centre on Aging Fellowship at the University of Manitoba; University of Manitoba Clinician Investigator Program	This work was supported directly through the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the Canada Foundation for Innovation (CFI; Project #38583), Research Manitoba (Grant #3906), the University of Manitoba -Department of Surgery Geographical Full Time (GFT) Research Grant, and the University of Manitoba Office of Research Services (ORS) -University Research Grant Program (URGP). F.A.Z. receives research support from the MPI Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS Grant #R03NS114335-01), the Canadian Institutes of Health Research (CIHR Grant #432061), CFI (Project #38583), Research Manitoba (Grant #3906), the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Centre on Aging, and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. L.F. is supported through the University of Manitoba -Department of Surgery GFT Research Grant, and ORS -URGP. C.B. is supported through the Centre on Aging Fellowship at the University of Manitoba, and A.G. is supported through the University of Manitoba Clinician Investigator Program.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2005, ACT NEUR S, V95, P25; Bennis FC, 2020, NEUROCRIT CARE, V33, P542, DOI 10.1007/s12028-020-00930-6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Bernard F, 2020, CAN J NEUROL SCI, V47, P551, DOI 10.1017/cjn.2020.54; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Froese L, 2021, NEUROCRIT CARE, V34, P325, DOI 10.1007/s12028-020-01003-4; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Klein SP, 2021, J NEUROTRAUM, V38, P506, DOI 10.1089/neu.2020.7160; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Mathieu F, 2020, J NEUROTRAUM, V37, P1556, DOI 10.1089/neu.2019.6814; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Thelin EP, 2020, J CLIN MONIT COMPUT, V34, P971, DOI 10.1007/s10877-019-00392-y; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1275, DOI 10.1007/s00701-019-03915-3; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	34	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	NOV 1	2020	1	1					157	168		10.1089/neur.2020.0028			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WU7FW	WOS:000716708100002	33274344	Green Published, hybrid			2022-02-06	
J	Galioto, R; Dhima, K; Berenholz, O; Busch, R				Galioto, Rachel; Dhima, Kaltra; Berenholz, Ophira; Busch, Robyn			Performance Validity Testing in Multiple Sclerosis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Multiple sclerosis; Effort; Performance validity; Cognition; Assessment	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY; COMPENSATION; VALIDATION; INVENTORY; ANXIETY; SCORES	Objective: Performance validity tests (PVTs) are designed to detect nonvalid responding on neuropsychological testing, but their associations with disease-specific and other factors are not well understood in multiple sclerosis (MS). We examined PVT performance among MS patients and associations with clinical characteristics, cognition, mood, and disability status. Method: Retrospective data analysis was conducted on a sample of patients with definite MS (n = 102) who were seen for a clinical neuropsychological evaluation. Comparison samples included patients with intractable epilepsy seen for presurgical workup (n = 102) and patients with nonacute mild traumatic brain injury (mTBI; n = 50). Patients completed the Victoria Symptom Validity Test (VSVT) and validity cutoffs were defined as <16/24 and <18/24 on the hard items. Results: In this MS cohort, 14.4% of patients scored <16 on the VSVT hard items and 21.2% scored <18. VSVT hard item scores were associated with disability status and depression, but not with neuropsychological scores, T2 lesion burden, atrophy, disease duration, or MS subtype. Patients applying for disability benefits were 6.75 times more likely to score <18 relative to those who were not seeking disability. Rates of nonvalid scores were similar to the mTBI group and greater than the epilepsy group. Conclusions: This study demonstrates that nonvalid VSVT scores are relatively common among MS patients seen for clinical neuropsychological evaluation. VSVT performance in this group relates primarily to disability status and psychological symptoms and does not reflect factors specific to MS (i.e., cognitive impairment, disease severity). Recommendations for future clinical and research practices are provided.	[Galioto, Rachel] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA; [Galioto, Rachel; Dhima, Kaltra; Berenholz, Ophira; Busch, Robyn] Cleveland Clin, Dept Neurol, Cleveland, OH 44106 USA; [Busch, Robyn] Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44106 USA		Galioto, R (corresponding author), 9500 Euclid Ave,P-57, Cleveland, OH 44195 USA.	galiotr@ccf.org					[Anonymous], 2013, ADAMANTIUS, V19, P314; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck ATSB., 2000, BDI FAST SCREEN MED; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Delis D.C., 2000, CALIFORNIA VERBAL LE; Ferrari R, 2016, J RHEUMATOL, V43, P2077, DOI 10.3899/jrheum.160686; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Greiffenstein M, 2009, CLIN NEUROPSYCHOL, V23, P286, DOI 10.1080/13854040802104873; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heaton RK, 1991, COMPREHENSIVE NORMS; Kalb R, 2018, MULT SCLER J, V24, P1665, DOI 10.1177/1352458518803785; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leavitt V.M., 2019, MULT SCLER J, P1; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morrow SA, 2016, J NEUROPSYCH CLIN N, V28, P118, DOI 10.1176/appi.neuropsych.15070167; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Silk-Eglit GM, 2016, ARCH CLIN NEUROPSYCH, V31, P231, DOI 10.1093/arclin/acv108; Slick D., 1997, VSVT VICTORIA SYMPTO; Smith A., 1982, SYMBOL DIGIT MODALIT; Suchy Y, 2012, CLIN NEUROPSYCHOL, V26, P1296, DOI 10.1080/13854046.2012.722230; Wechsler D., 2008, WECHSLER ADULT INTEL, VVol. 22, P498	34	8	8	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2020	26	10					1028	1035	PII S1355617720000466	10.1017/S1355617720000466			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	OO9FO	WOS:000587679200008	32342832				2022-02-06	
J	Lutkenhoff, ES; Wright, MJ; Shrestha, V; Real, C; McArthur, DL; Buitrago-Blanco, M; Vespa, PM; Monti, MM				Lutkenhoff, Evan S.; Wright, Matthew J.; Shrestha, Vikesh; Real, Courtney; McArthur, David L.; Buitrago-Blanco, Manuel; Vespa, Paul M.; Monti, Martin M.			The subcortical basis of outcome and cognitive impairment in TBI	NEUROLOGY			English	Article							EXECUTIVE DYSFUNCTION; VEGETATIVE STATE; BRAIN; CONSCIOUSNESS; NEUROPATHOLOGY; SENSITIVITY; THALAMUS; NUCLEI; CORTEX; MEMORY	Objective To understand how, biologically, the acute event of traumatic brain injury gives rise to a long-term disease, we address the relationship between evolving cortical and subcortical brain damage and measures of functional outcome and cognitive functioning at 6 months after injury. Methods For this longitudinal analysis, clinical and MRI data were collected in a tertiary neurointensive care setting in a continuous sample of 157 patients surviving moderate to severe traumatic brain injury between 2000 and 2018. For each patient, we collected T1- and T2-weighted MRI data acutely and at the 6-month follow-up, as well as acute measures of injury severity (Glasgow Coma Scale), follow-up measures of functional impairment (Glasgow Outcome Scale-extended), and, in a subset of patients, neuropsychological measures of attention, executive functions, and episodic memory. Results In the final cohort of 113 subcortical and 92 cortical datasets that survived (blind) quality control, extensive atrophy was observed over the first 6 months after injury across the brain. However, only atrophy within subcortical regions, particularly in the left thalamus, was associated with functional outcome and neuropsychological measures of attention, executive functions, and episodic memory. Furthermore, when brought together in an analytical model, longitudinal brain measurements could distinguish good from bad outcome with 90% accuracy, whereas acute brain and clinical measurements alone could achieve only 20% accuracy. Conclusion Despite great injury heterogeneity, secondary thalamic pathology is a measurable minimum common denominator mechanism directly relating biology to clinical measures of outcome and cognitive functioning, potentially linking the acute event and the longer-term disease of traumatic brain injury.	[Lutkenhoff, Evan S.; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Wright, Matthew J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Lutkenhoff, Evan S.; Wright, Matthew J.; Shrestha, Vikesh; Real, Courtney; McArthur, David L.; Buitrago-Blanco, Manuel; Vespa, Paul M.; Monti, Martin M.] David Geffen Sch Med UCLA, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Buitrago-Blanco, Manuel; Vespa, Paul M.; Monti, Martin M.] David Geffen Sch Med UCLA, Dept Neurosurg, Los Angeles, CA 90095 USA; [Buitrago-Blanco, Manuel; Vespa, Paul M.; Monti, Martin M.] David Geffen Sch Med UCLA, Dept Neurol, Los Angeles, CA 90095 USA; [Wright, Matthew J.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA		Monti, MM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.; Monti, MM (corresponding author), David Geffen Sch Med UCLA, Brain Injury Res Ctr, Los Angeles, CA 90095 USA.; Monti, MM (corresponding author), David Geffen Sch Med UCLA, Dept Neurosurg, Los Angeles, CA 90095 USA.; Monti, MM (corresponding author), David Geffen Sch Med UCLA, Dept Neurol, Los Angeles, CA 90095 USA.	monti@ucla.edu		Monti, Martin M/0000-0001-5511-3780	NIH/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS058489, NS100064, NS049471]; Tiny Blue Dot Foundation; James S. McDonnell Foundation; State of CaliforniaNeurotrauma Initiative	Study Funding by NIH/National Institute of Neurological Disorders and Stroke grants NS058489, NS100064, and NS049471; Tiny Blue Dot Foundation; James S. McDonnell Foundation; and the State of CaliforniaNeurotrauma Initiative.	[Anonymous], 1944, ARM IND TEST BATT MA; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Crone JS, 2017, CEREB CORTEX, V27, P2727, DOI 10.1093/cercor/bhw112; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Golden CJ, 1978, STROOP COLOR WORD TE; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hand DJ, 2010, STAT MED, V29, P1502, DOI 10.1002/sim.3859; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; Keuken MC, 2014, NEUROIMAGE, V94, P40, DOI 10.1016/j.neuroimage.2014.03.032; Kubat-Silman AK, 2002, BRAIN COGNITION, V50, P178, DOI 10.1016/S0278-2626(02)00502-X; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Monti, 2019, BIORXIV, DOI [10.1101/688283, DOI 10.1101/688283]; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rey A., 1964, EXAMEN CLIN PSYCHOL; Schiff ND, 2016, J NEURAL TRANSM, V123, P797, DOI 10.1007/s00702-016-1547-0; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2019, J NEUROL NEUROSUR PS, V90, P617, DOI 10.1136/jnnp-2017-317829; Schnakers C, 2017, CURR OPIN NEUROL, V30, P573, DOI 10.1097/WCO.0000000000000495; Scott RB, 2002, BRAIN, V125, P562, DOI 10.1093/brain/awf046; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; TBI Model Systems National Database, 2016, TBI MODEL SYSTEMS NA; TEASDALE G, 1974, LANCET, V2, P81; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	49	8	8	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	OCT 27	2020	95	17					E2398	E2408		10.1212/WNL.0000000000010825			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OP1CE	WOS:000587817900023	32907958	Green Published			2022-02-06	
J	Ritzel, RM; He, JY; Li, Y; Cao, TX; Khan, N; Shim, B; Sabirzhanov, B; Aubrecht, T; Stoica, BA; Faden, AI; Wu, LJ; Wu, JF				Ritzel, Rodney M.; He, Junyun; Li, Yun; Cao, Tuoxin; Khan, Niaz; Shim, Bosung; Sabirzhanov, Boris; Aubrecht, Taryn; Stoica, Bogdan A.; Faden, Alan I.; Wu, Long-Jun; Wu, Junfang			Proton extrusion during oxidative burst in microglia exacerbates pathological acidosis following traumatic brain injury	GLIA			English	Article						acidosis; chronic neurodegeneration; microglia; neuroinflammation; traumatic brain injury	ACUTE NEUROINFLAMMATION; PH; CHANNELS; NEUTROPHIL; BEHAVIOR; DAMAGE	Acidosis is among the least studied secondary injury mechanisms associated with neurotrauma. Acute decreases in brain pH correlate with poor long-term outcome in patients with traumatic brain injury (TBI), however, the temporal dynamics and underlying mechanisms are unclear. As key drivers of neuroinflammation, we hypothesized that microglia directly regulate acidosis after TBI, and thereby, worsen neurological outcomes. Using a controlled cortical impact model in adult male mice we demonstrate that intracellular pH in microglia and extracellular pH surrounding the lesion site are significantly reduced for weeks after injury. Microglia proliferation and production of reactive oxygen species (ROS) were also increased during the first week, mirroring the increase in extracellular ROS levels seen around the lesion site. Microglia depletion by a colony stimulating factor 1 receptor (CSF1R) inhibitor, PLX5622, markedly decreased extracellular acidosis, ROS production, and inflammation in the brain after injury. Mechanistically, we identified that the voltage-gated proton channel Hv1 promotes oxidative burst activity and acid extrusion in microglia. Compared to wildtype controls, microglia lacking Hv1 showed reduced ability to generate ROS and extrude protons. Importantly, Hv1-deficient mice exhibited reduced pathological acidosis and inflammation after TBI, leading to long-term neuroprotection and functional recovery. Our data therefore establish the microglial Hv1 proton channel as an important link that integrates inflammation and acidosis within the injury microenvironment during head injury.	[Ritzel, Rodney M.; He, Junyun; Li, Yun; Cao, Tuoxin; Khan, Niaz; Shim, Bosung; Sabirzhanov, Boris; Aubrecht, Taryn; Stoica, Bogdan A.; Faden, Alan I.; Wu, Junfang] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Ritzel, Rodney M.; He, Junyun; Li, Yun; Cao, Tuoxin; Khan, Niaz; Shim, Bosung; Sabirzhanov, Boris; Aubrecht, Taryn; Stoica, Bogdan A.; Faden, Alan I.; Wu, Junfang] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Faden, Alan I.; Wu, Junfang] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA; [Wu, Long-Jun] Mayo Clin, Dept Neurol, Rochester, MN USA		Wu, JF (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.; Wu, JF (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA.	junfang.wu@som.umaryland.edu	Wu, Long-Jun/AAK-7113-2020	Wu, Long-Jun/0000-0001-8019-3380; Li, Yun/0000-0003-2040-4451	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01 NR013601, F32 NS105355, K99 NS116032, R01 NS088627, R01 NS094527, R01 NS110567, R01 NS110635, R01 NS110825, RF1 NS110637]	National Institutes of Health, Grant/Award Numbers: 2R01 NR013601, F32 NS105355, K99 NS116032, R01 NS088627, R01 NS094527, R01 NS110567, R01 NS110635, R01 NS110825, RF1 NS110637	Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Clark RA, 2016, J LEUKOCYTE BIOL, V99, P1, DOI 10.1189/jlb.4CE0515-188RR; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; de Ceglia R, 2015, BRAIN BEHAV IMMUN, V45, P263, DOI 10.1016/j.bbi.2014.12.003; DeCoursey TE, 2016, IMMUNOL REV, V273, P194, DOI 10.1111/imr.12437; DeCoursey TE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0799; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; El Chemaly A, 2014, J LEUKOCYTE BIOL, V95, P827, DOI 10.1189/jlb.0513251; Ellingson BM, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101736; Diaz FE, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1218297; Eugenin J, 2016, J ALZHEIMERS DIS, V53, P857, DOI 10.3233/JAD-160083; Fan YY, 2014, J CEREBR BLOOD F MET, V34, P275, DOI 10.1038/jcbfm.2013.193; Finnie JW, 2016, VET PATHOL, V53, P962, DOI 10.1177/0300985815612155; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hong L, 2013, NEURON, V77, P274, DOI 10.1016/j.neuron.2012.11.013; Lei FY, 2020, P NATL ACAD SCI USA, V117, P23336, DOI 10.1073/pnas.1922788117; Li XF, 2020, BIOCHEM BIOPH RES CO, V525, P208, DOI 10.1016/j.bbrc.2020.02.012; Liu JL, 2015, J NEUROCHEM, V135, P347, DOI 10.1111/jnc.13242; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ritzel RM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1426-3; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Sabirzhanov B, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2079-y; Seredenina T, 2015, ANTIOXID REDOX SIGN, V23, P490, DOI 10.1089/ars.2013.5806; Shen Z, 2017, AUTOPHAGY, V13, P473, DOI 10.1080/15548627.2016.1274596; SIMON RP, 1993, J PHARMACOL EXP THER, V267, P1428; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Tian DS, 2016, J NEUROCHEM, V139, P96, DOI 10.1111/jnc.13751; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Tyrtyshnaia AA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0747-8; Wang CF, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6460; Wang LX, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0305-9; Wang YZ, 2015, ELIFE, V4, DOI 10.7554/eLife.05682; Wang YF, 2012, J BIOL CHEM, V287, P13877, DOI 10.1074/jbc.M112.345280; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu LJ, 2014, NEUROSCIENTIST, V20, P599, DOI 10.1177/1073858413519864; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Yin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072379; Yu Y, 2020, J NEUROCHEM, V152, P350, DOI 10.1111/jnc.14925; Zeng WZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14125; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zheng YR, 2017, JOVE-J VIS EXP, DOI 10.3791/55931	54	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAR	2021	69	3					746	764		10.1002/glia.23926		OCT 2020	19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PR6TH	WOS:000580646300001	33090575	Green Published, hybrid			2022-02-06	
J	Gabler, LF; Huddleston, SH; Dau, NZ; Lessley, DJ; Arbogast, KB; Thompson, X; Resch, JE; Crandall, JR				Gabler, Lee F.; Huddleston, Samuel H.; Dau, Nathan Z.; Lessley, David J.; Arbogast, Kristy B.; Thompson, Xavier; Resch, Jacob E.; Crandall, Jeff R.			On-Field Performance of an Instrumented Mouthguard for Detecting Head Impacts in American Football	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						American football; Concussion; Feature engineering; Head kinematics; Instrumented mouthguard; Machine learning; On-field impacts	ACCELERATION; VALIDATION; KINEMATICS; EXPOSURE; SYSTEM	Wearable sensors that accurately record head impacts experienced by athletes during play can enable a wide range of potential applications including equipment improvements, player education, and rule changes. One challenge for wearable systems is their ability to discriminate head impacts from recorded spurious signals. This study describes the development and evaluation of a head impact detection system consisting of a mouthguard sensor and machine learning model for distinguishing head impacts from spurious events in football games. Twenty-one collegiate football athletes participating in 11 games during the 2018 and 2019 seasons wore a custom-fit mouthguard instrumented with linear and angular accelerometers to collect kinematic data. Video was reviewed to classify sensor events, collected from instrumented players that sustained head impacts, as head impacts or spurious events. Data from 2018 games were used to train the ML model to classify head impacts using kinematic data features (127 head impacts; 305 non-head impacts). Performance of the mouthguard sensor and ML model were evaluated using an independent test dataset of 3 games from 2019 (58 head impacts; 74 non-head impacts). Based on the test dataset results, the mouthguard sensor alone detected 81.6% of video-confirmed head impacts while the ML classifier provided 98.3% precision and 100% recall, resulting in an overall head impact detection system that achieved 98.3% precision and 81.6% recall.	[Gabler, Lee F.; Huddleston, Samuel H.; Dau, Nathan Z.; Lessley, David J.; Crandall, Jeff R.] Biomech Consulting & Res LLC, 1627 Quail Run Dr, Charlottesville, VA 22911 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19146 USA; [Thompson, Xavier; Resch, Jacob E.] Univ Virginia, Dept Kinesiol, Charlottesville, VA 22904 USA		Gabler, LF (corresponding author), Biomech Consulting & Res LLC, 1627 Quail Run Dr, Charlottesville, VA 22911 USA.	lgabler@biocorellc.com		Thompson, Xavier/0000-0003-3228-3706	Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources.	Alfaro E, 2013, J STAT SOFTW, V54, P1; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; [Anonymous], J2111 SAE; Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Bartsch A, 2020, MIL MED, V185, P190, DOI 10.1093/milmed/usz334; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Breiman L, 1998, CLASSIFICATION REGRE; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campolettano ET, 2019, ANN BIOMED ENG, V47, P2086, DOI 10.1007/s10439-019-02309-x; Chen T., 22 ACM SIGKDD INT C; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Hastie T., 2009, ELEMENTS STAT LEARNI; Huddleston SH, 2019, INFORMS ANAL BODY KN; Joodaki H, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043038; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lee TA, 2020, CLIN J SPORT MED OFF, V1, P10; Miller LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039165; Motiwale S, 2016, APPL NEURAL NETWORKS; Myers B., 2009, SHOCK, V1, P54; Newman J A, 2000, Stapp Car Crash J, V44, P215; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Versace J, 1971, REV SEVERITY INDEX; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zuckerman SL, 2020, PHYSICIAN SPORTSMED, V48, P424, DOI 10.1080/00913847.2020.1731379	41	8	8	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2599	2612		10.1007/s10439-020-02654-2		OCT 2020	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000579677200003	33078368				2022-02-06	
J	Sintov, AC				Sintov, Amnon C.			AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin	INTERNATIONAL JOURNAL OF PHARMACEUTICS			English	Article						Amylolipid nanovesicles; Lipid-starch hybrid; Modified starch; Intranasal drug delivery; Brain targeting; Curcumin	NASAL DRUG-DELIVERY; INTRANASAL DELIVERY; IN-VITRO; NANOPARTICLES; DEGRADATION; CARRIERS; BIOAVAILABILITY; COMPLEXATION; NANOEMULSION; FORMULATION	AmyloLipid nanovesicles (ALNs) are new lipid-modified starch complex nanoparticles developed and presented as nanocarriers of curcumin for targeting the CNS via the intranasal route. Curcumin has been indicated as a promising active agent with a variety of pharmacological activities, including a potential ability to treat brain tumors, traumatic brain injury, and CNS disorders, such as Alzheimer's disease, as it may inhibit amyloid-beta-protein (A beta) aggregation and A beta-induced inflammation. Although curcumin has a tremendous potential as a therapeutic agent for CNS disorders, its low bioavailability and its rapid total body clearance reduce any chance for therapeutic levels to reach the brain. By using an optimized (2% crosslinked starch) curcumin-loaded ALNs, which was fabricated from a microemulsion as a precursor, an average of 141.5 +/- 55.9 ng/g brain levels and 11.9 +/- 12.0 ng/ml plasma concentrations were detected, one hour following intranasal administration of 160 mu g/kg dose of curcumin. In comparison, 1 h after IV administration of the same dose, no CUR was detected in the brain and the mean plasma level was approximately one half of the level monitored after intranasal ALNs, i.e., 7.25 +/- 0.20 ng/ml. It has been clearly demonstrated, therefore, that a well-designed ALN formulation proved itself as a promising carrier for intranasal delivery and brain targeting of curcumin.	[Sintov, Amnon C.] Ben Gurion Univ Negev, Fac Engn Sci, Dept Biomed Engn, IL-84105 Beer Sheva, Israel		Sintov, AC (corresponding author), Ben Gurion Univ Negev, Fac Engn Sci, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	asintov@bgu.ac.il					Abdou EM, 2017, INT J PHARMACEUT, V529, P667, DOI 10.1016/j.ijpharm.2017.07.030; Ahmad N, 2018, ARTIF CELL NANOMED B, V46, P717, DOI 10.1080/21691401.2017.1337024; Al Asmari Abdulrahman K, 2016, Drug Des Devel Ther, V10, P205, DOI 10.2147/DDDT.S93937; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anselmo AC, 2019, BIOENG TRANSL MED, V4, DOI 10.1002/btm2.10143; Arora P, 2002, DRUG DISCOV TODAY, V7, P967, DOI 10.1016/S1359-6446(02)02452-2; Botner S, 2012, J NANOMED NANOTECHNO, V3, P136, DOI DOI 10.4172/2157-7439.1000136; Chen X, 2013, J PHARM PHARMACOL, V65, P807, DOI 10.1111/jphp.12043; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Devkar TB, 2014, COLLOID SURFACE B, V122, P143, DOI 10.1016/j.colsurfb.2014.06.037; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Farkhondeh Tahereh, 2019, Current Drug Discovery Technologies, V16, P122, DOI 10.2174/1570163815666180330142724; Gao HL, 2016, ACTA PHARM SIN B, V6, P268, DOI 10.1016/j.apsb.2016.05.013; Giacomeli R, 2019, BRAIN RES, V1721, DOI 10.1016/j.brainres.2019.146325; Gordon ON, 2015, J BIOL CHEM, V290, P4817, DOI 10.1074/jbc.M114.618785; Griesser M, 2011, J BIOL CHEM, V286, P1114, DOI 10.1074/jbc.M110.178806; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Khan AR, 2018, J CONTROL RELEASE, V291, P37, DOI 10.1016/j.jconrel.2018.10.004; Lee HS, 2020, FOODS, V9, DOI 10.3390/foods9020194; Lungu II, 2019, MOLECULES, V24, DOI 10.3390/molecules24193547; Madane RG, 2016, DRUG DELIV, V23, P1326, DOI 10.3109/10717544.2014.975382; Md S, 2014, EXPERT OPIN DRUG DEL, V11, P827, DOI 10.1517/17425247.2014.894504; Merkus FWHM, 1996, J CONTROL RELEASE, V41, P69, DOI 10.1016/0168-3659(96)01357-0; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Mistry A, 2009, INT J PHARMACEUT, V379, P146, DOI 10.1016/j.ijpharm.2009.06.019; Mittal D, 2016, DRUG DELIV, V23, P130, DOI 10.3109/10717544.2014.907372; Mourtas S, 2011, BIOMATERIALS, V32, P1635, DOI 10.1016/j.biomaterials.2010.10.027; Mukherjee S, 2016, INT J CANCER, V139, P2838, DOI 10.1002/ijc.30398; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; Musumeci T, 2014, J PHARM SCI-US, V103, P628, DOI 10.1002/jps.23836; Nasr M, 2016, DRUG DELIV, V23, P1444, DOI 10.3109/10717544.2015.1092619; Nishimura RT, 2010, J CHEM EDUC, V87, P526, DOI 10.1021/ed8001607; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Parikh RH, 2016, CURR DRUG DELIV, V13, P1130, DOI 10.2174/1567201813666151202195729; Phukan Kunjan, 2016, Recent Pat Drug Deliv Formul, V10, P156; Porro C, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8030051; Ross C, 2018, INT J NANOMED, V13, P8507, DOI 10.2147/IJN.S183117; Sahni JK, 2011, J CONTROL RELEASE, V152, P208, DOI 10.1016/j.jconrel.2010.11.033; Sanidad KZ, 2016, J AGR FOOD CHEM, V64, P9189, DOI 10.1021/acs.jafc.6b04343; Shobo A, 2018, NANOMEDICINE-UK, V13, P997, DOI 10.2217/nnm-2017-0365; Sintov AC, 2016, INT REV NEUROBIOL, V130, P199, DOI 10.1016/bs.irn.2016.06.007; Sintov AC, 2017, DRUG DEV IND PHARM, V43, P830, DOI 10.1080/03639045.2016.1239730; Sintov AC, 2010, J CONTROL RELEASE, V148, P168, DOI 10.1016/j.jconrel.2010.08.004; Tomren MA, 2007, INT J PHARM, V338, P27, DOI 10.1016/j.ijpharm.2007.01.013; Tonnesen HH, 2002, INT J PHARMACEUT, V244, P127, DOI 10.1016/S0378-5173(02)00323-X; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; Voulgaropoulou SD, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146476; Wang S, 2012, J DRUG TARGET, V20, P831, DOI 10.3109/1061186X.2012.719230; Wang WR, 2012, INT J NANOMED, V7, P3667, DOI 10.2147/IJN.S30428; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wolfe Timothy R, 2004, J Emerg Nurs, V30, P141, DOI 10.1016/j.jen.2004.01.006; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010; Yavarpour-Bali H, 2019, INT J NANOMED, V14, P4449, DOI 10.2147/IJN.S208332; Zheng XY, 2015, PHARM RES-DORDR, V32, P3837, DOI 10.1007/s11095-015-1744-9; Zhu JL, 2017, FOOD FUNCT, V8, P907, DOI 10.1039/c6fo01770c	60	8	8	6	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5173	1873-3476		INT J PHARMACEUT	Int. J. Pharm.	OCT 15	2020	588								119725	10.1016/j.ijpharm.2020.119725			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	OA1MG	WOS:000577558100006	32763387				2022-02-06	
J	Burrowes, SAB; Rhodes, CS; Meeker, TJ; Greenspan, JD; Gullapalli, RP; Seminowicz, DA				Burrowes, Shana A. B.; Rhodes, Chandler Sours; Meeker, Timothy J.; Greenspan, Joel D.; Gullapalli, Rao P.; Seminowicz, David A.			Decreased grey matter volume in mTBI patients with post-traumatic headache compared to headache-free mTBI patients and healthy controls: a longitudinal MRI study	BRAIN IMAGING AND BEHAVIOR			English	Article						Persistent post-traumatic headache; Post-traumatic headache; Mild traumatic brain injury; Gray matter volume; Brain	TRAUMATIC BRAIN-INJURY; CORTICAL THICKNESS; CONCUSSION; MIGRAINE	Traumatic brain injury (TBI) occurs in 1.7 million people annually and many patients go on to develop persistent disorders including post-traumatic headache (PTH). PTH is considered chronic if it continues past 3 months. In this study we aimed to identify changes in cerebral grey matter volume (GMV) associated with PTH in mild TBI patients. 50 mTBI patients (31 Non-PTH; 19 PTH) underwent MRI scans: within 10 days post-injury, 1 month, 6 months and 18 months. PTH was assessed at visit 4 by a post-TBI headache questionnaire. Healthy controls (n = 21) were scanned twice 6 months apart. Compared to non-PTH, PTH patients had decreased GMV across two large clusters described as the right anterior-parietal (p = 0.012) and left temporal-opercular (p = 0.027). Compared to healthy controls non-PTH patients had decreased GMV in the left thalamus (p = 0.047); PTH patients had decreased GMV in several extensive clusters: left temporal-opercular (p = 0.003), temporal-parietal (p = 0.041), superior frontal gyrus (p = 0.008) and right middle frontal/superior frontal gyrus (0.004) and anterior-parietal (p = 0.003). Differences between PTH and non-PTH patients were most striking at early time points. These early changes may be associated with an increased risk of PTH. Patients with these changes should be monitored for chronic PTH.	[Burrowes, Shana A. B.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Burrowes, Shana A. B.; Meeker, Timothy J.; Greenspan, Joel D.; Gullapalli, Rao P.; Seminowicz, David A.] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, 650 W Baltimore St,8 South, Baltimore, MD 21201 USA; [Burrowes, Shana A. B.; Greenspan, Joel D.; Seminowicz, David A.] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA; [Rhodes, Chandler Sours; Gullapalli, Rao P.] Univ Maryland, Sch Med, Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		Seminowicz, DA (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, 650 W Baltimore St,8 South, Baltimore, MD 21201 USA.; Seminowicz, DA (corresponding author), Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA.	dseminowicz@umaryland.edu	Meeker, Timothy J/V-6885-2019; Seminowicz, David/F-8732-2015	Meeker, Timothy J/0000-0002-1833-6536; Burrowes, Shana/0000-0001-6857-6207; Greenspan, Joel/0000-0003-4062-9797; Seminowicz, David/0000-0003-3111-3756	Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; Department of Defense (NINDS/NIH) [1R01NS105503]; NIH/NCCIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AT007176-01A1]	Department of Defense (W81XWH-08-1-0725, W81XWH-12-1-0098 and NINDS/NIH 1R01NS105503 to RPG), NIH/NCCIH (R01 AT007176-01A1 to DAS).	Anderson K, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/693925; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bree D, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0720-6; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gennatas ED, 2017, J NEUROSCI, V37, P5065, DOI 10.1523/JNEUROSCI.3550-16.2017; Guillaume B, 2014, NEUROIMAGE, V94, P287, DOI 10.1016/j.neuroimage.2014.03.029; Jia ZH, 2017, NEUROIMAGE-CLIN, V14, P130, DOI 10.1016/j.nicl.2017.01.019; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kurth F, 2018, COMPUTATIONAL ANATOM; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; Pomares FB, 2017, J NEUROSCI, V37, P1090, DOI 10.1523/JNEUROSCI.2619-16.2016; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sprenger T, 2012, CURR OPIN NEUROL, V25, P252, DOI 10.1097/WCO.0b013e3283532ca3; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	27	8	9	3	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2020	14	5					1651	1659		10.1007/s11682-019-00095-7			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC9YM	WOS:000579512100032	30980274	Green Accepted, Green Submitted			2022-02-06	
J	Cheng, CH; Koo, BB; Calderazzo, S; Quinn, E; Aenlle, K; Steele, L; Klimas, N; Krengel, M; Janulewicz, P; Toomey, R; Michalovicz, LT; Kelly, KA; Heeren, T; Little, D; O'Callaghan, JP; Sullivan, K				Cheng, Chia-Hsin; Koo, Bang-Bon; Calderazzo, Samantha; Quinn, Emily; Aenlle, Kristina; Steele, Lea; Klimas, Nancy; Krengel, Maxine; Janulewicz, Patricia; Toomey, Rosemary; Michalovicz, Lindsay T.; Kelly, Kimberly A.; Heeren, Timothy; Little, Deborah; O'Callaghan, James P.; Sullivan, Kimberly			Alterations in high-order diffusion imaging in veterans with Gulf War Illness is associated with chemical weapons exposure and mild traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Gulf War Illness; Veterans; Cytokines; Neuroinflammation; Diffusion imaging; MRI	NEURITE ORIENTATION DISPERSION; HUMAN CEREBRAL-CORTEX; LOW-LEVEL SARIN; CYCLOSARIN EXPOSURE; NEUROINFLAMMATORY RESPONSE; CORTICOSTERONE PRIMES; SYMPTOMS; HEALTH; MODEL; WHITE	The complex etiology behind Gulf War Illness (GWI) has been attributed to the combined exposure to neuro-toxicant chemicals, brain injuries, and some combat experiences. Chronic GWI symptoms have been shown to be associated with intensified neuroinflammatory responses in animal and human studies. To investigate the neuroinflammatory responses and potential causes in Gulf War (GW) veterans, we focused on the effects of chemical/biological weapons (CBW) exposure and mild traumatic brain injury (mTBI) during the war. We applied a novel MRI diffusion processing method, Neurite density imaging (NDI), on high-order diffusion imaging to estimate microstructural alterations of brain imaging in Gulf War veterans with and without GWI, and collected plasma proinflammatory cytokine samples as well as self-reported health symptom scores. Our study identified microstructural changes specific to GWI in the frontal and limbic regions due to CBW and mTBI, and further showed distinctive microstructural patterns such that widespread changes were associated with CBW and more focal changes on diffusion imaging were observed in GW veterans with an mTBI during the war. In addition, microstructural alterations on brain imaging correlated with upregulated blood proinflammatory cytokine markers TNFRI and TNFRII and with worse outcomes on self-reported symptom measures for fatigue and sleep functioning. Taken together, these results suggest TNF signaling mediated inflammation affects frontal and limbic regions of the brain, which may contribute to the fatigue and sleep symptoms of the disease and suggest a strong neuroinflammatory component to GWI. These results also suggest exposures to chemical weapons and mTBI during the war are associated with different patterns of peripheral and central inflammation and highlight the brain regions vulnerable to further subtle microscale morphological changes and chronic signaling to nearby glia.	[Cheng, Chia-Hsin; Koo, Bang-Bon; Calderazzo, Samantha] Boston Univ, Sch Med, Boston, MA 02118 USA; [Quinn, Emily; Krengel, Maxine; Janulewicz, Patricia; Toomey, Rosemary; Heeren, Timothy; Sullivan, Kimberly] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Aenlle, Kristina; Klimas, Nancy] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA; [Aenlle, Kristina] Miami VA Healthcare Syst, Dept Vet Affairs, Res Serv, Miami, FL USA; [Steele, Lea] Baylor Coll Med, Houston, TX 77030 USA; [Michalovicz, Lindsay T.; Kelly, Kimberly A.; O'Callaghan, James P.] NIOSH, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Little, Deborah] Univ Texas Houston, Houston, TX 77025 USA		Koo, BB (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Sullivan, K (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.	bbkoo@bu.edu	kelly, Kimberly/J-9834-2012	kelly, Kimberly/0000-0002-1146-3137	department of Defense CDMRP new investigator awardUnited States Department of Defense [W81XWH-17-1-0440]; CDMRP GWI consortium award [W81XWH-13-2-0072]	Ms. Cheng and Dr. Koo contributed equally to this work as the 1st author. Drs. Koo and Sullivan are the corresponding authors. This work is supported by a department of Defense CDMRP new investigator award (W81XWH-17-1-0440) and CDMRP GWI consortium award (W81XWH-13-2-0072).	Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Abou-Donia MB, 2017, NEUROTOXICOL TERATOL, V61, P36, DOI 10.1016/j.ntt.2017.03.002; Alshelh Z., 2020, BRAIN BEHAV IMMUN, V1591, P31334; Banks CN, 2012, NEUROTOXICOLOGY, V33, P575, DOI 10.1016/j.neuro.2012.02.002; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Belgrad J, 2019, GLIA, V67, P2107, DOI 10.1002/glia.23668; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chao LL, 2018, MIL MED, V183, pE571, DOI 10.1093/milmed/usy109; Chao LDL, 2015, NEUROTOXICOLOGY, V48, P239, DOI 10.1016/j.neuro.2015.04.005; Chao LDL, 2011, NEUROTOXICOLOGY, V32, P814, DOI 10.1016/j.neuro.2011.06.006; Chao LL, 2010, NEUROTOXICOLOGY, V31, P493, DOI 10.1016/j.neuro.2010.05.006; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Fukutomi H, 2018, NEUROIMAGE, V182, P488, DOI 10.1016/j.neuroimage.2018.02.017; Gade DM, 2011, HEALTH ECON, V20, P401, DOI 10.1002/hec.1594; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Heaton KJ, 2007, NEUROTOXICOLOGY, V28, P761, DOI 10.1016/j.neuro.2007.03.006; Hoge C.W., 2008, NEW ENGL J MED, V358, P20; Janulewicz P.A., 2019, INT J ENV RES PUB HE, V16, P3571; Janulewicz P, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8110198; Jaundoo R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113355; Jeffrey MG, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02088; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson GA, 2014, NEUROTOXICOLOGY, V42, P12, DOI 10.1016/j.neuro.2014.02.009; Khaiboullina SF, 2015, CYTOKINE, V72, P1, DOI 10.1016/j.cyto.2014.11.019; Kimura Y, 2019, J MAGN RESON IMAGING, V49, P818, DOI 10.1002/jmri.26247; Koo BB, 2018, BRAIN BEHAV IMMUN, V67, P42, DOI 10.1016/j.bbi.2017.08.003; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Locker AR, 2017, J NEUROCHEM, V142, P444, DOI 10.1111/jnc.14071; McCunn P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215974; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Michalovicz LT, 2019, NEUROTOXICOLOGY, V70, P26, DOI 10.1016/j.neuro.2018.10.006; Miller JV, 2018, TOXICOL SCI, V165, P302, DOI 10.1093/toxsci/kfy130; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; National Academies of Sciences Engineering and Medicine, 2016, GULF WAR HLTH; Naughton SX, 2018, TOXICOLOGY, V406, P92, DOI 10.1016/j.tox.2018.06.004; O'Callaghan JP, 2015, J NEUROCHEM, V133, P708, DOI 10.1111/jnc.13088; O'Callaghan J, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.153951; O'Donovan A, 2015, PSYCHONEUROENDOCRINO, V51, P557, DOI 10.1016/j.psyneuen.2014.11.010; Parkitny L, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0122-z; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Proctor SP, 2006, NEUROTOXICOLOGY, V27, P931, DOI 10.1016/j.neuro.2006.08.001; Puri BK, 2012, BRIT J RADIOL, V85, pE270, DOI 10.1259/bjr/93889091; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; Rao AN, 2017, TRAFFIC, V18, P433, DOI 10.1111/tra.12489; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spradling KD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-84; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Sullivan K, 2018, NEUROTOXICOL TERATOL, V65, P1, DOI 10.1016/j.ntt.2017.11.002; Tang L.W., 2015, EVIDENCE BASED COMPL; Toomey R, 2009, J INT NEUROPSYCH SOC, V15, P717, DOI 10.1017/S1355617709990294; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079; Yee MK, 2016, J HEAD TRAUMA REHAB, V31, P320, DOI 10.1097/HTR.0000000000000173; Yeh FC, 2017, MAGN RESON MED, V77, P603, DOI 10.1002/mrm.26143; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yendiki A., 2011, FRONTIERS NEUROINFOR, P5; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Zundel CG, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060949	83	8	10	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2020	89						281	290		10.1016/j.bbi.2020.07.006			10	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	OH9GJ	WOS:000582897600028	32745586	Green Accepted			2022-02-06	
J	Blaze, J; Choi, I; Wang, ZY; Umali, M; Mendelev, N; Tschiffely, AE; Ahlers, ST; Elder, GA; Ge, YC; Haghighi, F				Blaze, Jennifer; Choi, Inbae; Wang, Zhaoyu; Umali, Michelle; Mendelev, Natalia; Tschiffely, Anna E.; Ahlers, Stephen T.; Elder, Gregory A.; Ge, Yongchao; Haghighi, Fatemeh			Blast-Related Mild TBI Alters Anxiety-Like Behavior and Transcriptional Signatures in the Rat Amygdala	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						mTBI; amygdala; blast; anxiety; transcriptome	TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; NEUROTROPHIC FACTOR; DNA METHYLATION; UP-REGULATION; BDNF; HIPPOCAMPUS; MODEL; FEAR; ACTIVATION	The short and long-term neurological and psychological consequences of traumatic brain injury (TBI), and especially mild TBI (mTBI) are of immense interest to the Veteran community. mTBI is a common and detrimental result of combat exposure and results in various deleterious outcomes, including mood and anxiety disorders, cognitive deficits, and post-traumatic stress disorder (PTSD). In the current study, we aimed to further define the behavioral and molecular effects of blast-related mTBI using a well-established (3 x 75 kPa, one per day on three consecutive days) repeated blast overpressure (rBOP) model in rats. We exposed adult male rats to the rBOP procedure and conducted behavioral tests for anxiety and fear conditioning at 1-1.5 months (sub-acute) or 12-13 months (chronic) following blast exposure. We also used next-generation sequencing to measure transcriptome-wide gene expression in the amygdala of sham and blast-exposed animals at the sub-acute and chronic time points. Results showed that blast-exposed animals exhibited an anxiety-like phenotype at the sub-acute timepoint but this phenotype was diminished by the chronic time point. Conversely, gene expression analysis at both sub-acute and chronic timepoints demonstrated a large treatment by timepoint interaction such that the most differentially expressed genes were present in the blast-exposed animals at the chronic time point, which also corresponded to aBdnf-centric gene network. Overall, the current study identified changes in the amygdalar transcriptome and anxiety-related phenotypic outcomes dependent on both blast exposure and aging, which may play a role in the long-term pathological consequences of mTBI.	[Blaze, Jennifer; Wang, Zhaoyu; Umali, Michelle; Mendelev, Natalia; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Blaze, Jennifer; Wang, Zhaoyu; Umali, Michelle; Mendelev, Natalia; Elder, Gregory A.; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Choi, Inbae; Haghighi, Fatemeh] James J Peters Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY 10468 USA; [Tschiffely, Anna E.; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma, Operat & Undersea Med Directorate, Silver Spring, MD USA; [Elder, Gregory A.; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Elder, Gregory A.; Ge, Yongchao] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Elder, Gregory A.] James J Peters Vet Affairs Med Ctr, Neurol Serv, Bronx, NY USA		Haghighi, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Haghighi, F (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Haghighi, F (corresponding author), James J Peters Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY 10468 USA.; Haghighi, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.	fatemeh.haghighi@mssm.edu	Ge, Yongchao/AAG-9317-2021	Ge, Yongchao/0000-0001-6448-5703; Mendelev, Natalia/0000-0001-8596-2986	Veterans Affairs Office of Research and Development; Research Career Scientist Award from the United States Department of Veterans AffairsUS Department of Veterans Affairs [1IK6CX002074]; Veterans Affairs Merit Grants [RX001705, CX001395, BX003794, CX001728, I01RX002660-01]; United States Department of Veterans AffairsUS Department of Veterans Affairs [I01RX002660-01, 1I01BX0004067-01A]	This work was supported in part by the Veterans Affairs Office of Research and Development. FH is the recipient of a Research Career Scientist Award (#1IK6CX002074) from the United States Department of Veterans Affairs. FH's research was supported by Veterans Affairs Merit Grants RX001705, CX001395, BX003794, and CX001728. GE was funded by merit grants I01RX002660-01 and 1I01BX0004067-01A from the United States Department of Veterans Affairs.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernabucci M, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0239-x; Boulle F, 2012, MOL PSYCHIATR, V17, P584, DOI 10.1038/mp.2011.107; Boyle MP, 2011, J COMP NEUROL, V519, P2061, DOI 10.1002/cne.22655; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; de Mooij-van Malsen A, 2009, BIOL PSYCHIAT, V66, P1123, DOI 10.1016/j.biopsych.2009.06.016; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Faul M, 2010, TRAUMATIC BRAIN INJU; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Frankowski JC, 2019, NEUROBIOL DIS, V129, P208, DOI 10.1016/j.nbd.2018.07.022; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Gomez-Lopez S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24028; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Klein RC, 2014, NEUROBIOL AGING, V35, P2046, DOI 10.1016/j.neurobiolaging.2014.02.019; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LUO Y, 2017, SCI REP UK, V7; Mahoney ER, 2021, MOL PSYCHIATR, V26, P888, DOI 10.1038/s41380-019-0458-5; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez JJ, 2014, NEUROBIOL AGING, V35, P15, DOI 10.1016/j.neurobiolaging.2013.07.002; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Savalli G, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu095; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; TANAKA M, 2019, MOL BRAIN, V0012; Tang XY, 2015, J ALZHEIMERS DIS, V47, P645, DOI 10.3233/JAD-150262; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	66	8	8	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	SEP 30	2020	14								160	10.3389/fnbeh.2020.00160			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	OB9HL	WOS:000578773600001	33192359	gold, Green Published			2022-02-06	
J	Stone, JR; Avants, BB; Tustison, NJ; Wassermann, EM; Gill, J; Polejaeva, E; Dell, KC; Carr, W; Yarnell, AM; LoPresti, ML; Walker, P; O'Brien, M; Domeisen, N; Quick, A; Modica, CM; Hughes, JD; Haran, FJ; Goforth, C; Ahlers, ST				Stone, James R.; Avants, Brian B.; Tustison, Nicholas J.; Wassermann, Eric M.; Gill, Jessica; Polejaeva, Elena; Dell, Kristine C.; Carr, Walter; Yarnell, Angela M.; LoPresti, Matthew L.; Walker, Peter; O'Brien, Meghan; Domeisen, Natalie; Quick, Alycia; Modica, Claire M.; Hughes, John D.; Haran, Francis J.; Goforth, Carl; Ahlers, Stephen T.			Functional and Structural Neuroimaging Correlates of Repetitive Low-Level Blast Exposure in Career Breachers	JOURNAL OF NEUROTRAUMA			English	Article						breachers; cortical thickness; diffusion tensor imaging; functional MRI; perfusion imaging; SiMLR	TRAUMATIC BRAIN-INJURY; WHITE-MATTER ABNORMALITIES; CORTICAL THICKNESS; PERFUSION; CONNECTIVITY; INTEGRITY; MECHANISMS; VETERANS; HISTORY; TDP-43	Combat military and civilian law enforcement personnel may be exposed to repetitive low-intensity blast events during training and operations. Persons who use explosives to gain entry (i.e., breach) into buildings are known as "breachers" or dynamic entry personnel. Breachers operate under the guidance of established safety protocols, but despite these precautions, breachers who are exposed to low-level blast throughout their careers frequently report performance deficits and symptoms to healthcare providers. Although little is known about the etiology linking blast exposure to clinical symptoms in humans, animal studies demonstrate network-level changes in brain function, alterations in brain morphology, vascular and inflammatory changes, hearing loss, and even alterations in gene expression after repeated blast exposure. To explore whether similar effects occur in humans, we collected a comprehensive data battery from 20 experienced breachers exposed to blast throughout their careers and 14 military and law enforcement controls. This battery included neuropsychological assessments, blood biomarkers, and magnetic resonance imaging measures, including cortical thickness, diffusion tensor imaging of white matter, functional connectivity, and perfusion. To better understand the relationship between repetitive low-level blast exposure and behavioral and imaging differences in humans, we analyzed the data using similarity-driven multi-view linear reconstruction (SiMLR). SiMLR is specifically designed for multiple modality statistical integration using dimensionality-reduction techniques for studies with high-dimensional, yet sparse, data (i.e., low number of subjects and many data per subject). We identify significant group effects in these data spanning brain structure, function, and blood biomarkers.	[Stone, James R.; Avants, Brian B.; Tustison, Nicholas J.; O'Brien, Meghan; Domeisen, Natalie] Univ Virginia, Dept Radiol & Med Imaging, 480 Ray C Hunt Dr,Box 801339, Charlottesville, VA 22903 USA; [Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Gill, Jessica] NINR, Tissue Injury Branch, NIH, Bethesda, MD 20892 USA; [Polejaeva, Elena] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Dell, Kristine C.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Yarnell, Angela M.] Uniformed Serv Univ Hlth Sci, Mil Emergency Med, Bethesda, MD USA; [Carr, Walter; LoPresti, Matthew L.] Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Hughes, John D.] Walter Reed Army Inst Res, Behav Biol Branch, Silver Spring, MD USA; [Walker, Peter] DoD Joint Artificial Intelligence Ctr, Hlth Mission Initiat, Washington, DC USA; [Quick, Alycia] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Modica, Claire M.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD USA; [Haran, Francis J.; Goforth, Carl; Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Silver Spring, MD USA		Stone, JR (corresponding author), Univ Virginia, Dept Radiol & Med Imaging, 480 Ray C Hunt Dr,Box 801339, Charlottesville, VA 22903 USA.	jrs7r@virginia.edu		avants, brian/0000-0002-4212-3362; Modica, Claire/0000-0002-7033-7632; O'Brien, Meghan/0000-0003-2023-3138	Joint Program Committee 5 Development of Exposure Standards to Repeated Blast Exposure program [603115HP-3730-001-A1118]; Office of Naval Research (ONR)Office of Naval Research [N00014-18-1-2440]; Cohen Veterans Bioscience; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1ZIANS002977-21]; U.S. Department of EnergyUnited States Department of Energy (DOE); U.S. Army Medical Research and Development Command	This work was supported/funded by the Joint Program Committee 5 Development of Exposure Standards to Repeated Blast Exposure program, work unit #603115HP-3730-001-A1118, Office of Naval Research (ONR) award #N00014-18-1-2440 with supplemental funding to the ONR award provided by Cohen Veterans Bioscience, imaging resources from the Center for Neuroscience and Regenerative Medicine, and the Clinical Neurosciences Program of the National Institute of Neurological Disorders and Stroke, Project #1ZIANS002977-21, to Dr. Wassermann.; This work was supported, in part, by an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Army Medical Research and Development Command.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants B., 2010, P 16 ANN M ORG HUM B; Avants B.B., 2020, SIMLR LEARNING SPARS; Avants B.B., 2019, SOFTWARE LEARN UNPUB; Avants B, 2012, LECT NOTES COMPUT SC, V7512, P206, DOI 10.1007/978-3-642-33454-2_26; Avants BB, 2019, NEUROBIOL AGING, V74, P191, DOI 10.1016/j.neurobiolaging.2018.10.002; Avants BB, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.3; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Avants BB, 2014, NEUROIMAGE, V84, P698, DOI 10.1016/j.neuroimage.2013.09.048; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; Carr W, 2017, SHOCK WAVES, V27, P829, DOI 10.1007/s00193-017-0766-0; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Clausen AN, 2020, NEUROPSYCHOPHARMACOL, V45, P491, DOI 10.1038/s41386-019-0539-9; Cook PA, 2014, NEUROIMAGE, V99, P477, DOI 10.1016/j.neuroimage.2014.05.008; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Dhillon PS, 2014, NEUROIMAGE, V99, P14, DOI 10.1016/j.neuroimage.2014.05.026; Dhollander T., 2016, UNSUPERVISED 3 TISSU; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Eierued C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101793; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Hirsch F.G., 1966, DA49146XZ372 DASA LO; JOLLIFFE IT, 1982, APPL STAT-J ROY ST C, V31, P300, DOI 10.2307/2348005; Kandel BM, 2015, METHODS, V73, P43, DOI 10.1016/j.ymeth.2014.10.016; Kou Zhifeng, 2015, Top Magn Reson Imaging, V24, P253, DOI 10.1097/RMR.0000000000000064; Larres DT, 2016, MIL MED, V181, P23, DOI 10.7205/MILMED-D-15-00152; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; McMillan CT, 2013, J NEUROL NEUROSUR PS, V84, P949, DOI 10.1136/jnnp-2012-304418; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Mlynash M, 2005, AM J NEURORADIOL, V26, P1479; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Newsome MR, 2018, BRAIN INJURY, V32, P1236, DOI 10.1080/02699052.2018.1494853; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Patel P, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19493; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wink AM, 2004, IEEE T MED IMAGING, V23, P374, DOI 10.1109/TMI.2004.824234; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	79	8	8	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2468	2481		10.1089/neu.2020.7141		SEP 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000575392200001	32928028	Green Published, hybrid			2022-02-06	
J	Master, CL; Podolak, OE; Ciuffreda, KJ; Metzger, KB; Joshi, NR; McDonald, CC; Margulies, SS; Grady, MF; Arbogast, KB				Master, Christina L.; Podolak, Olivia E.; Ciuffreda, Kenneth J.; Metzger, Kristina B.; Joshi, Nabin R.; McDonald, Catherine C.; Margulies, Susan S.; Grady, Matthew F.; Arbogast, Kristy B.			Utility of Pupillary Light Reflex Metrics as a Physiologic Biomarker for Adolescent Sport-Related Concussion	JAMA OPHTHALMOLOGY			English	Article							QUANTITATIVE PUPILLOMETRY; NORMATIVE DATA; INJURY; RECOVERY	Importance Concussion diagnosis remains clinical, without objective diagnostic tests available for adolescents. Known deficits in visual accommodation and autonomic function after concussion make the pupillary light reflex (PLR) a promising target as an objective physiological biomarker for concussion. Objective To determine the potential utility of PLR metrics as physiological biomarkers for concussion. Design, Setting, and Participants Prospective cohort of adolescent athletes between ages 12 and 18 years recruited between August 1, 2017, and December 31, 2018. The study took place at a specialty concussion program and private suburban high school and included healthy control individuals (n = 134) and athletes with a diagnosis of sport-related concussion (SRC) (n = 98). Analysis was completed June 30, 2020. Exposures Sports-related concussion and pupillometry assessments. Main Outcomes and Measures Pupillary light reflex metrics (maximum and minimum pupillary diameter, peak and average constriction/dilation velocity, percentage constriction, and time to 75% pupillary redilation [T75]). Results Pupillary light reflex metrics of 134 healthy control individuals and 98 athletes with concussion were obtained a median of 12.0 days following injury (interquartile range [IQR], 5.0-18.0 days). Eight of 9 metrics were significantly greater among athletes with concussion after Bonferroni correction (maximum pupil diameter: 4.83 mm vs 4.01 mm; difference, 0.82; 99.44% CI, 0.53-1.11; minimum pupil diameter: 2.96 mm vs 2.63 mm; difference, 0.33; 99.4% CI, 0.18-0.48; percentage constriction: 38.23% vs 33.66%; difference, 4.57; 99.4% CI, 2.60-6.55; average constriction velocity: 3.08 mm/s vs 2.50 mm/s; difference, 0.58; 99.4% CI, 0.36-0.81; peak constriction velocity: 4.88 mm/s vs 3.91 mm/s; difference, 0.97; 99.4% CI, 0.63-1.31; average dilation velocity, 1.32 mm/s vs 1.22 mm/s; difference, 0.10; 99.4% CI, 0.00-0.20; peak dilation velocity: 1.83 mm/s vs 1.64 mm/s; difference, 0.19; 99.4% CI, 0.07-0.32; and T75: 1.81 seconds vs 1.51 seconds; difference, 0.30; 0.10-0.51). In exploratory analyses, sex-based differences were observed, with girls with concussion exhibiting longer T75 (1.96 seconds vs 1.63 seconds; difference, 0.33; 99.4% CI, 0.02-0.65). Among healthy control individuals, diminished PLR metrics (eg, smaller maximum pupil size 3.81 mm vs 4.22 mm; difference, -0.41; 99.4% CI, -0.77 to 0.05) were observed after exercise. Conclusions and Relevance These findings suggest that enhancement of PLR metrics characterize acute adolescent concussion, while exercise produced smaller pupil sizes and overall slowing of PLR metrics, presumably associated with fatigue. Quantifiable measures of the PLR may serve in the future as objective physiologic biomarkers for concussion in the adolescent athlete. This study evaluates the potential utility of pupillary light reflex metrics as physiologic biomarkers for concussion. Question Do quantitative metrics of the pupillary light reflex (PLR) distinguish athletes with concussion from healthy control individuals? Findings In this cohort study, 8 PLR metrics (maximum and minimum pupillary diameter, percentage constriction, peak and average constriction velocity, peak and average dilation velocity, and time to 75% pupillary redilation) were greater among adolescent athletes with concussion compared with healthy control individuals. Meaning These results suggest that quantitative metrics of the pupillary light reflex are enhanced in adolescent sport-related concussion and distinguish athletes with concussion from healthy control individuals and may serve as a fast, portable, objective physiologic biomarker for adolescent sport concussion.	[Master, Christina L.; Grady, Matthew F.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, 3401 Civ Ctr Blvd,2nd Floor Wood Bldg, Philadelphia, PA 19104 USA; [Master, Christina L.; Podolak, Olivia E.; Metzger, Kristina B.; McDonald, Catherine C.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.; McDonald, Catherine C.; Grady, Matthew F.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ciuffreda, Kenneth J.; Joshi, Nabin R.] State Univ New York, Coll Optometry, New York, NY USA; [McDonald, Catherine C.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA		Master, CL (corresponding author), Childrens Hosp Philadelphia, Sports Med & Performance Ctr, 3401 Civ Ctr Blvd,2nd Floor Wood Bldg, Philadelphia, PA 19104 USA.	masterc@email.chop.edu		McDonald, Catherine/0000-0003-3856-8542; joshi, nabin/0000-0002-7513-6952	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS0975NIH]; Pennsylvania Department of Health [SAP4100077078]	This work was supported in part by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (grant R01NS0975NIH) and the Pennsylvania Department of Health (grant SAP4100077078).	Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Dalecki M, 2019, EUR J SPORT SCI, V19, P1257, DOI 10.1080/17461391.2019.1584249; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Filipe JAC, 2003, AUTON NEUROSCI-BASIC, V104, P66, DOI 10.1016/S1566-0702(02)00268-0; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; Joseph JR, 2020, J NEUROSURG, V133, P1886, DOI 10.3171/2019.7.JNS191272; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; LAM BL, 1987, AM J OPHTHALMOL, V104, P69, DOI 10.1016/0002-9394(87)90296-0; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Nystrom P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03985-4; Rickmann A, 2017, NEURO-OPHTHALMOLOGY, V41, P12, DOI 10.1080/01658107.2016.1226345; Sharma S, 2016, GRAEF ARCH CLIN EXP, V254, P1353, DOI 10.1007/s00417-016-3311-4; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Tekin K, 2018, CLIN EXP OPTOM, V101, P659, DOI 10.1111/cxo.12659; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Ting W, 2015, CANADIAN J NEUROLOGI, V42, pS40; Truong JQ, 2016, MIL MED, V181, P1382, DOI 10.7205/MILMED-D-15-00587; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Winston M, 2019, CLIN AUTON RES; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	35	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	NOV	2020	138	11					1135	1141		10.1001/jamaophthalmol.2020.3466		SEP 2020	7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	OX7WV	WOS:000574395800006	32970102	Green Published			2022-02-06	
J	Froese, L; Dian, J; Batson, C; Gomez, A; Unger, B; Zeiler, FA				Froese, Logan; Dian, Joshua; Batson, Carleen; Gomez, Alwyn; Unger, Bertram; Zeiler, Frederick A.			The impact of hypertonic saline on cerebrovascular reactivity and compensatory reserve in traumatic brain injury: an exploratory analysis	ACTA NEUROCHIRURGICA			English	Article						Cerebrovascular circulation; Cerebrovascular response; Hypertonic saline; Intracranial pressure; Pressure reactivity index; Sodium chloride	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; MANAGEMENT; INDEX; THRESHOLDS; MODELS; ADULT	Background Intravenous hypertonic saline is utilized commonly in critical care for treatment of acute or refractory elevations of intracranial pressure (ICP) in traumatic brain injury (TBI) patients. Though there is a clear understanding of the general physiological effects of a hypertonic saline solution over long periods of time, smaller epoch effects of hypertonic saline (HTS) have not been thoroughly analyzed. The aim of this study was to perform a direct evaluation of the high-frequency response of HTS on the cerebrovascular physiological responses in TBI. Methods We retrospectively reviewed our prospectively maintained adult TBI database for those with archived high-frequency cerebral physiology and available HTS treatment information. We evaluated different epochs of physiology around HTS bolus dosing, comparing pre- with post-HTS. We assessed for changes in slow fluctuations in ICP, pulse amplitude of ICP (AMP), cerebral perfusion pressure (CPP), mean arterial pressure (MAP), cerebrovascular reactivity (as measured through pressure reactivity index (PRx)), and cerebral compensatory reserve (correlation (R) between AMP (A) and ICP (P)). Comparisons of mean measures and percentage time above clinically relevant thresholds for the physiological parameters were compared pre- and post-HTS using descriptive statistics and Mann-WhitneyUtesting. We assessed for subgroups of physiological responses using latent profile analysis (LPA). Results Fifteen patients underwent 69 distinct bolus infusions of hypertonic saline. Apart from the well-documented decrease in ICP, there was also a reduction in AMP. The analysis of cerebrovascular reactivity response to HTS solution had two main effects. For patients with grossly impaired cerebrovascular reactivity pre-HTS (PRx > + 0.30), HTS bolus led to improved reactivity. However, for those with intact cerebrovascular reactivity pre-HTS (PRx < 0), HTS bolus demonstrated a trend towards more impaired reactivity. This indicates that HTS has different impacts, dependent on pre-bolus cerebrovascular status. There was no significant change in metrics of cerebral compensatory reserve. LPA failed to demonstrate any subgroups of physiological responses to HTS administration. Conclusions The direct decrease in ICP and AMP confirms that a bolus dose of a HTS solution is an effective therapeutic agent for intracranial hypertension. However, in patients with intact autoregulation, hypertonic saline may impair cerebral hemodynamics. These findings regarding cerebrovascular reactivity remain preliminary and require further investigation.	[Froese, Logan; Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Dian, Joshua; Gomez, Alwyn; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Batson, Carleen; Gomez, Alwyn; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada; [Unger, Bertram] Univ Manitoba, Rady Fac Hlth Sci, Dept Med, Sect Crit Care, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England.	log.froese@gmail.com; dianj@myumanitoba.ca; leenbatson@gmail.com; gomeza35@myumanitoba.ca; bertram.j.unger@gmail.com; Frederick.Zeiler@umanitoba.ca		Zeiler, Frederick/0000-0003-1737-0510	Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation [38583]; Research Manitoba [3906]; University of Manitoba - Department of Surgery GFT Research Grant; University of Manitoba Office of Research Services (ORS) - University Research Grant Program (URGP); Health Sciences Centre Foundation Winnipeg; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI), Research Manitoba; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Centre on Aging; University of Manitoba Rudy Falk ClinicianScientist Professorship; University of Manitoba Department of Surgery GFT Research Grant; Centre on Aging Fellowship at the University of Manitoba; University of Manitoba Clinician Investigator Program	This work was supported directly through the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment providing infrastructures and disposable support; the Canada Foundation for Innovation (CFI) (Project #: 38583), Research Manitoba (Grant #: 3906), University of Manitoba - Department of Surgery GFT Research Grant providing graduate student salary support; and the University of Manitoba Office of Research Services (ORS) -University Research Grant Program (URGP) providing hardware support. The sponsor had no role in the design or conduct of this research. FAZ receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation (CFI), Research Manitoba, the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Centre on Aging, and the University of Manitoba Rudy Falk ClinicianScientist Professorship. LF is supported by the University of Manitoba Department of Surgery GFT Research Grant and the University of Manitoba Office of Research Services (ORS) - University Research Grant Program (URGP). CB is supported by the Centre on Aging Fellowship at the University of Manitoba. AG is supported by the University of Manitoba Clinician Investigator Program.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; Balestreri M, 2005, ACT NEUR S, V95, P25; Bennis FC, 2020, NEUROCRIT CARE, V33, P542, DOI 10.1007/s12028-020-00930-6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Bernard J, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.926.48741; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Calviello LA, 2019, MED ENG PHYS, V74, P23, DOI 10.1016/j.medengphy.2019.07.019; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Flechet M, 2018, ACTA NEUROCHIR SUPPL, V126, P291, DOI 10.1007/978-3-319-65798-1_57; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Froese L, 2021, NEUROCRIT CARE, V34, P325, DOI 10.1007/s12028-020-01003-4; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Ji Z, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-43; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; Klein SP, 2021, J NEUROTRAUM, V38, P506, DOI 10.1089/neu.2020.7160; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manley GT, 2008, INTRACRANIAL PRESSUR; Mathieu F, 2020, J NEUROTRAUM, V37, P1556, DOI 10.1089/neu.2019.6814; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Oberski D, 2016, HUM-COMPUT INT-SPRIN, P275, DOI 10.1007/978-3-319-26633-6_12; Passi N, 2013, AM J NEURORADIOL, V34, P919, DOI 10.3174/ajnr.A3022; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tseng MY, 2007, J NEUROSURG, V107, P274, DOI 10.3171/JNS-07/08/0274; Tymko MM, 2019, CLIN AUTON RES, V29, P123, DOI 10.1007/s10286-018-0579-y; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Yin J, 2018, MED SCI MONITOR, V24, P1863, DOI 10.12659/MSM.907212; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1275, DOI 10.1007/s00701-019-03915-3; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	50	8	8	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2020	162	11					2683	2693		10.1007/s00701-020-04579-0		SEP 2020	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OC5DX	WOS:000571695800001	32959342	Green Published, Bronze			2022-02-06	
J	Huebschmann, NA; Luoto, TM; Karr, JE; Berghem, K; Blennow, K; Zetterberg, H; Ashton, NJ; Simren, J; Posti, JP; Gill, JM; Iverson, GL				Huebschmann, Nathan A.; Luoto, Teemu M.; Karr, Justin E.; Berghem, Ksenia; Blennow, Kaj; Zetterberg, Henrik; Ashton, Nicholas J.; Simren, Joel; Posti, Jussi P.; Gill, Jessica M.; Iverson, Grant L.			Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injuries; glial fibrillary acidic protein; plasma; serum; computed tomography	C-TERMINAL HYDROLASE-L1; INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; BLOOD; BIOMARKERS; S100B; PERFORMANCE; INCREASES	Objective:Identification and validation of blood-based biomarkers for the diagnosis and prognosis of mild traumatic brain injury (mTBI) is of critical importance. There have been calls for more research on mTBI in older adults. We compared blood-based protein marker glial fibrillary acidic protein (GFAP) concentrations in serum and in plasma within the same cohort of older adults and assessed their ability to discriminate between individuals based on intracranial abnormalities and functional outcome following mTBI. Methods:A sample of 121 older adults [>= 50 years old with head computed tomography (CT),n= 92] seeking medical care for a head injury [Glasgow Coma Scale scores of 14 (n= 6; 5.0%) or 15 (n= 115; 95.0%)] were enrolled from the emergency department (ED). The mean time between injury and blood sampling was 3.4 h (SD= 2.1; range = 0.5-11.7). Serum GFAP concentration was measured first using the Human Neurology 4-Plex Assay, while plasma GFAP concentration was later measured using the GFAP Discovery Kit, both on an HD-1 Single molecule array (Simoa) instrument. Glasgow Outcome Scale-Extended was assessed 1 week after injury. Results:Both serum and plasma GFAP levels were significantly higher in those with abnormal CT scans compared to those with normal head CT scans (plasma:U= 1,198,p< 0.001; serum:U= 1,253,p< 0.001). The ability to discriminate those with and without intracranial abnormalities was comparable between serum (AUC = 0.814) and plasma (AUC = 0.778). In the total sample, GFAP concentrations were considerably higher in plasma than in serum (Wilcoxon signed-rank testz= 0.42,p< 0.001,r= 0.42). Serum and plasma GFAP levels were highly correlated in the total sample and within all subgroups (Spearman'srhorange: 0.826-0.907). Both serum and plasma GFAP levels were significantly higher in those with poor compared to good functional outcome (serum:U= 1,625,p= 0.002; plasma:U= 1,539,p= 0.013). Neither plasma (AUC = 0.653) nor serum (AUC = 0.690) GFAP were adequate predictors of functional outcome 1 week after injury. Conclusions:Despite differences in concentration, serum and plasma GFAP levels were highly correlated and had similar discriminability between those with and without intracranial abnormalities on head CT following an mTBI. Neither serum nor plasma GFAP had adequate discriminability to identify patients who would have poor functional outcome.	[Huebschmann, Nathan A.; Karr, Justin E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Huebschmann, Nathan A.; Karr, Justin E.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland; [Karr, Justin E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Karr, Justin E.; Iverson, Grant L.] Home Base, Charlestown, MA 02129 USA; [Karr, Justin E.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA 02129 USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA 02129 USA; [Berghem, Ksenia] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Blennow, Kaj; Zetterberg, Henrik; Ashton, Nicholas J.; Simren, Joel] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik; Simren, Joel] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Ashton, Nicholas J.] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Ashton, Nicholas J.] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, London, England; [Ashton, Nicholas J.] South London & Maudsley Natl Hlth Serv Fdn, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England; [Ashton, Nicholas J.] South London & Maudsley Natl Hlth Serv Fdn, Biomed Res Unit Dementia, London, England; [Posti, Jussi P.] Univ Turku, Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr,Dept Neurosurg, Turku, Finland; [Gill, Jessica M.] NIH, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA		Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), MassGen Hosp Children, Sports Concuss Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Home Base, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Massachusetts Gen Hosp Program, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Spaulding Res Inst, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu	Posti, Jussi P./Y-2908-2019; Luoto, Teemu/W-6468-2018	Posti, Jussi P./0000-0002-5925-5193; Luoto, Teemu/0000-0002-7329-3284; Ashton, Nicholas/0000-0002-3579-8804	Finnish State Research Funding; Finnish Medical Society Duodecim; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Emil Aaltonen Foundation sr; Finnish Brain Foundation sr; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2017-00915, 2018-02532]; Alzheimer Drug Discovery Foundation (ADDF), USA [RDAPB-201809-2016615, 201809-2016862]; Swedish Alzheimer Foundation [AF-742881]; Hjarnfonden, Sweden [FO2017-0243]; Swedish government [ALFGBG-715986]; Swedish County Councils, the ALF-agreement [ALFGBG-715986]; European Union Joint Program for Neurodegenerative Disorders [JPND2019-466236]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; UK Dementia Research Institute at UCL	This study was financially supported by the Finnish State Research Funding, and the Finnish Medical Society Duodecim. TL and JP have received funding from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland). JP has received funding from the Academy of Finland (#17379), Emil Aaltonen Foundation sr and the Finnish Brain Foundation sr. KB was supported by the Swedish Research Council (#2017-00915), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB-201809-2016615), the Swedish Alzheimer Foundation (#AF-742881), Hjarnfonden, Sweden (#FO2017-0243), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466236). HZ was a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), and the UK Dementia Research Institute at UCL.	Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Cohen J, 1998, STAT POWER ANAL BEHA; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Greco V, 2017, METHODS MOL BIOL, V1619, P3, DOI 10.1007/978-1-4939-7057-5_1; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; O'Connell GC, 2019, BIOANALYSIS, V11, P2087, DOI 10.4155/bio-2019-0213; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Rezaii PG, 2019, J NEUROTRAUM, V36, P2407, DOI 10.1089/neu.2018.6053; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; THELIN EP, 2017, FRONT NEUROL, V8; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; U.S. Food and Drug Administration, 2018, FDA AUTH MARK 1 BLOO; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Ward MD, 2020, J APPL LAB MED, V5, P608, DOI 10.1093/jalm/jfaa039; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	47	8	8	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 18	2020	11								1054	10.3389/fneur.2020.01054			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NY6LF	WOS:000576497700001	33071938	Green Published, gold			2022-02-06	
J	Loring, HS; Parelkar, SS; Mondal, S; Thompson, PR				Loring, Heather S.; Parelkar, Sangram S.; Mondal, Santanu; Thompson, Paul R.			Identification of the first noncompetitive SARM1 inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						SARM1; Hydrolase; Neurodegeneration; NAD; Nicotinamide; TIR domain	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; DEGENERATION; ACTIVATION; BERBERINE; MICE	Sterile Alpha and Toll Interleukin Receptor Motif-containing protein 1 (SARM1) is a key therapeutic target for diseases that exhibit Wallerian-like degeneration; Wallerian degeneration is characterized by degeneration of the axon distal to the site of injury. These diseases include traumatic brain injury, peripheral neuropathy, and neurodegenerative diseases. SARM1 promotes neurodegeneration by catalyzing the hydrolysis of NAD(+) to form a mixture of ADPR and cADPR. Notably, SARM1 knockdown prevents degeneration, indicating that SARM1 inhibitors will likely be efficacious in treating these diseases. Consistent with this hypothesis is the observation that NAD(+) supplementation is axoprotective. To identify compounds that block the NAD(+) hydrolase activity of SARM1, we developed and performed a high-throughput screen (HTS). This HTS assay exploits an NAD(+) analog, etheno-NAD(+) (ENAD) that fluoresces upon cleavage of the nicotinamide moiety. From this screen, we identified berberine chloride and zinc chloride as the first noncompetitive inhibitors of SARM1. Though modest in potency, the noncompetitive mode of inhibition, suggests the presence of an allosteric binding pocket on SARM1 that can be targeted for future therapeutic development. Additionally, zinc inhibition and site-directed mutagenesis reveals that cysteines 629 and 635 are critical for SARM1 catalysis, highlighting these sites for the design of inhibitors targeting SARM1.	[Loring, Heather S.; Parelkar, Sangram S.; Mondal, Santanu; Thompson, Paul R.] UMass Med Sch, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA; [Loring, Heather S.; Parelkar, Sangram S.; Mondal, Santanu; Thompson, Paul R.] UMass Med Sch, Program Chem Biol, 364 Plantat St, Worcester, MA 01605 USA		Thompson, PR (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, LRB 826,364 Plantat St, Worcester, MA 01605 USA.	paul.thompson@umassmed.edu	Mondal, Santanu/L-9157-2015	Mondal, Santanu/0000-0002-7399-8364	University of Massachusetts Medical School, NIH [R35 GM118112, F31NS108610]	This work was supported by in part by institutional funds provided by the University of Massachusetts Medical School, NIH grant R35 GM118112 (P.R.T.), and F31NS108610 (H.S.L.).	Ahmed T, 2015, PHARMACOL REP, V67, P970, DOI 10.1016/j.pharep.2015.03.002; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fernandes KA, 2018, EXP EYE RES, V171, P54, DOI 10.1016/j.exer.2018.03.007; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Howell GR, 2013, EXP NEUROL, V246, P54, DOI 10.1016/j.expneurol.2012.01.014; Huang M, 2016, CURR TOP MED CHEM, V16, P867, DOI 10.2174/1568026615666150827095433; LILIENFELD DE, 1993, NEUROEPIDEMIOLOGY, V12, P219, DOI 10.1159/000110320; Loring HS, 2020, BIOCHEMISTRY-US, V59, P933, DOI 10.1021/acs.biochem.9b01078; Loring HS, 2019, CELL CHEM BIOL; Low JA, 2003, ANN ACAD MED SINGAP, V32, P778; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Wang JT, 2015, P NATL ACAD SCI USA, V112, P10093, DOI 10.1073/pnas.1508337112; Wang MS, 2002, ANN NEUROL, V52, P442, DOI 10.1002/ana.10300	22	8	8	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	SEP 15	2020	28	18							115644	10.1016/j.bmc.2020.115644			11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	NG5CT	WOS:000564001500006	32828421	Green Accepted			2022-02-06	
J	Shokouhi, G; Kosari-Nasab, M; Salari, AA				Shokouhi, Ghaffar; Kosari-Nasab, Morteza; Salari, Ali-Akbar			Silymarin sex-dependently improves cognitive functions and alters TNF-alpha, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury	LIFE SCIENCES			English	Article						Brain injury; Sex; Inflammation; Excitotoxicity; Memory; Hippocampus	MEMORY DEFICITS; RAT; EXCITOTOXICITY; INVOLVEMENT; SYMPTOMS; TRIGGERS; DEATH; MOTOR	Aims: Mild traumatic brain injury (mTBI) is an important risk factor for cognitive impairment. Despite intense efforts to develop efficient treatments, the current therapies are not often effective and far from satisfactory. Silymarin has been suggested as a therapeutic agent in the treatment of traumatic brain injury. This study aimed to determine whether silymarin can exert neuroprotective effects on memory impairment following mTBI in mice. Main methods: After mTBI induction, mice were treated with silymarin once daily for 20 consecutive days by oral gavage. To investigate cognitive functions, animals were subjected to Y-maze, novel-object recognition, and Morris-water maze. Levels of tumor necrosis factor (TNF)-alpha, glutamate, and brain derived neurotrophic factor (BDNF) were measured in the hippocampus. Key findings: Our findings showed that mTBI resulted in a significant decline in memory in the Y-maze and Morris-water maze in both sexes, whereas only impaired cognitive function in males in the novel-object recognition. We found notable increases in TNF-alpha and glutamate levels in the hippocampus of both sexes, while there was only a significant decrease in hippocampal BDNF in mTBI-induced females. In addition, silymarin treatment improved cognitive impairments in mTBI-induced males but not in females. Silymarin significantly reduced TNF-alpha and glutamate levels, and increased BDNF levels in the hippocampus of mTBI-induced male but not in female mice. Significance: This study demonstrates that silymarin treatment sex-dependently improves cognitive impairment in mTBI-induced mice, and suggests that silymarin may be a therapeutic agent for cognitive decline following mTBI in males. Further studies are needed to establish the validity of these findings in humans.	[Shokouhi, Ghaffar; Kosari-Nasab, Morteza] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Salari, Ali-Akbar] Salari Inst Cognit & Behav Disorders SICBD, POB 31396-45999, Alborz, Karaj, Iran		Salari, AA (corresponding author), Salari Inst Cognit & Behav Disorders SICBD, POB 31396-45999, Alborz, Karaj, Iran.	aa.salari@yahoo.com	Salari, Ali-Akbar/I-7843-2013	Salari, Ali-Akbar/0000-0002-4970-0337	Drug Applied Research Center at Tabriz University of Medical Sciences	This study was supported by a grant from the Drug Applied Research Center at Tabriz University of Medical Sciences.	Amani M, 2019, PHYSIOL BEHAV, V202, P52, DOI 10.1016/j.physbeh.2019.01.005; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bashiri H, 2020, PHYSIOL BEHAV, V223, DOI 10.1016/j.physbeh.2020.113003; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Chtourou Y, 2012, NEUROCHEM RES, V37, P469, DOI 10.1007/s11064-011-0632-x; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Desrumaux CM, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00310; Devi KP, 2017, CURR DRUG TARGETS, V18, P1529, DOI 10.2174/1389450117666161227125121; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; El-Elimat T, 2019, PLANTA MED, V85, P32, DOI 10.1055/a-0710-5673; Enayati M, 2020, LIFE SCI, V251, DOI 10.1016/j.lfs.2020.117597; Esmaeili MH, 2020, BEHAV BRAIN RES, V379, DOI 10.1016/j.bbr.2019.112359; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hirayama K, 2016, BRAIN RES, V1646, P297, DOI 10.1016/j.brainres.2016.06.018; Huo TG, 2015, MOL NEUROBIOL, V51, P980, DOI 10.1007/s12035-014-8753-2; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kosari-Nasab M, 2019, BEHAV PHARMACOL, V30, P220, DOI 10.1097/FBP.0000000000000450; Kosari-Nasab M, 2019, METAB BRAIN DIS, V34, P575, DOI 10.1007/s11011-018-0366-4; Kosari-Nasab M, 2018, LIFE SCI, V213, P198, DOI 10.1016/j.lfs.2018.10.040; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; Kosari-Nasab M, 2014, BEHAV PHARMACOL, V25, P325, DOI 10.1097/FBP.0000000000000051; Lecca D, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104528; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Muley MM, 2013, LIFE SCI, V93, P51, DOI 10.1016/j.lfs.2013.05.020; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; Neha, 2014, N-S ARCH PHARMACOL, V387, P777, DOI 10.1007/s00210-014-0990-4; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Onaolapo Adejoke Yetunde, 2017, Pathophysiology, V24, P51, DOI 10.1016/j.pathophys.2017.01.002; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Salari AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29595-0; Sarubbo F, 2018, J NEUROIMMUNE PHARM, V13, P24, DOI 10.1007/s11481-017-9759-0; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Thakare VN, 2017, PHYSIOL BEHAV, V179, P401, DOI 10.1016/j.physbeh.2017.07.010; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Toklu HZ, 2008, J SURG RES, V145, P214, DOI 10.1016/j.jss.2007.03.072; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yasen AL, 2018, J NEUROPHYSIOL, V120, P1318, DOI 10.1152/jn.00896.2017; Yon Burcu, 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P20180109, DOI 10.1515/jbcpp-2018-0109; Zhang H, 2001, CLIN CHEM, V47, P1458	59	8	8	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	SEP 15	2020	257								118049	10.1016/j.lfs.2020.118049			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	NN3TU	WOS:000568714500009	32634430				2022-02-06	
J	D'Cruz, K; Douglas, J; Serry, T				D'Cruz, Kate; Douglas, Jacinta; Serry, Tanya			Narrative storytelling as both an advocacy tool and a therapeutic process: Perspectives of adult storytellers with acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; ABI; Traumatic brain injury; TBI; Personal narrative approaches; Storytelling	QUALITY-OF-LIFE; SELF-CONCEPT; MENTAL-HEALTH; PEOPLE; REHABILITATION; IDENTITY; CARE; INTERVENTION; EXPERIENCE; COMMUNITY	As part of a larger study exploring narrative storytelling, this paper focuses upon the experiences of eight adults with ABI who had participated in storytelling workshops facilitated by an advocacy organization. Following participation in the storytelling workshops, each storyteller was interviewed twice, with three shorter interviews conducted with one participant with significant communication challenges. In total, 25 interview transcripts (17 interviews plus eight transcripts of produced personal narratives) were analysed using constructivist grounded theory methods. Data analysis produced two main themes and sub-themes; (1) Sharing and helping (feeling heard & releasing emotions) and, (2) Re-visiting my story (reflecting and learning). The themes capture insights into the process of storytelling and reveal the therapeutic potential of narrative storytelling when coupled with an altruistic opportunity to help others through story sharing. This study contributes to an emerging area of research and practice supporting positive identity growth following ABI. The findings present substantial implications for goal setting and meaningful productive engagement in brain injury rehabilitation.	[D'Cruz, Kate] La Trobe Univ, Dept Community & Clin Allied Hlth, Discipline Occupat Therapy, Melbourne, Vic, Australia; [Douglas, Jacinta; Serry, Tanya] La Trobe Univ, Dept Community & Clin Allied Hlth, Discipline Speech Pathol, Melbourne, Vic, Australia; [Douglas, Jacinta; Serry, Tanya] La Trobe Univ, Living Disabil Res Ctr, Melbourne, Vic, Australia; [Douglas, Jacinta] Summer Fdn, Melbourne, Vic, Australia		D'Cruz, K (corresponding author), La Trobe Univ, Dept Community & Clin Allied Hlth, Discipline Occupat Therapy, Melbourne, Vic, Australia.	k.dcruz@latrobe.edu.au	D'Cruz, Kate/ABC-7970-2021	D'Cruz, Kate/0000-0002-5155-1350; Douglas, Jacinta/0000-0003-0940-6624; Serry, Tanya/0000-0003-1538-7327			Adler JM, 2012, J PERS SOC PSYCHOL, V102, P367, DOI 10.1037/a0025289; Baker F, 2005, J MUSIC THER, V42, P111, DOI 10.1093/jmt/42.2.111; Baker F., 2005, AUSTR J MUSIC THERAP, V16, P25; Baker F., 2005, BRAIN IMPAIR, V6, P205, DOI [https://doi.org/10.1375/brim.2005.6.3.205, DOI 10.1375/BRIM.2005.6.3.205, 10.1375/brim.2005.6.3.205]; Baker FA, 2017, J MUSIC THER, V54, P35, DOI 10.1093/jmt/thw018; Beadle EJ, 2020, NEUROPSYCHOL REHABIL, V30, P393, DOI 10.1080/09602011.2018.1469416; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Bronken BA, 2012, QUAL HEALTH RES, V22, P1303, DOI 10.1177/1049732312450366; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charmaz K., 2013, CONSTRUCTING GROUNDE; Charon R., 2006, NARRATIVE MED HONORI; Chow EOW, 2015, CLIN REHABIL, V29, P315, DOI 10.1177/0269215514544039; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Corsten S, 2015, INT J LANG COMM DIS, V50, P788, DOI 10.1111/1460-6984.12173; Corsten S, 2014, APHASIOLOGY, V28, P440, DOI 10.1080/02687038.2013.843154; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; Davis Marsha Courville, 2004, Issues Ment Health Nurs, V25, P503, DOI 10.1080/01612840490443455; De Vecchi N, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917729291; De Vecchi N, 2016, INT J MENT HEALTH NU, V25, P183, DOI 10.1111/inm.12206; Docherty S, 1999, RES NURS HEALTH, V22, P177, DOI 10.1002/(SICI)1098-240X(199904)22:2<177::AID-NUR9>3.3.CO;2-8; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Ellis-Hill C, 2008, DISABIL REHABIL, V30, P150, DOI 10.1080/09638280701195462; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Fraas MR, 2015, TOP LANG DISORD, V35, P210, DOI 10.1097/TLD.0000000000000063; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Galvin KT, 2018, NURS INQ, V25, DOI 10.1111/nin.12235; Gauld S., 2018, EDORIUM J DISABILITY, V4; Gergen M.M., 2014, HISTORICAL SOCIAL PS, P173; GLASSMAN LR, 1991, ART PSYCHOTHER, V18, P149, DOI 10.1016/0197-4556(91)90022-3; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gubrium A, 2009, HEALTH PROMOT PRACT, V10, P186, DOI 10.1177/1524839909332600; Gubrium AC, 2014, AM J PUBLIC HEALTH, V104, P1606, DOI 10.2105/AJPH.2013.301310; Haigh C, 2011, NURS EDUC TODAY, V31, P408, DOI 10.1016/j.nedt.2010.08.001; Hartke RJ, 2007, TOP STROKE REHABIL, V14, P26, DOI 10.1310/tsr1401-26; Hersh D, 2015, TOP LANG DISORD, V35, P219, DOI 10.1097/TLD.0000000000000060; Hogan BA, 1999, NEUROREHABILITATION, V13, P21; Husserl E., 1970, CRISIS EUROPEAN SCI; Kersten P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020672; Lambert J., 2009, DIGITAL STORYTELLING; Levack W, 2017, BRIT J OCCUP THER, V80, P608, DOI 10.1177/0308022617722736; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levin Y, 2014, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-642-39599-4_1; Liamputtong P., 2012, QUALITATIVE RES METH; Lorenz LS, 2010, VISUAL STUD, V25, P210, DOI 10.1080/1472586X.2010.523273; McAdams, 2001, REV GEN PSYCHOL, V5, P100, DOI [DOI 10.1037/1089-2680.5.2.100, 10.1037/1089-2680.5.2.100]; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Pennebaker JW, 2000, LIT MED, V19, P3, DOI 10.1353/lm.2000.0011; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Roddy C., 2018, NEUROPSYCHOL REHABIL, DOI [10.1080/09602011.20181448288, DOI 10.1080/09602011.20181448288]; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Schipper K, 2011, BRAIN INJURY, V25, P832, DOI 10.3109/02699052.2011.589796; Shadden BR, 2007, TOP LANG DISORD, V27, P324, DOI 10.1097/01.TLD.0000299887.24241.39; Spence D.P., 1982, NARRATIVE TRUTH HIST; Stenhouse R, 2013, J PSYCHIATR MENT HLT, V20, P134, DOI 10.1111/j.1365-2850.2012.01900.x; Tamplin J., 2006, NORD J MUSIC THER, V15, P177, DOI [10.1080/08098130609478164, DOI 10.1080/08098130609478164]; Tamplin J, 2016, NORD J MUSIC THER, V25, P111, DOI 10.1080/08098131.2015.1011208; Todres, 2013, CARING WELL BEING LI; Todres L, 2009, INT J QUAL STUD HEAL, V4, P68, DOI 10.1080/17482620802646204; Willox AC, 2013, QUAL RES, V13, P127, DOI 10.1177/1468794112446105; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	76	8	8	3	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP 13	2020	30	8					1409	1429		10.1080/09602011.2019.1586733			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MT6UM	WOS:000555107800001	30822228				2022-02-06	
J	Yehene, E; Lichtenstern, G; Harel, Y; Druckman, E; Sacher, Y				Yehene, Einat; Lichtenstern, Gal; Harel, Yirmi; Druckman, Eran; Sacher, Yaron			Self-efficacy and acceptance of disability following mild traumatic brain injury: A pilot study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Acceptance of disability; emotional outcome; mild-Traumatic Brain Injury (mTBI); Post-Concussion Syndrome; self-efficacy	QUALITY-OF-LIFE; POST-CONCUSSION SYNDROME; POSTCONCUSSIVE SYMPTOMS; SOCIAL-PARTICIPATION; MISERABLE MINORITY; RATING-SCALE; STRESS; RECOVERY; ILLNESS; ADULTS	Recovery from mild traumatic brain injury (mTBI) and regaining emotional equilibrium afterward can take much longer than the typical three months. Recent works attribute persisting complaints to psychological factors, primarily the negative perception of mTBI. However, research has yet to demonstrate how self-beliefs concerning capability are linked to perception and ability to accept injury. The objective of this study was to investigate how perceived general self-efficacy (GSE) and acceptance of disability (AD) relate to emotional outcome following mTBI. Thirty individuals aged 21-57, all of whom were at least three-month post diagnosis of mTBI, underwent a psychiatric clinical interview assessing depression, post-traumatic stress disorder (PTSD), and quality of life (QoL), and completed self-report scales to evaluate psychological factors. Scores on AD, depression, and QoL for most life domains were significantly lower and worse than among the normative population. Pearson coefficients indicated significant correlations between psychological factors and emotional outcome. Mediation analysis showed a significant role of AD in mediating the correlation between GSE and depression/general QoL, irrespective of PTSD. Low self-efficacy accentuates negative perception of the injury which, in turn, leads to poor emotional outcomes post mTBI. Therefore, AD should become the focus of therapeutic interventions.	[Yehene, Einat; Lichtenstern, Gal; Druckman, Eran] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, 2 Rabenu Yeruham St POB 8401, IL-61161 Tel Aviv Yaffo, Israel; [Yehene, Einat] Sheba Med Ctr, Tel Hashomer Hosp, Ramat Gan, Israel; [Harel, Yirmi; Sacher, Yaron] Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; [Sacher, Yaron] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Yehene, E (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, 2 Rabenu Yeruham St POB 8401, IL-61161 Tel Aviv Yaffo, Israel.	einat.yehene@gmail.com		Yehene, Einat/0000-0001-9780-3974			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 1994, TASK FORC DSM 4 DIAG; Attawong T., 2005, NEPAL J NEUROSCI, V2, P67, DOI [10.3126/njn.v2i1.19997, DOI 10.3126/NJN.V2I1.19997]; Bandura, 1995, SELF EFFICACY CHANGI, P177, DOI [10.1017/CBO9780511527692.008, DOI 10.1017/CBO9780511527692]; Bandura A., 1995, SELF EFFICACY CHANGI; Bandura A., 1994, SELF EFFICACY, P71; Bauer JJ, 2001, J RES PERS, V35, P424, DOI 10.1006/jrpe.2001.2323; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Ben-Yishay Y., 2011, HDB HOLISTIC NEUROPS, P7; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bogart KR, 2014, REHABIL PSYCHOL, V59, P107, DOI 10.1037/a0035800; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands IMH, 2019, CLIN REHABIL, V33, P327, DOI 10.1177/0269215518795249; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cicerone K. D, 1991, J HEAD TRAUMA REHABI; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Connolly FR, 2014, J ADV NURS, V70, P714, DOI 10.1111/jan.12237; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; De Koning ME, 2018, BRAIN INJURY, V32, P540, DOI 10.1080/02699052.2018.1431844; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DEMBO T, 1956, Artif Limbs, V3, P4; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Gass CS, 2017, APPL NEUROPSYCH-ADUL, V24, P108, DOI 10.1080/23279095.2015.1107563; Geller ES, 2015, J ORGAN BEHAV MANAGE, V35, P151, DOI 10.1080/01608061.2015.1031427; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hayes, 2018, INTRO MEDIATION MODE; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jerusalem M., 1992, SELF EFFICACY RESOUR; Kraus J. F., 1996, NEUROLOGY AND TRAUMA, V2, P3, DOI DOI 10.1055/s-2008-1041052; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Linkowski D. C, 1971, REHABILITATION COUNS; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Livneh H, 2005, J COUNS DEV, V83, P12, DOI 10.1002/j.1556-6678.2005.tb00575.x; Lumley MA, 2011, J CLIN PSYCHOL, V67, P942, DOI 10.1002/jclp.20816; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MELAMED S, 1985, SCAND J REHABIL MED, P129; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Perroux M, 2013, SANTE PUBLIQUE, V25, P719, DOI 10.3917/spub.136.0719; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reynolds WM, 1995, PSYCHOL ASSESSMENT, V7, P472; Rothbaum BO, 2000, EFFECTIVE TREATMENTS FOR PTSD, P320; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schophaus M., 2000, SELF EFFICACY RAW DA; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Shabad P, 2001, SELF ACCEPTANCE GENE; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; War FA, 2013, INDIAN J NEUROTRAUM, V10, P115, DOI 10.1016/j.ijnt.2013.12.004; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; World Health Organization, 2007, INT CLASS FUNCT DIS	74	8	8	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 2	2020	27	5					468	477		10.1080/23279095.2019.1569523			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NC2YP	WOS:000561082300008	30806085				2022-02-06	
J	Ebner, F; Moseby-Knappe, M; Mattsson-Carlgren, N; Lilja, G; Dragancea, I; Unden, J; Friberg, H; Erlinge, D; Kjaergaard, J; Hassager, C; Wise, MP; Kuiper, M; Stammet, P; Wanscher, M; Horn, J; Ullen, S; Cronberg, T; Nielsen, N				Ebner, Florian; Moseby-Knappe, Marion; Mattsson-Carlgren, Niklas; Lilja, Gisela; Dragancea, Irina; Unden, Johan; Friberg, Hans; Erlinge, David; Kjaergaard, Jesper; Hassager, Christian; Wise, Matt P.; Kuiper, Michael; Stammet, Pascal; Wanscher, Michael; Horn, Janneke; Ullen, Susann; Cronberg, Tobias; Nielsen, Niklas			Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients	RESUSCITATION			English	Article						Out-of-hospital cardiac arrest; Neurological outcome prognostication; Serum biomarkers of neurological injury	FIBRILLARY ACIDIC PROTEIN; TARGETED TEMPERATURE MANAGEMENT; C-TERMINAL HYDROLASE-L1; AMERICAN-HEART-ASSOCIATION; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; EUROPEAN RESUSCITATION; UPDATE; CARE; 33-DEGREES-C	Objective: Neurological outcome prediction is crucial early after cardiac arrest. Serum biomarkers released from brain cells after hypoxic-ischaemic injury may aid in outcome prediction. The only serum biomarker presently recommended in the European Resuscitation Council prognostication guidelines is neuron-specific enolase (NSE), but NSE has limitations. In this study, we therefore analyzed the outcome predictive accuracy of the serum biomarkers glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) in patients after cardiac arrest. Methods: Serum GFAP and UCH-L1 were collected at 24, 48 and 72 h after cardiac arrest. The primary outcome was neurological function at 6-month follow-up assessed by the cerebral performance category scale (CPC), dichotomized into good (CPC1-2) and poor (CPC3-5). Prognostic accuracies were tested with receiver-operating characteristics by calculating the area under the receiver-operating curve (AUROC) and compared to the AU ROC of NSE. Results: 717 patients were included in the study. GFAP and UCH-L1 discriminated between good and poor neurological outcome at all time-points when used alone (AUROC GFAP 0.88 0.89; UCH-L1 0.85 0.87) or in combination (AU ROC 0.90 0.91). The combined model was superior to GFAP and UCH-L1 separately and NSE (AUROC 0.75 0.85) at all time-points. At specificities >= 95%, the combined model predicted poor outcome with a higher sensitivity than NSE at 24 h and with similar sensitivities at 48 and 72 h. Conclusion: GFAP and UCH-L1 predicted poor neurological outcome with high accuracy. Their combination may be of special interest for early prognostication after cardiac arrest where it performed significantly better than the currently recommended biomarker NSE.	[Ebner, Florian; Nielsen, Niklas] Lund Univ, Helsingborg Hosp, Dept Clin Sci Lund, Anaesthesia & Intens Care, Lund, Sweden; [Moseby-Knappe, Marion; Mattsson-Carlgren, Niklas; Lilja, Gisela; Dragancea, Irina; Cronberg, Tobias] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurol, Lund, Sweden; [Mattsson-Carlgren, Niklas] Lund Univ, Fac Med, Clin Memory Res Unit, Lund, Sweden; [Mattsson-Carlgren, Niklas] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Unden, Johan] Lund Univ, Hallands Hosp Halmstad, Dept Clin Sci Malmo, Anaesthesia & Intens Care, Halland, Sweden; [Friberg, Hans] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Anaesthesia & Intens Care, Malmo, Sweden; [Erlinge, David] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Cardiol, Lund, Sweden; [Kjaergaard, Jesper; Hassager, Christian] Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Kjaergaard, Jesper; Hassager, Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Wise, Matt P.] Univ Hosp Wales, Adult Crit Care, Cardiff, Wales; [Kuiper, Michael] Med Ctr Leeuwarden, Dept Intens Care, Leeuwarden, Netherlands; [Stammet, Pascal] Natl Fire & Rescue Corps, Med & Hlth Directorate, Luxembourg, Luxembourg; [Wanscher, Michael] Univ Copenhagen, Rigshosp, Dept Cardiothorac Anaesthesia, Copenhagen, Denmark; [Horn, Janneke] Univ Amsterdam, Dept Intens Care Med, Lab Expt Intens Care & Anaesthesiol, Amsterdam UMC,AMC, Amsterdam, Netherlands; [Ullen, Susann] Skane Univ Hosp, Clin Studies Sweden, Lund, Sweden		Ebner, F (corresponding author), Lund Univ, Helsingborg Hosp, Dept Clin Sci Lund, Anaesthesia & Intens Care, S-25187 Helsingborg, Sweden.	florian.ebner@med.lu.se	Stammet, Pascal/ABA-7580-2020; Kuiper, Michael/AAG-9878-2019; Mattsson-Carlgren, Niklas/H-7597-2019	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Kjaergaard, Jesper/0000-0001-5244-0399; Stammet, Pascal/0000-0002-0298-1012; Ebner, Florian/0000-0002-1019-0034; Hassager, Christian/0000-0002-1199-0981	Swedish Research CouncilSwedish Research CouncilEuropean Commission [134281]; Swedish Heart Lung FoundationSwedish Heart-Lung Foundation [20090275, 20120491]; Arbetsmarknadens Forsakringsaktiebolag Insurance Foundation [100001]; Skane University Hospital Foundations; Gyllenstierna-Krapperup Foundation; Swedish National HealthSystem [M2010/1837, M2010/1641, 353301]; County Council of Skane; Swedish Society of Medicine; Koch Foundation; TrygFonden (Denmark); European Clinical Research Infrastructures Network; Thelma Zoega Foundation; Stig and Ragna Gorthon Foundation; Thure Carlsson Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Lions Researchfund Skane; South Swedish Hospital Region Research Funds (Sodra Sjukvardsregionen Regionalt Forsknigsstod); Swedish Brain Foundation; Lundbeck FoundationLundbeckfonden [R1862015-2132]; Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences	Funding for the study was provided by the Swedish Research Council (grant 134281); Swedish Heart Lung Foundation (grants 20090275 and 20120491); Arbetsmarknadens Forsakringsaktiebolag Insurance Foundation (grant 100001); the Skane University Hospital Foundations, the Gyllenstierna-Krapperup Foundation, and governmental funding of clinical research within the Swedish National HealthSystem(grantsM2010/1837, M2010/1641,353301); theCounty Council of Skane; the Swedish Society of Medicine; the Koch Foundation; TrygFonden (Denmark); European Clinical Research Infrastructures Network; Thelma Zoega Foundation; Stig and Ragna Gorthon Foundation; Thure Carlsson Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Lions Researchfund Skane; South Swedish Hospital Region Research Funds (Sodra Sjukvardsregionen Regionalt Forsknigsstod); the Swedish Brain Foundation; the Lundbeck Foundation (R1862015-2132) and the Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences.	ABRAMSON NS, 1985, CRIT CARE MED, V13, P930, DOI 10.1097/00003246-198511000-00020; Andersson FI, 2010, BIOMOL NMR ASSIGN, V4, P41, DOI 10.1007/s12104-009-9203-3; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Beck B, 2018, RESUSCITATION, V126, P49, DOI 10.1016/j.resuscitation.2018.02.029; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1373/clinchem.2015.246280, 10.1136/bmj.h5527, 10.1148/radiol.2015151516]; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cronberg T, 2017, SEMIN NEUROL, V37, P81, DOI 10.1055/s-0036-1595814; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dragancea I, 2015, RESUSCITATION, V93, P164, DOI 10.1016/j.resuscitation.2015.04.013; Grasner JT, 2020, RESUSCITATION; Helwig K, 2017, NEUROCRIT CARE, V27, P68, DOI 10.1007/s12028-016-0371-6; Huang L, 2019, INT J MOL SCI, V20; JENNETT B, 1975, LANCET, V1, P480; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Liu H, 2019, P NATL ACAD SCI US; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Mattsson N, 2017, ANN NEUROL, V82, P665, DOI 10.1002/ana.25067; Moseby-Knappe M, 2019, JAMA NEUROL, V76, P64, DOI 10.1001/jamaneurol.2018.3223; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Petrova DT, 2013, CLIN BIOCHEM, V46, P1298, DOI 10.1016/j.clinbiochem.2013.06.018; Phelps R, 2013, CRIT CARE MED, V41, P1252, DOI 10.1097/CCM.0b013e31827ca975; R Core Team, 2017, R LANG ENV STAT COMP; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Shemilt M, 2019, CRIT CARE MED, V47, pE522, DOI 10.1097/CCM.0000000000003728; Stammet P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1729-7; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Zhou JQ, 2011, EXPERT OPIN DRUG MET, V7, P803, DOI 10.1517/17425255.2011.574127; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	39	8	8	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	SEP	2020	154						61	68		10.1016/j.resuscitation.2020.05.016			8	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	ND9JT	WOS:000562217400013	32445783	hybrid			2022-02-06	
J	Haider, MN; Leddy, JJ; Du, W; Macfarlane, AJ; Viera, KB; Willer, BS				Haider, Mohammad N.; Leddy, John J.; Du, William; Macfarlane, Alexander J.; Viera, Kaitlin B.; Willer, Barry S.			Practical Management: Brief Physical Examination for Sport-Related Concussion in the Outpatient Setting	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; management; Buffalo Concussion Physical Examination; Buffalo Concussion Treadmill Test	BASE-LINE; EXERCISE; DIAGNOSIS; PRESSURE; YOUTH	This article presents a brief, focused physical examination [PE, the Buffalo Concussion Physical Examination (BCPE)] for sport-related concussion (SRC) to be considered for use in the outpatient setting by sports medicine physicians, pediatricians, and primary-care physicians. This companion paper describes how to perform the PE, which was derived in a separate study presented in this journal. It is envisioned for use at the initial and follow-up outpatient visits both for acute concussions and in patients with prolonged symptoms. A pertinent PE, combined with other assessments, can help identify specific treatment targets in those with persistent symptoms after SRC. The BCPE includes orthostatic vital signs and examinations of the cranial nerves, oculomotor/ophthalmologic, cervical, and vestibular systems. Supplementary tests, including testing for exercise tolerance and neurocognitive function, may be performed if indicated. It is recommended that a PE be performed at the initial visit and every 1 to 2 weeks after SRC. On return of symptoms, cognition, and the PE to baseline, as well as normalization of any supplementary tests, patients can begin a return to play program.	[Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med, Dept Neurosci, Buffalo, NY USA; [Haider, Mohammad N.; Leddy, John J.; Viera, Kaitlin B.] SUNY Buffalo, Jacobs Sch Med, UBMD Orthoped & Sports Med, Buffalo, NY USA; [Du, William] SUNY Buffalo, Jacobs Sch Med, Dept Med, Buffalo, NY USA; [Macfarlane, Alexander J.] SUNY Buffalo, Jacobs Sch Med, Buffalo, NY USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med, Dept Psychiat, Buffalo, NY USA		Haider, MN (corresponding author), Univ Buffalo, Dept Orthoped & Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Haider Mohammad N, 2017, Concussion, V2, pCNC40, DOI 10.2217/cnc-2017-0001; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Low PA, 2008, CLIN AUTON RES, V18, P8, DOI 10.1007/s10286-007-1001-3; Maples W C, 1988, J Am Optom Assoc, V59, P549; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ostadimoghaddam H, 2017, CLIN EXP OPTOM, V100, P255, DOI 10.1111/cxo.12471; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shawkat FS, 2000, BRIT J OPHTHALMOL, V84, P175, DOI 10.1136/bjo.84.2.175; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12	24	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					513	517		10.1097/JSM.0000000000000687			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300030	30418199	Green Accepted			2022-02-06	
J	Li, JT; Ma, T; Huang, C; Huang, XC; Kang, Y; Long, ZZ; Liu, MB				Li, Jintao; Ma, Tian; Huang, Chao; Huang, Xiancong; Kang, Yue; Long, Zhizhou; Liu, Moubin			Protective Mechanism of Helmet Under Far-field Shock Wave	INTERNATIONAL JOURNAL OF IMPACT ENGINEERING			English	Article						Blast wave; Helmet; Protection; Underwash effect	TRAUMATIC BRAIN-INJURY; BALLISTIC IMPACT; BLAST-WAVE; HUMAN HEAD; MITIGATION; RESPONSES; PLATES	In order to understand the protective mechanism of helmet against shock wave, a head model under far-field blast is investigated experimentally and numerically. The distribution of overpressure on the surface of the head model are obtained and compared. The numerical simulations are carried out using the Multi-Material Arbitrary Lagrangian Eulerian (MM-ALE) technique with suitable material models for a Kevlar helmet and soft pads. The differences in the distributions of overpressure on the head models with and without the protection of the helmet are analyzed. The interaction of shock waves around the head and the helmet is investigated. Our experimental observations and numerical results indicate that, if protected by a helmet in the case of a shock wave acting from the front, the peaks of overpressure on the head are reduced at the top area, but increased at the rear area. The numerical simulations also show that the enhancement of the overpressure at the rear is mainly due to the collision of the shock wave. The underwash phenomenon also occurs when the shock wave acts from the side or the rear.	[Li, Jintao; Liu, Moubin] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Ma, Tian; Huang, Xiancong; Kang, Yue; Long, Zhizhou] PLA Acad Mil Sci, Inst Quartermaster Engn Technol, Beijing 100091, Peoples R China; [Huang, Chao] CAEP Software Ctr High Performance Numer Simulat, Beijing, Peoples R China; [Huang, Chao] Inst Appl Phys & Computat Math, Beijing 100088, Peoples R China		Liu, MB (corresponding author), Peking Univ, Coll Engn, Beijing 100871, Peoples R China.	mbliu@pku.edu.cn		Huang, Chao/0000-0002-5663-3814; Li, Jintao/0000-0002-9930-1449	National Defense 973 ProjectNational Basic Research Program of China [613307]; Science Challenge Project [TZ2018002]; Beijing Innovation Center for Engineering Science and Advanced Technology (BIC-ESAT)	This work has been supported by the National Defense 973 Project (No. 613307), the Science Challenge Project (No. TZ2018002) and the Beijing Innovation Center for Engineering Science and Advanced Technology (BIC-ESAT). Special thanks are given to Dr. Muhammad Saif Ullah Khalid for smoothing the paper and giving valuable comments.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Baker W.E., 1973, EXPLOSIONS AIR; Bin Tan L, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2884; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Cullis I G, 2001, J R Army Med Corps, V147, P16; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Feng K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00179; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hallquist JO, 1998, MANUAL L DT; Henrych J., 1979, DYNAMICS EXPLOSION I; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang C, 2019, INT J IMPACT ENG, V130, P266, DOI 10.1016/j.ijimpeng.2019.04.018; Hughes K, 2013, INT J IMPACT ENG, V61, P48, DOI 10.1016/j.ijimpeng.2013.05.001; Igra O, 2001, J FLUID MECH, V437, P255, DOI 10.1017/S0022112001004098; Injury NCDPoRoPWTB, 2000, JAMA-J AM MED ASSOC, V282, P974; Jason AM, 2010, FACIAL PROTECTIVE DE; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Kong XS, 2017, INT J IMPACT ENG, V101, P32, DOI 10.1016/j.ijimpeng.2016.11.006; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Li JT, 2019, COMPOS STRUCT, V214, P335, DOI 10.1016/j.compstruct.2019.02.019; Li XG, 2016, INT J IMPACT ENG, V91, P56, DOI 10.1016/j.ijimpeng.2015.12.010; Li Y.Q., MODELING ADV COMBAT; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Mills C., 1988, DESIGN CONCRETE STRU; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott D, 2008, APS DIV FLUID DYN M; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Palta E, 2018, INT J IMPACT ENG, V112, P125, DOI 10.1016/j.ijimpeng.2017.10.010; Planchard DC, 2013, SOLIDWORKS 2013 TUTO; Planchard DC, 2010, COMMANDS GUIDE TUTOR; Richmond DR., 1968, ESTIMATE MANS TOLERA; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Sadovskyi M., 1952, BASED EXPT DATA; Sarvghad-Moghaddam Hesam, 2017, Int J Numer Method Biomed Eng, V33, DOI 10.1002/cnm.2782; Sarvghad-Moghaddam H, 2017, COMPUT METHOD BIOMEC, V20, P16, DOI 10.1080/10255842.2016.1193597; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Sarvghad-Moghaddam H, 2014, BRAIN INJURY, V28, P631; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Sharma S, 2012, BLAST IMPACT; Tan LB, 2014, INT J NUMER METH BIO, V30, P1476, DOI 10.1002/cnm.2668; TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P175, DOI 10.1098/rspa.1950.0050; TAYLOR G, 1950, PROC R SOC LON SER-A, V201, P159, DOI 10.1098/rspa.1950.0049; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; Tolba AFF, 2002, RESPONSE FRP RETROFI; Toqueboeuf W, 1997, J PHYS IV, V7, P499, DOI 10.1051/jp4:1997386; Tse KM, 2019, J SANDW STRUCT MATER, V21, P2484, DOI 10.1177/1099636217733369; Zhang L., 2001, SAE TECHNICAL PAPER; Zhang L, 2011, J MOL CATAL A-CHEM, V335, P31, DOI 10.1016/j.molcata.2010.11.007; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zheng C, 2018, INT J IMPACT ENG, V113, P144, DOI 10.1016/j.ijimpeng.2017.11.013; Zhou LJ, 2013, PROCEEDINGS 2013 INTERNATIONAL CONFERENCE ON MECHATRONIC SCIENCES, ELECTRIC ENGINEERING AND COMPUTER (MEC), P2013, DOI 10.1109/MEC.2013.6885381	56	8	9	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0734-743X	1879-3509		INT J IMPACT ENG	Int. J. Impact Eng.	SEP	2020	143								103617	10.1016/j.ijimpeng.2020.103617			12	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	MA2HG	WOS:000541736600020					2022-02-06	
J	Pattinson, CL; Meier, TB; Guedes, VA; Lai, C; Devoto, C; Haight, T; Broglio, SP; McAllister, T; Giza, C; Huber, D; Harezlak, J; Cameron, K; McGinty, G; Jackson, J; Guskiewicz, K; Mihalik, J; Brooks, A; Duma, S; Rowson, S; Nelson, LD; Pasquina, P; McCrea, M; Gill, JM				Pattinson, Cassandra L.; Meier, Timothy B.; Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Haight, Thaddeus; Broglio, Steven P.; McAllister, Thomas; Giza, Christopher; Huber, Daniel; Harezlak, Jaroslaw; Cameron, Kenneth; McGinty, Gerald; Jackson, Jonathan; Guskiewicz, Kevin; Mihalik, Jason; Brooks, Alison; Duma, Stefan; Rowson, Steven; Nelson, Lindsay D.; Pasquina, Paul; McCrea, Michael; Gill, Jessica M.		CARE Consortium Investigators	Plasma Biomarker Concentrations Associated With Return to Sport Following Sport-Related Concussion in Collegiate Athletes-A Concussion Assessment, Research, and Education (CARE) Consortium Study	JAMA NETWORK OPEN			English	Article							TRAUMATIC BRAIN-INJURY; SERUM NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; TAU; PROTEIN	Question Are plasma biomarkers associated with a return-to-sport period of less than 14 days vs 14 days or more in male and female collegiate athletes following a sport-related concussion? Findings This diagnostic study, which included 127 collegiate athletes who had sustained a sports-related concussion, found that higher total tau concentrations 24 to 48 hours after injury and at the time of symptom resolution as well as lower glial fibrillary acidic protein levels acutely postinjury were associated with return-to-sport decisions. Meaning In this study, total tau and glial fibrillary acidic protein levels were associated with return to sport in male and female collegiate athletes following a sports-related concussion. This diagnostic study examines whether plasma biomarkers can differentiate collegiate athletes who return to sport in less than 14 days vs 14 days or more following a sports-related concussion. Importance Identifying plasma biomarkers associated with the amount of time an athlete may need before they return to sport (RTS) following a sport-related concussion (SRC) is important because it may help to improve the health and safety of athletes. Objective To examine whether plasma biomarkers can differentiate collegiate athletes who RTS in less than 14 days or 14 days or more following SRC. Design, Setting, and Participants This multicenter prospective diagnostic study, conducted by the National Collegiate Athletics Association-Department of Defense Concussion Assessment, Research, and Education Consortium, included 127 male and female athletes who had sustained an SRC while enrolled at 6 Concussion Assessment, Research, and Education Consortium Advanced Research Core sites as well as 2 partial-Advanced Research Core military service academies. Data were collected between February 2015 and May 2018. Athletes with SRC completed clinical testing and blood collection at preseason (baseline), postinjury (0-21 hours), 24 to 48 hours postinjury, time of symptom resolution, and 7 days after unrestricted RTS. Main Outcomes and Measures A total of 3 plasma biomarkers (ie, total tau protein, glial fibrillary acidic protein [GFAP], and neurofilament light chain protein [Nf-L]) were measured using an ultrasensitive single molecule array technology and were included in the final analysis. RTS was examined between athletes who took less than 14 days vs those who took 14 days or more to RTS following SRC. Linear mixed models were used to identify significant interactions between period by RTS group. Area under the receiver operating characteristic curve analyses were conducted to examine whether these plasma biomarkers could discriminate between RTS groups. Results The 127 participants had a mean (SD) age of 18.9 (1.3) years, and 97 (76.4%) were men; 65 (51.2%) took less than 14 days to RTS, and 62 (48.8%) took 14 days or more to RTS. Linear mixed models identified significant associations for both mean (SE) plasma total tau (24-48 hours postinjury, <14 days RTS vs >= 14 days RTS: -0.65 [0.12] pg/mL vs -0.14 [0.14] pg/mL; P = .008) and GFAP (postinjury, 14 days RTS vs >= 14 days RTS: 4.72 [0.12] pg/mL vs 4.39 [0.11] pg/mL; P = .04). Total tau at the time of symptom resolution had acceptable discrimination power (area under the receiver operating characteristic curve, 0.75; 95% CI, 0.63-0.86; P < .001). We also examined a combined plasma biomarker panel that incorporated Nf-L, GFAP, and total tau at each period to discriminate RTS groups. Although the analyses did reach significance at each time period when combined, results indicated that they were poor at distinguishing the groups (area under the receiver operating characteristic curve, <0.7). Conclusions and Relevance The findings of this study suggest that measures of total tau and GFAP may identify athletes who will require more time to RTS. However, further research is needed to improve our ability to determine recovery following an SRC.	[Pattinson, Cassandra L.; Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Gill, Jessica M.] NINR, NIH, Bldg 10 CRC,10 Ctr Dr, Bethesda, MD 20814 USA; [Pattinson, Cassandra L.] Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia; [Meier, Timothy B.; Huber, Daniel; Nelson, Lindsay D.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Haight, Thaddeus] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Haight, Thaddeus] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Giza, Christopher] Univ Calif Los Angeles, UCLA Steve Tisch BrainSPORT Program, Dept Neurosurg & Pediat, Los Angeles, CA USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA; [Cameron, Kenneth] Keller Army Community Hosp, West Point, NY USA; [McGinty, Gerald; Jackson, Jonathan] US Air Force Acad, Colorado Springs, CO 80840 USA; [Guskiewicz, Kevin; Mihalik, Jason] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Sports Med, Madison, WI 53706 USA; [Duma, Stefan; Rowson, Steven] Virginia Tech, Dept Biomed Engn, Blacksburg, VA USA; [Pasquina, Paul] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA		Gill, JM (corresponding author), NINR, NIH, Bldg 10 CRC,10 Ctr Dr, Bethesda, MD 20814 USA.	gillj@mail.nih.gov	Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014; Pattinson, Cassandra/A-5543-2019	Rowson, Steven/0000-0002-3227-0596; Harezlak, Jaroslaw/0000-0002-3070-7686; de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Pattinson, Cassandra/0000-0002-5975-7935	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; NCAA; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the NCAA and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler St, Ft Detrick, MD 21702, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award No. W81XWH-14-2-0151.	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister TW, 2018, MIL HLTH SYST RES S; McCrea M, 2019, MIL HLTH SYST RES S; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Motamedi V, 2018, SLEEP MED, V43, P71, DOI 10.1016/j.sleep.2017.11.1121; NCAA, INT CONS DIAGN MAN S; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Pattinson CL, 2020, J HEAD TRAUMA REHAB, V35, P66, DOI 10.1097/HTR.0000000000000485; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Wallace C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206466	31	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	AUG 27	2020	3	8							e2013191	10.1001/jamanetworkopen.2020.13191			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL3TU	WOS:000567343400003	32852552	gold, Green Published			2022-02-06	
J	Gotz, S; Bribian, A; Lopez-Mascaraque, L; Gotz, M; Grothe, B; Kunz, L				Goetz, Stefanie; Bribian, Ana; Lopez-Mascaraque, Laura; Goetz, Magdalena; Grothe, Benedikt; Kunz, Lars			Heterogeneity of astrocytes: Electrophysiological properties of juxtavascular astrocytes before and after brain injury	GLIA			English	Article						astrocyte heterogeneity; astrocyte proliferation; clones; K(+)channels; K(ir)4; 1; K(v)4; 3; reactive astrocytes	K+ CHANNEL EXPRESSION; REACTIVE ASTROCYTES; HIPPOCAMPAL ASTROCYTES; GLIAL-CELLS; GLUCOSE-UPTAKE; ION CHANNELS; WHOLE-CELL; KIR4.1; PROLIFERATION; CORTEX	Astrocyte heterogeneity is increasingly recognized, but still little is known about juxtavascular astrocytes with their somata directly adjacent to blood vessels, despite their importance after brain injury. As juxtavascular astrocytes originate from common progenitor cells, that is, have a clonal origin, they may intrinsically differ from other, non-juxtavascular astrocytes. To explore this, we examined the electrophysiological properties of these groups of astrocytes and the underlying ion channels. Using brain slices of BAC Aldh1l1-eGFP transgenic mice with astrocytes labeled by GFP expression, we compared juxtavascular and non-juxtavascular astrocytes in the somatosensory cortex by means of whole-cell patch-clamp recordings and immunohistochemical staining. Prior to injury, juxta- and non-juxtavascular astrocytes exhibit comparable electrophysiological properties with characteristic mostly passive conductance and a typical negative resting membrane potential. Immunohistochemical analysis of K(+)channels showed that all astrocytes were K(ir)4.1(+), but revealed an intriguing difference for K(v)4.3. The expression of K(v)4.3 in sibling astrocytes (non-juxtavascular, juxtavascular and pial) was dependent on their ontogenetic origin with lowest levels in juxtavascular astrocytes located in upper cortical layers. After traumatic brain injury (TBI), we found profound changes in the electrophysiological type of astrocytes with a predominance of non-passive properties and this pattern was significantly enriched in juxtavascular astrocytes. This was accompanied by pronounced down-regulation of K(ir)4.1 in proliferating astrocytes, which was significantly more in juxtavascular compared to non-juxtavascular astrocytes. Taken together, TBI induces profound differences in electrophysiological properties between juxtavascular and non-juxtavascular astrocytes that might be related to the preponderance of juxtavascular astrocyte proliferation.	[Goetz, Stefanie; Grothe, Benedikt; Kunz, Lars] Ludwig Maximilians Univ LMU Munich, Dept Biol 2, Div Neurobiol, Martinsried, Germany; [Goetz, Stefanie] Ludwig Maximilians Univ LMU Munich, Grad Sch Syst Neurosci, Martinsried, Germany; [Goetz, Stefanie; Goetz, Magdalena; Grothe, Benedikt] Ludwig Maximilians Univ LMU Munich, Biomed Ctr BMC, SyNergy Munich Cluster Syst Neurol, Munich, Germany; [Bribian, Ana; Lopez-Mascaraque, Laura] CSIC, Mol Cellular & Dev Neurobiol Dept, Inst Cajal, Madrid, Spain; [Goetz, Magdalena] Ludwig Maximilians Univ LMU Munich, Biomed Ctr BMC, Physiol Genom, Martinsried, Germany; [Goetz, Magdalena] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Stem Cell Res, Martinsried, Germany		Grothe, B; Kunz, L (corresponding author), Ludwig Maximilians Univ LMU Munich, Dept Biol 2, Div Neurobiol, Martinsried, Germany.; Gotz, M (corresponding author), Ludwig Maximilians Univ LMU Munich, Biomed Ctr BMC, Physiol Genom, Martinsried, Germany.	magdalena.goetz@helmholtz-muenchen.de; grothe@lmu.de; Lars.Kunz@bio.lmu.de	Lopez-Mascaraque, Laura/M-2448-2014	Lopez-Mascaraque, Laura/0000-0002-7154-5687; Kunz, Lars/0000-0003-3141-0005; Grothe, Benedikt/0000-0001-7317-0615	Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ 01EW1705B]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB (CRC) 870, SPP 1757]; Spanish Ministry of Economy and CompetitivenessSpanish Government [BFU2016-75207-R]; SyNergy -Munich Cluster for Systems Neurology; Projekt DEAL	Bundesministerium fur Bildung und Forschung, Grant/Award Number: EraNet (MicroNet grant FKZ 01EW1705B); Deutsche Forschungsgemeinschaft, Grant/Award Numbers: SFB (CRC) 870, SPP 1757; Spanish Ministry of Economy and Competitiveness, Grant/Award Number: BFU2016-75207-R; SyNergy -Munich Cluster for Systems Neurology; Open access funding enabled and organized by Projekt DEAL	Adermark L, 2008, NEUROCHEM INT, V52, P1365, DOI 10.1016/j.neuint.2008.02.006; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Bayraktar OA, 2020, NAT NEUROSCI, V23, P500, DOI 10.1038/s41593-020-0602-1; Cragnolini AB, 2018, MOL CELL NEUROSCI, V88, P240, DOI 10.1016/j.mcn.2018.02.007; Bekar LK, 2005, J NEUROPHYSIOL, V93, P1699, DOI 10.1152/jn.00850.2004; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Bordey A, 2001, J NEUROPHYSIOL, V85, P1719, DOI 10.1152/jn.2001.85.4.1719; Bordey A, 1997, J NEUROPHYSIOL, V78, P461, DOI 10.1152/jn.1997.78.1.461; Bribian A, 2016, NEUROSCIENCE, V323, P10, DOI 10.1016/j.neuroscience.2015.04.036; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cheng XY, 2019, J INTEGR NEUROSCI, V18, P203, DOI 10.31083/j.jin.2019.02.110; CHVATAL A, 1995, EUR J NEUROSCI, V7, P129, DOI 10.1111/j.1460-9568.1995.tb01027.x; Dallerac G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00159; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Du YX, 2015, J NEUROPHYSIOL, V113, P3744, DOI 10.1152/jn.00206.2015; Figueres-Onate M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33896; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Gangoso E, 2012, GLIA, V60, P2040, DOI 10.1002/glia.22418; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Gutierrez Y, 2019, GLIA, V67, P1852, DOI 10.1002/glia.23662; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Honsa P, 2014, GLIA, V62, P2004, DOI 10.1002/glia.22721; Isokawa M, 2005, J NEUROBIOL, V65, P125, DOI 10.1002/neu.20186; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Kelley KW, 2018, NEURON, V98, P306, DOI 10.1016/j.neuron.2018.03.010; Lanjakornsiripan D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03940-3; Ma BF, 2016, GLIA, V64, P214, DOI 10.1002/glia.22924; Macfarlane SN, 2000, GLIA, V30, P39, DOI 10.1002/(SICI)1098-1136(200003)30:1<39::AID-GLIA5>3.0.CO;2-S; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; Magaki SD, 2018, NEUROPHARMACOLOGY, V134, P218, DOI 10.1016/j.neuropharm.2017.11.009; McKhann GM, 1997, J NEUROSCI, V17, P6850; Meme W, 2009, NEUROSCI RES, V63, P236, DOI 10.1016/j.neures.2008.12.008; Mishima T, 2007, J NEUROSCI METH, V166, P32, DOI 10.1016/j.jneumeth.2007.06.021; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Morel L, 2017, J NEUROSCI, V37, P8706, DOI 10.1523/JNEUROSCI.3956-16.2017; Moroni RF, 2015, INT J DEV NEUROSCI, V47, P198, DOI 10.1016/j.ijdevneu.2015.09.004; Nwaobi SE, 2016, ACTA NEUROPATHOL, V132, P1, DOI 10.1007/s00401-016-1553-1; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Olsen ML, 2004, GLIA, V46, P63, DOI 10.1002/glia.10346; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Schools GP, 2006, J NEUROPHYSIOL, V96, P1383, DOI 10.1152/jn.00449.2006; Seifert G, 2018, BRAIN RES BULL, V136, P26, DOI 10.1016/j.brainresbull.2016.12.002; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Stephan J, 2014, GLIA, V62, P1992, DOI 10.1002/glia.22720; Tabernero A, 2001, J NEUROCHEM, V78, P890, DOI 10.1046/j.1471-4159.2001.00476.x; Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Westergard T, 2020, NEUROCHEM RES, V45, P1298, DOI 10.1007/s11064-020-02959-7; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005	59	8	8	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2021	69	2					346	361		10.1002/glia.23900		AUG 2020	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC4GG	WOS:000560229900001	32809228	Green Published, hybrid			2022-02-06	
J	Donnelly, KZ; Goldberg, S; Fournier, D				Donnelly, Kyla Z.; Goldberg, Shari; Fournier, Debra			A qualitative study of LoveYourBrain Yoga: a group-based yoga with psychoeducation intervention to facilitate community integration for people with traumatic brain injury and their caregivers	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; community integration; yoga; resilience; qualitative; meditation	OF-LIFE; REHABILITATION; PARTICIPATION; FEASIBILITY; EXPERIENCES; MODERATE; PROGRAM; SUPPORT; LEISURE; HEALTH	Purpose:To explore participants' experiences in a group-based yoga with psychoeducation intervention designed to facilitate community integration for people with traumatic brain injury and their caregivers. Materials and methods:We conducted semi-structured interviews with 13 people with traumatic brain injury and three caregivers who had completed LoveYourBrain Yoga, a 6-session, manualized, group-based yoga intervention that incorporates breathing exercises, yoga, meditation, and psychoeducation. Interviews were analyzed using content analysis. Results:We identified seven themes: ease of participation, belonging, sustaining community connection, physical health, self-regulation, self-efficacy, and resilience. All participants valued the community-based yoga studio environment and multifaceted structure of the program. Participants reported improvements in strength, balance, flexibility, and attention control, and a greater sense of belonging, community connection, and ability to move forward with their lives. Participants reported ongoing use of tools (e.g., breathing exercises) to cope with negative emotions and stress. About half of participants sustained relationships built during LoveYourBrain Yoga and felt more capable of accessing other activities in their community. Conclusions:LoveYourBrain Yoga successfully promoted community integration for people with traumatic brain injury. It also facilitated diverse and meaningful physical, psychological, and social health benefits, which suggest that it may be an effective mode of community-based rehabilitation.	[Donnelly, Kyla Z.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Goldberg, Shari] Colby Sawyer Coll, Sch Nursing & Hlth Profess, New London, CT USA; [Fournier, Debra] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA		Donnelly, KZ (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, 1 Med Dr, Lebanon, NH 03756 USA.	kyla.z.donnelly@dartmouth.edu					Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; [Anonymous], 2010, TRAUM BRAIN INJ CONC; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Birks YHR, 2014, EXPLORATION IMPLEMEN; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Callahan ML, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0867-x; CDC, 2015, C TRAUM BRAIN INJ US; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Combs MA, 2018, REHABIL PSYCHOL, V63, P182, DOI 10.1037/rep0000179; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Devine JM, 2016, ARCH PHYS MED REHAB, V97, P1392, DOI 10.1016/j.apmr.2016.04.015; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Donnelly KZ, 2017, BRAIN INJURY, V31, P208, DOI 10.1080/02699052.2016.1225988; Ekhtiari H, 2017, PROG BRAIN RES, V235, P239, DOI 10.1016/bs.pbr.2017.08.013; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Garrett R, 2011, DISABIL REHABIL, V33, P2404, DOI 10.3109/09638288.2011.573058; Gerber GJ, 2015, BRAIN INJURY, V29, P722, DOI 10.3109/02699052.2015.1004745; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Grimm Otr LA, 2017, INT J COMPLEMENTARY, V8, DOI [10.15406/ijcam.2017.08.00247, DOI 10.15406/IJCAM.2017.08.00247]; Hacker K, 2013, AM J PUBLIC HEALTH, V103, P1163, DOI 10.2105/AJPH.2013.301254; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Immink MA, 2014, TOP STROKE REHABIL, V21, P256, DOI 10.1310/tsr2103-256; Jamshed Shazia, 2014, J Basic Clin Pharm, V5, P87, DOI 10.4103/0976-0105.141942; Johansson B., 2014, TRAUMATIC BRAIN INJU; Kallio H, 2016, J ADV NURS, V72, P2954, DOI 10.1111/jan.13031; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kivunja S, 2018, J CLIN NURS; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Mitchell EJ, 2014, DISABIL REHABIL, V36, P1474, DOI 10.3109/09638288.2013.845259; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mueller C, 2017, BRAIN INJURY, V31, P1863, DOI 10.1080/02699052.2017.1346290; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Patel NK, 2011, ACT ADAPT AGING, V35, P151, DOI 10.1080/01924788.2011.574256; Quintard B., 2002, Annales de Readaptation et de Medecine Physique, V45, P456, DOI 10.1016/S0168-6054(02)00296-9; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Robinson-Smith G, 2000, ARCH PHYS MED REHAB, V81, P460, DOI 10.1053/mr.2000.3863; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Salas CE, 2016, NEUROPSYCHOL REHABIL, V1, P1; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sandhaug M, 2015, BRAIN INJURY, V29, P915, DOI 10.3109/02699052.2015.1022880; Schmid AA, 2016, COMPLEMENT THER MED, V28, P44, DOI 10.1016/j.ctim.2016.08.003; Schmid AA, 2016, DISABIL REHABIL, V38, P914, DOI 10.3109/09638288.2015.1062927; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Skoro-Kondza L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-33; Southwick SM, 2012, RESILIENCE: THE SCIENCE OF MASTERING LIFE'S GREATEST CHALLENGES, P1, DOI 10.1017/CBO9781139013857; Specht J, 2002, AM J OCCUP THER, V56, P436, DOI 10.5014/ajot.56.4.436; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; U.S. Census Bureau, 2015, AM COMM SURV 2015; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Weber KK, 2016, YOGA THERAPY TODAY; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Wright CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156826	70	8	8	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2482	2491		10.1080/09638288.2018.1563638			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000562793500011	30741032				2022-02-06	
J	Roberts, AL; Zafonte, RD; Speizer, FE; Baggish, A; Taylor, HA; Nadler, L; Weisskopf, MG				Roberts, Andrea L.; Zafonte, Ross D.; Speizer, Frank E.; Baggish, Aaron; Taylor, Herman A., Jr.; Nadler, Lee; Weisskopf, Marc G.			Modifiable Risk Factors for Poor Cognitive Function in Former American-Style Football Players: Findings from the Harvard Football Players Health Study	JOURNAL OF NEUROTRAUMA			English	Article						concussion; depression; pain; physical function; professional American-style football; sleep	TRAUMATIC BRAIN-INJURY; ANXIETY DISORDER; DECLINE; IMPAIRMENT; DEPRESSION; LIFE; DEMENTIA; ASSOCIATION	Recent attention to consequences of head trauma among former professional American-style football players has increased the likelihood that former players and their healthcare providers attribute neurocognitive effects to these exposures. In addition to head trauma, however, many potentially modifiable risk factors are associated with cognitive impairment. We examined the association of self-reported risk factors for cognitive impairment (e.g., cardiovascular health, sleep, pain, depression, anxiety, smoking, physical impairment, and physical activity) with cognition-related quality of life, measured by the Quality of Life in Neurological Disorders, Applied Cognition-General Concerns (Neuro-QOL) among 3803 former National Football League (NFL) players. We examined the prevalence of risk factors among men who had experienced a high number of concussion symptoms during playing years, comparing men with good current cognition-related QOL, the "healthy concussed," to men with poor cognition-related QOL, the "unhealthy concussed." Physical functioning, pain, depression, and anxiety were very strongly associated with poor cognitive-related QOL (risk ratio range, 2.21-2.70,p < 0.0001 for all). Short sleep duration and low physical activity were also strongly associated (RR = 1.69 and 1.57, respectively,p < 0.0001 for both). The largest differences between healthy and unhealthy concussed were in chronic pain (72.0% vs. 21.2%), depressive symptoms (50.3% vs. 6.3%), anxiety symptoms (53.4% vs. 11.6%), and physical impairment (52.4% vs. 12.5%). Substantial differences also existed in prevalence of sleep apnea, short sleep duration, high-intensity exercise, weight training, high blood pressure, and body mass index >= 35 kg/m(2)(all differences >10 percentage points). We identified cognitive risk factors, including chronic pain, mood problems, sleep problems, obesity, and lack of exercise, that were commonly present in former football players with cognition-related impairment. Better treatment for these factors may reduce cognitive problems in this population.	[Roberts, Andrea L.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Taylor, Herman A., Jr.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross D.] Harvard Med Sch, Boston, MA 02115 USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Speizer, Frank E.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Baggish, Aaron] Massachusetts Gen Hosp, Cardiovasc Performance Program, Boston, MA 02114 USA; [Nadler, Lee] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nadler, Lee] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA		Roberts, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	aroberts@hsph.harvard.edu			National Football League (NFL) Players Association	This study was funded by the National Football League (NFL) Players Association.	Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Beaudreau SA, 2008, AM J GERIAT PSYCHIAT, V16, P790, DOI 10.1097/JGP.0b013e31817945c3; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Centers for Disease Control and Prevention, 2017, DEF AD OV OB; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DeLuca AK, 2005, INT J GERIATR PSYCH, V20, P848, DOI 10.1002/gps.1366; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Geerlings MI, 2000, BRIT J PSYCHIAT, V176, P568, DOI 10.1192/bjp.176.6.568; Hassing LB, 2004, AGE AGEING, V33, P355, DOI 10.1093/ageing/afh100; HealthMeasures, PLEAS MOR INF; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Isaacson RS, 2019, ALZHEIMERS DEMENT, V15, P1588, DOI 10.1016/j.jalz.2019.08.198; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Northwestern University, 2018, HEALTHMEASURES TRANS; Osorio RS, 2015, NEUROLOGY, V84, P1964, DOI 10.1212/WNL.0000000000001566; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Robertson DA, 2013, AGEING RES REV, V12, P840, DOI 10.1016/j.arr.2013.06.004; Sinoff G, 2003, INT J GERIATR PSYCH, V18, P951, DOI 10.1002/gps.1004; Solfrizzi V, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.10.012; Tworoger SS, 2006, ALZ DIS ASSOC DIS, V20, P41, DOI 10.1097/01.wad.0000201850.52707.80; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	8	8	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					189	195		10.1089/neu.2020.7070		AUG 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000558262300001	32640866	hybrid, Green Published			2022-02-06	
J	Hannah, T; Dreher, N; Li, AY; Shankar, DS; Adams, R; Gometz, A; Lovell, MR; Choudhri, TF				Hannah, Theodore; Dreher, Nickolas; Li, Adam Y.; Shankar, Dhruv S.; Adams, Ryan; Gometz, Alex; Lovell, Mark R.; Choudhri, Tanvir F.			Assessing the predictive value of primary evaluation with the Immediate Post-Concussion Assessment and Cognitive Test following head injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; head injury; trauma; neuropsychological testing; ImPACT; Immediate Post Concussion Assessment and Cognitive Test; recovery; return to play; prognosis	RECOVERY; SPORT; IMPACT; SPECIFICITY; SENSITIVITY; SEVERITY	OBJECTIVE Concussions are a major public health concern, especially for high school and college student athletes. However, there are few prognostic metrics that can accurately quantify concussion severity in order to anticipate recovery time and symptom regression. The Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) is a widely used neurocognitive assessment that can diagnose and track recovery from concussions. This study assesses whether initial ImPACT scores, collected within 48 hours of the injury, can predict persistence of concussion at follow-up. METHODS Results from 6912 ImPACT tests were compiled in 2161 unique student athletes, ages 12-22 years. The authors defined a novel metric, the Severity Index (SI), which is a summation of the number of standard deviations from baseline at the 80% CI for each of the 5 composite scores reported by ImPACT. Patients were binned into groups based on SI (0-3.99, 4-7.99, 8-11.99, 12+) and the relationships between SI groups, composite scores, symptom profiles, and recovery time were characterized using 1-way and 2-way ANOVAs and Kaplan-Meier plots. A logistic regression assessed the value of SI for predicting concussion at follow-up. RESULTS Patients with a higher SI at diagnosis were more likely to still be concussed at their first follow-up (F-3(,)2300 = 93.06; p < 0.0001). Groups with a higher SI also displayed consistently slower recovery over a 42-day period and were more likely to report symptoms in all 4 symptom clusters (Migraine, Cognition, Sleep, and Neuropsychiatric). When controlling for sex, age, number of previous concussions, days between assessments, and location, SI significantly increased the odds of being concussed at follow-up (OR 1.122, 95% CI 1.088-1.142; p < 0.001). This model showed good discrimination with an area under the curve of 0.74. CONCLUSIONS SI is a useful prognostic tool for assessing head injury severity. Concussions with higher initial SI tend to last longer and have broader symptomatic profiles. These findings can help patients and providers estimate recovery based on similar ImPACT score profiles.	[Hannah, Theodore; Dreher, Nickolas; Li, Adam Y.; Shankar, Dhruv S.; Adams, Ryan; Choudhri, Tanvir F.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Gometz, Alex] Concuss Management New York, Phys Med & Rehabil, New York, NY USA; [Lovell, Mark R.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA		Dreher, N (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	nickolas.dreher@icahn.mssm.edu	Li, Adam Y./AAS-6860-2020	Li, Adam Y./0000-0001-7654-1469; Hannah, Theodore/0000-0001-6527-9725			de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Ianof Jéssica Natuline, 2014, Dement. neuropsychol., V8, P14, DOI 10.1590/S1980-57642014DN81000003; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Wolf Christopher, 2017, Mo Med, V114, P36	22	8	8	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2020	26	2					171	178		10.3171/2020.2.PEDS19709			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	NZ5UA	WOS:000577169500010	32384275	Bronze			2022-02-06	
J	Kontos, AP; Elbin, RJ; Trbovich, A; Womble, M; Said, A; Sumrok, VF; French, J; Kegel, N; Puskar, A; Sherry, N; Holland, C; Collins, M				Kontos, Anthony P.; Elbin, R. J.; Trbovich, Alicia; Womble, Melissa; Said, Azkya; Sumrok, Vanessa Fazio; French, Jonathan; Kegel, Nathan; Puskar, Alicia; Sherry, Natalie; Holland, Cyndi; Collins, Michael			Concussion Clinical Profiles Screening (CP Screen) Tool: Preliminary Evidence to Inform a Multidisciplinary Approach	NEUROSURGERY			English	Article						Clinical profiles; Concussion; mTBI; Symptoms	SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; BASE-LINE; NEUROCOGNITIVE IMPAIRMENT; HIGH-SCHOOL; SYMPTOMS; IMPACT; VALIDITY; SPECIFICITY; SENSITIVITY	BACKGROUND: Current concussion symptom inventories emphasize total number or symptoms and severity and overlap with other conditions, such as mental health disorders, which may limit their specificity and clinical utility. OBJECTIVE: To develop and test the reliability and validity of a new Concussion Clinical Profiles Screening tool (CP Screen) in both healthy controls and concussed. METHODS: CP Screen is a 29-item self-report, clinical profile-based symptom inventory that measures the following 5 concussion clinical profiles: 1) anxiety/mood, 2) cognitive/fatigue, 3) migraine, 4) ocular, and 5) vestibular; and the following 2 modifying factors: 1) sleep and 2) neck. Post-Concussion Symptom Scale (PCSS), vestibular/ocular motor screening (VOMS) tool, and Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) were conducted. CP Screen was administered in community a concussion surveillance program and 2 sports medicine concussion clinics. Responses include 248 athletes, 121 concussed, and 127 controls, enrolled between 2018 and 2019. RESULTS: Internal consistency of the CP Screen in the control (Cronbach's alpha = .87) and concussed (Cronbach's alpha = .93) samples was high. Moderate to high correlations among the CP Screen factors and PCSS factors and VOMS items, supporting concurrent validity. ROC curve analysis for identifying concussed from controls was significant (P < .001) for all CP Screen factor and modifier scores with excellent AUCs for migraine (.93), ocular (.88), vestibular (.85), and cognitive (.81) factors, demonstrating predictive validity. CONCLUSION: The CP Screen demonstrated strong reliability, concurrent validity with commonly used concussion assessment (ie, PCSS, VOMS, and ImPACT), and predictive validity for identifying concussion. The CP Screen extends current symptom inventories by evaluating more specific symptoms that may reflect clinical profiles and inform better clinical care.	[Kontos, Anthony P.; Trbovich, Alicia; Sumrok, Vanessa Fazio; French, Jonathan; Kegel, Nathan; Puskar, Alicia; Sherry, Natalie; Holland, Cyndi; Collins, Michael] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Concuss Program, Pittsburgh, PA USA; [Elbin, R. J.; Said, Azkya] Univ Arkansas, Fayetteville, AR 72701 USA; [Womble, Melissa] INOVA Sports Med Concuss Program, Dept Orthoped & Sports Med, INOVA Med Grp, Fairfax, VA USA		Kontos, AP (corresponding author), UPMC Freddie Fu Sports Med Ctr, UPMC Sports Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu					Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Iverson G, 2014, BRAIN INJ; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	33	8	8	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2020	87	2					348	355		10.1093/neuros/nyz545			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	OW8HL	WOS:000593120500093	31950187				2022-02-06	
J	Li, FX; Ducker, M; Sun, B; Szele, FG; Czernuszka, JT				Li, Fangxin; Ducker, Martin; Sun, Bin; Szele, Francis G.; Czernuszka, Jan T.			Interpenetrating polymer networks of collagen, hyaluronic acid, and chondroitin sulfate as scaffolds for brain tissue engineering	ACTA BIOMATERIALIA			English	Article						Scaffold; Subventricular zone; Collagen; Chondroitin sulfate; Hyaluronic acid	EMBRYONIC STEM-CELLS; SUBVENTRICULAR ZONE; EXTRACELLULAR-MATRIX; ADULT; CD44; PROTEOGLYCANS; IMPLANTATION; MIGRATION; HYDROGELS; RECEPTOR	Stem cells can provide neuro-protection and potentially neuro-replacement to patients suffering from traumatic brain injuries (TBI), with a practical option being delivery via engineered scaffolds. Collagen (Coll) and glycosaminoglycan (GAG) have been used as scaffolds for brain tissue engineering yet they often do not support cell differentiation and survival. In this study, we developed interpenetrating polymer network scaffolds comprising Coll, and incorporating two commonly found GAGs in the brain, chondroitin sulfate (CS) and/or hyaluronic acid (HA). We seeded these scaffolds with mouse neural stem cells from the subventricular zone (SVZ) niche. Compared to Coll-alone, all other substrates decreased the percent of nestin+ stem cells. Coll-CS-HA was more efficient at suppressing nestin expression than the other scaffolds; all SVZ cells lost nestin expression within 7 days of culture. In contrast to nestin, the percentage of microtubule associated protein 2 (MAP2+) neurons was greater in scaffolds containing, CS, HA or CS-HA, compared to Coll alone. Finally, Coll-CS increased the percentage of glial fibrillary acidic protein (GFAP+) astrocytes compared to Coll scaffolds. Overall, this work shows that Coll-HA and Coll-CS-HA scaffolds selectively enhance neurogenesis and may be advantageous in tissue engineering therapy for TBI. Statement of Significance Brain injury is devastating yet with few options for repair. Stem cells that reside in the subventricular zone (SVZ) only repair damage inefficiently due to poor control of their cellular progeny and unsuitable extracellular matrix substrates. To solve these problems, we have systematically generated collagen (Coll) scaffolds with interpenetrating polymer networks (IPN) of hyaluronic acid (HA) or chondroitin sulfate proteoglycans (CS) or both. The scaffolds had defined pore sizes, similar mechanical properties and all three stimulated neurogenesis, whereas only CS stimulated astrocyte genesis. Overall, this work suggests that Coll-HA and Coll-CS-HA scaffolds selectively enhance neurogenesis and may be advantageous in tissue engineering therapy for brain repair. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Li, Fangxin; Czernuszka, Jan T.] Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England; [Ducker, Martin; Sun, Bin; Szele, Francis G.] Univ Oxford, Dept Physiol Anat & Genet, South Parks Rd, Oxford OX1 3QX, England		Czernuszka, JT (corresponding author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.; Szele, FG (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, South Parks Rd, Oxford OX1 3QX, England.	Francis.Szele@dpag.ox.ac.uk; francis.szele@dpag.ox.ac.uk					[Anonymous], 2015, BRAIN INJ STAT; B.T. Foundation, 2015, TBI STAT FACTS TBI U; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377; Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Elias PZ, 2012, J MECH BEHAV BIOMED, V12, P63, DOI 10.1016/j.jmbbm.2012.03.014; Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003; Fujimoto T, 2001, INT IMMUNOL, V13, P359, DOI 10.1093/intimm/13.3.359; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040; Hurt-Camejo E, 1999, J BIOL CHEM, V274, P18957, DOI 10.1074/jbc.274.27.18957; Jaracz K, 2014, NEUROL NEUROCHIR POL, V48, P280, DOI 10.1016/j.pjnns.2014.07.004; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033; Koutsopoulos S, 2013, ACTA BIOMATER, V9, P5162, DOI 10.1016/j.actbio.2012.09.010; Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Le Roux P, 2016, TRANSLATIONAL RES TR; Lindwall C, 2013, BRAIN RES, V1503, P62, DOI 10.1016/j.brainres.2013.01.045; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lungu A, 2011, DIG J NANOMATER BIOS, V6, P1867; Mader KT, 2016, FARADAY DISCUSS, V187, P393, DOI 10.1039/c5fd00160a; Meissner KK, 2005, BRAIN RES, V1057, P105, DOI 10.1016/j.brainres.2005.07.057; Mizrak D, 2019, CELL REP, V26, P394, DOI 10.1016/j.celrep.2018.12.044; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ni YL, 2015, INT J BIOL MACROMOL, V74, P367, DOI 10.1016/j.ijbiomac.2014.10.058; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105; Pietrucha K, 2015, INT J BIOL MACROMOL, V80, P732, DOI 10.1016/j.ijbiomac.2015.07.005; Plepis AMD, 1996, POLYM ENG SCI, V36, P2932; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Schmitt M, 2015, CELL DEATH DIFFER, V22, P677, DOI 10.1038/cdd.2014.156; Schmitt M., 2014, ROLE CD44 WNT SS CAT, P164; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Shortkroff S, 2007, OSTEOARTHR CARTILAGE, V15, P147, DOI 10.1016/j.joca.2006.07.004; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Su WP, 2017, J BIOL CHEM, V292, P4434, DOI 10.1074/jbc.M116.774109; Sun B, 2018, CEREB CORTEX, V28, P1369, DOI 10.1093/cercor/bhx289; Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; Tamaddon M, 2013, J MATER SCI-MATER M, V24, P1153, DOI 10.1007/s10856-013-4882-9; Thomas LB, 1996, GLIA, V17, P1; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vidal BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151989; Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958	60	8	8	4	29	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	AUG	2020	112						122	135		10.1016/j.actbio.2020.05.042			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	ML5IY	WOS:000549500900010	32512215	Green Published			2022-02-06	
J	Schumacher, DJ; Martini, A; Holmboe, E; Carraccio, C; van der Vleuten, C; Sobolewski, B; Busari, J; Byczkowski, TL				Schumacher, Daniel J.; Martini, Abigail; Holmboe, Eric; Carraccio, Carol; van der Vleuten, Cees; Sobolewski, Brad; Busari, Jamiu; Byczkowski, Terri L.			Initial Implementation of Resident-Sensitive Quality Measures in the Pediatric Emergency Department: A Wide Range of Performance	ACADEMIC MEDICINE			English	Article							MEDICAL-EDUCATION; OUTCOMES; CARE; ASSOCIATION; PHYSICIANS	Purpose A lack of quality measures aligned with residents' work led to the development of resident-sensitive quality measures (RSQMs). This study sought to describe how often residents complete RSQMs, both individually and collectively, when they are implemented in the clinical environment. Method During academic year 2017-2018, categorical pediatric residents in the Cincinnati Children's Hospital Medical Center pediatric emergency department were assessed using RSQMs for acute asthma exacerbation (21 RSQMs), bronchiolitis (23 RSQMs), and closed head injury (19 RSQMs). Following eligible patient encounters, all individual RSQMs for the illnesses of interest were extracted from the health record. Frequencies of 3 performance classifications (opportunity and met, opportunity and not met, or no opportunity) were detailed for each RSQM. A composite score for each encounter was calculated by determining the proportion of individual RSQMs performed out of the total possible RSQMs that could have been performed. Results Eighty-three residents cared for 110 patients with asthma, 112 with bronchiolitis, and 77 with closed head injury during the study period. Residents had the opportunity to meet the RSQMs in most encounters, but exceptions existed. There was a wide range in the frequency of residents meeting RSQMs in encounters in which the opportunity existed. One closed head injury measure was met in all encounters in which the opportunity existed. Across illnesses, some RSQMs were met in almost all encounters, while others were met in far fewer encounters. RSQM composite scores demonstrated significant range and variation as well-asthma: mean = 0.81 (standard deviation [SD] = 0.11) and range = 0.47-1.00, bronchiolitis: mean = 0.62 (SD = 0.12) and range = 0.35-0.91, and closed head injury: mean = 0.63 (SD = 0.10) and range = 0.44-0.89. Conclusions Individually and collectively, RSQMs can distinguish variations in the tasks residents perform across patient encounters.	[Martini, Abigail] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA; [Schumacher, Daniel J.; Sobolewski, Brad; Byczkowski, Terri L.] Cincinnati Childrens Hosp Med Ctr, Pediat, Cincinnati, OH 45229 USA; [Schumacher, Daniel J.; Sobolewski, Brad; Byczkowski, Terri L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Holmboe, Eric] Accreditat Council Grad Med Educ, Chicago, IL USA; [Carraccio, Carol] Amer Board Pediat Inc, Competency Based Assessment, Chapel Hill, NC USA; [van der Vleuten, Cees] Maastricht Univ, Educ, Dept Educ Dev & Res, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Sch Hlth Profess Educ, Maastricht, Netherlands; [Busari, Jamiu] Maastricht Univ, Med Educ, Maastricht, Netherlands		Schumacher, DJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA.	daniel.schumacher@cchmc.org	Busari, Jamiu/C-9425-2018	Busari, Jamiu/0000-0002-8616-5564	Cincinnati Children's Hospital Medical Center	This study was funded by the Place Outcomes Award from Cincinnati Children's Hospital Medical Center.	Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bansal N, 2016, JAMA SURG, V151, P111, DOI 10.1001/jamasurg.2015.3637; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Cook DA, 2013, ACAD MED, V88, P162, DOI 10.1097/ACM.0b013e31827c3d78; Denson JL, 2016, JAMA-J AM MED ASSOC, V316, P2204, DOI 10.1001/jama.2016.17424; Dudek NL, 2005, ACAD MED, V80, pS84, DOI 10.1097/00001888-200510001-00023; Haan CK, 2008, ACAD MED, V83, P574, DOI 10.1097/ACM.0b013e318172318d; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heaslip Vanessa, 2012, Nurse Educ Pract, V12, P95, DOI 10.1016/j.nepr.2011.08.003; Holmboe ES, 2011, ACAD MED, V86, P460, DOI 10.1097/ACM.0b013e31820cb2a7; Iobst WF, 2010, MED TEACH, V32, P651, DOI 10.3109/0142159X.2010.500709; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Kogan JR, 2011, MED EDUC, V45, P1048, DOI 10.1111/j.1365-2923.2011.04025.x; Lau BD, 2015, JAMA SURG, V150, P813, DOI 10.1001/jamasurg.2015.0891; Mittiga Matthew R, 2010, J Grad Med Educ, V2, P571, DOI 10.4300/JGME-D-10-00106.1; Phillips RL, 2017, ANN FAM MED, V15, P140, DOI 10.1370/afm.2044; Regehr G, 2007, J SOC WORK EDUC, V43, P327, DOI 10.5175/JSWE.2007.200600607; Schumacher DJ, 2019, ACAD PEDIATR, V19, P177, DOI 10.1016/j.acap.2018.09.013; Schumacher DJ, 2018, ACAD MED, V93, P1071, DOI 10.1097/ACM.0000000000002093; Sirovich BE, 2014, JAMA INTERN MED, V174, P1640, DOI 10.1001/jamainternmed.2014.3337; Smirnova A, 2017, ACAD MED, V92, P1740, DOI 10.1097/ACM.0000000000001964; Swing SR, 2007, ACAD EMERG MED, V14, P463, DOI 10.1197/j.aem.2006.12.011; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Yin HS, 2015, J GEN INTERN MED, V30, P1363, DOI 10.1007/s11606-015-3329-z	25	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-2446	1938-808X		ACAD MED	Acad. Med.	AUG	2020	95	8					1248	1255		10.1097/ACM.0000000000003147			8	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Health Care Sciences & Services	NE8CS	WOS:000562831800047	31913878	Bronze			2022-02-06	
J	Shibahashi, K; Sugiyama, K; Tomio, J; Hoda, H; Morita, A				Shibahashi, Keita; Sugiyama, Kazuhiro; Tomio, Jun; Hoda, Hidenori; Morita, Akio			In-hospital mortality and length of hospital stay with craniotomy versus craniectomy for acute subdural hemorrhage: a multicenter, propensity score-matched analysis	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; craniotomy; craniectomy; acute subdural hemorrhage; mortality; propensity score matching; trauma	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HEMATOMA; EVACUATION; MANAGEMENT; SOFTWARE; OUTCOMES; REMOVE	OBJECTIVE The optimal surgical treatment for acute subdural hemorrhage (ASDH) remains controversial. The purpose of this study was to compare outcomes in patients who underwent craniotomy with those in patients who underwent decompressive craniectomy for the treatment of ASDH. METHODS Using the Japan Trauma Data Bank, a nationwide trauma registry, the authors identified patients aged >= 18 years with ASDH who underwent surgical evacuation after blunt head trauma between 2004 and 2015. Logistic regression analysis was used to estimate a propensity score to predict decompressive craniectomy use. They then used propensity score-matched analysis to compare patients who underwent craniotomy with those who underwent decompressive craniectomy. To identify the potential benefits and disadvantages of decompressive craniectomy among different subgroups, they estimated the interactions between treatment and the subgroups using logistic regression analysis. RESULTS Of 236,698 patients who were registered in the database, 1788 were eligible for propensity score-matched analysis. The final analysis included 514 patients who underwent craniotomy and 514 patients who underwent decompressive craniectomy. The in-hospital mortality did not differ significantly between the groups (41.6% for the craniotomy group vs 39.1% for the decompressive craniectomy group; absolute difference -2.5%; 95% CI -8.5% to 3.5%). The length of hospital stay was significantly longer in patients who underwent decompressive craniectomy (median 23 days [IQR 4-52 days] vs 30 days [IQR 7-60 days], p = 0.005). Subgroup analyses demonstrated qualitative interactions between decompressive craniectomy and the patient subgroups, suggesting that patients who were more severely injured (Glasgow Coma Scale score < 9 and probability of survival < 0.64) and those involved in high-energy injuries may be good candidates for decompressive craniectomy. CONCLUSIONS The results of this study showed that overall, decompressive craniectomy did not appear to be superior to craniotomy in ASDH treatment in terms of in-hospital mortality. In contrast, there were significant differences in the effectiveness of decompressive craniectomy between the subgroups. Thus, future studies should prioritize the identification of a subset of patients who will possibly benefit from the performance of each of the procedures.	[Shibahashi, Keita; Sugiyama, Kazuhiro; Hoda, Hidenori] Univ Tokyo, Tertiary Emergency Med Ctr, Tokyo Metropolitan Bokutoh Hosp, Tokyo, Japan; [Shibahashi, Keita; Morita, Akio] Univ Tokyo, Dept Neurol Surg, Nippon Med Sch, Tokyo, Japan; [Tomio, Jun] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Morita, Akio/0000-0002-2497-5772; Sugiyama, Kazuhiro/0000-0003-4543-3064			BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Nguyen HS, 2016, WORLD NEUROSURG, V95, P85, DOI 10.1016/j.wneu.2016.07.067; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jehan F, 2017, J TRAUMA ACUTE CARE, V83, P1148, DOI 10.1097/TA.0000000000001658; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kinoshita T, 2016, WORLD NEUROSURG, V89, P187, DOI 10.1016/j.wneu.2016.01.071; Kleiber C, 2008, USE R, P1, DOI 10.1007/978-0-387-77318-6_1; Kwon Young Sub, 2016, Korean J Neurotrauma, V12, P22, DOI 10.13004/kjnt.2016.12.1.22; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063; Tsermoulas G, 2016, WORLD NEUROSURG, V88, P569, DOI 10.1016/j.wneu.2015.10.045; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Wang SV, 2018, AM J EPIDEMIOL, V187, P1799, DOI 10.1093/aje/kwy049; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; 2006, MMWR MORB MORTAL WKL, V55, P201	30	8	8	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2020	133	2					504	513		10.3171/2019.4.JNS182660			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5TQ	WOS:000586087300027	31226690				2022-02-06	
J	Wang, JX; Li, K; Li, HJ; Ji, CY; Wu, ZY; Chen, HM; Chen, B				Wang, Juxiang; Li, Ke; Li, Hongjia; Ji, Chengyi; Wu, Ziyao; Chen, Huimin; Chen, Bin			Ultrasonographic optic nerve sheath diameter correlation with ICP and accuracy as a tool for noninvasive surrogate ICP measurement in patients with decompressive craniotomy	JOURNAL OF NEUROSURGERY			English	Article						ultrasonography; ONSD; optic nerve sheath diameter; ICP; intracranial pressure; traumatic brain injury; DC; decompressive craniotomy; trauma	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE THRESHOLDS; COMPUTED-TOMOGRAPHY; CRANIECTOMY	OBJECTIVE Increased intracranial pressure (ICP) results in enlarged optic nerve sheath diameter (ONSD). In this study the authors aimed to assess the association of ONSD and ICP in severe traumatic brain injury (TBI) after decompressive craniotomy (DC). METHODS ONSDs were measured by ocular ultrasonography in 40 healthy control adults. ICPs were monitored invasively with a microsensor at 6 hours and 24 hours after DC operation in 35 TBI patients. ONSDs were measured at the same time in these patients. Patients were assigned to 3 groups according to ICP levels, including normal (ICP <= 13 mm Hg), mildly elevated (ICP = 14-22 mm Hg), and severely elevated (ICP > 22 mm Hg) groups. ONSDs were compared between healthy control adults and TBI cases with DC. Then, the association of ONSD with ICP was analyzed using Pearson's correlation coefficient, linear regression analysis, and receiver operator characteristic curves. RESULTS Seventy ICP measurements were obtained among 35 TBI patients after DC, including 25, 27, and 18 measurements in the normal, mildly elevated, and severely elevated ICP groups, respectively. Mean ONSDs were 4.09 +/- 0.38 mm in the control group and 4.92 +/- 0.37, 5.77 +/- 0.41, and 6.52 +/- 0.44 mm in the normal, mildly elevated, and severely elevated ICP groups, respectively (p < 0.001). A significant linear correlation was found between ONSD and ICP (r = 0.771, p < 0.0001). Enlarged ONSD was a robust predictor of elevated ICP. With an ONSD cutoff of 5.48 mm (ICP > 13 mm Hg), sensitivity and specificity were 91.1% and 88.0%, respectively; a cutoff of 5.83 mm (ICP > 22 mm Hg) yielded sensitivity and specificity of 94.4% and 81.0%, respectively. CONCLUSIONS Ultrasonographic ONSD is strongly correlated with invasive ICP measurements and may serve as a sensitive and noninvasive method for detecting elevated ICP in TBI patients after DC.	[Wang, Juxiang] Xiamen Univ, Xiamen Cardiovasc Hosp, Dept Intens Care Unit, Xiamen, Fujian, Peoples R China; [Wang, Juxiang; Ji, Chengyi; Wu, Ziyao; Chen, Huimin] Fujian Univ Tradit Chinese Med, Hosp Xiamen 3, Dept Intens Care Unit, Xiamen, Fujian, Peoples R China; [Li, Ke] Xiamen Univ, Dept Intens Care Unit, Xiangan Hosp, Xiamen, Fujian, Peoples R China; [Li, Hongjia] Fujian Univ Tradit Chinese Med, Dept Neurosurg, Hosp Xiamen 3, Xiamen, Fujian, Peoples R China; [Chen, Bin] Xiamen Port Clin Xiamen Customs, 5Dept Healthcare, Xiamen, Fujian, Peoples R China		Chen, B (corresponding author), Xiamen Port Clin Xiamen Customs, Xiamen, Fujian, Peoples R China.	drchenbin@126.com		Chen, Bin/0000-0002-3152-4021	Science and Technology Benefit People Project of the Xiamen Science and Technology Bureau [3502Z20164062]; Medical Innovation Project in Fujian Province - Xiamen Health Commission [2015-CXB-48]	This work was supported by the Science and Technology Benefit People Project of the Xiamen Science and Technology Bureau (grant no. 3502Z20164062) and the Medical Innovation Project in Fujian Province funded by the Xiamen Health Commission (grant no. 2015-CXB-48).	Abou El Fadl MH, 2018, NEUROSURG CLIN N AM, V29, P213, DOI 10.1016/j.nec.2017.11.002; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen LM, 2019, BRIT J OPHTHALMOL, V103, P437, DOI 10.1136/bjophthalmol-2018-312934; Colton K, 2014, INJURY, V45, P2084, DOI 10.1016/j.injury.2014.08.041; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gao YZ, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1202-5; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Harary M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020465; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; Lele AV, 2019, NEUROSURGERY, V84, pE261, DOI 10.1093/neuros/nyy620; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Patterson DF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00278; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rajajee V, 2018, NEUROCRIT CARE, V29, P280, DOI 10.1007/s12028-018-0540-x; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Seo H, 2013, TRANSPL P, V45, P2272, DOI 10.1016/j.transproceed.2012.12.032; Stocchetti N, 2018, INTENS CARE MED, V44, P1321, DOI 10.1007/s00134-018-5251-4; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Szmygel L, 2016, CURR NEUROPHARMACOL, V14, P784, DOI 10.2174/1570159X14666160225155151	32	8	8	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2020	133	2					514	520		10.3171/2019.4.JNS183297			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5TQ	WOS:000586087300028	31323632	Bronze			2022-02-06	
J	Eagle, SR; Womble, MN; Elbin, RJ; Pan, R; Collins, MW; Kontos, AP				Eagle, Shawn R.; Womble, Melissa N.; Elbin, R. J.; Pan, Raymond; Collins, Michael W.; Kontos, Anthony P.			Concussion Symptom Cutoffs for Identification and Prognosis of Sports-Related Concussion: Role of Time Since Injury	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; symptoms; PCSS; clinical cutoffs; recovery	SLEEP DISORDERS; RECOVERY; DURATION	Background: Symptom reporting with scales such as the Post-Concussion Symptom Scale (PCSS) is one of the most sensitive markers of concussed status and/or recovery time, It is known that time from injury until initial clinic visit affects symptom presentation and recovery outcomes, but no study to date has evaluated changes in clinical cutoff scores for the PCSS based on earlier versus later clinical presentation postconcussion. Purpose: To evaluate if time since injury after sports-related concussion (SRC) affects clinical cutoff scores for total PCSS and PCSS factors in differentiating athletes with SRC from healthy controls and predicting prolonged recovery (>30 days) after SRC. Study Design: Cohort study; Level of evidence, 3. Methods: A chart review was conducted of clinical data from patients with SRC (age, 13-25 years; n = 588; female, n = 299) who presented to concussion specialty clinics. Participants were categorized on the basis of time from injury: early (<= 7 days; n = 348) and late (8-21 days; n = 240). Outcomes were total symptom severity (ie, total PCSS score) and total score for each of 4 symptom factors (cognitive/migraine/fatigue [CMF], affective, sleep, and somatic). Area under the curve (AUC) analyses were conducted using the Youden index to optimize sensitivity and specificity cutoffs. Results: In the early group, the CMF factor (cutoff, >= 7; AUC = 0.944), affective factor (cutoff, >= 1; AUC = 0.614), and total PCSS (cutoff, >= 7; AUC = 0.889) differentiated athletes with SRC from controls. In the late group, the CMF factor cutoff was reduced (cutoff, >= 4; AUC = 0.945), while the total PCSS score (cutoff, >= 7; AUC = 0.892), affective factor (cutoff, >= 1; AUC = 0.603), and sleep factor (cutoff, >= 1; AUC = 0.609) remained the same. In the early cohort, the CMF factor was the strongest predictor of protracted recovery (cutoff, >= 23; AUC = 0.717), followed by the total PCSS (cutoff, >= 39; AUC = 0.695) and affective factor (cutoff, >= 2; AUC = 0.614). The affective factor (cutoff, >= 1; AUC = 0.642) and total PCSS (cutoff, >= 35; AUC = 0.592) were significant predictors in the late cohort, but the cutoff threshold was reduced. Conclusion: The findings indicate that PCSS symptom clinical cutoffs for identifying injury and recovery prognosis change on the basis of time since injury. Specifically, the combination of CMF, affective, and sleep factors is the best differentiator of athletes with SRC from controls regardless of time since injury. Furthermore, the CMF factor is the most robust predictor of prolonged recovery if the patient is within 1 week of SRC, whereas the affective factor is the most robust predictor of prolonged recovery if the patient is within 2 to 3 weeks of SRC.	[Eagle, Shawn R.; Womble, Melissa N.; Elbin, R. J.; Pan, Raymond; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Pittsburgh, PA 15203 USA; [Eagle, Shawn R.; Womble, Melissa N.; Elbin, R. J.; Pan, Raymond; Collins, Michael W.; Kontos, Anthony P.] Univ Arkansas, Fayetteville, AR 72701 USA; [Eagle, Shawn R.; Pan, Raymond; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Freddie Fu Sports Med Ctr, Sch Med, Dept Orthopaed Surg,Concuss Program, 3850 S Water St, Pittsburgh, PA 15203 USA; [Womble, Melissa N.] INOVA Sports Med Concuss Program, Fairfax, VA USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Human Performance & Recreat, Fayetteville, AR 72701 USA		Eagle, SR (corresponding author), Univ Pittsburgh, UPMC Freddie Fu Sports Med Ctr, Sch Med, Dept Orthopaed Surg,Concuss Program, 3850 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Pardini D., 2004, BR J SPORTS MED, V38, P661; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	18	8	8	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2020	48	10					2544	2551	0363546520937291	10.1177/0363546520937291		JUL 2020	8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	MS8TC	WOS:000552084800001	32693612				2022-02-06	
J	Saikumar, J; Byrns, CN; Hemphill, M; Meaney, DF; Bonini, NM				Saikumar, Janani; Byrns, China N.; Hemphill, Matthew; Meaney, David F.; Bonini, Nancy M.			Dynamic neural and glial responses of a head-specific model for traumatic brain injury in Drosophila	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						neural injury; glial response; stress response; traumatic brain injury; Drosophila	SHOCK-PROTEIN PROTECTS; PROVIDES NEUROPROTECTION; OXIDATIVE STRESS; NEURONAL INJURY; TIME-COURSE; CELL-DEATH; EXPRESSION; HSP70; AGGREGATION; NEURODEGENERATION	Traumatic brain injury (TBI) is the strongest environmental risk factor for the accelerated development of neurodegenerative diseases. There are currently no therapeutics to address this due to lack of insight into mechanisms of injury progression, which are challenging to study in mammalian models. Here, we have de-veloped and extensively characterized a head-specific approach to TBI in Drosophila, a powerful genetic system that shares many con-served genes and pathways with humans. The Drosophila TBI (dTBI) device inflicts mild, moderate, or severe brain trauma by precise compression of the head using a piezoelectric actuator. Head -injured animals display features characteristic of mammalian TBI, including severity-dependent ataxia, life span reduction, and brain degeneration. Severe dTBI is associated with cognitive decline and transient glial dysfunction, and stimulates antioxidant, proteasome, and chaperone activity. Moreover, genetic or environmental aug-mentation of the stress response protects from severe dTBI-induced brain degeneration and life span deficits. Together, these findings present a tunable, head-specific approach for TBI in Dro-sophila that recapitulates mammalian injury phenotypes and under-scores the ability of the stress response to mitigate TBI-induced brain degeneration.	[Saikumar, Janani; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Byrns, China N.; Bonini, Nancy M.] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Hemphill, Matthew; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.; Bonini, NM (corresponding author), Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu	Saikumar, Janani/AAE-9461-2021	Bonini, Nancy/0000-0003-0226-5291; Meaney, David/0000-0002-0954-4122; Saikumar, Janani/0000-0002-8930-2472; Byrns, China/0000-0002-8091-9353	predoctoral Howard Hughes Medical Institute fellowship; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R35-NS097275, NS088176]; Paul G. Allen Frontiers group	We thank Marc Freeman, Dirk Bohmann, and Paul Taylor for sharing fly stocks. We thank Alexandra Perlegos, Ananth Srinivasan, and past members of the N.M.B. laboratory for critical input. We thank Michael Suplick and Fred Letterio (University of Pennsylvania Machine Shop) for making and modifying the fly collars. This work was supported by a predoctoral Howard Hughes Medical Institute fellowship (to J.S.); and funding from NIH Grant R35-NS097275 (to N.M.B.), the Paul G. Allen Frontiers group, and NIH Grant NS088176 (to D.F.M.).	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barnstedt O, 2016, NEURON, V89, P1237, DOI 10.1016/j.neuron.2016.02.015; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chung CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06543-0; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Eroglu B, 2014, J NEUROCHEM, V130, P626, DOI 10.1111/jnc.12781; Freeman MR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020552; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hindle SJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00414; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kim N, 2015, NEUROSCIENCE, V284, P912, DOI 10.1016/j.neuroscience.2014.11.010; Kinghorn KJ, 2016, J NEUROSCI, V36, P11654, DOI 10.1523/JNEUROSCI.4527-15.2016; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pinsonneault RL, 2011, METHODS MOL BIOL, V686, P357, DOI 10.1007/978-1-60761-938-3_17; Purice MD, 2017, ELIFE, V6, DOI 10.7554/eLife.23611; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saikumar J., PROTOCOL EXCHANGE, DOI [10.21203/rs.3.pex-949/v1, DOI 10.21203/RS.3.PEX-949/V1]; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Seidberg NA, 2003, J NEUROCHEM, V84, P514, DOI 10.1046/j.1471-4159.2003.01547.x; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Sun MK, 2017, JOVE-J VIS EXP, DOI 10.3791/55602; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Takata K, 2003, NEUROSCI LETT, V344, P87, DOI 10.1016/S0304-3940(03)00447-6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Volkenhoff A, 2015, CELL METAB, V22, P437, DOI 10.1016/j.cmet.2015.07.006; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.232; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	79	8	8	0	4	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 21	2020	117	29					17269	17277		10.1073/pnas.2003909117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MR0OZ	WOS:000553294300024	32611818	Green Published, Bronze			2022-02-06	
J	Hou, JM; Nelson, R; Mohammad, N; Mustafa, G; Plant, D; Thompson, FJ; Bose, P				Hou, Jiamei; Nelson, Rachel; Mohammad, Naweed; Mustafa, Golam; Plant, Daniel; Thompson, Floyd J.; Bose, Prodip			Effect of Simultaneous Combined Treadmill Training and Magnetic Stimulation on Spasticity and Gait Impairments after Cervical Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						ankle torque; locomotor training; magnetic stimulation; spasticity; spinal cord injury	TRAUMATIC BRAIN-INJURY; DEPENDENT ANKLE TORQUE; BODY-WEIGHT SUPPORT; INTRATHECAL BACLOFEN; ELECTRICAL-STIMULATION; NORADRENERGIC NEURONS; EPIDURAL STIMULATION; REFLEX EXCITABILITY; SUPRASPINAL CONTROL; GAMMA-MOTONEURONS	Cervical spinal cord injury (CSCI) can induce lifelong disabilities, including spasticity and gait impairments. The objective of this pre-clinical study was to evaluate the therapeutic effects of simultaneous and combined early locomotor treadmill training (Tm) and injury site magnetic stimulation (TMSsc) on spasticity and gait impairments in a rat model of C(6/7)moderate contusion SCI. The Tm training was initiated at post-injury (PI) day 8, whereas TMS treatment was added to Tm 14 days PI, and then the combined therapy (TMSTm) was continued for six weeks. Untreated CSCI animals revealed significant and enduring hindlimb spasticity (measured as velocity-dependent ankle torques and time-locked triceps surae electromyography), significant alterations in limb coordination, and significant reductions in forelimb grip strength. The TMSTm showed significantly lower spasticity, significantly more normal limb coordination (quantitated using three-dimensional (3D) kinematics and Catwalk gait analyses), and significantly greater forelimb grip strength compared with the CSCI untreated controls. In addition, three-dimensional gradient echo and diffusion tensor magnetic resonance imaging showed that TMSTm treated animals had smaller cavity volumes and better preservation of the white matter. In addition, compared with the CSCI untreated animals, the lumbar spinal cord (SC) of the treatment group revealed significant up-regulation of dopamine beta-hydroxylase, glutamic acid decarboxylase, gamma-aminobutyric acid receptor B, and brain-derived neurotrophic factor. The treatment-induced up-regulation of these molecules may have enhanced the activity-induced adaptive plasticity in the SC and contributed to normalization of pre- and post-synaptic reflex regulatory processes. In addition, the TMSTm therapy may have decreased injury-induced progressive maladaptive segmental and descending plasticity. Our data are the first to suggest that an early simultaneous combination of Tm and injury-site TMSsc application can be an effective therapy for CSCI-induced spasticity and gait impairments. These pre-clinical data demonstrated the feasibility and efficacy of a novel therapeutic strategy for SCI-induced spasticity and gait impairments.	[Hou, Jiamei; Mustafa, Golam; Thompson, Floyd J.; Bose, Prodip] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Thompson, Floyd J.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bose, Prodip] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Bose, Prodip] Univ Florida, Dept Neurol, Gainesville, FL USA; [Hou, Jiamei; Nelson, Rachel; Mohammad, Naweed; Mustafa, Golam; Thompson, Floyd J.; Bose, Prodip] North Florida South Georgia Vet Hlth Syst, BRRC, Gainesville, FL USA; [Plant, Daniel] North Florida South Georgia Vet Hlth Syst, Res Serv, Gainesville, FL USA		Bose, P (corresponding author), North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr 151, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	pkbose@ufl.edu			United States Department of Veteran Affairs Rehabilitation Research and Development Service (RRD) [B1005-R/1I01RX001005-01A2]	This work was supported by Merit Review Grant #B1005-R/1I01RX001005-01A2 (Bose), from the United States Department of Veteran Affairs Rehabilitation Research and Development Service (RR&D).	Adams MM, 2011, J SPINAL CORD MED, V34, P488, DOI 10.1179/2045772311Y.0000000028; Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Alam M, 2017, EXP NEUROL, V291, P141, DOI 10.1016/j.expneurol.2017.02.006; Alexeeva N, 2011, J SPINAL CORD MED, V34, P362, DOI 10.1179/2045772311Y.0000000018; Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Baker SN, 2017, J NEUROSCI, V37, P9778, DOI 10.1523/JNEUROSCI.3368-16.2017; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Barbeau H, 1999, ARCH PHYS MED REHAB, V80, P225, DOI 10.1016/S0003-9993(99)90126-0; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Basso DM, 2000, PHYS THER, V80, P808, DOI 10.1093/ptj/80.8.808; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Behrman AL, 2017, J NEUROL PHYS THER, V41, pS39, DOI 10.1097/NPT.0000000000000184; Benito J, 2012, Top Spinal Cord Inj Rehabil, V18, P106, DOI 10.1310/sci1802-106; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Bose PK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00258; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Crosbie J, 2014, SPINAL CORD, V52, P251, DOI 10.1038/sc.2013.158; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; Edgerton VR, 2011, EXPERT REV NEUROTHER, V11, P1351, DOI [10.1586/ERN.11.129, 10.1586/ern.11.129]; Edgerton VR, 2006, J NEUROTRAUM, V23, P560, DOI 10.1089/neu.2006.23.560; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; FUNG SJ, 1994, BRAIN RES BULL, V35, P423, DOI 10.1016/0361-9230(94)90155-4; Gladden MH, 2000, J PHYSIOL-LONDON, V527, P213, DOI 10.1111/j.1469-7793.2000.00213.x; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Guiraud D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-15; Hardin E, 2007, J REHABIL RES DEV, V44, P333, DOI 10.1682/JRRD.2007.03.0333; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema Susan, 2012, Handb Clin Neurol, V109, P259, DOI 10.1016/B978-0-444-52137-8.00016-4; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2018, JAMA NEUROL, V75, P1569, DOI 10.1001/jamaneurol.2018.2617; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; Hasegawa Y, 1995, NEUROREPORT, V7, P262, DOI 10.1097/00001756-199512290-00063; Hitzig Sander L, 2013, Top Spinal Cord Inj Rehabil, V19, P245, DOI 10.1310/sci1904-245; Hoffman Larisa, 2013, Top Spinal Cord Inj Rehabil, V19, P288, DOI 10.1310/sci1904-288; Hofstoetter US, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227057; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Hou JM, 2011, J NEUROTRAUM, V28, pA31; Hubli M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-5; Inanici F, 2018, IEEE T NEUR SYS REH, V26, P1272, DOI 10.1109/TNSRE.2018.2834339; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Jankowska E, 1998, J PHYSIOL-LONDON, V512, P521, DOI 10.1111/j.1469-7793.1998.521be.x; Jankowska E, 2000, EUR J NEUROSCI, V12, P701, DOI 10.1046/j.1460-9568.2000.00955.x; Jayaraman A, 2008, J SPINAL CORD MED, V31, P185, DOI 10.1080/10790268.2008.11760710; Kapadia Naaz, 2013, Top Spinal Cord Inj Rehabil, V19, P279, DOI 10.1310/sci1904-279; Karimi Mohammad Taghi, 2013, Eur J Orthop Surg Traumatol, V23, P631, DOI 10.1007/s00590-012-1049-1; Laliberte AM, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00512; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lee RH, 2000, J NEUROSCI, V20, P6734, DOI 10.1523/JNEUROSCI.20-17-06734.2000; Lewis MJ, 2018, J NEUROTRAUM, V35, P500, DOI 10.1089/neu.2017.5255; Li G, 2020, NEUROSCI BULL, V36, P372, DOI 10.1007/s12264-019-00442-0; Li P, 2001, BRAIN RES BULL, V54, P639, DOI 10.1016/S0361-9230(01)00470-1; LOVELY RG, 1990, BRAIN RES, V514, P206, DOI 10.1016/0006-8993(90)91417-F; Loy DN, 2002, EXP NEUROL, V177, P575, DOI 10.1006/exnr.2002.7959; Lu DC, 2016, NEUROREHAB NEURAL RE, V30, P951, DOI 10.1177/1545968316644344; Manella KJ, 2013, RESTOR NEUROL NEUROS, V31, P633, DOI 10.3233/RNN-120255; Mayr W, 2016, CURR OPIN NEUROL, V29, P721, DOI 10.1097/WCO.0000000000000382; Garcia AM, 2020, NEUROREHAB NEURAL RE, V34, P3, DOI 10.1177/1545968319893298; MEYTHALER JM, 1992, AM J PHYS MED REHAB, V71, P321, DOI 10.1097/00002060-199212000-00003; Mori F, 2011, J NEUROL, V258, P1281, DOI 10.1007/s00415-011-5924-1; Mori F, 2009, PROG BRAIN RES, V175, P429, DOI 10.1016/S0079-6123(09)17528-3; Mustafa G, 2017, NEURAL REGEN RES, V12, P981, DOI 10.4103/1673-5374.208594; National Spinal Cord Injury Statistical Center (NSCISC) T.N.S.C.I.S.C, 2019, 2018 ANN REP; Nielsen JF, 1997, MULT SCLER, V3, P18, DOI 10.1177/135245859700300103; Possover M, 2014, ARCH PHYS MED REHAB, V95, P610, DOI 10.1016/j.apmr.2013.10.030; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; Rossignol S, 2004, INTEGR COMP BIOL, V44, P71, DOI 10.1093/icb/44.1.71; Sangari S, 2019, J NEUROSCI, V39, P7872, DOI 10.1523/JNEUROSCI.1106-19.2019; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; Smania N, 2005, J NEUROL, V252, P307, DOI 10.1007/s00415-005-0642-1; Solopova IA, 2014, NEUROSCI LETT, V579, P64, DOI 10.1016/j.neulet.2014.07.015; Tazoe T, 2017, J PHYSIOL-LONDON, V595, P2715, DOI 10.1113/JP273679; Thomas SL, 2005, J NEUROPHYSIOL, V94, P2844, DOI 10.1152/jn.00532.2005; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; THOMPSON FJ, 1992, J NEUROPHYSIOL, V68, P1473, DOI 10.1152/jn.1992.68.5.1473; Thompson FJ, 1996, NEUROREPORT, V7, P2273; Tsuda S, 2016, NEUROREPORT, V27, P724, DOI 10.1097/WNR.0000000000000598; VISINTIN M, 1989, CAN J NEUROL SCI, V16, P315, DOI 10.1017/S0317167100029152; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Wang DC, 2002, J NEUROTRAUM, V19, P875, DOI 10.1089/08977150260190465; Wernig A, 1998, SPINAL CORD, V36, P744, DOI 10.1038/sj.sc.3100670; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; Wernig A, 2000, PROG BRAIN RES, V128, P89; Wernig A, 2009, BRAIN, V132, DOI 10.1093/brain/awn341; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004; Wirz M, 2006, ARCH PHYS MED REHAB, V87, P1218, DOI 10.1016/j.apmr.2006.05.024; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; YOUNG RR, 1989, NEW ENGL J MED, V320, P1553, DOI 10.1056/NEJM198906083202310; YOUNG W, 1992, J NEUROL NEUROSUR PS, V55, P635, DOI 10.1136/jnnp.55.8.635; Young W, 2015, CELL TRANSPLANT, V24, P429, DOI 10.3727/096368915X686904; Zhao C, 2017, J MED PRIMATOL, V46, P239, DOI 10.1111/jmp.12276	99	8	8	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2020	37	18					1999	2013		10.1089/neu.2019.6961		JUL 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NM7BH	WOS:000556431300001	32340533				2022-02-06	
J	De Luca, R; Portaro, S; Le Cause, M; De Domenico, C; Maggio, MG; Ferrera, MC; Giuffre, G; Bramanti, A; Calabro, RS				De Luca, Rosaria; Portaro, Simona; Le Cause, Maria; De Domenico, Carmen; Maggio, Maria Grazia; Ferrera, Maria Cristina; Giuffre, Grazia; Bramanti, Alessia; Calabro, Rocco Salvatore			Cognitive rehabilitation using immersive virtual reality at young age: A case report on traumatic brain injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						CAREN; cognitive deficits; neurorehabilitation; virtual reality	CHILDREN; INTERVENTION; ENVIRONMENT; ATTENTION	Adolescents having moderate to severe traumatic brain injury (TBI) often experience long-lasting cognitive, emotional, and behavioral problems. In current clinical practice, rehabilitation techniques to treat cognitive abnormalities may be classified in two main categories, i.e. conventional or advanced. Aim of this case study was to evaluate the safety and efficacy of an immersive virtual environment (Computer Assisted Rehabilitation Environment [CAREN]), in a young boy affected by severe TBI. A 15-year-old boy with TBI involving the right parietal-temporal region underwent two different rehabilitation trainings, including standard cognitive rehabilitation alone in a usual clinical setting (face-to-face intervention with a paper and pencil approach) or the same cognitive program using virtual scenarios by means of CAREN. We evaluated the patient's cognitive status, before and after the two different trainings, by using a specific psychometric battery to evaluate the cognitive and behavioral functioning, such as attention abilities, visuo-spatial and executive functions. Only at the end of the CAREN training, we observed a significant improvement in specific cognitive and motor domains, such as attention abilities, visuo-executive processes, emotional awareness, and balance. Cognitive training, using immersive Virtual Reality, may be a useful tool to facilitate cognitive recovery in TBI patients.	[De Luca, Rosaria; Portaro, Simona; Le Cause, Maria; De Domenico, Carmen; Maggio, Maria Grazia; Ferrera, Maria Cristina; Giuffre, Grazia; Bramanti, Alessia; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Maggio, Maria Grazia/ABA-1852-2020; Ferrera, Maria Cristina/ABH-4478-2020; Giuffre', Grazia/AAB-5311-2020	Ferrera, Maria Cristina/0000-0002-9518-058X; Giuffre', Grazia/0000-0002-4586-2355; /0000-0003-0757-2389			Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; Biffi E, 2017, METHOD INFORM MED, V56, P119, DOI 10.3414/ME16-02-0020; Calabro RS, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0268-4; De Luca R, 2018, INT J NEUROSCI, V128, P791, DOI 10.1080/00207454.2017.1403915; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Gilboa Y, 2015, BRAIN INJURY, V29, P1691, DOI 10.3109/02699052.2015.1075148; Glegg S, 2017, IEEE PULSE, V8, P3, DOI 10.1109/MPUL.2017.2750858; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Kalron A, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0124-y; Kolk A, 2019, APPL NEUROPSYCH-CHIL, V8, P326, DOI 10.1080/21622965.2018.1486193; Krysta K, 2016, PSYCHIAT DANUB, V28, pS116; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2; Maggio MG, 2018, J GERIATR PSYCH NEUR, V31, P312, DOI 10.1177/0891988718807973; Onakomaiya MM, 2017, MIL MED, V182, P128, DOI 10.7205/MILMED-D-16-00054; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Phillips NL, 2016, J NEUROTRAUM, V33, P2097, DOI 10.1089/neu.2015.4358; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Thomson J, 2001, PAY ATTENTION CHILDR; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Wade SL, 2018, J NEUROSURG SCI, V62, P187, DOI 10.23736/S0390-5616.17.04277-1; Weiss, 2011, J PHYS THER ED, V25, P59, DOI [10.1097/00001416-201110000-00011, DOI 10.1097/00001416-201110000-00011]; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	26	8	8	5	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 2	2020	9	3					282	287		10.1080/21622965.2019.1576525			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MI0RW	WOS:000547125800008	30838889				2022-02-06	
J	Ichkova, A; Rodriguez-Grande, B; Zub, E; Saudi, A; Fournier, ML; Aussudre, J; Sicard, P; Obenaus, A; Marchi, N; Badaut, J				Ichkova, Aleksandra; Rodriguez-Grande, Beatriz; Zub, Emma; Saudi, Amel; Fournier, Marie-Line; Aussudre, Justine; Sicard, Pierre; Obenaus, Andre; Marchi, Nicola; Badaut, Jerome			Early cerebrovascular and long-term neurological modifications ensue following juvenile mild traumatic brain injury in male mice	NEUROBIOLOGY OF DISEASE			English	Article						Head trauma; Pediatric; Cerebrovascular oxygenation; Blood-brain barrier; Cerebrovascular damage; Vasoreactivity; Neurological sequel	CEREBRAL-BLOOD-FLOW; NEUROVASCULAR UNIT; BARRIER; CONCUSSION; MODEL; PATHOPHYSIOLOGY; VASCULATURE; DYSFUNCTION; PROGRESSION; CHILDREN	Clinical evidence suggests that a mild traumatic brain injury occurring at a juvenile age (jmTBI) may be sufficient to elicit pathophysiological modifications. However, clinical reports are not adequately integrated with experimental studies examining brain changes occurring post-jmTBI. We monitored the cerebrovascular modifications and assessed the long-term behavioral and electrographic changes resulting from experimental jmTBI. In vivo photoacoustic imaging demonstrated a decrease of cerebrovascular oxygen saturation levels in the impacted area hours post-jmTBI. Three days post-jmTBI oxygenation returned to pre-jmTBI levels, stabilizing at 7 and 30 days after the injury. At the functional level, cortical arterioles displayed no NMDA vasodilation response, while vasoconstriction induced by thromboxane receptor agonist was enhanced at 1 day post-jmTBI. Arterioles showed abnormal NMDA vasodilation at 3 days post-jmTBI, returning to normality at 7 days post injury. Histology showed changes in vessel diameters from 1 to 30 days post-jmTBI. Neurological evaluation indicated signs of anxiety-like behavior up to 30 days post-jmTBI. EEG recordings performed at the cortical site of impact 30 days post-jmTBI did not indicate seizures activity, although it revealed a reduction of gamma waves as compared to age matched sham. Histology showed decrease of neuronal filament staining. In conclusion, experimental jmTBI triggers an early cerebrovascular hypo-oxygenation in vivo and faulty vascular reactivity. The exact topographical coherence and the direct casualty between early cerebrovascular changes and the observed long-term neurological modifications remain to be investigated. A potential translational value for cerebro-vascular oxygen monitoring in jmTBI is discussed.	[Ichkova, Aleksandra; Rodriguez-Grande, Beatriz; Fournier, Marie-Line; Aussudre, Justine; Obenaus, Andre; Badaut, Jerome] Univ Bordeaux, CNRS UMR5287, Bordeaux, France; [Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA; [Obenaus, Andre; Badaut, Jerome] Loma Linda Univ, Sch Med, Basic Sci Dept, Loma Linda, CA USA; [Obenaus, Andre] UC Riverside, Div Biomed Sci, Ctr Glial Neuronal Interact, Riverside, CA USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Zub, Emma; Saudi, Amel; Marchi, Nicola] Univ Montpellier, Inst Funct Genom, Dept Neurosci, Cerebrovasc & Glia Res Lab,UMR 5203,CNRS,U1191,IN, Montpellier, France; [Sicard, Pierre] Univ Montpellier, IPAM, PhyMedExp, CNRS,INSERM, Montpellier, France		Badaut, J (corresponding author), Bordeaux Univ, Brain Mol Imaging Grp, CNRS UMR 5287, 146 Rue Leo Saignat, F-33076 Bordeaux, France.; Marchi, N (corresponding author), Univ Montpellier, Cerebrovasc & Glia Res, Inst Funct Genom, CNRS UMR5203,INSERM U1191, 141 Rue Cardonille, F-34094 Montpellier 5, France.	nicola.marchi@igf.cnrs.fr; jerome.badaut@u-bordeaux.fr	Sicard, Pierre/N-7310-2018; Marchi, Nicola/J-8607-2016	Sicard, Pierre/0000-0001-5837-3916; Marchi, Nicola/0000-0001-9124-0226; Fournier, Marie-Line/0000-0001-7183-8132	Eranet neuron CNS-aflame TRAIN; BIS-Idex; TRAIL-Labex ANRFrench National Research Agency (ANR); Foundation des gueules cassees; Idex; grant RETP from the Fondation LeducqLeducq Foundation; ANR-EpicyteFrench National Research Agency (ANR); Neu-Vasc ANR/Eranet	This study was supported by grants Eranet neuron CNS-aflame & TRAIN, BIS-Idex, TRAIL-Labex ANR (JB), Foundation des gueules cassees (AI, JB), Idex funding (AO, JB), ANR-Epicyte (NM), Neu-Vasc ANR/Eranet (JB, NM) and grant RETP from the Fondation Leducq.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, NEUROL RES, V33, P133, DOI 10.1179/016164111X12881719352174; Armstead WM, 2011, NEUROL RES, V33, P127, DOI 10.1179/016164111X12881719352138; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Bajwa NM, 2019, J NEUROSCI RES, V97, P332, DOI 10.1002/jnr.24343; Bar-Klein G, 2017, BRAIN, V140, P1692, DOI 10.1093/brain/awx073; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Blanco VM, 2008, AM J PHYSIOL-HEART C, V294, pH2855, DOI 10.1152/ajpheart.91451.2007; Boussadia B, 2016, EXP NEUROL, V283, P39, DOI 10.1016/j.expneurol.2016.05.018; Boussadia B, 2018, NEUROSCIENCE, V370, P130, DOI 10.1016/j.neuroscience.2017.07.038; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Clement T., 2020, JUVENILE MILD TRAUMA, V68, DOI [10.1002/glia.23736, DOI 10.1002/GLIA.23736]; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Giannoni P, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00003; Giannoni P, 2018, CLIN SCI, V132, P361, DOI 10.1042/CS20171634; Giannoni P, 2016, NEUROBIOL DIS, V88, P107, DOI 10.1016/j.nbd.2016.01.001; Girard B, 2019, NEUROBIOL DIS, V129, P13, DOI 10.1016/j.nbd.2019.04.016; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Ichkova A, 2017, NEUROCHEM INT, V111, P93, DOI 10.1016/j.neuint.2017.03.022; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Jullienne A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22268-y; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kitchigina VF, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00036; Klement W, 2019, EPILEPSIA, V60, P1399, DOI 10.1111/epi.16019; Klement W, 2018, NEUROBIOL DIS, V113, P70, DOI 10.1016/j.nbd.2018.02.002; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Librizzi L, 2018, NEUROSCI LETT, V667, P75, DOI 10.1016/j.neulet.2017.01.013; Long JA, 2015, J CEREBR BLOOD F MET, V35, P1852, DOI 10.1038/jcbfm.2015.143; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mably AJ, 2018, CURR OPIN NEUROBIOL, V52, P182, DOI 10.1016/j.conb.2018.07.009; Marchi N, 2013, NEUROSCIENTIST, V19, P304, DOI 10.1177/1073858412462747; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McEvoy H, 2020, CEPHALALGIA, V40, P701, DOI 10.1177/0333102419896754; Miyauchi T, 2013, J NEUROTRAUM, V30, P1664, DOI 10.1089/neu.2013.2995; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tomkins O., 2011, PSYCHIAT NEUROL, V2011; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980; Zub E, 2019, FASEB J, V33, P13998, DOI 10.1096/fj.201901596R	65	8	8	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2020	141								104952	10.1016/j.nbd.2020.104952			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MC0EQ	WOS:000542971000025	32442681	hybrid, Green Submitted			2022-02-06	
J	Ling, DI; Cheng, J; Santiago, K; Ammerman, B; Jivanelli, B; Hannafin, J; Casey, E				Ling, Daphne I.; Cheng, Jennifer; Santiago, Kristen; Ammerman, Brittany; Jivanelli, Bridget; Hannafin, Jo; Casey, Ellen			Women Are at Higher Risk for Concussions Due to Ball or Equipment Contact in Soccer and Lacrosse	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							STATES HIGH-SCHOOL; ICE HOCKEY; SEX-DIFFERENCES; INJURY SURVEILLANCE; DIVISION I; HEAD; EPIDEMIOLOGY; SPORT; NECK; ACTIVATION	Background There is ample evidence to suggest sex- and gender-based differences in the incidence of sports-related concussions. The mechanisms of concussion may vary between male and female athletes and contribute to this observed difference. Understanding the underlying etiology by pooling data from primary studies across different settings and sport types will inform interventions that can reduce concussion rates. Questions/purposes Specifically, we asked: (1) In which sports are female athletes less likely to experience concussions from player contact? (2) In which sports are female athletes more likely to experience concussions because of ball or equipment contact? Methods PubMed, EMBASE, and Cochrane Library databases were searched to identify articles published from January 2000 to December 2018. Ten studies met the inclusion criteria, which were studies that reported concussion incidence by mechanism for both male and female athletes. Exclusion criteria included non-English studies, conference abstracts, and studies on non-sports related concussions. The sports represented by the 10 studies included ice hockey (n = 4), soccer (n = 5), basketball (n = 4), baseball/softball (n = 4), and lacrosse (n = 5). The rate ratio was calculated as the incidence rate in female athletes/male athletes for each concussion mechanism or activity. Data were pooled using the DerSimonian-Laird random-effects model. Study quality was assessed with the Newcastle-Ottawa Scale. Results Female athletes were at lower risk of player-contact-induced concussions in lacrosse (pooled rate ratio 0.33 [95% CI 0.25 to 0.43]; p < 0.001), basketball (pooled rate ratio 0.86 [95% CI 0.76 to 0.97]; p = 0.01), ice hockey (pooled rate ratio 0.64 [95% CI 0.56 to 0.73]; p < 0.001), soccer (pooled rate ratio 0.70 [95% CI 0.66 to 0.75]; p < 0.001), and soccer heading (pooled rate ratio 0.80 [95% CI 0.72 to 0.90]; p < 0.001); in these sports, men were at higher risk of concussions from player contact. Female athletes were more likely to experience concussions because of ball or equipment contact in lacrosse (pooled rate ratio 3.24 [95% CI 2.10 to 4.99]; p < 0.001), soccer (pooled rate ratio 2.04 [95% CI 1.67 to 2.49]; p < 0.001), and soccer heading (pooled rate ratio 2.63 [95% CI 1.84 to 3.77]; p < 0.001). Conclusions The mechanism or activity underlying concussions differs between male and female athletes across different sports. This finding remains the same regardless of whether there are rule differences between the men's and women's games. The implementation of other interventions are required to further ensure player safety, including protective head equipment, concussion prevention training, or rules limiting player contact in the men's game.	[Ling, Daphne I.; Hannafin, Jo] Hosp Special Surg, Sports Med Inst, 535 E 70th St, New York, NY 10021 USA; [Ling, Daphne I.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Cheng, Jennifer; Santiago, Kristen; Ammerman, Brittany; Casey, Ellen] Hosp Special Surg, Physiatry Serv, 535 E 70th St, New York, NY 10021 USA; [Jivanelli, Bridget] Hosp Special Surg, Kim Barrett Mem Lib, 535 E 70th St, New York, NY 10021 USA		Ling, DI (corresponding author), Hosp Special Surg, 535 East 70th St, New York, NY 10021 USA.	LingD@hss.edu	Jivanelli, Bridget/Y-7342-2019	Jivanelli, Bridget/0000-0002-8707-4859			Agel J, 2010, CAN J SURG, V53, P319; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lin CY, 2018, PM&R, V10, P1073, DOI 10.1016/j.pmrj.2018.03.008; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Simmons MM, 2017, J ATHL TRAINING, V52, P776, DOI 10.4085/1062-6050-52.4.03; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	37	8	8	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2020	478	7					1469	1479		10.1097/CORR.0000000000000995			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	MM1VY	WOS:000549947700017	31651591	Bronze, Green Published			2022-02-06	
J	Rivera-Lara, L; Geocadin, R; Zorrilla-Vaca, A; Healy, R; Radzik, BR; Palmisano, C; White, MA; Sha, D; Ponce-Mejia, L; Brown, C; Hogue, CW; Ziai, WC				Rivera-Lara, Lucia; Geocadin, Romergryko; Zorrilla-Vaca, Andres; Healy, Ryan; Radzik, Batya R.; Palmisano, Caitlin; White, Mirinda A.; Sha, Dhaval; Ponce-Mejia, Luciano; Brown, Charles; Hogue, Charles W.; Ziai, Wendy C.			Near-infrared Spectroscopy-derived Cerebral Autoregulation Indices Independently Predict Clinical Outcome in Acutely Ill Comatose Patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral oximetry; cerebral perfusion; near-infrared spectroscopy; cerebral autoregulation	TRAUMATIC BRAIN-INJURY; OXYGEN-SATURATION; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; CARDIAC-SURGERY; BLOOD-PRESSURE; VALIDATION; REACTIVITY; ULTRASOUND	Objective: Outcome prediction in comatose patients with acute brain injury remains challenging. Regional cerebral oxygenation (rSO(2)) derived from near-infrared spectroscopy (NIRS) is a surrogate for cerebral blood flow and can be used to calculate cerebral autoregulation (CA) continuously at the bedside from the derived cerebral oximetry index (COx). We hypothesized that COx derived thresholds for CA are associated with outcomes in patients with acute coma from neurological injury. Methods: A prospective cohort study was conducted in 88 acutely comatose adults with heterogenous brain injury diagnoses who were continuously monitored with COx for up to 3 consecutive days. Multivariable logistic regression was performed to investigate association between averaged COx and short (in-hospital and 3 mo) and long-term (6 mo) outcomes. Results: Six month mortality rate was 62%. Median COx in nonsurvivors at hospital discharge was 0.082 [interquartile range, IQR: 0.045 to 0.160] compared with 0.042 [IQR: -0.005 to 0.110] in survivors (P=0.012). At 6 months, median COx was 0.075 [IQR: 0.27 to 0.158] in nonsurvivors compared with 0.029 [IQR: -0.015 to 0.077] in survivors (P=0.02). In the multivariable logistic regression model adjusted for confounders, average COx >= 0.05 was associated with both in-hospital mortality (adjusted odds ratio [OR]=2.9, 95% confidence interval [CI]=1.15-7.33,P=0.02), mortality at 6 months (adjusted OR=4.4, 95% CI=1.41-13.7,P=0.01), and severe disability (modified Rankin Score >= 4) at 6 months (adjusted OR=4.4, 95% CI=1.07-17.8,P=0.04). Area under the receiver operating characteristic curve for predicting mortality and severe disability at 6 months were 0.783 and 0.825, respectively. Conclusions: Averaged COx >= 0.05 is independently associated with short and long-term mortality and long-term severe disability in acutely comatose adults with neurological injury. We propose that COx >= 0.05 represents an accurate threshold to predict long-term functional outcome in acutely comatose adults.	[Rivera-Lara, Lucia; Geocadin, Romergryko; White, Mirinda A.; Sha, Dhaval; Ponce-Mejia, Luciano; Brown, Charles; Ziai, Wendy C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rivera-Lara, Lucia; Geocadin, Romergryko; Zorrilla-Vaca, Andres; Healy, Ryan; Radzik, Batya R.; Ponce-Mejia, Luciano] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Rivera-Lara, Lucia; Geocadin, Romergryko] Johns Hopkins Univ Hosp, Div Neurocrit Care, Baltimore, MD 21287 USA; [Zorrilla-Vaca, Andres; Radzik, Batya R.; Palmisano, Caitlin; Ziai, Wendy C.] Univ Valle, Sch Med, Fac Hlth, Cali, Colombia; [Hogue, Charles W.] Northwestern Univ Feinberg, Dept Anesthesiol, Sch Med, Chicago, IL USA		Rivera-Lara, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Rivera-Lara, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Rivera-Lara, L (corresponding author), Johns Hopkins Univ Hosp, Div Neurocrit Care, Baltimore, MD 21287 USA.	lriver14@jhmi.edu	Rivera-Lara, Lucia/AAX-8233-2020; Vaca, Andres Zorrilla/I-9274-2014	Rivera-Lara, Lucia/0000-0002-9053-2283; Vaca, Andres Zorrilla/0000-0001-8140-8486	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL 92259]; Medtronic/Covidien, Dublin, IR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL092259] Funding Source: NIH RePORTER	C.H. is the PI on an NIH-sponsored clinical study (R01 HL 92259). C.H. receives research funding from Medtronic/Covidien, Dublin, IR, and he serves as a consultant to Medtronic/Covidien and Ornim Medical Inc., Foxborough, MA. L.R.-L. is the PI on an American Academy of Neurology/American Brain Foundation and grant from Medtronic/Covidien, Dublin, IR. The remaining authors have no conflicts of interest to disclose.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Berg RMG, 2016, SCAND J CLIN LAB INV, V76, P88, DOI 10.3109/00365513.2015.1091495; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Buckley EM, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011009; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Burton VJ, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0464-4; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; DONEGAN JH, 1985, AM J PHYSIOL, V249, pH421, DOI 10.1152/ajpheart.1985.249.2.H421; Foster CB, 2013, PEDIATR CRIT CARE ME, V14, P587, DOI 10.1097/PCC.0b013e31828a8964; Green MS, 2016, SEMIN CARDIOTHORAC V, V20, P213, DOI 10.1177/1089253216644346; Hayashida K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0500-6; Hemphill JC, 2013, INTENS CARE MED, V39, P1489, DOI 10.1007/s00134-013-2995-8; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Hori D, 2016, INTERACT CARDIOV TH, V22, P445, DOI 10.1093/icvts/ivv371; Ito N, 2010, RESUSCITATION, V81, P1736, DOI 10.1016/j.resuscitation.2010.08.011; Kessel B, 2016, ANZ J SURG, V86, P598, DOI 10.1111/ans.13461; Kim N, 2016, J CLIN MONIT COMPUT, V30, P821, DOI 10.1007/s10877-015-9779-3; Lang EW, 2016, ACTA NEUROCHIR SUPPL, V122, P221, DOI 10.1007/978-3-319-22533-3_44; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Massaro AN, 2015, J NEUROPHYSIOL, V114, P818, DOI 10.1152/jn.00353.2015; Moerman AT, 2015, ANESTHESIOLOGY, V123, P327, DOI 10.1097/ALN.0000000000000715; Nishiyama K, 2015, RESUSCITATION, V96, P135, DOI 10.1016/j.resuscitation.2015.07.049; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Ono M, 2013, ANESTH ANALG, V116, P198, DOI 10.1213/ANE.0b013e318271fb10; Rivera-Lara L, 2017, NEUROCRIT CARE, V27, P362, DOI 10.1007/s12028-017-0421-8; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Rogers CA, 2017, BRIT J ANAESTH, V119, P384, DOI 10.1093/bja/aex182; Schmidt B, 2016, J CLIN MONIT COMPUT, V30, P367, DOI 10.1007/s10877-015-9726-3; Sorensen H, 2016, CLIN PHYSIOL FUNCT I, V36, P427, DOI 10.1111/cpf.12244; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Vegesna A, 2017, TELEMED E-HEALTH, V23, P3, DOI 10.1089/tmj.2016.0051; Vilke A, 2014, MEDICINA-LITHUANIA, V50, P263, DOI 10.1016/j.medici.2014.10.001; Vretzakis G, 2014, J THORAC DIS, V6, pS60, DOI 10.3978/j.issn.2072-1439.2013.10.22; Wang XH, 2012, ASAIO J, V58, P122, DOI 10.1097/MAT.0b013e318241abd3; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; Yoshitani K, 2002, ANESTH ANALG, V94, P586, DOI 10.1097/00000539-200203000-00020; Yousef KM, 2014, INTENS CRIT CARE NUR, V30, P346, DOI 10.1016/j.iccn.2014.05.001; Zorrilla-Vaca A, 2018, CAN J ANESTH, V65, P529, DOI 10.1007/s12630-018-1065-7	48	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2020	32	3					234	241		10.1097/ANA.0000000000000589			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	MC3TE	WOS:000543212900008	30864999	Green Accepted			2022-02-06	
J	Smith, DR; Guertler, CA; Okamoto, RJ; Romano, AJ; Bayly, PV; Johnson, CL				Smith, Daniel R.; Guertler, Charlotte A.; Okamoto, Ruth J.; Romano, Anthony J.; Bayly, Philip V.; Johnson, Curtis L.			Multi-Excitation Magnetic Resonance Elastography of the Brain: Wave Propagation in Anisotropic White Matter	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						magnetic resonance elastography; brain; stiffness; anisotropy; white matter	FAST SHEAR-WAVES; IN-VIVO; MECHANICAL-PROPERTIES; MR ELASTOGRAPHY; VISCOELASTIC PROPERTIES; STIFFNESS; TISSUE; MOTION; PARAMETERS; INVERSION	Magnetic resonance elastography (MRE) has emerged as a sensitive imaging technique capable of providing a quantitative understanding of neural microstructural integrity. However, a reliable method for the quantification of the anisotropic mechanical properties of human white matter is currently lacking, despite the potential to illuminate the pathophysiology behind neurological disorders and traumatic brain injury. In this study, we examine the use of multiple excitations in MRE to generate wave displacement data sufficient for anisotropic inversion in white matter. We show the presence of multiple unique waves from each excitation which we combine to solve for parameters of an incompressible, transversely isotropic (ITI) material: shear modulus, mu, shear anisotropy, phi, and tensile anisotropy, zeta. We calculate these anisotropic parameters in the corpus callosum body and find the mean values as mu =3.78kPa, phi =0.151, and zeta =0.099 (at 50Hz vibration frequency). This study demonstrates that multi-excitation MRE provides displacement data sufficient for the evaluation of the anisotropic properties of white matter.	[Smith, Daniel R.; Johnson, Curtis L.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA; [Guertler, Charlotte A.; Okamoto, Ruth J.; Bayly, Philip V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Romano, Anthony J.] Naval Res Lab, Code 7160, Washington, DC 20375 USA		Johnson, CL (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.	clj@udel.edu		Guertler, Charlotte/0000-0003-0605-0239	Office of Naval ResearchOffice of Naval Research [N00014-17-P-7001, N00014-18-P-7004, N00014-18-1-2018]; Delaware INBRE Program [P20-GM103446]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB027577, R01-NS055951]; National Science FoundationNational Science Foundation (NSF) [CMMI-1727412]	Office of Naval Research (Grant Nos. N00014-17-P-7001, N00014-18-P-7004, and N00014-18-1-2018; Funder ID: 10.13039/100000006).; Delaware INBRE Program (Grant No. P20-GM103446).; National Institutes of Health (Grant Nos. R01-EB027577 and R01-NS055951; Funder ID: 10.13039/501100000272).; National Science Foundation (Grant No. CMMI-1727412; Funder ID: 10.13039/100000001).	Anderson AT, 2016, J MECH BEHAV BIOMED, V59, P538, DOI 10.1016/j.jmbbm.2016.03.005; [Anonymous], 2012, REGEN MED S3, V7, pS14; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2017, J BIOMECH, V57, P146, DOI 10.1016/j.jbiomech.2017.03.025; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2016, J MECH BEHAV BIOMED, V61, P554, DOI 10.1016/j.jmbbm.2016.04.024; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Green MA, 2013, NMR BIOMED, V26, P1387, DOI 10.1002/nbm.2964; Guenthner C, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3908; Guo J, 2016, MAGN RESON MED, V75, P1537, DOI 10.1002/mrm.25740; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Johnson CL, 2016, HUM BRAIN MAPP, V37, P4221, DOI 10.1002/hbm.23314; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Klatt D, 2015, J MAGN RESON IMAGING, V42, P297, DOI 10.1002/jmri.24806; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Manduca A, 2003, MED IMAGE ANAL, V7, P465, DOI 10.1016/S1361-8415(03)00038-0; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; McGarry MDJ, 2012, MED PHYS, V39, P6388, DOI 10.1118/1.4754649; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murphy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081668; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nir G, 2015, MAGN RESON MED, V73, P1514, DOI 10.1002/mrm.25280; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; Okamoto RJ, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519840444; Oliphant TE, 2001, MAGNET RESON MED, V45, P299, DOI 10.1002/1522-2594(200102)45:2<299::AID-MRM1039>3.0.CO;2-O; Romano A, 2014, MAGN RESON MED, V72, P1755, DOI 10.1002/mrm.25067; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sandroff BM, 2017, NEURORADIOLOGY, V59, P61, DOI 10.1007/s00234-016-1767-x; Schmidt JL, 2018, J MECH BEHAV BIOMED, V79, P30, DOI 10.1016/j.jmbbm.2017.11.045; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Solamen LM, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aacb08; Testu J, 2017, J MECH BEHAV BIOMED, V74, P333, DOI 10.1016/j.jmbbm.2017.06.027; Tweten DJ, 2017, MAGN RESON MED, V78, P2360, DOI 10.1002/mrm.26600; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Yin Z., 2018, 2018 JOINT ANN M ISM	53	8	8	1	3	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JUL	2020	142	7								10.1115/1.4046199			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	MM6UQ	WOS:000550290400005	32006012	Green Published			2022-02-06	
J	Tang, SJ; Fesharaki-Zadeh, A; Takahashi, H; Nies, SH; Smith, LM; Luo, A; Chyung, A; Chiasseu, M; Strittmatter, SM				Tang, Si Jie; Fesharaki-Zadeh, Arman; Takahashi, Hideyuki; Nies, Sarah Helena; Smith, Levi M.; Luo, Anin; Chyung, Annabel; Chiasseu, Marius; Strittmatter, Stephen M.			Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Tau; Fyn; Tauopathy; Alzheimer's disease; Traumatic brain injury; Stress	POSTTRAUMATIC-STRESS-DISORDER; GLUTAMATE-RECEPTOR 5; PRION PROTEIN; BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; COGNITIVE IMPAIRMENTS; TAU PATHOLOGY; MOUSE MODELS; MILD STRESS; A-BETA	Accumulation of misfolded phosphorylated Tau (Tauopathy) can be triggered by mutations or by trauma, and is associated with synapse loss, gliosis, neurodegeneration and memory deficits. Fyn kinase physically associates with Tau and regulates subcellular distribution. Here, we assessed whether pharmacological Fyn inhibition alters Tauopathy. In P301S transgenic mice, chronic Fyn inhibition prevented deficits in spatial memory and passive avoidance learning. The behavioral improvement was coupled with reduced accumulation of phospho-Tau in the hippocampus, with reductions in glial activation and with recovery of presynaptic markers. We extended this analysis to a trauma model in which very mild repetitive closed head injury was paired with chronic variable stress over 2 weeks to produce persistent memory deficits and Tau accumulation. In this model, Fyn inhibition beginning 24 h after the trauma ended rescued memory performance and reduced phospho-Tau accumulation. Thus, inhibition of Fyn kinase may have therapeutic benefit in clinical Tauopathies.	[Tang, Si Jie; Fesharaki-Zadeh, Arman; Takahashi, Hideyuki; Nies, Sarah Helena; Smith, Levi M.; Luo, Anin; Chyung, Annabel; Chiasseu, Marius; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat Repair, Dept Neurol, 333 Cedar St, New Haven, CT 06536 USA; [Tang, Si Jie; Fesharaki-Zadeh, Arman; Takahashi, Hideyuki; Nies, Sarah Helena; Smith, Levi M.; Luo, Anin; Chyung, Annabel; Chiasseu, Marius; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat Repair, Dept Neurosci, 333 Cedar St, New Haven, CT 06536 USA; [Nies, Sarah Helena] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany; [Smith, Levi M.] Halda Therapeut, 23 Business Pk Dr, Branford, CT 06405 USA		Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat Repair, Dept Neurol, 333 Cedar St, New Haven, CT 06536 USA.; Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat Repair, Dept Neurosci, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Tang, Si Jie/0000-0001-5136-7353	Falk Medical Research Trust; Boehringer Ingelheim FondsBoehringer Ingelheim	This work was supported by grants from the Falk Medical Research Trust and from the N.I.H. to S.M.S. S.H.N received a predoctoral fellowship from Boehringer Ingelheim Fonds.	Apicco DJ, 2018, NAT NEUROSCI, V21, P72, DOI 10.1038/s41593-017-0022-z; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dejanovic B, 2018, NEURON, V100, P1322, DOI 10.1016/j.neuron.2018.10.014; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Haas LT, 2017, CELL REP, V20, P76, DOI 10.1016/j.celrep.2017.06.023; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Karisetty BC, 2017, NEUROSCIENCE, V356, P89, DOI 10.1016/j.neuroscience.2017.05.020; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Klein ZA, 2017, NEURON, V95, P281, DOI 10.1016/j.neuron.2017.06.026; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lau DHW, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0317-4; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee S, 2019, J NEUROSCI, V39, P1910, DOI 10.1523/JNEUROSCI.2983-18.2018; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; McAteer Kelly M, 2017, Concussion, V2, pCNC32, DOI 10.2217/cnc-2016-0031; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nygaard HB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0119-0; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Ostrander MM, 2006, ENDOCRINOLOGY, V147, P2008, DOI 10.1210/en.2005-1041; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rush T, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104668; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Salazar SV, 2019, J NEUROSCI, V39, P758, DOI 10.1523/JNEUROSCI.1873-18.2018; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Smith LM, 2018, NEUROPHARMACOLOGY, V130, P54, DOI 10.1016/j.neuropharm.2017.11.042; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Takahashi H, 2017, ACTA NEUROPATHOL, V133, P785, DOI 10.1007/s00401-017-1668-z; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; van Dyck CH, 2019, JAMA NEUROL, V76, P1219, DOI 10.1001/jamaneurol.2019.2050; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Wen GH, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00287; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zou YX, 2015, J NEUROSCI, V35, P10429, DOI 10.1523/JNEUROSCI.1718-15.2015	72	8	8	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	JUL 1	2020	8	1							96	10.1186/s40478-020-00976-9			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MH7PW	WOS:000546917200001	32611392	gold, Green Published			2022-02-06	
J	Asoa, T; Sugiharaa, G; Muraia, T; Ubukataa, S; Urayamaa, S; Uenoa, T; Fujimotoa, G; Thuya, DHD; Fukuyamaa, H; Uedaa, K				Asoa, Toshihiko; Sugiharaa, Genichi; Muraia, Toshiya; Ubukataa, Shiho; Urayamaa, Shin-ichi; Uenoa, Tsukasa; Fujimotoa, Gaku; Dinh Ha Duy Thuya; Fukuyamaa, Hidenao; Uedaa, Keita			A venous mechanism of ventriculomegaly shared between traumatic brain injury and normal ageing	BRAIN			English	Article						brain ageing; normal pressure hydrocephalus; traumatic brain injury; venous drainage; ventricular enlargement	NORMAL-PRESSURE HYDROCEPHALUS; PULSE-WAVE ENCEPHALOPATHY; CHRONIC SUBDURAL-HEMATOMA; ALZHEIMERS-DISEASE; BLOOD-FLOW; ATROPHY; AGE; MRI; MORPHOLOGY; DIAGNOSIS	Recently, age-related timing dissociation between the superficial and deep venous systems has been observed; this was particularly pronounced in patients with normal pressure hydrocephalus, suggesting a common mechanism of ventriculomegaly. Establishing the relationship between venous drainage and ventricular enlargement would be clinically relevant and could provide insight into the mechanisms underlying brain ageing. To investigate a possible link between venous drainage and ventriculomegaly in both normal ageing and pathological conditions, we compared 225 healthy subjects (137 males and 88 females) and 71 traumatic brain injury patients of varying ages (53 males and 18 females) using MRI-based volumetry and a novel perfusion-timing analysis. Volumetry, focusing on the CSF space, revealed that the sulcal space and ventricular size presented different lifespan profiles with age; the latter presented a quadratic, rather than linear, pattern of increase. The venous timing shift slightly preceded this change, supporting a role for venous drainage in ventriculomegaly. In traumatic brain injury, a small but significant disease effect, similar to idiopathic normal pressure hydrocephalus, was found in venous timing, but it tended to decrease with age at injury, suggesting an overlapping mechanism with normal ageing. Structural bias due to, or a direct causative role of ventriculomegaly was unlikely to play a dominant role, because of the low correlation between venous timing and ventricular size after adjustment for age in both patients and controls. Since post-traumatic hydrocephalus can be asymptomatic and occasionally overlooked, the observation suggested a link between venous drainage and CSF accumulation. Thus, hydrocephalus, involving venous insufficiency, may be a part of normal ageing, can be detected non-invasively, and is potentially treatable. Further investigation into the clinical application of this new marker of venous function is therefore warranted.	[Asoa, Toshihiko; Sugiharaa, Genichi; Muraia, Toshiya; Ubukataa, Shiho; Uenoa, Tsukasa; Fujimotoa, Gaku; Uedaa, Keita] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Asoa, Toshihiko] RIKEN, Ctr Biosyst Dynam Res, Lab Brain Connect Imaging, Kobe, Hyogo, Japan; [Asoa, Toshihiko; Urayamaa, Shin-ichi; Dinh Ha Duy Thuya; Fukuyamaa, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Sugiharaa, Genichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Psychiat & Behav Sci, Tokyo, Japan; [Ubukataa, Shiho] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Urayamaa, Shin-ichi; Dinh Ha Duy Thuya; Fukuyamaa, Hidenao] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res & Educ Unit Leaders Integrated Med Syst, Kyoto, Japan		Asoa, T (corresponding author), RIKEN, Ctr Biosyst Dynam Res, Lab Brain Connect Imaging, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	aso.toshihiko@gmail.com	Aso, Toshihiko/C-2798-2018	Aso, Toshihiko/0000-0003-4814-089X	Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [JP15H05875, JP16H06395, JP16H06397, 19K09480]; Takeda Science FoundationTakeda Science Foundation (TSF); JSPSMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [17K10327, 150502-02]; General Insurance Association of Japan; Brain/MINDS-beyond from the Japan Agency for Medical Research and Development (AMED) [JP19dm0307004, JP19dm0307006]	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas (JP15H05875, JP16H06395, and JP16H06397) and a Grant-in-Aid for Scientific Research C (19K09480) from the Japan Society for the Promotion of Science (JSPS) and the Takeda Science Foundation awarded to T.A. This work was also supported by an Industrial Disease Clinical Research Grant (150502-02) awarded to T.M. and a Health Labor Sciences Research Grant, a Grantin-Aid for C (17K10327) from the JSPS, and a research grant from the General Insurance Association of Japan awarded to K.U. and Brain/MINDS-beyond from the Japan Agency for Medical Research and Development (AMED) (Grant Number JP19dm0307004 and JP19dm0307006).	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Amemiya S, 2014, RADIOLOGY, V270, P548, DOI 10.1148/radiol.13130982; Andeweg J, 1996, NEURORADIOLOGY, V38, P621, DOI 10.1007/s002340050321; ANDEWEG J, 1991, J NEUROL NEUROSUR PS, V54, P830, DOI 10.1136/jnnp.54.9.830; Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashraf A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00065; Aso T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222787; Aso T, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00256; Bateman GA, 2008, AM J NEURORADIOL, V29, P198, DOI 10.3174/ajnr.A0739; Bateman GA, 2004, MED HYPOTHESES, V62, P182, DOI 10.1016/S0306-9877(03)00330-X; Bateman GA, 2003, NEURORADIOLOGY, V45, P65, DOI 10.1007/s00234-002-0901-0; Bateman GA, 2008, NEURORADIOLOGY, V50, P491, DOI 10.1007/s00234-008-0374-x; Bateman GA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-11; Beggs CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-142; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Brautigam K, 2019, J CLIN NEUROSCI, V61, P10, DOI 10.1016/j.jocn.2018.10.147; Christen T, 2015, J MAGN RESON IMAGING, V41, P424, DOI 10.1002/jmri.24558; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; CORKIN S, 1989, J NEUROSCI, V9, P3876; Dagain A, 2008, CLIN ANAT, V21, P389, DOI 10.1002/ca.20635; De Vis JB, 2018, J MAGN RESON IMAGING, V47, P1091, DOI 10.1002/jmri.25833; DELEON MJ, 1987, NEUROBIOL AGING, V8, P319, DOI 10.1016/0197-4580(87)90070-4; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; FOGELHOLM R, 1975, J NEUROSURG, V42, P43, DOI 10.3171/jns.1975.42.1.0043; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; FUJISHIMA M, 1979, GERONTOLOGY, V26, P104; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Iseki C, 2014, J NEUROL SCI, V339, P108, DOI 10.1016/j.jns.2014.01.033; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Keong NCH, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16194; Kuriyama N, 2008, ANN NEUROL, V64, P217, DOI 10.1002/ana.21410; Kuriyama N, 2011, J NEUROIMAGING, V21, P365, DOI 10.1111/j.1552-6569.2011.00592.x; Le TT, 2012, AM J NEURORADIOL, V33, P61, DOI 10.3174/ajnr.A2761; Liao CC, 2017, MED HYPOTHESES, V108, P108, DOI 10.1016/j.mehy.2017.08.004; Lou DD, 2018, MOL NEUROBIOL, V55, P4928, DOI 10.1007/s12035-017-0687-z; Lv YT, 2013, ANN NEUROL, V73, P136, DOI 10.1002/ana.23763; Mazaika P. K., 2009, NEUROLMAGE S1, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Mihara F, 2003, MAGN RESON IMAGING, V21, P33, DOI 10.1016/S0730-725X(02)00629-X; MOODY DM, 1995, RADIOLOGY, V194, P469, DOI 10.1148/radiology.194.2.7824728; Namiki J., 2007, J JPN SOC EMERG MED, V10, P20; Narita W, 2016, AM J NEURORADIOL, V37, P1831, DOI 10.3174/ajnr.A4838; Nishida S, 2019, NEUROSURGERY, V85, P680, DOI 10.1093/neuros/nyy434; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; PORTNOY HD, 1994, CHILD NERV SYST, V10, P29, DOI 10.1007/BF00313582; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Relkin N, 2005, NEUROSURGERY, V57, pii, DOI DOI 10.1227/01.NEU; Ringstad G, 2017, BRAIN, V140, P2691, DOI 10.1093/brain/awx191; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Santini F, 2008, J MAGN RESON IMAGING, V28, P646, DOI 10.1002/jmri.21499; Satow T, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00387; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Thompson PM, 2003, J NEUROSCI, V23, P994; Tong YJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00787; Tong YJ, 2017, J CEREBR BLOOD F MET, V37, P564, DOI 10.1177/0271678X16631755; Tong YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106004; Tong YJ, 2012, NEUROIMAGE, V61, P1419, DOI 10.1016/j.neuroimage.2012.03.009; Virhammar J, 2014, J CEREBR BLOOD F MET, V34, P1771, DOI 10.1038/jcbfm.2014.138; Yau WYW, 2015, LANCET NEUROL, V14, P804, DOI 10.1016/S1474-4422(15)00135-0	70	8	9	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUN	2020	143		6				1843	1856		10.1093/brain/awaa125			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MA3AA	WOS:000541788700028	32372102	Green Published, hybrid			2022-02-06	
J	Baugh, CM; Meehan, WP; McGuire, TG; Hatfield, LA				Baugh, Christine M.; Meehan, William P.; McGuire, Thomas G.; Hatfield, Laura A.			Staffing, Financial, and Administrative Oversight Models and Rates of Injury in Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						medical model; medical autonomy; health policy; medical coverage; risk management	CONCUSSION-MANAGEMENT; QUALITY; SPORTS; WORK; CARE; ANTECEDENTS; PREVENTION; TRAINERS	Context: Structural features of health care environments are associated with patient health outcomes, but these relationships are not well understood in sports medicine. Objective: To evaluate the association between athlete injury outcomes and structural measures of health care at universities: (1) clinicians per athlete, (2) financial model of the sports medicine department, and (3) administrative reporting structure of the sports medicine department. Design: Descriptive epidemiology study. Setting: Collegiate sports medicine programs. Patients or Other Participants: Colleges that contribute data to the National Collegiate Athletic Association (NCAA) Injury Surveillance Program. Main Outcome Measure(s): We combined injury data from the NCAA Injury Surveillance Program, sports medicine staffing data from NCAA Research, athletic department characteristics from the United States Department of Education, and financial and administrative oversight model data from a previous survey. Rates of injury, reinjury, concussion, and time loss (days) in NCAA athletes. Results: Compared with schools that had an average number of clinicians per athlete, schools 1 standard deviation above average had a 9.5% lower injury incidence (103.6 versus 93.7 per 10000 athlete-exposures [AEs]; incidence rate ratio [IRR] = 0.905, P < .001), 2.7% lower incidence of reinjury (10.6 versus 10.3 per 10000 AEs; IRR = 0.973, P= .004), and 6.7% lower incidence of concussion (6.1 versus 5.7 per 10000 AEs; IRR = 0.933, P < .001). Compared with the average, schools that had 1 standard deviation more clinicians per athlete had 16% greater injury time loss (5.0 days versus 4.2 days; IRR = 1.16, P < .001). At schools with sports medicine departments financed by or reporting to the athletics department (or both), athletes had higher injury incidences (31% and 9%, respectively). Conclusions: The financial and reporting structures of collegiate sports medicine departments as well as the number of clinicians per athlete were associated with injury risk. Increasing the number of sports medicine clinicians on staff and structuring sports medicine departments such that they are financed by and report to a medical institution may reduce athlete injury incidence.	[Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Sports Concuss Clin, Boston, MA USA; [McGuire, Thomas G.; Hatfield, Laura A.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [McGuire, Thomas G.; Hatfield, Laura A.] Univ Colorado, Ctr Bioeth & Humanities, Sch Med, Dept Med,Div Gen Internal Med, Aurora, CO 80045 USA		Baugh, CM (corresponding author), Univ Colorado, 13080 East 19th Ave,CB B137, Aurora, CO 80045 USA.	christine.baugh@cuanschutz.edu	Hatfield, Laura A./I-6835-2019	Hatfield, Laura A./0000-0003-0366-3929	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; National College Athletic Association (NCAA)	This work was supported by the National Institute of Mental Health Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA Injury Surveillance Program. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes. We would also like to thank the athletic trainers who participated in the telephone survey on sports medicine staffing. This publication contains materials created, compiled or produced by the Datalys Center for Sports Injury Research and Prevention, Inc. on behalf of the National Collegiate Athletic Association. All rights reserved. The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the National College Athletic Association (NCAA). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA.	[Anonymous], TYP HLTH CAR QUAL ME; [Anonymous], EQ ATHL DAT AN; Baugh CM, 2020, J ATHL TRAINING, V55, P587, DOI 10.4085/1062-6050-0464.19; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Committee on Competitive Safeguards and Medical Aspects of Sport, IND MED CAR LEG BRIE; DeFreese JD, 2016, J ATHL TRAINING, V51, P28, DOI 10.4085/1062-6050-51.2.05; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Finch CF, 2012, BRIT J SPORT MED, V46, P70, DOI 10.1136/bjsports-2011-090329; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Gallucci AR, 2017, J ATHL TRAINING, V52, P785, DOI 10.4085/1062-6050-52.3.16; Goodman A, 2017, J ATHL TRAINING, V52, P23, DOI 10.4085/1062-6050-51.12.24; Grindem H, 2016, BRIT J SPORT MED, V50, P804, DOI 10.1136/bjsports-2016-096031; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Mazerolle SM, 2008, J ATHL TRAINING, V43, P505, DOI 10.4085/1062-6050-43.5.505; Mazerolle SM, 2011, J ATHL TRAINING, V46, P194, DOI 10.4085/1062-6050-46.2.194; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Rapp GC, 2019, J ATHL TRAINING, V54, P1237, DOI 10.4085/1062-6050-83-19	25	8	8	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2020	55	6					580	586		10.4085/1062-6050-0517.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK4ZE	WOS:000566740300004	32348154	Green Published, gold			2022-02-06	
J	Dalamagkas, K; Tsintou, M; Rathi, Y; O'Donnell, LJ; Pasternak, O; Gong, X; Zhu, A; Savadjiev, P; Papadimitriou, GM; Kubicki, M; Yeterian, EH; Makris, N				Dalamagkas, Kyriakos; Tsintou, Magdalini; Rathi, Yogesh; O'Donnell, Lauren J.; Pasternak, Ofer; Gong, Xue; Zhu, Anne; Savadjiev, Peter; Papadimitriou, George M.; Kubicki, Marek; Yeterian, Edward H.; Makris, Nikos			Individual variations of the human corticospinal tract and its hand-related motor fibers using diffusion MRI tractography	BRAIN IMAGING AND BEHAVIOR			English	Article						Two-tensor tractography; Diffusion tensor imaging; Corticospinal tract; Neural repair; Quantification	WHITE-MATTER; INTERNAL CAPSULE; PYRAMIDAL TRACT; ARCUATE FASCICULUS; IN-VIVO; ARTERIOVENOUS-MALFORMATIONS; IMAGING TRACTOGRAPHY; DTI TRACTOGRAPHY; BRAIN-TUMORS; EXACT ORIGIN	The corticospinal tract (CST) is one of the most well studied tracts in human neuroanatomy. Its clinical significance can be demonstrated in many notable traumatic conditions and diseases such as stroke, spinal cord injury (SCI) or amyotrophic lateral sclerosis (ALS). With the advent of diffusion MRI and tractography the computational representation of the human CST in a 3D model became available. However, the representation of the entire CST and, specifically, the hand motor area has remained elusive. In this paper we propose a novel method, using manually drawn ROIs based on robustly identifiable neuroanatomic structures to delineate the entire CST and isolate its hand motor representation as well as to estimate their variability and generate a database of their volume, length and biophysical parameters. Using 37 healthy human subjects we performed a qualitative and quantitative analysis of the CST and the hand-related motor fiber tracts (HMFTs). Finally, we have created variability heat maps from 37 subjects for both the aforementioned tracts, which could be utilized as a reference for future studies with clinical focus to explore neuropathology in both trauma and disease states.	[Dalamagkas, Kyriakos; Tsintou, Magdalini] Harvard Med Sch, Brigham & Womens Hosp, Surg Planning Lab, 1249 Boylston, Boston, MA 02215 USA; [Dalamagkas, Kyriakos; Tsintou, Magdalini; Rathi, Yogesh; O'Donnell, Lauren J.; Pasternak, Ofer; Savadjiev, Peter; Kubicki, Marek; Makris, Nikos] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Dalamagkas, Kyriakos] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Dalamagkas, Kyriakos] TIRR Mem Hermann Hosp, TIRR Mem Hermann Res Ctr, Houston, TX USA; [Dalamagkas, Kyriakos; Tsintou, Magdalini] UCL, Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, London, England; [Tsintou, Magdalini; Papadimitriou, George M.; Kubicki, Marek; Makris, Nikos] Massachusetts Gen Hosp, Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Ctr Neural Syst Invest,Ctr Moiphometr Anal,Dept P, Boston, MA 02129 USA; [Tsintou, Magdalini; Papadimitriou, George M.; Kubicki, Marek; Makris, Nikos] Massachusetts Gen Hosp, Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Ctr Neural Syst Invest,Ctr Moiphometr Anal,Dept N, Boston, MA 02129 USA; [Pasternak, Ofer; Savadjiev, Peter; Kubicki, Marek] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Yeterian, Edward H.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Makris, Nikos] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Makris, N (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.; Makris, N (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Ctr Neural Syst Invest,Ctr Moiphometr Anal,Dept P, Boston, MA 02129 USA.; Makris, N (corresponding author), Massachusetts Gen Hosp, Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Ctr Neural Syst Invest,Ctr Moiphometr Anal,Dept N, Boston, MA 02129 USA.; Makris, N (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	nikos@cma.mgh.harvard.edu	O'Donnell, Lauren J./ABA-7546-2020	O'Donnell, Lauren J./0000-0003-0197-7801	National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AT008865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH111917, K24MH116366, R01MH112748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG042512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA042271] Funding Source: NIH RePORTER; National Institute of Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R21DA042271] Funding Source: Medline; NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R21 AT008865, R21AT008865] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1 AG043640, R01 AG042512, R01 AG043640] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB015902] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R21 DA042271] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH111917, K24 MH116366, R01MH112748, R01MH111917, K24MH116366, R01 MH112748] Funding Source: Medline; National Institute of Aging & National Institute of Mental Health [R01AG042512] Funding Source: Medline		Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alshikho MJ, 2016, NEUROLOGY, V87, P2554, DOI 10.1212/WNL.0000000000003427; BARNARD JW, 1956, J COMP NEUROL, V105, P25, DOI 10.1002/cne.901050103; Basser Peter J., 2004, Journal of Integrative Neuroscience, V3, P227, DOI 10.1142/S0219635204000427; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baumgartner C. F., 2012, CDMRI WORKSH MICCAI; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Berman JI, 2007, J NEUROSURG, V107, P488, DOI 10.3171/JNS-07/09/0488; Berman JI, 2004, J NEUROSURG, V101, P66, DOI 10.3171/jns.2004.101.1.0066; Bernal B, 2010, ARCH NEUROL-CHICAGO, V67, P501, DOI 10.1001/archneurol.2010.59; BERTRAND G, 1965, J NEUROSURG, V22, P333, DOI 10.3171/jns.1965.22.4.0333; Betz W., 1874, CENTRALBLATT FU SPAC, V12, P595; Betz W., 1874, CBL MED WISS, V12, P595; Bouchard C, 1866, SECONDARY DEGENERATI; Bucci M, 2013, NEUROIMAGE-CLIN, V3, P361, DOI 10.1016/j.nicl.2013.08.008; Caiazzo G, 2018, NEURORADIOLOGY, V60, P497, DOI 10.1007/s00234-018-2003-7; Campbell AW, 1905, HISTOLOGICAL STUDIES; Carlson HL, 2014, EPILEPSY BEHAV, V37, P116, DOI 10.1016/j.yebeh.2014.06.020; Carpenter M.B, 1996, CARPENTERS HUMAN NEU; Catani M, 2007, BRAIN, V130, P602, DOI 10.1093/brain/awm008; Chen ZR, 2016, INT J COMPUT ASS RAD, V11, P1475, DOI 10.1007/s11548-015-1344-5; Chronister RB, 1997, FUNDAMENTAL NEUROSCI, P443; Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022; Clarke E, 1996, HUMAN BRAIN SPINAL C; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cruveilhier J, 1853, ARCH GEN MED, VV, P561; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; Dejerine J, 1895, ANATOMIE CTR NERVEUX, Vi-ii; Dini Leandro I, 2013, Surg Neurol Int, V4, P51, DOI 10.4103/2152-7806.110508; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Feng WW, 2015, ANN NEUROL, V78, P860, DOI 10.1002/ana.24510; Filippi M, 2016, DIFFUSION TENSOR IMA, P331; FINGER S., 1994, ORIGINS NEUROSCIENCE; Ford JC, 1997, MAGNET RESON MED, V37, P387, DOI 10.1002/mrm.1910370315; GALABURDA AM, 1987, NEUROPSYCHOLOGIA, V25, P853, DOI 10.1016/0028-3932(87)90091-1; Gall FJ, 1810, ANATOMIE PHYSL DU SY; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gropman AL, 1997, NEUROPEDIATRICS, V28, P198, DOI 10.1055/s-2007-973700; Hamidian S, 2018, BRAIN CONNECT, V8, P371, DOI 10.1089/brain.2018.0589; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hille B, 2001, ION CHANNELS EXCITAB, V3rd; HIRAYAMA K, 1962, NEUROLOGY, V12, P337, DOI 10.1212/WNL.12.5.337; Holmes G, 1909, BRAIN, V32, P1, DOI 10.1093/brain/32.1.1; Holodny AI, 2005, RADIOLOGY, V234, P649, DOI 10.1148/radiol.2343032087; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Itoh D, 2006, J COMPUT ASSIST TOMO, V30, P618, DOI 10.1097/00004728-200607000-00011; Jeong JW, 2015, MAGN RESON IMAGING, V33, P895, DOI 10.1016/j.mri.2015.05.003; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kilinc O, 2015, BRAIN DEV-JPN, V37, P352, DOI 10.1016/j.braindev.2014.05.003; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Kuo HC, 2017, DEV MED CHILD NEUROL, V59, P65, DOI 10.1111/dmcn.13192; KUYPERS H. G. J. M., 1964, PROGR BRAIN RES, V11, P178; KUYPERS HGJM, 1958, J COMP NEUROL, V110, P221, DOI 10.1002/cne.901100205; Lassek AM, 1939, ARCH NEURO PSYCHIATR, V42, P872, DOI 10.1001/archneurpsyc.1939.02270230094007; Le Gros Clark WE, 1959, ANTECEDENTS MAN INTR; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee DH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003317; Levin PM, 1938, J COMP NEUROL, V68, P411, DOI 10.1002/cne.900680403; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; Lu P, 2016, TRANSLATIONAL NEUROS, P297; Mai J.K., 2011, HUMAN NERVOUS SYSTEM, V3rd; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2007, NEUROIMAGE, V37, P1100, DOI 10.1016/j.neuroimage.2007.05.042; Malcolm JG, 2010, IEEE T MED IMAGING, V29, P1664, DOI 10.1109/TMI.2010.2048121; Mandelli ML, 2014, J NEUROSURG, V121, P349, DOI 10.3171/2014.4.JNS131160; Manley N. C., 2015, CELL THERAPY BRAIN I, P91, DOI [10.1007/978-3-319-15063-5_7, DOI 10.1007/978-3-319-15063-5_7]; Mikuni N, 2007, J NEUROSURG, V106, P593, DOI 10.3171/jns.2007.106.4.593; Mistichelli D, 1709, TRATTADO APOPLESSIA; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mormina E, 2015, AM J NEURORADIOL, V36, P1853, DOI 10.3174/ajnr.A4368; Nimsky C, 2016, ADV TECH STAND NEURO, V43, P37, DOI 10.1007/978-3-319-21359-0_2; Norton I, 2017, CANCER RES, V77, pE101, DOI 10.1158/0008-5472.CAN-17-0332; NYBERGHANSEN R, 1963, ACTA NEUROL SCAND, V39, P1, DOI 10.1111/j.1600-0404.1963.tb05384.x; O'Donnell LJ, 2015, SCHIZOPHR RES, V161, P133, DOI 10.1016/j.schres.2014.09.007; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Okada T, 2007, AM J NEURORADIOL, V28, P1107, DOI 10.3174/ajnr.A0493; Park JH, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0112045, 10.1371/journal.pone.0141010]; Peele TL, 1942, J COMP NEUROL, V77, P693, DOI 10.1002/cne.900770312; PELLEGRINO RG, 1984, BRAIN RES, V305, P357, DOI 10.1016/0006-8993(84)90442-6; Petersen MV, 2017, J NEUROSURG, V126, P1657, DOI 10.3171/2016.4.JNS1624; Petrou P, 2016, JAMA NEUROL, V73, P337, DOI 10.1001/jamaneurol.2015.4321; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pitres JA, 1884, RECHERCHES ANATOMO C; Pourfour du Petit F, 1710, THEORY CONTRALATERAL; Pujol S, 2015, J NEUROIMAGING, V25, P875, DOI 10.1111/jon.12283; Qazi AA, 2009, NEUROIMAGE, V47, pT98, DOI 10.1016/j.neuroimage.2008.06.034; Radmanesh A, 2015, CLIN NEUROL NEUROSUR, V129, P44, DOI 10.1016/j.clineuro.2014.11.021; Ropper A.H., 2014, ADAMS VICTORS PRINCI, V10th ed.; RUSSELL JR, 1961, NEUROLOGY, V11, P96, DOI 10.1212/WNL.11.2.96; Saporta ASD, 2011, PEDIATR NEUROL, V44, P270, DOI 10.1016/j.pediatrneurol.2010.11.006; Schafer E A, 1883, J Physiol, V4, P316; Schafer EA, 1910, Q J EXP PHYSIOL, V3, P355, DOI 10.1113/expphysiol.1910.sp000077; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Skirven TM., 2011, REHABILITATION HAND; Snow NJ, 2016, J NEUROSCI METH, V257, P109, DOI 10.1016/j.jneumeth.2015.09.025; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; T?rck L., 1852, AKAD WISSENSCH WIEN, V8, P511; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; Turck L, 1851, Z GESELLSCHAFT AERZT, P189; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van der Graaff MM, 2011, BRAIN, V134, P1211, DOI 10.1093/brain/awr016; Wassermann D, 2016, BRAIN STRUCT FUNCT, V221, P4705, DOI 10.1007/s00429-015-1179-4; Wassermann D, 2013, LECT NOTES COMPUT SC, V8149, P647, DOI 10.1007/978-3-642-40811-3_81; Weiss C, 2015, NEUROIMAGE-CLIN, V7, P424, DOI 10.1016/j.nicl.2015.01.006; Willis T, 1664, CEREBRI ANATOME CUI; YAGISHITA A, 1994, RADIOLOGY, V191, P455, DOI 10.1148/radiology.191.2.8153321; Yamada K, 2005, AM J NEURORADIOL, V26, P598; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; [No title captured]; [No title captured]; [No title captured]	121	8	8	2	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2020	14	3					696	714		10.1007/s11682-018-0006-y			19	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LV2EP	WOS:000538253100005	30617788	Green Accepted, Green Submitted			2022-02-06	
J	Nasution, RA; Islam, AA; Hatta, M; Prihantono				Nasution, Rizha Anshori; Islam, Andi Asadul; Hatta, Mochammad; Prihantono			Decreased neutrophil levels in mice with traumatic brain injury after cape administration	ANNALS OF MEDICINE AND SURGERY			English	Article						Traumatic brain injury; Myeloperoxidase; Caffeic acid phenethyl ester; Blood brain barrier	ACID PHENETHYL ESTER; MYELOPEROXIDASE; ACCUMULATION; RATS; INFLAMMATION; ISCHEMIA; TISSUE	Introduction: Peripheral leukocytes can worsen brain damage due to the release of cytotoxic mediators that interfere the blood brain barrier function. One of the oxidants released by activation leukocyte is hypochlorite acid (HOCl) which is formed through the myeloperoxidase (MPO)-H2O2-Cl- system. The neuroprotective effects of an experimental anti-inflammatory drug Caffeic Acid Phenethyl Ester (CAPE) tested in a Traumatic brain injury (TBI) model using Myeloperoxidase (MPO) analysis. Methods: This study compares the acute inflammatory response to TBI over time, as measured by MPO activity. Adult Sprague mice were treated for head trauma with marmarou model. At 24 h before trauma, all animals were blood test (n = 10) to examine MPO, then the animal was divided into 2 groups of injured animals treated with CAPE (n = 5), and those not treated with CAPE (n = 5). We used the MPO test to identify the level of polymorphonuclear leukocytes (PMNL) on day 4 and day 7. Results: Showed an increase in PMNL infiltration in CAPE untreated animals, this change significantly (P < 0.05) decreased at group of animals treated with CAPE. MPO serum activity in the CAPE untreated group vs treated with CAPE on day 4 +/- 11920410.076 (Standard deviation {SD} 895355.169) vs 6663184.485 (SD 895355.169) p < 0,05 and on day 7 +/- 14223286.992 (SD 802762.401) vs 9284222.028 (SD 953098.093) p < 0,05. These data indicate that MPO activity after TBI increases on day 4 also on day 7 and improves after being treated with CAPE. Conclusion: CAPE can reduce Neutrophil serum levels there by preventing brain damage in TBI.	[Nasution, Rizha Anshori] Pelamonia Hosp, Dept Neurosurg, Jalan Jendral Sudirman 27, Makassar 90157, Indonesia; [Nasution, Rizha Anshori] Hasanuddin Univ, Fac Med, Doctoral Program Med Sci, Makassar, Indonesia; [Islam, Andi Asadul] Hasanuddin Univ, Fac Med, Dept Neurosurg, Makassar, Indonesia; [Hatta, Mochammad] Hasanuddin Univ, Fac Med, Clin Microbiologist Program, Makassar, Indonesia; [Prihantono] Hasanuddin Univ, Dept Surg, Fac Med, Makassar, Indonesia		Nasution, RA (corresponding author), Pelamonia Hosp, Dept Neurosurg, Jalan Jendral Sudirman 27, Makassar 90157, Indonesia.	rizha_nst@yahoo.com; andiasadul@yahoo.com; hattaram@yahoo.com; prihantono.md@gmail.com	, prihantono/AAK-2259-2020; Hatta, Mochammad/D-3742-2019	, prihantono/0000-0002-8247-0457; Hatta, Mochammad/0000-0002-8456-4203			Aloutaibi G. T., 2017, African Journal of Traditional, Complementary and Alternative Medicines, V14, P138, DOI 10.21010/ajtcam.v14i5.17; Aratani Y, 2018, ARCH BIOCHEM BIOPHYS, V640, P47, DOI 10.1016/j.abb.2018.01.004; Ayla S, 2018, ACTA HISTOCHEM, V120, P117, DOI 10.1016/j.acthis.2018.01.001; Barichello T, 2012, BRAIN RES, V1471, P162, DOI 10.1016/j.brainres.2012.06.054; Branton, 2017, INT J CLIN DEV ANAT, V3, P9, DOI [10.11648/j.ijcda.20170303.11, DOI 10.11648/J.IJCDA.20170303.11]; Cetin A, 2019, FOLIA MORPHOL, V78, P221, DOI 10.5603/FM.a2018.0085; Cheng Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1153-1; Chu JJ, 2015, ENVIRON TOXICOL PHAR, V39, P683, DOI 10.1016/j.etap.2015.01.020; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; Golubinskaya V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/128046; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Horner H.C., 1992, SOC NEUR ABSTR, P173; Keep RF., 2017, PRIMER CEREBROVASCUL, P145, DOI [10.1016/B978-0-12-803058-5.00029-1, DOI 10.1016/B978-0-12-803058-5.00029-1]; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P164, DOI 10.6091/IBJ.1026.2012; Lian Hong, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1988; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Moosavi F, 2017, BIOORGAN MED CHEM, V25, P3233, DOI 10.1016/j.bmc.2017.04.026; Nussbaum C, 2013, ANTIOXID REDOX SIGN, V18, P692, DOI 10.1089/ars.2012.4783; Pravalika K, 2018, ACS CHEM NEUROSCI, V9, P421, DOI 10.1021/acschemneuro.7b00462; Salmas RE, 2017, CELL BIOCHEM FUNCT, V35, P304, DOI 10.1002/cbf.3277; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Ullen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064034; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yu GL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0583-x; Zhao C, 2019, CELL SIGNAL, V62, DOI 10.1016/j.cellsig.2019.05.010	26	8	8	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	JUN	2020	54						89	92		10.1016/j.amsu.2020.04.015			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LR5WR	WOS:000535765500020	32419943	gold, Green Published			2022-02-06	
J	Toma, M; Chan-Akeley, R; Lipari, C; Kuo, SH				Toma, Milan; Chan-Akeley, Rosalyn; Lipari, Christopher; Kuo, Sheng-Han			Mechanism of Coup and Contrecoup Injuries Induced by a Knock-Out Punch	MATHEMATICAL AND COMPUTATIONAL APPLICATIONS			English	Article						fluid-structure interaction; cerebrospinal fluid; comprehensive head model; brain; coup; contrecoup; injury; trauma	CEREBROSPINAL-FLUID; BRAIN; HEAD; BIOMECHANICS; SIMULATION	Primary Objective: The interaction of cerebrospinal fluid with the brain parenchyma in an impact scenario is studied. Research Design: A computational fluid-structure interaction model is used to simulate the interaction of cerebrospinal fluid with a comprehensive brain model. Methods and Procedures: The method of smoothed particle hydrodynamics is used to simulate the fluid flow, induced by the impact, simultaneously with finite element analysis to solve the large deformations in the brain model. Main Outcomes and Results: Mechanism of injury resulting in concussion is demonstrated. The locations with the highest stress values on the brain parenchyma are shown. Conclusions: Our simulations found that the damage to the brain resulting from the contrecoup injury is more severe than that resulting from the coup injury. Additionally, we show that the contrecoup injury does not always appear on the side opposite from where impact occurs.	[Toma, Milan] New York Inst Technol, Coll Osteopath Med, Dept Osteopath Manipulat Med, Old Westbury Campus,Northern Blvd, Old Westbury, NY 11568 USA; [Toma, Milan; Lipari, Christopher] New York Inst Technol, Coll Engn & Comp Sci, Dept Mech Engn, Old Westbury Campus,Northern Blvd, Old Westbury, NY 11568 USA; [Chan-Akeley, Rosalyn] Lang Res Ctr, NewYork Presbyterian Queens, 56-45 Main St, Flushing, NY 11355 USA; [Kuo, Sheng-Han] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA		Toma, M (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Osteopath Manipulat Med, Old Westbury Campus,Northern Blvd, Old Westbury, NY 11568 USA.; Toma, M (corresponding author), New York Inst Technol, Coll Engn & Comp Sci, Dept Mech Engn, Old Westbury Campus,Northern Blvd, Old Westbury, NY 11568 USA.	tomamil@tomamil.eu; roc9166@nyp.org; clipari@nyit.edu; sk3295@cumc.columbia.edu	Toma, Milan/D-4178-2011	Toma, Milan/0000-0003-2154-3728	New York Institute of Technology; New York Thoroughbred Horsemen's Association	This study was funded by a grant provided by the New York Institute of Technology and a donation from New York Thoroughbred Horsemen's Association. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.	ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bothwell SW, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0129-6; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; De Alvarenga V, 2019, J NEUROTRAUM, V36, pA4, DOI 10.1089/neu.2018.6143; Duckworth H., MODELLING BRAIN BIOM; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Eynde J.O., 2020, PLOS ONE, V15; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Ghaffari M, 2017, COMPUT BIOL MED, V91, P353, DOI 10.1016/j.compbiomed.2017.10.028; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hsu CY, 2017, MAGN RESON MED, V77, P398, DOI 10.1002/mrm.26087; Huff T., NEUROANATOMY CEREBRO; Khasawneh AH, 2018, BRAIN CIRC, V4, P14, DOI [10.4103/bc.BC_3_18, 10.4103/bc.bc_3_18]; Kimm D, 2015, PROCEDIA ENGINEER, V112, P502, DOI 10.1016/j.proeng.2015.07.232; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Li B, 2016, INT CONF MEAS, P756, DOI 10.1109/ICMTMA.2016.186; Liang ZY, 2015, APPL BIONICS BIOMECH, V2015, P1, DOI 10.1155/2015/837585; Linninger AA, 2016, ANNU REV FLUID MECH, V48, P219, DOI 10.1146/annurev-fluid-122414-034321; Lui ACP, 1998, CAN J ANAESTH, V45, P297, DOI 10.1007/BF03012018; Luo YH, 2012, P I MECH ENG H, V226, P499, DOI 10.1177/0954411912445729; Madhukar A, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2881; Matsumae M, 2016, NEUROL MED-CHIR, V56, P416, DOI 10.2176/nmc.ra.2016-0020; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; Ochieng D., 2018, PEDIAT HYDROCEPHALUS; Rengachary S.S., 2008, PRINCIPLES NEUROSURG; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Toma, 2017, SIGNIFICANCES BIOENG, V1, DOI DOI 10.31031/SBB.2017.01.000502; Toma Milan, 2020, Computer Methods, Imaging and Visualization in Biomechanics and Biomedical Engineering. Selected Papers from the 16th International Symposium CMBBE and 4th Conference on Imaging and Visualization. Lecture Notes in Computational Vision and Biomechanics (LNCVB 36), P36, DOI 10.1007/978-3-030-43195-2_4; Toma M., 2018, ADV INTELLIGENT SYST, P557; Toma M, 2020, J PEDIATR NEUROL, V18, P223, DOI 10.1055/s-0040-1708495; Toma M, 2020, INT J CRASHWORTHINES, V25, P175, DOI 10.1080/13588265.2018.1550910; Toma M, 2018, BRAIN INJURY, V32, P1576, DOI 10.1080/02699052.2018.1502470; Toma M, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2815; Toma M, 2016, COMPUT STRUCT, V173, P84, DOI 10.1016/j.compstruc.2016.06.001; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Vorwerk J, 2012, BIOMED ENG-BIOMED TE, V57, P795, DOI [10.1515/btm-2012-4152, 10.1515/bmt-2012-4152]; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Watanabe D, 2007, AUTOTECHNOLOGY, V7, P34; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	47	8	8	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1300-686X	2297-8747		MATH COMPUT APPL	Math. Comput. Appl.	JUN	2020	25	2							22	10.3390/mca25020022			14	Mathematics, Interdisciplinary Applications	Emerging Sources Citation Index (ESCI)	Mathematics	MN9UW	WOS:000551185600006		gold			2022-02-06	
J	Wang, WX; Prajapati, P; Nelson, PT; Springer, JE				Wang, Wang-Xia; Prajapati, Paresh; Nelson, Peter T.; Springer, Joe E.			The Mitochondria-Associated ER Membranes Are Novel Subcellular Locations Enriched for Inflammatory-Responsive MicroRNAs	MOLECULAR NEUROBIOLOGY			English	Article						Mitochondria-associated ER membrane; Subcellular; Neurodegeneration; Traumatic brain injury; microRNA; miR-146a	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; DONOR CHARACTERISTICS; BOUND RIBOSOMES; MESSENGER-RNAS; DYSFUNCTION; EXPRESSION; MIRNAS; CELLS	The mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) are specific ER domains that contact the mitochondria and function to facilitate communication between ER and mitochondria. Disruption of contact between the mitochondria and ER is associated with a variety of pathophysiological conditions including neurodegenerative diseases. Considering the many cellular functions of MAMs, we hypothesized that MAMs play an important role in regulating microRNA (miRNA) activity linked to its unique location between mitochondria and ER. Here we present new findings from human and rat brains indicating that the MAMs are subcellular sites enriched for specific miRNAs. We employed subcellular fractionation and TaqMan (R) RT-qPCR miRNA analysis to quantify miRNA levels in subcellular fractions isolated from male rat brains and six human brain samples. We found that MAMs contain a substantial number of miRNAs and the profile differs significantly from that of cytosolic, mitochondria, or ER. Interestingly, MAMs are particularly enriched in inflammatory-responsive miRNAs, including miR-146a, miR-142-3p, and miR-142-5p in both human and rat brains; miR-223 MAM enrichment was observed only in human brain samples. Further, mitochondrial uncoupling or traumatic brain injury in male rats resulted in the alteration of inflammatory miRNA enrichment in the isolated subcellular fractions. These observations demonstrate that miRNAs are distributed differentially in organelles and may re-distribute between organelles and the cytosol in response to cellular stress and metabolic demands.	[Wang, Wang-Xia; Nelson, Peter T.] Univ Kentucky, Sanders Brown Ctr Aging, 800 S Limestone, Lexington, KY 40536 USA; [Wang, Wang-Xia; Prajapati, Paresh; Springer, Joe E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Wang, Wang-Xia; Nelson, Peter T.] Univ Kentucky, Pathol & Lab Med, Lexington, KY 40536 USA; [Prajapati, Paresh; Springer, Joe E.] Univ Kentucky, Neurosci, Lexington, KY 40536 USA		Wang, WX (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 800 S Limestone, Lexington, KY 40536 USA.; Wang, WX (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA.; Wang, WX (corresponding author), Univ Kentucky, Pathol & Lab Med, Lexington, KY 40536 USA.	wwangc@uky.edu	Prajapati, Paresh/P-1058-2019; Wang, Wang-Xia/AAD-6900-2019	Prajapati, Paresh/0000-0002-3734-4662; Wang, Wang-Xia/0000-0002-8104-3779	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG280303]	Sincere thanks are given to the research volunteers at the Alzheimer's Disease Center at the University of Kentucky (UK-ADC), supported by NIH grant P30 AG280303.	Alexandrov PN, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00181; Area-Gomez E, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0215-0; Area-Gomez E, 2016, CURR OPIN GENET DEV, V38, P90, DOI 10.1016/j.gde.2016.04.006; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Arena A, 2017, CURR ALZHEIMER RES, V14, P1305, DOI 10.2174/1567205014666170706112701; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bernard-Marissal N, 2015, BRAIN, V138, P875, DOI 10.1093/brain/awv008; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clement C, 2016, MOL NEUROBIOL, V53, P1322, DOI 10.1007/s12035-015-9105-6; Csordas G, 2018, TRENDS CELL BIOL, V28, P523, DOI 10.1016/j.tcb.2018.02.009; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dave RS, 2010, J CELL BIOCHEM, V110, P834, DOI 10.1002/jcb.22592; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Elliott EI, 2018, J IMMUNOL, V200, P3047, DOI 10.4049/jimmunol.1701723; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Guardia-Laguarta C, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00017; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009; Jagannathan S, 2014, RNA, V20, P1489, DOI 10.1261/rna.045526.114; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Kim J, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0121-4; Leung AKL, 2015, TRENDS CELL BIOL, V25, P601, DOI 10.1016/j.tcb.2015.07.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YY, 2011, NEUROSCI LETT, V499, P109, DOI 10.1016/j.neulet.2011.05.044; Liao GN, 2011, J CELL SCI, V124, P589, DOI 10.1242/jcs.072421; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lukiw WJ, 2012, EXP NEUROL, V235, P484, DOI 10.1016/j.expneurol.2011.11.022; Manfredi G, 2016, NEUROBIOL DIS, V90, P35, DOI 10.1016/j.nbd.2015.08.004; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Missiroli S, 2016, CELL REP, V16, P2415, DOI 10.1016/j.celrep.2016.07.082; Mitsumura T, 2018, BLOOD ADV, V2, P3483, DOI 10.1182/bloodadvances.2018017954; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Novak J, 2015, ADV EXP MED BIOL, V887, P79, DOI 10.1007/978-3-319-22380-3_5; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Schmitt FA, 2001, GERONTOLOGIST, V41, P716, DOI 10.1093/geront/41.6.716; Schmitt FA, 2012, CURR ALZHEIMER RES, V9, P724; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614; van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Vilela SMF, 2009, MITOCHONDRION, V9, P247, DOI 10.1016/j.mito.2009.03.002; Voigt F, 2017, CELL REP, V21, P3740, DOI 10.1016/j.celrep.2017.12.008; Wang WX, 2017, MOL NEUROBIOL, V54, P8191, DOI 10.1007/s12035-016-0316-2; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang WX, 2015, NEURAL REGEN RES, V10, P1026, DOI 10.4103/1673-5374.160061; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang Wang-Xia, 2014, Genomics Proteomics & Bioinformatics, V12, P19, DOI 10.1016/j.gpb.2013.10.003; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wang WX, 2008, BBA-GENE REGUL MECH, V1779, P749, DOI 10.1016/j.bbagrm.2008.01.005; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Williamson Chad D, 2015, Curr Protoc Cell Biol, V68, DOI 10.1002/0471143030.cb0327s68; Zhang SJ, 2015, VIROLOGY, V481, P73, DOI 10.1016/j.virol.2015.01.034; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	83	8	8	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2020	57	7					2996	3013		10.1007/s12035-020-01937-y		MAY 2020	18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MC7MN	WOS:000535390300001	32451872	hybrid, Green Published			2022-02-06	
J	Lee, HY; Park, JH; Kim, AR; Park, M; Kim, TW				Lee, Hoo Young; Park, Jung Hyun; Kim, Ae Ryoung; Park, Misun; Kim, Tae-Woo			Neurobehavioral recovery in patients who emerged from prolonged disorder of consciousness: a retrospective study	BMC NEUROLOGY			English	Article						Brain injuries; Consciousness disorders; Rehabilitation; Treatment outcome	BRAIN-INJURY; COMA; REHABILITATION; CONNECTIVITY; STATE; OUTCOMES	Background We investigated the clinical course of patients with prolonged disorders of consciousness (PDoC), predictors of emergence from PDoC (EDoC), and the temporal dynamics of six neurobehavior domains based on the JFK Coma Recovery Scale-Revised (CRS-R) during the recovery. Methods A total of 50 traumatic and non-traumatic patients with PDoC were enrolled between October 2014 and February 2017. A retrospective analysis of the clinical findings and neurobehavioral signs was conducted using standardized methodology such as CRS-R. The findings were used to investigate the incidence and predictors of EDoC and determine the cumulative pattern of neurobehavioral recovery at 6 months, 1 year, and 2 years post-injury. Results The results showed that 46% of the subjects emerged from PDoC after 200 median days (64-1197 days) of injury onset. The significant predictors of EDoC included minimally conscious state (MCS) (vs. vegetative state), higher auditory, communication, arousal, total CRS-R scores, shorter lag time post-injury, and the absence of intra-axial lesions. In terms of cumulative recovery of motor and communication signs in patients who emerged from PDoC, 39 and 32% showed EDoC at 6 months post-injury, and 88 and 93% exhibited EDoC at 2 years post-injury, respectively. Conclusions Nearly half of the patients with PDoC recovered consciousness during inpatient rehabilitation. MCS, shorter lag time, the absence of intra-axial lesions, higher auditory, communication, arousal, and total CRS-R scores were important predictors for EDoC. Motor scores in the early stage of recovery and communication scores after prolonged intervals contributed to the higher levels of cumulative EDoC.	[Lee, Hoo Young; Kim, Tae-Woo] Natl Traff Injury Rehabil Hosp, TBI Rehabil Ctr, 260 Jungang Ro, Yangpyeong Gun 12564, Gyeonggi Do, South Korea; [Lee, Hoo Young; Kim, Tae-Woo] Seoul Univ, Seoul Natl Univ Hosp, Dept Rehabil Med, Coll Med, Seoul, South Korea; [Lee, Hoo Young; Park, Jung Hyun] Yonsei Univ, Grad Sch, Dept Med, Seoul, South Korea; [Park, Jung Hyun] Yonsei Univ, Rehabil Inst Neuromuscular Dis, Coll Med, Dept Rehabil Med,Gangnam Severance Hosp, Seoul, South Korea; [Kim, Ae Ryoung] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Rehabil Med, Daegu, South Korea; [Park, Misun] Catholic Univ Korea, Catholic Med Ctr, Clin Res Coordinating Ctr, Dept Biostat, Seoul, South Korea		Kim, TW (corresponding author), Natl Traff Injury Rehabil Hosp, TBI Rehabil Ctr, 260 Jungang Ro, Yangpyeong Gun 12564, Gyeonggi Do, South Korea.; Kim, TW (corresponding author), Seoul Univ, Seoul Natl Univ Hosp, Dept Rehabil Med, Coll Med, Seoul, South Korea.	taewookimmd@gmail.com		Park, Jung Hyun/0000-0003-3262-7476			Abdelrasoul AA, 2019, J COMPUT ASSIST TOMO, V43, P443, DOI 10.1097/RCT.0000000000000865; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bruno MA, 2011, CURR OPIN CRIT CARE, V17, P146, DOI 10.1097/MCC.0b013e328343476d; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; El Karoui I, 2015, CEREB CORTEX, V25, P4203, DOI 10.1093/cercor/bhu143; El-Serougy L, 2016, NEURORADIOL J, V29, P400, DOI 10.1177/1971400916665382; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino J, 2016, ARCH PHYS MED REHAB, V97, pe3, DOI DOI 10.1016/J.APMR.2016.08.006; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Han HJ, 2018, ANN REHABIL MED-ARM, V42, P536, DOI 10.5535/arm.2018.42.4.536; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2008, NAT CLIN PRACT NEURO, V4, P544, DOI 10.1038/ncpneuro0887; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee KB, 2016, BRAIN NEUROREHABIL, V10, pe5; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Razek AAKA, 2019, J COMPUT ASSIST TOMO, V43, P525, DOI 10.1097/RCT.0000000000000873; Razek AAKA, 2014, NEURORADIOLOGY, V56, P885, DOI 10.1007/s00234-014-1409-0; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shimamura Norihito, 2015, No Shinkei Geka, V43, P705, DOI 10.11477/mf.1436203106; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	43	8	8	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	MAY 20	2020	20	1							198	10.1186/s12883-020-01758-5			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT3FS	WOS:000536957100001	32434516	gold, Green Published			2022-02-06	
J	Yamazaki, K; Kawabori, M; Seki, T; Takamiya, S; Tateno, T; Konno, K; Watanabe, M; Houkin, K				Yamazaki, Kazuyoshi; Kawabori, Masahito; Seki, Toshitaka; Takamiya, Soichiro; Tateno, Takahiro; Konno, Kotaro; Watanabe, Masahiko; Houkin, Kiyohiro			FTY720 Attenuates Neuropathic Pain after Spinal Cord Injury by Decreasing Systemic and Local Inflammation in a Rat Spinal Cord Compression Model	JOURNAL OF NEUROTRAUMA			English	Article						allodynia; inflammation; FTY720; glial scar; spinal cord injury	FUNCTIONAL RECOVERY; ANIMAL-MODEL; IMPACT; TRANSPLANTATION	Neuropathic pain severely impairs rehabilitation and quality of life after spinal cord injury (SCI). The sphingosine-1-phosphate receptor agonist, FTY720, plays an important protective role in neuronal injury. This study aims to examine the effects of FTY720 in a rat acute SCI model, focusing on neuropathic pain. Female rats with SCI induced by 1-min clip compression were administered vehicle or 1.5 mg/kg of FTY720 24 h after the injury. Using the mechanical nociceptive threshold test, we monitored neuropathic pain and performed histological analysis of the pain pathway, including the mu opioid receptor (MOR), hydroxytryptamine transporter (HTT), and calcitonin gene-related peptide (CGRP). Motor score, SCI lesion volume, residual motor axons, inflammatory response, glial scar, and microvascular endothelial dysfunction were also compared between the two groups. FTY720 treatment resulted in significant attenuation of post-traumatic neuropathic pain. It also decreased systemic and local inflammation, thereby reducing the damaged areas and astrogliosis and resulting in motor functional recovery. Whereas there was no difference in the CGRP expression between the two groups, FTY720 significantly preserved the MOR in both the caudal and rostral areas of the spinal dorsal horn. Whereas HTT was preserved in the FTY720 group, it was significantly increased in the rostral side and decreased in the caudal side of the injury in the vehicle group. These results suggest that FTY720 ameliorates post-traumatic allodynia through regulation of neuroinflammation, maintenance of the blood-brain barrier, and inhibition of glial scar formation, thereby preserving the connectivity of the descending inhibitory pathway and reducing neuropathic pain.	[Yamazaki, Kazuyoshi; Kawabori, Masahito; Seki, Toshitaka; Takamiya, Soichiro; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Kawabori, Masahito; Houkin, Kiyohiro] Hokkaido Univ, Dept Neurol Cell Therapy, Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan; [Tateno, Takahiro] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Konno, Kotaro; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat & Embryol, Sapporo, Hokkaido, Japan		Kawabori, M (corresponding author), Hokkaido Univ, Dept Neurosurg, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	masahitokawabori@yahoo.co.jp	Kawabori, Masahito/AAH-7117-2020; Watanabe, Masahiko/S-3614-2019	Kawabori, Masahito/0000-0002-3574-8380; Watanabe, Masahiko/0000-0001-5037-7138	AMED [JP17bk0104045]; Japan Society for the Promotion of Science Fujita Memorial Fund for Medical ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science	This study was supported by AMED under Grant Number JP17bk0104045, and Japan Society for the Promotion of Science Fujita Memorial Fund for Medical Research.	Austin JW, 2012, J NEUROTRAUM, V29, P1838, DOI 10.1089/neu.2012.2354; Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bruce JC, 2002, EXP NEUROL, V178, P33, DOI 10.1006/exnr.2002.8026; Chiba Y, 2012, NEUROPATHOLOGY, V32, P139, DOI 10.1111/j.1440-1789.2011.01255.x; Chiba Y, 2009, NEUROSURGERY, V64, P991, DOI 10.1227/01.NEU.0000341905.57162.1D; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chuah MI, 2004, EXP NEUROL, V185, P15, DOI 10.1016/j.expneurol.2003.09.008; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Dohrmann G J, 1976, Surg Neurol, V6, P263; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; FUJITA T, 1994, J ANTIBIOT, V47, P208, DOI 10.7164/antibiotics.47.208; HAO JX, 1991, PAIN, V45, P175, DOI 10.1016/0304-3959(91)90186-2; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kawabori M, 2013, THER HYPOTHERMIA TEM, V3, P189, DOI 10.1089/ther.2013.0020; Kawabori M, 2013, WORLD J CARDIOL, V5, P75, DOI 10.4330/wjc.v5.i4.75; Kudo T, 2014, EUR J NEUROSCI, V39, P1796, DOI 10.1111/ejn.12503; Lee KD, 2009, J NEUROTRAUM, V26, P2335, DOI 10.1089/neu.2008.0840; Nees TA, 2017, PAIN, V158, P371, DOI 10.1097/j.pain.0000000000000783; Norimatsu Y, 2012, AM J PATHOL, V180, P1625, DOI 10.1016/j.ajpath.2011.12.012; Sapkota A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48609-z; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Seki T, 2008, J NEUROSURG-SPINE, V8, P365, DOI 10.3171/SPI/2008/8/4/365; Shono Y, 2006, CLIN LAB HAEMATOL, V28, P351, DOI 10.1111/j.1365-2257.2006.00809.x; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Sim-Selley LJ, 2018, J PHARMACOL EXP THER, V366, P509, DOI 10.1124/jpet.118.248260; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Stormer S, 1997, SPINAL CORD, V35, P446, DOI 10.1038/sj.sc.3100411; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wang JJ, 2015, BIOMATERIALS, V62, P76, DOI 10.1016/j.biomaterials.2015.04.060; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; XU XJ, 1992, PAIN, V48, P279, DOI 10.1016/0304-3959(92)90070-R; Zhang DD, 2015, BIOL CHEM, V396, P783, DOI 10.1515/hsz-2014-0276; Zhang J, 2009, TOHOKU J EXP MED, V219, P295, DOI 10.1620/tjem.219.295	38	8	8	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 1	2020	37	15					1720	1728		10.1089/neu.2019.6905		MAY 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MT3XG	WOS:000535558700001	32216535	Green Submitted, hybrid, Green Published			2022-02-06	
J	Kmush, BL; Mackowski, M; Ehrlich, J; Walia, B; Owora, A; Sanders, S				Kmush, Brittany L.; Mackowski, Madeline; Ehrlich, Justin; Walia, Bhavneet; Owora, Arthur; Sanders, Shane			Association of Professional Football Cumulative Head Impact Index Scores With All-Cause Mortality Among National Football League Players	JAMA NETWORK OPEN			English	Article							HIGH-SCHOOL FOOTBALL; AMERICAN FOOTBALL; 1ST EXPOSURE; BRAIN-INJURY; RISK; CONCUSSIONS; SUICIDE; AGE	Question Are repetitive head impacts during a professional football career associated with mortality among National Football League players? Findings In this cohort study of 13 & x202f;912 National Football League players, a 25% increase in repetitive head impacts during a professional football career was associated with a statistically significant increase in the hazard ratio of death. Meaning The findings suggest that repetitive head impacts are associated with an increase in the risk of all-cause mortality among professional football players. This cohort study examines the association between repetitive head impacts from professional football play and all-cause mortality among National Football League players. Importance Long-term adverse health outcomes, particularly those associated with repetitive head impacts, are of growing concern among US-style football players in the US and Canada. Objective To assess whether exposure to repetitive head impacts during a professional football career is associated with an increase in the risk of all-cause mortality. Design, Setting, and Participants This retrospective cohort study included 13 & x202f;912 players in the 1969 to 2017 National Football League (NFL) seasons. All cause-mortality up until July 1, 2018, was included. Data collection was performed from July 13, 2017, to July 1, 2018, as reported in the Pro Football Reference. Exposures The main exposure was a professional football cumulative head impact index (pfCHII). The pfCHII was measured by combining cumulative padded practice time and games played summed during seasons of play reported in the Pro Football Reference and a player position risk adjustment from helmet accelerometer studies. Main Outcomes and Measures Demographic characteristics except for the pfCHII were calculated for 14 & x202f;366 players with complete follow-up. The pfCHII was calculated for 13 & x202f;912 players (eliminating the 454 specials teams players). Cox proportional hazards regression was used to compare hazard ratios (HRs) of death by repetitive head impacts. Analyses were unadjusted and adjusted for birth year, body mass index, and height. Results Among 14 & x202f;366 NFL players who had follow-up for analysis, the mean (SD) age was 47.3 (14.8) years, the mean (SD) body mass index was 29.6 (3.9), and 763 of 14 & x202f;366 players (5.3%) had died. Among 13 & x202f;912 players in the pfCHII analysis, the median pfCHII was 32.63 (interquartile range, 13.71-66.12). A 1-log increase in pfCHII was significantly associated with an increased hazard of death for the 1969 to 2017 seasons (HR, 2.02; 95% CI, 1.21-3.37; P = .01) after adjustment. The quadratic pfCHII was also statistically significant (HR, 0.91; 95% CI, 0.85-0.98; P = .01), indicating that the hazard of death increased at a decreasing rate, whereas the pfCHII increased. Conclusions and Relevance The findings suggest that an increase in repetitive head impacts is associated with an increased hazard of death among NFL players. Reduction in repetitive head impacts from playing football or other activities through additional rule and equipment changes may be associated with reduced mortality.	[Kmush, Brittany L.; Mackowski, Madeline; Walia, Bhavneet; Owora, Arthur] Syracuse Univ, Dept Publ Hlth, 150 Crouse Dr,435C White Hall, Syracuse, NY 13244 USA; [Ehrlich, Justin; Sanders, Shane] Syracuse Univ, Dept Sport Analyt, Syracuse, NY USA; [Owora, Arthur] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA		Kmush, BL (corresponding author), Syracuse Univ, Dept Publ Hlth, 150 Crouse Dr,435C White Hall, Syracuse, NY 13244 USA.	blkmush@syr.edu		Owora, Arthur/0000-0002-4580-7428; Kmush, Brittany/0000-0003-2143-7554	David B. Falk College of Sport and Human Dynamics, Syracuse University, Syracuse, New York	This work was supported by funds from the David B. Falk College of Sport and Human Dynamics, Syracuse University, Syracuse, New York.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Abel Ernest L, 2006, Res Sports Med, V14, P239, DOI 10.1080/15438620600985795; Albuquerque FN, 2010, J AM COLL CARDIOL, V56, P1432, DOI 10.1016/j.jacc.2010.03.099; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; [Anonymous], 2002, NFL NFLPA COLL BARG; [Anonymous], 2011, NFL BFLPA COLL BARG; [Anonymous], 1993, NFL NFLPA COLL BARG; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Centers for Disease Control and Prevention, TBI REL EM DEP VIS H; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Donlan JM, 1982, NFL NFLPA COLLECTIVE; Ehrlich J, F1000 RES, DOI [10.12688/f1000research.21235.1, DOI 10.12688/F1000RESEARCH.21235.1]; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Haus L, 1974, NFL NFLPA COLLECTIVE; Interassociation Consensus: Diagnosis and Management of Sport-Related Concussion Best Practices, 2017, INT CONS DIAGN MAN S; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kemp JF, 1968, NFL NFLPA COLLECTIVE; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Li HM, 2017, AM J SPORT MED, V45, P2148, DOI 10.1177/0363546517702847; Lincoln AE, 2018, MED SCI SPORT EXER, V50, P486, DOI 10.1249/MSS.0000000000001466; Lomax ME, 1999, J SOC HIST, V33, P163, DOI 10.1353/jsh.1999.0017; Mackey J, 1970, NFL NFLPA COLLECTIVE; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martin Joyce A, 2017, Natl Vital Stat Rep, V66, P1; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Outdoor Foundation, 2018, OUTD PART REP 2018; Owora AH, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118813312; Perrine K, 2017, WORLD NEUROSURG, V102, P533, DOI 10.1016/j.wneu.2017.02.084; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; Tharmaratnam T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00445; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Venkataramani AS, 2018, JAMA-J AM MED ASSOC, V319, P800, DOI 10.1001/jama.2018.0140	46	8	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAY 11	2020	3	5							e204442	10.1001/jamanetworkopen.2020.4442			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LS2IO	WOS:000536213300001	32391891	Green Published, gold			2022-02-06	
J	Caplan, HW; Prabhakara, KS; Kumar, A; Toledano-Furman, NE; Martin, C; Carrillo, L; Moreno, NF; Bordt, AS; Olson, SD; Cox, CS				Caplan, Henry W.; Prabhakara, Karthik S.; Kumar, Akshita; Toledano-Furman, Naama E.; Martin, Cecilia; Carrillo, Louis; Moreno, Nicolas F.; Bordt, Andrea S.; Olson, Scott D.; Cox, Charles S., Jr.			Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						cell therapy; CNS trauma; cord blood; microglia; neuroinflammation; regenerative medicine; TBI; Treg; t-SNE	MICROGLIA; NEUROINFLAMMATION; INFLAMMATION; EXPRESSION; DISEASE	Traumatic brain injury (TBI) causes a profound inflammatory response within the central nervous system and peripheral immune system, which contributes to secondary brain injury and further morbidity and mortality. Preclinical investigations have demonstrated that treatments that downregulate microglia activation and polarize them toward a reparative/anti-inflammatory phenotype have improved outcomes in preclinical models. However, no therapy to date has translated into proven benefits in human patients. Regulatory T cells (Treg) have been shown to downregulate pathologic immune responses of the innate and adaptive immune system across a variety of pathologies. Furthermore, cellular therapy has been shown to augment host Treg responses in preclinical models; yet, studies investigating the use of Treg as a therapeutic for TBI are lacking. In a rodent TBI model, we demonstrate that human umbilical cord blood Treg modulate the central and peripheral immune response after injury in vitro and in vivo.	[Caplan, Henry W.; Prabhakara, Karthik S.; Kumar, Akshita; Toledano-Furman, Naama E.; Martin, Cecilia; Carrillo, Louis; Moreno, Nicolas F.; Bordt, Andrea S.; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, 6431 Fannin St,MSE R162, Houston, TX 77030 USA		Olson, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, 6431 Fannin St,MSE R162, Houston, TX 77030 USA.; Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, 6431 Fannin St MSB 5-230, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu; charles.s.cox@uth.tmc.edu		Kumar, Akshita/0000-0002-4021-4092; Caplan, Henry/0000-0003-0012-1606	NIH 2T32United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM0879201-11A1]	NIH 2T32, Grant/Award Number: GM0879201-11A1	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anania JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00464; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Boche D, 2013, NEUROPATH APPL NEURO, V39, P1, DOI 10.1111/nan.12009; Carrillo-Jimenez A, 2019, CELL REP, V29, P697, DOI 10.1016/j.celrep.2019.09.013; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Furman NET, 2018, NEUROMETHODS, V139, P191, DOI 10.1007/978-1-4939-8564-7_12; Furman NET, 2018, CYTOM PART A, V93A, P182, DOI 10.1002/cyto.a.23267; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Melief J, 2012, GLIA, V60, P1506, DOI 10.1002/glia.22370; O'Keefe GM, 2002, J NEUROVIROL, V8, P496, DOI 10.1080/13550280290100941; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Srivastava AK, 2019, REGEN MED, V14, P295, DOI 10.2217/rme-2018-0106; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Zhao H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01578	42	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	AUG	2020	9	8					903	916	e12706	10.1002/sctm.19-0444		MAY 2020	14	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	MP0NN	WOS:000530838400001	32383348	Green Published, gold			2022-02-06	
J	Huang, YP; Long, X; Tang, JY; Li, XL; Zhang, X; Luo, CY; Zhou, Y; Zhang, P				Huang, Yongpan; Long, Xian; Tang, Jiayu; Li, Xinliang; Zhang, Xiang; Luo, Chunyan; Zhou, Yan; Zhang, Pan			The Attenuation of Traumatic Brain Injury via Inhibition of Oxidative Stress and Apoptosis by Tanshinone IIA	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							BETA-AMYLOID PROTEIN; ACTIVATION; CRYPTOTANSHINONE; INVOLVEMENT; DEFICITS; PATHWAY; EDEMA; RATS	Traumatic brain injury (TBI) is a major source of mortality and long-term disability worldwide. The mechanisms associated with TBI development are poorly understood, and little progress has been made in the treatment of TBI. Tanshinone IIA is an effective agent to treat a variety of disorders; however, the mechanisms of Tanshinone IIA on TBI remain unclear. The aim of the present study was to investigate the therapeutic potential of Tanshinone IIA on TBI and its underlying molecular mechanisms. Changes in microvascular permeability were examined to determine the extent of TBI with Evans blue dye. Brain edema was assessed by measuring the wet weight to dry weight ratio. The expression levels of CD11, interleukin- (IL-) 1 beta, and tumor necrosis factor- (TNF-) alpha mRNA were determined by reverse transcription-quantitative PCR. Aquaporin-4 (AQP4), glial fibrillary acidic protein (GFAP), and p47phox protein expression levels were detected by western blotting. Superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-PX) activities, and malondialdehyde (MDA) content were determined using commercial kits. Cell apoptosis was detected by western blotting and TUNEL staining. Tanshinone IIA (10 mg/kg/day, intraperitoneal administration) significantly reduced brain water content and vascular permeability at 12, 24, 48, and 72 h after TBI. Tanshinone IIA downregulated the mRNA expression levels of various factors induced by TBI, including CD11, IL-1 beta, and TNF-alpha. Notably, CD11 mRNA downregulation suggested that Tanshinone IIA inhibited microglia activation. Further results showed that Tanshinone IIA treatment significantly downregulated AQP4 and GFAP expression. TBI-induced oxidative stress and apoptosis were markedly reversed by Tanshinone IIA, with an increase in SOD and GSH-PX activities and a decrease in the MDA content. Moreover, Tanshinone IIA decreased TBI-induced NADPH oxidase activation via the inhibition of p47phox. Tanshinone IIA attenuated TBI, and its mechanism of action may involve the inhibition of oxidative stress and apoptosis.	[Huang, Yongpan; Long, Xian; Zhang, Xiang; Luo, Chunyan; Zhou, Yan; Zhang, Pan] Changsha Social Work Coll, Sch Med, Dept Clin, Changsha, Hunan, Peoples R China; [Huang, Yongpan; Li, Xinliang] Hunan Acad Chinese Med, Inst Chinese Med, Dept Pharmacol, Changsha, Peoples R China; [Tang, Jiayu] Brain Hosp Hunan Prov, Dept Neurol, Changsha, Peoples R China		Li, XL (corresponding author), Hunan Acad Chinese Med, Inst Chinese Med, Dept Pharmacol, Changsha, Peoples R China.; Tang, JY (corresponding author), Brain Hosp Hunan Prov, Dept Neurol, Changsha, Peoples R China.	yongpanhuangxy@163.com; swallow1996@126.com; tangjiayu1978@163.com; lixinliang1024@163.com; 429263060@qq.com; 274498520@qq.com; zyzhouhangdoctor@163.com; haorenbudazhe@126.com		li, xinliang/0000-0002-0100-4076	Hunan National Science Funds [2017JJ2343]; Hunan Provincial Administration of Traditional Chinese Medicine Research Project Fund [201894]; Hunan Provincial Brain Hospital Key Scientific Research Project [2017A02]; Key R&D Program of Hunan Province [2018SK1030]; Changsha Social Work College National Project Cultivation Project	This work was supported by Hunan National Science Funds (No. 2017JJ2343) and Hunan Provincial Administration of Traditional Chinese Medicine Research Project Fund (201894 to Jiayu Tang), Hunan Provincial Brain Hospital Key Scientific Research Project (2017A02 to Jiayu Tang), Key R&D Program of Hunan Province (2018SK1030 to Jiayu Tang), and Changsha Social Work College National Project Cultivation Project.	Ahn JH, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100279; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Butterfield DA, 2016, PROTEOM CLIN APPL, V10, P1191, DOI 10.1002/prca.201600003; Chen J, 2018, BIOMED PHARMACOTHER, V104, P530, DOI 10.1016/j.biopha.2018.05.040; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Dumitrescu L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2406594; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao M, 2008, TRANSL RES, V151, P79, DOI [10.1016/j.trs1.2007.11.005, 10.1016/j.trsl.2007.11.005]; Ge R, 2013, BRAIN RES, V1527, P40, DOI 10.1016/j.brainres.2013.06.009; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Kim J, 2017, J CLIN INVEST, V127, P3447, DOI 10.1172/JCI93825; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lee SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103087; Li De-chuan, 2015, Yaoxue Xuebao, V50, P635; Li WT, 2020, FREE RADICAL BIO MED, V146, P79, DOI 10.1016/j.freeradbiomed.2019.10.408; Liu C, 2016, BRAIN RES, V1631, P137, DOI 10.1016/j.brainres.2015.11.040; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Maione F, 2018, PHARMACOL RES, V129, P482, DOI 10.1016/j.phrs.2017.11.018; Maione F, 2015, FITOTERAPIA, V100, P174, DOI 10.1016/j.fitote.2014.11.024; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Panwar P, 2018, BRIT J PHARMACOL, V175, P902, DOI 10.1111/bph.14133; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Qian YH, 2012, BRAIN RES BULL, V88, P354, DOI 10.1016/j.brainresbull.2012.03.007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shi LL, 2012, NEUROCHEM INT, V61, P227, DOI 10.1016/j.neuint.2012.04.019; Sun MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01089; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Wang Lin-Hui, 2018, Shengli Xuebao, V70, P52, DOI 10.13294/j.aps.2018.0006; Wang YL, 2017, J NEURORESTORATOLOGY, V5, P117, DOI 10.2147/JN.S125567; Wei B, 2013, ATHEROSCLEROSIS, V230, P148, DOI 10.1016/j.atherosclerosis.2013.07.005; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491; Zhang Y, 2012, INT J MOL SCI, V13, P13621, DOI 10.3390/ijms131013621; Zhu YH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4783602; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	39	8	9	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	MAY 4	2020	2020								4170156	10.1155/2020/4170156			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	LS1NP	WOS:000536158700002	32454938	gold, Green Published			2022-02-06	
J	Belding, JN; Fitzmaurice, S; Englert, RM; Lee, I; Kowitz, B; Highfill-McRoy, RM; Thomsen, CJ; da Silva, U				Belding, Jennifer N.; Fitzmaurice, Shannon; Englert, Robyn Martin; Lee, Isabell; Kowitz, Brad; Highfill-McRoy, Robyn M.; Thomsen, Cynthia J.; da Silva, Uade			Blast Exposure and Risk of Recurrent Occupational Overpressure Exposure Predict Deployment TBIs	MILITARY MEDICINE			English	Article; Proceedings Paper	International-Forum-on-Blast-Injury-Countermeasures Conference	MAY, 2019	MITRE, McLean, VA	Int Forum Blast Injury Countermeasures	MITRE		TRAUMATIC BRAIN-INJURY; OPERATION IRAQI FREEDOM; AFGHANISTAN	Introduction Traumatic brain injury (TBI) has been the leading cause of morbidity and mortality in recent military conflicts and deployment-related TBIs are most commonly caused by blast. However, knowledge of risk factors that increase susceptibility to TBI following an acute, high-level blast is limited. We hypothesized that recurrent occupational overpressure exposure (ROPE) may be one factor that increases susceptibility to mild TBI (mTBI) following blast. Materials and Methods Using military occupational specialty as a proxy, we examined the effects of high versus low ROPE on mTBI following blast exposure. Initial analyses included 111,641 active-duty-enlisted U.S. Marines who completed the 2003 or 2008 version of the Post-Deployment Health Assessment. Final analyses examined probable mTBI screens among Marines with at least one qualifying exposure as a function of whether the exposure was a blast and level of ROPE (N = 12,929). This study was approved by the Institutional Review Board at the Naval Health Research Center. Results Blast and ROPE were both independently and jointly associated with a probable mTBI. Marines who experienced a blast (vs other qualifying exposure) and those in high (vs low) risk occupations were 1.07 and 1.23 times more likely to sustain a probable mTBI, respectively. Furthermore, among those who experienced a blast during deployment, those in high-risk occupations were 1.45 times more likely than those in low-risk occupations to sustain a probable mTBI. Conclusions Blast exposure and ROPE were independently associated with mTBIs, and Marines with both blast exposure during deployment and ROPE were especially likely to sustain an mTBI. This suggests that ROPE heightens the risk of mTBI following blast. Ongoing research is examining the severity, symptomology, and sequelae of TBIs as a function of ROPE.	[Belding, Jennifer N.; Fitzmaurice, Shannon; Englert, Robyn Martin; Lee, Isabell; Kowitz, Brad; Highfill-McRoy, Robyn M.; Thomsen, Cynthia J.; da Silva, Uade] Naval Hlth Res Ctr, Hlth & Behav Sci Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Belding, Jennifer N.; Fitzmaurice, Shannon; Englert, Robyn Martin; Lee, Isabell; Kowitz, Brad; Highfill-McRoy, Robyn M.] Leidos, 10260 Campus Point Dr, San Diego, CA 92121 USA; [Lee, Isabell] Naval Med Ctr San Diego, Prevent Med Dept, San Diego, CA USA		Belding, JN (corresponding author), Naval Hlth Res Ctr, Hlth & Behav Sci Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.; Belding, JN (corresponding author), Leidos, 10260 Campus Point Dr, San Diego, CA 92121 USA.				U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [19-49, N1629]	Report No. 19-49 was supported by the U.S. Army Medical Research and Materiel Command under work unit no. N1629. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government.	Bitonte R, MILD TRAUMATIC BRAIN; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Defense and Veterans Brain Injury Center, 2018, BRAIN INJURY; Engel C., 2019, P FIND EXP REC 7 DEP; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; US Department of Defense, 2007, DEM 2007 PROF MIL CO; US Department of Defense, 2010, DEM 2010 PROF MIL CO; US Department of the Navy, 2014, DEPL HLTH ASS PROC O; US Department of the Navy, 2015, MIL OCC SPEC MAN SHO; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	19	8	8	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2020	185	5-6					E538	E544		10.1093/milmed/usz289			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	LY4LU	WOS:000540501500007	31665414	hybrid			2022-02-06	
J	Echemendia, RJ; Thelen, J; Meeuwisse, W; Hutchison, MG; Rizos, J; Comper, P; Bruce, JM				Echemendia, Ruben J.; Thelen, Joanie; Meeuwisse, Willem; Hutchison, Michael G.; Rizos, John; Comper, Paul; Bruce, Jared M.			Neuropsychological Assessment of Professional Ice Hockey Players: A Cross-Cultural Examination of Baseline Data Across Language Groups	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Cross-cultural; Traumatic brain injury; Sports; Concussion	VISUOSPATIAL MEMORY TEST; DEMOGRAPHICALLY CORRECTED NORMS; COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; NORMATIVE DATA; CONCUSSION; SYMPTOMS; SPORTS; HISTORY; RELIABILITY	Objective: Neuropsychological testing in sports has become routine across all levels of play. The National Hockey League (NHL) has conducted baseline neuropsychological assessment of all players since 1997. This study seeks to examine baseline differences among linguistically and culturally diverse groups within the NHL and to present comprehensive normative data for these groups. Method: Baseline data were obtained from 3,145 professional hockey players' baseline symptom reporting, neuropsychological test performance on a battery of traditional "paper and pencil" measures, and self-reported concussion history. In addition, 604 baseline post-injury paper and pencil evaluations were conducted the season following a concussion and 4,780 computerized baseline ImPACT administrations were obtained following the introduction of computerized testing. Results: Normative data for paper and pencil tests and ImPACT are presented for the major language groups within the league: English, French, Swedish, Russian, Czech, Finnish, and German (ImPACT only). It was found that symptom reporting, the number of concussions sustained, and neuropsychological test results vary significantly based on a players' language of origin. This variability was also present when players were tested in their language of origin. Conclusions: This study provides insight into the significant baseline differences that exist among NHL players regarding symptoms, concussion history, and cognitive functioning. The findings are discussed with respect to the evaluation and management of NHL players who sustain concussion and more generally in the context of neuropsychological assessment in cross-cultural settings, including the importance of examining neuropsychological functioning using culturally specific norms.	[Echemendia, Ruben J.] Univ Missouri, Psychol & Neurobehav Associates Inc, Kansas City, MO 64110 USA; [Thelen, Joanie; Bruce, Jared M.] Univ Missouri, Kansas City, MO 64110 USA; [Comper, Paul] Toronto Rehabil Inst, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Kinesiol & Phys Educ, Toronto, ON, Canada; [Meeuwisse, Willem] Univ Calgary, Hotchkiss Brain Inst, Sport Med Ctr, Calgary, AB, Canada; [Rizos, John] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada		Echemendia, RJ (corresponding author), Univ Orthoped Ctr, Concuss Care Clin, 101 Regent Ct, State Coll, PA 16801 USA.	rechemendia@comcast.net		Thelen, Joan/0000-0003-1802-9111			Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; ARDILA A, 1995, J CLIN EXP NEUROPSYC, V17, P143, DOI 10.1080/13803399508406589; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT, 1989, MILD HEAD INJURY, P257; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Benton A., 1976, MULTILINGUAL APHASIA; Brandt J., 2005, CLINICAL, V21, P553; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins M. W., 1996, JAMA-J AM MED ASSOC, V282, P964; DElia LF, 1996, COLOR TRAILS TEST; Echemendia R. J., 1999, PSU CANCELLATI UNPUB; Echemendia RJ, 2004, APPL NEUROPSYCHOL, V11, P1, DOI 10.1207/s15324826an1101_1; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2004, STUD NEUROPSYCHOL DE, P435; Echemendia RJ, 2002, STUD NEUROPSYCHOL DE, P181; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson, 2011, LITTLE BLACK BOOK NE; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P., 2016, BRIT J SPORT MED, P1, DOI 10.1136/bjsports-2017-097699; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Mitrushina MN, 1999, HDB NORMATIVE DATA N; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Pedraza O, 2008, NEUROPSYCHOL REV, V18, P184, DOI 10.1007/s11065-008-9067-9; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Robila M, 2007, SOC SCI J, V44, P113, DOI 10.1016/j.soscij.2006.12.025; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Smith A., 1982, SYMBOL DIGITS MODALI; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	51	8	8	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		240	256		10.1093/arclin/acz077			17	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800002	31897473	Bronze			2022-02-06	
J	Schur, S; Martel, P; Marcoux, J				Schur, Solon; Martel, Philippe; Marcoux, Judith			Optimal Bone Flap Size for Decompressive Craniectomy for Refractory Increased Intracranial Pressure in Traumatic Brain Injury: Taking the Patient's Head Size into Account	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Intracranial hypertension; Traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; HYPERTENSION; MANAGEMENT; HEMICRANIECTOMY; CLASSIFICATION; GUIDELINES; MORTALITY; EFFICACY; LESIONS	BACKGROUND: Decompressive craniectomy (DC) is a widely used treatment for refractory high intracranial pressure (ICP). While the Brain Trauma Foundation guidelines favor large DC, there remains a lack of consensus regarding the optimal size of DC in relationship to the patient's head size. The aim of this study is to determine the optimal size of DC to effectively control refractory ICP in traumatic brain injury and to measure that size with a method that takes into consideration the patient's head size. METHODS: All cases of unilateral DC performed to control refractory increased ICP due to cerebral edema during a 71/2-year period were included. Demographic and injury-related data were collected by retrospective chart review. The patients were categorized in 2 groups: 21 patients with a "small flaps" and 9 patients with a "large flap." RESULTS: Two groups had similar preoperative characteristics. The amount of cerebrospinal fluid drained and the doses of hyperosmolar therapy given were not different between the 2 groups. The postoperative ICP was significantly lower for the large craniectomy flap group: 13.3 mm Hg confidence interval 99% [12.7, 13.8] versus 16.9 mm Hg confidence interval 99% [16.5, 17.2] (P = 0.01), and this difference was maintained for 96 hours postoperatively. CONCLUSIONS: Better ICP control was achieved in patients who underwent a large decompressive craniectomy (ratio >65%) when compared with smaller craniectomy sizes. The proposed method of measuring the craniectomy size, to our knowledge, is the first to take into account the patient's head size and can be easily measured intraoperatively.	[Schur, Solon; Marcoux, Judith] McGill Univ, Dept Neurol, Montreal, PQ, Canada; [Schur, Solon; Marcoux, Judith] McGill Univ, Dept Neurosurg, Montreal, PQ, Canada; [Martel, Philippe] Charles LeMoyne Hosp, Dept Neurosurg, Longueuil, PQ, Canada; [Marcoux, Judith] McGill Univ Hlth Ctr, Dept Neurosurg, Montreal, PQ, Canada		Marcoux, J (corresponding author), McGill Univ, Dept Neurol, Montreal, PQ, Canada.; Marcoux, J (corresponding author), McGill Univ, Dept Neurosurg, Montreal, PQ, Canada.; Marcoux, J (corresponding author), McGill Univ Hlth Ctr, Dept Neurosurg, Montreal, PQ, Canada.	judith.marcoux@mcgill.ca					ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Reid P, 2018, WORLD NEUROSURG, V119, pE922, DOI 10.1016/j.wneu.2018.08.005; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; TEASDALE G, 1974, LANCET, V2, P81; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	25	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2020	137						E430	E436		10.1016/j.wneu.2020.01.232			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LN1QT	WOS:000532720800011	32035212				2022-02-06	
J	Ding, WB; Lin, HY; Hong, X; Ji, DL; Wu, F				Ding, Wenbin; Lin, Hongyan; Hong, Xin; Ji, Dongliang; Wu, Feng			Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease	TOXICOLOGY			English	Article						Poloxamer 188; Mild cognitive impairment in Parkinson's disease; Paraquat and maneb; Microglial phagocytic activity	TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; MICROGLIA; SYMPTOMS; DYSFUNCTION; ACTIVATION; DEMENTIA; EXPOSURE	Mild cognitive impairment in Parkinson's disease (PD-MCI) is considered as a nonmotor clinical symptom in Parkinson's disease (PD). Microglia-mediated inflammation contributes to cognitive function impairment. Poloxamer 188 (P188) is an amphipathic polymer which has cytoprotective effect in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic (DA) neurons degeneration in PD. But whether P188 could ameliorate cognitive impairment in PD is still illusive. In the present study, we showed in a mouse model that paraquat (10 mg/kg) and maneb (30 mg/kg) (P + M) treatment intraperitoneally twice a week for 6 consecutive weeks resulted in cognitive deficits and synapse loss in hippocampus, together with DA neuron damage in the substantia nigra pars compacta (SNpc). P188 (0.8 g/kg) injection via tail vein 30 min after P + M administration significantly restored DA neuron numbers in SNpc and synapse density in hippocampus, and alleviated P + M-mediated cognitive function impairment in novel object recognition task and morris water maze task (MWM). Pathological synapse loss might be attributed to increased microglial phagocytic activity and cell density, and P188 prevented P + M-induced phagocytic state changes of microglia, such as increase in cell body size and decrease in process length, and upregulated microglia abundance in hippocampus. Consistently, P188 attenuated P + M-mediated increased mRNA levels of microglia proliferation related CSF1r and CSF2ra, microglial engulfment associated CD68, ICAM1, and ICAM2, and pro-inflammatory IL-6, IL-1 beta, CD11b, and TNF-alpha in hippocampus. Together, these findings suggest that the biocompatible polymer P188 blunts microglia activation which may promote synaptic loss and exacerbate cognitive function in a mouse model of PD-MCI.	[Ding, Wenbin; Lin, Hongyan; Ji, Dongliang; Wu, Feng] Nantong Univ, Sch Pharm, Dept Pharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China; [Ding, Wenbin; Hong, Xin] Nantong Univ, Dept Intervent Radiol, Affiliated Hosp 2, 6 Haier Xiang North Rd, Nantong 226001, Jiangsu, Peoples R China		Wu, F (corresponding author), Nantong Univ, Sch Pharm, Dept Pharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	wf619@ntu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701286]; Research Program of Nantong [JC2019038]	This study was supported by funds from the Natural Science Foundation of China (No. 31300893); the Research Program of Nantong (No. JC2019038); the Natural Science Foundation of China (No. 81701286).	Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bliederhaeuser C, 2016, ACTA NEUROPATHOL, V131, P379, DOI 10.1007/s00401-015-1504-2; Bosboom JLW, 2004, J NEURAL TRANSM, V111, P1303, DOI 10.1007/s00702-004-0168-1; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Cholerton BA, 2014, MOVEMENT DISORD, V29, P756, DOI 10.1002/mds.25875; Dong HL, 2019, NEUROCHEM INT, V126, P178, DOI 10.1016/j.neuint.2019.03.013; Doorn KJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0090-1; Fengler S, 2017, MOVEMENT DISORD, V32, P1655, DOI 10.1002/mds.27135; FERRAZ HB, 1988, NEUROLOGY, V38, P550, DOI 10.1212/WNL.38.4.550; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hou LY, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101134; Huang YR, 2019, NEUROBIOL DIS, V124, P202, DOI 10.1016/j.nbd.2018.11.024; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Jackson-Lewis Vernice, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS183, DOI 10.1016/S1353-8020(11)70057-8; Jo M, 2017, J NEUROSCI, V37, P2878, DOI 10.1523/JNEUROSCI.2534-16.2017; Kehagia AA, 2013, NEURODEGENER DIS, V11, P79, DOI 10.1159/000341998; Li B, 2016, MOL BIOSYST, V12, P3088, DOI 10.1039/c6mb00284f; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; McGregor MM, 2019, NEURON, V101, P1042, DOI 10.1016/j.neuron.2019.03.004; Menza M, 2010, PSYCHOSOMATICS, V51, P474, DOI 10.1176/appi.psy.51.6.474; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; Ojagbemi A, 2013, J PARKINSON DIS, V3, P293, DOI 10.3233/JPD-130210; Paolicelli RC, 2017, NEURON, V95, P297, DOI 10.1016/j.neuron.2017.05.037; Ramirez-Moreno M.J., 2019, MOL NEUROBIOL; Sanchez-Guajardo V, 2015, NEUROSCIENCE, V302, P47, DOI 10.1016/j.neuroscience.2015.02.008; Sethi K, 2008, MOVEMENT DISORD, V23, pS521, DOI 10.1002/mds.22049; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yildirim T, 2015, INT J NEUROSCI, V125, P941, DOI 10.3109/00207454.2014.979289; Zhang YL, 2018, J NEUROTRAUM, V35, P661, DOI 10.1089/neu.2017.5284	35	8	8	6	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-483X			TOXICOLOGY	Toxicology	APR 30	2020	436								152437	10.1016/j.tox.2020.152437			8	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	LD6DI	WOS:000526120100006	32169474				2022-02-06	
J	Rowland, JA; Martindale, SL; Shura, RD; Miskey, HM; Bateman, JR; Epstein, EL; Stern, MJ; Hurley, RA; Taber, KH				Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Miskey, Holly M.; Bateman, James R.; Epstein, Erica L.; Stern, Mark J.; Hurley, Robin A.; Taber, Katherine H.			Initial Validation of the Mid-Atlantic Mental Illness Research, Education, and Clinical Center Assessment of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; deployment; structured interview; TBI; veteran	INTERVIEW	With the increasing prevalence of traumatic brain injury (TBI), the need for reliable and valid methods to evaluate TBI has also increased. The purpose of this study was to establish the validity and reliability of a new comprehensive assessment of TBI, the Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) Assessment of TBI (MMA-TBI). The participants in this study were post-deployment, combat exposed veterans. First, MMA-TBI outcomes were compared with those of independently conducted clinical TBI assessments. Next, MMA-TBI outcomes were compared with those of a different validated TBI measure (the Ohio State University TBI Identification method [OSU-TBI-ID]). Next, four TBI subject matter experts independently evaluated 64 potential TBI events based on both clinical judgment and Veterans Administration/Department of Defense (VA/DoD) Clinical Practice Guidelines. Results of the MMA-TBI algorithm (based on VA/DoD clinical guideline) were compared with those of the subject matter experts. Diagnostic correspondence with independently conducted expert clinical evaluation was 96% for lifetime TBI and 92% for deployment-acquired TBI. Consistency between the MMA-TBI and the OSU-TBI-ID was high (kappa = 0.90; Kendall Tau = 0.94). Comparison of MMA-TBI algorithm results with those of subject matter experts was high (kappa = 0.97-1.00). The MMA-TBI is the first TBI interview to be validated against an independently conducted clinical TBI assessment. Overall, results demonstrate the MMA-TBI is a highly valid and reliable instrument for determining TBI based on VA/DoD clinical guidelines. These results support the need for application of standardized TBI criteria across all diagnostic contexts.	[Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Miskey, Holly M.; Bateman, James R.; Epstein, Erica L.; Stern, Mark J.; Hurley, Robin A.; Taber, Katherine H.] Salisbury VA Med Ctr, Res & Acad Affairs, Salisbury, NC USA; [Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Miskey, Holly M.; Bateman, James R.; Epstein, Erica L.; Stern, Mark J.; Hurley, Robin A.; Taber, Katherine H.] Mid Atlant Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Shura, Robert D.; Miskey, Holly M.; Bateman, James R.; Epstein, Erica L.] Wake Forest Sch Med, Dept Neurol & Psychiat, Winston Salem, NC 27101 USA; [Hurley, Robin A.] Wake Forest Sch Med, Dept Psychiat & Radiol, Winston Salem, NC 27101 USA; [Hurley, Robin A.; Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Taber, Katherine H.] Via Coll Osteopath Med, Dept Phys Med & Rehabil, Blacksburg, VA USA		Rowland, JA (corresponding author), Salisbury VA Med Ctr, Res & Acad Affairs Serv Line, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Jared.Rowland@va.gov	Martindale, Sarah L/O-8553-2018; Rowland, Jared A./AAN-3030-2021	Martindale, Sarah L/0000-0002-0059-3454; Rowland, Jared A./0000-0002-3655-3411; Bateman, James/0000-0002-3646-9148	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENCUS Department of Veterans Affairs [I01 CX001135]; Salisbury VA Medical Center; MidAtlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC); Department of Veterans Affairs Office of Academic Affiliations Advanced Program in Mental Illness, Research, and TreatmentUS Department of Veterans Affairs	This work was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. This research was also supported by the Salisbury VA Medical Center, MidAtlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC) and the Department of Veterans Affairs Office of Academic Affiliations Advanced Program in Mental Illness, Research, and Treatment.	Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davenport ND, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00085; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Management of Concussion/m TBIWG, 2009, J REHABIL RES DEV, V46, pCP1; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Mueller A.E., 2015, ENCY CLIN PSYCHOL, P1; National Academies of Sciences Engineering and Medicine, 2019, EV DIS DET PROC TRAU; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433	12	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2020	37	16					1797	1805		10.1089/neu.2019.6972		APR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	MW0CL	WOS:000530003900001	32245339				2022-02-06	
J	Fairhurst, C; Kumar, R; Checketts, D; Tayo, B; Turner, S				Fairhurst, Charlie; Kumar, Ram; Checketts, Daniel; Tayo, Bola; Turner, Susie			Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							CENTRAL NEUROPATHIC PAIN; DOUBLE-BLIND; PARALLEL-GROUP; VALIDITY; RELIEF	Aim To assess the efficacy, safety, and tolerability of oromucosal nabiximols cannabinoid medicine as adjunct therapy for children with spasticity due to cerebral palsy/traumatic central nervous system injury with inadequate response to existing treatment. Method Overall, 72 patients (mean [SD] age 12y 4mo [3y 1mo], range 8-18y) were randomized at a ratio of 2:1 to receive nabiximols (n=47; 29 males, 18 females) or placebo (n=25; 15 males, 10 females) for 12 weeks (12 sprays/day max. based on clinical response/tolerability). The primary outcome was change from baseline in level of spasticity on a 0 to 10 Numerical Rating Scale (NRS), assessed by the primary caregiver at 12 weeks. Secondary outcomes included additional measures for spasticity, sleep quality, pain, health-related quality of life, comfort, depression, and safety. Results There was no significant difference in the spasticity 0 to 10 NRS between nabiximols versus placebo groups after 12 weeks. No statistically significant differences were observed for any secondary endpoint. Adverse events were predominantly mild or moderate in severity; however, three cases of hallucinations were reported. Interpretation Nabiximols was generally well tolerated; however, neuropsychiatric adverse events were observed. No significant reduction in spasticity with nabiximols treatment versus placebo was observed. What this paper adds Oromucosal nabiximols is generally well tolerated by paediatric patients. However, three cases of hallucinations were observed, one of which involved auditory hallucinations and a suicide attempt. Oromucosal nabiximols versus placebo did not reduce cerebral palsy/central nervous system injury-related spasticity.	[Fairhurst, Charlie; Turner, Susie] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Dept Paediat Neurosci, Westminster Bridge Rd, London SE1 7EH, England; [Kumar, Ram] Alder Hey Childrens Hosp, Dept Paediat Neurol, Liverpool, Merseyside, England; [Checketts, Daniel; Tayo, Bola] GW Res Ltd, Cambridge, England		Fairhurst, C (corresponding author), Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Dept Paediat Neurosci, Westminster Bridge Rd, London SE1 7EH, England.	charlie.fairhurst@gstt.nhs.uk		Fairhurst, Charlie/0000-0002-9534-0563	GW Research Ltd.	The authors would like to thank the patients who took part in the trial, as well as the staff that assisted with the trial at each site. The authors would also like to acknowledge and thank Helen J Dean BSc (Hons) of GW Research Ltd for her contributions to the management of the trial. Finally, the authors would like to thank the 08258 study group. The members of the 08258 study group are as follows: Nick Brown, Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, UK; Lucinda Carr, Great Ormond Street Hospital Foundation Trust, London, UK; Aviva Fattal-Valevski, Dana Children's Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel; Mary Gainsborough, Sirona Care & Health, Bristol, UK; Dafna Guttman, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel; Josef Kraus, Klinika detske neurologie 2. LF UK a FN Motol, Praha 5, Czech Republic; Katherine R Martin, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK; Santosh Mordekar, Sheffield Children's NHS Foundation Trust, Sheffield, UK; Valerie Orr, Royal Hospital for Children Glasgow, Glasgow, UK; Alison Sansome, Cambridge Community Services, Community Child Health, Cambridge, UK; Sarah Steel, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK; Richard Tomlinson, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK; Tong Hong Yeo, Royal Hospital for Children Glasgow, Glasgow, UK; William P Whitehouse, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK. And the safety review team: Alasdair Parker, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Neil Wimalasundera, Great Ormond Street Hospital Foundation Trust, London, UK. This trial was sponsored by GW Research Ltd. Bola Tayo and Daniel Checketts are employees of GW Research Ltd and own shares in GW Pharmaceuticals Plc. Charlie Fairhurst and Susie Turner have served as investigators on a single GW clinical trial each; Ram Kumar has served as an investigator on multiple GW trials. There were no direct or indirect financial gains for investigators.	Akgun K, 2019, J CENT NERV SYST DIS, V11, DOI 10.1177/1179573519831997; Alexander SPH, 2016, PROG NEURO-PSYCHOPH, V64, P157, DOI 10.1016/j.pnpbp.2015.07.001; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Bruni N, 2018, MOLECULES, V23, DOI 10.3390/molecules23102478; Dan B, 2017, DEV MED CHILD NEUROL, V59, P882, DOI 10.1111/dmcn.13496; Davis E, 2013, RES DEV DISABIL, V34, P344, DOI 10.1016/j.ridd.2012.08.018; Farrar JT, 2008, CLIN THER, V30, P974, DOI 10.1016/j.clinthera.2008.05.011; Friedman D, 2019, LANCET NEUROL, V18, P504, DOI 10.1016/S1474-4422(19)30032-8; Gough M, 2018, DEV MED CHILD NEUROL, V60, P638, DOI 10.1111/dmcn.13770; Howlett AC, 2017, ADV PHARMACOL, V80, P169, DOI 10.1016/bs.apha.2017.03.007; Hunt A, 2004, DEV MED CHILD NEUROL, V46, P9, DOI 10.1017/S0012162204000039; ICH Steering Committee, 1996, ICH HARM TRIP GUID G; Koppel BS, 2015, NEUROTHERAPEUTICS, V12, P788, DOI 10.1007/s13311-015-0376-4; Kovacs M., 2010, CHILDRENS DEPRESSION; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Marinelli L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016843; Markova J, 2019, INT J NEUROSCI, V129, P119, DOI 10.1080/00207454.2018.1481066; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mutlu A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-44; National Institute for Health and Care Excellence, 2017, CER PALS 25S ASS MAN; National Institute for Health and Care Excellence, 2012, SPAST 19S MAN CLIN G; Nielsen S, 2019, DEV MED CHILD NEUROL, V61, P631, DOI 10.1111/dmcn.14165; Notcutt W, 2012, MULT SCLER J, V18, P219, DOI 10.1177/1352458511419700; Novotna A, 2011, EUR J NEUROL, V18, P1122, DOI 10.1111/j.1468-1331.2010.03328.x; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Schless SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131011; Serpell MG, 2013, J NEUROL, V260, P285, DOI 10.1007/s00415-012-6634-z; White CM, 2019, J CLIN PHARMACOL, V59, P923, DOI 10.1002/jcph.1387; World Medical Association, 2005, DECL HELS ETH PRINC	30	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	SEP	2020	62	9					1031	+		10.1111/dmcn.14548		APR 2020	10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	MS0XP	WOS:000528812900001	32342496	hybrid			2022-02-06	
J	Champagne, AA; Coverdale, NS; Fernandez-Ruiz, J; Mark, CI; Cook, DJ				Champagne, Allen A.; Coverdale, Nicole S.; Fernandez-Ruiz, Juan; Mark, Clarisse I.; Cook, Douglas J.			Compromised resting cerebral metabolism after sport-related concussion: A calibrated MRI study	BRAIN IMAGING AND BEHAVIOR			English	Article						Cerebral blood flow; Calibrated MRI; Cerebrovascular physiology; Sport-related concussion; Cerebral metabolism	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; OXYGEN-CONSUMPTION; BAYESIAN-INFERENCE; CO2 REACTIVITY; BOLD; HYPERCAPNIA; TIME	Altered resting cerebral blood flow (CBF0) in the acute phase post-concussion may contribute to neurobehavioral deficiencies, often reported weeks after the injury. However, in addition to changes in CBF0, little is known about other physiological mechanisms that may be disturbed within the cerebrovasculature. The aim of this study was to assess whether changes in baseline perfusion following sport-related concussion (SRC) were co-localized with changes in cerebral metabolic demand. Forty-two subjects (15 SRC patients 8.0 +/- 4.6 days post-injury and 27 age-matched healthy control athletes) were studied cross-sectionally. CBF0, cerebrovascular reactivity (CVR), resting oxygen extraction (OEF0) and cerebral metabolic rate of oxygen consumption (CMRO2|0) were measured using a combination of hypercapnic and hyperoxic breathing protocols, and the biophysical model developed in calibrated MRI. Blood oxygenation level dependent and perfusion data were acquired simultaneously using a dual-echo arterial spin labelling sequence. SRC patients showed significant decreases in CBF0 spread across the grey-matter (P < 0.05, corrected), and these differences were also confounded by the effects of baseline end-tidal CO2 (P < 0.0001). Lower perfusion was co-localized with reductions in regional CMRO2|0 (P = 0.006) post-SRC, despite finding no group-differences in OEF0 (P = 0.800). Higher CVR within voxels showing differences in CBF was also observed in the SRC group (P = 0.001), compared to controls. Reductions in metabolic demand despite no significant changes in OEF0 suggests that hypoperfusion post-SRC may reflect compromised metabolic function after the injury. These results provide novel insight about the possible pathophysiological mechanisms underlying concussion that may affect the clinical recovery of athletes after sport-related head injuries.	[Champagne, Allen A.; Coverdale, Nicole S.; Mark, Clarisse I.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Fernandez-Ruiz, Juan] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico; [Cook, Douglas J.] Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada		Cook, DJ (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.; Cook, DJ (corresponding author), Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada.	a.champagne@queensu.ca; nc68@queensu.ca; jfr@unam.mx; dj.cook@queeensu.ca	Fernandez-Ruiz, Juan/B-6154-2012	Fernandez-Ruiz, Juan/0000-0002-4038-0904	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [315705]	This work was supported by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC) through a Collaborative Health Research Project Grant (#315705).	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andersson J. L. R., 2007, PRACTICE; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BARZILAY Z, 1985, AM J PHYSIOL, V248, pH500, DOI 10.1152/ajpheart.1985.248.4.H500; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bhogal AA, 2017, J CEREBR BLOOD F MET, V37, P1461, DOI 10.1177/0271678X16656864; Bhogal AA, 2015, NEUROIMAGE, V114, P239, DOI 10.1016/j.neuroimage.2015.04.014; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bokkers RPH, 2009, NEUROLOGY, V73, P869, DOI 10.1212/WNL.0b013e3181b7840c; Borogovac A, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/818456; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Champagne AA, 2017, NEUROIMAGE, V11, P44; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Chappell M. A, 2014, ARTERIAL SPIN LABELL; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Donahue MJ, 2016, J CEREBR BLOOD F MET, V36, P1767, DOI 10.1177/0271678X15608643; Duffin J, 2015, NEUROIMAGE, V114, P207, DOI 10.1016/j.neuroimage.2015.04.029; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Germuska M, 2016, NEUROIMAGE, V139, P313, DOI 10.1016/j.neuroimage.2016.06.004; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hoge RD, 2012, NEUROIMAGE, V62, P930, DOI 10.1016/j.neuroimage.2012.02.022; HORVATH I, 1994, J CEREBR BLOOD F MET, V14, P503, DOI 10.1038/jcbfm.1994.62; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Jones M, 2005, NEUROIMAGE, V27, P609, DOI 10.1016/j.neuroimage.2005.04.036; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Lajoie I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163071; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Liu PY, 2013, HUM BRAIN MAPP, V34, P2078, DOI 10.1002/hbm.22053; Liu P, 2018, 2018 4TH INTERNATIONAL CONFERENCE ON EDUCATION, MANAGEMENT AND INFORMATION TECHNOLOGY (ICEMIT 2018), P1; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Ma Y., 2014, P 22 SCI M INT SOC M, P3099; Ma YH, 2016, MAGN RESON MED, V76, P1905, DOI 10.1002/mrm.26069; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mutch W. A. C., 2018, FRONTIERS NEUROLOGY, V9; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Poublanc J, 2015, J CEREBR BLOOD F MET, V35, P1746, DOI 10.1038/jcbfm.2015.114; Raji CA, 2018, NEUROIMAG CLIN N AM, V28, P67, DOI 10.1016/j.nic.2017.09.003; Road W. P., 1996, AFNI SOFTWARE ANAL V, V173, P162; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Tower P, 2016, ARTERIAL SPIN LABEL, V281; Tukey J. W., 1977, EXPLORATORY DATA ANA; Umile EM, 1998, BRAIN INJURY, V12, P577; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang Y., 2018, CEREBRAL BLOOD FLOW, DOI [10.1007/s11682-018-9946-5, DOI 10.1007/S11682-018-9946-5]; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Woolrich MW, 2006, MAGN RESON MED, V56, P891, DOI 10.1002/mrm.21039; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Wu WC, 2007, IEEE T MED IMAGING, V26, P1319, DOI 10.1109/TMI.2007.898554; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; YANG SP, 1995, J CEREBR BLOOD F MET, V15, P115, DOI 10.1038/jcbfm.1995.13; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang X, 2013, MAGN RESON MED, V70, P1082, DOI 10.1002/mrm.24550; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	100	8	8	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	FEB	2021	15	1					133	146		10.1007/s11682-019-00240-2		APR 2020	14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PX7WX	WOS:000527895000001	32307673				2022-02-06	
J	Wang, YF; Wang, L; Hu, TP; Wang, F; Han, ZL; Yin, ZY; Ge, XT; Xie, KL; Lei, P				Wang, Yifeng; Wang, Lu; Hu, Tianpeng; Wang, Feng; Han, Zhaoli; Yin, Zhenyu; Ge, Xintong; Xie, Keliang; Lei, Ping			Hydrogen improves cell viability partly through inhibition of autophagy and activation of PI3K/Akt/GSK3 beta signal pathway in a microvascular endothelial cell model of traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Hydrogen; blood-brain barrier; brain microvascular endothelial barrier; traumatic brain injury; autophagy	MOLECULAR-HYDROGEN; INDUCED APOPTOSIS; CORTICAL-NEURONS; IN-VITRO; NEUROPROTECTION; INFLAMMATION; GSK-3-BETA; MTOR	Objective:Traumatic brain injury (TBI) is one of the most serious public health problems in the world. Hydrogen (H-2), a flammable, colorless, and odorless gas, has been observed to have preventive and therapeutic effects on brain trauma and other neurological disorders, but its exact mechanism has not been fully clarified. Methods: To further study the mechanism underlying the role of hydrogen gas in alleviating BBB damage after TBI, we performed the scratch injury model on cultured brain microvascular endothelial cells (bEnd.3), which formed the microvascular endothelial barrier - an integral part of the highly specialized BBB. Results: In the case of TBI, hydrogen was able to improve the decline of cell viability induced by TBI. More importantly, inhibition of PI3 K/Akt/GSK3 beta signal pathway or activation of autophagy reduced the protective effect of hydrogen on cell viability, indicating that such protective effect was regulated by PI3 K/Akt/GSK3 beta signal pathway and was related to the inhibition of autophagy. Conclusion: So we concluded that hydrogen improved the cell viability in a microvascular endothelial cell model of TBI partly through inhibition of autophagy, and inhibitory effect of hydrogen on autophagy was exerted by activating PI3 K/Akt/GSK3 beta signal pathway. These findings enriched our knowledge about the mechanism of hydrogen therapy against TBI.	[Wang, Yifeng; Wang, Lu; Hu, Tianpeng; Wang, Feng; Han, Zhaoli; Yin, Zhenyu; Lei, Ping] Tianjin Med Univ Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Ge, Xintong] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Xie, Keliang] Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ Gen Hosp, Dept Geriatr, Tianjin, Peoples R China.	leiping1974@163.com			Natural Science Foundation of Tianjin Municipal Science and Technology Commission [18JCQNJC81100]; Youth Incubation Foundation of General Hospital of Tianjin Medical University [ZYYFY2017036]	This work was supported by the Natural Science Foundation of Tianjin Municipal Science and Technology Commission; under Grant Nos. 18JCQNJC81100; and the Youth Incubation Foundation of General Hospital of Tianjin Medical University; under Grant Nos. ZYYFY2017036.	Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Che W, 2017, BRAIN RES BULL, V131, P100, DOI 10.1016/j.brainresbull.2017.03.014; Chen HG, 2013, INT J SURG, V11, P1060, DOI 10.1016/j.ijsu.2013.10.007; Chen KY, 2017, CELL PHYSIOL BIOCHEM, V43, P1634, DOI 10.1159/000484024; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; de Munck E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162723; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Ge L, 2017, ONCOTARGET, V8, P102653, DOI 10.18632/oncotarget.21130; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jowers CT, 2013, J NEUROSCI METH, V218, P1, DOI 10.1016/j.jneumeth.2013.04.020; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089; Li HY, 2014, TRANSL STROKE RES, V5, P618, DOI 10.1007/s12975-014-0354-x; Li Q, 2011, ANGIOGENESIS, V14, P173, DOI 10.1007/s10456-011-9201-9; Li XS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00127; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YP, 2019, INFLAMMATION, V42, P586, DOI 10.1007/s10753-018-0915-3; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martinotti S, 2020, METHODS MOL BIOL, V2109, P225, DOI 10.1007/7651_2019_259; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Quan XJ, 2019, ACTA PHARMACOL SIN, V40, P648, DOI 10.1038/s41401-018-0109-4; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sophia J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1126-4; Sun DL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/985457; Thabet NM, 2018, ARCH PHYSIOL BIOCHEM, V124, P185, DOI 10.1080/13813455.2017.1374978; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Wang CQ, 2017, NEUROSCIENCE, V343, P30, DOI 10.1016/j.neuroscience.2016.11.029; Wang L, 2018, SHOCK, V50, P308, DOI 10.1097/SHK.0000000000001018; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Xin YC, 2017, NEUROREPORT, V28, P694, DOI 10.1097/WNR.0000000000000824; Yu QJ, 2015, NEURAL REGEN RES, V10, P1882, DOI 10.4103/1673-5374.170324; Yu Y, 2015, MOL MED REP, V12, P3986, DOI 10.3892/mmr.2015.3874; Zhou XG, 2011, BIOCHEM BIOPH RES CO, V411, P271, DOI 10.1016/j.bbrc.2011.06.117	41	8	8	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN 2	2020	42	6					487	496		10.1080/01616412.2020.1747717		APR 2020	10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK7QE	WOS:000526652600001	32292127				2022-02-06	
J	Plessow, F; Pascual-Leone, A; McCracken, CM; Baker, J; Krishnan, S; Baggish, A; Connor, A; Courtney, TK; Nadler, LM; Speizer, FE; Taylor, HA; Weisskopf, MG; Zafonte, RD; Meehan, WP				Plessow, Franziska; Pascual-Leone, Alvaro; McCracken, Caitlin M.; Baker, Jillian; Krishnan, Supriya; Baggish, Aaron; Connor, Ann; Courtney, Theodore K.; Nadler, Lee M.; Speizer, Frank E.; Taylor, Herman A.; Weisskopf, Marc G.; Zafonte, Ross D.; Meehan, William P., III			Self-Reported Cognitive Function and Mental Health Diagnoses among Former Professional American-Style Football Players	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; football; mental health; quality of life	RETIRED NFL PLAYERS; DEPRESSIVE SYMPTOMS; LEAGUE PLAYERS; MASCULINITY; DISORDERS; RISK; HELP; PERFORMANCE; DYSFUNCTION; CONCUSSIONS	Clinical practice strongly relies on patients' self-report. Former professional American-style football players are hesitant to seek help for mental health problems, but may be more willing to report cognitive symptoms. We sought to assess the association between cognitive symptoms and diagnosed mental health problems and quality of life among a cohort of former professional players. In a cross-sectional design, we assessed self-reported cognitive function using items from the Quality of Life in Neurological Disorders (Neuro-QOL) Item Bank. We then compared mental health diagnoses and quality of life, assessed by items from the Patient-Reported Outcome Measurement Information System (PROMIS(R)), between former professional players reporting daily problems in cognitive function and former players not reporting daily cognitive problems. Of the 3758 former professional players included in the analysis, 40.0% reported daily problems due to cognitive dysfunction. Former players who reported daily cognitive problems were more likely to also report depression (18.0% vs. 3.3%, odds ratio [OR] = 6.42, 95% confidence interval [CI] [4.90-8.40]) and anxiety (19.1% vs. 4.3%, OR = 5.29, 95% CI [4.14-6.75]) than those without daily cognitive problems. Further, former players reporting daily cognitive problems were more likely to report memory loss and attention deficit(/hyperactivity) disorder and poorer general mental health, lower quality of life, less satisfaction with social activities and relationships, and more emotional problems. These findings highlight the potential of an assessment of cognitive symptoms for identifying former players with mental health, social, and emotional problems.	[Plessow, Franziska; Pascual-Leone, Alvaro; McCracken, Caitlin M.; Baker, Jillian; Krishnan, Supriya; Baggish, Aaron; Connor, Ann; Courtney, Theodore K.; Nadler, Lee M.; Speizer, Frank E.; Taylor, Herman A.; Weisskopf, Marc G.; Zafonte, Ross D.; Meehan, William P., III] Harvard Univ, Football Players Hlth Study, Harvard Med Sch, Boston, MA 02115 USA; [Plessow, Franziska] Massachusetts Gen Hosp, Dept Med, Neuroendocrine Unit, Boston, MA 02114 USA; [Plessow, Franziska; Pascual-Leone, Alvaro; Baggish, Aaron; Connor, Ann; Speizer, Frank E.; Zafonte, Ross D.; Meehan, William P., III] Harvard Med Sch, 401 Pk Dr,Suite 504W, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Boston, MA USA; [Pascual-Leone, Alvaro] Hebrew SeniorLife, Ctr Memory Hlth, Dept Neurol, Boston, MA USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Guttmann Brain Hlth Inst, Inst Guttmann, Barcelona, Spain; [McCracken, Caitlin M.] Oregon State Univ, Coll Pharm, Oregon Hlth Sci Univ, Portland, OR USA; [Baggish, Aaron] Massachusetts Gen Hosp, Dept Med, Cardiovasc Performance Program, Boston, MA 02114 USA; [Connor, Ann] Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Connor, Ann] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cognit Neurol, Boston, MA 02215 USA; [Courtney, Theodore K.; Speizer, Frank E.; Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Nadler, Lee M.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Speizer, Frank E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Taylor, Herman A.] Morehouse Med Sch, Cardiovasc Res Inst, Dept Med, Atlanta, GA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02114 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Pediat & Orthoped, Boston, MA USA		Plessow, F (corresponding author), Harvard Med Sch, 401 Pk Dr,Suite 504W, Boston, MA 02115 USA.	fplessow@mgh.harvard.edu	Courtney, Theodore K./P-4829-2019	Courtney, Theodore K./0000-0001-8139-1565	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025758] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21 AG051846, P01 AG031720] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH115949, R01 MH117063, R01 MH100186, R01 MH111875] Funding Source: Medline		Addis ME, 2005, J CLIN PSYCHOL, V61, P633, DOI 10.1002/jclp.20099; Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Airaksinen E, 2007, ACTA PSYCHIAT SCAND, V115, P458, DOI 10.1111/j.1600-0447.2006.00932.x; Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Brody D.J., 2018, PREVALENCE DEPRESSIO; Brooks GR, 2001, J AM COLL HEALTH, V49, P285, DOI 10.1080/07448480109596315; Buckholtz JW, 2012, NEURON, V74, P990, DOI 10.1016/j.neuron.2012.06.002; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Centers for Disease Control and Prevention, 2016, ALC US YOUR HLTH; Churchill TW, 2018, AM J MED, V131, P1491, DOI 10.1016/j.amjmed.2018.07.042; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Franz CE, 2011, AM J GERIAT PSYCHIAT, V19, P559, DOI 10.1097/JGP.0b013e3181ef79f1; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Gouttebarge V, 2017, INT J SPORTS MED, V38, P864, DOI 10.1055/s-0043-114010; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hasselbalch BJ, 2013, EUR PSYCHIAT, V28, P349, DOI 10.1016/j.eurpsy.2012.03.004; Jones TV, 2016, J MENT HEALTH, V25, P422, DOI 10.3109/09638237.2015.1124384; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; McGraw SA, 2018, J CLIN SPORT PSYCHOL, V12, P404, DOI 10.1123/jcsp.2017-0051; McTeague LM, 2016, J PSYCHIATR RES, V83, P37, DOI 10.1016/j.jpsychires.2016.08.001; Meehan WP, 2018, AM J CARDIOL, V122, P1879, DOI 10.1016/j.amjcard.2018.08.030; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; National Institute of Neurological Disorders and Stroke, 2010, US MAN QUAL LIF NEUR; Parker R, 2000, HEALTH PROMOT INT, V15, P277, DOI 10.1093/heapro/15.4.277; Samson RD, 2013, EUR J NEUROSCI, V37, P1903, DOI 10.1111/ejn.12183; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Simons CJP, 2009, ACTA PSYCHIAT SCAND, V120, P45, DOI 10.1111/j.1600-0447.2008.01339.x; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Steinfeldt JA, 2012, SPORT EXERC PERFORM, V1, P58, DOI 10.1037/a0024919; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; van der Flier WM, 2004, J NEUROL, V251, P671, DOI 10.1007/s00415-004-0390-7; Zafonte R, 2019, AM J IND MED, V62, P643, DOI 10.1002/ajim.22991	42	8	8	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1021	1028		10.1089/neu.2019.6661			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000525347900001	31672091	hybrid, Green Published			2022-02-06	
J	Craig, DI; Lininger, MR; Wayment, HA; Huffman, AH				Craig, Debbie I.; Lininger, Monica R.; Wayment, Heidi A.; Huffman, Ann H.			Investigation of strategies to improve concussion reporting in American football	RESEARCH IN SPORTS MEDICINE			English	Article						Sport-related concussion; community-based participatory research; American football; concussion reporting	SPORT; KNOWLEDGE; ATTITUDES; EDUCATION; DISCLOSURE; SYMPTOMS; HISTORY	While research on sport-related concussion has increased dramatically over the past decade, research investigating concussion reporting is in its early stages. The purpose of this project was to assess concussion reporting and work with stakeholders to develop and assess strategies to improve reporting. We used a multi-site, repeated measures design with three NCAA Division I football programs, including 223 athlete participants. A modified community-based participatory research (CBPR) approach was used to develop intervention strategies (Fall 2017 season) with stakeholders designed to increase concussion reporting intentions. Preseason and postseason surveys were administered to determine effectiveness. Main outcome measures included concussion knowledge, intervention effectiveness, and reporting intention measures. For all three programs, concussion knowledge was unrelated to reporting intentions. Two of the three programs implemented the intervention strategies and for these programs there was evidence that the interventions were effective. Specifically, athletes from these two programs perceived more support from coaches about reporting (P< 0.05; t= 2.83), received education more frequently (P< 0.05; t= 2.67), and reported being more likely to report concussion symptoms (P< 0.05; t= 2.14). Our study demonstrates that working with stakeholders to develop site-specific strategies to improve concussion reporting is an effective approach to help improve reporting behaviours.	[Craig, Debbie I.; Lininger, Monica R.] No Arizona Univ, Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Wayment, Heidi A.; Huffman, Ann H.] No Arizona Univ, WA Franke Coll Business, Psychol Sci, Flagstaff, AZ 86011 USA		Craig, DI (corresponding author), No Arizona Univ, Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA.	debbie.craig@nau.edu		Wayment, Heidi/0000-0001-5287-5966			Adame BJ, 2019, HEALTH COMMUN, V34, P1673, DOI 10.1080/10410236.2018.1517707; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Benton R. L., 1990, STAT POWER PLANNED C; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cripps A, 2017, J SPORT REHABIL, V26, P101, DOI 10.1123/jsr.2015-0043; D'Lauro C, 2017, BRIT J SPORT MED, V51, pA64; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hahs-Vaughn D.L, 2012, INTRO STAT CONCEPTS; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hopkins WG, 2018, NEW VIEW STAT; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; The Network for Public Health Law web site, 2014, SUMM MATR STAT LAWS; Valovich McLeod TC, 2017, J ATHL TRAINING, V52, P262; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	41	8	8	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	APR 2	2020	28	2					181	193		10.1080/15438627.2019.1586706			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	LK7PT	WOS:000531054800003	30859851				2022-02-06	
J	Brady, RD; Zhao, MZ; Wong, KR; Casilla-Espinosa, PM; Yamakawa, GR; Wortman, RC; Sun, M; Grills, BL; Mychasiuk, R; O'Brien, TJ; Agoston, DV; Lee, PVS; McDonald, SJ; Robinson, DL; Shultz, SR				Brady, Rhys D.; Zhao, Michael Z.; Wong, Ker R.; Casilla-Espinosa, Pablo M.; Yamakawa, Glenn R.; Wortman, Ryan C.; Sun, Mujun; Grills, Brian L.; Mychasiuk, Richelle; O'Brien, Terence J.; Agoston, Denes, V; Lee, Peter V. S.; McDonald, Stuart J.; Robinson, Dale L.; Shultz, Sandy R.			A novel rat model of heterotopic ossification after polytrauma with traumatic brain injury	BONE			English	Article						Ectopic bone; Fracture; Musculoskeletal injury; Femur; Computed tomography; Brady model	SPINAL-CORD-INJURY; EPIDEMIOLOGY; PREVALENCE; RECURRENCE; FRACTURES; IMPACT	Neurological heterotopic ossification (NHO) is characterized by abnormal bone growth in soft tissue and joints in response to injury to the central nervous system. The ectopic bone frequently causes pain, restricts mobility, and decreases the quality of life for those affected. NHO commonly develops in severe traumatic brain injury (TBI) patients, particularly in the presence of concomitant musculoskeletal injuries (i.e. polytrauma). There are currently no animal models that accurately mimic these combinations of injuries, which has limited our understanding of NHO pathobiology, as well as the development of biomarkers and treatments, in TBI patients. In order to address this shortcoming, here we present a novel rat model that combines TBI, femoral fracture, and muscle crush injury. Young adult male Sprague Dawley rats were randomly assigned into three different injury groups: triple sham-injury, peripheral injury only (i.e., sham-TBI + fracture + muscle injury) or triple injury (i.e., TBI + fracture + muscle injury). Evidence of ectopic bone in the injured hind-limb, as confirmed by micro-computed tomography (mu CT), was found at 6-weeks post-injury in 70% of triple injury rats, 20% of peripheral injury rats, and 0% of the sham-injured controls. Furthermore, the triple injury rats had higher ectopic bone severity scores than the sham-injured group. This novel model will provide a platform for future studies to identify underlying mechanisms, biomarkers, and develop evidence based pharmacological treatments to combat this debilitating long-term complication of TBI and polytrauma.	[Brady, Rhys D.; Zhao, Michael Z.; Wong, Ker R.; Casilla-Espinosa, Pablo M.; Yamakawa, Glenn R.; Wortman, Ryan C.; Sun, Mujun; Mychasiuk, Richelle; O'Brien, Terence J.; McDonald, Stuart J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Brady, Rhys D.; Casilla-Espinosa, Pablo M.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Grills, Brian L.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Agoston, Denes, V] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA; [Lee, Peter V. S.; Robinson, Dale L.] Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia		Brady, RD (corresponding author), Monash Univ, Dept Neurosci, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	rhys.brady@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Sun, Mujun/0000-0002-9923-9913; Yamakawa, Glenn/0000-0003-3079-6532; Robinson, Dale/0000-0003-1486-6991; McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621	Monash UniversityMonash University; Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; NHMRC ECR FellowshipNational Health and Medical Research Council of Australia [APP1166170]	This study was funded by a grant to RDB from Monash University, and a fellowship from the Australian National Health and Medical Research Council (NHMRC) to SRS. PMCE was funded by a NHMRC ECR Fellowship (#APP1166170). The authors would like to acknowledge Paul S. Hood, Stephen K. Hood and Michael A. Ryan for their assistance in constructing the injury device use to administer the muscle crush and fracture.	Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Argyropoulou MI, 2006, CRIT CARE, V10, DOI 10.1186/cc5083; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Convente MR, 2015, CURR OSTEOPOROS REP, V13, P116, DOI 10.1007/s11914-015-0258-z; Davies OG, 2015, CALCIFIED TISSUE INT, V97, P432, DOI 10.1007/s00223-015-0034-1; De Giacomo A, 2014, METHODS MOL BIOL, V1130, P35, DOI 10.1007/978-1-62703-989-5_3; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Eisenstein N, 2018, J ORTHOP RES, V36, P1061, DOI 10.1002/jor.23808; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hoyt BW, 2018, BONE, V109, P3, DOI 10.1016/j.bone.2018.02.009; Irie Milena Suemi, 2018, Braz Dent J, V29, P227, DOI 10.1590/0103-6440201801979; Kan L., 2011, BIOMED RES INT, V2010; Kan LX, 2011, J CELL BIOCHEM, V112, P2759, DOI 10.1002/jcb.23259; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; Kraft CT, 2016, J TRAUMA ACUTE CARE, V80, P156, DOI 10.1097/TA.0000000000000883; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Ranganathan K, 2015, PLAST RECONSTR SURG, V135, P1631, DOI 10.1097/PRS.0000000000001266; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sun M., 2019, AGED RATS HAVE ALTER; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wehner T, 2011, CLIN BIOMECH, V26, P147, DOI 10.1016/j.clinbiomech.2010.09.009; Wright D. W., 2019, SCI REP-UK, V9, P1; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	38	8	9	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	8756-3282	1873-2763		BONE	Bone	APR	2020	133								115263	10.1016/j.bone.2020.115263			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	KR1BX	WOS:000517355400033	32032779				2022-02-06	
J	Donnelly, J; Smielewski, P; Adams, H; Zeiler, FA; Cardim, D; Liu, XY; Fedriga, M; Hutchinson, P; Menon, DK; Czosnyka, M				Donnelly, Joseph; Smielewski, Peter; Adams, Hadie; Zeiler, Frederick A.; Cardim, Danilo; Liu, Xiuyun; Fedriga, Marta; Hutchinson, Peter; Menon, David K.; Czosnyka, Marek			Observations on the Cerebral Effects of Refractory Intracranial Hypertension After Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Intracranial pressure; Cerebral hemodynamics; Autoregulation; Cerebral oxygenation; Cerebral perfusion pressure; Intracranial hypertension	CEREBROVASCULAR AUTOREGULATION; OXYGEN DELIVERY; BLOOD-FLOW; PRESSURE; METABOLISM; REACTIVITY; DIFFUSION	Background Raised intracranial pressure (ICP) is a prominent cause of morbidity and mortality after severe traumatic brain injury (TBI). However, in the clinical setting, little is known about the cerebral physiological response to severe and prolonged increases in ICP. Methods Thirty-three severe TBI patients from a single center who developed severe refractory intracranial hypertension (ICP > 40 mm Hg for longer than 1 h) with ICP, arterial blood pressure, and brain tissue oxygenation (PBTO2) monitoring (subcohort, n = 9) were selected for retrospective review. Secondary parameters reflecting autoregulation (including pressure reactivity index-PRx, which was available in 24 cases), cerebrospinal compensatory reserve (RAP), and ICP pulse amplitude were calculated. Results PRx deteriorated from 0.06 +/- 0.26 a.u. at baseline levels of ICP to 0.57 +/- 0.24 a.u. (p < 0.0001) at high levels of ICP (> 50 mm Hg). In 4 cases, PRx was impaired (> 0.25 a.u.) before ICP was raised above 25 mm Hg. Concurrently, PBTO2 decreased from 27.3 +/- 7.32 mm Hg at baseline ICP to 12.68 +/- 7.09 mm Hg at high levels of ICP (p < 0.001). The pulse amplitude of the ICP waveform increased with increasing ICP but showed an 'upper breakpoint'-whereby further increases in ICP lead to decreases in pulse amplitude-in 6 out of the 33 patients. Discussion Severe intracranial hypertension after TBI leads to decreased brain oxygenation, impaired pressure reactivity, and changes in the pulse amplitude of ICP. Impaired pressure reactivity may denote increased risk of developing refractory intracranial hypertension in some patients.	[Donnelly, Joseph; Smielewski, Peter; Liu, Xiuyun; Fedriga, Marta; Czosnyka, Marek] Univ Cambridge, Brain Phys Lab, Div Neurosurg, Dept Clin Neurosci, Cambridge Biomed Campus, Cambridge, England; [Donnelly, Joseph] Univ Auckland, Dept Anaesthesiol, Auckland City Hosp, Level 12,Auckland Support Bldg,2 Pk Rd, Auckland, New Zealand; [Adams, Hadie; Hutchinson, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Dept Med, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Cardim, Danilo] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver Gen Hosp, Vancouver, BC, Canada; [Hutchinson, Peter; Menon, David K.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Donnelly, J (corresponding author), Univ Auckland, Dept Anaesthesiol, Auckland City Hosp, Level 12,Auckland Support Bldg,2 Pk Rd, Auckland, New Zealand.	joseph.donnelly@cantab.net	Cardim, Danilo Augusto/B-8447-2012; Liu, Xiuyun/V-4427-2017; Donnelly, Joseph/E-9235-2018	Cardim, Danilo Augusto/0000-0002-9261-1321; Liu, Xiuyun/0000-0001-9540-4865; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510			Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Beiner JM, 1997, COMP BIOCHEM PHYS A, V116, P245, DOI 10.1016/S0300-9629(96)00206-X; CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874; Czosnyka M, 2016, ACTA NEUROCHIR SUPPL, V122, P113, DOI 10.1007/978-3-319-22533-3_22; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Donnelly J, 2018, J CEREB BLOOD FLOW M; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Lang EW, 2015, NEUROCRIT CARE, V23, P85, DOI 10.1007/s12028-014-0074-9; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; NAGAO S, 1984, J NEUROSURG, V60, P566, DOI 10.3171/jns.1984.60.3.0566; NAKAGAWA Y, 1974, J NEUROSURG, V41, P427, DOI 10.3171/jns.1974.41.4.0427; Narotam PK, 2014, J NEUROTRAUM, V31, P630, DOI 10.1089/neu.2013.3104; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Team RC, 2019, R LANG ENV STAT COMP; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Wickham H, 2009, ELEGANT GRAPHICS DAT; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	31	8	9	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2020	32	2					437	447		10.1007/s12028-019-00748-x			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KV8ES	WOS:000520711600014	31240622	Green Published, hybrid			2022-02-06	
J	Sharma, S; Kumar, A; Choudhary, A; Sharma, S; Khurana, L; Sharma, N; Kumar, V; Bisht, A				Sharma, Swapnil; Kumar, Ashok; Choudhary, Ajay; Sharma, Shallu; Khurana, Lipika; Sharma, Neera; Kumar, Vijender; Bisht, Akansha			Neuroprotective Role of Oral Vitamin D Supplementation on Consciousness and Inflammatory Biomarkers in Determining Severity Outcome in Acute Traumatic Brain Injury Patients: A Double-Blind Randomized Clinical Trial	CLINICAL DRUG INVESTIGATION			English	Article							SUBARACHNOID HEMORRHAGE; PROGESTERONE; EPIDEMIOLOGY; RESPONSES	Background and Objective Early management of traumatic brain injury (TBI) is essential. We aimed to evaluate the efficacy of vitamin D over early clinical outcome and serum cytokine levels in patients with moderate to severe brain injury. Methods Thirty-five patients with moderate to severe traumatic brain injury who were admitted to the ICU unit were recruited into the study. Subjects were randomly allocated to a treatment regimen comprising either a one-time oral dose of 120,000 IU (two tablets of 60,000 IU each) of vitamin D (n = 20) or 8 mg of saccharide (two tablets of 4 g each) as placebo (n = 15). The main parameters evaluated included duration of mechanical ventilation and ICU stay, Glasgow Coma Scale (GCS) and cytokine levels (interleukin (IL)-6, tumour necrosis factor (TNF)-alpha, interferon (IFN)-gamma, IL-2). Results The results indicated an improvement in the level of consciousness after 7 days in the vitamin D-treated group compared with placebo. An elevation in GCS score by 3.86 units in the vitamin D-treated group with a 0.19-unit descent in the control group was recorded. Duration of mechanical ventilation was reduced in the vitamin D-treated group compared with the control group (4.7 days vs. 8.2 days, p value 0.0001). A noticeable reduction was recorded in inflammatory biomarkers (cytokines) in the vitamin D-treated group (IL-6 p = 0.08, TNF-alpha p = 0.02, IL-2 p = 0.36) with notable elevation in IFN-gamma (p = 0.65) compared to the control group. Conclusion In the acute phase of moderate to severe traumatic brain injury, vitamin D supplementation plays a vital role and has a favourable effect on the consciousness level of patients. Clinical trial Registry (CTRI) No. CTRI/2019/05/019259.	[Sharma, Swapnil; Kumar, Ashok; Sharma, Shallu; Bisht, Akansha] Banasthali Vidyapith, Dept Pharm, Banasthali 304022, Rajasthan, India; [Choudhary, Ajay] Dr RML Hosp, PGIMER, Dept Neurosurg, New Delhi 110001, India; [Khurana, Lipika] Sir Ganga Ram Hosp, Inst Obstet & Gynaecol, New Delhi 110060, India; [Sharma, Neera; Kumar, Vijender] Dr RML Hosp, PGIMER, Dept Biochem, New Delhi 110001, India		Choudhary, A (corresponding author), Dr RML Hosp, PGIMER, Dept Neurosurg, New Delhi 110001, India.	ajay7.choudhary@gmail.com	Choudary, Ajay/ABA-9382-2021	Choudary, Ajay/0000-0002-7153-8057; Kumar, Dr. Ashok/0000-0001-5735-3067			Alexander M, 1995, NEUROLOGY, V45, P50; Aminmansour B, 2012, ADV BIOMEDICAL RES, V4, P1; Bratton S, 2007, J NEUROTRAUM, V24, P59, DOI DOI 10.1089/neu.2007.9987; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Itoh T, 2013, J NEURAL TRANSM, V120, P767, DOI 10.1007/s00702-012-0918-4; KARPIAK SE, 1976, BRAIN RES, V102, P313, DOI 10.1016/0006-8993(76)90885-4; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lin AMY, 2003, FREE RADICAL BIO MED, V34, P1416, DOI 10.1016/S0891-5849(03)00105-9; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; McCarty MF, 2005, MED HYPOTHESES, V64, P1022, DOI 10.1016/j.mehy.2004.03.041; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Stein DG, 2011, PHYS MED REHABIL, V3, P100; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang HL, 2015, BRAIN INJURY, V29, P1165, DOI 10.3109/02699052.2015.1035330; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Wei IH, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-52; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yun HJ, 2008, RHEUMATOL INT, V29, P23, DOI 10.1007/s00296-008-0597-5	34	8	8	1	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	APR	2020	40	4					327	334		10.1007/s40261-020-00896-5			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KY3BL	WOS:000522445900004	32172522	Green Published, Bronze			2022-02-06	
J	Lalou, AD; Levrini, V; Czosnyka, M; Gergele, L; Garnett, M; Kolias, A; Hutchinson, PJ; Czosnyka, Z				Lalou, Afroditi D.; Levrini, Virginia; Czosnyka, Marek; Gergele, Laurent; Garnett, Matthew; Kolias, Angelos; Hutchinson, Peter J.; Czosnyka, Zofia			Cerebrospinal fluid dynamics in non-acute post-traumatic ventriculomegaly	FLUIDS AND BARRIERS OF THE CNS			English	Article						Cerebrospinal fluid; CSF dynamics; CSF infusion test; Hydrocephalus; Traumatic brain injury; Ventriculomegaly	INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; INFUSION TEST; COMPENSATORY RESERVE; CSF CIRCULATION; HYDROCEPHALUS; OUTFLOW; RESISTANCE; INDEX	Background Post-traumatic hydrocephalus (PTH) is potentially under-diagnosed and under-treated, generating the need for a more efficient diagnostic tool. We aim to report CSF dynamics of patients with post-traumatic ventriculomegaly. Materials and methods We retrospectively analysed post-traumatic brain injury (TBI) patients with ventriculomegaly who had undergone a CSF infusion test. We calculated the resistance to CSF outflow (Rout), AMP (pulse amplitude of intracranial pressure, ICP), dAMP (AMPplateau-AMPbaseline) and compensatory reserve index correlation coefficient between ICP and AMP (RAP). To avoid confounding factors, included patients had to be non-decompressed or with cranioplasty > 1 month previously and Rout > 6 mmHg/min/ml. Compliance was assessed using the elasticity coefficient. We also compared infusion-tested TBI patients selected for shunting versus those not selected for shunting (consultant decision based on clinical and radiological assessment and the infusion results). Finally, we used data from a group of shunted idiopathic Normal Pressure Hydrocephalus (iNPH) patients for comparison. Results Group A consisted of 36 patients with post-traumatic ventriculomegaly and Group B of 45 iNPH shunt responders. AMP and dAMP were significantly lower in Group A than B (0.55 +/- 0.39 vs 1.02 +/- 0.72; p < 0.01 and 1.58 +/- 1.21 vs 2.76 +/- 1.5; p < 0.01. RAP baseline was not significantly different between the two. Elasticity was higher than the normal limit in all groups (average 0.18 1/ml). Significantly higher Rout was present in those with probable PTH selected for shunting compared with unshunted. Mild/moderate hydrocephalus, ex-vacuo ventriculomegaly/encephalomalacia were inconsistently reported in PTH patients. Conclusions Rout and AMP were significantly lower in PTH compared to iNPH and did not always reflect the degree of hydrocephalus or atrophy reported on CT/MRI. Compliance appears reduced in PTH.	[Lalou, Afroditi D.; Levrini, Virginia; Czosnyka, Marek; Gergele, Laurent; Garnett, Matthew; Kolias, Angelos; Hutchinson, Peter J.; Czosnyka, Zofia] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Lalou, Afroditi D.; Levrini, Virginia; Czosnyka, Marek; Gergele, Laurent; Garnett, Matthew; Kolias, Angelos; Hutchinson, Peter J.; Czosnyka, Zofia] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Gergele, Laurent] Hop Prive Loire, Dept Intens Care, St Etienne, France		Lalou, AD (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Lalou, AD (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.	adl43@cam.ac.uk	; Lalou, Afroditi Despina/D-2938-2017	GERGELE, Laurent/0000-0002-7283-6793; Lalou, Afroditi Despina/0000-0003-3768-8681; Kolias, Angelos/0000-0003-3992-0587			[Anonymous], 2008, INTR PROC GUID IPG26; Bech-Azeddine R, 2005, ACTA NEUROCHIR, V147, P1027, DOI 10.1007/s00701-005-0589-0; BORGESEN SE, 1982, BRAIN, V105, P65, DOI 10.1093/brain/105.1.65; BORGESEN SE, 1992, ACTA NEUROCHIR, V119, P12, DOI 10.1007/BF01541775; Cartwright C, 2015, J CHILD NEUROL, V30, P170, DOI 10.1177/0883073814533006; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CZOSNYKA M, 1988, ACTA NEUROCHIR, V93, P140, DOI 10.1007/BF01402897; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; CZOSNYKA M, 1993, CHILD NERV SYST, V9, P17, DOI 10.1007/BF00301929; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; CZOSNYKA M, 1990, ACTA NEUROCHIR, V106, P1, DOI 10.1007/BF01809325; Czosnyka M, 2007, NEUROSURG FOCUS, V22, P5; Czosnyka M, 2012, ACTA NEUROCHIR SUPPL, V113, P71, DOI 10.1007/978-3-7091-0923-6_15; Czosnyka Z, 2008, EUR J ANAESTH, V25, P142, DOI 10.1017/S0265021507003249; Czosnyka Z, 2005, ACTA NEUROCHIR SUPPL, V95, P247; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Eide PK, 2007, NEUROL RES, V29, P798, DOI 10.1179/016164107X224132; Eisentrager A, 2013, MATH MED BIOL, V30, P157, DOI 10.1093/imammb/dqs001; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; EKSTEDT J, 1977, J NEUROL NEUROSUR PS, V40, P105, DOI 10.1136/jnnp.40.2.105; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Guyot LL, 2000, NEUROL RES, V22, P25; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Juniewicz H, 2005, PHYSIOL MEAS, V26, P1039, DOI 10.1088/0967-3334/26/6/013; Kant IMJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47731-2; Kasprowicz M, 2016, ACTA NEUROL SCAND, V134, P168, DOI 10.1111/ane.12541; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Kojoukhova M, 2015, ACTA NEUROCHIR, V157, P1709, DOI 10.1007/s00701-015-2503-8; Kowalsky RJ, 2018, J PHYS ACT HEALTH, V15, P788, DOI [10.1123/jpah.2017-0639, 10.3171/2017.7.JNS17555]; Lalou AD, 2019, J NEUROSURG, V130, P154, DOI 10.3171/2017.7.JNS17216; Lalou AD, 2018, ACTA NEUROCHIR, V160, P1097, DOI 10.1007/s00701-018-3497-9; Lalou DA, 2016, NEUROL RES, V38, P587, DOI 10.1080/01616412.2016.1189200; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Lilja-Cyron A, 2020, NEUROSURGERY, V86, P231, DOI 10.1093/neuros/nyz049; Malm J, 2011, NEUROLOGY, V76, P903, DOI 10.1212/WNL.0b013e31820f2dd0; Manet R, 2017, ACTA NEUROCHIR, V159, P2003, DOI 10.1007/s00701-017-3290-1; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Nabbanja E, 2018, ACTA NEUROCHIR SUPPL, V126, P229, DOI 10.1007/978-3-319-65798-1_46; Owler BK, 2004, J CEREBR BLOOD F MET, V24, P579, DOI 10.1097/00004647-200405000-00012; Owler BK, 2001, BRIT J NEUROSURG, V15, P439, DOI 10.1080/02688690120082477; Reinard Kevin, 2015, Surg Neurol Int, V6, P59, DOI 10.4103/2152-7806.154777; Swallow DMA, 2014, ACTA NEUROL SCAND, V130, P131, DOI 10.1111/ane.12246; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Toma AK, 2011, NEUROSURGERY, V68, P245, DOI 10.1227/NEU.0b013e318214a809; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241	55	8	8	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	MAR 30	2020	17	1							24	10.1186/s12987-020-00184-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LA1GI	WOS:000523702900002	32228689	Green Published, gold			2022-02-06	
J	Zhang, LJ; Xiao, H; Yu, X; Deng, YB				Zhang, Lijun; Xiao, Hong; Yu, Xing; Deng, Yongbing			Minocycline attenuates neurological impairment and regulates iron metabolism in a rat model of traumatic brain injury	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						Traumatic brain injury; Minocycline; Neurological impairment; Iron metabolism	INTRACEREBRAL-HEMORRHAGE; MICROGLIAL ACTIVATION; NEURODEGENERATION; HEPCIDIN; HORMONE	There is currently no effective treatment for neurological impairment caused by traumatic brain injury (TBI). It has been reported that excessive iron production in the brain may be a key factor in neurological impairment. In the present study, we investigated the effects of minocycline, a semi-synthetic tetracycline antibiotic, against TBI-induced neurological impairment and explored its underlying mechanism. Neurological impairment was assessed by foot-fault test, cylinder test, wire hang test, and Morris water maze. Nissl staining was performed to evaluate cell viability in the brain. The iron concentrations in cerebrospinal fluid (CSF), serum, and brain tissues were examined. The Fe2+- and Fe3+-chelating activity of minocycline was measured. Finally, the expression levels of important iron metabolism proteins ferritin, transferrin receptor 1 (TfR1), divalent metal transporter 1 (DMT1), ferroportin 1 (FPN1), and hepcidin in the hippocampus and cortex were measured by Western blot analysis. The results indicate that minocycline significantly attenuated the neurological impairment caused by TBI and increased neuronal viability. Minocycline showed a Fe2+- and Fe3+-chelating activity in vitro and reduced the iron concentration in CSF and brain tissues (cortex and hippocampus). Minocycline also inhibited the overexpression of ferritin and TfR1, but did not affect the expression of DMT1. Minocycline restored the expression of FPN1 by decreasing the expression of hepcidin. In conclusion, minocycline may attenuate neurological impairment caused by TBI and regulate iron metabolism.	[Zhang, Lijun] First Peoples Hosp Taizhou, Dept Neurosurg, Taizhou 318020, Zhejiang, Peoples R China; [Xiao, Hong; Yu, Xing; Deng, Yongbing] Fourth Peoples Hosp Chongqing, Dept Neurosurg, Chongqing 400014, Peoples R China		Deng, YB (corresponding author), Fourth Peoples Hosp Chongqing, Dept Neurosurg, Chongqing 400014, Peoples R China.	yongbingdeng@sina.com			Research on Basic Science and Advanced Techniques in Chongqing [cstc2015jcyjA10098]; Science and Technology Project of Taizhou, Zhejiang, China [1901ky57]; Research on Basic Science and Advanced Techniques of Yuzhong District, Chongqing [20170139]	This work was supported by Research on Basic Science and Advanced Techniques in Chongqing (cstc2015jcyjA10098), Science and Technology Project of Taizhou, Zhejiang, China (1901ky57) and Research on Basic Science and Advanced Techniques of Yuzhong District, Chongqing (20170139).	Ahmed ME, 2016, NEUROSCIENCE, V336, P39, DOI 10.1016/j.neuroscience.2016.08.036; Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Aronsson AF, 2006, NEUROPEPTIDES, V40, P65, DOI 10.1016/j.npep.2005.10.006; Barbosa EH, 2016, J MOTOR BEHAV, V48, P5, DOI 10.1080/00222895.2015.1024824; Budni J, 2016, CURR ALZHEIMER RES, V13, P1319, DOI 10.2174/1567205013666160819124206; Casha S, 2018, J NEUROTRAUM, V35, P1918, DOI 10.1089/neu.2018.5899; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Du F, 2015, MOL NEUROBIOL, V52, P101, DOI 10.1007/s12035-014-8847-x; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Ganz Tomas, 2012, Biochim Biophys Acta, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Ingrassia R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038019; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Li D, 2018, BRAIN RES, V1688, P15, DOI 10.1016/j.brainres.2017.10.018; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meng H., 2015, BRAIN RES, V30, P44; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Merati Z, 2018, THERIOGENOLOGY, V114, P266, DOI 10.1016/j.theriogenology.2018.03.041; Meythaler J, 2019, BRAIN INJURY, V33, P679, DOI 10.1080/02699052.2019.1566968; Naderi Y, 2017, BRAIN RES BULL, V131, P207, DOI 10.1016/j.brainresbull.2017.04.010; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Raha-Chowdhury R, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0161-7; Rooker S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/90123; Sangobowale M, 2018, NEUROSCI LETT, V682, P16, DOI 10.1016/j.neulet.2018.06.010; Sanuki R, 2019, BRAIN BEHAV IMMUN, V80, P427, DOI 10.1016/j.bbi.2019.04.023; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Tao R, 2010, J CARDIOVASC PHARM, V56, P659, DOI 10.1097/FJC.0b013e3181faeaf0; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang L, 2019, J CELL PHYSIOL, V234, P7600, DOI 10.1002/jcp.27522; Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626; Wang SM, 2010, CELL MOL LIFE SCI, V67, P123, DOI 10.1007/s00018-009-0167-3; Wu JM, 2009, NEUROL RES, V31, P183, DOI 10.1179/174313209X385680; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Wu ZH, 2016, J NEUROL SCI, V371, P88, DOI 10.1016/j.jns.2016.10.025; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xue MZ, 2010, AM J PATHOL, V176, P1193, DOI 10.2353/ajpath.2010.090361; Yan P, 2015, STROKE, V46, P1633, DOI 10.1161/STROKEAHA.115.008582; Yang L, 2012, BBA-MOL BASIS DIS, V1822, P500, DOI 10.1016/j.bbadis.2011.12.004; Yeh K.Y., 2011, AM J PHYSIOL-GASTR L, V301, P24; Zechel S, 2006, J NEUROSCI RES, V84, P790, DOI 10.1002/jnr.20991; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	50	8	9	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	MAR 30	2020	682								108302	10.1016/j.abb.2020.108302			10	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	LC6MX	WOS:000525448900010	32057758				2022-02-06	
J	Mayer, AR; Stephenson, DD; Dodd, AB; Robertson-Benta, CR; Reddy, SP; Shaff, NA; Yeates, KO; van der Horn, HJ; Wertz, CJ; Park, G; Oglesbee, SJ; Bedrick, EJ; Campbell, RA; Phillips, JP; Quinn, DK				Mayer, Andrew R.; Stephenson, David D.; Dodd, Andrew B.; Robertson-Benta, Cidney R.; Reddy, Sharvani Pabbathi; Shaff, Nicholas A.; Yeates, Keith Owen; van der Horn, Harm J.; Wertz, Christopher J.; Park, Grace; Oglesbee, Scott J.; Bedrick, Edward J.; Campbell, Richard A.; Phillips, John P.; Quinn, Davin K.			Comparison of Methods for Classifying Persistent Post-Concussive Symptoms in Children	JOURNAL OF NEUROTRAUMA			English	Article						pediatric mild traumatic brain injury; persistent post-concussive symptoms	TRAUMATIC BRAIN-INJURY; GOOD-OLD-DAYS; POSTCONCUSSION SYNDROME; SPORT; RELIABILITY; CONSENSUS	Pediatric mild traumatic brain injury (pmTBI) has received increased public scrutiny over the past decade, especially regarding children who experience persistent post-concussive symptoms (PPCS). However, several methods for defining PPCS exist in clinical and scientific literature, and even healthy children frequently exhibit non-specific, concussive-like symptoms. Inter-method agreement (six PPCS methods), observed misclassification rates, and other psychometric properties were examined in large cohorts of consecutively recruited adolescent patients with pmTBI (n = 162) 1 week and 4 months post-injury and in age/sex-matched healthy controls (HC; n = 117) at equivalent time intervals. Six published PPCS methods were stratified into Simple Change (e.g., International Statistical Classification of Diseases and Related Health Problems, 10th revision [ICD-10]) and Standardized Change (e.g., reliable change indices) algorithms. Among HC, test-retest reliability was fair to good across the 4-month assessment window, with evidence of bias (i.e., higher symptom ratings) during retrospective relative to other assessments. Misclassification rates among HC were higher (>30%) for Simple Change algorithms, with poor inter-rater reliability of symptom burden across HC and their parents. A 49% spread existed in terms of the proportion of pmTBI patients "diagnosed" with PPCS at 4 months, with superior inter-method agreement among standardized change algorithms. In conclusion, the self-reporting of symptom burden is only modestly reliable in typically developing adolescents over a 4-month period, with additional evidence for systematic bias in both adolescent and parental ratings. Significant variation existed for identifying pmTBI patients who had "recovered" (i.e., those who did not meet individual criteria for PPCS) from concussion across the six definitions, representing a considerable challenge for estimating the true incidence rate of PPCS in published literature. Although relatively straightforward to obtain, current findings question the utility of the most commonly used Simple Change scores for diagnosis of PPCS in clinical settings.	[Mayer, Andrew R.; Stephenson, David D.; Dodd, Andrew B.; Robertson-Benta, Cidney R.; Reddy, Sharvani Pabbathi; Shaff, Nicholas A.; van der Horn, Harm J.; Wertz, Christopher J.; Phillips, John P.] Lovelace Biomed & Environm Res Inst, Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Mayer, Andrew R.; Campbell, Richard A.; Quinn, Davin K.] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Phillips, John P.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Park, Grace; Oglesbee, Scott J.] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [van der Horn, Harm J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Bedrick, Edward J.] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA		Mayer, AR (corresponding author), Lovelace Biomed & Environm Res Inst, Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Yeates, Keith/AAJ-4223-2020		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 01 R01 NS098494-01A1]	This research was supported by grants from the National Institutes of Health (https://www.nih.gov), grant numbers NIH 01 R01 NS098494-01A1 and -03S1A1, to Andrew R. Mayer.	Achenbach T.M., MANUAL ASEBA ADULT F; Barker-Collo S, 2016, JSM BURNS TRAUMA, V1, P1006; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Crowe LM, 2018, ARCH PHYS MED REHAB, V99, P1360, DOI 10.1016/j.apmr.2017.12.026; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rausa VC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0881-z; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	39	8	8	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1504	1511		10.1089/neu.2019.6805		MAR 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000525509600001	31964232	Green Submitted, Green Published			2022-02-06	
J	Ji, WC; Li, M; Jiang, WT; Ma, X; Li, J				Ji, Wen-Chen; Li, Meng; Jiang, Wan-Ting; Ma, Xing; Li, Jia			Protective effect of brain-derived neurotrophic factor and neurotrophin-3 overexpression by adipose-derived stem cells combined with silk fibroin/chitosan scaffold in spinal cord injury	NEUROLOGICAL RESEARCH			English	Article						Spinal cord injury; adipose-derived stem; stromal cells; silk fibroin; chitosan scaffold; brain-derived neurotrophic factor; neurotrophin-3	MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; TRANSPLANTATION; TISSUE; DIFFERENTIATION; REGENERATION; INFLAMMATION; ACTIVATION; EXERCISE	Objectives: Spinal cord injury (SCI) is a most debilitating traumatic injury, and cytotherapy is a promising alternative treatment strategy. Here we investigated the effect and mechanism of adipose-derived stem/stromal cells (ASCs) with overexpressing brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) (BDNF-NT3) in combination with silk fibroin/chitosan scaffold (SFCS) in SCI. Methods: Female Sprague-Dawley rats were used as an SCI model. SFCS,SFCS and ASCs, or ASCs overexpressing NT3, BDNF, and BDNF-NT3 were implanted into SCI rats. Basso, Beattie, and Bresnahan score, pathological changes, and spinal cord tissue and nerve fiber morphology were observed and assayed. GAP-43, GFAP, and caspase-3 expression was determined using immunohistochemistry and western blotting. Results: Smoother spinal cords, less scar tissue, and lower inflammatory activity were found in the SFCS, SFCS and ASCs, ASCs with NT3, BDNF, and BDNF-NT3 overexpression treatment than in the untreated SCI rat groups. Increasing formation of nerve fibers was observed in the above groups in order. GAP-43 expression significantly increased, while GFAP and caspase-3 expression significantly decreased. These results indicated obvious alleviation in pathological changes and BDNF-NT3 overexpression in ASCs combined with SFCS treatment in SCI rats. Conclusion: Thus, BDNF-NT3 overexpression from ASCs with SFCS had synergistic neuroprotective effects on SCI and may be a treatment option for SCI.	[Ji, Wen-Chen; Li, Meng; Ma, Xing; Li, Jia] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Orthopaed, 277 Yanta West Rd, Xian 710061, Peoples R China; [Jiang, Wan-Ting] Fourth Hosp Xian, Dept Ultrasound Diag, Xian, Peoples R China		Ji, WC (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Orthopaed, 277 Yanta West Rd, Xian 710061, Peoples R China.	jiwenchenbaoyan@163.com			Natural Science Fundation of ChinaNational Natural Science Foundation of China (NSFC) [81701896]; Shaanxi Natural Science Basic Research Foundation [2018JQ8069]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2018jchz03]	This work was supported by grants from the Natural Science Fundation of China [no. 81701896]; Shaanxi Natural Science Basic Research Foundation [no. 2018JQ8069]; and The Fundamental Research Funds for the Central Universities [no. xjj2018jchz03].	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; de Moraes MA, 2010, POLYMERS-BASEL, V2, P719, DOI 10.3390/polym2040719; Duan HQ, 2018, CNS NEUROSCI THER, V24, P429, DOI 10.1111/cns.12801; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hung CC, 2016, J NEUROSCI, V36, P2027, DOI 10.1523/JNEUROSCI.3457-15.2016; Ji Wen-Chen, 2016, World J Exp Med, V6, P58, DOI 10.5493/wjem.v6.i3.58; Ji WC, 2015, MOL MED REP, V12, P4981, DOI 10.3892/mmr.2015.4099; Ji WC, 2013, EXP THER MED, V6, P513, DOI 10.3892/etm.2013.1185; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Kim SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21621-5; Kim YM, 2018, J EXERC REHABIL, V14, P335, DOI 10.12965/jer.1836264.132; Kolar MK, 2014, STEM CELLS DEV, V23, P1659, DOI 10.1089/scd.2013.0416; Levine J, 2016, BRAIN RES, V1638, P199, DOI 10.1016/j.brainres.2015.07.026; Li DW, 2017, CARBOHYD POLYM, V178, P69, DOI 10.1016/j.carbpol.2017.09.035; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mukhamedshina YO, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00343; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; Nandoe RDS, 2006, CELL TRANSPLANT, V15, P563, DOI 10.3727/000000006783981602; Nicola FD, 2017, BRAIN RES, V1663, P95, DOI 10.1016/j.brainres.2017.03.015; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Ohta Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071963; Ohta Y, 2017, CYTOTHERAPY, V19, P839, DOI 10.1016/j.jcyt.2017.04.002; Ritfeld GJ, 2015, CELL TRANSPLANT, V24, P2209, DOI 10.3727/096368915X686201; Rosety-Rodriguez M, 2014, ARCH PHYS MED REHAB, V95, P297, DOI 10.1016/j.apmr.2013.08.246; Sarveazad A, 2017, NEUROPEPTIDES, V61, P39, DOI 10.1016/j.npep.2016.07.004; Stewart AN, 2017, BRAIN RES, V1672, P91, DOI 10.1016/j.brainres.2017.07.005; Stewart AN, 2017, RESTOR NEUROL NEUROS, V35, P395, DOI 10.3233/RNN-160678; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Tang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107517; Terraf P, 2017, MOL NEUROBIOL, V54, P5657, DOI 10.1007/s12035-016-0089-7; Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a; Wang Changxing, 2017, Neurosignals, V25, P1, DOI 10.1159/000471828; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Zhang HW, 2017, ONCOTARGET, V8, P58985, DOI 10.18632/oncotarget.19775; Zhang Tao, 2013, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V27, P145; Zhang Y, 2018, NEURAL REGEN RES, V13, P1685, DOI 10.4103/1673-5374.238603; Zhao Y, 2015, CELL TISSUE BANK, V16, P335, DOI 10.1007/s10561-014-9476-3; Zhou J, 2014, J CELL MOL MED, V18, P326, DOI 10.1111/jcmm.12191; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	42	8	10	5	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY 3	2020	42	5					361	371		10.1080/01616412.2020.1735819		MAR 2020	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX9GT	WOS:000519180200001	32149594				2022-02-06	
J	Fei, MX; Wang, HD; Zhou, ML; Deng, CL; Zhang, L; Han, YL				Fei, Maoxing; Wang, Handong; Zhou, Mengliang; Deng, Chulei; Zhang, Li; Han, Yanling			Podoplanin influences the inflammatory phenotypes and mobility of microglia in traumatic brain injury	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Podoplanin; Traumatic brain injury; Microglia; Matrix metalloproteinases	WHITE-MATTER; ACTIVATION	Traumatic brain injury (TBI) represents a major cause of death and disability worldwide. Exacerbated neuroinflammation following TBI causes secondary injury. Podoplanin (PDPN) is a small transmembrane mucin-like glycoprotein that promotes the inflammatory response in different tissues and cells. However, the contribution of PDPN to neuroinflammation and microglial activation is unknown. Here, we found that PDPN was correlated with microglial activation after TBI in mice. Meanwhile, PDPN expression could be induced by trauma-related stimuli, such as lipopolysaccharide (LPS), ATP, H2O2 and hemoglobin (Hb), in primary microglia. Furthermore, with Hb treatment in vitro, knockdown of PDPN could decrease the proportion of Ml-like microglia and increase the proportion of M2-like microglia via reduced secretion of IL-1 beta and TNF-alpha and increased secretion of IL-10 and TGF-I beta compared to the control microglia. Immunofluorescence also showed that CD86-positive microglia were decreased and CD206-positive microglia were elevated in the PDPN-KD group. Additionally, PDPN knockdown impaired microglial mobility and phagocytosis and decreased the expression of matrix metalloproteinases (mainly MMP2 and MMP9). In summary, PDPN plays an important role in microglia-mediated inflammation and may serve as a potential target for TBI treatment. (C) 2019 Elsevier Inc. All rights reserved.	[Fei, Maoxing; Wang, Handong] Nanjing Med Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Peoples R China; [Wang, Handong; Zhou, Mengliang; Zhang, Li] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Med Sch, Nanjing 210002, Peoples R China; [Deng, Chulei] Southern Med Univ, Jinling Hosp, Dept Neurosurg, Guangzhou 510000, Peoples R China; [Han, Yanling] Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD; Zhou, ML (corresponding author), Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com; mengliangzhou@yahoo.com		Chulei, Deng/0000-0002-8445-7408; Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672503, 81702484]	This study was grant-supported by the National Natural Science Foundation of China (No.81672503 and No.81702484).	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Bisicchia E, 2019, SEMIN CELL DEV BIOL, V94, P104, DOI 10.1016/j.semcdb.2019.01.011; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Del Rey M.J., 2014, PLOS ONE, V9; Fernandez-Munoz B, 2011, INT J BIOCHEM CELL B, V43, P886, DOI 10.1016/j.biocel.2011.02.010; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Honma M, 2019, J DERMATOL, V46, P922, DOI 10.1111/1346-8138.15017; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kolar K, 2015, J NEUROPATH EXP NEUR, V74, P64, DOI 10.1097/NEN.0000000000000150; Krishnan H, 2018, CANCER SCI, V109, P1292, DOI 10.1111/cas.13580; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Noack M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1046-6; Rayes J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02402-6; Sikorska J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-018-5239-z; Song Y, 2014, CELL MOL NEUROBIOL, V34, P839, DOI 10.1007/s10571-014-0060-y; Ugorski M, 2016, AM J CANCER RES, V6, P370; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010	24	8	9	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAR 5	2020	523	2					361	367		10.1016/j.bbrc.2019.12.003			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	LB6IN	WOS:000524737600013	31866008				2022-02-06	
J	Loring, HS; Icso, JD; Nemmara, VV; Thompson, PR				Loring, Heather S.; Icso, Janneke D.; Nemmara, Venkatesh V.; Thompson, Paul R.			Initial Kinetic Characterization of Sterile Alpha and Toll/Interleukin Receptor Motif-Containing Protein 1	BIOCHEMISTRY			English	Article							NAD(+) CLEAVAGE ACTIVITY; AXON DEGENERATION; WALLERIAN DEGENERATION; INJURY; SARM1; MECHANISMS; DELETION	Sterile alpha and toll/interleukin receptor (TIR) motif-containing protein 1 (SARM1) plays a pivotal role in triggering the neurodegenerative processes that underlie peripheral neuropathies, traumatic brain injury, and neurodegenerative diseases. Importantly, SARNI1 knockdown or knockout prevents degeneration, thereby demonstrating that SARM1 is a promising therapeutic target. Recently, SARM1 was shown to promote neurodegeneration via its ability to hydrolyze NAD(+), forming nicotinamide and ADP ribose (ADPR). Herein, we describe the initial kinetic characterization of full-length SARM1, as well as the truncated constructs corresponding to the SAM(1-2)T1R and TIR domains, highlighting the distinct challenges that have complicated efforts to characterize this enzyme. Moreover, we show that bacterially expressed full-length SARM1 (k(cat)/K-M = 6000 +/- 2000 M-1 s(-1)) is at least as active as the TIR domain alone (k(cat)/K-M = 1500 +/- 300 M-1 s(-1)). Finally, we show that the SARM1 hydrolyzes NAD(+) via an ordered uni-bi reaction in which nicotinamide is released prior to ADPR.	[Loring, Heather S.; Icso, Janneke D.; Nemmara, Venkatesh V.; Thompson, Paul R.] UMass Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Loring, Heather S.; Icso, Janneke D.; Nemmara, Venkatesh V.; Thompson, Paul R.] UMass Med Sch, Program Chem Biol, Worcester, MA 01605 USA		Thompson, PR (corresponding author), UMass Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.; Thompson, PR (corresponding author), UMass Med Sch, Program Chem Biol, Worcester, MA 01605 USA.	paul.thompson@umassmed.edu	Nemmara, Venkatesh/AAL-8946-2020	Nemmara, Venkatesh/0000-0001-6925-869X; Icso, Janneke/0000-0002-2944-1956; Thompson, Paul/0000-0002-1621-3372	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R35 GM118112, F31NS108610]	This work was supported in part by National Institutes of Health Grants R35 GM118112 (P.R.T.) and F31NS108610 (H.S.L.).	BARRIO JR, 1972, P NATL ACAD SCI USA, V69, P2039, DOI 10.1073/pnas.69.8.2039; BISBY MA, 1995, J COMP NEUROL, V359, P653, DOI 10.1002/cne.903590411; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; INAGEDA K, 1995, J BIOCHEM-TOKYO, V117, P125, DOI 10.1093/oxfordjournals.jbchem.a124698; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Loring HS, 2020, CELL CHEM BIOL, V27, P1, DOI 10.1016/j.chembiol.2019.11.002; Loring HS, 2018, BIOCHEMISTRY-US, V57, P5524, DOI 10.1021/acs.biochem.8b00775; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Pergolizzi G, 2011, CHEM COMMUN, V47, P12655, DOI 10.1039/c1cc15499k; Sasaki Y, 2010, J BIOL CHEM, V285, P41211, DOI 10.1074/jbc.C110.193904; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14	28	8	8	0	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	MAR 3	2020	59	8					933	942		10.1021/acs.biochem.9b01078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KS3TK	WOS:000518234800003	32049506	Green Accepted			2022-02-06	
J	Miyashita, TL; Diakogeorgiou, E; Marrie, K				Miyashita, Theresa L.; Diakogeorgiou, Eleni; Marrie, Kaitlyn			The role of subconcussive impacts on sway velocities in Division I men's lacrosse players	SPORTS BIOMECHANICS			English	Article						Balance; concussion; instrumented	POSTURAL STABILITY; BALANCE DISORDERS; ANKLE INJURIES; HEAD IMPACTS; CONCUSSION; COHORT; RELIABILITY; IMPAIRMENT; DIZZINESS; TRAUMA	Head impacts resulting in a concussion negatively affect the vestibular system, but little is known about the effect of subconcussive impacts on this system. This study's objective was to determine if subconcussive head impacts sustained over one competitive lacrosse season, effect sway velocity. Healthy Division I male lacrosse players (n = 33; aged 19.52 +/- 1.20 years) wore instrumented helmets to track head impact exposures. At the beginning and end of the season the players completed an instrumented Balance Error Scoring System assessment to assess sway velocity. Score differentials were correlated to the head impact exposure data collected via instrumented helmets when averaged within participant. Paired samples t-tests revealed a post-season increase in sway velocity on the double leg stance, firm surface (p = 0.002, d = 0.59); tandem stance, firm surface (p = 0.033, d = 0.39) and double leg, foam surface (p = 0.014, d = 0.45) A significant correlation was found between change in tandem stance, firm surface sway velocities and linear acceleration (p < 0.001, r = 0.65). It appears subconcussive impacts may result in tandem stance balance deficits. Repetitive head impacts may negatively affect sway velocity, even in the absence of a diagnosed concussion injury.	[Miyashita, Theresa L.; Diakogeorgiou, Eleni; Marrie, Kaitlyn] Sacred Heart Univ, Athlet Training Dept, Fairfield, CT 06825 USA		Miyashita, TL (corresponding author), Sacred Heart Univ, Athlet Training Dept, Fairfield, CT 06825 USA.	miyashitat@sacredheart.edu		Miyashita, Theresa/0000-0001-5479-1598			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baloh R. W., 2010, BALOH HONRUBIAS CLIN, P360; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanes DA, 2006, J VESTIBUL RES-EQUIL, V16, P75; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mucha A, 2012, BRAIN INJURY PROFESS, V9, P12, DOI DOI 10.3109/02699052.2014.887144; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; Romero-Franco N, 2014, J PHYS THER SCI, V26, P683, DOI 10.1589/jpts.26.683; Wang HK, 2006, ARCH PHYS MED REHAB, V87, P821, DOI 10.1016/j.apmr.2006.02.024	29	8	8	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.	MAR 3	2020	19	2					180	188		10.1080/14763141.2018.1458892			9	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	KJ6VZ	WOS:000512198300004	29754531				2022-02-06	
J	Fernandes, FAO; de Sousa, RJA; Ptak, M; Wilhelm, J				Fernandes, Fabio A. O.; de Sousa, Ricardo J. Alves; Ptak, Mariusz; Wilhelm, Johannes			Certified Motorcycle Helmets: Computational Evaluation of the Efficacy of Standard Requirements with Finite Element Models	MATHEMATICAL AND COMPUTATIONAL APPLICATIONS			English	Article						crashworthiness; finite element model; head impact; helmet; numerical simulation; traumatic brain injury	BRAIN-TISSUE; HEAD; INJURY; IMPACTS; PERFORMANCE; PREDICTION; CRITERION; DESIGN; TRAUMA; DAMAGE	Every year, thousands of people die in the European Union as a direct result of road accidents. Helmets are one of the most important types of personal safety gear. The ECE R22.05 standard, adopted in 2000, is responsible for the certification of motorcycle helmets in the European Union and in many other countries. Two decades later, it is still being used with the same requirements, without any update. The aim of this work is to evaluate the efficacy of a motorcycle helmet certified by such standard, using computational models as an assessment tool. First, a finite element model of a motorcycle helmet available on the market was developed and validated by simulating the same impacts required by the standard. Then, a finite element model of the human head is used as an injury prediction tool to assess its safety performance. Results indicate a significant risk of brain injury, which is in accordance with previous studies available in the literature. Therefore, this work underlines and emphasizes the need of improving the requirements of ECE R22.05.	[Fernandes, Fabio A. O.; de Sousa, Ricardo J. Alves] Univ Aveiro, TEMA Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, P-3810193 Aveiro, Portugal; [Ptak, Mariusz; Wilhelm, Johannes] Wroclaw Univ Sci & Technol, Fac Mech Engn, Dept Machine Design & Res, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland		Fernandes, FAO (corresponding author), Univ Aveiro, TEMA Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, P-3810193 Aveiro, Portugal.	fabiofernandes@ua.pt; rsousa@ua.pt; mariusz.ptak@pwr.edu.pl; johannes.wilhelm@pwr.edu.pl	Wilhelm, Johannes/O-8330-2016; Fernandes, Fabio A.O./H-2680-2012; Ptak, Mariusz/B-1493-2013; de Sousa, Ricardo Alves/E-4405-2010	Wilhelm, Johannes/0000-0001-5114-5400; Fernandes, Fabio A.O./0000-0001-9751-8807; Ptak, Mariusz/0000-0001-8081-8336; de Sousa, Ricardo Alves/0000-0002-5848-6424	(FCT) Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and Technology [UIDB/00481/2020, UIDP/00481/2020]; Centro Portugal Regional Operational Programme (Centro2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund [CENTRO-01-0145-FEDER-022083]	This work was supported by the projects UIDB/00481/2020 and UIDP/00481/2020 (FCT) Fundacao para a Ciencia e a Tecnologia; and CENTRO-01-0145-FEDER-022083-Centro Portugal Regional Operational Programme (Centro2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aare M., 2003, INT RES COUNC BIOM I, P349; ABAQUS 6, 2010, ABAQUS 6 10 DOC HIBB; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 2001, P 17 INT TECHN C ENH; Bellora A., 2001, SAE T, V110, P383; Brands D.W.A., 1996, P AGARD M IMP HEAD I; Cernicchi A, 2008, INT J CRASHWORTHINES, V13, P451, DOI 10.1080/13588260802055460; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Deck C, 2003, STRUCT MAT, V13, P319; Deck C., 2009, P 7 EUR LS DYNA C SA; EPSR, ROAD FAT STAT EU INF; Fenner H., 2005, WORKSH CRIT HEAD INJ; Fernandes FAO, 2015, MATER DESIGN, V82, P335, DOI 10.1016/j.matdes.2015.06.004; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Fernandes F. A. O., 2013, P IRCOBI C GOTH, P431; Fernandes FAO, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040735; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Fernandes FAO, 2013, STRUCT ENG MECH, V48, P661, DOI 10.12989/sem.2013.48.5.661; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; GRANIER B, 2009, CARNETS GEOL 0518, P1; Han Y, 2020, INT J CRASHWORTHINES, V25, P493, DOI 10.1080/13588265.2019.1616886; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huss L, 2003, MUL LIN DIV, P1; Hyncik L, 2018, INT J VEH SAF, V10, P277, DOI DOI 10.1504/IJVS.2018.097720; Johnson G.I., 2000, INT J CRASHWORTHINES, V5, P491, DOI 10.1533/cras.2000.0156; Khanuja T, 2020, P I MECH ENG H, V234, P3, DOI 10.1177/0954411919881526; Kim GH, 1997, KSME INT J, V11, P292, DOI 10.1007/BF02946321; Kleiven, 2005, P IRCOBI C PRAG CZEC, P21; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2007, P 20 INT TECHN C ENH; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; MILLS NJ, 1992, P ANN C ASS, P149; Mordaka J., 2007, P IRCOBI C MAASTR NE, P83; Mustafa H, 2015, PROC TECH, V20, P91, DOI 10.1016/j.protcy.2015.07.016; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Newman J., 2005, P IRCOBI C PRAG CZEC; Newman J., 1975, SAE TECH PAP, DOI [10.4271/751162, DOI 10.4271/751162]; Newman J.A., 1980, SAE TECH PAP, DOI [10.4271/801317, DOI 10.4271/801317]; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pinnoji P.K., 2006, P IRCOBI C MADR, P159; Pinnoji PK, 2008, INT J CRASHWORTHINES, V13, P265, DOI 10.1080/13588260801933626; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; Prasartthong N., 2018, P 9 THAI SOC MECH EN; Pratellesi A, 2011, INT J CRASHWORTHINES, V16, P523, DOI 10.1080/13588265.2011.611397; Rashid B., 2012, P ASME 2012 INT MECH, P9; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Schmitt KU, 2019, TRAUMA BIOMECHANICS; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Tinard V, 2012, INT J CRASHWORTHINES, V17, P209, DOI 10.1080/13588265.2011.648465; Toma M, 2020, INT J CRASHWORTHINES, V25, P175, DOI 10.1080/13588265.2018.1550910; Vallee H., 1984, IRCOBI C DELFT, P99; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yu C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020492; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	76	8	8	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1300-686X	2297-8747		MATH COMPUT APPL	Math. Comput. Appl.	MAR	2020	25	1							12	10.3390/mca25010012			21	Mathematics, Interdisciplinary Applications	Emerging Sources Citation Index (ESCI)	Mathematics	LB0XS	WOS:000524361400003		gold			2022-02-06	
J	Hajiaghamemar, M; Seidi, M; Margulies, SS				Hajiaghamemar, Marzieh; Seidi, Morteza; Margulies, Susan S.			Head Rotational Kinematics, Tissue Deformations, and Their Relationships to the Acute Traumatic Axonal Injury	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							BRAIN-INJURY; DIRECTION; CRITERION; IMPACT	Head rotational kinematics and tissue deformation metrics obtained from finite element models (FEM) have the potential to be used as traumatic axonal injury (TAI) assessment criteria and headgear evaluation standards. These metrics have been used to predict the likelihood of TAI occurrence; however, their ability in the assessment of the extent of TAI has not been explored. In this study, a pig model of TAI was used to examine a wide range of head loading conditions in two directions. The extent of TAI was quantified through histopathology and correlated to the FEM-derived tissue deformations and the head rotational kinematics. Peak angular acceleration and maximum strain rate of axonal fiber and brain tissue showed relatively good correlation to the volume of axonal injury, with similar correlation trends for both directions separately or combined. These rotational kinematics and tissue deformations can estimate the extent of acute TAI. The relationships between the head kinematics and the tissue strain, strain rate, and strain times strain rate were determined over the experimental range examined herein, and beyond that through parametric simulations. These relationships demonstrate that peak angular velocity and acceleration affect the underlying tissue deformations and the knowledge of both help to predict TAI risk. These relationships were combined with the injury thresholds, extracted from the TAI risk curves, and the kinematic-based risk curves representing overall axonal and brain tissue strain and strain rate were determined for predicting TAI. After scaling to humans, these curves can be used for real-time TAI assessment.	[Hajiaghamemar, Marzieh; Seidi, Morteza; Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Hajiaghamemar, Marzieh; Seidi, Morteza; Margulies, Susan S.] Emory Univ, Atlanta, GA 30332 USA		Hajiaghamemar, M (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Hajiaghamemar, M (corresponding author), Emory Univ, Atlanta, GA 30332 USA.	memar@gatech.edu; seidi@gatech.edu; susan.margulies@gatech.edu			Biomechanics Consulting and Research, LLC (BioCore, LLC); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097549, R56NS055951]	Biomechanics Consulting and Research, LLC (BioCore, LLC).; National Institutes of Health (R01NS097549 and R56NS055951; Funder ID: 10.13039/100000002).	Atlan LS, 2018, J NEUROSCI RES, V96, P536, DOI 10.1002/jnr.24108; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Campolettano ET, 2020, ANN BIOMED ENG, V48, P92, DOI 10.1007/s10439-019-02382-2; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fukuda T., 2019, J PHYS FITNESS SPORT, V8, P1; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Giordano C., 2014, 2014220002 SAE; Hajiaghamemar M., 2019, BIOMECH MODEL MECHAN, P1; Hajiaghamemar M, 2019, J NEUROTRAUM, V36, pA51; Hajiaghamemar M, 2019, INT J LEGAL MED, V133, P847, DOI 10.1007/s00414-018-1918-1; Hajiaghamemar M, 2015, ANN BIOMED ENG, V43, P2143, DOI 10.1007/s10439-015-1255-1; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Nakadate H., 2017, 2017220003 SAE; Oeur RA, 2021, INT J CRASHWORTHINES, V26, P16, DOI 10.1080/13588265.2019.1634336; Patton D. A., 2014, THESIS; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pincemaille Y., 1989, 01487191 SAE; Post A, 2019, COMPUT METHOD BIOMEC, V22, P713, DOI 10.1080/10255842.2019.1588255; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Seidi M, 2015, INT J CRASHWORTHINES, V20, P134, DOI 10.1080/13588265.2014.983261; Singh A, 2017, BRAIN INJURY, V31, P1387, DOI 10.1080/02699052.2017.1321781; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Takhounts E.G., 2013, 2013220010 SAE; Untaroiu C., 2007, P 20 INT TECHN C ENH; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1	30	8	8	0	3	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAR	2020	142	3			SI				031006	10.1115/1.4046393			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KS8JM	WOS:000518552900011	32073595	Green Published, Bronze			2022-02-06	
J	Huang, ZJ; Cao, F; Wu, Y; Peng, JH; Zhong, JJ; Jiang, Y; Yin, C; Guo, ZD; Sun, XC; Jiang, L; Cheng, CJ				Huang, Zhi-Jian; Cao, Fang; Wu, Yue; Peng, Jian-Hua; Zhong, Jian-Jun; Jiang, Yong; Yin, Cheng; Guo, Zong-Duo; Sun, Xiao-Chuan; Jiang, Li; Cheng, Chong-Jie			Apolipoprotein E promotes white matter remodeling via the Dab1-dependent pathway after traumatic brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						apolipoprotein E; axonal regeneration; Disabled-1; traumatic brain injury	DENSITY-LIPOPROTEIN RECEPTOR; AXONAL INJURY; GENETIC-VARIATION; MOUSE MODEL; APOE GENE; MICE; REGENERATION; DEFICITS; HYPOXIA	Introduction Axonal injury results in long-term neurological deficits in traumatic brain injury (TBI) patients. Apolipoprotein E (ApoE) has been reported to activate intracellular adaptor protein Disabled-1 (Dab1) phosphorylation via its interaction with ApoE receptors. The Dab1 pathway acts as a regulator of axonal outgrowth and growth cone formation in the brain. Aims We hypothesized that ApoE may alleviate axonal injury and regulate axonal regeneration via the Dab1 pathway after TBI. Results In this study, we established a model of controlled cortical impact (CCI) to mimic TBI in vivo. Using diffusion tensor imaging to detect white matter integrity, we demonstrated that APOE-deficient mice exhibited lower fractional anisotropy (FA) values than APOE(+/+) mice at 28 days after injury. The expression levels of axonal regeneration and synapse plasticity biomarkers, including growth-associated protein 43 (GAP43), postsynaptic density protein 95 (PSD-95), and synaptophysin, were also lower in APOE-deficient mice. In contrast, APOE deficiency exerted no effects on the levels of myelin basic protein (MBP) expression, oligodendrocyte number, or oligodendrocyte precursor cell number. Neurological severity score (NSS) and behavioral measurements in the rotarod, Morris water maze, and Y maze tests revealed that APOE deficiency caused worse neurological deficits in CCI mice. Furthermore, Dab1 activation downregulation by the ApoE receptor inhibitor receptor-associated protein (RAP) or Dab1 shRNA lentivirus attenuated the beneficial effects of ApoE on FA values, GAP43, PSD-95, and synaptophysin expression, and neurological function tests. Additionally, the effects of ApoE on axonal regeneration were further validated in vitro. In a mechanical scratch injury model of primary cultured neurons, recombinant ApoE protein treatment enhanced axonal outgrowth and growth cone formation in injured neurons; however, these effects were attenuated by Dab1 shRNA, consistent with the in vivo results. Conclusion Collectively, these data suggest that ApoE promotes axonal regeneration partially through the Dab1 pathway, thereby contributing to functional recovery following TBI.	[Huang, Zhi-Jian; Wu, Yue; Zhong, Jian-Jun; Guo, Zong-Duo; Sun, Xiao-Chuan; Jiang, Li; Cheng, Chong-Jie] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Cao, Fang] Zunyi Med Coll, Dept Cerebrovasc, Affiliated Hosp, Zunyi, Guizhou, Peoples R China; [Peng, Jian-Hua; Jiang, Yong] Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, Luzhou, Peoples R China; [Yin, Cheng] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Neurosurg, Affiliated Hosp, Chengdu, Peoples R China		Jiang, L; Cheng, CJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	1472455234@qq.com; 358187887@qq.com		Peng, Jianhua/0000-0003-3348-9538	National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072]; Science and Technology benefits of Guizhou [[2019]1354]	National Natural Science Foundation for Youth of China, Grant/Award Number: 81601072; The Science and Technology benefits of Guizhou, Grant/Award Number: [2019]1354	Abadesco AD, 2014, EUR J NEUROSCI, V39, P579, DOI 10.1111/ejn.12416; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cheng CJ, 2015, TRANSL STROKE RES, V6, P446, DOI 10.1007/s12975-015-0426-6; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hashikawa-Hobara N, 2011, J PHARMACOL EXP THER, V338, P694, DOI 10.1124/jpet.111.181487; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Hong S, 2016, J NEUROTRAUM, V33, P362, DOI 10.1089/neu.2014.3860; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Leemhuis J, 2010, J NEUROSCI, V30, P14759, DOI 10.1523/JNEUROSCI.4036-10.2010; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI 10.1016/j.expneurol.2009.10.012; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Ng JMJ, 2012, J CELL MOL MED, V16, P789, DOI 10.1111/j.1582-4934.2011.01361.x; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Segarra M, 2018, SCIENCE, V361, DOI 10.1126/science.aao2861; Shu XG, 2013, MOL NEUROBIOL, V48, P78, DOI 10.1007/s12035-013-8418-6; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Tedeschi A, 2017, EXP NEUROL, V287, P409, DOI 10.1016/j.expneurol.2016.05.004; Teixeira CM, 2014, NEUROPSYCHOPHARMACOL, V39, P556, DOI 10.1038/npp.2013.226; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wang F, 2014, NEUROREPORT, V25, P1386, DOI 10.1097/WNR.0000000000000278; Yin C, 2012, NEUROSCI LETT, V515, P77, DOI 10.1016/j.neulet.2012.03.023; Yousuf A, 2015, J MOL NEUROSCI, V56, P597, DOI 10.1007/s12031-015-0554-1; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033	37	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUL	2020	26	7					698	710		10.1111/cns.13298		MAR 2020	13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	LY5VO	WOS:000517103500001	32115899	Green Published, gold			2022-02-06	
J	Ruesch, A; Yang, JS; Schmitt, S; Acharya, D; Smith, MA; Kainerstorfer, JM				Ruesch, Alexander; Yang, Jason; Schmitt, Samantha; Acharya, Deepshikha; Smith, Matthew A.; Kainerstorfer, Jana M.			Estimating intracranial pressure using pulsatile cerebral blood flow measured with diffuse correlation spectroscopy	BIOMEDICAL OPTICS EXPRESS			English	Article							NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; PERFUSION-PRESSURE; NONINVASIVE METHODS; AUTOREGULATION; REACTIVITY; MODERATE; ADULT; INDEX	Measuring intracranial pressure (ICP) is necessary for the treatment of severe head injury but measurement systems are highly invasive and introduce risk of infection and complications. We developed a non-invasive alternative for quantifying ICP using measurements of cerebral blood flow (CBF) by diffuse correlation spectroscopy. The recorded cardiac pulsation waveform in CBF undergoes morphological changes in response to ICP changes. We used the pulse shape to train a randomized regression forest to estimate the underlying ICP and demonstrate in five non-human primates that DCS-based estimation can explain over 90% of the variance in invasively measured ICP. (C) 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Ruesch, Alexander; Yang, Jason; Schmitt, Samantha; Acharya, Deepshikha; Smith, Matthew A.; Kainerstorfer, Jana M.] Carnegie Mellon Univ, Dept Biomed Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Schmitt, Samantha; Smith, Matthew A.; Kainerstorfer, Jana M.] Carnegie Mellon Univ, Neurosci Inst, 4400 Fifth Ave, Pittsburgh, PA 15213 USA; [Schmitt, Samantha; Smith, Matthew A.] Univ Pittsburgh, Dept Ophthalmol, 203 Lothrop St, Pittsburgh, PA 15213 USA		Kainerstorfer, JM (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.; Kainerstorfer, JM (corresponding author), Carnegie Mellon Univ, Neurosci Inst, 4400 Fifth Ave, Pittsburgh, PA 15213 USA.	jkainers@andrew.cmu.edu		Ruesch, Alexander/0000-0002-1890-4134; Smith, Matthew A/0000-0003-1192-9942	Center for Machine Learning and Health at Carnegie Mellon University; American Heart AssociationAmerican Heart Association [17SDG33700047]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21-EB024675]	Center for Machine Learning and Health at Carnegie Mellon University; American Heart Association (17SDG33700047); National Institutes of Health (R21-EB024675).	Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Balestreri M, 2005, ACT NEUR S, V95, P25; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka Z, 2017, ACTA NEUROCHIR, V159, P1979, DOI 10.1007/s00701-017-3282-1; Dagal A, 2009, CURR OPIN ANESTHESIO, V22, P547, DOI 10.1097/ACO.0b013e32833020be; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Edouard AR, 2005, BRIT J ANAESTH, V94, P216, DOI 10.1093/bja/aei034; Fanelli A, 2019, J NEUROSURG-PEDIATR, V24, P509, DOI 10.3171/2019.5.PEDS19178; FANTINI S, 1995, OPT ENG, V34, P32, DOI 10.1117/12.183988; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Fischer J. B., 2019, J CEREB BLOOD FLOW M, V39; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kochanek P. M., 2019, UPDATE BRAIN TRAU S1, V20; LASSEN NA, 1976, BRIT J ANAESTH, V48, P719, DOI 10.1093/bja/48.8.719; Le Roux P, 2016, INTRACRANIAL PRESSUR; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Lewis PM, 2007, ACTA NEUROCHIR, V149, P549, DOI 10.1007/s00701-007-1160-y; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petkus V, 2002, ULTRASONICS, V40, P829, DOI 10.1016/S0041-624X(02)00216-0; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; REID A, 1990, British Journal of Audiology, V24, P123, DOI 10.3109/03005369009077853; Robba C, 2020, CHILD NERV SYST, V36, P117, DOI 10.1007/s00381-019-04235-8; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Ruesch A., 2019, J CEREB BLOOD FLOW M, V37; Shotton J., 2013, DECISION FORESTCOM; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Swoboda M., 2013, NONINVASIVE INTRACRA; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Wager S, 2014, J MACH LEARN RES, V15, P1625; Weerakkody Ruwan Alwis, 2012, Acta Neurochir Suppl, V114, P181, DOI 10.1007/978-3-7091-0956-4_35; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Xu W, 2016, CHILD NERV SYST, V32, P1371, DOI 10.1007/s00381-016-3143-x; Yu G., 2011, HDB BIOMEDICAL OPTIC, P195; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	47	8	8	0	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	MAR 1	2020	11	3					1462	1476		10.1364/BOE.386612			15	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	KU2DF	WOS:000519518200019	32206422	Green Published, gold			2022-02-06	
J	Symons, GF; Clough, M; Fielding, J; O'Brien, WT; Shepherd, CE; Wright, DK; Shultz, SR				Symons, Georgia F.; Clough, Meaghan; Fielding, Joanne; O'Brien, William T.; Shepherd, Claire E.; Wright, David K.; Shultz, Sandy R.			The Neurological Consequences of Engaging in Australian Collision Sports	JOURNAL OF NEUROTRAUMA			English	Article						Australian rules football; chronic traumatic encephalopathy; concussion; mild traumatic brain injury; rugby; subconcussion	TRAUMATIC BRAIN-INJURY; RUGBY UNION PLAYERS; PROFESSIONAL FOOTBALL PLAYERS; HUMAN-IMMUNODEFICIENCY-VIRUS; LIFE COGNITIVE IMPAIRMENT; POST-CONCUSSION SYNDROME; CAVUM SEPTUM PELLUCIDUM; TEST-RETEST RELIABILITY; APPARENT FIBER DENSITY; DIFFUSE AXONAL INJURY	Collision sports are an integral part of Australian culture. The most common collision sports in Australia are Australian rules football, rugby union, and rugby league. Each of these sports often results in participants sustaining mild brain traumas, such as concussive and subconcussive injuries. However, the majority of previous studies and reviews pertaining to the neurological implications of sustaining mild brain traumas, while engaging in collision sports, have focused on those popular in North America and Europe. As part of this 2020 International Neurotrauma Symposium special issue, which highlights Australian neurotrauma research, this article will therefore review the burden of mild brain traumas in Australian collision sports athletes. Specifically, this review will first provide an overview of the consequences of mild brain trauma in Australian collision sports, followed by a summary of the previous studies that have investigated neurocognition, ocular motor function, neuroimaging, and fluid biomarkers, as well as neuropathological outcomes in Australian collision sports athletes. A review of the literature indicates that although Australians have contributed to the field, several knowledge gaps and limitations currently exist. These include important questions related to sex differences, the identification and implementation of blood and imaging biomarkers, the need for consistent study designs and common data elements, as well as more multi-modal studies. We conclude that although Australia has had an active history of investigating the neurological impact of collision sports participation, further research is clearly needed to better understand these consequences in Australian athletes and how they can be mitigated.	[Symons, Georgia F.; Clough, Meaghan; Fielding, Joanne; O'Brien, William T.; Wright, David K.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Shepherd, Claire E.] Univ New South Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	Shepherd, Claire E/C-9807-2011	Shepherd, Claire E/0000-0002-0399-3218	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1159645]	Sandy Schultz is funded by the Australian National Health and Medical Research Council (APP1159645).	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Adams R, 2018, CUREUS, V10, DOI 10.7759/cureus.3465; Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; AFL Annual Report, 2018, AFL ANN REP, pAustralia; AFL Annual Report, 2016, AFL ANN REP, pAustralia; AFL Injury Report, 2017, AFL INJ REP, pAustralia; AFL Injury Report, 2018, AFL INJ REP, pAustralia; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barth JT, 1989, MILD HEAD INJURY, P257; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Bleiberg J., 2006, SPORTS NEUROPSYCHOLO, P263; Born CM, 2004, EUR ARCH PSY CLIN N, V254, P295, DOI 10.1007/s00406-004-0496-z; Bouvier D, 2017, SPORTS MED, V47, P781, DOI 10.1007/s40279-016-0579-9; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Breedlove KM, 2019, J ATHL TRAINING, V54, P1241, DOI 10.4085/1062-6050-219-18; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0751-1; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Costello DM, 2018, J CLIN NEUROSCI, V56, P88, DOI 10.1016/j.jocn.2018.07.003; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; CULLEN KM, 1995, NEUROPATH APPL NEURO, V21, P312, DOI 10.1111/j.1365-2990.1995.tb01065.x; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Dremmen MHG, 2019, AM J NEURORADIOL, V40, P340, DOI 10.3174/ajnr.A5939; Durazzo TC, 2007, ALCOHOL, V41, P489, DOI 10.1016/j.alcohol.2007.07.007; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fein G, 2013, NEUROIMAGE-CLIN, V3, P47, DOI 10.1016/j.nicl.2013.06.018; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Forero DA, 2016, J GERONTOL A-BIOL, V71, P1069, DOI 10.1093/gerona/glw053; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Frechede B., 2007, 20 INT TECHN C ENH S, pFrance; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gabbett T, 2008, SPORTS MED, V38, P119, DOI 10.2165/00007256-200838020-00003; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gardner AJ, 2020, BRAIN INJURY, V34, P224, DOI 10.1080/02699052.2019.1683894; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Geekiyanage H, 2012, EXP NEUROL, V235, P491, DOI 10.1016/j.expneurol.2011.11.026; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Gray AJ, 2010, SPORTS MED, V40, P347, DOI 10.2165/11531400-000000000-00000; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hecimovich M, 2019, PHYSICIAN SPORTSMED, V47, P78, DOI 10.1080/00913847.2018.1525261; Hecimoyich M, 2018, J SCI MED SPORT, V21, P1004, DOI 10.1016/j.jsams.2018.03.011; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Hutchison MG, 2017, VIS DEV REHABIL, V3, P75; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Jackson G.D., 2019, J CONCUSSION, V3, pe2059700219861200; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2007, NZ J SPORTS MED, V34, P18; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King DA, 2009, CLIN J SPORT MED, V19, P277, DOI 10.1097/JSM.0b013e3181a7c6b0; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Ledwidge PS, 2019, CLIN J SPORT MED, V29, P292, DOI 10.1097/JSM.0000000000000512; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lee JK, 2017, AM J NEURORADIOL, V38, P1303, DOI 10.3174/ajnr.A5175; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Leigh JR, 2015, NEUROLOGY EYE MOVEME, VFifth; Leung FT, 2019, MUSCULOSKEL SCI PRAC, V39, P144, DOI 10.1016/j.msksp.2018.12.007; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lunter CM, 2019, EMERG MED AUSTRALAS, V31, P355, DOI 10.1111/1742-6723.13163; MacDonald LA, 2016, J SPORT SCI, V34, P1669, DOI 10.1080/02640414.2015.1132003; Maddocks D., 2017, BRIT J SPORT MED, V51, pA25, DOI [10.1136/bjsports-2016-097270.65, DOI 10.1136/BJSPORTS-2016-097270.65]; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Manning KY, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101627; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; MAWDSLEY C, 1963, LANCET, V2, P795; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntosh AS, 2019, J SCI MED SPORT, V22, P784, DOI 10.1016/j.jsams.2019.02.004; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Missler U, 1997, ACTA NEUROL SCAND, V96, P142; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moyron RB, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700061; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Nauman E.A., 2018, HDB CLIN NEUROLOGY, P245; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson PT, 2016, J NEUROPATH EXP NEUR, V75, P482, DOI 10.1093/jnen/nlw033; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; O'Connell B, 2018, BRAIN INJURY, V32, P1811, DOI 10.1080/02699052.2018.1532112; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Partridge B, 2015, NEUROETHICS-NETH, V8, P39, DOI 10.1007/s12152-014-9217-0; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pearce AJ, 2017, J SPORT SCI, V35, P1911, DOI 10.1080/02640414.2016.1241420; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Putukian M, 2011, PM&R, V3, pS425, DOI 10.1016/j.pmrj.2011.08.003; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Rockswold SB, 2019, J NEUROTRAUM, V36, P1099, DOI 10.1089/neu.2018.5796; Saw R, 2018, SPORTS HEALTH, V10, P208, DOI 10.1177/1941738117726070; Schick DM, 2008, BRIT J SPORT MED, V42, P447, DOI 10.1136/bjsm.2008.046672; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P186, DOI 10.1016/j.pscychresns.2013.03.001; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sorensen SS, 2014, TRANSL STROKE RES, V5, P711, DOI 10.1007/s12975-014-0364-8; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Taylor AE, 2011, BRIT J SPORT MED, V45, P1243, DOI 10.1136/bjsports-2011-090024; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Thiagarajan P., 2011, OPHTHAL PHYSL OPT, V31, P456468; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tripathy A, 2019, J ALZHEIMERS DIS, V67, P1277, DOI 10.3233/JAD-181039; Union R.F., 2016, ENGL PROF RUGB INJ S, pUK; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Willmott C, 2018, J SCI MED SPORT, V21, P442, DOI 10.1016/j.jsams.2017.09.591; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang YJ, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080199; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327	231	8	8	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					792	809		10.1089/neu.2019.6884			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200009	32056505				2022-02-06	
J	Wettervik, TS; Howells, T; Lewen, A; Enblad, P				Wettervik, Teodor Svedung; Howells, Timothy; Lewen, Anders; Enblad, Per			Blood Pressure Variability and Optimal Cerebral Perfusion Pressure-New Therapeutic Targets in Traumatic Brain Injury	NEUROSURGERY			English	Article						Autoregulation; Blood pressure variability; CPPopt; Traumatic brain injury	HEART-RATE-VARIABILITY; REACTIVITY; MANAGEMENT; GUIDELINES	BACKGROUND: Optimal cerebral perfusion pressure (CPPopt) is an autoregulatory-oriented target in the neurointensive care (NIC) of patients with traumatic brain injury (TBI), and deviation from CPPopt is associated with poor outcome. We recently found that blood pressure variability (BPV) is associated with deviation from CPPopt. OBJECTIVE: To evaluate BPV and other variables related to deviation from CPPopt and to evaluate challenges and strategies for autoregulatory-oriented treatment in TBI. METHODS: Data including arterial blood pressure and intracranial pressure (ICP) from 362 TBI patients treated at the NIC unit, Uppsala University Hospital, Sweden, between 2008 and 2016, were retrospectively analyzed day 2 to 5. RESULTS: Higher BPV was a strong predictor of both CPP deviation below and above CPPopt after multiple regression analyses. There was no other explanatory variable for CPP deviation above CPPopt, whereas also higher ICP and worse autoregulation (higher pressure reactivity index) were associated with CPP deviation below CPPopt. A higher BPV was, in turn, explained by older age, lower ICP, higher mean arterial blood pressure, and higher slow arterial blood pressure amplitude (0.018-0.067 Hz). CONCLUSION: BPV was strongly associated with deviation from CPPopt. High age is a risk factor for high BPV and hence CPP insults. Our treatment protocol is focused on avoiding CPP below 60 mm Hg. It is possible that a more restrictive upper level could generate more stable blood pressure and less deviation from CPPopt.	[Wettervik, Teodor Svedung; Howells, Timothy; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se	Wettervik, Teodor Mikael Svedung/S-5356-2017		Department of Neuroscience, Uppsala University	The study was funded by the Department of Neuroscience, Uppsala University. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; BRENNAN M, 1986, J HYPERTENS, V4, pS269; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; de Havenon A, 2017, STROKE VASC NEUROL, V2, P1, DOI 10.1136/svn-2016-000057; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elghozi JL, 2007, FUND CLIN PHARMACOL, V21, P337, DOI 10.1111/j.1472-8206.2007.00502.x; Grande PO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00315; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2019, J CLIN MONIT COMPUT; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Imai Y, 1997, AM J HYPERTENS, V10, P1281, DOI 10.1016/S0895-7061(97)00277-X; Lattanzi S, 2015, J STROKE CEREBROVASC, V24, P1493, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.014; Lee Young Soo, 2006, Korean Circulation Journal, V36, P565; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Schillaci G, 2012, HYPERTENSION, V60, P369, DOI 10.1161/HYPERTENSIONAHA.112.197491; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sykora M, 2008, CRIT CARE MED, V36, P3074, DOI 10.1097/CCM.0b013e31818b306d; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Sykora M, 2009, STROKE, V40, pE678, DOI 10.1161/STROKEAHA.109.565838; Sykora M, 2009, J NEUROL SCI, V284, P108, DOI 10.1016/j.jns.2009.04.028; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tillin T, 2007, J HYPERTENS, V25, P383, DOI 10.1097/HJH.0b013e3280115bea; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Ma XJ, 2007, ACTA PHARMACOL SIN, V28, P1550, DOI 10.1111/j.1745-7254.2007.00644.x	34	8	8	3	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2020	86	3					E300	E309		10.1093/neuros/nyz515			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LS6AA	WOS:000536463300009	31807783				2022-02-06	
J	Poudel, GR; Dominguez, DJF; Verhelst, H; Vander Linden, C; Deblaere, K; Jones, DK; Cerin, E; Vingerhoets, G; Caeyenberghs, K				Poudel, Govinda R.; Dominguez, D. Juan F.; Verhelst, Helena; Vander Linden, Catharine; Deblaere, Karel; Jones, Derek K.; Cerin, Ester; Vingerhoets, Guy; Caeyenberghs, Karen			Network diffusion modeling predicts neurodegeneration in traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							HEAD-INJURY; PROGRESSION; SYSTEM; RISK	Objective Traumatic brain injury (TBI) is a heterogeneous disease with multiple neurological deficits that evolve over time. It is also associated with an increased incidence of neurodegenerative diseases. Accordingly, clinicians need better tools to predict a patient's long-term prognosis. Methods Diffusion-weighted and anatomical MRI data were collected from 17 adolescents (mean age = 15y8mo) with moderate-to-severe TBI and 19 healthy controls. Using a network diffusion model (NDM), we examined the effect of progressive deafferentation and gray matter thinning in young TBI patients. Moreover, using a novel automated inference method, we identified several injury epicenters in order to determine the neural degenerative patterns in each TBI patient. Results We were able to identify the subject-specific patterns of degeneration in each patient. In particular, the hippocampus, temporal cortices, and striatum were frequently found to be the epicenters of degeneration across the TBI patients. Orthogonal transformation of the predicted degeneration, using principal component analysis, identified distinct spatial components in the temporal-hippocampal network and the cortico-striatal network, confirming the vulnerability of these networks to injury. The NDM model, best predictive of the degeneration, was significantly correlated with time since injury, indicating that NDM can potentially capture the pathological progression in the chronic phase of TBI. Interpretation These findings suggest that network spread may help explain patterns of distant gray matter thinning, which would be consistent with Wallerian degeneration of the white matter connections (i.e., "diaschisis") from diffuse axonal injuries and multifocal contusive injuries, and the neurodegenerative patterns of abnormal protein aggregation and transmission, which are hallmarks of brain changes in TBI. NDM approaches could provide highly subject-specific biomarkers relevant for disease monitoring and personalized therapies in TBI.	[Poudel, Govinda R.; Cerin, Ester] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Dominguez, D. Juan F.; Caeyenberghs, Karen] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Burwood, Vic, Australia; [Verhelst, Helena; Vingerhoets, Guy] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Oost Vlaanderen, Belgium; [Vander Linden, Catharine] Ghent Univ Hosp, Child Rehabil Ctr, Ghent, Oost Vlaanderen, Belgium; [Deblaere, Karel] Ghent Univ Hosp, Dept Neuroradiol, Ghent, Oost Vlaanderen, Belgium; [Jones, Derek K.] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, Wales		Caeyenberghs, K (corresponding author), Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Neuroplasticy & Multimodal Imaging NMI Lab, Burwood Campus,221 Burwood Highway, Burwood, Vic 3125, Australia.; Poudel, GR (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Behaviour Environm & Cognit Res Program, 215 Spring St, Melbourne, Vic 3000, Australia.	govinda.poudel@acu.edu.au; k.caeyenberghs@deakin.edu.au	Cerin, Ester/L-1271-2015; Poudel, Govinda/AAR-8078-2020	Cerin, Ester/0000-0002-7599-165X; Poudel, Govinda/0000-0002-0043-7531; Dominguez Duque, Juan Fernando/0000-0002-6715-1060; Verhelst, Helena/0000-0002-6861-0249; Jones, Derek K/0000-0003-4409-8049	Australian Catholic University (ACU); National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia [APP1143816]; Wellcome TrustWellcome TrustEuropean Commission [096646/Z/11/Z, 104943/Z/14/Z]; Special Research Fund (BOF) from the University of Ghent [01N00214]	Govinda Poudel is a Research Fellow on an ACURF Program grant by the Australian Catholic University (ACU). Karen Caeyenberghs is supported by a National Health and Medical Research Council Career Development Fellowship (APP1143816). Derek Jones is supported by a Wellcome Trust Investigator Award (096646/Z/11/Z) and a Wellcome Trust Strategic Award (104943/Z/14/Z). Data collection for this study was supported by a grant (#01N00214) from the Special Research Fund (BOF) from the University of Ghent.	Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; DELANGE EE, 1991, MAGN RESON IMAGING, V9, P469, DOI 10.1016/0730-725X(91)90031-G; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Freeze B, 2019, BRAIN, V142, P3072, DOI 10.1093/brain/awz223; Gao JJ, 2015, PARKINSONISM RELAT D, V21, P292, DOI 10.1016/j.parkreldis.2014.12.033; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Messaritaki E, 2019, NEUROIMAGE, V199, P495, DOI 10.1016/j.neuroimage.2019.05.052; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Pandya S, 2019, NEUROIMAGE, V192, P178, DOI 10.1016/j.neuroimage.2019.03.001; Pandya S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00692; Poudel GR, 2019, HUM BRAIN MAPP, V40, P4192, DOI 10.1002/hbm.24695; Raj A, 2018, BIOL PSYCHIAT-COGN N, V3, P788, DOI 10.1016/j.bpsc.2018.07.012; Raj A, 2015, CELL REP, V10, P359, DOI 10.1016/j.celrep.2014.12.034; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Takahata K, 2019, BRAIN, V142, P3265, DOI 10.1093/brain/awz238; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Torok J, 2018, BRAIN, V141, P863, DOI 10.1093/brain/awx371; Tournier JD, 2010, P INT SOC MAGN RES I; Vander Linden C, 2019, NEUROIMAGE-CLIN, V23, P101827; Vander Linden C, 2019, DEV MED CHILD NEUROL, V61, P672, DOI 10.1111/dmcn.14100; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Verhelst H, 2017, GAMES HEALTH J, V6, P28, DOI 10.1089/g4h.2016.0043	35	8	8	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	MAR	2020	7	3					270	279		10.1002/acn3.50984		FEB 2020	10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW0DD	WOS:000517450800001	32105414	Green Accepted, Green Published, gold			2022-02-06	
J	Weisz, HA; Kennedy, D; Widen, S; Spratt, H; Sell, SL; Bailey, C; Sheffield-Moore, M; DeWitt, DS; Prough, DS; Levin, H; Robertson, C; Hellmich, HL				Weisz, Harris A.; Kennedy, Deborah; Widen, Steven; Spratt, Heidi; Sell, Stacy L.; Bailey, Christine; Sheffield-Moore, Melinda; DeWitt, Douglas S.; Prough, Donald S.; Levin, Harvey; Robertson, Claudia; Hellmich, Helen L.			MicroRNA sequencing of rat hippocampus and human biofluids identifies acute, chronic, focal and diffuse traumatic brain injuries	SCIENTIFIC REPORTS			English	Article							NEUROINFLAMMATION; STRESS; CELLS	High-throughput sequencing technologies could improve diagnosis and classification of TBI subgroups. Because recent studies showed that circulating microRNAs (miRNAs) may serve as noninvasive markers of TBI, we performed miRNA-seq to study TBI-induced changes in rat hippocampal miRNAs up to one year post-injury. We used miRNA PCR arrays to interrogate differences in serum miRNAs using two rat models of TBI (controlled cortical impact [CCI] and fluid percussion injury [FPI]). The translational potential of our results was evaluated by miRNA-seq analysis of human control and TBI (acute and chronic) serum samples. Bioinformatic analyses were performed using Ingenuity Pathway Analysis, miRDB, and Qlucore Omics Explorer. Rat miRNA profiles identified TBI across all acute and chronic intervals. Rat CCI and FPI displayed distinct serum miRNA profiles. Human miRNA profiles identified TBI across all acute and chronic time points and, at 24 hours, discriminated between focal and diffuse injuries. In both species, predicted gene targets of differentially expressed miRNAs are involved in neuroplasticity, immune function and neurorestoration. Chronically dysregulated miRNAs (miR-451a, miR-30d-5p, miR-145-5p, miR-204-5p) are linked to psychiatric and neurodegenerative disorders. These data suggest that circulating miRNAs in biofluids can be used as "molecular fingerprints" to identify acute, chronic, focal or diffuse TBI and potentially, presence of neurodegenerative sequelae.	[Weisz, Harris A.; Kennedy, Deborah; Widen, Steven; Spratt, Heidi; Sell, Stacy L.; Bailey, Christine; Sheffield-Moore, Melinda; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ OfTexas Med Branch Galveston, Galveston, TX 77555 USA; [Levin, Harvey; Robertson, Claudia] Baylor Coll Med, Houston, TX 77030 USA		Hellmich, HL (corresponding author), Univ OfTexas Med Branch Galveston, Galveston, TX 77555 USA.	hhellmic@utmb.edu		Spratt, Heidi/0000-0002-9420-5028			Agoston V. A, 2019, J NEUROTRAUM, V36, P1; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688; Boone D. R, 2019, PLOS ONE, V14; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Cangelosi R, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-2; Chiu H, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00283; Cohen J., 2018, SCIENCE; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469; Gao X, 2016, CELL MOL BIOL, V62, P144, DOI 10.14715/cmb/2016.62.12.24; Hamdeh S. A, 2018, NATURE RES J; Harraz MM, 2012, P NATL ACAD SCI USA, V109, P18962, DOI 10.1073/pnas.1121288109; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Henshall DC, 2016, LANCET NEUROL, V15, P1368, DOI 10.1016/S1474-4422(16)30246-0; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/NMETH.1682, 10.1038/nmeth.1682]; Kim Y, 2016, EXP NEUROBIOL, V25, P296, DOI 10.5607/en.2016.25.6.296; Lee Bruce, 2005, NeuroRx, V2, P372; Liu XY, 2019, CELL, V177, P1022, DOI 10.1016/j.cell.2019.04.014; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Parikh RB, 2019, SCIENCE, V363, P810, DOI 10.1126/science.aaw0029; Peipei L, 2019, NATURE COMMUNICATION; Peixoto CA, 2017, EXP NEUROL, V298, P31, DOI 10.1016/j.expneurol.2017.08.013; Popovich P. G, 2017, NEUROSCIENTIST; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Rexach J, 2019, LANCET NEUROL, V18, P492, DOI 10.1016/S1474-4422(19)30033-X; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roitbak T, 2019, NEUROCHEM RES; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Sarkar SN, 2019, AGING DIS, V10, P329, DOI 10.14336/AD.2018.0409; Schneider R, 2018, J NEUROL NEUROSUR PS, V89, P851, DOI 10.1136/jnnp-2017-317492; Schork AJ, 2019, NAT NEUROSCI, V22, P353, DOI 10.1038/s41593-018-0320-0; Shu P, 2019, DEV CELL; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Wang P, 2015, ONCOTARGET, V6, P21148, DOI 10.18632/oncotarget.4125; Wang WC, 2017, ONCOTARGET, V8, P107109, DOI 10.18632/oncotarget.22346; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Yang Z, 2015, MOL IMMUNOL, V65, P267, DOI 10.1016/j.molimm.2014.12.018; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	46	8	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 24	2020	10	1							3341	10.1038/s41598-020-60133-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF4PV	WOS:000563280800003	32094409	gold, Green Published			2022-02-06	
J	Follmer, B; Varga, AA; Zehr, EP				Follmer, Bruno; Varga, Aaron Alexander; Zehr, E. Paul			Understanding concussion knowledge and behavior among mixed martial arts, boxing, kickboxing, and Muay Thai athletes and coaches	PHYSICIAN AND SPORTSMEDICINE			English	Article						Head injuries; brain concussion; traumatic brain injury; leadership; knowledge translation	SYMPTOMS; SPORT; RECOVERY; INJURY; IMPACT; TIME	Objectives: In combat sports, strikes to the head are not just incidental but a deliberate and clear determinant of success. Concussion is a complex injury that is poorly understood and inappropriate practices are often observed among athletes and coaches. The purpose of this study was to investigate concussion knowledge and behavior as well as address recommendations for combat sports athletes and coaches. Methods: 70 athletes and 35 coaches from combat sports disciplines completed an online-validated survey and a personal questionnaire about concussion knowledge, training experience, and knowledge translation. Athletes were divided into subgroups for analysis according to sex (male n = 55, female n = 15), skill level (amateur n = 52, professional n = 18), and weight classes (<66.2 kg: n = 25, 66.6 to 77.5 kg: n = 30, and >78 kg: n = 15). Results: The likely absence of health-care professionals during training was confirmed by 68.5% of coaches, and athletes declared that self-diagnosis (79%) and coaches' diagnosis (43.3%) were the most used method of suspected concussion assessment. Merely 5.7% of coaches properly recognized the level of traumatic brain injury a concussion represents, 68.8% were unfamiliar with any sideline assessment tools, and only 14.3% often seek out concussion knowledge. Athletes who were aware of the level of brain injury a concussion represents performed fewer sparring sessions per week (mild: 1.27 +/- 1.1; severe: 3.17 +/- 2.81; p = .05, d = .89) and had a greater likelihood of reporting concussive episodes. Most professional (55.5%), female (54.5%), and under 66.2 kg (50%) athletes returned to full practice within 1 week following a concussion diagnosis. Conclusions: Relevant key gaps of knowledge and behavior were verified in combat sports athletes and coaches. The awareness of basic concepts may improve injury reporting and safer behavior in athletes. Knowledge translation strategies with accessible language are recommended for coaches, in particular on how to identify acute symptoms and perform basic assessment.	[Follmer, Bruno; Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC, Canada; [Follmer, Bruno; Varga, Aaron Alexander; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Human Discovery Sci, Vancouver, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Zehr, E. Paul] Univ British Columbia, Fac Med, Dept Med, Div Neurol, Victoria, BC, Canada		Zehr, EP (corresponding author), Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Rehabil Neurosci Lab, Room 172,McKinnon Bldg,3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada.	pzehr@uvic.ca		Follmer, Bruno/0000-0001-5052-9648			Albicini M, 2018, J CONCUSSION, V2, p2059700218784826; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bennett LL, 2019, PHYSICIAN SPORTSMED, V47, P295, DOI 10.1080/00913847.2018.1552481; Berg GM, 2014, JAAPA-J AM ACAD PHYS, V27, DOI 10.1097/01.JAA.0000442712.05009.b1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Coswig VS, 2016, J STRENGTH COND RES, V30, P2156, DOI 10.1519/JSC.0000000000001340; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Follmer B, 2019, SPORTS HEALTH, V11, P280, DOI 10.1177/1941738119827966; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Ghoul N, 2019, J STRENGTH COND RES, V33, P1570, DOI 10.1519/JSC.0000000000002078; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Heath CJ, 2013, RES SPORTS MED, V21, P195, DOI 10.1080/15438627.2013.792082; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lystad Reidar P, 2018, Inj Epidemiol, V5, P25, DOI 10.1186/s40621-018-0155-x; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1113, DOI 10.1136/bjsports-2015-095093; Miarka B, 2016, INT J PERF ANAL SPOR, V16, P539, DOI 10.1080/24748668.2016.11868907; Nalepa B, 2017, PHYSICIAN SPORTSMED, V45, P145, DOI 10.1080/00913847.2017.1288544; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Pope JP, 2015, INT J SPORTS SCI COA, V10, P1055, DOI 10.1260/1747-9541.10.6.1055; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Saffary R, 2012, AM J LIFESTYLE MED, V6, P133, DOI 10.1177/1559827611411649; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zehr EP, 2016, BRIT J SPORT MED, V50, P1481, DOI 10.1136/bjsports-2016-096792	37	8	8	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT 1	2020	48	4					417	423		10.1080/00913847.2020.1729668		FEB 2020	7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	PD4KS	WOS:000516914800001	32067547				2022-02-06	
J	Bree, D; Mackenzie, K; Stratton, J; Levy, D				Bree, Dara; Mackenzie, Kimberly; Stratton, Jennifer; Levy, Dan			Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury	CEPHALALGIA			English	Article						Post-traumatic headache; concussion; cutaneous pain hypersensitivity; sex differences; anti-CGRP monoclonal antibody	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; DURAL AFFERENTS; SEX-DIFFERENCES; PAIN; MODEL; SENSITIZATION; MECHANISMS; RESPONSES; IMPACT	Introduction Females are thought to have increased risk of developing post-traumatic headache following a traumatic head injury or concussion. However, the processes underlying this susceptibility remain unclear. We previously demonstrated the development of post-traumatic headache-like pain behaviors in a male rat model of mild closed head injury, along with the ability of sumatriptan and an anti-calcitonin-gene-related peptide monoclonal antibody to ameliorate these behaviors. Here, we conducted a follow-up study to explore the development of post-traumatic headache-like behaviors and the effectiveness of these headache therapies in females subjected to the same head trauma protocol. Methods Adult female Sprague Dawley rats were subjected to a mild closed head injury using a weight-drop device (n = 126), or to a sham procedure (n = 28). Characterization of headache and pain related behaviors included assessment of changes in cutaneous cephalic and extracephalic tactile pain sensitivity, using von Frey monofilaments. Sensitivity to headache/migraine triggers was tested by examining the effect of intraperitoneal administration of a low dose of glyceryl trinitrate (100 mu g/kg). Treatments included acute systemic administration of sumatriptan (1 mg/kg) and repeated systemic administration of a mouse anti-calcitonin gene-related peptide monoclonal antibody (30 mg/kg). Serum levels of calcitonin gene-related peptide were measured at baseline and at various time points post head injury in new cohorts of females (n = 38) and males (n = 36). Results Female rats subjected to a mild closed head injury developed cutaneous mechanical hyperalgesia, which was limited to the cephalic region and was resolved 4 weeks later. Cephalic pain hypersensitivity was ameliorated by treatment with sumatriptan but was resistant to an early and prolonged treatment with the anti-calcitonin gene-related peptide monoclonal antibody. Following the resolution of the head injury-evoked cephalic hypersensitivity, administration of glyceryl trinitrate produced a renewed and pronounced cephalic and extracephalic pain hypersensitivity that was inhibited by sumatriptan, but only partially by the anti-calcitonin gene-related peptide treatment. Calcitonin gene-related peptide serum levels were elevated in females but not in males at 7 days post head injury. Conclusions Development of post-traumatic headache-like pain behaviors following a mild closed head injury, and responsiveness to treatment in rats is sexually dimorphic. When compared to the data obtained from male rats in the previous study, female rats display a prolonged state of cephalic hyperalgesia, increased responsiveness to a headache trigger, and a poorer effectiveness of an early and prolonged anti-calcitonin gene-related peptide treatment. The increased risk of females to develop post-traumatic headache may be linked to enhanced responsiveness of peripheral and/or central pain pathways and a mechanism independent of peripheral calcitonin gene-related peptide signaling.	[Bree, Dara; Levy, Dan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Mackenzie, Kimberly; Stratton, Jennifer; Levy, Dan] Teva Biol, Redwood City, CA USA		Levy, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, 330 Brookline Ave, Boston, MA 02215 USA.	dlevy1@bidmc.harvard.edu	Levy, Dan/AAF-1871-2021	Levy, Dan/0000-0003-0630-6660	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS078263, R01NS086830, R21NS101405]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: DL is supported by NIH Grants R01NS078263; R01NS086830, R21NS101405.	Avona A, 2019, J NEUROSCI, V39, P4323, DOI 10.1523/JNEUROSCI.0364-19.2019; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Boes T, 2012, CEPHALALGIA, V32, P924, DOI 10.1177/0333102412454947; Bree D, 2019, PAIN, V160, P1050, DOI 10.1097/j.pain.0000000000001481; Bree D, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0720-6; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dickie AC, 2017, J NEUROSCI, V37, P6488, DOI 10.1523/JNEUROSCI.3816-16.2017; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; Ferrari LF, 2016, NEUROSCIENCE, V317, P121, DOI 10.1016/j.neuroscience.2016.01.005; Ferrari LF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31221; Gregoire S, 2012, PAIN, V153, P1657, DOI 10.1016/j.pain.2012.04.023; Headache Classification Committee of the International Headache Society (IHS), 2018, CEPHALALGIA, V38, P1, DOI [10.1177/0333102417738202., DOI 10.1177/0333102413485658]; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jensen O K, 2001, Ugeskr Laeger, V163, P5029; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kopruszinski CM, 2017, CEPHALALGIA, V37, P560, DOI 10.1177/0333102416650702; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Mason BN, 2017, J NEUROSCI, V37, P204, DOI 10.1523/JNEUROSCI.2967-16.2016; Mills C, 2012, J PAIN, V13, P519, DOI 10.1016/j.jpain.2012.02.009; Munro G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19901-1; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nordhaug LH, 2019, J NEUROTRAUM, V36, P3244, DOI 10.1089/neu.2018.6328; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Parent AJ, 2012, BEHAV BRAIN RES, V229, P160, DOI 10.1016/j.bbr.2012.01.001; Pradhan AA, 2014, PAIN, V155, P269, DOI 10.1016/j.pain.2013.10.004; Rea BJ, 2018, PAIN, V159, P2306, DOI 10.1097/j.pain.0000000000001337; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Sang KN, 2018, MOL PAIN, V14, DOI 10.1177/1744806918783931; Sannajust S, 2019, PAIN, V160, P2036, DOI 10.1097/j.pain.0000000000001598; Scheff NN, 2011, J NEUROPHYSIOL, V106, P1662, DOI 10.1152/jn.00196.2011; Shansky RM, 2019, SCIENCE, V364, P825, DOI 10.1126/science.aaw7570; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; VOS BP, 1994, J NEUROSCI, V14, P2708; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Winner P, 2003, MAYO CLIN PROC, V78, P1214, DOI 10.4065/78.10.1214; Yan J, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-6; Zhao J, 2014, PAIN, V155, P1392, DOI 10.1016/j.pain.2014.04.019	51	8	8	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JUN	2020	40	7					748	760	0333102420907597	10.1177/0333102420907597		FEB 2020	13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU9XB	WOS:000514772700001	32077327	Green Submitted, Green Accepted			2022-02-06	
J	Inyang, E; Abhyankar, V; Chen, B; Cho, M				Inyang, Edidiong; Abhyankar, Vinay; Chen, Bo; Cho, Michael			Modulation of in vitro Brain Endothelium by Mechanical Trauma: Structural and Functional Restoration by Poloxamer 188	SCIENTIFIC REPORTS			English	Article							MATRIX METALLOPROTEINASES; BARRIER; INJURY; PERMEABILITY; DAMAGE; MICROBUBBLES; ANGIOGENESIS; MIGRATION; JUNCTIONS; CELLS	Brain injuries caused by an explosive blast or blunt force is typically presumed to associate with mechanical trauma to the brain tissue. Recent findings from our laboratory suggest that shockwaves produced by a blast can generate micron-sized bubbles in the tissue. The collapse of microbubbles (i.e., microcavitation) may induce a mechanical trauma and compromise the integrity of the blood-brain endothelium (BBE). To test our hypothesis, we engineered a BBE model to determine the effect of microbubbles on the structural and functional changes in the BBE. Using monolayers of mouse primary brain microvascular endothelial cells, the permeability coefficient was measured following simulated blast-induced microcavitation. This event down-regulated the expression of tight junction markers, disorganized the cell-cell junction, and increased permeability. Since poloxamers have been shown to rescue damaged cells, the cells were treated with the FDA-approved poloxamer 188 (P188). The results indicate P188 recovered the permeability, restored the tight junctions, and suppressed the expressions of matrix metalloproteinases. The biomimetic interface we developed appears to provide a systematic approach to replicate the structure and function of BBE, determine its alteration in response to traumatic brain injury, and test potential therapeutic treatments to repair the damaged brain endothelium.	[Inyang, Edidiong; Chen, Bo; Cho, Michael] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Abhyankar, Vinay] Rochester Inst Technol, Dept Biomed Engn, Rochester, NY 14623 USA		Cho, M (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.	michael.cho@uta.edu		Cho, Myoung Rae/0000-0002-8191-8045			Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Alam M, 2011, NEUROSCI LETT, V495, P135, DOI 10.1016/j.neulet.2011.03.056; Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Armstrong JK, 2001, BIORHEOLOGY, V38, P239; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Baskaran H, 2001, J SURG RES, V101, P56, DOI 10.1006/jsre.2001.6262; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P1262, DOI 10.1038/jcbfm.2010.37; Chen B, 2019, ACS APPL MATER INTER, V11, P4889, DOI 10.1021/acsami.8b21410; Cheslow L, 2016, CURR OPIN PHARMACOL, V26, P39, DOI 10.1016/j.coph.2015.09.010; Cisbani G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.121; Collins JM, 2007, BBA-BIOMEMBRANES, V1768, P1238, DOI 10.1016/j.bbamem.2007.01.012; Collis J, 2010, ULTRASONICS, V50, P273, DOI 10.1016/j.ultras.2009.10.002; Doggett TM, 2014, ALCOHOL CLIN EXP RES, V38, P2414, DOI 10.1111/acer.12525; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Iwaskiw AS, 2018, SHOCK WAVES, V28, P63, DOI 10.1007/s00193-017-0759-z; Janelidze S, 2017, NEUROBIOL AGING, V51, P104, DOI 10.1016/j.neurobiolaging.2016.11.017; Kanagaraj J, 2018, ANN BIOMED ENG, V46, P354, DOI 10.1007/s10439-017-1953-y; Keep RF, 2018, J CEREBR BLOOD F MET, V38, P1255, DOI 10.1177/0271678X18774666; Li Chun-hua, 2010, Zhongguo Yaolixue Tongbao, V26, P1418; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; McRae M, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1405774; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; Pardridge W. M., 2003, MOL INTERV, V3, P151; Pearson-Leary J, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.122; Ribecco-Lutkiewicz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19522-8; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shetty A, 2014, FRONTIERS CELLULAR N, V8; Smith ES, 2015, NEUROBIOL DIS, V73, P254, DOI 10.1016/j.nbd.2014.10.008; Sun S, 2015, J NEUROTRAUM, V32, P1441, DOI 10.1089/neu.2014.3699; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsoneva I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/314213; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Wang T, 2015, J MOL NEUROSCI, V55, P240, DOI 10.1007/s12031-014-0313-8; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Wang X, 2013, NATURE, V501, P578; Wong SW, 2017, ANN BIOMED ENG, V45, P1083, DOI 10.1007/s10439-016-1733-0; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Zheng YY, 2017, DNA CELL BIOL, V36, P853, DOI 10.1089/dna.2017.3818	49	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 20	2020	10	1							3054	10.1038/s41598-020-59888-2			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF1RQ	WOS:000563079900038	32080247	Green Published, gold			2022-02-06	
J	Garg, RK; Khan, J; Dawe, RJ; Conners, J; John, S; Prabhakaran, S; Kocak, M; Bhabad, S; Simpson, SL; Ouyang, BH; Jhaveri, M; Bleck, TP				Garg, Rajeev K.; Khan, Jawad; Dawe, Robert J.; Conners, James; John, Sayona; Prabhakaran, Shyam; Kocak, Mehmet; Bhabad, Sudeep; Simpson, Sean L.; Ouyang, Bichun; Jhaveri, Miral; Bleck, Thomas P.			The Influence of Diffusion Weighted Imaging Lesions on Outcomes in Patients with Acute Spontaneous Intracerebral Hemorrhage	NEUROCRITICAL CARE			English	Article						Cerebral hemorrhage; Diffusion magnetic resonance imaging; Cerebral infarction; Blood pressure; Outcome assessment	ENLARGED PERIVASCULAR SPACES; TRAUMATIC BRAIN-INJURY; ISCHEMIC LESIONS; STATIN USE; STROKE; MRI; RISK; INFLAMMATION; REDUCTION; DIAGNOSIS	Background/Objective Diffusion weighted imaging (DWI) lesions have been well described in patients with acute spontaneous intracerebral hemorrhage (sICH). However, there are limited data on the influence of these lesions on sICH functional outcomes. We conducted a prospective observational cohort study with blinded imaging and outcomes assessment to determine the influence of DWI lesions on long-term outcomes in patients with acute sICH. We hypothesized that DWI lesions are associated with worse modified Rankin Scale (mRS) at 3 months after hospital discharge. Methods Consecutive sICH patients meeting study criteria were consented for an magnetic resonance imaging (MRI) scan of the brain and evaluated for remote DWI lesions by neuroradiologists blinded to the patients' hospital course. Blinded mRS outcomes were obtained at 3 months. Logistic regression was used to determine significant factors (p < 0.05) associated with worse functional outcomes defined as an mRS of 4-6. The generalized estimating equation (GEE) approach was used to investigate the effect of DWI lesions on dichotomized mRS (0-3 vs 4-6) longitudinally. Results DWI lesions were found in 60 of 121 patients (49.6%). The presence of a DWI lesion was associated with increased odds for an mRS of 4-6 at 3 months (OR 5.987, 95% CI 1.409-25.435, p = 0.015) in logistic regression. Using the GEE model, patients with a DWI lesion were less likely to recover over time between 14 days/discharge and 3 months (p = 0.005). Conclusions DWI lesions are common in primary sICH, occurring in almost half of our cohort. Our data suggest that DWI lesions are associated with worse mRS at 3 months in good grade sICH and are predictive of impaired recovery after hospital discharge. Further research into the pathophysiologic mechanisms underlying DWI lesions may lead to novel treatment options that may improve outcomes associated with this devastating disease.	[Garg, Rajeev K.; Khan, Jawad; Dawe, Robert J.; Conners, James; John, Sayona; Kocak, Mehmet; Bhabad, Sudeep; Ouyang, Bichun; Jhaveri, Miral; Bleck, Thomas P.] Rush Univ, Med Ctr, 1725 West Harrison St,Suite 1106, Chicago, IL 60612 USA; [Simpson, Sean L.] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Prabhakaran, Shyam] Univ Chicago, Chicago, IL 60637 USA		Garg, RK (corresponding author), Rush Univ, Med Ctr, 1725 West Harrison St,Suite 1106, Chicago, IL 60612 USA.	rajeev_k_garg@rush.edu	Jhaveri, Miral/AAB-1894-2020; John, Sayona/AAR-6849-2020	Jhaveri, Miral/0000-0001-6733-0088; John, Sayona/0000-0002-2133-7265; Garg, Rajeev/0000-0002-1949-8019	American Heart Association Midwest Affiliate GrantAmerican Heart Association [11CRP7520073]; Rush University's Department of Neurological Sciences; NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K25 EB012236, R01EB024559]; Wake Forest CTSI NCATS [UL1TR001420]	Project primarily supported by the American Heart Association Midwest Affiliate Grant 11CRP7520073 (RKG), and Rush University's Department of Neurological Sciences (RKG). Additional support provided by NIBIB K25 EB012236 (SLS), R01EB024559 (SLS), and Wake Forest CTSI NCATS UL1TR001420 (SLS).	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Auriel E, 2015, STROKE, V46, P2129, DOI 10.1161/STROKEAHA.115.009208; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bendszus M, 1999, LANCET, V354, P1594, DOI 10.1016/S0140-6736(99)07083-X; Biffi A, 2011, NEUROLOGY, V76, P1581, DOI 10.1212/WNL.0b013e3182194be9; Blanco-Colio LM, 2007, AM HEART J, V153, P881, DOI 10.1016/j.ahj.2007.02.029; Boulanger M, 2019, STROKE, V50, P135, DOI 10.1161/STROKEAHA.118.021407; Buletko AB, 2018, NEUROLOGY, V91, pE1058, DOI 10.1212/WNL.0000000000006156; Butcher KS, 2013, STROKE, V44, P620, DOI 10.1161/STROKEAHA.111.000188; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Fam MD, 2017, NEUROLOGY, V89, P1553, DOI 10.1212/WNL.0000000000004493; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Garg RK, 2012, STROKE, V43, P67, DOI 10.1161/STROKEAHA.111.629493; Garg RK, 2011, NEUROLOGY, V76, pA212; Gioia LC, 2015, STROKE, V46, P1541, DOI 10.1161/STROKEAHA.114.008304; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Gregoire SM, 2011, BRAIN, V134, P2376, DOI 10.1093/brain/awr172; Hays A, 2006, NEUROLOGY, V66, P1330, DOI 10.1212/01.wnl.0000210523.22944.9b; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; JORGENSEN HS, 1994, STROKE, V25, P97, DOI 10.1161/01.STR.25.1.97; Justicia C, 2017, TRANSL STROKE RES, V8, P294, DOI 10.1007/s12975-016-0515-1; Kang DW, 2012, NEUROLOGY, V79, P848, DOI 10.1212/WNL.0b013e3182648a79; Kidwell CS, 2017, NEUROLOGY, V88, P782, DOI 10.1212/WNL.0000000000003630; Kimberly WT, 2009, NEUROLOGY, V72, P1230, DOI 10.1212/01.wnl.0000345666.83318.03; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lei CY, 2018, WORLD NEUROSURG, V111, P47, DOI 10.1016/j.wneu.2017.12.020; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Lin MS, 2019, ATHEROSCLEROSIS, V288, P137, DOI 10.1016/j.atherosclerosis.2019.07.009; Lord AS, 2016, STROKE, V47, P1768, DOI 10.1161/STROKEAHA.116.013229; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Menon RS, 2012, ANN NEUROL, V71, P199, DOI 10.1002/ana.22668; Noda H, 2009, CIRCULATION, V119, P2136, DOI 10.1161/CIRCULATIONAHA.108.795666; Prabhakaran S, 2010, STROKE, V41, P89, DOI 10.1161/STROKEAHA.109.566257; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sehba FA, 2005, J NEUROSURG, V102, P1094, DOI 10.3171/jns.2005.102.6.1094; Simpson SL, 2013, STAT METHODS MED RES, V22, P296, DOI 10.1177/0962280210395741; Smith CD, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.438; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Wu B, 2015, NEUROLOGY, V85, P2045, DOI 10.1212/WNL.0000000000002169; Wu TY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005760; Ye XH, 2019, NEUROCRIT CARE, V16, P1; Ye XH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00209; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	54	8	8	1	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					552	564		10.1007/s12028-020-00933-3		FEB 2020	13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000518375300001	32072457	Green Accepted			2022-02-06	
J	Sharma, A; Hind, K; Hume, P; Singh, J; Neary, JP				Sharma, Anick; Hind, Karen; Hume, Patria; Singh, Jyotpal; Neary, J. Patrick			Neurovascular Coupling by Functional Near Infra-Red Spectroscopy and Sport-Related Concussion in Retired Rugby Players: The UK Rugby Health Project	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						brain; concussion; contact sport; neuroimaging; retired athletes	CEREBRAL BLOOD-VOLUME; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER; FLOW; INDIVIDUALS; OXYGENATION; REACTIVITY; PHYSIOLOGY; HUMANS; IMPACT	Aim: This study investigated cerebral hemodynamic responses to a neurovascular coupling (NVC) test in retired contact athletes with a history of repeated mild traumatic brain injury (mTBI) and in controls with no history of mTBI. Methods: Twenty-one retired rugby players (47.7 +/- 12.9 year old; age at retirement: 38.5 +/- 8.9 year; number of years playing rugby: 12.7 +/- 3.7 year) with a history of three or more diagnosed concussions (8.9 +/- 7.9 concussions per player) and 23 controls with no history of mTBI (46.5 +/- 12.8 year old) performed a NVC test to detect task-orientated cerebral hemodynamic changes using functional near-infrared spectroscopy (fNIRS). Results: The NVC showed a statistically significant reduction in the cerebral hemodynamic response in comparison to the control group which had a greater relative increase of oxyhemoglobin (O(2)Hb). There were reductions in left middle frontal gyrus (MFG) O(2)Hb (-0.015 +/- 0.258 mu M) and relative increases in deoxyhemoglobin (HHb; -0.004 +/- 0.159 mu M) in the same region for the mTBI group in comparison to the control group (-0.160 +/- 0.311 mu M; -0.121 +/- 0.076 mu M for O(2)Hb and HHb, respectively). The mTBI group induced a greater rate of oxygen extraction compared to the control group. Conclusion: This was the first study to examine cerebral hemodynamic changes in retired rugby players in response to a NVC test, and we found reduced cerebral hemodynamic responses in participants with a history of mTBI compared to controls. These results suggest altered cerebral metabolic demands in participants with a history of multiple head injuries. Further research is needed to ascertain an understanding of the changes in hemodynamics from playing into retirement.	[Hind, Karen] Univ Durham, Dept Sport & Exercise Sci, Durham, England; [Hume, Patria] Auckland Univ Technol, Sports Performance Res Inst New Zealand SPRINZ, Fac Hlth & Environm Sci, Auckland, New Zealand; [Singh, Jyotpal; Neary, J. Patrick] Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK, Canada		Hind, K (corresponding author), Univ Durham, Dept Sport & Exercise Sci, Durham, England.	karen.hind@durham.ac.uk	Hume, Patria Anne/P-1084-2017; Hume, Patria/AAN-5514-2021; Hind, Karen/AAE-6433-2021	Hume, Patria Anne/0000-0003-1847-8128; Hume, Patria/0000-0003-1847-8128; 	AUT	The project received "UK Rugby Health SRIF RCRG project'' funding from AUT.	Akin A, 2006, BRAIN RES, V1107, P206, DOI 10.1016/j.brainres.2006.06.002; Alderliesten T, 2014, NEUROIMAGE, V85, P255, DOI 10.1016/j.neuroimage.2013.07.015; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; Cheng Y, 2017, NEUROIMAGE, V147, P976, DOI 10.1016/j.neuroimage.2016.12.082; Curtelin D, 2018, J CEREBR BLOOD F MET, V38, P136, DOI 10.1177/0271678X17691986; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Epps C., 2017, USE PECB REREGULATIO; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Ferreri L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00301; Forcione M, 2018, J IMAGING, V4, DOI 10.3390/jimaging4040059; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Helmich I, 2016, MED SCI SPORT EXER, V48, P2362, DOI 10.1249/MSS.0000000000001028; Hirose N, 2016, J ANESTH, V30, P603, DOI 10.1007/s00540-016-2165-6; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Jindal U, 2015, IEEE J TRANSL ENG HE, V3, DOI [10.1109/ITEHM.2015.2389230, 10.1109/JTEHM.2015.2389230]; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Liboni W, 2009, NEUROL SCI, V30, pS105, DOI 10.1007/s10072-009-0075-1; Lipnick MS, 2018, ANESTH ANALG, V126, P579, DOI 10.1213/ANE.0000000000002590; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Neary JP, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2010023; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Oudegeest-Sander MH, 2014, EXP PHYSIOL, V99, P586, DOI 10.1113/expphysiol.2013.076455; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Purkayastha S, 2019, J NEUROTRAUM, V36, P2385, DOI 10.1089/neu.2018.5861; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Schytz HW, 2019, J CEREBR BLOOD F MET, V39, P633, DOI 10.1177/0271678X17724138; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Sport England, 2017, ACT PEOPL SURV SPORT; Strangman GE, 2017, J APPL PHYSIOL, V123, P62, DOI 10.1152/japplphysiol.00947.2016; Tachtsidis I, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.039801; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Urban A, 2015, NAT METHODS, V12, P873, DOI [10.1038/NMETH.3482, 10.1038/nmeth.3482]; Vergotte G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00909; Wightman EL, 2015, PHYSIOL BEHAV, V149, P149, DOI 10.1016/j.physbeh.2015.05.035; Wu ZY, 2018, CNS NEUROSCI THER, V24, P539, DOI 10.1111/cns.12811; Yang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40358	49	8	8	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 13	2020	14								42	10.3389/fnhum.2020.00042			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	KR2NG	WOS:000517456400001	32116616	Green Published, gold, Green Accepted			2022-02-06	
J	Harper, MM; Rudd, D; Meyer, KJ; Kanthasamy, AG; Anantharam, V; Pieper, AA; Vazquez-Rosa, E; Shin, MK; Chaubey, K; Koh, Y; Evans, LP; Bassuk, AG; Anderson, MG; Dutca, L; Kudva, IT; John, M				Harper, Matthew M.; Rudd, Danielle; Meyer, Kacie J.; Kanthasamy, Anumantha G.; Anantharam, Vellareddy; Pieper, Andrew A.; Vazquez-Rosa, Edwin; Shin, Min-Kyoo; Chaubey, Kalyani; Koh, Yeojung; Evans, Lucy P.; Bassuk, Alexander G.; Anderson, Michael G.; Dutca, Laura; Kudva, Indira T.; John, Manohar			Identification of chronic brain protein changes and protein targets of serum auto-antibodies after blast-mediated traumatic brain injury	HELIYON			English	Article						Biochemistry; Neuroscience; Proteins; Retinal ganglion cell; Biomarker; Blast injury; Traumatic brain injury	EXPERIMENTAL RODENT MODEL; GANGLION-CELL DAMAGE; VISUAL DYSFUNCTIONS; MOUSE MODEL; MILD; MILITARY; NEURODEGENERATION; INFLAMMATION; SYSTEM; EYE	In addition to needing acute emergency management, blast-mediated traumatic brain injury (TBI) is also a chronic disorder with delayed-onset symptoms that manifest and progress over time. While the immediate consequences of acute blast injuries are readily apparent, chronic sequelae are harder to recognize. Indeed, the identification of individuals with mild-TBI or TBI-induced symptoms is greatly impaired in large part due to the lack of objective and robust biomarkers. The purpose of this study was to address these need by identifying candidates for serum-based biomarkers of blast TBI, and also to identify unique or differentially regulated protein expression in the thalamus in C57BL/6J mice exposed to blast using high throughput qualitative screens of protein expression. To identify thalamic proteins differentially or uniquely associated with blast exposure, we utilized an antibody-based affinity-capture strategy (referred to as "proteomics-based analysis of depletomes"; PAD) to deplete thalamic lysates from blast-treated mice of endogenous thalamic proteins also found in control mice. Analysis of this "depletome" detected 75 unique proteins, many with associations to the myelin sheath. To identify blast-associated proteins eliciting production of circulating autoantibodies, serum antibodies of blast-treated mice were immobilized, and their immunogens subsequently identified by proteomic analysis of proteins specifically captured following incubation with thalamic lysates (a variant of a strategy referred to as "proteomics-based expression library screening"; PELS). This analysis identified 46 blast-associated immunogenic proteins, including 6 shared in common with the PAD analysis (ALDOA, PHKB, HBA-A1, DPYSL2, SYN1, and CKB). These proteins and their autoantibodies are appropriate for further consideration as biomarkers of blast-mediated TBI.	[Harper, Matthew M.; Rudd, Danielle; Anderson, Michael G.; Dutca, Laura] Iowa City Dept Vet Affairs Med Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA 52246 USA; [Harper, Matthew M.; Anderson, Michael G.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Meyer, Kacie J.; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Ames, IA USA; [Anantharam, Vellareddy] PK Biosci, Ames, IA USA; [Pieper, Andrew A.; Vazquez-Rosa, Edwin; Shin, Min-Kyoo; Chaubey, Kalyani; Koh, Yeojung] Case Western Reserve Univ, Univ Hosp Cleveland, Geriatr Res Educ & Clin Ctr,Dept Psychiat, Harrington Discovery Inst,Louis Stokes VA Med Ctr, Cleveland, OH 44106 USA; [Evans, Lucy P.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Evans, Lucy P.; Bassuk, Alexander G.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Evans, Lucy P.] Univ Iowa, Dept Med Scientist Training Program, Iowa City, IA USA; [Kudva, Indira T.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [John, Manohar] Pathovacs Inc, Ames, IA USA		Harper, MM (corresponding author), Iowa City Dept Vet Affairs Med Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA 52246 USA.; Harper, MM (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	matthew-harper@uiowa.edu	; Anderson, Michael/B-4580-2009	Koh, Yeo Jung/0000-0002-4294-7871; Pieper, Andrew/0000-0001-6299-6577; Chaubey, Kalyani/0000-0002-6378-6739; Harper, Matthew/0000-0003-3395-2406; Bassuk, Alexander/0000-0002-4067-2157; Meyer, Kacie/0000-0003-2027-823X; Anderson, Michael/0000-0001-5730-6105	Department of Veterans AffairsUS Department of Veterans Affairs [RX000952]; Department of DefenseUnited States Department of Defense [W81XWH-14-1-0583]; Iowa City VA Center for the Prevention and Treatment of Visual Loss; Brockman Medical Research Foundation, Hamilton, Bermuda; Elizabeth Ring Mather & William Gwinn Mather Fund, Cleveland, OH, USA; S. Livingston Samuel Mather Trust, Cleveland, OH, USA; Department of Veterans Affairs Merit ReviewUS Department of Veterans Affairs [1IO1BX002444]	This work was supported by the Department of Veterans Affairs (RX000952), Department of Defense (W81XWH-14-1-0583), and the Iowa City VA Center for the Prevention and Treatment of Visual Loss. AAP is supported by the Brockman Medical Research Foundation, Hamilton, Bermuda, the Elizabeth Ring Mather & William Gwinn Mather Fund, Cleveland, OH, USA, the S. Livingston Samuel Mather Trust, Cleveland, OH, USA, and Department of Veterans Affairs Merit Review 1IO1BX002444 to AAP. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs, Department of Defense, or the U.S. Government.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Arevalo-Martin A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02365; Barker F, 2017, OPTOMETRY VISION SCI, V94, P4, DOI 10.1097/OPX.0000000000001001; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Blaya MO, 2019, NEUROPHARMACOLOGY, V145, P268, DOI 10.1016/j.neuropharm.2018.09.024; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Brundage John F, 2015, MSMR, V22, P2; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chmielewska N, 2018, NEUROL NEUROCHIR POL, V52, P318, DOI 10.1016/j.pjnns.2018.02.002; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Cockerham GC, 2013, OCUL SURF, V11, P25, DOI 10.1016/j.jtos.2012.09.004; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; DeWalt GJ, 2017, J COMP NEUROL, V525, P2955, DOI 10.1002/cne.24252; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Egg R, 2001, MULT SCLER J, V7, P285; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Goldberg MS, 2018, DEFENCE PEACE ECON, V29, P44, DOI 10.1080/10242694.2015.1129816; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greer N, 2016, VA EVIDENCE BASED SY; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Harper MM, 2014, INVEST OPHTH VIS SCI, V55, P1350, DOI 10.1167/iovs.13-13692; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Javidi E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00686; Jing Z, 2014, J CEREBR BLOOD F MET, V34, P1613, DOI 10.1038/jcbfm.2014.119; Koutroukides TA, 2011, J SEP SCI, V34, P1621, DOI 10.1002/jssc.201100060; Kudva IT, 2006, MOL CELL PROTEOMICS, V5, P1514, DOI 10.1074/mcp.T600013-MCP200; Kudva IT, 2015, PROTEOMICS, V15, P1829, DOI 10.1002/pmic.201400432; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Li YS, 2019, MIL MED, V184, P265, DOI 10.1093/milmed/usy330; Li YF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S4; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; McIlwain S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-308; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Shin N, 2019, ANTIOXID REDOX SIGN, V30, P1601, DOI 10.1089/ars.2017.7280; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Struebing FL, 2018, J NEUROTRAUM, V35, P118, DOI 10.1089/neu.2017.5104; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Toubi E, 2007, AUTOIMMUN REV, V6, P119, DOI 10.1016/j.autrev.2006.07.004; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Wang EW, 2013, NEUROL RES, V35, P285, DOI 10.1179/1743132812Y.0000000138; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wu L., 2018, J CEREBR BLOOD FLOW; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	87	8	8	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	FEB	2020	6	2							e03374	10.1016/j.heliyon.2020.e03374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS5SJ	WOS:000518367800078	32099918	Green Published			2022-02-06	
J	Powers, AY; Pinto, MB; Tang, OY; Chen, JS; Doberstein, C; Asaad, WF				Powers, Andrew Y.; Pinto, Mauricio B.; Tang, Oliver Y.; Chen, Jia-Shu; Doberstein, Cody; Asaad, Wael F.			Predicting mortality in traumatic intracranial hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; traumatic intracranial hemorrhage; risk stratification; trauma	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; ELDERLY-PATIENTS; ALCOHOL; AGE; ANTICOAGULATION; COMPLICATIONS; ASSOCIATION; SURVIVAL; MODELS	OBJECTIVE Traumatic intracranial hemorrhage (tICH) is a significant source of morbidity and mortality in trauma patients. While prognostic models for tICH outcomes may assist in alerting clinicians to high-risk patients, previously developed models face limitations, including low accuracy, poor generalizability, and the use of more prognostic variables than is practical. This study aimed to construct a simpler and more accurate method of risk stratification for all tICH patients. METHODS The authors retrospectively identified a consecutive series of 4110 patients admitted to their institution's level 1 trauma center between 2003 and 2013. For each admission, they collected the patient's sex, age, systolic blood pressure, blood alcohol concentration, antiplatelet/anticoagulant use, Glasgow Coma Scale (GCS) score, Injury Severity Score, presence of epidural hemorrhage, presence of subdural hemorrhage, presence of subarachnoid hemorrhage, and presence of intraparenchymal hemorrhage. The final study population comprised 3564 patients following exclusion of records with missing data. The dependent variable under study was patient death. A k-fold cross-validation was carried out with the best models selected via the Akaike Information Criterion. These models risk stratified the study partitions into grade I (< 1% predicted mortality), grade II (1%-10% predicted mortality), grade III (10%-40% predicted mortality), or grade IV (> 40% predicted mortality) tICH. Predicted mortalities were compared with actual mortalities within grades to assess calibration. Concordance was also evaluated. A final model was constructed using the entire data set. Subgroup analysis was conducted for each hemorrhage type. RESULTS Cross-validation demonstrated good calibration (p < 0.001 for all grades) with a mean concordance of 0.881 (95% CI 0.865-0.898). In the authors' final model, older age, lower blood alcohol concentration, antiplatelet/anticoagulant use, lower GCS score, and higher Injury Severity Score were all associated with greater mortality. Subgroup analysis showed successful stratification for subarachnoid, intraparenchymal, grade II-IV subdural, and grade I epidural hemorrhages. CONCLUSIONS The authors developed a risk stratification model for tICH of any GCS score with concordance comparable to prior models and excellent calibration. These findings are applicable to multiple hemorrhage subtypes and can assist in identifying low-risk patients for more efficient resource allocation, facilitate family conversations regarding goals of care, and stratify patients for research purposes. Future work will include testing of more variables, validation of this model across institutions, as well as creation of a simplified model whose outputs can be calculated mentally.	[Powers, Andrew Y.; Pinto, Mauricio B.; Tang, Oliver Y.; Chen, Jia-Shu; Doberstein, Cody; Asaad, Wael F.] Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Asaad, Wael F.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA; [Asaad, Wael F.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Asaad, Wael F.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI USA; [Asaad, Wael F.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI USA		Powers, AY (corresponding author), Brown Univ, Rhode Isl Hosp, Providence, RI 02912 USA.	andrew_powers@brown.edu	; Asaad, Wael/I-8485-2012	Pinto, Mauricio/0000-0002-6170-8382; Asaad, Wael/0000-0003-4406-9096			Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iba J, 2014, ACUTE MED SURG, V1, P31, DOI 10.1002/ams2.5; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Karni A, 2001, AM SURGEON, V67, P1098; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; TEASDALE G, 1974, LANCET, V2, P81; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185	27	8	9	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2020	132	2					552	559		10.3171/2018.11.JNS182199			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS5YL	WOS:000518384200025	30797192				2022-02-06	
J	Viniol, S; Thomas, RP; Koenig, AM; Betz, S; Mahnken, AH				Viniol, S.; Thomas, R. P.; Koenig, A. M.; Betz, S.; Mahnken, A. H.			Early whole-body CT for treatment guidance in patients with return of spontaneous circulation after cardiac arrest	EMERGENCY RADIOLOGY			English	Article						Early whole-body CT; Cardiac arrest; ROSC; Emergency radiology	HEALTH-CARE PROFESSIONALS; CHEST INJURIES SECONDARY; CARDIOPULMONARY-RESUSCITATION; COMPUTED-TOMOGRAPHY; PULMONARY ASPIRATION; EUROPEAN-SOCIETY; MULTIDETECTOR CT; WHITE-MATTER; GUIDELINES; COMPLICATIONS	Purpose Non-traumatic cardiac arrest (CA) and return of spontaneous circulation (ROSC) after cardiopulmonary resuscitation (CPR) are often associated with multiple pathologies. Expecting a high prevalence of important findings, a whole-body CT (WBCT) could be of relevance for therapy. The aim of this study is to investigate the feasibility and diagnostic yield of an early WBCT in this setting. Methods This single-center retrospective study included 100 consecutive patients (27 female; 73 male; mean age 68.5 +/- 12.57 years) with non-traumatic, in- and out-of-hospital CA and ROSC following CPR, who underwent a contrast-enhanced WBCT within 6 h after ROSC over 12 months. CT findings were determined corresponding to anatomical region. Results Early WBCT was successfully carried out in 100% of the patients with CA and ROSC after CPR. Acute pathologies were found not only in the chest but also in the head (15%) and the abdomen (6%). Early global brain edema (n = 12), acute stroke (n = 3), pulmonary embolism (n = 10), pneumothorax (26%), acute abdominal pathologies (n = 6), iatrogenic bleeding (4%), and CPR-related injuries (93%) were detected by CT right from the beginning of the post-cardiac arrest care. Conclusions An early WBCT is feasible and provides added diagnostic value for patients with ROSC after non-traumatic CA.	[Viniol, S.; Thomas, R. P.; Koenig, A. M.; Mahnken, A. H.] Philipps Univ, Marburg Univ Hosp, Dept Diagnost & Intervent Radiol, Marburg, Germany; [Betz, S.] Philipps Univ, Marburg Univ Hosp, Dept Emergency Med, Marburg, Germany		Viniol, S (corresponding author), Philipps Univ, Marburg Univ Hosp, Dept Diagnost & Intervent Radiol, Marburg, Germany.	viniol@staff.uni-marburg.de		Viniol, Simon/0000-0002-8161-499X			Axelsson A, 1996, RESUSCITATION, V33, P3, DOI 10.1016/S0300-9572(96)00993-8; Aygun N, 2002, NEUROSURG CLIN N AM, V13, P313, DOI 10.1016/S1042-3680(02)00009-8; Bergum D, 2015, RESUSCITATION, V87, P63, DOI 10.1016/j.resuscitation.2014.11.007; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cho SH, 2013, INJURY, V44, P1204, DOI 10.1016/j.injury.2012.10.004; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; Choi SJ, 2014, EMERG RADIOL, V21, P485, DOI 10.1007/s10140-014-1218-0; Dogan H, 2015, DIAGN INTERV RADIOL, V21, P307, DOI 10.5152/dir.2015.14403; Dunham GM, 2018, EUR RADIOL, V28, P4122, DOI 10.1007/s00330-017-5117-0; Franquet T, 2000, RADIOGRAPHICS, V20, P673, DOI 10.1148/radiographics.20.3.g00ma01673; Hayashi M, 2015, CIRC RES, V116, P1887, DOI 10.1161/CIRCRESAHA.116.304521; Hellevuo H, 2013, RESUSCITATION, V84, P760, DOI 10.1016/j.resuscitation.2013.02.015; Hoke RS, 2004, RESUSCITATION, V63, P327, DOI 10.1016/j.resuscitation.2004.05.019; Jiang LB, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0054-2; Kashiwagi Y, 2015, RESUSCITATION, V88, P86, DOI 10.1016/j.resuscitation.2014.12.022; Katritsis DG, 2016, ARRHYTH ELECTROPHYSI, V5, P177, DOI [10.15420/aer.2016.11.2, 10.15420/aer.2016:11:2]; Kim EY, 2011, RESUSCITATION, V82, P1285, DOI 10.1016/j.resuscitation.2011.05.023; Kim MJ, 2013, RESUSCITATION, V84, P361, DOI 10.1016/j.resuscitation.2012.07.011; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; LAWES EG, 1987, INTENS CARE MED, V13, P379; Lederer W, 2004, RESUSCITATION, V60, P157, DOI 10.1016/j.resuscitation.2003.10.003; Lee YH, 2016, RESUSCITATION, V99, P50, DOI 10.1016/j.resuscitation.2015.11.009; Machida H, 2015, RADIOGRAPHICS, V35, P991, DOI 10.1148/rg.2015140181; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Naples R, 2009, AM J EMERG MED, V27, P63, DOI 10.1016/j.ajem.2008.01.014; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Oschatz E, 2001, ANESTH ANALG, V93, P128; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Rossi A, 2014, EUR HEART J-CARD IMG, V15, P85, DOI 10.1093/ehjci/jet133; Scheel M, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-23; Sebastia C, 1999, RADIOGRAPHICS, V19, P45, DOI 10.1148/radiographics.19.1.g99ja0945; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Virkkunen I, 2007, ACTA ANAESTH SCAND, V51, P202, DOI 10.1111/j.1399-6576.2006.01229.x; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6	34	8	8	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	FEB	2020	27	1					23	29		10.1007/s10140-019-01723-x			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	KJ2YX	WOS:000511925000004	31468207				2022-02-06	
J	Winston, M; Zhou, A; Rand, CM; Dunne, EC; Warner, JJ; Volpe, LJ; Pigneri, BA; Simon, D; Bielawiec, T; Gordon, SC; Vitez, SF; Charnay, A; Joza, S; Kelly, K; Panicker, C; Rizvydeen, S; Niewijk, G; Coleman, C; Scher, BJ; Reed, DW; Hockney, SM; Buniao, G; Stewart, T; Trojanowski, L; Brogadir, C; Price, M; Kenny, AS; Bradley, A; Volpe, NJ; Weese-Mayer, DE				Winston, Molly; Zhou, Amy; Rand, Casey M.; Dunne, Emma C.; Warner, Justin J.; Volpe, Lena J.; Pigneri, Brooke A.; Simon, Drew; Bielawiec, Thomas; Gordon, Samantha C.; Vitez, Sally F.; Charnay, Aaron; Joza, Stephen; Kelly, Kristen; Panicker, Cia; Rizvydeen, Saajidha; Niewijk, Grace; Coleman, Cara; Scher, Bradley J.; Reed, David W.; Hockney, Sara M.; Buniao, Gigi; Stewart, Tracey; Trojanowski, Lynne; Brogadir, Cindy; Price, Michelle; Kenny, Anna S.; Bradley, Allison; Volpe, Nicholas J.; Weese-Mayer, Debra E.			Pupillometry measures of autonomic nervous system regulation with advancing age in a healthy pediatric cohort	CLINICAL AUTONOMIC RESEARCH			English	Article						Biomarkers; Pupillometry; Pediatrics; Autonomic nervous system; Development	PUPIL SIZE; QUANTITATIVE PUPILLOMETRY; LIGHT; DIAMETER; CHILDREN; AROUSAL	Purpose To determine if variables of the pupillary light response mature with age and sex in a healthy pediatric cohort and the utility of pupillometry in assessment among pediatric participants. Methods After 1 min in a dark room to establish baseline, pupillometry was performed on 323 healthy, pediatric participants (646 eyes; 2-21 years; 175 females). Variables included initial pupil diameter, pupil diameter after light stimulus, percent pupillary constriction, latency to onset of constriction, average constriction velocity, maximum constriction velocity, average dilation velocity, and time from light stimulus to 75% of the initial pupil diameter. Data analyses employed ANOVAs and non-linear regressions. Results Analyses of age group differences revealed that participants 12-21 years old had a larger initial pupil diameter and pupil diameter after light stimulus, with males aged 12-18 years demonstrating a larger pupil diameter than all younger participants (ps < 0.05). Participants 12-18 years old had a slower maximum constriction velocity than participants 6-11 years old, with no sex differences (ps < 0.05). Furthermore, males aged 12-18 years old had a smaller percent constriction than males 6-11 years old (ps < 0.05). Regressions revealed that percent constriction and dilation velocity seemed to mature linearly, initial pupil diameter and ending pupil diameter matured quadratically, and the constriction velocity terms matured cubically. Conclusions Results revealed maturation of the pupillary light response by age and sex in healthy pediatric participants. Given the value of the pupillary light response as a biomarker, the results provide normative benchmarks for comparison in health and disease, including opiate-exposed and concussion patients.	[Winston, Molly; Zhou, Amy; Rand, Casey M.; Dunne, Emma C.; Warner, Justin J.; Volpe, Lena J.; Pigneri, Brooke A.; Simon, Drew; Bielawiec, Thomas; Gordon, Samantha C.; Vitez, Sally F.; Charnay, Aaron; Joza, Stephen; Kelly, Kristen; Panicker, Cia; Rizvydeen, Saajidha; Niewijk, Grace; Coleman, Cara; Scher, Bradley J.; Reed, David W.; Hockney, Sara M.; Buniao, Gigi; Stewart, Tracey; Trojanowski, Lynne; Brogadir, Cindy; Price, Michelle; Kenny, Anna S.; Bradley, Allison; Weese-Mayer, Debra E.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Auton Med, Dept Pediat, CAMP, 225 E Chicago Ave,Box 165, Chicago, IL 60611 USA; [Rand, Casey M.; Weese-Mayer, Debra E.] Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Volpe, Nicholas J.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Weese-Mayer, Debra E.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Pediat Auton Med, Chicago, IL 60611 USA		Weese-Mayer, DE (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Auton Med, Dept Pediat, CAMP, 225 E Chicago Ave,Box 165, Chicago, IL 60611 USA.; Weese-Mayer, DE (corresponding author), Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA.; Weese-Mayer, DE (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Pediat Auton Med, Chicago, IL 60611 USA.	d-weese-mayer@northwestern.edu		Charnay, Aaron/0000-0003-0415-8684			Anderson CJ, 2009, DEV PSYCHOBIOL, V51, P207, DOI 10.1002/dev.20352; Anderson M, 2018, J NEUROSCI NURS, V50, P30, DOI 10.1097/JNN.0000000000000333; Atchison DA, 2008, J VISION, V8, DOI 10.1167/8.4.29; Beatty Jackson, 2000, PUPILLARY SYSTEM HDB; Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496; Bradley JC, 2011, J REFRACT SURG, V27, P202, DOI 10.3928/1081597X-20100511-01; Bradley JC, 2010, J CATARACT REFR SURG, V36, P277, DOI 10.1016/j.jcrs.2009.09.025; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; Bremner F, 2006, J NEUROL NEUROSUR PS, V77, P1163, DOI 10.1136/jnnp.2006.092833; Bremner F, 2009, CLIN AUTON RES, V19, P88, DOI 10.1007/s10286-009-0515-2; Bremner FD, 2006, J NEURO-OPHTHALMOL, V26, P209, DOI 10.1097/01.wno.0000235564.50518.1b; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P8049, DOI 10.1167/iovs.12-11282; Brown JT, 2015, J PEDIAT OPHTH STRAB, V52, P147, DOI 10.3928/01913913-20150317-11; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; Emelifeonwu JA, 2018, BRAIN INJURY, V32, P675, DOI 10.1080/02699052.2018.1429021; Fotiou D F, 2007, Electromyogr Clin Neurophysiol, V47, P11; Fotiou F, 2000, INT J PSYCHOPHYSIOL, V37, P111, DOI 10.1016/S0167-8760(00)00099-4; Giza E, 2011, INT J NEUROSCI, V121, P37, DOI 10.3109/00207454.2010.526730; Hartmann M, 2014, CURR BIOL, V24, pR281, DOI 10.1016/j.cub.2014.02.028; Kelbsch C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00129; Kim M, 2000, J INT NEUROPSYCH SOC, V6, P348, DOI 10.1017/S135561770000309X; KORCZYN AD, 1976, ARCH OPHTHALMOL-CHIC, V94, P1905; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Larson MD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1349-7; LOWENSTEIN O, 1950, ARCH NEURO PSYCHIATR, V64, P313, DOI 10.1001/archneurpsyc.1950.02310270002001; MacLachlan C, 2002, OPHTHAL PHYSL OPT, V22, P175, DOI 10.1046/j.1475-1313.2002.00023.x; Migeon A, 2013, PEDIATR ANESTH, V23, P1160, DOI 10.1111/pan.12243; MURRAY RB, 1983, LIFE SCI, V33, P495, DOI 10.1016/0024-3205(83)90123-6; Nuske HJ, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0098-4; Patwari PP, 2012, PEDIATR RES, V71, P280, DOI 10.1038/pr.2011.38; PIHA SJ, 1994, DIABETES RES CLIN PR, V26, P61, DOI 10.1016/0168-8227(94)90140-6; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Rickmann A, 2017, NEURO-OPHTHALMOLOGY, V41, P12, DOI 10.1080/01658107.2016.1226345; Silbert J, 2013, J AAPOS, V17, P609, DOI 10.1016/j.jaapos.2013.09.003; Silk JS, 2009, DEV PSYCHOPATHOL, V21, P7, DOI 10.1017/S0954579409000029; Team R, 2015, RSTUDIO INT DEV R; Williams K, 2012, PEDIATRICS, V129, pS153, DOI 10.1542/peds.2012-0055I; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132	39	8	8	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	FEB	2020	30	1					43	51		10.1007/s10286-019-00639-3			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KJ5PJ	WOS:000512112400008	31555934				2022-02-06	
J	Tian, WL; Czopka, T; Lopez-Schier, H				Tian, Weili; Czopka, Tim; Lopez-Schier, Hernan			Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration	COMMUNICATIONS BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; WALLERIAN DEGENERATION; NERVOUS-SYSTEM; MITOCHONDRIAL TRANSPORT; LATERAL-LINE; OPTIC-NERVE; REGENERATION; ACTIVATION; NEUROTOXICITY; MECHANISMS	Protecting the nervous system from chronic effects of physical and chemical stress is a pressing clinical challenge. The obligate pro-degenerative protein Sarm1 is essential for Wallerian axon degeneration. Thus, blocking Sarm1 function is emerging as a promising neuroprotective strategy with therapeutic relevance. Yet, the conditions that will most benefit from inhibiting Sarm1 remain undefined. Here we combine genome engineering, pharmacology and high-resolution intravital videmicroscopy in zebrafish to show that genetic elimination of Sarm1 increases Schwann-cell resistance to toxicity by diverse chemotherapeutic agents after axonal injury. Synthetic degradation of Sarm1-deficient axons reversed this effect, suggesting that glioprotection is a non-autonomous effect of delayed axon degeneration. Moreover, loss of Sarm1 does not affect macrophage recruitment to nerve-wound microenvironment, injury resolution, or neural-circuit repair. These findings anticipate that interventions aimed at inhibiting Sarm1 can counter heightened glial vulnerability to chemical stressors and may be an effective strategy to reduce chronic consequences of neurotrauma. Tian et al. showed that systemic elimination of Sarm1 in zebrafish increases Schwann-cell resistance to chemotherapeutics and protects axons from Wallerian degeneration. They use genetics, pharmacology, and high resolution intravital videomicroscopy to study Sarm1 in vivo.	[Tian, Weili; Lopez-Schier, Hernan] Helmholtz Zentrum Munich, Sensory Biol & Organogenesis, Munich, Germany; [Czopka, Tim] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany		Lopez-Schier, H (corresponding author), Helmholtz Zentrum Munich, Sensory Biol & Organogenesis, Munich, Germany.	hernan.lopez-schier@helmholtz-muenchen.de	Czopka, Tim/N-4970-2015	Czopka, Tim/0000-0002-6824-8112	Human Frontiers Science ProgrammeHuman Frontier Science Program; Helmholtz GemeinschaftHelmholtz Association	This research was supported by a Program Grant from the Human Frontiers Science Programme and by the Helmholtz Gemeinschaft to H.L.-S.	Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122; Ameh V, 2006, EUR J EMERG MED, V13, P233, DOI 10.1097/01.mej.0000206190.62201.ad; Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006; Auer F, 2018, CURR BIOL, V28, P549, DOI 10.1016/j.cub.2018.01.017; BASTMEYER M, 1994, GLIA, V11, P300, DOI 10.1002/glia.440110403; Bin Jenea M, 2016, Brain Plast, V2, P3, DOI 10.3233/BPL-160029; Bremer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178854; Carr MJ, 2017, CURR OPIN NEUROBIOL, V47, P52, DOI 10.1016/j.conb.2017.09.003; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cattin AL, 2016, CURR OPIN NEUROBIOL, V39, P38, DOI 10.1016/j.conb.2016.04.005; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Clements MP, 2017, NEURON, V96, P98, DOI 10.1016/j.neuron.2017.09.008; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; D'Rozario M, 2017, METHOD CELL BIOL, V138, P383, DOI 10.1016/bs.mcb.2016.08.001; Drerup CM, 2016, METHOD CELL BIOL, V131, P311, DOI 10.1016/bs.mcb.2015.06.007; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Esterberg R, 2016, J CLIN INVEST, V126, P3556, DOI 10.1172/JCI84939; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; Fontenas L, 2017, CURR OPIN NEUROBIOL, V47, P44, DOI 10.1016/j.conb.2017.09.008; Friedrich RW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00071; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Fukuda Y, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00481; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; Haehnel-Taguchi M, 2018, INTEGR COMP BIOL, V58, P874, DOI 10.1093/icb/icy066; Han SB, 2017, J NEUROSCI, V37, P10955, DOI 10.1523/JNEUROSCI.0903-17.2017; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Imai S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05784-1; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Jortner BS, 2000, TOXICOL PATHOL, V28, P54, DOI 10.1177/019262330002800108; Kaiser J, 2014, CORTEX, V54, P33, DOI 10.1016/j.cortex.2014.01.010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; Lin MY, 2017, NEURON, V94, P595, DOI 10.1016/j.neuron.2017.04.004; Lindborg JA, 2017, J NEUROSCI, V37, P10258, DOI 10.1523/JNEUROSCI.2085-17.2017; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Loreto A, 2015, CELL REP, V13, P2539, DOI 10.1016/j.celrep.2015.11.032; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Mandal A, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00144; McLeary F, 2019, EUR J PHARMACOL, V842, P49, DOI 10.1016/j.ejphar.2018.09.034; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Missios S, 2014, J NEUROSURG-PEDIATR, V14, P688, DOI 10.3171/2014.8.PEDS14112; Mistry P, 2015, P NATL ACAD SCI USA, V112, P5455, DOI 10.1073/pnas.1422576112; Morell P, 1996, NEUROTOXICOLOGY, V17, P685; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Muto A, 2013, CURR BIOL, V23, P307, DOI 10.1016/j.cub.2012.12.040; O'Donnell KC, 2013, J NEUROSCI, V33, P14778, DOI 10.1523/JNEUROSCI.1331-13.2013; Ohki Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0146-8; Olt J, 2016, METHOD CELL BIOL, V133, P253, DOI 10.1016/bs.mcb.2016.02.004; Omura T, 2015, NEURON, V86, P1215, DOI 10.1016/j.neuron.2015.05.005; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Ozaki T, 2009, BBA-MOL CELL RES, V1793, P1848, DOI 10.1016/j.bbamcr.2009.10.002; Park JY, 2013, NEURAL REGEN RES, V8, P3401, DOI 10.3969/j.issn.1673-5374.2013.36.005; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pujol-Marti J, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.11.012; Pujol-Marti J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00047; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Rosenberg AF, 2014, J NEUROSCI, V34, P14668, DOI 10.1523/JNEUROSCI.2007-14.2014; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sasaki Y, 2018, J NEUROSCI, V38, P6546, DOI 10.1523/JNEUROSCI.3304-17.2018; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Simon DJ, 2018, CURR OPIN NEUROL, V31, P693, DOI 10.1097/WCO.0000000000000621; Soto J, 2017, GLIA, V65, P864, DOI 10.1002/glia.23131; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Sztal T. E., 2016, JOVE-J VIS EXP, V116, P1; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Vargas ME, 2015, J NEUROSCI, V35, P15026, DOI 10.1523/JNEUROSCI.2484-15.2015; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Walker LJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22540; Waller, 1850, PHILOS T R SOC LOND, VI, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021]; Wehner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00143-0; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xiao Y, 2016, METHODS MOL BIOL, P271, DOI 10.1007/978-1-4939-3771-4_18; Xiao Y, 2015, CURR BIOL, V25, pR1068, DOI 10.1016/j.cub.2015.09.038; Xiao Y, 2015, DIS MODEL MECH, V8, P553, DOI 10.1242/dmm.018184; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Yang SF, 2011, REGION ANESTH PAIN M, V36, P444, DOI 10.1097/AAP.0b013e318228c835; Ziegenfuss JS, 2012, NAT NEUROSCI, V15, P979, DOI 10.1038/nn.3135; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	96	8	8	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA		2399-3642		COMMUN BIOL	Commun. Biol.	JAN 30	2020	3	1							49	10.1038/s42003-020-0776-9			14	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	KI1XK	WOS:000511140800001	32001778	Green Published, gold			2022-02-06	
J	Szu, JI; Chaturvedi, S; Patel, DD; Binder, DK				Szu, Jenny, I; Chaturvedi, Som; Patel, Dillon D.; Binder, Devin K.			Aquaporin-4 Dysregulation in a Controlled Cortical Impact Injury Model of Posttraumatic Epilepsy	NEUROSCIENCE			English	Article						posttraumatic epilepsy; spontaneous seizure; traumatic brain injury; controlled cortical impact injury; aquaporin-4; Kir4.1	TRAUMATIC BRAIN-INJURY; KIR4.1 POTASSIUM CHANNELS; FLUID PERCUSSION INJURY; CENTRAL-NERVOUS-SYSTEM; SCLEROTIC HIPPOCAMPUS; WATER TRANSPORT; K+ HOMEOSTASIS; RISK-FACTORS; HEAD-INJURY; SEIZURES	Posttraumatic epilepsy (PTE) is a long-term negative consequence of traumatic brain injury (TBI) in which recurrent spontaneous seizures occur after the initial head injury. PTE develops over an undefined period during which circuitry reorganization in the brain causes permanent hyperexcitability. The pathophysiology by which trauma leads to spontaneous seizures is unknown and clinically relevant models of PTE are key to understanding the molecular and cellular mechanisms underlying the development of PTE. In the present study, we used the controlled-cortical impact (CCI) injury model of TBI to induce PTE in mice and to characterize changes in aquaporin-4 (AQP4) expression. A moderate-severe TBI was induced in the right frontal cortex and video-electroencephalographic (vEEG) recordings were performed in the ipsilateral hippocampus to monitor for spontaneous seizures at 14, 30, 60, and 90 days post injury (dpi). The percentage of mice that developed PTE were 13%, 20%, 27%, and 14% at 14, 30, 60, and 90 dpi, respectively. We found a significant increase in AQP4 in the ipsilateral frontal cortex and hippocampus of mice that developed PTE compared to those that did not develop PTE. Interestingly, AQP4 was found to be mislocalized away from the perivascular endfeet and towards the neuropil in mice that developed PTE. Here, we report for the first time, AQP4 dysregulation in a model of PTE which may carry significant implications for epileptogenesis after TBI. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of IBRO.	[Szu, Jenny, I; Chaturvedi, Som; Patel, Dillon D.; Binder, Devin K.] Univ Calif Riverside, Ctr Glial Neuronal Interact, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA		Binder, DK (corresponding author), Univ Calif Riverside, Sch Med, Div Biomed Sci, 1247 Webber Hall, Riverside, CA 92521 USA.	dbinder@ucr.edu					Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Cheung G, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/109106; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciappelloni S, 2019, CELL REP, V27, P3860, DOI 10.1016/j.celrep.2019.05.097; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Heuser K, 2012, J NEUROPATH EXP NEUR, V71, P814, DOI 10.1097/NEN.0b013e318267b5af; Hubbard JA, 2013, NEUROCHEM INT, V63, P638, DOI 10.1016/j.neuint.2013.01.017; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ihara Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150095; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim JE, 2009, NEUROSCIENCE, V163, P781, DOI 10.1016/j.neuroscience.2009.07.028; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Lapato AS, 2017, NEUROSCIENCE, V346, P409, DOI 10.1016/j.neuroscience.2017.01.035; Lee DJ, 2012, EXP NEUROL, V235, P246, DOI 10.1016/j.expneurol.2012.02.002; Lee TS, 2004, ACTA NEUROPATHOL, V108, P493, DOI 10.1007/s00401-004-0910-7; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacAulay N, 2012, NEUROCHEM RES, V37, P2299, DOI 10.1007/s11064-012-0731-3; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Masaki H, 2010, ACTA HISTOCHEM CYTOC, V43, P99, DOI 10.1267/ahc.10016; MATHERN GW, 1994, EPILEPSY RES, V19, P129, DOI 10.1016/0920-1211(94)90023-X; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; ORKAND RK, 1986, ANN NY ACAD SCI, V481, P269, DOI 10.1111/j.1749-6632.1986.tb27157.x; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Ruiz-Ederra J, 2007, J BIOL CHEM, V282, P21866, DOI 10.1074/jbc.M703236200; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Shandra O, 2019, J NEUROSCI, P1018; Smith AJ, 2014, J CELL BIOL, V204, P559, DOI 10.1083/jcb.201308118; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007	66	8	8	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 21	2020	428						140	153		10.1016/j.neuroscience.2019.12.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK6ZP	WOS:000512888300016	31866558				2022-02-06	
J	Wright, T; Urban, R; Durham, W; Dillon, EL; Randolph, KM; Danesi, C; Gilkison, C; Karmonik, C; Zgaljardic, DJ; Masel, B; Bishop, J; Pyles, R; Seidler, R; Hierholzer, AH; Sheffield-Moore, M				Wright, Traver; Urban, Randall; Durham, William; Dillon, E. Lichar; Randolph, Kathleen M.; Danesi, Christopher; Gilkison, Charles; Karmonik, Christof; Zgaljardic, Dennis J.; Masel, Brent; Bishop, James; Pyles, Richard; Seidler, Rachael; Hierholzer, Ashton H.; Sheffield-Moore, Melinda			Growth Hormone Alters Brain Morphometry, Connectivity, and Behavior in Subjects with Fatigue after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						fatigue; GH; TBI	QUALITY-OF-LIFE; FUNCTIONAL CONNECTIVITY; PITUITARY DYSFUNCTION; GH REPLACEMENT; NETWORK; CONCUSSION; DEFICIENCY; DISRUPTION; SEVERITY; RECOVERY	Pituitary dysfunction with reduced growth hormone (GH) secretion is common in patients following traumatic brain injury (TBI), and these patients often develop chronic symptoms including fatigue and altered cognition. We examined 18 subjects with a history of mild TBI, fatigue, and insufficient GH secretion. Subjects received GH replacement in a year-long, double-blind, placebo-controlled, crossover study, and were assessed for changes in physical performance, body composition, resting energy expenditure, fatigue, sleep, mood, and neuropsychological status. Additionally, magnetic resonance imaging (MRI) was used to assess changes in brain structure and resting state functional connectivity. GH replacement resulted in decreased fatigue, sleep disturbance, and anxiety, as well as increased resting energy expenditure, improved body composition, and altered perception of submaximal effort when performing exercise testing. Associated brain changes included increased frontal cortical thickness and gray matter volume and resting state connectivity changes in regions associated with somatosensory networks. GH replacement altered brain morphology and connectivity and reduced fatigue and related symptoms in mild TBI patients. Additional studies are needed to understand the mechanisms causing TBI-related fatigue and symptom relief with GH replacement.	[Wright, Traver; Urban, Randall; Durham, William; Dillon, E. Lichar; Randolph, Kathleen M.; Danesi, Christopher; Gilkison, Charles; Sheffield-Moore, Melinda] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Pyles, Richard] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Hierholzer, Ashton H.] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Wright, Traver; Randolph, Kathleen M.; Sheffield-Moore, Melinda] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Karmonik, Christof] Houston Methodist Res Inst, Radiol Dept, Houston, TX USA; [Zgaljardic, Dennis J.] Transit Learning Ctr, Galveston, TX USA; [Masel, Brent] Ctr Neuro Skills, Bakersfield, CA USA; [Bishop, James] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Seidler, Rachael] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA		Urban, R (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	rurban@utmb.edu		Wright, Traver/0000-0001-7020-930X	TIRR Foundation by Transitional Learning Center of Galveston [014-106]; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001439]; Burroughs Wellcome FundBurroughs Wellcome Fund [1016348]	This research was funded by the TIRR Foundation by grant from the Transitional Learning Center of Galveston (014-106). The Institute for Translational Sciences at the University of Texas Medical Branch provided clinical support funded in part by a Clinical and Translational Science Award (UL1TR001439) from the National Center for Advancing Translational Sciences, National Institutes of Health. Additional support was provided by a Collaborative Research Travel Grant from the Burroughs Wellcome Fund (1016348). Pfizer generously supplied the growth hormone and placebo for this study (WI1906888).	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Arce VM, 2013, NEUROSCI RES, V76, P179, DOI 10.1016/j.neures.2013.03.014; Barake M, 2014, J CLIN ENDOCR METAB, V99, P852, DOI 10.1210/jc.2013-3921; Beck A.T., 1996, MANUAL BECK DEPRESSI; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard JA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00031; Bonnelle V, 2016, CEREB CORTEX, V26, P807, DOI 10.1093/cercor/bhv247; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Dai XJ, 2014, NEUROPSYCH DIS TREAT, V10, P2163, DOI 10.2147/NDT.S69681; Delis DC., 2001, DELIS KAPLAN EXECUTI; Devesa J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082294; Devesa J, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020014; Devesa J, 2015, INT J MOL SCI, V16, P30470, DOI 10.3390/ijms161226244; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Elbornsson M, 2017, EUR J ENDOCRINOL, V176, P99, DOI 10.1530/EJE-16-0875; Felician O, 2004, ANN NEUROL, V55, P749, DOI 10.1002/ana.20109; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gaser C., 2016, HBM 2016, V2016, P336; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hu YM, 2019, PSYCHONEUROENDOCRINO, V103, P67, DOI 10.1016/j.psyneuen.2018.12.229; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Kullmann S, 2012, HUM BRAIN MAPP, V33, P1052, DOI 10.1002/hbm.21268; Lafargue G, 2003, EUR J NEUROSCI, V17, P2741, DOI 10.1046/j.1460-9568.2003.02700.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Mossberg KA, 2017, J NEUROTRAUM, V34, P845, DOI 10.1089/neu.2016.4552; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Nyberg F, 2013, NAT REV ENDOCRINOL, V9, P357, DOI 10.1038/nrendo.2013.78; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Stern RA, 2003, NAB NEUROPSYCHOLOGIC; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Takarada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109422; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tinaz S, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00496; Urban R.J., J NEUROTRAUM, DOI [10.1089/neu.20XX.6688, DOI 10.1089/NEU.20XX.6688]; Urban R.J., J NEUROTRAUM, DOI [10.1089/neu.20XX.6689, DOI 10.1089/NEU.20XX.6689]; VANDEWEGHE M, 1993, CLIN ENDOCRINOL, V39, P409, DOI 10.1111/j.1365-2265.1993.tb02387.x; Wechsler D., 2008, WECHSLER ADULT INTEL; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	66	8	8	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1052	1066		10.1089/neu.2019.6690		JAN 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000508672200001	31797721	Green Published			2022-02-06	
J	Antonakakis, M; Dimitriadis, SI; Zervakis, M; Papanicolaou, AC; Zouridakis, G				Antonakakis, Marios; Dimitriadis, Stavros, I; Zervakis, Michalis; Papanicolaou, Andrew C.; Zouridakis, George			Aberrant Whole-Brain Transitions and Dynamics of Spontaneous Network Microstates in Mild Traumatic Brain Injury	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						MEG; mTBI; beamforming; dynamic functional connectivity analysis; network microstates; symbolic dynamics; chronnectomics; connectomic biomarkers	RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; CORTICAL CONNECTIONS; BAND OSCILLATIONS; COUPLING MODES; MAGNETOENCEPHALOGRAPHY; MEG; SYNCHRONIZATION; QUANTIZATION	Dynamic Functional Connectivity (DFC) analysis is a promising approach for the characterization of brain electrophysiological activity. In this study, we investigated abnormal alterations due to mild Traumatic Brain Injury (mTBI) using DFC of the source reconstructed magnetoencephalographic (MEG) resting-state recordings. Brain activity in several well-known frequency bands was first reconstructed using beamforming of the MEG data to determine ninety anatomical brain regions of interest. A DFC graph was formulated using the imaginary part of phase-locking values, which were obtained from 30 mTBI patients and 50 healthy controls (HC). Subsequently, we estimated normalized Laplacian transformations of individual, statistically and topologically filtered quasi-static graphs. The corresponding eigenvalues of each node synchronization were then computed and through the neural-gas algorithm, we quantized the evolution of the eigenvalues resulting in distinct network microstates (NMstates). The discrimination level between the two groups was assessed using an iterative cross-validation classification scheme with features either the NMstates in each frequency band, or the combination of the so-called chronnectomics (flexibility index, occupancy time of NMstate, and Dwell time) with the complexity index over the evolution of the NMstates across all frequency bands. Classification performance based on chronnectomics showed 80% accuracy, 99% sensitivity, and 49% specificity. However, performance was much higher (accuracy: 91-97%, sensitivity: 100%, and specificity: 77-93%) when focusing on the microstates. Exploring the mean node degree within and between brain anatomical networks (default mode network, frontoparietal, occipital, cingulo-opercular, and sensorimotor), a reduced pattern occurred from lower to higher frequency bands, with statistically significant stronger degrees for the HC than the mTBI group. A higher entropic profile on the temporal evolution of the modularity index was observed for both NMstates for the mTBI group across frequencies. A significant difference in the flexibility index was observed between the two groups for the beta frequency band. The latter finding may support a central role of the thalamus impairment in mTBI. The current study considers a complete set of frequency-dependent connectomic markers of mTBI-caused alterations in brain connectivity that potentially could serve as markers to assess the return of an injured subject back to normality.	[Antonakakis, Marios] Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Antonakakis, Marios; Zervakis, Michalis] Tech Univ Crete, Sch Elect & Comp Engn, Digital Image & Signal Proc Lab, Khania, Greece; [Antonakakis, Marios] Cardiff Univ, Sch Psychol, CUBRIC, Neuroinformat Grp, Cardiff, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Sch Med, Cardiff, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Sch Psychol, Cardiff, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff, Wales; [Papanicolaou, Andrew C.] Univ Tennessee, Ctr Hlth Sci, Le Bonheur Childrens Hosp, Dept Pediat, Memphis, TN 38163 USA; [Papanicolaou, Andrew C.] Univ Tennessee, Ctr Hlth Sci, Le Bonheur Childrens Hosp, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Zouridakis, George] Univ Houston, Dept Engn Technol, Biomed Imaging Lab, Houston, TX USA; [Zouridakis, George] Univ Houston, Dept Comp Sci, Biomed Imaging Lab, Houston, TX 77204 USA; [Zouridakis, George] Univ Houston, Dept Biomed Engn, Biomed Imaging Lab, Houston, TX USA; [Zouridakis, George] Univ Houston, Dept Elect & Comp Engn, Biomed Imaging Lab, Houston, TX USA		Antonakakis, M (corresponding author), Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany.; Antonakakis, M (corresponding author), Tech Univ Crete, Sch Elect & Comp Engn, Digital Image & Signal Proc Lab, Khania, Greece.; Antonakakis, M (corresponding author), Cardiff Univ, Sch Psychol, CUBRIC, Neuroinformat Grp, Cardiff, Wales.	marios.antonakakis@uni-muenster.de	Antonakakis, Marios/ABD-8218-2020; DIMITRIADIS, STAVROS I/AAN-8992-2020	Antonakakis, Marios/0000-0003-1173-7895; DIMITRIADIS, STAVROS I/0000-0002-0000-5392	Department of Defense Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0135]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; MARIE-CURIE COFUND EU-UK Research Fellowship	The Department of Defense Congressionally Directed Medical Research Program W81XWH-08-2-0135 has supported the current work. This study was part of the project Integrated Clinical Protocol, conducted by the Investigators and staff of The Mission Connect Mild Traumatic Brain Injury Translational Research Consortium. SD was supported by MRC grant MR/K004360/1 (Behavioral and Neurophysiological Effects of Schizophrenia Risk Genes: A Multi-locus, Pathway Based Approach) and by a MARIE-CURIE COFUND EU-UK Research Fellowship.	Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Antonakakis M, 2019, ALTERATIONS DYNAMIC, DOI [10.1101/596155, DOI 10.1101/596155]; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Antonakakis M, 2015, IEEE ENG MED BIO, P7426, DOI 10.1109/EMBC.2015.7320108; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Assistant Secretary D. O. D, 2007, TRAUM BRAIN INJ DEF; Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; Baker AP, 2014, ELIFE, V3, DOI 10.7554/eLife.01867; Barch DM, 2013, TRENDS COGN SCI, V17, P603, DOI 10.1016/j.tics.2013.09.004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharath RD, 2016, EUR J NEUROL, V23, P1729, DOI 10.1111/ene.13104; Bressler SL, 2015, CURR OPIN NEUROBIOL, V31, P62, DOI 10.1016/j.conb.2014.08.010; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2016, IEEE SIGNAL PROC MAG, V33, P52, DOI 10.1109/MSP.2015.2478915; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Coste CP, 2016, NEUROIMAGE, V128, P264, DOI 10.1016/j.neuroimage.2016.01.026; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitriadis SI, 2013, BRAIN TOPOGR, V26, P397, DOI 10.1007/s10548-013-0276-z; Dimitriadis SI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00506; Dimitriadis SI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00306; Dimitriadis SI, 2017, BRAIN CONNECT, V7, P661, DOI 10.1089/brain.2017.0512; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00163; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Douw L, 2018, HUM BRAIN MAPP, V39, P104, DOI 10.1002/hbm.23827; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Graham FC, 1997, PAGE REGIONAL C SERI; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Guntekin B, 2013, NEUROIMAGE-CLIN, V3, P39, DOI 10.1016/j.nicl.2013.07.003; Hall EL, 2013, NEUROIMAGE, V67, P203, DOI 10.1016/j.neuroimage.2012.11.011; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hillebrand A, 2016, P NATL ACAD SCI USA, V113, P3867, DOI 10.1073/pnas.1515657113; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; HORN RA, 1990, SIAM J MATRIX ANAL A, V11, P481, DOI 10.1137/0611034; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunt BAE, 2016, P NATL ACAD SCI USA, V113, P13510, DOI 10.1073/pnas.1608587113; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kaltiainen H, 2018, BRAIN TOPOGR, V31, P1037, DOI 10.1007/s10548-018-0667-2; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Li Lianyang, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3165, DOI 10.1109/EMBC.2018.8513045; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Luckhoo H, 2012, NEUROIMAGE, V62, P530, DOI 10.1016/j.neuroimage.2012.04.046; Maestu F, 2015, NEUROIMAGE-CLIN, V9, P103, DOI 10.1016/j.nicl.2015.07.011; MARTINETZ TM, 1993, IEEE T NEURAL NETWOR, V4, P558, DOI 10.1109/72.238311; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; O'Neill GC, 2015, NEUROIMAGE, V115, P85, DOI 10.1016/j.neuroimage.2015.04.030; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2018, NEUROIMAGE, V173, P632, DOI 10.1016/j.neuroimage.2018.02.032; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sherman MA, 2016, P NATL ACAD SCI USA, V113, pE4885, DOI 10.1073/pnas.1604135113; Shine JM, 2016, NEURON, V92, P544, DOI 10.1016/j.neuron.2016.09.018; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Symons AE, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00239; Tewarie P, 2015, HUM BRAIN MAPP, V36, P603, DOI 10.1002/hbm.22650; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vidaurre D, 2016, NEUROIMAGE, V126, P81, DOI 10.1016/j.neuroimage.2015.11.047; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Weiskopf N, 2011, NEUROIMAGE, V54, P2116, DOI 10.1016/j.neuroimage.2010.10.023; Wens V, 2015, HUM BRAIN MAPP, V36, P4604, DOI 10.1002/hbm.22943; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	96	8	8	2	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5188		FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	JAN 15	2020	13								90	10.3389/fncom.2019.00090			19	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Mathematical & Computational Biology; Neurosciences & Neurology	KG4KO	WOS:000509914300001	32009921	Green Published, Green Accepted, gold			2022-02-06	
J	He, GL; Luo, Z; Shen, TT; Wang, ZZ; Li, P; Luo, X; Yang, J; Tan, YL; Wang, Y; Gao, P; Yang, XS				He, Gen-Lin; Luo, Zhen; Shen, Ting-Ting; Wang, Ze-Ze; Li, Ping; Luo, Xue; Yang, Ju; Tan, Yu-Long; Wang, Yuan; Gao, Peng; Yang, Xue-Sen			TREM2 Regulates Heat Acclimation-Induced Microglial M2 Polarization Involving the PI3K-Akt Pathway Following EMF Exposure	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						EMF; heat acclimation; microglial polarization; TREM2; PI3K-Akt pathway	TRAUMATIC BRAIN-INJURY; MYELOID CELLS-2 TREM2; PSEUDOMONAS-AERUGINOSA; RAT; NEUROPROTECTION; INFLAMMATION; MACROPHAGES; INVOLVEMENT; EXPRESSION; PROTECTS	The function of triggering receptor expressed on myeloid cells-2 (TREM2) has been described within microglia with a beneficial activated phenotype. However, the role of TREM2 underlying microglial phenotypic alterations in the cross-tolerance protection of heat acclimation (HA) against the inflammatory stimuli electromagnetic field (EMF) exposure is less well known. Here, we investigated the TREM2-related signaling mechanism induced by HA in EMF-stimulated N9 microglial cells (N9 cells). We found that EMF exposure significantly increased the production of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha, IL-1 beta, and IL-6), and the expression of M1 markers (CD11b and CD86); meanwhile, decreased the levels of anti-inflammatory cytokines (IL-4 and IL-10) and the expression of M2 markers (CD206 and Arg1) in N9 cells. Clearly, HA treatment decreased the secretion of TNF-alpha, IL-1 beta and IL-6 and the expression of CD11b and CD86, and enhanced the production of IL-4 and IL-10 and the expression of CD206 and Arg1. Moreover, TREM2 esiRNA and selective inhibitor of PI3K clearly decreased anti-inflammatory cytokines production, M2 markers expression, and phosphorylation of PI3K and Akt following HA plus EMF stimulation. These results indicate that TREM2 and PI3K-Akt pathway are involved in the cross-tolerance protective effect of HA in microglial polarization towards the EMF exposure. This finding inspires future studies that aim to explore the non-drug approaches underlying EMF stimulation and other central nervous system (CNS) inflammatory diseases.	[He, Gen-Lin; Luo, Zhen; Shen, Ting-Ting; Wang, Ze-Ze; Li, Ping; Luo, Xue; Yang, Ju; Tan, Yu-Long; Yang, Xue-Sen] Army Med Univ, Dept Trop Med, Chongqing, Peoples R China; [He, Gen-Lin; Yang, Xue-Sen] Army Med Univ, Minist Educ China, Key Lab Extreme Environm Med, Chongqing, Peoples R China; [Wang, Yuan] Army Med Univ, Xinan Hosp, Dept Nucl Med, Chongqing, Peoples R China; [Gao, Peng] Army Med Univ, Minist Educ, Key Lab Med Protect Electromagnet Radiat, Chongqing, Peoples R China		Yang, XS (corresponding author), Army Med Univ, Dept Trop Med, Chongqing, Peoples R China.; Yang, XS (corresponding author), Army Med Univ, Minist Educ China, Key Lab Extreme Environm Med, Chongqing, Peoples R China.	xuesenyyy@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472952, 81773396]	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81472952 and 81773396).	Ammari M, 2008, BIOMED PHARMACOTHER, V62, P273, DOI 10.1016/j.biopha.2008.03.002; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Boza-Serrano A, 2019, ACTA NEUROPATHOL, V138, P251, DOI 10.1007/s00401-019-02013-z; Brillaud E, 2007, TOXICOLOGY, V238, P23, DOI 10.1016/j.tox.2007.05.019; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cianciulli A, 2016, INT IMMUNOPHARMACOL, V36, P282, DOI 10.1016/j.intimp.2016.05.007; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.10179; He GL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0762-9; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Horowitz M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00548; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Li CW, 2018, CELL PHYSIOL BIOCHEM, V47, P1769, DOI 10.1159/000491059; Mausset-Bonnefont AL, 2004, NEUROBIOL DIS, V17, P445, DOI 10.1016/j.nbd.2004.07.004; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Patton MG, 2018, CELL STRESS CHAPERON, V23, P1117, DOI 10.1007/s12192-018-0923-0; Piccio L, 2007, EUR J IMMUNOL, V37, P1290, DOI 10.1002/eji.200636837; Qin C, 2017, STROKE, V48, P3336, DOI 10.1161/STROKEAHA.117.018505; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Sun MX, 2013, INVEST OPHTH VIS SCI, V54, P3451, DOI 10.1167/iovs.12-10938; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Wolfe CM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010081; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yang XD, 2017, BRAIN BEHAV IMMUN, V64, P162, DOI 10.1016/j.bbi.2017.03.003; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Yi JF, 2017, CELL PHYSIOL BIOCHEM, V41, P101, DOI 10.1159/000455979; Yu TY, 2019, J CELL PHYSIOL, V234, P4217, DOI 10.1002/jcp.27185; Zhang LJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00306; Zhang XJ, 2019, INT IMMUNOPHARMACOL, V68, P48, DOI 10.1016/j.intimp.2018.12.064; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986; Zhu M, 2014, SCAND J IMMUNOL, V79, P187, DOI 10.1111/sji.12148	44	8	8	8	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JAN 15	2020	13								591	10.3389/fncel.2019.00591			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KG4TO	WOS:000509939900001	32009907	Green Published, gold			2022-02-06	
J	Qiu, SH; Jiang, WH; Alam, MS; Chen, SX; Lai, CX; Wang, TY; Li, XD; Liu, J; Gao, MY; Tang, YH; Li, XW; Zeng, JF; Feng, Y				Qiu, Suhao; Jiang, Wenheng; Alam, Mohammad Shah; Chen, Shaoxuan; Lai, Changxin; Wang, Tianyao; Li, Xiangdong; Liu, Jun; Gao, Mingyuan; Tang, Yaohui; Li, Xiaowei; Zeng, Jianfeng; Feng, Yuan			Viscoelastic characterization of injured brain tissue after controlled cortical impact (CCI) using a mouse model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Controlled cortical impact; Viscoelastic property; Indentation	MECHANICAL-PROPERTIES; HEAD-INJURY; MATTER; PATHOPHYSIOLOGY; VALIDATION	Background: Mechanical properties of the brain tissue are crucial to understand the mechanisms of traumatic brain injury (TBI). Injured brain tissue could induce changes of mechanical properties and anatomical structures. However, limited data is available for the injured tissue. New Method: We developed a custom-built device to introduce controlled cortical impact (CCI) to brain with controlled impact velocity and direction. A study protocol for measuring the viscoelastic properties of injured brain tissue was also developed. Micro-scale morphological changes of the vasculature were quantified by analyzing confocal images of the brain tissue using CLARITY method. Results: Results showed significant differences of the instantaneous shear modulus of the impact region from different impact angles. However, no significant differences were found for long-term shear modulus by varying the impact angles and velocities. Analysis of the vasculature showed an increased radius of the vessels in the injured tissue compared with that in the control group. Comparison with existing methods: A combination of three different impact velocities and three different impact angles were adopted for producing injury to the brain. In addition, viscoelastic properties were compared between the injured and non-injured regions. The corresponding morphological changes of the vasculature system were also investigated. Conclusions: The instantaneous shear modulus at the impact region was significantly different for the three impact angles. Compared to that of the control group, increased radius of the vasculature was also observed in the injured brain tissue. Results indicated that the biomechanical and structural changes of the injured tissue were closely related to the impact angles and velocities. Viscoelastic measurements could also help validation of computational models.	[Qiu, Suhao; Chen, Shaoxuan; Lai, Changxin; Feng, Yuan] Shanghai Jiao Tong Univ, Inst Med Imaging Technol, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Jiang, Wenheng; Gao, Mingyuan; Zeng, Jianfeng] Soochow Univ, Sch Radiat Med & Protect, State Key Lab Radiat Med & Protect, Suzhou 215123, Peoples R China; [Jiang, Wenheng; Gao, Mingyuan; Zeng, Jianfeng] Soochow Univ, Collaborat Innovat Ctr Radiat Med, Sch Radiol & Interdisciplinary Sci RAD X, Jiangsu Higher Educ Inst,Ctr Mol Imaging & Nucl M, Suzhou 215123, Peoples R China; [Alam, Mohammad Shah; Li, Xiaowei] Shanghai Jiao Tong Univ, Sch Biomed Engn, Bio ID Ctr, Shanghai 200240, Peoples R China; [Alam, Mohammad Shah] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Anat & Histol, Gazipur 1706, Bangladesh; [Wang, Tianyao; Liu, Jun] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, 801 Heqing Rd, Shanghai 200240, Peoples R China; [Li, Xiangdong] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 899 PinhaiLu, Suzhou 215000, Peoples R China; [Tang, Yaohui] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Tang, Yaohui] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China		Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Inst Med Imaging Technol, Sch Biomed Engn, Shanghai 200030, Peoples R China.; Zeng, JF (corresponding author), Soochow Univ, Sch Radiat Med & Protect, State Key Lab Radiat Med & Protect, Suzhou 215123, Peoples R China.; Zeng, JF (corresponding author), Jiangsu Higher Educ Inst, Collaborat Innovat Ctr Radiol Med, Suzhou 215123, Peoples R China.	jfzeng@suda.edu.cn; fengyuan@sjtu.edu.cn	Shah Alam, Mohammad/AAW-6458-2021; , Gao MY/ABC-2193-2021	Shah Alam, Mohammad/0000-0003-2657-9121; 	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31870941]; Shanghai Science and Technology Committee (STCSM)Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee [1944190700]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Grant 31870941 (YF) from National Natural Science Foundation of China (NSFC) and grant 1944190700 from Shanghai Science and Technology Committee (STCSM) are acknowledged. Support from Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and animal preparation assistance from Wei Chen are also acknowledged. We thank Prof. Philip V. Bayly for helpful discussions.	Alfasi AM, 2013, J NEUROSURG, V119, P1255, DOI 10.3171/2013.7.JNS121973; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bayly P.V., 2012, ANN REV BIOMED ENG; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen L, 2018, SMALL, V14, DOI 10.1002/smll.201702700; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Destrade M, 2015, INT J NONLIN MECH, V75, P54, DOI 10.1016/j.ijnonlinmec.2015.02.014; Doshi H., 2015, PLOS ONE, V10, DOI [10.1371/joumal.pone.0118061.p.e0118061, DOI 10.1371/JOUMAL.PONE.0118061.P.E0118061]; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Feng Y, 2017, J MECH BEHAV BIOMED, V71, P407, DOI 10.1016/j.jmbbm.2017.04.008; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10640; Lu LH, 2019, J NEUROTRAUM, V36, P1828, DOI 10.1089/neu.2018.5929; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; Mao HJ, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P469, DOI 10.1016/B978-0-12-809831-8.00012-X; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Ouyang W, 2018, J NEUROSCI RES, V96, P1412, DOI 10.1002/jnr.24261; Pabon MM, 2016, CNS NEUROSCI THER, V22, P200, DOI 10.1111/cns.12485; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Qiu SH, 2018, J BIOMECH, V69, P81, DOI 10.1016/j.jbiomech.2018.01.007; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Suarez MW, 2015, ULTRASONICS, V61, P151, DOI 10.1016/j.ultras.2015.04.014; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tse KM., 2015, AM J ENG TECHNOLOGY, V1, P28; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1; Zhao HF, 2019, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2018, VOL 9	52	8	9	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 15	2020	330								108463	10.1016/j.jneumeth.2019.108463			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KO3DN	WOS:000515428200012	31698000				2022-02-06	
J	Ben Shimon, M; Shavit-Stein, E; Altman, K; Pick, CG; Maggio, N				Ben Shimon, Marina; Shavit-Stein, Efrat; Altman, Keren; Pick, Chaim G.; Maggio, Nicola			Thrombin as Key Mediator of Seizure Development Following Traumatic Brain Injury	FRONTIERS IN PHARMACOLOGY			English	Article						mild traumatic brain injury; epilepsy; thrombin; Protease Activated Receptor 1 (PAR1); N-Methyl-D-Aspartate (NMDA)	LONG-TERM POTENTIATION; POSTTRAUMATIC EPILEPSY; SYNAPTIC-TRANSMISSION; STATUS EPILEPTICUS; ANIMAL-MODELS; DYSFUNCTION; STIMULATION; MODULATION; MICE	Traumatic brain injury (TBI) commonly leads to development of seizures, accounting for approximately 20% of newly diagnosed epilepsy. Despite the high clinical significance, the mechanisms underlying the development of posttraumatic seizures (PTS) remain unclear, compromising appropriate management of these patients. Accumulating evidence suggest that thrombin, the main serine protease of the coagulation cascade, is involved in PTS genesis by mediating inflammation and hyperexcitability following blood brain barrier breakdown. In order to further understand the role of thrombin in PTS, we generated a combined mild TBI (mTBI) and status epilepticus mice model, by injecting pilocarpine to mice previously submitted to head injury. Interestingly, mTBI was able to reduce seizure onset in the pilocarpine animal model as well as increase the death rate in the treated animals. In turn, pilocarpine worsened spatial orientation of mTBI treated mice. Finally, thrombin activity as well as the expression of IL1-beta and TNF-alpha was significantly increased in the mTBI-pilocarpine treated animals. In conclusion, these observations indicate a synergism between thrombin and mTBI in lowering seizure in the pilocarpine model and possibly aggravating inflammation. We believe that these results will improve the understanding of PTS pathophysiology and contribute to the development of more targeted therapies in the future.	[Ben Shimon, Marina; Shavit-Stein, Efrat; Altman, Keren; Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel; [Shavit-Stein, Efrat; Maggio, Nicola] Tel Aviv Univ, Sackler Fac Med, Dept Neurol & Neurosurg, Tel Aviv, Israel; [Shavit-Stein, Efrat; Pick, Chaim G.; Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel		Maggio, N (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Neurol & Neurosurg, Tel Aviv, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Maggio, N (corresponding author), Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel.	Nicola.maggio@sheba.health.gov.il					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Ben Shimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188524; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; De Luca C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102128; Edut S, 2014, J MOL NEUROSCI, V54, P684, DOI 10.1007/s12031-014-0399-z; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00032; Maggio N, 2017, HIPPOCAMPUS, V27, P860, DOI 10.1002/hipo.22736; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2013, NEUROBIOL DIS, V50, P171, DOI 10.1016/j.nbd.2012.10.017; Peets AD, 2005, CRIT CARE, V9, pR725, DOI 10.1186/cc3884; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Popovic M, 2012, MOL CELL BIOCHEM, V359, P301, DOI 10.1007/s11010-011-1024-x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vezzani A, 2009, EPILEPSY CURR, V9, P146, DOI 10.1111/j.1535-7511.2009.01323.x; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	50	8	8	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JAN 14	2020	10								1532	10.3389/fphar.2019.01532			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KH5BI	WOS:000510662800001	32009953	gold, Green Published			2022-02-06	
J	Berkowitz, BA; Olds, HK; Richards, C; Joy, J; Rosales, T; Podolsky, RH; Childers, KL; Hubbard, WB; Sullivan, PG; Gao, SS; Li, YC; Qian, HH; Roberts, R				Berkowitz, Bruce A.; Olds, Hailey K.; Richards, Collin; Joy, Joydip; Rosales, Tilman; Podolsky, Robert H.; Childers, Karen Lins; Hubbard, W. Brad; Sullivan, Patrick G.; Gao, Shasha; Li, Yichao; Qian, Haohua; Roberts, Robin			Novel imaging biomarkers for mapping the impact of mild mitochondrial uncoupling in the outer retina in vivo	PLOS ONE			English	Article							FREE-RADICAL PRODUCTION; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; OXYGEN-CONSUMPTION; RESERVE CAPACITY; MOUSE MODEL; DNP; QUANTIFICATION; CONTRIBUTES; HOMEOSTASIS	Purpose To test the hypothesis that imaging biomarkers are useful for evaluating in vivo rod photoreceptor cell responses to a mitochondrial protonophore. Methods Intraperitoneal injections of either the mitochondrial uncoupler 2,4 dinitrophenol (DNP) or saline were given to mice with either higher [129S6/eVTac (S6)] or lower [C57BL/6J (B6)] mitochondrial reserve capacities and were studied in dark or light. We measured: (i) the external limiting membrane-retinal pigment epithelium region thickness (ELM-RPE; OCT), which decreases substantially with upregulation of a pH-sensitive water removal co-transporter on the apical portion of the RPE, and (ii) the outer retina R1 (= 1/(spin lattice relaxation time (T1), an MRI parameter proportional to oxygen / free radical content. Results In darkness, baseline rod energy production and consumption are relatively high compared to that in light, and additional metabolic stimulation with DNP provoked thinning of the ELM-RPE region compared to saline injection in S6 mice; ELM-RPE thickness was unresponsive to DNP in B6 mice. Also, dark-adapted S6 mice given DNP showed a decrease in outer retina R1 values compared to saline injection in the inferior retina. In dark-adapted B6 mice, transretinal R1 values were unresponsive to DNP in superior and inferior regions. In light, with its relatively lower basal rod energy production and consumption, DNP caused ELM-RPE thinning in both S6 and B6 mice. Conclusions The present results raise the possibility of non-invasively evaluating the mouse rod mitochondrial energy ecosystem using new DNP-assisted OCT and MRI in vivo assays.	[Berkowitz, Bruce A.; Olds, Hailey K.; Richards, Collin; Joy, Joydip; Rosales, Tilman; Roberts, Robin] Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, Detroit, MI USA; [Podolsky, Robert H.; Childers, Karen Lins] Beaumont Hlth, Beaumont Res Inst, Royal Oak, MI USA; [Hubbard, W. Brad; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Hubbard, W. Brad; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Sullivan, Patrick G.] Lexington VA Hlth Care Syst, Lexington, KY USA; [Gao, Shasha; Li, Yichao; Qian, Haohua] NEI, Visual Funct Core, NIH, Bethesda, MD 20892 USA; [Gao, Shasha] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou, Peoples R China		Berkowitz, BA (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, Detroit, MI USA.	baberko@med.wayne.edu		Berkowitz, Bruce/0000-0003-0291-2209; Childers, Karen/0000-0002-7645-1583; Richards, Collin/0000-0002-9833-5938	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 EY026584, R01 AG058171]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [14-13A]; VA Merit AwardUS Department of Veterans Affairs [1I01BX003405]; NIH intramural Research ProgramsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY000503, EY000530]; NEI Core Grant [P30 EY04068]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Fight for Sight Summer Student Fellowship; Wayne State University School of Medicine Medical Student Summer Research Fellowships	This research was gratefully supported by the National Institutes of Health [RO1 EY026584 (BAB) and R01 AG058171 (BAB)], Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) Grant 14-13A and VA Merit Award 1I01BX003405 (PGS), NIH intramural Research Programs EY000503 and EY000530 to HQ, NEI Core Grant P30 EY04068, and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute, BAB), a Fight for Sight Summer Student Fellowship (CR), and Wayne State University School of Medicine Medical Student Summer Research Fellowships (HKO and JJ).	Adijanto J, 2009, J GEN PHYSIOL, V133, P603, DOI 10.1085/jgp.200810169; Berkowitz BA, 2008, RETINAL AND CHOROIDAL ANGIOGENESIS, P151, DOI 10.1007/978-1-4020-6780-8_8; Berkowitz BA, 2019, INVEST OPHTH VIS SCI, V60, P1566, DOI 10.1167/iovs.18-26164; Berkowitz BA, 2018, INVEST OPHTH VIS SCI, V59, P5957, DOI 10.1167/iovs.18-25682; Berkowitz BA, 2018, INVEST OPHTH VIS SCI, V59, P2999, DOI 10.1167/iovs.18-23829; Berkowitz BA, 2018, J MAGN RESON, V291, P94, DOI 10.1016/j.jmr.2018.01.013; Berkowitz BA, 2017, FASEB J, V31, P4179, DOI 10.1096/fj.201700229R; Berkowitz BA, 2017, INVEST OPHTH VIS SCI, V58, P3286, DOI 10.1167/iovs.17-21850; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P5314, DOI 10.1167/iovs.16-20186; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P577, DOI 10.1167/iovs.15-18972; Berkowitz BA, 2016, PROG RETIN EYE RES, V51, P90, DOI 10.1016/j.preteyeres.2015.09.001; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P7931, DOI 10.1167/iovs.15-18420; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P606, DOI 10.1167/iovs.14-15687; Berkowitz BA, 2014, NEUROBIOL AGING, V35, P1883, DOI 10.1016/j.neurobiolaging.2014.02.020; Berry BJ, 2018, J MOL BIOL, V430, P3873, DOI 10.1016/j.jmb.2018.03.025; Bissig D, 2012, MOL VIS, V18, P2561; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chen JJ, 2008, MAGN RESON MED, V59, P731, DOI 10.1002/mrm.21570; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Geisler JG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030280; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Khan RS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7180632; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; Li YC, 2018, INVEST OPHTH VIS SCI, V59, P1084, DOI 10.1167/iovs.17-23011; Li YC, 2016, INVEST OPHTH VIS SCI, V57, pOCT105, DOI 10.1167/iovs.15-18539; LINSENMEIER RA, 1992, J GEN PHYSIOL, V99, P177, DOI 10.1085/jgp.99.2.177; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Mellon EA, 2010, P NATL ACAD SCI USA, V107, P11787, DOI 10.1073/pnas.1006951107; Muhlhans J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026496; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; NUUTINEN EM, 1983, AM J PHYSIOL, V244, pH396, DOI 10.1152/ajpheart.1983.244.3.H396; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Paasonen J, 2018, NEUROIMAGE, V172, P9, DOI 10.1016/j.neuroimage.2018.01.014; Pallanck LJ, 2010, J CELL BIOL, V191, P1225, DOI 10.1083/jcb.201011068; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; PARVER L M, 1991, Eye (London), V5, P181; Perkins GA, 2003, MOL VIS, V9, P60; Perron NR, 2013, J BIOENERG BIOMEMBR, V45, P101, DOI 10.1007/s10863-012-9477-5; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Quarrie R, 2014, AM J PHYSIOL-HEART C, V307, pH996, DOI 10.1152/ajpheart.00189.2014; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Trick GL, 2005, PROG RETIN EYE RES, V24, P259, DOI 10.1016/j.preteyeres.2004.08.001; Venkatesan, 1999, MAGNETIC RESONANCE I; Wu B, 2017, EXP NEUROL, V293, P83, DOI 10.1016/j.expneurol.2017.03.020; Zhurakovskaya E, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0456-18.2019	59	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226840	10.1371/journal.pone.0226840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	WOS:000534350000028	31923239	Green Published, gold			2022-02-06	
J	Duclos, C; Dumont, M; Paquet, J; Blais, H; Van der Maren, S; Menon, DK; Bernard, F; Gosselin, N				Duclos, Catherine; Dumont, Marie; Paquet, Jean; Blais, Helene; Van der Maren, Solenne; Menon, David K.; Bernard, Francis; Gosselin, Nadia			Sleep-wake disturbances in hospitalized patients with traumatic brain injury: association with brain trauma but not with an abnormal melatonin circadian rhythm	SLEEP			English	Article						sleep; circadian rhythms; traumatic brain injury; melatonin; actigraphy; acute care	CYCLE DISTURBANCES; ACUTE-PHASE; CONSCIOUSNESS; SECRETION; ICU	Study Objectives: To test whether the sleep-wake cycle disruption in patients hospitalized with traumatic brain injury (TBI) (1) is also found in patients with traumatic injuries other than TBI (non-TBI) and (2) is associated with a weaker or abnormal circadian clock signal. Methods: Forty-two non-mechanically ventilated and non-sedated patients hospitalized for moderate-to-severe TBI were compared to 34 non-TBI patients. They wore wrist actigraphs for 9.4 +/- 4.2 days, starting 19.3 +/- 12.6 days post-injury. Of these, 17 TBI and 14 non-TBI patients had their urine collected every hour for 25 hours, starting 18.3 +/- 12.3 days post-injury. We calculated urinary 6-sulfatoxymelatonin concentration to obtain total 24-hour excretion, excretion onset, offset, duration, amplitude, and acrophase. Using Student's t-tests, we compared groups on actigraphy (daytime activity ratio, nighttime total sleep time, and fragmentation index) and melatonin variables. We investigated associations between melatonin and actigraphy variables using Pearson's correlations. Results: TBI patients had poorer daytime activity ratio (TBI: 77.5 +/- 9.4%; non-TBI: 84.6 +/- 6.9%), shorter nighttime total sleep time (TBI: 353.5 +/- 96.6 min; non-TBI: 421.2 +/- 72.2 min), and higher fragmentation index (TBI: 72.2 +/- 30.0; non-TBI: 53.5 +/- 23.6) (all p-values < 0.01). A melatonin rhythm was present in both groups, and no group differences were found on melatonin variables. No associations were found between melatonin and actigraphy variables in TBI patients. Conclusion: Moderate-to-severe TBI patients have more serious sleep-wake disturbances than non-TBI patients hospitalized in the same environment, suggesting that the brain injury itself alters the sleep-wake cycle. Despite their deregulated 24-hour sleep-wake cycle, TBI patients have a normal circadian clock signal.	[Duclos, Catherine; Dumont, Marie; Paquet, Jean; Blais, Helene; Van der Maren, Solenne; Gosselin, Nadia] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Ctr Integre Univ Sante & Serv Sociaux Nord Ile Mo, 5400 Boul Gouin Ouest,Local E-0330, Montreal, PQ H4J 1C5, Canada; [Duclos, Catherine; Dumont, Marie] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Van der Maren, Solenne; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Menon, David K.] Univ Cambridge, Dept Med, Cambridge, England; [Bernard, Francis] Hop Sacre Coeur Montreal, Dept Intens Care, Ctr Integre Univ Sante & Serv Soc Nord Ile Montre, Montreal, PQ, Canada; [Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada		Gosselin, N (corresponding author), Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Ctr Integre Univ Sante & Serv Sociaux Nord Ile Mo, 5400 Boul Gouin Ouest,Local E-0330, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca		Dumont, Marie/0000-0002-6196-5098	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [115172]; Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec [24742]	This study was supported by the Canadian Institutes of Health Research (grant no. 115172) and by the Fonds de Recherche du Quebec - Sante (grant no. 24742).	Arendt J, 2005, J BIOL RHYTHM, V20, P291, DOI 10.1177/0748730405277492; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benhaberou-Brun D, 1999, SLEEP, V22, P877, DOI 10.1093/sleep/22.7.877; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Duclos C, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0709-x; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Gehlbach BK, 2012, SLEEP, V35, P1105, DOI 10.5665/sleep.1998; Hagen C, 1972, RANCHO AMIGOS LEVELS; Johnston JD, 2015, J ENDOCRINOL, V226, pT187, DOI 10.1530/JOE-15-0119; Korompeli A, 2017, J CRIT CARE, V38, P269, DOI 10.1016/j.jcrc.2016.12.006; Little A, 2012, MINERVA ANESTESIOL, V78, P406; Lushington K, 1996, CHRONOBIOL INT, V13, P411, DOI 10.3109/07420529609020912; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091; NOWAK R, 1987, CLIN ENDOCRINOL, V27, P445, DOI 10.1111/j.1365-2265.1987.tb01172.x; Oldham MA, 2016, CRIT CARE MED, V44, P207, DOI 10.1097/CCM.0000000000001282; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Pisani MA, 2015, AM J RESP CRIT CARE, V191, P731, DOI 10.1164/rccm.201411-2099CI; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; TEASDALE G, 1974, LANCET, V2, P81; Telias I, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2366-0; TZISCHINSKY O, 1993, J BIOL RHYTHM, V8, P199, DOI 10.1177/074873049300800303; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697	30	8	8	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	JAN	2020	43	1							zsz191	10.1093/sleep/zsz191			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ8EZ	WOS:000548322500005	31562742	Green Published, Green Submitted, Bronze			2022-02-06	
J	Eid, MAM; Abdel-Salam, AA; Salem, HM; Mahrous, SE; Seleiman, MF; Alsadon, AA; Solieman, THI; Ibrahim, AA				Eid, Mohamed A. M.; Abdel-Salam, Ali A.; Salem, Haythum M.; Mahrous, Samira E.; Seleiman, Mahmoud F.; Alsadon, Abdullah A.; Solieman, Talaat H. I.; Ibrahim, Abdullah A.			Interaction Effects of Nitrogen Source and Irrigation Regime on Tuber Quality, Yield, and Water Use Efficiency of Solanum tuberosum L.	PLANTS-BASEL			English	Article						tuber yield; quality; WUE; nitrogen source; drip irrigation	FERTILIZER NITROGEN; POTATO CULTIVARS; DRIP IRRIGATION; GROWTH; STRESS; SOILS	Two field experiments were conducted to investigate the effects of three drip irrigation regimes (G(1): 120% crop evapotranspiration (ETc), G(2): 100% ETc, and G(3): 80% ETc) and four nitrogen (N) source treatments (S-0: non-fertilized; S-1: urea, S-2: ammonium nitrate, and S-3: ammonium sulfate on water consumption use, water utilization efficiency, chlorophyll, yield and tubers quality of potato (Solanum tuberosum L.; cv Diamond) under a drip irrigation system during two successive winter seasons (2015/16 and 2016/17)). Nitrogen fertilization was applied at 380 kg ha(-1) as standard application for potato in the investigated area. The highest tubers yield was obtained from potato grown with G(1) S-2 (65.8 Mg ha(-1)), G(1) S-3 (63.6 Mg ha(-1)), G(2) S-2 (64.1 Mg ha(-1)), and G(2) S-3 (62.4 Mg ha(-1)), while the lowest tubers yield was obtained from potato grown with G(3) S-0 (10.1 Mg ha(-1)) and G(2)S(0) (17.4 Mg ha(-1)). Different treatments of N source resulted in a significant increase for water use efficiency (WUtE) compared with unfertilized treatment. For the interaction effect, the highest WUtE was obtained from potato grown with G(3) S-2 (18.1 kg m(-3)), followed by G(3) S-3 (17.6 kg m(-3)), while the lowest WUtE was obtained from plants grown with G(3)S(0) (3.0 kg m(-3)). However, the highest chlorophyll content was obtained from plants grown with G1 and any N source, followed by G(2)S(1-3), while the lowest chlorophyll content was obtained from those grown with G(3)S(0). The highest N, S, protein, and P contents in tubers were obtained from plants grown with G(3)S(3,) G(3)S(2), and G(2)S(2), while the highest K content in tubers was obtained from plants grown with G(1)S(1) and G(1)S(2). In concussion, the integrative effects of G(1) or G(2) with S-2 or S-3 is recommended for high productivity, while the integrative effects of G(3)S(3) and G(3)S(2) are recommended for high quality tubers.	[Eid, Mohamed A. M.; Mahrous, Samira E.] ARC, SWERI, POB 12112, Giza, Egypt; [Abdel-Salam, Ali A.; Salem, Haythum M.] Benha Univ, Fac Agr, Dept Soils & Water, POB 13637, Banha, Egypt; [Seleiman, Mahmoud F.; Alsadon, Abdullah A.; Solieman, Talaat H. I.; Ibrahim, Abdullah A.] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, POB 2460, Riyadh 11451, Saudi Arabia; [Seleiman, Mahmoud F.] Menoufia Univ, Fac Agr, Dept Crop Sci, Shibin Al Kawm 32514, Egypt; [Solieman, Talaat H. I.] Alexandria Univ, Fac Agr, Vegetable Crops Dept, POB 21527, Alexandria, Egypt		Seleiman, MF (corresponding author), King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, POB 2460, Riyadh 11451, Saudi Arabia.; Seleiman, MF (corresponding author), Menoufia Univ, Fac Agr, Dept Crop Sci, Shibin Al Kawm 32514, Egypt.	m.eid86@yahoo.com; alyabsalam@yahoo.com; salemh2000eg@yahoo.com; samira_mahrous@yahoo.com; mseleiman@ksu.edu.sa; alsadon@ksu.edu.sa; talaat.solieman@yahoo.com; adrahim@ksu.edu.sa	Seleiman, Mahmoud F./X-8480-2019		Deanship of Scientific Research at King Saud UniversityKing Saud University [RGP-1438-011]	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group No. (RGP-1438-011).	Abu-Zinada I.A.I., 2009, J AL AZHAR U GAZA NA, V11, P15; Ahmed A., 2009, MIDDLE E RUSS J PLAN, V3, P47; Alva AK, 2012, J CROP IMPROV, V26, P211, DOI 10.1080/15427528.2011.626891; AMZALLAG GN, 1992, J EXP BOT, V43, P81, DOI 10.1093/jxb/43.1.81; Badr MA, 2012, AGR WATER MANAGE, V110, P9, DOI 10.1016/j.agwat.2012.03.008; Badr MA, 2010, GESUNDE PFLANZ, V62, P63, DOI 10.1007/s10343-010-0222-x; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; BARCZAK B., 2010, MONOGRAPH UTP BYDGOS, V144, P131; Belanger G, 2002, AM J POTATO RES, V79, P269, DOI 10.1007/BF02986360; Brady N C, 2008, NATURE PROPERTIES SO, P975; Cambouris AN, 2016, AGRON J, V108, P391, DOI 10.2134/agronj2015.0351; Cantore V, 2014, INT J PLANT PROD, V8, P409; CAO WX, 1993, J PLANT NUTR, V16, P1691, DOI 10.1080/01904169309364643; CHAPMAN HD, 1982, PRICED PUBLICATION U, V4034; Costache MA, 2012, ROM BIOTECH LETT, V17, P7702; Darwish T, 2003, NUTR CYCL AGROECOSYS, V67, P1, DOI 10.1023/A:1025107202143; DASBERG S, 1985, SOIL SCI SOC AM J, V49, P293, DOI 10.2136/sssaj1985.03615995004900020003x; DAVIS JM, 1986, AM POTATO J, V63, P71, DOI 10.1007/BF02853685; DOORENBOS J, 1977, CROP WATER REQUIREME, P24; Eid T. A., 2013, Journal of Applied Sciences Research, V9, P1457; Ekin Z, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11123417; El-Mokh F., 2015, American Journal of Plant Sciences, V6, P501, DOI 10.4236/ajps.2015.64054; Fabeiro C, 2001, AGR WATER MANAGE, V48, P255, DOI 10.1016/S0378-3774(00)00129-3; FAO, 1985, IRRIG DRAIN, P29; FAOSTAT, WORLD POT PROD QUANT; Farrag K, 2016, EGYPT MIDEAST J APPL, V6, P774; Foti S, 1995, POTATO RES, V38, P307, DOI 10.1007/BF02357733; Gao Y, 2014, PLANT PROD SCI, V17, P138, DOI 10.1626/pps.17.138; Gultekin R., 2018, International Journal of Agriculture, Environment and Food Sciences, V2, P93; Harris P. M., 1978, The potato crop: the scientific basis for improvement., P244; Hassanpanah D, 2010, POTATO RES, V53, P383, DOI 10.1007/s11540-010-9179-5; Ierna A, 2012, AGR WATER MANAGE, V115, P276, DOI 10.1016/j.agwat.2012.09.011; Israelsen OW, 1962, IRRIGATION PRINCIPLE; Izmirlioglu G, 2015, INT J MOL SCI, V16, P24490, DOI 10.3390/ijms161024490; Jensen M.E., 1983, DESIGN OPERATION FAR, P827; Kahsay WS, 2019, COGENT FOOD AGR, V5, DOI 10.1080/23311932.2019.1572985; KHALIL AA, 2014, J SOIL SCI AGR ENG M, V5, P1067, DOI DOI 10.21608/jssae.2014.49566; Khan I, 2014, J SOIL SCI PLANT NUT, V14, P267; KLIKOCKA H., 2003, FERTIL FERTIL, V4, P143; Klikocka H., 2009, SULFUR METABOLISM PL, P45; Klute A., 1986, MONOGRAPH; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Leonel M, 2017, J FOOD SCI TECH MYS, V54, P2372, DOI 10.1007/s13197-017-2677-6; Leonel M, 2016, J SCI FOOD AGR, V96, P1900, DOI 10.1002/jsfa.7295; Marouani A., 2015, J NEW SCI AGR BIOTEC, V13, P339; Meier U., 2001, BBCH MONOGRAPH GROWT; Motsara M.R., 2008, GUIDE LAB ESTABLISHM, V19; NADERIDARBAGHSHAHI, 2012, INT J AGR CROP SCI, V4, P1688; Naumann M., 2019, POTATO RES, V63, P1; Onder S, 2005, AGR WATER MANAGE, V73, P73, DOI 10.1016/j.agwat.2004.09.023; PAGE AL, 1982, MONOGRAPH, V9; Qiqige S, 2017, J PLANT NUTR, V40, P1651, DOI 10.1080/01904167.2016.1269345; RANGANNA S, 1977, HDB ANAL QUALITY CON; RITCHIE JT, 1974, AGR METEOROL, V14, P183, DOI 10.1016/0002-1571(74)90018-1; Rykaczewska K., 2013, American Journal of Plant Sciences, V4, P2386, DOI 10.4236/ajps.2013.412295; Sahota T.S., 2006, ONTARIO FARMER, V9, P10; SAOUD AA, 1992, FERT RES, V31, P351, DOI 10.1007/BF01051286; Shrestha RK, 2010, AM J POTATO RES, V87, P229, DOI 10.1007/s12230-010-9131-x; Smith M., 1992, CROPWAT COMPUTER PRO, V46; Srek P, 2010, FIELD CROP RES, V118, P183, DOI 10.1016/j.fcr.2010.05.009; Sriom D P, 2017, INT J CUR MICROBIOL, V6, P1456, DOI [10.20546/ijcmas.2017.608.428, DOI 10.20546/IJCMAS.2017.608.428]; Tein B, 2014, FIELD CROP RES, V156, P1, DOI 10.1016/j.fcr.2013.10.012; Vermeiren L., 1984, CROP EVAPOTRANSPIRAT, P36; Wang FX, 2006, AGR WATER MANAGE, V79, P248, DOI 10.1016/j.agwat.2005.02.016; WANG N, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/su11205621; Winkelmann H. H., 1992, Kartoffelbau, V43, P412; Yuan BZ, 2003, AGR WATER MANAGE, V63, P153, DOI 10.1016/S0378-3774(03)00174-4	67	8	8	4	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2223-7747		PLANTS-BASEL	Plants-Basel	JAN	2020	9	1							110	10.3390/plants9010110			20	Plant Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences	KL2DE	WOS:000513238700110	31952245	gold, Green Published			2022-02-06	
J	Gebril, HM; Rose, RM; Gesese, R; Emond, MP; Huo, YQ; Aronica, E; Boison, D				Gebril, Hoda M.; Rose, Rizelle Mae; Gesese, Raey; Emond, Martine P.; Huo, Yuqing; Aronica, Eleonora; Boison, Detlev			Adenosine kinase inhibition promotes proliferation of neural stem cells after traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						Traumatic brain injury; dentate gyrus; neurogenesis; regeneration; adenosine kinase	ADULT NEUROGENESIS; HIPPOCAMPUS; DEFICIENCY; RAT; ACTIVATION; EXPRESSION; MICROGLIA; SPECTRUM; RECEPTOR; MOUSE	Traumatic brain injury (TBI) is a major public health concern and remains a leading cause of disability and socio-economic burden. To date, there is no proven therapy that promotes brain repair following an injury to the brain. In this study, we explored the role of an isoform of adenosine kinase expressed in the cell nucleus (ADK-L) as a potential regulator of neural stem cell proliferation in the brain. The rationale for this hypothesis is based on coordinated expression changes of ADK-L during foetal and postnatal murine and human brain development indicating a role in the regulation of cell proliferation and plasticity in the brain. We first tested whether the genetic disruption of ADK-L would increase neural stem cell proliferation after TBI. Three days after TBI, modelled by a controlled cortical impact, transgenic mice, which lack ADK-L (ADK(Delta neuron)) in the dentate gyrus (DG) showed a significant increase in neural stem cell proliferation as evidenced by significant increases in doublecortin and Ki67-positive cells, whereas animals with transgenic overexpression of ADK-L in dorsal forebrain neurons (ADK-L-tg) showed an opposite effect of attenuated neural stem cell proliferation. Next, we translated those findings into a pharmacological approach to augment neural stem cell proliferation in the injured brain. Wild-type C57BL/6 mice were treated with the small molecule adenosine kinase inhibitor 5-iodotubercidin for 3 days after the induction of TBI. We demonstrate significantly enhanced neural stem cell proliferation in the DG of 5-iodotubercidin-treated mice compared to vehicle-treated injured animals. To rule out the possibility that blockade of ADK-L has any effects in non-injured animals, we quantified baseline neural stem cell proliferation in ADK(Delta neuron) mice, which was not altered, whereas baseline neural stem cell proliferation in ADK-L-tg mice was enhanced. Together these findings demonstrate a novel function of ADK-L involved in the regulation of neural stem cell proliferation after TBI.	[Gebril, Hoda M.; Boison, Detlev] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosurg, 683 Hoes Ln W, Piscataway, NJ 08854 USA; [Gebril, Hoda M.; Rose, Rizelle Mae; Gesese, Raey; Emond, Martine P.] Legacy Res Inst, Robert Stone Dow Neurobiol Labs, Portland, OR 97232 USA; [Huo, Yuqing] Augusta Univ, Vasc Biol Ctr, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Aronica, Eleonora] Univ Amsterdam, Ctr Neurosci, Vasc Biol Ctr, Med Coll Georgia,Dept Cellular Biol & Anat, Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen SEIN Nederland, Heemstede, Netherlands		Boison, D (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosurg, 683 Hoes Ln W, Piscataway, NJ 08854 USA.	detlev.boison@rutgers.edu	Boison, Detlev/ABE-6302-2020	Gebril, Hoda/0000-0001-5797-9406	Good Samaritan Hospital Foundation; National Institutes of healthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS088024, NS065957]	We acknowledge generous support from Dale Rice, Rocky Dixon, the Good Samaritan Hospital Foundation, and the National Institutes of health (NS088024, NS065957) for this project.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Bang SA, 2016, J NEUROTRAUM, V33, P1005, DOI 10.1089/neu.2015.4051; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004; Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899; Boison D, 2015, NEUROPHARMACOLOGY, V97, P18, DOI 10.1016/j.neuropharm.2015.04.031; Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361; Boison D, 2012, NEUROPHARMACOLOGY, V62, P1527, DOI 10.1016/j.neuropharm.2011.01.048; Bolon B., 2015, PATHOLOGY DEV MOUSE; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Cui XA, 2009, BIOCHEM BIOPH RES CO, V388, P46, DOI 10.1016/j.bbrc.2009.07.106; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Fedele DE, 2004, NEUROSCI LETT, V370, P160, DOI 10.1016/j.neulet.2004.08.031; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Hirabayashi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-82; Hsieh J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018911; Huber A, 2002, NEUROSCI LETT, V329, P289, DOI 10.1016/S0304-3940(02)00684-5; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kiese K, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00099; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002; Long Q, 2017, P NATL ACAD SCI USA; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Masino SA, 2013, NEUROPHARMACOLOGY, V68, P116, DOI 10.1016/j.neuropharm.2012.08.013; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Miao ZG, 2015, HUM MOL GENET, V24, P5855, DOI 10.1093/hmg/ddv307; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Osborne DM, 2018, NEUROPHARMACOLOGY, V141, P89, DOI 10.1016/j.neuropharm.2018.08.025; Parent JM, 2007, PROG BRAIN RES, V163, P529, DOI 10.1016/S0079-6123(07)63028-3; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sandau US, 2019, EPILEPSIA, V60, P615, DOI 10.1111/epi.14674; Sandau US, 2016, J NEUROSCI, V36, P12117, DOI 10.1523/JNEUROSCI.2146-16.2016; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Shen HY, 2012, J CLIN INVEST, V122, P2567, DOI 10.1172/JCI62378; Staufner C, 2016, J INHERIT METAB DIS, V39, P273, DOI 10.1007/s10545-015-9904-y; Studer FE, 2006, NEUROSCIENCE, V142, P125, DOI 10.1016/j.neuroscience.2006.06.016; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Toda T, 2019, MOL PSYCHIATR, V24, P67, DOI 10.1038/s41380-018-0036-2; Williams-Karnesky RL, 2013, J CLIN INVEST, V123, P3552, DOI 10.1172/JCI65636	52	8	9	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	1							17	10.1093/braincomms/fcaa017			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3SX	WOS:000574931600017	32322821	Green Published, gold			2022-02-06	
J	Jurick, SM; Crocker, LD; Merritt, VC; Hoffman, SN; Keller, AV; Eglit, GML; Thomas, KR; Norman, SB; Schiehser, DM; Rodgers, CS; Twamley, EW; Jak, AJ				Jurick, Sarah M.; Crocker, Laura D.; Merritt, Victoria C.; Hoffman, Samantha N.; Keller, Amber, V; Eglit, Graham M. L.; Thomas, Kelsey R.; Norman, Sonya B.; Schiehser, Dawn M.; Rodgers, Carie S.; Twamley, Elizabeth W.; Jak, Amy J.			Psychological Symptoms and Rates of Performance Validity Improve Following Trauma-Focused Treatment in Veterans with PTSD and History of Mild-to-Moderate TBI	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Posttraumatic stress disorder; Performance validity; Effort; Cognitive rehabilitation; Post-concussive symptoms; Depressive symptoms	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MEMORY MALINGERING TOMM; IRAQI FREEDOM VETERANS; BRAIN-INJURY; DIGIT SPAN; TRIAL 1; POSTCONCUSSION SYNDROME; INVALID PERFORMANCE; CROSS-VALIDATION	Objective: Iraq and Afghanistan Veterans with posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) history have high rates of performance validity test (PVT) failure. The study aimed to determine whether those with scores in the invalid versus valid range on PVTs show similar benefit from psychotherapy and if psychotherapy improves PVT performance. Method: Veterans (N = 100) with PTSD, mild-to-moderate TBI history, and cognitive complaints underwent neuropsychological testing at baseline, post-treatment, and 3-month post-treatment. Veterans were randomly assigned to cognitive processing therapy (CPT) or a novel hybrid intervention integrating CPT with TBI psychoeducation and cognitive rehabilitation strategies from Cognitive Symptom Management and Rehabilitation Therapy (CogSMART). Performance below standard cutoffs on any PVT trial across three different PVT measures was considered invalid (PVT-Fail), whereas performance above cutoffs on all measures was considered valid (PVT-Pass). Results: Although both PVT groups exhibited clinically significant improvement in PTSD symptoms, the PVT-Pass group demonstrated greater symptom reduction than the PVT-Fail group. Measures of post-concussive and depressive symptoms improved to a similar degree across groups. Treatment condition did not moderate these results. Rate of valid test performance increased from baseline to follow-up across conditions, with a stronger effect in the SMART-CPT compared to CPT condition. Conclusion: Both PVT groups experienced improved psychological symptoms following treatment. Veterans who failed PVTs at baseline demonstrated better test engagement following treatment, resulting in higher rates of valid PVTs at follow-up. Veterans with invalid PVTs should be enrolled in trauma-focused treatment and may benefit from neuropsychological assessment after, rather than before, treatment.	[Jurick, Sarah M.; Crocker, Laura D.; Merritt, Victoria C.; Hoffman, Samantha N.; Keller, Amber, V; Eglit, Graham M. L.; Norman, Sonya B.; Schiehser, Dawn M.; Twamley, Elizabeth W.; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, San Diego, CA USA; [Jurick, Sarah M.; Crocker, Laura D.; Norman, Sonya B.; Schiehser, Dawn M.; Twamley, Elizabeth W.; Jak, Amy J.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Thomas, Kelsey R.; Norman, Sonya B.; Schiehser, Dawn M.; Twamley, Elizabeth W.; Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA; [Norman, Sonya B.] Natl Ctr PTSD, White River Jct, VT USA; [Rodgers, Carie S.] PsychArmor Inst, San Diego, CA USA		Jurick, SM (corresponding author), 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	sjurick@ucsd.edu		Hoffman, Samantha/0000-0002-2792-8576; Merritt, Victoria/0000-0001-5683-4168; , Sarah/0000-0002-5573-6459	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]; Veterans Affairs Office of Academic Affiliations Fellowship Program; VA San Diego Center of Excellence for Stress and Mental Health [IK2 RX002459]; VA Rehabilitation RD Service	This work was supported by the Department of Defense (award W81XWH-11-1-0641). This material is further supported with resources of the Veterans Affairs Office of Academic Affiliations Fellowship Program and the VA San Diego Center of Excellence for Stress and Mental Health, and Laura Crocker received salary support during this work from Career Development Award Number IK2 RX002459 from the VA Rehabilitation R&D Service. Special thanks to Briana Boyd and Mark Sanderson-Cimino.	Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Blake D., 1995, CLIN ADM PTSD SCALE; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Burnham KP., 2002, MODEL SELECTION MULT; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Crawford EF, 2017, J NERV MENT DIS, V205, P140, DOI 10.1097/NMD.0000000000000594; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Denning JH, 2014, APPL NEUROPSYCH-ADUL, V21, P269, DOI 10.1080/23279095.2013.811076; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Flaherty JM, 2015, BRAIN INJURY, V29, P1630, DOI 10.3109/02699052.2015.1075249; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Heck RH, 2013, MULTILEVEL MODELING; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horner MD, 2017, ARCH CLIN NEUROPSYCH, V32, P228, DOI 10.1093/arclin/acw094; Horner MD, 2014, CLIN NEUROPSYCHOL, V28, P703, DOI 10.1080/13854046.2014.925143; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Jurick SM, 2019, ARCH CLIN NEUROPSYCH, V34, P366, DOI 10.1093/arclin/acy048; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Niesten IJM, 2018, ARCH CLIN NEUROPSYCH, V33, P1080, DOI 10.1093/arclin/acy004; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Roor JJ, 2020, APPL NEUROPSYCH-ADUL, V27, P188, DOI 10.1080/23279095.2018.1519509; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Suchy Y, 2012, CLIN NEUROPSYCHOL, V26, P1296, DOI 10.1080/13854046.2012.722230; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; Titov Nickolai, 2011, Cognitive Behaviour Therapy, V40, P126, DOI 10.1080/16506073.2010.550059; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Weathers F.W., 1993, 9 ANN C ISTSS; Wechsler D., 2008, WECHSLER ADULT INTEL; Westbrook D, 2005, BEHAV RES THER, V43, P1243, DOI 10.1016/j.brat.2004.09.006; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Woodard JL, 2017, NEUROPSYCHOLOGY, V31, P1020, DOI 10.1037/neu0000386; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	86	8	8	2	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2020	26	1			SI		108	118	PII S1355617719000997	10.1017/S1355617719000997			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	KH1RZ	WOS:000510425100011	31658923				2022-02-06	
J	Mihalik, JP; Wasserman, EB; Teel, EF; Marshall, SW				Mihalik, Jason P.; Wasserman, Erin B.; Teel, Elizabeth F.; Marshall, Stephen W.			Head Impact Biomechanics Differ Between Girls and Boys Youth Ice Hockey Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Child; Concussion; Gender; Injury prevention; Kinematics; Mild traumatic brain injury; Pediatrics; Sports	FOOTBALL PLAYERS; MUSCLE STRENGTH; INJURY RATES; RISK-FACTORS; EPIDEMIOLOGY; MECHANISMS; EXPOSURE	The influence of sex on head impact biomechanics is unknown for youth ice hockey. We sought to determine sex differences in head impact severity and frequency in youth ice hockey players. Male (n = 110) and female (n = 25) players (13-16 years old) were recruited from a local hockey organization. Players wore helmets instrumented with the Head Impact Telemetry System for all competitions and practices throughout the season. Seven team-seasons were captured. Random intercepts general mixed linear models determined whether linear acceleration and rotational acceleration differed by sex. Linear regression models evaluated the relationship between sex and impact frequency. All head impact biomechanics were natural log-transformed as their distributions were right-skewed. Females sustained fewer impacts per player than males (27 fewer impacts per player-season, p < 0.0001) even when analysis was limited to games only (21 fewer impacts per player-season, p < 0.0001). The linear acceleration was higher among females (1.07 g; 95% CI 1.00, 1.13; p = 0.04). There were no other meaningful sex differences in head impact severity. Female players are not permitted to body check, and this likely explains why they sustain fewer head impacts than males. However, as a result, females likely sustain a higher proportion of head impacts through illegal or unintentional head contact, and these impacts may result in more force being delivered to the head.	[Mihalik, Jason P.; Wasserman, Erin B.; Teel, Elizabeth F.; Marshall, Stephen W.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27515 USA; [Mihalik, Jason P.; Teel, Elizabeth F.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA; [Mihalik, Jason P.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Teel, Elizabeth F.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Mihalik, Jason P.] 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA		Mihalik, JP (corresponding author), 2201 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878; Teel, Elizabeth/0000-0002-2846-5884	Ontario Neurotrauma Foundation (ONF); National Operating Committee on Standards for Athletic Equipment (NOCSAE); USA Hockey Foundation (USAHF)	The authors would like to thank the hockey organizations, parents, and players participating in our research endeavors, namely the Raleigh Youth Hockey Association and Carolina Lightning Hockey. We would also like to acknowledge Robert Lynall, Alice (Pierce) Feldbusch, and Julianne Schmidt, and our undergraduate research assistants for assistance with data collection. The data presented in this study were collected during projects funded in whole or in part by the Ontario Neurotrauma Foundation (ONF), the National Operating Committee on Standards for Athletic Equipment (NOCSAE), and the USA Hockey Foundation (USAHF). The results and opinions expressed herein are those of the authors and do not constitute endorsement by the ONF, NOCSAE, or USAHF. The authors have no other conflicts of interest to report.	Agel J, 2010, CAN J SURG, V53, P319; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hootman JM, 2007, J ATHL TRAINING, V42, P311; International Ice Hockey Federation, COUNTR NUMB REG IC H; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	22	8	8	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					104	111		10.1007/s10439-019-02343-9			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KI8PN	WOS:000511620300012	31435751				2022-02-06	
J	Mohamed, AZ; Corrigan, F; Collins-Praino, LE; Plummer, SL; Soni, N; Nasrallah, FA				Mohamed, Abdalla Z.; Corrigan, Frances; Collins-Praino, Lyndsey E.; Plummer, Stephanie L.; Soni, Neha; Nasrallah, Fatima A.			Evaluating spatiotemporal microstructural alterations following diffuse traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Diffusion tensor Imaging; Structural magnetic resonance imaging; Axonal injury; Neuroinflammation	AMYLOID PRECURSOR PROTEIN; WHITE-MATTER; AXONAL INJURY; RAT-BRAIN; INFLAMMATORY RESPONSE; CYTOTOXIC EDEMA; CEREBRAL EDEMA; FIBER DENSITY; TENSOR; MODERATE	Background: Diffuse traumatic brain injury (TBI) is known to lead to microstructural changes within both white and grey matter detected in vivo with diffusion tensor imaging (DTI). Numerous studies have shown alterations in fractional anisotropy (FA) and mean diffusivity (MD) within prominent white matter tracts, but few have linked these to changes within the grey matter with confirmation via histological assessment. This is especially important as alterations in the grey matter may be predictive of long-term functional deficits. Methods: A total of 33 male Sprague Dawley rats underwent severe closed-head TBI. Eight animals underwent tensor-based morphometry (TBM) and DTI at baseline (pre-TBI), 24 hours (24 h), 7, 14, and 30 days post-TBI. Immunohistochemical analysis for the detection of ionised calcium-binding adaptor molecule 1 (IBA1) to assess microglia number and percentage of activated cells, beta-amyloid precursor protein (APP) as a marker of axonal injury, and myelin basic protein (MBP) to investigate myelination was performed at each time-point. Results: DTI showed significant alterations in FA and RD in numerous white matter tracts including the corpus callosum, internal and external capsule, and optic tract and in the grey-matter in the cortex, thalamus, and hippocampus, with the most significant effects observed at 14 D post-TBI. TBM confirmed volumetric changes within the hippocampus and thalamus. Changes in DTI were in line with significant axonal injury noted at 24 h post-injury via immunohistochemical analysis of APP, with widespread microglial activation seen within prominent white matter tracts and the grey matter, which persisted to 30 D within the hippocampus and thalamus. Microstructural alterations in MBP + ve fibres were also noted within the hippocampus and thalamus, as well as the cortex. Conclusion: This study confirms the widespread effects of diffuse TBI on white matter tracts which could be detected via DTI and extends these findings to key grey matter regions, with a comprehensive investigation of the whole brain. In particular, the hippocampus and thalamus appear to be vulnerable to ongoing pathology post-TBI, with DTI able to detect these alterations supporting the clinical utility in evaluating these regions post-TBI.	[Mohamed, Abdalla Z.; Soni, Neha; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia; [Corrigan, Frances] Univ South Australia, Div Hlth Sci, Head Injury Lab, Adelaide, SA 5000, Australia; [Collins-Praino, Lyndsey E.] Univ Adelaide, Adelaide Med Sch, CANDL, Adelaide, SA 5005, Australia; [Plummer, Stephanie L.] Univ Adelaide, Adelaide Med Sch, Translat Neuropathol Lab, Adelaide, SA 5005, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79,Upland Rd, Brisbane, Qld 4072, Australia.	f.nasrallah@uq.edu.au	Mohaned, Abdalla/AAL-8721-2020; Mohaned, Abdalla/ABF-9320-2021; Mohamed, Abdalla/ABG-8718-2021; Nasrallah, Fatima/N-3398-2016	Mohaned, Abdalla/0000-0003-4499-672X; Mohaned, Abdalla/0000-0003-4499-672X; Plummer, Stephanie/0000-0002-9582-1703; Nasrallah, Fatima/0000-0002-7385-9559; Corrigan, Frances/0000-0001-6150-8893	Motor Accident Insurance Commission (MAIC) [2014000857]; Queensland Government, Australia; Neurosurgical Research Foundation; Australian Government through NCRIS	This work as supported by Motor Accident Insurance Commission (MAIC) (Grant:2014000857), the Queensland Government, Australia for the research grant to FN. This work was also supported by grants from the Neurosurgical Research Foundation to FC and LCP. We thank the Australian Government support through NCRIS and the National Imaging Facility for the operation of 9.4T MRI at Centre of Advanced Imaging, University of Queensland, Brisbane, Australia. We thank Jessica Sharkey and Michail Laoumtzis for technical assistance.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chang EH, 2017, DATA BRIEF, V10, P438, DOI 10.1016/j.dib.2016.12.018; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2011, NEUROMETHODS, V62, P193, DOI 10.1007/978-1-61779-301-1_11; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Evilsizor M.N., 2015, BRAIN NEUROTRAUMA MO, DOI [10.1201/b18126, DOI 10.1201/B18126]; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kenney K, 2018, JAMA NEUROL, V75, P1043, DOI 10.1001/jamaneurol.2018.0347; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Palacios E., 2018, NODDI STUDY BIORXIV, DOI [10.1101/345629, DOI 10.1101/345629]; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Plummer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190449; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; RAGHAVENDRA RV, 2000, EXP NEUROL, V0161, P00102, DOI DOI 10.1006/exnr.1999.7269; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scholz J, 2014, DIFFUSION MRI, P301, DOI DOI 10.1016/B978-0-12-396460-1.00014-7; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; van Tilborg E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16797-1; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	104	8	8	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	25								102136	10.1016/j.nicl.2019.102136			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU2JR	WOS:000519535200045	31865019	Green Published, gold, Green Accepted			2022-02-06	
J	Rawlins, MLW; Johnson, BR; Register-Mihalik, JK; DeAngelis, K; Schmidt, JD; D'Lauro, CJ				Rawlins, Michelle L. Weber; Johnson, Brian R.; Register-Mihalik, Johna K.; DeAngelis, Karin; Schmidt, Julianne D.; D'Lauro, Christopher J.			United States Air Force Academy Cadets' Perceived Costs of Concussion Disclosure	MILITARY MEDICINE			English	Article							TREATMENT SEEKING; STIGMA; SPORT; NONDISCLOSURE; PERCEPTIONS; MOTIVATIONS; RECOVERY; DISORDER; BARRIERS; CARE	Introduction Concussion is unique among sport-related injuries as effective clinical diagnosis and treatment often rely on symptom-report for clinician diagnosis and treatment. However, at-risk populations such as collegiate athletes and military academy cadets often have been shown to under-report concussions and symptoms, complicating diagnosis, treatment, and policy-based interventions. The purpose of this study was to explore factors influencing concussion reporting in United States Air Force Academy (USAFA) cadets. Materials and Methods Semi-structured interviews were conducted on 34 cadets (18 with concussion history; 16 without concussion history). This study was approved by the USAFA Institutional Review Board. Analysis included a five-cycle process of clarifying the topic at hand through an introduction, conducting a literature review, data collection and summarization, relating current findings to current literature, and making final interpretations. Data were summarized by creation of a codebook after reading five transcripts and identifying meaningful units. A four-person research team read and identified meaningful units individually, then met to discuss common meaningful units and codebook creation. Once the codebook was created, the lead researcher used the codebook to code all transcripts. Results Eight themes were generated from interview transcripts. This manuscript focuses on the perceived costs following a concussion theme and the following subthemes: perceived costs to physical fitness, military career aspirations, pilot qualifications, sport, reputation, academics, and lack of time. Conclusions Cadet interviews described a complex environment where concussions were often viewed as costly to future career ambitions and provided potential reasons for non-disclosure largely including disruption in daily life. Reduction in perceived and actual harms due to concussion disclosure will require not only improving clinical care, but also addressing barriers to self-disclosure. Additionally, research suggests the sooner one reports a concussion, the sooner they return to physical or military activity. Educational interventions should be designed to address the perceived costs identified from our study and educate cadets that while some costs may be reality, others may not. Secondly, it should also be stressed to cadets that the sooner one seeks medical attention following a concussion, the sooner they may return to activity. Messaging around these themes may decrease the costs associated with time removed from academics, athletics, or military activities therefore minimizing attempts at concussion self-management. Lastly, if efforts are made to improve the overall concussion disclosure stigma, cadets may increase seeking care after injury because their reputation may not be as impacted.	[Rawlins, Michelle L. Weber; Schmidt, Julianne D.] Univ Georgia, 330 River Rd, Athens, GA 30602 USA; [Johnson, Brian R.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Campus Box 8700, Chapel Hill, NC 27599 USA; [DeAngelis, Karin; D'Lauro, Christopher J.] US Air Force Acad, USAF Acad, 2354 Fairchild Hall, Colorado Springs, CO 80840 USA		Rawlins, MLW (corresponding author), Univ Georgia, 330 River Rd, Athens, GA 30602 USA.		D'Lauro, Christopher/X-1518-2019	D'Lauro, Christopher/0000-0003-0894-6602	National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults [FP00004605, AWD00004388]; U.S. Air Force Summer Faculty Fellowship Program; National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults Grant; National Collegiate Athletic Association-Department of Defense Research Grand Challenge	This project was conducted in part with support from the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults (FP00004605 and AWD00004388). Additional funding for this project was supported from the U.S. Air Force Summer Faculty Fellowship Program. MichelleWeber has received stipend and travel funds from The National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults Grant and the U.S. Air Force Summer Faculty Fellowship Program. Johna Register-Mihalik, Julianne Schmidt, Brian R. Johnson, Christopher D'Lauro were awarded the described grant from the National Collegiate Athletic Association-Department of Defense Research Grand Challenge, and too received travel funds. Karin DeAngelis has no conflicts of interest to declare.	Anderson R, 2011, 5 WAYS DOING QUALITA; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Britt TW, 2016, WORK STRESS, V30, P318, DOI 10.1080/02678373.2016.1246490; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; D'Lauro C, 2017, BRIT J SPORT MED, V51, pA64; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Dondanville KA, 2018, BEST PRACT MENT HLTH, V14, P15; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Guba E., 1985, NATURALISTIC INQUIRY; Guba EgonG., 1981, EFFECTIVE EVALUATION; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Johnson BR, 2018, MIL MED, V183, P101, DOI 10.1093/milmed/usx106; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Lincoln Y. S, 1986, NEW DIRECTIONS PROGR, V30, P73, DOI [DOI 10.1002/EV.1427, 10.1002/ev.1427]; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Masuda A, 2017, INT J ADV COUNS, V39, P188, DOI 10.1007/s10447-017-9291-1; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miller AK, 2011, PSYCHOL WOMEN QUART, V35, P119, DOI 10.1177/0361684310384104; Mittal D, 2013, PSYCHIATR REHABIL J, V36, P86, DOI 10.1037/h0094976; Osorio C, 2013, ANXIETY STRESS COPIN, V26, P539, DOI 10.1080/10615806.2012.725470; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Topper K, 2015, J TRAUMA STRESS, V28, P375, DOI 10.1002/jts.22032; Toth KE, 2014, J OCCUP REHABIL, V24, P732, DOI 10.1007/s10926-014-9504-y; Wertz F.J., 2011, 5 WAYS DOING QUALITA	31	8	8	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185	1-2					E269	E275		10.1093/milmed/usz162			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KM6BW	WOS:000514224500049	31268525	Bronze			2022-02-06	
J	Roitbak, T				Roitbak, Tamara			MicroRNAs and Regeneration in Animal Models of CNS Disorders	NEUROCHEMICAL RESEARCH			English	Article						MicroRNA; MiR-155; Neurorestoration; Post-stroke inflammation; Cerebral blood flow; Functional recovery	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MESENCHYMAL STROMAL CELLS; ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; CIRCULATING MICRORNAS; NEURITE OUTGROWTH; PARKINSONS-DISEASE; AXON REGENERATION; EMERGING ROLES	microRNAs (miRNAs) are recently identified small RNA molecules that regulate gene expression and significantly influence the essential cellular processes associated with CNS repair after trauma and neuropathological conditions including stroke and neurodegenerative disorders. A number of specific miRNAs are implicated in regulating the development and propagation of CNS injury, as well as its subsequent regeneration. The review focuses on the functions of the miRNAs and their role in brain recovery following CNS damage. The article introduces a brief description of miRNA biogenesis and mechanisms of miRNA-induced gene suppression, followed by an overview of miRNAs involved in the processes associated with CNS repair, including neuroprotection, neuronal plasticity and axonal regeneration, vascular reorganization, neuroinflammation, and endogenous stem cell activation. Specific emphasis is placed on the role of multifunctional miRNA miR-155, as it appears to be involved in multiple neurorestorative processes during different CNS pathologies. In association with our own studies on miR-155, I introduce a new and unexplored approach to cerebral regeneration: regulation of brain tissue repair through a direct modulation of specific miRNA activity. The review concludes with discussion on the challenges and the future potential of miRNA-based therapeutic approaches to CNS repair.	[Roitbak, Tamara] Univ New Mexico, Hlth Sci Ctr, Dept Neurosurg, 1101 Yale Blvd, Albuquerque, NM 87106 USA		Roitbak, T (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurosurg, 1101 Yale Blvd, Albuquerque, NM 87106 USA.	troitbak@salud.unm.edu		Roitbak, Tamara/0000-0003-1599-6819	National Institute of Neurological Disorders and Stroke-NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082225]	This work was supported by the National Institute of Neurological Disorders and Stroke-NIH R01NS082225 Grant.	Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashhab MU, 2013, J MOL NEUROSCI, V51, P950, DOI 10.1007/s12031-013-0013-9; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Barca-Mayo O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00013; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bayraktar R, 2017, MOL ONCOL, V11, P1673, DOI 10.1002/1878-0261.12144; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bekris LM, 2013, BIOMARKERS, V18, P455, DOI 10.3109/1354750X.2013.814073; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bielefeld Pascal, 2017, Brain Plast, V3, P43, DOI 10.3233/BPL-160036; Bisicchia E, 2018, MOL NEUROBIOL, V55, P6894, DOI 10.1007/s12035-018-0889-z; Blandford SN, 2018, GLIA, V66, P2267, DOI 10.1002/glia.23445; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Cardoso AL, 2016, CURR OPIN PHARMACOL, V26, P1, DOI 10.1016/j.coph.2015.09.001; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Chakraborty C, 2017, MOL THER-NUCL ACIDS, V8, P132, DOI 10.1016/j.omtn.2017.06.005; Chandran R, 2017, NEUROCHEM INT, V111, P12, DOI 10.1016/j.neuint.2017.01.015; Chen JJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7027380; Chopp M, 2015, EXPERT OPIN EMERG DR, V20, P523, DOI 10.1517/14728214.2015.1061993; Cichon C, 2014, TISSUE BARRIERS, V2, DOI 10.4161/21688362.2014.944446; Costa A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-87; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; Dewdney B, 2018, J STROKE CEREBROVASC, V27, P522, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.058; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Dietrich J, 2006, ADV EXP MED BIOL, V557, P191; Doeppner TR, 2017, J CEREBR BLOOD F MET, V37, P914, DOI 10.1177/0271678X16647738; Doeppner TR, 2013, ACTA NEUROPATHOL, V126, P251, DOI 10.1007/s00401-013-1142-5; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; El Waly B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00145; Elramah S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00031; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan Z, 2016, MOL NEUROBIOL, V53, P7057, DOI 10.1007/s12035-015-9620-5; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2017, RESTOR NEUROL NEUROS, V35, P251, DOI 10.3233/RNN-160675; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galloway DA, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00059; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Ghibaudi M, 2017, PROG NEUROBIOL, V158, P69, DOI 10.1016/j.pneurobio.2017.07.005; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hachisuka S, 2014, SPINAL CORD, V52, P596, DOI 10.1038/sc.2014.86; Harraz MM, 2012, P NATL ACAD SCI USA, V109, P18962, DOI 10.1073/pnas.1121288109; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He QQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35205; He QW, 2016, CNS NEUROSCI THER, V22, P507, DOI 10.1111/cns.12525; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Herrera-Carrillo E, 2017, NUCLEIC ACIDS RES, V45, P10369, DOI 10.1093/nar/gkx779; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hoss AG, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00036; Hu YW, 2016, NEUROSCI LETT, V622, P61, DOI 10.1016/j.neulet.2016.04.034; Hu ZH, 2017, CURR OPIN NEUROBIOL, V45, P24, DOI 10.1016/j.conb.2017.02.014; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huang LG, 2015, CNS NEUROSCI THER, V21, P496, DOI 10.1111/cns.12383; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jadhav SP, 2014, J NEUROCHEM, V130, P388, DOI 10.1111/jnc.12731; Jee MK, 2012, HUM GENE THER, V23, P508, DOI 10.1089/hum.2011.121; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Jiang YQ, 2017, MOL MED REP, V16, P2522, DOI 10.3892/mmr.2017.6862; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kanninen KM, 2016, BBA-MOL BASIS DIS, V1862, P403, DOI 10.1016/j.bbadis.2015.09.020; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khoshnam SE, 2017, J STROKE, V19, P166, DOI 10.5853/jos.2016.01368; Kim W, 2014, NEUROBIOL AGING, V35, P1712, DOI 10.1016/j.neurobiolaging.2014.01.021; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landskroner-Eiger S, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006643; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li M, 2016, INFLAMMATION, V39, P1681, DOI 10.1007/s10753-016-0402-7; Li N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/235195; Li XQ, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0243-1; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Lin ST, 2013, P NATL ACAD SCI USA, V110, P17468, DOI 10.1073/pnas.1317182110; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu XS, 2017, MOL NEUROBIOL, V54, P227, DOI 10.1007/s12035-015-9655-7; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Londin E, 2015, P NATL ACAD SCI USA, V112, pE1106, DOI 10.1073/pnas.1420955112; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lukovic D, 2015, STEM CELLS, V33, P1036, DOI 10.1002/stem.1959; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Lv YN, 2017, CELL MOL NEUROBIOL, V37, P195, DOI 10.1007/s10571-016-0361-4; Ma FY, 2017, PHARM BIOL, V55, P1263, DOI 10.1080/13880209.2017.1297838; Madathil SK, 2011, BIOESSAYS, V33, P21, DOI 10.1002/bies.201000069; Mao GC, 2017, J MOL NEUROSCI, V61, P152, DOI 10.1007/s12031-016-0871-z; Martinez B, 2017, NEURAL REGEN RES, V12, P1945, DOI 10.4103/1673-5374.221147; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; Martirosyan NL, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00056; Mashima R, 2015, IMMUNOLOGY, V145, P323, DOI 10.1111/imm.12468; Mathieu J, 2013, ADV EXP MED BIOL, V786, P329, DOI 10.1007/978-94-007-6621-1_18; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Murugaiyan G, 2015, J CLIN INVEST, V125, P1069, DOI 10.1172/JCI74347; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Narayan A, 2015, NAT METHODS, V12, P343, DOI [10.1038/NMETH.3311, 10.1038/nmeth.3311]; NELSON E, 1977, ARCH NEUROL-CHICAGO, V34, P332, DOI 10.1001/archneur.1977.00500180026005; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Paeschke N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091830; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Pena-Philippides JC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009244; Peng ZF, 2013, J NEUROSCI RES, V91, P1349, DOI 10.1002/jnr.23255; Perera MN, 2006, J CLIN NEUROSCI, V13, P1, DOI 10.1016/j.jocn.2005.07.005; Phuah NH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/804510; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Quiroz JFD, 2014, DIS MODEL MECH, V7, P601, DOI 10.1242/dmm.014837; Raoof R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02969-6; Ratnadiwakara M, 2018, SEMIN CELL DEV BIOL, V79, P113, DOI 10.1016/j.semcdb.2017.10.008; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Roitbak T, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-25; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruvkun Gary, 2004, Cell, VS116, pS93, DOI 10.1016/S0092-8674(04)00034-0; Schneider JA, 2010, STROKE, V41, pS144, DOI 10.1161/STROKEAHA.110.598326; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Serwanski David R, 2018, Neuroglia, V1, P91, DOI 10.3390/neuroglia1010008; Shi MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146pe40; Sinoy S, 2017, MOL NEUROBIOL, V54, P3683, DOI 10.1007/s12035-016-9940-0; Song J, 2016, J MOL NEUROSCI, V60, P115, DOI 10.1007/s12031-016-0784-x; Su W, 2016, BRAIN BEHAV IMMUN, V52, P1, DOI 10.1016/j.bbi.2015.07.003; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Sun LQ, 2017, ONCOTARGET, V8, P59181, DOI 10.18632/oncotarget.19469; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Sun P, 2018, J CEREBR BLOOD F MET, V38, P1125, DOI 10.1177/0271678X18773871; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tarassishin L, 2011, GLIA, V59, P1911, DOI 10.1002/glia.21233; Tedeschi A, 2017, EXP NEUROL, V287, P409, DOI 10.1016/j.expneurol.2016.05.004; Thounaojam MC, 2013, MOL NEUROBIOL, V47, P1034, DOI 10.1007/s12035-013-8400-3; Tian YS, 2019, J NEUROSURG, V130, P977, DOI 10.3171/2017.5.JNS163165; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Ujigo S, 2014, SPINE, V39, P1099, DOI 10.1097/BRS.0000000000000356; van der Ree MH, 2016, ALIMENT PHARM THER, V43, P102, DOI 10.1111/apt.13432; van Solingen C, 2014, J CELL MOL MED, V18, P1104, DOI 10.1111/jcmm.12255; Vijayan M, 2016, BBA-MOL BASIS DIS, V1862, P1984, DOI 10.1016/j.bbadis.2016.08.003; WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0; Wang CM, 2014, BIOMED REP, V2, P611, DOI 10.3892/br.2014.297; Wang HB, 2017, DEV CELL, V40, P566, DOI 10.1016/j.devcel.2017.03.001; Wang HQ, 2016, BRAIN PATHOL, V26, P167, DOI 10.1111/bpa.12267; Wang P, 2016, NEUROCHEM RES, V41, P2627, DOI 10.1007/s11064-016-1975-0; Wang P, 2015, J NEUROSCI RES, V93, P1756, DOI 10.1002/jnr.23637; Wang WM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00096; Wang XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0014-7; Wang Y, 2015, J CEREBR BLOOD F MET, V35, P1977, DOI 10.1038/jcbfm.2015.156; Wang YM, 2018, CLIN J PAIN, V34, P825, DOI 10.1097/AJP.0000000000000608; Wang Y, 2014, J NEUROL SCI, V339, P144, DOI 10.1016/j.jns.2014.02.002; Weber M, 2014, AM J PHYSIOL-HEART C, V306, pH1192, DOI 10.1152/ajpheart.00521.2013; Wen Y, 2015, MOL MED, V21, P197, DOI 10.2119/molmed.2014.00199; White RE, 2012, NEUROREPORT, V23, P590, DOI 10.1097/WNR.0b013e3283540394; WICKENS M, 1994, NATURE, V367, P17, DOI 10.1038/367017a0; Wu D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00035; Xin HQ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00377; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xing GP, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898980; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xu LJ, 2015, EXP NEUROL, V264, P1, DOI 10.1016/j.expneurol.2014.11.007; Yan ZY, 2015, TUMOR BIOL, V36, P5323, DOI 10.1007/s13277-015-3193-9; Yin KJ, 2015, CURR VASC PHARMACOL, V13, P352, DOI 10.2174/15701611113119990016; Yin KJ, 2014, NEUROCHEM INT, V77, P9, DOI 10.1016/j.neuint.2014.03.013; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Yuan BQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0424-3; Zeng LL, 2016, CNS NEUROSCI THER, V22, P961, DOI 10.1111/cns.12589; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019; Zhang N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091427; Zhang RL, 2011, J CEREBR BLOOD F MET, V31, P614, DOI 10.1038/jcbfm.2010.134; Zhang RL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00201; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhou JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068469	207	8	8	1	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2020	45	1			SI		188	203		10.1007/s11064-019-02777-6			16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KI9RW	WOS:000511696200017	30877519	Green Accepted			2022-02-06	
J	Tamura, K; Furutani, T; Oshiro, R; Oba, Y; Ling, A; Murata, N				Tamura, Kaori; Furutani, Troy; Oshiro, Ross; Oba, Yukiya; Ling, Ayaka; Murata, Nathan			Concussion Recovery Timeline of High School Athletes Using A Stepwise Return-to-Play Protocol: Age and Sex Effects	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; return to sport; adolescents	SYMPTOMS; SPORT; FOOTBALL	Context: Implementation of a stepwise return-to-play (RTP) protocol has become the standard management strategy for high school athletes to ensure a safe RTP after concussion. The detailed characteristics of the recovery timeline throughout the steps of an RTP protocol have not been delineated among the adolescent population. Objective: To investigate the days spent in each step of the stepwise RTP protocol in an adolescent population and examine the effects of age and sex on recovery time. Design: Cross-sectional study. Setting: Local schools. Patients or Other Participants: Student-athletes from 57 schools. Intervention(s): A total of 726 patients with concussion (age = 15.5 +/- 1.2 years, males = 454, females = 272) were included. The 7-step RTP protocol consists of the following steps: (1) complete cognitive rest, (2) full return to school, (3) light exercise, (4) running progression, (5) noncontact training drills and weight training, (6) full-contact practice or training, and (7) return to game play. The data were obtained by certified athletic trainers as a part of the statewide standardized concussion-management protocol. Main Outcome Measure(s): Days spent in steps 0 to 6 as well as a breakdown of days by sex and age. Results: The average total RTP days were 20.2 +/- 13.9. Half of this time was spent in the return-to-school phase (steps 2-3: 10.2 +/- 10.0 days). Compared with 17-year-old participants, younger participants (age = 14-16 years) took 3 or 4 days longer to start step 3 and to reach step 6 (P < .05). Females took longer to reach step 6 than males (21.6 +/- 15.5 versus 19.3 +/- 12.7 days) because they took longer to reach step 3 (14.7 +/- 11.4 days) than males (13.0 +/- 10.0 days; P < .05). Conclusions: Our study provides an estimated stepwise concussion recovery timeline for adolescent student-athletes. Clearance to start step 3 was the benchmark for the recovery timeline, as the duration of the exercise portion of the protocol was consistent across the age and sex groups.	[Tamura, Kaori; Furutani, Troy; Oshiro, Ross; Oba, Yukiya; Ling, Ayaka; Murata, Nathan] Univ Hawaii Manoa, Coll Educ, Dept Kinesiol & Rehabil Sci, 1337 Lower Campus Rd,PE-A Complex 231, Honolulu, HI 96822 USA; [Furutani, Troy; Oshiro, Ross; Ling, Ayaka; Murata, Nathan] Univ Hawaii Manoa, Coll Educ, Hawaii Concuss Awareness & Management Program, Honolulu, HI 96822 USA		Tamura, K (corresponding author), Univ Hawaii Manoa, Coll Educ, Dept Kinesiol & Rehabil Sci, 1337 Lower Campus Rd,PE-A Complex 231, Honolulu, HI 96822 USA.	ktamura@hawaii.edu					Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	15	8	8	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2020	55	1					6	10		10.4085/1062-6050-452-18			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KC9BJ	WOS:000507465600002	31876456	gold, Green Published			2022-02-06	
J	Ware, AL; Shukla, A; Goodrich-Hunsaker, NJ; Lebel, C; Wilde, EA; Abildskov, TJ; Bigler, ED; Cohen, DM; Mihalov, LK; Bacevice, A; Bangert, BA; Taylor, HG; Yeates, KO				Ware, Ashley L.; Shukla, Ayushi; Goodrich-Hunsaker, Naomi J.; Lebel, Catherine; Wilde, Elisabeth A.; Abildskov, Tracy J.; Bigler, Erin D.; Cohen, Daniel M.; Mihalov, Leslie K.; Bacevice, Ann; Bangert, Barbara A.; Taylor, H. Gerry; Yeates, Keith O.			Post-acute white matter microstructure predicts post-acute and chronic post-concussive symptom severity following mild traumatic brain injury in children	NEUROIMAGE-CLINICAL			English	Article						Pediatric traumatic brain injury; Concussion; Mild traumatic brain injury; Diffusion tensor imaging	TENSOR IMAGING FINDINGS; COMMON DATA ELEMENTS; POSTCONCUSSIVE SYMPTOMS; MOTION; SPORTS; RECOMMENDATIONS; BIOMARKERS; QUALITY; IMPACT; SCALE	Introduction: Mild traumatic brain injury (TBI) is a global public health concern that affects millions of children annually. Mild TBI tends to result in subtle and diffuse alterations in brain tissue, which challenges accurate clinical detection and prognostication. Diffusion tensor imaging (DTI) holds promise as a diagnostic and prognostic tool, but little research has examined DTI in post-acute mild TBI. The current study compared post-acute white matter microstructure in children with mild TBI versus those with mild orthopedic injury (Op, and examined whether post-acute DTI metrics can predict post-acute and chronic post-concussive symptoms (PCS). Materials and methods: Children aged 8-16.99 years with mild TBI (n = 132) or CH (n = 69) were recruited at emergency department visits to two children's hospitals, during which parents rated children's pre-injury symptoms retrospectively. Children completed a post-acute ( < 2 weeks post-injury) assessment, which included a 3T MRI, and 3- and 6-month post-injury assessments. Parents and children rated PCS at each assessment. Mean diffusivity (MD) and fractional anisotropy (FA) were derived from diffusion-weighted MRI using Automatic Fiber Quantification software. Multiple multivariable linear and negative binomial regression models were used to test study aims, with False Discovery Rate (FDR) correction for multiple comparisons. Results: No significant group differences were found in any of the 20 white matter tracts after FDR correction. DTI metrics varied by age and sex, and site was a significant covariate. No interactions involving group, age, and sex were significant. DTI metrics in several tracts robustly predicted PCS ratings at 3- and 6-months post-injury, but only corpus callosum genu MD was significantly associated with post-acute PCS after FDR correction. Significant group by DTI metric interactions on chronic PCS ratings indicated that left cingulum hippocampus and thalamic radiation MD was positively associated with 3-month PCS in the CH group, but not in the mild TBI group. Conclusions: Post-acute white matter microstructure did not differ for children with mild TBI versus CH after correcting for multiple comparisons, but was predictive of post-acute and chronic PCS in both injury groups. These findings support the potential prognostic utility of this advanced DTI technique.	[Ware, Ashley L.; Yeates, Keith O.] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Ware, Ashley L.; Shukla, Ayushi; Lebel, Catherine; Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Shukla, Ayushi; Lebel, Catherine] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Goodrich-Hunsaker, Naomi J.; Wilde, Elisabeth A.; Abildskov, Tracy J.; Bigler, Erin D.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Goodrich-Hunsaker, Naomi J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Cohen, Daniel M.; Mihalov, Leslie K.; Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH USA; [Cohen, Daniel M.; Mihalov, Leslie K.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Bacevice, Ann; Bangert, Barbara A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Ware, Ashley L.; Lebel, Catherine; Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada		Ware, AL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	Ashley.ware@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Lebel, Catherine/B-4298-2015	Lebel, Catherine/0000-0002-0344-4032	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury [1R01HD076885]	Funding Information: National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury, 1R01HD076885.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Afacan O, 2016, PEDIATR RADIOL, V46, P1728, DOI 10.1007/s00247-016-3677-9; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2015, FRONTIERS NEUROENGIN; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blumenthal JD, 2002, NEUROIMAGE, V16, P89, DOI 10.1006/nimg.2002.1076; Brown TT, 2010, NEUROIMAGE, V53, P139, DOI 10.1016/j.neuroimage.2010.06.017; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Duhaime AC, 2012, J NEUROTRAUM, V29, P629, DOI 10.1089/neu.2011.1927; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ewing-Cobbs L, 2019, J NEUROTRAUM, V36, P1738, DOI 10.1089/neu.2018.6071; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ghodadra A, 2016, AM J NEURORADIOL, V37, P274, DOI 10.3174/ajnr.A4505; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Lebel C, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3778; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mac Donald CL, 2019, J NEUROTRAUM, V36, P264, DOI 10.1089/neu.2018.5629; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Morioka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48126-z; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Okamoto RJ, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519840444; Ozer K, 2010, J PEDIATR ORTHOPED, V30, P324, DOI 10.1097/BPO.0b013e3181d8fa8c; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Rauch SL, 2005, BIOL PSYCHIAT, V57, P1261, DOI 10.1016/j.biopsych.2005.02.014; Reikeras O, 2010, INFLAMM RES, V59, P409, DOI 10.1007/s00011-010-0167-7; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spader HS, 2019, J NEUROSURG, V130, P1321, DOI 10.3171/2017.12.JNS171597; STEVENS G, 1985, SOC SCI RES, V14, P142, DOI 10.1016/0049-089X(85)90008-0; Tamnes CK, 2018, DEV COGN NEUROS-NETH, V33, P161, DOI 10.1016/j.dcn.2017.12.002; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; Vertes PE, 2015, J CHILD PSYCHOL PSYC, V56, P299, DOI 10.1111/jcpp.12365; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilde EA, 2018, BRAIN INJURY, V32, P1266, DOI 10.1080/02699052.2018.1494855; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu JZ, 2004, J BIOMECH, V37, P147, DOI 10.1016/S0021-9290(03)00240-9; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	75	8	8	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	25								102106	10.1016/j.nicl.2019.102106			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KU2JR	WOS:000519535200070	31896466	Green Published, gold			2022-02-06	
J	Wright, J; Sohlberg, MM; Watson-Stites, R; McCart, M				Wright, Jim; Sohlberg, McKay Moore; Watson-Stites, Ryann; McCart, Melissa			Identification of Key Therapy Ingredients for SLPs Serving on Multidisciplinary Teams Facilitating Return to Learn for Students With Prolonged Cognitive Effects After Concussion A Retrospective Case Series Analysis	TOPICS IN LANGUAGE DISORDERS			English	Article						cognitive rehabilitation; concussion; speech-language pathology	TRAUMATIC BRAIN-INJURY; SPEECH-LANGUAGE PATHOLOGY; POSTCONCUSSION SYNDROME; BEHAVIORAL INTERVENTION; SYMPTOMS; CHILDREN; REHABILITATION; MANAGEMENT; IMPACT; MODEL	Purpose: This retrospective case series utilized clinical data mining (CDM) to understand the potential key components in an integrated treatment approach delivered by speech-language pathologists (SLPs) treating adolescents experiencing persistent cognitive effects postconcussion. The first purpose was to describe the profiles of students treated in our clinic, how they were treated, and the nature of multidisciplinary communication. The second purpose was to generate testable hypotheses about effective intervention options for this population. Methods: Fifteen students aged 13-18 years experiencing prolonged concussion symptoms (PCS) were referred to our SLP graduate training clinic by a local pediatric neuropsychologist for cognitive rehabilitation services. Clinical data mining extracted clinical data in 4 main categories: (a) student characteristics, (b) SLP treatment parameters, (c) clinical outcomes following SLP treatment, and (d) the nature of multidisciplinary communication between practitioners. Results: Aligned with risk factors for PCS as reported in the literature, data on student characteristics revealed that the majority of students had sustained multiple previous concussions and reported a history of depression/anxiety. Data on SLP treatment parameters identified metacognitive strategy instruction and the training of assistive technology for cognition as the most frequent interventions selected to address academic goals. Data showing the frequency and type of multidisciplinary communication revealed that SLPs communicated most often with the pediatric neuropsychologist and educational liaison. Clinical outcome data revealed that 12 of the 15 students achieved their academic goals at the time of discharge. Conclusions: Overall, CDM results suggested that when working in a multidisciplinary team, SLPs can provide cognitive rehabilitation, support symptom reduction, and deliver psychoeducation potentially effective for students experiencing PCS. Key treatment and outcome measurement issues important for developing testable interventions are discussed.	[Wright, Jim; Sohlberg, McKay Moore] Univ Oregon, Dept Commun Disorders & Sci, Eugene, OR 97403 USA; [McCart, Melissa] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR 97403 USA; [Watson-Stites, Ryann] Slocum Ctr Orthoped & Sports Med, Eugene, OR USA		Wright, J (corresponding author), 5284 Univ Oregon, Dept Commun Disorders & Sci, Eugene, OR 97403 USA.	jwrigh16@uoregon.edu	McCart, Melissa/AAN-1506-2020				Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Crooke PJ, 2015, J SPEECH LANG HEAR R, V58, pS1871, DOI 10.1044/2015_JSLHR-L-15-0243; Dachtyl SA, 2017, AM J SPEECH-LANG PAT, V26, P716, DOI 10.1044/2017_AJSLP-16-0138; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Epstein I, 2011, SOC WORK, V56, P284, DOI 10.1093/sw/56.3.284; Foy K, 2009, BRIT J HOSP MED, V70, P440, DOI 10.12968/hmed.2009.70.8.43536; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Glang AE, 2019, J HEAD TRAUMA REHAB, V34, P77, DOI 10.1097/HTR.0000000000000447; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Griffiths GG, 2016, NEUROPSYCHOL REHABIL, V26, P161, DOI 10.1080/09602011.2015.1007878; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Hossler P., 2014, PRINCIPALS RES REV, V9, P1; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Ketcham C J, 2017, CUR RES CONCUSSION, V4, pe8; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Knollman-Porter K, 2019, SEMIN SPEECH LANG, V40, P3, DOI 10.1055/s-0038-1676363; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P249, DOI 10.1016/j.rehab.2017.01.005; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCarty CA, 2016, PEDIETR, V138, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Romm KE, 2018, J SCHOOL HEALTH, V88, P813, DOI 10.1111/josh.12687; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Scheenen ME, 2017, CLIN REHABIL, V31, P1019, DOI 10.1177/0269215516687101; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Williams-Butler M. A., 2019, HEALTH-LONDON, V11, P880, DOI [10.4236/health.2019.117071, DOI 10.4236/HEALTH.2019.117071]; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	70	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JAN-MAR	2020	40	1			SI		6	35		10.1097/TLD.0000000000000198			30	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	KL0TB	WOS:000513144400003					2022-02-06	
J	Zhao, JW; Xu, C; Cao, HL; Zhang, L; Wang, XY; Chen, SW				Zhao, Jianwei; Xu, Chen; Cao, Heli; Zhang, Lin; Wang, Xuyang; Chen, Shiwen			Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats	PEERJ			English	Article						Traumatic brain injury; Integrated analysis; Neuroinflammation; Neurodegeneration; Bioinformatics	ALZHEIMERS-DISEASE; HEAD-INJURY; RISK; TREM2; INFLAMMATION; DYSFUNCTION; ACTIVATION; EXPRESSION; LONGEVITY; APOPTOSIS	Background: Traumatic brain injury (TBI) is a common neurological emergency observed in hospitals. A considerable number of patients suffer from long-term disabilities after TBI. This study aimed to identify altered gene expression signatures and mechanisms related to TBI-induced chronic neuroinflammation and neurodegeneration. Methods: An integrated analysis was performed using published RNA-sequencing studies to determine TBI-induced differentially expressed genes (DEGs). Based on the DEG data, functional annotation, signal-net, and transcription factor analyses were conducted to understand the mechanism of chronic neuroinflammation and neurodegeneration induced after TBI. Results: Two datasets were obtained using the Gene Expression Omnibus database, of which, 6,513 DEGs were identified (6,464 upregulated and 49 downregulated). Positive regulation of biological process, positive regulation of cellular process, nucleus, and heterocyclic compound binding were Gene Ontology terms significantly enriched in post-TBI rat models. Leukocyte transendothelial migration, chemokine signaling pathway, neurotrophin signaling pathway, and longevity-regulating pathway were significantly enriched after TBI. With regard to the signal-net analysis, FOXO3, DGKZ and ILK were considered the most critical genes derived using high-betweenness centrality calculation. A total of 44 TFs, including FOXO1, SRY and KLF4, were predicted to play an important role in the upregulation of gene expression. Using integrated bioinformatics analysis, TBI was found to be associated with a significant inflammatory response and neurodegeneration. FOXO3, apolipoprotein (APOE), microtubule-associated protein tau (MAPT), and TREM2 were probably associated with the TBI pathological process. The mitochondrial electron transport chain may be associated with neurodegeneration in patients with TBI, serving as a potential therapeutic target.	[Zhao, Jianwei; Xu, Chen; Cao, Heli; Zhang, Lin; Wang, Xuyang; Chen, Shiwen] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China		Chen, SW (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China.	chenshiwen@126.com			project of Shanghai Science and Technology Commission [19ZR1438600]	This work was supported by the project of Shanghai Science and Technology Commission (19ZR1438600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Broer L, 2015, J GERONTOL A-BIOL, V70, P110, DOI 10.1093/gerona/glu166; Dalmasso MC, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0394-9; Castranio EL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0569-2; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Garcia-Escudero V, 2017, NEUROSCI LETT, V655, P101, DOI 10.1016/j.neulet.2017.07.007; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Lupton MK, 2016, NEUROBIOL AGING, V40, P68, DOI 10.1016/j.neurobiolaging.2015.12.023; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; R Core Team, 2018, STATS PACK LANG ENV; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Thrash JC, 2009, NEUROCHEM RES, V34, P38, DOI 10.1007/s11064-008-9657-1; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Willcox DC, 2006, AGE, V28, P313, DOI 10.1007/s11357-006-9020-x; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang C, 2017, ONCOTARGET, V8, P113543, DOI 10.18632/oncotarget.22708; ZHANG L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI DOI 10.1007/s10571-015-0227-1; Zhang YB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.77	47	8	8	0	3	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	DEC 19	2019	7								e8324	10.7717/peerj.8324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JW9SD	WOS:000503384800012	31875163	Green Published, gold			2022-02-06	
J	Silva, PE; Marqueti, RD; Livino-de-Carvalho, K; de Araujo, AET; Castro, J; da Silva, VM; Vieira, L; Souza, VC; Dantas, LO; Cipriano, G; Nobrega, OT; Babault, N; Durigan, JLQ				Silva, Paulo Eugenio; Marqueti, Rita de Cassia; Livino-de-Carvalho, Karina; Tavares de Araujo, Amaro Eduardo; Castro, Joana; da Silva, Vinicius Maldaner; Vieira, Luciana; Souza, Vinicius Carolino; Dantas, Lucas Ogura; Cipriano, Gerson, Jr.; Nobrega, Otavio Toledo; Babault, Nicolas; Quagliotti Durigan, Joao Luiz			Neuromuscular electrical stimulation in critically ill traumatic brain injury patients attenuates muscle atrophy, neurophysiological disorders, and weakness: a randomized controlled trial	JOURNAL OF INTENSIVE CARE			English	Article						Critical care; Electrical stimulation therapy; Muscular atrophy; Muscle weakness; Neuromuscular diseases; Traumatic brain injury	ICU-ACQUIRED WEAKNESS; CRITICAL ILLNESS; CARE; CHRONAXIE; STRENGTH; FEASIBILITY; MYOPATHY; INSULIN; FORCE	Background Critically ill traumatic brain injury (TBI) patients experience extensive muscle damage during their stay in the intensive care unit. Neuromuscular electrical stimulation (NMES) has been considered a promising treatment to reduce the functional and clinical impacts of this. However, the time needed for NMES to produce effects over the muscles is still unclear. This study primarily aimed to assess the time needed and effects of an NMES protocol on muscle architecture, neuromuscular electrophysiological disorder (NED), and muscle strength, and secondarily, to evaluate the effects on plasma systemic inflammation, catabolic responses, and clinical outcomes. Methods We performed a randomized clinical trial in critically ill TBI patients. The control group received only conventional physiotherapy, while the NMES group additionally underwent daily NMES for 14 days in the lower limb muscles. Participants were assessed at baseline and on days 3, 7, and 14 of their stay in the intensive care unit. The primary outcomes were assessed with muscle ultrasound, neuromuscular electrophysiology, and evoked peak force, and the secondary outcomes with plasma cytokines, matrix metalloproteinases, and clinical outcomes. Results Sixty participants were randomized, and twenty completed the trial from each group. After 14 days, the control group presented a significant reduction in muscle thickness of tibialis anterior and rectus femoris, mean of - 0.33 mm (- 14%) and - 0.49 mm (- 21%), p < 0.0001, respectively, while muscle thickness was preserved in the NMES group. The control group presented a higher incidence of NED: 47% vs. 0% in the NMES group, p < 0.0001, risk ratio of 16, and the NMES group demonstrated an increase in the evoked peak force (2.34 kg/f, p < 0.0001), in contrast to the control group (- 1.55 kg/f, p < 0.0001). The time needed for the NMES protocol to prevent muscle architecture disorders and treat weakness was at least 7 days, and 14 days to treat NED. The secondary outcomes exhibited less precise results, with confidence intervals that spanned worthwhile or trivial effects. Conclusions NMES applied daily for fourteen consecutive days reduced muscle atrophy, the incidence of NED, and muscle weakness in critically ill TBI patients. At least 7 days of NMES were required to elicit the first significant results.	[Silva, Paulo Eugenio; Nobrega, Otavio Toledo] Univ Brasilia, Hlth Sci & Technol PhD Program, Brasilia, DF, Brazil; [Silva, Paulo Eugenio; Tavares de Araujo, Amaro Eduardo; Castro, Joana] Hosp Base Dist Fed, Phys Therapy Div, Brasilia, DF, Brazil; [Marqueti, Rita de Cassia; Cipriano, Gerson, Jr.; Quagliotti Durigan, Joao Luiz] Univ Brasilia, Rehabil Sci Program, Brasilia, DF, Brazil; [Livino-de-Carvalho, Karina] Hosp Reg Santa Maria, Phys Therapy Div, Brasilia, DF, Brazil; [da Silva, Vinicius Maldaner] Escola Super Ciencias Saude, Brasilia, DF, Brazil; [Vieira, Luciana] Hosp Base Dist Fed, Clin Res Ctr, Brasilia, DF, Brazil; [Souza, Vinicius Carolino; Nobrega, Otavio Toledo] Univ Brasilia, Sci Hlth Program, Brasilia, DF, Brazil; [Dantas, Lucas Ogura] Univ Fed Sao Carlos, Phys Therapy Dept, Sao Carlos, SP, Brazil; [Nobrega, Otavio Toledo] Inst Univ Geriatr Montreal, Ctr Rech, Montreal, PQ, Canada; [Babault, Nicolas] Univ Bourgogne Franche Comte, UFR STAPS, INSERM, U1093,Cognit Actionet Plasticite Senorimotric, Dijon, France		Silva, PE (corresponding author), Univ Brasilia, Hlth Sci & Technol PhD Program, Brasilia, DF, Brazil.; Silva, PE (corresponding author), Hosp Base Dist Fed, Phys Therapy Div, Brasilia, DF, Brazil.	pauloeugenio.bsb@gmail.com	Durigan, Joao Luiz Quagliotti/D-1110-2012; Babault, Nicolas/D-7541-2013; de Cassia Marqueti, Rita/D-1622-2012; Gerson C, G Cipriano/K-6317-2014; Nobrega, Otavio T/J-7738-2012	Durigan, Joao Luiz Quagliotti/0000-0002-7511-5289; Babault, Nicolas/0000-0001-6563-503X; de Cassia Marqueti, Rita/0000-0001-9126-3882; Gerson C, G Cipriano/0000-0001-6323-7003; Nobrega, Otavio T/0000-0003-1775-7176; Ogura Dantas, Lucas/0000-0002-6188-7552; Silva, Paulo Eugenio/0000-0001-9153-0848	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) [193.000.862/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [447529/2014-5, 310359/2014-7]; Programa Ciencias sem Fronteiras, Pesquisador Visitante Especial [88881.068106/2014-01]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	This work was supported by the Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF; Process number: 193.000.862/2014), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Process number: 447529/2014-5; 310359/2014-7), and Programa Ciencias sem Fronteiras, Pesquisador Visitante Especial (Process number: 88881.068106/2014-01). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.	Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Angelopoulos E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-39; Arts IMP, 2010, MUSCLE NERVE, V41, P32, DOI 10.1002/mus.21458; Botter A, 2011, EUR J APPL PHYSIOL, V111, P2461, DOI 10.1007/s00421-011-2093-y; Boutron I, 2017, ANN INTERN MED, V167, P40, DOI 10.7326/M17-0046; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Burke D, 2014, CLIN RESPIR  J, P1; Clarissa C, 2019, J INTENSIVE CARE, V7, DOI 10.1186/s40560-018-0355-z; Cohen J., 2013, STAT POWER ANAL BEHA; Colson S, 2000, INT J SPORTS MED, V21, P281, DOI 10.1055/s-2000-8882; Dow DE, 2004, MUSCLE NERVE, V30, P77, DOI 10.1002/mus.20054; ENOKA RM, 1988, SPORTS MED, V6, P146, DOI 10.2165/00007256-198806030-00003; Fischer A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1199-3; Fossat G, 2018, JAMA-J AM MED ASSOC, V320, P368, DOI 10.1001/jama.2018.9592; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Gruther W, 2010, J REHABIL MED, V42, P593, DOI 10.2340/16501977-0564; Hester JM, 2017, CRIT CARE MED, V45, P1037, DOI 10.1097/CCM.0000000000002305; Hirose T, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.02.010; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; KANNUS P, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P89; Katsogianni A, 2019, HEAL SCI J, V13, P1; Kho ME, 2015, J CRIT CARE, V30, P32, DOI 10.1016/j.jcrc.2014.09.014; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Lacomis D, 2013, MUSCLE NERVE, V47, P452, DOI 10.1002/mus.23615; Laghi F, 2017, MUSCLE NERVE; Latronico N, 2016, INTENS CARE MED, V42, P1790, DOI 10.1007/s00134-016-4475-4; Latronico N, 2007, CRIT CARE, V11, DOI 10.1186/cc5671; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maffiuletti NA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-137; Maffiuletti NA, 2011, EUR J APPL PHYSIOL, V111, P2391, DOI 10.1007/s00421-011-2133-7; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Natsume T, 2018, EUR J APPL PHYSIOL, V118, P1339, DOI 10.1007/s00421-018-3866-3; Nishida O, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-017-0270-8; Ojima M, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0206-8; Palakshappa JA, 2018, J CRIT CARE, V47, P324, DOI 10.1016/j.jcrc.2018.04.003; Paternostro-Sluga T, 2002, AM J PHYS MED REHAB, V81, P253, DOI 10.1097/00002060-200204000-00003; PICHON F, 1995, MED SCI SPORT EXER, V27, P1671; Poulsen JB, 2011, CRIT CARE MED, V39, P456, DOI 10.1097/CCM.0b013e318205c7bc; Reid JC, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0349-x; Routsi C, 2010, CRIT CARE, V14, DOI 10.1186/cc8987; Russo TL, 2007, MUSCLE NERVE, V35, P87, DOI 10.1002/mus.20668; Segers J, 2014, J CRIT CARE, V29, P1082, DOI 10.1016/j.jcrc.2014.06.024; Silva PE, 2018, J CRIT CARE, V44, P87, DOI 10.1016/j.jcrc.2017.10.026; Silva PE, 2017, J CRIT CARE, V37, P141, DOI 10.1016/j.jcrc.2016.09.012; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Strasser EM, 2009, ANN SURG, V249, P738, DOI 10.1097/SLA.0b013e3181a38e71; Vanpee G, 2014, CRIT CARE MED, V42, P701, DOI 10.1097/CCM.0000000000000030; Vivodtzev I, 2014, CRIT CARE, V18, DOI 10.1186/cc13888; Weber-Carstens S, 2013, AM J RESP CRIT CARE, V187, P387, DOI 10.1164/rccm.201209-1649OC; Witteveen E, 2017, CRIT CARE MED, V45, P972, DOI 10.1097/CCM.0000000000002408	53	8	8	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-0492			J INTENSIVE CARE	J. Intensive Care	DEC 12	2019	7	1							59	10.1186/s40560-019-0417-x			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV9XO	WOS:000502713400001	31890221	Green Published, gold			2022-02-06	
J	Brito, A; Costantini, TW; Berndtson, AE; Smith, A; Doucet, JJ; Godat, LN				Brito, Alex; Costantini, Todd W.; Berndtson, Allison E.; Smith, Alan; Doucet, Jay J.; Godat, Laura N.			Readmissions After Acute Hospitalization for Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Recidivism; Elderly trauma	REHOSPITALIZATION; RATES	Background: Traumatic brain injury (TBI) is associated with functional deficits, impaired cognition, and medical complications that continue well after the initial injury. Many patients seek medical care at other health care facilities after discharge, rather than returning to the admitting trauma center, making assessment of readmission rates and readmission diagnoses difficult to determine. The objective of this study was to determine the incidence and factors associated with readmission to any acute care hospital after an index admission for TBI. Materials and methods: The Nationwide Readmission Database was queried for all patients admitted with a TBI during the first 3 mo of 2015. Nonelective readmissions for this population were then collected for the remainder of 2015. Patients who died during the index admission were excluded. Demographic data, injury mechanism, type of TBI, the number of readmissions, days from discharge to readmission, readmission diagnosis, and mortality were studied. Results: Of the 15,277 patients with an index admission for TBI, 5296 patients (35%) required at least 1 readmission. Forty percent of readmissions occurred within the first 30 d after discharge from the index trauma admission. The most common primary diagnosis on readmission was SDH, followed by septicemia, urinary tract infection, and aspiration. Readmission rates increased with age, with 75% of readmissions occurring in patients aged >65 y. Initial discharge to a skilled nursing facility (Relative Risk [RR], 1.60) or leaving the hospital against medical advice (RR, 1.59) increased the risk of readmission. Patients with fall as their mechanism of injury and a subdural hematoma were more likely to require readmission compared with other types of mechanisms with TBI (RR, 1.59 and RR, 1.21, respectively; P < 0.001). Notably, the first readmission was to a different hospital for 39.5% of patients and 46.9% of patients had admissions to at least one facility outside that of their original presentation. Conclusions: Hospital readmission is common for patients discharged after TBI. Elderly patients who fall with resultant subdural hematoma are at especially high risk for complications and readmission. Understanding potentially preventable causes for readmission can be used to guide discharge planning pathways to decrease morbidity in this patient population. (C) 2019 Elsevier Inc. All rights reserved.	[Brito, Alex; Costantini, Todd W.; Berndtson, Allison E.; Smith, Alan; Doucet, Jay J.; Godat, Laura N.] Univ Calif San Diego Hlth, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92103 USA		Godat, LN (corresponding author), Univ Calif San Diego Hlth, Div Trauma Surg Crit Care Burns & Acute Care Surg, 200 W Arbor Dr 8896, San Diego, CA 92103 USA.	lgodat@ucsd.edu	/O-3005-2018	/0000-0001-9617-001X			Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Li CY, 2018, ARCH PHYS MED REHAB, V99, P1279, DOI 10.1016/j.apmr.2017.12.006; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Onukwugha E, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.17.00075; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016	13	8	8	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2019	244						332	337		10.1016/j.jss.2019.06.071			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	JG3EL	WOS:000491957000046	31306890				2022-02-06	
J	Jang, SH; Kim, OL; Kim, SH; Kim, JB				Jang, Sung Ho; Kim, Oh Lyong; Kim, Seong Ho; Kim, Jong Bum			The Relation Between Loss of Consciousness, Severity of Traumatic Brain Injury, and Injury of Ascending Reticular Activating System in Patients With Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Loss of Consciousness; Ascending Reticular Activating System; Diffusion Tensor Tractography	IMPAIRED CONSCIOUSNESS; AROUSAL SYSTEM; CONNECTIVITY; MILD; DISORDERS; DIAGNOSIS	Objective Loss of consciousness is an indicator of the severity of traumatic brain injury and the ascending reticular activating system has been considered as a main structure for consciousness. However, no study on the relation between loss of consciousness and ascending reticular activating system injury in traumatic brain injury has been reported. We investigated the relation between loss of consciousness, severity of traumatic brain injury, and ascending reticular activating system injury using diffusion tensor tractography. Design One hundred twenty patients were recruited. Three components of ascending reticular activating system, fractional anisotropy, and tract volume were measured. Results In lower dorsal and ventral ascending reticular activating system, fractional anisotropy and tract volume value in mild group were higher than those of moderate and severe groups, and there was no difference between moderate and severe groups. In upper ascending reticular activating system, fractional anisotropy value in mild group was higher than in moderate group, and it was higher than in moderate group than in severe group. Tract volume value in mild group was higher than in severe group. Loss of consciousness showed moderate negative correlations with tract volume value of lower dorsal ascending reticular activating system (r = -0.348), fractional anisotropy value of lower ventral ascending reticular activating system (r = -0.343), and fractional anisotropy value of upper ascending reticular activating system (r = -0.416). Conclusions Injury severity was different among the three traumatic brain injury groups in upper ascending reticular activating system but did not differ between moderate and severe groups in lower dorsal and ventral ascending reticular activating system.	[Jang, Sung Ho; Kim, Jong Bum] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Daegu, South Korea		Kim, JB (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea.				DGIST R&D Program of the Ministry of Science, ICT and Future Planning [19-BD-0401]	This study was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (19-BD-0401).	Arico I, 2016, BRAIN INJURY, V30, P159, DOI 10.3109/02699052.2015.1089595; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Billeri L, 2019, BRAIN INJURY, V33, P364, DOI 10.1080/02699052.2018.1553309; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Cavanna AE, 2011, BEHAV NEUROL, V24, P107, DOI [10.3233/BEN-2011-0322, 10.1155/2011/645159]; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Jang SH, 2016, NEURAL REGEN RES, V11, P352, DOI 10.4103/1673-5374.177746; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Leo A, 2016, EXP BRAIN RES, V234, P2189, DOI 10.1007/s00221-016-4622-8; Lin JS, 2000, SLEEP MED REV, V4, P471, DOI 10.1053/smrv.2000.0116; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Paus T, 2000, PROG BRAIN RES, V126, P65; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; TEASDALE G, 1974, LANCET, V2, P81; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	29	8	8	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2019	98	12					1067	1071		10.1097/PHM.0000000000001243			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JO6BR	WOS:000497662300008	31206359				2022-02-06	
J	Kay, AB; Morris, DS; Collingridge, DS; Majercik, S				Kay, Annika B.; Morris, David S.; Collingridge, Dave S.; Majercik, Sarah			Platelet dysfunction on thromboelastogram is associated with severity of blunt traumatic brain injury	AMERICAN JOURNAL OF SURGERY			English	Article								Background: Platelet dysfunction associated with isolated traumatic brain injury (TBI) can be measured using thromboelastography-platelet mapping (TEG-PM). We hypothesized that platelet dysfunction can be detected after blunt TBI, and the degree of dysfunction is associated with increased TBI severity and in-hospital mortality. Methods: This was a retrospective review of adult trauma patients admitted to a single level 1 trauma center from August 2013 to March 2015 who suffered isolated severe blunt TBI. Subjects were included if they received a TEG-PM within 24 h from injury, and excluded if on preinjury antiplatelet medications. Results: 119 subjects were analyzed. Severe TBI subjects (AIS-head 5) had ADPi 18.4 points higher than moderate TBI subjects (AIS-head 3) (p=0.001). Platelet dysfunction was not associated with TBI progression. ADPi significantly predicted mortality (OR 1.033; 95% CI 1.005-1.061, p=0.02). Conclusion: Platelet dysfunction occurs immediately after isolated blunt TBI, is more pronounced with increasing TBI severity, and is associated with higher odds of in-hospital mortality. Further investigation is needed to determine whether this is a marker of disease severity or a therapeutic target. (C) 2019 Elsevier Inc. All rights reserved.	[Kay, Annika B.; Morris, David S.; Majercik, Sarah] Intermt Med Ctr, Div Trauma Serv & Surg Crit Care, 5121 South Cottonwood St, Murray, UT 84157 USA; [Collingridge, Dave S.] Intermt Med Ctr, Off Res, Murray, UT USA		Kay, AB (corresponding author), Intermt Med Ctr, Div Trauma Serv & Surg Crit Care, 5121 South Cottonwood St, Murray, UT 84157 USA.	Annika.kay@imail.org; Dave.morris2@imail.org; Dave.collingridge@imail.org; Sarah.majercik@imail.org	Morris, David Stephen/AAW-1940-2021	Morris, David Stephen/0000-0001-7036-2849				0	8	8	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2019	218	6					1134	1137		10.1016/j.amjsurg.2019.09.024			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JP0VG	WOS:000497991500017	31575420				2022-02-06	
J	Lowry, R; Haarbauer-Krupa, JK; Breiding, MJ; Thigpen, S; Rasberry, CN; Lee, SM				Lowry, Richard; Haarbauer-Krupa, Juliet K.; Breiding, Matthew J.; Thigpen, Sally; Rasberry, Catherine N.; Lee, Sarah M.			Concussion and Academic Impairment Among US High School Students	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; SPORTS; RISK; EPIDEMIOLOGY; PLACEMENT; SYMPTOMS; CHILDREN	Introduction: Sports and physical activities are a frequent cause of traumatic brain injury, primarily concussions, among adolescents. These concussions may adversely affect students' ability to learn and impair academic achievement in educational settings. Methods: The 2017 Youth Risk Behavior Survey, conducted among a nationally representative sample of 14,765 U.S. high school students, was analyzed in 2018 to examine associations between self-reported sports- and physical activity-related concussions and symptoms of cognitive impairment (difficulty concentrating, remembering, or making decisions) and self-reported academic grades (mostly A's=4.0, mostly B's=3.0, mostly C's=2.0, mostly D's=1.0, mostly F's=0.0). Adjusted prevalence ratio and the difference in self-reported estimated grade point average were adjusted for sex, race/ethnicity, grade, and athlete status (participation on sports teams) and considered statistically significant if p<0.05. Results: Male students were more likely than female students (17.1% vs 13.0%), and athletes were more likely than nonathletes (21.4% vs 7.6%) to have a self-reported sports- and physical activity-related concussion in the 12 months preceding the survey. Students with a reported sports- and physical activity-related concussion were more likely than students without one to report symptoms of cognitive impairment regardless of whether they were male (adjusted prevalence ratio=1.49), female (adjusted prevalence ratio=1.37), athletes (adjusted prevalence ratio=1.45), or nonathletes (adjusted prevalence ratio=1.42). Self-reported grade point average decreased significantly from 3.14 among students who reported no concussions (referent), to 3.04 among students who reported a single concussion, and 2.81 among students who reported >= 2 concussions. Conclusions: School-based programs are needed to monitor students' academic performance and provide educational support and resources to promote academic success following a concussion. Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.	[Lowry, Richard; Rasberry, Catherine N.] Ctr Dis Control & Prevent CDC, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Haarbauer-Krupa, Juliet K.; Breiding, Matthew J.] CDC, Traumat Brain Injury Team, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Thigpen, Sally] CDC, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Lee, Sarah M.] CDC, Sch Hlth Branch, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA		Lowry, R (corresponding author), Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, 1600 Clifton Rd NE,Mail Stop E-75, Atlanta, GA 30329 USA.	rlowry@cdc.gov	Rasberry, Catherine/P-1984-2016	Rasberry, Catherine/0000-0001-8256-6961			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Brener ND, MMWR RECOMM REP, V62, P1; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2018, C MAN TRAUM BRAIN IN; CDC, MMWR MORB MORTAL WKL, V46, P224; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Guskiewicz KM, J ATHL TRAIN, V36, P263; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Institute of Medicine & National Research Council, 2014, SPORTS RELATED CONCU; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2846; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; Petersen AC., 1987, J ADOLESCENT RES, V2, P383, DOI DOI 10.1177/074355488724006; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sanchez E, 2011, ACT RES REPORT SERIE; Schootman M, 2000, BRAIN INJURY, V14, P373; Sticca F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187367; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	41	8	8	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	DEC	2019	57	6					733	740		10.1016/j.amepre.2019.08.016			8	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	JN5QQ	WOS:000496953200005	31753255				2022-02-06	
J	Marin, C; Laxe, S; Langdon, C; Alobid, I; Berenguer, J; Fuentes, M; Bernabeu, M; Mullol, J				Marin, Concepcio; Laxe, Sara; Langdon, Cristobal; Alobid, Isam; Berenguer, Joan; Fuentes, Mireya; Bernabeu, Montserrat; Mullol, Joaquim			Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons	MOLECULAR NEUROBIOLOGY			English	Article						Excitotoxicity; Olfaction; Olfactory training; Parkinson's disease; Traumatic brain injury; Dopamine; Neurogenesis	ODOR DETECTION; NORADRENERGIC MODULATION; PARKINSONS-DISEASE; CELL-DEATH; DISCRIMINATION; GLUTAMATE; SMELL; NEURONS; MODEL; MOUSE	Glutamatergic excitotoxicity is involved in pathologies affecting the central nervous system, including traumatic brain injury (TBI) and neurodegenerative diseases, such as Parkinson's disease (PD), in which olfactory dysfunction is an early symptom. Interestingly, our group has recently shown that bilateral administration of the glutamate agonist, N-methyl-d-aspartate (NMDA) in the olfactory bulbs (OBs) induces an olfactory dysfunction 1 week after lesions. Although a wide range of treatments have been attempted, no standard therapy has been established to treat olfactory disorders. Increasing evidence suggests a beneficial effect of olfactory training (OT) in olfactory function. However, the mechanisms underlying OT effects remain unknown. We investigated the effects of OT on the olfactory dysfunction induced by excitotoxicity in bilateral OB NMDA-lesioned animals. We compared OT effects with the ones obtained with neuroprotective therapies (pramipexole and MK801). We studied the underlying mechanisms involved in OT effects investigating the changes in the subventricular zone (SVZ) neurogenesis and in the number of periglomerular dopaminergic interneurons. One week after lesion, NMDA decreased the number of correct trials in the olfactory discrimination tests in the non-trained group (p < 0.01). However, OT performed for 1 week after lesions prevented olfactory dysfunction (p < 0.01). Pramipexole did not prevent olfactory dysfunction, whereas MK801 treatment showed a partial recovery (p < 0.05). An increase in SVZ neurogenesis (p < 0.05) associated with an increase in OB dopaminergic interneurons (p < 0.05) was related to olfactory function prevention induced by OT. The present results suggest a role for dopaminergic OB interneurons underlying the beneficial effects of OT improving olfactory dysfunction in bilaterally OB NMDA-lesioned animals.	[Marin, Concepcio; Langdon, Cristobal; Alobid, Isam; Fuentes, Mireya; Mullol, Joaquim] IDIBAPS, INGENIO, CELLEX, IRCE, Dept 2B,Villarroel 170, Barcelona 08036, Catalonia, Spain; [Marin, Concepcio; Langdon, Cristobal; Alobid, Isam; Fuentes, Mireya; Bernabeu, Montserrat; Mullol, Joaquim] Ctr Biomed Invest Resp Dis CIBERES, Barcelona, Spain; [Laxe, Sara] Univ Autonoma Barcelona, Guttmann Inst Hosp Neurorehabil, Brain Injury Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain; [Berenguer, Joan] Univ Barcelona, Hosp Clin, Neuroradiol Sect, Dept Imaging, Barcelona, Catalonia, Spain		Marin, C; Mullol, J (corresponding author), IDIBAPS, INGENIO, CELLEX, IRCE, Dept 2B,Villarroel 170, Barcelona 08036, Catalonia, Spain.; Marin, C; Mullol, J (corresponding author), Ctr Biomed Invest Resp Dis CIBERES, Barcelona, Spain.; Mullol, J (corresponding author), Univ Barcelona, Hosp Clin, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain.; Mullol, J (corresponding author), Univ Barcelona, Hosp Clin, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain.	cmarin@clinic.cat; jmullol@clinic.cat		Langdon, Cristobal/0000-0003-1540-8095	Fundacio La Marato TV3 [110610]	This work was supported by a research grant (110610) from Fundacio La Marato TV3.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Albrecht S, 2009, CURR MED RES OPIN, V25, P2977, DOI 10.1185/03007990903364954; Alonso SB, 2019, EMBO J, V38, DOI 10.15252/embj.201798791; Altundag A, 2015, LARYNGOSCOPE, V125, P1763, DOI 10.1002/lary.25245; Ardiles Y, 2007, EXP NEUROL, V207, P275, DOI 10.1016/j.expneurol.2007.06.022; Attems J, 2015, GERONTOLOGY, V61, P485, DOI 10.1159/000381619; BAKER H, 1983, J NEUROSCI, V3, P69; Bastien-Dionne PO, 2010, J COMP NEUROL, V518, P1847, DOI 10.1002/cne.22307; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Birte-Antina W, 2018, INT J GERIATR PSYCH, V33, P212, DOI 10.1002/gps.4725; Blomqvist EH, 2003, ACTA OTO-LARYNGOL, V123, P862, DOI 10.1080/00016480310002140; Boesveldt S, 2017, CHEM SENSES, V42, P513, DOI 10.1093/chemse/bjx025; Bonzano S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00189; Bonzano S, 2014, EUR J NEUROSCI, V40, P3450, DOI 10.1111/ejn.12724; Bowman GL, 2017, NEUROLOGY, V89, P1432, DOI 10.1212/WNL.0000000000004383; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Bruce K, 2018, BEHAV PROCESS, V155, P26, DOI 10.1016/j.beproc.2017.07.003; Brushfield AM, 2008, BEHAV NEUROSCI, V122, P54, DOI 10.1037/0735-7044.122.1.54; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Choi JH, 2010, J COMP PATHOL, V142, P147, DOI 10.1016/j.jcpa.2009.10.013; Damm M, 2014, LARYNGOSCOPE, V124, P826, DOI 10.1002/lary.24340; de Miranda AS, 2017, MOL NEUROBIOL, V54, P7063, DOI 10.1007/s12035-016-0226-3; DeLong MR, 2015, JAMA NEUROL, V72, P1354, DOI 10.1001/jamaneurol.2015.2397; Devore S, 2013, BEHAV NEUROSCI, V127, P498, DOI 10.1037/a0033329; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Doty RL, 2018, OTOLARYNG CLIN N AM, V51, P815, DOI 10.1016/j.otc.2018.03.014; Doty RL, 2017, LANCET NEUROL, V16, P478, DOI 10.1016/S1474-4422(17)30123-0; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; DOTY RL, 1989, PSYCHOPHARMACOLOGY, V98, P310, DOI 10.1007/BF00451680; Doty RL, 1998, PSYCHOPHARMACOLOGY, V136, P75, DOI 10.1007/s002130050541; Escanilla O, 2008, PHYSIOL BEHAV, V94, P621, DOI 10.1016/j.physbeh.2008.03.008; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; Fleiner F, 2012, ENT-EAR NOSE THROAT, V91, P198, DOI 10.1177/014556131209100508; Gudziol V, 2010, EUR ARCH OTO-RHINO-L, V267, P239, DOI 10.1007/s00405-009-1076-7; Gudziol V, 2009, ARCH OTOLARYNGOL, V135, P291, DOI 10.1001/archoto.2008.524; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061680; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; He J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10019; Huart C, 2019, J BIOENERG BIOMEMBR, V51, P77, DOI 10.1007/s10863-018-9780-x; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Hummel T, 2018, RHINOLOGY, V56, DOI 10.4193/Rhin17.163; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Jia N, 2016, BIOCHEM BIOPH RES CO, V478, P1376, DOI 10.1016/j.bbrc.2016.08.132; Jiang RS, 2017, AM J RHINOL ALLERGY, V31, P317, DOI 10.2500/ajra.2017.31.4466; Jimenez A, 1999, BRAIN RES, V839, P190, DOI 10.1016/S0006-8993(99)01657-1; KAWANO T, 1982, J NEUROCHEM, V39, P342, DOI 10.1111/j.1471-4159.1982.tb03953.x; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Knudsen K, 2015, ACTA NEUROL SCAND, V132, P395, DOI 10.1111/ane.12406; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Langdon C, 2016, PEDIAT ALLERG IMM-UK, V27, P867, DOI 10.1111/pai.12655; Lauterbach EC, 2010, J NEUROPSYCH CLIN N, V22, P8, DOI 10.1176/appi.neuropsych.22.1.8; Lee JH, 2016, BRAIN STRUCT FUNCT, V221, P3259, DOI 10.1007/s00429-015-1099-3; Lepousez G, 2014, P NATL ACAD SCI USA, V111, P13984, DOI 10.1073/pnas.1404991111; Lethbridge R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035024; Liu HA, 2011, EXP NEUROL, V228, P270, DOI 10.1016/j.expneurol.2011.01.021; LiuY WTP, 2007, J NEUROSCI, V27, P2846, DOI [10.1523/JNEUROSCI.0116-07.2007, DOI 10.1523/JNEUROSCI.0116-07.2007]; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lledo PM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018945; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Marin C, 2019, MOL NEUROBIOL; Marin C, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0796-4; Marin C, 2017, NEUROSCIENCE, V364, P28, DOI 10.1016/j.neuroscience.2017.09.008; Marino-Sanchez FS, 2010, RHINOLOGY, V48, P273, DOI [10.4193/Rhin09.206, 10.4193/Rhino09.206]; Martoncikova M, 2011, ACTA HISTOCHEM, V113, P326, DOI 10.1016/j.acthis.2010.01.002; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Mihalick SM, 2000, J EXP ANAL BEHAV, V73, P305, DOI 10.1901/jeab.2000.73-305; Morlein D, 2013, MEAT SCI, V94, P425, DOI 10.1016/j.meatsci.2013.03.020; Motyl J, 2018, NEUROPHARMACOLOGY, V135, P139, DOI 10.1016/j.neuropharm.2018.02.023; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Oleszkiewicz A, 2018, LARYNGOSCOPE, V128, P1518, DOI 10.1002/lary.26985; Patel DA, 2012, INT J DEV NEUROSCI, V30, P1, DOI 10.1016/j.ijdevneu.2011.11.001; Patel ZM, 2017, CURR OPIN OTOLARYNGO, V25, P43, DOI 10.1097/MOO.0000000000000328; Pavlis M, 2006, PHYSIOL BEHAV, V87, P109, DOI 10.1016/j.physbeh.2005.09.011; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Pekala K, 2016, INT FORUM ALLERGY RH, V6, P299, DOI 10.1002/alr.21669; Philpot BD, 1998, NEUROSCIENCE, V85, P969, DOI 10.1016/S0306-4522(97)00667-2; Pignatelli A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00007; Prichard A, 2015, J EXP ANAL BEHAV, V104, P133, DOI 10.1002/jeab.169; Reichelt D, 2016, CNS NEUROL DISORD-DR, V15, P1325, DOI 10.2174/1871527315666160801145442; Rey NL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.026; Rodrigues LS, 2019, BEHAV PHARMACOL, V30, P343, DOI 10.1097/FBP.0000000000000443; Rosser N, 2008, PHYSIOL BEHAV, V93, P1024, DOI 10.1016/j.physbeh.2008.01.011; Sawada M, 2011, J NEUROSCI, V31, P11587, DOI 10.1523/JNEUROSCI.0614-11.2011; Sohrabji F, 2000, J NEUROBIOL, V45, P61, DOI 10.1002/1097-4695(20001105)45:2<61::AID-NEU1>3.0.CO;2-L; Sorokowska A, 2017, RHINOLOGY, V55, P17, DOI 10.4193/Rhin16.195; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Tatti R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4791; Tillerson JL, 2006, BEHAV BRAIN RES, V172, P97, DOI 10.1016/j.bbr.2006.04.025; Tseng CS, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00005; Wang Z, 2017, J ALZHEIMERS DIS, V56, P415, DOI 10.3233/JAD-160724; Woodward MR, 2017, NEUROL-CLIN PRACT, V7, P5, DOI 10.1212/CPJ.0000000000000293; YOUNGENTOB SL, 1995, BRAIN RES, V670, P82, DOI 10.1016/0006-8993(94)01275-M; Zhang WF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36538-2; Ziemssen T, 2007, PARKINSONISM RELAT D, V13, P323, DOI 10.1016/j.parkreldis.2006.12.014; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	105	8	9	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2019	56	12					8063	8075		10.1007/s12035-019-1639-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JK5CI	WOS:000494860800011	31177483				2022-02-06	
J	Mollayeva, T; Hurst, M; Escobar, M; Colantonio, A				Mollayeva, Tatyana; Hurst, Mackenzie; Escobar, Michael; Colantonio, Angela			Sex-specific incident dementia in patients with central nervous system trauma	ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING			English	Article						Traumatic brain injury; Spinal cord injury; Comorbidity; Risk factors; Dementia; Prognostic modeling		Introduction Despite evidence that central nervous system (CNS) trauma, including traumatic brain injury and spinal cord injury, can cause sustained neurocognitive impairment, it remains unclear whether trauma-related variables are associated with incident dementia independently of other known risk factors. Methods All adults without dementia entering the health-care system with diagnoses of CNS trauma were examined for occurrence of dementia. All trauma-related variables were examined as predictors in sex-specific Cox regression models, controlling for other known risk factors. Results Over a median follow-up of 52 months, 32,834 of 712,708 patients (4.6%) developed dementia. Traumatic brain injury severity and spinal cord injury interacted with age to influence dementia onset; women were at a greater risk of developing dementia earlier than men, all other factors being equal. Discussion Risk stratification of patients with CNS trauma by sex is vital in identifying those most likely to develop dementia and in understanding the course and modifying factors.	[Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada; [Mollayeva, Tatyana; Hurst, Mackenzie; Colantonio, Angela] Univ Hlth Network, Toronto Rehab, Toronto, ON, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Escobar, Michael] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Mollayeva, T (corresponding author), Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Hlth Network, Toronto Rehab, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada.	tatyana.mollayeva@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD089106]; Canadian Institutes for Health Research Grant-Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	This work was supported by the postdoctoral research grant from the Alzheimer's Association (AARF-16-442937) to TM. The authors were also supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R21HD089106 and the Canadian Institutes for Health Research Grant-Institute for Gender and Health (#CGW-126580). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Alladi S, 2018, NEUROLOGY, V91, P264, DOI 10.1212/WNL.0000000000005941; Allen PA, 2002, J GERONTOL B-PSYCHOL, V57, pP173, DOI 10.1093/geronb/57.2.P173; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bombardier CH, 2016, ARCH PHYS MED REHAB, V97, P1628, DOI 10.1016/j.apmr.2016.03.008; Breitner JCS, 2006, J GERIATR PSYCH NEUR, V19, P129, DOI 10.1177/0891988706291081; Budisin B, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000153; Calvo RY, 2016, INJURY, V47, P677, DOI 10.1016/j.injury.2015.10.055; Cedernaes J, 2017, SLEEP MED REV, V31, P102, DOI 10.1016/j.smrv.2016.02.002; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Cook IA, 2007, INT J GERIATR PSYCH, V22, P332, DOI 10.1002/gps.1678; Coronado V.G., CTR DIS CONTROL PREV, P1; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Dichgans M, 2016, ALZHEIMERS DEMENT, V12, P1235, DOI 10.1016/j.jalz.2016.06.004; Elbert T, 2004, NEUROSCIENTIST, V10, P129, DOI 10.1177/1073858403262111; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; Groot C, 2018, NEUROLOGY, V91, pE1851, DOI 10.1212/WNL.0000000000006503; Harrell FE Jr, 2017, REGRESSION MODELING; Hastie T., 2009, MODEL ASSESSMENT SEL, P219; Hladky SB, 2019, HANDB EXP PHARMACOL, V253, P385, DOI 10.1007/164_2017_37; Institute for Clinical Evaluation Sciences, PRIV COD PROT PERS H; James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Khachaturian ZS, 2015, ALZHEIMERS DEMENT, V11, P1261, DOI 10.1016/j.jalz.2015.10.002; Killin LOJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0342-y; Larsson SC, 2018, J ALZHEIMERS DIS, V66, P579, DOI 10.3233/JAD-180529; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Li Wei, 2017, Alzheimers Dement (Amst), V6, P196, DOI 10.1016/j.dadm.2017.01.008; Lim MM, 2019, JAMA NEUROL, V76, P114, DOI 10.1001/jamaneurol.2018.3738; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mangin D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3526; Maresova P, 2015, CURR ALZHEIMER RES, V12, P903, DOI 10.2174/156720501209151019111448; Metcalfe J, 2015, PSYCHOL SCI, V26, P1833, DOI 10.1177/0956797615597912; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856, DOI 10.1152/jappl.1980.49.5.856; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017165; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Rulli E, 2018, BRIT J CANCER, V119, P1456, DOI 10.1038/s41416-018-0302-8; Sepulveda E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0878-6; Tan XL, 2019, J NEUROTRAUM, V36, P87, DOI 10.1089/neu.2017.5491; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Vatcheva KP., 2015, EPIDEMIOLOGY SUNNYVA, V6, DOI DOI 10.4172/2161-1165.1000216; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Yang D., 2013, SAS GLOB FORUM; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zhuang ZR, 2019, ACS CHEM NEUROSCI, V10, P649, DOI 10.1021/acschemneuro.8b00482	60	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2352-8729		ALZH DEMENT-DADM	Alzheimers Dement.-Diagn. Assess. Dis. Monit.	DEC	2019	11	1					355	367		10.1016/j.dadm.2019.03.003			13	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VK5MP	WOS:000723892800041	31065582	Green Published, gold			2022-02-06	
J	Weiss, R; He, C; Gise, R; Parsikia, A; Mbekeani, JN				Weiss, Rebecca; He, Catherine; Gise, Ryan; Parsikia, Afshin; Mbekeani, Joyce N.			Patterns of Pediatric Firearm-Related Ocular Trauma in the United States	JAMA OPHTHALMOLOGY			English	Article							EMERGENCY-DEPARTMENT; GUNSHOT WOUNDS; EYE INJURY; CHILDREN; EPIDEMIOLOGY; PREVENTION; IMPAIRMENT; OUTCOMES	This study evaluates the epidemiologic patterns of firearm-related ocular injuries among children and adolescents in the United States, using multiyear demographic, hospitalization, and clinical data reported in the National Trauma Data Bank. Question What is the epidemiologic pattern of firearm-related ocular trauma in the pediatric population in the United States? Findings In this analysis of 1972 firearm-related ocular injuries recorded in the National Trauma Data Bank, almost a quarter of all such injuries between 2008 and 2014 occurred in the pediatric population, mostly among male adolescents 12 to 18 years of age. Although most firearm-related ocular injuries occurred in white patients, male black adolescents were represented disproportionately. Meaning The study findings suggest that pediatric firearm-related ocular injuries may be associated with substantial morbidity and mortality; identifiable risk factors in vision loss among children included race/ethnicity, sex, and age group. Importance Gun violence represents a substantial public health issue, and firearm-related injuries rank second among the causes of injury-related deaths in children aged 0 to 17 years in the United States. Ocular trauma from firearm-related injuries can lead to devastating vision loss, but little is known to date about the specific demographics and characteristics of such injuries in children. Objective To evaluate the epidemiologic pattern of pediatric firearm-related ocular injuries. Design, Setting, and Participants This retrospective analysis used deidentified data from the National Trauma Data Bank, the largest national registry of hospitalized trauma cases in the United States. The firearm-related ocular injuries (n = 1972) of pediatric patients (defined as those younger than 21 years) hospitalized between January 1, 2008, and December 31, 2014, were analyzed. Statistical analyses were conducted from July 15, 2017, to June 15, 2019. Exposure Firearm-related ocular trauma. Main Outcomes and Measures Pediatric patients with firearm-related ocular injuries were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes and external causes of injury codes. Patient demographics (age, sex, and race/ethnicity), type of ocular injury, injury intent, geographic location, length of hospital admission, health insurance status, disposition at discharge, Injury Severity Score (ISS), and Glasgow Coma Scale (GCS) score were collected. Results A total of 8715 firearm-related ocular injuries were identified. Of these injuries, 1972 (22.6%) occurred in pediatric patients, most of whom were male (1678 [85.1%]) and adolescents (1037 [52.6%]), with a mean (SD) age of 15.2 (5) years. Common locations of injury were home (761 [38.6%]) and street (490 [24.8%]). Mean (SD) hospital length of stay was 7.6 (12) days, ISS was 16 (13.1), and GCS score was 11 (5.1). The most common types of firearm-related ocular injuries were open wound of the eyeball (820 [41.6%]) and ocular adnexa (502 [25.5%]), orbital injuries or fractures (591 [30.0%]), and contusion of the eye or adnexa (417 [21.1%]). Patients aged 0 to 3 years had greater odds of unintentional injuries (odds ratio [OR], 4.41; 95% CI, 2.51-7.75; P < .001) and injuries occurring at home (OR, 5.39; 95% CI, 2.81-10.38; P < .001), and those aged 19 to 21 years had greater odds of assault injuries (OR, 2.17; 95% CI, 1.77-2.66; P < .001) and injuries occurring on the street (OR, 1.61; 95% CI, 1.3-1.98; P < .001). Black patients had the greatest odds of having injuries with assault intention (OR, 4.53; 95% CI, 3.68-5.59; P < .001), and white patients had the greatest likelihood for self-inflicted injury (OR, 7.1; 95% CI, 5.92-9.51; P < .001). Traumatic brain injury resulted mostly from self-inflicted trauma (OR, 5.99; 95% CI, 4.16-8.63; P < .001), as did visual pathway injuries (OR, 2.86; 95% CI, 1.95-4.20; P < .001). The inpatient mortality rate was 12.2%. Conclusions and Relevance This study found that pediatric firearm-related ocular injuries from 2008 through 2014 were predominantly sight-threatening and associated with traumatic brain injury. If the possible risk factors, including sex, age, race/ethnicity, and injury intention, can be confirmed for 2015 through 2019, these findings may be useful in developing strategies to prevent pediatric firearm-related ocular injuries.	[Weiss, Rebecca; Mbekeani, Joyce N.] Montefiore Med Ctr, Dept Ophthalmol & Visual Sci, 111 E 210th St, Bronx, NY 10467 USA; [Weiss, Rebecca; He, Catherine; Mbekeani, Joyce N.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Gise, Ryan] Massachusetts Eye & Ear Infirm, Neuroophthalmol Serv, Boston, MA 02114 USA; [Parsikia, Afshin] Jacobi Med Ctr, Dept Surg Trauma, Bronx, NY USA; [Mbekeani, Joyce N.] Jacobi Med Ctr, Dept Surg Ophthalmol, 1400 Pelham Pkwy, Bronx, NY 10461 USA		Mbekeani, JN (corresponding author), Jacobi Med Ctr, Dept Surg Ophthalmol, 1400 Pelham Pkwy, Bronx, NY 10461 USA.	jnanjinga888@gmail.com					American College of Surgeons, NTDB; Bachier-Rodriguez M, 2017, AM J SURG, V213, P785, DOI 10.1016/j.amjsurg.2016.10.004; Barmparas G, 2017, INT J SURG, V43, P137, DOI 10.1016/j.ijsu.2017.05.068; Barmparas G, 2010, J PEDIATR SURG, V45, P1404, DOI 10.1016/j.jpedsurg.2009.09.017; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Blinder A, 2018, NY TIMES; Bratton SL, 1997, PEDIATRICS, V100, P609, DOI 10.1542/peds.100.4.609; Carter PM, 2017, ACAD EMERG MED, V24, P803, DOI 10.1111/acem.13200; Carter PM, 2013, PEDIATRICS, V132, P213, DOI 10.1542/peds.2013-0163; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, WELC WISQARS; Chadha RK, 2011, BRIT J OPHTHALMOL, V95, P642, DOI 10.1136/bjo.2010.182386; ChildStats.gov, 2018, AM CHILDR BRIEF KEY; Crutcher CL, 2016, J RACIAL ETHN HEALTH, V3, P687, DOI 10.1007/s40615-015-0187-7; Cutler GJ, 2015, PEDIATRICS, V136, P28, DOI 10.1542/peds.2014-3573; Davis JS, 2013, J SURG RES, V184, P556, DOI 10.1016/j.jss.2012.12.047; DiScala C, 2004, PEDIATRICS, V113, P1306, DOI 10.1542/peds.113.5.1306; Fantus RJ, 2017, B AM COLL SURG; Fleischhauer JC, 1999, ARCH OPHTHALMOL-CHIC, V117, P1437; Fowler KA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3486; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hagan JF, 2017, BRIGHT FUTURES GUIDE, V4th; Hardin AP, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2151; Harrison J, 1997, ICD CODING FIREARM I; Hemenway D, 2013, NEW ENGL J MED, V368, P2033, DOI 10.1056/NEJMsb1302631; Keil S, 2017, ARCH DIS CHILD, V102, P566, DOI 10.1136/archdischild-2016-311775; Kliewer W, 1998, J CONSULT CLIN PSYCH, V66, P199, DOI 10.1037/0022-006X.66.1.199; Kuhn F, 2006, OPHTHAL EPIDEMIOL, V13, P209, DOI 10.1080/09286580600665886; Lee R, 2015, J AAPOS, V19, P163, DOI 10.1016/j.jaapos.2015.01.010; Leventhal JM, 2014, PEDIATRICS, V133, P219, DOI 10.1542/peds.2013-1809; Listman DA, 2004, PEDIATRICS, V113, pE15, DOI 10.1542/peds.113.1.e15; Mair JS, 2003, ANNU REV PUBL HEALTH, V24, P209, DOI 10.1146/annurev.publhealth.24.100901.140826; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P662, DOI 10.1001/archopht.123.5.662; Miller KN, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3083; National Trauma Data Bank, 2018, NTDB RES DAT SET US; Oyetunji TA, 2014, AM SURGEON, V80, P366; Roberts M, 2006, AHRQ PUBLICATION, V06-0004; Scribano PV, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.4.e5; SHARIF K W, 1990, Eye (London), V4, P855; Singman E., 2013, MED INSTRUM, DOI [10.7243/2052-6962-1-3, DOI 10.7243/2052-6962-1-3]; Smedley B, 2002, COMMITTEE UNDERSTAND; Stone ME, 2016, J TRAUMA ACUTE CARE, V80, P604, DOI 10.1097/TA.0000000000000976; US Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, 2003, GUID IND FDA STAFF P	44	8	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	DEC	2019	137	12					1363	1370		10.1001/jamaophthalmol.2019.3562			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	JZ6BQ	WOS:000505186800005	31600369	Bronze, Green Published			2022-02-06	
J	Zhang, G; Guo, TF; Guo, X; Tang, S; Fleming, M; Liu, WK				Zhang, Gang; Guo, Tian Fu; Guo, Xu; Tang, Shan; Fleming, Mark; Liu, Wing Kam			Fracture in tension-compression-asymmetry solids via phase field modeling	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Nonlinear elastic materials; Fracture; Phase field; Tension-compression asymmetry; Soft tissue	TRAUMATIC BRAIN-INJURY; MECHANICAL CHARACTERIZATION; VARIATIONAL-PRINCIPLES; BRITTLE-FRACTURE; PART I; TISSUE; ALGORITHM; PHYSICS	Many nonlinear elastic materials exhibit an asymmetric response when loaded in tension versus compression. In this paper, we study the fracture of such nonlinearly elastic materials with tension-compression asymmetry by virtue of phase field modeling. An additive decomposition of strain energy is utilized and extended to account for the modulus difference between tension and compression. This strain energy decomposition is demonstrated for both a neo-Hookean model and an Odgen model. The decomposition is proven to be consistent with the basic requirements of thermodynamics and is important for fracture modeling under the stress states with both compression and tension. The implementation of the phase field model with both decomposed energy of neo-Hookean and Odgen model is given. The implemented model is capable of capturing the tension-compression asymmetry of nonlinear elastic solids. It also can model crack initiation and propagation efficiently especially when the material undergoes both tension and compression, demonstrated through several typical specimens with pre-set crack. The stress fields around the crack tip break the classical law of singularity for the elastic solids with tension- compression symmetry (sigma proportional to r(-0.5)), which is greatly influenced by the ratio of tensile modulus to compressive modulus. The hardening of the material can delay the fracture with more diffusive fracture process zone, demonstrated by the modified Odgen model. The proposed approach shows a great potential to predict the damage behavior of the materials with tension-compression asymmetry at finite strain. (C) 2019 Elsevier B.V. All rights reserved.	[Zhang, Gang] Wuhan Inst Technol, Sch Mech & Elect Engn, Wuhan 430200, Hubei, Peoples R China; [Guo, Tian Fu] ASTAR, Inst High Performance Comp, Singapore 138632, Singapore; [Guo, Xu; Tang, Shan] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dept Engn Mech, Dalian 116023, Peoples R China; [Guo, Xu; Tang, Shan] Dalian Univ Technol, Int Res Ctr Computat Mech, Dalian, Peoples R China; [Fleming, Mark; Liu, Wing Kam] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA		Guo, X; Tang, S (corresponding author), Dalian Univ Technol, Dept Engn Mech, Dalian, Peoples R China.	guoxu@dlut.edu.cn; shantang@dlut.edu.cn	Guo, Tianfu/B-3653-2012	Guo, Tianfu/0000-0003-2828-3631	NSF of ChinaNational Natural Science Foundation of China (NSFC) [11732004, 11821202]; Program for Changjiang Scholars, Innovative Research Team in University (PCSIRT)Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)	S.T. appreciates the support from NSF of China (Project No. 11872139). X.G. Thanks the support from NSF of China (11732004, 11821202), and Program for Changjiang Scholars, Innovative Research Team in University (PCSIRT).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Ambartsumyan S., 1965, IZV AKAD NAUK SSSR M, V4, P77; Ambartsumyan S. A., 1966, MECH SOLIDS+, V1, P29; Ambartsumyan S.A., 1986, ELASTICITY THEORY DI; Amor H, 2009, J MECH PHYS SOLIDS, V57, P1209, DOI 10.1016/j.jmps.2009.04.011; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Borden MJ, 2012, COMPUT METHOD APPL M, V217, P77, DOI 10.1016/j.cma.2012.01.008; Bourdin B, 2011, INT J FRACTURE, V168, P133, DOI 10.1007/s10704-010-9562-x; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Du ZL, 2016, INT J SOLIDS STRUCT, V100, P54, DOI 10.1016/j.ijsolstr.2016.07.009; Du ZL, 2014, J MECH PHYS SOLIDS, V73, P183, DOI 10.1016/j.jmps.2014.08.006; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Francfort GA, 1998, J MECH PHYS SOLIDS, V46, P1319, DOI 10.1016/S0022-5096(98)00034-9; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hocine NA, 2002, INT J FRACTURE, V117, P1, DOI 10.1023/A:1020967429222; Hofacker M, 2013, INT J NUMER METH ENG, V93, P276, DOI 10.1002/nme.4387; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Larsen C. J., 2010, MODELS DYNAMIC FRACT, P131; Larsen CJ, 2010, MATH MOD METH APPL S, V20, P1021, DOI 10.1142/S0218202510004520; Li Y, 2016, J MECH PHYS SOLIDS, V88, P204, DOI 10.1016/j.jmps.2015.12.007; Miehe C, 2004, J MECH PHYS SOLIDS, V52, P2617, DOI 10.1016/j.jmps.2004.03.011; Miehe C, 2010, INT J NUMER METH ENG, V83, P1273, DOI 10.1002/nme.2861; Miehe C, 2015, COMPUT METHOD APPL M, V294, P449, DOI 10.1016/j.cma.2014.11.016; Miehe C, 2014, J MECH PHYS SOLIDS, V65, P93, DOI 10.1016/j.jmps.2013.06.007; Miehe C, 2010, COMPUT METHOD APPL M, V199, P2765, DOI 10.1016/j.cma.2010.04.011; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Rosati L, 2004, INT J NUMER METH ENG, V60, P461, DOI 10.1002/nme.970; Tang S, 2019, COMPUT METHOD APPL M, V347, P477, DOI 10.1016/j.cma.2018.12.035; Tang S, 2015, COMPUT MECH, V56, P63, DOI 10.1007/s00466-015-1155-0; Tang S, 2012, J MECH PHYS SOLIDS, V60, P199, DOI 10.1016/j.jmps.2011.11.003; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	39	8	8	7	21	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	DEC 1	2019	357								112573	10.1016/j.cma.2019.112573			18	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematics; Mechanics	JE1BJ	WOS:000490427600022					2022-02-06	
J	Lace, JW; Grant, AF; Ruppert, P; Kaufman, DAS; Teague, CL; Lowell, K; Gfeller, JD				Lace, John W.; Grant, Alex F.; Ruppert, Phillip; Kaufman, David A. S.; Teague, Carson L.; Lowell, Kimberly; Gfeller, Jeffrey D.			Detecting noncredible performance with the neuropsychological assessment battery, screening module: A simulation study	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; embedded validity test; neuropsychological assessment battery; mild traumatic brain injury; simulation study	TRAUMATIC BRAIN-INJURY; EMBEDDED VALIDITY INDEXES; ADULT INTELLIGENCE SCALE; MEMORY MALINGERING TOMM; CARD SORTING TEST; REPEATABLE BATTERY; DIGIT SPAN; STRUCTURED INVENTORY; SAMPLE; VETERANS	Objective: While the Neuropsychological Assessment Battery, Screening Module (S-NAB) is a commonly used cognitive screening measure, no composite embedded performance validity test (PVT) formula has yet been described within it. This study sought to empirically derive PVT formulas within the S-NAB using an analog simulation paradigm. Method: Seventy-two university students (M age = 18.92) were randomly assigned to either an Asymptomatic (AS) or simulated mild traumatic brain injury (S-mTBI) group and were administered a neuropsychological test battery that included the S-NAB and standalone and embedded PVTs. The AS group was instructed to perform optimally, and the S-mTBI group received symptom and test coaching to help simulate mTBI-related impairment. Both groups received warnings regarding the presence of PVTs throughout the test battery. Results: Groups showed significant differences (all ps < .001) on all S-NAB domain scores and PVTs. In the S-NAB, the Attention (S-ATT) and Executive Function (S-EXE) domains showed the largest effect sizes (Cohen's ds = 2.02 and 1.79, respectively). Seven raw scores from S-ATT and S-EXE subtests were entered as predictor variables in a direct logistic regression (LR). The model accurately classified 90.3% of cases. Two PVT formulas were described: (1) an exponentiated equation from LR results and (2) an arithmetic formula using four individually meaningful variables. Both formulas demonstrated outstanding discriminability between groups (AUCs = .96-.97) and yielded good classification statistics compared to other PVTs. Conclusions: This study is the first to describe composite, embedded PVT formulas within the S-NAB. Implications, limitations, and appropriate future directions of inquiry are discussed.	[Lace, John W.; Grant, Alex F.; Kaufman, David A. S.; Teague, Carson L.; Lowell, Kimberly; Gfeller, Jeffrey D.] St Louis Univ, Dept Psychol, 3700 Lindell Blvd, St Louis, MO 63108 USA; [Ruppert, Phillip] St Louis Univ, Dept Psychiat & Behav Neurosci, St Louis, MO 63108 USA		Lace, JW (corresponding author), St Louis Univ, Dept Psychol, 3700 Lindell Blvd, St Louis, MO 63108 USA.	john.lace@slu.edu	Lace, John/AAF-7063-2020	Lace, John/0000-0003-3628-0334			American Academy of Clinical Neuropsychology Consensus Conference, 2018, ANN M AM AC CLIN NEU; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bain KM, 2019, ASSESSMENT, V26, P1320, DOI 10.1177/1073191117725172; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; BOONE KB, 2007, ASSESSMENT MALINGERE, P27; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Cool D, 2016, THESIS; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Crighton AH, 2015, ARCH CLIN NEUROPSYCH, V30, P181, DOI 10.1093/arclin/acv002; Dandachi-FitzGerald B, 2013, J EXP PSYCHOPATHOL, V4, P46, DOI 10.5127/jep.025511; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Delacre M, 2017, INT REV SOC PSYCHOL, V30, P92, DOI 10.5334/irsp.82; Donders J, 2012, ARCH CLIN NEUROPSYCH, V27, P440, DOI 10.1093/arclin/acs043; Emmert N, 2018, APPL NEUROPSYCH-ADUL, V25, P38, DOI 10.1080/23279095.2016.1238827; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fischer-Baum S, 2016, NEUROPSYCHOLOGY, V30, P791, DOI 10.1037/neu0000286; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Goette WF, 2019, CLIN NEUROPSYCHOL, V33, P1044, DOI 10.1080/13854046.2018.1538429; Grant Aaron, 2018, THESIS; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Hacker D, 2017, ARCH CLIN NEUROPSYCH, V32, P215, DOI 10.1093/arclin/acw087; Hamzah N, 2021, APPL NEUROPSYCH-ADUL, V28, P416, DOI 10.1080/23279095.2019.1648264; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jelicic M, 2006, J PSYCHOPATHOL BEHAV, V28, P19, DOI 10.1007/s10862-006-4535-0; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P14; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lenhard W, 2016, COMPUTATION EFFECT S; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lippa SM, 2017, APPL NEUROPSYCH-ADUL, V24, P73, DOI 10.1080/23279095.2015.1100617; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; McCrea M., 2008, MILD TRAUMATIC BRAIN; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mohler S., 2019, ANN C INT NEUR SOC N; Mueller K, 2015, ARCH CLIN NEUROPSYCH, V30, P588; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Novitski J, 2012, ARCH CLIN NEUROPSYCH, V27, P190, DOI 10.1093/arclin/acr119; Parks A, 2015, THESIS; Paulson D, 2015, ARCH CLIN NEUROPSYCH, V30, P207, DOI 10.1093/arclin/acv009; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Pearson, 2009, ADV CLIN SOLUTIONS W; Porteus S. D, 1959, MAZE TEST CLIN PSYCH; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Randolph C., 1998, RBANS MANUAL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Riordan P, 2020, APPL NEUROPSYCH-ADUL, V27, P82, DOI 10.1080/23279095.2018.1485678; Rogers R., 2008, CLIN ASSESSMENT MALI; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P802; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schwarz LR, 2006, CLIN NEUROPSYCHOL, V20, P741, DOI 10.1080/13854040590967054; Sekely A, 2018, PSYCHOL INJ LAW, V11, P233, DOI 10.1007/s12207-018-9329-7; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Shum D, 2000, BRAIN COGNITION, V44, P59; Shura RD, 2018, NEUROPSYCHOL REV, V28, P269, DOI 10.1007/s11065-018-9377-5; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Steyerberg E. W., 2009, CLIN PREDICTION MODE, DOI [10.1007/978-0-387-77244-8, 10. 1007/978-0-387-77244-8., DOI 10.1007/978-0-387-77244-8]; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Victor T. L., 2012, MILD TRAUMATIC BRAIN; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Wardin L., 2014, THESIS; White T, 2003, NEUROPSYCHOLOGICAL A; Whiteside DM, 2019, APPL NEUROPSYCH-ADUL, V26, P472, DOI 10.1080/23279095.2018.1443935; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Williams KD, 2020, APPL NEUROPSYCH-ADUL, V27, P181, DOI 10.1080/23279095.2018.1517768; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	114	8	8	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAR 20	2021	35	3					572	596		10.1080/13854046.2019.1694703		NOV 2019	25	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	RD0SE	WOS:000500098100001	31790343				2022-02-06	
J	Olla, P; Rykulski, N; Hurtubise, JL; Bartol, S; Foote, R; Cutler, L; Abeare, K; McVinnie, N; Sabelli, AG; Hastings, M; Erdodi, LA				Olla, Phillip; Rykulski, Nicholas; Hurtubise, Jessica L.; Bartol, Stephen; Foote, Rachel; Cutler, Laura; Abeare, Kaitlyn; McVinnie, Nora; Sabelli, Alana G.; Hastings, Maurissa; Erdodi, Laszlo A.			Short-term effects of cannabis consumption on cognitive performance in medical cannabis patients	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Cannabis; cognitive functioning; performance validity; repeated testing	INTELLIGENCE SCALE-4TH EDITION; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; DIGIT SPAN; OFFICIAL POSITION; DOUBLE-BLIND; CLINICAL NEUROPSYCHOLOGY; PROCESSING SPEED; AMERICAN ACADEMY	This observational study examined the acute cognitive effects of cannabis. We hypothesized that cognitive performance would be negatively affected by acute cannabis intoxication. Twenty-two medical cannabis patients from Southwestern Ontario completed the study. The majority (n = 13) were male. Mean age was 36.0 years, and mean level of education was 13.7 years. Participants were administered the same brief neurocognitive battery three times during a six-hour period: at baseline ("Baseline"), once after they consumed a 20% THC cannabis product ("THC"), and once again several hours later ("Recovery"). The average self-reported level of cannabis intoxication prior to the second assessment (i.e., during THC) was 5.1 out of 10. Contrary to expectations, performance on neuropsychological tests remained stable or even improved during the acute intoxication stage (THC; d: .49-.65, medium effect), and continued to increase during Recovery (d: .45-.77, medium-large effect). Interestingly, the failure rate on performance validity indicators increased during THC. Contrary to our hypothesis, there was no psychometric evidence for a decline in cognitive ability following THC intoxication. There are several possible explanations for this finding but, in the absence of a control group, no definitive conclusion can be reached at this time.	[Olla, Phillip; Foote, Rachel] Audacia Biosci, Windsor, ON, Canada; [Rykulski, Nicholas] Michigan State Univ, Coll Human Med, Lansing, MI USA; [Hurtubise, Jessica L.; Cutler, Laura; Abeare, Kaitlyn; Sabelli, Alana G.; Hastings, Maurissa; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Bartol, Stephen] Wayne State Univ, Sch Med, Detroit, MI USA; [McVinnie, Nora] Univ Windsor, Brain Cognit Neurosci Program, Windsor, ON, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com	Cutler, Laura/AAI-6283-2021	Cutler, Laura/0000-0003-2957-8693; Bartol, Stephen/0000-0001-6896-9043			Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Becke M, 2019, J CLIN EXP NEUROPSYC, V41, P786, DOI 10.1080/13803395.2019.1621268; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Colizzi M, 2018, NEUROSCI BIOBEHAV R, V93, P1, DOI 10.1016/j.neubiorev.2018.07.014; Colizzi Marco, 1800, Curr Addict Rep, V4, P62, DOI 10.1007/s40429-017-0142-2; Conners, 2004, CONNERS CONTINUOUS P; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desrosiers NA, 2015, J ANAL TOXICOL, V39, P251, DOI 10.1093/jat/bkv012; Di Marzo V., 2001, J CANNABIS THERAPEUT, V1, P43, DOI [10.1300/J175v01n01_04, DOI 10.1300/J175V01N01_04]; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Englund A, 2016, J PSYCHOPHARMACOL, V30, P140, DOI 10.1177/0269881115615104; Englund A, 2013, J PSYCHOPHARMACOL, V27, P19, DOI 10.1177/0269881112460109; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L., 2019, PSYCHOL NEUROSCI; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Erdodi LA, 2010, J ATTEN DISORD, V14, P43, DOI 10.1177/1087054709347199; Fischer AS, 2014, SCHIZOPHR RES, V158, P176, DOI 10.1016/j.schres.2014.04.033; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hall W, 2018, DRUG ALCOHOL REV, V37, P3, DOI 10.1111/dar.12651; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Hindocha C, 2015, EUR NEUROPSYCHOPHARM, V25, P325, DOI 10.1016/j.euroneuro.2014.11.014; Honarmand K, 2011, NEUROLOGY, V76, P1153, DOI 10.1212/WNL.0b013e318212ab0c; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Kalfon TBO, 2016, J PSYCHOSOM RES, V87, P30, DOI 10.1016/j.jpsychores.2016.06.004; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lynch SG, 2010, CLIN NEUROPSYCHOL, V24, P963, DOI 10.1080/13854046.2010.502128; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; MCCAFFREY RJ, 1993, ARCH CLIN NEUROPSYCH, V8, P519; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Merten T, 2013, PSYCHOL INJ LAW, V6, P122, DOI 10.1007/s12207-013-9155-x; MILLS L, 1972, AGENTS ACTIONS, V2, P201, DOI 10.1007/BF02087044; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Roser P, 2008, EUR NEUROPSYCHOPHARM, V18, P569, DOI 10.1016/j.euroneuro.2008.04.008; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schoedel KA, 2011, HUM PSYCHOPHARM CLIN, V26, P224, DOI 10.1002/hup.1196; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P1373, DOI 10.1080/13854046.2019.1619839; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schuster RM, 2016, NEUROPSYCHOLOGY, V30, P405, DOI 10.1037/neu0000281; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; SPREEN O, 1965, J NERV MENT DIS, V140, P323, DOI 10.1097/00005053-196505000-00002; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Theisen ME, 1998, ASSESSMENT, V5, P85, DOI 10.1177/107319119800500110; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; van Helvoort D, 2019, CLIN NEUROPSYCHOL, V33, P1069, DOI 10.1080/13854046.2018.1559359; Wade DT, 2003, CLIN REHABIL, V17, P21, DOI 10.1191/0269215503cr581oa; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler, 1997, WECHSLER ADULT INTEL; Winton-Brown TT, 2011, NEUROPSYCHOPHARMACOL, V36, P1340, DOI 10.1038/npp.2011.17; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	104	8	8	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2021	28	6					647	657		10.1080/23279095.2019.1681424		NOV 2019	11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WC3NK	WOS:000500094400001	31790276				2022-02-06	
J	Steinman, J; Cahill, LS; Koletar, MM; Stefanovic, B; Sled, JG				Steinman, Joe; Cahill, Lindsay S.; Koletar, Margaret M.; Stefanovic, Bojana; Sled, John G.			Acute and chronic stage adaptations of vascular architecture and cerebral blood flow in a mouse model of TBI	NEUROIMAGE			English	Article						Cerebral blood flow; MRI; Serial two-photon tomography; Traumatic brain injury; Vasculature	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION; RESPONSES; MICROCIRCULATION; ANGIOGENESIS; PRINCIPLE; PERICYTES; PERFUSION; RECOVERY	The 3D organization of cerebral blood vessels determines the overall capacity of the cerebral circulation to meet the metabolic requirements of the brain. Imaging methodologies which combine 3D microvascular structural imaging with blood flow quantification can shed light on the relationship between vascular structure and function, in health and disease. This study applies Arterial Spin Labeling (ASL) MRI with a hypercapnic challenge and ex vivo Serial Two-Photon Tomography (STPT) to examine the relationship between blood flow and vascular architecture following traumatic brain injury (TBI) in a mouse. Mice were exposed to a controlled cortical impact TBI and allowed to recover for either 1 day or 4 weeks. At each time point, ASL MRI was performed to quantify cerebral perfusion and the brain vasculature was imaged in 3D with STPT. Registration of ASL to STPT enabled flow changes to be related to the underlying microvascular structure in each ASL voxel. Hypoperfusion under rest and hypercapnia was observed both 1 day and 4 weeks post-TBI. Vessel density and vascular volume were reduced 1 day post-TBI, recovering by 4 weeks; however, the reorganized vasculature at the latter time point possessed an abnormal radial pattern. Our findings demonstrate functionally significant long-term changes in the vascular architecture following injury and illustrate why metrics beyond traditional measures of vessel density are required to understand the impact of vascular structure on function.	[Steinman, Joe; Cahill, Lindsay S.; Sled, John G.] Hosp Sick Children, Mouse Imaging Ctr, 25 Orde St, Toronto, ON M5T 3HT, Canada; [Steinman, Joe; Stefanovic, Bojana; Sled, John G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Koletar, Margaret M.; Stefanovic, Bojana] Sunnybrook Res Inst, Toronto, ON, Canada		Steinman, J (corresponding author), Hosp Sick Children, Mouse Imaging Ctr, 25 Orde St, Toronto, ON M5T 3HT, Canada.	joe.steinman@mail.utoronto.ca	Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Steinman, Joe/0000-0002-1354-4221	Canadian Institutes of Health Research GrantCanadian Institutes of Health Research (CIHR) [FRN -152961]	This work was supported by the Canadian Institutes of Health Research Grant FRN -152961.	Amato SP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00031; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Cahill LS, 2017, J CEREBR BLOOD F MET, V37, P994, DOI 10.1177/0271678X16649194; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Chugh BP, 2012, MAGN RESON MED, V68, P98, DOI 10.1002/mrm.23209; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dazai Jun, 2011, J Vis Exp, DOI 10.3791/2497; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dorr A, 2017, J CEREBR BLOOD F MET, V37, P1046, DOI 10.1177/0271678X16669514; Engelhard K., 2009, ACP-APPL CARDIOPUL P, V13, P157; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Fry BC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.50; GOBEL U, 1989, J CEREBR BLOOD F MET, V9, P491, DOI 10.1038/jcbfm.1989.72; Han HC, 2012, J VASC RES, V49, P185, DOI 10.1159/000335123; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Holmes HE, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00020; Hutchinson EB, 2006, NEUROIMAGE, V32, P520, DOI 10.1016/j.neuroimage.2006.03.033; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; KRASZNAI L, 1994, NEUROL RES, V16, P40; Lugo-Hernandez E, 2017, J CEREBR BLOOD F MET, V37, P3355, DOI 10.1177/0271678X17698970; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Noakes TLS, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3802; Nordsletten DA, 2006, AM J PHYSIOL-HEART C, V291, pH296, DOI 10.1152/ajpheart.00814.2005; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/NMETH.1854, 10.1038/nmeth.1854]; Rajajee V, 2012, NEUROSURGERY, V70, P1195, DOI 10.1227/NEU.0b013e3182417dca; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Rennie MY, 2012, AM J PHYSIOL-HEART C, V302, pH1261, DOI 10.1152/ajpheart.00776.2011; Rennie MY, 2011, AM J PHYSIOL-HEART C, V300, pH675, DOI 10.1152/ajpheart.00510.2010; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Steinman J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186676; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Unterberg AW, 1997, ACT NEUR S, V70, P106; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Vogel J, 2004, J CEREBR BLOOD F MET, V24, P849, DOI 10.1097/01.WCB.0000126564.89011.11; Vousden DA, 2015, BRAIN STRUCT FUNCT, V220, P2043, DOI 10.1007/s00429-014-0774-0; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	60	8	8	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 15	2019	202								116101	10.1016/j.neuroimage.2019.116101			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	JG1TX	WOS:000491861000001	31425794	Green Submitted			2022-02-06	
J	Neckel, ND; Dai, HN; Burns, MP				Neckel, Nathan D.; Dai, Haining; Burns, Mark P.			A Novel Multi-Dimensional Analysis of Rodent Gait Reveals the Compensation Strategies Used during Spontaneous Recovery from Spinal Cord and Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						gait analysis; multi-dimensional modeling; spinal cord injury; traumatic brain injury	INTERLIMB COORDINATION; FORELIMB FUNCTION; LOCOMOTION; SPEED; DEFICITS; IMPACT; RATS; MICE	As rodent locomotion becomes a more popular behavioral assay, proper rodent gait analysis becomes more and more important. Gait measures, such as stride length, cycle time, and duty factor, are not independent of one another, making statistical comparisons between groups a tricky endeavor. Instead of identifying the mathematical relationships between a group of locomotor measures, we simply tracked the steps of rodents in x,y,t space. By plotting with respect to the reference limb, we are able to quantify locomotor changes in space, time, and coordination simultaneously. With our technique, we show that the overall locomotion of 77 rats 1 week after a C4/5 right overhemisection injury was significantly different than pre-injury. This difference was maintained in untreated animals for the entire 7 weeks of the study, but how this difference arose changed. Initially, the right forelimb exhibited very abnormal stepping, but eventually reduced its difference from pre-injury levels. Conversely, the left forelimb was initially mildly different from pre-injury, but further deviated from normal stepping as the weeks went on. Our new gait analysis technique helps to show the trade-off between the restoration of function and the spontaneous development of compensatory techniques. When we applied this new analysis technique to 13 mice after a severe controlled cortical impact, we found that their locomotion was no different from 12 sham mice for the entire 4 weeks of the study. We believe that this gait analysis method succinctly addresses the confound of interdependency of gait measures and does so across multiple injury models.	[Neckel, Nathan D.; Dai, Haining; Burns, Mark P.] Georgetown Univ, Dept Neurosci, New Res Bldg,Room EP-04, Washington, DC 20057 USA		Neckel, ND (corresponding author), Georgetown Univ, Dept Neurosci, New Res Bldg,Room EP-04, Washington, DC 20057 USA.	nathan.neckel@georgetown.edu		Burns, Mark P/0000-0003-4750-2000	NIH/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00HD067339]; NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007459]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051656]; NIDRR [H133P100015]	This work has been funded in part by NIH/NCMRR (R00HD067339 PI Neckel), NIH/NICHD (T32HD007459 Bregman), NIH/NINDS (R01NS051656 Bregman), NIDRR (H133P100015 Bregman).	Batka RJ, 2014, ANAT REC, V297, P1839, DOI 10.1002/ar.22955; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Broom L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03336-1; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cline MM, 2017, BRAIN RES, V1657, P140, DOI 10.1016/j.brainres.2016.11.027; Dai H, 2011, RESTOR NEUROL NEUROS, V29, P91, DOI 10.3233/RNN-2011-0583; Dai HN, 2009, J NEUROTRAUM, V26, P1719, DOI [10.1089/neu.2008.0592, 10.1089/neu.2008-0592]; Frigon A, 2014, J NEUROPHYSIOL, V111, P1885, DOI 10.1152/jn.00524.2013; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HRUSKA RE, 1979, LIFE SCI, V25, P181, DOI 10.1016/0024-3205(79)90390-4; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lynskey JV, 2006, J NEUROTRAUM, V23, P617, DOI 10.1089/neu.2006.23.617; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Neckel ND, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0308-0; Neckel ND, 2015, J NEUROSCI METH, V253, P244, DOI 10.1016/j.jneumeth.2015.06.017; Neckel ND, 2013, J NEUROSCI METH, V214, P27, DOI 10.1016/j.jneumeth.2013.01.008; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; TAYLOR CR, 1978, AM ZOOL, V18, P153; Thibaudier Y, 2017, J NEUROTRAUM, V34, P1751, DOI 10.1089/neu.2016.4421; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456	21	8	8	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 1	2020	37	3					517	527		10.1089/neu.2018.5959		NOV 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KE7WH	WOS:000495443800001	30343623	Green Published			2022-02-06	
J	Zvejniece, L; Stelfa, G; Vavers, E; Kupats, E; Kuka, J; Svalbe, B; Zvejniece, B; Albert-Weissenberger, C; Siren, AL; Plesnila, N; Dambrova, M				Zvejniece, Liga; Stelfa, Gundega; Vavers, Edijs; Kupats, Einars; Kuka, Janis; Svalbe, Baiba; Zvejniece, Baiba; Albert-Weissenberger, Christiane; Siren, Anna-Leena; Plesnila, Nikolaus; Dambrova, Maija			Skull Fractures Induce Neuroinflammation and Worsen Outcomes after Closed Head Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						neuroinflammation; skull fracture; traumatic brain injury; weight-drop model	TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; MOUSE MODEL; TISSUE INHIBITOR; DAMAGE; METALLOPROTEINASES; EXPRESSION; MANAGEMENT; DENSITY; BALANCE	The weight-drop model is used widely to replicate closed-head injuries in mice; however, the histopathological and functional outcomes may vary significantly between laboratories. Because skull fractures are reported to occur in this model, we aimed to evaluate whether these breaks may influence the variability of the weight-drop (WD) model. Male Swiss Webster mice underwent WD injury with either a 2 or 5 mm cone tip, and behavior was assessed at 2 h and 24 h thereafter using the neurological severity score. The expression of interleukin (IL)-6, IL-1 beta, tumor necrosis factor-alpha, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 genes was measured at 12 h and 1, 3, and 14 days after injury. Before the injury, micro-computed tomography (micro-CT) was performed to quantify skull thickness at the impact site. With a conventional tip diameter of 2 mm, 33% of mice showed fractures of the parietal bone; the 5 mm tip produced only 10% fractures. Compared with mice without fractures, mice with fractures had a severity-dependent worse functional outcome and a more pronounced upregulation of inflammatory genes in the brain. Older mice were associated with thicker parietal bones and were less prone to skull fractures. In addition, mice that underwent traumatic brain injury (TBI) with skull fracture had macroscopic brain damage because of skull depression. Skull fractures explain a considerable proportion of the variability observed in the WD model in mice-i.e., mice with skull fractures have a much stronger inflammatory response than do mice without fractures. Using older mice with thicker skull bones and an impact cone with a larger diameter reduces the rate of skull fractures and the variability in this very useful closed-head TBI model.	[Zvejniece, Liga; Stelfa, Gundega; Vavers, Edijs; Kupats, Einars; Kuka, Janis; Svalbe, Baiba; Zvejniece, Baiba; Dambrova, Maija] Latvian Inst Organ Synth, Aizkraukles 21, LV-1006 Riga, Latvia; [Stelfa, Gundega] Latvia Univ Life Sci & Technol, Jelgava, Latvia; [Kupats, Einars; Dambrova, Maija] Riga Stradins Univ, Riga, Latvia; [Zvejniece, Baiba] Univ Latvia, Riga, Latvia; [Albert-Weissenberger, Christiane; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, Wurzburg, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, Munich, Germany		Zvejniece, L (corresponding author), Latvian Inst Organ Synth, Aizkraukles 21, LV-1006 Riga, Latvia.	liga@farm.osi.lv	Vavers, Edijs/AAW-5840-2021; Siren, Anna-Leena/AAE-1374-2019	Siren, Anna-Leena/0000-0002-2217-0081; Kupats, Einars/0000-0003-3597-0093; Vavers, Edijs/0000-0003-1322-1307; Kuka, Janis/0000-0002-0411-0229	EU-ERA-NET NEURON project CnsAflame	This study was supported by the framework of the EU-ERA-NET NEURON project CnsAflame.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Berkner J, 2016, METHODS MOL BIOL, V1462, P11, DOI 10.1007/978-1-4939-3816-2_2; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dambrova M, 2010, INT IMMUNOPHARMACOL, V10, P455, DOI 10.1016/j.intimp.2010.01.006; De Guzman E, 2017, CRIT CARE CLIN, V33, P423, DOI 10.1016/j.ccc.2017.03.011; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Garg C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1069-9; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hamel A, 2013, INT J LEGAL MED, V127, P111, DOI 10.1007/s00414-011-0627-9; Hasan I, 2015, ANN ANAT, V199, P52, DOI 10.1016/j.aanat.2014.02.009; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kerr HA, 2013, CLIN SPORT MED, V32, P273, DOI 10.1016/j.csm.2012.12.008; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Lillie EM, 2016, J BONE MINER RES, V31, P299, DOI 10.1002/jbmr.2613; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0364-7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masciantonio MG, 2017, PROG MOL BIOL TRANSL, V147, P101, DOI 10.1016/bs.pmbts.2017.01.001; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; McGrath A., 2019, PEDIAT SKULL FRACTUR; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Monje A, 2014, CLIN ORAL IMPLAN RES, V25, P723, DOI 10.1111/clr.12133; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parsa A, 2015, CLIN ORAL IMPLAN RES, V26, pE1, DOI 10.1111/clr.12315; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rodriguez JA, 2013, J THROMB HAEMOST, V11, P1464, DOI 10.1111/jth.12312; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Salia SM, 2018, WORLD NEUROSURG, V114, pE833, DOI 10.1016/j.wneu.2018.03.095; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Sun MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01089; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164214; Wang XK, 1998, STROKE, V29, P516, DOI 10.1161/01.STR.29.2.516; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	62	8	8	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					295	304		10.1089/neu.2019.6524		NOV 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000495444300001	31441378	Green Published, Green Submitted, hybrid			2022-02-06	
J	Liddle, L; Reinders, R; South, S; Blacker, D; Knuckey, N; Colbourne, F; Meloni, B				Liddle, Lane; Reinders, Ryan; South, Samantha; Blacker, David; Knuckey, Neville; Colbourne, Frederick; Meloni, Bruno			Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POLY-ARGININE R18; ISCHEMIC-STROKE; MOUSE MODEL; NEUROPROTECTION; TRANSFORMATION; INHIBITION; HEMATOMA; RECOVERY; THERAPY	Background Cationic arginine-rich peptides (CARPs) have demonstrated neuroprotective and/or behavioural efficacy in ischemic and hemorrhagic stroke and traumatic brain injury models. Therefore, in this study we investigated the safety and neuroprotective efficacy of the CARPs poly-arginine-18 (R18; 18-mer of arginine) and its D-enantiomer R18D given in the acute bleeding phase in an intracerebral hemorrhage (ICH) model. Methods One hundred and fifty-eight male Sprague-Dawley rats received collagenase-induced ICH. Study 1 examined various doses of R18D (30, 100, 300, or 1000 nmol/kg) or R18 (100, 300, 1000 nmol/kg) administered intravenously 30 minutes post-collagenase injection on hemorrhage volume 24 hours after ICH. Study 2 examined R18D (single intravenous dose) or R18 (single intravenous dose, plus 6 daily intraperitoneal doses) at 300 or 1000 nmol/kg commencing 30 minutes post-collagenase injection on behavioural outcomes (Montoya staircase test, and horizontal ladder test) in the chronic post-ICH period. A histological assessment of tissue loss was assessed using a Nissl stain at 28 days after ICH. Results When administered during ongoing bleeding, neither R18 or R18D exacerbated hematoma volume or worsened functional deficits. Lesion volume assessment at 28 days post-ICH was not reduced by the peptides; however, animals treated with the lower R18D 300 nmol/kg dose, but not with the higher 1000 nmol/kg dose, demonstrated a statistically increased lesion size compared to saline treated animals. Conclusion Overall, both R18 and R18D appeared to be safe when administered during a period of ongoing bleeding following ICH. Neither peptide appears to have any statistically significant effect in reducing lesion volume or improving functional recovery after ICH. Additional studies are required to further assess dose efficacy and safety in pre-clinical ICH studies.	[Liddle, Lane; Reinders, Ryan; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [South, Samantha] Univ Western Australia, Off Res Enterprise, Perth, WA, Australia; [Blacker, David; Knuckey, Neville; Meloni, Bruno] Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia; [Blacker, David; Knuckey, Neville; Meloni, Bruno] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Blacker, David] Sir Charles Gairdner Hosp, Dept Neurol, Nedlands, WA, Australia; [Knuckey, Neville; Meloni, Bruno] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA, Australia; [Colbourne, Frederick] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada		Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Colbourne, F (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082	Canada Research Chair awardNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Branch Out Neurological Foundation	FC is supported by a Canada Research Chair award (http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx).LL is supported by a Branch Out Neurological Foundation award (https://www.branchoutfoundation.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye O, 2011, TRANSL STROKE RES, V2, P17, DOI 10.1007/s12975-010-0037-1; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Ballarin B, 2018, ACTA PHARMACOL SIN, V39, P661, DOI 10.1038/aps.2018.5; Bao HJ, 2016, NEUROSCI LETT, V628, P219, DOI 10.1016/j.neulet.2016.06.046; Beray-Berthat V, 2010, J NEUROSCI METH, V191, P180, DOI 10.1016/j.jneumeth.2010.06.025; Birk AV, 2015, BBA-BIOENERGETICS, V1847, P1075, DOI 10.1016/j.bbabio.2015.06.006; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chiu LS, 2017, TRANSL NEUROSCI, V8, P147, DOI 10.1515/tnsci-2017-0021; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Corbett D, 2017, NEUROREHAB NEURAL RE, V31, P699, DOI 10.1177/1545968317724285; da Silva-Candal A, 2015, J CEREBR BLOOD F MET, V35, P1206, DOI 10.1038/jcbfm.2015.28; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Edwards AB, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0352-0; Guptill JT, 2017, J CLIN PHARMACOL, V57, P770, DOI 10.1002/jcph.853; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Instrum R, 2013, ACTA PHARMACOL SIN, V34, P3, DOI 10.1038/aps.2012.175; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Lei BL, 2012, TRANSL STROKE RES, V3, pS94, DOI 10.1007/s12975-012-0176-7; Li L, 2013, CELL MOL NEUROBIOL, V33, P893, DOI 10.1007/s10571-013-9955-2; Li Q, 2018, FRONT NEUROL, V9; LoPresti MA, 2014, J NEUROL SCI, V345, P3, DOI 10.1016/j.jns.2014.06.057; MacLellan CL, 2004, J CEREBR BLOOD F MET, V24, P432, DOI 10.1097/00004647-200404000-00008; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; Marshall J, 2015, J BIOL CHEM, V290, P22030, DOI 10.1074/jbc.M115.662791; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Michel-Monigadon D, 2010, CEREBROVASC DIS, V29, P564, DOI 10.1159/000306643; Milani D, 2017, NEUROSCI RES, V114, P9, DOI 10.1016/j.neures.2016.09.002; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Moutal A, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00471; Nogueira RG, 2015, J NEUROINTERV SURG, V7, P16, DOI 10.1136/neurintsurg-2013-010743; Paciaroni M, 2008, STROKE, V39, P2249, DOI 10.1161/STROKEAHA.107.510321; Pandey AS, 2014, TRANSL STROKE RES, V5, P313, DOI 10.1007/s12975-014-0344-z; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Righy C, 2016, CURR NEUROPHARMACOL, V14, P392, DOI 10.2174/1570159X14666151230110058; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Sussman ES, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00069; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang ZF, 2019, J CEREBR BLOOD F MET, V39, P1588, DOI 10.1177/0271678X18762637; Wilkinson CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210660; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Zhang J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.08	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224870	10.1371/journal.pone.0224870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	WOS:000532694400076	31697775	Green Published, gold			2022-02-06	
J	Ardila, A				Ardila, Alfredo			Psychiatric disorders associated with acquired brain pathology	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Acquired psychopathy; delusional disorders; mood disorders; neuropsychiatry; psychosis	HEAD-INJURY; RISK-FACTOR; PSYCHOTIC DISORDER; MOOD DISORDERS; SCHIZOPHRENIA; INDIVIDUALS; DEPRESSION; SOMATOPARAPHRENIA; NEUROPSYCHIATRY; ABNORMALITIES	Acquired brain pathology can be associated with diverse psychiatric manifestations. Three major types of psychiatric disorders potentially found in cases of acquired brain pathology are examined: (1) psychosis, (2) mood disorders, and (3) personality disorders with special emphasis in so-called ?acquired psychopathy.? Two types of psychotic manifestations are reviewed: (a) Schizophrenia-like psychosis; (b) Other delusional disorder, specifically, somatoparaphrenia and delusional misidentification syndromes, which include reduplicative paramnesias, Capgras syndrome, Fr?goli syndrome, and ?doubles of the self-syndrome.? Schizophrenia-like psychosis has been reported as sequelae of traumatic brain injury with a prevalence of around 1 to 9%. On the other hand, the other delusional disorders are usually associated with right hemisphere or bilateral lesions. The significance of mood disorders particularly in cases of frontal lobe pathology has been reported, including: depression, bipolar disorder, alcohol abuse, panic disorder, and increased risk of suicide are frequently observed. Personality disorders are frequent in cases of brain pathology, particularly frontal lesions. It is concluded that the analysis of the psychiatric changes associated with acquired brain pathology has not only a clinical importance but also a fundamental interest, advancing the understanding of the neurological bases of major psychiatric conditions.	[Ardila, Alfredo] Florida Int Univ, Dept Commun Sci & Disorders, 11200 SW 8th St,AHC3-431B, Miami, FL 33199 USA		Ardila, A (corresponding author), Florida Int Univ, Dept Commun Sci & Disorders, 11200 SW 8th St,AHC3-431B, Miami, FL 33199 USA.	ardilaa@fiu.edu					Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Almeida OP, 2003, PSYCHOL MED, V33, P675, DOI 10.1017/S003329170300758X; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; [Anonymous], 2018, WHAT IS PSYCH; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Atta Kamil, 2006, Psychiatry (Edgmont), V3, P56; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Broomhall L., 2005, PSYCHIAT PSYCHOL LAW, V12, P367, DOI DOI 10.1375/PPLT.12.2.367; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cummings J, 1985, CLIN NEUROPSYCHIATRY; de Oliveira-Souza R, 2008, NEUROIMAGE, V40, P1202, DOI 10.1016/j.neuroimage.2007.12.054; Deb S, 1999, AM J PSYCHIAT, V156, P374; Devine MJ, 2014, J NEUROL, V261, P600, DOI 10.1007/s00415-014-7242-x; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Feinberg TE, 2005, PSYCHIAT CLIN N AM, V28, P665, DOI 10.1016/j.psc.2005.05.002; FEINBERG TE, 1990, NEUROLOGY, V40, P1391, DOI 10.1212/WNL.40.9.1391; Feinberg TE, 2014, CORTEX, V61, P74, DOI 10.1016/j.cortex.2014.07.004; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Gandola M, 2012, CORTEX, V48, P1165, DOI 10.1016/j.cortex.2011.06.012; HAKIM H, 1988, J NEUROL NEUROSUR PS, V51, P839, DOI 10.1136/jnnp.51.6.839; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; Harris JC, 2017, CURR OPIN PSYCHIATR, V30, P65, DOI 10.1097/YCO.0000000000000318; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Herrick S., 2014, J LAW ENFORCEMENT, V4, P1; Invernizzi P, 2013, BEHAV NEUROL, V26, P139, DOI [10.1155/2013/548467, 10.3233/BEN-2012-110226]; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kumral E, 2004, NEUROLOGY, V62, P110, DOI 10.1212/WNL.62.1.110; LEVINE DN, 1984, NEUROLOGY, V34, P577, DOI 10.1212/WNL.34.5.577; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mitchell DGV, 2006, NEUROCASE, V12, P164, DOI 10.1080/13554790600611288; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Murai T, 1997, NEUROPSY NEUROPSY BE, V10, P190; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petrie A, 2013, PERSONALITY FRONTAL; Rabins P V, 1991, J Neuropsychiatry Clin Neurosci, V3, P6; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Singh A, 2000, STROKE, V31, P637, DOI 10.1161/01.STR.31.3.637; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Weber S, 2008, BEHAV SCI LAW, V26, P7, DOI 10.1002/bsl.802; Witzel JG, 2016, EUR ARCH PSY CLIN N, V266, P533, DOI 10.1007/s00406-015-0620-2; Yang YL, 2008, BEHAV SCI LAW, V26, P65, DOI 10.1002/bsl.788; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0	57	8	8	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2019	26	6					591	597		10.1080/23279095.2018.1463224			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9ER	WOS:000488884700010	30183352				2022-02-06	
J	Alsalaheen, B; Landel, R; Hunter-Giordano, A; Shimamura, KK; Quatman-Yates, C; Hanke, T; Mcculloch, KL				Alsalaheen, Bara; Landel, Rob; Hunter-Giordano, Airelle; Shimamura, Kathryn Kumagai; Quatman-Yates, Catherine; Hanke, Timothy; Mcculloch, Karen L.			A Treatment-Based Profiling Model for Physical Therapy Management of Patients Following a Concussive Event	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						concussion; mTBI; physical therapy; whiplash	LOW-BACK-PAIN; SPORTS-RELATED CONCUSSION; EXTREMITY MUSCULOSKELETAL INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CLASSIFICATION-SYSTEM; VESTIBULAR REHABILITATION; POOR RECOVERY; SYMPTOMS; RELIABILITY	SYNOPSIS: Concussions are a public health concern that affects individuals across the life span. The multifaceted effects of concussion warrant an interdisciplinary management strategy that may include physical therapy. However, physical therapists may feel underprepared for clinical decision making following a concussive event. We propose a new treatment-based profiling model to help physical therapists manage patients following a concussive event. This profiling model, based on symptom type and intensity, disability status, and response to movement, prioritizes treatment emphasis on (1) symptom management, (2) movement system optimization, or (3) performance optimization. We consider contextual factors that modify treatment decision making and present examples of each treatment-based profile.	[Alsalaheen, Bara] Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 East Kearsley St, Flint, MI 48502 USA; [Alsalaheen, Bara] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara] Univ Michigan, Michigan NeuroSport, Michigan Med, Ann Arbor, MI 48109 USA; [Landel, Rob] Univ Southern Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Hunter-Giordano, Airelle] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Shimamura, Kathryn Kumagai] Azusa Pacific Univ, Dept Phys Therapy, Azusa, CA USA; [Quatman-Yates, Catherine] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Columbus, OH 43210 USA; [Quatman-Yates, Catherine] Ohio State Univ, Sports Med Res Inst, Columbus, OH 43210 USA; [Hanke, Timothy] Midwestern Univ, Coll Hlth Sci, Phys Therapy Program, Downers Grove, IL 60515 USA; [Mcculloch, Karen L.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Div Phys Therapy, Chapel Hill, NC 27515 USA		Alsalaheen, B (corresponding author), Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 East Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu	Quatman-Yates, Catherine/AAK-4507-2021				Alrwaily M, 2016, PHYS THER, V96, P1057, DOI 10.2522/ptj.20150345; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; American Physical Therapy Association, 2015, PHYS THER PRACT MOV; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2013, US ICF PRACT MAN US; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bayliss MS, 2003, QUAL LIFE RES, V12, P953, DOI 10.1023/A:1026167214355; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borsting E, 1999, OPTOMETRY VISION SCI, V76, P221, DOI 10.1097/00006324-199904000-00025; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Childs MJD, 2004, J ORTHOP SPORT PHYS, V34, P686, DOI 10.2519/jospt.2004.34.11.686; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; DELITTO A, 1995, PHYS THER, V75, P470, DOI 10.1093/ptj/75.6.470; DELITTO A, 1995, PHYS THER, V75, P488, DOI 10.1093/ptj/75.6.488; Durish CL, 2019, J INT NEUROPSYCH SOC, V25, P346, DOI 10.1017/S1355617718001169; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fersum KV, 2013, EUR J PAIN, V17, P916, DOI 10.1002/j.1532-2149.2012.00252.x; Fritz JM, 2004, J ORTHOP SPORT PHYS, V34, P674; Fritz JM, 2003, SPINE, V28, P1363; Fritz JM, 2007, J ORTHOP SPORT PHYS, V37, P290, DOI 10.2519/jospt.2007.2498; Fritz JM, 2007, PHYS THER, V87, P513, DOI 10.2522/ptj.20060192; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lundblad M, 2017, INT J SPORTS PHYS TH, V12, P286; Maitland G, 2001, MAITLANDS VERTEBRAL; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Patrick DL, 2000, J CLIN EPIDEMIOL, V53, P779, DOI 10.1016/S0895-4356(00)00205-5; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Popovich M, 2018, NEUROLOGY, V91, pS15; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Stratford P., 1995, PHYSIOTHER CAN, V47, P258, DOI DOI 10.3138/PTC.47.4.258; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598	67	8	8	1	6	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					829	841		10.2519/jospt.2019.8869			13	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100008	31610759				2022-02-06	
J	Antoni, A; Schwendenwein, E; Binder, H; Schauperl, M; Datler, P; Hajdu, S				Antoni, Anna; Schwendenwein, Elisabeth; Binder, Harald; Schauperl, Martin; Datler, Philip; Hajdu, Stefan			Delayed Intracranial Hemorrhage in Patients with Head Trauma and Antithrombotic Therapy	JOURNAL OF CLINICAL MEDICINE			English	Article						delayed intracranial hemorrhage; head trauma; traumatic brain injury; antithrombotic therapy	COMPUTED-TOMOGRAPHY; BRAIN-INJURY; ANTICOAGULANT-THERAPY; ANTIPLATELET AGENTS; PREINJURY WARFARIN; BLUNT TRAUMA; CT; MANAGEMENT; RISK; MORTALITY	Background: Delayed intracranial hemorrhage can occur up to several weeks after head trauma and was reported more frequently in patients with antithrombotic therapy. Due to the risk of delayed intracranial hemorrhage, some hospitals follow extensive observation and cranial computed tomography (CT) protocols for patients with head trauma, while others discharge asymptomatic patients after negative CT. Methods: We retrospectively analyzed data on patients with head trauma and antithrombotic therapy without pathologies on their initial CT. During the observation period, we followed a protocol of routine repeat CT before discharge for patients using vitamin K antagonists, clopidogrel or direct oral anticoagulants. Results: 793 patients fulfilled the inclusion criteria. Acetylsalicylic acid (ASA) was the most common antithrombotic therapy (46.4%), followed by vitamin K antagonists (VKA) (32.2%) and Clopidogrel (10.8%). We observed 11 delayed hemorrhages (1.2%) in total. The group of 390 patients receiving routine repeat CT showed nine delayed hemorrhages (2.3%). VKA were used in 6 of these 11 patients. One patient needed an urgent decompressive craniectomy while the other patients were discharged after an extended observation period. The patient requiring surgical intervention due to delayed hemorrhage showed neurological deterioration during the observation period. Conclusions: Routine repeat CT scans without neurological deterioration are not necessary if patients are observed in a clinical setting. Patients using ASA as single antithrombotic therapy do not require in-hospital observation after a negative CT scan.	[Antoni, Anna; Schwendenwein, Elisabeth; Binder, Harald; Schauperl, Martin; Hajdu, Stefan] Med Univ Vienna, Dept Orthoped & Trauma Surg, A-1090 Vienna, Austria; [Datler, Philip] Med Univ Vienna, Dept Anesthesia Intens Care Med & Pain Med, A-1090 Vienna, Austria		Antoni, A (corresponding author), Med Univ Vienna, Dept Orthoped & Trauma Surg, A-1090 Vienna, Austria.	anna.antoni@muv.ac.at; elisabeth.schwendenwein@muv.ac.at; harald.binder@muv.ac.at; martin.schauperl@muv.ac.at; philip.datler@muv.ac.at; stefan.hajdu@muv.ac.at		Binder, Harald/0000-0002-9212-7214			Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bauman ZM, 2017, AM SURGEON, V83, P429; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Hill JH, 2018, BRAIN INJURY, V32, P735, DOI 10.1080/02699052.2018.1441442; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kuczawski M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013742; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mudge AM, 2019, INTERN MED J, V49, P28, DOI 10.1111/imj.14182; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Parra MW, 2013, J NEUROSURG, V119, P760, DOI 10.3171/2013.3.JNS12503; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Scantling D, 2017, EUR J TRAUMA EMERG S, V43, P741, DOI 10.1007/s00068-017-0793-7; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Snedden TR, 2013, J SPEC PEDIATR NURS, V18, P211, DOI 10.1111/jspn.12038; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6	34	8	8	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	NOV	2019	8	11							1780	10.3390/jcm8111780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV3VR	WOS:000502294400023	31731421	Green Published, gold			2022-02-06	
J	Cherian, I; Burhan, H; Dashevskiy, G; Motta, SJH; Parthiban, J; Wang, Y; Tong, H; Torregrossa, F; Grasso, G				Cherian, Iype; Burhan, Hira; Dashevskiy, Gleb; Motta, Shugar Jhamil Hinojosa; Parthiban, Jutty; Wang, Yonghong; Tong, Haibo; Torregrossa, Fabio; Grasso, Giovanni			Cisternostomy: A Timely Intervention in Moderate to Severe Traumatic Brain Injuries: Rationale, Indications, and Prospects	WORLD NEUROSURGERY			English	Article						Cisternostomy; Decompressive hemicraniectomy; Traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; GLYMPHATIC PATHWAY; MECHANISMS	Traumatic brain injury (TBI) represents a major public health concern worldwide, with no significant change in its epidemiology over the last 30 years. After TBI, the primary injury induces irreversible brain damage, which is untreatable. The subsequent secondary injury plays a critical role in the clinical prognosis because without effective treatment it will provide additional tissue damage. The resulting scenario is the rise in intracranial pressure (ICP) with the development of progressive neurological deficits. Current optimal management is based on a progressive, target-driven approach combining both medical and surgical treatment strategies among which is decompressive hemicraniectomy. With the advent of technology, research in the glymphatic pathways, and advances in microscopic surgery, a novel surgical technique-the cisternostomy-has emerged that holds promise in managing rising ICP in TBI-affected patients. In this article we describe the rationale for cisternostomy, an emerging microneurosurgical approach for the management of moderate to severe TBI.	[Cherian, Iype; Burhan, Hira; Dashevskiy, Gleb; Motta, Shugar Jhamil Hinojosa] Nobel Med Coll & Teaching Hosp, Inst Neurosci, Dept Neurosurg, Biratnagar, Nepal; [Parthiban, Jutty] Kovai Med Ctr & Hosp, Dept Neurosurg, Coimbatore, Tamil Nadu, India; [Wang, Yonghong; Tong, Haibo] Shanxi Dayi Hosp, Dept Neurosurg, Taiyuan, Shanxi, Peoples R China; [Torregrossa, Fabio; Grasso, Giovanni] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost, Palermo, Italy		Wang, Y (corresponding author), Shanxi Dayi Hosp, Dept Neurosurg, Taiyuan, Shanxi, Peoples R China.	wyh200533@126.com	Torregrossa, Fabio/AAC-5220-2022; Burhan, Hira/AAI-9712-2020; grasso, giovanni/K-3774-2018	grasso, giovanni/0000-0001-5362-0092			Aaron G, 2014, OTOLARYNG HEAD NECK, V151, P1061, DOI 10.1177/0194599814551122; Abdulqader MN, 2018, J ACUTE DIS, V7, P43, DOI 10.4103/2221-6189.228877; Abode-Iyamah KO, 2018, WORLD NEUROSURG, V118, pE414, DOI 10.1016/j.wneu.2018.06.204; Bothwell SW, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0129-6; Cherian I, 2018, J NEUROSCI RES, V96, P744, DOI 10.1002/jnr.24145; Cherian Iype, 2016, Surg Neurol Int, V7, pS711; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Cherian I, 2016, CHIN J TRAUMATOL, V19, P7, DOI 10.1016/j.cjtee.2016.01.003; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Eide PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25666-4; ELFIKI A, 2019, OPEN J MOD NEUROSURG, V9, P7, DOI DOI 10.4236/ojmn.2019.91002; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Grasso Giovanni, 2016, Bull Emerg Trauma, V4, P119; Grasso G, 2016, J NEUROSCI RES, V94, P825, DOI 10.1002/jnr.23803; Grasso Giovanni, 2016, F1000Res, V5, P911, DOI 10.12688/f1000research.8723.1; Grasso G, 2015, WORLD NEUROSURG, V84, P594, DOI 10.1016/j.wneu.2015.01.043; Hoz SS, 2018, J NEUROSCI RURAL PRA, V9, P650, DOI 10.4103/jnrp.jnrp_92_18; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Masoudi Mohammad Sadegh, 2016, Bull Emerg Trauma, V4, P161; Osborne C, 2014, J NEUROL NEUROSUR PS, V85, DOI 10.1136/jnnp-2014-309236.105; Perez IP, 2019, NEUROCIRUGIA, V30, P77, DOI 10.1016/j.neucir.2018.11.003; Rainey-Smith SR, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0094-x; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Taniguchi D, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0997-9; Taoka T, 2018, MAGN RESON MED SCI, V17, P111, DOI 10.2463/mrms.rev.2017-0116; Zhang DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08959-y	33	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2019	131						385	390		10.1016/j.wneu.2019.07.082			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JG3GV	WOS:000491963300169	31658580				2022-02-06	
J	Daugherty, J; DePadilla, L; Sarmiento, K				Daugherty, Jill; DePadilla, Lara; Sarmiento, Kelly			Effectiveness of the US Centers for Disease Control and Prevention HEADS UP coaches' online training as an educational intervention	HEALTH EDUCATION JOURNAL			English	Article						Concussion; injury prevention; traumatic brain injury; USA; youth sports	TRAUMATIC BRAIN-INJURIES; CONCUSSION; SPORTS; YOUTH; KNOWLEDGE; MANAGEMENT; LAWS	Background: Concussions are common among youth athletes. Responsibility for the recognition and management of concussion is often put on coaches. To equip coaches with appropriate knowledge and skills, the US Centers for Disease Control and Prevention (CDC) launched the HEADS UP: Concussion in Youth Sports online training. Objectives: To determine whether HEADS UP coaches' training improves knowledge, attitudes and behavioural intentions. Methods: Knowledge questions were grouped into scales by level of difficulty. Differences between pre- and post-test scores were calculated based on the Wilcoxon Signed Rank Test Z-score and effect sizes were interpreted. Results: Coaches displayed a high level of knowledge in the pre-test. While lower difficulty questions did not show improvement from pre- to post-test, moderate and high difficulty questions did. Use of the training was associated with improved knowledge about symptom resolution, return-to-play recommendations and under-reporting of incidents of concussion. Coaches demonstrated improvement in five of the seven concussion-related attitude and behavioural intention items post training. Conclusion: HEADS UP training improved coaches' knowledge on select topics and helped them feel more comfortable about responding to concussion among their athletes. This study provides insight into how to better focus future HEADS UP concussion health education efforts to fit coaches' informational needs.	[Daugherty, Jill; DePadilla, Lara; Sarmiento, Kelly] US Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE, Atlanta, GA 30341 USA		Daugherty, J (corresponding author), US Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE, Atlanta, GA 30341 USA.	JDaugherty@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Abernathy T, 2001, CANADIAN HLTH SERVIC; Anderson L. W., 2001, TAXONOMY LEARNING TE; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Centers for Disease Control and Prevention, 2017, WHAT IS CONC; Centers for Disease Control and Prevention, 2019, HEADS YOUTH SPORTS O; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen J., 2013, STAT POWER ANAL BEHA; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Di Iorio CK, 2005, MEASUREMENT HLTH BEH; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; Post E, 2019, J ATHL TRAINING, V54, P177, DOI 10.4085/1062-6050-440-17; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sarmiento K, 2019, J SAFETY RES, V69, P217, DOI 10.1016/j.jsr.2019.01.005; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Stewart C, 2006, J PHYS EDUC RECREAT, V77, P34, DOI 10.1080/07303084.2006.10597861; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	35	8	8	1	22	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0017-8969	1748-8176		HEALTH EDUC J	Health Educ. J.	NOV	2019	78	7					784	797		10.1177/0017896919846185			14	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	IU5RD	WOS:000483644100006	31530957	Green Accepted			2022-02-06	
J	Rebbeck, T; Evans, K; Elliott, JM				Rebbeck, Trudy; Evans, Kerrie; Elliott, James M.			Concussion in Combination With Whiplash-Associated Disorder May Be Missed in Primary Care: Key Recommendations for Assessment and Management	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						mild traumatic brain injury; neck trauma; screening	TRAUMATIC BRAIN-INJURY; CLINICAL-PREDICTION RULE; MODERATE/SEVERE DISABILITY; TRAFFIC COLLISIONS; PROGNOSTIC-FACTORS; POST-CONCUSSION; FULL RECOVERY; TASK-FORCE; SYMPTOMS; PAIN	SYNOPSIS: Whiplash and concussion may have similar presenting symptoms, biomechanical mechanisms, and neurophysiological sequelae, but neither enjoys a gold standard diagnostic test. Guidelines for whiplash and concussion are developed and implemented separately. This disparate process may contribute to misdiagnosis, delay appropriate primary care management, and impair patient outcomes. In our clinical commentary, we present 3 cases where signs and symptoms consistent with whiplash were identified in primary care. Symptoms in all cases included neck pain, headache, dizziness, and concentration deficits, raising suspicion of coexisting postconcussion syndrome. All cases were referred for specialist physical therapy. Characteristics consistent with poor recovery in both whiplash and postconcussion syndrome were confirmed, and multidisciplinary management, drawing from both whiplash and concussion guidelines, was implemented. All patients reported improvement in activities of daily living after tailored management addressing both neck and head injury-related factors, suggesting that these conditions were not mutually exclusive. Self-reported outcomes included reductions in neck disability and postconcussion symptoms of between 20% and 40%. It may be appropriate for whiplash and concussion guidelines to be amalgamated, enhanced, and mutually recognized on a patient-by-patient basis. Primary health care professionals might consider minimum screening to identify postconcussion syndrome in patients following motor vehicle collision by administering questionnaires and assessing cranial nerve function, balance, and cognition. Management should then incorporate principles from both whiplash and concussion guidelines and harmonize with available imaging guidelines for suspected spine and head trauma.	[Rebbeck, Trudy; Evans, Kerrie; Elliott, James M.] Univ Sydney, Fac Hlth Sci, Lidcombe, Australia; [Evans, Kerrie] Healthia Ltd, Bowen Hills, Australia; [Rebbeck, Trudy; Elliott, James M.] Northern Sydney Local Hlth Dist, Royal North Shore Hosp, Kolling Inst Med Res, St Leonards, NSW, Australia		Rebbeck, T (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Physiotherapy, 75 East St, Lidcombe, NSW 2141, Australia.	trudy.rebbeck@sydney.edu.au	Rebbeck, Trudy/AAF-6300-2021	Rebbeck, Trudy/0000-0002-4453-4739; Evans, Kerrie/0000-0002-7592-7850; Elliott, James/0000-0002-8890-6012	Sydney Research Accelerator fellowship, The University of Sydney; National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HD079076-05]	Dr Rebbeck is supported by a Sydney Research Accelerator fellowship, The University of Sydney, and a National Health and Medical Research Council Career Development Fellowship. Dr Elliott is supported by a National Institutes of Health R01 award (5R01HD079076-05). The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article.	Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; American College of Radiology, ACR APPR CRIT SUSP S; Anderson SE, 2012, RADIOLOGY, V262, P567, DOI 10.1148/radiol.11102115; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Balla J, 1987, Clin Exp Neurol, V23, P179; Bandong Aila Nica, 2019, JMIR Form Res, V3, pe12216, DOI 10.2196/12216; Bandong AN, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3439-5; Bandong AN, 2018, MUSCULOSKEL SCI PRAC, V34, P14, DOI 10.1016/j.msksp.2017.11.006; Bazarian JJ, 2004, ANN EMERG MED, V44, P142, DOI 10.1016/j.annemergmed.2004.03.029; Beeckmans K, 2017, ACTA NEUROL BELG, V117, P493, DOI 10.1007/s13760-017-0745-3; Berglund A, 2001, J CLIN EPIDEMIOL, V54, P851, DOI 10.1016/S0895-4356(00)00369-3; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Chien A, 2010, MANUAL THER, V15, P48, DOI 10.1016/j.math.2009.05.012; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; Cooke G, 2013, AUST FAM PHYSICIAN, V42, P65; Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389; Daffner Richard H, 2007, J Am Coll Radiol, V4, P762, DOI 10.1016/j.jacr.2007.08.006; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Dunne-Proctor RL, 2016, CLIN J PAIN, V32, P645, DOI 10.1097/AJP.0000000000000309; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Erichsen J.E., 1867, RAILWAY OTHER INJURI; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Farrell SF, 2019, J MAGN RESON IMAGING, V49, P1638, DOI 10.1002/jmri.26567; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; FRANKEL CJ, 1959, JAMA-J AM MED ASSOC, V169, P216, DOI 10.1001/jama.1959.03000200014004; French L., 2008, J SPECIAL OPERATIONS, V8, P68; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Holm LW, 2009, J MANIP PHYSIOL THER, V32, pS61, DOI 10.1016/j.jmpt.2008.11.011; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kessels RPC, 2000, J INT NEUROPSYCH SOC, V6, P271, DOI 10.1017/S1355617700633027; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLINICAL PRAC; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matsumoto M, 2010, SPINE, V35, P1684, DOI 10.1097/BRS.0b013e3181c9a8c7; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Nakashima H, 2015, SPINE, V40, P392, DOI 10.1097/BRS.0000000000000775; O'leary S, 2015, MUSCLE NERVE, V52, P772, DOI 10.1002/mus.24612; Okada E, 2011, EUR SPINE J, V20, P1567, DOI 10.1007/s00586-011-1774-x; Ontario Neurotrauma Foundation, 2018, GUIDELINE FOR CONCUS; Osmotherly PG, 2012, PHYS THER, V92, P718, DOI 10.2522/ptj.20110261; Pastakia K, 2011, OPEN ACCESS EMERG M, V3, P29, DOI 10.2147/OAEM.S17853; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rebbeck T, 2016, MAN THER, V25, pe10, DOI [10.1016/j.math.2016.05.009, DOI 10.1016/J.MATH.2016.05.009]; Rebbeck T, 2017, J ORTHOP SPORT PHYS, V47, P481, DOI 10.2519/jospt.2017.7138; Rebbeck Trudy, 2016, J Physiother, V62, P111, DOI 10.1016/j.jphys.2016.02.006; Ritchie C, 2015, J ORTHOP SPORT PHYS, V45, P242, DOI 10.2519/jospt.2015.5642; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Robinson JP, 2007, ARCH PHYS MED REHAB, V88, P774, DOI 10.1016/j.apmr.2007.03.004; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; RUBIN AM, 1995, AM J OTOL, V16, P216; Sarrami P, 2017, J ORTHOP TRAUMATOL, V18, P9, DOI 10.1007/s10195-016-0431-x; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Scholten-Peeters GGM, 2002, SPINE, V27, P412, DOI 10.1097/00007632-200202150-00018; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; SPITZER WO, 1995, SPINE, V20, pS1; State Insurance Regulatory Authority, 2014, GUID MAN AC WHIPL AS; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterling M, 2014, J PHYSIOTHER, V60, P5, DOI 10.1016/j.jphys.2013.12.004; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Strudwick K, 2018, EMERG MED AUSTRALAS, V30, P754, DOI 10.1111/1742-6723.13131; Styrke J, 2014, SCAND J PAIN, V5, P229, DOI 10.1016/j.sjpain.2014.06.001; Takasaki H, 2012, ARCH PHYS MED REHAB, V93, P1774, DOI 10.1016/j.apmr.2012.05.013; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Ulbrich EJ, 2012, J MAGN RESON IMAGING, V36, P1413, DOI 10.1002/jmri.23769; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Viano DC, 2015, TRAFFIC INJ PREV, V16, P747, DOI 10.1080/15389588.2015.1013188; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Walton DM, 2016, J ORTHOP SPORT PHYS, V46, P920, DOI 10.2519/jospt.2016.6594; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Weiss D.S., 2007, CROSS CULTURAL ASSES, P219, DOI 10.1007/978-0-387-70990-1_10; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	90	8	8	0	7	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					819	828		10.2519/jospt.2019.8946			10	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100007	31610758				2022-02-06	
J	Sperl, A; Heller, RA; Biglari, B; Haubruck, P; Seelig, J; Schomburg, L; Bock, T; Moghaddam, A				Sperl, Andre; Heller, Raban Arved; Biglari, Bahram; Haubruck, Patrick; Seelig, Julian; Schomburg, Lutz; Bock, Tobias; Moghaddam, Arash			The Role of Magnesium in the Secondary Phase After Traumatic Spinal Cord Injury. A Prospective Clinical Observer Study	ANTIOXIDANTS			English	Article						traumatic spinal cord injury; Magnesium; neuroprotection; neurotrauma; regeneration	BRAIN-INJURY; INFLAMMATORY RESPONSE; POLYETHYLENE-GLYCOL; IMPACT TRAUMA; SULFATE; REMISSION; OUTCOMES; THERAPY; EDEMA; SERUM	In the secondary injury phase after traumatic spinal cord injury (TSCI), oxidative stress and neuroinflammatory responses at the site of injury constitute crucial factors controlling damage extent and may serve as potential therapeutic targets. We determined Magnesium (Mg) serum concentration dynamics in context with the potential of neurological remission in patients with TSCI as Mg is suspected to limit the production of reactive oxygen species and reduce lipid peroxidation. A total of 29 patients with acute TSCI were enrolled, and blood samples were drawn over 3 months at 11 time-points and Mg quantification was performed. Patients were divided into those with (G1, n = 18) or without neurological remission (G0, n = 11). Results show a slight drop in Mg level during the first 4 h after injury, then remained almost unchanged in G1, but increased continuously during the first 7 days after injury in G0. At day 7 Mg concentrations in G1 and G0 were significantly different (p = 0.039, G0 > G1). Significant differences were detected between patients in G1 that presented an AIS (ASIA Impairment Scale) conversion of 1 level versus those with more than 1 level (p = 0.014, G1 AIS imp. = +1 > G1 AI imp. > +1). Low and decreasing levels of Mg within the first 7 days are indicative of a high probability of neurological remission, whereas increasing levels are associated with poor neurological outcome.	[Sperl, Andre; Heller, Raban Arved; Haubruck, Patrick; Bock, Tobias] Heidelberg Univ Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Dept Trauma & Reconstruct Surg, Heidelberg Trauma Res Grp, D-06221 Heidelberg, Germany; [Heller, Raban Arved; Seelig, Julian; Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, D-10117 Berlin, Germany; [Heller, Raban Arved; Seelig, Julian; Schomburg, Lutz] Free Univ Berlin, D-10117 Berlin, Germany; [Heller, Raban Arved; Seelig, Julian; Schomburg, Lutz] Humboldt Univ, D-10117 Berlin, Germany; [Heller, Raban Arved; Seelig, Julian; Schomburg, Lutz] Berlin Inst Hlth, D-10117 Berlin, Germany; [Biglari, Bahram] Berfsgenssenschaftl Unfallklink Trauma Ctr Ludwig, Dept Paraplegiol, D-0621 Ludwigshafen, Germany; [Haubruck, Patrick] Univ Sydney, Kolling Inst Med Res, Inst Bone & Joint Res, Raymond Purves Bone & Joint Res Labs, St Leonards, NSW 2065, Australia; [Moghaddam, Arash] Hosp Aschaffenburg Alzenau, Ctr Orthoped Trauma Surg & Sports Med, Aschaffenburg Trauma & Orthoped Res Grp, D-63739 Aschaffenburg, Germany		Sperl, A (corresponding author), Heidelberg Univ Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Dept Trauma & Reconstruct Surg, Heidelberg Trauma Res Grp, D-06221 Heidelberg, Germany.	andre.sperl@gmx.de; Raban.Heller@med.uni-heidelberg.de; bahram.biglari@bgu-ludwigshafen.de; patrick.haubruck@sydney.edu.au; julian.seelig@charite.de; lutz.schomburg@charite.de; tobias.bock@stud.uni-heidelberg.de; Arash.Moghaddam-Alvandi@klinikum-ab-alz.de	Heller, Raban/P-4152-2019; Seelig, Julian/AAU-6678-2021	Heller, Raban/0000-0001-8006-9742; Sperl, Andre/0000-0001-8069-8389; Schomburg, Lutz/0000-0001-9445-1555	Deutsche Forschungsgemeinschaft (DFG Research Unit 2558 TraceAge)German Research Foundation (DFG) [Scho 849/6-1]	This project received no specific grant fromany funding agency in the public, commercial, or not-for-profit sectors. Research in the lab of LS is supported by the Deutsche Forschungsgemeinschaft (DFG Research Unit 2558 TraceAge, Scho 849/6-1).	Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Auguie B., 2017, MISCELLANEOUS FUNCTI; Biglari B, 2021, J SPINAL CORD MED, V44, P229, DOI 10.1080/10790268.2019.1632060; Biglari B, 2015, J INT MED RES, V43, P250, DOI 10.1177/0300060514559794; Blache D, 2006, FREE RADICAL BIO MED, V41, P277, DOI 10.1016/j.freeradbiomed.2006.04.008; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chanimov M, 2006, MED SCI MONITOR, V12, pBR63; Dhandapani SS, 2008, INDIAN J NEUROTRAUM, V5, P27, DOI 10.1016/S0973-0508(08)80025-1; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; Erdman J., 2011, NUTR TRAUMATIC BRAIN; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Ferbert T, 2017, J NEUROTRAUM, V34, P607, DOI 10.1089/neu.2015.4294; Gok B, 2007, CHINESE J PHYSIOL, V50, P93; GUNTHER T, 1984, BIOCHEM BIOPH RES CO, V119, P124, DOI 10.1016/0006-291X(84)91627-9; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; Hachem LD, 2017, J SPINAL CORD MED, V40, P665, DOI 10.1080/10790268.2017.1329076; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; HELLER R, 2016, INJURY, V47, pS35, DOI DOI 10.1016/S0020-1383(16)30580-0; Heller RA, 2017, SPINAL CORD, V55, P1002, DOI 10.1038/sc.2017.69; Heller RA, 2019, J TRACE ELEM MED BIO, V51, P141, DOI 10.1016/j.jtemb.2018.10.006; Hoane Michael R, 2004, Clin Calcium, V14, P65; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; LEMKE M, 1987, BIOCHEM BIOPH RES CO, V147, P1170, DOI 10.1016/S0006-291X(87)80192-4; Lemke M, 1990, J NEUROTRAUM, V7, P41, DOI 10.1089/neu.1990.7.41; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; MAGUIRE ME, 1984, TRENDS PHARMACOL SCI, V5, P73, DOI 10.1016/0165-6147(84)90372-9; Malpuech-Brugere C, 2000, BBA-MOL BASIS DIS, V1501, P91, DOI 10.1016/S0925-4439(00)00018-1; Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.031; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; Moghaddam A, 2017, SPINAL CORD, V55, P8, DOI 10.1038/sc.2016.104; Moghaddam A, 2016, SPINAL CORD, V54, P957, DOI 10.1038/sc.2016.44; Moghaddam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159764; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Naomi L., 2011, MAGNESIUM CENTRAL NE, P167; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Noronha JL, 2002, INTENS CARE MED, V28, P667, DOI 10.1007/s00134-002-1281-y; PAZDERNIK TL, 1992, NEUROCHEM RES, V17, P11, DOI 10.1007/BF00966860; Regan RF, 1998, J NEUROCHEM, V70, P77; Romani A.M.P., 2011, MAGNESIUM CENTRAL NE, V512, P13, DOI [10.1017/UPO9780987073051.003, DOI 10.1017/UPO9780987073051.003]; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Ryan MF, 1998, ANN CLIN BIOCHEM, V35, P449, DOI 10.1177/000456329803500401; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Swaminathan R, 2003, Clin Biochem Rev, V24, P47; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Vink R, 2009, MAGNESIUM RES, V22, p158S; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiseman DB, 2009, J NEUROSURG-SPINE, V10, P308, DOI 10.3171/spi.2009.10.4.308	61	8	8	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	NOV	2019	8	11							509	10.3390/antiox8110509			12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	JV3LS	WOS:000502268400005	31653023	Green Published, gold			2022-02-06	
J	Veliz, P; McCabe, SE; Eckner, JT; Schulenberg, JE				Veliz, Phil; McCabe, Sean Esteban; Eckner, James T.; Schulenberg, John E.			Concussion, sensation-seeking and substance use among US adolescents	SUBSTANCE ABUSE			English	Article						Concussion; substance use; adolescents	TRAUMATIC BRAIN-INJURY; PREVALENCE; RISK; BEHAVIOR; ALCOHOL	Background: No large-scale epidemiological survey of adolescents in the US has assessed the association between lifetime history of concussion, propensity toward sensation-seeking, and recent substance use. Methods: This study assesses the association between lifetime history of diagnosed concussions, sensation-seeking, and recent substance use (i.e., cigarette use, binge drinking, marijuana use, illicit drug use, and nonmedical prescription drug use) using the 2016 and 2017 Monitoring the Future study of 25,408 8th, 10th, and 12th graders. Results: Lifetime diagnosis of concussion was associated with greater odds of past 30-day/2-week substance use. Adolescents who indicated multiple diagnosed concussions (versus none) had two times greater odds of all types of recent substance use, after adjusting for potential confounding factors. Adolescents indicating multiple diagnosed concussions also had higher adjusted odds of cigarette use, binge drinking, and marijuana use) when compared to adolescents who only indicated one diagnosed concussion. Accounting for adolescents? propensity toward sensation-seeking did not significantly change the association between substance use and multiple diagnosed concussions. Conclusions: This study provides needed epidemiological data regarding concussion and substance use among US adolescents. Exposure to a single diagnosed concussion is associated with a modest increase in the risk of substance use and this association increases with the accumulation of multiple diagnosed concussions. These associations hold when controlling for sensation-seeking. Substance use prevention efforts should be directed toward adolescents who have a history of multiple concussions.	[Veliz, Phil; McCabe, Sean Esteban] Univ Michigan, Sch Nursing, Ctr Study Drugs Alcohol Smoking & Hlth, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Schulenberg, John E.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA		Veliz, P (corresponding author), Univ Michigan, Sch Nursing, 400 North Ingalls, Ann Arbor, MI 48109 USA.	ptveliz@umich.edu	; Schulenberg, John/A-2212-2008	McCabe, Sean/0000-0002-9622-4652; Schulenberg, John/0000-0003-2129-8486; Veliz, Philip/0000-0003-2544-3468	National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [L40DA042452, R01DA031160, R01DA036541, R01DA001411]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA203809]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The development of this manuscript was supported by research grants from the National Institute on Drug Abuse [L40DA042452, R01DA031160, R01DA036541, and R01DA001411], National Institute of Child Health and Human Development [K23HD078502], and National Cancer Institute [R01CA203809], National Institutes of Health. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Argyriou E, 2018, PHARMACOL BIOCHEM BE, V164, P106, DOI 10.1016/j.pbb.2017.07.013; Bachman JG, 2015, MONITORING FUTURE OC; Beidler E., 2017, BRIT J SPORT MED, V51, pA66.2, DOI [10.1136/bjsports-2016-097270.172, DOI 10.1136/BJSPORTS-2016-097270.172]; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Brown TN, 2001, 49 U MICH I SOC RES; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Faul M, 2016, TRAUMATIC BRAIN INJU; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jackson KM, 2008, ALCOHOL CLIN EXP RES, V32, P723, DOI 10.1111/j.1530-0277.2008.00643.x; Johnston L D, 1985, NIDA Res Monogr, V57, P31; Keyes KM, 2015, DRUG ALCOHOL DEPEN, V155, P267, DOI 10.1016/j.drugalcdep.2015.06.031; Kim E, 2002, NEUROREHABILITATION, V17, P297; Livingston EM, 2017, J AM ACAD CHILD PSY, V56, P895, DOI 10.1016/j.jaac.2017.07.787; Malmberg M, 2010, J BEHAV MED, V33, P474, DOI 10.1007/s10865-010-9278-4; Miech R. A., 2017, MONITORING FUTURE NA, VI; O?Connor KL, 2017, BRIT J SPORT MED, V51, pA33, DOI DOI 10.1136/BJSPORTS-2016-097270.84; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Patrick ME, 2013, ALCOHOL RES-CURR REV, V35, P193; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Veliz P, 2019, JAMA PEDIATR, V173, P399, DOI 10.1001/jamapediatrics.2019.0001; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; Veliz PT, 2015, SUBST USE MISUSE, V50, P156, DOI 10.3109/10826084.2014.962049; Zarrett N, 2018, TEEN SPORT AM WHY PA	29	8	8	3	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0889-7077	1547-0164		SUBST ABUS	Subst. Abus.	APR 3	2021	42	2					183	191		10.1080/08897077.2019.1671938		OCT 2019	9	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	SE4GO	WOS:000494174400001	31638885	Green Accepted			2022-02-06	
J	McConnell, B; Duffield, T; Hall, T; Piantino, J; Seitz, D; Soden, D; Williams, C				McConnell, Blake; Duffield, Tyler; Hall, Trevor; Piantino, Juan; Seitz, Dylan; Soden, Daniel; Williams, Cydni			Post-traumatic Headache After Pediatric Traumatic Brain Injury: Prevalence, Risk Factors, and Association With Neurocognitive Outcomes	JOURNAL OF CHILD NEUROLOGY			English	Article						cognition; concussion; headache; pediatric; outcome; traumatic brain injury; risk factor	SPORT CONCUSSION; CHILDREN; SYMPTOMS; SLEEP; INTELLIGENCE; PREDICTORS; RECOVERY; SEVERITY; VALIDITY; BEHAVIOR	Post-traumatic headache is common after pediatric traumatic brain injury and affects thousands of children every year, but little is known about how headache affects recovery after traumatic brain injury in other symptom domains. We aimed to determine the association between headache and other common symptoms after pediatric traumatic brain injury and explore whether subjective complaints of headache are associated with objective deficits on specialized neurocognitive testing. We conducted a retrospective cohort study of children ages 3-19 years following traumatic brain injury with a completed Sports Concussion Assessment Tool (SCAT) questionnaire. Post-traumatic headache was defined by a score more than 2 on the SCAT question for headache and define headache groups for comparison. In our cohort, we analyzed data from the Delis-Kaplan Executive Function System and the Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-II). Headache was reported in 40 (33%) patients presenting for post-traumatic brain injury care among 121 pediatric traumatic brain injury patients and did not differ by injury severity. Median total SCAT symptom score in the headache group was 5-fold higher compared to patients without headache (median 45.5 vs 9; P < .001). Significantly lower-scaled scores in color naming, matrix reasoning, letter sequencing, and letter switching were also found in the headache group (all P <= .03). Our study shows that headache, as reported by patients on the SCAT, is associated with higher symptom scores in all other symptom domains, including sleep, mood, sensory, and cognitive. Headache was also associated with worse objective neurocognitive measures and may identify patients who could benefit from specialized follow-up care and management.	[McConnell, Blake] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA; [Duffield, Tyler] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Hall, Trevor; Seitz, Dylan; Soden, Daniel] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Psychol, Portland, OR 97239 USA; [Piantino, Juan] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Neurol, Portland, OR 97239 USA; [Williams, Cydni] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, Portland, OR 97239 USA		McConnell, B (corresponding author), Oregon Hlth & Sci Univ, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97239 USA.	mcconneb@ohsu.edu	Piantino, Juan/AAI-2184-2019	Piantino, Juan/0000-0002-8861-5709; Williams, Cydni/0000-0002-2049-7662	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL133115]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Williams is supported by the Agency for Healthcare Research and Quality, grant number K12HS022981. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Dr Piantino is supported by the National Heart, Lung, and Blood Institute grant number K12HL133115.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Bruni O, 2008, SLEEP MED, V9, P542, DOI 10.1016/j.sleep.2007.08.010; Cahill C, 2007, ACTA NEUROPSYCHIATR, V19, P219; Canivez GL, 2009, SCHOOL PSYCHOL QUART, V24, P252, DOI 10.1037/a0018030; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Araújo Caroline Martins de, 2012, Dement. neuropsychol., V6, P74, DOI 10.1590/S1980-57642012DN06020002; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Dodd JN, 2018, PEDIATR NEUROL, V89, P58, DOI 10.1016/j.pediatrneurol.2018.09.007; Dosi C, 2015, SEMIN PEDIATR NEUROL, V22, P105, DOI 10.1016/j.spen.2015.04.005; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Faul M, 2010, TRAUMATIC BRAIN INJU; Gera G, 2018, MIL MED, V183, P327, DOI 10.1093/milmed/usx162; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Holland PR, 2014, CEPHALALGIA, V34, P725, DOI 10.1177/0333102414541687; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kacperski J, 2016, SEMIN PEDIATR NEUROL, V23, P27, DOI 10.1016/j.spen.2015.08.005; Kanazawa S, 2006, BRIT J HEALTH PSYCH, V11, P623, DOI 10.1348/135910705X69842; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutuk MO, 2018, BRAIN DEV-JPN, V40, P857, DOI 10.1016/j.braindev.2018.06.001; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Powers SW, 2003, PEDIATRICS, V112, pE1, DOI 10.1542/peds.112.1.e1; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Slover Robin, 2010, Adv Pediatr, V57, P141, DOI 10.1016/j.yapd.2010.08.009; Smith AP, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00042; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Torres-Ferrus M, 2019, CEPHALALGIA, V39, P91, DOI 10.1177/0333102418777509; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Williams CN, 2018, PEDIATR NEUROL, V89, P31, DOI 10.1016/j.pediatrneurol.2018.07.013; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083	54	8	8	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2020	35	1					63	70	0883073819876473	10.1177/0883073819876473		OCT 2019	8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	JV9PU	WOS:000491818200001	31581879	Green Accepted			2022-02-06	
J	Braun, DJ; Bachstetter, AD; Sudduth, TL; Wilcock, DM; Watterson, DM; Van Eldik, LJ				Braun, David J.; Bachstetter, Adam D.; Sudduth, Tiffany L.; Wilcock, Donna M.; Watterson, D. Martin; Van Eldik, Linda J.			Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia	GEROSCIENCE			English	Article						Myosin light chain kinase; Cerebrovascular; Microhemorrhage; Neuroinflammation; Vascular cognitive impairment and dementia; Knockout	BLOOD-BRAIN-BARRIER; EPITHELIAL TIGHT PERMEABILITY; INDUCED-INCREASE; LUNG INJURY; INHIBITION; DYSFUNCTION; ACTIVATION; ISOFORM; PATHWAY; HEALTH	The blood-brain barrier (BBB) is critical in maintenance of brain homeostasis, and loss of its functional integrity is a key feature across a broad range of neurological insults. This includes both acute injuries such as traumatic brain injury and stroke, as well as more chronic pathologies associated with aging, such as vascular cognitive impairment and dementia (VCID). A specific form of myosin light chain kinase (MLCK210) is a major regulator of barrier integrity in general, including the BBB. Studies have demonstrated the potential of MLCK210 as a therapeutic target for peripheral disorders involving tissue barrier dysfunction, but less is known about its potential as a target for chronic neurologic disorders. We report here that genetic knockout (KO) of MLCK210 protects against cerebral microhemorrhages and neuroinflammation induced by chronic dietary hyperhomocysteinemia. Overall, the results are consistent with an accumulating body of evidence supporting MLCK210 as a potential therapeutic target for tissue barrier dysfunction and specifically implicate it in BBB dysfunction and neuroinflammation in a model of VCID.	[Braun, David J.; Bachstetter, Adam D.; Sudduth, Tiffany L.; Watterson, D. Martin; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA; [Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Sudduth, Tiffany L.; Wilcock, Donna M.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Watterson, D. Martin] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA		Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu	Braun, David/AAJ-5829-2021		NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32AG058456, P30AG028383] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG028383, R01 AG031311, F32 AG058456, T32 AG000260] Funding Source: Medline		Al-Sadi R, 2019, AM J PHYSIOL-GASTR L, V316, pG278, DOI 10.1152/ajpgi.00126.2018; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Arnaud C, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007893; Beard RS, 2014, J CELL SCI, V127, P1840, DOI 10.1242/jcs.144550; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Cunningham KE, 2012, ANN NY ACAD SCI, V1258, P34, DOI 10.1111/j.1749-6632.2012.06526.x; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Fazal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059965; Gaceb A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00322; Gilbert S, 2012, EMBO MOL MED, V4, P109, DOI 10.1002/emmm.201100192; Guo MZ, 2012, SHOCK, V38, P436, DOI 10.1097/SHK.0b013e318268c731; Hicks K, 2010, AM J PHYSIOL-CELL PH, V298, pC1583, DOI 10.1152/ajpcell.00458.2009; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Janelidze S, 2017, NEUROBIOL AGING, V51, P104, DOI 10.1016/j.neurobiolaging.2016.11.017; Khapchaev AY, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1676, DOI 10.1134/S000629791613006X; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Lorentz CA, 2017, MOL MED, V23, P155, DOI 10.2119/molmed.2016.00256; Luh C, 2019, TRANSL STROKE RES, V10, P534, DOI 10.1007/s12975-018-0677-0; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nighot M, 2017, AM J PATHOL, V187, P2698, DOI 10.1016/j.ajpath.2017.08.005; Ohlmann P, 2005, AM J PHYSIOL-HEART C, V289, pH2342, DOI 10.1152/ajpheart.00511.2004; Price BR, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00350; Ranaivo HR, 2007, AM J PATHOL, V170, P439, DOI 10.2353/ajpath.2007.060219; Recoquillon S, 2015, CLIN SCI, V129, P687, DOI 10.1042/CS20140625; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Rossi JL, 2013, J NEUROTRAUM, V30, P1672, DOI 10.1089/neu.2013.2898; Sudduth TL, 2017, NEUROSCIENCE, V341, P42, DOI 10.1016/j.neuroscience.2016.11.024; Sudduth TL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt262; Sudduth TL, 2013, J CEREBR BLOOD F MET, V33, P708, DOI 10.1038/jcbfm.2013.1; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wang T, 2016, PULM CIRC, V6, P234, DOI 10.1086/686491; Wang T, 2014, AM J RESP CELL MOL, V50, P1129, DOI 10.1165/rcmb.2013-0434OC; Weekman EM, 2017, ASN NEURO, V9, DOI 10.1177/1759091417742296; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wu LL, 2014, AM J PATHOL, V184, P2260, DOI 10.1016/j.ajpath.2014.05.003; Xiong YJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00292; Xu C, 2018, NEUROCHEM RES, V43, P1454, DOI 10.1007/s11064-018-2560-5; Zahs A, 2012, AM J PHYSIOL-GASTR L, V303, pG705, DOI 10.1152/ajpgi.00157.2012; Zhang HF, 2015, N-S ARCH PHARMACOL, V388, P953, DOI 10.1007/s00210-015-1125-2; Zhou T, 2015, PULM CIRC, V5, P335, DOI 10.1086/680357; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	52	8	8	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2509-2715	2509-2723		GEROSCIENCE	GeroScience	OCT	2019	41	5			SI		671	679		10.1007/s11357-019-00072-4			9	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	JR4SU	WOS:000499617400013	31104189	Green Published, hybrid			2022-02-06	
J	De Pauw, R; Coppieters, I; Caeyenbergh, K; Kregel, J; Aerts, H; Lenoir, D; Cagnie, B				De Pauw, Robby; Coppieters, Iris; Caeyenbergh, Karen; Kregel, Jeroen; Aerts, Hannelore; Lenoir, Dorine; Cagnie, Barbara			Associations between brain morphology and motor performance in chronic neck pain: A whole-brain surface-based morphometry approach	HUMAN BRAIN MAPPING			English	Article						chronic pain; FreeSurfer; idiopathic neck pain; primary motor cortex; surface-based morphology; whiplash-associated disorder	WHIPLASH-ASSOCIATED DISORDERS; CERVICAL FLEXOR MUSCLES; VOXEL-BASED MORPHOMETRY; CORTICAL THICKNESS; CEREBRAL-CORTEX; SENSORIMOTOR DISTURBANCES; QUANTITATIVE METAANALYSIS; GEOMETRICALLY ACCURATE; CENTRAL SENSITIZATION; STANDING BALANCE	Changes in brain morphology are hypothesized to be an underlying process that drive the widespread pain and motor impairment in patients with chronic neck pain. However, no earlier research assessed whole-brain cortical morphology in these patients. This case-control study assesses group-differences in whole-brain morphology between female healthy controls (HC; n = 34), and female patients with chronic idiopathic neck pain (CINP; n = 37) and whiplash-associated disorders (CWAD; n = 39). Additionally, the associations between whole-brain morphology and motor performance including balance, strength, and neuromuscular control were assessed. Cortical volume, thickness, and surface area were derived from high resolution T1-weighted images. T2*-weighted images were obtained to exclude traumatic brain injury. Vertex-wise general-linear-model-analysis revealed cortical thickening in the left precuneus and increased volume in the left superior parietal gyrus of patients with CINP compared to HC, and cortical thickening of the left superior parietal gyrus compared to HC and CWAD. Patients with CWAD showed a smaller cortical volume in the right precentral and superior temporal gyrus compared to HC. ANCOVA-analysis revealed worse neuromuscular control in CWAD compared to HC and CINP, and in CINP compared to HC. Patients with CWAD showed decreased levels of strength and sway area compared to CINP and HC. Partial correlation analysis revealed significant associations between the volume of the precentral gyrus, and neuromuscular control and strength together with an association between the volume of the superior temporal gyrus and strength. Our results emphasize the role of altered gray matter alterations in women with chronic neck pain, and its association with pain and motor impairment.	[De Pauw, Robby; Kregel, Jeroen; Lenoir, Dorine; Cagnie, Barbara] Univ Ghent, Fac Med & Hlth Sci, Dept Rehabil Sci, Ghent, Belgium; [Coppieters, Iris; Kregel, Jeroen; Lenoir, Dorine] Vrije Univ Brussel, Physiotherapy Human Physiol & Anat KIMA, Brussels, Belgium; [Coppieters, Iris; Kregel, Jeroen; Lenoir, Dorine] Pain Mot Int Res Grp, Ghent, Belgium; [Caeyenbergh, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Brisbane, Qld, Australia; [Aerts, Hannelore] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium		De Pauw, R (corresponding author), Univ Ghent, Campus UZ 3B3,Corneel Heymanslaan 10, B-9000 Ghent, Belgium.	robby.depauw@ugent.be	Coppieters, Iris/M-8749-2014; Coppieters, Iris/AAI-3812-2021; De Pauw, Robby/ABF-6976-2020; cagnie, barbara/D-9830-2017	Coppieters, Iris/0000-0003-1598-632X; De Pauw, Robby/0000-0002-4242-9062; cagnie, barbara/0000-0003-4342-4519; Aerts, Hannelore/0000-0002-8806-7482			Abdi Herve., 2010, ENCY RES DESIGN, V1, P169; Ailliet L, 2015, EUR SPINE J, V24, P88, DOI 10.1007/s00586-014-3359-y; Anstey R, 2016, J ORTHOP SPORT PHYS, V46, P894, DOI 10.2519/jospt.2016.6588; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Borchgrevink G, 1997, INJURY, V28, P331, DOI 10.1016/S0020-1383(97)00027-2; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Cagnie B, 2008, J APPL PHYSIOL, V104, P230, DOI 10.1152/japplphysiol.00918.2007; Cagnie B, 2007, ARCH PHYS MED REHAB, V88, P1441, DOI 10.1016/j.apmr.2007.06.776; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chiu TTW, 2005, J ORTHOP SPORT PHYS, V35, P567; Coppieters I, 2018, HUM BRAIN MAPP, V39, P1721, DOI 10.1002/hbm.23947; Coppieters I, 2017, PAIN PHYSICIAN, V20, pE1025; Coppieters I, 2016, J PAIN, V17, P949, DOI 10.1016/j.jpain.2016.04.005; Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389; Cremers HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184923; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; De Pauw R, 2018, SPINE J, V18, P1406, DOI 10.1016/j.spinee.2018.01.009; De Pauw R, 2017, PAIN PHYSICIAN, V20, P245; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Falla D, 2004, MANUAL THER, V9, P125, DOI 10.1016/j.math.2004.05.003; Falla D, 2003, PHYS THER, V83, P899, DOI 10.1093/ptj/83.10.899; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Freitag P, 2001, NEUROREHAB NEURAL RE, V15, P31, DOI 10.1177/154596830101500105; Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Guzman J, 2009, J MANIP PHYSIOL THER, V32, pS17, DOI 10.1016/j.jmpt.2008.11.007; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Hodges P. W., 2011, J ORTHOPAEDIC SPORTS, V41, pA27; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Jorritsma W, 2012, EUR SPINE J, V21, P93, DOI 10.1007/s00586-011-1920-5; Jull G., 2008, WHIPLASH HEADACHE NE, P101; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Karlsborg M, 1998, Ugeskr Laeger, V160, P6211; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Koerte I. K., 2016, FRONTIERS NEUROSCIEN; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Kucyi A, 2017, NEUROSCIENTIST, V23, P397, DOI 10.1177/1073858416667716; Kucyi A, 2015, TRENDS NEUROSCI, V38, P86, DOI 10.1016/j.tins.2014.11.006; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Malfliet A, 2015, PAIN PHYSICIAN, V18, P223; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Meisingset I, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0517-2; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Olson LE, 2006, J MANIP PHYSIOL THER, V29, P134, DOI 10.1016/j.jmpt.2005.12.009; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pearson I, 2009, J ORTHOP SPORT PHYS, V39, P179, DOI 10.2519/jospt.2009.2950; Phillips Ceri J, 2009, Rev Pain, V3, P2, DOI 10.1177/204946370900300102; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; R Core Team, 2017, R LANG ENV STAT COMP; Rajtmajer SM, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.7015.00097, 10.3389/fnana.2015.00097]; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reid KJ, 2011, CURR MED RES OPIN, V27, P449, DOI 10.1185/03007995.2010.545813; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Ruhe A., 2011, CHIROPR MAN THER, V19, P1; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Silva AG, 2013, PHYSIOTHER THEOR PR, V29, P1, DOI 10.3109/09593985.2012.677111; Sjolander P, 2008, MANUAL THER, V13, P122, DOI 10.1016/j.math.2006.10.002; Smallwood RF, 2013, J PAIN, V14, P663, DOI 10.1016/j.jpain.2013.03.001; SPITZER WO, 1995, SPINE, V20, pS1; Stanton TR, 2016, PHYS THER REHABIL J, V96, P876, DOI 10.2522/ptj.20150241; Sterling M, 2004, MANUAL THER, V9, P60, DOI 10.1016/j.math.2004.01.006; Strimpakos N., 2001, PHYS THER REV, V6, P39; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Woodhouse A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-90; Ylinen J, 2004, EUR J PAIN, V8, P473, DOI 10.1016/j.ejpain.2003.11.005	94	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	OCT 1	2019	40	14					4266	4278		10.1002/hbm.24700			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IS9FN	WOS:000482454100018	31222905	Green Published			2022-02-06	
J	Foster, K; Mitchell, R; Van, C; Young, A; McCloughen, A; Curtis, K				Foster, Kim; Mitchell, Rebecca; Van, Connie; Young, Alexandra; McCloughen, Andrea; Curtis, Kate			Resilient, recovering, distressed: A longitudinal qualitative study of parent psychosocial trajectories following child critical injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Paediatric critical injury; Parent; Longitudinal; Qualitative; Psychosocial; Resilience	POSTTRAUMATIC STRESS SYMPTOMS; TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL RESILIENCE; FAMILIES; CAREGIVER	Introduction: The psychological distress and risk of mental health problems for parents of children with critical injury is well-established. There has been little exploration, however, of parent experiences and psychosocial trajectories over time following child critical injury. To address this knowledge gap, a longitudinal qualitative study was conducted to explore parent experiences and support needs and identify parent psychosocial trajectories in the 12 months following child critical injury. Methods: Semi- structured in-depth interviews were conducted with 27 parents at three time points over a 12 month period: the immediate hospital period post-child injury, and 6 and 12 months following injury, resulting in a total of 81 interviews. Data were analysed using a longitudinal within and across-case thematic analysis of patterns emerging over time. Findings: Three parent trajectory patterns were identified: resilient trajectory where parents were temporarily disrupted by the child's injury and hospitalisation, but recovered their mental and emotional wellbeing quickly, which was maintained over time; recovering trajectory where parents were initially disrupted at the time of injury but their mental and emotional wellbeing fluctuated over time and had not been fully restored by 12 months; and distressed trajectory where parents experienced significant psychosocial disruption due to their child's injury and struggled to adapt and regain their wellbeing over time, remaining emotionally distressed about the circumstances and impacts of the injury on their child and family. Illustrative narratives that represent each trajectory are presented. Conclusions: This is the first qualitative study to report the psychosocial trajectories of parents of critically injured children. Clinical application of insights provided by these trajectories can assist clinicians to use targeted strategies to help strengthen parental adaptation and prevent adverse mental health outcomes, and address families' psychosocial support needs following child injury. Screening for parent psychological distress and post-traumatic stress disorder is needed from the time of the child's admission, and a dedicated trauma support role can facilitate an integrated care approach for children and families with complex needs across the care continuum. (C) 2019 The Authors. Published by Elsevier Ltd.	[Foster, Kim] Australian Catholic Univ, Sch Nursing Midwifery & Paramed, 115 Victoria Parade, Fitzroy, Vic 3065, Australia; [Foster, Kim] Melbourne Hlth, Northwestern Mental Hlth, Grattan St, Parkville, Vic 3050, Australia; [Foster, Kim; Van, Connie; Young, Alexandra; McCloughen, Andrea; Curtis, Kate] Univ Sydney, Fac Hlth & Med, Susan Wakil Sch Nursing & Midwifery, Sydney Nursing Sch, 88 Mallett St, Camperdown, NSW 2006, Australia; [Mitchell, Rebecca] Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, Sydney, NSW 2109, Australia; [Curtis, Kate] Wollongong Hosp, Illawarra Shoalhaven Local Hlth Dist, Loftus St, Wollongong, NSW 2500, Australia; [Curtis, Kate] Univ Wollongong, Illawarra Hlth & Med Res Inst, Bldg 32,Northfields Ave, Wollongong, NSW 2522, Australia; [Curtis, Kate] George Inst Global Hlth, Level 5,1 King St, Newtown, NSW 2042, Australia		Foster, K (corresponding author), Australian Catholic Univ, Level 1 North,City Campus,Grattan St, Parkville, Vic 3050, Australia.; Foster, K (corresponding author), Royal Melbourne Hosp, NorthWestern Mental Hlth, Level 1 North,City Campus,Grattan St, Parkville, Vic 3050, Australia.	Kim.Foster@acu.edu.au	Mitchell, Rebecca/Z-5476-2019; McCloughen, Andrea/AAV-8764-2021	Mitchell, Rebecca/0000-0003-1939-1761; Foster, Kim/0000-0001-6931-2422	Day of Difference Foundation, a charitable organisation	The Day of Difference Foundation, a charitable organisation, funded the research. The funding body reviewed the study proposal but has not been involved in the data collection, analysis, interpretation, writing of the manuscript or decision to submit the manuscript for publication.	Bakker A, 2013, HEALTH PSYCHOL, V32, P1076, DOI 10.1037/a0033983; Barrington IL, 2005, ABBREVIATED INJURY S; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Ciarrochi J, 2015, J POSIT PSYCHOL, V10, P520, DOI 10.1080/17439760.2015.1015154; Creswell J.W ., 2007, QUAL INQ; Curtis K, 2016, J PAEDIATR CHILD H, V52, P832, DOI 10.1111/jpc.13189; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Foster K, 2017, INJURY, V48, P114, DOI 10.1016/j.injury.2016.09.034; Franck LS, 2015, INT J NURS STUD, V52, P10, DOI 10.1016/j.ijnurstu.2014.06.011; Goldsmith H, 2018, J CLIN NURS, V27, P1589, DOI 10.1111/jocn.14230; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hobfoll SE, 2009, J CONSULT CLIN PSYCH, V77, P138, DOI 10.1037/a0014360; Holland J., 2011, QUALITATIVE SOCIAL R, V12, P9; Kenardy J, 2017, J AFFECT DISORDERS, V214, P8, DOI 10.1016/j.jad.2017.02.031; Landolt MA, 2012, J CHILD PSYCHOL PSYC, V53, P767, DOI 10.1111/j.1469-7610.2011.02520.x; Le Brocque RM, 2010, J PEDIATR PSYCHOL, V35, P646, DOI 10.1093/jpepsy/jsq035; Le Brocque RM, 2010, J PEDIATR PSYCHOL, V35, P637, DOI 10.1093/jpepsy/jsp050; Lowe SR, 2015, CURR PSYCHOL, V34, P537, DOI 10.1007/s12144-015-9362-6; Mancini AD, 2015, ASSESSMENT, V22, P298, DOI 10.1177/1073191114550816; Masten A, 2010, RESILIENCE LIFESPAN, P213; Muscara F, 2015, EUR PSYCHIAT, V30, P555, DOI 10.1016/j.eurpsy.2014.12.008; Ogilvie R, 2016, INJURY, V47, P1966, DOI 10.1016/j.injury.2016.04.037; Phillips C, 2008, BURNS, V34, P56, DOI 10.1016/j.burns.2006.12.003; Plano Clark, 2018, DESIGNING CONDUCTING; Saldana J., 2015, CODING MANUAL QUALIT; Scheeringa MS, 2008, J CLIN CHILD ADOLESC, V37, P508, DOI 10.1080/15374410802148178; Schuster MA, 2011, FUTURE CHILD, V21, P91; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Sterling M, 2011, PAIN, V152, P1272, DOI 10.1016/j.pain.2011.01.056; Ungar M, 2008, BRIT J SOC WORK, V38, P218, DOI 10.1093/bjsw/bc1343; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z	38	8	8	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2019	50	10					1605	1611		10.1016/j.injury.2019.05.003			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	JJ2FC	WOS:000493975800005	31101410	Green Published, hybrid			2022-02-06	
J	Karamyan, VT				Karamyan, Vardan T.			Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders	MEDICAL HYPOTHESES			English	Article						Neuroprotection; Neuropeptide; Neurogenic inflammation; Brain edema; Drug target	ANGIOTENSIN BINDING-SITE; EXTRACELLULAR GLUTAMATE LEVELS; NEUROTENSIN RECEPTOR; CEREBRAL-ISCHEMIA; CELL-DEATH; BRAIN; STROKE; INVOLVEMENT; BRADYKININ; RECOVERY	Stroke and traumatic brain injury (TBI) are significant clinical problems characterized by high rate of mortality and long-lasting disabilities, and an unmet need for new treatments. Current experimental stroke and TBI research are evolving to focus more on understanding the brain's self-protective mechanisms to meet the critical need of developing new therapies for these disorders. In this hypothesis-based manuscript, I provide several lines of evidence that peptidase neurolysin (Nln) is one of the brain's potent, self-protective mechanisms promoting preservation and recovery of the brain after acute injury. Based on published experimental observations and ongoing studies in our laboratory, I posit that Nln is a compensatory and cerebroprotective mechanism in the post-stroke/TBI brain that functions to process a diverse group of extracellular neuropeptides and by that to reduce excitotoxicity, oxidative stress, edema formation, blood brain barrier hyper-permeability, and neuroinflammation. If this hypothesis is correct, Nln could potentially serve as a single therapeutic target to modulate the function of multiple targets, the involved neuropeptide systems, critically involved in various mechanisms of brain injury and cerebroprotection/restoration. Such multi-pathway target would be highly desired for pharmacotherapy of stroke and TBI, because targeting one pathophysiological pathway has proven to be ineffective for such complex disorders.	[Karamyan, Vardan T.] TTUHSC, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Karamyan, Vardan T.] TTUHSC, Sch Pharm, Ctr Blood Brain Barrier Res, Amarillo, TX USA		Karamyan, VT (corresponding author), 1300 Coulter St, Amarillo, TX 79106 USA.	vardan.karamyan@ttuhsc.edu			American Heart AssociationAmerican Heart Association [14BGIA20380826]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS106879]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS106879] Funding Source: NIH RePORTER	This research was supported by research grants from the American Heart Association (14BGIA20380826) and NIH (1R01NS106879). I apologize that the scope of this manuscript prevented citation of many important studies.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Amadoro G, 2007, NEUROPHARMACOLOGY, V52, P1366, DOI 10.1016/j.neuropharm.2007.01.020; Antonelli T, 2004, CEREB CORTEX, V14, P466, DOI 10.1093/cercor/bhh008; Antonelli T, 2008, CEREB CORTEX, V18, P1748, DOI 10.1093/cercor/bhm217; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Checler F, 2018, NEUROCHEM RES, V43, P2017, DOI 10.1007/s11064-018-2624-6; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Crowley MG, 2017, CNS NEUROL DISORD-DR, V16, P414, DOI 10.2174/1871527316666170320150659; DAUCH P, 1992, J NEUROCHEM, V59, P1862, DOI 10.1111/j.1471-4159.1992.tb11021.x; Ferraro L, 2009, MINI-REV MED CHEM, V9, P1429, DOI 10.2174/138955709789957495; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Iadecola C, 2004, STROKE, V35, P348, DOI 10.1161/01.STR.0000115162.16321.AA; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Janatpour ZC, 2019, J NEUROTRAUM, V36, P3115, DOI 10.1089/neu.2019.6376; Januzzi JL, 2016, ARTERIOSCL THROM VAS, V36, P1692, DOI 10.1161/ATVBAHA.116.307847; Karamyan VT, 2008, LIFE SCI, V83, P421, DOI 10.1016/j.lfs.2008.07.003; Karamyan VT, 2008, EUR J PHARMACOL, V590, P87, DOI 10.1016/j.ejphar.2008.05.035; Karamyan VT, 2007, REGUL PEPTIDES, V143, P15, DOI 10.1016/j.regpep.2007.03.006; Karamyan VT, 2007, BRAIN RES, V1143, P83, DOI 10.1016/j.brainres.2007.01.051; Karamyan VT, 2008, NEUROENDOCRINOLOGY, V88, P256, DOI 10.1159/000140635; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Kunz M, 2013, J NEUROTRAUM, V30, P1638, DOI 10.1089/neu.2012.2774; Lorente L., 2016, INT J MOL SCI, V17; Mecca AP, 2011, EXP PHYSIOL, V96, P1084, DOI 10.1113/expphysiol.2011.058578; NARUSE I, 1995, PROG NEUROBIOL, V47, P135, DOI 10.1016/0301-0082(95)00024-P; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1942, DOI 10.1152/ajpheart.00948.2002; Rashid M, 2018, J CLIN NEUROSCI, V48, P245, DOI 10.1016/j.jocn.2017.11.018; Rashid M, 2014, J NEUROCHEM, V129, P179, DOI 10.1111/jnc.12513; Rashid M, 2010, J PHARMACOL EXP THER, V335, P754, DOI 10.1124/jpet.110.171439; Richter F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36330-2; Shrimpton CN, 2002, ENDOCR REV, V23, P647, DOI 10.1210/er.2001-0032; Sobey CG, 2003, BRIT J PHARMACOL, V139, P1369, DOI 10.1038/sj.bjp.0705415; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Speth RC, 2008, HEART FAIL REV, V13, P299, DOI 10.1007/s10741-007-9078-2; Tovar-y-Romo LB, 2016, J NEUROCHEM, V136, P13, DOI 10.1111/jnc.13362; Vaidya B, 2018, DRUG DISCOV TODAY, V23, P1385, DOI 10.1016/j.drudis.2018.02.011; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; Villapol S, 2015, AM J HYPERTENS, V28, P289, DOI 10.1093/ajh/hpu197; Vincent B, 1996, J NEUROSCI, V16, P5049; Wangler NJ, 2012, J BIOL CHEM, V287, P114, DOI 10.1074/jbc.M111.273052; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39	45	8	8	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2019	131								109309	10.1016/j.mehy.2019.109309			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IW0IS	WOS:000484646200016	31443781	Green Accepted			2022-02-06	
J	Landry, AP; Ting, WKC; Zador, Z; Sadeghian, A; Cusimano, MD				Landry, Alexander P.; Ting, Windsor K. C.; Zador, Zsolt; Sadeghian, Alireza; Cusimano, Michael D.			Using artificial neural networks to identify patients with concussion and postconcussion syndrome based on antisaccades	JOURNAL OF NEUROSURGERY			English	Article						artificial neural network; machine learning; concussion; postconcussive syndrome; antisaccade; eye movement; trauma	TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; DEFICITS	OBJECTIVE Artificial neural networks (ANNs) have shown considerable promise as decision support tools in medicine, including neurosurgery. However, their use in concussion and postconcussion syndrome (PCS) has been limited. The authors explore the value of using an ANN to identify patients with concussion/PCS based on their antisaccade performance. METHODS Study participants were prospectively recruited from the emergency department and head injury clinic of a large teaching hospital in Toronto. Acquaintances of study participants were used as controls. Saccades were measured using an automated, portable, head-mounted device preprogrammed with an antisaccade task. Each participant underwent 100 trials of the task and 11 saccade parameters were recorded for each trial. ANN analysis was performed using the MATLAB Neural Network Toolbox, and individual saccade parameters were further explored with receiver operating characteristic (ROC) curves and a logistic regression analysis. RESULTS Control (n = 15), concussion (n = 32), and PCS (n = 25) groups were matched by age and level of education. The authors examined 11 saccade parameters and found that the prosaccade error rate (p = 0.04) and median antisaccade latency (p = 0.02) were significantly different between control and concussion/PCS groups. When used to distinguish concussion and PCS participants from controls, the neural networks achieved accuracies of 67% and 72%, respectively. This method was unable to distinguish study patients with concussion from those with PCS, suggesting persistence of eye movement abnormalities in patients with PCS. The authors' observations also suggest the potential for improved results with a larger training sample. CONCLUSIONS This study explored the utility of ANNs in the diagnosis of concussion/PCS based on antisaccades. With the use of an ANN, modest accuracy was achieved in a small cohort. In addition, the authors explored the pearls and pitfalls of this novel approach and identified important future directions for this research.	[Landry, Alexander P.; Ting, Windsor K. C.; Zador, Zsolt; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON, Canada; [Landry, Alexander P.; Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Sadeghian, Alireza] Ryerson Univ, Dept Comp Sci, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Landry, AP (corresponding author), St Michaels Hosp, Toronto, ON, Canada.	alex.landry@mail.utoronto.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 123371]; Canadian Institute for Military and Veteran Health Research (Advanced Analytic Initiative)	This work was supported by the Canadian Institutes of Health Research (MOP 123371) and the Canadian Institute for Military and Veteran Health Research (Advanced Analytic Initiative).	Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Bittencourt J, 2013, NEUROPSYCH DIS TREAT, V9, P1393, DOI 10.2147/NDT.S45931; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Coe BC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0192; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; FORSSTROM JJ, 1995, ANN MED, V27, P509, DOI 10.3109/07853899509002462; Frieden TR, 2015, TRAUMATIC BRAIN INJU; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; May R, 2011, ARTIFICIAL NEURAL NETWORKS - METHODOLOGICAL ADVANCES AND BIOMEDICAL APPLICATIONS, P19; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Nyffeler T, 2007, EUR J NEUROSCI, V26, P1381, DOI 10.1111/j.1460-9568.2007.05758.x; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Sinha M, 2001, J TRAUMA, V50, P308, DOI 10.1097/00005373-200102000-00018; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang Q. J., 2000, ARTECH MICR, P82	33	8	8	1	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2019	131	4					1235	1242		10.3171/2018.6.JNS18607			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JD8RN	WOS:000490249600029	30497186	Bronze			2022-02-06	
J	Loring, DW; Goldstein, FC				Loring, David W.; Goldstein, Felicia C.			If Invalid PVT Scores Are Obtained, Can Valid Neuropsychological Profiles Be Believed?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance Validity Tests; Base rates; Test validation; Test specificity	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY; TEST-PERFORMANCE; WORKING-MEMORY; CLINICAL NEUROPSYCHOLOGY; MULTIPLE-SCLEROSIS; AMERICAN ACADEMY; INFORMATION; IMPAIRMENT; ACCURACY	Background: Performance Validity Testing (PVT) decision-making rules may be indeterminate in patients with neurological disease in which PVT characteristics have not been adequately studied. We report a patient with multiple sclerosis (MS) who failed computerized PVT testing but had normal memory scores with a neuropsychological profile consistent with expected MS disease-related weaknesses. Method: Neuropsychological testing was conducted on two occasions in a middle-aged woman with an established MS diagnosis to address concerns of possible memory decline. Testing was discontinued after PVT scores below recommended cut-points were obtained during the first evaluation. During the second assessment, subthreshold PVT scores on a different computerized PVT were obtained, but unlike the first assessment, the entire neuropsychological protocol was administered. Results: Despite subthreshold computerized PVT scores, normal learning and memory performance was obtained providing objective data to answer the referral question. Other neuropsychological findings included decreased processing speed, poor working memory, and poor executive function consistent with her MS diagnosis. Embedded PVT scores were normal. Conclusions: We speculate that poor computerized PVT scores resulted from the disease-related features of MS, although we also discuss approaches to reconcile apparently contradictory PVT versus neuropsychological results if the contributions of disease-related variables on PVTs scores are discounted. This case demonstrates the value of completing the assessment protocol despite obtaining PVT scores below publisher recommended cutoffs in clinical evaluations. If subthreshold PVT scores are considered evidence of performance invalidity, it is still necessary to have an approach for interpreting seemingly credible neuropsychological test results rather than simply dismissing them as invalid.	[Loring, David W.; Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, 12 Execut Pk, Atlanta, GA 30329 USA		Loring, DW (corresponding author), Emory Brain Hlth Ctr, Dept Neurol, 12 Execut Pk, Atlanta, GA 30329 USA.	dloring@emory.edu					Benedict RHB, 2017, J INT NEUROPSYCH SOC, V23, P832, DOI 10.1017/S1355617717000959; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Bowman S., 2013, PERSPECT HLTH INF MA, V10, P1; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chiaravalloti ND, 2013, J CLIN EXP NEUROPSYC, V35, P180, DOI 10.1080/13803395.2012.760537; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; FARR SP, 1986, HDB CLIN NEUROPSYCHO, P213; Faust D, 2003, ASSESSMENT, V10, P428, DOI 10.1177/1073191103259534; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hamberger MJ, 2003, J INT NEUROPSYCH SOC, V9, P479, DOI 10.1017/S135561770393013X; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Loring DW, 2007, NEUROPSYCHOL REV, V17, P413, DOI 10.1007/s11065-007-9043-9; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; Loring DW, 2011, CLIN NEUROPSYCHOL, V25, P799, DOI 10.1080/13854046.2011.583279; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE., 1995, REY COMPLEX FIGURE T; Pearson, 2009, ADV CLIN SOLUT WAIS; Rickards TA, 2018, APPL NEUROPSYCH-ADUL, V25, P219, DOI 10.1080/23279095.2017.1278602; Robinson JS, 2018, ARCH CLIN NEUROPSYCH, V33, P238, DOI 10.1093/arclin/acx069; Robinson M, 2016, J PAIN, V17, P637, DOI 10.1016/j.jpain.2016.01.476; Roman CAF, 2016, J CLIN EXP NEUROPSYC, V38, P261, DOI 10.1080/13803395.2015.1105199; Schmidt M., 1996, REY AUDITORY VERBAL; Slick D. J., 1997, MANUAL VICTORIA SYMP; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; SWETS JA, 1992, AM PSYCHOL, V47, P522, DOI 10.1037/0003-066X.47.4.522; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73	42	8	8	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2019	34	7					1192	1202		10.1093/arclin/acz028			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	KF8XL	WOS:000509519900009	31365058				2022-02-06	
J	Mao, YF; Zhuang, ZR; Chen, YZ; Zhang, XL; Shen, YY; Lin, GS; Wu, RH				Mao, Yifei; Zhuang, Zerui; Chen, Yanzi; Zhang, Xiaolei; Shen, Yuanyu; Lin, Guisen; Wu, Renhua			Imaging of glutamate in acute traumatic brain injury using chemical exchange saturation transfer	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Chemical exchange saturation transfer (CEST); glutamate (Glu); traumatic brain injury (TBI); cognitive outcome	PROTON MRS; NEUROTRANSMITTER; SEQUENCE	Background: Chemical exchange saturation transfer (CEST) is an important contrast mechanism in the field of magnetic resonance imaging. Herein, we used CEST for glutamate (GIuCEST) imaging to evaluate the Glu alterations in acute mild to moderate traumatic brain injury (TBI) and correlated such alterations with the cognitive outcome at 1-month postinjury. Methods: Thirty-two patients with well-documented mild-to-moderate TBI and 15 healthy controls (HC group) underwent 3.0-Tesla magnetic resonance imaging (MRI) with GIuCEST, and magnetic resonance spectroscopy (MRS) scans. The Montreal Cognitive Assessment (MoCA) examination was administered to all study subjects at 1-month postinjury for cognitive outcome acquisition and divided TBI patients into patients with good cognitive outcome (GCO group) and with poor cognitive outcome (PCO group). Results: The GIuCEST% values for the occipital gray matter (OGM) and bilateral parietooccipital white matter (PWM) were higher in the PCO group compared with the HC and GCO groups (P<0.05), whereas the GluCFST% value showed no significant differences between the GCO and HC groups (P>0.05). In comparison with HCs, TBI patients had a significantly increased GIuCEST% value for the OGM and bilateral PWM (P<0.05). GIuCEST performed better than MRS in the prediction of cognitive outcome for TBI patients (P<0.05). Conclusions: Glu is significantly increased in acute TBI and strongly correlates with the cognitive outcome at 1 month postinjury. GIuCEST may supply new insight into TBI and help to improve the accuracy of short-term outcome prediction.	[Mao, Yifei; Chen, Yanzi; Shen, Yuanyu; Lin, Guisen; Wu, Renhua] Shantou Univ, Affiliated Hosp 2, Med Coll, Dept Med Imaging, 69 North Dongxia Rd, Shantou 515041, Peoples R China; [Mao, Yifei] Shenzhen Matern & Child Healthcare Hosp, Dept Radiol, Shenzhen 518028, Peoples R China; [Zhuang, Zerui; Zhang, Xiaolei] Shantou Univ, Affiliated Hosp 2, Med Coll, Dept Neurosurg, Shantou 515041, Peoples R China; Civil Aviat Flight Univ China, Coll Air Traff Control, Guanghan 618307, Peoples R China		Wu, RH (corresponding author), Shantou Univ, Affiliated Hosp 2, Med Coll, Dept Med Imaging, 69 North Dongxia Rd, Shantou 515041, Peoples R China.	rhwu@stu.edu.cn		Zhang, Xiaolei/0000-0002-5909-5820	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471730, 31870981]; Medical Research Foundation of Guangdong Province [A2018361]; Grant for Key Disciplinary Project of Clinical Medicine under the Guangdong High-level University Development Program [002-18119101]	This work has received funding by the National Natural Science Foundation of China (Grant No. 81471730, Grant No. 31870981), Medical Research Foundation of Guangdong Province (Grant No. A2018361), and Grant for Key Disciplinary Project of Clinical Medicine under the Guangdong High-level University Development Program (Grant No. 002-18119101).	Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Dai ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112219; Davis KA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7095; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dixon WT, 2010, MAGN RESON MED, V63, P253, DOI 10.1002/mrm.22193; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gopinath SP, 2000, ACT NEUR S, V76, P437; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Huang DX, 2015, MOL MED REP, V11, P3279, DOI 10.3892/mmr.2015.3165; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Lin GS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00901; Liu GS, 2013, NMR BIOMED, V26, P810, DOI 10.1002/nbm.2899; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Shen YY, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3735; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Sun PZ, 2016, CONTRAST MEDIA MOL I, V11, P195, DOI 10.1002/cmmi.1680; TEASDALE G, 1974, LANCET, V2, P81; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252; Wu RH, 2015, NMR BIOMED, V28, P555, DOI 10.1002/nbm.3284; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Xiao G, 2015, PHYS MED BIOL, V60, P4719, DOI 10.1088/0031-9155/60/12/4719; Yang ZX, 2012, NEURORADIOLOGY, V54, P451, DOI 10.1007/s00234-011-0900-0; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang H, 2017, J CEREBR BLOOD F MET, V37, P3422, DOI 10.1177/0271678X17690165; Zhang ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19026; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	35	8	8	0	6	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	OCT	2019	9	10			SI		1652	+		10.21037/qims.2019.09.08			15	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	JI8XV	WOS:000493747500004	31728309	Green Published, gold			2022-02-06	
J	Matharu, D; Dhotre, D; Balasubramanian, N; Pawar, N; Sagarkar, S; Sakharkar, A				Matharu, Dollwin; Dhotre, Dhiraj; Balasubramanian, Nagalakshmi; Pawar, Namrata; Sagarkar, Sneha; Sakharkar, Amul			Repeated mild traumatic brain injury affects microbial diversity in rat jejunum	JOURNAL OF BIOSCIENCES			English	Article						Gut microbiota; gut-brain axis; mild traumatic brain injury; Proteobacteria; jejunum; 16S rRNA amplicon	HELICOBACTER-PYLORI INFECTION; CHAIN FATTY-ACIDS; GUT-MICROBIOTA; BUTYRATE; ANXIETY; STRESS; AXIS; SYSTEM; MICROORGANISMS; DYSBIOSIS	Traumatic brain injuries (TBI) manifest into post-traumatic stress disorders such as anxiety comorbid with gut ailments. The perturbations in gut microbial communities are often linked to intestinal and neuropsychological disorders. We have previously reported anxiety and abnormalities in gut function in mild TBI (MTBI)-exposed rats. The current study demonstrates the changes in gut microbiome of MTBI-exposed animals and discusses its implications in intestinal health and behaviours. The rats were subjected to repeated MTBI (rMTBI) and microbial composition in jejunum was examined after 6 h, 48 h and 30 days of rMTBI. Significant reduction in bacterial diversity was observed in the rMTBI-exposed animals at all the time points. Principal coordinate analysis based on weighted UniFrac distances indicated substantial differences in gut microbial diversity and abundances in rMTBI-exposed animals as compared to that in healthy controls. The abundance of Proteobacteria increased dramatically with reciprocal decrease in Firmicutes after rMTBI. At the genus level, Helicobacter, Lactobacillus, Campylobacter, and Streptococcus were found to be differentially abundant in the jejunum of rMTBI-exposed rats as compared to sham controls indicating profound dysbiosis from the healthy state. Furthermore, substantial depletion in butyrate-producing bacterial communities was observed in rMTBI-exposed animals. These results suggest that the traumatic stress alters the gut microbiome with possible implications in gut health and neuropsychopathology.	[Matharu, Dollwin; Balasubramanian, Nagalakshmi; Pawar, Namrata; Sagarkar, Sneha; Sakharkar, Amul] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India; [Dhotre, Dhiraj] Natl Ctr Cell Sci, Natl Ctr Microbial Resource, Pune 411007, Maharashtra, India		Sagarkar, S; Sakharkar, A (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	ssneha1102@gmail.com; amul.sakharkar@unipune.ac.in			University Grants Commission, Government of India (UGC, GOI) [F.4-5/151-FRP/2014/BSR]; Science and Engineering Research Board (SERB, GOI) [EMR/2017/000621]; Council for Scientific and Industrial Research (CSIR, GOI) [37(1718)/18/EMR-II]; University Research Grant Scheme, Savitribai Phule Pune University (SPPU); DST-PURSE, SPPU; Department Research and Development Program (DRDP), Department of Biotechnology, Savitribai Phule Pune University; UGC-GOIUniversity Grants Commission, India [2061330923]	This work was supported by the grants from the University Grants Commission, Government of India (UGC, GOI; F.4-5/151-FRP/2014/BSR); Science and Engineering Research Board (SERB, GOI, EMR/2017/000621); Council for Scientific and Industrial Research (CSIR, GOI, 37(1718)/18/EMR-II); University Research Grant Scheme, Savitribai Phule Pune University (SPPU) and DST-PURSE, SPPU to AJS. AJS also acknowledges funds received through the Department Research and Development Program (DRDP), Department of Biotechnology, Savitribai Phule Pune University. NB thanks UGC-GOI for the award of Junior Research Fellowship (File No. 2061330923).	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Andrews S., 2010, BABRAHAM BIOINFORMAT; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bartels LE, 2016, J CROHNS COLITIS, V10, P443, DOI 10.1093/ecco-jcc/jjv229; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Bourassa MW, 2016, NEUROSCI LETT, V625, P56, DOI 10.1016/j.neulet.2016.02.009; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Cenit MC, 2017, WORLD J GASTROENTERO, V23, P5486, DOI 10.3748/wjg.v23.i30.5486; Chen Guang-Hua, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P526; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinan TG, 2017, NAT REV GASTRO HEPAT, V14, P69, DOI 10.1038/nrgastro.2016.200; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Esquivel-Elizondo S, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00051-17; Evrensel A, 2015, CLIN PSYCHOPHARM NEU, V13, P239, DOI 10.9758/cpn.2015.13.3.239; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Grochowska M, 2018, ACTA NEUROBIOL EXP, V78, P69, DOI 10.21307/ane-2018-008; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Howard Benjamin M, 2017, Trauma Surg Acute Care Open, V2, pe000108, DOI 10.1136/tsaco-2017-000108; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Kopylova E, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00003-15; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Logsdon AF, 2018, EXP BIOL MED, V243, P159, DOI 10.1177/1535370217743766; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayer EA, 2000, GUT, V47, P861, DOI 10.1136/gut.47.6.861; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Papamichael K, 2014, WORLD J GASTROENTERO, V20, P6374, DOI 10.3748/wjg.v20.i21.6374; Pozuelo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12693; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sagarkar S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13074; Sagarkar S, 2019, BRAIN RES, V1711, P183, DOI 10.1016/j.brainres.2019.01.022; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; SCHMITT MG, 1976, GASTROENTEROLOGY, V70, P211; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sheh A, 2013, GUT MICROBES, V4, P505, DOI 10.4161/gmic.26205; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Smith Katherine, 2013, Nat Rev Gastroenterol Hepatol, V10, P260, DOI 10.1038/nrgastro.2013.68; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; TANNOCK GW, 1974, INFECT IMMUN, V9, P591, DOI 10.1128/IAI.9.3.591-598.1974; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whittle N, 2014, BIOCHEM SOC T, V42, P569, DOI 10.1042/BST20130233; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	81	8	9	0	9	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0250-5991	0973-7138		J BIOSCIENCES	J. Biosci.	OCT	2019	44	5							120	10.1007/s12038-019-9940-0			12	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	IZ5QI	WOS:000487137800003					2022-02-06	
J	Terry, DP; Mewborn, CM; Miller, LS				Terry, Douglas P.; Mewborn, Catherine M.; Miller, L. Stephen			Repeated Sport-Related Concussion Shows Only Minimal White Matter Differences Many Years After Playing High School Football	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Diffusion tensor imaging; Former athletes; mTBI; Middle age; Cognition	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL STATUS RBANS; TENSOR IMAGING FINDINGS; COGNITIVE DYSFUNCTION; AXONAL INJURY; SPATIAL STATISTICS; CORPUS-CALLOSUM; DIFFUSION; MILD; ABNORMALITIES	Objective: Multiple concussions sustained in youth sport may be associated with later-life brain changes and worse cognitive outcomes. We examined the association between two or more concussions during high school football and later-life white matter (WM) microstructure (i.e., 22-47 years following football retirement) using diffusion tensor imaging (DTI). Method: Forty former high school football players aged 40-65 who received 2+ concussions during high school football (N = 20), or denied concussive events (N = 20) were recruited. Participants underwent neurocognitive testing and DTI scanning. Results: Groups did not statistically differ on age, education, or estimated pre-morbid intelligence. Tract-based Spatial Statistics (TBSS) correcting for Family-Wise Error (FWE)(p < .05) did not yield differences between groups at the whole-brain level. Region of interest analyses showed higher mean diffusivity (MD) in the anterior limb of the internal capsule (ALIC) in the concussed group compared to the non-concussed former players. More liberal analyses (i.e., p < .001, uncorrected for multiple comparisons, >= 8 voxels) also revealed that former players endorsing 2+ concussions had higher MD in the ALIC. Analyses that covaried for age did not reveal differences at either threshold. Concussive histories were not associated with worse cognitive functioning, nor did it impact the relationship between neuropsychological scores and DTI metrics. Discussion: Results suggest only minimal neuroanatomical brain differences in former athletes many years following original concussive injuries compared to controls.	[Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02129 USA; [Mewborn, Catherine M.; Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA		Miller, LS (corresponding author), Univ Georgia, 125 Baldwin St,Psychol Bldg Rm 202, Athens, GA 30602 USA.	lsmiller@uga.edu		Miller, L. Stephen/0000-0002-2181-0876			Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Green P., 2004, MED SYMPTOM VALIDITY; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hayes A.F., 2013, METHODOLOGY SOCIAL S; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Terry DP, 2015, ARCH CLIN NEUROPSYCH, V30, P341, DOI 10.1093/arclin/acv020; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Weinberger DR, 2016, AM J PSYCHIAT, V173, P27, DOI 10.1176/appi.ajp.2015.15060753; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	65	8	8	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2019	25	9					950	960	PII S1355617719000754	10.1017/S1355617719000754			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	JB3VM	WOS:000488484800006	31383046				2022-02-06	
J	Vedin, T; Svensson, S; Edelhamre, M; Karlsson, M; Bergenheim, M; Larsson, PA				Vedin, Tomas; Svensson, Sebastian; Edelhamre, Marcus; Karlsson, Mathias; Bergenheim, Mikael; Larsson, Per-Anders			Management of mild traumatic brain injury-trauma energy level and medical history as possible predictors for intracranial hemorrhage	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Brain injuries; Traumatic; Epidemiology; Practice guidelines as topic; Intracranial hemorrhage; Traumatic; S100B Calcium Binding Protein Beta Subunit	COMPUTED-TOMOGRAPHY; EPIDEMIOLOGY; MODERATE	Purpose Head trauma is common in the emergency department. Identifying the few patients with serious injuries is time consuming and leads to many computerized tomographies (CTs). Reducing the number of CTs would reduce cost and radiation. The aim of this study was to evaluate the characteristics of adults with head trauma over a 1-year period to identify clinical features predicting intracranial hemorrhage. Methods Medical record data have been collected retrospectively in adult patients with traumatic brain injury. A total of 1638 patients over a period of 384 days were reviewed, and 33 parameters were extracted. Patients with high-energy multitrauma managed with ATLS (TM) were excluded. The analysis was done with emphasis on patient history, clinical findings, and epidemiological traits. Logistic regression and descriptive statistics were applied. Results Median age was 58 years (18-101, IQR 35-77). High age, minor head injury, new neurological deficits, and low trauma energy level correlated with intracranial hemorrhage. Patients younger than 59 years, without anticoagulation or antiplatelet therapy who suffered low-energy trauma, had no intracranial hemorrhages. The hemorrhage frequency in the entire cohort was 4.3% (70/1638). In subgroup taking anticoagulants, the frequency of intracranial hemorrhage was 8.6% (10/116), and in the platelet-inhibitor subgroup, it was 11.8% (20/169). Conclusion This study demonstrates that patients younger than 59 years with low-energy head trauma, who were not on anticoagulants or platelet inhibitors could possibly be discharged based on patient history. Maybe, there is no need for as extensive medical examination as currently recommended. These findings merit further studies.	[Vedin, Tomas; Svensson, Sebastian; Edelhamre, Marcus; Larsson, Per-Anders] Lund Univ, Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden; [Karlsson, Mathias] Karolinska Inst, Cent Sjukshuset & Karlstad, Rosenborgsgatan 9, S-65230 Karlstad, Sweden; [Bergenheim, Mikael] Umea Univ, Cent Sjukshuset & Karlstad, Rosenborgsgatan 9, S-65230 Karlstad, Sweden		Vedin, T (corresponding author), Lund Univ, Clin Sci, Svartbrodragranden 3-5, S-25187 Helsingborg, Sweden.	tvedin@gmail.com; Sebastian.svensson@skane.se; marcus_e@telia.com; mathias.karlsson@liv.se; Mikael.bergenheim@liv.se; P-a.larsson@telia.com		Vedin, Tomas/0000-0003-1913-7958	Gorthon Foundation, Helsingborg	This work was supported by the Gorthon Foundation, Helsingborg.	af Geijerstam J, 2005, CRIT CARE, V9, pP281; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Brenner David J., 2010, Reviews on Environmental Health, V25, P63; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Goldberg J, 2011, J PEDIATR SURG, V46, P1777, DOI 10.1016/j.jpedsurg.2011.02.052; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Network TBI, 2016, TRAUM BRAIN INJ NETW; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Webster NJ, 2017, ADV EMERG NURS J, V39, P300, DOI 10.1097/TME.0000000000000169	21	8	8	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2019	45	5					901	907		10.1007/s00068-018-0941-8			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JD5FT	WOS:000490009600017	29550926	hybrid, Green Published			2022-02-06	
J	Weber, ML; Lynall, RC; Hoffman, NL; Miller, EH; Kaminski, TW; Buckley, TA; Benjamin, HJ; Miles, CM; Whitlow, CT; Lintner, L; Broglio, SP; McCrea, M; McAllister, T; Schmidt, JD; Hoy, AM; Hazzard, JB; Kelly, LA; Ortega, JD; Port, N; Putukian, M; Langford, TD; Tierney, R; Campbell, DE; McGinty, G; O'Donnell, P; Buckley, T; Clugston, JR; Feigenbaum, LA; Eckner, JT; Guskiewicz, K; Mihalik, JP; Miles, JD; Master, CL; Collins, M; Kontos, AP; Bazarian, JJ; Chrisman, SPD; Bullers, CT; Miles, CM; Dykhuizen, BH				Weber, M. L.; Lynall, R. C.; Hoffman, N. L.; Miller, E. H.; Kaminski, T. W.; Buckley, T. A.; Benjamin, H. J.; Miles, C. M.; Whitlow, C. T.; Lintner, L.; Broglio, S. P.; McCrea, M.; McAllister, T.; Schmidt, J. D.; Hoy, April Marie (Reed); Hazzard, Joseph B., Jr.; Kelly, Louise A.; Ortega, Justus D.; Port, Nicholas; Putukian, Margot; Langford, T. Dianne; Tierney, Ryan; Campbell, Darren E.; McGinty, Gerald; O'Donnell, Patrick; Buckley, Thomas; Clugston, James R.; Feigenbaum, Luis A.; Eckner, James T.; Guskiewicz, Kevin; Mihalik, Jason P.; Miles, Jessica Dysart; Master, Christina L.; Collins, Micky; Kontos, Anthony P.; Bazarian, Jeffrey J.; Chrisman, Sara P. D.; Bullers, Christopher Todd; Miles, Christopher M.; Dykhuizen, Brian H.		CARE Consortium Investigators	Health-Related Quality of Life Following Concussion in Collegiate Student-Athletes With and Without Concussion History	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Sport-related concussion; Mild traumatic brain injury; Short-Form 12; Hospital anxiety and depression scale	EXTREMITY MUSCULOSKELETAL INJURY; CLINICAL-OUTCOMES ASSESSMENT; NEUROCOGNITIVE PERFORMANCE; SUBSEQUENT INJURY; HOSPITAL ANXIETY; RISK; DEPRESSION; INCREASES; IMPACT; MANAGEMENT	The purpose of this study was to compare global and specific health-related quality of life (HRQOL) throughout concussion recovery between those with and without concussion history. Student-athletes diagnosed with concussion completed global (Short Form-12v2; SF-12) and specific (Hospital Anxiety and Depression Scale: HADS) HRQOL assessments at baseline, 24-48 h, asymptomatic, return-to- play, and 6-months post-injury. Baseline scores were compared to post-injury time points for SF-12 subscores (physical and mental; PCS-12, MCS-12) and HADS subscores (depression and anxiety; HADS-D, HADS-A). We conducted a 2 9 5 mixed model ANOVA for group (with and without concussion history) and time (four post-injury assessments compared to baseline). We did not observe interaction or main effects for group, except those with concussion history had worse HADS-D subscores than those without concussion history. PCS-12 subscores were worse at 24-48 h, asymptomatic, and return-to-play compared to baseline, but returned to baseline 6-months post-injury. MCS-12 subscores did not differ at any time points. HADS-D subscores worsened 2448 h post-injury, but improved for additional assessments compared to baseline. HADS-A improved post-injury compared to baseline at asymptomatic, return-to-play, and 6-month assessments, but was similar to baseline 24-48 h post-injury. HRQOL physical aspects slightly worsened post-injury and restored to baseline after returning to play.	[Weber, M. L.; Lynall, R. C.; Miller, E. H.; Schmidt, J. D.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, Athens, GA 30602 USA; [Hoffman, N. L.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61761 USA; [Kaminski, T. W.; Buckley, T. A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Benjamin, H. J.] Univ Chicago, Orthopaed Surg Rehabil Med & Pediat, Chicago, IL 60637 USA; [Miles, C. M.; Lintner, L.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC 27101 USA; [Whitlow, C. T.] Wake Forest Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC 27101 USA; [Whitlow, C. T.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Broglio, S. P.] Univ Michigan, Injury Ctr, NeuroTruama Res Lab, Ann Arbor, MI 48109 USA; [McCrea, M.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, T.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Hoy, April Marie (Reed)] Azusa Pacific Univ, Azusa, CA 91702 USA; [Hazzard, Joseph B., Jr.] Bloomsburg Univ, Bloomsburg, PA USA; [Kelly, Louise A.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Ortega, Justus D.] Humboldt State Univ, Arcata, CA 95521 USA; [Port, Nicholas] Indiana Univ, Bloomington, IN 47405 USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Langford, T. Dianne; Tierney, Ryan] Temple Univ, Philadelphia, PA 19122 USA; [Campbell, Darren E.; McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [O'Donnell, Patrick] US Coast Guard Acad, New London, CT USA; [Benjamin, H. J.] Univ Chicago, Chicago, IL 60637 USA; [Kaminski, T. W.; Buckley, Thomas] Univ Delaware, Newark, DE 19716 USA; [Clugston, James R.] Univ Florida, Gainesville, FL 32611 USA; [Schmidt, J. D.] Univ Georgia, Athens, GA 30602 USA; [Feigenbaum, Luis A.] Univ Miami, Coral Gables, FL 33124 USA; [Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Guskiewicz, Kevin; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Miles, Jessica Dysart] Univ North Georgia, Dahlonega, GA USA; [Master, Christina L.] Univ Penn, Philadelphia, PA 19104 USA; [Collins, Micky; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Bazarian, Jeffrey J.] Univ Rochester, Rochester, NY 14627 USA; [Chrisman, Sara P. D.] Univ Washington, Seattle, WA 98195 USA; [Bullers, Christopher Todd; Miles, Christopher M.] Wake Forest Univ, Winston Salem, NC 27101 USA; [Dykhuizen, Brian H.] Wilmington Coll, Wilmington, OH USA		Weber, ML (corresponding author), Univ Georgia, Dept Kinesiol, Concuss Res Lab, Athens, GA 30602 USA.	mlw76648@uga.edu	Buckley, Thomas A/B-7525-2016; Lynall, Robert/M-2888-2014	Buckley, Thomas A/0000-0002-0515-0150; Lynall, Robert/0000-0002-0785-6640; Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DOD); U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-20151]	This project was supported, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-20151. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds).	[Anonymous], 2001, CROSSING QUALITY CHA; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cho CH, 2015, CLIN ORTHOP RELAT R, V473, P3494, DOI 10.1007/s11999-015-4258-1; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Da Silva-Gane M, 2012, CLIN J AM SOC NEPHRO, V7, P2002, DOI 10.2215/CJN.01130112; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Hyodo I, 1999, SUPPORT CARE CANCER, V7, P396, DOI 10.1007/s005200050299; Jalan R, 1995, J HEPATOL, V23, P697, DOI 10.1016/0168-8278(95)80036-0; Kemp S., 2015, BRIT J SPORT MED, V2015; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kosinski M., 1995, SF 12 SCORE SF 12 PH; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Leach CA, 2013, ATHL TRAIN SPORTS HL, V5, P115; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Martens EJ, 2009, EVID-BASED MENT HEAL, V12, P8, DOI 10.1136/ebmh.12.1.8; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; National Collegiate Athletic Association, 2014, CONC MAN DIAGN BEST; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Parker SL, 2012, J NEUROSURG-SPINE, V16, P471, DOI 10.3171/2012.1.SPINE11842; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SF-12v2 Health Survey, 2000, SCOR SF 12V2 SUMM ME; Smid DE, 2017, J AM MED DIR ASSOC, V18, P53, DOI 10.1016/j.jamda.2016.08.002; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Steer J, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2014-000069; Stocker RPJ, 2017, ARCH CLIN NEUROPSYCH, V32, P349, DOI 10.1093/arclin/acx003; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P219; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	8	8	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2136	2146		10.1007/s10439-018-02151-7			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	JQ0HT	WOS:000498636800010	30302664				2022-02-06	
J	Zheng, HJ; Hu, SS; Cao, J; Yao, LF; Zhang, N				Zheng, Huajiang; Hu, Shanshan; Cao, Jin; Yao, Lufeng; Zhang, Nan			Long non-coding RNA TUG1 alleviates LPS-induced injury of PC-12 cells by down-regulating microRNA-127	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						Spinal cord injury; lncRNA TUG1; microRNA-127; Inflammatory injury; NF-kappa B/p38MAPK	SPINAL-CORD-INJURY; INFLAMMATORY RESPONSE; TRAUMATIC BRAIN; LNCRNA TUG1; APOPTOSIS; ACTIVATION; CANCER; CONTRIBUTES; EXPRESSION; PROTECTS	The limited therapeutic strategies and the unsatisfied prognosis for spinal cord injury (SCI) make the identification of innovative therapeutic targets for SCI become very urgent. Herein, we explored the role of long non cording RNA taurine up-regulated gene 1 (lncRNA TUG1) in lipopolysaccharide (LPS)-treated PC-12 cells and studied the downstream effector and signaling cascades. We found that LPS-induced decrease of cell viability, increase of apoptosis and release of IL-6 and TNF-alpha were mitigated by TUG1 overexpression. MicroRNA (miR-127) was negatively regulated by TUG1. Effects of TUG1 on LPS-treated PC-12 cells were reversed by miR-127 overexpression. Besides, TUG1 inactivated NF-kappa B and p38MAPK pathways in LPS-treated PC-12 cells via down regulating miR-127. Dynactin 4 and protein tyrosine phosphatase (PTP) were the target genes of miR-127. miR-127 regulated the NF-kappa B and p38MAPK pathways in PC-12 cells at least by targeting dynactin 4 and PTP. In conclusion, we discovered that TUG1 alleviated LPS-induced PC-12 cell inflammatory injury might be through down-regulating miR-127, influencing dynactin 4 and PTP, and then inactivating NF-kappa B and p38MAPK pathways.	[Zheng, Huajiang; Hu, Shanshan; Cao, Jin; Yao, Lufeng; Zhang, Nan] Ningbo 6 Hosp, Dept Orthoped, Ningbo 315040, Zhejiang, Peoples R China		Cao, J (corresponding author), Ningbo 6 Hosp, Dept Orthoped, Ningbo 315040, Zhejiang, Peoples R China.	caojin0290@sina.com					Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Babu J, 2018, ESSENTIAL ORTHOPEDIC, P227; Burgess KS, 2018, CLIN PHARMACOL THER, V104, P130, DOI 10.1002/cpt.892; Cao JQ, 2017, INT J ONCOL, V51, P1115, DOI 10.3892/ijo.2017.4110; Chen DY, 2018, MOL MED REP, V17, P1340, DOI 10.3892/mmr.2017.7987; Cong L, 2016, BASIC CLIN PHARMACOL, V119, P193, DOI 10.1111/bcpt.12562; Crown ED, 2008, EXP NEUROL, V213, P257, DOI 10.1016/j.expneurol.2008.05.025; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Gomes CPC, 2017, MOL THER-NUCL ACIDS, V8, P494, DOI 10.1016/j.omtn.2017.07.014; Gu SX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040732; Guan JW, 2017, ONCOL LETT, V14, P4965, DOI 10.3892/ol.2017.6771; Gum RJ, 2003, MOL ENDOCRINOL, V17, P1131, DOI 10.1210/me.2002-0288; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Han X, 2012, NEUROSCI LETT, V511, P28, DOI 10.1016/j.neulet.2012.01.030; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li J, 2016, EXP BIOL MED, V241, P644, DOI 10.1177/1535370215622708; Li P, 2016, AM J TRANSL RES, V8, P1935; Li Q, 2017, MOL MED REP, V16, P4119, DOI 10.3892/mmr.2017.7109; Liang ZY, 2018, BIOMED PHARMACOTHER, V103, P897, DOI 10.1016/j.biopha.2018.04.085; Liu XZ, 1997, J NEUROSCI, V17, P5395; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk K. H. K, 2017, CHALLENGING TOPICS N, P83; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Noble BT, 2018, J NEUROIMMUNOL, V321, P1, DOI 10.1016/j.jneuroim.2018.05.007; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Rong FJ, 2018, EXP THER MED, V15, P4191, DOI 10.3892/etm.2018.5973; Rust R, 2017, J NEUROSCI, V37, P4658, DOI 10.1523/JNEUROSCI.0498-17.2017; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shi L, 2017, ONCOGENE, V36, P1631, DOI 10.1038/onc.2016.332; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; Su S, 2016, FEBS J, V283, P1261, DOI 10.1111/febs.13660; Yao ZC, 2018, BIOMED PHARMACOTHER, V104, P102, DOI 10.1016/j.biopha.2018.05.006; Yin DD, 2015, CELL PHYSIOL BIOCHEM, V35, P1892, DOI 10.1159/000373999; Ying HJ, 2015, J IMMUNOL, V194, P1239, DOI 10.4049/jimmunol.1402088; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhang HF, 2018, BIOMED PHARMACOTHER, V101, P663, DOI 10.1016/j.biopha.2018.02.129; Zhang ZQ, 2017, BIOMED PHARMACOTHER, V96, P1154, DOI 10.1016/j.biopha.2017.11.107; Zhou HJ, 2018, AM J PHYSIOL-CELL PH, V315, pC52, DOI 10.1152/ajpcell.00278.2017	40	8	9	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	OCT	2019	110								104287	10.1016/j.yexmp.2019.104287			8	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	JA9BD	WOS:000488144100021	31326411				2022-02-06	
J	Prescott, RJ				Prescott, Robin J.			Two-tailed significance tests for 2 x 2 contingency tables: What is the alternative?	STATISTICS IN MEDICINE			English	Article						alternative hypotheses; Fisher's exact test; two-tailed tests; 2 x 2 contingency tables	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY	Two-tailed significance testing for 2 x 2 contingency tables has remained controversial. Within the medical literature, different tests are used in different papers and that choice may decide whether findings are adjudged to be significant or nonsignificant; a state of affairs that is clearly undesirable. In this paper, it is argued that a part of the controversy is due to a failure to recognise that there are two possible alternative hypotheses to the Null. It is further argued that, while one alternative hypothesis can lead to tests with greater power, the other choice is more applicable in medical research. That leads to the recommendation that, within medical research, 2 x 2 tables should be tested using double the one-tailed exact probability from Fisher's exact test or, as an approximation, the chi-squared test with Yates' correction for continuity.	[Prescott, Robin J.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Studies, Edinburgh EH8 9YL, Midlothian, Scotland		Prescott, RJ (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Studies, Edinburgh EH8 9YL, Midlothian, Scotland.	robin.prescott@ed.ac.uk		Prescott, Robin/0000-0002-3266-0797			[Anonymous], 1999, STAT MED, V18, P1905; Bernard SA, 2015, EMERG MED J, V32, P60, DOI 10.1136/emermed-2013-202930; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Gschwantler-Kaulich D, 2016, EJSO-EUR J SURG ONC, V42, P665, DOI 10.1016/j.ejso.2016.02.007; Heschl S, 2018, INJURY, V49, P916, DOI 10.1016/j.injury.2018.02.013; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson S, 2018, LANCET, V392, P409, DOI 10.1016/S0140-6736(18)31470-3; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Martin Bland Bland M., 2015, INTRO MED STAT, V4th; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Prescott RJ, 2019, GAIT POSTURE, V72, P240, DOI 10.1016/j.gaitpost.2018.06.172; Senn S., 2007, STAT ISSUES DRUG DEV, V2nd; Terpstra T.J., 1952, INDAGATIONES MATH, V55, P327, DOI 10. 1016/S1385-7258(52)50043-X.; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577; Yates F., 1934, J R STAT SOC, V1, P217, DOI DOI 10.2307/2983604	16	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	SEP 30	2019	38	22					4264	4269		10.1002/sim.8294			6	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	IW4UC	WOS:000484974200008	31264237	Green Submitted			2022-02-06	
J	Chen, P; Zhang, HG; Zhang, QT; Zhou, W; Deng, YB; Hu, X; Zhang, LY				Chen, Peng; Zhang, Hongguang; Zhang, Qingtao; Zhou, Wei; Deng, Yongbing; Hu, Xi; Zhang, Lianyang			Basic Fibroblast Growth Factor Reduces Permeabiliy and Apoptosis of Human Brain Microvascular Endothelial Cells in Response to Oxygen and Glucose Deprivation Followed by Reoxygenation via the Fibroblast Growth Factor Receptor 1 (FGFR1)/ERK Pathway	MEDICAL SCIENCE MONITOR			English	Article						Blood-Brain Barrier; Brain Injuries; Receptor,Fibroblast Growth Factor,Type 2	TRAUMATIC BRAIN; SUBARACHNOID HEMORRHAGE; BARRIER DISRUPTION; INJURY; NEUROGENESIS; CONTRIBUTES; INTEGRITY; RECOVERY; RELEASE; VEGF	Background: Disruption of the blood-brain barrier (BBB) is a mechanism in the pathogenesis of traumatic brain injury. Basic fibroblast growth factor (bFGF) is expressed in angiogenesis, neurogenesis, and neuronal survival. This study aimed to investigate the role of bFGF in vitro in human brain microvascular endothelial cells (HBMECs) challenged by oxygen-glucose deprivation/reperfusion (OGD/R). Material/Methods: HBMECs were cultured in glucose-free medium and an environment with <0.5% oxygen in an anaerobic chamber. Immunocytochemistry, Western blot, and quantitative reverse transcription-polymerase chain reaction (qRTPCR) were used to measure the protein and mRNA expression levels of bFGF, tight junction, adherens junction, apoptotic proteins, and matrix metalloproteinases (MMPs). The effects of bFGF on the viability of HBMECs was evaluated using the cell counting kit-8 (CCK-8) assay. Cell apoptosis was evaluated using the TUNEL assay, and endothelial permeability was quantified using a transwell migration assay with fluorescein isothio-cyanate (FITC) conjugated with dextran. The effects of bFGF were evaluated following inhibition of fibroblast growth factor receptor 1 (FGFR1) with PD173074 and inhibition of ERK with PD98059. Results: Following OGD/R of HBMECs, bFGF significantly reduced cell permeability and apoptosis and significantly inhibited the down-regulation of the expressions of proteins associated with tight junctions, adherens junctions, apoptosis and matrix metalloproteinases (MMPs). The effects of bFGF were mediated by the activation of FGFR1 and ERK, as they were blocked by FGFR1 and ERK inhibitors. Conclusions: Permeability and apoptosis of HBMECs challenged by OGD/R were reduced by bFGF by activation of the FGFR1 and the ERK pathway.	[Chen, Peng; Zhang, Hongguang; Zhang, Lianyang] Army Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Trauma Ctr,Peoples Liberat Army PLA, Chongqing, Peoples R China; [Chen, Peng; Zhang, Qingtao; Zhou, Wei; Deng, Yongbing; Hu, Xi] Chongqing Emergency Med Ctr, Dept Neurosurg, Chongqing, Peoples R China		Zhang, LY (corresponding author), Army Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Trauma Ctr,Peoples Liberat Army PLA, Chongqing, Peoples R China.	dpzhangly@163.com			Foundation of the Program of Technology of Education Committee of Chongqing [KJQN201800122]; Program of Technology of Science and Technology Committee of Yuzhong District in Chongqing [20180131]	The study was supported by the Foundation of the Program of Technology of Education Committee of Chongqing (No. KJQN201800122) and the Program of Technology of Science and Technology Committee of Yuzhong District in Chongqing (No. 20180131)	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Langford D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-8; Li QX, 2018, WORLD NEUROSURG, V117, pE117, DOI 10.1016/j.wneu.2018.05.202; Lin L, 2018, MOL NEUROBIOL, V55, P3131, DOI 10.1007/s12035-017-0544-0; Liu Y, 2014, MOL MED REP, V9, P333, DOI 10.3892/mmr.2013.1803; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Nakamura K, 2016, BRAIN RES, V1630, P98, DOI 10.1016/j.brainres.2015.11.003; Narasimhan P, 2009, STROKE, V40, P1467, DOI 10.1161/STROKEAHA.108.534644; Nasser M, 2016, CNS NEUROL DISORD-DR, V15, P1030, DOI 10.2174/1871527315666160815093525; Nishikawa H, 2018, STROKE, V49, P2743, DOI 10.1161/STROKEAHA.118.021757; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Olczak M, 2019, FORENSIC SCI INT, V301, P28, DOI 10.1016/j.forsciint.2019.05.010; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Raballo R, 2000, J NEUROSCI, V20, P5012; Rosen L, 2000, Oncologist, V5 Suppl 1, P20; Sulhan S, 2018, J NEUROSCI RES; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5; Ye LB, 2016, NEUROTHERAPEUTICS, V13, P844, DOI 10.1007/s13311-016-0437-3	31	8	8	2	10	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	SEP 25	2019	25						7191	7201		10.12659/MSM.918626			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JB1CQ	WOS:000488297700001	31551405	Green Published			2022-02-06	
J	Houck, ZM; Asken, BM; Bauer, RM; Caccese, JB; Buckley, TA; McCrea, MA; McAllister, TW; Broglio, SP; Clugston, JR				Houck, Zachary M.; Asken, Breton M.; Bauer, Russell M.; Caccese, Jaclyn B.; Buckley, Thomas A.; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.; Clugston, James R.		Care Consortium Investigators	Academic aptitude mediates the relationship between socioeconomic status and race in predicting ImPACT scores in college athletes	CLINICAL NEUROPSYCHOLOGIST			English	Article						Cognitive functioning; sociodemographic factors; repetitive head impact exposure; CARE consortium; concussion	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; RACIAL DISPARITIES; READING LEVEL; LATER-LIFE; CONCUSSION; EDUCATION; FOOTBALL; LITERACY; SCHOOL; HEAD	Objective: To evaluate the influences of sociodemographic factors, estimated head impact exposure, and academic aptitude on ImPACT scores in college athletes. Methods: Data were reported on 18,886 participants (58% male) from the NCAA/DoD CARE Consortium. Race, SES, concussion history, estimated repetitive head impact exposure (eRHIE), and academic aptitude (SAT or ACT score) were our predictors of interest. Cognition was measured using ImPACT composite scores. We evaluated the mediating effects of academic aptitude on sociodemographic predictors and eRHIE on ImPACT scores. We then evaluated a football-only subsample and added age of first exposure to football (AFE) to the model. Males, females, and football players were analyzed separately using structural equation modeling. Results: Academic aptitude was associated with Black/African American race, SES, and each of the ImPACT composite scores. There were significant indirect effects of Black/African American race and SES on all ImPACT composite scores. Academic aptitude fully mediated SES effects and either fully or partially mediated race effects. Contrary to expectation, greater concussion history and eRHIE predicted better ImPACT scores. Conclusions: Academic aptitude, a stable indicator of premorbid cognitive function, consistently and most strongly predicted baseline ImPACT scores in collegiate student-athletes. Concussion and eRHIE history demonstrated a small positive, but non-significant, relationship with cognitive scores at the time of college athletic participation. This study suggests that attempts to characterize cognitive ability across the lifespan must consider premorbid functioning and sociodemographic variables.	[Houck, Zachary M.; Asken, Breton M.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Asken, Breton M.] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA; [Caccese, Jaclyn B.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Wauwatosa, WI USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA		Houck, ZM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	zhouck@phhp.ufl.edu	Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603; Clugston, James/0000-0002-2103-1039; Bauer, Russell/0000-0001-6807-2535; Asken, Breton/0000-0001-8419-142X	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense (DHP funds).	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alvarez-Bueno C, 2017, J AM ACAD CHILD PSY, V56, P729, DOI 10.1016/j.jaac.2017.06.012; [Anonymous], 2017, NATL DISTRIBUTIONS C; [Anonymous], 2017, PERCENTILES TOTAL SA; [Anonymous], 2018, SCHOLASTIC APTITUDE; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Brewster PWH, 2014, NEUROPSYCHOLOGY, V28, P846, DOI 10.1037/neu0000098; Bright P, 2018, NEUROPSYCHOL REHABIL, V28, P1019, DOI 10.1080/09602011.2016.1231121; BRODNICK RJ, 1995, EDUC PSYCHOL MEAS, V55, P583, DOI 10.1177/0013164495055004006; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Cole JS, 2010, RES HIGH EDUC, V51, P305, DOI 10.1007/s11162-009-9160-9; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dotson VM, 2009, J INT NEUROPSYCH SOC, V15, P580, DOI 10.1017/S1355617709090821; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.2307/1131385; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; HEATON RK, 1991, COMPREHENSIVE NORM S; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Houck Z. M., J INT NEUROPSYCHOLOG; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jefferson AL, 2011, J AM GERIATR SOC, V59, P1403, DOI 10.1111/j.1532-5415.2011.03499.x; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Larrabee G. J., 2015, NEUROLOGY; Liu SY, 2015, J INT NEUROPSYCH SOC, V21, P677, DOI 10.1017/S1355617715000806; Lovell M, 2000, IMPACT IMMEDIATE POS; Manly JJ, 1999, J INT NEUROPSYCH SOC, V5, P191, DOI 10.1017/S135561779953302X; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; NEVINS D, 2018, ATHLETIC TRAINING SP, V11, P174, DOI DOI 10.3928/19425864-20180802-02; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Rohit M, 2007, J INT NEUROPSYCH SOC, V13, P462, DOI 10.1017/S1355617707070506; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Ryan EL, 2005, J INT NEUROPSYCH SOC, V11, P889, DOI 10.1017/S1355617705051040; Sayegh P, 2014, ARCH CLIN NEUROPSYCH, V29, P731, DOI 10.1093/arclin/acu059; Sisco S, 2015, J GERONTOL B-PSYCHOL, V70, P557, DOI 10.1093/geronb/gbt133; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Sone JY, 2018, J NEUROSURG-PEDIATR, V22, P1, DOI 10.3171/2018.1.PEDS17640; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern R. A., 2015, NEUROLOGY, DOI [10.1212/WNL.0000000000001358, DOI 10.1212/WNL.0000000000001358]; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; TIDES, 2016, NCAA COLL SPORT RAC; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Wechsler D, 2001, WTAR WECHSLER TEST A; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wilson RS, 2015, PSYCHOL AGING, V30, P279, DOI 10.1037/pag0000024; Womble MN, 2021, CLIN J SPORT MED, V31, pE193, DOI 10.1097/JSM.0000000000000761; Zahodne LB, 2017, PSYCHOL AGING, V32, P118, DOI 10.1037/pag0000154	65	8	8	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 2	2020	34	3					561	579		10.1080/13854046.2019.1666923		SEP 2019	19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KV3OJ	WOS:000487536500001	31549576				2022-02-06	
